<SEC-DOCUMENT>0001493152-24-043200.txt : 20241031
<SEC-HEADER>0001493152-24-043200.hdr.sgml : 20241031
<ACCEPTANCE-DATETIME>20241031161555
ACCESSION NUMBER:		0001493152-24-043200
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		124
CONFORMED PERIOD OF REPORT:	20240630
FILED AS OF DATE:		20241031
DATE AS OF CHANGE:		20241031

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTA GLOBAL GROUP LTD
		CENTRAL INDEX KEY:			0001981519
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41978
		FILM NUMBER:		241415433

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 1, SUITE 1, 29-33, THE CORSO
		CITY:			MANLY
		STATE:			C3
		ZIP:			2095
		BUSINESS PHONE:		61 1800 151 865

	MAIL ADDRESS:	
		STREET 1:		LEVEL 1, SUITE 1, 29-33, THE CORSO
		CITY:			MANLY
		STATE:			C3
		ZIP:			2095
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>form20-f.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:MMA="http://altaglobalgroup.com/20240630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_022_IFRS%2D2024%2D(with%2DECD) -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_MMA_altaglobalgroup.com_20240630 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20230701_20240630 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0001981519 -->
<!-- Field: Set; Name: xdx; ID: xdx_07A_XDX_form20%2Df.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<!-- Field: Set; Name: xdx; ID: xdx_063_AUD_0_iso4217%2D%2DAUD -->
<!-- Field: Set; Name: xdx; ID: xdx_077_SO_form20%2Df.xdxs -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000004" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000005" name="dei:EntityCentralIndexKey">0001981519</ix:nonNumeric>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0135" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0136" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0137" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:UnearnedRevenue" contextRef="AsOf2024-06-30" id="xdx2ixbrl0201" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:CurrentFinancialLiabilities" contextRef="AsOf2024-06-30" id="xdx2ixbrl0207" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilities" contextRef="AsOf2024-06-30" id="xdx2ixbrl0219" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:UnlistedOptionsReserve" contextRef="AsOf2023-06-30" id="xdx2ixbrl0247" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30_custom_UnlistedOptionReserveMember" id="xdx2ixbrl0259" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember" id="xdx2ixbrl0266" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0267" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0272" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember" id="xdx2ixbrl0273" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0274" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0276" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0279" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember" id="xdx2ixbrl0280" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0281" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0286" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember" id="xdx2ixbrl0287" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0289" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0290" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember" id="xdx2ixbrl0294" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0295" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0296" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0297" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfEquityFromConversionOfConvertibleNotes" contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember" id="xdx2ixbrl0301" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfEquityFromConversionOfConvertibleNotes" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0302" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfEquityFromConversionOfConvertibleNotes" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0303" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfEquityFromConversionOfConvertibleNotes" contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0304" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes" contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0307" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0309" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0310" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes" contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0311" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember" id="xdx2ixbrl0315" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0317" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0318" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0319" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IncreaseDecreaseThroughOptionsForfeited" contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0321" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IncreaseDecreaseThroughOptionsForfeited" contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember" id="xdx2ixbrl0322" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IncreaseDecreaseThroughOptionsForfeited" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0324" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:OverAllotmentOptionsLapsed" contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0328" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:OverAllotmentOptionsLapsed" contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:OverAllotmentOptionsLapsed" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0331" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:OverAllotmentOptionsLapsed" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-07-012023-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0348" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0349" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2022-07-012023-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0354" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2022-07-012023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-07-012023-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0360" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0361" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-07-012023-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-07-012023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0369" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-07-012022-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0390" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2021-07-012022-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0396" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2021-07-012022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-07-012022-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0402" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0403" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-07-012022-06-30_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="xdx2ixbrl0410" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-07-012022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0411" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0464" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:BankGuaranteeDepositReceivedPaid" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0466" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0478" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProceedsFromIssuingShares" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProceedsFromIssuingShares" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0484" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ReserachAndDevelopmentIncome" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0614" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ReserachAndDevelopmentIncome" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0616" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0705" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0706" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0707" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0709" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0710" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0711" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0713" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0714" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0715" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0745" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0746" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0747" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level1OfFairValueHierarchyMember" id="xdx2ixbrl0757" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level2OfFairValueHierarchyMember" id="xdx2ixbrl0758" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl0759" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2024-06-30" id="xdx2ixbrl0760" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level1OfFairValueHierarchyMember" id="xdx2ixbrl0762" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level2OfFairValueHierarchyMember" id="xdx2ixbrl0763" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl0764" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2024-06-30" id="xdx2ixbrl0765" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level1OfFairValueHierarchyMember" id="xdx2ixbrl0767" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level2OfFairValueHierarchyMember" id="xdx2ixbrl0768" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl0769" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2024-06-30" id="xdx2ixbrl0770" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level1OfFairValueHierarchyMember" id="xdx2ixbrl0772" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level2OfFairValueHierarchyMember" id="xdx2ixbrl0773" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2024-06-30_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl0774" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2024-06-30" id="xdx2ixbrl0775" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level1OfFairValueHierarchyMember" id="xdx2ixbrl0777" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level2OfFairValueHierarchyMember" id="xdx2ixbrl0778" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl0779" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2023-06-30" id="xdx2ixbrl0780" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level1OfFairValueHierarchyMember" id="xdx2ixbrl0782" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level2OfFairValueHierarchyMember" id="xdx2ixbrl0783" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl0784" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2023-06-30" id="xdx2ixbrl0785" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level1OfFairValueHierarchyMember" id="xdx2ixbrl0787" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level2OfFairValueHierarchyMember" id="xdx2ixbrl0788" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level1OfFairValueHierarchyMember" id="xdx2ixbrl0792" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level2OfFairValueHierarchyMember" id="xdx2ixbrl0793" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2024-06-30" id="xdx2ixbrl0827" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2024-06-30" id="xdx2ixbrl0829" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AccruedIncomeOtherThanContractAssets" contextRef="AsOf2023-06-30" id="xdx2ixbrl0940" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ResearchAndDevelopmentIncome" contextRef="AsOf2024-06-30" id="xdx2ixbrl0942" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_custom_PlantAndEquipmentMember" id="xdx2ixbrl1005" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_custom_PlantAndEquipmentMember" id="xdx2ixbrl1007" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember" id="xdx2ixbrl1017" decimals="0" unitRef="USD">40683</ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember" id="xdx2ixbrl1025" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_ifrs-full_ComputerEquipmentMember" id="xdx2ixbrl1027" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember" id="xdx2ixbrl1041" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_ifrs-full_OfficeEquipmentMember" id="xdx2ixbrl1043" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember" id="xdx2ixbrl1045" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_ifrs-full_OfficeEquipmentMember" id="xdx2ixbrl1047" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_custom_FurnitrueAndFittingsMember" id="xdx2ixbrl1061" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_custom_FurnitrueAndFittingsMember" id="xdx2ixbrl1063" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_custom_FurnitrueAndFittingsMember" id="xdx2ixbrl1065" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_custom_FurnitrueAndFittingsMember" id="xdx2ixbrl1067" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-07-012023-06-30_ifrs-full_BrandNamesMember" id="xdx2ixbrl1108" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-07-012023-06-30_ifrs-full_BrandNamesMember" id="xdx2ixbrl1111" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-07-012023-06-30_custom_PlatformDevelopmentMember" id="xdx2ixbrl1123" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ResearchDevelopmentTaxIncentive" contextRef="From2023-07-012024-06-30_custom_PlatformDevelopmentMember" id="xdx2ixbrl1125" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ProvisionForRefundLiability" contextRef="AsOf2024-06-30" id="xdx2ixbrl1162" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:UnearnedRevenue" contextRef="AsOf2024-06-30" id="xdx2ixbrl1185" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ReserveOfUnbilledShareOption" contextRef="AsOf2023-06-30" id="xdx2ixbrl1193" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ReserveOfUnbilledShareOption" contextRef="AsOf2022-06-30" id="xdx2ixbrl1194" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:NumberOfShareIssuedAndFullyPaid" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1213" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:NumberOfShareIssuedAndFullyPaid" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1214" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfSharesFromConversionOfConvertibleNotes" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1217" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfSharesFromConversionOfConvertibleNotes" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1218" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:AdvisorOptionsExercisedShares" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1221" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:AdvisorOptionsExercisedShares" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1222" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssuedAndFullyPaidValue" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1233" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssuedAndFullyPaidValue" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1234" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:PaymentsForShareIssueCosts" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1237" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:PaymentsForShareIssueCosts" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1238" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfEquityFromConversionOfConvertibleNotes" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1241" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssueOfEquityFromConversionOfConvertibleNotes" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1242" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:AdvisorOptionsExercisedValue" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1245" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:AdvisorOptionsExercisedValue" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1246" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ConvertibleNotesIssuedInLieuOfPaymentForServices" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl1279" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ConvertibleNotesIssuedInLieuOfPaymentForServices" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1281" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1333" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:IssuedSharesHeldByKeyManagementPersonnel" contextRef="From2022-07-012023-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1352" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:RepurchasedSharesHeldByKeyManagementPersonnel" contextRef="From2023-07-012024-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1355" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:RepurchasedSharesHeldByKeyManagementPersonnel" contextRef="From2022-07-012023-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1356" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:ResignationOfKeyManagementPersonnelShares" contextRef="From2023-07-012024-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1359" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:ResignationOfKeyManagementPersonnelShares" contextRef="From2021-07-012022-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1361" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:ReverseShareSplitSharesHeldByKeyManagementPersonnel" contextRef="From2023-07-012024-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1363" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1373" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExpiredOptionsHeldByKeyManagementPersonnel" contextRef="From2023-07-012024-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1379" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExpiredOptionsHeldByKeyManagementPersonnel" contextRef="From2021-07-012022-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1381" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExercisedOptionsHeldByKeyManagementPersonnel" contextRef="From2022-07-012023-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1384" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExercisedOptionsHeldByKeyManagementPersonnel" contextRef="From2021-07-012022-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1385" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="MMA:ReverseShareSplitOptionsHeldByKeyManagementPersonnel" contextRef="From2023-07-012024-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="xdx2ixbrl1387" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2023-07-012024-06-30_ifrs-full_ParentMember" id="xdx2ixbrl1429" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2022-07-012023-06-30_ifrs-full_ParentMember" id="xdx2ixbrl1430" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2021-07-012022-06-30_ifrs-full_ParentMember" id="xdx2ixbrl1431" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:Modification" contextRef="From2022-06-012023-06-30_custom_AmortizationMember" id="xdx2ixbrl1524" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" id="xdx2ixbrl1557" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" id="xdx2ixbrl1558" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:CurrentFinancialLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember" id="xdx2ixbrl1567" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember" id="xdx2ixbrl1570" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember" id="xdx2ixbrl1573" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:CurrentDebtInstrumentsIssued" contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember" id="xdx2ixbrl1576" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentDebtInstrumentsIssued" contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember" id="xdx2ixbrl1579" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:CurrentDerivativeFinancialLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember" id="xdx2ixbrl1582" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember" id="xdx2ixbrl1585" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DebtSecurities" contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember" id="xdx2ixbrl1588" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExpenseFromReach" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1750" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExpenseFromWarrants" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1753" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExpenseFromWarrants" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1754" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExpenseFromOverAllotmentOption" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1757" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExpenseFromOverAllotmentOption" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1758" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExpenseFromRestrictedShareUnits" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1761" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ExpenseFromRestrictedShareUnits" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1762" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-06-30_ifrs-full_ShareOptionsMember" id="xdx2ixbrl1789" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_ifrs-full_ShareOptionsMember" id="xdx2ixbrl1791" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_ifrs-full_ShareOptionsMember" id="xdx2ixbrl1795" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_ifrs-full_ShareOptionsMember" id="xdx2ixbrl1797" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_ifrs-full_ShareOptionsMember" id="xdx2ixbrl1799" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_ifrs-full_ShareOptionsMember" id="xdx2ixbrl1800" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_ifrs-full_ShareOptionsMember" id="xdx2ixbrl1801" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-06-30_custom_AdvisorMember" id="xdx2ixbrl1809" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_AdvisorMember" id="xdx2ixbrl1811" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_custom_AdvisorMember" id="xdx2ixbrl1816" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_custom_AdvisorMember" id="xdx2ixbrl1817" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_custom_AdvisorMember" id="xdx2ixbrl1820" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_custom_AdvisorMember" id="xdx2ixbrl1821" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-06-30_custom_AdvisorMember" id="xdx2ixbrl1823" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_custom_ReachMember" id="xdx2ixbrl1828" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-06-30_custom_ReachMember" id="xdx2ixbrl1829" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_ReachMember" id="xdx2ixbrl1831" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_custom_ReachMember" id="xdx2ixbrl1833" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_ReachMember" id="xdx2ixbrl1835" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_custom_ReachMember" id="xdx2ixbrl1836" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_custom_ReachMember" id="xdx2ixbrl1837" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_ReachMember" id="xdx2ixbrl1839" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_custom_ReachMember" id="xdx2ixbrl1840" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_custom_ReachMember" id="xdx2ixbrl1841" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_custom_ReachMember" id="xdx2ixbrl1845" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1847" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1848" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1849" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1852" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1853" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1855" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1856" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1857" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1859" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1860" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1861" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1864" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_ifrs-full_RestrictedShareUnitsMember" id="xdx2ixbrl1865" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1867" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1868" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1869" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1872" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1873" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1876" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1877" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1879" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1880" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1881" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1883" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1884" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_custom_OverAllotmentOptionsMember" id="xdx2ixbrl1885" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1887" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1888" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1889" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1892" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1893" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1895" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1896" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1897" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1899" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1900" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1901" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1904" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_ifrs-full_WarrantsMember" id="xdx2ixbrl1905" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-06-30" id="xdx2ixbrl1909" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1917" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl1920" unitRef="Integer" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1921" unitRef="Integer" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember" id="xdx2ixbrl1967" name="MMA:ExpectedTermShareOptionsGranted">P3Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember" id="xdx2ixbrl1979" name="MMA:ExpectedTermShareOptionsGranted">P2Y313DT21H36M</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember" id="xdx2ixbrl1991" name="MMA:ExpectedTermShareOptionsGranted">P2Y313DT21H36M</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember" id="xdx2ixbrl2003" name="MMA:ExpectedTermShareOptionsGranted">P4Y328DT12H</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember" id="xdx2ixbrl2015" name="MMA:ExpectedTermShareOptionsGranted">P3Y109DT12H</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember" id="xdx2ixbrl2027" name="MMA:ExpectedTermShareOptionsGranted">P3Y54DT18H</ix:nonNumeric>
  <ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesOneMember" id="xdx2ixbrl2037" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesTwoMember" id="xdx2ixbrl2045" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember" id="xdx2ixbrl2067" name="MMA:ExpectedTermShareOptionsGranted">P43DT19H12M</ix:nonNumeric>
  <ix:nonFraction name="MMA:AuditorsRemunerationForRelatedFees" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl2201" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AuditorsRemunerationForTaxServices" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl2203" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AuditorsRemunerationForTaxServices" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl2204" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AuditorsRemunerationForTaxServices" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl2205" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AuditorsRemunerationForOtherServices" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl2207" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AuditorsRemunerationForOtherServices" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl2208" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AuditorsRemunerationForOtherServices" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl2209" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="MMA:ContingentAssetsAndLiabilities" contextRef="AsOf2023-06-30" id="xdx2ixbrl2219" unitRef="USD" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="mma-20240630.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-07-01to2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_UnlistedOptionReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:UnlistedOptionReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:UnlistedOptionReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_UnlistedOptionReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:UnlistedOptionReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_PlantAndEquipmentMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_PlantAndEquipmentMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_FixturesAndFittingsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_FixturesAndFittingsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_IntangibleAssetsUnderDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_OneMajorProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">MMA:OneMajorProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_OneMajorProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">MMA:OneMajorProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_OneMajorProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">MMA:OneMajorProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_Level1OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_Level2OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_Level3OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_Level1OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_Level2OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_Level3OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAJuly21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAJuly21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAJuly21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAJuly21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAJuly21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAJuly21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAJuly21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAJuly21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAAugust21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAAugust21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAAugust21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAAugust21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAAugust21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAAugust21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAAugust21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAAugust21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesB1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesB1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesB1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesB1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesB2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesB2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesB2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesB2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAExtensionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAExtensionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAExtensionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAExtensionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAExtensionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAExtensionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAExtensionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAExtensionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_PrivatePlacementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:PrivatePlacementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_PrivatePlacementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:PrivatePlacementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_PrivatePlacementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:PrivatePlacementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_PrivatePlacementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:PrivatePlacementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_MixedMartialArtsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:MixedMartialArtsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_MixedMartialArtsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:MixedMartialArtsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_MixedMartialArtsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:MixedMartialArtsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_MixedMartialArtsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:MixedMartialArtsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SteppenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SteppenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SteppenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SteppenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SteppenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SteppenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SteppenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SteppenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_PlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_PlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_FurnitrueAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:FurnitrueAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_FurnitrueAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:FurnitrueAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_PlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_PlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_ifrs-full_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_ifrs-full_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_FurnitrueAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:FurnitrueAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_FurnitrueAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:FurnitrueAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_FurnitrueAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:FurnitrueAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_PlatformDevelopmentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_PlatformDevelopmentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_PlatformDevelopmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_PlatformDevelopmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_PlatformDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_PlatformDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PlatformDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_PlatformDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_PlatformDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_SteppenPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:SteppenPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-31_custom_MixedMartialsArtsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:MixedMartialsArtsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_custom_HypeKitIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:HypeKitIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_MrLangtonMember_custom_SnowflowerHoldingsPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">MMA:MrLangtonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">MMA:SnowflowerHoldingsPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_MrWilliamsMember_custom_ChampSevenPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">MMA:MrWilliamsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">MMA:ChampSevenPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_MrTaylorMember_custom_NalarooHoldingsPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">MMA:MrTaylorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">MMA:NalarooHoldingsPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_MrHartMember_custom_JHartFamilyTrustAccountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">MMA:MrHartMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">MMA:JHartFamilyTrustAccountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_EmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">MMA:EmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_EmployeementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">MMA:EmployeementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_EmployeementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">MMA:EmployeementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_Mr.LangtonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MMA:Mr.LangtonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_Mr.LangtonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:Mr.LangtonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-10-012025-10-02_custom_Mr.LangtonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:Mr.LangtonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-01</xbrli:startDate>
        <xbrli:endDate>2025-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_ParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_ParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_ifrs-full_ParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_ParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_Wimp2WarriorLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_UnitedStatesOfAmericaCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">MMA:UnitedStatesOfAmericaCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_Wimp2WarriorLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_Wimp2WarriorProductionsPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorProductionsPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_AustraliaCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">MMA:AustraliaCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_Wimp2WarriorProductionsPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorProductionsPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_Wimp2WarriorDigitalPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorDigitalPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_AustraliaCountryOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">MMA:AustraliaCountryOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_Wimp2WarriorDigitalPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorDigitalPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_Wimp2WarriorIrelandLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorIrelandLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_IrelandCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">MMA:IrelandCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_Wimp2WarriorIrelandLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorIrelandLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_HypeCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:HypeCoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_UnitedStatesOfAmericaCountryOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">MMA:UnitedStatesOfAmericaCountryOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_HypeCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:HypeCoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012024-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-012023-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-31_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012024-06-30_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-012023-06-30_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_AmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ConvertibleInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ConvertibleInstrumentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesAJulyTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesAAugustTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesBOneConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesB2ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesAExtensionConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ReachConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:ReachConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:PrivatePlacementConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:MixedMartialArtsLLCConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_SteppenConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SteppenConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_AdvisorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_AdvisorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_AdvisorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_AdvisorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_AdvisorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_AdvisorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_AdvisorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ReachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_RestrictedShareUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_ifrs-full_RestrictedShareUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_ifrs-full_RestrictedShareUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_RestrictedShareUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_ifrs-full_RestrictedShareUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_RestrictedShareUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_OverAllotmentOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_OverAllotmentOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_OverAllotmentOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_OverAllotmentOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_OverAllotmentOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_OverAllotmentOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_OverAllotmentOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_ifrs-full_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_ifrs-full_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_ifrs-full_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ifrs-full_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_ifrs-full_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_ifrs-full_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:EmployeeStockOwnershipPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:EmployeeStockOwnershipPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:EmployeeStockOwnershipPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:EmployeeStockOwnershipPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:ReachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:ReachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">MMA:BetweenOneAndTwoYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">MMA:BetweenTwoAndFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">MMA:BetweenOneAndTwoYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">MMA:BetweenTwoAndFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-07-31_custom_NonadjustingEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">MMA:NonadjustingEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-09-30_custom_NonadjustingEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">MMA:NonadjustingEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-09-30_custom_NonadjustingEventMember_custom_MrMcGregorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001981519</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">MMA:NonadjustingEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:MrMcGregorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>MMA:Integer</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="AUD">
      <xbrli:measure>iso4217:AUD</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="xdx2ixbrl0614" toRefs="Footnote000633"/>
  <ix:relationship fromRefs="Fact000615" toRefs="Footnote000633"/>
  <ix:relationship fromRefs="xdx2ixbrl0616" toRefs="Footnote000633"/>
  <ix:relationship fromRefs="Fact001122" toRefs="Footnote001133"/>
  <ix:relationship fromRefs="xdx2ixbrl1123" toRefs="Footnote001133"/>
  <ix:relationship fromRefs="Fact001228" toRefs="Footnote001251"/>
  <ix:relationship fromRefs="Fact001229" toRefs="Footnote001251"/>
  <ix:relationship fromRefs="Fact001230" toRefs="Footnote001251"/>
  <ix:relationship fromRefs="Fact001240" toRefs="Footnote001252"/>
  <ix:relationship fromRefs="xdx2ixbrl1241" toRefs="Footnote001252"/>
  <ix:relationship fromRefs="xdx2ixbrl1242" toRefs="Footnote001252"/>
  <ix:relationship fromRefs="Fact001244" toRefs="Footnote001257"/>
  <ix:relationship fromRefs="xdx2ixbrl1245" toRefs="Footnote001257"/>
  <ix:relationship fromRefs="xdx2ixbrl1246" toRefs="Footnote001257"/>
  <ix:relationship fromRefs="Fact001484" toRefs="Footnote001500"/>
  <ix:relationship fromRefs="Fact001485" toRefs="Footnote001500"/>
  <ix:relationship fromRefs="Fact001486" toRefs="Footnote001500"/>
  <ix:relationship fromRefs="Fact001487" toRefs="Footnote001500"/>
  <ix:relationship fromRefs="Fact001488" toRefs="Footnote001500"/>
  <ix:relationship fromRefs="Fact001489" toRefs="Footnote001500"/>
  <ix:relationship fromRefs="Fact001490" toRefs="Footnote001500"/>
  <ix:relationship fromRefs="Fact001491" toRefs="Footnote001500"/>
  <ix:relationship fromRefs="Fact001678" toRefs="Footnote001683"/>
  <ix:relationship fromRefs="Fact001674" toRefs="Footnote001686"/>
  <ix:relationship fromRefs="Fact001744" toRefs="Footnote001767"/>
  <ix:relationship fromRefs="Fact001745" toRefs="Footnote001767"/>
  <ix:relationship fromRefs="Fact001746" toRefs="Footnote001767"/>
  <ix:relationship fromRefs="Fact001752" toRefs="Footnote001776"/>
  <ix:relationship fromRefs="xdx2ixbrl1753" toRefs="Footnote001776"/>
  <ix:relationship fromRefs="xdx2ixbrl1754" toRefs="Footnote001776"/>
  <ix:relationship fromRefs="Fact001756" toRefs="Footnote001781"/>
  <ix:relationship fromRefs="xdx2ixbrl1757" toRefs="Footnote001781"/>
  <ix:relationship fromRefs="xdx2ixbrl1758" toRefs="Footnote001781"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_907_edei--DocumentType_c20230701__20240630_z7ilBnhTT9Hj"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000014" name="dei:DocumentType">20-F</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Mark
One)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--DocumentRegistrationStatement_c20230701__20240630_zs6ZuJFjskql"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000015" name="dei:DocumentRegistrationStatement">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
    STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--DocumentAnnualReport_c20230701__20240630_zdDBGM2FDaWg"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleantrue" id="Fact000016" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNUAL
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the fiscal year ended <span id="xdx_90B_edei--DocumentPeriodEndDate_c20230701__20240630_zxJMlIJZQFwk"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:datemonthdayyearen" id="Fact000017" name="dei:DocumentPeriodEndDate"><span id="xdx_90C_edei--CurrentFiscalYearEndDate_c20230701__20240630_zs3sZAOJD2U"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:datemonthdayen" id="Fact000018" name="dei:CurrentFiscalYearEndDate">June 30</ix:nonNumeric></span>, <span id="xdx_901_edei--DocumentFiscalYearFocus_c20230701__20240630_zPOguiXeX67g"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000019" name="dei:DocumentFiscalYearFocus">2024</ix:nonNumeric></span></ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--DocumentTransitionReport_c20230701__20240630_z7fQburvI9la"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000020" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--DocumentShellCompanyReport_c20230701__20240630_zLlWLX7QF4qe"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000021" name="dei:DocumentShellCompanyReport">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHELL
    COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of event requiring this shell company report _________</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the transition period from _______ to _________</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
file number: <span id="xdx_907_edei--EntityFileNumber_c20230701__20240630_zR3KINPjiA06"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000022" name="dei:EntityFileNumber">001-41978</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_907_edei--EntityRegistrantName_c20230701__20240630_z0XpoDOL2a7l"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000023" name="dei:EntityRegistrantName">ALTA
GLOBAL GROUP LIMITED</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
applicable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Translation
of Registrant&#8217;s name into English)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20230701__20240630_zMuXRaBa28U1"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:edgarprovcountryen" id="Fact000024" name="dei:EntityIncorporationStateCountryCode">Australia</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Jurisdiction
of incorporation or organization)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20230701__20240630_zki7960lrgz8"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000025" name="dei:EntityAddressAddressLine1">Level
1, Suite 1,</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressAddressLine2_c20230701__20240630_zu70c1IDsxEa"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000026" name="dei:EntityAddressAddressLine2">29-33 The Corso</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityAddressCityOrTown_c20230701__20240630_zsuuBCWwxv91"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000027" name="dei:EntityAddressCityOrTown">Manly</ix:nonNumeric></span>,
New South Wales <span id="xdx_907_edei--EntityAddressPostalZipCode_c20230701__20240630_zr9Ipy2fU8pk"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000028" name="dei:EntityAddressPostalZipCode">2095</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>+61
1800 151 865</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--ContactPersonnelName_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zzZ6XL72l4Qh"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000029" name="dei:ContactPersonnelName">Nick
Langton</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chief
Executive Officer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zwjZdZHxH3vg"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000030" name="dei:EntityAddressAddressLine1">Level
1, Suite 1,</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressAddressLine2_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z8yviYh86Vhd"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000031" name="dei:EntityAddressAddressLine2">29-33 The Corso</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressCityOrTown_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zg8XtPgdi64c"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000032" name="dei:EntityAddressCityOrTown">Manly</ix:nonNumeric></span>,
New South Wales <span id="xdx_909_edei--EntityAddressPostalZipCode_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zjwazZf2iVVb"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000033" name="dei:EntityAddressPostalZipCode">2095</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--CityAreaCode_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zebTG9XTAO6a"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000034" name="dei:CityAreaCode">+61</ix:nonNumeric></span>
<span id="xdx_90D_edei--LocalPhoneNumber_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zBU2iyyIWOt6"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000035" name="dei:LocalPhoneNumber">1800 151 865</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copies
to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jeffrey
J. Fessler, Esq.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Seth
A. Lemings, Esq.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sheppard,
Mullin, Richter &amp; Hampton LLP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30
Rockefeller Plaza</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
York, NY 10112</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Telephone:
(212) 653-8700</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Facsimile:
(212) 653-8701</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered or to be registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20230701__20240630_zhkxdUlJrbM9"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000036" name="dei:Security12bTitle">Ordinary
    Shares, no par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20230701__20240630_zRTZmS6375zl"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000037" name="dei:TradingSymbol">MMA</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--SecurityExchangeName_c20230701__20240630_zAK0SLsboOU9"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:exchnameen" id="Fact000038" name="dei:SecurityExchangeName">NYSE
    American</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered or to be registered pursuant to Section 12(g) of the Act: <b>None</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
for which there is a reporting obligation pursuant to Section 15(d) of the Act: <b>None</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of outstanding shares as of June 30, 2024 was <span id="xdx_90A_edei--EntityCommonStockSharesOutstanding_iI_c20240630_zJbvX3bJwXle"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-06-30" id="Fact000039" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,282,686</ix:nonFraction></span> Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744; <span id="xdx_907_edei--EntityWellKnownSeasonedIssuer_c20230701__20240630_zz4HUnKPaHa7"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000040" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744; <span id="xdx_906_edei--EntityVoluntaryFilers_c20230701__20240630_zdHNgrSHPzv9"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000041" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
</b>&#8211; Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 from their obligations under those Sections.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityCurrentReportingStatus_c20230701__20240630_zPRWuICzEw5k"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000042" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>
&#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityInteractiveDataCurrent_c20230701__20240630_zQZDoARaIuv9"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000043" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>
&#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth
company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221;
in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    Accelerated Filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    Filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityFilerCategory_c20230701__20240630_zb4uqxnpKTV5"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:entityfilercategoryen" id="Fact000044" name="dei:EntityFilerCategory">Non-accelerated
    Filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company <span id="xdx_905_edei--EntityEmergingGrowthCompany_c20230701__20240630_z2AHm3N0i868"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleantrue" id="Fact000045" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided
pursuant to Section 13(a) of the Exchange Act. <span id="xdx_900_edei--EntityExTransitionPeriod_c20230701__20240630_zxxj2ragfVsa"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000046" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;
The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards
Board to its Accounting Standards Codification after April 5, 2012.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report: <span id="xdx_901_edei--IcfrAuditorAttestationFlag_c20230701__20240630_z49wan2sZYkc"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000047" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. <span id="xdx_90C_edei--DocumentFinStmtErrorCorrectionFlag_c20230701__20240630_z8Ngbm0UZfxl"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000048" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    GAAP</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 85%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--DocumentAccountingStandard_c20230701__20240630_z4Z9iI8pnh24"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000049" name="dei:DocumentAccountingStandard">International Financial Reporting Standards</ix:nonNumeric></span> as issued by the International Accounting Standards Board </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 85%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
&#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the
registrant has elected to follow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Item 17 &#9744; Item 18</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744; No <span id="xdx_906_edei--EntityShellCompany_dbF_c20230701__20240630_zSmZo0UxqlTb"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000050" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">TABLE
OF CONTENTS</span></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">Presentation of Financial and Other Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">ii</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">PART I</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">ITEM 3. KEY INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">[Reserved]</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">Capitalization and Indebtedness</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_008">Reasons for the Offer and Use of Proceeds</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_009">Risk Factors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_010">ITEM 4. INFORMATION ON THE COMPANY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">20</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_011">History and Development of the Company</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">20<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_012">Business Overview</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">24<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_013">Organizational Structure</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">31<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_014">Property, Plants and Equipment</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">31<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_015">ITEM 4A. UNRESOLVED STAFF COMMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">31<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_016">ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">31<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_017">Operating Results</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">32</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_018">Liquidity and Capital Resources</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">39</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_019">Research and Development, Patents and Licenses, etc.</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">41</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020">Trend Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021">Critical Accounting Estimates</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_022">ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_023">Directors and Senior Management</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_024">Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">47</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_001">Board Practices</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_002">Employees</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">53</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_003">Share Ownership</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">53</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_004">Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">54</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_005">ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">54</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_006">Major Shareholders</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">54</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_007">Related Party Transactions</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">55</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_008">Interests of Experts and Counsel</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_009">ITEM 8. FINANCIAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_010">Consolidated Statements and Other Financial Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_011">Significant Changes</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_012">ITEM 9. THE OFFER AND LISTING</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_013">Offering and Listing Details</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_014">Plan of Distribution</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_015">Markets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_016">Selling Shareholders</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_017">Dilution</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_018">Expenses of the Issue</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_019">ITEM 10. ADDITIONAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_020">Share Capital</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_021">Memorandum and Articles of Association</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">57</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_022">Material Contracts</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>
                                                                            <p style="text-align: center; margin-top: 0; margin-bottom: 0">57</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_023">Exchange controls</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">57</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_024">Taxation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">57</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_025">Dividends and Paying Agents</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_026">Statement by Experts</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_027">Documents on Display</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_028">Subsidiary Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_029">Annual Report to Security Holders</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_030">ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_031">ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_032">PART II</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_033">ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">64</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_034">ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">64</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_035">ITEM 15. CONTROLS AND PROCEDURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">64</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_036">Disclosure Controls and Procedures</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">64</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_037">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">64</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_038">Attestation Report of the Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_039">Changes in Internal Control Over Financial Reporting</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_040">ITEM 16. [RESERVED]</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_041">ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_042">ITEM 16B. CODE OF ETHICS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_043">ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_044">ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_045">ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">66</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_046">ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_047">ITEM 16G. CORPORATE GOVERNANCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">66</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_048">ITEM 16H. MINE SAFETY DISCLOSURE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">67</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_049">ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">67</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_050">ITEM 16J. INSIDER TRADING POLICIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">67</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_051">ITEM 16K. CYBERSECURITY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">68</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_052">PART III</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_053">ITEM 17. FINANCIAL STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">68</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_054">ITEM 18. FINANCIAL STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">68</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_025">ITEM 19. EXHIBITS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>PRESENTATION
OF FINANCIAL AND OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references to &#8220;U.S. dollars,&#8221; &#8220;dollars,&#8221; &#8220;$,&#8221; &#8220;USD&#8221; or &#8220;US$&#8221; are to the U.S.
dollar. All references to &#8220;Australian dollars,&#8221; &#8220;AUD&#8221; or &#8220;A$&#8221; are to the Australian dollar, the official
currency of Australia. All references to &#8220;IFRS&#8221; are to International Financial Reporting Standards, as issued by the International
Accounting Standards Board, or the IASB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated or the context otherwise requires, all references in this annual report to the terms &#8220;Alta,&#8221; &#8220;the
Company,&#8221; &#8220;the Group,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; and &#8220;we&#8221; refer to Alta Global Group Limited
and its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements cover Alta Global Group Limited as a Group consisting of Alta Global Group Limited and the entities
it controlled at the end of, or during, the year ended June 30, 2024. The consolidated financial statements are presented in AUD or A$
dollars, which is Alta Global Group Limited&#8217;s presentation currency. We prepared our annual consolidated financial statements for
fiscal years ended June 30, 2024, 2023 and 2022 in accordance with IFRS, as issued by the IASB. Unless otherwise noted, our financial
information presented herein for the fiscal years ended June 30, 2024, 2023 and 2022 is stated in dollars, our presentation currency.
All references herein to &#8220;our financial statements,&#8221; &#8220;our audited consolidated financial information,&#8221; and/or
&#8220;our audited consolidated financial statements&#8221; are to the Company&#8217;s consolidated financial statements included elsewhere
in this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
Global Group Limited is incorporated and domiciled in Australia. The Company&#8217;s ordinary shares, no par value (&#8220;Ordinary Shares&#8221;) are listed on the NYSE American
under the trading ticker &#8220;MMA.&#8221; Alta Global Group Limited&#8217;s registered office and principal place of business are:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registered
    office</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
    place of business</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wimp
    2 Warrior LLC</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1, Suite 1, 29-33 The Corso</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8
    The Green, Ste R</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manly,
    New South Wales 2095</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dover,
    DE 19901</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
fiscal year ends on June 30. References in this annual report to a fiscal year, such as &#8220;fiscal year 2024,&#8221; &#8220;fiscal
year 2023&#8221; and &#8220;fiscal year 2022,&#8221; relate to our fiscal year ended on June 30 of that calendar year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Events</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2024, the registration statement on Form F-1 (File No 333-275618) relating to our initial public offering (&#8220;IPO&#8221;)
of our Ordinary Shares was declared effective by the Securities Exchange Commission (&#8220;SEC&#8221;). On April 2, 2024, we closed
our IPO, pursuant to which we issued and sold 1,300,000 Ordinary Shares. See &#8220;Item 4. Information on the Company&#8221; for additional
information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we had a total of 10,282,686 Ordinary Shares issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Share and Other Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report includes market, economic and industry data as well as certain statistics and information relating to our business, markets,
and other industry data, which we obtained or extrapolated from various third-party industry and research sources, as well as assumptions
that we have made that are based on those data and other similar sources. Industry publications and other third-party surveys and forecasts
generally state that the information contained therein has been obtained from sources believed to be reliable, but that the accuracy
and completeness of such information is not guaranteed. While we believe that such data is reliable, we have not independently verified
such data and cannot guarantee the accuracy or completeness thereof. Additionally, we cannot assure you that any of the assumptions underlying
these statements are accurate or correctly reflect our position in the industry, and not all of our internal estimates have been verified
by any independent sources. Furthermore, we cannot assure you that a third-party using different methods to assemble, analyze, or compute
market data would obtain the same results. We do not intend, and do not assume any obligations, to update industry or market data set
forth in this annual report. Finally, behavior, preferences, and trends in the marketplace tend to change. As a result, investors and
prospective investors should be aware that data in this annual report and estimates based on such data may not be reliable indicators
of future results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rounding</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
in this annual report have been rounded off to the nearest dollar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Presentation
Currency and Exchange Rates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency and presentational currency of Alta Global Group Limited is Australian dollars. Foreign currency amounts are translated
into the presentation currency in the manner described in Note 2 to our audited financial statements for the year ended June 30, 2024,
included in this annual report on Form 20-F.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
Growth Company Status</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
qualify as an &#8220;emerging growth company,&#8221; as defined in the U.S. Jumpstart Our Business Startups Act of 2012, or JOBS Act,
and we may take advantage of certain exemptions, including exemptions from various reporting requirements that are otherwise applicable
to publicly traded entities that do not qualify as emerging growth companies. These exemptions include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                            being required to comply with the auditor attestation requirements of Section 404 of the
                                            Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                            being required to comply with any requirement that may be adopted by the Public Company Accounting
                                            Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s
                                            report providing additional information about the audit and the financial statements (i.e.,
                                            an auditor discussion and analysis).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section
13(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, for complying with new or revised accounting standards.
This means that an &#8220;emerging growth company&#8221; can delay the adoption of certain accounting standards until those standards
would otherwise apply to private companies. Given that we currently report and expect to continue to report our financial results under
IFRS as issued by the IASB, we will not be able to avail ourselves of this extended transition period and, as a result, we will adopt
new or revised accounting standards on the relevant dates on which adoption of such standards is required by the IASB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an emerging growth company until the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues
exceed US$1.235 billion; (ii) the last day of the fiscal year following the fifth anniversary of the date of our initial public offering;
(iii) the date that we become a &#8220;large accelerated filer&#8221; as defined in Rule 12b-2 under the Exchange Act, which would occur
if the aggregate worldwide market value of our Ordinary Shares, including Ordinary Shares represented by warrants, held by non-affiliates
is at least US$700 million as of the last business day of our most recently completed second fiscal quarter; or (iv) the date on which
we have issued more than US$1.0 billion in non-convertible debt securities during any three-year period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
Regarding Forward-Looking Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the
Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that involve substantial risks
and uncertainties. Forward-looking statements include information concerning possible or assumed future results of operations, including
descriptions of our business plan and strategies and trends we expect to affect our business. These statements often include words such
as &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;suggests,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221;
&#8220;estimates,&#8221; &#8220;targets,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221;
&#8220;may,&#8221; &#8220;will,&#8221; &#8220;forecast,&#8221; and other similar expressions. These forward-looking statements are contained
throughout this annual report, including matters discussed under &#8220;Item 3. Key Information&#8212;Risk Factors,&#8221; &#8220;Item
5. Operating and Financial Review and Prospects,&#8221; and in other sections of this annual report<i>.</i> We base these forward-looking
statements or projections on our current expectations, plans and assumptions that we have made in light of our experience in the industry,
as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate
under the circumstances and at such time. As you read and consider this annual report, you should understand that these statements are
not guarantees of future performance or results. The forward-looking statements and projections are subject to and involve risks, uncertainties
and assumptions and you should not place undue reliance on these forward-looking statements or projections. Although we believe that
these forward-looking statements and projections are based on reasonable assumptions at the time they are made, you should be aware that
many factors could affect our actual financial results or results of operations, and could cause actual results to differ materially
from those expressed in the forward-looking statements and projections. Factors that may materially affect such forward-looking statements
and projections include, but are not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    goals and strategies, including with respect to the development and expansion of our business;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    capital commitments and/or intentions with respect to our business, including the sufficiency of our liquidity and capital resources;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    nature and extent of future competition in our industry and in the markets in which we operate or plan to operate;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    price of, and our ability to successfully integrate, any acquired businesses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    expected cash flows from our business; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    planned capital expenditures.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
forward-looking statements speak only as of the date of this annual report on Form 20-F. You should not place undue reliance on these
forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by
the forward-looking statements we make in this annual report are reasonable, we cannot assure you that these plans, objectives, expectations
or intentions will be achieved. We disclose important factors that could cause our actual results to differ materially from our expectations
under &#8220;Risk Factors&#8221; and elsewhere in this annual report. This annual report also contains estimates and other statistical
data made by independent parties and by us relating to market size and growth and other data about our industry. These data involve a
number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. In addition, projections, assumptions
and estimates of our future performance and the future performance of the markets in which we operate are necessarily subject to a high
degree of uncertainty and risk. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot
be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions
of future events. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and
it is not possible for management to predict all risk factors and uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements made in this annual report on Form 20-F relate only to events or information as of the date on which the statements
are made in this annual report on Form 20-F. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to
reflect the occurrence of unanticipated events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>PART
I</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>ITEM
    1.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IDENTITY
    OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>ITEM
    2.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OFFER
    STATISTICS AND EXPECTED TIMETABLE</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    3.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>KEY
    INFORMATION</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>[Reserved]</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>Capitalization and Indebtedness</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_008"></span>Reasons for the Offer and Use of Proceeds</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_009"></span>Risk Factors</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>An
investment in our Ordinary Shares is subject to a number of risks. You should carefully consider the following risk factors, which should
be read in conjunction with all the other information presented in this annual report. The risks and uncertainties described below are
not the only ones we face. Additional risks and uncertainties that we do not know about or currently think are immaterial may also impair
our business operations. Any of the following risks, if they occur, could materially and adversely affect our business, results of operations,
financial condition, and cash flows.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of Key Risks</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to numerous risks and uncertainties, discussed in more detail below. These risks include, among others, the following
key risks:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Financial Position and Need for Additional Capital</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    will require substantial capital to finance our operations, which may not be available to us on acceptable terms, or at all;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    have incurred operating losses in the past, may incur operating losses in the future, and may not achieve or maintain profitability
    in the future;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    have disclosed that there is substantial doubt about our ability to continue as a going concern. We will require additional capital
    in order to execute our business plan and continue the operation of our business. Any capital-raising transaction we are able to
    complete may result in substantial dilution to our existing shareholders. Our auditors have issued an audit report that contains
    an explanatory paragraph regarding the Company&#8217;s ability to continue as a going concern and their opinion is not modified with
    respect to this matter;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in public and consumer tastes and preferences and industry trends could reduce demand for our services and content offerings and
    adversely affect our business;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    in-gym programming has been and may in the future be materially impacted by the ongoing COVID-19 pandemic, and could be impacted
    by similar events in the future;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to generate revenue, is subject to many factors, including many that are beyond our control, such as general macroeconomic
    conditions;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    rely on technology, such as our information systems, to conduct our business. Failure to protect our technology against breakdowns
    and security breaches could adversely affect our business;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    unauthorized disclosure of sensitive or confidential client or customer information could harm our business and standing with our
    clients and customers;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may be unable to protect our trademarks and other intellectual property rights, and others may allege that we infringe upon their
    intellectual property rights;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exchange
    rates may cause fluctuations in our results of operations;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    partner gyms could take actions that harm our business;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    success depends substantially on the value of our brand;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    rely on contracts and relationships and a termination of any such contract or relationship may have a material adverse effect on
    our business;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    planned growth could place strains on our management, employees, information systems and internal controls, which may adversely impact
    our business;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are subject to a number of risks related to automated clearing house, or ACH, credit card and debit card payments we accept;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    partner gyms may be unable to attract and retain members, which may materially and adversely affect our business, results of operations
    and financial condition;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    we are unable to identify and secure suitable partner gyms, our revenue growth rate and profits may be negatively impacted;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    and our partner gyms could be subject to claims related to health and safety risks;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    we are unable to retain our key employees, we may not be able to successfully manage our business and pursue our strategic objectives;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">use
    of social media may adversely impact our reputation or subject us to fines or other penalties;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are subject to international tax regulations;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to adapt to or manage new content distribution platforms or changes in consumer behavior resulting from new technologies;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    markets in which we operate are highly competitive;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may be unsuccessful in any strategic acquisitions and investments, and we may pursue acquisitions or investments for their strategic
    value in spite of the risk of lack of profitability;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are subject to risks associated with operating in international markets;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may not be able to attract and retain key professional fighters or coaches;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    expansion into new markets may present increased risks due to our unfamiliarity with the area, different rules and regulations and
    challenging operating environments;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    MMA Final Fight Night events are subject to governmental and state athletic commission regulation;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    related to government regulation;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are an &#8220;emerging growth company,&#8221; and our election to comply with the reduced disclosure requirements as a public company
    may make our Ordinary Shares less attractive to investors;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    we fail to establish and maintain proper internal controls, our ability to produce accurate financial statements or comply with applicable
    regulations could be impaired;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will incur increased costs as a result of having become a listed public company;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    market price of our Ordinary Shares could fluctuate significantly, and you could lose all or part of your investment;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    market price of our Ordinary Shares could be adversely affected by future sales and distributions of our Ordinary Shares or the perception
    that such sales and distributions may occur;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    securities or industry analysts do not publish research or reports about our business, or publish negative reports about our business,
    our share price and trading volume could decline;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may issue additional Ordinary Shares in the future, which may dilute our existing shareholders, and we may also issue securities
    that have rights and privileges that are more favorable than the rights and privileges accorded to our existing shareholders;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are not likely to issue dividends for the foreseeable future;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    a foreign private issuer, we are permitted and expect to follow certain home country corporate governance practices in lieu of certain
    NYSE American requirements applicable to domestic issuers;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    a foreign private issuer, we are permitted to file less information with the SEC than a domestic issuer;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may lose our foreign private issuer status, which would then require us to comply with the Exchange Act&#8217;s domestic reporting
    regime and cause us to incur additional legal, accounting and other expenses;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Constitution and Australian laws and regulations applicable to us may adversely affect our ability to take actions that could be
    beneficial to our shareholders;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    NYSE American may delist our Ordinary Shares from trading on its exchange, which could limit investors&#8217; ability to make transactions
    in our Ordinary Shares and subject us to additional trading restrictions; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australian
    companies may not be able to initiate shareholder derivative actions, thereby depriving shareholders of the ability to protect their
    interests;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">anti-takeover
    provisions in our Constitution and our right to issue preference shares could make a third-party acquisition of us difficult; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">you
    will have limited ability to bring an action against us or against our directors and officers, or to enforce a judgment against us
    or them, because we are incorporated in Australia and certain of our directors and officers reside outside the United States.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Financial Position and Need for Additional Capital</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will require substantial capital to finance our operations, which may not be available to us on acceptable terms, or at all.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will require further funding to support our ongoing activities and operations. There can be no assurance that such funding will be available
on satisfactory terms or at all. Any inability to obtain funding will adversely affect our business and financial condition and consequently
our performance. We may seek to raise further funds through equity or debt financing, joint ventures or other means. There can be no
assurance that additional financing will be available when needed or, if available, that the terms of such financing will be favorable
to us, which may result in substantial dilution to our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have incurred operating losses in the past, may incur operating losses in the future, and may not achieve or maintain profitability in
the future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred loss after tax of A$14,408,346 and A$20,597,436 for fiscal year 2024 and fiscal year 2023, respectively, and may continue
to incur net losses in the future. Our historical operating losses were reflective of non-cash operating expenses including the interest
component of the convertible notes and the fair value movement in the derivative liability of our convertible notes. The interest component
of the convertible notes was A$3,207,498 and A$4,420,224 for fiscal year 2024 and 2023, respectively. The fair value movement in the
derivative liability of our convertible notes was a gain of A$3,400,685 and a loss of A$6,870,729 for fiscal year 2024 and 2023, respectively.
All convertible notes were redeemed or converted for the period ended June 30, 2024 and looking forward into future financial years will
not be a component of operating losses. We expect our operating expenses to increase in the future as we grow our business, continue
our sales and marketing efforts related to our products, platform and programs, invest in research and development, expand our operating
infrastructure, add content and features to our platform, expand into new geographies, and develop new products. We will also incur operating
expenses in connection with legal, accounting, and other fees related to operating as a public company listed on a U.S. exchange. These
efforts and additional expenses may be more costly than we expect, and we cannot guarantee that we will be able to increase our revenue
to offset our operating expenses. Our revenue growth may slow or our revenue may decline for a number of other reasons, including reduced
demand of our product and services, increased competition, a decrease in the growth or reduction in size of our overall market, the impacts
to our business from the COVID-19 pandemic, or if we cannot capitalize on growth opportunities. If our revenue does not grow at a greater
rate than our operating expenses, we will not be able to achieve and maintain profitability, which may have a material adverse effect
on the trading price of our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have disclosed that there is substantial doubt about our ability to continue as a going concern. We may require additional capital in
order to execute our business plan and continue the operation of our business. Any capital-raising transaction we are able to complete
may result in substantial dilution to our existing shareholders. Our auditors have issued an audit report that contains an explanatory
paragraph regarding the Company&#8217;s ability to continue as a going concern and their opinion is not modified with respect to this
matter.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of our loss after tax, net cash outflows from operating activities, net asset and net current asset position, our independent
registered public accounting firm included an explanatory paragraph in its report on our financial statements as of, and for the year
ended June 30, 2024 that raises substantial doubt about our ability to continue as a going concern. The conditions giving rise to this
uncertainty and our plan with respect to this uncertainty are disclosed in Note 3 to our consolidated financial statements appearing
at the end of this report. If we are unable to obtain sufficient funding, we could be forced to delay, reduce or eliminate our product
development programs or future research and development efforts, our financial condition and results of operations will be materially
and adversely affected, and we may be unable to continue as a going concern. After the date of this annual report, future financial statements
may continue to disclose substantial doubt about our ability to continue as a going concern, which could cause investors or other financing
sources to be unwilling to provide additional funding to us on commercially reasonable terms or at all. Any capital raising transaction
we are able to complete may result in substantial dilution to our existing shareholders, require us to relinquish significant rights,
or restrict our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in public and consumer tastes and preferences and industry trends could reduce demand for our services and content offerings and adversely
affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to generate revenues is highly sensitive to rapidly changing consumer preferences and industry trends, as well as the popularity
of martial arts and combat sports. Our success depends on our ability to offer premium in-gym products and services and content through
popular channels of distribution that meet the changing preferences of the broad consumer market and respond to competition from an expanding
array of services facilitated by technological developments in the delivery of martial arts and combat sports instruction and content.
Changes in consumers&#8217; tastes or a change in the perception of our brands and business partners could adversely affect our operating
results. Our failure to avoid a negative perception among consumers or anticipate and respond to changes in consumer preferences, including
in the form of in-gym products and services and content creation or distribution, could result in reduced demand for our services and
content offerings or those of our clients, which could have an adverse effect on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
in-gym programming has been and may in the future be materially impacted by the ongoing COVID-19 pandemic and could be impacted by similar
events in the future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic continues to impact worldwide consumer behavior and economic activity. A public health pandemic such as the COVID-19
pandemic poses the risk that we or our employees, in-gym partner gyms, in- gym members, suppliers and other business partners may be
prevented from conducting business activities for an indefinite period of time, including due to shutdowns, travel restrictions, social
distancing requirements, stay at home orders and advisories and other restrictions that may be suggested or mandated by governmental
authorities. The COVID-19 pandemic may also have the effect of heightening many of the other risks described elsewhere in this annual
report, such as those relating to our growth strategy, international operations, our ability to attract and retain members, our supply
chain, health and safety risks to participants in our in-gym programs, loss of key employees and changes in consumer preferences, as
well as risks related to our ability to generate sufficient cash to operate as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
duration of the COVID-19 pandemic and the extent of its impact remains highly uncertain and difficult to predict. However, the continued
spread of the virus and the measures taken in response to it, particularly in Australia and New Zealand, have disrupted our operations
and have adversely impacted our in-gym membership programming, resulting in the cancellation of a significant number of pre-filled programs,
creating a need to re-adjust our fiscal year 2021 revenue. In response, in 2020 we embarked on a stringent project of cost control and
retention of core talent that were able to create a six month operating runway during a period in which we recognized zero revenues.
Our partner gyms began reopening in 2021 as local guidelines allowed, and as of June 30, 2023 all of our in-gym partner gyms were open
and operating. As the COVID-19 pandemic continues to impact areas in which we and our in-gym partners operate, certain of our licensees
have had to re-close, and additional in-gym partner gyms may have to re-close, pursuant to local guidelines. In-gym members have generally
not and will not be charged membership dues while their gyms are temporarily closed and are typically credited for any membership dues
paid for periods when their gym is closed due to the COVID-19 pandemic. Compared to the periods prior to the COVID-19 pandemic, we have
experienced and may in the future experience decreased new licensee enrollments, in part as a result of the COVID-19 pandemic. In addition,
as a result of the COVID-19 pandemic, we experienced, and may in the future experience, a decrease in our net in-gym membership base
compared to in-gym membership levels in March 2020, and the COVID-19 pandemic may have an ongoing impact on consumer behavior.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
the constantly evolving nature of the COVID-19 pandemic and the emergence of new variants of coronavirus have negatively impacted, and
may in the future negatively impact, our operating results. The significance of the ultimate operational and financial impact to us will
depend on how long and widespread the disruptions caused by the COVID-19 pandemic, and the corresponding response to contain the virus
and treat those affected by it, prove to be.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
ability to generate revenue is subject to many factors, including many that are beyond our control, such as general macroeconomic conditions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business depends on discretionary consumer spending. Many factors related to discretionary consumer spending, including economic conditions
affecting disposable consumer income such as unemployment levels, fuel prices, interest rates, changes in tax rates, and tax laws that
impact individuals and inflation can significantly impact our operating results. While consumer spending may decline at any time for
reasons beyond our control, the risks associated with our businesses become more acute in periods of a slowing economy or recessions.
There can be no assurance that consumers will not be adversely impacted by current economic conditions, or by any future deterioration
in economic conditions, thereby possibly impacting on our operating results and growth. A prolonged period of reduced consumer spending
could have an adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
rely on technology, such as our information systems, to conduct our business. Failure to protect our technology against breakdowns and
security breaches could adversely affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on technology, such as our information systems, content distribution systems and payment processing systems, to conduct our business.
This technology is vulnerable to service interruptions and security breaches from inadvertent or intentional actions by our employees,
partners, and vendors, or from attacks by malicious third parties. Such attacks are of ever-increasing levels of sophistication and are
made by groups and individuals with a wide range of motives and expertise, including organized criminal groups, &#8220;hacktivists,&#8221;
nation states, and others. The techniques used to breach security safeguards evolve rapidly, and they may be difficult to detect for
an extended period of time, and the measures we take to safeguard our technology may not adequately prevent such incidents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we have taken steps to protect our confidential and personal information and that of our clients and other business relationships and
have invested in information technology, there can be no assurance that our efforts will prevent service interruptions or security breaches
in our systems or the unauthorized or inadvertent wrongful use or disclosure of such confidential information. Such incidents could adversely
affect our business operations, reputation, and client relationships. Any such breach may require us to expend significant resources
to mitigate the breach of security and to address matters related to any such breach, including, but not limited to, the payment of fines.
Although we are in the process of obtaining an insurance policy that covers data security, privacy liability, and cyber-attacks, our
insurance may not be adequate to cover losses arising from breaches or attacks on our systems. We also may be required to notify regulators
about any actual or perceived personal data breach as well as the individuals who are affected by the incident within strict time periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our use of technology systems presents the potential for further vulnerabilities. For instance, we may be subject to boycotts,
spam, spyware, ransomware, phishing and social engineering, viruses, worms, malware, distributed denial-of-service attacks, password
attacks, man-in-the-middle attacks, cybersquatting, impersonation of employees or officers, abuse of comments and message boards, fake
reviews, doxing, and swatting. While we have internal policies in place to protect against these vulnerabilities, we can make no assurances
that we will not be adversely affected should one of these events occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Unauthorized
disclosure of sensitive or confidential client or customer information could harm our business and standing with our clients and customers.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
protection of our client, customer, employee, and other Company data is critical to us. We collect, store, transmit, and use personal
information relating to, among others, our clients, employees, consumers, and event participants. We rely on commercially available systems,
software, tools, and monitoring to provide security for processing, transmission, and storage of confidential client and customer information.
Our facilities and systems, and those of our third-party service providers, may be vulnerable to security breaches, acts of vandalism,
payment card terminal tampering, computer viruses, misplaced, lost or stolen data, programming or human errors, or other similar events.
Any security breach involving the misappropriation, loss or other unauthorized disclosure of client or customer information, whether
by us or our third-party service providers, could damage our reputation, result in the loss of clients and customers, expose us to risk
of litigation and liability or regulatory investigations or actions, disrupt our operations, and harm our business. In addition, as a
result of recent security breaches, the media and public scrutiny of information security and privacy has become more intense. As a result,
we may incur significant costs to change our business practices or modify our service offerings in connection with the protection of
personally identifiable information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be unable to protect our trademarks and other intellectual property rights, and others may allege that we infringe upon their intellectual
property rights.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have invested significant resources in brands associated with our business in an attempt to obtain and protect our public recognition.
These brands are essential to our success and competitive position. We have also invested significant resources in the premium content
that we produce.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
trademarks, tradenames and other intellectual property rights are critical to our success and our competitive position. Our intellectual
property rights may be challenged and invalidated by third parties. Further, policing unauthorized use and other violations of our intellectual
property is difficult, particularly given our global scope, so we are susceptible to others infringing, diluting or misappropriating
our intellectual property rights. If we are unable to maintain and protect our intellectual property rights adequately, we may lose an
important advantage in the markets in which we compete. In particular, the laws of certain foreign countries do not protect intellectual
property rights in the same manner as do the laws of the United States and, accordingly, our intellectual property is at greater risk
in those countries even where we take steps to protect such intellectual property. While we believe we have taken, and take in the ordinary
course of business, appropriate available legal steps to reasonably protect our intellectual property, we cannot predict whether these
steps will be adequate to prevent infringement or misappropriation of these rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, in the ordinary course of our business, we may become involved in opposition and cancellation proceedings with respect
to some of our intellectual property or third-party intellectual property. Any opposition and cancellation proceedings or other litigation
or dispute involving the scope or enforceability of our intellectual property rights or any allegation that we infringe, misappropriate
or dilute upon the intellectual property rights of others, regardless of the merit of these claims, could be costly, time-consuming and
may damage our reputation. If any infringement or other intellectual property claim made against us by any third party is successful,
if we are required to indemnify a third party with respect to a claim, or if we are required to, or decide to, cease use of a brand,
rebrand or obtain non-infringing intellectual property (such as through a license which may not be available to us on commercially reasonable
terms, or at all), it may adversely affect our business and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exchange
rates may cause fluctuations in our results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we derive revenues from our international operations, we may incur currency translation losses or gains due to changes in the values
of foreign currencies relative to the Australian dollar. We cannot, however, predict the effect of exchange rate fluctuations upon future
operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
partner gyms could take actions that harm our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
partner gyms are contractually obligated to operate their gyms in accordance with the operational, safety and health standards set forth
in our agreements with them. However, partner gyms are independent third parties and their actions are outside of our control. In addition,
we cannot be certain that our partner gyms will have the business acumen or financial resources necessary to operate successful gyms
in their approved locations. Our partner gyms own, operate and oversee the daily operations of their gyms. As a result, the ultimate
success and quality of any partner gym rests with the partner gym itself. If our partner gyms do not successfully operate gyms in a manner
consistent with required standards and comply with local laws and regulations, our brand image and reputation could be harmed, which
in turn could adversely affect our results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
although we believe we generally maintain positive working relationships with our partner gyms, disputes with partner gyms could damage
our brand image and reputation and our relationships with our partner gyms, generally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
success depends substantially on the value of our brand.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success is dependent in large part upon our ability to maintain and enhance the value of our brand, our partner gyms&#8217; connection
to our brand and maintaining a positive relationship with our partner gyms. Brand value can be severely damaged even by isolated incidents,
particularly if the incidents receive considerable negative publicity or result in litigation. Some of these incidents may relate to
the way we manage our relationships with our partner gyms, our growth strategies, our development efforts or the ordinary course of our,
or our partners&#8217;, businesses. Other incidents that could be damaging to our brand may arise from events that are or may be beyond
our ability to control, such as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions
    taken (or not taken) by one or more of our partner gyms or their employees relating to health, safety, welfare or otherwise;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">data
    security breaches or fraudulent activities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation
    and legal claims;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">third-party
    misappropriation, dilution or infringement of our intellectual property; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">illegal
    activity targeted at us or others.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consumer
demand for our products and services and our brand&#8217;s value could diminish significantly if any such incidents or other matters
erode consumer confidence in us or our business, which may result in fewer memberships and, which, in turn, could materially and adversely
affect our results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
rely on contracts and relationships and a termination of any such contract or relationship may have a material adverse effect on our
business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on business relationships with our partner gyms, including UFC Gym, our coaches, and Alta ambassadors. A principal component of
our marketing program has been to partner with high-profile marketing partners to help us extend the reach of our brand. Although we
have partnered with several well-known partners, we may not be able to attract and partner with new marketing partners in the future.
In addition, if the actions of our partners damage their reputation, our partnerships may be less attractive to our current or prospective
members. Any of these failures by us or our partners could adversely affect our business and revenues. In addition, the termination,
variation and non-renewal of contracts may have a material adverse effect on our financial performance, financial position and/or reputation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
some of our long-standing customer relationships are governed by a license agreement, most of our customer relationships are governed
through the acceptance of our terms and conditions at the trainalta.com website.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
existing form of license agreement, in which we act as a principal, is a revenue share arrangement, such that both parties share in each
other&#8217;s success. There are no exclusivity provisions contained in our license agreement and our partner gyms have no right to reduce
or limit their performance under the agreement. Either party may terminate the license upon written notice to the other party. If the
agreement is terminated in this manner, the termination will take effect after the completion of the relevant series and the series finale,
but prior to a new series beginning. Additionally, we may terminate the agreement upon written notice, with immediate effect, upon certain
conduct by the partner gym. If the license is not terminated, it will expire ten years from the commencement date of the agreement. For
more information relating to the key terms of each of our product offerings, please refer to the Business section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
consumers subscribing for the 20-week Warrior Training Program or UFC Fit must accept our terms and conditions, which do not contain
exclusivity provisions and provide no right for the consumer to reduce or limit performance under the agreement. The consumer can terminate
the agreement prior to the start of the program but not once the program has commenced. Similarly, partner gyms that provide the 20-week
Warrior Training Program or UFC Fit must accept our terms and conditions, which do not contain exclusivity provisions and provide no
right for the partner gym to reduce or limit performance under the agreement. Either party may terminate this agreement upon written
notice to the other party. If the agreement is terminated in this manner, the termination will take effect after the completion of the
relevant series and the series finale, but prior to a new series beginning.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
gym academy memberships, there are no exclusivity provisions and no rights for the consumer or the partner gym to reduce or limit performance
under the agreement. Either party may terminate this Agreement upon written notice to the other party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
planned growth could place strains on our management, employees, information systems and internal controls, which may adversely impact
our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the past several years, we have experienced growth in our business activities and operations, including an increase in the number of
partner gyms. Our past expansion has placed, and our planned future expansion may place, significant demands on our administrative, operational,
financial and other resources. Any failure to manage our growth effectively may harm our business. To be successful, we will need to
continue to implement management information systems and improve our operating, administrative, financial and accounting systems and
controls. We will also need to train new employees and maintain close coordination among our executive, accounting, finance, legal, human
resources, risk management, marketing, technology, sales and operations functions. These processes are time-consuming and expensive,
increase management responsibilities and divert management&#8217;s attention, and we may not realize a return on our investment. In addition,
we believe the culture we foster at our and our partner gyms is an important contributor to our success. However, as we expand, we may
have difficulty maintaining our culture or adapting it sufficiently to meet the needs of our operations. These risks may be heightened
as we continue to grow our business. Our failure to successfully execute on our planned expansion of partner gyms could materially and
adversely affect our results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to a number of risks related to automated clearing house, or ACH, credit card and debit card payments we accept.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
accept payments through ACH, credit card and debit card transactions. For ACH, credit card and debit card payments, we pay interchange
and other fees, which may increase over time. An increase in those fees would require us to either increase the prices we charge for
our memberships, which could cause us to lose members, or suffer an increase in our operating expenses, either of which could harm our
operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we or any of our processing vendors have problems with our billing software, or the billing software malfunctions, it could have an adverse
effect on our member satisfaction and could cause one or more of the major credit card companies to disallow our continued use of their
payment products. In addition, if our billing software fails to work properly and, as a result, we do not automatically charge our members&#8217;
credit cards, debit cards or bank accounts on a timely basis or at all, we could lose membership revenue, which may materially harm our
operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to adequately control fraudulent ACH, credit card and debit card transactions, we may face civil liability, diminished public
perception of our security measures and significantly higher ACH, credit card and debit card related costs, each of which could adversely
affect our business, financial condition and results of operations. The termination of our ability to process payments through ACH transactions
or on any major credit or debit card may significantly impair our ability to operate our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
partner gyms may be unable to attract and retain members, which may materially and adversely affect our business, results of operations
and financial condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
target market consists of those seeking regular exercise and those new to martial arts and combat sports. The success of our business
depends on our and our partners&#8217; ability to attract and retain members. Our and our partner gyms&#8217; marketing efforts may not
be successful in attracting members and membership levels may materially decline over time, especially at partner gyms in operation for
an extended period of time. Members may cancel their memberships at any time after giving proper advance written notice, subject to an
initial minimum term applicable to certain memberships. We may also cancel or suspend memberships if a member fails to provide payment
for an extended period of time. In addition, we experience attrition and must continually engage existing members and attract new members
in order to maintain membership levels. Some of the factors that could lead to a decline in membership levels include changing desires
and behaviors of consumers or their perception of our brand, changes in discretionary spending trends and general economic conditions,
market maturity or saturation, a decline in our ability to deliver quality services at competitive prices, direct and indirect competition
in our industry, and a decline in the public&#8217;s interest in health and fitness, among other factors. In order to increase membership
levels, we may from time to time offer promotions. If we and our partner gyms are not successful in optimizing price or in adding new
memberships, our business may suffer. Any decrease in our average dues or fees or higher membership costs may adversely impact our results
of operation and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to identify and secure suitable partner gyms, our revenue growth rate and profits may be negatively impacted.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
successfully expand our business, we must continue to identify and secure gyms to partner with to offer our products and services. In
addition to finding gyms with the right demographic and other measures we employ in our selection process, we also need to evaluate the
penetration of our competitors in the market. Our competitors could copy our format, or we could be forced to pay significantly higher
costs to partner gyms. As we increase our number of partner gyms, we may also partner with gyms in higher-cost geographies, which could
entail greater costs. We may require higher operating margins to produce the level of return we expect. Failure to provide our anticipated
level of return could adversely affect our results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
and our partner gyms could be subject to claims related to health and safety risks.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
of our partner gyms may pose potential health and safety risks to members through the use of our products and services and our partner
gyms&#8217; facilities, including exercise and martial arts and combat sports equipment. Although participants sign waivers prior to
using our products and services, and though our partner gyms carry insurance for the risks associated with our products and services,
claims might be asserted against us and our partner gyms for injuries suffered by or death of members or guests while exercising and
using the facilities at our partner gyms. We may not be able to successfully defend such claims. We also may not be able to maintain
our general liability insurance on acceptable terms in the future or maintain a level of insurance that would provide adequate coverage
against potential claims. Depending upon the outcome, these matters may have a material adverse effect on our results of operations,
financial condition and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to retain our key employees and/or hire additional qualified employees, we may not be able to successfully manage our businesses
and pursue our strategic objectives.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are highly dependent on the services of our senior management team, including our Chief Executive Officer, and other key employees at
our corporate headquarters. Competition for such employees can be intense, and the inability to attract and retain the additional qualified
employees required to expand our activities, or the loss of current key employees, could adversely affect our operating efficiency and
financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of social media may adversely impact our reputation or subject us to fines or other penalties.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been a substantial increase in the use of social media platforms, including blogs, social media websites and other forms of internet-based
communication, which allow individuals access to a broad audience of consumers and other interested persons. Negative commentary about
us may be posted on social media platforms at any time and may harm our reputation or business. Consumers value readily available information
about gyms and often act on such information without further investigation and without regard to its accuracy. The harm may be immediate
without affording us an opportunity for redress or correction. In addition, social media platforms provide users with access to such
a broad audience that collective action against our brand or business, such as boycotts, can be more easily organized. If such actions
were organized, we could suffer reputational damage as well as physical damage to our partner gym locations. We also use social medial
platforms as marketing tools, such as Facebook and Instagram accounts. As laws and regulations rapidly evolve to govern the use of these
platforms and devices, the failure by us, our employees, our partners or third parties acting at our direction to abide by applicable
laws and regulations in the use of these platforms and devices could adversely impact our and our partners&#8217; business, financial
condition and results of operations or subject us to fines or other penalties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to international tax regulations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is expected that a substantial amount of our future revenues will be derived from sales activities in foreign jurisdictions. Recent changes
in the global tax environment focusing on the prevention of tax leakage will require us to have sophisticated systems in place to identify
the jurisdictions in which we will be subject to tax and the correct allocation of taxable income across those jurisdictions. As we have
operations and employees in foreign jurisdictions, there is a risk that we may have a permanent establishment or, depending on the structure
used, controlled foreign subsidiaries. Accordingly, our foreign operations may give rise to foreign tax liabilities including employment
tax obligations which may require registrations with the local tax authorities, payment of income tax and withholding obligations. In
some cases, there may be an attribution of the income from the foreign jurisdiction to the Australian entity which could give rise to
Australian tax liabilities. In addition, our foreign operations may give rise to a transfer pricing risk if we have foreign related entities
and any dealings between the Australian entities and the foreign entities are not at arm&#8217;s length.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to adapt to or manage new content distribution platforms or changes in consumer behavior resulting from new technologies.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
must successfully adapt to and manage technological advances in our industry, including the emergence of alternative distribution platforms.
If we are unable to adopt or are late in adopting technological changes and innovations that other martial arts and combat sports providers
offer, it may lead to a loss of clients subscribing for our content. If we fail to adapt our distribution methods and content to emerging
technologies and new distribution platforms, while also effectively preventing digital piracy, our ability to generate revenue from our
targeted audiences may decline and could result in an adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 25.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
markets in which we operate are highly competitive.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face competition from studio fitness concepts, full-service health clubs; racquet, tennis, country and other athletic clubs, value focused
health clubs, at-home fitness offerings, including digital fitness content and from other forms of entertainment and leisure activities
in a rapidly changing and increasingly fragmented environment. Any increased competition, which may not be foreseeable, or our failure
to adequately address any competitive factors, could result in reduced demand for our business which could have an adverse effect on
our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 25.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be unsuccessful in any strategic acquisitions and investments, and we may pursue acquisitions or investments for their strategic
value in spite of the risk of lack of profitability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may face uncertainty in connection with acquisitions and investments. To the extent we choose to pursue certain investment or acquisition
strategies, we may be unable to identify suitable targets for these deals, or to make these deals on favorable terms. If we identify
suitable acquisition candidates or investments our ability to realize a return on the resources expended pursuing such deals, and to
successfully implement or enter into them will depend on a variety of factors. Additionally, we may decide to make or enter into acquisitions
or investments with the understanding that such acquisitions or investments may not be profitable, but may be of strategic value to us.
We cannot provide assurances that the anticipated strategic benefits of these deals will be realized in the long-term or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to risks associated with operating in international markets.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to risks associated with operating in international markets including, but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">political
    instability, adverse changes in diplomatic relations and unfavorable economic conditions in the markets in which we have international
    operations or into which we may expand;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on the enforcement of intellectual property rights;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    tax consequences;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">less
    sophisticated legal systems in some foreign countries, which could impair our ability to enforce our contractual rights in those
    countries; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in managing operations due to distance, language and cultural differences.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to attract and retain key professional fighters or coaches.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is dependent upon identifying, recruiting and retaining highly regarded professional fighters and coaches to develop, promote
and teach our products and services. We may not be able to attract and retain key professional fighters or coaches due to, among other
things, competition for the same fighters or coaches. Our inability to recruit and retain professional fighters or coaches could adversely
affect our operating results and have a material adverse effect on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
expansion into new markets may present increased risks due to our unfamiliarity with the area, different rules and regulations and challenging
operating environments.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may expand our operations to geographic areas where we have little or no meaningful experience. Those markets may have different competitive
conditions, consumer tastes and discretionary spending patterns than our existing markets, which may cause our services to be less successful
than in existing markets. Expanded operations into new markets may not generate the same level of revenues and may result in higher operating
expenses. There is no guarantee that we will be successful in further expanding our operations and our inability to do so may result
in a material adverse effect on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
MMA Final Fight Night events are subject to governmental and state athletic commission regulation.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
MMA Final Fight Night events are subject to regulation by governmental entities and state athletic commissions within the jurisdiction
of such events. If we operate an MMA Final Fight Night event, we will be responsible for adhering to all government sanctioning requirements
and safety protocols that apply to such an event. If our partner gyms operate an MMA Final Fight Night event, they will have the same
responsibility. If we or our partner gyms fail to adhere to all regulations and protocols, we may be subject to disciplinary action from
the relevant governing body, which may include cancellation of registration, suspension of registration or a written warning. For example,
in Sydney NSW, the Combat Sports Authority of NSW regulates combat sports in accordance with the Combat Sports Act 2013 (the &#8220;Act&#8221;),
the Combat Sports Regulation 2014 and the rules made under section 107 of the Act. The objectives of the Act are to promote the health
and safety of combat sport contestants, promote the integrity of combat sport contests, regulate combat sport contests on a harm minimization
basis and promote the development of the combat sport industry. Persons engaging or participating in combat sports must be registered
under the Act in the appropriate Combatant, Promoter or Industry Participant registration class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Government Regulation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide services in various jurisdictions abroad, and we expect to continue to expand our international presence. We face, and expect
to continue to face, additional risks in the case of our existing and future international operations, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">political
    instability, adverse changes in diplomatic relations and unfavorable economic conditions in the markets in which we have international
    operations or into which we may expand;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">more
    restrictive or otherwise unfavorable government regulation of the entertainment and sports industry, which could result in increased
    compliance costs or otherwise restrict the manner in which we provide services and the amount of related fees charged for such services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on the enforcement of intellectual property rights;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enhanced
    difficulties of integrating any foreign acquisitions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on the ability of foreign subsidiaries to repatriate profits or otherwise remit earnings;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    tax consequences;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">less
    sophisticated legal systems in some foreign countries, which could impair our ability to enforce our contractual rights in those
    countries;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on technology infrastructure;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variability
    in venue security standards and accepted practices; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in managing operations due to distance, language and cultural differences, including issues associated with (i) business practices
    and customs that are common in certain foreign countries but might be prohibited by U.S. law and our internal policies and procedures
    and (ii) management and operational systems and infrastructures, including internal financial control and reporting systems and functions,
    staffing and managing of foreign operations, which we might not be able to do effectively or on a cost&#8212;efficient basis.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
and our partner gyms are also subject to the U.S. Fair Labor Standards Act of 1938, as amended, and various other laws in Australia,
the United States and Europe governing such matters as minimum-wage requirements, overtime and other working conditions. A significant
number of our and our partners&#8217; employees are paid at rates related to the U.S. federal minimum wage, and past increases in the
U.S. federal minimum wage have increased labor costs, as would future increases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
partner gyms are responsible for compliance with state laws that regulate the relationship between martial arts and combat sports clubs
and their members. Nearly all states have consumer protection regulations that limit the collection of monthly membership dues prior
to opening, require certain disclosures of pricing information, mandate the maximum length of contracts and &#8220;cooling off&#8221;
periods for members (after the purchase of a membership), set escrow and bond requirements for health clubs, govern member rights in
the event of a member relocation or disability, provide for specific member rights when a club closes or relocates, or preclude automatic
membership renewals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of the states where our partner gyms operate have health and safety regulations that apply to martial arts and combat sports clubs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the collection, maintenance, use, disclosure and disposal of individually identifiable data by our, or our partners&#8217;, businesses
are regulated at the federal, state and provincial levels as well as by certain financial industry groups, such as the Payment Card Industry
Organization and the NACHA. Federal, state and financial industry groups may also consider from time to time new privacy and security
requirements that may apply to our businesses and may impose further restrictions on our collection, disclosure and use of individually
identifiable information that are housed in one or more of our databases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulators
may impose significant fines for privacy and data protection violations. Our business operations involve the collection, transfer, use,
disclosure, security, and disposal of personal or sensitive information in various locations around the world, including the E.U. In
Australia, the collection, use, storage and disclosure of personal and sensitive information is governed by the Privacy Act 1988 (Cth)
(&#8220;Privacy Act&#8221;) and the Australian Privacy Principles contained at Schedule 1 of the Privacy Act (&#8220;Australian Privacy
Principles&#8221;). Failures or breaches of data protection systems can result in reputational damage, regulatory impositions (such as
for breaches of the Privacy Act or Australian Privacy Principles) and financial loss, including claims for compensation by customers
or penalties by the Australian telecommunications regulators or other authorities. As a result, our business is subject to complex and
evolving Australian, U.S. and international laws and regulations regarding privacy and data protection. Many of these laws and regulations
are subject to change and uncertain interpretation and could result in claims, changes to our business practices, penalties, increased
cost of operations, or otherwise harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States and certain foreign jurisdictions, we may have direct and indirect interactions with government agencies and state-affiliated
entities in the ordinary course of our business. In particular, athletic commissions and other applicable regulatory agencies require
us to obtain licenses for promoters, medical clearances, licenses for athletes, or permits for events in order for us to promote and
conduct our live events and productions. In the event that we fail to comply with the regulations of a particular jurisdiction, whether
through our acts or omissions or those of third parties, we may be prohibited from promoting and conducting our live events and productions
in that jurisdiction. The inability to present our live events and productions in jurisdictions could lead to a decline in various revenue
streams in such jurisdictions, which could have an adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended (the &#8220;<b>FCPA</b>&#8221;), and other anti-bribery and
anti-money laundering laws in countries outside of the United States in which we conduct our activities. The FCPA generally prohibits
companies and their intermediaries from making, promising, authorizing or offering improper payments or other things of value to foreign
government officials for the purpose of obtaining or retaining business, directing business to any person, or securing any improper business
advantage. The FCPA also requires U.S. issuers to make and keep books and records that accurately and fairly reflect the transactions
of the corporation and to devise and maintain an adequate system of internal accounting controls. Other countries in which we operate
also have anti-bribery laws, some of which prohibit improper payments to government and non-government persons and entities. We operate
in a number of countries which are considered to be at a heightened risk for corruption. Additionally, we operate adjacent to industry
segments, such as sports marketing, that have been the subject of past anti-corruption enforcement efforts. As a global company, a risk
exists that our employees, contractors, agents, managers, or other business partners or representatives could engage in business practices
prohibited by applicable U.S. laws and regulations, such as the FCPA, as well as the laws and regulations of other countries prohibiting
corrupt payments to government officials and others, such as the Bribery Act. There can be no guarantee that our compliance programs
will prevent corrupt business practices by one or more of our employees, contractors, agents, managers, or vendors, or that regulators
in the U.S. or in other markets will view our program as adequate should any such issue arise. Any actual or alleged violation of the
FCPA or other applicable anti-corruption laws could result in whistleblower complaints, sanctions, settlements, prosecution, enforcement
actions, fines, damages, adverse media coverage, investigations, severe criminal or civil sanctions, any of which could have a material
adverse effect on our reputation, as well as our business, financial condition, results of operations and prospects. Responding to any
investigation or action would also likely result in a materially significant diversion of management&#8217;s attention and resources
and significant defense costs and other professional fees. In addition, the U.S. government may seek to hold us liable for successor
liability for FCPA violations committed by companies in which we invest or that we acquire.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also required to comply with economic sanctions laws imposed by the United States or by other jurisdictions where we do business,
which may restrict our transactions in certain markets, and with certain customers, business partners, and other persons and entities.
As a result, we may be prohibited from, directly or indirectly (including through a third-party intermediary), procuring goods, services,
or technology from, or engaging in transactions with, individuals and entities subject to sanctions, including sanctions arising from
the conflict involving Russia and Ukraine. We cannot guarantee that our efforts to remain in compliance with sanctions requirements will
be successful. Any violation of sanctions laws could result in fines, civil and criminal sanctions against us or our employees, prohibitions
on the conduct of our business (e.g., debarment from doing business with International Development Banks and similar organizations),
and damage to our reputation, which could have an adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
various regulations set out above have not materially impacted or affected the offering of our four core products: the Warrior Training
Program, UFC Fit Program, Alta Academy and the Alta Community.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are an &#8220;emerging growth company,&#8221; and our election to comply with the reduced disclosure requirements as a public company
may make our Ordinary Shares less attractive to investors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. For as long as we continue to be an emerging growth company,
we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies, including exemption from compliance with the auditor attestation requirements of Section 404, reduced disclosure obligations
regarding executive compensation and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation
and stockholder approval of any golden parachute payments not previously approved. We will remain an emerging growth company until the
earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the closing of our IPO, (b) in which we have total
annual gross revenue of at least US$1.235 billion or (c) in which we are deemed to be a large accelerated filer, which means the market
value of our Ordinary Shares held by non-affiliates exceeds US$700 million as of the end of our prior second fiscal quarter, and (2)
the date on which we have issued more than US$1.0 billion in non-convertible debt during the prior three-year period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards until such time as those
standards apply to private companies. We may, in the future, elect not to avail ourselves of this exemption from new or revised accounting
standards and, therefore, may be subject to the same new or revised accounting standards as other public companies that are not emerging
growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict if investors will find our Ordinary Shares less attractive because we may rely on these exemptions. If some investors
find our Ordinary Shares less attractive as a result, there may be a less active trading market for our Ordinary Shares and our share
price may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to establish and maintain proper internal controls, our ability to produce accurate financial statements or comply with applicable
regulations could be impaired.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
404(a) of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, requires that, beginning with this annual report for the year ending
June 30, 2024, our management must assess and report annually on the effectiveness of our internal controls over financial reporting
and identify any material weaknesses in our internal controls over financial reporting. Although Section 404(b) of the Sarbanes-Oxley
Act requires our independent registered public accounting firm to issue an annual report that addresses the effectiveness of our internal
controls over financial reporting, we have opted to rely on the exemptions provided to us by virtue of being a foreign private issuer
and emerging growth company, and consequently will not be required to comply with SEC rules that implement Section 404(b) of the Sarbanes-Oxley
Act until we lose our emerging growth company status.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to maintain and improve the effectiveness of our disclosure controls and procedures and internal controls over financial reporting,
we will need to expend significant resources and provide significant management oversight. We have commenced the process of reviewing
and improving our internal controls over financial reporting for compliance with Section 404(a) of the Sarbanes Oxley Act. Implementing
any appropriate changes to our internal controls may require specific compliance training for our directors and employees, entail substantial
costs in order to modify our existing accounting systems, take significant periods of time to complete, and divert management&#8217;s
attention from other business concerns. These changes may not, however, be effective in maintaining the adequacy of our internal controls.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this filing, we have identified deficiencies in our internal controls that are deemed to be a material weakness. The matters
involving internal controls and procedures that our management considered to be a material weakness under the standards of the United
States Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;) were (1) the lack of a formally implemented system of internal
control over financial reporting and limited or no associated written documentation of our internal control policies and procedures,
and (2) the lack of sufficient resources and key accounting personnel with sufficient knowledge and experience in reporting and compliance
with the SEC and PCAOB. Consequently, we have determined there is a material weakness in our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
this material weakness did not result in material adjustments to the financial statements, there is a reasonable possibility that a material
misstatement of the annual financial statements would not have been prevented or detected on a timely basis due to the failure to design
and implement appropriate segregation of duty controls. We are still in the process of remediating these control weaknesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to remediate the identified material weaknesses, group finance continues to enhance the finance and reporting function with the
support of the Audit and Risk Committee, whose primary purpose is to assist the Board in overseeing the integrity of the Company&#8217;s
financial statements, compliance with legal and regulatory requirements, the Company&#8217;s independent registered auditors&#8217; qualifications
and independence, and the performance of the Company&#8217;s independent registered auditors, and the design and implementation of the
Company&#8217;s internal audit function.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we plan to further remediate the identified material weaknesses by implementing and enhancing the following controls:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delegation
    of authority, documenting stringent controls throughout the business. This will be reviewed by the Board on an annual basis, or more
    frequently if there are significant changes in the business.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continue
    to upgrade our financial reporting close process. This process will include enhancing the monthly review process performed by both
    the CFO and CEO, and formal reporting to the Board.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documenting
    our internal control policies and procedures and designing an education process for the entire Company to ensure policies and procedures
    are understood and adhered to by all.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establishing
    effective monitoring and oversight controls for non-recurring and complex transactions to ensure the accuracy and completeness of
    our company&#8217;s consolidated financial statements and related disclosures.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
support of the above, we intend to enhance the finance and accounting function with additional key hires with relevant skills and continuing
professional education of all staff.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to conclude that we have effective internal controls over financial reporting or, at the appropriate time, our independent
auditors are unwilling or unable to provide us with an unqualified report on the effectiveness of our internal controls over financial
reporting as required by Section 404(b) of the Sarbanes-Oxley Act, investors may lose confidence in our operating results, the price
of our Ordinary Shares could decline and we may be subject to litigation or regulatory enforcement actions. In addition, if we are unable
to meet the requirements of Section 404 of the Sarbanes-Oxley Act, we may not be able to remain listed on the NYSE American.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will incur increased costs as a result of having become a listed public company.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a listed public company, we incur legal, accounting, insurance and other expenses that would not be incurred by a private company, including
costs associated with public company reporting requirements. We are an Australian public company and will incur costs in order to comply
with the Corporations Act requirements for financial reporting. The Corporations Act reporting standards differ in certain significant
respects from generally accepted accounting principles in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also have incurred and will incur costs associated the Exchange Act, the Sarbanes-Oxley Act, the related rules implemented by the SEC
and the rules and regulations of the applicable listing standards of the NYSE American. We expect these rules and regulations to increase
our legal and financial compliance costs and to make some activities more time-consuming and costly, although we are currently unable
to estimate these costs with any degree of certainty. These and other laws and regulations could also make it more difficult or costly
for us to obtain certain types of insurance, including director and officer liability insurance, and we may be forced to accept reduced
policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. These and other laws and regulations
could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees
or as our senior management. Furthermore, if we are unable to satisfy our obligations as a public company, we could be subject to delisting
of our Ordinary Shares, fines, sanctions and other regulatory action and potentially civil litigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market price of our Ordinary Shares could fluctuate significantly, and you could lose all or part of your investment.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our Ordinary Shares could fluctuate significantly as a result of a number of factors, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations
    in our financial performance;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">economic
    and stock market conditions generally and specifically as they may impact us, participants in our industry or comparable companies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in financial estimates and recommendations by securities analysts following our Ordinary Shares or comparable companies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">earnings
    and other announcements by, and changes in market evaluations of, us, participants in our industry or comparable companies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to meet or exceed any future earnings guidance we may issue;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in business or regulatory conditions affecting us, participants in our industry or comparable companies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in accounting standards, policies, guidance, interpretations or principles;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    or implementation by our competitors or us of acquisitions, technological innovations, or other strategic actions by our competitors;
    or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">trading
    volume of our Ordinary Shares or sales of shares by our management team, directors or principal shareholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
and other factors could limit or prevent investors from readily selling their Ordinary Shares or otherwise negatively affect the liquidity
of our Ordinary Shares, and you could lose all or part of your investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market price of our Ordinary Shares could be adversely affected by future sales and distributions of our Ordinary Shares or the perception
that such sales and distributions may occur.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
sales, distributions or issuances of a substantial number of our Ordinary Shares or the perception that such sales or distributions might
occur, could cause a decline in the market price of our Ordinary Shares or could impair our ability to obtain capital through a subsequent
offering of our equity securities or securities convertible into equity securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities or industry analysts do not publish research or reports about our business, or publish negative reports about our business,
our share price and trading volume could decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our Ordinary Shares will depend, in part, upon the research and reports that securities or industry analysts publish
about us or our businesses. We do not have any control over analysts as to whether they will cover us, and if they do, whether such coverage
will continue. If analysts do not commence coverage of us, or if one or more of these analysts cease coverage of us or fail to regularly
publish reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline.
In addition, if one or more of the analysts who cover us downgrade our Ordinary Shares or change their opinion of our Ordinary Shares,
our share price may likely decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may issue additional Ordinary Shares in the future, which may dilute our existing shareholders. We may also issue securities that have
rights and privileges that are more favorable than the rights and privileges accorded to our existing shareholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue additional securities in the future, including Ordinary Shares, and options, rights, warrants and other convertible securities
for any purpose and for such consideration and on such terms and conditions we may determine appropriate or necessary, including in connection
with equity awards, financings or other strategic transactions. Subject to the requirements of the Corporations Act, our board of directors
will be able to determine the class, designations, preferences, rights and powers of any additional shares, including any rights to share
in our profits, losses and dividends or other distributions, any rights to receive assets upon our dissolution or liquidation and any
redemption, conversion and exchange rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are not likely to issue dividends for the foreseeable future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that our proposed operations will result in sufficient revenues to enable profitable operations or to generate positive
cash flow. For the foreseeable future, we anticipate that we will use any funds available to finance our growth and that we will not
pay cash dividends to shareholders. Unless we pay dividends, our shareholders will not be able to receive a return on their shares unless
they sell them. There is no assurance that shareholders will be able to sell shares when desired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
a foreign private issuer, we are permitted and expect to follow certain home country corporate governance practices in lieu of certain
NYSE American requirements applicable to domestic issuers.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a foreign private issuer listed on the NYSE American, we are permitted to follow certain home country corporate governance practices
in lieu of certain NYSE American practices. Following our home country corporate governance practices, as opposed to the requirements
that would otherwise apply to a U.S. company listed on the NYSE American, may provide less protection than is afforded to investors under
the NYSE American rules applicable to domestic issuers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
particular, we follow home country law instead of the NYSE American practice regarding:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    NYSE American&#8217;s requirement to have a compensation committee and a nominating and corporate governance committee composed solely
    of independent members of the board of directors.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    NYSE American&#8217;s requirement that our independent directors meet in regularly scheduled executive sessions. The Corporations
    Act does not require the independent directors of an Australian company to have such regularly scheduled executive sessions and,
    accordingly, we have claimed this exemption.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    NYSE American&#8217;s corporate governance listing standards applicable to domestic issuers requiring disclosure within four business
    days of any determination to grant a waiver of the code of business conduct and ethics to directors and officers. Although we will
    require board approval of any such waiver, we may choose not to disclose the waiver in the manner set forth in the NYSE American
    corporate governance listing standards, as permitted by the foreign private issuer exemption.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    NYSE American&#8217;s requirement that an issuer provide for a quorum as specified in its bylaws for any meeting of the holders of
    ordinary shares, which quorum may not be less than 33 1/3% of the outstanding shares of an issuer&#8217;s voting ordinary shares.
    In compliance with Australian law, our Constitution provides that two shareholders present shall constitute a quorum for a general
    meeting.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    seek exemption from the NYSE American requirement that issuers obtain shareholder approval prior to the issuance of securities in
    connection with certain acquisitions, private placements of securities, the establishment or amendment of certain stock option, purchase
    or other compensation plans. Applicable Australian laws differ to NYSE American requirements, with the former requiring prior shareholder
    approval in numerous circumstances, including (i) issuance of equity securities to related parties, e.g. directors or their associates
    other than (generally speaking), in their sole capacity as an existing security holder (where the benefit is provided on the same
    terms to all other security holders), or in certain circumstances where the benefit provided through the issuance is on arms&#8217;
    length terms, or (ii) the issuance results in a shareholder or their associates obtaining a relevant interest (as that term is defined
    in Australian law) increasing to more than 20%, or increasing from a starting point that is above 20% and below 90%.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to take all actions necessary for us to maintain compliance as a foreign private issuer under the applicable corporate governance
requirements of the Sarbanes-Oxley Act, the rules adopted by the SEC and the NYSE American corporate governance rules and listing standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we are a foreign private issuer, our officers, directors and principal shareholders are not subject to short-swing profit and insider
trading reporting obligations under Section 16 of the Exchange Act. They will, however, be subject to the obligations to report changes
in share ownership under Section 13 of the Exchange Act and related SEC rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
a foreign private issuer, we are permitted to file less information with the SEC than a domestic issuer.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a foreign private issuer, we are exempt from certain rules under the Exchange Act that impose requirements for proxy solicitations under
Section 14 of the Exchange Act. In addition, our officers, directors and principal shareholders are exempt from the reporting and &#8220;short-swing&#8221;
profit recovery provisions of Section 16 of the Exchange Act. Moreover, we are not required to file periodic reports and financial statements
with the SEC as frequently or as promptly as a domestic issuer, nor are we generally required to comply with the SEC&#8217;s Regulation
FD, which restricts the selective disclosure of material non-public information. Under Australian law, we prepare financial statements
on an annual and semi-annual basis, we are not required to prepare or file quarterly financial information. For as long as we are a &#8220;foreign
private issuer,&#8221; we intend to file our annual financial statements on Form 20-F and furnish our semi-annual financial statements
on Form 6-K to the SEC as long as we are subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act. However, the
information we file or furnish is not the same as the information that is required in annual on Form 10-K or Form 10-Q for U.S. domestic
issuers. Accordingly, there may be less information publicly available concerning us then there is for a company that files as a domestic
issuer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may lose our foreign private issuer status, which would then require us to comply with the Exchange Act&#8217;s domestic reporting regime
and cause us to incur additional legal, accounting and other expenses.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to determine our status as a foreign private issuer on an annual basis at the end of our second fiscal quarter. In order
to maintain our current status as a foreign private issuer, either (1) a majority of our Ordinary Shares must be either directly or indirectly
owned of record by non-residents of the United States or (2) (a) a majority of our executive officers or directors must not be U.S. citizens
or residents, (b) more than 50% of our assets cannot be located in the United States and (c) our business must be administered principally
outside the United States. If we lost this status, we would be required to comply with the Exchange Act reporting and other requirements
applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may
also be required to make changes in our corporate governance practices and to comply with United States generally accepted accounting
principles, as opposed to IFRS. The regulatory and compliance costs to us under U.S. securities laws if we are required to comply with
the reporting requirements applicable to a U.S. domestic issuer may be higher than the cost we would incur as a foreign private issuer.
As a result, we expect that a loss of foreign private issuer status would increase our legal and financial compliance costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Constitution and Australian laws and regulations applicable to us may adversely affect our ability to take actions that could be beneficial
to our shareholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an Australian company we are subject to different corporate requirements than a corporation organized under the laws of the United States.
Our Constitution, as well as the Australian Corporations Act, set forth various rights and obligations that are unique to us as an Australian
company. These requirements may operate differently than those of many U.S. companies. You should carefully review the summary of these
matters set forth under the section entitled &#8220;Description of Share Capital&#8221;, and the copy of our Constitution (which is included
as an exhibit to this report), prior to investing in the Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
NYSE American may delist our Ordinary Shares from trading on its exchange, which could limit investors&#8217; ability to make transactions
in our Ordinary Shares and subject us to additional trading restrictions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that our Ordinary Shares will continue to be listed on the NYSE American in the future. In order to continue listing
our Ordinary Shares on the NYSE American, we must maintain certain financial, distribution and share price levels and must maintain a
minimum number of holders of our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the NYSE American delists our Ordinary Shares and we are not able to list our Ordinary Shares on another national securities exchange,
a reduction in some or all of the following may occur, each of which could have a material adverse effect on our shareholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    liquidity of our Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    market price of our Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain financing for the continuation of our operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of investors that will consider investing in our Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of market makers in our Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    availability of information concerning the trading prices and volume of our Ordinary Shares; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of broker-dealers willing to execute trades in our Ordinary Shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Australian
companies may not be able to initiate shareholder derivative actions, thereby depriving shareholders of the ability to protect their
interests.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a public company limited by shares, registered and operating under the Corporations Act in Australia. Australian companies may not
have standing to initiate a shareholder derivative action in a federal court of the United States. The circumstances in which any such
action may be brought, and the procedures and defenses that may be available in respect to any such action, may result in the rights
of shareholders of an Australian company being more limited than those of shareholders of a company organized in the United States. Accordingly,
shareholders may have fewer alternatives available to them if they believe that corporate wrongdoing has occurred. Unless certain narrowly
identified principles exist, Australian courts are also unlikely to recognize or enforce against us judgments of courts in the United
States based on certain liability provisions of U.S. securities law and to impose liabilities against us, in original actions brought
in Australia, based on certain liability provisions of U.S. securities laws that are penal in nature. There is no statutory recognition
in Australia of judgments obtained in the United States, although the courts of Australia may recognize and enforce the non-penal judgment
of a foreign court of competent jurisdiction without retrial on the merits, upon being satisfied about all the relevant circumstances
in which that judgment was obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Anti-takeover
provisions in our Constitution and our right to issue preference shares could make a third-party acquisition of us difficult.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
provisions of our Constitution may discourage, delay or prevent a change in control or management that shareholders may consider favorable,
including power to issue preference shares and the proportional takeover approval provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Constitution, any proportional takeover scheme must be approved by those shareholders holding shares included in the class of shares
in respect of which the offer to acquire those shares was first made. The registration of the transfer of any shares following the acceptance
of an offer made under a scheme is prohibited until that scheme is approved by the relevant shareholder class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also subject to the relevant takeover laws contained in Chapter 6 of the Corporations Act. Subject to a range of exceptions, the
Corporations Act prohibits the acquisition of a direct or indirect interest in issued voting shares of a company, if the acquisition
of that interest will lead to a person&#8217;s voting power (either alone or in combination with their &#8220;associates&#8221; as that
term is defined in the Corporations Act) in that company increasing to more than 20%, or increasing from a starting point that is above
20% and below 90% which may discourage takeover offers being made for us or may discourage the acquisition of a significant position
in our Ordinary Shares. This may have the ancillary effect of entrenching our board of directors and may deprive or limit our shareholders
the opportunity to sell their Ordinary Shares and may further restrict the ability of our shareholders to obtain a premium from such
transactions. See &#8220;Description of Share Capital.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
will have limited ability to bring an action against us or against our directors and officers, or to enforce a judgment against us or
them, because we are incorporated in Australia and certain of our directors and officers reside outside the United States.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated in Australia, certain of our directors and officers reside outside the United States and substantially all of the assets
of those persons are located outside the United States. As a result, it may be impracticable or at least more expensive for you to bring
an action against us or against these individuals in Australia in the event that you believe that your rights have been infringed under
the applicable securities laws or otherwise. There is doubt as to the enforceability in the Commonwealth of Australia, in original actions
or in actions for enforcement of judgments of U.S. courts, of civil liabilities predicated solely upon federal or state securities laws
of the U.S., especially in the case of enforcement of judgments of U.S. courts where the defendant has not been properly served in Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    4.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_010"></span>INFORMATION
    ON THE COMPANY</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_011"></span>A.
History and Development of the Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a technology-driven company transforming the global martial arts and combat sports industry by unlocking new monetization opportunities
and driving greater consumer participation. While martial arts and combat sports gyms offer excellent in-gym experiences, they are poised
for growth in building sales channels, improving customer onboarding, and optimizing member engagement, growth, and retention within
their communities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
platform represents a unique opportunity to consolidate the global community of martial arts and combat sports through a single, comprehensive
digital solution that facilitates the sector&#8217;s evolution. By converting one of the world&#8217;s largest fan bases into active
participants, our platform is redefining engagement. We offer four core products: the Warrior Training Program, UFC Fight Fit Program,
Alta Academy, and the Alta Community. The Warrior Training Program, which we have successfully commercialized globally, has been instrumental
in helping us partner with leading gyms and coaches worldwide while building a strong base of enthusiastic participants and customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MMA
is among the fastest-growing sports globally in terms of both participation and audience growth, with millions of dedicated fans engaging
with the sport daily, both digitally and in-person. In the US alone, there are over 45,000 martial arts and combat sports gyms generating
more than US$12.6 billion in annual revenue, according to IBISWorld. Moreover, the Sports &amp; Fitness Industry Association estimates
that over 11.8 million people will engage in various martial arts disciplines this year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
benefit from the growth fueled by professional MMA leagues such as the UFC, PFL, ONE Championship, and Bellator. Their marketing and
broadcast reach continue to expand the sport&#8217;s fan base, providing a fertile environment for us to convert interest into participation
through our premium online and in-gym training experiences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
further scale our impact, we have partnered with globally recognized athletes, coaches, and influencers who promote our vision and drive
the adoption of our platform. Key ambassadors include MMA icons such as UFC champion Daniel Cormier, UFC broadcaster Laura Sanko, and
Eugene Bareman, head coach at City Kickboxing. Additionally, one of our co-founders, John Kavanagh, is a renowned MMA coach known for
training Conor McGregor, and he has helped develop exclusive training programs offered through our platform, including at his gym, SBG
Ireland.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
deep knowledge of the sector, accumulated since our inception, has enabled us to understand the unique needs of gyms, coaches, and consumers
in martial arts and combat sports. With over 4,000 gym records in our global database and 550 gyms already on the Alta Platform, we&#8217;ve
created an optimal pathway for consumer engagement, including diverse training disciplines like jiu-jitsu, boxing, MMA, Muay Thai, judo,
and karate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2018, we have successfully run 206 Warrior Training Programs globally, engaging over 5,100 participants, averaging 25 per program. Our
revenue model has proven successful, with the average gross revenue per participant in the program being A$1,496. The Warrior Training
Program offers a 20-week, 100-lesson curriculum that introduces participants to the foundations of MMA. At the end of the program, participants
have the opportunity to compete in a sanctioned amateur MMA contest, creating a clear path from learning the fundamentals of various
disciplines to in-competition experience. Many participants choose to continue training or specialize in a particular martial art, driving
long-term engagement and revenue for both our partner gyms and Alta.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
partner gyms have seen tangible growth in revenue and membership due to increased participation and engagement. Our unique community-based
approach has expanded the participation demographics of martial arts worldwide, with significant female representation and an average
participant age in the mid-to-late 30s, with some participants in their 60s. Graduates of our programs often become long-term, loyal
members of both the Alta and gym communities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We&#8217;ve
also established a Partner Referral Agreement with UFC Gym, co-designing and launching the UFC Fight Fit Program, a 10-week Alta training
program. UFC Gym has the option to roll out this program across its 150+ global locations, further extending our reach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Alta Community product, an extension of our core offerings, is the first global, cloud-based community growth and management platform
for martial arts and combat sports. It&#8217;s designed to connect participants, coaches, and gym operators worldwide, fostering individual
and collective community growth. This tool is essential for optimizing the digital and in-gym experience of our members, facilitating
easier discovery, participation, and connection within the martial arts world, all through a simple monthly subscription model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conclusion, by combining our proprietary training programs with the Alta Community platform, we&#8217;ve created a commercial environment
that enhances efficiency and drives growth. Our first-mover advantage positions us to lead the aggregation of this large, untapped sector
by providing an accessible, inclusive &#8220;on-ramp&#8221; to martial arts participation, no matter the location.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta&#8217;s
long-term growth strategy focuses on building a unified global platform that connects martial arts fans, participants, gym operators,
and coaches. By integrating digital experiences with key business tools, we streamline gym operations, enhance participant engagement,
and unlock new revenue streams. Our platform simplifies customer acquisition, member management, and payments for gyms while increasing
accessibility through web, app, and social channels. Additionally, embedded monetization opportunities like subscriptions, merchandise,
and partnerships drive sustainable revenue growth and maximize user lifetime value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we continue to expand into North America, the UK, Australia, and beyond&#8212;coupled with our growing partnerships, including UFC Gym&#8212;Alta
is strategically positioned for scalable global growth. Our platform unites the MMA community, empowering fans and participants alike
to connect deeply with the sport. Through our combined B2C and B2B offerings and ongoing investment in technology, we&#8217;re building
long-term value for all stakeholders and shaping the future of the martial arts industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Progress</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
July 1, 2023, we have increased our gym footprint, expanding into new territories including Illinois, Arizona and Hawaii. We have also
engaged major martial arts academies including Renzo Gracie, American Top Team and American Kickboxing Academy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2023, we launched our first online offering, the Alta Academy, to complement and further leverage our in-gym training experiences
for our customers. This activates our multi-year exclusive content agreements with our key global talent, which is a critical element
of our top of funnel marketing systems to drive in-gym participation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
launch of the Alta Academy, we have expanded our digital content, including the digital syllabus for the Warrior Training Program, and
extended our online training into other disciplines beyond MMA, including jiu jitsu, boxing, wrestling, and Muay Thai, among others,
with new masterclasses delivered by our elite coaching talent, including Rafael Cordeiro, Mike Angove, Nikki Lloyd-Griffiths.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2023, we launched four new membership tiers for Alta members, including an In-Gym Training membership tier, which leverages
underutilized capacity within our gym partner network and allows Alta members to train in our partner gyms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2023, we launched the first iteration of the Alta Community platform, which we believe will drive the growth of the gym and
coaching communities through the provision of new content and channels. This included the launch of gym channels. The gym channels feature
is used to house multimedia content that pertains to a specific gym&#8217;s profile on the Alta Community. This currently includes multimedia
content such as gym walkthrough videos (point of view videos demonstrating the gym&#8217;s facility) as well as interviews with gym owners
and coaches.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2023, we successfully completed our pilot UFC Fit program with UFC Gym in San Jose, California.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2023, we completed the acquisition of the assets of Steppen Pty Ltd, a fitness technology company based in Australia (&#8220;Steppen&#8221;).
Steppen is a dynamic fitness app designed to inspire, guide, and support users on their fitness journey. The Steppen platform quickly
resonated with young fitness enthusiasts around the globe, particularly in the U.S., accumulating a large following quickly after its
global launch in mid-2021. The Steppen App has seen success with over 395,000 downloads, predominantly from the U.S., reaching over 1.8
million impressions on the Apple App Store. With a robust database of over 270,000 accounts, we believe that the Steppen App has established
a substantial user base. We plan to continue Steppen App&#8217;s operations and integrate key aspects of its proprietary Apple mobile
application technology, while exploring ways to optimize content and services for users, leveraging the acquired expertise and technology.
We believe the synergy from this acquisition is poised to drive growth, diversification, and market expansion for Alta in the burgeoning
health and wellness sector. As consideration for the asset acquisition, we issued Steppen an unsecured and non-redeemable convertible
promissory note (on the same terms as the private placement completed in June 2023 (the &#8220;Private Placement&#8221;)), with a principal
amount of US$64,977.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2023, we completed the acquisition of the assets of Mixed Martials Arts LLC, an independent MMA media company, based in the U.S.
Mixed Martial Arts LLC represents a valuable opportunity to us, as it is one of the last independent MMA media companies not acquired
by a major corporation, making it a novel asset in the digital MMA landscape. With a substantial digital presence, the platform boasts
more than 260,000 forum accounts, more than 350,000 monthly engaged sessions, and a significant social media footprint, including over
5 million followers across Facebook pages. Mixed Martial Arts LLC has previously initiated effective monetization strategies, generating
peak annual revenues of up to US$600,000. With the right investment in technology and user engagement, we believe there is considerable
potential for revitalizing and growing the platform&#8217;s user base and revenue streams. As consideration for the asset acquisition,
we issued Mixed Martials Arts LLC an unsecured and non-redeemable convertible promissory note (on the same terms as the recently completed
Private Placement), with a principal amount of US$250,000 and paid US$25,000 in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2023, we launched ticketing services for live Alta events and seminars, including the Warrior Training Program finale events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 2, 2024, we completed our initial public offering, raising US$6,500,000 by selling 1,300,000 shares at US$5.00 per share. All previously
issued convertible notes were converted or redeemed. As of June 30, 2024, there are no convertible notes, host, or derivative liabilities
on the Consolidated Statement of Financial Position. Remaining interest and final fair value movement in derivative liability are reflected
in the Consolidated Statement of Profit or Loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Throughout
April 2024, we partnered with renowned combat sports figures, including Rafael Cordeiro (Mike Tyson&#8217;s coach) for online Muay Thai
training and former UFC champion Daniel Cormier for wrestling instructional videos, targeting both beginners and seasoned athletes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2024, we celebrated success in expanding the global MMA community. The Warrior Training Program at SBG Ireland has historically attracted
over 700 new members, boosting gym memberships and revenue. MMA superstar Conor McGregor, an Alta investor, endorsed the program to help
drive global combat sports participation. We also announced a strategic partnership with Upper Management in Mexico to launch the Warrior
Training Program in multiple gyms and create content for the burgeoning Mexican MMA fanbase. Further, we also showcased our partnership
with City Kickboxing in New Zealand, transforming over 800 beginners into cage-ready athletes through the Warrior Training Program, significantly
boosting gym memberships and community engagement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2024, we completed the acquisition of the assets of Hype Kit, Inc. (&#8220;Hype&#8221;) for US$100,000, an all-in-one digital marketing
platform, designed to help small businesses grow in today&#8217;s age of social media. Hype&#8217;s software platform strengthens the
Company&#8217;s vision to convert 640 million MMA fans to participants by providing invaluable tools to our gym owner, coach, and athlete
partners to not only grow their revenues, but also operate more efficiently, save costs and enhance the offerings to their members and
community. This acquisition is expected to accelerate Alta&#8217;s technology roadmap, bringing forward new subscription revenue opportunities
for us, whilst creating cost synergies by materially reducing product development overhead and bringing valuable technology expertise,
skills and talent into the business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2024, we partnered with legendary MMA coach Eric Nicksick and former UFC fighters Jessica-Rose Clark and Gilbert Melendez to help
strengthen our connection to 640 million global MMA fans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, we announced a revenue share agreement with UFC Gym Group in relation to the intention of rolling out the Warrior Training
Program and Hype across UFC Gym Group&#8217;s global network of gyms, consisting of both corporate-owned and franchise locations (with
over 150 locations in 40 countries, including 80 in the United States). In addition, UFC Gym Group has hundreds of gyms in development.
In the initial phase, these programs are expected to be introduced in locations across the United States, the Middle East, the UK, Germany,
Mexico, India and Central Asia. Any revenue from the Warrior Training Program will be shared, with the UFC Gym Group receiving 70% and
the Company receiving 30%. The agreement is effective for three years and either party may terminate the agreement upon written notice
to the other of a breach of the agreement if such breach is not cured within 10 days following receipt of written notice of the breach.
In addition, UFC Gym Group can terminate the agreement upon 60 days written notice to us. While we can provide no assurances, we believe,
based on historical operating data, that this partnership has the potential to produce gross revenue of over US$7 million per annum,
with the ability to grow with UFC Gym Group as they develop additional locations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, Conor McGregor was appointed as a global ambassador (&#8220;Ambassador Agreement&#8221;) and will provide services customarily
associated with such roles for a company in the mixed martial arts and technology sector (&#8220;Services&#8221;). The term of the Ambassador
Agreement shall be effective for three years and either party may terminate the agreement upon 10 days prior written notice if the other
party breaches the agreement and does not cure such breach within such time period. In consideration for providing these Services under
the Ambassador Agreement, and pursuant to the exemption from registration provided for in Regulation S promulgated under the Securities
Act, Mr. McGregor received 700,000 performance share rights that will vest once the 30-day volume-weighted average price (VWAP) achieves
the following trigger: 150,000 shares on execution of the Ambassador Agreement; 100,000 shares when the share price reaches US$7.50;
150,000 shares when the share price reaches US$10.00; 150,000 shares when the share price reaches US$15.00 and 150,000 shares when the
share price reaches US$20.00. Aligned with the three (3) year term of the Ambassador Agreement, Mr. McGregor is restricted from selling
shares within three (3) years of issuance unless specific conditions are met, such as the Company&#8217;s written consent, a sale or
liquidation of the Company, or if the Company breaches the agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated on March 27, 2013 under the laws of Australia under the name Wimp 2 Warrior Limited and changed our name to Alta Global
Group Limited on February 2, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at Level 1, Suite 1, 29-33 The Corso, Manly, New South Wales 2095, and our telephone number there
is +61 1800 151 865. Our website address is https://www.trainalta.com. Information on our website is not incorporated by reference into
or otherwise part of this annual report. Our annual reports on Form 20-F, current reports on Form 6-K, amendments to these reports, and
other information regarding issuers that file electronically with the SEC, can be accessed, free of charge, on the SEC&#8217;s website
at www.sec.gov.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a foreign private issuer as defined by the rules under the Securities Act and the Exchange Act. Our status as a foreign private issuer
also exempts us from compliance with certain laws and regulations of the SEC and certain regulations of the NYSE American, including
the proxy rules, the short-swing profits recapture rules, and certain governance requirements such as independent director oversight
of the nomination of directors and executive compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Initial Public Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2024, the registration statement on Form F-1 (File No 333-275618) relating to the IPO of our Ordinary Shares was declared effective
by the SEC. On April 2, 2024, we closed our IPO, pursuant to which we issued and sold 1,300,000 Ordinary Shares. Our Ordinary Shares
began trading on the NYSE American on March 28, 2024, under the symbol &#8220;MMA.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_012"></span>B.
Business Overview</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Mission</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
Alta we strive to enrich lives by enabling <span style="text-decoration: underline">all</span> people to participate in the community and transformational power of martial arts.
Our mission is to empower community driven growth in the global martial arts and combat sports sector, leveraging technology to bridge
the gap between passion and participation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
was founded on the belief that participation in combat sports and martial arts enriches lives by building physical strength, discipline,
self-confidence, mental resilience, and a sense of community &#8212; qualities many believe set it apart from other sports. Alta Global
Group Limited is a pioneering technology company uniting passion and participation in global combat sports with a vision of converting
640 million fans to participants. Alta is enabling the global martial arts and combat sports industry to maximize the monetization opportunities
available to the sector by increasing consumer participation in the sport and building upon existing community offerings within the sector.
While the Company believes martial arts and combat sport gyms have a superb in-gym product, they are ripe for transformation when it
comes to building sales channels, enhancing customer onboarding, optimizing engagement, and driving the growth and retention of members
and membership revenues within their gym communities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Opportunity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
640 million combat sports fans worldwide, mixed martial arts (MMA) has reached unprecedented popularity. We benefit from the sector&#8217;s
growth, driven by major MMA leagues like UFC, PFL, ONE Championship, and Bellator, whose marketing efforts expand the sport&#8217;s fan
base. Our goal is to convert this interest into engagement through our premium online and in-gym training experiences. According to IBISWorld
statistics, there are currently over 45,597 martial arts and combat sports gyms in the US alone that are expected to generate over US$12.6
billion in annual revenue in 2024. Additionally, according to Sports &amp; Fitness Industry Association&#8217;s Single Sport Reports
for Martial Arts and Boxing Fitness, it is estimated that more than 11.8 million people engaged in various martial arts and combat sports
disciplines in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta&#8217;s
business model complements existing industry players without cannibalizing their market. As Alta scales, its first-mover advantage in
grassroots MMA participation unlocks significant potential, especially in North America, where the martial arts industry is projected
to reach 67,000 academies by 2025, with fanbase growth accelerating exponentially.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
has already signed partnership agreements with over 500 gyms locations globally. These partnerships ensure that fans can easily find
a coach and gym, while Alta manages the entire payment process&#8212;collecting 100% of fees and paying gyms their share. Additionally,
in the current financial year, Alta has partnered with UFC Gym globally in an enterprise agreement to roll-out Alta products and services
across UFC Group&#8217;s global network of 150+ gyms, increasing Alta&#8217;s partnership footprint to over 650 Gyms worldwide.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aligned
with the combat sports industry, Alta champions martial arts as a more holistic and enriching training experience compared to traditional
fitness activities that compete with the sector.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Products and Platform</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
Global Group is leading the way in helping the global martial arts and combat sports industry unlock new revenue opportunities by boosting
consumer participation. While fan interest often translates into participation, the gym community remains fragmented, with many small,
owner-operated businesses. Participants, businesses, and coaches face various challenges&#8212;from knowing how to start their training
journeys, to managing member communities on social platforms and dealing with costly and inconsistent marketing efforts. That&#8217;s
where Alta steps in.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
believes that combat sports gyms and coaches provide exceptional in-gym experiences that, with the right technology, can reach a much
wider audience, greatly expanding their monetization opportunities and growing the sport. Similarly, to how companies such as OpenTable,
Yelp and Toast have revolutionized the restaurant sector through technology, Alta serves the vast and fragmented martial arts sector.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have accumulated deep sector knowledge of how martial arts and combat sports operate globally, enabling us to recognize
the unique preferences and needs of the gyms, coaches and consumers within this market. We have leveraged the extensive information in
our gym inventory and community database to create an optimal pathway to attract consumers to participate in our proprietary training
programs as well as training via the weekly timetable of our partner gyms. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
operates a cap-ex light technology platform and avoids the need for heavy investments in physical infrastructure. We are not a franchise
and do not own gyms. Instead, we provide subscription-based products and services, offering both B2B SaaS solutions and B2C products
and programs, with prices ranging from US$0 to US$170 per month covering online engagement, online content and immersive in-gym experiences.
In addition, through its B2B SaaS offering Hype, Alta captures up to 5% of all transactions processed through its platform.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
currently has three business units designed to provide services to and monetize all key stakeholders in the sector, namely fans, participants,
coaches, gym owners and athletes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trainalta.com
- </b>partners with gyms and coaches to deliver a range of consumer products that drive participation in martial arts for fans and beginners
including the Alta Warrior Training Program. This Program has been a cornerstone of our success and has connected thousands of combat
sports fans with local gyms. We have run over 206 Warrior Training Programs globally, with over 5,000 participants, generating significant
revenue for our partner gyms. This beginner-friendly program offers an accessible on-ramp for those looking to turn passion into participation
and has been run in North America, Ireland, UK, and Australia and New Zealand. Its goal-oriented nature, coupled with the fact that all
participants start at the same level, has brought a new cohort to gyms, ultimately increasing memberships and monetization. Alta continues
to provide the experience of training to become a combat athlete to thousands of beginners every year throughout gyms in the US, Europe,
and Oceania. As a result, our gym partners have experienced significant incremental revenue growth because of increased participation
within their community. Our community development approach to acquiring participants has redefined the participation demographics for
martial arts worldwide. Specifically, we have strong female participation rates; the average age of our members is mid to late 30&#8217;s,
with our oldest participants being in their 60s; most participants become valuable, long-standing members of their gym community after
completing their first Alta program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mixed
Martial Arts.com - </b>In November 2023, Alta strengthened its bond with the fan community by acquiring mixedmartialarts.com, one of
the world&#8217;s most enduring online MMA communities. Mixedmartialarts.com offers news, fighter profiles, fight schedules, and the
iconic &#8216;Underground&#8217; forum. With over 260,000 forum accounts, 350,000 monthly sessions, and more than 5 million followers
on Meta, this premier digital network is vital for connecting fans, elite athletes, coaches, and participants across the sport. Investing
in mixedmartialarts.com will enhance organic traffic and lead generation for all of Alta&#8217;s offerings and generate additional advertising
revenue for the group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Hype.Co,
Mobile Marketing solution - </b>Recognizing that many combat sports gym owners relied solely on social media for customer acquisition,
Alta acquired Hype.CO in May 2024. Hype.CO is a subscription based mobile marketing platform designed to help gym owners, coaches and
athlete influencers cultivate relationships with their fans and followers free from social media restrictions to a platform with more
freedom and tools to communicate and monetize. Hype acts as the bridge from where gyms find their customers (i.e., social media) to how
they monetize them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Alta&#8217;s
solutions&#8212;</b>including trainalta.com, mixedmartialarts.com, Hype &#8212;empower small businesses to compete with larger &#8216;mass
affluent&#8217; gym networks by providing digital tools and cost-effective outreach to increase visibility and connect with fans. This
is especially critical as the combat sports fan base continues to expand, driven largely by the success of the UFC. Alta&#8217;s value
proposition is clear: it facilitates the digital transformation of the combat sports sector, benefiting all stakeholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
further strengthen its connection with MMA fans globally, Alta has continued to build partnerships with leading industry figures, leveraging
their reach and influence to give gym partners far greater exposure than they could potentially achieve alone. Alta&#8217;s iconic partnerships
include former 2-time UFC Champion Daniel Cormier, and UFC Commentator Laura Sanko, Since June 30, Alta has grown its ambassadorial partnerships
to include leading MMA coach Eric Nicksick and former UFC fighters Jessica-Rose Clark and Gilbert Melendez. More recently Alta has partnered
with the biggest name in combat sports, five-time MMA world champion Conor McGregor. These partnerships help amplify its brand and drive
platform adoption. With a combined social media reach of their ambassadors of well over 60 million followers, Alta is well-positioned
for continued growth in this booming sector.</span></p>


<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Next Growth Engines</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future growth strategy is driven by clear principles that focus on building an integrated ecosystem to empower coaches, engage participants,
and drive sustainable revenue. We aim to surpass current industry leaders by creating a global platform that connects the entire martial
arts community.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Building
a Global Martial Arts Ecosystem</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will eliminate fragmentation by linking consumer digital experiences with business tools for gym owners. This unified platform supports
five key revenue streams and connects fans, participants, coaches, and gym operators worldwide, unlocking untapped value and driving
industry integration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supporting
Coaches and Gyms</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
platform equips gyms and coaches with essential tools for customer acquisition, member management, payments, and marketing. These features
streamline operations and allow them to focus on business growth, ensuring the broader success of the ecosystem.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Enhancing
Engagement with Accessible Training</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participants
will access martial arts training through our web, app, and social channels. By partnering with validated gyms and offering expert-curated
resources, we make the sport more approachable, fostering higher participation and trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Driving
Recurring Revenue<br/>
</b>Our ecosystem embeds monetization opportunities&#8212;subscriptions, merchandise, partnerships, and transaction fees&#8212;into the
user experience, boosting retention, transaction volumes, and sustainable revenue growth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maximizing
User Engagement and Lifetime Value</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
platform integrates social engagement, training, and business tools, encouraging deeper participation and increasing user lifetime value.
This interconnectedness drives long-term revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Global
Leadership in Martial Arts</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strategy positions Alta as the leading global brand for martial arts training, community, and commerce. By leveraging our brand&#8217;s
strength, we create lasting connections with participants, partners, and investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organic
Growth Through Community</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we will invest in targeted paid promotions, partnerships, and maintaining a presence at targeted sector and community events, our main
focus is organic growth through community building, maintaining a low customer acquisition cost and fostering sustainable demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expanding
Globally</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
already has a footprint in North America, the UK, Ireland, Australia, and New Zealand, with a new partnership in Mexico and a rollout
planned with UFC Gym&#8217;s 150+ locations across 38 countries. Our scalable model allows us to expand internationally without significant
cost increases, presenting substantial growth opportunities globally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
has introduced effective solutions to the challenges faced by gym owners and coaches worldwide. As part of its next phase, Alta&#8217;s
digital platform will unify the global MMA community&#8212;fans, participants, gym operators, and coaches&#8212;to boost participation
and unlock new monetization opportunities for everyone involved. This platform will provide opportunities for fans to interact with their
idols and offer digital tools and community connections to enhance participants&#8217; training journeys from their entry into the sport
and beyond. By reimagining the original MMA communities such as the &#8216;Underground&#8217; Alta is empowering MMA fans to tell their
stories and take ownership of their history, community, and identity, in a space where their stories are their own, and they can control
the narrative. This will provide a great complement to the mass entertainment aspect of the sport, which is driven successfully by the
UFC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta&#8217;s
platform is designed to fuel revenue growth by combining B2C and B2B subscriptions with transaction fees for services and products offered
by gyms, coaches, and athlete influencers. As fans and participants engage with the platform, connecting with these offerings, Alta captures
additional value from every transaction, driving sustained growth across the entire ecosystem.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to continue to invest in technology to enhance the experience for all participants on the Alta Community Platform, namely customers,
coaches and gym owners, in order to drive lifetime value and expand sales channels through referrals and organic promotion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
supports the entire martial arts and combat sports ecosystem, driving community engagement, increasing participation, and creating new
monetization opportunities for all stakeholders, including gyms, coaches, participants, and fans. We believe martial arts provides a
more holistic and deeply rewarding experience for both physical and mental development, offering benefits that go far beyond those of
conventional fitness training.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aligned
with the broader combat sports industry, Alta competes with traditional fitness trends and the mass-affluent fitness sector, which is
dominated by large corporate gym networks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees
and Human Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we employ 4 employees in product development and engineering, 14 employees in sales and marketing, and 6 employees
in a corporate office capacity. We also leverage external service providers to support our operations. None of our employees are represented
by labor unions, and we believe we have an excellent relationship with our employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that an engaged, diverse, and inclusive culture is essential for the success of our business, and we consider our employees to
be the foundation for our growth and success. As such, our future success depends in large part on our ability to attract, train, retain
and motivate qualified personnel. The growth and development of our workforce is an integral part of our success. We are also committed
to developing and fostering a culture of diversity and inclusion and know that a company&#8217;s ultimate success is directly linked
to its ability to identify and hire talented individuals from all backgrounds and perspectives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further detail see the section titled &#8220;Item 6. Directors, Senior Management and Employees.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Government
Regulation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide services in various jurisdictions abroad, and we expect to continue to expand our international presence. We face, and expect
to continue to face, additional risks in the case of our existing and future international operations, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">political
    instability, adverse changes in diplomatic relations and unfavorable economic conditions in the markets in which we have international
    operations or into which we may expand;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">more
    restrictive or otherwise unfavorable government regulation of the entertainment and sports industry, which could result in increased
    compliance costs or otherwise restrict the manner in which we provide services and the amount of related fees charged for such services;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on the enforcement of intellectual property rights;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enhanced
    difficulties of integrating any foreign acquisitions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on the ability of foreign subsidiaries to repatriate profits or otherwise remit earnings;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    tax consequences;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">less
    sophisticated legal systems in some foreign countries, which could impair our ability to enforce our contractual rights in those
    countries;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on technology infrastructure;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variability
    in venue security standards and accepted practices; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in managing operations due to distance, language and cultural differences, including issues associated with (i) business practices
    and customs that are common in certain foreign countries but might be prohibited by U.S. law and our internal policies and procedures
    and (ii) management and operational systems and infrastructures, including internal financial control and reporting systems and functions,
    staffing and managing of foreign operations, which we might not be able to do effectively or on a cost&#8212;efficient basis.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
and our partner gyms are also subject to the U.S. Fair Labor Standards Act of 1938, as amended, and various other laws in Australia,
the United States and Europe governing such matters as minimum-wage requirements, overtime and other working conditions. A significant
number of our and our partners&#8217; employees are paid at rates related to the U.S. federal minimum wage, and past increases in the
U.S. federal minimum wage have increased labor costs, as would future increases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
partner gyms are responsible for compliance with state laws that regulate the relationship between martial arts and combat sports clubs
and their members. Nearly all states have consumer protection regulations that limit the collection of monthly membership dues prior
to opening, require certain disclosures of pricing information, mandate the maximum length of contracts and &#8220;cooling off&#8221;
periods for members (after the purchase of a membership), set escrow and bond requirements for health clubs, govern member rights in
the event of a member relocation or disability, provide for specific member rights when a club closes or relocates, or preclude automatic
membership renewals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of the states where our partner gyms operate have health and safety regulations that apply to martial arts and combat sports clubs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the collection, maintenance, use, disclosure and disposal of individually identifiable data by our, or our partners&#8217;, businesses
are regulated at the federal, state and provincial levels as well as by certain financial industry groups, such as the Payment Card Industry
Organization and the NACHA. Federal, state and financial industry groups may also consider from time to time new privacy and security
requirements that may apply to our businesses and may impose further restrictions on our collection, disclosure and use of individually
identifiable information that are housed in one or more of our databases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulators
may impose significant fines for privacy and data protection violations. Our business operations involve the collection, transfer, use,
disclosure, security, and disposal of personal or sensitive information in various locations around the world, including the E.U. In
Australia, the collection, use, storage and disclosure of personal and sensitive information is governed by the Privacy Act 1988 (Cth)
(&#8220;Privacy Act&#8221;) and the Australian Privacy Principles contained at Schedule 1 of the Privacy Act (&#8220;Australian Privacy
Principles&#8221;). Failures or breaches of data protection systems can result in reputational damage, regulatory impositions (such as
for breaches of the Privacy Act or Australian Privacy Principles) and financial loss, including claims for compensation by customers
or penalties by the Australian telecommunications regulators or other authorities. As a result, our business is subject to complex and
evolving Australian, U.S. and international laws and regulations regarding privacy and data protection. Many of these laws and regulations
are subject to change and uncertain interpretation and could result in claims, changes to our business practices, penalties, increased
cost of operations, or otherwise harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States and certain foreign jurisdictions, we may have direct and indirect interactions with government agencies and state-affiliated
entities in the ordinary course of our business. In particular, athletic commissions and other applicable regulatory agencies require
us to obtain licenses for promoters, medical clearances, licenses for athletes, or permits for events in order for us to promote and
conduct our live events and productions. In the event that we fail to comply with the regulations of a particular jurisdiction, whether
through our acts or omissions or those of third parties, we may be prohibited from promoting and conducting our live events and productions
in that jurisdiction. The inability to present our live events and productions in jurisdictions could lead to a decline in various revenue
streams in such jurisdictions, which could have an adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended (the &#8220;<b>FCPA</b>&#8221;), and other anti-bribery and
anti-money laundering laws in countries outside of the United States in which we conduct our activities. The FCPA generally prohibits
companies and their intermediaries from making, promising, authorizing or offering improper payments or other things of value to foreign
government officials for the purpose of obtaining or retaining business, directing business to any person, or securing any improper business
advantage. The FCPA also requires U.S. issuers to make and keep books and records that accurately and fairly reflect the transactions
of the corporation and to devise and maintain an adequate system of internal accounting controls. Other countries in which we operate
also have anti-bribery laws, some of which prohibit improper payments to government and non-government persons and entities. We operate
in a number of countries which are considered to be at a heightened risk for corruption. Additionally, we operate adjacent to industry
segments, such as sports marketing, that have been the subject of past anti-corruption enforcement efforts. As a global company, a risk
exists that our employees, contractors, agents, managers, or other business partners or representatives could engage in business practices
prohibited by applicable U.S. laws and regulations, such as the FCPA, as well as the laws and regulations of other countries prohibiting
corrupt payments to government officials and others, such as the Bribery Act. There can be no guarantee that our compliance programs
will prevent corrupt business practices by one or more of our employees, contractors, agents, managers, or vendors, or that regulators
in the U.S. or in other markets will view our program as adequate should any such issue arise. Any actual or alleged violation of the
FCPA or other applicable anti-corruption laws could result in whistleblower complaints, sanctions, settlements, prosecution, enforcement
actions, fines, damages, adverse media coverage, investigations, severe criminal or civil sanctions, any of which could have a material
adverse effect on our reputation, as well as our business, financial condition, results of operations and prospects. Responding to any
investigation or action would also likely result in a materially significant diversion of management&#8217;s attention and resources
and significant defense costs and other professional fees. In addition, the U.S. government may seek to hold us liable for successor
liability for FCPA violations committed by companies in which we invest or that we acquire.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also required to comply with economic sanctions laws imposed by the United States or by other jurisdictions where we do business,
which may restrict our transactions in certain markets, and with certain customers, business partners, and other persons and entities.
As a result, we may be prohibited from, directly or indirectly (including through a third-party intermediary), procuring goods, services,
or technology from, or engaging in transactions with, individuals and entities subject to sanctions, including sanctions arising from
the conflict involving Russia and Ukraine. We cannot guarantee that our efforts to remain in compliance with sanctions requirements will
be successful. Any violation of sanctions laws could result in fines, civil and criminal sanctions against us or our employees, prohibitions
on the conduct of our business (e.g., debarment from doing business with International Development Banks and similar organizations),
and damage to our reputation, which could have an adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
various regulations set out above have not materially impacted or affected the offering of our three business units designed to provide
services to and monetize all key stakeholders in the sector, namely fans, participants, coaches, gym owners and athletes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TrainAlta
                                            (www.trainalta.com) partners with gyms and coaches to deliver a range of consumer products
                                            that drive participation in martial arts for fans and beginners.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hype
                                            (www.hype.co) is a mobile marketing platform designed to help gym owners, coaches and athlete
                                            partners grow revenue from their followers and audiences in today&#8217;s age of social media.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MixedMartialArts.com
                                            (www.mixedmartialarts.com) is a leading platform for the MMA community, providing access
                                            to MMA news and media, fighter data, fight schedules and access to the legendary Underground
                                            forum.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_013"></span>C.
Organizational Structure</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
Global Group Limited is the parent company of the Group. The Group consists of Alta Global Group Limited and each of the subsidiaries
of Alta Global Group Limited. See Exhibit 8.1 &#8220;List of subsidiaries of the Registrant&#8221; of this annual report for a list of
our subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_014"></span>D.
Property, Plants and Equipment</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to conduct our business in a profitable manner relies in part on our proprietary methods and designs, which we protect as trade
secrets. We rely upon trade secret laws, physical and technological security measures and contractual commitments to protect our trade
secrets, including entering into non-disclosure agreements with employees, consultants and third parties with access to our trade secrets.
However, such measures may not provide adequate protection and the value of our trade secrets could be lost through misappropriation
or breach of our confidentiality agreements. Furthermore, third parties may claim that we are infringing upon their intellectual property
rights, which may prevent or inhibit our operations and cause us to suffer significant litigation expense even if these claims have no
merit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Properties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not own any real estate. Our registered office in Australia is located at Level 1, Suite 1, 29-33 The Corso, Manly, New South Wales
2095. Our registered office in the U.S. is 8 The Green, Ste R Dover, DE 19901.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
lease approximately 127 square meters of office premises in Australia pursuant to a lease that expires on June 6, 2026. Our monthly lease
fees are approximately A$9,239 exclusive of GST or approximately US$6,169, based on a currency exchange rate of $0.6677 as of June 28,
2024, as published by the Federal Reserve Board. We believe our leased business locations are sufficient to meet our current needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    4A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_015"></span>UNRESOLVED
    STAFF COMMENTS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    5.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_016"></span>OPERATING
    AND FINANCIAL REVIEW AND PROSPECTS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion should be read together with our consolidated financial statements and the related notes thereto included elsewhere
in this annual report. The following discussion is based on our financial information prepared in accordance with the International Financial
Reporting Standards, or IFRS, as issued by the IASB, which may differ in material respects from generally accepted accounting principles
in other jurisdictions, including U.S. GAAP, as well as &#8220;Presentation of Financial and Other Information&#8221; and &#8220;Item
4. Information on the Company&#11834;B. Business Overview.&#8221; Some of the information contained in this discussion and analysis or
set forth elsewhere in this annual report, including information with respect to our plans and strategy for our business, includes forward-looking
statements that reflect plans, estimates and beliefs and involve numerous risks and uncertainties, including but not limited to those
described in &#8220;Item 3. Key Information&#8212;Risk Factors&#8221; and &#8220;Note Regarding Forward-Looking Statements.&#8221; Therefore,
actual results may differ materially from those contained in any forward-looking statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion should be read in conjunction with our Audited Consolidated Financial Statements for the fiscal years ended June
30, 2024, 2023 and 2022 and the notes thereto included under &#8220;Item 18&#8221;.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
discussion and analysis for the year ended June 30, 2022 can be found in our prospectus dated March 27, 2024, filed with the SEC on March
28, 2024 (File No. 333-275618). Unless otherwise indicated discussion under this Item is based on Australian dollars and is presented
in accordance with IFRS.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_017"></span>A.
Operating Results</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a technology company that is enabling the global martial arts and combat sports industry to maximize the monetization opportunities
available to the sector by increasing consumer participation in the sport and building upon existing community offerings within the sector.
While we believe martial arts and combat sport gyms have a superb in-gym product, they are ripe for transformation when it comes to building
sales channels, customer onboarding, optimizing engagement and driving the growth and retention of members and membership revenues within
their gym communities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the Alta Platform represents a considerable opportunity to aggregate the vast global community ecosystem for martial arts
and combat sports, via a single platform solution that will define the sector&#8217;s digital transformation, converting one of the world&#8217;s
largest fan bases into participants. The Alta Platform serves as a comprehensive solution for martial arts and combat sports.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the reporting periods, our principal activity was the provision and administration of the Warrior Training Program. Specifically, the
provision of marketing intellectual property, payments software, training syllabus and outsourced customer sales and service resources
to our licensee partner gyms throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year 2024, the Company recorded a loss after tax of A$14,408,346, compared to a loss after tax of A$20,597,436 in the fiscal
2023, and had a cash balance as at June 30, 2024 of A$3,544,837 compared to A$3,702,567 at June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
July 1, 2023, we have increased our gym footprint, expanding into new territories including Illinois, Arizona and Hawaii. We have also
engaged major martial arts academies including Renzo Gracie, American Top Team and American Kickboxing Academy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2023, we launched our first online offering, the Alta Academy, to complement and further leverage our in-gym training experiences
for our customers. This activates our multi-year exclusive content agreements with our key global talent, which is a critical element
of our top of funnel marketing systems to drive in-gym participation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
launch of the Alta Academy, we have expanded our digital content, including the digital syllabus for the Warrior Training Program, and
extended our online training into other disciplines beyond MMA, including jiu jitsu, boxing, wrestling, and Muay Thai, among others,
with new masterclasses delivered by our elite coaching talent, including Rafael Cordeiro, Mike Angove, Nikki Lloyd-Griffiths.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2023, we launched four new membership tiers for Alta members, including an In-Gym Training membership tier, which leverages
underutilized capacity within our gym partner network and allows Alta members to train in our partner gyms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2023, we launched the first iteration of the Alta Community platform, which we believe will drive the growth of the gym and
coaching communities through the provision of new content and channels. This included the launch of gym channels. The gym channels feature
is used to house multimedia content that pertains to a specific gym&#8217;s profile on the Alta Community. This currently includes multimedia
content such as gym walkthrough videos (point of view videos demonstrating the gym&#8217;s facility) as well as interviews with gym owners
and coaches.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2023, we successfully completed our pilot UFC Fit program with UFC Gym in San Jose, California.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2023, we completed the acquisition of the assets of Steppen Pty Ltd, a fitness technology company based in Australia (&#8220;Steppen&#8221;).
Steppen is a dynamic fitness app designed to inspire, guide, and support users on their fitness journey. The Steppen platform quickly
resonated with young fitness enthusiasts around the globe, particularly in the U.S., accumulating a large following quickly after its
global launch in mid-2021. The Steppen App has seen success with over 395,000 downloads, predominantly from the U.S., reaching over 1.8
million impressions on the Apple App Store. With a robust database of over 270,000 accounts, we believe that the Steppen App has established
a substantial user base. We plan to continue Steppen App&#8217;s operations and integrate key aspects of its proprietary Apple mobile
application technology, while exploring ways to optimize content and services for users, leveraging the acquired expertise and technology.
We believe the synergy from this acquisition is poised to drive growth, diversification, and market expansion for Alta in the burgeoning
health and wellness sector. As consideration for the asset acquisition, we issued Steppen an unsecured and non-redeemable convertible
promissory note (on the same terms as the private placement completed in June 2023 (the &#8220;Private Placement&#8221;)), with a principal
amount of US$64,977.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2023, we completed the acquisition of the assets of Mixed Martials Arts LLC, an independent MMA media company, based in the U.S.
Mixed Martial Arts LLC represents a valuable opportunity to us, as it is one of the last independent MMA media companies not acquired
by a major corporation, making it a novel asset in the digital MMA landscape. With a substantial digital presence, the platform boasts
more than 260,000 forum accounts, more than 350,000 monthly engaged sessions, and a significant social media footprint, including over
5 million followers across Facebook pages. Mixed Martial Arts LLC has previously initiated effective monetization strategies, generating
peak annual revenues of up to US$600,000. With the right investment in technology and user engagement, we believe there is considerable
potential for revitalizing and growing the platform&#8217;s user base and revenue streams. As consideration for the asset acquisition,
we issued Mixed Martials Arts LLC an unsecured and non-redeemable convertible promissory note (on the same terms as the recently completed
Private Placement), with a principal amount of US$250,000 and paid US$25,000 in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2023, we launched ticketing services for live Alta events and seminars, including the Warrior Training Program finale events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 2, 2024, we completed our initial public offering, raising US$6,500,000 by selling 1,300,000 shares at US$5.00 per share. All previously
issued convertible notes were converted or redeemed. As of June 30, 2024, there are no convertible notes, host, or derivative liabilities
on the Consolidated Statement of Financial Position. Remaining interest and final fair value movement in derivative liability are reflected
in the Consolidated Statement of Profit or Loss and Other Comprehensive Loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Throughout
April 2024, we partnered with renowned combat sports figures, including Rafael Cordeiro (Mike Tyson&#8217;s coach) for online Muay Thai
training and former UFC champion Daniel Cormier for wrestling instructional videos, targeting both beginners and seasoned athletes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2024, we celebrated success in expanding the global MMA community. The Warrior Training Program at SBG Ireland has historically attracted
over 700 new members, boosting gym memberships and revenue. MMA superstar Conor McGregor, an Alta investor, endorsed the program to help
drive global combat sports participation. We also announced a strategic partnership with Upper Management in Mexico to launch the Warrior
Training Program in multiple gyms and create content for the burgeoning Mexican MMA fanbase. Further, we also showcased our partnership
with City Kickboxing in New Zealand, transforming over 800 beginners into cage-ready athletes through the Warrior Training Program, significantly
boosting gym memberships and community engagement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2024, we completed the acquisition of the assets of Hype Kit, Inc. (&#8220;Hype&#8221;) for US$100,000, an all-in-one digital marketing
platform, designed to help small businesses grow in today&#8217;s age of social media. Hype&#8217;s software platform strengthens the
Company&#8217;s vision to convert 640 million MMA fans to participants by providing invaluable tools to our gym owner, coach, and athlete
partners to not only grow their revenues, but also operate more efficiently, save costs and enhance the offerings to their members and
community. This acquisition is expected to accelerate Alta&#8217;s technology roadmap, bringing forward new subscription revenue opportunities
for us, whilst creating cost synergies by materially reducing product development overhead and bringing valuable technology expertise,
skills and talent into the business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2024, we partnered with legendary MMA coach Eric Nicksick and former UFC fighters Jessica-Rose Clark and Gilbert Melendez to help
strengthen our connection to 640 million global MMA fans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, we announced a revenue share agreement with UFC Gym Group in relation to the intention of rolling out the Warrior Training
Program and Hype across UFC Gym Group&#8217;s global network of gyms, consisting of both corporate-owned and franchise locations (with
over 150 locations in 40 countries, including 80 in the United States). In addition, UFC Gym Group has hundreds of gyms in development.
In the initial phase, these programs are expected to be introduced in locations across the United States, the Middle East, the UK, Germany,
Mexico, India and Central Asia. Any revenue from the Warrior Training Program will be shared, with the UFC Gym Group receiving 70% and
the Company receiving 30%. The agreement is effective for three years and either party may terminate the agreement upon written notice
to the other of a breach of the agreement if such breach is not cured within 10 days following receipt of written notice of the breach.
In addition, UFC Gym Group can terminate the agreement upon 60 days written notice to us. While we can provide no assurances, we believe,
based on historical operating data, that this partnership has the potential to produce gross revenue of over US$7 million per annum,
with the ability to grow with UFC Gym Group as they develop additional locations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, Conor McGregor was appointed as a global ambassador (&#8220;Ambassador Agreement&#8221;) and will provide services customarily
associated with such roles for a company in the mixed martial arts and technology sector (&#8220;Services&#8221;). The term of the Ambassador
Agreement shall be effective for three years and either party may terminate the agreement upon 10 days prior written notice if the other
party breaches the agreement and does not cure such breach within such time period. In consideration for providing these Services under
the Ambassador Agreement, and pursuant to the exemption from registration provided for in Regulation S promulgated under the Securities
Act, Mr. McGregor received 700,000 performance share rights that will vest once the 30-day volume-weighted average price (VWAP) achieves
the following trigger: 150,000 shares on execution of the Ambassador Agreement; 100,000 shares when the share price reaches US$7.50;
150,000 shares when the share price reaches US$10.00; 150,000 shares when the share price reaches US$15.00 and 150,000 shares when the
share price reaches US$20.00. Aligned with the three (3) year term of the Ambassador Agreement, Mr. McGregor is restricted from selling
shares within three (3) years of issuance unless specific conditions are met, such as the Company&#8217;s written consent, a sale or
liquidation of the Company, or if the Company breaches the agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inflation
and Seasonality</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
believes inflation has not had a material impact on our company&#8217;s operations or financial condition and that our operations are
not currently subject to seasonal influences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conditions
in Australia</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated under the laws of, and our principal offices are located in, the Commonwealth of Australia. Therefore, we are directly
affected by political and economic conditions in Australia. See Item 3.D. &#8220;Key Information - Risk Factors&#8221; for a description
of factors that could materially affect our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental
regulation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not believe our activities create any significant environmental impact to any material extent. For more information regarding the
governmental regulations applicable to us, please refer to Item 4.B. of this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Indicators of Performance and Financial Condition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial results for fiscal year 2024 show significant improvement compared to the previous year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduced
                                            Losses: The loss after tax decreased to A$14,408,346 in fiscal 2024 from A$20,597,436 in
                                            fiscal 2023, an improvement of A$6,189,090.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
                                            Position: As of June 30, 2024, the cash balance was A$3,544,837, which was A$157,730 lower
                                            than the A$3,702,567 on June 30, 2023.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            Asset Position: The Company&#8217;s financial position dramatically improved to a net asset
                                            position of A$2,558,544 at June 30, 2024, shifting from a net liability of A$31,134,307 on
                                            June 30, 2023. The primary reason for improvement was due to conversion and redemption of
                                            convertible notes into equity shares and cash.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
factors contributing to this improvement include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduced
                                            finance costs.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
                                            value movement in derivative liability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
significant development was the redemption or conversion of all convertible notes upon the Company&#8217;s NYSE- American listing on
March 27, 2024. This action:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eliminated
                                            these financial liabilities from the balance sheet.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Removed
                                            the impact of non-cash expenses related to convertible notes, such as interest components
                                            and fair value movements of derivative liabilities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Components of Results of Operations </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenues</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
revenue consists of license fees and are recognized upon the provision of the right to use our intellectual property related to the Warrior
Training Program, which is a set of mixed martial arts training programs and relevant branding and support.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
enter into contracts with our partner gyms for the partner gym to run our Alta branded Warrior Training Program for 20 weeks within their
gym. The contract is accompanied by a license agreement between us and our partner gyms. The determination of the program revenue amount
is dependent on the number of participants in each series for each gym. We receive payment in advance directly from the participant.
We are then required to settle contractual payments to the partner gyms as a percentage of the total training fees collected from participants.
Net revenue from program fees is the gross program fees, less contractual payments to our partner gyms. Revenues from sales of the Warrior
Training Program represented greater than 70% of our net revenues during the periods ended June 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Income</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ticketing
Services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2023, we launched ticketing services for live Alta events and seminars, including the Warrior Training Program finale events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contractual
Obligations to Gyms</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
enter into license agreements with partner gyms for the implementation of our branded 20 week Warrior Training Program. Under the license
agreements, we receive all revenue generated from the implementation of our Warrior Training Program by our partner gyms, and subsequently
distributes a portion of such revenues to our gym partners based on the terms of the license agreements. We recognize these contractual
obligations to gyms as a component of net revenue from program fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Marketing
and Advertising</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incur marketing and advertising expenses for the promotion, and the generation of leads and revenue for the Warrior Training Program.
Marketing and advertising expenses are recognized as an expense as incurred. Our marketing and advertising costs consist primarily of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">salaries
    and related overhead expenses for personnel in marketing and advertising functions (for example wages, salaries and associated on
    costs such as superannuation, share-based incentives and payroll taxes, plus travel costs and recruitment fees for new hires); and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">third
    party costs for consultants who perform marketing and advertising activities on our behalf and under our direction, rent costs for
    our global offices, and other miscellaneous costs.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Management
and Administration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
and administration costs are recognized as an expense as incurred. Our management and administration costs consist primarily of employee
salaries and related costs for employees in executive, corporate and administrative functions. Other significant management and administration
expenses include audit fees, legal fees, finance support fees and other business consultant fees. Employee salaries and benefits include
wages and salaries, superannuation, non-monetary benefits, payroll taxes, annual leave and long service leave.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financing
Costs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
convertible notes can be converted into Ordinary Shares upon specific conversion events and are recognized as financial liabilities as
the number of Ordinary Shares to be issued may vary with changes in fair value. Interest related to the financial liability is recognized
in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
Value on Financial Liabilities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value of financial liabilities comprises the fair value adjustment relating to embedded derivatives relating to the conversion option
within convertible notes. Please refer to Notes 21 of our consolidated financial statements for further detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share
Based Payment Expense</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
based compensation expenses are recognized in line with our accounting policy for share based compensation, which is described Note 22
of our consolidated financial statements. Share based compensation expenses consist of costs related to share based incentives granted
to personnel across all functions and key advisers and ambassadors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Information
Technology Costs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
technology costs are incurred to support our technology stack including subscriptions and systems and maintenance costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Depreciation
and Amortization</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
Plant and Equipment, intangible assets and Right of Use assets such as trademarks and platform development costs are held and depreciated
on straight-line basis. The depreciation and amortization is recognized in the profit and loss. For further detail please refer to Notes
11, 12, and 20, respectively, of our consolidated financial statements for further detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expenses include rent, foreign exchange gains and losses and other general costs that we incur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of operations and comparison of the years ended June 30, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our results of operations for the periods ending June 30, 2024 and June 30, 2023, respectively, and provides
information regarding the dollar and percentage increase (or decrease) during such periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Year Ended June 30,</span></td>
    <td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td>
    <td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td>
    <td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td>
    <td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Consolidated Income Statement
    Data:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Revenue:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue from
    Program Fees</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">929,319</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">937,415</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,096</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less:
    Contractual payments to gyms</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(537,012</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(574,025</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,013</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net Revenue from program
    fees</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">392,307</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">363,390</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,917</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other income:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other
    income</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,005</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,173,421</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,003,416</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(86</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenue and other income</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">562,312</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,536,811</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(974,499</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(63</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Expenses:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Program expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">160,578</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">229,848</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(69,270</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(30</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Employee Salaries and benefits</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,504,592</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,219,655</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,284,937</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">30</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Share Based Payments</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,521,598</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,365,384</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,156,214</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">91</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising fees</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">613,348</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">721,713</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(108,365</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,790,344</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">864,419</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">925,925</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">107</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Rent</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,169</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,793</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(624</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">IT costs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">566,709</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">633,220</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(66,511</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation and amortization</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">520,697</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">360,021</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">160,676</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">45</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net foreign exchange gain</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(146,543</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(47,359</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(99,184</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">209</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance costs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,262,927</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,472,730</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,209,803</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(27</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,565,924</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,432,094</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,830</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value movement in
    derivative liability</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,400,685</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,870,729</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,271,414</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">49</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,970,658</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,134,247</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,163,589</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Loss before income tax
    expense</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14,408,346</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(20,597,436</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,189,090</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(30</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Income tax expense</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Loss after income tax
    expense for the year</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14,408,346</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(20,597,436</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,189,090</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(30</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other comprehensive loss,
    net of tax</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(20,710</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(36,465</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,754</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total comprehensive loss for the year attributable
    to the members of the Alta Global Group Limited</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14,429,056</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(20,633,901</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,204,844</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(30</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Loss per share:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Basic loss per share</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1.40</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5.26</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Diluted loss per share</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1.40</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5.26</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comparison
of key movements in revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from Program fees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period ending June 30, 2024, we generated A$929,319 in revenue from program fees and A$392,307 in net revenue from program fees,
which deducts our contractual payments to the gyms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows movement within revenue for the periods ending June 30, 2024 and June 30, 2023, respectively, together with the
changes in those items:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Year Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
    from program fees<b>:</b></i></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Revenue from
    Program Fees</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">929,319</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">937,415</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,096</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Less:
    Contractual liabilities to gyms</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(537,012</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(574,025</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,013</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif">Net revenue from program
    fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">392,307</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">363,390</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,917</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">8</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
revenue from Programs has remained consistent over the two reporting periods, while we remained focused on the development of the ALTA
Community platform which will be launch in fiscal year 2025, as well as the integration of MixedMartialsArts.com and Hype.Co, both acquired
in fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moving
forward our focus shifts to other revenue activation beyond the Warrior Training Programs and right sizing our operating costs to reflect
the lower human intervention sales products of the Community Platform and Hype.co. The acquisition of Hype.Co, revitalization of MixedMartialsArts.com,
partnership with UFC Gym and partnership with Conor McGregor collectively brings forward the realisation of Alta&#8217;s long-term growth
strategy of focusing on building a unified global platform that connects martial arts fans, participants, gym operators, and coaches.
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Income</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income was A$170,005 for the period ending June 30, 2024, compared to A$1,173,421 for the period ending June 30, 2023. The following
table shows movement within other income, together with the changes in those items:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Year Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other income:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Research and
    development tax incentive</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,149,525</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,149,525</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Finale, Franchise fee and
    others fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">167,021</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">144,421</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">639</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Merchandise
    sales</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,984</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,296</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,688</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">130</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Other
    income</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,005</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,173,287</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,003,416</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(86</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income decreased mainly due to reduction in R&amp;D rebate in FY24. The FY 2024 Research and Development incentive will be applied for
on lodging of the FY 2024 tax return with the Australian Tax Office and recognised once reasonable assurance that the Company will comply
with the conditions and that the grants will be received.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to section C. Research and Development, Patents and Licenses, etc. for further details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finale,
franchise fee and others fees increased due to the activation of ticketing services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comparison
of key movements in expenses incurred </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Program
Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been a decrease of A$69,270 in program expenses for the period ending June 30, 2024 compared with the period ending June 30, 2023.
The decrease in program expenses is due to cost savings achieved through procuring merchandise and streamlining finale costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employee
salaries and benefits and professional fees</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
salaries and benefits increased by A$1,284,937 for the period ending June 30, 2024. This was primarily due to new staff hires, salary
increases and activation of ambassadors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
fees increased by A$925,925 for the period ending June 30, 2024. This is primarily related to increases in accounting, legal and audit
services fees pertaining to initial public offering on the NYSE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share
Based Compensation Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
based compensation expenses increased by A$2,156,214 for the period ending June, 30 2024. This increase was due to the issuance of
restricted share units as per the employee incentive plan, advisor options, reach options, warrants and over-allotment option to
underwriter. Please refer to Note 22 of our consolidated financial statements for further detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
Value movement in Financial Liabilities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value on financial liabilities comprises the fair value adjustment relating to embedded derivatives relating to the conversion option
within convertible notes. The fair value gain for the period ending June 30, 2024 was A$3,400,685 compared to a fair value loss of A$6,870,729
for the period ending June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to Note 21 of our consolidated financial statements for further detail. In addition, please refer to &#8216;Key Indicators of Performance
and Financial Condition&#8217; section above to understand the impact of non-cash accounting expense on the profit and loss for the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Finance
Costs</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance
costs relating to the convertible notes decreased by A$1,209,803 in the period ending June 30, 2024. This reduction was primarily due
to the conversion event on March 27, 2024, resulting in the interest expense to be recognized for 9-months for the period ending June
30,2024 compared to 12-months for the period ending June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expenses increased by A$133,830 for the period ending June 30, 2024. The increase is primarily due to capital raising fees, international
travel and insurance. These costs were primarily due to the company successfully closing out an initial public offering on the NYSE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><span id="a_018"></span>B. Liquidity
and Capital Resources</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sources
of Liquidity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
our inception through June 30, 2024, we have funded our operations principally with A$31 million in proceeds from the sale of our Ordinary
Shares and convertible notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, the Company had a cash balance of A$3,544,837, as compared with A$3,702,567 as of June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024 we successfully listed on the New York Stock Exchange and on April 2, 2024, the Company received net proceeds of US$5,767,887
(A$8,842,460) after deducting underwriting discounts and offering expenses from the initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ongoing operation of the Group remains dependent upon raising further additional funding from shareholders or other parties. In light
of increasing expenditures to be incurred in executing on the Group&#8217;s current strategic plans, the Group is dependent on obtaining
financing through equity financing, debt financing or other means.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to arrange such funding in the future will depend in part upon the prevailing capital market conditions as well as the business
performance of the Group. There is no assurance that the Group will be successful in its efforts to raise additional funding on terms
satisfactory to the Group. See &#8220;Item 3. Key Information &#8211; D. Risk Factors &#8211; Risks Related to Our Financial Position
and Need for Additional Capital.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Group does not obtain additional funding, it may not be able to continue its operations as a going concern and therefore may not
be able to realize its assets and extinguish its liabilities in the ordinary course of operations and at the amounts stated in the financial
statements. Alternatively, the Group may be required to delay, reduce the scope of, or eliminate its current or future commercial activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is confident that it will be able to raise additional funds as required to meet its obligations as and when they fall due and
are of the opinion that the use of the going concern basis remains appropriate. However, there is a material uncertainty that may cast
significant doubt or substantial doubt as contemplated by PCAOB standards about the Group&#8217;s ability to continue as a going concern
and therefore the Group may be unable to realize its assets and discharge its liabilities in the normal course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">For
    the Year Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash Flow Data:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Net cash used
    in operating activities</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,386,196</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,555,868</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Net cash (used in)/provided
    by investing activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(223,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">69,673</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash provided by financing activities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,472,851</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,655,252</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
Flows from Operating Activities.</i> Net cash outflows from operating activities increased by A$3,830,328 over the comparable period.
This was due to increase in payments to suppliers, professional fees, gyms and employees. In fiscal 2024, costs pertaining to the IPO
are also included in net cash used in operating activities. Costs relating to the IPO included legal, accounting, audit and underwriting
fees and represented a significant portion of the uplift in net cash outflows from operating activities for the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
Flows from Investing Activities. </i>Net cash outflows from investing activities increased by A$293,347 due to the acquisition of intangible
assets, including both internally generated and externally acquired including the acquisition of MMA LLC and Hype.CO during the reporting
period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
Flows from Financing Activities.</i> Net cash inflows provided by financing activities increased by A$817,599. Cash provided by financing
activities at June 30, 2024 primarily represents the proceeds from the initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
Obligations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employee
Liabilities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we had A$509,964 accrued in annual leave and long service leave balances for our employees, as compared to A$376,119
as of June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Trade
and Other Payables</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we had A$1,991,536 in trade and other payables, as compared to A$2,034,436 as of June 30, 2023. There were no other
significant contractual obligations at June 30, 2024 or 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_019"></span>C.
Research and Development, Patents and Licenses, etc.</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product development strategy is based on typical inputs such as market and user research, routine strategy planning, and iterative financial
analysis, but it is first and foremost based on the principle of co-evolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
approach enables the simultaneous growth of our organization alongside our growing global constituents. Our goal is to ensure that our
platform remains relevant, starting with mixed martial arts, and extending to community-driven sports globally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
we intend to continue to invest in research and development projects and enhance our product management, user experience design, software
engineering and quality assurance skills to help expand and improve the functionality of our current platform and broaden our capabilities
to address new market opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development (R&amp;D) Grant</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
R&amp;D Grant relates to tax incentive payments from the Australian government&#8217;s Innovation Australia Research and Development
Tax Incentive Plan for research and development activities conducted in Australia in relation to the development of the technology underlying
our platform that meets the regulatory criteria. A refundable tax offset is available to eligible companies with an annual aggregate
revenue of less than A$20,000,000. Eligible companies can receive cash amounts equal to 43.5% of eligible research and development expenditures
from the Australian Taxation Office (the &#8220;ATO&#8221;). For fiscal year 2023, we received an R&amp;D Grant for A$480,853 as compared
to A$697,028 for fiscal year 2022. The amount of the R&amp;D Grant, if any, for fiscal year 2024 has not yet been finalized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incur research and development expenses related to the development of our software platform. The goal of our research and development
activities is to develop and provide a complete cloud-based solution that connects consumers with gyms, provides training programs for
members, provides complete gym management capabilities, and integrates payment technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development rebate recognition. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will continue to apply for the Research and Development incentive as long as it continues to be eligible and will conduct eligible
research and development activities. The applicable legislation that governs the eligibility to participate in the R&amp;D incentive
program is Division 355 of the Income Tax Assessment Act 1997 (ITAA 1997). The fiscal year 2024 R&amp;D incentive will be applied for
on lodging of the fiscal year 2024 tax return in November 2024 and any associated rebate will be recognized in fiscal year 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
comparison, A$1,149,525 was recognized as of June 30, 2023, which included rebates from FY21, FY22 and FY23.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_020"></span>D.
Trend Information</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to our disclosure set forth under &#8220;Item 3. Key Information&#11834;D. Risk Factors,&#8221; &#8220;Item 4. Information on the
Company&#8221; and elsewhere in this &#8220;Item 5. Operating and Financial Review and Prospects&#8221; for information regarding the
material risks, business developments, strategies, and operations that are most likely to affect our business and results of operations
through 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_021"></span>E.
Critical Accounting Estimates</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts
in the financial statements. Management continually evaluates its judgements and estimates in relation to assets, liabilities, contingent
liabilities, revenue and expenses. Management bases its judgements, estimates and assumptions on historical experience and on other various
factors, including expectations of future events, management believes to be reasonable under the circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
accounting judgements, estimates and assumptions that have significant potential to result in a material adjustment to the carrying amounts
of assets and liabilities during each of the years are discussed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reverse
Share Split</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 24, 2024, there was a Reverse Share Split of our issued and outstanding Ordinary Shares and Ordinary Share equivalents on the
basis of four (4) securities for every five (5) securities held. All issued and outstanding Ordinary Shares and Ordinary Share equivalents
and per share data have been adjusted throughout this annual report to reflect the Reverse Share Split for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going
Concern</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements for the reporting periods have been prepared on a going concern basis which contemplates continuity
of normal business activities and the realization of assets and settlement of liabilities in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.2pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have assessed that there is a substantial doubt related to going concern that may cast significant doubt over our ability to continue
as a going concern as we incurred a loss after tax of A$14,408,346 for the year ended June 30, 2024 compared to A$20,597,436 for the
year ended June 30, 2023, had net cash outflows from operating activities of A$9,386,196 for the year ended June 30, 2024 compared to
$5,555,868 for the year ended June 30, 2023, had a net asset position of $2,558,544 as at June 30, 2024 compared to net liability $31,134,307
as at June 30, 2023, and net current asset position of $1,049,355 as at June 30, 2024, compared to net current liability position of
$21,916,914 as at June, 30 2023. As a result of these conditions, the Company may be unable to realize its assets and discharge its liabilities
in the normal, course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.2pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2024, the Company successfully listed on the NYSE American. In addition, all convertible notes that were on issue prior to
the initial public offering have either been converted into Ordinary Shares or redeemed and therefore there is no convertible note debt,
host or derivative liabilities on the Consolidated Statement of Financial Position as at June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remaining interest on convertible notes and the final fair value movement in derivative liability is reflected in the Consolidated Statement
of Profit or Loss for the year ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ongoing operation of the Company remains dependent upon raising additional funds. In light of the future expenditures to be incurred
in executing on our strategic plans, we are dependent on obtaining financing through equity financing, debt financing or other means.
The ability to arrange such funding in the future will depend in part upon the prevailing capital market conditions as well as our business
performance. There is no assurance that we will be successful in our efforts to raise additional funding on terms satisfactory to us.
If we do not obtain additional funding, we may be required to delay, reduce the scope of, or eliminate our current operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
we believe that we will be able to raise additional funds as required to meet our obligations as and when they become due and are of
the opinion that the use of the going concern basis remains appropriate. Our ability to continue as a going concern and to pay debts
as and when they become due is dependent on the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    have historically been successful in raising funds;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    have listed on the New York Stock Exchange in the United States. As a listed vehicle, we have capital raising options such as placements,
    share purchase plans, rights issues and entitlement offers, dividend reinvestment plans, hybrids and retail notes, warrants and PIPEs;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    level of expenditure continues to be managed and will continue to be managed to maximize run-way; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    have reason to believe that in addition to the cash flow currently available, additional revenues will continue to be received through
    the sale of our products and services throughout the course of the year.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we decide to raise capital, the issuance of additional Ordinary Shares would result in dilution to our existing shareholders. We cannot
assure you that we will be successful in completing any financings or that any such equity or debt financing will be available to us
if and when required or on satisfactory terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
we be unable to raise additional funds on a timely basis, we may be required to realize our assets and discharge our liabilities other
than in the normal course of business and at amounts different to those stated in the financial statements. The financial statements
do not include any adjustments to the recoverability and classification of asset carrying amounts or the amount of liabilities that might
result should we be unable to continue as a going concern and meet our debts as and when they become due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
From Contracts With Customers Involving Program Fees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
recognizing revenue in relation to the sale of goods to customers, the key performance obligation of the entity is considered to be the
point of delivery of the rights to use the license and the relevant training program to the gyms as the customers, as this is deemed
to be the time that the gym obtains control of the promised service and therefore the benefits of unimpeded access.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination
of Variable Consideration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Judgement
is exercised in estimating variable consideration which is determined having regard to past experience with respect to the cancelled
contracts with the entity where the partner gyms maintains a right of termination pursuant to the license agreement. Revenue will only
be recognized to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognized under
the contract will not occur when the uncertainty associated with the variable consideration is subsequently resolved. We have determined
that any deposit received for training programs scheduled until a month after year end will reliably proceed and we have recognized the
relevant gross revenue as probable and measurable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share-Based
Payment Transactions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity measures the cost of equity-settled transactions with employees by reference to the fair value of the equity instruments
at the date at which they are granted. The fair value is determined by using either the Black-Scholes model taking into account the terms
and conditions upon which the instruments were granted. The accounting estimates and assumptions relating to equity-settled share-based
payments would have no impact on the carrying amounts of assets and liabilities within the next annual reporting period but may impact
profit or loss and equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition
of Deferred Tax Assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognized for deductible temporary differences only if the entity considers it is probable that future taxable amounts
will be available to utilize those temporary differences and losses. We have not recognized deferred tax assets from brought forward
losses as we do not believe that it is probable that there are future taxable profits available to recover the asset as at the reporting
dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intangible
assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets acquired as part of a business combination, other than goodwill, are initially measured at their fair value at the date of the
acquisition. Intangible assets acquired separately are initially recognized at cost. Indefinite life intangible assets are not amortized
and are subsequently measured at cost less any impairment. Finite life intangible assets are subsequently measured at cost less amortization
and any impairment. The gains or losses recognized in profit or loss arising from the derecognition of intangible assets are measured
as the difference between net disposal proceeds and the carrying amount of the intangible asset. The method and useful lives of finite
life intangible assets are reviewed annually. Changes in the expected pattern of consumption or useful life are accounted for prospectively
by changing the amortization method or period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trademarks</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
costs associated with patents or trademarks are deferred and amortized on a straight-line basis over the period of their expected benefit,
being their finite life of 10 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capitalized
Web Development Costs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in developing our platform that will contribute to future year financial benefits through revenue generation and/or cost reduction
are capitalized. The amortization of these costs is recognized in the profit and loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Software</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
costs associated with software are deferred and amortized on a straight-line basis over the period of their expected benefit, being their
finite life of four years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impairment
of Non-Financial Assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
assess impairment of non-financial assets at each reporting date by evaluating conditions specific to the us and to the particular asset
that may lead to impairment. If an impairment trigger exists, the recoverable amount of the asset is determined. This involves fair value
less costs of disposal or value-in-use calculations, which incorporate a number of key estimates and assumptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impairment
of Receivables</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
and other receivables are assessed at each reporting date for impairment by assessing conditions and events specific to us and a provision
for refund raised accordingly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Finance
Costs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance
costs attributable to qualifying assets are capitalized as part of the asset. All other finance costs are expensed in the period in which
they are incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Valuation
of Derivative Liability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the conversion feature pertaining to the convertible notes is determined at each reporting date and the changes in fair
value are recognized in the profit and loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issued
capital</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
Shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are shown in equity as
a deduction, net of tax, from the proceeds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    6.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_022"></span>DIRECTORS,
    SENIOR MANAGEMENT AND EMPLOYEES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_023"></span>A.
Directors and Senior Management</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information regarding our executive officers and board of directors as of June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
    Officers</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nick
    Langton</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founder,
    Director and Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neale
    Java</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Independent
    Non-Executive Directors</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vaughn
    Taylor</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board of Directors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hugh
    Williams</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jonathan
    Hart</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and Company Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nick
Langton &#8211; Founder, Director and Chief Executive Officer</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nick
Langton has served as our Chief Executive Officer and director since February 2017. Mr. Langton is a leading financial services executive
with over 25 years of experience. As CEO, Mr. Langton has led some of Australia&#8217;s largest wealth advisory firms including the Private
Wealth division of Perpetual Limited (ASX:PPT) and Bridges Financial Services, a wholly owned subsidiary of Insignia Financial Ltd (ASX:IFL).
Mr. Langton has an undergraduate degree in economics from University of Sydney, postgraduate in finance from Securities Institute of
Australia and completed the Advanced Management Program at Harvard Business School. Mr. Langton has served as a director of Fortnum Private
Wealth since May 2018. We believe Mr. Langton is qualified to serve as a member of our board of directors because of his role in founding
the Company, as well as his deep sector knowledge, expertise and contacts in the martial arts community globally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Neale
Java &#8211; Chief Financial Officer</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neale
Java has served as our Chief Financial Officer since March 2023. Mr. Java brings a track record of leadership in the technology industry
and partnering with executive leadership and boards to drive exceptional growth in enterprise value. This record is complemented by his
results in taking companies from start-up to scale up, broad experience in accessing capital markets and has a strong track record of
growing companies globally with rapidly evolving strategies. Prior to serving as our Chief Financial Officer, Mr. Java was the Chief
Financial Officer of Gelteq ltd from June 2022 to February 2023; Chief Financial Officer of Control Bionics Ltd. (ASX:CBL) from February
2021 to June 2022; and Chief Financial Officer and Chief Operating Officer at thedocyard Limited (ASX:TDY) from October 2019 to December
2020. In addition, Mr. Java served as the Executive Director at thedocyard (ASX:TDY) from June 2020 to December 2020 and served on the
advisory board of Treety. Mr. Java received a Bachelor of Electrical Engineering from University of Wollongong in 2006, a Master of Applied
Finance from Macquarie University in 2012 and an Executive Master of Business Administration from INSEAD in 2019. He has also completed
the Executive Program for Growing Companies at the Graduate School of Business of Stanford University in 2016 and is a graduate and member
of the Australian Institute of Company Directors since 2021. We believe Mr. Java is qualified to serve as the Chief Financial Officer
because he brings significant strategic, operational and financial expertise across from a range of publicly listed and private companies,
particularly emerging technologies, SaaS and e-commerce companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent
Non-Executive Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Vaughn
Taylor &#8211; Chairman of the Board of Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify; text-indent: 34pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vaughn
Taylor has served as our Non-Executive Chairman since August 2021. Previously, from July 2010 to April 2021, Mr. Taylor served as Executive
Director and Chief Investment Officer of AMB Capital Partners, or AMB, the global investment platform of the Western Australian based
Bennett Family, whose wealth is tied to the Australian Iron Ore industry. Mr. Taylor was with AMB since the formation of the investment
platform in 2010, and was responsible for executing on the investment strategy, expanding the investment platform and portfolio into
offshore markets, overseeing the operations and portfolio on a day-to-day basis and sourcing new investment opportunities. Throughout
his career, Mr. Taylor has been a board member of a number of leading organizations both in Australia and internationally across a range
of sectors. In addition to his role as Non-Executive Chairman of Alta, Mr. Taylor is currently serving as a Non-Executive Director of
IperionX Limited (NASDAQ:IPX, ASX:IPX) (leading developer of low carbon titanium for advanced industries including space, aerospace,
electric vehicles and 3D printing) from March 2021 to present, Non-Executive Chairman of Frontier Pets Pty Ltd (an Australian pet food
manufacturer and direct to consumer sales business) from May 2021 to present, Non-Executive Chairman of Urban Rest Holdings Pty Ltd (trading
as Urban Rest) (a global serviced apartment provider focusing on the corporate traveler), Non-Executive Director of Year 13 Pty Ltd (a
youth engagement platform connecting youth with career advice and post-school opportunities) from May 2021 to September 2024 and Non-Executive
Director of Xcend Pty Ltd (an Australian share registry and unitholder registry provider to listed and unlisted companies and funds)
from September 2022 to present. Mr. Taylor holds a Bachelor of Business (Accounting) and a Master of Business (Real Estate) from RMIT
University and gained further accreditation at the Robert H. Smith School of Business at the University of Maryland (USA). Mr. Taylor
also holds a Graduate Diploma in Applied Finance and Investment from Financial Services Professional Body, FINSIA. We believe Mr. Taylor
is qualified to serve as a member of our board of directors because of his extensive experience in investing growth capital into operating
companies and working with founders to build highly successful businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify; text-indent: 13pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hugh
Williams &#8211; Director</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.8pt 0pt 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hugh
Williams has served as our director since August 2021. For the past 13 years Mr. Williams has been Managing Director of Pitt Street Real
Estate Partners, which is a diversified real estate financier, developer and investor. During this period, Mr. Williams has sat on more
than 20 private company boards and chaired numerous committees in that time. We believe Mr. Williams is qualified to serve as a member
of our board of directors because of his extensive experience in strategy, development, and operation of highly successful businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Jonathan
Hart &#8211; Director and Company Secretary</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jonathan
Hart has served as our director since May 2023 and Secretary since August 2021. Mr. Hart is a corporate lawyer and has over 20 years
of corporate advisory experience. He has extensive cross border experience specializing in corporate advisory, scale up and debt and
equity financing, across a broad range of industry sectors. Mr. Hart holds a Bachelor of Laws and Commerce from Murdoch University. Mr.
Hart currently serves as a director of Hartness Consulting Pty Ltd, established in 2012 specializing in corporate advisory and debt and
equity services to private and publicly listed companies in a range of sectors including technology, healthcare and resources. From April
2023 to May 2024, Mr. Hart served as a director of Xcend, an Australian share registry and unitholder registry provider to listed and
unlisted companies and funds. Since December 2022, Mr. Hart has served as company secretary of Urban Rest, a global service apartment
provider focusing on the corporate traveler. Since March 2023, Mr. Hart has served as a company secretary of Noviqtech Limited, a company
harnessing the power of artificial intelligence and distributed ledger technology to provide trusted and transparent reporting across
supply chains, carbon emissions reporting, and guarantee of origin. Since September 2024, Mr. Hart has served as a company secretary of
Opyl Limited, a provider of AI-driven solutions for predicting, simulating, and optimising clinical trials on a global scale. Since September
2024, Mr. Hart has served as a company secretary of Brazilian Rare Earths Limited, a company that owns and operates a district scale Tier
1 Rare Earths Province, located in Brazil. Since October 2024, Mr. Hart has served as a company secretary of Frontier Pets Pty Ltd, a
provider of premium quality pet food made from 100% whole of-life free-range protein and certified organic produce. From March 2020 to
March &#160;2024, Mr. Hart has served as company secretary of HeraMED Limited, a medical data and technology company involved in the
digital transformation of maternity care. We believe Mr. Hart is qualified to serve as a member of our board of directors because he
brings extensive legal and corporate experience as well as a strong business background to our company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships among our directors and senior executives, and there are no arrangements or understandings with major shareholders,
customers, suppliers or others, pursuant to which any person referred to above was selected as a director or member of senior management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_024"></span>B.
Compensation</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Overview</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
remuneration philosophy is to align director and senior management objectives with shareholder and business objectives by providing a
fixed remuneration component and typically offering short-term and long-term incentives based on individual and Company performance and
tenure at the Company. Our board believes the remuneration philosophy to be appropriate and effective in its ability to attract and retain
the best executives and directors to run and manage the consolidated entity, as well as create goal congruence between directors, executives
and shareholders. Our board is responsible for determining the appropriate remuneration package for our executive officers and independent
non-executive directors and may be advised by independent executive compensation specialist advice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officers in Australia receive a superannuation guarantee contribution required under Australian law and do not receive any
other retirement benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remuneration
of Executive Officers</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended June 30, 2024, the aggregate cash remuneration paid to our executive officers was A$731,589 comprising A$668,859
in cash and A$62,730 in post-employment superannuation and other similar payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officers receive fixed compensation as well as short-term and long-term incentives. The level of fixed remuneration is set
to provide a base level of compensation which we consider both appropriate to the applicable position and competitive in the marketplace.
Fixed compensation is comprised of base salary inclusive of superannuation contribution and other similar payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, our board may approve cash bonuses for our executive officers based on individual performance, company performance or as
otherwise determined appropriate. Payments of such bonuses will generally be made in the fiscal year following the year in which they
were earned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also provide long-term incentives with the creation of shareholder wealth. Details of the share rights are provided further below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remuneration
of Independent Non-Executive Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended June 30, 2024, the aggregate remuneration paid to our independent non-executive directors was A$315,000 comprising
A$315,000 in cash and A$0 in post-employment superannuation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also provide long-term incentives to align our non-executive directors with the creation of shareholder wealth. Details of the share
rights are provided further below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreements with Executive Officers</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nick
Langton</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an employment agreement with Nick Langton, the Chief Executive Officer of the Company, on July 1, 2023. Pursuant to the
employment agreement, Mr. Langton shall receive a base salary of A$300,000 per annum, exclusive of superannuation. Either party may terminate
the employment agreement upon twelve months written notice. We may also terminate the employment agreement by giving Mr. Langton pay
in lieu of notice for part or a whole of the notice period, or by requesting that Mr. Langton undertake alternative, or no duties, for
the duration of his notice. If Mr. Langton does not work during his entire notice period, we reserve the right to withhold any salary
owed to Mr. Langton for the unworked portion of his notice period. We may also terminate the employment agreement without notice if Mr.
Langton engages in misconduct as specified in the employment agreement. If terminated other than due to voluntary resignation, death,
disability or for cause, then Mr. Langton will be entitled to a lump sum severance payment, equivalent to 12 months&#8217; pay (exclusive
of short or long-term incentives).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.95pt; text-align: justify; text-indent: 13pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Neale
Java</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2pt; text-align: justify; text-indent: 34pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an employment agreement with Neale Java, the Chief Financial Officer of the Company, on February 20, 2023. Pursuant to the
employment agreement, Mr. Java shall receive a base salary of A$300,000 per annum, inclusive of superannuation. Under Mr. Java&#8217;s
employment agreement, subject to the Company raising a minimum of A$15 million by June 30, 2024, Mr. Java was eligible for a short term
incentive up to a maximum of A$150,000, payable on completion of a successful capital raising. The actual short term incentive paid in
June 2024 was A$98,589. Mr. Java&#8217;s employment is subject to a probationary period of six months. After such probationary period
has ended, either party may terminate the employment agreement upon 3 months&#8217; written notice, and we may terminate the employment
agreement by giving Mr. Java pay in lieu of notice for part or a whole of the notice period. We may also terminate the employment agreement
immediately &#8220;for cause&#8221; if Mr. Java is guilty of serious misconduct or otherwise commits a serious or persistent breach of
the employment agreement. During the probationary period, Mr. Java may terminate his employment upon four weeks&#8217; written notice
or immediately by forfeiting four weeks&#8217; compensation, and the Company may terminate Mr. Java&#8217;s employment upon one weeks&#8217;
written notice or immediately with one weeks&#8217; compensation in lieu of written notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Summary
of Remuneration of Directors and Executive Officers</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the remuneration received by our executive officers for the fiscal year ended June 30, 2024 are set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Salary/Fees</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Post-
                                            </b></span><b><span style="font-family: Times New Roman, Times, Serif">employment</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Superannuation</b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Short-
                                            </b></span><b><span style="font-family: Times New Roman, Times, Serif">term</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incentive</b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Share rights</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Executive Officers</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 33%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Nick Langton (1)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">300,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">315,953</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">648,953</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Neale Java (2)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">270,270</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,730</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,589</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,190</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">461,779</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the remuneration received by our directors for the fiscal year ended June 30, 2024 are set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Salary/Fees</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Post-
                                            </b></span><b><span style="font-family: Times New Roman, Times, Serif">employment</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Superannuation</b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Short-
                                            term</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incentive</b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Share rights</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 33%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Hugh Williams (3)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,451</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">101,451</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vaughn Taylor (4)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">150,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">135,198</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">285,195</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Jonathan Hart (5)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">90,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">87,438</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">A$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">177,438</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
For the fiscal year ending June 30, 2024, Mr. Langton, through Snowflower Holdings Pty Ltd as trustee for the Snowflower Family Trust
Account, was issued 172,000 share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. 50%
of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable
on October 1, 2026. Tanya Langton, spouse of Mr. Langton, was issued 6,000 share rights (subject to vesting conditions) which may be
converted into Ordinary Shares under the EIP. 50% of the share rights will vest and become exercisable on October 1, 2025 and the balance
of the 50% of the share rights will vest and become exercisable on October 1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
For the fiscal year ending June 30, 2024, under Mr. Java&#8217;s employment agreement, Mr. Java was paid a short-term incentive of A$98,589.
Mr. Java, through 3213 Ventures Pty Ltd as trustee for the Java Holdings Trust, was issued 34,400 share rights (subject to vesting conditions)
which may be converted into Ordinary Shares under the EIP. 50% of the share rights will vest and become exercisable on October 1, 2025
and the balance of the share rights will vest and become exercisable on October 1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
For the fiscal year ending June 30, 2024, Mr. Williams, through Champ 7 Pty Ltd as trustee for the Williams Family Trust Account, was
issued 14,400 share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. 50% of the share
rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October
1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
For the fiscal year ending June 30, 2024, Mr. Taylor, through Nalaroo Holdings Pty Ltd as trustee for the Lavoipierre Taylor Fam Trust
Account, was issued 73,600 share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. 50%
of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable
on October 1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
For the fiscal year ending June 30, 2024, Mr. Hart, as trustee for the J Hart Family Trust Account, was issued 47,600 share rights (subject
to vesting conditions) which may be converted into Ordinary Shares under the EIP. 50% of the share rights will vest and become exercisable
on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive
Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Start-Up
Employee Share Option Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2021, our board approved a Start-Up Employee Share Option Plan, or ESOP. The ESOP was available for employees, directors, advisors
and consultants, with the ESOP to be managed by the board, at its discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ESOP was designed with the aim to be tax efficient for our recipients and remove any taxation event on issuance or vesting. In Australia,
the Australian Taxation Office, or ATO, developed &#8220;start up ESOP concessions&#8221; for companies, like ours, that are deemed to
be start-ups under criteria established by the ATO. The start up concessions were developed to make Australia competitive in order to
attract and retain top talent in the start-up eco-system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have issued options under the ESOP on the following terms:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options
                                            may be exercised for Ordinary Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three
                                            year vesting - cliff vesting on three-year anniversary after issuance;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">strike
                                            price &#8211; net tangible assets adjusted for convertible notes, divided by the number of
                                            outstanding Ordinary Shares assuming conversion of any convertible notes (&#8220;Net Tangible
                                            Asset&#8221;). The Net Tangible Asset method has been adopted as per valuation guidelines
                                            set by the ATO; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            board has discretion to force vesting or conversion on certain liquidity events such as an
                                            initial public offering or sale of our Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 31, 2024, we have options to purchase up to 784,098 Ordinary Shares outstanding at a weighted average exercise price of A$1.28
per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employee
Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Background</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2023, our board approved our Employee Incentive Plan, or EIP. The EIP provides ongoing incentives to any full time or part time
employee of the Company or any of its subsidiaries (including a director or secretary of the Company or its subsidiaries who holds salaried
employment with the Company or its subsidiaries on a full or part time basis) who is determined by the board to be eligible to receive
grants of securities under the EIP. Such individuals are referred to as the Eligible Participants. The Company intends to make offers
to Eligible Participants in Australia and other jurisdictions including the United States, subject to compliance with applicable laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Key
Terms</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employee
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the EIP, the Company may offer or issue to Eligible Participants, the following awards (&#8220;Employee Awards&#8221;):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>performance
    rights</b>: a right to be issued or provided with an Ordinary Share at no issue price on specific vesting conditions being achieved;
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>options</b>:
    a right to be issued or provided with an Ordinary Share upon the payment of the exercise price and which can only be exercised if
    specific vesting conditions are achieved; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>loan
    shares</b>: Ordinary Shares issued subject to a limited recourse loan and at no interest rate, subject to specific vesting conditions;
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>deferred
    share awards</b>: Ordinary Shares issued to Eligible Participants: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">who
    elect to receive Ordinary Shares instead of any wages, salary, director&#8217;s fees, or other remuneration; or </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    the Company, in its discretion, in addition to their wages, salary and remuneration, or in lieu of any discretionary cash bonus or
    other incentive payment; or</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exempt
    share awards: </b>Ordinary Shares issued for no consideration or at an issue price which is a discount to the market price with the
    intention that up to A$1,000 (or such other amount which is exempted from tax under the Income Tax Assessment Act 1936 (Cth) or the
    Income Tax Assessment Act 1997 (Cth) from time to time) of the total value or discount received by each employee will be exempt from
    tax<b>.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligible
Employees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
Awards may be granted at the discretion of the board to any person who is an employee or director of, or an individual who provides services
to, the Company, collectively, the Primary Participants, or another person who is a spouse, parent, child or sibling of the Primary Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Price</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board has discretion to determine the issue price and/or exercise price for the Employee Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vesting
and Exercise of Employee Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Employee Awards held by a participant will vest in and become exercisable on the satisfaction of any vesting conditions specified in
the offer and in accordance with the rules of the EIP. Vesting conditions may be waived at the discretion of the board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
of Control</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event a takeover bid is made to acquire all of the Company&#8217;s Ordinary Shares on issue, or a scheme of arrangement, selective
capital reduction or other transaction is initiated which has an effect similar to a full takeover bid, the board may waive unsatisfied
vesting conditions in relation to some or all Employee Awards. Further, if a takeover bid is made to acquire all of the Company&#8217;s
Ordinary Shares on issue, participants may accept the takeover bid in respect of any Employee Awards (other than exempt share awards)
which they hold notwithstanding the restriction period in respect of those Employee Awards has not expired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Claw
Back</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any vesting conditions of an Employee Award are mistakenly waived or deemed satisfied when in fact they were not satisfied, then, in
accordance with the terms of the EIP, the board may determine that the relevant Employee Awards expire (if not yet exercised), or it
may otherwise recover from the participant some or all of the Ordinary Shares issued on exercise of the Employee Awards or any proceeds
received from the sale of those shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Variation
of Share Capital</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
prior to the exercise of an Employee Awards, the Company undergoes a reorganization of capital or bonus issue, the terms of the Employee
Awards will be changed to the extent necessary to comply with the applicable listing rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
<span id="k_001"></span>Board Practices</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Composition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 31, 2024, our board consisted of four directors, three of whom are independent non-executive directors. Vaughn Taylor is the
Chair of our board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that each of our directors has relevant industry experience. The membership of our board is directed by the following requirements
of our Constitution and Board Charter:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
    must be a minimum of 3 directors and may be a maximum of 10 directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    respect of a matter where a director has a material interest, the director may not vote in relation to the proposed arrangement except
    as permitted by the Corporations Act;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Chairman of our board should, where possible, be a non-executive director; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    board should, collectively, have the appropriate mix of qualifications, expertise and experience which will assist the board in fulfilling
    its responsibilities, as well as assisting the Company in achieving growth and delivering value to shareholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board is responsible for overseeing the performance of management. Our board has established delegated limits of authority, which define
the matters that are delegated to management and those that require board&#8217;s approval. The functions and responsibilities reserved
for the board and executive management are set out in our Board Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
non-executive director has a letter of appointment confirming the terms and conditions of their appointment as a director of the Company.
There are no benefits payable to non-executive directors upon termination. In addition, the Company has entered into Deeds of Access,
Insurance and Indemnity with its directors. Similar arrangements will be put in place for directors nominated for appointment upon the
approval by the board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has or will agree to indemnify each of its directors against all liabilities incurred while holding office to the extent permitted
by Australian law, including indemnifying directors for any legal expenses incurred in defending proceedings relating to their directorship
of the Company. Any indemnified amounts must be repaid to the Company to the extent that a director is reimbursed from an insurance policy
maintained by the Company for the directors. The Company has also agreed to obtain and pay the premiums for insurance policies for each
of its directors, which include run-off cover for each director for a period of seven years after the director ceased to hold office.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br/>
Election of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
are elected at our annual general meeting of shareholders. No director, except a Managing Director, shall retain office for a period
in excess of three years without submitting for re-election. Our Board of Directors has the power to appoint any person to be a director,
either to fill a vacancy or as an additional director (provided that the total number of directors does not exceed the maximum allowed
by law), and any director so appointed may hold office only until the next annual general meeting when he or she shall be eligible for
election.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Committees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">To
assist our board of directors with the effective discharge of its duties, we have established a Remuneration and Nomination Committee
and an Audit and Risk Committee, which committees operate under specific charters approved by our board of directors, which are available
on our website.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remuneration
and Nomination Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Remuneration and Nomination Committee are Vaughn Taylor, Hugh Williams and Jonathan Hart. Mr. Williams acts as chairman
of the committee. The committee&#8217;s role involves:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying,
    evaluating and recommending qualified nominees to serve on our board of directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating,
    adopting and administering our compensation plans and similar programs advisable for us, as well as modifying or terminating existing
    plans and programs;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    policies with respect to equity compensation arrangements; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing,
    reviewing and reporting on various remuneration matters to our board of directors.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
and Risk Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Audit and Risk Committee are Vaughn Taylor, Hugh Williams and Jonathan Hart. Mr. Taylor acts as chairman of the committee.
Subject to applicable phase-in requirements, the members of the committee will meet the criteria for independence of audit committee
members set forth in Rule 10A-3 under the Exchange Act and Section 303A.06 and 303.07 of the New York Stock Exchange&#8217;s listing
standards. Each member of our Audit and Risk Committee meets the financial literacy requirements of the listing standards of the NYSE
American. The principal duties and responsibilities of our Audit and Risk Committee includes, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    and reporting on various auditing and accounting matters to our board of directors, including the selection of our independent accountants,
    the scope of our annual audits, fees to be paid to the independent accountants, the performance of our independent accountants and
    our accounting practices;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    and reporting on various risk management matters to our board of directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">considering
    and approving or disapproving all related-party transactions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    our annual and semi-annual financial statements and reports and discussing the statements and reports with our independent registered
    public accounting firm and management;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and pre-approving the engagement of our independent registered public accounting firm to perform audit services and any permissible
    non-audit services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating
    the performance of our independent registered public accounting firm and deciding whether to retain their services; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    procedures for the receipt, retention and treatment of complaints received by us regarding financial controls, accounting or auditing
    matters.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Conduct</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted a Corporate Code of Conduct applicable to all directors, officers and employees, which provides a framework for decisions
and actions in relation to ethical conduct in employment. It underpins the Company&#8217;s commitment to integrity and fair dealing in
its business affairs and to a duty of care to all employees, clients and stakeholders. The document sets out the principles covering
appropriate conduct in a variety of contexts and outlines the minimum standard of behavior expected from employees, including to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">act
    honestly, with integrity and in the best interests of the Company as a whole;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operate
    within the law at all times;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">carry
    out their work to a high standard;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preserve
    the confidentiality of sensitive information of the Company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">avoid
    conflicts of interest which may influence the conduct of duties;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    participate in corrupt conduct; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">observe
    the Company&#8217;s Code of Conduct, Securities Trading Policy and insider trading laws.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
directors and executives also have a fiduciary relationship with shareholders of the Company, making it unlawful to improperly use their
position to gain advantage for themselves. At all times, directors and officers must act in the best interest of the Company and eliminate
or abstain from participating in any discussion or decision-making process in relation to matters which they have a conflict of interest,
not engage in insider trading and comply with all applicable anti-bribery laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Diversity Matrix</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
    Diversity Matrix (As of June 30, 2024)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Country
    of Principal Executive Offices:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"/>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    Private Issuer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"/>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
    Prohibited under Home Country Law</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"/>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Number of Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"/>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 44%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Female</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Male</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 12%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Binary</b></span></p></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 12%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Did
Not<br/>
 Disclose<br/>
 Gender</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part
    I: Gender Identity</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#11834;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#11834;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part
    II: Demographic Background</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underrepresented
    Individual in Home Country Jurisdiction</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LGBTQ+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Did
    Not Disclose Demographic Background</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
<span id="k_002"></span>Employees</b></span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had 24, 31 and 25 employees as of June 30, 2024, 2023 and 2022, respectively. As of June 30, 2024, we employed 4 employees in product
development and engineering, 14 employees in sales and marketing and 6 employees in corporate office capacity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table describes the number of employees by geographic location as of June 30, 2024, 2023 and 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Country</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif">Australia</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">USA</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
<span id="k_003"></span>Share Ownership</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares and any outstanding beneficial ownership of our directors and officers and/or entities affiliated with these individuals are disclosed
in &#8220;Item 7. Major Shareholders and Related Party Transactions&#8212;A. Major Shareholders.&#8221; See &#8220;B. Compensation&#8212;Incentive
Plans&#8221; of this Item 6 for information on our incentive programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.
<span id="k_004"></span>Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
Applicable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_005"></span>ITEM
    7.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MAJOR
    SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
<span id="k_006"></span>Major Shareholders</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to
persons who possess sole or shared voting power or investment power with respect to those securities and include Ordinary Shares issuable
upon the exercise of options that are immediately exercisable or exercisable within 60 days of October 31, 2024. Percentage ownership
calculations are based on Ordinary Shares outstanding as of October 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information with respect to the beneficial ownership of our Ordinary Shares as of October 31, 2024 for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person, or group of affiliated persons, known by us to beneficially own 5% or more of our outstanding Ordinary Shares;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of member of our board of directors and each named executive officer; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    members of our board of directors and our executive officers as a group.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise indicated, all of the shares reflected in the table are Ordinary Shares and all persons listed below have sole voting and
investment power with respect to the shares beneficially owned by them, subject to applicable community property laws. The information
is not necessarily indicative of beneficial ownership for any other purpose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal shareholders have not, nor have they within the past three years had, any position, office, or other material relationship
with us, other than as disclosed in this annual report. See &#8220;Item 6. Directors, Senior Management and Employees&#8221; and &#8220;Item
7. Major Shareholders and Related Party Transactions&#8221; for further information regarding the principal shareholders. The business
address of each principal shareholder is Level 12, 44 Market Street, Sydney, NSW 2000 Australia, unless otherwise indicated below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Ordinary
    Shares</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary
                                            Shares</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficially</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Owned</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
                                            Voting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Power
                                            (1)(2)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Directors and Executive
    Officers:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Nick Langton (3)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">986,314</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.41</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.41</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vaughn Taylor (4)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">242,920</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.32</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.32</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Hugh Williams (5)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">372,532</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.56</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.56</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Jonathan Hart (6)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,952</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Neale Java</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,044</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">All executive officers
    and directors as a group (5 persons)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,620,762</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15.29</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15.29</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Principal Shareholders:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Snowflower Holdings Pty Ltd &lt;Snowflower
    Family A/C&gt;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">982,768</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.38</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.38</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
    less than 1%.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares included on this table includes those shares owned by the beneficial owner&#8217;s spouse, and entity or trust controlled
    by the beneficial owner, or owned by another person in the owner&#8217;s household.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    member of the Board has been awarded options to purchase Ordinary Shares for services on the Board. Shares awarded are issued to
    the recipient and vest over the term of services. In the event of early termination of services and not serving for the full term
    for which the shares were awarded, a pro rata portion of the shares are required to be returned to the Company.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Langton is a director of Snowflower Holdings Pty Ltd. Ordinary Shares held by Snowflower Holdings Pty Ltd (Snowflower Family Trust),
    an entity controlled by Mr. Langton. Mr. Langton has voting and dispositive control over all of these securities of the company.
    Also includes 3,554 Ordinary Shares held by Mrs. Tanya Langton, Mr. Langton&#8217;s wife.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    Shares held by Nalaroo Holdings Pty Ltd (Lavoipierre Taylor Family Trust), an entity controlled by Mr. Taylor.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    Shares held by Champ 7 Pty Ltd (Williams Family Trust), an entity controlled by Mr. Williams and 164,026 Ordinary Shares held by
    Gibb Street Capital Pty Ltd, an entity controlled by Mr. Williams.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    Shares held by Jonathan Hart (J Hart Family Trust). Mr. Hart is a beneficiary under the trust.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant
Changes in the Ownership of Major Shareholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no significant changes in the percentage ownership of our major shareholders during the past three years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Major
Shareholders Voting Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major
shareholders do not have different voting rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record
Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, there were 307 holders of record of our Ordinary Shares, of which 18 record holders, holding approximately 15.73%
of our Ordinary Shares, had registered addresses in the United States. These numbers are not representative of the number of
beneficial holders of our shares nor are they representative of where such beneficial holders reside, since many of these Ordinary
Shares were held of record by brokers or other nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of 30 June, 2023, there were 134 holders of record of our Ordinary Shares, of which 6 record holders, holding approximately 0.90% of
our Ordinary Shares, had registered addresses in the United States. These numbers are not representative of the number of beneficial
holders of our shares nor are they representative of where such beneficial holders reside, since many of these Ordinary Shares were
held of record by brokers or other nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of 30 June, 2022, there were 134 holders of record of our Ordinary Shares, of which 6 record holders, holding approximately 0.90% of
our Ordinary Shares, had registered addresses in the United States. These numbers are not representative of the number of beneficial
holders of our shares nor are they representative of where such beneficial holders reside, since many of these Ordinary Shares were
held of record by brokers or other nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
<span id="k_007"></span>Related Party Transactions</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than compensation arrangements which are described under &#8220;Item 6. Directors, Senior Management and Employees&#8212;Remuneration&#8221;
or as described below, since July 1, 2023 through the date of this annual report, we did not enter into any transactions or loans required
to be described by Item 7.B. of Form 20-F.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deed
of access, insurance and indemnity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into indemnity agreements with each of our directors and certain of our officers. These agreements provide the directors
and officers with contractual rights to indemnification and expense advancement and are governed by the laws of New South Wales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Transaction Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted a written related party transactions policy. Pursuant to this policy, our Audit and Risk Committee review
all material facts of all related party transactions and either approve or disapprove entry into the related party transactions, subject
to certain limited exceptions. In determining whether to approve or disapprove entry into a related party transaction, our Audit and
Risk Committee take into account, among other factors, the following; (i) whether the related party transaction is on terms no less favorable
than terms generally available to an unqualified third-party under the same or similar circumstances and (ii) the extent of the related
person&#8217;s interest in the transaction. Furthermore, the policy requires that all related party transactions required to be disclosed
in our filings with the SEC be so disclosed in accordance with applicable laws, rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
<span id="k_008"></span>Interests of Experts and Counsel</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    8.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_009"></span>FINANCIAL
    INFORMATION</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
<span id="k_010"></span>Consolidated Statements and Other Financial Information</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Item 18. Financial Statements&#8221; for the Company&#8217;s consolidated financial statements including the notes thereto and
report of the independent accounting firm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Legal
Proceedings</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may become involved in legal proceedings arising in the ordinary course of business. We are not aware of any legal proceedings
nor are we subject to any threatened litigation that we believe is material to our business or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends
and Dividend Policy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our incorporation, we have not declared or paid any dividends on our issued share capital. Any determination to pay dividends in the
future will be at the discretion of our board and subject to Australian law. If our board of directors elects to pay dividends, the form,
frequency and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial conditions,
contractual restrictions and other factors that our board of directors may deem relevant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
<span id="k_011"></span>Significant Changes</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no significant changes that have occurred since the date of the financial statements included with this annual report except
as disclosed in this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    9.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_012"></span>THE
    OFFER AND LISTING</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
<span id="k_013"></span>Offering and Listing Details</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Item 9. The Offer and Listing&#11834;C. Markets.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
<span id="k_014"></span>Plan of Distribution</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
<span id="k_015"></span>Markets</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Ordinary Shares are listed on the NYSE American under the symbol &#8220;MMA.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
<span id="k_016"></span>Selling Shareholders</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
<span id="k_017"></span>Dilution</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.
<span id="k_018"></span>Expenses of the Issue</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    10.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.75in; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_019"></span>ADDITIONAL
    INFORMATION</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
<span id="k_020"></span>Share Capital</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
<span id="k_021"></span>Memorandum and Articles of Association</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information called for by this item is included in Exhibit 2.1 &#8220;Description of Securities&#8221; of this annual report. A copy
of our Certificate of Registration is attached as Exhibit 1.1 to this annual report, and a copy of our Constitution is attached as Exhibit
1.2 to this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
<span id="k_022"></span>Material Contracts</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise disclosed in this annual report on Form 20-F (including the Exhibits), we are not currently, and have not been in the last
two years, party to any material contract, other than contracts entered into in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
<span id="k_023"></span>Exchange controls</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia
has largely abolished exchange controls on investment transactions. The Australian dollar is freely convertible into U.S. dollars. In
addition, (other than as specified in &#8220;Item 10. Additional Information &#8211; E. Taxation&#8221; below and certain restrictions
imposed under Australian law in relation to dealings with the assets of and transactions with, designated countries, entities and persons
specified by the Australian Government Department of Foreign Affairs and Trade from time to time, including, persons connected with terrorism)
there are currently no specific rules or limitations regarding the export from Australia of profits, dividends, capital, or similar funds
belonging to foreign investors, except that certain payments to non-residents must be reported to the Australian Transaction Reports
and Analysis Centre, which monitors such transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Foreign Acquisitions and Takeovers Act 1975</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Australian law, foreign persons require the approval of the Australian Federal Treasurer to acquire more than a limited percentage of
interests in an Australian company. These limitations are set forth in the Australian <i>Foreign Acquisitions and Takeovers Act 1975
</i>(Cth) and the <i>Foreign Acquisitions and Takeovers Regulations 2015 </i>(Cth) (together, the &#8220;FIRB Legislation&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the FIRB Legislation, in general terms, any foreign person (either alone or together with any one or more of its associates) is prohibited
from acquiring 20% or more of the voting power (including potential voting power) or issued shares (including rights to, and other prescribed
interests in, issued shares) in an Australian entity, whose total issued securities value or total asset value (whichever is higher)
exceed A$310 million (or A$1,339 million for investors from free trade agreement countries, including the United States). All acquisitions
of direct interests in Australian entities (generally comprising 10% or more of the voting power or issued shares) by foreign government
investors, must be notified to the Australian Federal Treasurer in accordance with the FIRB Legislation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
applicable thresholds are met, the Australian Federal Treasurer may prevent a proposed acquisition or impose conditions on such acquisition
if satisfied that the acquisition would be contrary to the national interest. If a foreign person acquires shares or an interest in shares
in an Australian company in contravention of the FIRB Legislation, the Australian Federal Treasurer may make a range of orders including
an order the divestiture of such person&#8217;s shares or interest in shares in that Australian company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
<span id="k_024"></span>Taxation</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TAXATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following is a summary of certain material U.S. federal and Australian income tax considerations to U.S. Holders, as defined below, of
the acquisition, ownership and disposition of Ordinary Shares. This discussion is based on the laws in force as of the date of this annual
report, and is subject to changes in the relevant income tax law, including changes that could have retroactive effect. The following
summary does not take into account or discuss the tax laws of any country or other taxing jurisdiction other than the United States and
Australia. Holders are advised to consult their tax advisors concerning the overall tax consequences of the acquisition, ownership and
disposition of Ordinary Shares in their particular circumstances. This discussion is not intended, and should not be construed, as legal
or professional tax advice. Each investor should consult its own tax adviser with regard to the application of the U.S. federal tax laws
to their particular situation, as well as any tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
summary does not address the effects of U.S. federal estate and gift tax laws, the alternative minimum tax, the Medicare tax on certain
net investment income or any state and local tax considerations within the United States, and is not a comprehensive description of all
U.S. federal or Australian income tax considerations that may be relevant to a decision to acquire or dispose of Ordinary Shares. Furthermore,
this summary does not address U.S. federal or Australian income tax considerations relevant to holders subject to taxing jurisdictions
other than, or in addition to, the United States and Australia, and does not address all possible categories of holders, some of which
may be subject to special tax rules.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Material U.S. Federal Income Tax Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary, subject to the limitations set forth below, describes certain material U.S. federal income tax consequences to a U.S.
Holder (as defined below) of the acquisition, ownership and disposition of our Ordinary Shares as of the date hereof. Except where noted,
this summary is limited to U.S. Holders who purchase Ordinary Shares and hold such shares as capital assets within the meaning of Section
1221 of the Internal Revenue Code of 1986, as amended, or the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section does not discuss the tax consequences to any particular holder, nor any tax considerations that may apply to U.S. Holders subject
to special tax rules, such as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance
    companies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks
    or other financial institutions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">individual
    retirement and other tax-deferred accounts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
    investment companies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">real
    estate investment trusts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">individuals
    who are former U.S. citizens or former long-term U.S. residents;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">brokers,
    dealers or traders in securities, commodities or currencies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">traders
    that elect to use a mark-to-market method of accounting;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investors
    subject to special tax accounting rules as a result of any item of gross income with respect to our Ordinary Shares being taken into
    account in an applicable financial statement;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    holding our Ordinary Shares through a partnership (including an entity or arrangement treated as a partnership for U.S. federal income
    tax purposes) or S corporation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">grantor
    trusts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
    entities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that hold Ordinary Shares as a position in a straddle or as part of a hedging, constructive sale, conversion or other integrated
    transaction for U.S. federal income tax purposes;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that have a functional currency other than the U.S. dollar;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that hold our Ordinary Shares in connection with a trade or business outside the United States;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that own (directly, indirectly or constructively) 5% or more of our equity;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    subject to special tax accounting rules under Section 451(b) of the Code; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that are not U.S. Holders (as defined below).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this section, a &#8220;U.S. Holder&#8221; means a beneficial owner of Ordinary Shares that is, for U.S. federal income tax purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual who is a citizen or resident of the United States;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation (or any other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under
    the laws of the United States or any state thereof or the District of Columbia;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate the income of which is subject to U.S. federal income taxation regardless of its source; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust (i) the administration of which is subject to the primary supervision of a court in the United States and for which one or
    more U.S. persons have the authority to control all substantial decisions or (ii) that has an election in effect under applicable
    income tax regulations to be treated as a U.S. person for U.S. federal income tax purposes.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, this summary does not address the 3.8% Medicare contribution tax imposed on certain net investment income, the U.S. federal
estate and gift tax or the alternative minimum tax consequences of the acquisition, ownership, and disposition of our Ordinary Shares.
We have not received nor do we expect to seek a ruling from the U.S. Internal Revenue Service, or the IRS, regarding any matter discussed
herein. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of those
set forth below. Each prospective investor should consult its own tax advisors with respect to the U.S. federal, state, local and non-U.S.
tax consequences of acquiring, owning and disposing of our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an entity or arrangement treated as a partnership for U.S. federal income tax purposes acquires, owns or disposes of Ordinary Shares,
the U.S. federal income tax treatment of a partner in such partnership generally will depend on the status of the partner and the activities
of the partnership. Any such partner or partnership should consult its own tax advisor as to the U.S. federal income tax consequences
of acquiring, owning and disposing of our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion below is based upon the provisions of the Code, and the U.S. Treasury regulations, rulings and judicial decisions thereunder
as of the date hereof, and such authorities may be replaced, revoked or modified, possibly with retroactive effect, so as to result in
U.S. federal income tax consequences different from those discussed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
are urged to consult your own tax advisor with respect to the U.S. federal, as well as state, local and non-U.S., tax consequences to
you of acquiring, owning and disposing of Ordinary Shares in light of your particular circumstances, including the possible effects of
changes in U.S. federal and other tax laws.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in &#8220;Dividends and Dividend Policy&#8221; above, we do not currently anticipate paying any distributions on our Ordinary
Shares in the foreseeable future. However, to the extent there are any distributions made with respect to our Ordinary Shares in the
foreseeable future, and subject to the passive foreign investment company, or PFIC, rules discussed below, the gross amount of any such
distributions (without deduction for any withholding tax) made out of our current or accumulated earnings and profits (as determined
for U.S. federal income tax purposes) will generally be taxable to you as ordinary dividend income on the date such distribution is actually
or constructively received. Distributions in excess of our current and accumulated earnings and profits, as so determined, will be treated
first as a tax-free return of capital to the extent of your adjusted tax basis in the Ordinary Shares, as applicable, and thereafter
as capital gain. Notwithstanding the foregoing, we do not intend to maintain calculations of earnings and profits, as determined for
U.S. federal income tax purposes. Consequently, you should expect to treat any distributions paid with respect to our Ordinary Shares
as dividend income. See &#8220;Backup Withholding Tax and Information Reporting Requirements&#8221; below. If you are a corporate U.S.
Holder, dividends paid to you generally will not be eligible for the dividends-received deduction generally allowed under the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a non-corporate U.S. Holder, dividends paid to you by a &#8220;qualified foreign corporation&#8221; may be subject to taxation
at a maximum rate of 20% if the dividends are &#8220;qualified dividends.&#8221; Dividends will be treated as qualified dividends if
(a) certain holding period requirements are satisfied, (b) we are eligible for benefits under the Convention between the Government of
the United States of America and the Government of Australia for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion
with Respect to Taxes on Income, as amended, or the Treaty, or our Ordinary Shares are readily tradable on an established U.S. securities
market, and (c) we were not, in the taxable year prior to the year in which the dividend was paid, and are not, in the taxable year in
which the dividend is paid, a PFIC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Ordinary Shares have been approved for listing on the NYSE American. We do not believe we were a PFIC for our taxable years ended June
30, 2022, June 30, 2023 or June 30, 2024, and do not expect to be a PFIC for our taxable year ended June 30, 2025. However, our status
as a PFIC in the current taxable year ending June 30, 2025 and future taxable years will depend in part upon our use of the funds from
our initial public offering, as well as our income and assets (which for this purpose depends in part on the market value of our shares)
in those years. See the discussion below under &#8220;Passive Foreign Investment Company.&#8221; In addition, although we believe that
our Ordinary Shares will generally be considered to be readily tradable on an established securities market, there can be no assurance
that the Ordinary Shares will continue to be considered readily tradable on an established securities market in later years. You should
consult your tax advisor regarding the availability of the reduced tax rate on any dividends paid with respect to our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includible
distributions paid in Australian dollars, including any Australian withholding taxes, will be included in your gross income in a U.S.
dollar amount calculated by reference to the spot exchange rate in effect on the date of actual or constructive receipt, regardless of
whether the Australian dollars are converted into U.S. dollars at that time. If Australian dollars are converted into U.S. dollars on
the date of actual or constructive receipt, your tax basis in those Australian dollars will be equal to their U.S. dollar value on that
date and, as a result, you generally should not be required to recognize any foreign exchange gain or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Australian dollars so received are not converted into U.S. dollars on the date of receipt, you will have a basis in the Australian dollars
equal to their U.S. dollar value on the date of receipt. Any gain or loss on a subsequent conversion or other disposition of the Australian
dollars generally will be treated as ordinary income or loss to you and generally will be income or loss from sources within the United
States for foreign tax credit limitation purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
you receive with respect to Ordinary Shares will be treated as foreign source income, which may be relevant in calculating your foreign
tax credit limitation. The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes
of income. For these purposes, dividends generally will be categorized as &#8220;passive&#8221; income. Subject to certain limitations,
you generally will be entitled, at your option, to claim either a credit against your U.S. federal income tax liability or a deduction
in computing its U.S. federal taxable income in respect of any Australian taxes withheld. If you elect to claim a deduction, rather than
a foreign tax credit, for Australian taxes withheld for a particular taxable year, the election will apply to all foreign taxes paid
or accrued by you or on your behalf in the particular taxable year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
availability of the foreign tax credit and the application of the limitations on its availability are fact specific and are subject to
complex rules. You are urged to consult your own tax advisor as to the consequences of Australian withholding taxes and the availability
of a foreign tax credit or deduction. See &#8220;Australian Tax Considerations-Taxation of Dividends.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sale,
Exchange or Other Disposition of Ordinary Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the PFIC rules discussed below, you generally will, for U.S. federal income tax purposes, recognize capital gain or loss on a sale,
exchange or other disposition of Ordinary Shares equal to the difference between the amount realized on the disposition (determined in
the case of sales, exchanges or dispositions in currencies other than U.S. dollars by reference to the spot exchange rate in effect on
the date of the sale, exchange or disposition or, if sold, exchanged or disposed of on an established securities market and you are a
cash basis taxpayer or an electing accrual basis taxpayer, the spot exchange rate in effect on the settlement date) and your adjusted
tax basis (as determined in U.S. dollars) in the Ordinary Shares. Your initial tax basis will be your U.S. dollar purchase price for
such Ordinary Shares. If you are an accrual basis taxpayer that is not eligible to or does not elect to determine the amount realized
using the spot rate on the settlement date, you will recognize foreign currency gain or loss to the extent of any difference between
the U.S. dollar amount realized on the date of sale, exchange or disposition and the U.S. dollar value of the currency received at the
spot rate on the settlement date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"></p>

<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
we are not a PFIC and have not been treated as a PFIC during your holding period for your Ordinary Shares, this recognized gain or loss
will generally be long-term capital gain or loss if you have held the Ordinary Shares for more than one year. Generally, if you are a
non-corporate U.S. Holder, long-term capital gains are subject to U.S. federal income tax at preferential rates. For foreign tax credit
limitation purposes, gain or loss recognized upon a disposition generally will be treated as from sources within the United States. However,
in limited circumstances, the Treaty can re-source U.S. source income as Australian source income. The deductibility of capital losses
is subject to limitations for U.S. federal income tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should consult your own tax advisor regarding the availability of a foreign tax credit or deduction in respect of any Australian tax
imposed on a sale or other disposition of Ordinary Shares. See &#8220;Australian Tax Considerations-Tax on Sales or other Dispositions
of Shares.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Passive
Foreign Investment Company</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rules governing PFICs can result in adverse tax consequences to U.S. Holders. We generally will be classified as a PFIC for any taxable
year if (i) at least 75% of our gross income for the taxable year consists of certain types of passive income (the &#8220;<i>Income Test</i>&#8221;)
or (ii) at least 50% of our gross assets during the taxable year, based on a quarterly average and generally determined by value, produce
or are held for the production of passive income (the &#8220;<i>Asset Test</i>&#8221;). Passive income for this purpose generally includes,
among other things, dividends, interest, rents, royalties, gains from commodities and securities transactions and gains from the disposition
of assets that produce or are held for the production of passive income. In determining whether a foreign corporation is a PFIC, a pro-rata
portion of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is
taken into account. Under this rule, we should be deemed to own a proportionate share of the assets and to have received a proportionate
share of the income of our principal subsidiaries for purposes of the PFIC determination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we do not believe that we were a PFIC for the current year, our determination is based on an interpretation of complex provisions of
the law, which are subject to changes, potentially retroactively. In addition, because PFIC status is determined on an annual basis based
on facts and circumstances, and generally cannot be determined until the end of the taxable year, and because the calculation of the
value of our assets may be based in part on the value of our securities, which may fluctuate considerably, there can be no assurance
that we are not a PFIC for the current taxable year or will not be a PFIC for future taxable years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>U.S.
Federal Income Tax Treatment of a Shareholder of a PFIC</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC for any taxable year during which you hold Ordinary Shares, absent certain elections (including the mark-to-market election
or qualified electing fund election described below), you generally will be subject to adverse rules (regardless of whether we continue
to be classified as a PFIC) with respect to (1) any &#8220;excess distribution&#8221; (generally, any distributions you receive on your
Ordinary Shares in a taxable year that are greater than 125% of the average annual distributions you receive in the three preceding taxable
years or, if shorter, your holding period) and (2) any gain recognized from a sale or other disposition (including a pledge) of such
Ordinary Shares. Under these rules:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    excess distribution or gain will be allocated ratably over your holding period for the Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount allocated to the current taxable year, and any taxable year prior to the first taxable year in which we were classified as
    a PFIC in the U.S. holder&#8217;s holding period, will be treated as ordinary income arising in the current taxable year; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount allocated to each other taxable year during your holding period in which we were classified as a PFIC (i) will be subject
    to income tax at the highest rate in effect for that year and applicable to you and (ii) will be subject to an interest charge generally
    applicable to underpayments of tax with respect to the resulting tax attributable to each such year.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if you are a non-corporate U.S. Holder, you will not be eligible for reduced rates of taxation on any dividends that we pay
if we are a PFIC for either the taxable year in which the dividend is paid or the preceding year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
PFIC status is determined annually, if you held Ordinary Shares during any taxable year while we were a PFIC, such determination generally
will apply to you for subsequent years, whether or not we meet either the Income Test or Asset Test for PFIC status in those subsequent
years. However, if we cease to be a PFIC, you can avoid the continuing impact of the PFIC rules by making a special election to recognize
gain as if your Ordinary Shares had been sold on the last day of the last taxable year during which we were a PFIC. You are urged to
consult your tax advisor about this election.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC, the tax liability for amounts allocated to years prior to the year of disposition or excess distribution cannot be offset
by any net operating loss, and gains (but not losses) recognized on the transfer of the Ordinary Shares cannot be treated as capital
gains, even if the Ordinary Shares are held as capital assets. Furthermore, unless otherwise provided by the U.S. Treasury Department,
if we are a PFIC, you will be required to file an annual report (currently Form 8621) describing your interest in us, making an election
on how to report PFIC income, and providing other information about your share of our income and any gain realized on the disposition
of our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"></p>

<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC for any taxable year during which any of our non-U.S. subsidiaries is also a PFIC, during such year you would be treated
as owning a proportionate amount (by value) of the shares of the lower-tier PFIC for purposes of the application of these rules to such
subsidiary. It is possible that any subsidiary we own would be a PFIC for the current taxable year or future taxable years. You should
consult your tax advisor regarding the tax consequences if the PFIC rules apply to any of our subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PFIC
&#8220;Mark-to-market&#8221; Election</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
certain circumstances, a holder of &#8220;marketable stock&#8221; of a PFIC can avoid certain of the adverse rules described above by
making a mark-to-market election with respect to such stock. For purposes of these rules, &#8220;marketable stock&#8221; is stock which
is &#8220;regularly traded&#8221; (traded in greater than <i>de minimis</i> quantities on at least 15 days during each calendar quarter)
on a &#8220;qualified exchange&#8221; or other market within the meaning of applicable U.S. Treasury Regulations. A &#8220;qualified
exchange&#8221; includes a national securities exchange that is registered with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you make a mark-to-market election, you must include in gross income, as ordinary income, for each taxable year that we are a PFIC an
amount equal to the excess, if any, of the fair market value of your Ordinary Shares that are &#8220;marketable stock&#8221; at the close
of the taxable year over your adjusted tax basis in such Ordinary Shares. If you make such election, you may also claim a deduction as
an ordinary loss in each such year for the excess, if any, of your adjusted tax basis in such Ordinary Shares over their fair market
value at the end of the year, but only to the extent of the net amount previously included in income as a result of the mark-to-market
election. The adjusted tax basis of your Ordinary Shares with respect to which the mark-to-market election applies would be adjusted
to reflect amounts included in gross income or allowed as a deduction because of such election. If you make an effective mark-to-market
election, any gain you recognize upon the sale or other disposition of your Ordinary Shares in a year that we are a PFIC will be treated
as ordinary income and any loss will be treated as ordinary loss, but only to the extent of the net amount previously included in income
as a result of the mark-to-market election.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
current law, the mark-to-market election may be available to U.S. Holders of Ordinary Shares if the Ordinary Shares are listed on the
NYSE American, which constitutes a qualified exchange, although there can be no assurance that the Ordinary Shares will be &#8220;regularly
traded&#8221; for purposes of the mark-to-market election. Additionally, because a mark-to-market election cannot be made for equity
interests in any lower-tier PFIC that we may own, if you make a mark-to-mark election with respect to us, you may continue to be subject
to the PFIC rules with respect to any indirect investments held by us that are treated as an equity interest in a PFIC for U.S. federal
income tax purposes, notwithstanding the fact that the value of such equity interest had already been taken into account indirectly via
mark-to-market adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you make a mark-to-market election, it will be effective for the taxable year for which the election is made and all subsequent taxable
years unless the Ordinary Shares are no longer regularly traded on a qualified exchange or the IRS consents to the revocation of the
election. You are urged to consult your tax advisors about the availability of the mark-to-market election, and whether making the election
would be advisable in your particular circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PFIC
&#8220;QEF&#8221; election</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively,
in certain cases a U.S. Holder can avoid the interest charge and the other adverse PFIC tax consequences described above by obtaining
certain information from the PFIC and electing to treat us as a &#8220;qualified electing fund&#8221; under Section 1295 of the Code.
However, we do not anticipate that this option will be available to you because we do not intend to provide the information regarding
our income that would be necessary to permit you to make this election.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are urged to contact your own tax advisor regarding the determination of whether we are a PFIC and the tax consequences of such status.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Backup
Withholding Tax and Information Reporting Requirements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
of dividends with respect to the Ordinary Shares and proceeds from the sale, exchange or other disposition of the Ordinary Shares, by
a U.S. paying agent or other U.S. intermediary, or made into the United States, will be reported to the IRS and to you as may be required
under applicable Treasury regulations. Backup withholding may apply to these payments if you fail to provide an accurate taxpayer identification
number or certification of exempt status or otherwise fail to comply with applicable certification requirements. Certain U.S. Holders
(including, among others, corporations) are not subject to backup withholding and information reporting. Backup withholding is not an
additional tax. Any amounts withheld under the backup withholding rules from a payment to you will be refunded (or credited against your
U.S. federal income tax liability, if any), provided the required information is timely furnished to the IRS. Prospective investors should
consult their own tax advisors as to their qualification for exemption from backup withholding and the procedure for establishing an
exemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
individual U.S. Holders (and under Treasury regulations, certain entities) may be required to report to the IRS (currently on Form 8938)
information with respect to their investment in the Ordinary Shares not held through an account with a U.S. financial institution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion above is not intended to constitute a complete analysis of all tax considerations applicable to an investment in Ordinary
Shares. You should consult with your own tax advisor concerning the tax consequences to you in your particular situation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Australian
Tax Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this section, we discuss the material Australian income tax, stamp duty and goods and services tax considerations related to the acquisition,
ownership and disposal by the absolute beneficial owners of the Ordinary Shares. This discussion has been reviewed by K&amp;L Gates,
Australian counsel to Alta with respect to certain tax matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is based upon existing Australian tax law as of the date of this annual report, which is subject to change, possibly retrospectively.
This discussion does not address all aspects of Australian tax law which may be important to particular investors in light of their individual
investment circumstances, such as shares held by investors subject to special tax rules (for example, financial institutions, insurance
companies or tax exempt organizations). In addition, this summary does not discuss any foreign or state tax considerations, other than
stamp duty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospective
investors are urged to consult their tax advisors regarding the Australian and foreign income and other tax considerations of the acquisition,
ownership and disposition of the shares. As used in this summary a &#8220;Non-Australian Shareholder&#8221; is a holder that is not an
Australian tax resident and is not carrying on business in Australia through a permanent establishment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of Dividends</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia
operates a dividend imputation system under which dividends may be declared to be &#8220;franked&#8221; to the extent of tax paid on
company profits. Fully franked dividends paid to Non-Australian Shareholders are not subject to dividend withholding tax. An exemption
for dividend withholding tax can also apply to unfranked dividends that are declared to be conduit foreign income, or CFI, and paid to
Non-Australian Shareholders. Dividend withholding tax will be imposed at 30%, unless a shareholder is a resident of a country with which
Australia has a double taxation agreement and qualifies for the benefits of the treaty. Under the provisions of the current Treaty, the
Australian tax withheld on unfranked dividends that are not declared to be CFI paid by us to a resident of the United States which is
beneficially entitled to that dividend is limited to 15% where that resident is a qualified person for the purposes of the Treaty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a Non-Australian Shareholder is a company and owns a 10% or more interest, the Australian tax withheld on dividends paid by us to which
a resident of the United States is beneficially entitled is limited to 5%. In limited circumstances the rate of withholding can be reduced
to zero.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
on Sales or other Dispositions of Shares-Capital gains tax</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Australian
Shareholders will not be subject to Australian capital gains tax on the gain made on a sale or other disposal of Ordinary Shares, unless
they, together with associates, hold 10% or more of our issued capital, at the time of disposal or for 12 months of the last two years
prior to disposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Australian
Shareholders who own a 10% or more interest would be subject to Australian capital gains tax if more than 50% of our direct or indirect
assets, determined by reference to market value, consists of Australian land, leasehold interests or Australian mining, quarrying or
prospecting rights. The Treaty is unlikely to limit Australia&#8217;s right to tax any gain in these circumstances. Net capital gains
are calculated after reduction for capital losses, which may only be offset against capital gains.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
on Sales or other Dispositions of Shares-Shareholders Holding Shares on Revenue Account</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
Non-Australian Shareholders may hold shares on revenue rather than on capital account for example, share traders. These shareholders
may have the gains made on the sale or other disposal of the shares included in their assessable income under the ordinary income taxing
provisions of the income tax law, if the gains are sourced in Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Australian
Shareholders assessable under these ordinary income provisions in respect of gains made on shares held on revenue account would be assessed
for such gains at the Australian tax rates for non-Australian residents, which start at a marginal rate of 32.5%. Some relief from Australian
income tax may be available to Non-Australian Shareholders under the Treaty. Non-Australian Shareholders that are companies deriving
Australian sourced income will be assessed at the applicable Australian corporate tax of either 25% or 30%, depending on the composition
and level of income derived by the corporate shareholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"></p>

<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent an amount would be included in a Non-Australian Shareholder&#8217;s assessable income under both the capital gains tax provisions
and the ordinary income provisions, the capital gain amount would generally be reduced, so that the shareholder would not be subject
to double tax on any part of the income gain or capital gain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dual
Residency</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a shareholder is a resident of both Australia and the United States under those countries&#8217; domestic taxation laws, that shareholder
may be subject to tax as an Australian resident. If, however, the shareholder is determined to be a U.S. resident for the purposes of
the Treaty, the Australian tax would be subject to limitation by the Treaty. Shareholders should obtain specialist taxation advice in
these circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stamp
Duty</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
stamp duty should be payable by Australian residents or non-Australian residents on the issue and trading of shares that are quoted on
the ASX or NYSE American at all relevant times unless they acquire a significant interest (i.e., the shares that are subject of the arrangement
do not represent 90% or more of all issued shares) and the company is a landholder for duty purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Australian
Death Duty</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia
does not have estate or death duties. As a general rule, no capital gains tax liability is realized upon the inheritance of a deceased
person&#8217;s shares. The disposal of inherited shares by beneficiaries may, however, give rise to a capital gains tax liability if
the gain falls within the scope of Australia&#8217;s jurisdiction to tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Goods
and Services Tax</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issue or transfer of shares to a non-Australian resident investor will not incur Australian goods and services tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.
<span id="k_025"></span>Dividends and Paying Agents</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G.
<span id="k_026"></span>Statement by Experts</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H.
<span id="k_027"></span>Documents on Display</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files reports, including annual reports on Form 20-F, furnishes current reports on Form 6-K and discloses other information with
the SEC pursuant to the rules and regulations of the SEC that apply to foreign private issuers. The SEC maintains a website that contains
reports and information statements regarding issuers that file electronically with the SEC. Our reports (including this annual report)
and information statements and other information about us can be downloaded from the SEC&#8217;s website at www.sec.gov or from the investor
relations page on our website at https://altaglobalgroup.com. Information on our website is not incorporated by reference into or otherwise
part of this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I.
<span id="k_028"></span>Subsidiary Information</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>J.
<span id="k_029"></span>Annual Report to Security Holders</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    11.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_030"></span>QUANTITATIVE
    AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to market risk in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial
position due to adverse changes in financial market prices and rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management believes that the financial institutions that hold our investments are financially sound and accordingly, minimal credit risk
exists with respect to these investments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not invest our excess cash and cash equivalents in interest-bearing accounts and term deposits with banks in Australia. Thereby we
do not believe that we have a material exposure to interest rate risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conduct our activities in mostly in Australia, New Zealand, Ireland and USA. We are required to make certain payments in U.S. dollars
and other currencies, however we believe an adverse movement in end-of-period exchange rates would not have a material impact on our
operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently utilize derivative financial instruments or other financial instruments subject to market risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    12.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_031"></span>DESCRIPTION
    OF SECURITIES OTHER THAN EQUITY SECURITIES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_032"></span>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    13.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_033"></span>DEFAULTS,
    DIVIDEND ARREARAGES AND DELINQUENCIES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    14.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_034"></span>MATERIAL
    MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2024, we completed our U.S. initial public offering of 1,300,000 Ordinary Shares, at an offering price of US$5.00 per Ordinary
Share for aggregate gross proceeds to us of approximately US$6,500,000. The net offering proceeds to us, after deducting underwriting
discounts and commissions and other offering expenses, were approximately US$5,767,887. The offering commenced in March 2024 and did
not terminate before all of the securities registered in the registration statement were sold. The effective date of the registration
statement on Form F-1 (File No. 333-275618) for the offering was March 27, 2024. ThinkEquity LLC acted as representative for the underwriters
for the offering. The net proceeds from our offering have been used, and are expected to continue to be used, as described in the final
prospectus for the offering filed with the U.S. Securities and Exchange Commission on March 28, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    15.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_035"></span>CONTROLS
    AND PROCEDURES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
<span id="k_036"></span>Disclosure Controls and Procedures</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure
controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of June 30, 2024. The Company&#8217;s disclosure controls
and procedures are designed to provide reasonable assurance that the information we are required to disclose in the reports we file or
submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s
rules and forms and (2) accumulated and communicated to our management to allow timely decisions regarding required disclosures. There
are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human
error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures
can only provide reasonable assurance of achieving their control objectives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on such evaluation, concluded that, as of the Evaluation Date, our disclosure controls and procedures are not effective in recording,
processing, summarizing and reporting, on a timely basis, information required to be included in periodic filings under the Exchange
Act and that such information is accumulated and communicated to management, including our principal executive and financial officers,
as appropriate to allow timely decisions regarding required disclosure. In particular, we have identified material weaknesses in internal
control over financial reporting, as discussed below in section B.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
<span id="k_037"></span>Management&#8217;s Annual Report on Internal Control Over Financial Reporting</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f)
and 15d-15(f) under the Exchange Act. Internal control over financial reporting is a process designed by, or under the supervision of,
our Company&#8217;s Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management and other
personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with IFRS accounting standards and includes those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in
accordance with IFRS accounting standards, and that receipts and expenditures of the company are being made only in accordance with authorizations
of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management conducted an assessment of the effectiveness of our internal control over financial reporting as of June 30, 2024 based on
the criteria set forth in Internal Control&#8212;Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the
Treadway Commission (2013 framework).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on that assessment, our management concluded that our internal control over financial reporting was not effective as of June 30, 2024
due to ineffective controls over the following reporting areas to be material weaknesses:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.15pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            lack of a formally implemented system of internal control over financial reporting and limited
                                            or no associated written documentation of our internal control policies and procedures, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 38.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 38.15pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 38.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20.15pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            lack of sufficient resources and key accounting personnel with sufficient knowledge and experience
                                            in reporting and compliance with the SEC and PCAOB.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequently,
we have determined there is a material weakness in our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
<span id="k_038"></span>Attestation Report of the Registered Public Accounting Firm</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report does not include an attestation report of our registered public accounting firm due to a transition period established
by rules of the SEC for newly public companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
<span id="k_039"></span>Changes in Internal Control Over Financial Reporting</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been no change to the Company&#8217;s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange
Act) that occurred during the period covered by this annual report that has materially affected, or is reasonably likely to materially
affect, internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_040"></span>[RESERVED]</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_041"></span>AUDIT
    COMMITTEE FINANCIAL EXPERT</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Audit and Risk Committee are Vaughn Taylor, Hugh Williams and Jonathan Hart. Mr. Taylor acts as chairman of the committee.
Subject to applicable phase-in requirements, the members of the committee will meet the criteria for independence of audit committee
members set forth in Rule 10A-3 under the Exchange Act and Section 303A.06 and 303.07 of the New York Stock Exchange&#8217;s listing
standards. Each member of our Audit and Risk Committee will meet the financial literacy requirements of the listing standards of the
NYSE American. The Board of Directors has determined that Vaughn Taylor and Hugh Williams both qualify as an &#8220;audit committee financial
expert&#8221; as that term is defined in Item 16A of Form 20-F.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_042"></span>ITEM
    16B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CODE
    OF ETHICS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 6, 2024, we adopted a code of ethics that applies to all of our employees, officers and directors, including our executive officers,
and the full text of our code of ethics is available on our investor relations section of our website, https://altaglobalgroup.com. We
intend to disclose future amendments to our code of ethics, or any waivers of such code, on our website or in public filings. Information
on our website is not incorporated by reference into or otherwise part of this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16C.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_043"></span>PRINCIPAL
    ACCOUNTANT FEES AND SERVICES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 9, 2023 BDO Audit Pty Ltd (&#8220;BDO&#8221;) was appointed as our independent registered public accounting firm upon recommendation
by the Audit and Risk Committee to the Board and the approval of the Board. BDO served as our independent registered public accounting
firm for the fiscal year ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BDO
has served as our independent registered public accounting firm for the fiscal years ended June 30 2024, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the fees billed to us by our independent registered public accounting firm during the fiscal years ended June
30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; font-style: italic; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(in
    A$ thousands)</span></td><td style="font-weight: bold; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Audit fees</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">382</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Audit-related fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">130</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">207</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tax fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">All other fees</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">512</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">407</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Fees</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
fees are fees billed for professional services rendered by the principal accountant for the audit of the registrant&#8217;s annual combined
financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or
engagements for those fiscal years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit-Related
Fees</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-related
fees are fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our
financial statements and not reported under the previous category. These services would include, among others: accounting consultations,
U.S. Sarbanes-Oxley Act of 2002 assessments, and audits in connection with acquisitions, internal control reviews, attest services that
are not required by statute or regulation and consultation concerning financial accounting and reporting standards. They also include
fees for assurance reporting on our current and historical financial information included in our SEC registration statement in connection
with our IPO and also fees for the review of the interim financial information in connection with our IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Tax
Fees</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
fees are fees billed for professional services for tax due diligence and tax consultations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>All
Other Fees</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2024 and 2023, there were no other fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee Pre-Approval Policies and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit committee is responsible for pre-approving audit and non-audit services provided to us by our independent registered public accounting
firm. All of the non-audit services provided to us by the independent auditors following the formation of our audit committee were pre-approved
by the audit committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16D.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_044"></span>EXEMPTIONS
    FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Audit and Risk Committee are Vaughn Taylor, Hugh Williams and Jonathan Hart. Subject to applicable phase-in requirements,
the members of the committee will meet the criteria for independence of audit committee members set forth in Rule 10A-3 under the Exchange
Act and Section 303A.06 and 303.07 of the New York Stock Exchange&#8217;s listing standards. Currently, the Company is relying on the
exemption provided for in Rule 10A-3(b)(iv)(A) which allows a minority of the members of the audit committee to remain exempt from the
independence requirements of Rule 10A-3(b)(1)(ii) for one year from the effectiveness of the registration statement relating to the Company&#8217;s
IPO. The Company does not believe that reliance on such exemption would materially adversely affect the ability of the audit committee
to act independently and to satisfy the requirements of Rule 10A-3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_045"></span>ITEM
    16E.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURCHASES
    OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2024, no purchases of our equity securities were made by or on behalf of the Company or any affiliated purchaser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16F.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_046"></span>CHANGE
    IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16G.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_047"></span>CORPORATE
    GOVERNANCE</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign
Private Issuer Status</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a &#8220;foreign private issuer,&#8221; as defined by the SEC, we are permitted to follow home country corporate governance practices
instead of certain corporate governance practices required by the NYSE American for U.S. domestic issuers. While we intend to follow
most NYSE American corporate governance listing standards, we intend to follow Australian law for certain corporate governance practices
in lieu of NYSE American corporate governance listing standards as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exemption
    from the requirement to have a committees composed solely of independent members of the board of directors;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exemption
    from quorum requirements applicable to meetings of shareholders under NYSE American rules. In accordance with generally accepted
    business practice and Australian law, our Constitution provides quorum requirements that are generally applicable to meetings of
    shareholders under Australian law (see Exhibit 1.2 to this annual report for more detail);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exemption
    from the NYSE American corporate governance listing standards applicable to domestic issuers requiring disclosure within four business
    days of any determination to grant a waiver of the code of business conduct and ethics to directors and officers. Although we will
    require board approval of any such waiver, we may choose not to disclose the waiver in the manner set forth in the NYSE American
    corporate governance listing standards, as permitted by the foreign private issuer exemption; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exemption
    from the requirement to obtain shareholder approval for certain issuances of securities, including shareholder approval of employee
    share plans.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to follow our home country, Australia, practices in lieu of the foregoing requirements. Although we currently comply with the
NYSE American corporate governance rules applicable other than as noted above, we may in the future decide to use the foreign private
issuer exemption with respect to some or all of any other NYSE American corporate governance rules where we are permitted to follow our
home country governance requirements in lieu of such NYSE American rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we are a foreign private issuer, we are exempt from certain rules under the Exchange Act that impose certain disclosure obligations and
procedural requirements for proxy solicitations under Section 14 of the Exchange Act. Additionally, our officers, directors and principal
shareholders are not subject to short-swing profit and insider trading reporting obligations under Section 16 of the Exchange Act. They
will, however, be subject to the obligations to report changes in share ownership under Section 13 of the Exchange Act and related SEC
rules. In addition, we are not required to comply with Regulation FD, which restricts the selective disclosure of material information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16H.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_048"></span>MINE
    SAFETY DISCLOSURE</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16I.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_049"></span>DISCLOSURE
    REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16J.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_050"></span>INSIDER
    TRADING POLICIES</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted a securities trading policy which outlines when directors, senior management and other employees may deal
in our securities and procedures to reduce the risk of insider trading. A copy of the insider trading policy is attached as Exhibit 11.1
to this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16K.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_051"></span>CYBERSECURITY</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s executive officers oversee the strategic processes to safeguard data and comply with relevant regulations and have overall
responsibility for evaluating cybersecurity risks, as well as related policies and risks in connection with the company&#8217;s supply
chain, suppliers and other service providers. The Company does not currently engage any assessors, consultants, auditors, or other third
parties in connection with any such processes, given the size and scale of the Company, the resources available to it, the anticipated
expenditures, and the risks it faces in terms of cybersecurity. The Company&#8217;s executive officers are responsible for overseeing
and periodically reviewing and identifying risks from cybersecurity threats associated with its use of any third-party service provider.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the start of its latest completed fiscal year and up to the date of this Annual Report, the Company is not aware of any risks from cybersecurity
threats, including as a result of any previous cybersecurity incidents, that have materially affected or are reasonably likely to materially
affect the Company, including its business strategy, results of operations, or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is collectively responsible for oversight of risks from cybersecurity threats. The Company&#8217;s executive officers together
with its product and engineering team, oversee the overall processes to safeguard data and comply with relevant regulations and will
report material cybersecurity incidents to the Board. The Company&#8217;s executive officers have limited experience in the area of cybersecurity,
but where necessary in the view of the Company&#8217;s executive officers, the Company will consult with external advisers to manage
and remediate any cybersecurity incidents. For material cybersecurity incidents, the Company&#8217;s executive officers will promptly
inform, update, and seek the instructions of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_052"></span>PART
III</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    17.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_053"></span>FINANCIAL
    STATEMENTS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have elected to provide financial statements and related information pursuant to Item 18.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    18.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="k_054"></span>FINANCIAL
    STATEMENTS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements and the related notes required by this Item are included in this annual report beginning on page F-1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALTA
GLOBAL GROUP LIMITED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
FINANCIAL STATEMENTS<br/>
FOR THE YEARS ENDED JUNE 30, 2024, 2023 AND 2022</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 415.3pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; background-color: White">
  <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Page</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="font: 10pt Times New Roman, Times, Serif"><a href="#fin_01">Report of Independent Registered Public Accounting Firm</a> (BDO Audit Pty Ltd, Sydney, Australia, PCAOB ID#<span id="xdx_909_edei--AuditorFirmId_c20230701__20240630_zK9Ozht3X7K8"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000051" name="dei:AuditorFirmId">2256</ix:nonNumeric></span>)</td>
    <td>&#160;</td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-2</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; background-color: White">
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fin_001">Consolidated Statement of Profit or Loss and Other Comprehensive Loss for the years ended June 30, 2024, 2023 and 2022</a></span></td>
    <td style="width: 0.1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in">F-3</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fin_002">Consolidated Statement of Financial Position as of June 30, 2024 and 2023.</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-4</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; background-color: White">
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fin_003">Consolidated Statement of Changes in Equity for the years ended June 30, 2024, 2023 and 2022</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fin_004">Consolidated Statement of Cash Flows for the years ended June 30, 2024, 2023 and 2022</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; background-color: White">
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fin_005">Notes to the Consolidated Financial Statements</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-7</td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 75; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><img src="logo_001.jpg" alt=""/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 30%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
    +61 2 9251 4100</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
    +61 2 9240 9821</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>www.bdo.com.au</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    11, 1 Margaret Street</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sydney
    NSW 2000</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></p></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="fin_01"></span><span style="font-family: Times New Roman, Times, Serif">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
and Board of Directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
Global Group Limited</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1, Suite 1, 29-33 The Corso</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manly, New South Wales 2095</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
on Consolidated Financial Statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated statements of financial position of Alta Global Group Limited and its subsidiaries
(together the &#8220;Company&#8221;) as of June 30, 2024 and 2023, the related consolidated statements of profit or loss and other
comprehensive loss, statement of changes in equity, and cash flows for each of the three years ended June 30, 2024, and the related
notes and schedules (collectively referred to as the &#8216;consolidated financial statements&#8217;). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company as of June 30,
2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended June 30, 2024,
in conformity with International Financial Reporting Standards as issued by the International Accounting Standard Board and
interpretations (collectively &#8216;IFRS&#8217;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantial
doubt about the Company&#8217;s ability to continue as a Going Concern</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As described
in Note 3 to the consolidated financial statements, the Company has suffered recurring losses from operations that raises substantial
doubt about its ability to continue as a going concern. Management&#8217;s evaluation of the events and conditions and management&#8217;s
plans regarding these matters are also described in Note 3. The consolidated financial statements do not include any adjustments that
might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
for opinion</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion
on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (&#8216;PCAOB&#8217;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
<span id="xdx_90F_edei--AuditorName_c20230701__20240630_zcC5PEFJJGo4"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000052" name="dei:AuditorName">BDO Audit Pty Ltd</ix:nonNumeric></span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><img src="logo_002.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--AuditorLocation_c20230701__20240630_zR4YOgU07woh"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000053" name="dei:AuditorLocation">Sydney,
Australia</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
31, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>




<p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">BDO
Audit Pty Ltd ABN 33 134 022 870 is a member of a national association of independent entities which are all members of BDO Australia
Ltd ABN 77 050 110 275, an Australian company limited by guarantee. BDO Audit Pty Ltd and BDO Australia Ltd are members of BDO International
Ltd, a UK company limited by guarantee, and form part of the international BDO network of independent member firms.</span></p>
<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 76 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="fin_001"></span>CONSOLIDATED
STATEMENT OF<br/>
PROFIT OR LOSS AND OTHER COMPREHENSIVE LOSS FOR THE<br/>
YEARS ENDED JUNE 30, 2024, 2023 AND 2022</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_113_zgZbrfk9zFmi" summary="xdx: Statement - Profit or Loss and Other Comprehensive Loss" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49D_20230701__20240630_zoBPFYv8Kl83" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49F_20220701__20230630_zFQLF5nyqio" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_494_20210701__20220630_zALcfV7Kj9d9" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Revenue
    </b></span></p></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Note</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>2024</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>2023</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><br/>
    2022</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--RevenueFromProgramFees_maNRFPFzWFE_zScpGUM9Kqr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%"><span style="font-family: Times New Roman, Times, Serif">Revenue from Program Fees</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">5</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:RevenueFromProgramFees" contextRef="From2023-07-01to2024-06-30" id="Fact000055" format="ixt:numdotdecimal" decimals="0" unitRef="USD">929,319</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:RevenueFromProgramFees" contextRef="From2022-07-012023-06-30" id="Fact000056" format="ixt:numdotdecimal" decimals="0" unitRef="USD">937,415</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:RevenueFromProgramFees" contextRef="From2021-07-012022-06-30" id="Fact000057" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,050,044</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--ContractualPaymentsToGyms_iN_di_msNRFPFzWFE_zm8F99fnLpD" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less: Contractual payments
    to gyms</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">5</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MMA:ContractualPaymentsToGyms" contextRef="From2023-07-01to2024-06-30" id="Fact000059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">537,012</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MMA:ContractualPaymentsToGyms" contextRef="From2022-07-012023-06-30" id="Fact000060" format="ixt:numdotdecimal" decimals="0" unitRef="USD">574,025</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MMA:ContractualPaymentsToGyms" contextRef="From2021-07-012022-06-30" id="Fact000061" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,215,191</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_ecustom--NetRevenueFromProgramFees_iT_mtNRFPFzWFE_maRzjU4_zx2VV91fTe1i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    Revenue from Program Fees</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:NetRevenueFromProgramFees" contextRef="From2023-07-01to2024-06-30" id="Fact000063" format="ixt:numdotdecimal" decimals="0" unitRef="USD">392,307</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:NetRevenueFromProgramFees" contextRef="From2022-07-012023-06-30" id="Fact000064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">363,390</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:NetRevenueFromProgramFees" contextRef="From2021-07-012022-06-30" id="Fact000065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">834,853</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--OtherIncome_maRzjU4_zBJUYAnhSpx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other Income</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">5</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2023-07-01to2024-06-30" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">170,005</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2022-07-012023-06-30" id="Fact000068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,173,421</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2021-07-012022-06-30" id="Fact000069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,950</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eifrs-full--Revenue_iT_mtRzjU4_maPLBTzBMp_zSzoDIqnP44d" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    Revenue</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-07-01to2024-06-30" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">562,312</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-07-012023-06-30" id="Fact000072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,536,811</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-07-012022-06-30" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">940,803</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--ExpenseByNatureAbstract_iB_z2tHXJbJLoCk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--ProgramExpenses_i01_maEBNzI1g_zJ7dbbcf7tIh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Program Expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ProgramExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">160,578</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ProgramExpenses" contextRef="From2022-07-012023-06-30" id="Fact000080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">229,848</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ProgramExpenses" contextRef="From2021-07-012022-06-30" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">342,600</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eifrs-full--WagesAndSalaries_i01_maEBNzI1g_zdXjT7Kep0Ak" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Employee salaries and benefits</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:WagesAndSalaries" contextRef="From2023-07-01to2024-06-30" id="Fact000083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,504,592</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:WagesAndSalaries" contextRef="From2022-07-012023-06-30" id="Fact000084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,219,655</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:WagesAndSalaries" contextRef="From2021-07-012022-06-30" id="Fact000085" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,664,013</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_i01_maEBNzI1g_z8z17CJt65Sc" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Share Based Payments</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">22</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2023-07-01to2024-06-30" id="Fact000087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,521,598</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2022-07-012023-06-30" id="Fact000088" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,365,384</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2021-07-012022-06-30" id="Fact000089" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,546,983</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--AdvertisingExpense_i01_maEBNzI1g_z9iYBmjPVz0l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising fees</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:AdvertisingExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">613,348</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:AdvertisingExpense" contextRef="From2022-07-012023-06-30" id="Fact000092" format="ixt:numdotdecimal" decimals="0" unitRef="USD">721,713</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:AdvertisingExpense" contextRef="From2021-07-012022-06-30" id="Fact000093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,615,399</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eifrs-full--ProfessionalFeesExpense_i01_maEBNzI1g_zkyLkkxuTwri" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,790,344</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2022-07-012023-06-30" id="Fact000096" format="ixt:numdotdecimal" decimals="0" unitRef="USD">864,419</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-07-012022-06-30" id="Fact000097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">685,870</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--RentExpenses_i01_maEBNzI1g_zmlHDU8YTNj1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Rent</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:RentExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,169</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:RentExpenses" contextRef="From2022-07-012023-06-30" id="Fact000100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,793</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:RentExpenses" contextRef="From2021-07-012022-06-30" id="Fact000101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,366</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--ITCosts_i01_maEBNzI1g_zr99WeEp4oK7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">IT costs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ITCosts" contextRef="From2023-07-01to2024-06-30" id="Fact000103" format="ixt:numdotdecimal" decimals="0" unitRef="USD">566,709</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ITCosts" contextRef="From2022-07-012023-06-30" id="Fact000104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">633,220</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ITCosts" contextRef="From2021-07-012022-06-30" id="Fact000105" format="ixt:numdotdecimal" decimals="0" unitRef="USD">640,403</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--DepreciationExpense_i01_maEBNzI1g_zugqybr164Xl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation and amortization</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">520,697</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2022-07-012023-06-30" id="Fact000108" format="ixt:numdotdecimal" decimals="0" unitRef="USD">360,021</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2021-07-012022-06-30" id="Fact000109" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,651</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--NetForeignExchangeGain_i01N_di_msEBNzI1g_zzwivWECjsL1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net foreign exchange gain</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:NetForeignExchangeGain" contextRef="From2023-07-01to2024-06-30" id="Fact000111" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,543</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:NetForeignExchangeGain" contextRef="From2022-07-012023-06-30" id="Fact000112" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,359</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:NetForeignExchangeGain" contextRef="From2021-07-012022-06-30" id="Fact000113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,079</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eifrs-full--FinanceCosts_i01_maEBNzI1g_zPh0OAum7J9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance costs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2023-07-01to2024-06-30" id="Fact000115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,262,927</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2022-07-012023-06-30" id="Fact000116" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,472,730</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2021-07-012022-06-30" id="Fact000117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,191,803</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--OtherExpenseByNature_i01_maEBNzI1g_z2Q7d4fOlJF7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:OtherExpenseByNature" contextRef="From2023-07-01to2024-06-30" id="Fact000119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,565,924</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:OtherExpenseByNature" contextRef="From2022-07-012023-06-30" id="Fact000120" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,432,094</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:OtherExpenseByNature" contextRef="From2021-07-012022-06-30" id="Fact000121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">965,808</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--FairValueMovementInDerivativeLiability_i01N_di_msEBNzI1g_zzM8xypHWq96" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair Value movement in derivative liability</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">8</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MMA:FairValueMovementInDerivativeLiability" contextRef="From2023-07-01to2024-06-30" id="Fact000123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,400,685</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:FairValueMovementInDerivativeLiability" contextRef="From2022-07-012023-06-30" id="Fact000124" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,870,729</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MMA:FairValueMovementInDerivativeLiability" contextRef="From2021-07-012022-06-30" id="Fact000125" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,751,564</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eifrs-full--ExpenseByNature_i01T_mtEBNzI1g_msPLBTzBMp_zdhnHikhqwM8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2023-07-01to2024-06-30" id="Fact000127" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,970,658</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2022-07-012023-06-30" id="Fact000128" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,134,247</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2021-07-012022-06-30" id="Fact000129" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,138,253</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--ProfitLossBeforeTax_iT_mtPLBTzBMp_maPLzK0W_z5Z1aN677sbf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss
    before income tax expense</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-07-01to2024-06-30" id="Fact000131" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,408,346</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2022-07-012023-06-30" id="Fact000132" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,597,436</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-07-012022-06-30" id="Fact000133" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,197,450</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_405_eifrs-full--IncomeTaxExpenseContinuingOperations_msPLzK0W_z9ZzYug4Ais3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax expense</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">7</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0135">-</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0136">-</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0137">-</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--ProfitLoss_iT_mtPLzK0W_maCIzKWZ_z78BWGimqMy3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss after income tax expense
    for the period</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000139" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,408,346</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-07-012023-06-30" id="Fact000140" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,597,436</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-07-012022-06-30" id="Fact000141" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,197,450</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eifrs-full--OtherComprehensiveIncome_maCIzKWZ_zIySwb178bci" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other comprehensive loss,
    net of tax</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2023-07-01to2024-06-30" id="Fact000143" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,710</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2022-07-012023-06-30" id="Fact000144" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">36,465</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2021-07-012022-06-30" id="Fact000145" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,312</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eifrs-full--ComprehensiveIncome_iT_mtCIzKWZ_zOduquq27uZ3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    comprehensive loss for the period attributable to Alta Global Group Limited</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-07-01to2024-06-30" id="Fact000147" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,429,056</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-07-012023-06-30" id="Fact000148" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,633,901</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-07-012022-06-30" id="Fact000149" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,228,762</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_zrcD9hd7Q6Gd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Basic loss per share</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">27</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2023-07-01to2024-06-30" id="Fact000151" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.40</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2022-07-012023-06-30" id="Fact000152" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">5.26</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2021-07-012022-06-30" id="Fact000153" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.86</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--DilutedEarningsLossPerShare_zbujsPwdpGi6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Diluted loss per share</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">27</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2023-07-01to2024-06-30" id="Fact000155" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.40</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2022-07-012023-06-30" id="Fact000156" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">5.26</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2021-07-012022-06-30" id="Fact000157" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.86</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above consolidated statements should be read in conjunction with the accompanying notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="fin_002"></span>CONSOLIDATED
STATEMENT OF FINANCIAL POSITION<br/>
AS AT JUNE 30, 2024 AND 2023</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_111_zF9rnYLCGASb" summary="xdx: Statement - Consolidated Statement of Financial Position" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_497_20240630_zDp0d9Udnag7" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_490_20230630_zKoO7VqzCWBh" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Note</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eifrs-full--CurrentAssetsAbstract_iB_zt2adsLvqxa8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current
                                    Assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5pt"></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--CashAndCashEquivalents_i01I_maCAz26C_zOoLxYsLMsma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 54%"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">9</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000162" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,544,837</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000163" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,702,567</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--TradeAndOtherCurrentReceivables_i01I_maCAz26C_zaj4t5rpBgg7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Trade and other receivables</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="AsOf2024-06-30" id="Fact000165" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,115</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="AsOf2023-06-30" id="Fact000166" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,365,638</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eifrs-full--OtherCurrentAssets_i01I_maCAz26C_zu16jHZjy5u7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf2024-06-30" id="Fact000168" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,840</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf2023-06-30" id="Fact000169" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,641</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eifrs-full--CurrentAssets_i01TI_mtCAz26C_maAzWmj_zpZIFT7mmjV7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2024-06-30" id="Fact000171" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,623,792</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2023-06-30" id="Fact000172" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,101,846</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eifrs-full--NoncurrentAssetsAbstract_iB_zTmAX2IJjpE2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-current
                                    assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5pt"></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eifrs-full--PropertyPlantAndEquipment_i01I_maNAzQbZ_zzmQVWEpYIPh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property, Plant and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">11</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2024-06-30" id="Fact000177" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,698</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30" id="Fact000178" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94,928</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eifrs-full--RightofuseAssets_i01I_maNAzQbZ_zp48oidEuOh8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Right-of-use asset</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">20</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2024-06-30" id="Fact000180" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,463</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2023-06-30" id="Fact000181" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,540</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eifrs-full--IntangibleAssetsOtherThanGoodwill_i01I_maNAzQbZ_zTPXJH1xkrci" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">12</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-06-30" id="Fact000183" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,297,263</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30" id="Fact000184" format="ixt:numdotdecimal" decimals="0" unitRef="USD">811,361</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherNoncurrentAssets_i01I_maNAzQbZ_zi4I1ZEdsnv1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other Assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf2024-06-30" id="Fact000186" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,109</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf2023-06-30" id="Fact000187" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,110</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--NoncurrentAssets_i01TI_mtNAzQbZ_maAzWmj_zII4gpceUeKc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    non-current assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2024-06-30" id="Fact000189" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,695,533</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2023-06-30" id="Fact000190" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,128,939</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eifrs-full--Assets_i01TI_mtAzWmj_maNALznMP_zTVymJCCJBg2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2024-06-30" id="Fact000192" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,319,325</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2023-06-30" id="Fact000193" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,230,785</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eifrs-full--CurrentLiabilitiesAbstract_iB_zFW9S2WrXtb5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current
                                    liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5pt"></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eifrs-full--TradeAndOtherCurrentPayables_i01I_maCLzXgc_zsFDm4l0jEQj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Trade and other payables</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">13</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="AsOf2024-06-30" id="Fact000198" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,991,536</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="AsOf2023-06-30" id="Fact000199" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,034,436</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--UnearnedRevenue_i01I_maCLzXgc_z3Aqc9OQJFNa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unearned revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">15</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0201">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:UnearnedRevenue" contextRef="AsOf2023-06-30" id="Fact000202" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,290</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eifrs-full--CurrentProvisionsForEmployeeBenefits_i01I_maCLzXgc_zciBzC2iXh42" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current Employee Entitlements</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">14</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CurrentProvisionsForEmployeeBenefits" contextRef="AsOf2024-06-30" id="Fact000204" format="ixt:numdotdecimal" decimals="0" unitRef="USD">454,342</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CurrentProvisionsForEmployeeBenefits" contextRef="AsOf2023-06-30" id="Fact000205" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,227</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentFinancialLiabilities_i01I_maCLzXgc_ziHEkdxv3kEc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current Financial Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">21</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0207">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilities" contextRef="AsOf2023-06-30" id="Fact000208" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,331,307</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eifrs-full--CurrentLeaseLiabilities_i01I_maCLzXgc_zsI4ecFHfUnc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Current Lease Liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">20</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2024-06-30" id="Fact000210" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,559</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2023-06-30" id="Fact000211" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,500</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--CurrentLiabilities_i01TI_mtCLzXgc_maLzurM_zS8qNpwI6ysh" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2024-06-30" id="Fact000213" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,574,437</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2023-06-30" id="Fact000214" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,018,760</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--NoncurrentLiabilitiesAbstract_iB_zSwmQPd5fcxg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-current
                                    liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br/></b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eifrs-full--NoncurrentFinancialLiabilities_i01I_maNLzkQB_zhgqEM9U2Ylh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-current Financial Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">21</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0219">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilities" contextRef="AsOf2023-06-30" id="Fact000220" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,273,278</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eifrs-full--NoncurrentProvisionsForEmployeeBenefits_i01I_maNLzkQB_zCkkLS7XeMPe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-current Employee Entitlements</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">14</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" contextRef="AsOf2024-06-30" id="Fact000222" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,622</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" contextRef="AsOf2023-06-30" id="Fact000223" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,892</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eifrs-full--NoncurrentLeaseLiabilities_i01I_maNLzkQB_zIKRZyG3kTWh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Non-current Lease Liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">20</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2024-06-30" id="Fact000225" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,722</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2023-06-30" id="Fact000226" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,162</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eifrs-full--NoncurrentLiabilities_i01TI_mtNLzkQB_maLzurM_zgdYGXskldIb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    non-current liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2024-06-30" id="Fact000228" format="ixt:numdotdecimal" decimals="0" unitRef="USD">186,344</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-06-30" id="Fact000229" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,346,332</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--Liabilities_iTI_mtLzurM_msNALznMP_zBvFvbNEeKol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf2024-06-30" id="Fact000231" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,760,781</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf2023-06-30" id="Fact000232" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,365,092</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eifrs-full--NetAssetsLiabilities_iTI_mtNALznMP_zArvsxbICJC3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net
    assets/(liabilities)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:NetAssetsLiabilities" contextRef="AsOf2024-06-30" id="Fact000234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,558,544</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:NetAssetsLiabilities" contextRef="AsOf2023-06-30" id="Fact000235" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,134,307</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eifrs-full--EquityAbstract_iB_zoqKWELBhtTk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5pt"></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--IssuedCapital_i01I_maEzyHj_zd8As3yzyDp2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issued Capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">17</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2024-06-30" id="Fact000240" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,779,703</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2023-06-30" id="Fact000241" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eifrs-full--ReserveOfSharebasedPayments_i01I_maEzyHj_z0Fxa2AdJ7we" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based payment reserve</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">16</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2024-06-30" id="Fact000243" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,734,601</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2023-06-30" id="Fact000244" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,912,367</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--UnlistedOptionsReserve_i01I_maEzyHj_zktG2hEmsiV6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unlisted options reserve</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">16</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:UnlistedOptionsReserve" contextRef="AsOf2024-06-30" id="Fact000246" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,741,457</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0247">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eifrs-full--ReserveOfExchangeDifferencesOnTranslation_i01I_maEzyHj_zN8vxtAUxQA2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign currency translation reserve</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">16</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" contextRef="AsOf2024-06-30" id="Fact000249" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">86,542</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" contextRef="AsOf2023-06-30" id="Fact000250" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">65,832</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eifrs-full--AccumulatedOtherComprehensiveIncome_i01I_maEzyHj_zQHlaq9lP0hi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated losses</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:AccumulatedOtherComprehensiveIncome" contextRef="AsOf2024-06-30" id="Fact000252" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">52,610,675</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:AccumulatedOtherComprehensiveIncome" contextRef="AsOf2023-06-30" id="Fact000253" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">38,366,123</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_408_eifrs-full--Equity_i01TI_mtEzyHj_zge2pFtztjak" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    equity/(deficit)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-06-30" id="Fact000255" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,558,544</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30" id="Fact000256" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,134,307</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above consolidated statements should be read in conjunction with the accompanying notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fin_003"></span>CONSOLIDATED
STATEMENT OF CHANGES IN EQUITY<br/>
FOR YEARS ENDED JUNE 30, 2024, 2023 AND 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_114_zTHb6TavhObi" summary="xdx: Statement - Consolidated Statement of Changes in Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_4B5_ifrs-full--ComponentsOfEquityAxis_ifrs-full--IssuedCapitalMember_zkeexwv9ORTh" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_4BA_ifrs-full--ComponentsOfEquityAxis_custom--UnlistedOptionReserveMember_z9YVTVLJYDNf" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_4B3_ifrs-full--ComponentsOfEquityAxis_ifrs-full--ReserveOfSharebasedPaymentsMember_z3tm9i47qs96" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_4BF_ifrs-full--ComponentsOfEquityAxis_ifrs-full--ReserveOfExchangeDifferencesOnTranslationMember_zkfXJTbHga4" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_4B0_ifrs-full--ComponentsOfEquityAxis_ifrs-full--AccumulatedOtherComprehensiveIncomeMember_zyPxoAsBCBfk" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_4B5_zouQaIRDydPh" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued
                                            Capital</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unlisted
                                            Option Reserve</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-based
                                            Payment Reserve</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign
                                            Currency Translation Reserve</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated
                                            Losses</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_435_c20230701__20240630_eifrs-full--Equity_iS_zIAR1bMYCmoj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opening
                                            balance as at July 1, 2023</b></span></p></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30_ifrs-full_IssuedCapitalMember" id="Fact000258" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0259">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000260" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,912,367</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000261" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">65,832</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000262" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">38,366,123</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30" id="Fact000263" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,134,307</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_407_eifrs-full--ProfitLoss_zk7WnwEBm5qj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss after tax</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0265">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0266">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0267">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0268">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000269" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,408,346</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000270" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,408,346</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_404_eifrs-full--OtherComprehensiveIncome_zz7sPnRrlzN7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other comprehensive (loss)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0272">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0273">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0274">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000275" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,710</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0276">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2023-07-01to2024-06-30" id="Fact000277" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,710</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eifrs-full--ComprehensiveIncome_zrHBcORClY5a" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total comprehensive (loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0279">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0280">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0281">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000282" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,710</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000283" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,408,346</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-07-01to2024-06-30" id="Fact000284" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,429,056</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_z4W5wNp4aCV4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based payments (see Note 22)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0286">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0287">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000288" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,521,598</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0289">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0290">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-07-01to2024-06-30" id="Fact000291" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,521,598</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eifrs-full--IssueOfEquity_zDlS1CP6Wb6c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Issued of Shares fully paid net of Transaction
    cost (see Note 17)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember" id="Fact000293" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,789,914</ix:nonFraction></span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0294">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0295">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0296">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0297">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2023-07-01to2024-06-30" id="Fact000298" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,789,914</ix:nonFraction></span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--IssueOfEquityFromConversionOfConvertibleNotes_zcb6ZaRr82Mj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Issue of Shares from conversion of convertible
    notes (see Note 17)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:IssueOfEquityFromConversionOfConvertibleNotes" contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember" id="Fact000300" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,177,751</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0301">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0302">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0303">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0304">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:IssueOfEquityFromConversionOfConvertibleNotes" contextRef="From2023-07-01to2024-06-30" id="Fact000305" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,177,751</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--IssueOfUnlistedSharesFromConversionOfConvertibleNotes_zNLK9m39oSPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Issue of Unlisted Shares from conversion
    of convertible notes (see Note 17)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0307">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes" contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember" id="Fact000308" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,741,457</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0309">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0310">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0311">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes" contextRef="From2023-07-01to2024-06-30" id="Fact000312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,741,457</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eifrs-full--IncreaseDecreaseThroughExerciseOfOptions_zTDBz8N5eXX" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advisor options exercised (see Note 17)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember" id="Fact000314" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,426,757</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0315">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000316" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,426,757</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0317">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0318">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0319">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--IncreaseDecreaseThroughOptionsForfeited_zbsWJZjkMaC8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advisor options forfeited (see Note 22)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0321">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0322">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MMA:IncreaseDecreaseThroughOptionsForfeited" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000323" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">108,813</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0324">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MMA:IncreaseDecreaseThroughOptionsForfeited" contextRef="From2023-07-01to2024-06-30" id="Fact000326" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">108,813</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_ecustom--OverAllotmentOptionsLapsed_zgrGgMRc8Lrb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Over allotment options
    lapsed (see Note 22)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0328">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0329">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MMA:OverAllotmentOptionsLapsed" contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000330" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">163,794</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0331">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:OverAllotmentOptionsLapsed" contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000332" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,794</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0333">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_43E_c20230701__20240630_eifrs-full--Equity_iE_zF34Jyd1QO5b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Closing balance as at
    June 30, 2024</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-06-30_ifrs-full_IssuedCapitalMember" id="Fact000335" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,779,703</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-06-30_custom_UnlistedOptionReserveMember" id="Fact000336" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,741,457</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000337" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,734,601</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000338" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">86,542</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000339" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">52,610,675</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-06-30" id="Fact000340" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,558,544</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_4BD_ifrs-full--ComponentsOfEquityAxis_ifrs-full--IssuedCapitalMember_zTbvF2OlPI4d" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_4BB_ifrs-full--ComponentsOfEquityAxis_ifrs-full--ReserveOfSharebasedPaymentsMember_zt1az4pW7lg9" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_4B1_ifrs-full--ComponentsOfEquityAxis_ifrs-full--ReserveOfExchangeDifferencesOnTranslationMember_z0bPkx1XKFz3" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_4B0_ifrs-full--ComponentsOfEquityAxis_ifrs-full--AccumulatedOtherComprehensiveIncomeMember_zLaLaqnNWOm2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_4B2_zsF5erpebA0c" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2023</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Issued
    Capital</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Share-based</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Payment
    Reserve</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Foreign
    Currency</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Translation
    Reserve</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Accumulated
    Losses</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Total</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_43A_c20220701__20230630_eifrs-full--Equity_iS_z3GUhFZWEEEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; width: 40%; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>Opening
    balance as at July 1, 2022</b></span></p></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_IssuedCapitalMember" id="Fact000342" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000343" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,546,983</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000344" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,367</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000345" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,768,687</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30" id="Fact000346" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,865,790</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_401_eifrs-full--ProfitLoss_zZ7NfytaZFK" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss after tax</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0348">-</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0349">-</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0350">-</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-07-012023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000351" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,597,436</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-07-012023-06-30" id="Fact000352" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,597,436</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherComprehensiveIncome_zYoVNlWLQJX7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other comprehensive (loss)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0354">-</span></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000356" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">36,465</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0357">-</span></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2022-07-012023-06-30" id="Fact000358" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">36,465</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_400_eifrs-full--ComprehensiveIncome_z5AKEgBlAWE2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total comprehensive (loss)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0360">-</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0361">-</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000362" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">36,465</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-07-012023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000363" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,597,436</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-07-012023-06-30" id="Fact000364" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,633,901</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zpPzr0EifCfj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Share-based payments (see
    Note 22)</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0366">-</span></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,365,384</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0368">-</span></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0369">-</span></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-07-012023-06-30" id="Fact000370" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,365,384</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_431_c20220701__20230630_eifrs-full--Equity_iE_zTo5u2bLr8wk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Closing balance as at
    June 30, 2023</span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30_ifrs-full_IssuedCapitalMember" id="Fact000372" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000373" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,912,367</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000374" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">65,832</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000375" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">38,366,123</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30" id="Fact000376" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,134,307</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued
                                            Capital</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-based</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payment
                                            Reserve</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign
                                            Currency</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Translation
                                            Reserve</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated
                                            Losses</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_43F_c20210701__20220630_eifrs-full--Equity_iS_zVOEz9ky7gcd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opening
                                            balance as at July 1, 2021</b></span></p></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-06-30_ifrs-full_IssuedCapitalMember" id="Fact000378" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0379">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000380" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,945</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000381" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,571,237</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-06-30" id="Fact000382" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,184,011</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_436_c20210701__20220630_eifrs-full--Equity_iS_znLNTLwNfP93" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opening
balance</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-06-30_ifrs-full_IssuedCapitalMember" id="Fact000384" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000386" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,945</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000387" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,571,237</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-06-30" id="Fact000388" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,184,011</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_402_eifrs-full--ProfitLoss_zwVhLwb2RCZ1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss after tax</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0390">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0392">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-07-012022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000393" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,197,450</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-07-012022-06-30" id="Fact000394" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,197,450</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_409_eifrs-full--OtherComprehensiveIncome_zhBFIcBK9nc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other comprehensive (loss)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0396">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0397">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000398" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,312</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0399">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2021-07-012022-06-30" id="Fact000400" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,312</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_400_eifrs-full--ComprehensiveIncome_zHQolsMrEpn8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total comprehensive (loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0402">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000404" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,312</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-07-012022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000405" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,197,450</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-07-012022-06-30" id="Fact000406" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,228,762</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zvQRl9BOThSd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Share-based payments (see
    Note 22)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0408">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000409" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,546,983</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0410">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0411">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-07-012022-06-30" id="Fact000412" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,546,983</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_431_c20210701__20220630_eifrs-full--Equity_iE_zZZ7eBTdJfEg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Closing balance as at
    June 30, 2022</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_IssuedCapitalMember" id="Fact000414" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000415" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,546,983</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000416" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,367</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000417" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,768,687</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30" id="Fact000418" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,865,790</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_437_c20210701__20220630_eifrs-full--Equity_iE_zoQaoMXSc8lj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Closing balance</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_IssuedCapitalMember" id="Fact000420" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000421" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,546,983</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" id="Fact000422" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,367</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" id="Fact000423" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,768,687</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-06-30" id="Fact000424" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,865,790</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above consolidated statements should be read in conjunction with the accompanying notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="fin_004"></span>CONSOLIDATED
STATEMENT OF CASH FLOWS<br/>
FOR THE YEARS ENDED JUNE 30, 2024, 2023 AND 2022</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_112_zTBkb6aPZzYl" summary="xdx: Statement - Consolidated Statement of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_49C_20230701__20240630_zwfHMkHRf6c7" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_497_20220701__20230630_zYUOBx4izec3" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td id="xdx_49A_20210701__20220630_zRWDU3KgAOc5" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Note</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--CashFlowsFromUsedInOperatingActivitiesAbstract_iB_zeRWsfW92Osj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
                                            flows from operating activities</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--ProceedsFromTrainingParticipants_i01_maNCUIOzOnV_zIKEATS8x9Hk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; width: 38%"><span style="font-family: Times New Roman, Times, Serif">Receipts from training participants
    (inclusive of GST)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ProceedsFromTrainingParticipants" contextRef="From2023-07-01to2024-06-30" id="Fact000430" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,453,848</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ProceedsFromTrainingParticipants" contextRef="From2022-07-012023-06-30" id="Fact000431" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,493,676</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ProceedsFromTrainingParticipants" contextRef="From2021-07-012022-06-30" id="Fact000432" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,004,336</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--PaymentsToSuppliersForGoodsAndServices_i01N_di_msNCUIOzOnV_z5BnfheIEgzi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Payments to member gyms, suppliers &amp; employees
    (inclusive of GST)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-07-01to2024-06-30" id="Fact000434" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,848,391</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2022-07-012023-06-30" id="Fact000435" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,106,683</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-07-012022-06-30" id="Fact000436" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,136,314</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_403_ecustom--ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure_i01_maNCUIOzOnV_zBadFmk7PkQ7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Receipts from Government grants and tax incentives
    related to expenditure</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" contextRef="From2023-07-01to2024-06-30" id="Fact000438" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,776</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" contextRef="From2022-07-012023-06-30" id="Fact000439" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,109,645</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" contextRef="From2021-07-012022-06-30" id="Fact000440" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,950</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--InterestPaidClassifiedAsOperatingActivities_i01N_di_msNCUIOzOnV_zUF7TNfSwlQc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Interest and other finance
    costs paid</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000442" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,429</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From2022-07-012023-06-30" id="Fact000443" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,506</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From2021-07-012022-06-30" id="Fact000444" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,157</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_407_eifrs-full--CashFlowsFromUsedInOperatingActivities_i01T_mtNCUIOzOnV_maIDICAz7Hd_zcLM7Xufakeh" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in operating activities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">18</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000446" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,386,196</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2022-07-012023-06-30" id="Fact000447" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,555,868</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2021-07-012022-06-30" id="Fact000448" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,055,185</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eifrs-full--CashFlowsFromUsedInInvestingActivitiesAbstract_iB_zPOjak3KzPgb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
                                            flows from investing activities</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eifrs-full--PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_i01N_di_msCFFUIzrx1_zPmUKkCZ9GP8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Payments for property equipment, net of disposal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000454" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,635</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2022-07-012023-06-30" id="Fact000455" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,796</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2021-07-012022-06-30" id="Fact000456" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,429</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eifrs-full--PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_i01N_di_msCFFUIzrx1_z9iJIJDaCAsf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Payments for intangible assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000458" format="ixt:numdotdecimal" decimals="0" unitRef="USD">205,039</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From2022-07-012023-06-30" id="Fact000459" format="ixt:numdotdecimal" decimals="0" unitRef="USD">352,181</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From2021-07-012022-06-30" id="Fact000460" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,043,468</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_400_eifrs-full--ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities_i01_maCFFUIzrx1_zReUt5OovX2j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Receipt from Government grants and tax incentives
    related to assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0462">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" contextRef="From2022-07-012023-06-30" id="Fact000463" format="ixt:numdotdecimal" decimals="0" unitRef="USD">383,936</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0464">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--BankGuaranteeDepositReceivedPaid_i01_maCFFUIzrx1_zDxuVazqTXi1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Bank guarantee deposit
    received/(paid)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0466">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="MMA:BankGuaranteeDepositReceivedPaid" contextRef="From2022-07-012023-06-30" id="Fact000467" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,714</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MMA:BankGuaranteeDepositReceivedPaid" contextRef="From2021-07-012022-06-30" id="Fact000468" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">62,823</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_404_eifrs-full--CashFlowsFromUsedInInvestingActivities_i01T_mtCFFUIzrx1_maIDICAz7Hd_zeXYXC6AR2Mi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash (used in)/from investing activities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000470" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">223,674</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2022-07-012023-06-30" id="Fact000471" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,673</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2021-07-012022-06-30" id="Fact000472" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,165,720</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--CashFlowsFromUsedInFinancingActivitiesAbstract_iB_z7AcomVm8mi8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
                                            flows from financing activities</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--ProceedsFromIssueOfBondsNotesAndDebentures_i01_maCFFUIzOXK_zbs7up2WWsrk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Proceeds from convertible notes, net of transaction
    costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0478">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures" contextRef="From2022-07-012023-06-30" id="Fact000479" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,655,252</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures" contextRef="From2021-07-012022-06-30" id="Fact000480" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,679,651</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--ProceedsFromIssuingShares_i01_maCFFUIzOXK_zAydf4qrJCLh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Proceeds from issue of
    equity, net of transaction costs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:ProceedsFromIssuingShares" contextRef="From2023-07-01to2024-06-30" id="Fact000482" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,472,851</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0484">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eifrs-full--CashFlowsFromUsedInFinancingActivities_i01T_mtCFFUIzOXK_maIDICAz7Hd_zSmoq7szrZg9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash from financing activities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000486" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,472,851</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2022-07-012023-06-30" id="Fact000487" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,655,252</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2021-07-012022-06-30" id="Fact000488" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,679,651</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_iT_mtIDICAz7Hd_zQ0QuBHvudv4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net (decrease) /increase in cash and cash equivalents</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2023-07-01to2024-06-30" id="Fact000490" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">137,019</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2022-07-012023-06-30" id="Fact000491" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,169,057</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2021-07-012022-06-30" id="Fact000492" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,541,254</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--CashAndCashEquivalents_iS_zg46janeO824" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents at the beginning
    of the financial period</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000494" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,702,567</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2022-06-30" id="Fact000495" format="ixt:numdotdecimal" decimals="0" unitRef="USD">569,975</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2021-06-30" id="Fact000496" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,142,541</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--EffectOfExchangeRateChangesOnCashAndCashEquivalents_zvpxaf6QrrMj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Effect of exchange rate
    changes on cash</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2023-07-01to2024-06-30" id="Fact000498" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,710</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2022-07-012023-06-30" id="Fact000499" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">36,465</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2021-07-012022-06-30" id="Fact000500" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,312</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_407_eifrs-full--CashAndCashEquivalents_iE_zUaVPFiv6W3f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Cash
    and cash equivalents at the end of the financial period</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">9</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000502" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,544,837</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000503" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,702,567</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2022-06-30" id="Fact000504" format="ixt:numdotdecimal" decimals="0" unitRef="USD">569,975</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above consolidated statements should be read in conjunction with the accompanying notes.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000506" name="MMA:DisclosureOfCorporateInformationExplanatory"><p id="xdx_802_ecustom--DisclosureOfCorporateInformationExplanatory_zKvUq3Clw8ac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fin_005"></span>Note
1. <span id="xdx_82C_z2zVPpVWW9d4">Corporate information</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
Global Group Limited (the &#8220;Company&#8221; or the &#8220;Parent Entity&#8221;) was incorporated and is domiciled in Australia. The
Company changed its registered name from Wimp 2 Warrior Limited to Alta Global Group Limited on 2 February 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, an Australian company, is listed solely on NYSE American and is governed by the rules of the NYSE American and the U.S. Securities
and Exchange Commission. For purposes of U.S. securities law, the Company is a &#8220;foreign private issuer&#8221; (FPI). In addition,
the Company qualifies as an &#8220;emerging growth company&#8221; for U.S. securities law purposes. The Company is a for-profit Australian
unlisted public company limited by shares with a principal place of business at Level 1, Suite 1, 29-33 The Corso, Manly, New South Wales
2095.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000508" name="ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory"><p id="xdx_80F_eifrs-full--DisclosureOfMaterialAccountingPolicyInformationExplanatory_zVZKIqpaNDYi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
2. <span id="xdx_82C_zCWmDwl6Zsa2">Material Accounting Policy Information</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting policies that are material to the consolidated entity are set out below. These policies have been consistently applied to
all the periods presented, unless otherwise stated. The consolidated financial statements are presented in AUD, which is also the Company&#8217;s
functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000510" name="MMA:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory"><p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zLWoyHT7f1h4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_z5EOTOYkseMa">Basis
of preparation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Statement
of compliance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements have been prepared in accordance with International Financial Reporting Standards and International Accounting Standards
as issued by the International Accounting Standards Board (IASB) and Interpretations (collectively IFRSs).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in compliance with adopted IFRS Accounting Standards requires the use of certain critical accounting
estimates. It also requires Company management to exercise judgment in applying the Company&#8217;s accounting policies. The areas where
significant judgments and estimates have been made in preparing the financial statements and their effect are disclosed in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of measurement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on the basis of historical cost, except for the measurement at fair value of selected financial
assets and financial liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principles
of consolidation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements incorporate all the assets, liabilities and results of the Company and all the subsidiary companies
and other interests it controlled during the period. The Company controls an entity when it is exposed to, or has the rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power over the entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets, liabilities and results of its subsidiaries are fully consolidated into the consolidated financial statements from the date which
control is obtained. The consolidation of a subsidiary is discontinued from the date that control ceases. Intercompany transactions,
balances and unrealised gains or losses on transactions between Company entities are fully eliminated on consolidation. Accounting policies
of subsidiaries have been changed and adjustments made where necessary to ensure uniformity of the accounting policies of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
segments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
segments are presented using the &#8216;management approach&#8217;, where the information presented is on the same basis as the internal
reports provided to the Chief Operating Decision Makers (&#8220;CODM&#8221;). The CODM is responsible for the allocation of resources
to operating segments and assessing their performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
currency translation</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements are presented in Australian dollars, which is the Company&#8217;s functional and presentation currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign
currency transactions</b></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
currency transactions are translated into Australian dollars using the exchange rates prevailing at the dates of the transactions. Foreign
exchange gains and losses resulting from the settlement of such transactions and from the translation at financial year-end exchange
rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000512" name="MMA:DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory"><p id="xdx_843_ecustom--DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory_z1Hgye0KsVl2" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_zWuiSy060qmb">New
or amended Accounting Standards and Interpretations adopted</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity has adopted all of the new or amended Accounting Standards and Interpretations issued by the International Accounting
Standards Board (&#8220;IASB&#8221;) that are mandatory for the current reporting period. The adoption of these new or amended Accounting
Standards and Interpretations did not have a material impact on these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
new or amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000514" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue"><p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zWgutcGrSGvf" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zvb94Drawd5g">Revenue
Recognition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
entity recognises revenue as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
is recognised at an amount that reflects the consideration to which the entity is expected to be entitled in exchange for transferring
goods or services to a customer. For each contract with a customer, the entity; identifies the contract with a customer; identifies the
performance obligations in the contract; determines the transaction price which takes into account estimates of variable consideration
and the time value of money; allocates the transaction price to the separate performance obligations on the basis of the relative stand-alone
selling price of each distinct good or service to be delivered; and recognises revenue when or as each performance obligation is satisfied
in a manner that depicts the transfer to the customer of the goods or services promised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variable
consideration within the transaction price, if any, reflects concessions provided to the customer such as discounts, rebates and refunds,
any potential bonuses receivable from the customer and any other contingent events. Such estimates are determined using either the &#8216;expected
value&#8217; or &#8216;most likely amount&#8217; method. The measurement of variable consideration is subject to a constraining principle
whereby revenue will only be recognised to the extent that it is highly probable that a significant reversal in the amount of cumulative
revenue recognised will not occur. The measurement constraint continues until the uncertainty associated with the variable consideration
is subsequently resolved. Amounts received that are subject to the constraining principle are recognised as a refund liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Program
revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Program
revenue consists of license fees which are recognized following the occurrence of both the transfer of the right to use the Company&#8217;s
intellectual property upon signing of the license agreement and once usage of the license occurs at the commencement of the Alta MMA
Training Program. The Company&#8217;s intellectual property consists of a set of mixed martial arts training programs and relevant branding
and support. A license agreement consists of the right to use the intellectual property of the Company and either party may terminate
the license upon written notice to the other party. If the agreement is terminated in this manner, the termination will take effect after
the completion of the relevant series and the series finale, but prior to a new series beginning. The amount of program revenue is dependent
on the number of participants in each series for each gym.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the license agreement, a usage-based royalty arrangement is in place between the Company and the gyms. The Company recognizes program
revenue following the occurrence of both the transfer of the right to use the Company&#8217;s intellectual property upon signing of the
license agreement and once usage of the license which occurs at the commencement of the Alta MMA Training Program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the ultimate responsibility of ensuring the Alta MMA Training Program meets customer specifications and price determination.
The Company is therefore considered the principal in these arrangements. The Company receives training fees directly from the participants
and subsequently distributes a portion of such revenues to our gym partners based on the terms of the license agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contractual
Payments to Gyms</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to settle contractual payments to the gyms as a percentage of the total training fees collected from participants.
Net revenue from program fees is recognised as revenue from program fees less the contractual obligations payable to the gyms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of merchandise</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from the sale of program merchandise is recognised at the point in time when the gyms obtain control of the goods, which is generally
at the time of delivery.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Event
revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from event ticket sales is recognised at the point in time when the event occurs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
income</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income is recognised when it is received or when the right to receive payment is established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
&amp; Development Incentive</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
grant, including the R&amp;D incentives, shall not be recognised until there is reasonable assurance that the Company will comply with
the conditions attaching to them and that the grants will be received.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000516" name="ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory"><p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_zCmauZD2bCv7" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zPdht4323M98">Current
and non-current classification</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities are presented in the statement of financial position based on current and non-current classification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
asset is classified as current when: it is either expected to be realised or intended to be sold or consumed in the consolidated entity&#8217;s
normal operating cycle; it is held primarily for the purpose of trading; it is expected to be realised within 12 months after the reporting
period; or the asset is cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least 12
months after the reporting period. All other assets are classified as non-current.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
liability is classified as current when: it is either expected to be settled in the consolidated entity&#8217;s normal operating cycle;
it is held primarily for the purpose of trading; it is due to be settled within 12 months after the reporting period; or there is no
unconditional right to defer the settlement of the liability for at least 12 months after the reporting period. All other liabilities
are classified as non-current.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are always classified as non-current.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 83 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2. Material accounting policies &#8211; continued</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000518" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"><p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z6JHM18DlQFi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zef1A3MXZ5gf">Cash
and cash equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, deposits held at call with financial institutions, other short- term, highly liquid investments
with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant
risk of changes in value. For the statement of cash flows presentation purposes, cash and cash equivalents also includes bank overdrafts,
which are shown within trade and other payables in current liabilities on the statement of financial position.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000520" name="ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory"><p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_zTN3oWH4mND" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zC3f22kXjIY8">Trade
and other receivables</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
receivables are initially recognised at fair value and subsequently measured at amortised cost using the effective interest method, less
any allowance for expected credit losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
Credit Losses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
entity has applied the simplified approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure
the expected credit losses, trade receivables have been grouped based on days overdue. Trade and other receivables are recognised at
amortised cost, less any allowance for expected credit losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000522" name="ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_zOh8kVKiKExi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_z0DuZnRTGZai">Trade
and other payables</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent liabilities for goods and services provided to the entity prior to the end of the financial year and which are
unpaid. Other payables include cash received from the participants on behalf of the gyms. Due to their short-term nature, they are
measured at amortised cost and are not discounted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000524" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"><p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zyaJcYXLvUoi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_867_ziIbfAwfRSI">Plant
and equipment</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant
and equipment are stated at cost less accumulated depreciation and impairment. Historical cost includes expenditure that is directly
attributable to the acquisition of the items. Depreciation is calculated on a straight- line basis to write off the net cost of each
item of property, plant and equipment over their expected useful lives as follows:</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000526" name="MMA:DisclosureOfPlantAndEquipmentExplanatory"><p id="xdx_89B_ecustom--DisclosureOfPlantAndEquipmentExplanatory_zPBliGXyq3T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zv1CcCTCwcm4">Schedule
of plant and equipment</span></span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant</span>
  <span style="font-family: Times New Roman, Times, Serif">and equipment</span></td>
  <td style="text-align: justify; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfsPt9JFpDG7" title="Plant and equipment expected useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_PlantAndEquipmentMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact000528" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">3</ix:nonNumeric></span> to <span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvJr7kJy3nya" title="Plant and equipment expected useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_PlantAndEquipmentMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact000530" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">5</ix:nonNumeric></span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment </span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDn0FDktRmE3" title="Plant and equipment expected useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact000532" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">3</ix:nonNumeric></span> to <span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeji3SbvkXEc" title="Plant and equipment expected useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact000534" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">5</ix:nonNumeric></span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z15C8fLpd4Eg" title="Plant and equipment expected useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact000536" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">3</ix:nonNumeric></span> to <span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0UF2Vhc2Ja3" title="Plant and equipment expected useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact000538" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">5</ix:nonNumeric></span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fittings</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zopvstrbwii" title="Plant and equipment expected useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_FixturesAndFittingsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact000540" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">3</ix:nonNumeric></span> to <span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zMB2rxsqL89k" title="Plant and equipment expected useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_FixturesAndFittingsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact000542" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">5</ix:nonNumeric></span> years</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8AA_zi0EQHikbYs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
item of property, plant and equipment is derecognised upon disposal or when there is no future economic benefit to the entity. Gains
and losses between the carrying amount and the disposal proceeds are taken to profit or loss.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 84 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Note 2. Material accounting policies &#8211; continued</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000544" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory"><p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zrpkeb5x5Jyl" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zv3Ku9MmHXh3">Intangible
assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Intangible
assets acquired as part of a business combination, other than goodwill, are initially measured at their fair value at the date of the
acquisition. Intangible assets acquired separately in an asset acquisition are separately recognised at cost. Indefinite life intangible
assets are not amortized and are subsequently measured at cost less any impairment. Finite life intangible assets are subsequently measured
at cost less amortization and any impairment. The gains or losses recognized in profit or loss arising from the derecognition of intangible
assets are measured as the difference between net disposal proceeds and the carrying amount of the intangible asset. The method and useful
lives of finite life intangible assets are reviewed annually. Changes in the expected pattern of consumption or useful life are accounted
for prospectively by changing the amortization method or period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trademarks</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
costs associated with patents or trademarks are deferred and amortised on a straight-line basis over the period of their expected benefit,
being their finite life of <span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230701__20240630__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z8g1pe4TkYFh" title="Finite life"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_BrandNamesMember" format="ixt-sec:duryear" id="Fact000546" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">10</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Platform
development cost</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in both internally and from external providers in developing the platform that will contribute to future year financial benefits
through revenue generation and/or cost reduction are capitalised to software. These costs are amortised on a straight-line basis over
the estimated useful life (<span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230701__20240630__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_zsQkVMOUpuC1" title="Estimated useful life"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_IntangibleAssetsUnderDevelopmentMember" format="ixt-sec:duryear" id="Fact000548" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">4</ix:nonNumeric></span> years) since first used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and development</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
costs are expensed in the period in which they are incurred. Development costs are capitalised when it is probable that the project will
be a success considering its commercial and technical feasibility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000550" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory"><p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_z6jDUkAuXDz4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zTDEIoZr1NUi">Impairment
of non-financial assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired.
Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount
may not be recoverable. An impairment loss is recognised for the amount by which the asset&#8217;s carrying amount exceeds its recoverable
amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverable
amount is the higher of an asset&#8217;s fair value less costs of disposal and value-in-use. The value-in-use is the present value of
the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to
which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000552" name="ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory"><p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForBorrowingsExplanatory_zwuFTkpzwCE" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z0VzBxCjiaEh">Borrowings</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
and borrowings are initially recognised at the fair value of the consideration received, net of transaction costs. They are subsequently
measured at amortised cost using the effective interest method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000554" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"><p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_zviXwugsp4ci" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zNxA6SudASV6">Employee
benefits</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
employee benefits</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
for wages and salaries, including non-monetary benefits, annual leave and long service leave expected to be settled wholly within 12
months of the reporting date are measured at the amounts expected to be paid when the liabilities are settled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
long-term employee benefits</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
liability for annual leave and long service leave not expected to be settled within 12 months of the reporting date are measured at the
present value of expected future payments to be made in respect of services provided by employees up to the reporting date using the
projected unit credit method. Consideration is given to expected future wage and salary levels, experience of employee departures and
periods of service. Expected future payments are discounted using market yields at the reporting date on corporate bonds with terms to
maturity and currency that match, as closely as possible, the estimated future cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 85 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000556" name="ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory"><p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_zagF7g4ZnBnj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zFBEnXYRAhb9">Goods
and Services Tax (GST) and other similar taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues,
expenses, and assets are recognised net of the amount of associated GST, unless the GST incurred is not recoverable from the tax authority.
In this case it is recognised as part of the cost of the acquisition of the asset or as part of the expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
and payables are stated inclusive of the amount of GST receivable or payable. The net amount of GST recoverable from, or payable to,
the tax authority is included in other receivables or other payables in the statement of financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
flows are presented on a gross basis. The GST components of cash flows arising from investing or financing activities which are recoverable
from, or payable to the tax authority, are presented as operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
and contingencies are disclosed net of the amount of GST recoverable from, or payable to, the tax authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000558" name="ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory"><p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_z7UZ10hq7KW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zbxymr0havy1">Issued
capital</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
Shares are classified as equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incremental
costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000560" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory"><p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_z9EXnSHpGG71" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z2Uc5pIoszw3">Income
tax</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax expense for the year is the tax payable on the current year&#8217;s taxable income based on the national income tax rate for
each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences between the tax bases
of assets and liabilities and their carrying amounts in the financial statements, and to unused tax losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are recognised for temporary differences at the tax rates expected to apply when the assets are recovered
or liabilities are settled, based on those tax rates which are enacted or substantively enacted for each jurisdiction. The relevant tax
rates are applied to the cumulative amounts of deductible and taxable temporary differences to measure the deferred tax asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
exception is made for certain temporary differences arising from the initial recognition of an asset or a liability. No deferred tax
asset or liability is recognised in relation to these temporary differences if they arose in a transaction, other than a business combination,
that at the time of the transaction did not affect either accounting profit or taxable profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilise those temporary differences and losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax liabilities and assets are not recognised for temporary differences between the carrying amount and tax bases of investments in controlled
entities where the parent company is able to control the timing of the reversal of the temporary differences and it is probable that
the differences will not reverse in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 86 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets and liabilities and when
the deferred tax balances relate to the same taxation authority. Current tax assets and tax liabilities are offset where the Company
has a legally enforceable right to offset and intends either to settle on a net basis, or to realise the asset and settle the liability
simultaneously.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
and deferred tax is recognised as income or an expense and included in profit and loss for the period except where the tax arises from
a transaction which is recognized in other comprehensive oncome or equity, in which case the tax is recognized in other comprehensive
income to equity respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000562" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"><p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zdTMHsYOXaP6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zVf7QaLVuKyb">Convertible
note</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
issuance of the convertible notes, an assessment is made to determine whether the convertible notes contain an equity instrument or whether
the whole instrument should be classified as a financial liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
it is determined that the whole instrument is a financial liability and no equity instrument, the conversion option is separated from
the host debt and classified as a derivative liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying value of the host contract at initial recognition is determined as a difference between the consideration received and the fair
value of the embedded derivative. The host contract is subsequently measured at amortised cost using the effective interest rate method.
The embedded derivative it subsequently measured at fair value at the end of each reporting period through the profit and loss. Refer
Note 21 Financial Liabilities for disclosure of key terms of the convertible notes. The convertible note and the derivative are presented
as financial liabilities on the Consolidated Statement of Financial Position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
conversion at maturity, the financial liability is reclassified to equity and no gain or loss is recognised. Transaction costs are deducted
from equity, net of associated income tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000564" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zbIP0X0RvChc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_z63x5obPaPLh">Share-based
payments</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides benefits to consultants, advisors and employees (including directors) of the consolidated entity in the form of share-based
payment transactions, whereby employees render services in exchange for shares or rights over shares (&#8216;equity-settled transactions&#8217;).
The cost of these equity-settled transactions with employees is measured by reference to the fair value at the date at which they are
granted. The fair value is determined by an external valuation using a Black- Scholes option pricing model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of equity-settled transactions is recognised, together with a corresponding increase in equity, over the period in which the performance
conditions are fulfilled, ending on the date on which the relevant employees become fully entitled to the award (&#8216;vesting date&#8217;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cumulative expense recognised for equity-settled transactions at each reporting date until vesting date reflects (i) the extent to
which the vesting period has expired and (ii) the number of awards that, in the opinion of the directors of the consolidated entity,
will ultimately vest. This opinion is formed based on the best available information at balance date. No adjustment is made for the
likelihood of market performance conditions being met as the effect of these conditions is included in the determination of fair
value at grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
expense is recognised for awards that do not ultimately vest, except for awards where vesting is conditional upon a market condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
an equity-settled award is cancelled, it is treated as if it had vested on the date of cancellation, and any expense not yet recognised
for the award is recognised immediately. However, if a new award is substituted for the cancelled award, and designated as a replacement
award on the date that it is granted, the cancelled and new award are treated as if they were a modification of the original award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 87 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000566" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_zLWgODhl9lx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zZqvh4CQZkl">Classification
and measurement of financial liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial liabilities include trade and other payables, financial liabilities measured at amortised cost and derivative
financial instruments. Financial liabilities are initially measured at fair value, and, where applicable, adjusted for transaction costs
unless the Company&#8217;s designated a financial liability at fair value through profit or loss. Subsequently, financial liabilities
are measured at amortised cost using the effective interest method except for derivatives and financial liabilities designated at FVTPL,
which are carried subsequently at fair value with gains or losses recognised in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000568" name="MMA:DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory"><p id="xdx_849_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zT3b4FHdxfmd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zB22HaKcvmXh">Right-of-use
assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
right-of-use asset is recognised at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the
initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of
any lease incentives received, any initial direct costs incurred, and, except where included in the cost of inventories, an estimate
of costs expected to be incurred for dismantling and removing the underlying asset, and restoring the site or asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever
is the shorter. Where the consolidated entity expects to obtain ownership of the leased asset at the end of the lease term, the depreciation
is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000570" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory"><p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zl6SNw2t7hH8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zXTYeAfytfQ3">Lease
liabilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
lease liability is recognised at the commencement date of a lease. The lease liability is initially recognised at the present value
of the lease payments to be made over the term of the lease, discounted using the interest rate implicit in the lease or, if that
rate cannot be readily determined, the consolidated entity&#8217;s incremental borrowing rate. Lease payments comprise of fixed
payments less any lease incentives receivable, variable lease payments that depend on an index or a rate, amounts expected to be
paid under residual value guarantees, exercise price of a purchase option when the exercise of the option is reasonably certain to
occur, and any anticipated termination penalties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
variable lease payments that do not depend on an index or a rate are expensed in the period in which they are incurred. Lease liabilities
are measured at amortised cost using the effective interest method. The carrying amounts are remeasured if there is a change in the following:
future lease payments arising from a change in an index or a rate used; residual guarantee; lease term; certainty of a purchase option
and termination penalties. When a lease liability is remeasured, an adjustment is made to the corresponding right-of use asset, or to
profit or loss if the carrying amount of the right-of-use asset is fully written down.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000572" name="ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory"><p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zCfMV6dNjvJj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_z1E0xhyEtYXb">Fair
value measurement</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
an asset or liability, financial or non-financial, is measured at fair value for recognition or disclosure purposes, the fair value is
based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date; and assumes that the transaction will take place either: in the principal market; or in the absence of a principal
market, in the most advantageous market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is measured using the assumptions that market participants would use when pricing the asset or liability, assuming they act in
their economic best interests. For non-financial assets, the fair value measurement is based on its highest and best use. Valuation
techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, are used,
maximising the use of relevant observable inputs and minimising the use of unobservable inputs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 88 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities measured at fair value are classified into three levels, using a fair value hierarchy that reflects the significance
of the inputs used in making the measurements. Classifications are reviewed at each reporting date and transfers between levels are determined
based on a reassessment of the lowest level of input that is significant to the fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
recurring and non-recurring fair value measurements, external valuers may be used when internal expertise is either not available or
when the valuation is deemed to be significant. External valuers are selected based on market knowledge and reputation. Where there is
a significant change in fair value of an asset or liability from one period to another, an analysis is undertaken, which includes a verification
of the major inputs applied in the latest valuation and a comparison, where applicable, with external sources of data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000574" name="ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"><p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zXjiRW99MTq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zOAF0IV5dM12">Earnings
per share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share is calculated by dividing the profit attributable to the owners of the Company, excluding any costs of servicing equity
other than Ordinary Shares, by the weighted average number of Ordinary Shares outstanding during the financial year, adjusted for bonus
elements in Ordinary Shares issued during the financial year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
earnings per share</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
earnings per share adjusts the figures used in the determination of basic earnings per share to take into account the after income tax
effect of interest and other financing costs associated with dilutive potential Ordinary Shares and the weighted average number of shares
assumed to have been issued for no consideration in relation to dilutive potential Ordinary Shares.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000576" name="MMA:DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory"><p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory_zOiSGHp5bbcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z9Eg5Ihndbg5">Parent
entity financial information</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial information for the Parent entity, Alta Global Group Limited, disclosed in Note 19 has been prepared on the same basis as the
consolidated financial statement. Investments in subsidiaries are accounted for at cost less provision for impairment in the financial
statements of the Parent entity.</span></p>

</ix:nonNumeric><p id="xdx_850_z2I5YxyRBWQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000578" name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory"><p id="xdx_801_eifrs-full--DisclosureOfAccountingJudgementsAndEstimatesExplanatory_zamoch7k25zl" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
3. <span id="xdx_82A_zM3hqiOvn0Dl">Critical accounting judgements, estimates and assumptions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts
in the financial statements. Management continually evaluates its judgements and estimates in relation to assets, liabilities, contingent
liabilities, revenue and expenses. Management bases its judgements, estimates and assumptions on historical experience and on other various
factors, including expectations of future events, management believes to be reasonable under the circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going
concern</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements for the reporting periods have been prepared on a going concern basis which contemplates continuity
of normal business activities and the realization of assets and settlement of liabilities in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have assessed that there is a substantial doubt related to going concern that may cast significant doubt over our ability to continue
as a going concern as we incurred a loss after tax of A$<span id="xdx_90C_eifrs-full--ProfitLoss_iN_di_c20230701__20240630_zWbS7VEMTIi6" title="Loss after tax"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000580" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,408,346</ix:nonFraction></span> for the year ended June 30, 2024 compared to A$<span id="xdx_90B_eifrs-full--ProfitLoss_iN_di_c20220701__20230630_zYmtPEvDJfF8" title="Loss after tax"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-07-012023-06-30" id="Fact000582" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,597,436</ix:nonFraction></span> for the
year ended June 30, 2023, had net cash outflows from operating activities of A$<span id="xdx_90F_eifrs-full--CashFlowsFromUsedInOperatingActivities_iN_di_c20230701__20240630_zUp9D04ZiWqd" title="Net cash outflows from operating activities"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000584" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,386,196</ix:nonFraction></span> for the year ended June 30, 2024 compared to
$<span id="xdx_908_eifrs-full--CashFlowsFromUsedInOperatingActivities_iN_di_c20220701__20230630_zoW58SEPfcVd" title="Net cash outflows from operating activities"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2022-07-012023-06-30" id="Fact000586" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,555,868</ix:nonFraction></span> for the year ended June 30,2023, had a net asset position of $<span id="xdx_909_eifrs-full--NetAssetsLiabilities_iI_c20240630_zHJjNRQBBxNh" title="Net assets liabilities"><ix:nonFraction name="ifrs-full:NetAssetsLiabilities" contextRef="AsOf2024-06-30" id="Fact000588" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,558,544</ix:nonFraction></span> as at June 30, 2024 compared to net liability $<span id="xdx_900_eifrs-full--NetAssetsLiabilities_iNI_di_c20230630_za0F9jocwZm4" title="Net assets liabilities"><ix:nonFraction name="ifrs-full:NetAssetsLiabilities" contextRef="AsOf2023-06-30" id="Fact000590" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,134,307</ix:nonFraction></span>
as at June 30, 2023, and net current asset position of $<span id="xdx_90B_eifrs-full--CurrentAssetsLiabilities_iI_c20240630_zwyoWwfi5yb5" title="Net current assets liabilities"><ix:nonFraction name="ifrs-full:CurrentAssetsLiabilities" contextRef="AsOf2024-06-30" id="Fact000592" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,049,355</ix:nonFraction></span> as at June 30, 2024, compared to net current liability position of
$<span id="xdx_900_eifrs-full--CurrentAssetsLiabilities_iI_c20230630_zVBZwfQvHUul" title="Net current assets liabilities"><ix:nonFraction name="ifrs-full:CurrentAssetsLiabilities" contextRef="AsOf2023-06-30" id="Fact000594" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,916,914</ix:nonFraction></span> as at June, 30 2023. As a result of these conditions, the Company may be unable to realize its assets and discharge its liabilities
in the normal, course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 89 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3. Critical accounting judgements, estimates and assumptions - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2024, the Company successfully listed on the NYSE American. In addition, all convertible notes that were on issue prior to
the initial public offering have either been converted into Ordinary Shares or redeemed and therefore there is no convertible note debt,
host or derivative liabilities, on the Consolidated Statement of Financial Position as at June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remaining interest on convertible notes and the final fair value movement in derivative liability is reflected in the Consolidated Statement
of Profit or Loss for the year ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ongoing operation of the Company remains dependent upon raising additional funds. In light of the future expenditures to be incurred
in executing on our strategic plans, we are dependent on obtaining financing through equity financing, debt financing or other means.
The ability to arrange such funding in the future will depend in part upon the prevailing capital market conditions as well as our business
performance. There is no assurance that we will be successful in our efforts to raise additional funding on terms satisfactory to us.
If we do not obtain additional funding, we may be required to delay, reduce the scope of, or eliminate our current operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
we believe that we will be able to raise additional funds as required to meet our obligations as and when they become due and are of
the opinion that the use of the going concern basis remains appropriate. Our ability to continue as a going concern and to pay debts
as and when they become due is dependent on the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we have historically been successful in raising funds,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we have now listed on the New York Stock Exchange in the United States. As a listed vehicle, we have capital raising options such as placements, Share Purchase Plans, Rights issues and entitlement offers, Dividend Reinvestment Plans, Hybrids and Retail notes and PIPEs;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our level of expenditure continues to be managed and will continue to be managed to maximize run-way; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we have reason to believe that in addition to the cash flow currently available, additional revenues will continue to be received through the sale of our products and services throughout the course of the year.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we decide to raise capital, the issuance of additional Ordinary Shares would result in dilution to our existing shareholders. We cannot
assure you that we will be successful in completing any financings or that any such equity or debt financing will be available to us
if and when required or on satisfactory terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
we be unable to raise additional funds on a timely basis, we may be required to realize our assets and discharge our liabilities other
than in the normal course of business and at amounts different to those stated in the financial statements. The financial statements
do not include any adjustments to the recoverability and classification of asset carrying amounts or the amount of liabilities that might
result should we be unable to continue as a going concern and meet our debts as and when they become due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers involving program fees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
recognising revenue in relation to the sale of goods to customers, the key performance obligation of the entity is considered to be the
point in time of the rights to use the license and the relevant training program to the gyms as the customers, as this is deemed to be
the time that the gym obtains control of the promised service and therefore the benefits of unimpeded access.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination
of variable consideration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Judgement
is exercised in estimating variable consideration which is determined having regard to past experience with respect to the cancelled
contracts with the entity where the member gyms maintain a right of terminate pursuant to the licence agreement. Revenue will only be
recognised to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognised under
the contract will not occur when the uncertainty associated with the variable consideration is subsequently resolved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 90 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3. Critical accounting judgements, estimates and assumptions - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based
payment transactions</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity measures the cost of equity-settled transactions with employees by reference to the fair value of the equity instruments
at the date at which they are granted. The fair value is determined by using Black-Scholes model taking into account the terms and conditions
upon which the instruments were granted. The accounting estimates and assumptions relating to equity-settled share-based payments would
have no impact on the carrying amounts of assets and liabilities within the next annual reporting period but may impact profit or loss
and equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible
Notes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined the convertible note instrument to be a financial liability. It is separated into two components being the host
debt and derivative liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying value of the host contract at initial recognition is determined as the difference between the consideration received and
the fair value of the embedded derivative. The host contract is subsequently measured at amortised cost using the effective interest
rate method. The derivative liability is recognised as such due to its conversion feature relating to a qualified equity investment
and the likelihood of its occurrence. The embedded derivative is subsequently measured at fair value at the end of each reporting
period through the profit and loss based on the Monte Carlo simulation as valued by an external valuer. The convertible note and the
derivative are presented as financial liabilities on the Consolidated Statement of Financial Position, refer to Note 21 Financial
Liabilities for further details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition
of deferred tax assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilise those temporary differences and losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of unrecognised deferred tax assets are reviewed at each reporting date. Previously unrecognised deferred tax assets
are only recognised to the extent that it is probable that there are future taxable profits available to recover the asset. The Company
has not recognised the benefit of these unused deductible temporary differences and unused tax losses. These losses will only be recognised
where it is probable that future taxable profit will be available against which the benefits of the deferred tax asset will be utilised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
term</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lease term is a significant component in the measurement of both the right-of-use asset and lease liability. Judgement is exercised in
determining whether there is reasonable certainty that an option to extend the lease or purchase the underlying asset will be exercised,
or an option to terminate the lease will not be exercised, when ascertaining the periods to be included in the lease term. In determining
the lease term, all facts and circumstances that create an economical incentive to exercise an extension option, or not to exercise a
termination option, are considered at the lease commencement date. Factors considered may include the importance of the asset to the
consolidated entity&#8217;s operations; comparison of terms and conditions to prevailing market rates; incurrence of significant penalties;
existence of significant leasehold improvements; and the costs and disruption to replace the asset. The consolidated entity reassesses
whether it is reasonably certain to exercise an extension option, or not exercise a termination option, if there is a significant event
or significant change in circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value measurement hierarchy</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity is required to classify all assets and liabilities, measured at fair value, using a three level hierarchy, based
on the lowest level of input that is significant to the entire fair value measurement, being:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly;
and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Unobservable inputs for the asset or liability. Considerable judgement is required to determine what is significant to fair value
and therefore which category the asset or liability is placed in can be subjective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of assets and liabilities classified as level 3 is determined by the use of valuation models. These include discounted cash
flow analysis or the use of observable inputs that require significant adjustments based on unobservable inputs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 91 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
3. Critical accounting judgements, estimates and assumptions - continued</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimation
of useful lives of assets</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity determines the estimated useful lives and related depreciation and amortisation charges for its property, plant and
equipment and finite life intangible assets. The useful lives could change significantly as a result of technical innovations or some
other event. The depreciation and amortisation charge will increase where the useful lives are less than previously estimated lives,
or technically obsolete or non-strategic assets that have been abandoned or sold will be written off or written down.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impairment
of non-financial assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity assesses impairment of non-financial assets at each reporting date by evaluating conditions specific to the consolidated
entity and to the particular asset that may lead to impairment. If an impairment trigger exists, the recoverable amount of the asset
is determined. This involves fair value less costs of disposal or value-in-use calculations, which incorporate a number of key estimates
and assumptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
Credit Losses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
allowance for expected credit losses requires a degree of estimation judgment. The Company has applied the simplified approach to measuring
expected credit losses, which uses a lifetime expected loss allowance. To measure the expected credit losses, trade receivables have
been grouped based on days overdue. Trade and other receivables are recognised at amortised cost, less any allowance for expected credit
losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Provision
for Refund Liability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for refund liability is recognised for expected volume payable to customers in relation to sales made until the end of the
reporting period. The Company&#8217;s obligation to provide a refund, cancellation or credit note falls under the Company&#8217;s standard
trading terms, and is recognised as a provision. The estimate of expected returns requires judgement and reflects the amount that the
reporting entity expects to repay or credit customers, using either the expected value method or the most-likely amount method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capitalised
platform development costs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred both internally and from external providers in developing the platform that meet the recognition criteria of development costs
under IAS 38 have been capitalised as intangible assets and are amortised over their useful life.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development Incentive</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Judgement
is required in determining the amount of grant revenue relating to the research and development incentive claim. There are certain transactions
and calculations undertaken during the ordinary course of business for which the ultimate tax determination may be subject to change.
The Company calculates its research and development claim based on the Company&#8217;s understanding of the tax law. Where the final
outcome of these matters is different from the amounts that were initially recorded, such differences will impact the profit or loss
in the year in which such determination is made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000596" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory"><p id="xdx_806_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_z8q4UGVZWgn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4. <span id="xdx_82B_zj6fkDj2LyY">Operating segments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identification
of reportable operating segments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Segment
reporting is based on the information that management uses to make decisions about the operation of the Company. Operating segment determination
is based on the internal reports that are reviewed and used by the Board of Directors (who are identified as the Chief Operating Decision
Makers (&#8220;CODM&#8221;)) in assessing performance and in determining the allocation of resources. The Company has identified one
operating segment as the provision and administration of mixed martial arts training programs, gym programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CODM reviews EBITDA (earnings before interest, tax, depreciation, and amortization). The accounting policies adopted for internal reporting
to the CODM are consistent with those adopted in the financial statements. Application of IFRS 8 and quantitative thresholds for determination
of reportable segments sees the consolidated entity disclosing only one reportable operating segment. The consolidated financial statements
for the years ended June 30, 2024, 2023 and 2022 have been presented by this single operating segment and have been presented and disclosed
as one reportable operating segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 92 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000598" name="ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory"><p id="xdx_807_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zOINLqwhVRZg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5. <span id="xdx_827_zJ2bG0nWdlOd">Revenue</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000600" name="ifrs-full:DisclosureOfProductsAndServicesExplanatory"><p id="xdx_89D_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zgRfiURJm5Ik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BD_zRj385CWGvBl">Schedule
of revenue</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20230701__20240630_zIQo217YJPrd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20220701__20230630_zQpYeWBDJ2Xd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20210701__20220630_zFnuaU5RM3V" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Program fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--RevenueFromProgramFees_maRFROSz9dU_zNLAODQU0TP1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Revenue from program fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:RevenueFromProgramFees" contextRef="From2023-07-01to2024-06-30" id="Fact000602" format="ixt:numdotdecimal" decimals="0" unitRef="USD">929,319</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:RevenueFromProgramFees" contextRef="From2022-07-012023-06-30" id="Fact000603" format="ixt:numdotdecimal" decimals="0" unitRef="USD">937,415</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:RevenueFromProgramFees" contextRef="From2021-07-012022-06-30" id="Fact000604" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,050,044</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RevenueFromContractualPaymentsToGyms_msRFROSz9dU_zdeZp0jLQw3e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Contractual payments to gyms</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:RevenueFromContractualPaymentsToGyms" contextRef="From2023-07-01to2024-06-30" id="Fact000606" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">537,012</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:RevenueFromContractualPaymentsToGyms" contextRef="From2022-07-012023-06-30" id="Fact000607" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">574,025</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:RevenueFromContractualPaymentsToGyms" contextRef="From2021-07-012022-06-30" id="Fact000608" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,215,191</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eifrs-full--RevenueFromRenderingOfServices_iT_mtRFROSz9dU_maRz2tF_zhT4NkeQssek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Revenue from program fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:RevenueFromRenderingOfServices" contextRef="From2023-07-01to2024-06-30" id="Fact000610" format="ixt:numdotdecimal" decimals="0" unitRef="USD">392,307</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:RevenueFromRenderingOfServices" contextRef="From2022-07-012023-06-30" id="Fact000611" format="ixt:numdotdecimal" decimals="0" unitRef="USD">363,390</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:RevenueFromRenderingOfServices" contextRef="From2021-07-012022-06-30" id="Fact000612" format="ixt:numdotdecimal" decimals="0" unitRef="USD">834,853</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Other Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ReserachAndDevelopmentIncome_maORzfCZ_zv9rjJaX42g5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research and Development tax incentive<span id="xdx_F47_zP06pBrLhtAl">*</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0614">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ReserachAndDevelopmentIncome" contextRef="From2022-07-012023-06-30" id="Fact000615" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,149,525</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0616">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--FranchiseFeeIncome_maORzfCZ_zaa66nRRvk4c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Finale, franchise fee and other fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:FranchiseFeeIncome" contextRef="From2023-07-01to2024-06-30" id="Fact000618" format="ixt:numdotdecimal" decimals="0" unitRef="USD">167,021</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:FranchiseFeeIncome" contextRef="From2022-07-012023-06-30" id="Fact000619" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:FranchiseFeeIncome" contextRef="From2021-07-012022-06-30" id="Fact000620" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,378</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--RevenueFromSaleOfGoods_maORzfCZ_zfMcMFP3uw71" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Merchandise sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="From2023-07-01to2024-06-30" id="Fact000622" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,984</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="From2022-07-012023-06-30" id="Fact000623" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,296</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="From2021-07-012022-06-30" id="Fact000624" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,572</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--OtherRevenue_iT_mtORzfCZ_maRz2tF_zwfzTIvJ2cn3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total other income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-07-01to2024-06-30" id="Fact000626" format="ixt:numdotdecimal" decimals="0" unitRef="USD">170,005</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2022-07-012023-06-30" id="Fact000627" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,173,421</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2021-07-012022-06-30" id="Fact000628" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,950</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--Revenue_iT_mtRz2tF_zTIGx62L0Xs9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-07-01to2024-06-30" id="Fact000630" format="ixt:numdotdecimal" decimals="0" unitRef="USD">562,312</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-07-012023-06-30" id="Fact000631" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,536,811</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-07-012022-06-30" id="Fact000632" format="ixt:numdotdecimal" decimals="0" unitRef="USD">940,803</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0D_zgTDBqwENKc1" style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F16_zk811PLJDAUd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000633" xml:lang="en-US">The Company will continue
                                                                                                                                                              to apply for the Research and Development incentive as long as it continues to be eligible and will conduct eligible research and
                                                                                                                                                              development activities. The applicable legislation that governs the eligibility to participate in the R&amp;D incentive program is
                                                                                                                                                              Division 355 of the Income Tax Assessment Act 1997 (ITAA 1997). The FY 2024 Research and Development incentive will be applied for
                                                                                                                                                              on lodging of the FY 2024 tax return with the Australian Tax Office and recognised once reasonable assurance that the Company will
                                                                                                                                                              comply with the conditions and that the grants will be received.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A3_zEIWAm8Tm0Wd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Disaggregation
of Revenue</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000635" name="ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"><p id="xdx_89E_eifrs-full--DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_zUgRACWRC7W6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disaggregation of revenue from contracts with customers is disclosed below. The Company only has one major product line, being the provision
of Gym Programs. All revenues are generated by the Australian Parent Entity:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BA_zGUPKhuQw4sd">Schedule
of disaggregation of revenue</span></b></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20230701__20240630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_z531tjLvweVk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220701__20230630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_zOPIEMxM5Cc8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20210701__20220630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_z2YKwg6pYU2f" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RevenueFromProgramFees_zmPTuSmNiD3j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Revenue from program fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:RevenueFromProgramFees" contextRef="From2023-07-012024-06-30_custom_OneMajorProductMember" id="Fact000637" format="ixt:numdotdecimal" decimals="0" unitRef="USD">929,319</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:RevenueFromProgramFees" contextRef="From2022-07-012023-06-30_custom_OneMajorProductMember" id="Fact000638" format="ixt:numdotdecimal" decimals="0" unitRef="USD">937,415</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:RevenueFromProgramFees" contextRef="From2021-07-012022-06-30_custom_OneMajorProductMember" id="Fact000639" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,050,044</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--RevenueFromContractualPaymentsToGyms_z0gRDUB3W7a5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Contractual payments to gyms</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:RevenueFromContractualPaymentsToGyms" contextRef="From2023-07-012024-06-30_custom_OneMajorProductMember" id="Fact000641" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">537,012</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:RevenueFromContractualPaymentsToGyms" contextRef="From2022-07-012023-06-30_custom_OneMajorProductMember" id="Fact000642" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">574,025</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:RevenueFromContractualPaymentsToGyms" contextRef="From2021-07-012022-06-30_custom_OneMajorProductMember" id="Fact000643" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,215,191</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eifrs-full--RevenueFromRenderingOfServices_iT_maRz2tF_z3F89R5objXi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net Revenue from program fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:RevenueFromRenderingOfServices" contextRef="From2023-07-012024-06-30_custom_OneMajorProductMember" id="Fact000645" format="ixt:numdotdecimal" decimals="0" unitRef="USD">392,307</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:RevenueFromRenderingOfServices" contextRef="From2022-07-012023-06-30_custom_OneMajorProductMember" id="Fact000646" format="ixt:numdotdecimal" decimals="0" unitRef="USD">363,390</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:RevenueFromRenderingOfServices" contextRef="From2021-07-012022-06-30_custom_OneMajorProductMember" id="Fact000647" format="ixt:numdotdecimal" decimals="0" unitRef="USD">834,853</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zra1ZJXvLff8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Timing
of revenue recognition</i> &#8211; All goods transferred at a point in time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000649" name="ifrs-full:DisclosureOfExpensesExplanatory"><p id="xdx_803_eifrs-full--DisclosureOfExpensesExplanatory_zeuAdbXSyMLa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. <span id="xdx_82E_z6MWtveDC26k">Expenses</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000651" name="MMA:DisclosureOfDetailedInformationAboutExpensesExplanatory"><p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutExpensesExplanatory_z3e8eACAxv52" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B0_zwL6ZQpkNdwc">Schedule
of expenses</span></b></span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230701__20240630_z7fmhUciUL3f" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20220701__20230630_zLR1IN4xc7og" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20210701__20220630_z8qJsQzhXZCf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--ProgramExpensesEventCosts_maPEzyGE_z1crUWk8SLUk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Event
    Costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesEventCosts" contextRef="From2023-07-01to2024-06-30" id="Fact000653" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,909</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesEventCosts" contextRef="From2022-07-012023-06-30" id="Fact000654" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,876</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesEventCosts" contextRef="From2021-07-012022-06-30" id="Fact000655" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,513</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--ProgramExpensesProgramCosts_maPEzyGE_zig9SqT0Iqz5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Program
    costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesProgramCosts" contextRef="From2023-07-01to2024-06-30" id="Fact000657" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,046</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesProgramCosts" contextRef="From2022-07-012023-06-30" id="Fact000658" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,447</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesProgramCosts" contextRef="From2021-07-012022-06-30" id="Fact000659" format="ixt:numdotdecimal" decimals="0" unitRef="USD">253,614</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--ProgramExpensesMerchantFees_maPEzyGE_z5QXY1FBIba2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merchant
    fees</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesMerchantFees" contextRef="From2023-07-01to2024-06-30" id="Fact000661" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,550</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesMerchantFees" contextRef="From2022-07-012023-06-30" id="Fact000662" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,427</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesMerchantFees" contextRef="From2021-07-012022-06-30" id="Fact000663" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,327</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--ProgramExpensesOtherCosts_maPEzyGE_zAcumNvOKD6h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesOtherCosts" contextRef="From2023-07-01to2024-06-30" id="Fact000665" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,073</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesOtherCosts" contextRef="From2022-07-012023-06-30" id="Fact000666" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,098</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpensesOtherCosts" contextRef="From2021-07-012022-06-30" id="Fact000667" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--ProgramExpenses_iT_mtPEzyGE_zyQPoCeOpQY9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    program expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000669" format="ixt:numdotdecimal" decimals="0" unitRef="USD">160,578</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpenses" contextRef="From2022-07-012023-06-30" id="Fact000670" format="ixt:numdotdecimal" decimals="0" unitRef="USD">229,848</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:ProgramExpenses" contextRef="From2021-07-012022-06-30" id="Fact000671" format="ixt:numdotdecimal" decimals="0" unitRef="USD">342,600</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--FinanceCostsConvertibleNotesInterestContractualAndEffective_maFCzg2h_zq1HsTJLnapg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    notes interest &#8211; contractual and effective</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:FinanceCostsConvertibleNotesInterestContractualAndEffective" contextRef="From2023-07-01to2024-06-30" id="Fact000673" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,207,498</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:FinanceCostsConvertibleNotesInterestContractualAndEffective" contextRef="From2022-07-012023-06-30" id="Fact000674" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,420,224</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:FinanceCostsConvertibleNotesInterestContractualAndEffective" contextRef="From2021-07-012022-06-30" id="Fact000675" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,162,646</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--FinanceCostsBankFees_maFCzg2h_zSZqLiHzNKn2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    fees</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:FinanceCostsBankFees" contextRef="From2023-07-01to2024-06-30" id="Fact000677" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,286</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:FinanceCostsBankFees" contextRef="From2022-07-012023-06-30" id="Fact000678" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,071</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:FinanceCostsBankFees" contextRef="From2021-07-012022-06-30" id="Fact000679" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,454</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--FinanceCostsBankInterestAndLeaseInterest_maFCzg2h_zKEaGTWQJ1y2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    interest and lease interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:FinanceCostsBankInterestAndLeaseInterest" contextRef="From2023-07-01to2024-06-30" id="Fact000681" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,143</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:FinanceCostsBankInterestAndLeaseInterest" contextRef="From2022-07-012023-06-30" id="Fact000682" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,435</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:FinanceCostsBankInterestAndLeaseInterest" contextRef="From2021-07-012022-06-30" id="Fact000683" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,703</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--FinanceCosts_iT_mtFCzg2h_z7IH9r1XTqL9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    finance costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2023-07-01to2024-06-30" id="Fact000685" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,262,927</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2022-07-012023-06-30" id="Fact000686" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,472,730</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2021-07-012022-06-30" id="Fact000687" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,191,803</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 93 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. Expenses &#8211; continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr id="xdx_40F_ecustom--UnrealizedCurrencyGains_i01N_di_maNFEGzlIR_zxdzxHTpr0qa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left; padding-left: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized
    currency (gains)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="MMA:UnrealizedCurrencyGains" contextRef="From2023-07-01to2024-06-30" id="Fact000689" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,094</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="MMA:UnrealizedCurrencyGains" contextRef="From2022-07-012023-06-30" id="Fact000690" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,181</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="MMA:UnrealizedCurrencyGains" contextRef="From2021-07-012022-06-30" id="Fact000691" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,660</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_405_ecustom--RealizedCurrencyGainslosses_i01N_di_maNFEGzlIR_zmoIvMjR4wO2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
    currency (gains)/losses</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="MMA:RealizedCurrencyGainslosses" contextRef="From2023-07-01to2024-06-30" id="Fact000693" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,449</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="MMA:RealizedCurrencyGainslosses" contextRef="From2022-07-012023-06-30" id="Fact000694" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,178</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MMA:RealizedCurrencyGainslosses" contextRef="From2021-07-012022-06-30" id="Fact000695" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,581</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--NetForeignExchangeGain_i01NT_di_mtNFEGzlIR_zWAZunepoqjb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    foreign exchange (gains)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ifrs-full:NetForeignExchangeGain" contextRef="From2023-07-01to2024-06-30" id="Fact000697" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,543</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ifrs-full:NetForeignExchangeGain" contextRef="From2022-07-012023-06-30" id="Fact000698" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,359</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ifrs-full:NetForeignExchangeGain" contextRef="From2021-07-012022-06-30" id="Fact000699" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,079</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zkhENqCHTiMb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000701" name="ifrs-full:DisclosureOfIncomeTaxExplanatory"><p id="xdx_809_eifrs-full--DisclosureOfIncomeTaxExplanatory_zm3Hho4gqaX3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7. <span id="xdx_823_zHAHMbZhK2l9">Income Tax</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000703" name="MMA:DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory"><p id="xdx_890_ecustom--DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory_zscoYR2oR6N2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z4CNgLHWqwEl" style="display: none">Schedule
of Income Tax Expenses</span><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230701__20240630_zfxLcEGBTYY8" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220701__20230630_zntEBKkkbrk3" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20210701__20220630_zuLqSjss5J9k" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($</b><b>)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income tax expense consists of the following:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--DeferredTaxExpenseIncome_maITECOzfzo_zESb20Fef0Zc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0705">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0706">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--CurrentTaxExpenseIncome_maITECOzfzo_z4Yfix7ZhNtc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Current tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0710">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0711">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_mtITECOzfzo_zPDylCD3bfil" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Total Income tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0713">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0714">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0715">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Effective tax rate reconciliation:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--ProfitLossBeforeTax_z5MTAICaLnu5" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Loss before income tax expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-07-01to2024-06-30" id="Fact000717" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,408,346</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2022-07-012023-06-30" id="Fact000718" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,597,436</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-07-012022-06-30" id="Fact000719" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,197,450</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_maITECOzcFn_zZEoUrsnybQj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prima facie income tax benefit on loss before income tax calculated at <span id="xdx_902_eifrs-full--ApplicableTaxRate_pid_dp_c20230701__20240630_zUiOgGZVODZc" title="Tax rate" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluY29tZSBUYXggRXhwZW5zZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2023-07-01to2024-06-30" id="Fact000725" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>% (2022: <span id="xdx_90D_eifrs-full--ApplicableTaxRate_pid_dp_c20210701__20220630_z2ukeGc6alk5" title="Tax rate" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluY29tZSBUYXggRXhwZW5zZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2021-07-012022-06-30" id="Fact000727" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>%)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" contextRef="From2023-07-01to2024-06-30" id="Fact000721" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,602,086</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" contextRef="From2022-07-012023-06-30" id="Fact000722" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,149,359</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" contextRef="From2021-07-012022-06-30" id="Fact000723" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,799,363</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Add tax effect of</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DeferredTaxExpenseIncomeOtherNonAllowableItems_maITECOzcFn_zYmYfegG7Mag" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left">- other non-allowable items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:DeferredTaxExpenseIncomeOtherNonAllowableItems" contextRef="From2023-07-01to2024-06-30" id="Fact000729" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">831,249</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:DeferredTaxExpenseIncomeOtherNonAllowableItems" contextRef="From2022-07-012023-06-30" id="Fact000730" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,297,349</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:DeferredTaxExpenseIncomeOtherNonAllowableItems" contextRef="From2021-07-012022-06-30" id="Fact000731" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,430</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Less tax effect of</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes_msITECOzcFn_zPEPbeLJLYT4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left">- items not assessable for income tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" contextRef="From2023-07-01to2024-06-30" id="Fact000733" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,590,831</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" contextRef="From2022-07-012023-06-30" id="Fact000734" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,435,790</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" contextRef="From2021-07-012022-06-30" id="Fact000735" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,377,243</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting_msITECOzcFn_zUb9IH5K4qNf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; text-align: left">- items deductible for taxation not accounting</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" contextRef="From2023-07-01to2024-06-30" id="Fact000737" format="ixt:numdotdecimal" decimals="0" unitRef="USD">251,784</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" contextRef="From2022-07-012023-06-30" id="Fact000738" format="ixt:numdotdecimal" decimals="0" unitRef="USD">772,848</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" contextRef="From2021-07-012022-06-30" id="Fact000739" format="ixt:numdotdecimal" decimals="0" unitRef="USD">114,471</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss_maITECOzcFn_zYSSn8aD2NHa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Deferred tax not recognised</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000741" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">431,790</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" contextRef="From2022-07-012023-06-30" id="Fact000742" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,189,068</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" contextRef="From2021-07-012022-06-30" id="Fact000743" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,680,021</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_mtITECOzcFn_zE1YYBiIuBL3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0745">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0747">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AE_zlmeI0SEI5d2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has carried forward tax losses, calculated according to Australian income tax legislation of $<span id="xdx_901_eifrs-full--DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_c20230701__20240630_z5mM5xEQTWlc" title="Caarried forward tax loss"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" contextRef="From2023-07-01to2024-06-30" id="Fact000749" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,042,509</ix:nonFraction></span> at 30 June 2024 (2023
$<span id="xdx_90D_eifrs-full--DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_c20220701__20230630_zQxxAPUSZT2" title="Caarried forward tax loss"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" contextRef="From2022-07-012023-06-30" id="Fact000751" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,315,346</ix:nonFraction></span>) which will be deductible from future assessable income provided that income is derived. Deferred tax assets and liabilities
are based on the assumption that no adverse change will occur in the income tax legislation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
benefit of these losses will only be recognized where it is probable that future taxable profit will be available against which the benefits
of the deferred tax asset can be utilised. This is based on the anticipation that the Company will derive sufficient future assessable
income to enable the benefit to be realised and comply with the conditions of deductibility imposed by the law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has assessed future forecast profits and concluded that not enough criteria has been satisfied to recognise any deferred tax
assets at the period ended 30 June 2024. Unused tax losses do not have an expiry date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 94 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000753" name="ifrs-full:DisclosureOfFairValueMeasurementExplanatory"><p id="xdx_80E_eifrs-full--DisclosureOfFairValueMeasurementExplanatory_zHgM4fnHcQwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. <span id="xdx_829_zobUHEApnBq3">Fair value measurement</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value hierarchy</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables detail the consolidated entity&#8217;s assets and liabilities, measured or disclosed at fair value, using a three level
hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that
                                            the entity can access at the measurement date.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            2: Inputs other than quoted prices included within Level 1 that are observable for the asset
                                            or liability, either directly or indirectly.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            3: Unobservable inputs for the asset or liability. Considerable judgement is required to
                                            determine what is significant to fair value and therefore which category the asset or liability
                                            is placed in can be subjective.</span></td></tr></table>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000755" name="ifrs-full:DisclosureOfFinancialAssetsExplanatory"><p id="xdx_89A_eifrs-full--DisclosureOfFinancialAssetsExplanatory_z8h86UUdFcxh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zTa0x4G2KBib" style="display: none">Schedule
of Fair Value Assets and &#160;Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49D_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zeMVVKkSBJMg" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zoLD7BLiRh5j" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49A_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zTI1Dp2Umppj" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49C_20240630_zZGmXuYbrzB8" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">Consolidated- June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialAssetsAtFairValue_iI_znrdl0xnuuD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; padding-bottom: 1pt; width: 40%">Assets</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0757">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0759">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialAssetsAtFairValue_iTI_zkuPaf0L1W6j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0762">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0763">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0765">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValue_iI_zWJMsn824O9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Derivative Liabilities &#8211; refer Note 21</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0767">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0769">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_zGUV0WEvPhq" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0774">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0775">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49E_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zKFzHVh7ZZX8" style="text-align: center">Level 1</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49C_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zQsvMZmMXTse" style="text-align: center">Level 2</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_490_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z7eUzszco5m3" style="text-align: center">Level 3</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20230630_zZjQJ5h2psV2" style="text-align: center">Total</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">Consolidated &#8211; June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialAssetsAtFairValue_iI_z9lPUJOZCFoe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-style: italic; padding-bottom: 1pt">Assets</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0778">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0779">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0780">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialAssetsAtFairValue_iTI_zFbX6SlvPo3k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0782">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0783">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0785">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValue_iI_zsWxZpZCbt21" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Derivative Liabilities &#8211; refer Note 21</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0787">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level3OfFairValueHierarchyMember" id="Fact000789" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,694,729</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-06-30" id="Fact000790" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,694,729</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_zwPEIDdwxdy6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0792">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0793">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-06-30_ifrs-full_Level3OfFairValueHierarchyMember" id="Fact000794" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,694,729</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-06-30" id="Fact000795" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,694,729</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_z2kXpfF5bD73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no transfers between levels during the financial periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of trade and other receivables and trade and other payables are assumed to approximate their fair values due to their
short-term nature. The fair value of financial liabilities is estimated by discounting the remaining contractual maturities at the current
market interest rate that is available for similar financial liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Valuation
techniques for fair value measurements categorised within level 3</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Financial Liabilities for the host liability and the derivative liability has been determined using a combination of
Monte Carlo Simulation (MCS) and Black-Scholes model (BSM). The Group used valuations specialists to perform these valuations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3 liabilities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Movements
in level 3 liabilities during the current and previous financial years are set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000797" name="MMA:DisclosureOfDerivativeLiabilityExplanatory"><p id="xdx_89C_ecustom--DisclosureOfDerivativeLiabilityExplanatory_zz6cZ8Gpqwmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_z0DzVDLs8pOa" style="display: none">Schedule
of Fair Value Measurement of Derivative Liability</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Derivative liability</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Total</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: normal; text-align: left">Consolidated</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Balance at 1 July 2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DerivativeFinancialLiabilities_iS_c20220701__20230630_z0R7TJj55djc" title="Balance" style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2022-06-30" id="Fact000799" format="ixt:numdotdecimal" decimals="0" unitRef="USD">878,653</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eifrs-full--FinancialLiabilities_iS_c20220701__20230630_zuoCRlVBY6zh" title="Balance" style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2022-06-30" id="Fact000801" format="ixt:numdotdecimal" decimals="0" unitRef="USD">878,653</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value of derivative liability recognised for convertible notes issued during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_c20220701__20230630_z1AjGBA7dQOd" title="Fair value of derivative liability recognised for convertible notes issued during the year" style="text-align: right"><ix:nonFraction name="MMA:FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" contextRef="From2022-07-012023-06-30" id="Fact000803" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,945,347</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_c20220701__20230630_zYkbUdeWnAie" title="Fair value of derivative liability recognised for convertible notes issued during the year" style="text-align: right"><ix:nonFraction name="ifrs-full:ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability" contextRef="From2022-07-012023-06-30" id="Fact000805" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,945,347</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Fair value movement recognised in profit or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--FairValueMovementRecognisedInProfitOrLoss_c20220701__20230630_zcgU848FByG6" title="Fair value movement recognised in profit or loss" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:FairValueMovementRecognisedInProfitOrLoss" contextRef="From2022-07-012023-06-30" id="Fact000807" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,870,729</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_c20220701__20230630_zLriMIYpnDTk" title="Fair value movement recognised in profit or loss" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" contextRef="From2022-07-012023-06-30" id="Fact000809" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,870,729</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance at 30 June 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iS_c20230701__20240630_zUyZwqyKuxpa" title="Balance" style="text-align: right"><ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2023-06-30" id="Fact000811" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,694,729</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iS_c20230701__20240630_zwSEuwbL1w7j" title="Balance" style="text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2023-06-30" id="Fact000813" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,694,729</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value of derivative liability recognised for convertible notes issued during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_c20230701__20240630_zZwxa5bWvOjf" title="Fair value of derivative liability recognised for convertible notes issued during the year" style="text-align: right"><ix:nonFraction name="MMA:FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" contextRef="From2023-07-01to2024-06-30" id="Fact000815" format="ixt:numdotdecimal" decimals="0" unitRef="USD">280,198</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_c20230701__20240630_zRBTYXplDnr3" title="Fair value of derivative liability recognised for convertible notes issued during the year" style="text-align: right"><ix:nonFraction name="ifrs-full:ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability" contextRef="From2023-07-01to2024-06-30" id="Fact000817" format="ixt:numdotdecimal" decimals="0" unitRef="USD">280,198</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Fair value movement recognised in profit or loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--FairValueMovementRecognisedInProfitOrLoss_c20230701__20240630_zIm3QAun1PMe" title="Fair value movement recognised in profit or loss" style="text-align: right">(<ix:nonFraction name="MMA:FairValueMovementRecognisedInProfitOrLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000819" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,400,685</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_c20230701__20240630_zxljolWGhcy8" title="Fair value movement recognised in profit or loss" style="text-align: right">(<ix:nonFraction name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" contextRef="From2023-07-01to2024-06-30" id="Fact000821" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,400,685</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Fair value of derivative liability for convertible notes which converted or matured during the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_c20230701__20240630_zbI4NgGD8dyg" title="Fair value of derivative liability for convertible notes which converted or matured during the year" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" contextRef="From2023-07-01to2024-06-30" id="Fact000823" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,574,242</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_c20230701__20240630_zlodQOI4j9a1" title="Fair value of derivative liability for convertible notes which converted or matured during the year" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" contextRef="From2023-07-01to2024-06-30" id="Fact000825" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,574,242</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance at 30 June 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eifrs-full--DerivativeFinancialLiabilities_iE_c20230701__20240630_zMQCn8i4GJHb" title="Balance" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0827">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eifrs-full--FinancialLiabilities_iE_c20230701__20240630_zM3ylSxHFXo7" title="Balance" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0829">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zb7fpPVRTIQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 95 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Fair value measurement - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000831" name="ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory"><p id="xdx_895_eifrs-full--DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_zXNXdVFKxRtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
level 3 liabilities unobservable inputs at issue date of each of the convertible notes series are as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zLarCb241h71" style="display: none">Schedule
of Unobservable Inputs Level 3 Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zp3vfSB85J27" title="Implied Valuation" style="width: 18%; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAConvertibleNotesMember" id="Fact000833" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zZuZEBvwtkOh" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAConvertibleNotesMember" id="Fact000835" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">74</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zz7X8ueMA5a7" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAConvertibleNotesMember" id="Fact000837" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zEPFKyGEfIme" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAConvertibleNotesMember" id="Fact000839" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A - July 21</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zVuGci006Ksb" title="Implied Valuation" style="width: 18%; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAJuly21Member" id="Fact000841" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zP3yLd1B7I38" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAJuly21Member" id="Fact000843" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">74</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zsuvP1fU9DMc" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAJuly21Member" id="Fact000845" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.1</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_ziGwy7zjDOC2" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAJuly21Member" id="Fact000847" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A &#8211; August 21</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_z6TN7GPgOxN" title="Implied Valuation" style="width: 18%; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAAugust21Member" id="Fact000849" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zl5TIWyXdeH2" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAAugust21Member" id="Fact000851" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">62</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zEt0xB5LCaR7" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAAugust21Member" id="Fact000853" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zLjvyPV6RtJ6" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAAugust21Member" id="Fact000855" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series B1</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zQSDF0mM3Zf2" title="Implied Valuation" style="width: 18%; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesB1Member" id="Fact000857" format="ixt:numdotdecimal" decimals="0" unitRef="USD">120,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zGrlA1CI2Yqk" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesB1Member" id="Fact000859" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">74</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zMPstv8V9ubf" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesB1Member" id="Fact000861" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.6</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zkyr6J9Gc0ki" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesB1Member" id="Fact000863" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series B2</i></b></span></p></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_ziaqCXgeU2e6" title="Implied Valuation" style="width: 18%; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesB2Member" id="Fact000865" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_z0Wwew0eU187" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesB2Member" id="Fact000867" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">66</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_ztpjbijgfsRa" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesB2Member" id="Fact000869" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_zHvD5ZKsQMd4" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesB2Member" id="Fact000871" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 96 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Fair value measurement - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A Extension</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_z0AOX32bewYc" title="Implied Valuation" style="width: 18%; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAExtensionMember" id="Fact000873" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_zcsirHDeCGW3" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAExtensionMember" id="Fact000875" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">65</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_z4qFyH8cKW24" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAExtensionMember" id="Fact000877" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.5</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_zcUyIbIbYoa7" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAExtensionMember" id="Fact000879" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Reach</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zCDcShhAlquf" title="Implied Valuation" style="width: 18%; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_ReachMember" id="Fact000881" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zZrAv0MSz1j9" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_ReachMember" id="Fact000883" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">60</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zcs5oKG0sfj3" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_ReachMember" id="Fact000885" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.6</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zINygeJBMhK7" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_ReachMember" id="Fact000887" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Private Placement</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zSVK1qaCez68" title="Implied Valuation" style="width: 18%; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_PrivatePlacementsMember" id="Fact000889" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,685,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zSb9oj4dlbGf" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_PrivatePlacementsMember" id="Fact000891" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">60</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zOtHhs1KwYWb" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_PrivatePlacementsMember" id="Fact000893" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.5</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_ztoHxmtYGFnb" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_PrivatePlacementsMember" id="Fact000895" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Mixed Martial Arts LLC</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zFPOfH2Wgr7g" title="Implied Valuation" style="width: 18%; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_MixedMartialArtsLLCMember" id="Fact000897" format="ixt:numdotdecimal" decimals="0" unitRef="USD">384,750</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zv0Qp6BZ5WO2" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_MixedMartialArtsLLCMember" id="Fact000899" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">49</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zxXFvfO9oiO8" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_MixedMartialArtsLLCMember" id="Fact000901" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.3</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zneXfVnHL4pa" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_MixedMartialArtsLLCMember" id="Fact000903" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Steppen</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_z7ojOPxh03G9" title="Implied Valuation" style="width: 18%; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SteppenMember" id="Fact000905" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zrheWO1kl34c" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SteppenMember" id="Fact000907" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">47</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zGVfRKO4ghTd" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SteppenMember" id="Fact000909" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.2</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zSnsYp7Ur1yk" title="Volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:SignificantUnobservableInputLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SteppenMember" id="Fact000911" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zY97X2Z96y8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000913" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory"><p id="xdx_801_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zQeufRG7NDz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9. <span id="xdx_827_zk8cTcBkazje">Cash and cash equivalents</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000915" name="MMA:DisclosureOfCashEquivalentsExplanatory"><p id="xdx_898_ecustom--DisclosureOfCashEquivalentsExplanatory_znCeSEql0yEe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zq6UPO9nt3Nh" style="display: none">Schedule
of Cash and Cash Equivalents</span> &#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240630_zE3HFPXSzMMl" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230630_zzUAlB3ozL8j" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CashOnHand_iI_maCACEz9Hz_z7vm8uu5LhW2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Cash on hand</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:CashOnHand" contextRef="AsOf2024-06-30" id="Fact000917" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:CashOnHand" contextRef="AsOf2023-06-30" id="Fact000918" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--BalancesWithBanks_iI_maCACEz9Hz_zQjt6dNqt0q3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash at bank</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:BalancesWithBanks" contextRef="AsOf2024-06-30" id="Fact000920" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,543,837</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:BalancesWithBanks" contextRef="AsOf2023-06-30" id="Fact000921" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,701,567</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--CashAndCashEquivalents_iTI_mtCACEz9Hz_ztzFeQB6I0X5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total cash and cash equivalents</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000923" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,544,837</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000924" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,702,567</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--CashAndCashEquivalents_iI_zArdMXCRT3Kj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cash as per above</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000926" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,544,837</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000927" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,702,567</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--CashAndCashEquivalents_iI_zHAwqU2KunJ1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Balance as per statement of cash flows</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000929" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,544,837</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000930" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,702,567</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zxsqNlcv4yVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000932" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory"><p id="xdx_80F_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zlvdalxYgf7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. <span id="xdx_82C_zaBZ9RRnxN02">Trade and other receivables</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000934" name="MMA:DisclosureOfTradeAndOtherReceivableExplanatory"><p id="xdx_897_ecustom--DisclosureOfTradeAndOtherReceivableExplanatory_z9Kqk8ZxLgz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zGeOOPl2rvgj" style="display: none">Schedule
of Trade and Other Receivables</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240630_z3HBqL7GOEQ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230630_zHNoveeYHHv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--TradeReceivables_iI_zsAQml8LWkt4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Trade Receivables</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2024-06-30" id="Fact000936" format="ixt:numdotdecimal" decimals="0" unitRef="USD">657</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2023-06-30" id="Fact000937" format="ixt:numdotdecimal" decimals="0" unitRef="USD">351,905</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--AccruedIncomeOtherThanContractAssets_iI_zSfGSPbkl2kh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AccruedIncomeOtherThanContractAssets" contextRef="AsOf2024-06-30" id="Fact000939" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,443</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ResearchAndDevelopmentIncome_iI_zh8sjvLVx2t6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research and Development Tax incentive receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0942">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ResearchAndDevelopmentIncome" contextRef="AsOf2023-06-30" id="Fact000943" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,776</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--OtherReceivables_iI_zd4qP7ry3Kz2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other advances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:OtherReceivables" contextRef="AsOf2024-06-30" id="Fact000945" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,618</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:OtherReceivables" contextRef="AsOf2023-06-30" id="Fact000946" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,952,560</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AllowancesForCreditLoss_iI_z2DkDzNVX90f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less; allowance for credit losses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:AllowancesForCreditLoss" contextRef="AsOf2024-06-30" id="Fact000948" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,603</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:AllowancesForCreditLoss" contextRef="AsOf2023-06-30" id="Fact000949" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,603</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eifrs-full--TradeAndOtherReceivables_iI_zLn2rvVIKUk5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total trade and other receivables</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherReceivables" contextRef="AsOf2024-06-30" id="Fact000951" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,115</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherReceivables" contextRef="AsOf2023-06-30" id="Fact000952" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,365,638</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zV6ypdRDyQI8" style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The Company has applied the simplified approach to measuring expected credit losses, which use a lifetime expected loss allowance. The Company also recognizes a refund liability in line with our revenue recognition policy in Note 2.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<ix:exclude><!-- Field: Page; Sequence: 97 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000954" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory"><p id="xdx_80F_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zRlvJlKEhEn8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. <span id="xdx_82F_zy9uEqfyaXb4">Property and equipment</span></b></span></p>



<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000956" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"><p id="xdx_890_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z4Spbpyx1bjc" style="margin: 0"><span id="xdx_8BE_zN9nwSU0bEv3" style="display: none">Schedule
of Property and Equipment</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20240630_z8yuAJ8MDg4g" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230630_z1pR9LZM9mv3" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zWF0lFKBxGBa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Plant and equipment - at cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:PropertyPlantAndEquipmentCost" contextRef="AsOf2024-06-30_custom_PlantAndEquipmentMember" id="Fact000958" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,410</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:PropertyPlantAndEquipmentCost" contextRef="AsOf2023-06-30_custom_PlantAndEquipmentMember" id="Fact000959" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,210</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zhsKji62vnnh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:PropertyPlantAndEquipmentAccumulatedDepreciation" contextRef="AsOf2024-06-30_custom_PlantAndEquipmentMember" id="Fact000961" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">59,339</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:PropertyPlantAndEquipmentAccumulatedDepreciation" contextRef="AsOf2023-06-30_custom_PlantAndEquipmentMember" id="Fact000962" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">56,002</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zlbJnq9EQAbc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2024-06-30_custom_PlantAndEquipmentMember" id="Fact000964" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,071</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_custom_PlantAndEquipmentMember" id="Fact000965" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,208</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zusnWBfhM3Q5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer equipment - at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:PropertyPlantAndEquipmentCost" contextRef="AsOf2024-06-30_ifrs-full_ComputerEquipmentMember" id="Fact000967" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,047</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:PropertyPlantAndEquipmentCost" contextRef="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember" id="Fact000968" format="ixt:numdotdecimal" decimals="0" unitRef="USD">95,612</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zg5am1rBKOma" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:PropertyPlantAndEquipmentAccumulatedDepreciation" contextRef="AsOf2024-06-30_ifrs-full_ComputerEquipmentMember" id="Fact000970" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">82,269</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:PropertyPlantAndEquipmentAccumulatedDepreciation" contextRef="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember" id="Fact000971" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">54,929</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zNDHpHcK1DJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2024-06-30_ifrs-full_ComputerEquipmentMember" id="Fact000973" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,778</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember" id="Fact000974" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,683</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zIM4Jcl8lSX" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office equipment - at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:PropertyPlantAndEquipmentCost" contextRef="AsOf2024-06-30_ifrs-full_OfficeEquipmentMember" id="Fact000976" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,090</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:PropertyPlantAndEquipmentCost" contextRef="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember" id="Fact000977" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,090</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_znmNN4ZfWcLh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:PropertyPlantAndEquipmentAccumulatedDepreciation" contextRef="AsOf2024-06-30_ifrs-full_OfficeEquipmentMember" id="Fact000979" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,508</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:PropertyPlantAndEquipmentAccumulatedDepreciation" contextRef="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember" id="Fact000980" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,313</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zphmh3ylXEb8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2024-06-30_ifrs-full_OfficeEquipmentMember" id="Fact000982" format="ixt:numdotdecimal" decimals="0" unitRef="USD">582</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember" id="Fact000983" format="ixt:numdotdecimal" decimals="0" unitRef="USD">777</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20240630_zSZhQ5pO2klj" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20230630_z8ignUUSiYHa" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_401_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zbhg8nWwLbE6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Furniture &amp; Fittings - at cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:PropertyPlantAndEquipmentCost" contextRef="AsOf2024-06-30_custom_FurnitrueAndFittingsMember" id="Fact000985" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,537</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:PropertyPlantAndEquipmentCost" contextRef="AsOf2023-06-30_custom_FurnitrueAndFittingsMember" id="Fact000986" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,537</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zXX3RNQf27Vi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:PropertyPlantAndEquipmentAccumulatedDepreciation" contextRef="AsOf2024-06-30_custom_FurnitrueAndFittingsMember" id="Fact000988" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,270</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:PropertyPlantAndEquipmentAccumulatedDepreciation" contextRef="AsOf2023-06-30_custom_FurnitrueAndFittingsMember" id="Fact000989" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,277</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zB2QfahSvp6a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture &amp; Fittings</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2024-06-30_custom_FurnitrueAndFittingsMember" id="Fact000991" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,267</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_custom_FurnitrueAndFittingsMember" id="Fact000992" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,260</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_iI_zkm2lYfdlUP8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" contextRef="AsOf2024-06-30" id="Fact000994" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,698</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" contextRef="AsOf2023-06-30" id="Fact000995" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94,928</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Property Plant and Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zVFYtlUGy7wj" title="Balance" style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_custom_PlantAndEquipmentMember" id="Fact000997" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,208</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zk7vtZqiWWD6" title="Balance" style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2022-06-30_custom_PlantAndEquipmentMember" id="Fact000999" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,189</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zvjrp2I2G7j9" title="Additions" style="text-align: right"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_custom_PlantAndEquipmentMember" id="Fact001001" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zy1ZnIoxVdTk" title="Additions" style="text-align: right"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_custom_PlantAndEquipmentMember" id="Fact001003" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,110</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zqDqMIPBKfM5" title="Disposals" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1005">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zPdfmzEqGjf2" title="Disposals" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1007">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zi58GAOax3G4" title="Depreciation expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_custom_PlantAndEquipmentMember" id="Fact001009" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,337</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zBGSt9KmaFS8" title="Depreciation expense" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_custom_PlantAndEquipmentMember" id="Fact001011" format="ixt:numdotdecimal" decimals="0" unitRef="USD">909</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year-</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zfdWwaqGZKm6" title="Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2024-06-30_custom_PlantAndEquipmentMember" id="Fact001013" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,071</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zPWkzJKvfsJ" title="Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_custom_PlantAndEquipmentMember" id="Fact001015" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,208</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Computer Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_dxL_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z0wStTmp5A38" title="Balance::XDX::40683" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1017">51,971</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4L3npPCvlXd" title="Balance" style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2022-06-30_ifrs-full_ComputerEquipmentMember" id="Fact001019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,971</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zaseSOdCciGk" title="Additions" style="text-align: right"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember" id="Fact001021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,435</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhEak30rSyW1" title="Additions" style="text-align: right"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_ifrs-full_ComputerEquipmentMember" id="Fact001023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,687</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zCZIanT1yvD3" title="Disposals" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1025">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zENb5yXRlG3h" title="Disposals" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1027">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zUczSfeONi0d" title="Depreciation expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember" id="Fact001029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,628</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zrE1kMCHaAw6" title="Depreciation expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_ifrs-full_ComputerEquipmentMember" id="Fact001031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,975</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zuIv6oRJpop1" title="Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2024-06-30_ifrs-full_ComputerEquipmentMember" id="Fact001033" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,778</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zHOwuc7dgvAc" title="Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember" id="Fact001035" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,683</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Office Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zT2gdA7rI0t3" title="Balance" style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember" id="Fact001037" format="ixt:numdotdecimal" decimals="0" unitRef="USD">777</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zN8t4gG398gj" title="Balance" style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2022-06-30_ifrs-full_OfficeEquipmentMember" id="Fact001039" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,036</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zLTP0e5mOfIc" title="Additions" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1041">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zolyYfpC2JQb" title="Additions" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zgZmtYyTAoY1" title="Disposals" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1045">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zw8BMhz9U5q9" title="Disposals" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1047">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zhP0D86yJe92" title="Depreciation expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember" id="Fact001049" format="ixt:numdotdecimal" decimals="0" unitRef="USD">195</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zS1QX8kqxTJe" title="Depreciation expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_ifrs-full_OfficeEquipmentMember" id="Fact001051" format="ixt:numdotdecimal" decimals="0" unitRef="USD">259</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zWmH4FGeTYLd" title="Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2024-06-30_ifrs-full_OfficeEquipmentMember" id="Fact001053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">582</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zqDQ2A5bx5f3" title="Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember" id="Fact001055" format="ixt:numdotdecimal" decimals="0" unitRef="USD">777</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Furniture &amp; Fittings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zUuFgb9s88Th" title="Balance" style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_custom_FurnitrueAndFittingsMember" id="Fact001057" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,260</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_z0mcpFwLBkek" title="Balance" style="text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2022-06-30_custom_FurnitrueAndFittingsMember" id="Fact001059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,224</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zsScsLS2XRJ5" title="Additions" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1061">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zhsKqTjcgoN8" title="Additions" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zuuCmdALG1i3" title="Disposals" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1065">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zbCw4R72GJRb" title="Disposals" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1067">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zGkHTu3gvSf" title="Depreciation expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30_custom_FurnitrueAndFittingsMember" id="Fact001069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,993</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zIbrUGFllXP" title="Depreciation expense" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30_custom_FurnitrueAndFittingsMember" id="Fact001071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,964</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zPHniialTjY3" title="Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2024-06-30_custom_FurnitrueAndFittingsMember" id="Fact001073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,267</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zilSXRxgllok" title="Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-06-30_custom_FurnitrueAndFittingsMember" id="Fact001075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,260</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zvW3f4OGcHdd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<ix:exclude><!-- Field: Page; Sequence: 98 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001077" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory"><p id="xdx_801_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zEYzozc3Twtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. <span id="xdx_82C_zZ3eG6Rctsjf">Intangible assets</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001079" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"><p id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_z4WWHGzNnSo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zy6ZJQJ4JJph" style="display: none">Schedule of Intangible assets</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240630_zbw9mhXi0cv6" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230630_zVFbHzDTLJyg" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWfOL3bUkefb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Trademark - at cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-06-30_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact001081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,243</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact001082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,843</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdMrzRmD2v78" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-06-30_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact001084" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,653</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact001085" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,429</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zGeCtoaUP3yc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark - at cost, net</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-06-30_ifrs-full_BrandNamesMember" id="Fact001087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,590</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30_ifrs-full_BrandNamesMember" id="Fact001088" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,414</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zg6787Dj2mm2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Platform development - at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-06-30_custom_PlatformDevelopmentMember_ifrs-full_GrossCarryingAmountMember" id="Fact001090" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,988,033</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30_custom_PlatformDevelopmentMember_ifrs-full_GrossCarryingAmountMember" id="Fact001091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,136,149</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbSFxOeozqT4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-06-30_custom_PlatformDevelopmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact001093" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">713,360</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30_custom_PlatformDevelopmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact001094" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">351,202</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zldqW3wFluei" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Platform
    development - at cost, net</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-06-30_custom_PlatformDevelopmentMember" id="Fact001096" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,274,673</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30_custom_PlatformDevelopmentMember" id="Fact001097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">784,947</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_zD3AUrzw6X02" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total intangible assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-06-30" id="Fact001099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,297,263</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30" id="Fact001100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">811,361</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zb65yvA8fY6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001102" name="MMA:DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory"><p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory_zM5JV1YW6tRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliations
of the movement of intangible assets are set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zzUebXIuSik5" style="display: none">Schedule of Reconciliations of the Movement of Intangible Assets</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20230701__20240630_zFOOXYRKZj65" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220701__20230630_zhreG6tQh7Hj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Trademark</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zvsRasfCteeb" style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left">Balance at beginning of the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30_ifrs-full_BrandNamesMember" id="Fact001104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,414</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2022-06-30_ifrs-full_BrandNamesMember" id="Fact001105" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,414</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z5BTHYfs6fwe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-07-012024-06-30_ifrs-full_BrandNamesMember" id="Fact001107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1108">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_za34hXYLEzpa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization expense</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-07-012024-06-30_ifrs-full_BrandNamesMember" id="Fact001110" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,224</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1111">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zAKkxVkEsDnf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Balance at end of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-06-30_ifrs-full_BrandNamesMember" id="Fact001113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,590</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30_ifrs-full_BrandNamesMember" id="Fact001114" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,414</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Platform development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_z6NxPuO4om8h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30_custom_PlatformDevelopmentMember" id="Fact001116" format="ixt:numdotdecimal" decimals="0" unitRef="USD">784,947</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2022-06-30_custom_PlatformDevelopmentMember" id="Fact001117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,034,302</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AdditionsFromInternalDevelopment_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zxLtOsQJ3KCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additions from internal development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:AdditionsFromInternalDevelopment" contextRef="From2023-07-012024-06-30_custom_PlatformDevelopmentMember" id="Fact001119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">177,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:AdditionsFromInternalDevelopment" contextRef="From2022-07-012023-06-30_custom_PlatformDevelopmentMember" id="Fact001120" format="ixt:numdotdecimal" decimals="0" unitRef="USD">352,182</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zsbD745T533l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additions acquired <span id="xdx_F4D_zkhnk0Ru9lo1">*</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-07-012024-06-30_custom_PlatformDevelopmentMember" id="Fact001122" format="ixt:numdotdecimal" decimals="0" unitRef="USD">674,220</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ResearchDevelopmentTaxIncentive_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zMTiZn8U98hh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research &amp; Development tax incentive</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1125">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:ResearchDevelopmentTaxIncentive" contextRef="From2022-07-012023-06-30_custom_PlatformDevelopmentMember" id="Fact001126" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">383,937</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_znukqCAigQqi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization expense</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-07-012024-06-30_custom_PlatformDevelopmentMember" id="Fact001128" format="ixt:numdotdecimal" decimals="0" unitRef="USD">361,950</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-07-012023-06-30_custom_PlatformDevelopmentMember" id="Fact001129" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,600</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zQrmniWgl8Fa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Balance at end of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-06-30_custom_PlatformDevelopmentMember" id="Fact001131" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,274,673</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-06-30_custom_PlatformDevelopmentMember" id="Fact001132" format="ixt:numdotdecimal" decimals="0" unitRef="USD">784,947</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F00_zE8r3Az3I4Oa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_zFnGGzVFHNc1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001133" xml:lang="en-US">Included in additions
is acquired intangible assets of:</ix:footnote></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            September 2023, we completed the acquisition of the assets of Steppen Pty Ltd, a fitness
                                            technology company based in Australia (&#8220;Steppen&#8221;). As consideration for the asset
                                            acquisition, we issued Steppen an unsecured and non-redeemable convertible promissory note
                                            (on the same terms as the recently completed Private Placement), with a principal amount
                                            of US$ <span id="xdx_909_eifrs-full--NotionalAmount_iI_c20230930__ifrs-full--CounterpartiesAxis__custom--SteppenPtyLtdMember_zFJXAam8TyIf" title="Principal amount"><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="AsOf2023-09-30_custom_SteppenPtyLtdMember" id="Fact001135" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,977</ix:nonFraction></span> (AUD$<span id="xdx_909_eifrs-full--NotionalAmount_iI_uAUD_c20230930__ifrs-full--CounterpartiesAxis__custom--SteppenPtyLtdMember_zRZTSBvMObUa" title="Principal amount"><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="AsOf2023-09-30_custom_SteppenPtyLtdMember" id="Fact001137" format="ixt:numdotdecimal" decimals="0" unitRef="AUD">100,000</ix:nonFraction></span>).</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            October 2023, we completed the acquisition of the assets of Mixed Martials Arts LLC, an independent
                                            MMA media company, based in the US. As consideration for the asset acquisition, we issued
                                            Mixed Martials Arts LLC an unsecured and non-redeemable convertible promissory note (on the
                                            same terms as the recently completed Private Placement), with a principal amount of US$<span id="xdx_907_eifrs-full--NotionalAmount_iI_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_zOAvpzW7u2w1" title="Principal amount"><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="AsOf2023-10-31_custom_MixedMartialsArtsLLCMember" id="Fact001139" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>
                                            (AUD$<span id="xdx_90C_eifrs-full--NotionalAmount_iI_uAUD_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_z6Z71mZKZNod" title="Principal amount"><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="AsOf2023-10-31_custom_MixedMartialsArtsLLCMember" id="Fact001141" format="ixt:numdotdecimal" decimals="0" unitRef="AUD">384,750</ix:nonFraction></span>) and paid US$<span id="xdx_901_eifrs-full--Cash_iI_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_zPWHyb4ReqE4" title="Cash"><ix:nonFraction name="ifrs-full:Cash" contextRef="AsOf2023-10-31_custom_MixedMartialsArtsLLCMember" id="Fact001143" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> in cash.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            May 2024, we completed the acquisition of the assets of Hype Kit, Inc, a Delaware corporation
                                            (&#8220;Hype&#8221;), an all in-one digital marketing platform, designed to help small businesses
                                            grow in today&#8217;s age of social media. Hype&#8217;s software platform strengthens the
                                            Company&#8217;s vision to convert 640 million MMA fans to participants by providing invaluable
                                            tools to our gym owner, coach, and athlete partners to not only grow their revenues, but
                                            also operate more efficiently, save costs and enhance the offerings to <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">their
members and community. This acquisition is expected to accelerate Alta&#8217;s technology roadmap, bringing forward new subscription
revenue opportunities for us, whilst creating cost synergies by materially reducing product development overhead and bringing valuable
technology expertise, skills and talent into the business. The acquisition was completed, and the asset purchased for consideration of
USD$<span id="xdx_909_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20240531__ifrs-full--CounterpartiesAxis__custom--HypeKitIncMember_zawEFdzTJqK8" title="Asset purchased for consideration"><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2024-05-31_custom_HypeKitIncMember" id="Fact001145" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> (AUD$<span id="xdx_90F_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_uAUD_c20240531__ifrs-full--CounterpartiesAxis__custom--HypeKitIncMember_zZK4K0AcQjJ8" title="Asset purchased for consideration"><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2024-05-31_custom_HypeKitIncMember" id="Fact001147" format="ixt:numdotdecimal" decimals="0" unitRef="AUD">153,000</ix:nonFraction></span>)</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
                                            determined both the acquired intangible assets did not pass the concentration test under
                                            IFRS 3 Business Combinations. Thereby were accounted for as acquisition of intangible assets.</span></td></tr></table>

</ix:nonNumeric><p id="xdx_8AF_zbbEO8hZJnC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001149" name="ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory"><p id="xdx_804_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_zcQYsSvbk3A3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
13. <span id="xdx_822_zGhoTcN7FY48">Trade and other payables</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001151" name="MMA:DisclosureOfDetailedInformationAboutTradeAndOtherPayables"><p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayables_zcigglHseYi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_z1pFUCbStljj" style="display: none">Schedule of Trade and Other Payables</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zzRqt8QejHec" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20230630_zH2rBd2YQCe7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--TradeAndOtherPayablesPayableToMemberGyms_iI_maTAOPzf2r_zCUAJCQhg4Zg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Payable to member gyms</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:TradeAndOtherPayablesPayableToMemberGyms" contextRef="AsOf2024-06-30" id="Fact001153" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,019</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:TradeAndOtherPayablesPayableToMemberGyms" contextRef="AsOf2023-06-30" id="Fact001154" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,065</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--TaxesPayable_iI_maTAOPzf2r_zKTaaUbe5Cug" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:TaxesPayable" contextRef="AsOf2024-06-30" id="Fact001156" format="ixt:numdotdecimal" decimals="0" unitRef="USD">603,550</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:TaxesPayable" contextRef="AsOf2023-06-30" id="Fact001157" format="ixt:numdotdecimal" decimals="0" unitRef="USD">560,204</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--TradePayables_iI_maTAOPzf2r_zgIV4zl7CxY5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:TradePayables" contextRef="AsOf2024-06-30" id="Fact001159" format="ixt:numdotdecimal" decimals="0" unitRef="USD">540,102</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:TradePayables" contextRef="AsOf2023-06-30" id="Fact001160" format="ixt:numdotdecimal" decimals="0" unitRef="USD">723,105</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ProvisionForRefundLiability_iI_maTAOPzf2r_zWEOr8VpVAW6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Provision for refund liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ProvisionForRefundLiability" contextRef="AsOf2023-06-30" id="Fact001163" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--OtherPayables_iI_maTAOPzf2r_z17Syid3zER2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other Payables</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:OtherPayables" contextRef="AsOf2024-06-30" id="Fact001165" format="ixt:numdotdecimal" decimals="0" unitRef="USD">778,865</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:OtherPayables" contextRef="AsOf2023-06-30" id="Fact001166" format="ixt:numdotdecimal" decimals="0" unitRef="USD">620,062</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--TradeAndOtherPayables_iTI_mtTAOPzf2r_z50oSktPub1h" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total trade and other payables</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayables" contextRef="AsOf2024-06-30" id="Fact001168" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,991,536</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayables" contextRef="AsOf2023-06-30" id="Fact001169" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,034,436</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zIyO2Ceq2SC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 99 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001171" name="MMA:DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory"><p id="xdx_802_ecustom--DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory_zbZkKAmb7Nf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 14. <span id="xdx_82D_zkyzW3h2Nzmh">Current and Non-current Employee
   Entitlements</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001173" name="MMA:DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory"><p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory_zErYGqEv8pT3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>&#160;</span></b></span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zXK32yoCCa14" style="display: none">Schedule of Current and Non-current Employee Entitlements</span></span></p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240630_zqnFK1vvJbF2" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20230630_zcvpot8RqXdk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--CurrentProvisionsForEmployeeBenefits_iI_zCIX6RQcOSr" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Current Employee Entitlement</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:CurrentProvisionsForEmployeeBenefits" contextRef="AsOf2024-06-30" id="Fact001175" format="ixt:numdotdecimal" decimals="0" unitRef="USD">454,342</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:CurrentProvisionsForEmployeeBenefits" contextRef="AsOf2023-06-30" id="Fact001176" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,227</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NoncurrentProvisionsForEmployeeBenefits_iI_zOZjPFsDm7Za" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Non-current Employee Entitlements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" contextRef="AsOf2024-06-30" id="Fact001178" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,622</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" contextRef="AsOf2023-06-30" id="Fact001179" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,892</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_zhkCFXDhSoY4" style="margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001181" name="MMA:DisclosureOfUnearnedRevenueExplanatory"><p id="xdx_809_ecustom--DisclosureOfUnearnedRevenueExplanatory_z7AejCwtqwGd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Note 15. <span id="xdx_823_zAeQQ3gvKGfb">Unearned Revenue</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001183" name="MMA:DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory"><p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory_z3LdcY8UUL4" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;<span id="xdx_8BD_zxG2tDSKM5E" style="display: none">Schedule
of Unearned Revenue</span> </span></p>



<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20240630_zlEvGQQGNqj7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20230630_z3CsV6nWAyO" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--UnearnedRevenue_iI_zK8QSeSdAgD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 68%">Unearned Revenue</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%"><ix:nonFraction name="MMA:UnearnedRevenue" contextRef="AsOf2023-06-30" id="Fact001186" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,290</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_z9WGi1GHZQI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001188" name="ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory"><p id="xdx_80C_eifrs-full--DisclosureOfReservesAndOtherEquityInterestExplanatory_z1PhttHcLPxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
16. <span id="xdx_825_zLDmVOVogjB2">Reserves</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>&#160;</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001190" name="MMA:ScheduleOfReservesTableTextBlock"><p id="xdx_89E_ecustom--ScheduleOfReservesTableTextBlock_zLJbJUzbgzZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z2pBebaXDblc" style="display: none">Schedule
of Reserves</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zz9bVQNbSrpf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230630_zGg46BUY79G2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220630_ztcrbkNkzbc8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ReserveOfUnbilledShareOption_iI_zMGgFfZ6q9V6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Unlisted share option reserve</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:ReserveOfUnbilledShareOption" contextRef="AsOf2024-06-30" id="Fact001192" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,741,457</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1193">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ReserveOfSharebasedPayments_iI_zbS34NmH7cqi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share based payment reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2024-06-30" id="Fact001196" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,734,601</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2023-06-30" id="Fact001197" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,912,367</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2022-06-30" id="Fact001198" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,546,983</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ForeignCurrencyReserves_iI_zpouhT90SLgj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign currency translation reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:ForeignCurrencyReserves" contextRef="AsOf2024-06-30" id="Fact001200" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">86,542</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:ForeignCurrencyReserves" contextRef="AsOf2023-06-30" id="Fact001201" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">65,832</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:ForeignCurrencyReserves" contextRef="AsOf2022-06-30" id="Fact001202" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,367</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A3_zLb9z1LwcYXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001204" name="ifrs-full:DisclosureOfIssuedCapitalExplanatory"><p id="xdx_809_eifrs-full--DisclosureOfIssuedCapitalExplanatory_zK2uWri3r9q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
17. <span id="xdx_82F_z8Wgqef40LOc">Issued capital</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001206" name="MMA:DisclosureOfDetailedInformationIssuedCapitalExplanatory"><p id="xdx_895_ecustom--DisclosureOfDetailedInformationIssuedCapitalExplanatory_zPMktKfppKH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B7_zoD0Hqlev9Rc" style="display: none">Schedule
of Issued Capital</span> </b></span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230701__20240630_zn9pNIbOrWV7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220701__20230630_zgDxKzy7dyEa" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210701__20220630_zG8jp2ktb71k" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--OwnersShareCapital_iS_zKCVHf2eUfy" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Owners share capital, opening (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="MMA:OwnersShareCapital" contextRef="AsOf2023-06-30" id="Fact001208" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,918,750</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="MMA:OwnersShareCapital" contextRef="AsOf2022-06-30" id="Fact001209" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,918,750</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="MMA:OwnersShareCapital" contextRef="AsOf2021-06-30" id="Fact001210" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,918,750</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--NumberOfShareIssuedAndFullyPaid_iI_zUBhQRo77FOj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issued and fully paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:NumberOfShareIssuedAndFullyPaid" contextRef="From2023-07-01to2024-06-30" id="Fact001212" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,315,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssueOfSharesFromConversionOfConvertibleNotes_iI_zG1RDQWZHy72" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue of shares from the conversion of <br/>the convertible notes (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:IssueOfSharesFromConversionOfConvertibleNotes" contextRef="From2023-07-01to2024-06-30" id="Fact001216" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,706,794</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1217">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--AdvisorOptionsExercisedShares_iI_zGuEBkkcJVe4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Advisor Options exercised (3)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:AdvisorOptionsExercisedShares" contextRef="From2023-07-01to2024-06-30" id="Fact001220" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">327,142</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1221">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--OwnersShareCapital_iE_ztL346Cfxugi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Owners share capital, closing</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:OwnersShareCapital" contextRef="AsOf2024-06-30" id="Fact001224" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,267,686</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:OwnersShareCapital" contextRef="AsOf2023-06-30" id="Fact001225" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,918,750</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:OwnersShareCapital" contextRef="AsOf2022-06-30" id="Fact001226" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,918,750</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230701__20240630_zbeUkXxhmbZ2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220701__20230630_zXLDYJL3Y0W4" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210701__20220630_zsfkk35OcLkg" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--IssuedCapital_iS_zg69Yz2AiQjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Owners share capital, opening <span id="xdx_F47_zjFCNTsI7pm9">(1)</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2023-06-30" id="Fact001228" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2022-06-30" id="Fact001229" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2021-06-30" id="Fact001230" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--IssuedAndFullyPaidValue_iI_zIhtblNtgsr6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issued and fully paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:IssuedAndFullyPaidValue" contextRef="From2023-07-01to2024-06-30" id="Fact001232" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,964,825</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1233">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--PaymentsForShareIssueCosts_iN_di_zxb1M40zgww4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share issue transaction costs net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:PaymentsForShareIssueCosts" contextRef="From2023-07-01to2024-06-30" id="Fact001236" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,174,911</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1238">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IssueOfEquityFromConversionOfConvertibleNotes_znczo8SFg057" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issue of shares from the conversion of <br/>the convertible notes <span id="xdx_F4A_z5LnXeVHYML3">(2)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:IssueOfEquityFromConversionOfConvertibleNotes" contextRef="From2023-07-01to2024-06-30" id="Fact001240" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,177,751</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1242">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--AdvisorOptionsExercisedValue_zr5sXAezuH2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Advisor Options exercised <span id="xdx_F45_zRA9StAPqgO3">(3)</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:AdvisorOptionsExercisedValue" contextRef="From2023-07-01to2024-06-30" id="Fact001244" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,426,757</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1246">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--IssuedCapital_iE_zRkkrDEpE2b7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Owners share capital, closing</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2024-06-30" id="Fact001248" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,779,703</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2023-06-30" id="Fact001249" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2022-06-30" id="Fact001250" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F09_zUXUyW0TuCdi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zk2zoxoSlYo7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001251" xml:lang="en-US">On
                                            January 24, 2024, there was a reverse share split of our issued and outstanding Ordinary
                                            Shares and Ordinary Share equivalents on the basis of four (4) securities for every five
                                            (5) securities held. All issued and outstanding Ordinary Shares and Ordinary Share equivalents
                                            and per share data have been adjusted throughout the financial statements to reflect the
                                            reverse share split for all periods presented.</ix:footnote></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0B_z4wSMrtrgtMl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zV3MPtwn4PV5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001252" xml:lang="en-US">The
                                            issue of shares from the conversion of convertible notes reflects and includes the face value
                                            of the note and interest accrued at a fixed rate defined in the agreements, along with the
                                            value of the derivative prior to conversion. This interest figure includes both the accrued
                                            interest rate (contractual and effective) relating to the convertible notes, with the contractual
                                            capitalised interest rate ranging between <span id="xdx_902_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLfugi4sxe0j" title="Contractual capitalised interest rate" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="MMA:ContractualCapitalisedInterestRate" contextRef="AsOf2024-06-30_ifrs-full_BottomOfRangeMember" id="Fact001254" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span>% to <span id="xdx_90B_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_za6aLsj3gMFg" title="Contractual capitalised interest rate" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="MMA:ContractualCapitalisedInterestRate" contextRef="AsOf2024-06-30_ifrs-full_TopOfRangeMember" id="Fact001256" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>% per annum, and the derivative reflects the effective interest rate being the cost of the relevant conversion discounts to market value at
the conversion date.</ix:footnote></span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 100 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
17. Issued capital - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_zQiZMShGsO8i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z4piaXKlPuyl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001257" xml:lang="en-US">Note
                                            that <span id="xdx_905_ecustom--AdvisorOptionsExercisedShares_c20230701__20240630_zL4BG4Y3jk25" title="Advisor options exercised, shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="MMA:AdvisorOptionsExercisedShares" contextRef="From2023-07-01to2024-06-30" id="Fact001259" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">327,142</ix:nonFraction></span> Advisor Options fully vested and were exercised into Shares between July 2023
                                            and December 2023 and <span id="xdx_901_ecustom--AdvisorOptionsForfeitedShares_iI_c20240630_z7hRoX7U4kUl" title="Advisor options forfeited, shares" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="MMA:AdvisorOptionsForfeitedShares" contextRef="AsOf2024-06-30" id="Fact001261" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,193</ix:nonFraction></span> Advisor Options were forfeited.</ix:footnote></span></td></tr></table>

</ix:nonNumeric><p id="xdx_8A2_zO7XnYCpxdM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capital
risk management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company&#8217;s objectives when managing capital is to safeguard its ability to continue as a going concern, so that it can provide returns for shareholders and benefits for other stakeholders and to maintain an optimum capital structure.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s capital includes Ordinary Share capital and financial liabilities supported by financial assets. There are no externally
imposed capital requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company effectively manages capital by assessing the Company&#8217;s financial risks and adjusting
its capital structure in response to changes in these risks and the market. These responses include the management of debt and share
issuances.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001263" name="ifrs-full:DisclosureOfCashFlowStatementExplanatory"><p id="xdx_807_eifrs-full--DisclosureOfCashFlowStatementExplanatory_zsT9oPvTwQPe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
    18. <span><span id="xdx_828_zKzNiEnoiVBe">Notes to statement of cash flows</span></span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001265" name="MMA:DetailedInformationOfNotesToStatementOfCashFlowExplanatory"><p id="xdx_893_ecustom--DetailedInformationOfNotesToStatementOfCashFlowExplanatory_z3gzsXiaQOCj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BF_z9B1HJRpJk28" style="display: none">Schedule
of Statement of Cash Flows</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20230701__20240630_zCZgGGC0xLB9" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220701__20230630_zVOfxZpP9ld6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20210701__20220630_zbQ7onH0NoSh" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--ProfitLoss_zjN1Qm2AZwja" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Loss after income tax</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-01to2024-06-30" id="Fact001267" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,408,346</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-07-012023-06-30" id="Fact001268" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,597,436</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-07-012022-06-30" id="Fact001269" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,197,450</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Non-cash flows in operating loss: <br/></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--AccruedInterestOnConvertibleNotes_zypX2Jcdkgn4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued interest on convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:AccruedInterestOnConvertibleNotes" contextRef="From2023-07-01to2024-06-30" id="Fact001271" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,207,497</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:AccruedInterestOnConvertibleNotes" contextRef="From2022-07-012023-06-30" id="Fact001272" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,420,225</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:AccruedInterestOnConvertibleNotes" contextRef="From2021-07-012022-06-30" id="Fact001273" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,162,646</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_zsUZZzs3Y7Q5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share-based payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2023-07-01to2024-06-30" id="Fact001275" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,521,598</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2022-07-012023-06-30" id="Fact001276" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,365,384</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2021-07-012022-06-30" id="Fact001277" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,546,983</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ConvertibleNotesIssuedInLieuOfPaymentForServices_zLCLJwjBx6r9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible notes issued in lieu of payment for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1279">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ConvertibleNotesIssuedInLieuOfPaymentForServices" contextRef="From2022-07-012023-06-30" id="Fact001280" format="ixt:numdotdecimal" decimals="0" unitRef="USD">624,426</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1281">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--DepreciationExpense_zU9Y8aFwHzJi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortisation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2023-07-01to2024-06-30" id="Fact001283" format="ixt:numdotdecimal" decimals="0" unitRef="USD">520,697</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2022-07-012023-06-30" id="Fact001284" format="ixt:numdotdecimal" decimals="0" unitRef="USD">360,021</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2021-07-012022-06-30" id="Fact001285" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,651</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--FairValueMovementRecognisedInProfitOrLoss_zL3EcxUjLw5e" style="vertical-align: bottom; background-color: White">
    <td>Fair value movement of derivatives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:FairValueMovementRecognisedInProfitOrLoss" contextRef="From2023-07-01to2024-06-30" id="Fact001287" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,400,685</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:FairValueMovementRecognisedInProfitOrLoss" contextRef="From2022-07-012023-06-30" id="Fact001288" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,870,729</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:FairValueMovementRecognisedInProfitOrLoss" contextRef="From2021-07-012022-06-30" id="Fact001289" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,751,564</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in assets and liabilities: <br/></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_zhVXlvxLV4Gc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Decrease in trade and other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" contextRef="From2023-07-01to2024-06-30" id="Fact001291" format="ixt:numdotdecimal" decimals="0" unitRef="USD">372,390</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" contextRef="From2022-07-012023-06-30" id="Fact001292" format="ixt:numdotdecimal" decimals="0" unitRef="USD">506,737</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" contextRef="From2021-07-012022-06-30" id="Fact001293" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,933</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustmentsForDecreaseIncreaseInOtherAssets_ze3Sk78lgjqb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">(Increase)/Decrease in other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2023-07-01to2024-06-30" id="Fact001295" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">189,621</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2022-07-012023-06-30" id="Fact001296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,091</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2021-07-012022-06-30" id="Fact001297" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,015,343</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_zdy0c54ElOV4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Increase/(decrease) in trade and other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" contextRef="From2023-07-01to2024-06-30" id="Fact001299" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,719</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" contextRef="From2022-07-012023-06-30" id="Fact001300" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">153,292</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" contextRef="From2021-07-012022-06-30" id="Fact001301" format="ixt:numdotdecimal" decimals="0" unitRef="USD">993,662</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--AdjustmentsForIncreaseDecreaseInNetDeferredRevenue_zcQro3SQ9jnd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Decrease in net deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:AdjustmentsForIncreaseDecreaseInNetDeferredRevenue" contextRef="From2023-07-01to2024-06-30" id="Fact001303" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">174,290</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:AdjustmentsForIncreaseDecreaseInNetDeferredRevenue" contextRef="From2022-07-012023-06-30" id="Fact001304" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">121,453</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:AdjustmentsForIncreaseDecreaseInNetDeferredRevenue" contextRef="From2021-07-012022-06-30" id="Fact001305" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">339,222</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--AdjustmentsForIncreaseDecreaseInProvisionForRefund_zplmHTrvaQX6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">(Decrease)/increase in provision for refund</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:AdjustmentsForIncreaseDecreaseInProvisionForRefund" contextRef="From2023-07-01to2024-06-30" id="Fact001307" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">70,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:AdjustmentsForIncreaseDecreaseInProvisionForRefund" contextRef="From2022-07-012023-06-30" id="Fact001308" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:AdjustmentsForIncreaseDecreaseInProvisionForRefund" contextRef="From2021-07-012022-06-30" id="Fact001309" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_znZg4nO42Jeh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Increase in employee entitlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="From2023-07-01to2024-06-30" id="Fact001311" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,845</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="From2022-07-012023-06-30" id="Fact001312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">160,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="From2021-07-012022-06-30" id="Fact001313" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,833</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CashFlowsFromUsedInOperatingActivities_iT_zC6BozSyb4Hk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact001315" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,386,196</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2022-07-012023-06-30" id="Fact001316" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,555,868</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2021-07-012022-06-30" id="Fact001317" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,055,185</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>
<!-- Field: Split-Segment; Name: 001 -->
</ix:nonNumeric><p id="xdx_8A5_zgILBGjOaYUa" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 101 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001319" name="ifrs-full:DisclosureOfRelatedPartyExplanatory"><p id="xdx_807_eifrs-full--DisclosureOfRelatedPartyExplanatory_zl62GiCpgfic" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
19. <span id="xdx_82D_z2h9PnTIZ4Li">Related parties transactions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif">(a)
Directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following persons held office as Directors of the Company during the years reported:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas
                                            Langton</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hugh
                                            Williams</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vaughn
                                            Taylor</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jonathan
                                            Hart</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Remuneration of Key Management Personnels</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key management personnel remuneration:<b></b></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001321" name="ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory"><p id="xdx_89C_eifrs-full--DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_zlyhUauOV7od" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B1_ztW2AXnKZ5hk" style="display: none">Schedule
of Key Management Personnel Remuneration</span></span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230701__20240630_z8Ufl7TIa9M8" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220701__20230630_zGjgdSXwEsl5" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20210701__20220630_z50Pej9t8m4g" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_maKMPCzfQ1_z264cbSzJCg3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Short term benefits</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2023-07-01to2024-06-30" id="Fact001323" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,031,194</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2022-07-012023-06-30" id="Fact001324" format="ixt:numdotdecimal" decimals="0" unitRef="USD">657,879</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2021-07-012022-06-30" id="Fact001325" format="ixt:numdotdecimal" decimals="0" unitRef="USD">671,709</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_maKMPCzfQ1_z7sfxupR6eTc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Post employment benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" contextRef="From2023-07-01to2024-06-30" id="Fact001327" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,730</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" contextRef="From2022-07-012023-06-30" id="Fact001328" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,191</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" contextRef="From2021-07-012022-06-30" id="Fact001329" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,542</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationOtherLongtermBenefits_maKMPCzfQ1_zywIFKfYPxtj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Long term benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits" contextRef="From2023-07-01to2024-06-30" id="Fact001331" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,474</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits" contextRef="From2022-07-012023-06-30" id="Fact001332" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,892</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1333">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_maKMPCzfQ1_z7Wyf9d7WGxj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Share Based payments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="From2023-07-01to2024-06-30" id="Fact001335" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,808,863</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="From2022-07-012023-06-30" id="Fact001336" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,065,554</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="From2021-07-012022-06-30" id="Fact001337" format="ixt:numdotdecimal" decimals="0" unitRef="USD">897,586</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensation_iT_mtKMPCzfQ1_zf2g8IvGk3Hc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2023-07-01to2024-06-30" id="Fact001339" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,919,261</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2022-07-012023-06-30" id="Fact001340" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,775,516</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2021-07-012022-06-30" id="Fact001341" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,612,837</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



</ix:nonNumeric><p id="xdx_8A8_zjfv98xoiAk3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Related Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
Held by Key Management Personnel:</b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" continuedAt="ConU001345-01" escape="true" id="Fact001345" name="ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"><p id="xdx_892_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_gL3DOTBRPE-JAYXU_zCIemTAmLuvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zxAlHNVdoD31" style="display: none">Schedule
of Shares Held by Key Management Personnel</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zRpO73yah3pg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares<br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zbnpnm9YoWB2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zN4pOFKcU7x4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares<br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--NumberOfSharesOutstanding_iS_z6l8k3OwFZy4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Opening Balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2023-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001347" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,149,362</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2022-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001348" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,786,093</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2021-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001349" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,955,616</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssuedSharesHeldByKeyManagementPersonnel_zumMm30xbNVh" style="vertical-align: bottom; background-color: White">
    <td>Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:IssuedSharesHeldByKeyManagementPersonnel" contextRef="From2023-07-012024-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001351" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">296,535</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1352">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:IssuedSharesHeldByKeyManagementPersonnel" contextRef="From2021-07-012022-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001353" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">477,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--RepurchasedSharesHeldByKeyManagementPersonnel_ztRpphVMuAx3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Repurchased</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1355">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1356">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:RepurchasedSharesHeldByKeyManagementPersonnel" contextRef="From2021-07-012022-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001357" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">1,200,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--ResignationOfKeyManagementPersonnelShares_zR9740m7UdG8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Resignation of Key Management Personnel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1359">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:ResignationOfKeyManagementPersonnelShares" contextRef="From2022-07-012023-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001360" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">530,609</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1361">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ReverseShareSplitSharesHeldByKeyManagementPersonnel_z68QYMVcqyo4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Reverse Share Split</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1363">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:ReverseShareSplitSharesHeldByKeyManagementPersonnel" contextRef="From2022-07-012023-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001364" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">106,122</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:ReverseShareSplitSharesHeldByKeyManagementPersonnel" contextRef="From2021-07-012022-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001365" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">446,523</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eifrs-full--NumberOfSharesOutstanding_iE_zocCRjlKg23d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Closing Balance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2024-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001367" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,445,897</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2023-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001368" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,149,362</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2022-06-30_custom_SharesHeldByKeyManagementPersonnelMember" id="Fact001369" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,786,093</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_z91aLLHt8lzl" style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 102 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"><b>Note 19. Related parties transactions - continued</b> <br/>&#160; <br/><b>Options Held by Key Management Personnel:</b></p>

<div id="xdx_C01_gL3DOTBRPE-JAYXU_zMLnDwIEtkV4"><ix:continuation continuedAt="ConU001345-02" id="ConU001345-01"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zf2re8yb9Pk9" summary="xdx: Disclosure - Schedule of Shares Held by Key Management Personnel (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_z16uc5B0wdi4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_zPEoY8showuh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_zRAtYVHqkyIj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option<br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zNJcdu9WjZP6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Opening Balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001371" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">654,364</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001372" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">515,850</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1373">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--IssuedOptionsHeldByKeyManagementPersonnel_zItZ45f2rf3d" style="vertical-align: bottom; background-color: White">
    <td>Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:IssuedOptionsHeldByKeyManagementPersonnel" contextRef="From2023-07-012024-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001375" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">342,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:IssuedOptionsHeldByKeyManagementPersonnel" contextRef="From2022-07-012023-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001376" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">279,221</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:IssuedOptionsHeldByKeyManagementPersonnel" contextRef="From2021-07-012022-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001377" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">644,813</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ExpiredOptionsHeldByKeyManagementPersonnel_z58RYCageMSb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Expired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:ExpiredOptionsHeldByKeyManagementPersonnel" contextRef="From2022-07-012023-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001380" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">106,078</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1381">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ExercisedOptionsHeldByKeyManagementPersonnel_zMGYypES4Ac5" style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MMA:ExercisedOptionsHeldByKeyManagementPersonnel" contextRef="From2023-07-012024-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001383" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">205,086</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1385">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ReverseShareSplitOptionsHeldByKeyManagementPersonnel_zJN8YGPKezs2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Reverse share split</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:ReverseShareSplitOptionsHeldByKeyManagementPersonnel" contextRef="From2022-07-012023-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001388" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">34,629</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:ReverseShareSplitOptionsHeldByKeyManagementPersonnel" contextRef="From2021-07-012022-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001389" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">128,963</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_uShares_zEbdpHm4JAd8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Closing Balance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001391" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">791,278</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001392" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">654,364</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_custom_OptionHeldByKeyManagementPersonnelMember" id="Fact001393" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">515,850</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span id="xdx_C0B_gL3DOTBRPE-JAYXU_zL91IvndAerc"><ix:continuation id="ConU001345-02"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></ix:continuation></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related Party Transaction by Key Management Personnel</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending June 30, 2024, Mr. Langton, through Snowflower Holdings Pty Ltd as trustee for the Snowflower Family Trust Account, was issued <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrLangtonMember__srt--ConsolidatedEntitiesAxis__custom--SnowflowerHoldingsPtyLtdMember_z3efiHHc5Ee8" title="Shares issued"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2024-06-30_custom_MrLangtonMember_custom_SnowflowerHoldingsPtyLtdMember" id="Fact001395" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">172,000</ix:nonFraction></span> share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_90B_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrLangtonMember__srt--ConsolidatedEntitiesAxis__custom--SnowflowerHoldingsPtyLtdMember_zPIQJVk2PnUb" title="Percentage vest and exercisable"><ix:nonFraction name="MMA:PercentageOfOrdinarySharesUnderVestAndExercisable" contextRef="AsOf2024-06-30_custom_MrLangtonMember_custom_SnowflowerHoldingsPtyLtdMember" id="Fact001397" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending June 30, 2024, Mr. Williams, through Champ 7 Pty Ltd as trustee for the Williams Family Trust Account, was issued <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrWilliamsMember__srt--ConsolidatedEntitiesAxis__custom--ChampSevenPtyLtdMember_zMcxa8J8xqm5" title="Shares issued"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2024-06-30_custom_MrWilliamsMember_custom_ChampSevenPtyLtdMember" id="Fact001399" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,400</ix:nonFraction></span> share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_904_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrWilliamsMember__srt--ConsolidatedEntitiesAxis__custom--ChampSevenPtyLtdMember_zy9BhnJG88V1" title="Percentage vest and exercisable"><ix:nonFraction name="MMA:PercentageOfOrdinarySharesUnderVestAndExercisable" contextRef="AsOf2024-06-30_custom_MrWilliamsMember_custom_ChampSevenPtyLtdMember" id="Fact001401" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending June 30, 2024, Mr. Taylor, through Nalaroo Holdings Pty Ltd as trustee for the Lavoipierre Taylor Fam Trust Account, was issued <span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrTaylorMember__srt--ConsolidatedEntitiesAxis__custom--NalarooHoldingsPtyLtdMember_z2o4W3FUAdnc" title="Shares issued"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2024-06-30_custom_MrTaylorMember_custom_NalarooHoldingsPtyLtdMember" id="Fact001403" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">73,600</ix:nonFraction></span> share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_906_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrTaylorMember__srt--ConsolidatedEntitiesAxis__custom--NalarooHoldingsPtyLtdMember_z6NwqkrPWWha" title="Percentage vest and exercisable"><ix:nonFraction name="MMA:PercentageOfOrdinarySharesUnderVestAndExercisable" contextRef="AsOf2024-06-30_custom_MrTaylorMember_custom_NalarooHoldingsPtyLtdMember" id="Fact001405" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending June 30, 2024, Mr. Hart, as trustee for the J Hart Family Trust Account, was issued <span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrHartMember__srt--ConsolidatedEntitiesAxis__custom--JHartFamilyTrustAccountMember_zf1QpC1AidL" title="Shares issued"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2024-06-30_custom_MrHartMember_custom_JHartFamilyTrustAccountMember" id="Fact001407" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,600</ix:nonFraction></span> share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_909_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrHartMember__srt--ConsolidatedEntitiesAxis__custom--JHartFamilyTrustAccountMember_z8nNzM1zcBH" title="Percentage vest and exercisable"><ix:nonFraction name="MMA:PercentageOfOrdinarySharesUnderVestAndExercisable" contextRef="AsOf2024-06-30_custom_MrHartMember_custom_JHartFamilyTrustAccountMember" id="Fact001409" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span></p>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 103 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
19. Related parties transactions - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending June 30, 2024, under Mr. Java&#8217;s employment agreement, Mr. Java was paid a short-term incentive of A$<span id="xdx_90E_eifrs-full--ShorttermEmployeeBenefitsExpense_c20230701__20240630__ifrs-full--TypesOfContractsAxis__custom--EmploymentAgreementMember_zqWMt2fdddG5" title="Short term incentive"><ix:nonFraction name="ifrs-full:ShorttermEmployeeBenefitsExpense" contextRef="From2023-07-012024-06-30_custom_EmploymentAgreementMember" id="Fact001411" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,589</ix:nonFraction></span>. Mr. Java, through 3213 Ventures Pty Ltd as trustee for the Java Holdings Trust, was issued <span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_c20240630__ifrs-full--TypesOfContractsAxis__custom--EmployeementAgreementMember_zEdJosbXeRck" title="Number of shares issued"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2024-06-30_custom_EmployeementAgreementMember" id="Fact001413" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,400</ix:nonFraction></span> share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_90A_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfContractsAxis__custom--EmployeementAgreementMember_z1Dyd7BTtm6a" title="Share percent rate"><ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_EmployeementAgreementMember" id="Fact001415" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
related parties:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tanya Langton, our Head of Global Events and Logistics and the spouse of Mr. Langton, was issued <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--TitleOfIndividualAxis__custom--Mr.LangtonMember_zAdSyQ260zVk" title="Number of shares issued"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2024-06-30_custom_Mr.LangtonMember" id="Fact001417" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></span> share rights
(subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_dp_uPure_c20230701__20240630__ifrs-full--CounterpartiesAxis__custom--Mr.LangtonMember_zmGyEy77xI04" title="Share percent rate"><ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_Mr.LangtonMember" id="Fact001419" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% of the share rights will vest and become
exercisable on October 1, 2025 and the balance of the <span id="xdx_906_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_dp_uPure_c20251001__20251002__ifrs-full--CounterpartiesAxis__custom--Mr.LangtonMember_zXlDlkFMwEvd" title="Share percent rate"><ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="From2025-10-012025-10-02_custom_Mr.LangtonMember" id="Fact001421" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% of the share rights will vest and become exercisable on October 1, 2026. </span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as disclosed, the Company did not enter into any transactions or loans with any:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enterprises
                                            that directly or indirectly, through one or more intermediaries, control, are controlled
                                            by or are under common control with us;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">associates;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">individuals
                                            owning, directly or indirectly, an interest in our voting power that gives them significant
                                            influence over us, and close members of any such individual&#8217;s family;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">key
                                            management personnel and close members of such individuals&#8217; families; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enterprises
                                            in which a substantial shareholder interest in our voting power is owned, directly or indirectly,
                                            by any person described in (iii) or (iv) or over which such person is able to exercise significant
                                            influence.</span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Parent Entity</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
individual financial statements of the Parent Entity show the following aggregate amounts:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of the parent entity</b></span></p>

<p id="xdx_89E_eifrs-full--DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable_zoM2Bmqxj5o2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B0_zjctP2YwIvI3" style="display: none">Schedule
of Financial Statement of the Parent Entity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zSXxUIAl0Cck" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zjM5jYv77izc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zjQKGBBDYFZ6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--ProfitLoss_maCIzNLL_zDn1hZgYZyye" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Loss for the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-012024-06-30_ifrs-full_ParentMember" id="Fact001425" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,029,605</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-07-012023-06-30_ifrs-full_ParentMember" id="Fact001426" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,053,426</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-07-012022-06-30_ifrs-full_ParentMember" id="Fact001427" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,667,136</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eifrs-full--OtherComprehensiveIncome_maCIzNLL_zMeO8C25X5x7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other comprehensive loss for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1429">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1430">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1431">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--ComprehensiveIncome_iT_mtCIzNLL_zwEW5ZRdOqhj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total comprehensive loss for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-07-012024-06-30_ifrs-full_ParentMember" id="Fact001433" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,029,605</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-07-012023-06-30_ifrs-full_ParentMember" id="Fact001434" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,053,426</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-07-012022-06-30_ifrs-full_ParentMember" id="Fact001435" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,667,136</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zWiOzrj7VAKk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zcBJeHqVoGHc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">Financial position of the parent entity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--AssetsAbstract_iB_zO8hUtgYDft8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--CurrentAssets_iI_maAz7FR_zpofYFRmmuw8" style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left">Current assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001440" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,309,505</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001441" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,307,155</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--NoncurrentAssets_iI_maAz7FR_zomskbMru34b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Non-current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001443" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,687,347</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001444" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,120,872</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--Assets_iTI_mtAz7FR_maNALzqK8_z1JShNb2Qfx9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001446" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,996,852</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001447" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,428,027</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--LiabilitiesAbstract_iB_zi5mrwglFOe3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--CurrentLiabilities_iI_maLzEC6_zBiiu21DG2f7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001452" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,577,040</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,018,760</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--NoncurrentLiabilities_iI_maLzEC6_z9EyNWr0JILf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Non-current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001455" format="ixt:numdotdecimal" decimals="0" unitRef="USD">186,344</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001456" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,346,332</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--Liabilities_iTI_mtLzEC6_msNALzqK8_zmxJgWPBkxr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001458" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,763,384</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001459" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,365,092</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NetAssetsLiabilities_iTI_mtNALzqK8_zjlDFZKoVrjb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Assets/Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NetAssetsLiabilities" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001461" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,233,468</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:NetAssetsLiabilities" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001462" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,937,065</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--EquityAbstract_iB_znTnlfsUqlW9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ContributedEquity_iI_msEzyRy_zUQu06RTKUp7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Contributed equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ContributedEquity" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001467" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,779,703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ContributedEquity" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001468" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,385,281</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--OtherReserves_iI_maEzyRy_zVvfq1xdVIg1" style="vertical-align: bottom; background-color: White">
    <td>Reserves</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:OtherReserves" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001470" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,476,103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:OtherReserves" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001471" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,912,367</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--RetainedEarnings_iI_maEzyRy_z4RIiPyAcVGc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated losses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001473" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,022,338</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001474" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">37,234,713</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eifrs-full--Equity_iTI_mtEzyRy_zgjPtwCoELr7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-06-30_ifrs-full_ParentMember" id="Fact001476" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,233,468</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-06-30_ifrs-full_ParentMember" id="Fact001477" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,937,065</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
</table>

<p id="xdx_8A2_zt2ZAqJHOzEa" style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">There were no material contingent assets and liabilities in the Parent Entity at June 30, 2024 (nil &#8211; June 30, 2023).</p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 104 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
19. Related parties transactions - continued</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s subsidiaries at June 30, 2024 are set out below. Unless otherwise stated, they have share capital consisting solely of
Ordinary Shares that are held directly by the company, and the proportion of ownership interests held equals the voting rights held by
the company. The country of incorporation or registration is also their principal place of business.</span></p>

<p id="xdx_893_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesTable_zfQLFJExX3rc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zQpISVlRSD9" style="display: none">Schedule
of Country Incorporation Principal Place of Business</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230701__20240630_zKincIqhWO09" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20220701__20230630_zy4RLrW8z9Zh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span>Name of entity</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span>Place of business</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ownership interest held</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 31%; text-align: left"><span id="xdx_906_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorLLCMember_zjhQuTH3faod"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorLLCMember" id="Fact001480" name="ifrs-full:NameOfParentEntity">Wimp 2 Warrior LLC</ix:nonNumeric></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 31%; text-align: left"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaCountryMember_z1mKcAau5sr7"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_UnitedStatesOfAmericaCountryMember" id="Fact001481" name="ifrs-full:PrincipalPlaceOfBusiness">United States of America</ix:nonNumeric></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_dp_uPure_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorLLCMember_z4G0DA1wbnG1" style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorLLCMember" id="Fact001482" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorLLCMember_z0THeK77642k" style="width: 14%; text-align: right"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-07-012023-06-30_custom_Wimp2WarriorLLCMember" id="Fact001483" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_906_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorProductionsPtyLtdMember_fKg_____zFLc9ciUo9y3"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorProductionsPtyLtdMember" id="Fact001484" name="ifrs-full:NameOfParentEntity">Wimp 2 Warrior Productions Pty Ltd</ix:nonNumeric></span> *</td><td>&#160;</td>
    <td><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--AustraliaCountryMember_fKg_____zj8Pdp6U7Ttf"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_AustraliaCountryMember" id="Fact001485" name="ifrs-full:PrincipalPlaceOfBusiness">Australia</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorProductionsPtyLtdMember_fKg_____zn2k5Omfhzxa" style="text-align: right"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorProductionsPtyLtdMember" id="Fact001486" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorProductionsPtyLtdMember_fKg_____zuvKQUrNqwZ4" style="text-align: right"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-07-012023-06-30_custom_Wimp2WarriorProductionsPtyLtdMember" id="Fact001487" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">95</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_90E_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorDigitalPtyLtdMember_fKg_____z8iNRJ5RwCa6"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorDigitalPtyLtdMember" id="Fact001488" name="ifrs-full:NameOfParentEntity">Wimp 2 Warrior Digital Pty Ltd</ix:nonNumeric></span> *</td><td>&#160;</td>
    <td><span id="xdx_900_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--AustraliaCountryOneMember_fKg_____zmR4iEqtea1b"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_AustraliaCountryOneMember" id="Fact001489" name="ifrs-full:PrincipalPlaceOfBusiness">Australia</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorDigitalPtyLtdMember_fKg_____ziACokCJrrZg" style="text-align: right"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorDigitalPtyLtdMember" id="Fact001490" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorDigitalPtyLtdMember_fKg_____z13MQWplYtMg" style="text-align: right"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-07-012023-06-30_custom_Wimp2WarriorDigitalPtyLtdMember" id="Fact001491" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_908_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorIrelandLimitedMember_z0VxsEIvAEih"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorIrelandLimitedMember" id="Fact001492" name="ifrs-full:NameOfParentEntity">Wimp 2 Warrior (Ireland) Limited</ix:nonNumeric></span></td><td>&#160;</td>
    <td><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--IrelandCountryMember_zdUFTcIXkPy4"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_IrelandCountryMember" id="Fact001493" name="ifrs-full:PrincipalPlaceOfBusiness">Ireland</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorIrelandLimitedMember_zztHnkEkO83k" style="text-align: right"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorIrelandLimitedMember" id="Fact001494" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorIrelandLimitedMember_z8AcFDgp26y7" style="text-align: right"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-07-012023-06-30_custom_Wimp2WarriorIrelandLimitedMember" id="Fact001495" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span id="xdx_905_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--HypeCoMember_zMZL9jajf4Na"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_HypeCoMember" id="Fact001496" name="ifrs-full:NameOfParentEntity">Hype.Co</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaCountryOneMember_zURtWeNeIXP4"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_UnitedStatesOfAmericaCountryOneMember" id="Fact001497" name="ifrs-full:PrincipalPlaceOfBusiness">United States of America</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--HypeCoMember_zjbbSeN7yLEl" style="text-align: right"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-07-012024-06-30_custom_HypeCoMember" id="Fact001498" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--HypeCoMember_zdu1MdFin8h6" style="text-align: right"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-07-012023-06-30_custom_HypeCoMember" id="Fact001499" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0E_zm1TLYJpUC48" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F15_zHV6CTquVWrf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001500" xml:lang="en-US">Entities deregistered
in the period to June 30, 2024.</ix:footnote></span></td>
</tr></table>
<!-- Field: Split-Segment; Name: 003 -->
<p id="xdx_8A9_zoQJgkpoqYFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001502" name="ifrs-full:DisclosureOfLeasesExplanatory"><p id="xdx_809_eifrs-full--DisclosureOfLeasesExplanatory_zNkExyc59oRi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
20. <span id="xdx_824_zZoHeZqsNnu2">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the commencement of a lease contract, the Company assesses whether the contract conveys the right to control the use of an identified
asset for a period of time in exchange for consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2024, the Company determined with reasonable certainty that it would exercise its extension option at its current
premises for two additional years. As a result, the Company has reassessed the lease term and related balances, which are reflected in
the table below:</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001504" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"><p id="xdx_896_eifrs-full--DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_ziCf63XLziz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zgDoRZq7aEC" style="display: none">Summary
of Changes in ROU Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">(a) Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left">Right of use asset</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_ecustom--RightofuseAsset_iS_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW0f7JEjAIBf" title="Right of use asset" style="width: 12%; text-align: right"><ix:nonFraction name="MMA:RightofuseAsset" contextRef="AsOf2023-05-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact001506" format="ixt:numdotdecimal" decimals="0" unitRef="USD">613,691</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--RightofuseAsset_iS_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSdyrWfuM371" title="Right of use asset" style="width: 12%; text-align: right"><ix:nonFraction name="MMA:RightofuseAsset" contextRef="AsOf2022-05-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact001508" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,829</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--AccumulatedAmortization_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zu5Y3ybHL2k2" title="Less: amortization for the period" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:AccumulatedAmortization" contextRef="From2023-06-012024-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact001510" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">358,228</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--AccumulatedAmortization_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwUwV0tJBMAj" title="Less: amortization for the period" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:AccumulatedAmortization" contextRef="From2022-06-012023-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact001512" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">243,290</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Balance at end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--RightofuseAsset_iE_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBKN7ji4A6pg" title="Balance at end of the year" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:RightofuseAsset" contextRef="AsOf2024-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact001514" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,463</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RightofuseAsset_iE_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRbDrCbrBQYh" title="Balance at end of the year" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:RightofuseAsset" contextRef="AsOf2023-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact001516" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,540</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--RightofuseAsset_iS_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zP7koQHKeQ7h" title="Balance at beginning of year" style="text-align: right"><ix:nonFraction name="MMA:RightofuseAsset" contextRef="AsOf2023-05-31_custom_AmortizationMember" id="Fact001518" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,540</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--RightofuseAsset_iS_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z3DQrTKCygZi" title="Balance at beginning of yea" style="text-align: right"><ix:nonFraction name="MMA:RightofuseAsset" contextRef="AsOf2022-05-31_custom_AmortizationMember" id="Fact001520" format="ixt:numdotdecimal" decimals="0" unitRef="USD">276,907</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Modification</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--Modification_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z15ci9QCcPV4" title="Modification" style="text-align: right"><ix:nonFraction name="MMA:Modification" contextRef="From2023-06-012024-06-30_custom_AmortizationMember" id="Fact001522" format="ixt:numdotdecimal" decimals="0" unitRef="USD">212,682</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--Modification_iI_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zFcuqlNEuE85" title="Modification" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1524">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: amortization for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--AccumulatedAmortization_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z9s5QEJz6Znf" title="Less: amortization for the period" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:AccumulatedAmortization" contextRef="From2023-06-012024-06-30_custom_AmortizationMember" id="Fact001526" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">114,759</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--AccumulatedAmortization_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zXSlPeqKqUFj" title="Less: amortization for the period" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="MMA:AccumulatedAmortization" contextRef="From2022-06-012023-06-30_custom_AmortizationMember" id="Fact001528" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">119,367</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--RightofuseAsset_iE_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zl2WOe0KbKKa" title="Balance at end of the year" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:RightofuseAsset" contextRef="AsOf2024-06-30_custom_AmortizationMember" id="Fact001530" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,463</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RightofuseAsset_iE_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z4q3N2QxJHUa" title="Balance at end of the year" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:RightofuseAsset" contextRef="AsOf2023-06-30_custom_AmortizationMember" id="Fact001532" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,540</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">(b) Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--CurrentLeaseLiabilities_iI_c20240630_zvPMDte7J3Ck" title="Current lease liability" style="text-align: right"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2024-06-30" id="Fact001534" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,559</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--CurrentLeaseLiabilities_iI_c20230630_z0Q5x28E5D8f" title="Current lease liability" style="text-align: right"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2023-06-30" id="Fact001536" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Non-current lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eifrs-full--NoncurrentLeaseLiabilities_iI_c20240630_zH0pDaMPTQg1" title="Non-current lease liability" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2024-06-30" id="Fact001538" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,722</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--NoncurrentLeaseLiabilities_iI_c20230630_zkpth2DWjvO" title="Non-current lease liability" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2023-06-30" id="Fact001540" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,162</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--LeaseLiabilities_iI_c20240630_zo6k1lIA5MWb" title="Total lease liabilities" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-06-30" id="Fact001542" format="ixt:numdotdecimal" decimals="0" unitRef="USD">259,281</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eifrs-full--LeaseLiabilities_iI_c20230630_zVnNtNHtgcc7" title="Total lease liabilities" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-06-30" id="Fact001544" format="ixt:numdotdecimal" decimals="0" unitRef="USD">175,662</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zFubkFPUCDsf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 105 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
20. Leases - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total of future lease payments (including those lease payments that are not included in the measurement of the lease liability, e.g.
for short-term leases and leases of low-value items) are disclosed for each of the following periods.</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001546" name="ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory"><p id="xdx_896_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_z4D0wss8f2u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_z4oesS1LIrvl" style="display: none">Summary
of Future Minimum Lease Payments</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240630_zUciWd6oymo5" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230630_ztQ9kyY1o8H4" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_maLLzHsH_zkrOBgGJZKt2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Less than one year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact001548" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">135,680</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact001549" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">127,361</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_maLLzHsH_zFpGlH0qhgBe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">One to two years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" id="Fact001551" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">46,240</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" id="Fact001552" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,214</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_maLLzHsH_zcGWuInT1sGg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Two to five years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" id="Fact001554" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,267</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:GrossLeaseLiabilities" contextRef="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" id="Fact001555" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,214</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_maLLzHsH_zqXC9JRz2M7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Five years and over</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1557">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1558">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--LeaseLiabilities_iI_pp0p0_hifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_mtLLzHsH_zaXrmVWwrCHh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total future lease payments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-06-30_ifrs-full_LeaseLiabilitiesMember" id="Fact001560" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">217,187</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-06-30_ifrs-full_LeaseLiabilitiesMember" id="Fact001561" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">183,789</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>
<!-- Field: Split-Segment; Name: 004 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001563" name="ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory"><p id="xdx_803_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_ze4kvS2LGDXd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. <span id="xdx_823_zloOrkesuHc">Financial Liabilities</span></b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001565" name="MMA:DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory"><p id="xdx_890_ecustom--DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory_zqPXXi9zrlvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Financial Liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ConvertibleInstrumentsMember_zaJvSGUngEdf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ConvertibleInstrumentsMember_zCpBCtaqKjte" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--CurrentFinancialLiabilities_iI_maFLz9PT_zeQSQ1S9pWb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Convertible note payable - Current</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1567">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilities" contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember" id="Fact001568" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,331,307</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--NoncurrentFinancialLiabilities_iI_maFLz9PT_zppzfpe3V7e6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible note payable &#8211; Non Current</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1570">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilities" contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember" id="Fact001571" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,273,278</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--FinancialLiabilities_iTI_mtFLz9PT_zI8Yo4b5cuEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Financial Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1573">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember" id="Fact001574" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,604,585</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CurrentDebtInstrumentsIssued_iI_maDSznTX_zTv2A2z8q3Fi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Host Liability - Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1576">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:CurrentDebtInstrumentsIssued" contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember" id="Fact001577" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,567,450</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--NoncurrentDebtInstrumentsIssued_iI_maDSznTX_z4DzOPj9qQP8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Host Liability &#8211; Non Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1579">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentDebtInstrumentsIssued" contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember" id="Fact001580" format="ixt:numdotdecimal" decimals="0" unitRef="USD">342,406</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_maDSznTX_zmEHtWJZpfW3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Derivative liability -Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1582">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:CurrentDerivativeFinancialLiabilities" contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember" id="Fact001583" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,763,857</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iI_maDSznTX_zsde6Hflx1I2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Derivative liability - Non Current</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1585">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember" id="Fact001586" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,930,872</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--DebtSecurities_iTI_mtDSznTX_zRBnTMDqk59c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Convertible Notes Payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1588">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:DebtSecurities" contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember" id="Fact001589" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,604,585</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zrTwn8lBud84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
convertible notes issued by the Company have been split into the debt liability and a derivative component. The fair value of the Financial
Liabilities for the host liability and the derivative liability has been determined using a combination of Monte Carlo Simulation (MCS)
and Black-Scholes model (BSM).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the reporting period <span id="xdx_90F_eifrs-full--DescriptionOfConversionOfDebtToEquity_c20230701__20240630_zIGQYDd4iXLd" title="Conversion of debt to equity"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact001591" name="ifrs-full:DescriptionOfConversionOfDebtToEquity">Series A &#8211; July 21 matured and converted to equity on 7 July 2023, while Series A, Series A &#8211; Aug 21,
Series B1, Series B2 and Series A Extension matured and converted to equity on 31 December 2023.</ix:nonNumeric></span> During the reporting period the Company
issued two additional Convertible Notes for the acquisition of Mixed Martial Arts LLC and Steppen. Mixed Martial Arts LLC, Steppen, Reach
and Private Placement convertible notes converted to equity or were redeemed for cash on March 28, 2024, on successful listing on the
NYSE by the Company, as per the conversion date in the table below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001593" name="ifrs-full:DisclosureOfDebtSecuritiesExplanatory"><p id="xdx_891_eifrs-full--DisclosureOfDebtSecuritiesExplanatory_zFeaMSLBtDbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
notes held by investors in the reporting period are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zxHj016l3T8k">Schedule
of Convertible
Notes held by Investors</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="font-style: italic; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series A</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Key Terms of this Series A convertible notes are as follows</i></span></p></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zKTyBiGTOkBg"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember" id="Fact001594" name="MMA:ConvertibleNotesIssueDate">23-Dec-20</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zckboiGTorYi"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember" id="Fact001595" name="MMA:ConvertibleNotesPreModificationMaturityDate">23-Dec-22</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zy6NsfBzcmn1"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember" id="Fact001596" name="MMA:ConvertibleNotesModificationDate">1-Dec-22</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zHUeRarlkhh9"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember" id="Fact001597" name="MMA:ConvertibleNotesModifiedMaturityDate">31-Dec-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zcIukupuO0J"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember" id="Fact001598" name="MMA:ConvertibleNotesConversionDate">31 -Dec 23</ix:nonNumeric></span> </span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_907_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zgvjtyeejJQb"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember" id="Fact001599" name="MMA:ConvertibleNotesTerm">2.0</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zQJ6vqZUYUhj"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember" id="Fact001600" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,319,818</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zzaC5xHGzy18"><ix:nonFraction name="ifrs-full:BorrowingsInterestRate" contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember" id="Fact001601" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zyhe1TlxgTyc"><ix:nonFraction name="MMA:ConvertibleNotesConversionDiscount" contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember" id="Fact001602" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 106 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. - Financial Liabilities - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
A &#8211; July 21</b></span></p></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series A convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zu4HVLcYvDy6"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember" id="Fact001603" name="MMA:ConvertibleNotesIssueDate">7-Jul-21</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zVw4aqQOT9M6"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember" id="Fact001604" name="MMA:ConvertibleNotesModifiedMaturityDate">7-Jul-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zZ9Q6iCydPHg"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember" id="Fact001605" name="MMA:ConvertibleNotesConversionDate">7-Jul-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_z6nUxvTzCBxg"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember" id="Fact001606" name="MMA:ConvertibleNotesTerm">2.0</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_z2VAU81ictC8"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember" id="Fact001607" format="ixt:numdotdecimal" decimals="0" unitRef="USD">525,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zNKm7fP3bmN1"><ix:nonFraction name="ifrs-full:BorrowingsInterestRate" contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember" id="Fact001608" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zr4LC4BBNQCf"><ix:nonFraction name="MMA:ConvertibleNotesConversionDiscount" contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember" id="Fact001609" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Series A &#8211; August 21</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series A convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zGC5Z3bs0jm4"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember" id="Fact001610" name="MMA:ConvertibleNotesIssueDate">20-Aug-21</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zhjRokEV9uZg"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember" id="Fact001611" name="MMA:ConvertibleNotesPreModificationMaturityDate">9 -Dec-22</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zGyLx2NaRVcf"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember" id="Fact001612" name="MMA:ConvertibleNotesModificationDate">1-Dec-22</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zqmVPs1uki4e"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember" id="Fact001613" name="MMA:ConvertibleNotesModifiedMaturityDate">31-Dec-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zUypov1Yt4I9"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember" id="Fact001614" name="MMA:ConvertibleNotesConversionDate">31-Dec-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zMyTSVokMg52"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember" id="Fact001615" name="MMA:ConvertibleNotesTerm">1.3</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_z6GWYtXKE1sl"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember" id="Fact001616" format="ixt:numdotdecimal" decimals="0" unitRef="USD">172,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zuI6b4KWOevf"><ix:nonFraction name="ifrs-full:BorrowingsInterestRate" contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember" id="Fact001617" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zTaNP8xp7Vd4"><ix:nonFraction name="MMA:ConvertibleNotesConversionDiscount" contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember" id="Fact001618" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series B1 </b></span></p></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series B1 convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zWfOZme1Qlii" title="Issue Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember" id="Fact001620" name="MMA:ConvertibleNotesIssueDate">15-Dec-21</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zmCvEJVYHqge" title="Pre Modification Maturity Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember" id="Fact001622" name="MMA:ConvertibleNotesPreModificationMaturityDate">15-Dec-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zNcDhXuvCkxl" title="Modification Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember" id="Fact001624" name="MMA:ConvertibleNotesModificationDate">1-Dec-22</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zfod4Eb7KKQi" title="Modified Maturity Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember" id="Fact001626" name="MMA:ConvertibleNotesModifiedMaturityDate">31-Dec-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zPo4oyaBhY13" title="Conversion Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember" id="Fact001628" name="MMA:ConvertibleNotesConversionDate">31.Dec-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zRR89usCshda" title="Term (Years)"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember" id="Fact001630" name="MMA:ConvertibleNotesTerm">2.0</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zh2qeau6QYyd" title="Face Value"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember" id="Fact001632" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,982,652</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_z2RkfJdY8C14" title="Interest Rate"><ix:nonFraction name="ifrs-full:BorrowingsInterestRate" contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember" id="Fact001634" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zn8ri5Kc6ZQ2" title="Conversion Discount (Qualified Equity Investment)"><ix:nonFraction name="MMA:ConvertibleNotesConversionDiscount" contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember" id="Fact001636" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  </table>
<!-- Field: Split-Segment; Name: 005 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 107 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. Financial Liabilities - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series B2</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_49B_20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zNADu065PWEg" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series B2 convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zsyxpG9JlFw3" title="Issue Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember" id="Fact001638" name="MMA:ConvertibleNotesIssueDate">1-July-22</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zaZemu70Nlfa" title="Pre Modification Maturity Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember" id="Fact001640" name="MMA:ConvertibleNotesPreModificationMaturityDate">30-June-24</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zSVSzLOnKTri" title="Modification Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember" id="Fact001642" name="MMA:ConvertibleNotesModificationDate">1-Dec-22</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zelEyzEEiQI5" title="Modified Maturity Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember" id="Fact001644" name="MMA:ConvertibleNotesModifiedMaturityDate">31-Dec-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zODcW7e9H2ea" title="Conversion Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember" id="Fact001646" name="MMA:ConvertibleNotesConversionDate">31-Dec-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_908_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_z0Nz8qhfQSqg" title="Term (Years)"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember" id="Fact001648" name="MMA:ConvertibleNotesTerm">2.0</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--Borrowings_iI_zYYZTZcwJVXi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember" id="Fact001650" format="ixt:numdotdecimal" decimals="0" unitRef="USD">671,284</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--BorrowingsInterestRate_iI_dp_zk827CPePtqk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:BorrowingsInterestRate" contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember" id="Fact001652" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40D_ecustom--ConvertibleNotesConversionDiscount_iI_dp_z1ZMFc69oupb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ConvertibleNotesConversionDiscount" contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember" id="Fact001654" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A Extension</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_490_20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_ze0iFRIDr6x5" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series A Extension convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_z0jHywvp22f3" title="Issue Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember" id="Fact001656" name="MMA:ConvertibleNotesIssueDate">16-Nov-22</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_z2eM1iM8iNFk" title="Modified Maturity Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember" id="Fact001658" name="MMA:ConvertibleNotesModifiedMaturityDate">31-Dec-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_zDaBPU3ZfVM9" title="Conversion Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember" id="Fact001660" name="MMA:ConvertibleNotesConversionDate">31-Dec-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90C_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_zE0O8PAIVCB7" title="Term (Years)"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember" id="Fact001662" name="MMA:ConvertibleNotesTerm">1.1</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--Borrowings_iI_zIUvqsnhOYsa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember" id="Fact001664" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,571,873</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zGDBoyRcRY1l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:BorrowingsInterestRate" contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember" id="Fact001666" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40C_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zYGxmwqqxsoi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ConvertibleNotesConversionDiscount" contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember" id="Fact001668" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reach</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_49C_20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zTXJDxkEE2R4" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Reach convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zPbnewNmlso2" title="Issue Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember" id="Fact001670" name="MMA:ConvertibleNotesIssueDate">13-Feb-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zuMY3qoLdYEi" title="Modified Maturity Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember" id="Fact001672" name="MMA:ConvertibleNotesModifiedMaturityDate">13-Feb-25</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date <span>**</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_fKio___zzovJym22qA5" title="Conversion Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember" id="Fact001674" name="MMA:ConvertibleNotesConversionDate">28-Mar-24</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_906_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_z2EoLPwOvzGd" title="Term (Years)"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember" id="Fact001676" name="MMA:ConvertibleNotesTerm">2.0</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--Borrowings_iI_z2XJThR4Fri8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value<span id="xdx_F41_zNopM9pTRBHk">*</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember" id="Fact001678" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,195,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zKBPam9e4uX2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:BorrowingsInterestRate" contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember" id="Fact001680" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40C_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zyhLh5GJx81b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ConvertibleNotesConversionDiscount" contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember" id="Fact001682" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" border="0" style="width: 100%">
<tr style="vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span id="xdx_F0E_zKL2Udiju9o9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_znFHf0D56aPg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001683" xml:lang="en-US">$<span id="xdx_90A_ecustom--ReachConvertibleNote_iI_c20230609_zjH8cFvlAAXd" title="Reach convertible note"><ix:nonFraction name="MMA:ReachConvertibleNote" contextRef="AsOf2023-06-09" id="Fact001685" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,025,841</ix:nonFraction></span> of Reach convertible
  notes, inclusive of accrued interest, were rolled into the Private Placement on June 9, 2023.</ix:footnote></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F0E_zxaqEBv0byX2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zLqqctjjK8Xa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001686" xml:lang="en-US">$<span id="xdx_905_ecustom--RedeemedForCash_iI_c20230609_zCA5HXL5Vhw9" title="Redeemed for cash"><ix:nonFraction name="MMA:RedeemedForCash" contextRef="AsOf2023-06-09" id="Fact001688" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,029,617</ix:nonFraction></span> was redeemed for
  cash, the remaining Reach notes were converted to equity.</ix:footnote></span></td></tr>
</table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 108 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. Financial Liabilities - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private Placement</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_492_20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zxJnD1OVLjCl" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Private Placement convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zwOryoGKMuH6" title="Issue Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember" id="Fact001690" name="MMA:ConvertibleNotesIssueDate">9-June-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zbZSoW7dIIeb" title="Modified Maturity Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember" id="Fact001692" name="MMA:ConvertibleNotesModifiedMaturityDate">9-June-25</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zah2YYs5M7K9" title="Conversion Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember" id="Fact001694" name="MMA:ConvertibleNotesConversionDate">28-Mar-24</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zhmq8lVWG9h6" title="Term (Years)"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember" id="Fact001696" name="MMA:ConvertibleNotesTerm">2.0</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--Borrowings_iI_zwFImW4vuCMc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember" id="Fact001698" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,215,591</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--BorrowingsInterestRate_iI_dp_zLyRrty2aXwb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:BorrowingsInterestRate" contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember" id="Fact001700" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40E_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zWkIssbJvNT" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ConvertibleNotesConversionDiscount" contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember" id="Fact001702" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Mixed Martial Arts LLC</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zs9BukUeVvQh" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Mixed Martial Arts LLC convertible note are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zD0tPBtp9qYc" title="Issue Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember" id="Fact001704" name="MMA:ConvertibleNotesIssueDate">26-Oct-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zwXMJjMwZSaa" title="Modified Maturity Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember" id="Fact001706" name="MMA:ConvertibleNotesModifiedMaturityDate">9-June-25</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zpsVSs6NRFXb" title="Conversion Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember" id="Fact001708" name="MMA:ConvertibleNotesConversionDate">28-Mar-24</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zR8PSRGxxDHl" title="Term (Years)"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember" id="Fact001710" name="MMA:ConvertibleNotesTerm">1.6</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--Borrowings_iI_zlaq9EcrMb04" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember" id="Fact001712" format="ixt:numdotdecimal" decimals="0" unitRef="USD">384,750</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zjOm9BPcbhdl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:BorrowingsInterestRate" contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember" id="Fact001714" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zUwCHLGeSDA8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ConvertibleNotesConversionDiscount" contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember" id="Fact001716" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Steppen</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zV5NkY2FKv9a" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Steppen convertibles note are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zPS1k4VugEkf" title="Issue Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember" id="Fact001718" name="MMA:ConvertibleNotesIssueDate">20-Sept-23</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_z1Z7w84Wwr8f" title="Modified Maturity Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember" id="Fact001720" name="MMA:ConvertibleNotesModifiedMaturityDate">9-June-25</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zQZudroVO076" title="Conversion Date"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember" id="Fact001722" name="MMA:ConvertibleNotesConversionDate">28-Mar-24</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_909_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_z70CTMpfQvjg" title="Term (Years)"><ix:nonNumeric contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember" id="Fact001724" name="MMA:ConvertibleNotesTerm">1.7</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--Borrowings_iI_zZX5LndO1Qvf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember" id="Fact001726" format="ixt:numunitdecimalin" decimals="0" unitRef="USD">100,00</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_z1k97hEW8njb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:BorrowingsInterestRate" contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember" id="Fact001728" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zhn77hyBMTBl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ConvertibleNotesConversionDiscount" contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember" id="Fact001730" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zUP2P9rsNNw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 109 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<!-- Field: Split-Segment; Name: 006 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001732" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory"><p id="xdx_80A_eifrs-full--DisclosureOfSharebasedPaymentArrangementsExplanatory_z7jXmKXxKkTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
22. <span id="xdx_82F_zXPz7nTRBZd8">Share-based payments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the periods 30 June 2024 and 30 June 2023, the Company granted share options to advisors and consultants (as remuneration for services
provided), as well as select employees and Directors of the Company under the board approved Employee Share Option Plan (ESOP).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share option converts into one Ordinary Share of the Company on exercise. An option may be exercised by either (a) paying to the Company
the Exercise Price of the Option being exercised (Cash Exercise) or (b) if elected by the Option Holder by setting off the total Exercise
Price against the number of Shares which they are entitled to receive upon exercise (Cashless Exercise Facility). The options carry neither
rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting, subject to meeting the vesting
conditions, to the date of their expiry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
are exercisable at a price determined by each option grant and range from $<span id="xdx_903_eifrs-full--ExercisePriceShareOptionsGranted2019_c20230701__20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zm8e2mhUOYG3" title="Options exercise price"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_ifrs-full_BottomOfRangeMember" id="Fact001734" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> (relating to options granted as consideration for foregone
cash payment for services provided), to $<span id="xdx_90C_eifrs-full--ExercisePriceShareOptionsGranted2019_c20230701__20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zMHhzXywCiJj" title="Options exercise price"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_ifrs-full_TopOfRangeMember" id="Fact001736" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.73</ix:nonFraction></span> per share (relating to issuances under the ESOP which qualifies for the ATO ESS start-up
tax concessions available for SME unlisted companies). All options are vested over three years. If the options remain unexercised after
the period agreed from the date of grant the options expire. Options are forfeited if the employee leaves the Company before the options
vest unless otherwise agreed by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
values of the Options are calculated by applying the Black-Scholes model. The Company used valuations specialists to perform these valuations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the reporting periods the Company also issued share rights (RSU&#8217;s) to select employees of the Company under the board approved
Employee Incentive Plan (EIP). These share rights may be converted into Ordinary Shares under the EIP. Fifty percent of the principal
share rights will vest and be exercisable on October 1, 2025 and the remaining fifty percent of the share rights will vest and be exercisable
on and from October 1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
values of the Share Rights are calculated by applying the Black-Scholes model. The Company used valuations specialists to perform these
valuations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001738" name="MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory"><p id="xdx_89C_ecustom--DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory_zN7vP3I5GsLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the expense arising from performance rights, options and warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zzlTyOOagvZ9" style="display: none">Schedule
of Details
of Expense from Performance Rights, Options and Warrants</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20230701__20240630_zbTNw46nTdP7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20220701__20230630_zfHF8YVugIP1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210701__20220630_zdrmwvM8F5qb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_401_ecustom--ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants_zsKmtVilZz2l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">ESOP</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" contextRef="From2023-07-01to2024-06-30" id="Fact001740" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,851,329</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" contextRef="From2022-07-012023-06-30" id="Fact001741" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,052,245</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" contextRef="From2021-07-012022-06-30" id="Fact001742" format="ixt:numdotdecimal" decimals="0" unitRef="USD">914,682</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ExpenseFromAdvisorOptions_zu5tFb578ita" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Advisor Options (<span id="xdx_F4B_zpQRCuO1gUSj">1</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ExpenseFromAdvisorOptions" contextRef="From2023-07-01to2024-06-30" id="Fact001744" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,086,938</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ExpenseFromAdvisorOptions" contextRef="From2022-07-012023-06-30" id="Fact001745" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,164,524</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ExpenseFromAdvisorOptions" contextRef="From2021-07-012022-06-30" id="Fact001746" format="ixt:numdotdecimal" decimals="0" unitRef="USD">632,301</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ExpenseFromReach_zGGVHWYA6tx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Reach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ExpenseFromReach" contextRef="From2023-07-01to2024-06-30" id="Fact001748" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,584</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ExpenseFromReach" contextRef="From2022-07-012023-06-30" id="Fact001749" format="ixt:numdotdecimal" decimals="0" unitRef="USD">148,615</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1750">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ExpenseFromWarrants_zD48Kq8Z27o5" style="vertical-align: bottom; background-color: White">
    <td>Warrants (<span id="xdx_F4A_zfSSfVJn8vod">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ExpenseFromWarrants" contextRef="From2023-07-01to2024-06-30" id="Fact001752" format="ixt:numdotdecimal" decimals="0" unitRef="USD">253,391</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1754">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ExpenseFromOverAllotmentOption_zWWZWEjmo0l8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over allotment Option (<span id="xdx_F4D_zxKdHZoVn1U3">3</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:ExpenseFromOverAllotmentOption" contextRef="From2023-07-01to2024-06-30" id="Fact001756" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,794</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1757">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ExpenseFromRestrictedShareUnits_zV5Ip81jRSg5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">RSU</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="MMA:ExpenseFromRestrictedShareUnits" contextRef="From2023-07-01to2024-06-30" id="Fact001760" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,119,562</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1761">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1762">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--AdjustmentsForSharebasedPayments_zfi1McJs0u3l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Share based payments<span>*</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2023-07-01to2024-06-30" id="Fact001764" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,521,598</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2022-07-012023-06-30" id="Fact001765" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,365,384</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2021-07-012022-06-30" id="Fact001766" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,546,983</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0F_zfvwNt1Cb1W7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zQbK9VJWeAAb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001767" xml:lang="en-US">Note
                                            that <span id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20231201__20231231_z1ntXt81TKLc" title="Advisor Options vested and were exercised" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20230701__20230731_zsw5zmqiLNi5" title="Advisor Options vested and were exercised" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="From2023-12-012023-12-31" id="Fact001769" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer"><ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="From2023-07-012023-07-31" id="Fact001771" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">327,142</ix:nonFraction></ix:nonFraction></span></span> Advisor Options vested and were exercised into Shares between July 2023 and
                                            December 2023 and <span id="xdx_90D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20230701__20230731_zKizMct8TSnl" title="Advisor Options forfeited" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20231201__20231231_zKUJz83i5Z6a" title="Advisor Options forfeited" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-07-012023-07-31" id="Fact001773" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-12-012023-12-31" id="Fact001775" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">16,193</ix:nonFraction></ix:nonFraction></span></span> Advisor Options were forfeited. At June 30, 2024, nil remaining
                                            Advisor Options were on issue.</ix:footnote></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 110 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 22. Share-based payments - continued </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F09_zjH7gYny6ZK4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zbT7EnCd82F1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001776" xml:lang="en-US">Note
                                            that this expense is pertaining to the issuance of warrants (equating to <span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_c20240630_zPVvZcVXmXD9" title="Ordinary Shares on exercise" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2024-06-30" id="Fact001778" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">65,000</ix:nonFraction></span> Ordinary
                                            Shares on exercise) to the Underwriter as part of the underwriting agreement. These Warrants
                                            will be exercisable at any time and from time to time, in whole or in part, during the four
                                            and a half year period commencing 180 days from the commencement of sales of the securities
                                            in the Offering, at a price per share equal to <span id="xdx_905_ecustom--PricePerShareEqualPercentage_iI_pid_dp_uPure_c20240630_zpx8vpOmpta2" title="Price per share equal percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="MMA:PricePerShareEqualPercentage" contextRef="AsOf2024-06-30" id="Fact001780" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">125.0</ix:nonFraction></span>% of the public offering price per share
                                            of common stock at the Offering. The issuance acts as additional compensation for ThinkEquity
                                            services that would be rendered over a 24 month period from the Closing of the initial public
                                            offering. As these services vary and are not for a specific service, the fair value of this
                                            allocation cannot be estimated reliably. Thereby, the fair value of these warrants at grant
                                            date were calculated by applying the Black-Scholes model. The Company used valuations specialists
                                            to perform these valuations.</ix:footnote></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F07_z1ExF2q2dkia" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zuG97JGqyOt6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001781" xml:lang="en-US">Note
                                            that this expense is pertaining to the option granted to the underwriter, exercisable within
                                            45 days after the closing of the Offering, to acquire up to an additional 15% of the total
                                            number of Shares to be offered by the company in the offering, solely for the purpose of
                                            covering over-allotments. This over-allotment option essentially granted the underwriter
                                            the right to sell more shares than originally planned if the demand for a security issue
                                            proves higher than expected. The fair value of this service cannot be estimated reliably
                                            as the exercise was subjective on share price performance and/or timing. Thereby, the fair
                                            value of these options at grant date were calculated using the Black-Scholes model. The Company
                                            used valuations specialists to perform these valuations. In addition, please note that these
                                            options have not been exercised and the 45-day limit has expired.</ix:footnote></span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_8A5_zvXasCpC8D23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" continuedAt="ConU001785-01" escape="true" id="Fact001785" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"><p id="xdx_89B_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_gL3DONAWAEPOS-CCDSRYTS_zLdCoagaqoFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the number of share options outstanding during the year, adjusted to account for the 4-for-5 reverse share split, are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zie5q2dMivca" style="display: none">Schedule
of Share Options Outstanding</span> </span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zpIu8TKQSEIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zT0ZdCYCd0Ia" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEL8MFiIDWX8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">ESOP</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zaCuikKPvXwk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_ifrs-full_ShareOptionsMember" id="Fact001787" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">784,098</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_ifrs-full_ShareOptionsMember" id="Fact001788" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">556,074</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1789">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_ziQ24PRGCSJ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1791">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_ifrs-full_ShareOptionsMember" id="Fact001792" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">312,886</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_ifrs-full_ShareOptionsMember" id="Fact001793" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">556,074</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zXiJsBu31pIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1795">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_ifrs-full_ShareOptionsMember" id="Fact001796" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">84,862</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1797">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_ziochB4w4CW" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1799">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1800">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1801">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zy1SwpRnmMj4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-06-30_ifrs-full_ShareOptionsMember" id="Fact001803" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">784,098</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_ifrs-full_ShareOptionsMember" id="Fact001804" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">784,098</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_ifrs-full_ShareOptionsMember" id="Fact001805" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">556,074</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zAMLUNedCfVh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zVowqlhaKXa5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zYqWLc91NQT2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Advisor</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NumberOfOutstandingShareOptions_iS_z1L7ZHhxvQ9a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_custom_AdvisorMember" id="Fact001807" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">344,055</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_custom_AdvisorMember" id="Fact001808" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">312,362</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1809">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zyEytC2iajIl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_custom_AdvisorMember" id="Fact001812" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">31,693</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30_custom_AdvisorMember" id="Fact001813" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">312,362</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zm6UOdWMkotd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_AdvisorMember" id="Fact001815" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">16,913</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1816">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1817">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_zXT4V55qKwD7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_AdvisorMember" id="Fact001819" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">327,142</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1821">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zgIWzJvbFhoe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1823">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_custom_AdvisorMember" id="Fact001824" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">344,055</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30_custom_AdvisorMember" id="Fact001825" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">312,362</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zl4QMN0nRSI9" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<!-- Field: Split-Segment; Name: 006 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 111 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
22. Share-based payments - continued</b></span></p>

<div id="xdx_C05_gL3DONAWAEPOS-CCDSRYTS_zA2sYRtyBcs5"><ix:continuation continuedAt="ConU001785-02" id="ConU001785-01"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zslACzMhU9tc" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_zLNUsYbj6BM4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_zcGgiBCgAs8c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_z1msQrsCpqO3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Reach</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_z0wnwwZW2c55" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_custom_ReachMember" id="Fact001827" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,794</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1828">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1829">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zIevBLXCvk17" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1831">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30_custom_ReachMember" id="Fact001832" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">45,794</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1833">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zqLlGVnPiBE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1836">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1837">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zYiK8trvcQJg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1839">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1840">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1841">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_znAfnnCNqR2i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-06-30_custom_ReachMember" id="Fact001843" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">45,794</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30_custom_ReachMember" id="Fact001844" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">45,794</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1845">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_134_ztGsmADBP6rg" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z3gTDnsoHiC6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zSgZzqTQl59h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zv5DPlOD9FAf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">RSU</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zFUkEMCvCeH6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Beginning of period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1847">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1849">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zdO032jRXR19" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Granted during the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember" id="Fact001851" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">630,729</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1852">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1853">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zmCPQZbZOM3f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1856">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1857">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zOIdtiSw2wH1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1859">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1860">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zY0EaKJuuY4l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-06-30_ifrs-full_RestrictedShareUnitsMember" id="Fact001863" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">630,729</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1864">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1865">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in; text-indent: 415.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zlndA609UQXa" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zjy79EmtAnMe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zVSEPxvDiP23" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zm40GPRGot73" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Over
Allotment Option</b></span></p></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zZydOI649Ml7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Beginning of period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1867">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1868">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1869">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zOaT1nzIB0n2" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Granted during the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_OverAllotmentOptionsMember" id="Fact001871" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">195,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1872">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1873">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zeVrQaoAsEEg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_custom_OverAllotmentOptionsMember" id="Fact001875" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">195,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1877">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zKLkeRxCt1e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1879">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1880">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1881">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zROkvJPuz1p5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1883">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1884">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1885">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_134_zkdJ4abczpX5" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zVDnI1AIPlq6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zRvjjm2URI49" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z4LVeCGloSO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Warrants</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zEHg2LB82Pkj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Beginning of period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1887">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1888">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1889">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zd12xeSBVpMc" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Granted during the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember" id="Fact001891" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">65,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1893">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zQT8UOdLmZ69" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1895">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1897">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zWsGAbE1pg4h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercised during the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1899">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1901">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zXzUnf10OM9g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>End of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-06-30_ifrs-full_WarrantsMember" id="Fact001903" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">65,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1904">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1905">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_307_134_zgsdPe6Mub58" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left; font-weight: bold">-</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230701__20240630_z8wiG2VaH71h" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220701__20230630_zntefkRvtYek" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210701__20220630_zy3dOiDeVKX2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left; font-weight: bold">Total</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zMJsBnROtpL1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Total beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30" id="Fact001907" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,173,947</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30" id="Fact001908" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">868,436</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1909">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zc3ZCu4nKXvg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-07-01to2024-06-30" id="Fact001911" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">890,729</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30" id="Fact001912" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">390,373</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-07-012022-06-30" id="Fact001913" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">868,436</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zckuoh90y0yl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-07-01to2024-06-30" id="Fact001915" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">211,913</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2022-07-012023-06-30" id="Fact001916" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">84,862</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1917">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_zsaBm20S1mC1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total exercised during the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-07-01to2024-06-30" id="Fact001919" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">327,142</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1920">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1921">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zEMqyJJkkW36" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total end of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-06-30" id="Fact001923" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1,525,621</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-06-30" id="Fact001924" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1,173,947</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-06-30" id="Fact001925" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">868,436</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C06_gL3DONAWAEPOS-CCDSRYTS_zjNuB6s6Nr3d"><ix:continuation id="ConU001785-02">&#160;</ix:continuation></span></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001927" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"><p id="xdx_894_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_zLqMcBhNMhm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
model inputs for options granted during the reporting periods include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zXaxj4jkHgsd" style="display: none">Schedule of Model Inputs For Options Granted</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Spot Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Share price volatility</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expected Dividend yield</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Risk free interest rate</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: left">ESOP</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center">31 Aug 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwiW1HJN1MO4" title="Exercise price" style="width: 8%; text-align: right"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember" id="Fact001929" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.62</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zDFwX3b0khS7" title="Term"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember" format="ixt-sec:durwordsen" id="Fact001931" name="MMA:ExpectedTermShareOptionsGranted">3 years</ix:nonNumeric></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwC39eLLumH6" title="Spot Price" style="width: 8%; text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember" id="Fact001933" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.72</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z7vpmOsdVDS2" title="Share price volatility" style="width: 8%; text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember" id="Fact001935" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">67.3</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zGzIQdSMS2Ue" title="Expected Dividend yield" style="width: 8%; text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember" id="Fact001937" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zbpb4cPW1Oka" title="Risk free interest rate" style="width: 8%; text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember" id="Fact001939" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">31 Aug 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zN9dtrKZISr6" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember" id="Fact001941" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zBlwKFxqdSVc" title="Term"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember" format="ixt-sec:durwordsen" id="Fact001943" name="MMA:ExpectedTermShareOptionsGranted">3 years</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zm7dDir5dXd4" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember" id="Fact001945" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z3sq4I7xBfx" title="Share price volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember" id="Fact001947" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">67.3</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zGcNvvUIGB8e" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember" id="Fact001949" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAeOpglSioy3" title="Risk free interest rate" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember" id="Fact001951" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">1 March 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zNl5jIFDc18l" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember" id="Fact001953" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.62</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zn7gmENV0T1b" title="Term"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember" format="ixt-sec:durwordsen" id="Fact001955" name="MMA:ExpectedTermShareOptionsGranted">3 years</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z70HkW9Loazc" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember" id="Fact001957" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.51</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zkI6z7rokWq1" title="Share price volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember" id="Fact001959" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66.4</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zKsEONNPaa7b" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember" id="Fact001961" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z1vY07LGRiV2" title="Risk free interest rate" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember" id="Fact001963" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">23 Feb 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zZft4wILXyA8" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember" id="Fact001965" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.23</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zDCyCkERdntl" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl1967">3.0 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zf75uEmCFXZe" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember" id="Fact001969" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zhFc5mcLYgE5" title="Share price volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember" id="Fact001971" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">64.5</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_ztHGl2tNpBLh" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember" id="Fact001973" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zhXwOzHtxTB2" title="Risk free interest rate" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember" id="Fact001975" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.6</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">ADVISOR</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">21 Aug 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zYMipOurz7Ce" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember" id="Fact001977" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.62</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zYiQrzB11aO4" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl1979">2.86 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zFPHUSJqn0xh" title="Spot Price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember" id="Fact001981" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zKH0zpSK8td8" title="Share price volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember" id="Fact001983" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66.6</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zCE7KYEMdCHj" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember" id="Fact001985" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zUdufrAhHwWa" title="Risk free interest rate" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember" id="Fact001987" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.5</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">21 Aug 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zWn0O9NJtKij" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember" id="Fact001989" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zyS8ITAhAVR4" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl1991">2.86 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zyM7LTMrzWo2" title="Spot Price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember" id="Fact001993" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zhxHmLbKfjw7" title="Share price volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember" id="Fact001995" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66.6</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zdZWkcAX6486" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember" id="Fact001997" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zNC2K1gdRyR6" title="Risk free interest rate" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember" id="Fact001999" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.5</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">21 Aug 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zwN0GVWippR6" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember" id="Fact002001" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zhBZrWaRMKCc" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2003">4.90 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z8TFcGfj4zdc" title="Spot Price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember" id="Fact002005" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.80</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zu4xG2uR458i" title="Share price volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember" id="Fact002007" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65.4</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zuAUfDCcDdlk" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember" id="Fact002009" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zQVKgHW1k8l9" title="Risk free interest rate" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember" id="Fact002011" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 112 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"><b>Note 22. Share-based payments - continued</b> <br/>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><b>REACH</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center">13 Feb 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zZQEtN6Pzct3" title="Exercise price" style="width: 8%; text-align: right"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember" id="Fact002013" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.72</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwW1e80gsR66" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2015">3.30 years</span></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_znsVwwLptyL" title="Spot Price" style="width: 8%; text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember" id="Fact002017" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.72</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zfQrBpTA1u8g" title="Share price volatility" style="width: 8%; text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember" id="Fact002019" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65.4</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zn5lfo5or8Y2" title="Expected Dividend yield" style="width: 8%; text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember" id="Fact002021" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zR7Va2ECUpH3" title="Risk free interest rate" style="width: 8%; text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember" id="Fact002023" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.5</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">9 June 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zKQSRAJNEPh4" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember" id="Fact002025" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.73</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_ztyrLtWrhxek" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2027">3.15 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zkfOTVCgvvTj" title="Spot Price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember" id="Fact002029" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAzmPIORftGb" title="Share price volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember" id="Fact002031" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60.1</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zGZ6o6GNw5El" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember" id="Fact002033" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z2dTS2bmDgc7" title="Risk free interest rate" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember" id="Fact002035" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.8</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; width: 26%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>RSUs</i></b></span></p></td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">10 Oct 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zibSXiBCyBua" title="Exercise price" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2037">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z5EkOGDVtM9g" title="Term"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesOneMember" format="ixt-sec:durwordsen" id="Fact002039" name="MMA:ExpectedTermShareOptionsGranted">3 years</ix:nonNumeric></span> </span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zGYXz6SpYCNg" title="Spot Price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesOneMember" id="Fact002041" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.64</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zZo3vobg82K3" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesOneMember" id="Fact002043" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">1 Mar 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAaSYZsNwukf" title="Exercise price" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2045">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zIxxyPIMTuYd" title="Term"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesTwoMember" format="ixt-sec:durwordsen" id="Fact002047" name="MMA:ExpectedTermShareOptionsGranted">3 years</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z4Ki0WrJwBef" title="Spot Price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesTwoMember" id="Fact002049" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.52</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zwluHli8TD4a" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesTwoMember" id="Fact002051" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; width: 26%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">27 March 2024 <br/>Over allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$<span id="xdx_907_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zu5MBbNTMDF2" title="Exercise price"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember" id="Fact002053" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.25</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zUaywUXzRkNf" title="Term"><ix:nonNumeric contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember" format="ixt-sec:durwordsen" id="Fact002055" name="MMA:ExpectedTermShareOptionsGranted">5 years</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zjC43O1s1xU" title="Spot Price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember" id="Fact002057" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zLZAbKVM5Ylg" title="Share price volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember" id="Fact002059" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">62.9</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zXUTadKNxa54" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember" id="Fact002061" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z0TGklOTh1X9" title="Risk free interest rate" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember" id="Fact002063" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.7</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">27 March 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zzoC9o8biOs1" title="Exercise price" style="text-align: right"><ix:nonFraction name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember" id="Fact002065" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zJbilHvygFM6" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2067">0.12 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z8glpTZU43se" title="Spot Price" style="text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember" id="Fact002069" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zC34yg0pE2J1" title="Share price volatility" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember" id="Fact002071" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">46</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zYwsN2oQZuhb" title="Expected Dividend yield" style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember" id="Fact002073" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zzLv8qrWEdm3" title="Risk free interest rate" style="text-align: right"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember" id="Fact002075" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.7</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zQv9I7UmGjic" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
share-based payment expense of $<span id="xdx_900_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_c20230701__20240630_zEMfU1FcYsij" title="Share-based payment expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" contextRef="From2023-07-01to2024-06-30" id="Fact002077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,521,598</ix:nonFraction></span> for the period ended June 30, 2024 ($<span id="xdx_90A_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_c20220701__20230630_zsFF1UkbIxz1" title="Share-based payment expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" contextRef="From2022-07-012023-06-30" id="Fact002079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,365,384</ix:nonFraction></span> June 30, 2023 and $<span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_c20210701__20220630_zOvxWlqhnKWf" title="Share-based payment expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" contextRef="From2021-07-012022-06-30" id="Fact002081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,546,983</ix:nonFraction></span> June 30, 2022)
has been recognized in the Consolidated Statement of Profit or Loss and Other Comprehensive Loss.</span></p>
<!-- Field: Split-Segment; Name: 007 -->
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact002083" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory"><p id="xdx_80F_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_z19gR1T87w8h" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
23. <span id="xdx_825_zsDDXFtwq5Fb">Financial Instruments</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capital
management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s objectives when managing share capital, reserves, and accumulated losses, which represents the group&#8217;s capital,
are to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27.2pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">safeguard
                                            their ability to continue as a going concern, so that they can continue to provide returns
                                            for shareholders and benefits for other stakeholders; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27.2pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sustain
                                            future product development.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
risk management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities expose it to a variety of financial risks: market risk (primarily currency risk), credit risk, and liquidity
risk. The Company&#8217;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimise
potential adverse effects on the financial performance of the Group. The Group uses different methods to measure different types of risk
to which it is exposed. These methods include sensitivity analysis in the case of foreign exchange risk and aging analysis for credit
risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
risk management is carried out by the Chief Financial Officer (CFO) and overseen by the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 113 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
23. Financial Instruments - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
exchange risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
exchange risk arises when future commercial transactions and recognised assets and liabilities are denominated in a currency that is
not the entity&#8217;s functional currency. The risk is measured using sensitivity analysis and cash flow forecasting. The Group operates
internationally and is exposed to foreign exchange risk arising primarily from currency exposures to the NZ Dollar, Euro, and US Dollar.<br/>
<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial results are reported in AU dollar and a substantial portion of our operating revenues and expenses are reported
in AU dollar. Revenue and expenses recorded in local currency other that AU dollar are where practical received in to and paid out of
local currency bank accounts mitigating the Company&#8217;s exposure to foreign currency risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Credit
risk</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span>Credit
risk arises from cash and cash equivalents, derivative financial instruments and deposits with banks and financial institutions, as well
as credit exposures to customers, including outstanding receivables and committed transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no significant concentrations of credit risk. For banks and financial institutions, only independently rated and reputable
parties are accepted. The Company has policies in place to ensure that sales of products and services are made to customers in advance
of the products and service being provided The maximum exposure to credit risk at the reporting date is the carrying amount of the financial
assets recognised in the statement of financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
risk</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
risk arises from the Company&#8217;s management of cash and working capital. It is the risk that the Company will encounter difficulty
in meeting its financial obligations as they fall due. The Company&#8217;s policy is to ensure that it will always have sufficient cash
to allow it to meet its liabilities as and when they fall due. The Company manages its liquidity needs by carefully monitoring scheduled
debt servicing payments for long-term financial liabilities as well as cash-outflows due in day-to-day business.</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining
contractual maturities</b></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables detail the Company&#8217;s remaining contractual maturity for its financial instrument liabilities. The tables have
been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the financial liabilities
are required to be paid. The tables include both interest and principal cash flows disclosed as remaining contractual maturities and
therefore these totals may differ from their carrying amount in the statement of financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 114 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact002085" name="ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities"><p id="xdx_899_eifrs-full--MaturityAnalysisForDerivativeFinancialLiabilities_zmqIs3oMerJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zL7ylA6J4bQ5" style="display: none">Schedule of Contractual Maturities of Financial Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted average interest rate</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">1 year or less</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Between 1 and 2 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Between 2 and 5 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Remaining contractual maturities</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: right">Consolidated 2024</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">%</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: right">Non - Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: right">Non-interest bearing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: right">Trade and other payables</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90D_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zAGFYhjDxtIb" title="Trade and other payables"><ix:nonFraction name="MMA:NonInterestBearingTradeAndOtherPayables" contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,991,536</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90F_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zjEhDrcI2Wv8" title="Trade and other payables"><ix:nonFraction name="MMA:NonInterestBearingTradeAndOtherPayables" contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002089" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_905_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zpaaKBwzA6i5" title="Trade and other payables"><ix:nonFraction name="MMA:NonInterestBearingTradeAndOtherPayables" contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002091" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_901_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20240630_zldy8Z2iyq19" title="Trade and other payables"><ix:nonFraction name="MMA:NonInterestBearingTradeAndOtherPayables" contextRef="AsOf2024-06-30" id="Fact002093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,991,536</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: right">Interest bearing &#8211; fixed rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Financial liability &#8211; host debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--WeightedAverageInterestRateFinancialLiability_iI_dp0_c20240630_zuNNjP2RFd9k" title="Financial liability host debt, interest rate"><ix:nonFraction name="MMA:WeightedAverageInterestRateFinancialLiability" contextRef="AsOf2024-06-30" id="Fact002095" format="ixt:zerodash" decimals="INF" scale="-2" sign="-" unitRef="Pure">-</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zssHN2F98Tul" title="Financial liability host debt"><ix:nonFraction name="MMA:InterestBearingFinancialLiabilities" contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002097" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_z3t7TJ963uBl" title="Financial liability host debt"><ix:nonFraction name="MMA:InterestBearingFinancialLiabilities" contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002099" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z21AJOBZySKi" title="Financial liability host debt"><ix:nonFraction name="MMA:InterestBearingFinancialLiabilities" contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002101" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630_z1yiloxkna74" title="Financial liability host debt"><ix:nonFraction name="MMA:InterestBearingFinancialLiabilities" contextRef="AsOf2024-06-30" id="Fact002103" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90B_ecustom--WeightedAverageInterestRateLeaseLiabilities_iI_dp_c20240630_zM1qdZZFqPN" title="Lease liability, interest rate"><ix:nonFraction name="MMA:WeightedAverageInterestRateLeaseLiabilities" contextRef="AsOf2024-06-30" id="Fact002105" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.5</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zmGKCmZrR8F8" title="Lease liability"><ix:nonFraction name="MMA:InterestBearingLeaseLiabilities" contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,680</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zWDbO4mkhAAe" title="Lease liability"><ix:nonFraction name="MMA:InterestBearingLeaseLiabilities" contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002109" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,240</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zI3hjwTvwQv4" title="Lease liability"><ix:nonFraction name="MMA:InterestBearingLeaseLiabilities" contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002111" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,267</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_ecustom--InterestBearingLeaseLiabilities_iI_c20240630_zpg69TbDuLd7" title="Lease liability"><ix:nonFraction name="MMA:InterestBearingLeaseLiabilities" contextRef="AsOf2024-06-30" id="Fact002113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,187</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total non - derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zspTi7iZw5Ia" title="Total non derivative"><ix:nonFraction name="MMA:InterestBearingNonderivativesNet" contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,127,216</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zDOvgUrtcnkd" title="Total non derivative"><ix:nonFraction name="MMA:InterestBearingNonderivativesNet" contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,240</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zhM2wTrcZvgd" title="Total non derivative"><ix:nonFraction name="MMA:InterestBearingNonderivativesNet" contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,267</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--InterestBearingNonderivativesNet_iI_c20240630_zSpfGTsSvth" title="Total non derivative"><ix:nonFraction name="MMA:InterestBearingNonderivativesNet" contextRef="AsOf2024-06-30" id="Fact002121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,208,723</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Derivative liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zY0puwu87v19" title="Derivative liability"><ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002123" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zFOAZPIeeSlj" title="Derivative liability"><ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002125" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z0PZcVQpVV94" title="Derivative liability"><ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002127" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zzyZZwk2JGs3" title="Derivative liability"><ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002129" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total Derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zJT640jk7xki" title="Total Derivative"><ix:nonFraction name="MMA:DerivativeNet" contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002131" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zldH818xG4k5" title="Total Derivative"><ix:nonFraction name="MMA:DerivativeNet" contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002133" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zdOlvf57h8pd" title="Total Derivative"><ix:nonFraction name="MMA:DerivativeNet" contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002135" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z9FaEzyxcmT3" title="Total Derivative"><ix:nonFraction name="MMA:DerivativeNet" contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002137" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted average interest rate</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">1 year or less</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Between 1 and 2 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Between 2 and 5 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Remaining contractual maturities</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: right">Consolidated 2023</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">%</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$&#8217;000</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: right">Non - Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: right">Non-interest bearing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: right">Trade and other payables</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_906_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_z3gL200IRes6" title="Trade and other payables"><ix:nonFraction name="MMA:NonInterestBearingTradeAndOtherPayables" contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002139" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,034,436</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90F_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zrKT3uzobfA5" title="Trade and other payables"><ix:nonFraction name="MMA:NonInterestBearingTradeAndOtherPayables" contextRef="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002141" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_909_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zwqG8zTZpYeb" title="Trade and other payables"><ix:nonFraction name="MMA:NonInterestBearingTradeAndOtherPayables" contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002143" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_905_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20230630_zFvFouHP9Rpe" title="Trade and other payables"><ix:nonFraction name="MMA:NonInterestBearingTradeAndOtherPayables" contextRef="AsOf2023-06-30" id="Fact002145" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,034,436</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: right">Interest bearing &#8211; fixed rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Financial liability &#8211; host debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--WeightedAverageInterestRateFinancialLiability_iI_dp_c20230630_zVjE6ivMpZ37" title="Financial liability host debt, interest rate"><ix:nonFraction name="MMA:WeightedAverageInterestRateFinancialLiability" contextRef="AsOf2023-06-30" id="Fact002147" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.3</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zHs72L1Ausz" title="Financial liability host debt"><ix:nonFraction name="MMA:InterestBearingFinancialLiabilities" contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002149" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,567,450</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zP3kOTppbBPc" title="Financial liability host debt"><ix:nonFraction name="MMA:InterestBearingFinancialLiabilities" contextRef="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002151" format="ixt:numdotdecimal" decimals="0" unitRef="USD">342,406</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zAT19ASuhY9c" title="Financial liability host debt"><ix:nonFraction name="MMA:InterestBearingFinancialLiabilities" contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002153" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630_zIEyyFsONtyj" title="Financial liability host debt"><ix:nonFraction name="MMA:InterestBearingFinancialLiabilities" contextRef="AsOf2023-06-30" id="Fact002155" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,909,856</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_901_ecustom--WeightedAverageInterestRateLeaseLiabilities_iI_dp_c20230630_zojSqwTSq367" title="Lease liability, interest rate"><ix:nonFraction name="MMA:WeightedAverageInterestRateLeaseLiabilities" contextRef="AsOf2023-06-30" id="Fact002157" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.5</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zhDwAz4unqrh" title="Lease liability"><ix:nonFraction name="MMA:InterestBearingLeaseLiabilities" contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002159" format="ixt:numdotdecimal" decimals="0" unitRef="USD">127,361</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zjer506cwoua" title="Lease liability"><ix:nonFraction name="MMA:InterestBearingLeaseLiabilities" contextRef="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002161" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,214</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zkbLXDcgJUl5" title="Lease liability"><ix:nonFraction name="MMA:InterestBearingLeaseLiabilities" contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002163" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,214</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--InterestBearingLeaseLiabilities_iI_c20230630_zXaOdmWeiSll" title="Lease liability"><ix:nonFraction name="MMA:InterestBearingLeaseLiabilities" contextRef="AsOf2023-06-30" id="Fact002165" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,789</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total non- derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zCMf8xnJkdQ5" title="Total non derivative"><ix:nonFraction name="MMA:InterestBearingNonderivativesNet" contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002167" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,729,247</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_z8DFT3JIkVm9" title="Total non derivative"><ix:nonFraction name="MMA:InterestBearingNonderivativesNet" contextRef="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002169" format="ixt:numdotdecimal" decimals="0" unitRef="USD">370,620</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zi0xVLG49y3f" title="Total non derivative"><ix:nonFraction name="MMA:InterestBearingNonderivativesNet" contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002171" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,214</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--InterestBearingNonderivativesNet_iI_c20230630_z9hiMHw0kdqk" title="Total non derivative"><ix:nonFraction name="MMA:InterestBearingNonderivativesNet" contextRef="AsOf2023-06-30" id="Fact002173" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,128,081</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right">Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Derivative liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zcOMTIzqZbGe" title="Derivative liability"><ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002175" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zM6uQnzhAKn3" title="Derivative liability"><ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember" id="Fact002177" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zpAyoNrO7S3i" title="Derivative liability"><ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002179" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_ztZ686PwIUTe" title="Derivative liability"><ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002181" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total Derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zNYDA59I2b86" title="Total Derivative"><ix:nonFraction name="MMA:DerivativeNet" contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002183" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zwF3bPnGL0nk" title="Total Derivative"><ix:nonFraction name="MMA:DerivativeNet" contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember" id="Fact002185" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z7LOudniHYe1" title="Total Derivative"><ix:nonFraction name="MMA:DerivativeNet" contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002187" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z4s8KQ3JF9Ef" title="Total Derivative"><ix:nonFraction name="MMA:DerivativeNet" contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember" id="Fact002189" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_z8FLUolzQ9ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cash flows in the maturity analysis above are not expected to occur significantly earlier than contractually disclosed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
value estimation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of financial assets and financial liabilities must be estimated for recognition and measurement or for disclosure purposes.
The carrying value less impairment provision of trade receivables and payables are assumed to approximate their fair values due to their
short-term nature. The fair value of financial liabilities approximates their carrying values.</span></p>
<!-- Field: Split-Segment; Name: 008 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<ix:exclude><!-- Field: Page; Sequence: 115 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact002191" name="ifrs-full:DisclosureOfAuditorsRemunerationExplanatory"><p id="xdx_80B_eifrs-full--DisclosureOfAuditorsRemunerationExplanatory_zr4PohzpPwI3" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
24. <span id="xdx_821_zNjg5AvMloTe">Remuneration of auditors</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the financial year the following fees were paid or payable for services provided by BDO Audit Pty Ltd, the auditor of the Company and
its network firms:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact002193" name="MMA:DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory"><p id="xdx_894_ecustom--DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory_zXikr6Qpbrn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zRyWnlqB32K1" style="display: none">Schedule
of Auditor of Company And Network Firms</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630_zyiCcR45ncQi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20220701__20230630_z0GTml52JB48" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20210701__20220630_zSQQV1q2WU6l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_ecustom--AuditFees_maARzvWE_zoMxcxcCpukl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Audit fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:AuditFees" contextRef="From2023-07-01to2024-06-30" id="Fact002195" format="ixt:numdotdecimal" decimals="0" unitRef="USD">382,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:AuditFees" contextRef="From2022-07-012023-06-30" id="Fact002196" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MMA:AuditFees" contextRef="From2021-07-012022-06-30" id="Fact002197" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AuditorsRemunerationForRelatedFees_maARzvWE_zy6LK5ZY02q" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit &#8211; related fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:AuditorsRemunerationForRelatedFees" contextRef="From2023-07-01to2024-06-30" id="Fact002199" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MMA:AuditorsRemunerationForRelatedFees" contextRef="From2022-07-012023-06-30" id="Fact002200" format="ixt:numdotdecimal" decimals="0" unitRef="USD">207,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2201">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--AuditorsRemunerationForTaxServices_maARzvWE_z4RJ2TO962s" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2204">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2205">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--AuditorsRemunerationForOtherServices_maARzvWE_zffeOOzGx6jd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">All other fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2207">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2208">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--AuditorsRemuneration_iT_mtARzvWE_zNo5mXFi4NWl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AuditorsRemuneration" contextRef="From2023-07-01to2024-06-30" id="Fact002211" format="ixt:numdotdecimal" decimals="0" unitRef="USD">512,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AuditorsRemuneration" contextRef="From2022-07-012023-06-30" id="Fact002212" format="ixt:numdotdecimal" decimals="0" unitRef="USD">407,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ifrs-full:AuditorsRemuneration" contextRef="From2021-07-012022-06-30" id="Fact002213" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zpuBIFsYQq03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact002215" name="ifrs-full:DisclosureOfContingentLiabilitiesExplanatory"><p id="xdx_803_eifrs-full--DisclosureOfContingentLiabilitiesExplanatory_z0QIU8hGybJ" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
25. <span id="xdx_822_zzlVQ9CIeA67">Contingent Assets and Liabilities</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span id="xdx_908_ecustom--ContingentAssetsAndLiabilities_iI_do_c20240630_zFdSoxTw3Dw2" title="Contingent assets and liabilities"><ix:nonFraction name="MMA:ContingentAssetsAndLiabilities" contextRef="AsOf2024-06-30" id="Fact002217" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> material contingent assets and liabilities at 30 June 2024 (<span id="xdx_90D_ecustom--ContingentAssetsAndLiabilities_iI_dxL_c20230630_zIe52x9SNw9g" title="Contingent assets and liabilities::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2219">nil</span></span> &#8211; 30 June 2023).</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 211.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact002221" name="ifrs-full:DisclosureOfCommitmentsExplanatory"><p id="xdx_80C_eifrs-full--DisclosureOfCommitmentsExplanatory_zOW6WtARr5X6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
26. <span id="xdx_82B_zXjtrYmRRsx5">Commitments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no material Commitments at 30 June 2024 (nil- 30 June 2023).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact002223" name="ifrs-full:EarningsPerShareExplanatory"><p id="xdx_80D_eifrs-full--EarningsPerShareExplanatory_zbq8YVeo4z09" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
27. <span id="xdx_82C_zGz7VkubTiBj">Loss per share</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#160;</span></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact002225" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory"><p id="xdx_894_eifrs-full--DisclosureOfEarningsPerShareExplanatory_z2gfqV42e5sf" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zfG8VLK2iRZ8" style="display: none">Schedule
of Loss Per Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20230701__20240630_z5OKycaLQuzh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20220701__20230630_zyo6SvBhm3Gh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20210701__20220630_zXACTB5yy1vi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--ProfitLoss_z8mOM71kfIce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Reconciliation of loss after tax</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-07-01to2024-06-30" id="Fact002227" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,408,346</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-07-012023-06-30" id="Fact002228" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,597,436</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-07-012022-06-30" id="Fact002229" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,197,450</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted average number of Ordinary Shares outstanding during the period used in calculating loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eifrs-full--WeightedAverageShares_c20230701__20240630_zqxVKKgyFjbg" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_"><span id="xdx_90E_eifrs-full--AdjustedWeightedAverageShares_c20230701__20240630_zJtY3EvBYG47" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2023-07-01to2024-06-30" id="Fact002231" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2023-07-01to2024-06-30" id="Fact002233" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,267,686</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eifrs-full--WeightedAverageShares_c20220701__20230630_zXpNQlPC7uGe" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_"><span id="xdx_901_eifrs-full--AdjustedWeightedAverageShares_c20220701__20230630_zqdX5ODnil6f" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2022-07-012023-06-30" id="Fact002235" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2022-07-012023-06-30" id="Fact002237" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,918,750</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eifrs-full--WeightedAverageShares_c20210701__20220630_zJUWCLRzmHad" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_"><span id="xdx_900_eifrs-full--AdjustedWeightedAverageShares_c20210701__20220630_zbPAg7HgieJ8" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2021-07-012022-06-30" id="Fact002239" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2021-07-012022-06-30" id="Fact002241" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,918,750</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss per share attributable to the owners of Alta Global Group Limited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_zQrX25DKJi8e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2023-07-01to2024-06-30" id="Fact002243" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.40</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2022-07-012023-06-30" id="Fact002244" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">5.26</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2021-07-012022-06-30" id="Fact002245" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.86</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eifrs-full--DilutedEarningsLossPerShare_zzWRcAhXdkp9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diluted loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2023-07-01to2024-06-30" id="Fact002247" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.40</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2022-07-012023-06-30" id="Fact002248" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">5.26</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2021-07-012022-06-30" id="Fact002249" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.86</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>
<!-- Field: Split-Segment; Name: 009 -->
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact002251" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory"><p id="xdx_80E_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zJrL28D0u9f9" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
28. <span id="xdx_82A_zy2qSiVgkG6g">Events after the reporting period</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2024, at the discretion of the Board under the Company&#8217;s Employee Incentive Plan (EIP), <span id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20240701__20240731__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zU4wO7MWG1Ji" title="Vested and convertible shares"><ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="From2024-07-012024-07-31_custom_NonadjustingEventMember" id="Fact002253" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">40,000</ix:nonFraction></span> share rights have fully vested
and converted into Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, various employees and consultants were issued an aggregate of <span id="xdx_904_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20240901__20240930__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zrFFaZd90yf6" title="Vested and convertible shares"><ix:nonFraction name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" contextRef="From2024-09-012024-09-30_custom_NonadjustingEventMember" id="Fact002255" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">139,500</ix:nonFraction></span> share rights (subject to vesting conditions) which
may be converted into Ordinary Shares under the Company&#8217;s Employee Incentive Plan. All share rights granted will vest and become
exercisable in three tranches between May 2025 and August 2027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, we announced a revenue share agreement with UFC Gym, LLC in relation to the intention of rolling out the Warrior Training
Program and Hype across UFC Gym&#8217;s global network of gyms, consisting of both corporate owned locations and franchises (with over
150 locations in 40 countries, including 80 in the United States) (&#8220;UFC Group&#8221;). In the initial phase, these programs will
be introduced in locations across the US, the Middle East, the UK, Germany, Mexico, India and Central Asia. The revenue from the Warrior
Training Program is shared, with the UFC Group receiving 70% and the Company receiving 30%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, Conor McGregor was appointed as a global ambassador (&#8220;Ambassador Agreement&#8221;) and will provide services customarily
associated with such roles for a company in the mixed martial arts and technology sector (&#8220;Services&#8221;). The term of the Ambassador
Agreement shall be effective for three years and either party may terminate the agreement upon 10 days prior written notice if the other
party breaches the agreement and does not cure such breach within such time period. <span id="xdx_903_eifrs-full--DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_c20240901__20240930__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CounterpartiesAxis__custom--MrMcGregorMember_z8ovFbOfBNKd" title="Description of contracts shares"><ix:nonNumeric contextRef="From2024-09-012024-09-30_custom_NonadjustingEventMember_custom_MrMcGregorMember" id="Fact002257" name="ifrs-full:DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares">In consideration for providing these Services under
the Ambassador Agreement, and pursuant to the exemption from registration provided for in Regulation S promulgated under the Securities
Act, Mr. McGregor received 700,000 performance share rights that will vest once the 30-day volume-weighted average price (VWAP) achieves
the following trigger: 150,000 shares on execution of the Ambassador Agreement; 100,000 shares when the share price reaches $7.50; 150,000
shares when the share price reaches $10.00; 150,000 shares when the share price reaches $15.00 and 150,000 shares when the share price
reaches $20.00. Aligned with the three (3) year term of the Ambassador Agreement, Mr. McGregor is restricted from selling shares within
three (3) years of issuance unless specific conditions are met, such as the Company&#8217;s written consent, a sale or liquidation of
the Company, or if the Company breaches the agreement.</ix:nonNumeric></span></span></p>

</ix:nonNumeric><p id="xdx_81D_zSzhLfRx4z34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 116 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_025"></span>ITEM
    19.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBITS</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibits are filed or furnished, as indicated, as part of this annual report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.7in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1981519/000149315223041783/ex3-1.htm" style="-sec-extract: exhibit">Certificate of the Registration of the Registrant (incorporated by reference to Exhibit 3.1 to the Registration Statement on Form F-1 filed on November 17, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1981519/000149315223041783/ex3-2.htm" style="-sec-extract: exhibit">Constitution of the Registrant (incorporated by reference to Exhibit 3.2 to the Registration Statement on Form F-1 filed on November 17, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><a href="ex2-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Securities</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1981519/000149315223041783/ex4-3.htm" style="-sec-extract: exhibit">Employee Incentive Plan (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form F-1 filed on November 17, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1981519/000149315223041783/ex4-4.htm" style="-sec-extract: exhibit">Employee Option Plan (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form F-1 filed on November 17, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3+#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1981519/000149315223041783/ex10-1.htm" style="-sec-extract: exhibit">Employment Agreement between the Company and Nick Langton (incorporated by reference to Exhibit 10.1 to the Registration Statement on Form F-1 filed on November 17, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4+#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1981519/000149315223041783/ex10-2.htm" style="-sec-extract: exhibit">Employment Agreement between the Company and Neale Java (incorporated by reference to Exhibit 10.2 to the Registration Statement on Form F-1 filed on November 17, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5+#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1981519/000149315223041783/ex10-3.htm" style="-sec-extract: exhibit">Consultancy Agreement between the Company and Jonathan Hart (incorporated by reference to Exhibit 10.3 to the Registration Statement on Form F-1 filed on November 17, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1981519/000149315223041783/ex10-4.htm">Form of Deed of Access, Insurance and Indemnity (incorporated by reference to Exhibit 10.4 to the Registration Statement on Form F-1 filed on November 17, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1981519/000149315224035067/ex21-1.htm" style="-sec-extract: exhibit">List of subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 to the Registration Statement on Form F-1 filed on September 5, 2024)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><a href="ex11-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Trading Policy</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex12-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act, as amended</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex12-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act, as amended</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex13-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex13-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><a href="ex97-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clawback Policy</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document. (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within
    the Inline XBRL document).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    with this annual report on Form 20-F.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">This
    certification is deemed not filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section,
    nor shall it be deemed incorporated by reference into any filing under the Securities Act, or the Exchange Act.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
    management contract or compensatory plan.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit were omitted by means of marking such portions
    with an asterisk because such information is both not material and is the type that the Company treats as private or confidential.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 117; Options: NewSection; Value: 69 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized
the undersigned to sign this annual report on its behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALTA
    GLOBAL GROUP LIMITED</b></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, 2024</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td>By:</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Nick Langton</i></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%">Name:</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nick
    Langton</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td>Title:</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Neale Java</i></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neale
    Java</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 118; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex2-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
2.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF SHARE CAPITAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following descriptions are summaries of the material terms of our Constitution. Reference is made to the more detailed provisions of
the Constitution. Please note that this summary is not intended to be exhaustive. For further information please refer to the full version
of our Constitution which is included as an exhibit to our Annual Report on Form 20-F for the fiscal year ended June 30, 2024.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a public company limited by shares registered under the Corporations Act which is regulated by the Australian Securities and Investments
Commission, or ASIC. Our corporate affairs are principally governed by our Constitution and the Corporations Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally
speaking, the terms of our Constitution are not significantly different than a U.S. company&rsquo;s charter documents, except we do not
have a limit on our authorized share capital and the concept of par value is not recognized under Australian law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to restrictions on the issue of securities in our Constitution and the Corporations Act and any other applicable law, we may at any time
issue shares and grant options or warrants on any terms, with the rights and restrictions and for the consideration that our board determines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rights and restrictions attaching to Ordinary Shares are derived through a combination of our Constitution, the common law applicable
to Australia, the Corporations Act and other applicable law. A general summary of some of the rights and restrictions attaching to our
Ordinary Shares are summarized below. Each Ordinary Shareholder is entitled to receive notice of, and to be present, vote and speak at,
general meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reverse
Share Split</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 24, 2024, we effectuated a four-for-five (4:5) Reverse Share Split of our Ordinary Shares. No fractional shares were issued in
connection with the Reverse Share Split as all fractional shares were rounded up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Constitution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Constitution is similar in nature to the bylaws of a U.S. corporation. It does not provide for or prescribe any specific objectives or
purposes of Alta. It may be amended or repealed and replaced by special resolution of shareholders, which is a resolution passed by at
least 75% of the votes cast by shareholders entitled to vote on the resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Australian law, a company has the legal capacity and powers of an individual both within and outside Australia. The material provisions
of our Constitution are summarized below. This summary is not intended to be complete nor to constitute a definitive statement of the
rights and liabilities of our shareholders. Our Constitution is filed as an exhibit to this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Interested
Directors</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
director who has a material personal interest in a matter that is being considered at a meeting of directors must not be present while
the matter is being considered at the meeting or vote on that matter except where permitted by the Corporations Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Directors&rsquo;
Compensation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our Constitution, the total aggregate fixed sum per annum to be paid to the directors (excluding salaries of executive directors)
from time to time will not exceed the sum determined by the shareholders in a general meeting and the total aggregate fixed sum will
be divided among the directors as the directors shall determine and, in default of agreement between them, then in equal shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remuneration
payable by the Company to the Managing Director and any other executive Directors may be by way of salary, bonuses, or any other elements
but must not include a commission on, or percentage of, operating revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Powers
Exercisable by Directors</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our Constitution (subject to the Corporations Act), the management and control of our business affairs are vested in our board. Subject
to the Corporations Act, our board has the power to raise or borrow money, and charge any of our property or business or any uncalled
capital, and may issue debentures or give any other security for any of our debts, liabilities or obligations or of any other person,
in each case, in the manner and on terms it deems fit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rotation
of Directors</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our Constitution, there must be an election of Directors at the Company&rsquo;s annual general meeting. Upon the Company&rsquo;s admission
to a Financial Market, no director except a Managing Director shall hold office for a period of three years, or beyond the third annual
general meeting following the Director&rsquo;s election, whichever is the longer, without submitting themselves for re-election. If no
Director is standing for election or re-election, then the directors to retire at an annual general meeting are those who have been longest
in office since their last election and if there are 2 or more who were elected on the same day, then the Director to retire will be
decided by lot, unless the relevant Directors agree otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rights
and Restrictions on Classes of Shares</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Corporations Act, the rights attaching to our Ordinary Shares are detailed in our Constitution. Our Constitution provides that
the Board may issue shares from time to time with preferred, deferred or other special rights, whether in relation to dividends, voting,
return of share capital, or otherwise. Subject to the Corporations Act, or any rights and restrictions attached to a class of shares
currently on issue, we may issue further shares on such terms and conditions as our board resolves. Currently, our outstanding share
capital consists of only Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividend
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Corporations Act, our board may from time to time determine to pay any interim, special or final dividends to shareholders, fix
the amount of dividend, the record date for determining entitlements to, and for payment of, a dividend and the method of payment of
a dividend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Voting
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our Constitution, each shareholder has one vote determined by a show of hands at a meeting of the shareholders unless a poll is required
under the Constitution or the Corporations Act. On a poll vote, each shareholder shall have one vote for each fully paid share and a
fractional vote for each share that is not fully paid, such fraction being equivalent to the proportion of the amount that has been paid
to such date on that share. Shareholders may vote by proxy. Under Australian law, shareholders of a public company are not permitted
to approve corporate matters by written consent. Our Constitution does not provide for cumulative voting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Right
To Share in Our Profits</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Corporations Act and pursuant to our Constitution, our shareholders are entitled to participate in our profits only by payment
of dividends. Our board may from time to time determine to pay dividends to the shareholders; however, under the Corporations Act, we
must not pay a dividend unless: (a) our assets exceed our liabilities immediately before the dividend is declared and the excess is sufficient
for the payment of the dividend; (b) the payment of the dividend is fair and reasonable to our shareholders as a whole; and (c) the payment
of the dividend does not materially prejudice our ability to pay our creditors. Unless any share is issued on terms providing to the
contrary, all dividends are to be apportioned and paid proportionately to the amounts paid, or credited as paid on the relevant shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rights
to Share in the Surplus in the Event of Liquidation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Constitution provides for the right of shareholders to participate if there is a surplus of assets in the event of our liquidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
Redemption Provision for Ordinary Shares</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no redemption provisions in our Constitution in relation to Ordinary Shares. Under our Constitution and subject to the Corporations
Act, redeemable preference shares may be issued and liable to be redeemed on the terms that they are issued, which may be at our option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Variation
or Cancellation of Share Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rights attached to shares in a class of shares may only be varied or cancelled (unless otherwise provided by the terms of issue of Shares
in a class, in which case the procedure set out in the terms of issue applies), by either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    special resolution passed by members holding shares in the class; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    written consent of members with at least 75% of the shares in the class.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Liability
for Further Capital Calls</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to our Constitution, the board may make any calls from time to time upon shareholders in respect of all monies unpaid on partly-paid
shares (if any), subject to the terms upon which any of the partly-paid shares have been issued. Each shareholder is liable to pay the
amount of each call in the manner, at the time, and at the place specified by the board. Calls may be made payable by installment. Failure
to pay a call will result in interest becoming payable on the unpaid amount and ultimately, forfeiture of those shares. As of the date
of this prospectus, all of our issued shares are fully paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Comparison
of Australian and Delaware Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below provides a summary of the Australian law applicable to Alta as an Australian public company, and certain rights attaching
to Alta&rsquo;s shares. These laws and/or rights may be different to those which would apply if Alta were incorporated in Delaware and
subject to Delaware and US federal laws, the table below provides a summary comparison for illustrative purposes. Investors should also
carefully review the relevant risks highlighted in this section in this regard and the summary of the matters set forth under the section
entitled &ldquo;Description of Share Capital&rdquo;, as well as the copy of our Constitution (which is included as an exhibit to the
registration statement to which this prospectus forms a part), prior to investing in the Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Matter</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Australian
    public company</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listed
    US company incorporated in Delaware</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share
    capital</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Corporations Act does not:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    prescribe the minimum amount of share capital that Alta should have;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    prescribe a minimum issue price for each share in Alta; or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    require Alta to place a maximum limit on the share capital that its members may subscribe.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australian
    law does not contain any concept of authorized capital or par value per share.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    Australian law and our Constitution, the issue price of shares is set by the Alta Directors collectively as a board at the time of
    each issue.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    US company&rsquo;s certificate of incorporation may authorize the issue of up to a maximum number of shares, which may consist of
    different classes of shares and stipulate the par value for those shares.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuing
    additional shares</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the Corporations Act, our Constitution authorizes the Alta Board to allot and issue securities in the capital of Alta to any person
    on such terms and with such rights as the Board determines.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            US company&rsquo;s by-laws will generally permit the issue of authorized and unissued shares
                                            of any class by vote of the board of directors in such manner, for such consideration and
                                            on such terms as the board of directors may determine, without stockholder approval.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
    under the NYSE listing rules, a listed company will not be able to disparately reduce or restrict voting rights of the shares through
    any corporate action or issuance.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
    of shares</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            Australian law and our Constitution, securities in Alta are generally freely transferable.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Alta Directors may however refuse to register a transfer of shares in limited circumstances as detailed in our Constitution, and
    where the transfer would be contrary to the Corporations Act.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            the DGCL, shares are generally freely transferable.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    of shares may be subject to restrictions imposed by US federal or state securities laws, by the certificate of incorporation or by-laws
    or by an agreement signed with the holders of shares at issue.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
    a transfer of shares shall be made only on the transfer books of a Delaware incorporated company or by a transfer agent designated
    to transfer shares of a Delaware incorporated company. Where a Delaware incorporated company Shares are certificated, certificates
    must be surrendered for cancellation before a new certificate, if any, is issued.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividends
    and distributions</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Constitution permits the Board to declare dividends to shareholders from time to time in
                                            its sole discretion.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the Corporations Act, a company may only pay a dividend where, in summary, the company&rsquo;s assets exceed its liabilities at the
    relevant time to the extent of the dividend to be declared, the payment is fair and reasonable to the company&rsquo;s shareholders
    as a whole and does not materially prejudice the company&rsquo;s ability to pay its creditors.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            the DGCL, the board of directors of a company incorporated in Delaware is permitted to declare
                                            and pay dividends to stockholders either:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    out of that company&rsquo;s surplus, which is defined to be the net assets less statutory capital; or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    if no surplus exists, then out of the net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal
    year, provided that the capital of the corporation is not less than the aggregate amount of the capital represented by the corporation&rsquo;s
    outstanding stock of all classes having a preference on distribution of assets.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
    of common stock will generally be entitled to receive dividends when and as declared by the company&rsquo;s Board out of funds legally
    available for that purpose.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting
    rights and Quorum Requirements</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Constitution provides that:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    on a show of hands each individual present who is a member, proxy, attorney or representative of a member entitled to vote has one
    vote;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    on a poll each shareholder has one vote for every fully paid share held and a fraction of a vote for each partly paid share held,
    with the fraction of the vote being equivalent to the portion of the share paid up; and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    two shareholders present constitutes a quorum.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally
    speaking, a company incorporated in Delaware&rsquo;s certificate of incorporation provides that each stockholder is entitled to one
    vote for each share of capital stock entitled to vote, unless otherwise provided by the DGCL or the company&rsquo;s governing documents.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Variation
    in rights</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            the Corporations Act, if a company has a constitution that sets out a procedure for varying
                                            or cancelling rights attached to shares in a class of shares, those rights may be varied
                                            or cancelled only in accordance with the procedure.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    our Constitution, the rights may only be varied or cancelled:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    with the consent in writing of the holders of at least 75% of the issued Shares of that class; or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    with the sanction of a special resolution passed at a separate general meeting of the holders of the Shares of the class.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    company must give written notice of the variation or cancellation to the members of the class within 7 days after the variation or
    cancellation is made.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Corporations Act also provides that where shareholders in an affected class do not all agree (whether by resolution or written consent)
    to the:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    variation or cancellation of their rights; or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    a modification to the relevant constitution to allow rights to be varied or cancelled,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">then
    shareholders with at least 10% of the votes in the affected class may apply to the court (within a limited time frame) to have the
    variation, cancellation or modification set aside.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to the shares&rsquo; terms of issue, the rights attached to a class of shares are not deemed varied by the issue of further shares
    of that class.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            the DGCL, any amendment to the company incorporated Delaware&rsquo;s certificate of incorporation
                                            requires approval by holders of the outstanding shares of a particular class if that amendment
                                            would:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    increase or decrease the aggregate number of authorized shares of that class;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    increase or decrease the par value of the shares of that class; or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    alter or change the powers, preferences or special rights of the shares of that class so as to affect them adversely.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    an amendment would alter or change the powers, preferences or special rights of one or more series of any class so as to adversely
    affect that series without adversely affecting the entire class, then only the shares of the series so affected shall be considered
    a separate class and entitled to such separate class approval of the proposed amendment.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the DGCL, amendments to a company incorporated in Delaware&rsquo;s certificate of incorporation also generally require:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    a board resolution recommending the amendment; and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    approval of a majority of the outstanding shares entitled to vote and a majority of the outstanding shares of each class entitled
    to vote.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    amendments to the relevant company&rsquo;s certificate of incorporation could, in the future, require approval of only the majority
    of the shares of the then issued and outstanding preferred stock, because the DGCL and the company&rsquo;s certificate of incorporation
    permit the company to issue preferred shares with powers, preferences and rights superior to those of common stock.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to a company incorporated in Delaware&rsquo;s by-laws, a company incorporated in Delaware&rsquo;s by-laws or certificate of incorporation
    may be adopted, amended or repealed by the board of directors or by the affirmative vote of the holders of a majority of the voting
    power of all of the shares of the corporation then issued and outstanding and entitled to vote generally in any election of directors,
    voting together as a single class.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
    party and director transactions</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Corporations Act governs the provision of financial benefits to related parties of public
                                            companies and requires that shareholder approval is obtained prior to financial benefits
                                            being provided to related parties or giving the financial benefit falls within a specific
                                            exception set out in the Corporations Act (for example, a benefit given on arms&rsquo; length
                                            terms or the reasonable remuneration or reimbursement of an officer or employee).</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors,
    when entering into transactions with Alta, are also subject to the Australian common law and statutory duties to avoid actual and
    potential conflicts of interest. There are also disclosure requirements and voting restrictions imposed on directors under the Corporations
    Act on matters involving a material personal interest.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    the parameters summarized above, under our Constitution a director&rsquo;s position as such does not disqualify that person from:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    holding any other office or place of profit or employment (except with Alta&rsquo;s auditor), on such terms as the Alta Directors
    approve;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    being a shareholder in or a director of a company promoted by Alta or in which Alta may be interested as a vendor, shareholder or
    otherwise; or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    entering into an agreement with Alta.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    director must also comply with:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    the material personal interest provisions set out in section 191 of the Corporations Act; and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    section 195 of the Corporations Act in relation to being present and voting at a board meeting that considers a matter in which he
    or she has a material personal interest.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            the DGCL, no contract or transaction between a company incorporated in Delaware and one or
                                            more of its directors or officers, or between the relevant company and any other corporation,
                                            partnership, association or other organization in which one or more of its directors or officers
                                            are directors or officers or have a financial interest will be void or voidable solely for
                                            that reason, or solely because the relevant director or officer is present at or participates
                                            in the company board or committee meeting that authorizes the contract or transaction, or
                                            solely because the vote of the relevant director or officer is counted for that purpose,
                                            if:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    the material facts as to the director&rsquo;s or officer&rsquo;s relationship or interest, and as to the contract or transaction,
    are disclosed or known to the board of directors or committee, and the board of directors or committee in good faith authorizes the
    contract or transaction by the affirmative votes of a majority of the disinterested directors, even though the disinterested directors
    be less than a quorum; or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    the material facts as to the director&rsquo;s or officer&rsquo;s relationship or interest and as to the contract or transaction are
    disclosed or known to the stockholders entitled to vote thereon, and the contract or transaction is specifically approved in good
    faith by vote of the stockholders; or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    the contract or transaction is fair to the company as of the time that it is authorized, approved or ratified by the board of directors,
    committee or stockholders.</FONT></P></TD></TR>

</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Protection
    against oppression of shareholders</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Corporations Act empowers the court to make any order it considers appropriate if conduct
                                            of a company&rsquo;s affairs is found to be oppressive to a member or members.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
    orders may include winding up, regulating the conduct of the company&rsquo;s affairs, authorizing a member to institute derivative
    proceedings or requiring a person to engage in or abstain from specified conduct.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    DGCL contains no equivalent statutory provisions. However, Delaware law may provide judicial remedies to stockholders in comparable
    circumstances.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Buy-back
    of shares</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Corporations Act allows Alta to buy-back its own shares through a specific buy-back procedure
                                            provided that:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    the buy-back does not materially prejudice Alta&rsquo;s ability to pay its creditors; and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    Alta follows the relevant procedures set out in the Corporations Act.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    buy-back procedure includes the form of shareholder approval (for example, ordinary, special or unanimous resolutions), a notice
    period and disclosure to be given to the shareholders, depending on the type of buy-back to be undertaken.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            DGCL generally permits a Delaware incorporated company to purchase or redeem its outstanding
                                            shares out of funds legally available for that purpose without obtaining stockholder approval,
                                            provided that:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    the capital of a Delaware incorporated company is not impaired;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    such purchase or redemption would not cause the capital of a Delaware incorporated company to become impaired;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    the purchase price does not exceed the price at which the shares are redeemable at the option of a Delaware incorporated company;
    and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    immediately following any such redemption a Delaware incorporated company shall have outstanding one or more shares of one or more
    classes or series of stock, which shares shall have full voting powers.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Takeovers</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Corporations Act prohibits the acquisition of a relevant interest in voting shares of a company
                                            where the acquisition would increase a person&rsquo;s voting power in the company to over
                                            20% or increases from a starting point that is above 20% and below 90%, except in certain
                                            circumstances.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Corporations Act also sets out disclosure requirements for persons who have or cease to have a substantial holding in a company.
    Compulsory acquisition is permitted by holders with an interest of 90% or more of a class of securities.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    exceptions to this general takeover prohibition are set out in the Corporations Act, including:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    an acquisition resulting from a scheme of arrangement undertaken in accordance with the Corporations Act and approved by the court;
    and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    an acquisition that results from the acceptance of an offer under a takeover bid.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    this respect, any takeover bid made for Alta must be on the same terms for all shareholders, subject to minor exceptions, and must
    comply with the timetable, disclosure and other requirements set out in the Corporations Act.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    purpose of these provisions is to seek to ensure that shareholders in a target company that they have a reasonable and equal opportunity
    to share in any premium for control and that they are given reasonable time and sufficient information to assess the merits of the
    proposal.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
                                            203 of the DGCL applies to a company and provides that if a holder acquires 15% or more of
                                            a company&rsquo;s voting stock (an &ldquo;Interested Holder&rdquo;) without prior approval
                                            of the board of directors, then for three years a company cannot engage in a broad range
                                            of business combinations with such Interested Holder. Such business combinations include
                                            (a) certain mergers or consolidations with the Interested Holder or entities affiliated with
                                            the Interested Holder,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
    certain sales, leases, exchanges, mortgages, pledges, transfers or other dispositions of the company assets to the Interested Holder,
    which assets have an aggregate market value equal to 10% or more of either all of the assets of a company or all of the outstanding
    stock of a company,(c) certain transactions which result in the issuance or transfer by a company or by any direct or indirect majority
    owned subsidiary, to the Interested Holder, of any stock of a company or of such a company subsidiary, (d) certain transactions involving
    a company or any direct or indirect majority-owned subsidiaries which have the effect, directly or indirectly, of increasing the
    proportionate share of the stock of any class or series, or securities convertible into the stock of any class or series, of the
    company or such subsidiary which is owned by the Interested Holder, except as a result of immaterial changes due to fractional share
    adjustments or as a result of any purchase or redemption of any shares of stock not caused, directly or indirectly by the Interested
    holder, and (e) any receipt by the Interested Holder of the benefit, directly or indirectly (except proportionately as a stockholder
    of the company), of any loans, advances, guarantees, pledges or other financial benefits (other than those expressly permitted by
    Section 203(c)(3)(i)-(iv)) provided by or through the company or any direct or indirect majority-owned subsidiary.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Section 203 limitation would not apply if (a) the business combination was approved by the board of directors of the company before
    the holder became an Interested Holder, (b) the business combination is subsequently approved by the a company board of directors
    and also by two-thirds of the a company stock held by persons other than such Interested Holder at an annual or special meeting of
    stockholders, or (c) upon consummation of the transaction which resulted in the stockholder becoming an Interested Holder of the
    company, the Interested Holder owned at least 85% of the company&rsquo;s voting stock which was outstanding at the time the transaction
    commenced (excluding stock owned by any directors who are also officers and certain employee stock plans).</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    effect of the restriction is to give the company&rsquo;s board of directors the ability to prevent or inhibit an unsolicited takeover
    attempt initiated through a merger or asset purchase proposal. It may also dissuade unsolicited tender offer proposals unless the
    offeror is confident of achieving the 85% shareholding level via the tender offer.</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual
    shareholder meetings</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the Corporations Act, the annual general meeting of Alta is required to be held at least once every calendar year and within five
    months after the end of each financial year.&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The DGCL requires a company incorporated
    in Delaware to have an annual stockholders&rsquo; meeting to elect directors, unless directors are elected by written consent in
    lieu of an annual meeting.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under the DGCL, a director or stockholder of a company incorporated
    in Delaware may petition the Court of Chancery of Delaware for an order compelling the holding of an annual meeting if:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679; <FONT STYLE="font-family: Times New Roman, Times, Serif">no
    annual meeting has been held, or action by written consent to elect directors in lieu of an annual meeting has been taken, for a
    period of 30 days after the date designated for the annual meeting; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679; <FONT STYLE="font-family: Times New Roman, Times, Serif">no
    date for an annual meeting has been designated for a period of 13 months after the latest to occur of the company&rsquo;s
    organization, the last annual meeting or the last action by written consent to elect directors in lieu of an annual
    meeting.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholders&rsquo;
    right to request or requisition a general meeting</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 39%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Corporations Act requires the Directors to call a general meeting on the request of members
                                            with at least 5% of the vote that may be cast at the general meeting or at least 100 Shareholders
                                            who are entitled to vote at a general meeting.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
    with at least 5% of the votes that may be cast at the general meeting may also call and arrange to hold a general meeting at their
    own expense.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                            meetings of stockholders shall be held at a time designated by or in the manner provided
                                            in the bylaws.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special
    meetings of stockholders may be called by the board of directors or by such person or persons as may be authorized by the certificate
    of incorporation or by the bylaws.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notice
    of Meetings</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Corporations Act requires at least 28 days&rsquo; notice of a general meeting of company listed on a financial exchange.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    DGCL provide that notice of a stockholders&rsquo; meeting be delivered not less than ten days nor more than 60 days before the date
    of the meeting to each stockholder entitled to vote at such meeting, except as otherwise provided in the company&rsquo;s by-laws
    or as required by the DGCL.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Remuneration
    reports</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Corporations Act requires that a public company&rsquo;s annual report must include a report
                                            by the Directors on the company&rsquo;s remuneration framework (<B>remuneration report</B>).</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the company&rsquo;s annual general meeting, shareholders must vote to approve or reject the remuneration report.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    vote on the resolution is advisory only and does not bind the directors or the company. However, if the company&rsquo;s remuneration
    report receives a &lsquo;no&rsquo; vote of 25% of more, the company&rsquo;s subsequent remuneration report must explain whether and
    how shareholders&rsquo; concerns have been taken into account.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    the company&rsquo;s subsequent remuneration report receives a &lsquo;no&rsquo; vote of 25% or more, shareholders will vote at the
    same annual general meeting to determine whether the directors (other than the managing director) will need to stand for re-election
    within 90 days.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    the resolution passes, then the &lsquo;spill meeting&rsquo; at which the directors face re-election, will take place within 90 days.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Constitution provides that the directors are entitled to be remunerated. The extend of such remuneration shall be determined by the
    Alta Board, subject to laws relating to the giving of benefits to related parties, and to the extent applicable, any maximum amount
    that is from time to time approved by the shareholders of the company in a general meeting in accordance with any applicable listing
    rules.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Constitution also provides that:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14pt; text-align: justify; text-indent: -15pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14pt; text-align: justify; text-indent: -15pt"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            the U.S., the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (U.S.) requires
                                            all &lsquo;reporting companies&rsquo; to have an advisory Shareholder vote on pay at least
                                            once every three years.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
    must report the results and say how they have responded to these when making decisions on pay the following year.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
    long as Alta qualifies as an &lsquo;emerging growth company,&rsquo; it will not be required to hold an advisory Shareholder vote
    on pay.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company will be an emerging growth company until the earliest of: (i) the last day of the fiscal year in which our annual gross revenues
    exceed US$1.235 billion, (ii) the last day of the fiscal year following the fifth anniversary of the date of the first sale of common
    equity securities of the company pursuant to an effective registration statement under the Securities Act of 1933, (iii) the date
    on which the Company has, during the previous three year period, issued more than US$1 billion in non-convertible debt, or (iv) the
    date that we become a &lsquo;large accelerated filer&rsquo; as defined in Rule 12b-2 under the U.S. Exchange Act.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    company becomes a large accelerated filer if it meets the following conditions as of the end of its fiscal year: (i) it has an aggregate
    worldwide market value of the voting and non-voting common equity held by non-affiliates of US$700 million or more as of the last
    business day of its second fiscal quarter; (ii) it has been subject to the requirements of Section 13(a) or 15(d) of the U.S. Exchange
    Act for at least 12 months; (iii) it has filed at least one annual report pursuant to Section 13(a) or 15(d) of the U.S. Exchange
    Act; and (iv) it is not eligible to rely on certain requirements for smaller reporting companies for its annual and quarterly reports.</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
    remuneration may be provided in the form of shares or other securities of the company or any subsidiary of the company, or options
    or rights to acquire such shares or other securities, on such terms as the Alta Board may decide; and</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
    directors may also be paid all travelling, and other expenses properly incurred by them: (a) in attending and returning from: (i)
    meetings of directors or any committee; or (ii) general meetings of the company; or (b) otherwise in connection with the business
    of the company.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approval
    of Corporate Matters by Written Consent</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Constitution provides that anything which may be done by resolution of the Company in a general meeting, may be done by written resolution.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise specified in a corporation&rsquo;s certificate of incorporation, shareholders may take action permitted to be taken at
    an annual or special meeting, without a meeting, prior notice or a vote, if consents, in writing, setting forth the action, are signed
    by shareholders with not less than the minimum number of votes that would be necessary to authorize the action at a meeting. All
    consents must be dated and are only effective if the requisite signatures are collected within 60 days of the earliest dated consent
    delivered.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Special
    resolutions</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            the Corporations Act, a special resolution must be a resolution that is passed by at least
                                            75% of the votes cast by members entitled to vote on the resolution.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
    by special resolution of shareholders is required for actions such as modifying or repealing our Constitution, changing Alta&rsquo;s
    name or company type, selectively reducing or buying back capital (in some circumstances), providing financial assistance in connection
    with the acquisition of shares in the company, and undertaking a voluntary winding up of Alta.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    DGCL contains no concept of special resolutions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Removing
    directors</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Corporations Act provides that a public company may by resolution at a general meeting remove
                                            a director from office.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
    of intention to move the resolution must be given by the company at least 2 months before the meeting is to be held, and the company
    must notify the director as soon as possible after notice of the intention is received.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to certain exceptions, the DGCL provides that directors may be removed with or without cause by the affirmative vote of the holders
    of a majority of the voting power of all of the outstanding shares of capital stock entitled to vote generally in the election of
    directors.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Duties
    and liability of directors</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
                                            duties imposed by the Corporations Act on directors and officers of companies include duties
                                            to exercise duties and powers with due care and diligence, in good faith and for a proper
                                            purpose, and not to improperly use their position or information obtained through their position
                                            to gain advantage or cause detriment to the company.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the Corporations Act, there is a general prohibition on a company or a related body corporate exempting officers from any liability
    incurred as an officer of the company.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            Delaware law, the directors of a company incorporated in Delaware have fiduciary obligations,
                                            including the duty of care and the duty of loyalty.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    duty of care requires directors to act in good faith, with the care that a reasonable person in a similar position and circumstances
    would exercise and in a manner the director reasonably believes to be in the best interests of the company and its stockholders.
    Directors must inform themselves of all reasonably available material information before making business decisions on behalf of the
    company and to act with requisite care in discharging their duties to the company.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    duty of loyalty requires directors to act in good faith and in the company&rsquo;s best interests.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the DGCL, a company incorporated in Delaware may include in its certificate of incorporation a provision eliminating the personal
    liability of a director or officer to the company or its stockholders for monetary damages for a breach of fiduciary duty as a director
    or officer.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
    the provision may not eliminate liability for:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif">breach
    of the director&rsquo;s or officer&rsquo;s duty of loyalty;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">acts
    or omissions not in good faith or which involve intentional misconduct or a knowing violation of the law;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">directors
    for unlawful payment of dividends;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">directors
    for unlawful purchases or redemptions of shares;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">any
    transaction from which the director or officer derived an improper personal benefit; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">an
    officer in any action by or in the right of the corporation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bringing
    or intervening in legal proceedings on behalf of the entity</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            member, former member or person entitled to be a member of a company, or an officer or former
                                            officer of a company, may bring proceedings on behalf of a company and in the company&rsquo;s
                                            name where the company is unwilling or unable to do so.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceedings
    may only be brought if leave is granted by a Court, including Federal Court, the Supreme Court of a State or Territory of Australia,
    or Federal Circuit and Family Court of Australia, for the person to bring or intervene in proceedings.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leave
    will generally be granted if the court is satisfied that:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            DGCL permits a stockholder to bring a derivative action on behalf of a company if those in
                                            control of the company have failed to assert a claim belonging to the relevant company.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    actions have certain standing and eligibility requirements, including that the plaintiff in the action must generally have been a
    stockholder of the company at the time that the act complained of occurred and must maintain his or her status as a stockholder of
    the company throughout the course of the litigation. Derivative plaintiffs must have previously made a demand on the directors of
    the company to assert the corporate claim, unless such a demand would have been futile.</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif">it is probable
    that the company itself will not bring the proceedings or properly take responsibility for them;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">the applicant is acting
    in good faith;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">it is in the best interests
    of the company that the applicant be granted leave;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">if the application
    relates to leave to bring proceedings, there is a serious question to be tried;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">either at least 14
    days before making the application, the applicant gave written notice of the application to the company, or it is appropriate to
    grant leave even though the notice period was not provided.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Continuous
    disclosure</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Corporations Act contains provisions which require a listed company to comply with the relevant
                                            disclosure rules of their financial market, in summary being such information concerning
                                            the company that a reasonable person would expect to have a material effect on the price
                                            or the value of the company&rsquo;s shares.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    are also periodic reporting and disclosure rules that apply, requiring it (among other things) to report to ASIC at the end of every
    half year and annually in respect of its financial statements and reports.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
                                            reporting companies are subject to US federal securities laws and regulations in relation
                                            to its ongoing disclosure obligations.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
    listed on a national securities exchange, the US company will also be subject to the ongoing disclosure obligations of such exchange.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    NYSE listing rules and US federal securities laws and regulations will generally require disclosure to the public of any material
    information that would reasonably be expected to affect the value of a company&rsquo;s shares or influence investors&rsquo; decisions.
    This includes:</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif">annual
    reports on Form 10-K;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">quarterly reports on
    Form 10-Q;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">current reports containing
    material information required to be disclosed on Form 8-K;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">company insider reports;
    and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">proxy statement.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inspection
    of Books and Records</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inspection
    of our records is governed by the Corporations Act. Any member of the public has the right to inspect or obtain copies of our registers,
    and the Company may charge a fee not exceeding the prescribed fee set by regulation. Shareholders are not required to pay a fee for
    inspection of our registers or minute books of the meetings of shareholders. Other corporate records, including minutes of directors&rsquo;
    meetings, financial records and other documents, are not open for inspection by the public or shareholders. Where a shareholder is
    acting in good faith and an inspection is deemed to be made for a proper purpose, a shareholder may apply to the court to make an
    order for inspection of our books.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    shareholders of a Delaware corporation have the right, upon written demand, to inspect or obtain copies of the corporation&rsquo;s
    shares ledger and its other books and records for any purpose reasonably related to such person&rsquo;s interest as a shareholder</FONT></TD></TR>

</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Insider
    trading</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Corporations Act prohibits any person who:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">US
    federal securities laws generally prohibit any person who possesses material non-public information relating to a company incorporated
    in the US or its securities from buying or selling those securities or procuring others to do so, or from communicating the material
    non-public information to third parties.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 36%">possesses information that is not generally available, but if it were generally available,
                                            a reasonable person would expect it to have a material effect on the price or value of company&rsquo;s
                                            securities (<B>Inside Information</B>); and</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 44%">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">
                                            knew, or ought reasonably to have known, that the information was Inside Information,</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">from applying for, buying or selling those securities (or entering an agreement to do so) or procuring others to do so. The prohibition also extends to the communication of the information (or causing the information to be communicated) directly or indirectly to third parties if the person knew, or ought reasonably to have known, that the recipient would or would be likely to apply for, buy or sell the securities (or enter an agreement to do so), or procure others to do so.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">This prohibition is subject to certain limited exceptions.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Winding
    up</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            members of a solvent company may determine to wind-up the company under the Corporations
                                            Act. A special resolution is required.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
    the passing of the resolution, the company must cease to carry on its business except so far as the liquidator considers is required
    for the beneficial disposal or winding up of that business, but the corporate state and corporate powers of the company continue
    until it is deregistered.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Constitution states that if Alta is wound up, if the assets available for distribution among the shareholders are insufficient to
    repay the whole of the paid up capital, the assets must be distributed so that, as nearly as may be, the losses are borne by the
    shareholders in proportion to the capital paid up, or which ought to have been paid up, at the commencement of the winding up, on
    the Shares held by them respectively, alternatively, if the assets available for distribution among the shareholders are more than
    sufficient to repay the whole of the capital paid up at the commencement of the winding up, the excess must be distributed among
    the shareholders in proportion to the capital at the commencement of the winding up paid up, or which ought to have been paid up,
    on the Shares held by them respectively.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
    a liquidator may, with the sanction of a special resolution, divide the assets of Alta among the shareholders in kind. The liquidator
    cannot compel any member to accept marketable securities in respect of which there is a liability as part of a distribution of assets
    of Alta.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Corporations Act also provides that subject to provisions as to preferential payments, the property of a company must, on its winding
    up, be applied in satisfaction of its liabilities equally and, subject to that application, must, unless the company&rsquo;s constitution
    otherwise provides, be distributed among the members according to their rights and interests in the company.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            DGCL permits the board of directors to authorize the dissolution of a company incorporated
                                            in Delaware if:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    a majority of the directors in office adopt a resolution to approve dissolution at a board meeting called for that purpose;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    holders of a majority of the issued and outstanding shares entitled to vote on the matter adopt a resolution to approve dissolution
    at a stockholders&rsquo; meeting called for that purpose; and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    a certificate of dissolution is filed with the Delaware Secretary of State.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14pt; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    DGCL also permits stockholders to authorize the dissolution of a company incorporated in Delaware without board action if:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    all of the stockholders entitled to vote on the matter provide written consent to dissolution; and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14pt; text-align: justify; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    a certificate of dissolution is filed with the Delaware Secretary of State.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General
Meetings of Shareholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Australian law, shareholders of a public company are not permitted to approve corporate matters by written consent. General meetings
of shareholders may be called by our board. Notice of the proposed meeting of our shareholders is required at least 28 days prior to
such meeting under the Corporations Act. Except as permitted under the Corporations Act, shareholders may not convene a meeting. Under
the Corporations Act, shareholders with at least 5% of the votes that may be cast at a general meeting may call and arrange to hold a
general meeting. The meeting must be called in the same way in which general meetings of the company may be called, including the dispatch
of a notice of meeting including the matters to be voted upon. The shareholders calling the meeting must pay the expenses of calling
and holding the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporations Act requires the directors to call and arrange to hold a general meeting on the request of shareholders with at least 5%
of the votes that may be cast at a general meeting. The request must be made in writing, state any resolution to be proposed at the meeting,
be signed by the shareholders making the request and be given to the Company. The board must call the meeting not more than 21 days after
the request is made. The meeting must be held not later than two months after the request is given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
Ownership Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no limitations on the rights to own securities imposed by our Constitution. However, acquisitions and proposed acquisitions of shares
in Australian companies may be subject to review and approval by the Australian Federal Treasurer under the Foreign Acquisitions and
Takeovers Act 1975, or the FATA, which generally applies to acquisitions or proposed acquisitions by a foreign person (as defined in
the FATA) or associated foreign persons in certain transactions including those dealing with national security matters, of a sensitive
nature or dealing with an interest in land, or which are otherwise over certain monetary thresholds, including where the transaction:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">would
    result in such persons having an interest in 20% or more of the issued shares of, or control of 20% or more of the voting power in,
    an Australian company; and/or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    non-associated foreign persons that would result in such foreign person having an interest in 40% or more of the issued shares of,
    or control of 40% or more of the voting power in, an Australian company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is currently not considered by the Directors to be an Australian land corporation for the purposes of the FATA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
prior approval of the Australian Federal Treasurer is required for an investor to be issued shares in the Company is an assessment which
must be undertaken by each investor, as compliance with the FATA in those circumstances is the investor&rsquo;s obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separate
and stricter rules apply for foreign government investors (defined by the FATA). Generally, foreign government investors must seek prior
Foreign Investment Review Board approval where they acquire a direct interest in an entity or business. The term &lsquo;direct interest&rsquo;
has a very broad meaning under the Foreign Acquisitions and Takeovers Regulations 2015 and ranges from a 10% interest in an entity to
an interest of any percentage in an entity which gives the foreign government investor the ability to influence or participate in the
central management and control of the entity or business or determine its policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Australian Federal Treasurer may prevent a proposed acquisition in the above categories or impose conditions on such acquisition if the
Treasurer is satisfied that the acquisition would be contrary to the national interest. If a foreign person acquires shares or an interest
in shares in an Australian company in contravention of the FATA, the Australian Federal Treasurer may take a number of actions including
imposing civil or criminal penalties or ordering the divestiture of such person&rsquo;s shares or interest in shares in the Company.
The Australian Federal Treasurer may order divestiture pursuant to the FATA if he determines that the acquisition has resulted in that
foreign person, either alone or together with other non-associated or associated foreign persons, controlling the Company and that such
control is contrary to the national interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ownership
Threshold</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no provisions in our Constitution that require a shareholder to disclose ownership above a certain threshold. Upon becoming a U.S.
public company, our shareholders will also be subject to disclosure requirements under U.S. securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issues
of Shares and Change in Capital</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to our Constitution, the Corporations Act, and any other applicable law, we may at any time issue shares and grant options or warrants
on any terms, with preferred, deferred or other special rights and restrictions and for the consideration and other terms that the directors
determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the requirements of our Constitution, the Corporations Act, and any other applicable law, including relevant shareholder approvals,
we may consolidate or divide our share capital into a larger or smaller number by resolution, reduce our share capital (provided that
the reduction is fair and reasonable to our shareholders as a whole and does not materially prejudice our ability to pay creditors) or
buy back our Ordinary Shares whether under an equal access buy-back or on a selective basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Change
of Control</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeovers
of Australian public companies, such as Alta are regulated by the Corporations Act, which prohibits the acquisition of a &ldquo;relevant
interest&rdquo; in issued share capital of a public company if the acquisition will lead to that person&rsquo;s or someone else&rsquo;s
voting power in the company (when aggregated with their &ldquo;associates&rdquo;) increasing from 20% or below to more than 20%, or increasing
from a starting point that is above 20% and below 90%, subject to a range of exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a person will have a relevant interest in the securities of a company if the person:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    the holder of the securities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
    power to exercise, or control the exercise of, a right to vote attached to the securities; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
    the power to dispose of, or control the exercise of a power to dispose of, the securities, including any indirect or direct power
    or control.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at a particular time, a person has a relevant interest in issued securities and the person:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
    entered or enters into an agreement with another person with respect to the securities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
    given or gives another person an enforceable right, or has been or is given an enforceable right by another person, in relation to
    the securities (whether the right is enforceable presently or in the future and whether or not on the fulfillment of a condition);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
    granted or grants an option to, or has been or is granted an option by, another person with respect to the securities; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    other person would have a relevant interest in the securities if the agreement were performed, the right enforced or the option exercised,</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">then
the other person is taken to already have a relevant interest in the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are a number of exceptions to the above prohibition on acquiring a relevant interest in issued share capital in a company above 20%.
In general terms, applicable exceptions which may apply include a regulated takeover, or a &ldquo;whitewash resolution&rdquo; of shareholders,
among other exemptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASIC
and the Australian Takeovers Panel have a wide range of powers relating to breaches of takeover provisions, including the ability to
make orders canceling contracts, freezing transfers of, and rights attached to, securities, and forcing a party to dispose of securities.
There are certain defenses to breaches of the takeover provisions provided in the Corporations Act. Our Constitution, which is included
as an exhibit to this registration statement to which this prospectus forms a part, also contains a requirement for our shareholders
to approve any proportionate takeover bid (i.e., a bid for a specified proportion of a class of securities) without the approval of a
majority of our shareholders voting at a general meeting. For these provisions to be effective they must be approved by shareholders
at a general meeting at least every three years. The clause in the Constitution is operative until July 20, 2026 unless re-approved for
a longer period. The existence of these provisions may have the effect of discouraging proportionate takeover bids.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our Ordinary Shares is VStock Transfer, LLC. Its address is 18 Lafayette Place, Woodmere, NY 11598,
and its telephone number is (212) 828-8436.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Ordinary Shares are listed on the NYSE American under the symbol &ldquo;MMA.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.1
<SEQUENCE>3
<FILENAME>ex11-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
11.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 15pc"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B><IMG SRC="ex11-1_001.jpg" ALT=""></FONT></TD>
  <TD STYLE="text-align: right"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B> Alta Global Group Limited<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></FONT></P>
                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACN 163 057 565</FONT></FONT></P>
                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1, Suite 1, 29-33 The Corso Manly</FONT></FONT></P>
                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NSW 2095</FONT></FONT></P></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
TRADING POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6
March 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTRODUCTION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            policy outlines:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                            Key Management Personnel (KMP) and other Employees may deal in Company Securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                            KMP and other Employees may deal in listed securities of another entity (because they may
                                            obtain Inside Information about another entity&rsquo;s securities while performing their
                                            duties for the Group); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">procedures
                                            to reduce the risk of insider trading and the appearance of insider trading.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Securities Trading Policy has been prepared to address the requirements of the NYSE American
                                            Listing Rules which requires the Company to provide a framework to KMP and Employees when
                                            Dealing in Securities of the Company. The Securities Trading Policy has been prepared taking
                                            into consideration the following:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            size, nature and stage of the development of the Company&rsquo;s business (see below for
                                            further details);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obligations
                                            under the Corporations Act not to Deal in Company Securities whilst in possession of Inside
                                            Information;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rights
                                            of shareholders under the Constitution of the Company to freely trade their shares; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">contractual
                                            and statutory rights embedded in the Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            noted above, the Company&rsquo;s Securities Trading Policy has been prepared with the stage
                                            of development of the Company. Accordingly, the Closed Periods are based around the release
                                            of this information, rather than the release of financial reports. This aspect of the Company&rsquo;s
                                            Securities Trading Policy may change should the stage of development of the Company change
                                            in the future.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BREACH
                                            OF POLICY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            breach of this Policy by an Employee (even if the Employee is not a KMP) is serious and may
                                            lead to disciplinary action, including dismissal in serious cases. It may also be a breach
                                            of the law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider
                                            trading is a serious matter which is a criminal offence. It is punishable by substantial
                                            fines or imprisonment or both.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider
                                            trading may also attract civil penalties. A court may impose substantial pecuniary penalties
                                            for insider trading and order payment of compensation to persons who suffer loss or damage
                                            because of insider trading.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEN
                                            EMPLOYEES MAY DEAL</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Employee (who is not a KMP) may Deal in Company Securities or the Securities of a Transaction Entity if he or she does not have information
that he or she knows, or ought reasonably to know, is Inside Information in relation to Company Securities or the Securities of a Transaction
Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEN
                                            EMPLOYEES MAY NOT DEAL</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Employee who is not a KMP may not Deal or procure another person to Deal in Company Securities or the Securities of a Transaction Entity
if he or she has information that he or she knows, or ought reasonably to know, is Inside Information in relation to Company Securities
or the Securities of a Transaction Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEN
                                            A KMP MAY DEAL</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the requirements of this Policy (including the required prior approvals and restrictions during Closed Periods), a KMP may Deal in
Company Securities or the Securities of a Transaction Entity if he or she does not have information that he or she knows, or ought reasonably
to know, is Inside Information in relation Company Securities or the Securities of a Transaction Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEN
                                            A KMP MAY NOT DEAL IN COMPANY SECURITIES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to Clauses 7 and 8 of this Policy, a KMP may not Deal or procure another person to Deal in
                                            Company Securities:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            he or she has information that he or she knows, or ought reasonably to know, is Inside Information
                                            in relation to Company Securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">during
                                            a Closed Period;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            he or she has information that he or she knows, or ought reasonably to know, has not been
                                            announced to the market under NYSE American rules in relation to Company Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            KMP may not Deal or procure another person to Deal in the Securities of a Transaction Entity
                                            if he or she has information that he or she knows, or ought reasonably to know, is Inside
                                            Information in relation to the Securities of a Transaction Entity.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KMP
                                            are prohibited at all times from Dealing in financial products issued or created over or
                                            in respect of the Company&rsquo;s Securities. For the avoidance of doubt this clause does
                                            not apply to an option over unissued capital granted by the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KMP
                                            are prohibited at all times from entering into margin lending or similar arrangements in
                                            respect to Company Securities they hold or in which they have a Relevant Interest.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXCLUDED
                                            TRADING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy does not prohibit Dealing in the Company&rsquo;s Securities during a Closed Period as outlined in Schedule 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXCEPTIONAL
                                            CIRCUMSTANCES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Approving Officer may give clearance during a Closed Period for a KMP to sell (but not buy)
                                            Company Securities in Exceptional Circumstances.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Approving Officer may not give clearance under the exception in clause 8.1 if there is a
                                            matter about which there is Inside Information in relation to Company Securities (whether
                                            or not the KMP knows about the matter) when the KMP requests clearance or proposes to Deal
                                            in Company Securities. This prohibition is subject to any lawful obligation to the contrary
                                            (for example, for an order of a court)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            KMP seeking clearance to Deal in the Securities must outline in writing to the Approving
                                            Officer the circumstances of their severe financial hardship or as to why their circumstances
                                            are otherwise exceptional and that the proposed Dealing in the Securities is the only reasonable
                                            course of action available.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Approving Officer will decide if the Exceptional Circumstances exist.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            list of matters that may constitute Exceptional Circumstances is contained in Schedule 3.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLEARANCE
                                            FROM THE APPROVING OFFICER</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            least 2 Business Days prior to when a KMP intends to Deal in Company Securities, the KMP
                                            must first inform the Approving Officer (and at the same time the Company Secretary) by submitting
                                            a completed Securities Trading Request Form (See Schedule 6). If the KMP is not able to fax
                                            or email a scanned copy of the Securities Trading Request Form, then the KMP may send an
                                            email with the same information in it to the Approving Officer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Approving Officer must approve or reject the Securities Trading Request as soon as practicable
                                            (generally within 2 Business Days). The KMP must not Deal in Company Securities until it
                                            has received the clearance from the Approving Officer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Approving Officer may not give clearance if:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            is a matter about which there is or may be Inside Information in relation to Company Securities
                                            (whether or not the KMP knows about the matter) when the KMP requests clearance or proposes
                                            to deal in Company Securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Securities Trading Request form is lodged during a Closed Period;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            proposed Dealing is during a Closed Period; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Approving Officer has any other reason to believe that the proposed Dealing breaches this
                                            Policy.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            making a determination under 9.3(a) about the existence of Inside Information the Approving
                                            Officer should exercise caution and refuse the clearance if there is any possibility that
                                            Inside Information may exist.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Irrespective
                                            of any clearances given under this Policy, the Employee or KMP is not to Deal with Company
                                            Securities whilst in possession of Inside Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Approving Officer must:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">keep
                                            a written record of:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            information received from a KMP in connection with this Policy; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            clearance given under this policy, including the duration for which the clearance applies;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">send
                                            a copy of the written record to the Company Secretary for keeping.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company Secretary must keep a file of any written record referred to in clauses 9.1 and 9.6.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.8</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purposes of this policy, written requests and clearances may include facsimiles and emails
                                            and are valid for a period the earlier of:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
                                            Business Days;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Business Day before the Company enters a Closed Period; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            time that the KMP comes into possession of Inside Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEALINGS
                                            IN WHICH A KMP HAS A RELEVANT INTEREST</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
KMP must prohibit any Dealing in the Company Securities in which the KMP has a Relevant Interest while the KMP is in possession of Inside
Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMUNICATING
                                            INSIDE INFORMATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            an Employee (including a KMP) has information that he or she knows, or ought reasonably to
                                            know, is Inside Information in relation to Company Securities or the Securities of Transaction
                                            Entity, the Employee must not directly or indirectly communicate that information to another
                                            person if he or she knows, or ought reasonably to know, that the other person would or would
                                            be likely to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deal
                                            in Company Securities or the Securities of a Transaction Entity; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">procure
                                            another person to Deal in Company Securities or the Securities of a Transaction Entity.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            otherwise authorized, an Employee must not inform colleagues (except the Approving Officer)
                                            about Inside Information or its details.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTIFICATION
                                            OF TRADES IN COMPANY SECURITIES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KMP
must notify the Company Secretary of any Dealings in the Company&rsquo;s securities with two business days of such Deal occurring. Initial,
ongoing and final notifications will be required which must include the details set out in Schedule 4 to this Securities Trading Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SPECULATIVE
                                            DEALING</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
KMP may not deal in Company Securities on considerations of a short term nature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DISTRIBUTION
                                            OF POLICY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
policy must be distributed to all KMPs and Employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSISTANCE
                                            AND ADDITIONAL INFORMATION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
who are unsure about any information they may have in their possession, and whether they can use that information for Dealing in Company
Securities or Securities in a Transaction Entity, should contact the Authorized Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
1 &ndash; Defined Terms</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this policy:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approving
Officer</B> means:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                            a KMP who is not a Director, the Chief Executive Officer;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                            a Director (except the chairman of the board), the chairman of the board; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                            the chairman of the board, any other two Directors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
Day</B> means any day of the week other than a Saturday, Sunday or Public Holiday.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Closed
Period</B> means:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">during
                                            the 10 Business Day period prior to the expected release of, and two hours after the actual
                                            release of, announcements regarding:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
                                            figures;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">profit
                                            and production forecasts;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">material
                                            borrowings or material changes to terms of existing borrowings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">material
                                            changes to liquidity and material cash flow information;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                            changes in operations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(F)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                            litigation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(G)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                            mergers, joint ventures, acquisitions, restructures, or takeovers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(H)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">major
                                            asset purchases or sales;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">material
                                            new products and technology; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(J)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">capital
                                            raisings by the Company (except participation by a KMP in the capital raising itself).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">during
                                            the 5 Business Day period prior to the expected release of, and two hours after the actual
                                            release of, the following:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">quarterly
                                            activity reports, quarterly cash flow statements, half year financial results, and full year
                                            financial results;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            disclosure document for the offer of Securities in the Company containing Inside Information
                                            or information that has not been announced to the market under NYSE American Listing Rules;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            target statement for a takeover offer for Securities in the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            bidder&rsquo;s statement for the issue of Securities in the Company; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            scheme booklet for a merger by way of a scheme of arrangement involving the Securities of
                                            the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
</B>means ALTA Global Group Limited (ACN 163 057 565).</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Securities</B> means all Securities in the Company or a Group member whether or not listed or traded on the NYSE American or other financial
market (including financial products issued or created over or in respect of the Company&rsquo;s Securities).</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporations
Act</B> means the Corporations Act 2001.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deal
</B>includes acquiring, disposing of, subscribing for, and Dealing has a corresponding meaning. A decision to join, or subscribe for
shares under, any dividend reinvestment plan is not dealing in Company Securities.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
</B>means a director of the Company.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employee
</B>means any employee or consultant of the Company.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exceptional
Circumstance</B> has the meaning outlined in Schedule 3.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Generally
available information</B> is information that is:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                            readily observable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                            been made known in a manner likely to bring it to the attention of persons who commonly invest
                                            in securities of the relevant type and a reasonable period for that information to be disseminated
                                            has elapsed since it was made known; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">consists
                                            of deductions, conclusions or inferences made or drawn from information falling under paragraphs
                                            (a) or (b).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Group
</B>means the Company and each of its controlled entities.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inside
Information</B> means information that is not generally available and if it were generally available, a reasonable person would expect
it to have a Material Effect on the price or value of the Company&rsquo;s Securities. For the purposes of this Policy, Inside Information
generally includes, but is not limited to the following (prior to it being generally available):</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">material
                                            results;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
                                            figures;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">profit
                                            and production forecasts;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">material
                                            borrowings or material changes to terms of existing borrowings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">material
                                            changes to liquidity and material cash flow information;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                            changes in operations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                            litigation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">impending
                                            mergers, joint ventures, acquisitions, restructures, takeovers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">major
                                            asset purchases or sales; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">material
                                            new products and technology.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insider
Trading </B>in relation to this Policy means if a person has information about securities and the person knows, or ought reasonably to
know, that the information is Inside Information, the person is prohibited from:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 36.55pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dealing
                                            in the securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">procuring
                                            another person to Deal in the securities; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">giving
                                            the information to another person who the person knows, or ought reasonably to know, is likely
                                            to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deal
                                            in the securities; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">procure
                                            someone else to Deal in the securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
Management Personnel</B> or <B>KMP</B> means those persons having authority and responsibility for planning, directing and controlling
the activities of the entity, directly or indirectly, including any director (whether executive or otherwise), chief executive officer,
chief financial officer or company secretary of that entity, as determined in accordance with Accounting Standard AASB 124 &lsquo;Related
Party Disclosure&rsquo;.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of this Policy, information is taken to be <B>Material</B> or will have a <B>Material Effect </B>if the information would,
or would be likely to, influence persons who commonly acquire securities in deciding whether or not to acquire or dispose of the Company&rsquo;s
Securities<B>.</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relevant
Interest</B> A person has a Relevant Interest in securities if they:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 36.55pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are
                                            the holder of the securities; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                            power to exercise, or control the exercise of, a right to vote attached to the securities;
                                            or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                            power to dispose of, or control the exercise of a power to dispose of, the securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
</B>includes shares, debentures, rights, options, employee options, prescribed interests and warrants and Securities has a corresponding
meaning.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transaction
Entity </B>means an entity which the Company has business dealings which is listed on any financial market.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
2 &ndash; Exclusions From The Securities Trading Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dealing
excluded from the operation of Policy includes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transfers
                                            of Securities already held into a superannuation fund or other saving scheme in which the
                                            KMP is a beneficiary;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.6pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transfers
                                            of Securities where there is no change in beneficial ownership;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.6pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            investment in, or trading in units of, a fund or other scheme (other than a scheme only investing
                                            in the securities of the entity) where the assets of the fund or other scheme are invested
                                            at the discretion of a third party;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.6pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            a KMP is a trustee, trading in Securities by that trust provided the KMP is not a beneficiary
                                            of the trust and any decision to trade during a Closed Period is taken by the other trustees
                                            or by the investment managers independently of the KMP;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.6pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">undertakings
                                            to accept, or acceptance of, a takeover offer;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.6pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">trading
                                            under an offer or invitation made to all or most of the security holders, such as, a rights
                                            issue, a security purchase plan, a dividend or distribution reinvestment plan and an equal
                                            access buy-back, where the plan that determines the timing and structure of the offer has
                                            been approved by the board. This includes decisions relating to whether or not to take up
                                            the entitlements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.6pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            exercise (but not the sale of securities following exercise) of an option or a right under
                                            an employee incentive scheme, or the conversion of a convertible security;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.6pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">trading
                                            under a non-discretionary trading plan for which prior written clearance has been provided
                                            in accordance with procedures set out in the trading policy (including a plan whereby the
                                            Company or an agent sells Securities on behalf of KMP to meet any taxation consequences arising
                                            from the conversion of rights or exercise of options held by KMP) and where:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.6pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.3in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            KMP did not enter into the plan or amend the plan during a Closed Period;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            trading plan does not permit the KMP to exercise any influence or discretion over how, when,
                                            or whether to trade; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity&rsquo;s trading policy does not allow for the cancellation of a trading plan during
                                            a Closed Period other than in exceptional circumstances; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            issue or grant of Company Securities by the Company to a KMP where shareholder approval for
                                            the issue of the Company Securities has been obtained and if Inside Information exists both
                                            the Company and KMP are fully aware of the Inside Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.6pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
3 &ndash; Exceptional Circumstances</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of this Policy, Exceptional Circumstances include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">severe
                                            financial hardship whereby the Employee has a pressing financial commitment that cannot be
                                            satisfied otherwise than by selling the relevant Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
example, a tax liability of an Employee would not normally constitute severe financial hardship unless the person has no other means
of satisfying the liability. A tax liability relating to Securities received under an employee incentive scheme would also not normally
constitute severe financial hardship or otherwise be considered an Exceptional Circumstance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 70.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Employee is required by a court order, or there are court enforceable undertakings, for example,
                                            in a bona fide family settlement, to transfer or sell the securities of the entity or there
                                            is some other overriding legal or regulatory requirement for him or her to do so.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            unforeseen circumstance that is considered by the Board to be consistent with the objectives
                                            of this Policy.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
4 &ndash; Notification Requirements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Initial
disclosure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            KMP will provide the following information as at the date of appointment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">details
                                            of all Company Securities registered in the KMP&rsquo;s name. These details include the number
                                            and class of the Company Securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">details
                                            of all Company Securities not registered in the KMP&rsquo;s name but in which the KMP has
                                            a Relevant Interest. These details include the number and class of the Company Securities,
                                            the name of the registered holder and the circumstances giving rise to the Relevant Interest;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">details
                                            of all contracts (other than contracts to which the Company is a party) to which the KMP
                                            is a party or under which the KMP is entitled to a benefit, and that confer a right to call
                                            for or deliver shares in, debentures of, or interests in a managed investment scheme made
                                            available by, the Company or a related body corporate. These details include the number and
                                            class of shares, debentures or interests, the name of the registered holder if the shares,
                                            debentures or interests have been issued and the nature of the KMP&rsquo;s interest under
                                            contract.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            KMP will provide the required information as soon as reasonably possible after the date of
                                            appointment and in any event not later than two Business Days after the date KMP&rsquo;s
                                            date of appointment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ongoing
disclosure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            KMP will provide the following information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">details
                                            of changes in Company Securities registered in the KMP&rsquo;s name other than changes occurring
                                            as a result of corporate actions by the Company. These details include the date of the change,
                                            the number and class of the Company Securities held before and after the change, and the
                                            nature of the change, for example on-market transfer. The KMP will also provide details of
                                            the consideration payable in connection with the change, or if a market consideration is
                                            not payable, the value of the Company Securities the subject of the change;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">details
                                            of changes in Company Securities not registered in the KMP&rsquo;s name but in which the
                                            KMP has a Relevant Interest. These details shall include the date of the change, the number
                                            and class of the Company Securities held before and after the change, the name of the registered
                                            holder before and after the change, and the circumstances giving rise to the Relevant Interest.
                                            The KMP will also provide details of the consideration payable in connection with the change,
                                            or if a market consideration is not payable, the value of the Company Securities the subject
                                            of the change; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">details
                                            of all changes to contracts (other than contracts to which the Company is a party) to which
                                            the KMP is a party or under which the KMP is entitled to a benefit, and that confer a right
                                            to call for or deliver shares in, debentures of, or interests in a managed investment scheme
                                            made available by, the Company or a related body corporate. These details include the date
                                            of the change, the number and class of the shares, debentures or interests to which the interest
                                            relates before and after the change, the name of the registered holder if the shares, debentures
                                            or interests have been issued, and the nature of the KMP&rsquo;s interests under the contract.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.45pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            KMP will provide the required information as soon as reasonably possible after the date of
                                            the change and in any event no later than two Business Days after the date of the change.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Final
disclosure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            KMP will provide the following information as at the date of ceasing to be a KMP.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">details
                                            of all Company Securities registered in the KMP&rsquo;s name. These details include the number
                                            and class of the Securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">details
                                            of all Company Securities not registered in the KMP&rsquo;s name but in which the KMP has
                                            a Relevant Interest. These details include the number and class of the Company Securities,
                                            the name of the registered holder and the circumstances giving rise to the Relevant Interest;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">details
                                            of all contracts (other than contracts to which the Company is a party) to which the KMP
                                            is a party or under which the KMP is entitled to a benefit, and that confer a right to call
                                            for or delivery shares in, debentures of, or interests in a managed investment scheme made
                                            available by, the Company or a related body corporate. These details include the number and
                                            class of the shares, debentures or interests, the name of the registered holder if the shares
                                            debentures or interests have been issued and the nature of the interest under the contract.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            KMP will provide the required information as soon as reasonably possible after the date of
                                            ceasing to be a KMP and in any event no later than two Business Days after the date of ceasing
                                            to be a KMP.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
5 - Form of Acknowledgement by Employee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            have read and understood the document titled &ldquo;Securities Trading Policy&rdquo; of the
                                            ALTA Global Group Limited. (the <B>Securities Trading Policy</B>).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            agree to be bound by, and to comply with, the Securities Trading Policy.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            acknowledge and agree that the Securities Trading Policy forms part of the terms of my appointment
                                            as an employee/director/consultant of ALTA Global Group Limited.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:
&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
...&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;..&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>To
be returned to the Company Secretary on completion.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I><B>Schedule
6 - Securities Trading Request</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Securities Trading Policy of the ALTA Global Group Limited, before dealing in any Company Securities you are required
to obtain clearance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
forward this request to Approving Officer by email to Jonathan@trainalta.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 40%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 50%">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD>
  <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD>
  <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Location:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD>
  <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD>
  <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
request permission to trade the following Securities which are currently held / proposed to be held by myself personally and/or other
parties with whom I have a Relevant Interest as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registered
    Name of <BR>
Security Holder</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 26%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Type
    of Company <BR>
Security</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Company<BR>
 Securities</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Buy/Sell
    </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
confirm that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it is not a Closed Period;</FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I am not in possession of Inside Information;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            will not deal in the above Company Securities until I am notified that clearance is approved;
                                            and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I may be refused permission to deal without explanation.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed:
__________________________________ Date: _______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
form is valid for a period of 5 Business Days from the date of approval. After this time, clearance will lapse and a further request
will need to be completed. This form will be returned to you with the period of validation completed if approval has been granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>For
completion by the Approving Officer:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
for the above dealing bas been <I>cleared for a period of 5 Business Days / refused</I> (Approving Officer to delete one).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed:
__________________________________ Date: _______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Approving Officer: _______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>ex12-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
12.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO RULES 13a-14(a) AND 15d-14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Nick Langton, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            have reviewed this annual report on Form 20-F of Alta Global Group Limited;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            on my knowledge, this report does not contain any untrue statement of a material fact or
                                            omit to state a material fact necessary to make the statements made, in light of the circumstances
                                            under which such statements were made, not misleading with respect to the period covered
                                            by this report;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            on my knowledge, the financial statements, and other financial information included in this
                                            report, fairly present in all material respects the financial condition, results of operations
                                            and cash flows of the company as of, and for, the periods presented in this report;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            company&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining
                                            disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
                                            and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)
                                            and 15d-15(f)) for the company and have:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
                                            such disclosure controls and procedures, or caused such disclosure controls and procedures
                                            to be designed under our supervision, to ensure that material information relating to the
                                            company, including its consolidated subsidiaries, is made known to us by others within those
                                            entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
                                            such internal control over financial reporting, or caused such internal control over financial
                                            reporting to be designed under our supervision, to provide reasonable assurance regarding
                                            the reliability of financial reporting and the preparation of financial statements for external
                                            purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
                                            the effectiveness of the company&rsquo;s disclosure controls and procedures and presented
                                            in this report our conclusions about the effectiveness of the disclosure controls and procedures,
                                            as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
                                            in this report any change in the company&rsquo;s internal control over financial reporting
                                            that occurred during the period covered by the annual report that has materially affected,
                                            or is reasonably likely to materially affect, the company&rsquo;s internal control over financial
                                            reporting; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            company&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent
                                            evaluation of internal control over financial reporting, to the company&rsquo;s auditors
                                            and the audit committee of the company&rsquo;s board of directors (or persons performing
                                            the equivalent functions):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            significant deficiencies and material weaknesses in the design or operation of internal control
                                            over financial reporting which are reasonably likely to adversely affect the company&rsquo;s
                                            ability to record, process, summarize and report financial information; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            fraud, whether or not material, that involves management or other employees who have a significant
                                            role in the company&rsquo;s internal control over financial reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
October 31, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
  Nick Langton</I> </FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 50%">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nick Langton</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
Executive Officer)</FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>5
<FILENAME>ex12-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
12.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO RULES 13a-14(a) AND 15d-14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Neale Java, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            have reviewed this annual report on Form 20-F of Alta Global Group Limited;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            on my knowledge, this report does not contain any untrue statement of a material fact or
                                            omit to state a material fact necessary to make the statements made, in light of the circumstances
                                            under which such statements were made, not misleading with respect to the period covered
                                            by this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            on my knowledge, the financial statements, and other financial information included in this
                                            report, fairly present in all material respects the financial condition, results of operations
                                            and cash flows of the company as of, and for, the periods presented in this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            company&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining
                                            disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
                                            and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)
                                            and 15d-15(f)) for the company and have:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
                                            such disclosure controls and procedures, or caused such disclosure controls and procedures
                                            to be designed under our supervision, to ensure that material information relating to the
                                            company, including its consolidated subsidiaries, is made known to us by others within those
                                            entities, particularly during the period in which this report is being prepared;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
                                            such internal control over financial reporting, or caused such internal control over financial
                                            reporting to be designed under our supervision, to provide reasonable assurance regarding
                                            the reliability of financial reporting and the preparation of financial statements for external
                                            purposes in accordance with generally accepted accounting principles;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
                                            the effectiveness of the company&rsquo;s disclosure controls and procedures and presented
                                            in this report our conclusions about the effectiveness of the disclosure controls and procedures,
                                            as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
                                            in this report any change in the company&rsquo;s internal control over financial reporting
                                            that occurred during the period covered by the annual report that has materially affected,
                                            or is reasonably likely to materially affect, the company&rsquo;s internal control over financial
                                            reporting; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            company&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent
                                            evaluation of internal control over financial reporting, to the company&rsquo;s auditors
                                            and the audit committee of the company&rsquo;s board of directors (or persons performing
                                            the equivalent functions):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            significant deficiencies and material weaknesses in the design or operation of internal control
                                            over financial reporting which are reasonably likely to adversely affect the company&rsquo;s
                                            ability to record, process, summarize and report financial information; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            fraud, whether or not material, that involves management or other employees who have a significant
                                            role in the company&rsquo;s internal control over financial reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
October 31, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-bottom: 1pt; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Neale Java
  </FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 50%">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neale Java</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
Financial Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>6
<FILENAME>ex13-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
13.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report of Alta Global Group Limited (the &ldquo;Company&rdquo;) on Form 20-F for the fiscal year ended June
30, 2024 (the &ldquo;Annual Report&rdquo;) as filed with the Securities and Exchange Commission on the date hereof, I, Nick Langton,
Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, as amended; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 31, 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Nick Langton</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nick Langton</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>7
<FILENAME>ex13-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 13.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report of Alta Global Group Limited (the &ldquo;Company&rdquo;) on Form 20-F for the fiscal year ended June
30, 2024 (the &ldquo;Annual Report&rdquo;) as filed with the Securities and Exchange Commission on the date hereof, I, Neale Java, Chief
Financial Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Annual
    Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, as amended; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the information
    contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the
    Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 31, 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Neale Java</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 57%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neale Java</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>8
<FILENAME>ex97-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
97.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALTA
GLOBAL GROUP LIMITED</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLAWBACK
POLICY</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Purpose
    and Scope</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors (the &ldquo;<B>Board</B>&rdquo;) of the Company believes that it is in the best interests of the Company and its shareholders
to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company&rsquo;s pay-for-performance
compensation philosophy. The Board has therefore adopted this Clawback Policy (this &ldquo;<B>Policy</B>&rdquo;), which provides for
the reasonably prompt recovery of erroneously awarded Incentive Compensation (as defined below) in the event of a Triggering Event (as
defined below). Unless otherwise defined herein, the capitalized terms have the meanings set forth under &ldquo;XIV. Definitions.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>II.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Administration</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy is designed to comply with and shall be interpreted to be consistent with Section 10D of the Exchange Act, Rule 10D-1 of the Exchange
Act, the listing standards of the NYSE American and other regulations, rules and guidance of the Securities and Exchange Commission (the
&ldquo;<B>SEC</B>&rdquo;) thereunder, and related securities regulations and regulations of the stock exchange or association on which
Company&rsquo;s common shares are listed (collectively, the &ldquo;<B>Listing Standards</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy shall be administered by the Remuneration and Nomination Committee of the Board, or in the absence of such committee, a majority
of the independent directors serving on a subcommittee of the Board (any such committee or subcommittee of the Board, the &ldquo;<B>Committee</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
determinations made by the Committee shall be final and binding. In addition, the Company shall file all disclosures with respect to
this Policy in accordance with the Listing Standards. The Committee hereby has the power and authority to enforce the terms and conditions
of this Policy and to use any and all of the Company&rsquo;s resources it deems appropriate to recoup any excess Incentive Compensation
subject to this Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>III.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Covered
    Executives</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy applies to the Company&rsquo;s current and former Covered Executives, as determined by the Committee in accordance with the Listing
Standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IV.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Events
    That Trigger Recoupment Under This Policy</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board or Committee will be required to recoup any excess Incentive Compensation received by any Covered Executive during the three (3)
completed fiscal years (together with any intermittent stub fiscal year period(s) of less than nine (9) months resulting from the Company&rsquo;s
transition to different fiscal year measurement dates) immediately preceding the date the Company is deemed (as determined pursuant to
the immediately following sentence) to be required to prepare a Covered Accounting Restatement of its financial statements (the &ldquo;<B>Three-Year
Recovery Period</B>&rdquo;) irrespective of any fault, misconduct or responsibility of such Covered Executive for the Covered Accounting
Restatement. For purposes of the immediately preceding sentence, the Company is deemed to be required to prepare a Covered Accounting
Restatement on the earlier of: (A) the date upon which the Board or applicable committee of the Board, or the officer or officers of
the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the
Company is required to prepare a Covered Accounting Restatement; or (B) the date a court, regulator, or other legally authorized body
directs the Company to prepare a Covered Accounting Restatement (each, a &ldquo;<B>Triggering Event</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>V.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Excess
    Incentive Compensation: Amount Subject to Recovery</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of Incentive Compensation to be recovered shall be the excess of the Incentive Compensation &ldquo;received&rdquo; by the Covered
Executive over the amount of Incentive Compensation which would have been received by the Covered Executive had the amount of such Incentive
Compensation been calculated based on the restated amounts, as determined by the Committee. For purposes of this Policy, Incentive Compensation
shall be deemed &ldquo;received&rdquo;, either wholly or in part, in the fiscal year during which any applicable Financial Reporting
Measure is attained, even if the payment, vesting or grant of such Incentive Compensation occurs after the end of such fiscal year. Amounts
required to be recouped under this Policy shall be calculated on a pre-tax basis. The date of receipt of the Incentive Compensation depends
upon the terms of the award of such Incentive Compensation. For example:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the <I>grant</I> of an award of Incentive Compensation is based, either wholly or in part,
                                            on the satisfaction of a Financial Reporting Measure performance goal, then the award would
                                            be deemed received in the fiscal period when that measure was <I>satisfied</I>;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the <I>vesting</I> of an equity award of Incentive Compensation occurs only upon the satisfaction
                                            of a Financial Reporting Measure performance condition, then the award would be deemed received
                                            in the fiscal period when it <I>vests</I>;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the <I>earning</I> of a non-equity incentive plan award of Incentive Compensation is based
                                            on the satisfaction of the relevant Financial Reporting Measure performance goal, then the
                                            non-equity incentive plan award will be deemed received in the fiscal year in which that
                                            performance goal is <I>satisfied</I>; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the <I>earning</I> of a cash award of Incentive Compensation is based on the satisfaction
                                            of a Financial Reporting Measure performance goal, then the cash award will be deemed received
                                            in the fiscal period when that measure is <I>satisfied</I>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is specifically understood that, to the extent that the impact of the Covered Accounting Restatement on the amount of Incentive Compensation
received cannot be calculated directly from the information in the Covered Accounting Restatement (e.g., if such restatement&rsquo;s
impact on the Company&rsquo;s share price is not clear), then such excess amount of Incentive Compensation shall be determined based
on the Committee&rsquo;s reasonable estimate of the effect of the Covered Accounting Restatement on the share price or total shareholder
return upon which the Incentive Compensation was received. The Company shall maintain documentation for the determination of such excess
amount and provide such documentation to the New York Stock Exchange (&ldquo;<B>NYSE</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VI.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Method
    of Recovery</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee will determine, in its sole discretion, the methods for recovering excess Incentive Compensation hereunder, which methods may
include, without limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">requiring
                                            reimbursement of cash Incentive Compensation previously paid;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">seeking
                                            recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other
                                            disposition of any equity-based awards;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offsetting
                                            the recouped amount from any compensation otherwise owed by the Company to the Covered Executive;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancelling
                                            outstanding vested or unvested equity awards; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">taking
                                            any other remedial and recovery action permitted by law, as determined by the Committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything in this Section VI, and subject to applicable law, the Committee may cause recoupment under this Policy from any amount of Incentive
Compensation approved, awarded, granted, paid or payable to any Covered Executive prior to, on, or following the Effective Date (as defined
below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VII.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Impracticability</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall recover any excess Incentive Compensation in accordance with this Policy unless such recovery would be impracticable,
as determined by the Committee in accordance with the Listing Standards. It is specifically understood that recovery will only be deemed
impractical if: (A) the direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered
(before concluding that it would be impracticable to recover any amount of erroneously awarded Incentive Compensation based on the expense
of enforcement, the Committee shall make a reasonable attempt to recover such erroneously awarded Incentive Compensation, document such
reasonable attempt(s) to recover, and provide that documentation to the NYSE); (B) recovery would violate home country law where that
law was adopted prior to the November 28, 2022 (before concluding that it would be impracticable to recover any amount of erroneously
awarded Incentive Compensation based on violation of home country law, the Committee shall obtain an opinion of home country counsel,
acceptable to the applicable national securities exchange or association on which Company&rsquo;s common shares are trading, that recovery
would result in such a violation, and must provide such opinion to the exchange or association); or (C) recovery would likely cause an
otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the registrant, to fail to meet the
requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a), and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VIII.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Other
    Recoupment Rights; Acknowledgement</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may require that any employment agreement, equity award agreement, or similar agreement entered into on or after the Effective
Date shall, as a condition to the grant of any benefit thereunder, require a Covered Executive to agree to abide by the terms of this
Policy. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that
may be available to the Company pursuant to the terms of any similar policy in any employment agreement, equity award agreement, or similar
agreement and any other legal remedies available to the Company. The Company shall provide notice and seek written acknowledgement of
this Policy from each Covered Executive; <I>provided</I>, that the failure to provide such notice or obtain such acknowledgement shall
have no impact on the applicability or enforceability of this Policy to, or against, any Covered Executive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IX.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>No
    Indemnification of Covered Executives</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any right to indemnification under any plan, policy or agreement of the Company or any of its affiliates, the Company shall not indemnify
any Covered Executives against the loss of any excess Incentive Compensation. In addition, the Company will be prohibited from paying
or reimbursing a Covered Executive for premiums of any third-party insurance purchased to fund any potential recovery obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>X.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Indemnification</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent allowable pursuant to applicable law, each member of the Board or the Committee and any officer or other employee to whom
authority to administer any component of this Policy is designated shall be indemnified and held harmless by the Company from any loss,
cost, liability, or expense that may be imposed upon or reasonably incurred by such member in connection with or resulting from any claim,
action, suit, or proceeding to which he or she may be a party or in which he or she may be a party or in which he or she may be involved
by reason of any action or failure to act pursuant to this Policy and against and from any and all amounts paid by him or her in satisfaction
of judgment in such action, suit, or proceeding against him or her; <I>provided</I>, <I>however</I>, that he or she gives the Company
an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own
behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such individuals
may be entitled pursuant to the Company&rsquo;s Constitution or Certificate of Registration, as a matter of law, or otherwise, or any
power that the Company may have to indemnify them or hold them harmless.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XI.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Effective
    Date</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy shall be effective as of the date the Policy is adopted by the Board (the &ldquo;<B>Board Adoption Date</B>&rdquo;). This Policy
shall apply to any Incentive Compensation that is received by Covered Executives on or after October 2, 2023 (the &ldquo;<B>Effective
Date</B>&rdquo;), even if such Incentive Compensation was approved, awarded, granted, or paid to Covered Executives prior to the Effective
Date or the Board Adoption Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XII.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Amendment
    and Termination; Interpretation</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board may amend this Policy from time to time in its sole discretion and shall amend this Policy as it deems necessary to reflect and
comply with further regulations, rules and guidance of the SEC, and NYSE American listing standards. The Board may terminate this Policy
at any time. The Committee is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate,
or advisable for the administration of this Policy. This Policy is designed and intended be interpreted in a manner that is consistent
with the requirements of the Listing Standards. To the extent of any inconsistency between this Policy and such regulations, rules and
guidance, such regulations, rules and guidance shall control and this Policy shall be deemed amended to incorporate such regulations,
rules and guidance until or unless the Board or the Committee expressly determine otherwise. This Policy shall be applicable, binding
and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives,
to the fullest extent of the law. For the avoidance of doubt, this Policy shall be in addition to (and not in substitution of) any other
clawback policy of the Company in effect from time to time or applicable to any Covered Executive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XIII.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Successors</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other
legal representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XIV.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Definitions</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Policy, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo;
                                            means <B>Alta Global Group Limited</B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            &ldquo;<B>Covered Accounting Restatement</B>&rdquo; is any accounting restatement of the
                                            Company&rsquo;s financial statements due to the Company&rsquo;s material noncompliance with
                                            any financial reporting requirement under the securities laws. A Covered Accounting Restatement
                                            includes any required accounting restatement to correct an error in previously issued financial
                                            statements that is material to the previously issued financial statements (commonly referred
                                            to as &ldquo;Big R&rdquo; restatements), or that would result in a material misstatement
                                            if the error were corrected in the current period or left uncorrected in the current period
                                            (commonly referred to as &ldquo;little r&rdquo; restatements). A Covered Accounting Restatement
                                            does not include (A) an out-of-period adjustment when the error is immaterial to the previously
                                            issued financial statements, and the correction of the error is also immaterial to the current
                                            period; (B) a retrospective application of a change in accounting principle; (C) a retrospective
                                            revision to reportable segment information due to a change in the structure of an issuer&rsquo;s
                                            internal organization; (D) a retrospective reclassification due to a discontinued operation;
                                            (E) a retrospective application of a change in reporting entity, such as from a reorganization
                                            of entities under common control; or (F) a retrospective revision for stock splits, reverse
                                            stock splits, stock dividends or other changes in capital structure.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Covered
                                            Executive</B>&rdquo; means any person who:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Has
                                            received applicable Incentive Compensation:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                            the Three-Year Recovery Period; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
                                            beginning service as an Executive Officer; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Has
                                            served as an Executive Officer at any time during the performance period for such Incentive
                                            Compensation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchange
                                            Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Executive
                                            Officer(s)</B>&rdquo; means an &ldquo;executive officer&rdquo; as defined in Exchange Act
                                            Rule 10D-1(d) and the Listing Standards, and includes any person who is the Company&rsquo;s
                                            president, principal financial officer, principal accounting officer (or if there is no such
                                            accounting officer, the controller), any vice-president of the issuer in charge of a principal
                                            business unit, division, or function (such as sales, administration, or finance), any other
                                            officer who performs a policy-making function, or any other person who performs similar policy-making
                                            functions for the Company (with any executive officers of the Company&rsquo;s parent(s) or
                                            subsidiaries being deemed Covered Executives of the Company if they perform such policy making
                                            functions for the Company), and such other senior executives/employees who may from time
                                            to time be deemed subject to the Policy by the Board in its sole discretion. All executive
                                            officers of the Company identified by the Board pursuant to 17 CFR 229.401(b) shall be deemed
                                            &ldquo;Executive Officers.&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Financial
                                            Reporting Measure(s)</B>&rdquo; means any measures that are determined and presented in accordance
                                            with the accounting principles used in preparing the Company&rsquo;s financial statements,
                                            and any measure that is derived wholly or in part from such measures, including share price
                                            and total shareholder return, including but not limited to, financial reporting measures
                                            including &ldquo;non-IFRS financial measures&rdquo; for purposes of Exchange Act Regulation
                                            G and 17 CFR 229.10, as well other measures, metrics and ratios that are not non-IFRS measures.
                                            Financial Reporting Measures may or may not be included in a filing with the SEC, and may
                                            be presented outside the Company&rsquo;s financial statements, such as in Management&rsquo;s
                                            Discussion and Analysis of Financial Conditions and Results of Operations. Financial Reporting
                                            Measures include without limitation, any of the following:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
                                            share price.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            shareholder return.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            income.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
                                            before interest, taxes, depreciation, and amortization (EBITDA).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Funds
                                            from operations.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
                                            measures such as working capital or operating cash flow.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Return
                                            measures such as return on invested capital or return on assets.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
                                            measures such as earnings per share.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Incentive
                                            Compensation</B>&rdquo; means any compensation which was approved, awarded or granted to,
                                            or earned by a Covered Executive (A) while the Company had a class of securities listed on
                                            a national securities exchange or a national securities association, and (B) following on
                                            or after the Effective Date (including any award under any long-term or short-term incentive
                                            compensation plan of the Company, including any other short-term or long-term cash or equity
                                            incentive award or any other payment) that, in each case, is granted, earned, or vested based
                                            wholly or in part upon the attainment of any Financial Reporting Measure (i.e., any measures
                                            that are determined and presented in accordance with the accounting principles used in preparing
                                            the Company&rsquo;s financial statements, and any measure that is derived wholly or in part
                                            from such measures. Incentive Compensation may include (but is not limited to) any of the
                                            following:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                            bonuses and other short- and long-term cash incentives;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
                                            options;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
                                            appreciation rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
                                            shares;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
                                            share units;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
                                            shares; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
                                            units.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>APPENDIX
I</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acknowledgment
of Clawback Policy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
the undersigned, agree and acknowledge that I am fully bound by, and subject to, all of the terms and conditions of the Clawback Policy
(as may be amended, restated, supplemented or otherwise modified from time to time, the &ldquo;<B>Policy</B>&rdquo;) of Alta Global Group
Limited (the &ldquo;<B>Company</B>&rdquo;) if I am a &ldquo;Covered Executive&rdquo; or become a &ldquo;Covered Executive.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any inconsistency between the Policy and the terms of any agreement to which I am a party, or the terms of any compensation
plan, program or agreement under which any compensation has been, or will be, granted, awarded, earned or paid, the terms of the Policy
shall govern. In the event it is determined by the Compensation Committee of the Board of Directors of the Company (the &ldquo;<B>Committee</B>&rdquo;)
that any amounts granted, awarded, earned or paid to me must be forfeited or reimbursed by the Company, I will promptly take any action
necessary to effectuate such forfeiture and/or reimbursement. Any capitalized terms used in this Acknowledgement without definition shall
have the meaning set forth in the Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex11-1_001.jpg
<TEXT>
begin 644 ex11-1_001.jpg
M_]C_X  02D9)1@ ! @$ E0"5  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@ .061O8F4 9
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MQ\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#   !$0(1 #\
M]5HHK%\7^(8O#.ASZBQ!FQY=NA_BE;[OX#J:$KNRZ@>=?%[Q1]KO4\.6C_N;
M0B2Z(Z-*1PO7^$'\S7G2(TCK&@+,Q"JHY))X %.GFEN9GN)V+R2NSNQZEF.2
M?SKNOA/X7_M753K5TF;73R#&".'F/*_]\CG\JZ=*<?3^OQ8MST;P+X:7PSH,
M5JX'VN<":Z;OO8?=Z#A1Q71445S-W=WU&%>._&G_ )#UC_UX#_T9)7L5>._&
MG_D/6/\ UX#_ -&25=+XU\P9Q&C_ /(7L?\ K\@_]#6OIFOF;1_^0O8_]?D'
M_H:U],U5;=?,$,FABN(7@G4/'*C(ZGH588(_*OFK6M*N=#U2XTN[&)+>0KGL
MR]58>Q'-?3%1O!!(VZ2-&/JR@G]14PGR7TO<#Y>HKW3XHV]NG@N]9(D5A);8
M*J ?]:GM7A=;0ES*]K:V$%6M+TZYU?4+?3;1=TUS(L:CL,]2?8#DU['\)H()
M/"$;21HQ^U3\LH)ZCU%=HEO!&VY(T5AT(4 _RJ)5K-JVWF%BKHFDVVAZ7;Z7
M:#$=O&%ST+-U9C[D\U'XAT2W\0Z/<:5<\"9#L?NCCE''7H:TJ*QN[WZC/F&_
MLKC3;V:PNUV36\C1R*?53BNJ^&?BC^P-<%I<OMLM0*Q29/RI)_RS?\S@^QKH
M?C!X7_U?B>S3TAO !^$<G]#^%>6].172FJD->HMCZEHKDOAOXG'B'0EAN'S>
MV(6&;.-S*!\DGX@8/O76USM6;3Z#"BBBD 5X7\3?%']OZX;.V?-EI^Z*/'W7
MDS^\D_3 ^GO7H_Q(\4#P[H3Q6[XO;X-##C&Y5(^>3\ >/>O!^O6M:,?M?)?Y
M@R>QLKC4;R&PM%WS7$BQQJ.Y8XKO_&.D:]X$L;%M"U"YBL6C6.X6*1U07.,N
M^!T#]OI5SX/^%_\ 6>)[Q/6&S!'X22?T'XUZ)KFD6VNZ5<:5=C*7$9 ;J58<
MJP]P>:<ZBYDMTM_Z\@/ _P#A-/%O_07O/^_K_P"->V^"_$D?B?0H;XD?:8P(
MKI!CB50,G'8-U%>!:GIUSI6H3Z==KMFMI6C<?3H1[$<BNB^''B@^'==2.X?%
ME?%89\YVJ2?DD[]">?:G."<?=2TUT["3/>:\=^-/_(>L?^O ?^C)*]A!!&17
MCWQI_P"0]8_]> _]&25G2^->C&SA]'_Y"]C_ -?D'_H:U]-5\Q:=-';ZA:W$
MIVQQ7$3N>3A58$GCV%>W?\+5\%?\_<G_ 'YF_P#B*NLFVK)O<$=?17(K\5/!
M3,%^V.,D#)AF _\ 0*ZZLFFMU;U Y+XJ?\B3>_\ 72V_]'1UX/7N_P 5/^1)
MO?\ KI;?^CDKPBMJ/P_,1[C\(_\ D3H_^OJ?^8KM*XOX1_\ (G1_]?4_\Q7:
M5E/XGZC*&N:Q:Z#I5QJMV?W=NA(7(!=CPJ#W)XKP:?QSXMGGDG_M2YC\QV?9
M'(Z1KN.=J@'@#L*Z3XM^*/[0U)= M'S;V+;IR.C3$=/^ @X^M<!%%)-(D,2E
MWD8(BCJ68X 'XFM:<$HWDM^_81WO@=?$?C74)+35=1NYM)BC)O$:1]LFX$)'
MU[GD^PKD?$6B7/A[5[C2KGDPM\C] Z'E''U%>[>"_#D?AC0H;' ^T./-NG&,
MF1@,C/H!P*P?BOX7_M721K5HF;K3P3( .7A/+?\ ?)Y_.IC47/9:18'F?@OQ
M))X8UZ&^R?L\G[FZ0=&C;J?J#@CZ5]"Q21S1I-$P=)%#HPZ%6&01^%?+M>Q?
M"3Q1]OTYO#]V^;BQ7=!G&6A)Z?\  2?RIUHZ<RZ;@CT.BBBL1GSUXYU^?Q#X
MAN;F3*Q0.UO!&3]U$)'J1DG)-9NAZ8VLZO::6KB/[5.D>\]@3R>A[445T_#'
M3HA'TA8V5OIUG#8VBA(;>-8XU'8*,5/117,,\N^,GA^'R[?Q'#A9=RVTX[N,
M$HWU&,?2O*Z**Z*3O'T8F>[_  Q\03:[X<5+K)GL'^S/(?XU !0]>N#@UQ?Q
MI_Y#UC_UX#_T9)11415JC^8SSRBBBMA!7O\ \/->F\0>&H9[H'S[<FWD<X^<
MH!A_Q!&?>BBLZWP^C!$'Q4_Y$F]_ZZ6W_HZ.O!Z***/P_,#W'X1_\B='_P!?
M4_\ ,5M>,=<?P]X>N]3B7=*BA(O0/(=JL>1P,YHHK-ZU'_B&?.TDCRR-+*Q9
MY&+.QZDDY)/XUWGPAT"'4=8EU>XPRZ<%,4?/,KYVM^ !_&BBMJKM%V["1[/3
M7174HX#*P(8'D$'@@T45S#/GKQQH47AWQ)=:?;G,)(FA'=4D^8*>!TZ50T+5
M[G0M5M]5M3AX) 2O0,IX93[$445U1UBK]4(]O_X3NP_Y]IOS3_&BBBL>1#/_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>logo_001.jpg
<TEXT>
begin 644 logo_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  G &<# 2(  A$! Q$!_\0
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M_BIY[9B'M9)(QCN.5HK>O@&YWI;,B%=)6EN=;\-_^1ZL?]R7_P! -=U\8/\
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<D*'.1Y"#M]****N,I6W/-Q6#PT9I*G';LC__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>logo_002.jpg
<TEXT>
begin 644 logo_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  5 #(# 2(  A$! Q$!_\0
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6MDE.9978O)(?=F))HHH OT444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>mma-20240630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa+PWbP9z5Z8yekhvWB1bRmavy8gGB7rsikts862EQUL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:MMA="http://altaglobalgroup.com/20240630" elementFormDefault="qualified" targetNamespace="http://altaglobalgroup.com/20240630">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://altaglobalgroup.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss" id="ProfitOrLossAndOtherComprehensiveLoss">
          <link:definition>00000002 - Statement - Profit or Loss and Other Comprehensive Loss</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/StatementOfFinancialPosition" id="StatementOfFinancialPosition">
          <link:definition>00000003 - Statement - Consolidated Statement of Financial Position</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/StatementOfChangesInEquity" id="StatementOfChangesInEquity">
          <link:definition>00000004 - Statement - Consolidated Statement of Changes in Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/StatementOfCashFlows" id="StatementOfCashFlows">
          <link:definition>00000005 - Statement - Consolidated Statement of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/CorporateInformation" id="CorporateInformation">
          <link:definition>995611 - Disclosure - Corporate information</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation" id="MaterialAccountingPolicyInformation">
          <link:definition>995612 - Disclosure - Material Accounting Policy Information</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions" id="CriticalAccountingJudgementsEstimatesAndAssumptions">
          <link:definition>995613 - Disclosure - Critical accounting judgements, estimates and assumptions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/OperatingSegments" id="OperatingSegments">
          <link:definition>995614 - Disclosure - Operating segments</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/Revenue" id="Revenue">
          <link:definition>995615 - Disclosure - Revenue</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/Expenses" id="Expenses">
          <link:definition>995616 - Disclosure - Expenses</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/IncomeTax" id="IncomeTax">
          <link:definition>995617 - Disclosure - Income Tax</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/FairValueMeasurement" id="FairValueMeasurement">
          <link:definition>995618 - Disclosure - Fair value measurement</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/CashAndCashEquivalents" id="CashAndCashEquivalents">
          <link:definition>995619 - Disclosure - Cash and cash equivalents</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/TradeAndOtherReceivables" id="TradeAndOtherReceivables">
          <link:definition>995620 - Disclosure - Trade and other receivables</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>995621 - Disclosure - Property and equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/IntangibleAssets" id="IntangibleAssets">
          <link:definition>995622 - Disclosure - Intangible assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/TradeAndOtherPayables" id="TradeAndOtherPayables">
          <link:definition>995623 - Disclosure - Trade and other payables</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements" id="CurrentAndNon-currentEmployeeEntitlements">
          <link:definition>995624 - Disclosure - Current and Non-current Employee Entitlements</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/UnearnedRevenue" id="UnearnedRevenue">
          <link:definition>995625 - Disclosure - Unearned Revenue</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/Reserves" id="Reserves">
          <link:definition>995626 - Disclosure - Reserves</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/IssuedCapital" id="IssuedCapital">
          <link:definition>995627 - Disclosure - Issued capital</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/NotesToStatementOfCashFlows" id="NotesToStatementOfCashFlows">
          <link:definition>995628 - Disclosure - Notes to statement of cash flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactions" id="RelatedPartiesTransactions">
          <link:definition>995629 - Disclosure - Related parties transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/Leases" id="Leases">
          <link:definition>995630 - Disclosure - Leases</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/FinancialLiabilities" id="FinancialLiabilities">
          <link:definition>995631 - Disclosure - Financial Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/Share-basedPayments" id="Share-basedPayments">
          <link:definition>995632 - Disclosure - Share-based payments</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/FinancialInstruments" id="FinancialInstruments">
          <link:definition>995633 - Disclosure - Financial Instruments</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/RemunerationOfAuditors" id="RemunerationOfAuditors">
          <link:definition>995634 - Disclosure - Remuneration of auditors</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities" id="ContingentAssetsAndLiabilities">
          <link:definition>995635 - Disclosure - Contingent Assets and Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/Commitments" id="Commitments">
          <link:definition>995636 - Disclosure - Commitments</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/LossPerShare" id="LossPerShare">
          <link:definition>995637 - Disclosure - Loss per share</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/EventsAfterReportingPeriod" id="EventsAfterReportingPeriod">
          <link:definition>995638 - Disclosure - Events after the reporting period</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies" id="MaterialAccountingPolicyInformationPolicies">
          <link:definition>995639 - Disclosure - Material Accounting Policy Information (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables" id="MaterialAccountingPolicyInformationTables">
          <link:definition>995640 - Disclosure - Material Accounting Policy Information (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/RevenueTables" id="RevenueTables">
          <link:definition>995641 - Disclosure - Revenue (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ExpensesTables" id="ExpensesTables">
          <link:definition>995642 - Disclosure - Expenses (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/IncomeTaxTables" id="IncomeTaxTables">
          <link:definition>995643 - Disclosure - Income Tax (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/FairValueMeasurementTables" id="FairValueMeasurementTables">
          <link:definition>995644 - Disclosure - Fair value measurement (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/CashAndCashEquivalentsTables" id="CashAndCashEquivalentsTables">
          <link:definition>995645 - Disclosure - Cash and cash equivalents (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/TradeAndOtherReceivablesTables" id="TradeAndOtherReceivablesTables">
          <link:definition>995646 - Disclosure - Trade and other receivables (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>995647 - Disclosure - Property and equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
          <link:definition>995648 - Disclosure - Intangible assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/TradeAndOtherPayablesTables" id="TradeAndOtherPayablesTables">
          <link:definition>995649 - Disclosure - Trade and other payables (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlementsTables" id="CurrentAndNon-currentEmployeeEntitlementsTables">
          <link:definition>995650 - Disclosure - Current and Non-current Employee Entitlements (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/UnearnedRevenueTables" id="UnearnedRevenueTables">
          <link:definition>995651 - Disclosure - Unearned Revenue (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ReservesTables" id="ReservesTables">
          <link:definition>995652 - Disclosure - Reserves (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/IssuedCapitalTables" id="IssuedCapitalTables">
          <link:definition>995653 - Disclosure - Issued capital (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/NotesToStatementOfCashFlowsTables" id="NotesToStatementOfCashFlowsTables">
          <link:definition>995654 - Disclosure - Notes to statement of cash flows (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables" id="RelatedPartiesTransactionsTables">
          <link:definition>995655 - Disclosure - Related parties transactions (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/LeasesTables" id="LeasesTables">
          <link:definition>995656 - Disclosure - Leases (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/FinancialLiabilitiesTables" id="FinancialLiabilitiesTables">
          <link:definition>995657 - Disclosure - Financial Liabilities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/Share-basedPaymentsTables" id="Share-basedPaymentsTables">
          <link:definition>995658 - Disclosure - Share-based payments (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/FinancialInstrumentsTables" id="FinancialInstrumentsTables">
          <link:definition>995659 - Disclosure - Financial Instruments (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/RemunerationOfAuditorsTables" id="RemunerationOfAuditorsTables">
          <link:definition>995660 - Disclosure - Remuneration of auditors (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/LossPerShareTables" id="LossPerShareTables">
          <link:definition>995661 - Disclosure - Loss per share (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails" id="ScheduleOfPlantAndEquipmentDetails">
          <link:definition>995662 - Disclosure - Schedule of plant and equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative" id="MaterialAccountingPolicyInformationDetailsNarrative">
          <link:definition>995663 - Disclosure - Material Accounting Policy Information (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative" id="CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative">
          <link:definition>995664 - Disclosure - Critical accounting judgements, estimates and assumptions (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfRevenueDetails" id="ScheduleOfRevenueDetails">
          <link:definition>995665 - Disclosure - Schedule of revenue (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails" id="ScheduleOfDisaggregationOfRevenueDetails">
          <link:definition>995666 - Disclosure - Schedule of disaggregation of revenue (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfExpensesDetails" id="ScheduleOfExpensesDetails">
          <link:definition>995667 - Disclosure - Schedule of expenses (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails" id="ScheduleOfIncomeTaxExpensesDetails">
          <link:definition>995668 - Disclosure - Schedule of Income Tax Expenses (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical" id="ScheduleOfIncomeTaxExpensesDetailsParenthetical">
          <link:definition>995669 - Disclosure - Schedule of Income Tax Expenses (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails" id="ScheduleOfFairValueAssetsAndLiabilitiesDetails">
          <link:definition>995670 - Disclosure - Schedule of Fair Value Assets and Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails" id="ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails">
          <link:definition>995671 - Disclosure - Schedule of Fair Value Measurement of Derivative Liability (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails" id="ScheduleOfUnobservableInputsLevel3LiabilitiesDetails">
          <link:definition>995672 - Disclosure - Schedule of Unobservable Inputs Level 3 Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails" id="ScheduleOfCashAndCashEquivalentsDetails">
          <link:definition>995673 - Disclosure - Schedule of Cash and Cash Equivalents (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails" id="ScheduleOfTradeAndOtherReceivablesDetails">
          <link:definition>995674 - Disclosure - Schedule of Trade and Other Receivables (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
          <link:definition>995675 - Disclosure - Schedule of Property and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/IncomeTaxDetailsNarrative" id="IncomeTaxDetailsNarrative">
          <link:definition>995676 - Disclosure - Income Tax (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails" id="ScheduleOfIntangibleAssetsDetails">
          <link:definition>995677 - Disclosure - Schedule of Intangible assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails" id="ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails">
          <link:definition>995678 - Disclosure - Schedule of Reconciliations of the Movement of Intangible Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails" id="ScheduleOfTradeAndOtherPayablesDetails">
          <link:definition>995679 - Disclosure - Schedule of Trade and Other Payables (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails" id="ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails">
          <link:definition>995680 - Disclosure - Schedule of Current and Non-current Employee Entitlements (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfUnearnedRevenueDetails" id="ScheduleOfUnearnedRevenueDetails">
          <link:definition>995681 - Disclosure - Schedule of Unearned Revenue (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfReservesDetails" id="ScheduleOfReservesDetails">
          <link:definition>995682 - Disclosure - Schedule of Reserves (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails" id="ScheduleOfIssuedCapitalDetails">
          <link:definition>995683 - Disclosure - Schedule of Issued Capital (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical" id="ScheduleOfIssuedCapitalDetailsParenthetical">
          <link:definition>995684 - Disclosure - Schedule of Issued Capital (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails" id="ScheduleOfStatementOfCashFlowsDetails">
          <link:definition>995685 - Disclosure - Schedule of Statement of Cash Flows (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails" id="ScheduleOfKeyManagementPersonnelRemunerationDetails">
          <link:definition>995686 - Disclosure - Schedule of Key Management Personnel Remuneration (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails" id="ScheduleOfSharesHeldByKeyManagementPersonnelDetails">
          <link:definition>995687 - Disclosure - Schedule of Shares Held by Key Management Personnel (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative" id="RelatedPartiesTransactionsDetailsNarrative">
          <link:definition>995688 - Disclosure - Related parties transactions (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails" id="ScheduleOfFinancialStatementOfParentEntityDetails">
          <link:definition>995689 - Disclosure - Schedule of Financial Statement of the Parent Entity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails" id="ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails">
          <link:definition>995690 - Disclosure - Schedule of Country Incorporation Principal Place of Business (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails" id="SummaryOfChangesInRouAssetsDetails">
          <link:definition>995691 - Disclosure - Summary of Changes in ROU Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails" id="SummaryOfFutureMinimumLeasePaymentsDetails">
          <link:definition>995692 - Disclosure - Summary of Future Minimum Lease Payments (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails" id="ScheduleOfFinancialLiabilitiesDetails">
          <link:definition>995693 - Disclosure - Schedule of Financial Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails" id="ScheduleOfConvertibleNotesHeldByInvestorsDetails">
          <link:definition>995694 - Disclosure - Schedule of Convertible Notes held by Investors (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/FinancialLiabilitiesDetailsNarrative" id="FinancialLiabilitiesDetailsNarrative">
          <link:definition>995695 - Disclosure - Financial Liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails" id="ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails">
          <link:definition>995696 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical" id="ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical">
          <link:definition>995697 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails" id="ScheduleOfShareOptionsOutstandingDetails">
          <link:definition>995698 - Disclosure - Schedule of Share Options Outstanding (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails" id="ScheduleOfModelInputsForOptionsGrantedDetails">
          <link:definition>995699 - Disclosure - Schedule of Model Inputs For Options Granted (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" id="ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails">
          <link:definition>995700 - Disclosure - Schedule of Contractual Maturities of Financial Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails" id="ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails">
          <link:definition>995701 - Disclosure - Schedule of Auditor of Company And Network Firms (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative" id="Share-basedPaymentsDetailsNarrative">
          <link:definition>995702 - Disclosure - Share-based payments (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilitiesDetailsNarrative" id="ContingentAssetsAndLiabilitiesDetailsNarrative">
          <link:definition>995703 - Disclosure - Contingent Assets and Liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails" id="ScheduleOfLossPerShareDetails">
          <link:definition>995704 - Disclosure - Schedule of Loss Per Share (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative" id="EventsAfterReportingPeriodDetailsNarrative">
          <link:definition>995705 - Disclosure - Events after the reporting period (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="mma-20240630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="mma-20240630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="mma-20240630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="mma-20240630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="MMA_UnlistedOptionReserveMember" name="UnlistedOptionReserveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_PlantAndEquipmentMember" name="PlantAndEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_OneMajorProductMember" name="OneMajorProductMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ImpliedValuationMember" name="ImpliedValuationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesAConvertibleNotesMember" name="SeriesAConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesAJuly21Member" name="SeriesAJuly21Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesAAugust21Member" name="SeriesAAugust21Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesB1Member" name="SeriesB1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesB2Member" name="SeriesB2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesAExtensionMember" name="SeriesAExtensionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ReachMember" name="ReachMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_PrivatePlacementsMember" name="PrivatePlacementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_MixedMartialArtsLLCMember" name="MixedMartialArtsLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SteppenMember" name="SteppenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_FurnitrueAndFittingsMember" name="FurnitrueAndFittingsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_PlatformDevelopmentMember" name="PlatformDevelopmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SteppenPtyLtdMember" name="SteppenPtyLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_MixedMartialsArtsLLCMember" name="MixedMartialsArtsLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_HypeKitIncMember" name="HypeKitIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SharesHeldByKeyManagementPersonnelMember" name="SharesHeldByKeyManagementPersonnelMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_OptionHeldByKeyManagementPersonnelMember" name="OptionHeldByKeyManagementPersonnelMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_MrLangtonMember" name="MrLangtonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SnowflowerHoldingsPtyLtdMember" name="SnowflowerHoldingsPtyLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_MrWilliamsMember" name="MrWilliamsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ChampSevenPtyLtdMember" name="ChampSevenPtyLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_MrTaylorMember" name="MrTaylorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_NalarooHoldingsPtyLtdMember" name="NalarooHoldingsPtyLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_MrHartMember" name="MrHartMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_JHartFamilyTrustAccountMember" name="JHartFamilyTrustAccountMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_EmploymentAgreementMember" name="EmploymentAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_EmployeementAgreementMember" name="EmployeementAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_Mr.LangtonMember" name="Mr.LangtonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_Wimp2WarriorLLCMember" name="Wimp2WarriorLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_UnitedStatesOfAmericaCountryMember" name="UnitedStatesOfAmericaCountryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_Wimp2WarriorProductionsPtyLtdMember" name="Wimp2WarriorProductionsPtyLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AustraliaCountryMember" name="AustraliaCountryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_Wimp2WarriorDigitalPtyLtdMember" name="Wimp2WarriorDigitalPtyLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AustraliaCountryOneMember" name="AustraliaCountryOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_Wimp2WarriorIrelandLimitedMember" name="Wimp2WarriorIrelandLimitedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IrelandCountryMember" name="IrelandCountryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_HypeCoMember" name="HypeCoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_UnitedStatesOfAmericaCountryOneMember" name="UnitedStatesOfAmericaCountryOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AmortizationMember" name="AmortizationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesAJulyTwentyOneConvertibleNotesMember" name="SeriesAJulyTwentyOneConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesAAugustTwentyOneConvertibleNotesMember" name="SeriesAAugustTwentyOneConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesBOneConvertibleNotesMember" name="SeriesBOneConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesB2ConvertibleNotesMember" name="SeriesB2ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SeriesAExtensionConvertibleNotesMember" name="SeriesAExtensionConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ReachConvertibleNotesMember" name="ReachConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_PrivatePlacementConvertibleNotesMember" name="PrivatePlacementConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_MixedMartialArtsLLCConvertibleNotesMember" name="MixedMartialArtsLLCConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_SteppenConvertibleNotesMember" name="SteppenConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AdvisorMember" name="AdvisorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_OverAllotmentOptionsMember" name="OverAllotmentOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_EmployeeStockOwnershipPlanMember" name="EmployeeStockOwnershipPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExercisePricesOneMember" name="ExercisePricesOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExercisePricesTwoMember" name="ExercisePricesTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExercisePricesThreeMember" name="ExercisePricesThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExercisePricesFourMember" name="ExercisePricesFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_BetweenOneAndTwoYearsMember" name="BetweenOneAndTwoYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_BetweenTwoAndFiveYearsMember" name="BetweenTwoAndFiveYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_NonadjustingEventMember" name="NonadjustingEventMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_MrMcGregorMember" name="MrMcGregorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_RevenueFromProgramFees" name="RevenueFromProgramFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ContractualPaymentsToGyms" name="ContractualPaymentsToGyms" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_NetRevenueFromProgramFees" name="NetRevenueFromProgramFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ProgramExpenses" name="ProgramExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_RentExpenses" name="RentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ITCosts" name="ITCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_FairValueMovementInDerivativeLiability" name="FairValueMovementInDerivativeLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_UnearnedRevenue" name="UnearnedRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_UnlistedOptionsReserve" name="UnlistedOptionsReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IfrsStatementLineItems" name="IfrsStatementLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IssueOfEquityFromConversionOfConvertibleNotes" name="IssueOfEquityFromConversionOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes" name="IssueOfUnlistedSharesFromConversionOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IncreaseDecreaseThroughOptionsForfeited" name="IncreaseDecreaseThroughOptionsForfeited" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_OverAllotmentOptionsLapsed" name="OverAllotmentOptionsLapsed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ProceedsFromTrainingParticipants" name="ProceedsFromTrainingParticipants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" name="ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_BankGuaranteeDepositReceivedPaid" name="BankGuaranteeDepositReceivedPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureCorporateInformationAbstract" name="DisclosureCorporateInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfCorporateInformationExplanatory" name="DisclosureOfCorporateInformationExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfMaterialAccountingPolicyAbstract" name="DisclosureOfMaterialAccountingPolicyAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract" name="DisclosureOfAccountingJudgementsAndEstimatesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_RevenueFromContractsWithCustomersAbstract" name="RevenueFromContractsWithCustomersAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfExpensesAbstract" name="DisclosureOfExpensesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfTradeAndOtherPayablesAbstract" name="DisclosureOfTradeAndOtherPayablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" name="DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory" name="DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfUnearnedRevenueAbtract" name="DisclosureOfUnearnedRevenueAbtract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfUnearnedRevenueExplanatory" name="DisclosureOfUnearnedRevenueExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfReservesAbstract" name="DisclosureOfReservesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory" name="DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory" name="DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory" name="DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory" name="DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfPlantAndEquipmentExplanatory" name="DisclosureOfPlantAndEquipmentExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory" name="DisclosureOfDetailedInformationAboutExpensesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory" name="DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfDerivativeLiabilityExplanatory" name="DisclosureOfDerivativeLiabilityExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfCashEquivalentsExplanatory" name="DisclosureOfCashEquivalentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfTradeAndOtherReceivableExplanatory" name="DisclosureOfTradeAndOtherReceivableExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory" name="DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables" name="DisclosureOfDetailedInformationAboutTradeAndOtherPayables" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory" name="DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory" name="DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ScheduleOfReservesTableTextBlock" name="ScheduleOfReservesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory" name="DisclosureOfDetailedInformationIssuedCapitalExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory" name="DetailedInformationOfNotesToStatementOfCashFlowExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory" name="DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory" name="DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory" name="DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_RevenueFromContractualPaymentsToGyms" name="RevenueFromContractualPaymentsToGyms" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ReserachAndDevelopmentIncome" name="ReserachAndDevelopmentIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ProgramExpensesEventCosts" name="ProgramExpensesEventCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ProgramExpensesProgramCosts" name="ProgramExpensesProgramCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ProgramExpensesMerchantFees" name="ProgramExpensesMerchantFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ProgramExpensesOtherCosts" name="ProgramExpensesOtherCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective" name="FinanceCostsConvertibleNotesInterestContractualAndEffective" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_FinanceCostsBankFees" name="FinanceCostsBankFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_FinanceCostsBankInterestAndLeaseInterest" name="FinanceCostsBankInterestAndLeaseInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_UnrealizedCurrencyGains" name="UnrealizedCurrencyGains" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_RealizedCurrencyGainslosses" name="RealizedCurrencyGainslosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems" name="DeferredTaxExpenseIncomeOtherNonAllowableItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" name="DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" name="DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" name="DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" name="FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_FairValueMovementRecognisedInProfitOrLoss" name="FairValueMovementRecognisedInProfitOrLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" name="FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" name="FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ResearchAndDevelopmentIncome" name="ResearchAndDevelopmentIncome" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AllowancesForCreditLoss" name="AllowancesForCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_PropertyPlantAndEquipmentCost" name="PropertyPlantAndEquipmentCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_PropertyPlantAndEquipmentAccumulatedDepreciation" name="PropertyPlantAndEquipmentAccumulatedDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AdditionsFromInternalDevelopment" name="AdditionsFromInternalDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ResearchDevelopmentTaxIncentive" name="ResearchDevelopmentTaxIncentive" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_TradeAndOtherPayablesPayableToMemberGyms" name="TradeAndOtherPayablesPayableToMemberGyms" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_TaxesPayable" name="TaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_TradePayables" name="TradePayables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ProvisionForRefundLiability" name="ProvisionForRefundLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ReserveOfUnbilledShareOption" name="ReserveOfUnbilledShareOption" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ForeignCurrencyReserves" name="ForeignCurrencyReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_OwnersShareCapital" name="OwnersShareCapital" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_NumberOfShareIssuedAndFullyPaid" name="NumberOfShareIssuedAndFullyPaid" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IssueOfSharesFromConversionOfConvertibleNotes" name="IssueOfSharesFromConversionOfConvertibleNotes" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AdvisorOptionsExercisedShares" name="AdvisorOptionsExercisedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IssuedAndFullyPaidValue" name="IssuedAndFullyPaidValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AdvisorOptionsExercisedValue" name="AdvisorOptionsExercisedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ContractualCapitalisedInterestRate" name="ContractualCapitalisedInterestRate" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AdvisorOptionsForfeitedShares" name="AdvisorOptionsForfeitedShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AccruedInterestOnConvertibleNotes" name="AccruedInterestOnConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices" name="ConvertibleNotesIssuedInLieuOfPaymentForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue" name="AdjustmentsForIncreaseDecreaseInNetDeferredRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund" name="AdjustmentsForIncreaseDecreaseInProvisionForRefund" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IssuedSharesHeldByKeyManagementPersonnel" name="IssuedSharesHeldByKeyManagementPersonnel" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_RepurchasedSharesHeldByKeyManagementPersonnel" name="RepurchasedSharesHeldByKeyManagementPersonnel" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ResignationOfKeyManagementPersonnelShares" name="ResignationOfKeyManagementPersonnelShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel" name="ReverseShareSplitSharesHeldByKeyManagementPersonnel" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IssuedOptionsHeldByKeyManagementPersonnel" name="IssuedOptionsHeldByKeyManagementPersonnel" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExpiredOptionsHeldByKeyManagementPersonnel" name="ExpiredOptionsHeldByKeyManagementPersonnel" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExercisedOptionsHeldByKeyManagementPersonnel" name="ExercisedOptionsHeldByKeyManagementPersonnel" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel" name="ReverseShareSplitOptionsHeldByKeyManagementPersonnel" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfRelatedPartiesTransactionsAbstract" name="DisclosureOfRelatedPartiesTransactionsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IfrsStatementTable" name="IfrsStatementTable" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" />
    <element id="MMA_PercentageOfOrdinarySharesUnderVestAndExercisable" name="PercentageOfOrdinarySharesUnderVestAndExercisable" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ContributedEquity" name="ContributedEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_RightofuseAsset" name="RightofuseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AccumulatedAmortization" name="AccumulatedAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_Modification" name="Modification" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ConvertibleNotesIssueDate" name="ConvertibleNotesIssueDate" nillable="true" xbrli:periodType="instant" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ConvertibleNotesPreModificationMaturityDate" name="ConvertibleNotesPreModificationMaturityDate" nillable="true" xbrli:periodType="instant" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ConvertibleNotesModificationDate" name="ConvertibleNotesModificationDate" nillable="true" xbrli:periodType="instant" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ConvertibleNotesModifiedMaturityDate" name="ConvertibleNotesModifiedMaturityDate" nillable="true" xbrli:periodType="instant" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ConvertibleNotesConversionDate" name="ConvertibleNotesConversionDate" nillable="true" xbrli:periodType="instant" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ConvertibleNotesTerm" name="ConvertibleNotesTerm" nillable="true" xbrli:periodType="instant" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ConvertibleNotesConversionDiscount" name="ConvertibleNotesConversionDiscount" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ReachConvertibleNote" name="ReachConvertibleNote" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_RedeemedForCash" name="RedeemedForCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" name="ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExpenseFromAdvisorOptions" name="ExpenseFromAdvisorOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExpenseFromReach" name="ExpenseFromReach" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExpenseFromWarrants" name="ExpenseFromWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExpenseFromOverAllotmentOption" name="ExpenseFromOverAllotmentOption" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExpenseFromRestrictedShareUnits" name="ExpenseFromRestrictedShareUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_PricePerShareEqualPercentage" name="PricePerShareEqualPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ExpectedTermShareOptionsGranted" name="ExpectedTermShareOptionsGranted" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_NonInterestBearingTradeAndOtherPayables" name="NonInterestBearingTradeAndOtherPayables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_WeightedAverageInterestRateFinancialLiability" name="WeightedAverageInterestRateFinancialLiability" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_InterestBearingFinancialLiabilities" name="InterestBearingFinancialLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_WeightedAverageInterestRateLeaseLiabilities" name="WeightedAverageInterestRateLeaseLiabilities" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_InterestBearingLeaseLiabilities" name="InterestBearingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_InterestBearingNonderivativesNet" name="InterestBearingNonderivativesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DerivativeNet" name="DerivativeNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AuditFees" name="AuditFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AuditorsRemunerationForRelatedFees" name="AuditorsRemunerationForRelatedFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ContingentAssetsAndLiabilities" name="ContingentAssetsAndLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_PlatformDevelopmentNet" name="PlatformDevelopmentNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AdditionsThroughIntangibleAssetsOtherThanGoodwill" name="AdditionsThroughIntangibleAssetsOtherThanGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_RiskFreeRateMember" name="RiskFreeRateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_CurrentHostFinancialLiabilities" name="CurrentHostFinancialLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_NoncurrentHostFinancialLiabilities" name="NoncurrentHostFinancialLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_PreModificationMaturityDate" name="PreModificationMaturityDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ModificationDate" name="ModificationDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ModifiedMaturityDate" name="ModifiedMaturityDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_ConversionDate" name="ConversionDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AdvisorOptionsExercised" name="AdvisorOptionsExercised" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_HostLiabilityCurrent" name="HostLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_HostLiabilityNonCurrent" name="HostLiabilityNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_DisclosureOfLeasesLiabilityExplanatory" name="DisclosureOfLeasesLiabilityExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_LaterThanTwoYearAndNotLaterThanTwoYearsMember" name="LaterThanTwoYearAndNotLaterThanTwoYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_TradeAndOtherPayablesMember" name="TradeAndOtherPayablesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_LessAccumulatedAmortization" name="LessAccumulatedAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AccumulatedDepreciationAmortisationMember" name="AccumulatedDepreciationAmortisationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill" name="AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_NonInterestBearingTradePayables" name="NonInterestBearingTradePayables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_RightofuseAssetMember" name="RightofuseAssetMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_FinancialLiabilityHostDebtMember" name="FinancialLiabilityHostDebtMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AccumulatedAmortizationMember" name="AccumulatedAmortizationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_PerformanceShare" name="PerformanceShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_Hype.CoMember" name="Hype.CoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_UnitedStatesOfAmericaMember" name="UnitedStatesOfAmericaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AustraliaMember" name="AustraliaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_AustraliaOneMember" name="AustraliaOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_IrelandMember" name="IrelandMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_UnitedStatesOfAmericaOneMember" name="UnitedStatesOfAmericaOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MMA_LeaseLiabilitiesPayments" name="LeaseLiabilitiesPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>mma-20240630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Cover" xlink:href="mma-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss" xlink:href="mma-20240630.xsd#ProfitOrLossAndOtherComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/StatementOfFinancialPosition" xlink:href="mma-20240630.xsd#StatementOfFinancialPosition" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/StatementOfChangesInEquity" xlink:href="mma-20240630.xsd#StatementOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/StatementOfCashFlows" xlink:href="mma-20240630.xsd#StatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CorporateInformation" xlink:href="mma-20240630.xsd#CorporateInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions" xlink:href="mma-20240630.xsd#CriticalAccountingJudgementsEstimatesAndAssumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/OperatingSegments" xlink:href="mma-20240630.xsd#OperatingSegments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Revenue" xlink:href="mma-20240630.xsd#Revenue" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Expenses" xlink:href="mma-20240630.xsd#Expenses" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IncomeTax" xlink:href="mma-20240630.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FairValueMeasurement" xlink:href="mma-20240630.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CashAndCashEquivalents" xlink:href="mma-20240630.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherReceivables" xlink:href="mma-20240630.xsd#TradeAndOtherReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/PropertyAndEquipment" xlink:href="mma-20240630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IntangibleAssets" xlink:href="mma-20240630.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherPayables" xlink:href="mma-20240630.xsd#TradeAndOtherPayables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements" xlink:href="mma-20240630.xsd#CurrentAndNon-currentEmployeeEntitlements" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/UnearnedRevenue" xlink:href="mma-20240630.xsd#UnearnedRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Reserves" xlink:href="mma-20240630.xsd#Reserves" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IssuedCapital" xlink:href="mma-20240630.xsd#IssuedCapital" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/NotesToStatementOfCashFlows" xlink:href="mma-20240630.xsd#NotesToStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactions" xlink:href="mma-20240630.xsd#RelatedPartiesTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Leases" xlink:href="mma-20240630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialLiabilities" xlink:href="mma-20240630.xsd#FinancialLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Share-basedPayments" xlink:href="mma-20240630.xsd#Share-basedPayments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialInstruments" xlink:href="mma-20240630.xsd#FinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RemunerationOfAuditors" xlink:href="mma-20240630.xsd#RemunerationOfAuditors" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities" xlink:href="mma-20240630.xsd#ContingentAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Commitments" xlink:href="mma-20240630.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/LossPerShare" xlink:href="mma-20240630.xsd#LossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/EventsAfterReportingPeriod" xlink:href="mma-20240630.xsd#EventsAfterReportingPeriod" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RevenueTables" xlink:href="mma-20240630.xsd#RevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ExpensesTables" xlink:href="mma-20240630.xsd#ExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IncomeTaxTables" xlink:href="mma-20240630.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FairValueMeasurementTables" xlink:href="mma-20240630.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CashAndCashEquivalentsTables" xlink:href="mma-20240630.xsd#CashAndCashEquivalentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherReceivablesTables" xlink:href="mma-20240630.xsd#TradeAndOtherReceivablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/PropertyAndEquipmentTables" xlink:href="mma-20240630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IntangibleAssetsTables" xlink:href="mma-20240630.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherPayablesTables" xlink:href="mma-20240630.xsd#TradeAndOtherPayablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlementsTables" xlink:href="mma-20240630.xsd#CurrentAndNon-currentEmployeeEntitlementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/UnearnedRevenueTables" xlink:href="mma-20240630.xsd#UnearnedRevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ReservesTables" xlink:href="mma-20240630.xsd#ReservesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IssuedCapitalTables" xlink:href="mma-20240630.xsd#IssuedCapitalTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/NotesToStatementOfCashFlowsTables" xlink:href="mma-20240630.xsd#NotesToStatementOfCashFlowsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables" xlink:href="mma-20240630.xsd#RelatedPartiesTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/LeasesTables" xlink:href="mma-20240630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialLiabilitiesTables" xlink:href="mma-20240630.xsd#FinancialLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Share-basedPaymentsTables" xlink:href="mma-20240630.xsd#Share-basedPaymentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialInstrumentsTables" xlink:href="mma-20240630.xsd#FinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RemunerationOfAuditorsTables" xlink:href="mma-20240630.xsd#RemunerationOfAuditorsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/LossPerShareTables" xlink:href="mma-20240630.xsd#LossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails" xlink:href="mma-20240630.xsd#ScheduleOfPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative" xlink:href="mma-20240630.xsd#CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfRevenueDetails" xlink:href="mma-20240630.xsd#ScheduleOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:href="mma-20240630.xsd#ScheduleOfDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfExpensesDetails" xlink:href="mma-20240630.xsd#ScheduleOfExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails" xlink:href="mma-20240630.xsd#ScheduleOfIncomeTaxExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical" xlink:href="mma-20240630.xsd#ScheduleOfIncomeTaxExpensesDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfFairValueAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails" xlink:href="mma-20240630.xsd#ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfUnobservableInputsLevel3LiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:href="mma-20240630.xsd#ScheduleOfCashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails" xlink:href="mma-20240630.xsd#ScheduleOfTradeAndOtherReceivablesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="mma-20240630.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IncomeTaxDetailsNarrative" xlink:href="mma-20240630.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="mma-20240630.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails" xlink:href="mma-20240630.xsd#ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails" xlink:href="mma-20240630.xsd#ScheduleOfTradeAndOtherPayablesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails" xlink:href="mma-20240630.xsd#ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfUnearnedRevenueDetails" xlink:href="mma-20240630.xsd#ScheduleOfUnearnedRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfReservesDetails" xlink:href="mma-20240630.xsd#ScheduleOfReservesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails" xlink:href="mma-20240630.xsd#ScheduleOfIssuedCapitalDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical" xlink:href="mma-20240630.xsd#ScheduleOfIssuedCapitalDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails" xlink:href="mma-20240630.xsd#ScheduleOfStatementOfCashFlowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails" xlink:href="mma-20240630.xsd#ScheduleOfKeyManagementPersonnelRemunerationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails" xlink:href="mma-20240630.xsd#ScheduleOfSharesHeldByKeyManagementPersonnelDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:href="mma-20240630.xsd#RelatedPartiesTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails" xlink:href="mma-20240630.xsd#ScheduleOfFinancialStatementOfParentEntityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails" xlink:href="mma-20240630.xsd#ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails" xlink:href="mma-20240630.xsd#SummaryOfChangesInRouAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails" xlink:href="mma-20240630.xsd#SummaryOfFutureMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails" xlink:href="mma-20240630.xsd#ScheduleOfConvertibleNotesHeldByInvestorsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialLiabilitiesDetailsNarrative" xlink:href="mma-20240630.xsd#FinancialLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails" xlink:href="mma-20240630.xsd#ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical" xlink:href="mma-20240630.xsd#ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails" xlink:href="mma-20240630.xsd#ScheduleOfShareOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails" xlink:href="mma-20240630.xsd#ScheduleOfModelInputsForOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails" xlink:href="mma-20240630.xsd#ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative" xlink:href="mma-20240630.xsd#Share-basedPaymentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilitiesDetailsNarrative" xlink:href="mma-20240630.xsd#ContingentAssetsAndLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails" xlink:href="mma-20240630.xsd#ScheduleOfLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative" xlink:href="mma-20240630.xsd#EventsAfterReportingPeriodDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss" xlink:title="00000002 - Statement - Profit or Loss and Other Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NetRevenueFromProgramFees" xlink:label="loc_MMANetRevenueFromProgramFees" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromProgramFees" xlink:label="loc_MMARevenueFromProgramFees" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_MMANetRevenueFromProgramFees" xlink:to="loc_MMARevenueFromProgramFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContractualPaymentsToGyms" xlink:label="loc_MMAContractualPaymentsToGyms" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_MMANetRevenueFromProgramFees" xlink:to="loc_MMAContractualPaymentsToGyms" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullRevenue" xlink:to="loc_MMANetRevenueFromProgramFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-fullOtherIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullRevenue" xlink:to="loc_ifrs-fullOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-fullExpenseByNature" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpenses" xlink:label="loc_MMAProgramExpenses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_MMAProgramExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-fullWagesAndSalaries" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullWagesAndSalaries" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdvertisingExpense" xlink:label="loc_ifrs-fullAdvertisingExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullAdvertisingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-fullProfessionalFeesExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullProfessionalFeesExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RentExpenses" xlink:label="loc_MMARentExpenses" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_MMARentExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ITCosts" xlink:label="loc_MMAITCosts" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_MMAITCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-fullDepreciationExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullDepreciationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-fullNetForeignExchangeGain" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullNetForeignExchangeGain" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherExpenseByNature" xlink:label="loc_ifrs-fullOtherExpenseByNature" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullOtherExpenseByNature" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueMovementInDerivativeLiability" xlink:label="loc_MMAFairValueMovementInDerivativeLiability" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_MMAFairValueMovementInDerivativeLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullExpenseByNature" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/StatementOfFinancialPosition" xlink:title="00000003 - Statement - Consolidated Statement of Financial Position">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentReceivables" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullTradeAndOtherCurrentReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-fullOtherCurrentAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullOtherCurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-fullOtherNoncurrentAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullOtherNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnearnedRevenue" xlink:label="loc_MMAUnearnedRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_MMAUnearnedRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:label="loc_ifrs-fullCurrentProvisionsForEmployeeBenefits" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentProvisionsForEmployeeBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="loc_ifrs-fullNoncurrentProvisionsForEmployeeBenefits" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullNoncurrentProvisionsForEmployeeBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-fullNetAssetsLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNetAssetsLiabilities" xlink:to="loc_ifrs-fullAssets" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNetAssetsLiabilities" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-fullReserveOfSharebasedPayments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullReserveOfSharebasedPayments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnlistedOptionsReserve" xlink:label="loc_MMAUnlistedOptionsReserve" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_MMAUnlistedOptionsReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-fullReserveOfExchangeDifferencesOnTranslation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullReserveOfExchangeDifferencesOnTranslation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:label="loc_ifrs-fullAccumulatedOtherComprehensiveIncome" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullAccumulatedOtherComprehensiveIncome" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/StatementOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated Statement of Changes in Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/StatementOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statement of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProceedsFromTrainingParticipants" xlink:label="loc_MMAProceedsFromTrainingParticipants" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_MMAProceedsFromTrainingParticipants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" xlink:label="loc_MMAReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_MMAReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-fullInterestPaidClassifiedAsOperatingActivities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullInterestPaidClassifiedAsOperatingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_BankGuaranteeDepositReceivedPaid" xlink:label="loc_MMABankGuaranteeDepositReceivedPaid" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_MMABankGuaranteeDepositReceivedPaid" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures" xlink:label="loc_ifrs-fullProceedsFromIssueOfBondsNotesAndDebentures" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullProceedsFromIssueOfBondsNotesAndDebentures" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-fullProceedsFromIssuingShares" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullProceedsFromIssuingShares" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CorporateInformation" xlink:title="995611 - Disclosure - Corporate information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation" xlink:title="995612 - Disclosure - Material Accounting Policy Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions" xlink:title="995613 - Disclosure - Critical accounting judgements, estimates and assumptions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/OperatingSegments" xlink:title="995614 - Disclosure - Operating segments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Revenue" xlink:title="995615 - Disclosure - Revenue" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Expenses" xlink:title="995616 - Disclosure - Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IncomeTax" xlink:title="995617 - Disclosure - Income Tax" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FairValueMeasurement" xlink:title="995618 - Disclosure - Fair value measurement" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CashAndCashEquivalents" xlink:title="995619 - Disclosure - Cash and cash equivalents" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherReceivables" xlink:title="995620 - Disclosure - Trade and other receivables" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/PropertyAndEquipment" xlink:title="995621 - Disclosure - Property and equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IntangibleAssets" xlink:title="995622 - Disclosure - Intangible assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherPayables" xlink:title="995623 - Disclosure - Trade and other payables" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements" xlink:title="995624 - Disclosure - Current and Non-current Employee Entitlements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/UnearnedRevenue" xlink:title="995625 - Disclosure - Unearned Revenue" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Reserves" xlink:title="995626 - Disclosure - Reserves" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IssuedCapital" xlink:title="995627 - Disclosure - Issued capital" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/NotesToStatementOfCashFlows" xlink:title="995628 - Disclosure - Notes to statement of cash flows" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RelatedPartiesTransactions" xlink:title="995629 - Disclosure - Related parties transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Leases" xlink:title="995630 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialLiabilities" xlink:title="995631 - Disclosure - Financial Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Share-basedPayments" xlink:title="995632 - Disclosure - Share-based payments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialInstruments" xlink:title="995633 - Disclosure - Financial Instruments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RemunerationOfAuditors" xlink:title="995634 - Disclosure - Remuneration of auditors" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities" xlink:title="995635 - Disclosure - Contingent Assets and Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Commitments" xlink:title="995636 - Disclosure - Commitments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/LossPerShare" xlink:title="995637 - Disclosure - Loss per share" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/EventsAfterReportingPeriod" xlink:title="995638 - Disclosure - Events after the reporting period" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies" xlink:title="995639 - Disclosure - Material Accounting Policy Information (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables" xlink:title="995640 - Disclosure - Material Accounting Policy Information (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RevenueTables" xlink:title="995641 - Disclosure - Revenue (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ExpensesTables" xlink:title="995642 - Disclosure - Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IncomeTaxTables" xlink:title="995643 - Disclosure - Income Tax (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FairValueMeasurementTables" xlink:title="995644 - Disclosure - Fair value measurement (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CashAndCashEquivalentsTables" xlink:title="995645 - Disclosure - Cash and cash equivalents (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherReceivablesTables" xlink:title="995646 - Disclosure - Trade and other receivables (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/PropertyAndEquipmentTables" xlink:title="995647 - Disclosure - Property and equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IntangibleAssetsTables" xlink:title="995648 - Disclosure - Intangible assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherPayablesTables" xlink:title="995649 - Disclosure - Trade and other payables (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlementsTables" xlink:title="995650 - Disclosure - Current and Non-current Employee Entitlements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/UnearnedRevenueTables" xlink:title="995651 - Disclosure - Unearned Revenue (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ReservesTables" xlink:title="995652 - Disclosure - Reserves (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IssuedCapitalTables" xlink:title="995653 - Disclosure - Issued capital (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/NotesToStatementOfCashFlowsTables" xlink:title="995654 - Disclosure - Notes to statement of cash flows (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables" xlink:title="995655 - Disclosure - Related parties transactions (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/LeasesTables" xlink:title="995656 - Disclosure - Leases (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialLiabilitiesTables" xlink:title="995657 - Disclosure - Financial Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Share-basedPaymentsTables" xlink:title="995658 - Disclosure - Share-based payments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialInstrumentsTables" xlink:title="995659 - Disclosure - Financial Instruments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RemunerationOfAuditorsTables" xlink:title="995660 - Disclosure - Remuneration of auditors (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/LossPerShareTables" xlink:title="995661 - Disclosure - Loss per share (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails" xlink:title="995662 - Disclosure - Schedule of plant and equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative" xlink:title="995663 - Disclosure - Material Accounting Policy Information (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative" xlink:title="995664 - Disclosure - Critical accounting judgements, estimates and assumptions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfRevenueDetails" xlink:title="995665 - Disclosure - Schedule of revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-fullRevenueFromRenderingOfServices" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromProgramFees" xlink:label="loc_MMARevenueFromProgramFees" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullRevenueFromRenderingOfServices" xlink:to="loc_MMARevenueFromProgramFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromContractualPaymentsToGyms" xlink:label="loc_MMARevenueFromContractualPaymentsToGyms" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullRevenueFromRenderingOfServices" xlink:to="loc_MMARevenueFromContractualPaymentsToGyms" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-fullOtherRevenue" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReserachAndDevelopmentIncome" xlink:label="loc_MMAReserachAndDevelopmentIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullOtherRevenue" xlink:to="loc_MMAReserachAndDevelopmentIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FranchiseFeeIncome" xlink:label="loc_ifrs-fullFranchiseFeeIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullOtherRevenue" xlink:to="loc_ifrs-fullFranchiseFeeIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-fullRevenueFromSaleOfGoods" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullOtherRevenue" xlink:to="loc_ifrs-fullRevenueFromSaleOfGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullRevenue" xlink:to="loc_ifrs-fullRevenueFromRenderingOfServices" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullRevenue" xlink:to="loc_ifrs-fullOtherRevenue" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:title="995666 - Disclosure - Schedule of disaggregation of revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfExpensesDetails" xlink:title="995667 - Disclosure - Schedule of expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpenses" xlink:label="loc_MMAProgramExpenses" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesEventCosts" xlink:label="loc_MMAProgramExpensesEventCosts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_MMAProgramExpenses" xlink:to="loc_MMAProgramExpensesEventCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesProgramCosts" xlink:label="loc_MMAProgramExpensesProgramCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_MMAProgramExpenses" xlink:to="loc_MMAProgramExpensesProgramCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesMerchantFees" xlink:label="loc_MMAProgramExpensesMerchantFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_MMAProgramExpenses" xlink:to="loc_MMAProgramExpensesMerchantFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesOtherCosts" xlink:label="loc_MMAProgramExpensesOtherCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_MMAProgramExpenses" xlink:to="loc_MMAProgramExpensesOtherCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective" xlink:label="loc_MMAFinanceCostsConvertibleNotesInterestContractualAndEffective" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceCosts" xlink:to="loc_MMAFinanceCostsConvertibleNotesInterestContractualAndEffective" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FinanceCostsBankFees" xlink:label="loc_MMAFinanceCostsBankFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceCosts" xlink:to="loc_MMAFinanceCostsBankFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FinanceCostsBankInterestAndLeaseInterest" xlink:label="loc_MMAFinanceCostsBankInterestAndLeaseInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceCosts" xlink:to="loc_MMAFinanceCostsBankInterestAndLeaseInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-fullNetForeignExchangeGain" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnrealizedCurrencyGains" xlink:label="loc_MMAUnrealizedCurrencyGains" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNetForeignExchangeGain" xlink:to="loc_MMAUnrealizedCurrencyGains" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RealizedCurrencyGainslosses" xlink:label="loc_MMARealizedCurrencyGainslosses" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNetForeignExchangeGain" xlink:to="loc_MMARealizedCurrencyGainslosses" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails" xlink:title="995668 - Disclosure - Schedule of Income Tax Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-fullDeferredTaxExpenseIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:to="loc_ifrs-fullDeferredTaxExpenseIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-fullCurrentTaxExpenseIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:to="loc_ifrs-fullCurrentTaxExpenseIncome" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical" xlink:title="995669 - Disclosure - Schedule of Income Tax Expenses (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails" xlink:title="995670 - Disclosure - Schedule of Fair Value Assets and Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails" xlink:title="995671 - Disclosure - Schedule of Fair Value Measurement of Derivative Liability (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails" xlink:title="995672 - Disclosure - Schedule of Unobservable Inputs Level 3 Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:title="995673 - Disclosure - Schedule of Cash and Cash Equivalents (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashOnHand" xlink:label="loc_ifrs-fullCashOnHand" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashOnHand" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BalancesWithBanks" xlink:label="loc_ifrs-fullBalancesWithBanks" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashAndCashEquivalents" xlink:to="loc_ifrs-fullBalancesWithBanks" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails" xlink:title="995674 - Disclosure - Schedule of Trade and Other Receivables (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="995675 - Disclosure - Schedule of Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IncomeTaxDetailsNarrative" xlink:title="995676 - Disclosure - Income Tax (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="995677 - Disclosure - Schedule of Intangible assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails" xlink:title="995678 - Disclosure - Schedule of Reconciliations of the Movement of Intangible Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails" xlink:title="995679 - Disclosure - Schedule of Trade and Other Payables (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-fullTradeAndOtherPayables" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_TradeAndOtherPayablesPayableToMemberGyms" xlink:label="loc_MMATradeAndOtherPayablesPayableToMemberGyms" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherPayables" xlink:to="loc_MMATradeAndOtherPayablesPayableToMemberGyms" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_TaxesPayable" xlink:label="loc_MMATaxesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherPayables" xlink:to="loc_MMATaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_TradePayables" xlink:label="loc_MMATradePayables" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherPayables" xlink:to="loc_MMATradePayables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProvisionForRefundLiability" xlink:label="loc_MMAProvisionForRefundLiability" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherPayables" xlink:to="loc_MMAProvisionForRefundLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPayables" xlink:label="loc_ifrs-fullOtherPayables" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullTradeAndOtherPayables" xlink:to="loc_ifrs-fullOtherPayables" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails" xlink:title="995680 - Disclosure - Schedule of Current and Non-current Employee Entitlements (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfUnearnedRevenueDetails" xlink:title="995681 - Disclosure - Schedule of Unearned Revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfReservesDetails" xlink:title="995682 - Disclosure - Schedule of Reserves (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails" xlink:title="995683 - Disclosure - Schedule of Issued Capital (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical" xlink:title="995684 - Disclosure - Schedule of Issued Capital (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails" xlink:title="995685 - Disclosure - Schedule of Statement of Cash Flows (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails" xlink:title="995686 - Disclosure - Schedule of Key Management Personnel Remuneration (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensation" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationShorttermEmployeeBenefits" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullKeyManagementPersonnelCompensation" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationPostemploymentBenefits" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullKeyManagementPersonnelCompensation" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationOtherLongtermBenefits" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullKeyManagementPersonnelCompensation" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationSharebasedPayment" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullKeyManagementPersonnelCompensation" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationSharebasedPayment" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails" xlink:title="995687 - Disclosure - Schedule of Shares Held by Key Management Personnel (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:title="995688 - Disclosure - Related parties transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails" xlink:title="995689 - Disclosure - Schedule of Financial Statement of the Parent Entity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-fullNetAssetsLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNetAssetsLiabilities" xlink:to="loc_ifrs-fullAssets" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNetAssetsLiabilities" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContributedEquity" xlink:label="loc_MMAContributedEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_MMAContributedEquity" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves" xlink:label="loc_ifrs-fullOtherReserves" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullOtherReserves" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullRetainedEarnings" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails" xlink:title="995690 - Disclosure - Schedule of Country Incorporation Principal Place of Business (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails" xlink:title="995691 - Disclosure - Summary of Changes in ROU Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails" xlink:title="995692 - Disclosure - Summary of Future Minimum Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-fullGrossLeaseLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLeaseLiabilities" xlink:to="loc_ifrs-fullGrossLeaseLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails" xlink:title="995693 - Disclosure - Schedule of Financial Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinancialLiabilities" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinancialLiabilities" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DebtSecurities" xlink:label="loc_ifrs-fullDebtSecurities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued" xlink:label="loc_ifrs-fullCurrentDebtInstrumentsIssued" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullDebtSecurities" xlink:to="loc_ifrs-fullCurrentDebtInstrumentsIssued" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDebtInstrumentsIssued" xlink:label="loc_ifrs-fullNoncurrentDebtInstrumentsIssued" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullDebtSecurities" xlink:to="loc_ifrs-fullNoncurrentDebtInstrumentsIssued" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentDerivativeFinancialLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullDebtSecurities" xlink:to="loc_ifrs-fullCurrentDerivativeFinancialLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentDerivativeFinancialLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullDebtSecurities" xlink:to="loc_ifrs-fullNoncurrentDerivativeFinancialLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails" xlink:title="995694 - Disclosure - Schedule of Convertible Notes held by Investors (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialLiabilitiesDetailsNarrative" xlink:title="995695 - Disclosure - Financial Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails" xlink:title="995696 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical" xlink:title="995697 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails" xlink:title="995698 - Disclosure - Schedule of Share Options Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails" xlink:title="995699 - Disclosure - Schedule of Model Inputs For Options Granted (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" xlink:title="995700 - Disclosure - Schedule of Contractual Maturities of Financial Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails" xlink:title="995701 - Disclosure - Schedule of Auditor of Company And Network Firms (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemuneration" xlink:label="loc_ifrs-fullAuditorsRemuneration" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AuditFees" xlink:label="loc_MMAAuditFees" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAuditorsRemuneration" xlink:to="loc_MMAAuditFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AuditorsRemunerationForRelatedFees" xlink:label="loc_MMAAuditorsRemunerationForRelatedFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAuditorsRemuneration" xlink:to="loc_MMAAuditorsRemunerationForRelatedFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForTaxServices" xlink:label="loc_ifrs-fullAuditorsRemunerationForTaxServices" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAuditorsRemuneration" xlink:to="loc_ifrs-fullAuditorsRemunerationForTaxServices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices" xlink:label="loc_ifrs-fullAuditorsRemunerationForOtherServices" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAuditorsRemuneration" xlink:to="loc_ifrs-fullAuditorsRemunerationForOtherServices" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative" xlink:title="995702 - Disclosure - Share-based payments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilitiesDetailsNarrative" xlink:title="995703 - Disclosure - Contingent Assets and Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails" xlink:title="995704 - Disclosure - Schedule of Loss Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative" xlink:title="995705 - Disclosure - Events after the reporting period (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>mma-20240630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Cover" xlink:href="mma-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss" xlink:href="mma-20240630.xsd#ProfitOrLossAndOtherComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/StatementOfFinancialPosition" xlink:href="mma-20240630.xsd#StatementOfFinancialPosition" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/StatementOfChangesInEquity" xlink:href="mma-20240630.xsd#StatementOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/StatementOfCashFlows" xlink:href="mma-20240630.xsd#StatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CorporateInformation" xlink:href="mma-20240630.xsd#CorporateInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions" xlink:href="mma-20240630.xsd#CriticalAccountingJudgementsEstimatesAndAssumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/OperatingSegments" xlink:href="mma-20240630.xsd#OperatingSegments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Revenue" xlink:href="mma-20240630.xsd#Revenue" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Expenses" xlink:href="mma-20240630.xsd#Expenses" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IncomeTax" xlink:href="mma-20240630.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FairValueMeasurement" xlink:href="mma-20240630.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CashAndCashEquivalents" xlink:href="mma-20240630.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherReceivables" xlink:href="mma-20240630.xsd#TradeAndOtherReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/PropertyAndEquipment" xlink:href="mma-20240630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IntangibleAssets" xlink:href="mma-20240630.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherPayables" xlink:href="mma-20240630.xsd#TradeAndOtherPayables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements" xlink:href="mma-20240630.xsd#CurrentAndNon-currentEmployeeEntitlements" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/UnearnedRevenue" xlink:href="mma-20240630.xsd#UnearnedRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Reserves" xlink:href="mma-20240630.xsd#Reserves" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IssuedCapital" xlink:href="mma-20240630.xsd#IssuedCapital" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/NotesToStatementOfCashFlows" xlink:href="mma-20240630.xsd#NotesToStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactions" xlink:href="mma-20240630.xsd#RelatedPartiesTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Leases" xlink:href="mma-20240630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialLiabilities" xlink:href="mma-20240630.xsd#FinancialLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Share-basedPayments" xlink:href="mma-20240630.xsd#Share-basedPayments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialInstruments" xlink:href="mma-20240630.xsd#FinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RemunerationOfAuditors" xlink:href="mma-20240630.xsd#RemunerationOfAuditors" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities" xlink:href="mma-20240630.xsd#ContingentAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Commitments" xlink:href="mma-20240630.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/LossPerShare" xlink:href="mma-20240630.xsd#LossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/EventsAfterReportingPeriod" xlink:href="mma-20240630.xsd#EventsAfterReportingPeriod" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RevenueTables" xlink:href="mma-20240630.xsd#RevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ExpensesTables" xlink:href="mma-20240630.xsd#ExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IncomeTaxTables" xlink:href="mma-20240630.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FairValueMeasurementTables" xlink:href="mma-20240630.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CashAndCashEquivalentsTables" xlink:href="mma-20240630.xsd#CashAndCashEquivalentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherReceivablesTables" xlink:href="mma-20240630.xsd#TradeAndOtherReceivablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/PropertyAndEquipmentTables" xlink:href="mma-20240630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IntangibleAssetsTables" xlink:href="mma-20240630.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherPayablesTables" xlink:href="mma-20240630.xsd#TradeAndOtherPayablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlementsTables" xlink:href="mma-20240630.xsd#CurrentAndNon-currentEmployeeEntitlementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/UnearnedRevenueTables" xlink:href="mma-20240630.xsd#UnearnedRevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ReservesTables" xlink:href="mma-20240630.xsd#ReservesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IssuedCapitalTables" xlink:href="mma-20240630.xsd#IssuedCapitalTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/NotesToStatementOfCashFlowsTables" xlink:href="mma-20240630.xsd#NotesToStatementOfCashFlowsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables" xlink:href="mma-20240630.xsd#RelatedPartiesTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/LeasesTables" xlink:href="mma-20240630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialLiabilitiesTables" xlink:href="mma-20240630.xsd#FinancialLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Share-basedPaymentsTables" xlink:href="mma-20240630.xsd#Share-basedPaymentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialInstrumentsTables" xlink:href="mma-20240630.xsd#FinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RemunerationOfAuditorsTables" xlink:href="mma-20240630.xsd#RemunerationOfAuditorsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/LossPerShareTables" xlink:href="mma-20240630.xsd#LossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails" xlink:href="mma-20240630.xsd#ScheduleOfPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative" xlink:href="mma-20240630.xsd#CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfRevenueDetails" xlink:href="mma-20240630.xsd#ScheduleOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:href="mma-20240630.xsd#ScheduleOfDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfExpensesDetails" xlink:href="mma-20240630.xsd#ScheduleOfExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails" xlink:href="mma-20240630.xsd#ScheduleOfIncomeTaxExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical" xlink:href="mma-20240630.xsd#ScheduleOfIncomeTaxExpensesDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfFairValueAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails" xlink:href="mma-20240630.xsd#ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfUnobservableInputsLevel3LiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:href="mma-20240630.xsd#ScheduleOfCashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails" xlink:href="mma-20240630.xsd#ScheduleOfTradeAndOtherReceivablesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="mma-20240630.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IncomeTaxDetailsNarrative" xlink:href="mma-20240630.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="mma-20240630.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails" xlink:href="mma-20240630.xsd#ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails" xlink:href="mma-20240630.xsd#ScheduleOfTradeAndOtherPayablesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails" xlink:href="mma-20240630.xsd#ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfUnearnedRevenueDetails" xlink:href="mma-20240630.xsd#ScheduleOfUnearnedRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfReservesDetails" xlink:href="mma-20240630.xsd#ScheduleOfReservesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails" xlink:href="mma-20240630.xsd#ScheduleOfIssuedCapitalDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical" xlink:href="mma-20240630.xsd#ScheduleOfIssuedCapitalDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails" xlink:href="mma-20240630.xsd#ScheduleOfStatementOfCashFlowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails" xlink:href="mma-20240630.xsd#ScheduleOfKeyManagementPersonnelRemunerationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails" xlink:href="mma-20240630.xsd#ScheduleOfSharesHeldByKeyManagementPersonnelDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:href="mma-20240630.xsd#RelatedPartiesTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails" xlink:href="mma-20240630.xsd#ScheduleOfFinancialStatementOfParentEntityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails" xlink:href="mma-20240630.xsd#ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails" xlink:href="mma-20240630.xsd#SummaryOfChangesInRouAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails" xlink:href="mma-20240630.xsd#SummaryOfFutureMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails" xlink:href="mma-20240630.xsd#ScheduleOfConvertibleNotesHeldByInvestorsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialLiabilitiesDetailsNarrative" xlink:href="mma-20240630.xsd#FinancialLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails" xlink:href="mma-20240630.xsd#ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical" xlink:href="mma-20240630.xsd#ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails" xlink:href="mma-20240630.xsd#ScheduleOfShareOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails" xlink:href="mma-20240630.xsd#ScheduleOfModelInputsForOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails" xlink:href="mma-20240630.xsd#ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative" xlink:href="mma-20240630.xsd#Share-basedPaymentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilitiesDetailsNarrative" xlink:href="mma-20240630.xsd#ContingentAssetsAndLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails" xlink:href="mma-20240630.xsd#ScheduleOfLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative" xlink:href="mma-20240630.xsd#EventsAfterReportingPeriodDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_40" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag_40" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag_40" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorFirmId_40" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorName_40" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorLocation_40" xlink:type="arc" order="63" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss" xlink:title="00000002 - Statement - Profit or Loss and Other Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/StatementOfFinancialPosition" xlink:title="00000003 - Statement - Consolidated Statement of Financial Position" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/StatementOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated Statement of Changes in Equity">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-fullComponentsOfEquityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullComponentsOfEquityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-fullComponentsOfEquityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullComponentsOfEquityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-fullComponentsOfEquityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullComponentsOfEquityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-fullIssuedCapitalMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullIssuedCapitalMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnlistedOptionReserveMember" xlink:label="loc_MMAUnlistedOptionReserveMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMAUnlistedOptionReserveMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-fullReserveOfSharebasedPaymentsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullReserveOfSharebasedPaymentsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-fullReserveOfExchangeDifferencesOnTranslationMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullReserveOfExchangeDifferencesOnTranslationMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-fullAccumulatedOtherComprehensiveIncomeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullAccumulatedOtherComprehensiveIncomeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherComprehensiveIncome_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullComprehensiveIncome_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-fullIssueOfEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIssueOfEquity_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssueOfEquityFromConversionOfConvertibleNotes" xlink:label="loc_MMAIssueOfEquityFromConversionOfConvertibleNotes_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIssueOfEquityFromConversionOfConvertibleNotes_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes" xlink:label="loc_MMAIssueOfUnlistedSharesFromConversionOfConvertibleNotes_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIssueOfUnlistedSharesFromConversionOfConvertibleNotes_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughExerciseOfOptions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughExerciseOfOptions_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IncreaseDecreaseThroughOptionsForfeited" xlink:label="loc_MMAIncreaseDecreaseThroughOptionsForfeited_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIncreaseDecreaseThroughOptionsForfeited_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OverAllotmentOptionsLapsed" xlink:label="loc_MMAOverAllotmentOptionsLapsed_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAOverAllotmentOptionsLapsed_70" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/StatementOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statement of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CorporateInformation" xlink:title="995611 - Disclosure - Corporate information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation" xlink:title="995612 - Disclosure - Material Accounting Policy Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions" xlink:title="995613 - Disclosure - Critical accounting judgements, estimates and assumptions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/OperatingSegments" xlink:title="995614 - Disclosure - Operating segments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Revenue" xlink:title="995615 - Disclosure - Revenue" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Expenses" xlink:title="995616 - Disclosure - Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IncomeTax" xlink:title="995617 - Disclosure - Income Tax" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FairValueMeasurement" xlink:title="995618 - Disclosure - Fair value measurement" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CashAndCashEquivalents" xlink:title="995619 - Disclosure - Cash and cash equivalents" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherReceivables" xlink:title="995620 - Disclosure - Trade and other receivables" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/PropertyAndEquipment" xlink:title="995621 - Disclosure - Property and equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IntangibleAssets" xlink:title="995622 - Disclosure - Intangible assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherPayables" xlink:title="995623 - Disclosure - Trade and other payables" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements" xlink:title="995624 - Disclosure - Current and Non-current Employee Entitlements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/UnearnedRevenue" xlink:title="995625 - Disclosure - Unearned Revenue" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Reserves" xlink:title="995626 - Disclosure - Reserves" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IssuedCapital" xlink:title="995627 - Disclosure - Issued capital" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/NotesToStatementOfCashFlows" xlink:title="995628 - Disclosure - Notes to statement of cash flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RelatedPartiesTransactions" xlink:title="995629 - Disclosure - Related parties transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Leases" xlink:title="995630 - Disclosure - Leases" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialLiabilities" xlink:title="995631 - Disclosure - Financial Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Share-basedPayments" xlink:title="995632 - Disclosure - Share-based payments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialInstruments" xlink:title="995633 - Disclosure - Financial Instruments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RemunerationOfAuditors" xlink:title="995634 - Disclosure - Remuneration of auditors" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities" xlink:title="995635 - Disclosure - Contingent Assets and Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Commitments" xlink:title="995636 - Disclosure - Commitments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/LossPerShare" xlink:title="995637 - Disclosure - Loss per share" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/EventsAfterReportingPeriod" xlink:title="995638 - Disclosure - Events after the reporting period" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies" xlink:title="995639 - Disclosure - Material Accounting Policy Information (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables" xlink:title="995640 - Disclosure - Material Accounting Policy Information (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RevenueTables" xlink:title="995641 - Disclosure - Revenue (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ExpensesTables" xlink:title="995642 - Disclosure - Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IncomeTaxTables" xlink:title="995643 - Disclosure - Income Tax (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FairValueMeasurementTables" xlink:title="995644 - Disclosure - Fair value measurement (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CashAndCashEquivalentsTables" xlink:title="995645 - Disclosure - Cash and cash equivalents (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherReceivablesTables" xlink:title="995646 - Disclosure - Trade and other receivables (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/PropertyAndEquipmentTables" xlink:title="995647 - Disclosure - Property and equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IntangibleAssetsTables" xlink:title="995648 - Disclosure - Intangible assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherPayablesTables" xlink:title="995649 - Disclosure - Trade and other payables (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlementsTables" xlink:title="995650 - Disclosure - Current and Non-current Employee Entitlements (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/UnearnedRevenueTables" xlink:title="995651 - Disclosure - Unearned Revenue (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ReservesTables" xlink:title="995652 - Disclosure - Reserves (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IssuedCapitalTables" xlink:title="995653 - Disclosure - Issued capital (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/NotesToStatementOfCashFlowsTables" xlink:title="995654 - Disclosure - Notes to statement of cash flows (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables" xlink:title="995655 - Disclosure - Related parties transactions (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/LeasesTables" xlink:title="995656 - Disclosure - Leases (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialLiabilitiesTables" xlink:title="995657 - Disclosure - Financial Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Share-basedPaymentsTables" xlink:title="995658 - Disclosure - Share-based payments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialInstrumentsTables" xlink:title="995659 - Disclosure - Financial Instruments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RemunerationOfAuditorsTables" xlink:title="995660 - Disclosure - Remuneration of auditors (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/LossPerShareTables" xlink:title="995661 - Disclosure - Loss per share (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails" xlink:title="995662 - Disclosure - Schedule of plant and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlantAndEquipmentMember" xlink:label="loc_MMAPlantAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_MMAPlantAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-fullComputerEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullComputerEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-fullOfficeEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullOfficeEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullFixturesAndFittingsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative" xlink:title="995663 - Disclosure - Material Accounting Policy Information (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopmentMember" xlink:label="loc_ifrs-fullIntangibleAssetsUnderDevelopmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullIntangibleAssetsUnderDevelopmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative" xlink:title="995664 - Disclosure - Critical accounting judgements, estimates and assumptions (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfRevenueDetails" xlink:title="995665 - Disclosure - Schedule of revenue (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:title="995666 - Disclosure - Schedule of disaggregation of revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-fullProductsAndServicesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullProductsAndServicesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-fullProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-fullProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OneMajorProductMember" xlink:label="loc_MMAOneMajorProductMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullProductsAndServicesDomain" xlink:to="loc_MMAOneMajorProductMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromProgramFees" xlink:label="loc_MMARevenueFromProgramFees_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARevenueFromProgramFees_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromContractualPaymentsToGyms" xlink:label="loc_MMARevenueFromContractualPaymentsToGyms_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARevenueFromContractualPaymentsToGyms_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-fullRevenueFromRenderingOfServices_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenueFromRenderingOfServices_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfExpensesDetails" xlink:title="995667 - Disclosure - Schedule of expenses (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails" xlink:title="995668 - Disclosure - Schedule of Income Tax Expenses (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical" xlink:title="995669 - Disclosure - Schedule of Income Tax Expenses (Details) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails" xlink:title="995670 - Disclosure - Schedule of Fair Value Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel1OfFairValueHierarchyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:to="loc_ifrs-fullLevel1OfFairValueHierarchyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel2OfFairValueHierarchyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:to="loc_ifrs-fullLevel2OfFairValueHierarchyMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel3OfFairValueHierarchyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:to="loc_ifrs-fullLevel3OfFairValueHierarchyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-fullFinancialAssetsAtFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsAtFairValue_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtFairValue_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails" xlink:title="995671 - Disclosure - Schedule of Fair Value Measurement of Derivative Liability (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails" xlink:title="995672 - Disclosure - Schedule of Unobservable Inputs Level 3 Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="loc_ifrs-fullUnobservableInputsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullUnobservableInputsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain" xlink:label="loc_ifrs-fullUnobservableInputsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullUnobservableInputsAxis" xlink:to="loc_ifrs-fullUnobservableInputsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain" xlink:label="loc_ifrs-fullUnobservableInputsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullUnobservableInputsAxis" xlink:to="loc_ifrs-fullUnobservableInputsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ImpliedValuationMember" xlink:label="loc_MMAImpliedValuationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullUnobservableInputsDomain" xlink:to="loc_MMAImpliedValuationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember" xlink:label="loc_ifrs-fullHistoricalVolatilityForSharesMeasurementInputMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullUnobservableInputsDomain" xlink:to="loc_ifrs-fullHistoricalVolatilityForSharesMeasurementInputMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateMeasurementInputMember" xlink:label="loc_ifrs-fullInterestRateMeasurementInputMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullUnobservableInputsDomain" xlink:to="loc_ifrs-fullInterestRateMeasurementInputMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProbabilityOfDefaultMeasurementInputMember" xlink:label="loc_ifrs-fullProbabilityOfDefaultMeasurementInputMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullUnobservableInputsDomain" xlink:to="loc_ifrs-fullProbabilityOfDefaultMeasurementInputMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-fullComponentsOfEquityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullComponentsOfEquityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-fullComponentsOfEquityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullComponentsOfEquityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-fullComponentsOfEquityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullComponentsOfEquityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAConvertibleNotesMember" xlink:label="loc_MMASeriesAConvertibleNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesAConvertibleNotesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAJuly21Member" xlink:label="loc_MMASeriesAJuly21Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesAJuly21Member_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAAugust21Member" xlink:label="loc_MMASeriesAAugust21Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesAAugust21Member_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesB1Member" xlink:label="loc_MMASeriesB1Member_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesB1Member_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesB2Member" xlink:label="loc_MMASeriesB2Member_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesB2Member_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAExtensionMember" xlink:label="loc_MMASeriesAExtensionMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesAExtensionMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachMember" xlink:label="loc_MMAReachMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMAReachMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PrivatePlacementsMember" xlink:label="loc_MMAPrivatePlacementsMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMAPrivatePlacementsMember_280" xlink:type="arc" order="282" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MixedMartialArtsLLCMember" xlink:label="loc_MMAMixedMartialArtsLLCMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMAMixedMartialArtsLLCMember_320" xlink:type="arc" order="322" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SteppenMember" xlink:label="loc_MMASteppenMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASteppenMember_360" xlink:type="arc" order="362" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_410" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities" xlink:label="loc_ifrs-fullSignificantUnobservableInputLiabilities_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullSignificantUnobservableInputLiabilities_410" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:title="995673 - Disclosure - Schedule of Cash and Cash Equivalents (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails" xlink:title="995674 - Disclosure - Schedule of Trade and Other Receivables (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="995675 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlantAndEquipmentMember" xlink:label="loc_MMAPlantAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_MMAPlantAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-fullComputerEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullComputerEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-fullOfficeEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullOfficeEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FurnitrueAndFittingsMember" xlink:label="loc_MMAFurnitrueAndFittingsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_MMAFurnitrueAndFittingsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PropertyPlantAndEquipmentCost" xlink:label="loc_MMAPropertyPlantAndEquipmentCost_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAPropertyPlantAndEquipmentCost_230" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PropertyPlantAndEquipmentAccumulatedDepreciation" xlink:label="loc_MMAPropertyPlantAndEquipmentAccumulatedDepreciation_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAPropertyPlantAndEquipmentAccumulatedDepreciation_230" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment_230" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_230" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_230" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDisposalsAndRetirementsPropertyPlantAndEquipment_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisposalsAndRetirementsPropertyPlantAndEquipment_230" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDepreciationPropertyPlantAndEquipment_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDepreciationPropertyPlantAndEquipment_230" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IncomeTaxDetailsNarrative" xlink:title="995676 - Disclosure - Income Tax (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="995677 - Disclosure - Schedule of Intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlatformDevelopmentMember" xlink:label="loc_MMAPlatformDevelopmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_MMAPlatformDevelopmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill_150" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails" xlink:title="995678 - Disclosure - Schedule of Reconciliations of the Movement of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlatformDevelopmentMember" xlink:label="loc_MMAPlatformDevelopmentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_MMAPlatformDevelopmentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-fullCounterpartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullCounterpartiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-fullCounterpartiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCounterpartiesAxis" xlink:to="loc_ifrs-fullCounterpartiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-fullCounterpartiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCounterpartiesAxis" xlink:to="loc_ifrs-fullCounterpartiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SteppenPtyLtdMember" xlink:label="loc_MMASteppenPtyLtdMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCounterpartiesDomain" xlink:to="loc_MMASteppenPtyLtdMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MixedMartialsArtsLLCMember" xlink:label="loc_MMAMixedMartialsArtsLLCMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCounterpartiesDomain" xlink:to="loc_MMAMixedMartialsArtsLLCMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_HypeKitIncMember" xlink:label="loc_MMAHypeKitIncMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCounterpartiesDomain" xlink:to="loc_MMAHypeKitIncMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdditionsFromInternalDevelopment" xlink:label="loc_MMAAdditionsFromInternalDevelopment_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAAdditionsFromInternalDevelopment_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ResearchDevelopmentTaxIncentive" xlink:label="loc_MMAResearchDevelopmentTaxIncentive_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAResearchDevelopmentTaxIncentive_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-fullNotionalAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNotionalAmount_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-fullCash_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCash_140" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_140" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails" xlink:title="995679 - Disclosure - Schedule of Trade and Other Payables (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails" xlink:title="995680 - Disclosure - Schedule of Current and Non-current Employee Entitlements (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfUnearnedRevenueDetails" xlink:title="995681 - Disclosure - Schedule of Unearned Revenue (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfReservesDetails" xlink:title="995682 - Disclosure - Schedule of Reserves (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails" xlink:title="995683 - Disclosure - Schedule of Issued Capital (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical" xlink:title="995684 - Disclosure - Schedule of Issued Capital (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContractualCapitalisedInterestRate" xlink:label="loc_MMAContractualCapitalisedInterestRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAContractualCapitalisedInterestRate_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorOptionsExercisedShares" xlink:label="loc_MMAAdvisorOptionsExercisedShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAAdvisorOptionsExercisedShares_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorOptionsForfeitedShares" xlink:label="loc_MMAAdvisorOptionsForfeitedShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAAdvisorOptionsForfeitedShares_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails" xlink:title="995685 - Disclosure - Schedule of Statement of Cash Flows (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails" xlink:title="995686 - Disclosure - Schedule of Key Management Personnel Remuneration (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails" xlink:title="995687 - Disclosure - Schedule of Shares Held by Key Management Personnel (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SharesHeldByKeyManagementPersonnelMember" xlink:label="loc_MMASharesHeldByKeyManagementPersonnelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_MMASharesHeldByKeyManagementPersonnelMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OptionHeldByKeyManagementPersonnelMember" xlink:label="loc_MMAOptionHeldByKeyManagementPersonnelMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_MMAOptionHeldByKeyManagementPersonnelMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-fullNumberOfSharesOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesOutstanding_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssuedSharesHeldByKeyManagementPersonnel" xlink:label="loc_MMAIssuedSharesHeldByKeyManagementPersonnel_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIssuedSharesHeldByKeyManagementPersonnel_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RepurchasedSharesHeldByKeyManagementPersonnel" xlink:label="loc_MMARepurchasedSharesHeldByKeyManagementPersonnel_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARepurchasedSharesHeldByKeyManagementPersonnel_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ResignationOfKeyManagementPersonnelShares" xlink:label="loc_MMAResignationOfKeyManagementPersonnelShares_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAResignationOfKeyManagementPersonnelShares_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel" xlink:label="loc_MMAReverseShareSplitSharesHeldByKeyManagementPersonnel_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAReverseShareSplitSharesHeldByKeyManagementPersonnel_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssuedOptionsHeldByKeyManagementPersonnel" xlink:label="loc_MMAIssuedOptionsHeldByKeyManagementPersonnel_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIssuedOptionsHeldByKeyManagementPersonnel_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpiredOptionsHeldByKeyManagementPersonnel" xlink:label="loc_MMAExpiredOptionsHeldByKeyManagementPersonnel_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAExpiredOptionsHeldByKeyManagementPersonnel_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisedOptionsHeldByKeyManagementPersonnel" xlink:label="loc_MMAExercisedOptionsHeldByKeyManagementPersonnel_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAExercisedOptionsHeldByKeyManagementPersonnel_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel" xlink:label="loc_MMAReverseShareSplitOptionsHeldByKeyManagementPersonnel_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAReverseShareSplitOptionsHeldByKeyManagementPersonnel_150" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:title="995688 - Disclosure - Related parties transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementTable" xlink:label="loc_MMAIfrsStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIfrsStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrLangtonMember" xlink:label="loc_MMAMrLangtonMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_MMAMrLangtonMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrWilliamsMember" xlink:label="loc_MMAMrWilliamsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_MMAMrWilliamsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrTaylorMember" xlink:label="loc_MMAMrTaylorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_MMAMrTaylorMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrHartMember" xlink:label="loc_MMAMrHartMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_MMAMrHartMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SnowflowerHoldingsPtyLtdMember" xlink:label="loc_MMASnowflowerHoldingsPtyLtdMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_MMASnowflowerHoldingsPtyLtdMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ChampSevenPtyLtdMember" xlink:label="loc_MMAChampSevenPtyLtdMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_MMAChampSevenPtyLtdMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NalarooHoldingsPtyLtdMember" xlink:label="loc_MMANalarooHoldingsPtyLtdMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_MMANalarooHoldingsPtyLtdMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_JHartFamilyTrustAccountMember" xlink:label="loc_MMAJHartFamilyTrustAccountMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_MMAJHartFamilyTrustAccountMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="loc_ifrs-fullTypesOfContractsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_ifrs-fullTypesOfContractsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain" xlink:label="loc_ifrs-fullTypesOfContractsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfContractsAxis" xlink:to="loc_ifrs-fullTypesOfContractsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain" xlink:label="loc_ifrs-fullTypesOfContractsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfContractsAxis" xlink:to="loc_ifrs-fullTypesOfContractsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_EmploymentAgreementMember" xlink:label="loc_MMAEmploymentAgreementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfContractsDomain" xlink:to="loc_MMAEmploymentAgreementMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_EmployeementAgreementMember" xlink:label="loc_MMAEmployeementAgreementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfContractsDomain" xlink:to="loc_MMAEmployeementAgreementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Mr.LangtonMember" xlink:label="loc_MMAMr.LangtonMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_MMAMr.LangtonMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-fullCounterpartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_ifrs-fullCounterpartiesAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-fullCounterpartiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCounterpartiesAxis" xlink:to="loc_ifrs-fullCounterpartiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-fullCounterpartiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCounterpartiesAxis" xlink:to="loc_ifrs-fullCounterpartiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Mr.LangtonMember" xlink:label="loc_MMAMr.LangtonMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCounterpartiesDomain" xlink:to="loc_MMAMr.LangtonMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesIssued_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PercentageOfOrdinarySharesUnderVestAndExercisable" xlink:label="loc_MMAPercentageOfOrdinarySharesUnderVestAndExercisable_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAPercentageOfOrdinarySharesUnderVestAndExercisable_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-fullShorttermEmployeeBenefitsExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullShorttermEmployeeBenefitsExpense_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_110" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails" xlink:title="995689 - Disclosure - Schedule of Financial Statement of the Parent Entity (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParentMember" xlink:label="loc_ifrs-fullParentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_ifrs-fullParentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherComprehensiveIncome_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullComprehensiveIncome_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-fullAssetsAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAssetsAbstract_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAssets_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-fullLiabilitiesAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesAbstract_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilities_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-fullNetAssetsLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNetAssetsLiabilities_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-fullEquityAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquityAbstract_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContributedEquity" xlink:label="loc_MMAContributedEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAContributedEquity_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves" xlink:label="loc_ifrs-fullOtherReserves_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherReserves_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullRetainedEarnings_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_60" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails" xlink:title="995690 - Disclosure - Schedule of Country Incorporation Principal Place of Business (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:label="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-fullConsolidatedStructuredEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:to="loc_ifrs-fullConsolidatedStructuredEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesAxis" xlink:to="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-fullConsolidatedStructuredEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesAxis" xlink:to="loc_ifrs-fullConsolidatedStructuredEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorLLCMember" xlink:label="loc_MMAWimp2WarriorLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:to="loc_MMAWimp2WarriorLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorProductionsPtyLtdMember" xlink:label="loc_MMAWimp2WarriorProductionsPtyLtdMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:to="loc_MMAWimp2WarriorProductionsPtyLtdMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorDigitalPtyLtdMember" xlink:label="loc_MMAWimp2WarriorDigitalPtyLtdMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:to="loc_MMAWimp2WarriorDigitalPtyLtdMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorIrelandLimitedMember" xlink:label="loc_MMAWimp2WarriorIrelandLimitedMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:to="loc_MMAWimp2WarriorIrelandLimitedMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_HypeCoMember" xlink:label="loc_MMAHypeCoMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:to="loc_MMAHypeCoMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-fullGeographicalAreasAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:to="loc_ifrs-fullGeographicalAreasAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-fullGeographicalAreasDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullGeographicalAreasAxis" xlink:to="loc_ifrs-fullGeographicalAreasDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-fullGeographicalAreasDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullGeographicalAreasAxis" xlink:to="loc_ifrs-fullGeographicalAreasDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnitedStatesOfAmericaCountryMember" xlink:label="loc_MMAUnitedStatesOfAmericaCountryMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullGeographicalAreasDomain" xlink:to="loc_MMAUnitedStatesOfAmericaCountryMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AustraliaCountryMember" xlink:label="loc_MMAAustraliaCountryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullGeographicalAreasDomain" xlink:to="loc_MMAAustraliaCountryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AustraliaCountryOneMember" xlink:label="loc_MMAAustraliaCountryOneMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullGeographicalAreasDomain" xlink:to="loc_MMAAustraliaCountryOneMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IrelandCountryMember" xlink:label="loc_MMAIrelandCountryMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullGeographicalAreasDomain" xlink:to="loc_MMAIrelandCountryMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnitedStatesOfAmericaCountryOneMember" xlink:label="loc_MMAUnitedStatesOfAmericaCountryOneMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullGeographicalAreasDomain" xlink:to="loc_MMAUnitedStatesOfAmericaCountryOneMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NameOfParentEntity" xlink:label="loc_ifrs-fullNameOfParentEntity_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNameOfParentEntity_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PrincipalPlaceOfBusiness" xlink:label="loc_ifrs-fullPrincipalPlaceOfBusiness_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullPrincipalPlaceOfBusiness_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_160" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails" xlink:title="995691 - Disclosure - Summary of Changes in ROU Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AmortizationMember" xlink:label="loc_MMAAmortizationMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_MMAAmortizationMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RightofuseAsset" xlink:label="loc_MMARightofuseAsset_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARightofuseAsset_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AccumulatedAmortization" xlink:label="loc_MMAAccumulatedAmortization_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAAccumulatedAmortization_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Modification" xlink:label="loc_MMAModification_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAModification_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities_150" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails" xlink:title="995692 - Disclosure - Summary of Future Minimum Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-fullNotLaterThanOneYearMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullNotLaterThanOneYearMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanTwoYearsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanTwoYearsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanFiveYearsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanFiveYearsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-fullGrossLeaseLiabilities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullGrossLeaseLiabilities_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities_110" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails" xlink:title="995693 - Disclosure - Schedule of Financial Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConvertibleInstrumentsMember" xlink:label="loc_ifrs-fullConvertibleInstrumentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_ifrs-fullConvertibleInstrumentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued" xlink:label="loc_ifrs-fullCurrentDebtInstrumentsIssued_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentDebtInstrumentsIssued_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDebtInstrumentsIssued" xlink:label="loc_ifrs-fullNoncurrentDebtInstrumentsIssued_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentDebtInstrumentsIssued_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentDerivativeFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentDerivativeFinancialLiabilities_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentDerivativeFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentDerivativeFinancialLiabilities_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DebtSecurities" xlink:label="loc_ifrs-fullDebtSecurities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDebtSecurities_30" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails" xlink:title="995694 - Disclosure - Schedule of Convertible Notes held by Investors (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-fullBorrowingsByNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullBorrowingsByNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-fullBorrowingsByNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullBorrowingsByNameAxis" xlink:to="loc_ifrs-fullBorrowingsByNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-fullBorrowingsByNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullBorrowingsByNameAxis" xlink:to="loc_ifrs-fullBorrowingsByNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAConvertibleNotesMember" xlink:label="loc_MMASeriesAConvertibleNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesAConvertibleNotesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAJulyTwentyOneConvertibleNotesMember" xlink:label="loc_MMASeriesAJulyTwentyOneConvertibleNotesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesAJulyTwentyOneConvertibleNotesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAAugustTwentyOneConvertibleNotesMember" xlink:label="loc_MMASeriesAAugustTwentyOneConvertibleNotesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesAAugustTwentyOneConvertibleNotesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesBOneConvertibleNotesMember" xlink:label="loc_MMASeriesBOneConvertibleNotesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesBOneConvertibleNotesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesB2ConvertibleNotesMember" xlink:label="loc_MMASeriesB2ConvertibleNotesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesB2ConvertibleNotesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAExtensionConvertibleNotesMember" xlink:label="loc_MMASeriesAExtensionConvertibleNotesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesAExtensionConvertibleNotesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachConvertibleNotesMember" xlink:label="loc_MMAReachConvertibleNotesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMAReachConvertibleNotesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PrivatePlacementConvertibleNotesMember" xlink:label="loc_MMAPrivatePlacementConvertibleNotesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMAPrivatePlacementConvertibleNotesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MixedMartialArtsLLCConvertibleNotesMember" xlink:label="loc_MMAMixedMartialArtsLLCConvertibleNotesMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMAMixedMartialArtsLLCConvertibleNotesMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SteppenConvertibleNotesMember" xlink:label="loc_MMASteppenConvertibleNotesMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASteppenConvertibleNotesMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesIssueDate" xlink:label="loc_MMAConvertibleNotesIssueDate_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesIssueDate_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesPreModificationMaturityDate" xlink:label="loc_MMAConvertibleNotesPreModificationMaturityDate_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesPreModificationMaturityDate_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesModificationDate" xlink:label="loc_MMAConvertibleNotesModificationDate_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesModificationDate_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesModifiedMaturityDate" xlink:label="loc_MMAConvertibleNotesModifiedMaturityDate_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesModifiedMaturityDate_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesConversionDate" xlink:label="loc_MMAConvertibleNotesConversionDate_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesConversionDate_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesTerm" xlink:label="loc_MMAConvertibleNotesTerm_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesTerm_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-fullBorrowings_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowings_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-fullBorrowingsInterestRate_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsInterestRate_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesConversionDiscount" xlink:label="loc_MMAConvertibleNotesConversionDiscount_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesConversionDiscount_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachConvertibleNote" xlink:label="loc_MMAReachConvertibleNote_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAReachConvertibleNote_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RedeemedForCash" xlink:label="loc_MMARedeemedForCash_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARedeemedForCash_120" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialLiabilitiesDetailsNarrative" xlink:title="995695 - Disclosure - Financial Liabilities (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails" xlink:title="995696 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical" xlink:title="995697 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails" xlink:title="995698 - Disclosure - Schedule of Share Options Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOptionsMember" xlink:label="loc_ifrs-fullShareOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_ifrs-fullShareOptionsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorMember" xlink:label="loc_MMAAdvisorMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_MMAAdvisorMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachMember" xlink:label="loc_MMAReachMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_MMAReachMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestrictedShareUnitsMember" xlink:label="loc_ifrs-fullRestrictedShareUnitsMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_ifrs-fullRestrictedShareUnitsMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OverAllotmentOptionsMember" xlink:label="loc_MMAOverAllotmentOptionsMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_MMAOverAllotmentOptionsMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantsMember" xlink:label="loc_ifrs-fullWarrantsMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_ifrs-fullWarrantsMember_350" xlink:type="arc" order="351" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_500" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_500" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_500" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_500" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_500" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_500" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_500" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_500" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails" xlink:title="995699 - Disclosure - Schedule of Model Inputs For Options Granted (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_EmployeeStockOwnershipPlanMember" xlink:label="loc_MMAEmployeeStockOwnershipPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_MMAEmployeeStockOwnershipPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorMember" xlink:label="loc_MMAAdvisorMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_MMAAdvisorMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachMember" xlink:label="loc_MMAReachMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_MMAReachMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestrictedShareUnitsMember" xlink:label="loc_ifrs-fullRestrictedShareUnitsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_ifrs-fullRestrictedShareUnitsMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantsMember" xlink:label="loc_ifrs-fullWarrantsMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_ifrs-fullWarrantsMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:label="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:label="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesOneMember" xlink:label="loc_MMAExercisePricesOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="loc_MMAExercisePricesOneMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesTwoMember" xlink:label="loc_MMAExercisePricesTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="loc_MMAExercisePricesTwoMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesThreeMember" xlink:label="loc_MMAExercisePricesThreeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="loc_MMAExercisePricesThreeMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesFourMember" xlink:label="loc_MMAExercisePricesFourMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="loc_MMAExercisePricesFourMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-fullExercisePriceShareOptionsGranted2019_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullExercisePriceShareOptionsGranted2019_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpectedTermShareOptionsGranted" xlink:label="loc_MMAExpectedTermShareOptionsGranted_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAExpectedTermShareOptionsGranted_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_140" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" xlink:title="995700 - Disclosure - Schedule of Contractual Maturities of Financial Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-fullNotLaterThanOneYearMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullNotLaterThanOneYearMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_BetweenOneAndTwoYearsMember" xlink:label="loc_MMABetweenOneAndTwoYearsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_MMABetweenOneAndTwoYearsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_BetweenTwoAndFiveYearsMember" xlink:label="loc_MMABetweenTwoAndFiveYearsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_MMABetweenTwoAndFiveYearsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NonInterestBearingTradeAndOtherPayables" xlink:label="loc_MMANonInterestBearingTradeAndOtherPayables_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMANonInterestBearingTradeAndOtherPayables_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_WeightedAverageInterestRateFinancialLiability" xlink:label="loc_MMAWeightedAverageInterestRateFinancialLiability_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAWeightedAverageInterestRateFinancialLiability_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_InterestBearingFinancialLiabilities" xlink:label="loc_MMAInterestBearingFinancialLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAInterestBearingFinancialLiabilities_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_WeightedAverageInterestRateLeaseLiabilities" xlink:label="loc_MMAWeightedAverageInterestRateLeaseLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAWeightedAverageInterestRateLeaseLiabilities_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_InterestBearingLeaseLiabilities" xlink:label="loc_MMAInterestBearingLeaseLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAInterestBearingLeaseLiabilities_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_InterestBearingNonderivativesNet" xlink:label="loc_MMAInterestBearingNonderivativesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAInterestBearingNonderivativesNet_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullDerivativeFinancialLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDerivativeFinancialLiabilities_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DerivativeNet" xlink:label="loc_MMADerivativeNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMADerivativeNet_90" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails" xlink:title="995701 - Disclosure - Schedule of Auditor of Company And Network Firms (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative" xlink:title="995702 - Disclosure - Share-based payments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-fullExercisePriceShareOptionsGranted2019_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullExercisePriceShareOptionsGranted2019_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilitiesDetailsNarrative" xlink:title="995703 - Disclosure - Contingent Assets and Liabilities (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails" xlink:title="995704 - Disclosure - Schedule of Loss Per Share (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative" xlink:title="995705 - Disclosure - Events after the reporting period (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" xlink:to="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" xlink:to="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NonadjustingEventMember" xlink:label="loc_MMANonadjustingEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" xlink:to="loc_MMANonadjustingEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-fullCounterpartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="loc_ifrs-fullCounterpartiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-fullCounterpartiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCounterpartiesAxis" xlink:to="loc_ifrs-fullCounterpartiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-fullCounterpartiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCounterpartiesAxis" xlink:to="loc_ifrs-fullCounterpartiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrMcGregorMember" xlink:label="loc_MMAMrMcGregorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCounterpartiesDomain" xlink:to="loc_MMAMrMcGregorMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:label="loc_ifrs-fullDescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>mma-20240630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US">Components of equity [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US">Issued capital [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnlistedOptionReserveMember" xlink:label="MMA_UnlistedOptionReserveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnlistedOptionReserveMember" xlink:to="MMA_UnlistedOptionReserveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_UnlistedOptionReserveMember_lbl" xml:lang="en-US">Unlisted option reserve [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl" xml:lang="en-US">Reserve of share-based payments [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xml:lang="en-US">Reserve of exchange differences on translation [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated other comprehensive income [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlantAndEquipmentMember" xlink:label="MMA_PlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PlantAndEquipmentMember" xlink:to="MMA_PlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_PlantAndEquipmentMember_lbl" xml:lang="en-US">Plant and equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US">Range [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US">Bottom of range [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US">Top of range [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer equipment [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OfficeEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OfficeEquipmentMember_lbl" xml:lang="en-US">Office equipment [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="ifrs-full_FixturesAndFittingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FixturesAndFittingsMember" xlink:to="ifrs-full_FixturesAndFittingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FixturesAndFittingsMember_lbl" xml:lang="en-US">Fixtures and fittings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="ifrs-full_BrandNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BrandNamesMember" xlink:to="ifrs-full_BrandNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BrandNamesMember_lbl" xml:lang="en-US">Brand names [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopmentMember" xlink:label="ifrs-full_IntangibleAssetsUnderDevelopmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsUnderDevelopmentMember" xlink:to="ifrs-full_IntangibleAssetsUnderDevelopmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsUnderDevelopmentMember_lbl" xml:lang="en-US">Intangible assets under development [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesAxis_lbl" xml:lang="en-US">Products and services [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OneMajorProductMember" xlink:label="MMA_OneMajorProductMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OneMajorProductMember" xlink:to="MMA_OneMajorProductMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_OneMajorProductMember_lbl" xml:lang="en-US">One major product [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level1OfFairValueHierarchyMember" xlink:to="ifrs-full_Level1OfFairValueHierarchyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 1 of fair value hierarchy [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 2 of fair value hierarchy [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 3 of fair value hierarchy [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnobservableInputsAxis" xlink:to="ifrs-full_UnobservableInputsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnobservableInputsAxis_lbl" xml:lang="en-US">Unobservable inputs [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ImpliedValuationMember" xlink:label="MMA_ImpliedValuationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ImpliedValuationMember" xlink:to="MMA_ImpliedValuationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ImpliedValuationMember_lbl" xml:lang="en-US">Implied valuation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAConvertibleNotesMember" xlink:label="MMA_SeriesAConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAConvertibleNotesMember" xlink:to="MMA_SeriesAConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesAConvertibleNotesMember_lbl" xml:lang="en-US">Series A Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember" xlink:label="ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember" xlink:to="ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_lbl" xml:lang="en-US">Historical volatility for shares, measurement input [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateMeasurementInputMember" xlink:label="ifrs-full_InterestRateMeasurementInputMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateMeasurementInputMember" xlink:to="ifrs-full_InterestRateMeasurementInputMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRateMeasurementInputMember_lbl" xml:lang="en-US">Interest rate, measurement input [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProbabilityOfDefaultMeasurementInputMember" xlink:label="ifrs-full_ProbabilityOfDefaultMeasurementInputMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProbabilityOfDefaultMeasurementInputMember" xlink:to="ifrs-full_ProbabilityOfDefaultMeasurementInputMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProbabilityOfDefaultMeasurementInputMember_lbl" xml:lang="en-US">Probability of default, measurement input [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAJuly21Member" xlink:label="MMA_SeriesAJuly21Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAJuly21Member" xlink:to="MMA_SeriesAJuly21Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesAJuly21Member_lbl" xml:lang="en-US">Series A July21 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAAugust21Member" xlink:label="MMA_SeriesAAugust21Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAAugust21Member" xlink:to="MMA_SeriesAAugust21Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesAAugust21Member_lbl" xml:lang="en-US">Series A August21 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesB1Member" xlink:label="MMA_SeriesB1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesB1Member" xlink:to="MMA_SeriesB1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesB1Member_lbl" xml:lang="en-US">Series B1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesB2Member" xlink:label="MMA_SeriesB2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesB2Member" xlink:to="MMA_SeriesB2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesB2Member_lbl" xml:lang="en-US">Series B2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAExtensionMember" xlink:label="MMA_SeriesAExtensionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAExtensionMember" xlink:to="MMA_SeriesAExtensionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesAExtensionMember_lbl" xml:lang="en-US">Series A extension [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachMember" xlink:label="MMA_ReachMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReachMember" xlink:to="MMA_ReachMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ReachMember_lbl" xml:lang="en-US">Reach [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PrivatePlacementsMember" xlink:label="MMA_PrivatePlacementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PrivatePlacementsMember" xlink:to="MMA_PrivatePlacementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_PrivatePlacementsMember_lbl" xml:lang="en-US">Private Placements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MixedMartialArtsLLCMember" xlink:label="MMA_MixedMartialArtsLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MixedMartialArtsLLCMember" xlink:to="MMA_MixedMartialArtsLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_MixedMartialArtsLLCMember_lbl" xml:lang="en-US">Mixed martial arts LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SteppenMember" xlink:label="MMA_SteppenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SteppenMember" xlink:to="MMA_SteppenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SteppenMember_lbl" xml:lang="en-US">Steppen [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FurnitrueAndFittingsMember" xlink:label="MMA_FurnitrueAndFittingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FurnitrueAndFittingsMember" xlink:to="MMA_FurnitrueAndFittingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_FurnitrueAndFittingsMember_lbl" xml:lang="en-US">Furnitrue and fittings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US">Gross carrying amount [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US">Accumulated depreciation and amortisation [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlatformDevelopmentMember" xlink:label="MMA_PlatformDevelopmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PlatformDevelopmentMember" xlink:to="MMA_PlatformDevelopmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_PlatformDevelopmentMember_lbl" xml:lang="en-US">Platform development [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CounterpartiesAxis_lbl" xml:lang="en-US">Counterparties [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SteppenPtyLtdMember" xlink:label="MMA_SteppenPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SteppenPtyLtdMember" xlink:to="MMA_SteppenPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SteppenPtyLtdMember_lbl" xml:lang="en-US">Steppen Pty Ltd [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MixedMartialsArtsLLCMember" xlink:label="MMA_MixedMartialsArtsLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MixedMartialsArtsLLCMember" xlink:to="MMA_MixedMartialsArtsLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_MixedMartialsArtsLLCMember_lbl" xml:lang="en-US">Mixed Martials Arts LLC [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_HypeKitIncMember" xlink:label="MMA_HypeKitIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_HypeKitIncMember" xlink:to="MMA_HypeKitIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_HypeKitIncMember_lbl" xml:lang="en-US">Hype Kit, Inc [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US">Categories of related parties [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SharesHeldByKeyManagementPersonnelMember" xlink:label="MMA_SharesHeldByKeyManagementPersonnelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SharesHeldByKeyManagementPersonnelMember" xlink:to="MMA_SharesHeldByKeyManagementPersonnelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SharesHeldByKeyManagementPersonnelMember_lbl" xml:lang="en-US">Shares Held By Key Management Personnel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OptionHeldByKeyManagementPersonnelMember" xlink:label="MMA_OptionHeldByKeyManagementPersonnelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OptionHeldByKeyManagementPersonnelMember" xlink:to="MMA_OptionHeldByKeyManagementPersonnelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_OptionHeldByKeyManagementPersonnelMember_lbl" xml:lang="en-US">Option Held By Key Management Personnel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrLangtonMember" xlink:label="MMA_MrLangtonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MrLangtonMember" xlink:to="MMA_MrLangtonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_MrLangtonMember_lbl" xml:lang="en-US">MrLangton [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SnowflowerHoldingsPtyLtdMember" xlink:label="MMA_SnowflowerHoldingsPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SnowflowerHoldingsPtyLtdMember" xlink:to="MMA_SnowflowerHoldingsPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SnowflowerHoldingsPtyLtdMember_lbl" xml:lang="en-US">Snowflower Holdings Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrWilliamsMember" xlink:label="MMA_MrWilliamsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MrWilliamsMember" xlink:to="MMA_MrWilliamsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_MrWilliamsMember_lbl" xml:lang="en-US">MrWilliams [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ChampSevenPtyLtdMember" xlink:label="MMA_ChampSevenPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ChampSevenPtyLtdMember" xlink:to="MMA_ChampSevenPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ChampSevenPtyLtdMember_lbl" xml:lang="en-US">Champ Seven Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrTaylorMember" xlink:label="MMA_MrTaylorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MrTaylorMember" xlink:to="MMA_MrTaylorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_MrTaylorMember_lbl" xml:lang="en-US">MrTaylor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NalarooHoldingsPtyLtdMember" xlink:label="MMA_NalarooHoldingsPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NalarooHoldingsPtyLtdMember" xlink:to="MMA_NalarooHoldingsPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_NalarooHoldingsPtyLtdMember_lbl" xml:lang="en-US">Nalaroo Holdings Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrHartMember" xlink:label="MMA_MrHartMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MrHartMember" xlink:to="MMA_MrHartMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_MrHartMember_lbl" xml:lang="en-US">Mr Hart [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_JHartFamilyTrustAccountMember" xlink:label="MMA_JHartFamilyTrustAccountMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_JHartFamilyTrustAccountMember" xlink:to="MMA_JHartFamilyTrustAccountMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_JHartFamilyTrustAccountMember_lbl" xml:lang="en-US">J Hart Family Trust Account [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfContractsAxis_lbl" xml:lang="en-US">Types of contracts [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_EmploymentAgreementMember" xlink:label="MMA_EmploymentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_EmploymentAgreementMember" xlink:to="MMA_EmploymentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_EmploymentAgreementMember_lbl" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_EmployeementAgreementMember" xlink:label="MMA_EmployeementAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_EmployeementAgreementMember" xlink:to="MMA_EmployeementAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_EmployeementAgreementMember_lbl" xml:lang="en-US">Employeement Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Mr.LangtonMember" xlink:label="MMA_Mr.LangtonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Mr.LangtonMember" xlink:to="MMA_Mr.LangtonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_Mr.LangtonMember_lbl" xml:lang="en-US">Mr.Langton [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParentMember" xlink:label="ifrs-full_ParentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParentMember" xlink:to="ifrs-full_ParentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParentMember_lbl" xml:lang="en-US">Parent [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis_lbl" xml:lang="en-US">Consolidated structured entities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorLLCMember" xlink:label="MMA_Wimp2WarriorLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Wimp2WarriorLLCMember" xlink:to="MMA_Wimp2WarriorLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_Wimp2WarriorLLCMember_lbl" xml:lang="en-US">Wimp2 Warrior LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasAxis_lbl" xml:lang="en-US">Geographical areas [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnitedStatesOfAmericaCountryMember" xlink:label="MMA_UnitedStatesOfAmericaCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnitedStatesOfAmericaCountryMember" xlink:to="MMA_UnitedStatesOfAmericaCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_UnitedStatesOfAmericaCountryMember_lbl" xml:lang="en-US">United States Of America Country [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorProductionsPtyLtdMember" xlink:label="MMA_Wimp2WarriorProductionsPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Wimp2WarriorProductionsPtyLtdMember" xlink:to="MMA_Wimp2WarriorProductionsPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_Wimp2WarriorProductionsPtyLtdMember_lbl" xml:lang="en-US">Wimp2 Warrior Productions Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AustraliaCountryMember" xlink:label="MMA_AustraliaCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AustraliaCountryMember" xlink:to="MMA_AustraliaCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AustraliaCountryMember_lbl" xml:lang="en-US">Australia Country [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorDigitalPtyLtdMember" xlink:label="MMA_Wimp2WarriorDigitalPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Wimp2WarriorDigitalPtyLtdMember" xlink:to="MMA_Wimp2WarriorDigitalPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_Wimp2WarriorDigitalPtyLtdMember_lbl" xml:lang="en-US">Wimp2 Warrior Digital Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AustraliaCountryOneMember" xlink:label="MMA_AustraliaCountryOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AustraliaCountryOneMember" xlink:to="MMA_AustraliaCountryOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AustraliaCountryOneMember_lbl" xml:lang="en-US">Australia Country One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorIrelandLimitedMember" xlink:label="MMA_Wimp2WarriorIrelandLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Wimp2WarriorIrelandLimitedMember" xlink:to="MMA_Wimp2WarriorIrelandLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_Wimp2WarriorIrelandLimitedMember_lbl" xml:lang="en-US">Wimp2 Warrior Ireland Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IrelandCountryMember" xlink:label="MMA_IrelandCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IrelandCountryMember" xlink:to="MMA_IrelandCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_IrelandCountryMember_lbl" xml:lang="en-US">Ireland Country [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_HypeCoMember" xlink:label="MMA_HypeCoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_HypeCoMember" xlink:to="MMA_HypeCoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_HypeCoMember_lbl" xml:lang="en-US">Hype Co [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnitedStatesOfAmericaCountryOneMember" xlink:label="MMA_UnitedStatesOfAmericaCountryOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnitedStatesOfAmericaCountryOneMember" xlink:to="MMA_UnitedStatesOfAmericaCountryOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_UnitedStatesOfAmericaCountryOneMember_lbl" xml:lang="en-US">United States Of America Country One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AmortizationMember" xlink:label="MMA_AmortizationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AmortizationMember" xlink:to="MMA_AmortizationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AmortizationMember_lbl" xml:lang="en-US">Amortization [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAxis_lbl" xml:lang="en-US">Maturity [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotLaterThanOneYearMember" xlink:to="ifrs-full_NotLaterThanOneYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl" xml:lang="en-US">Not later than one year [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_lbl" xml:lang="en-US">Later than one year and not later than two years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xml:lang="en-US">Later than one year and not later than three years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_lbl" xml:lang="en-US">Later than one year and not later than five years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xml:lang="en-US">Liabilities arising from financing activities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilitiesMember_lbl" xml:lang="en-US">Lease liabilities [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_lbl" xml:lang="en-US">Types of antidilutive instruments [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConvertibleInstrumentsMember" xlink:label="ifrs-full_ConvertibleInstrumentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConvertibleInstrumentsMember" xlink:to="ifrs-full_ConvertibleInstrumentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConvertibleInstrumentsMember_lbl" xml:lang="en-US">Convertible instruments [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsByNameAxis_lbl" xml:lang="en-US">Borrowings by name [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAJulyTwentyOneConvertibleNotesMember" xlink:label="MMA_SeriesAJulyTwentyOneConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAJulyTwentyOneConvertibleNotesMember" xlink:to="MMA_SeriesAJulyTwentyOneConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesAJulyTwentyOneConvertibleNotesMember_lbl" xml:lang="en-US">Series A July-21 convertible notes [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAAugustTwentyOneConvertibleNotesMember" xlink:label="MMA_SeriesAAugustTwentyOneConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAAugustTwentyOneConvertibleNotesMember" xlink:to="MMA_SeriesAAugustTwentyOneConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesAAugustTwentyOneConvertibleNotesMember_lbl" xml:lang="en-US">Series A August 21 convertible notes [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesBOneConvertibleNotesMember" xlink:label="MMA_SeriesBOneConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesBOneConvertibleNotesMember" xlink:to="MMA_SeriesBOneConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesBOneConvertibleNotesMember_lbl" xml:lang="en-US">Series B1 convertible notes [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesB2ConvertibleNotesMember" xlink:label="MMA_SeriesB2ConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesB2ConvertibleNotesMember" xlink:to="MMA_SeriesB2ConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesB2ConvertibleNotesMember_lbl" xml:lang="en-US">Series B2 Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAExtensionConvertibleNotesMember" xlink:label="MMA_SeriesAExtensionConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAExtensionConvertibleNotesMember" xlink:to="MMA_SeriesAExtensionConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SeriesAExtensionConvertibleNotesMember_lbl" xml:lang="en-US">Series A Extension Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachConvertibleNotesMember" xlink:label="MMA_ReachConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReachConvertibleNotesMember" xlink:to="MMA_ReachConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ReachConvertibleNotesMember_lbl" xml:lang="en-US">Reach Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PrivatePlacementConvertibleNotesMember" xlink:label="MMA_PrivatePlacementConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PrivatePlacementConvertibleNotesMember" xlink:to="MMA_PrivatePlacementConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_PrivatePlacementConvertibleNotesMember_lbl" xml:lang="en-US">Private Placement Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MixedMartialArtsLLCConvertibleNotesMember" xlink:label="MMA_MixedMartialArtsLLCConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MixedMartialArtsLLCConvertibleNotesMember" xlink:to="MMA_MixedMartialArtsLLCConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_MixedMartialArtsLLCConvertibleNotesMember_lbl" xml:lang="en-US">Mixed Martial Arts LLC Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SteppenConvertibleNotesMember" xlink:label="MMA_SteppenConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SteppenConvertibleNotesMember" xlink:to="MMA_SteppenConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_SteppenConvertibleNotesMember_lbl" xml:lang="en-US">Steppen Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOptionsMember" xlink:label="ifrs-full_ShareOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOptionsMember" xlink:to="ifrs-full_ShareOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOptionsMember_lbl" xml:lang="en-US">Share options [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorMember" xlink:label="MMA_AdvisorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdvisorMember" xlink:to="MMA_AdvisorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AdvisorMember_lbl" xml:lang="en-US">Advisor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestrictedShareUnitsMember" xlink:label="ifrs-full_RestrictedShareUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedShareUnitsMember" xlink:to="ifrs-full_RestrictedShareUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RestrictedShareUnitsMember_lbl" xml:lang="en-US">Restricted share units [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OverAllotmentOptionsMember" xlink:label="MMA_OverAllotmentOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OverAllotmentOptionsMember" xlink:to="MMA_OverAllotmentOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_OverAllotmentOptionsMember_lbl" xml:lang="en-US">Over Allotment Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantsMember" xlink:label="ifrs-full_WarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantsMember" xlink:to="ifrs-full_WarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WarrantsMember_lbl" xml:lang="en-US">Warrants [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_EmployeeStockOwnershipPlanMember" xlink:label="MMA_EmployeeStockOwnershipPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_EmployeeStockOwnershipPlanMember" xlink:to="MMA_EmployeeStockOwnershipPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_EmployeeStockOwnershipPlanMember_lbl" xml:lang="en-US">Employee Stock Ownership Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_lbl" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesOneMember" xlink:label="MMA_ExercisePricesOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExercisePricesOneMember" xlink:to="MMA_ExercisePricesOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExercisePricesOneMember_lbl" xml:lang="en-US">Exercise Prices One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesTwoMember" xlink:label="MMA_ExercisePricesTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExercisePricesTwoMember" xlink:to="MMA_ExercisePricesTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExercisePricesTwoMember_lbl" xml:lang="en-US">Exercise Prices Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesThreeMember" xlink:label="MMA_ExercisePricesThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExercisePricesThreeMember" xlink:to="MMA_ExercisePricesThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExercisePricesThreeMember_lbl" xml:lang="en-US">Exercise Prices Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesFourMember" xlink:label="MMA_ExercisePricesFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExercisePricesFourMember" xlink:to="MMA_ExercisePricesFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExercisePricesFourMember_lbl" xml:lang="en-US">Exercise Prices Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_BetweenOneAndTwoYearsMember" xlink:label="MMA_BetweenOneAndTwoYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_BetweenOneAndTwoYearsMember" xlink:to="MMA_BetweenOneAndTwoYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_BetweenOneAndTwoYearsMember_lbl" xml:lang="en-US">Between 1 and 2 Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_BetweenTwoAndFiveYearsMember" xlink:label="MMA_BetweenTwoAndFiveYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_BetweenTwoAndFiveYearsMember" xlink:to="MMA_BetweenTwoAndFiveYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_BetweenTwoAndFiveYearsMember_lbl" xml:lang="en-US">Between 2 and 5 Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NonadjustingEventMember" xlink:label="MMA_NonadjustingEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NonadjustingEventMember" xlink:to="MMA_NonadjustingEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_NonadjustingEventMember_lbl" xml:lang="en-US">Nonadjusting Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrMcGregorMember" xlink:label="MMA_MrMcGregorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MrMcGregorMember" xlink:to="MMA_MrMcGregorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_MrMcGregorMember_lbl" xml:lang="en-US">Mr McGregor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="ifrs-full_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US">Profit or loss [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromProgramFees" xlink:label="MMA_RevenueFromProgramFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RevenueFromProgramFees" xlink:to="MMA_RevenueFromProgramFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_RevenueFromProgramFees_lbl" xml:lang="en-US">Revenue from Program Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContractualPaymentsToGyms" xlink:label="MMA_ContractualPaymentsToGyms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ContractualPaymentsToGyms" xlink:to="MMA_ContractualPaymentsToGyms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="MMA_ContractualPaymentsToGyms_lbl" xml:lang="en-US">Less: Contractual payments to gyms</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NetRevenueFromProgramFees" xlink:label="MMA_NetRevenueFromProgramFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NetRevenueFromProgramFees" xlink:to="MMA_NetRevenueFromProgramFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="MMA_NetRevenueFromProgramFees_lbl" xml:lang="en-US">Net Revenue from Program Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherIncome_lbl" xml:lang="en-US">Other Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US">Total Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="ifrs-full_ExpenseByNatureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNatureAbstract" xlink:to="ifrs-full_ExpenseByNatureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseByNatureAbstract_lbl" xml:lang="en-US">Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpenses" xlink:label="MMA_ProgramExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpenses" xlink:to="MMA_ProgramExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ProgramExpenses_lbl" xml:lang="en-US">Program Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="ifrs-full_WagesAndSalaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WagesAndSalaries" xlink:to="ifrs-full_WagesAndSalaries_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WagesAndSalaries_lbl" xml:lang="en-US">Employee salaries and benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US">Share Based Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdvertisingExpense" xlink:label="ifrs-full_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdvertisingExpense" xlink:to="ifrs-full_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdvertisingExpense_lbl" xml:lang="en-US">Advertising fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="ifrs-full_ProfessionalFeesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfessionalFeesExpense_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RentExpenses" xlink:label="MMA_RentExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RentExpenses" xlink:to="MMA_RentExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_RentExpenses_lbl" xml:lang="en-US">Rent</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ITCosts" xlink:label="MMA_ITCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ITCosts" xlink:to="MMA_ITCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ITCosts_lbl" xml:lang="en-US">IT costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="ifrs-full_DepreciationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationExpense_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="ifrs-full_NetForeignExchangeGain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeGain" xlink:to="ifrs-full_NetForeignExchangeGain_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NetForeignExchangeGain_lbl" xml:lang="en-US">Net foreign exchange gain</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US">Finance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherExpenseByNature" xlink:label="ifrs-full_OtherExpenseByNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_OtherExpenseByNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherExpenseByNature_lbl" xml:lang="en-US">Other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueMovementInDerivativeLiability" xlink:label="MMA_FairValueMovementInDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueMovementInDerivativeLiability" xlink:to="MMA_FairValueMovementInDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="MMA_FairValueMovementInDerivativeLiability_lbl" xml:lang="en-US">Fair Value movement in derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseByNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ExpenseByNature_lbl" xml:lang="en-US">Total Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US">Loss before income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US">Loss after income tax expense for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US">Total comprehensive loss for the period attributable to Alta Global Group Limited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US">Basic loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US">Diluted loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of financial position [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl" xml:lang="en-US">Trade and other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentAssets" xlink:label="ifrs-full_OtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentAssets" xlink:to="ifrs-full_OtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US">Property, Plant and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US">Right-of-use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="ifrs-full_OtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl" xml:lang="en-US">Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US">Total non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US">Trade and other payables</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnearnedRevenue" xlink:label="MMA_UnearnedRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnearnedRevenue" xlink:to="MMA_UnearnedRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_UnearnedRevenue_lbl" xml:lang="en-US">Unearned revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl" xml:lang="en-US">Current Employee Entitlements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="ifrs-full_CurrentFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialLiabilities_lbl" xml:lang="en-US">Current Financial Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US">Current Lease Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="ifrs-full_NoncurrentFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_lbl" xml:lang="en-US">Non-current Financial Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:to="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_lbl" xml:lang="en-US">Non-current Employee Entitlements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US">Non-current Lease Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US">Total non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="ifrs-full_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="ifrs-full_NetAssetsLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetAssetsLiabilities" xlink:to="ifrs-full_NetAssetsLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NetAssetsLiabilities_lbl" xml:lang="en-US">Net assets/(liabilities)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US">Issued Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="ifrs-full_ReserveOfSharebasedPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPayments" xlink:to="ifrs-full_ReserveOfSharebasedPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfSharebasedPayments_lbl" xml:lang="en-US">Share-based payment reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnlistedOptionsReserve" xlink:label="MMA_UnlistedOptionsReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnlistedOptionsReserve" xlink:to="MMA_UnlistedOptionsReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_UnlistedOptionsReserve_lbl" xml:lang="en-US">Unlisted options reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xml:lang="en-US">Foreign currency translation reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl" xml:lang="en-US">Accumulated losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US">Total equity/(deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US">Statement of changes in equity [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="MMA_IfrsStatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IfrsStatementLineItems" xlink:to="MMA_IfrsStatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_IfrsStatementLineItems_lbl" xml:lang="en-US">IfrsStatementLineItems [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_2_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_2_lbl" xml:lang="en-US">Loss after tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherComprehensiveIncome_2_lbl" xml:lang="en-US">Other comprehensive (loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_2_lbl" xml:lang="en-US">Total comprehensive (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US">Share-based payments (see Note 22)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="ifrs-full_IssueOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssueOfEquity_lbl" xml:lang="en-US">Issued of Shares fully paid net of Transaction cost (see Note 17)</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssueOfEquityFromConversionOfConvertibleNotes" xlink:label="MMA_IssueOfEquityFromConversionOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssueOfEquityFromConversionOfConvertibleNotes" xlink:to="MMA_IssueOfEquityFromConversionOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_IssueOfEquityFromConversionOfConvertibleNotes_lbl" xml:lang="en-US">Issue of Shares from conversion of convertible notes (see Note 17)</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes" xlink:label="MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes" xlink:to="MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes_lbl" xml:lang="en-US">Issue of Unlisted Shares from conversion of convertible notes (see Note 17)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xml:lang="en-US">Advisor options exercised (see Note 17)</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IncreaseDecreaseThroughOptionsForfeited" xlink:label="MMA_IncreaseDecreaseThroughOptionsForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IncreaseDecreaseThroughOptionsForfeited" xlink:to="MMA_IncreaseDecreaseThroughOptionsForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_IncreaseDecreaseThroughOptionsForfeited_lbl" xml:lang="en-US">Advisor options forfeited (see Note 22)</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OverAllotmentOptionsLapsed" xlink:label="MMA_OverAllotmentOptionsLapsed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OverAllotmentOptionsLapsed" xlink:to="MMA_OverAllotmentOptionsLapsed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_OverAllotmentOptionsLapsed_lbl" xml:lang="en-US">Over allotment options lapsed (see Note 22)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_3_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProceedsFromTrainingParticipants" xlink:label="MMA_ProceedsFromTrainingParticipants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProceedsFromTrainingParticipants" xlink:to="MMA_ProceedsFromTrainingParticipants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ProceedsFromTrainingParticipants_lbl" xml:lang="en-US">Receipts from training participants (inclusive of GST)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="ifrs-full_PaymentsToSuppliersForGoodsAndServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:to="ifrs-full_PaymentsToSuppliersForGoodsAndServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsToSuppliersForGoodsAndServices_lbl" xml:lang="en-US">Payments to member gyms, suppliers &amp; employees (inclusive of GST)</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" xlink:label="MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" xlink:to="MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure_lbl" xml:lang="en-US">Receipts from Government grants and tax incentives related to expenditure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities_lbl" xml:lang="en-US">Interest and other finance costs paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Payments for property equipment, net of disposal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Payments for intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Receipt from Government grants and tax incentives related to assets</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_BankGuaranteeDepositReceivedPaid" xlink:label="MMA_BankGuaranteeDepositReceivedPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_BankGuaranteeDepositReceivedPaid" xlink:to="MMA_BankGuaranteeDepositReceivedPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_BankGuaranteeDepositReceivedPaid_lbl" xml:lang="en-US">Bank guarantee deposit received/(paid)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash (used in)/from investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures" xlink:label="ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures" xlink:to="ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_lbl" xml:lang="en-US">Proceeds from convertible notes, net of transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="ifrs-full_ProceedsFromIssuingShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssuingShares" xlink:to="ifrs-full_ProceedsFromIssuingShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssuingShares_lbl" xml:lang="en-US">Proceeds from issue of equity, net of transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xml:lang="en-US">Net (decrease) /increase in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CashAndCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents at the beginning of the financial period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CashAndCashEquivalents_3_lbl" xml:lang="en-US">Cash and cash equivalents at the end of the financial period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureCorporateInformationAbstract" xlink:label="MMA_DisclosureCorporateInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureCorporateInformationAbstract" xlink:to="MMA_DisclosureCorporateInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureCorporateInformationAbstract_lbl" xml:lang="en-US">Corporate Information</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfCorporateInformationExplanatory" xlink:label="MMA_DisclosureOfCorporateInformationExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfCorporateInformationExplanatory" xlink:to="MMA_DisclosureOfCorporateInformationExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfCorporateInformationExplanatory_lbl" xml:lang="en-US">Corporate information</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfMaterialAccountingPolicyAbstract" xlink:label="MMA_DisclosureOfMaterialAccountingPolicyAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfMaterialAccountingPolicyAbstract" xlink:to="MMA_DisclosureOfMaterialAccountingPolicyAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfMaterialAccountingPolicyAbstract_lbl" xml:lang="en-US">Material Accounting Policy Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:to="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_lbl" xml:lang="en-US">Material Accounting Policy Information</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract" xlink:label="MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract" xlink:to="MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract_lbl" xml:lang="en-US">Critical Accounting Judgements Estimates And Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl" xml:lang="en-US">Critical accounting judgements, estimates and assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xml:lang="en-US">Disclosure of operating segments [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xml:lang="en-US">Operating segments</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromContractsWithCustomersAbstract" xlink:label="MMA_RevenueFromContractsWithCustomersAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RevenueFromContractsWithCustomersAbstract" xlink:to="MMA_RevenueFromContractsWithCustomersAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_RevenueFromContractsWithCustomersAbstract_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfExpensesAbstract" xlink:label="MMA_DisclosureOfExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfExpensesAbstract" xlink:to="MMA_DisclosureOfExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_DisclosureOfExpensesAbstract_lbl" xml:lang="en-US">Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfExpensesExplanatory" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfExpensesExplanatory" xlink:to="ifrs-full_DisclosureOfExpensesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory_lbl" xml:lang="en-US">Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl" xml:lang="en-US">Notes and other explanatory information [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xml:lang="en-US">Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementExplanatory" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementExplanatory_lbl" xml:lang="en-US">Fair value measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xml:lang="en-US">Trade and other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract_lbl" xml:lang="en-US">Disclosure of detailed information about intangible assets [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfTradeAndOtherPayablesAbstract" xlink:label="MMA_DisclosureOfTradeAndOtherPayablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfTradeAndOtherPayablesAbstract" xlink:to="MMA_DisclosureOfTradeAndOtherPayablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfTradeAndOtherPayablesAbstract_lbl" xml:lang="en-US">Trade And Other Payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_lbl" xml:lang="en-US">Trade and other payables</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" xlink:label="MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" xlink:to="MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract_lbl" xml:lang="en-US">Current And Non-current Employee Entitlements</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory" xlink:label="MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory" xlink:to="MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory_lbl" xml:lang="en-US">Current and Non-current Employee Entitlements</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfUnearnedRevenueAbtract" xlink:label="MMA_DisclosureOfUnearnedRevenueAbtract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfUnearnedRevenueAbtract" xlink:to="MMA_DisclosureOfUnearnedRevenueAbtract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfUnearnedRevenueAbtract_lbl" xml:lang="en-US">Unearned Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfUnearnedRevenueExplanatory" xlink:label="MMA_DisclosureOfUnearnedRevenueExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfUnearnedRevenueExplanatory" xlink:to="MMA_DisclosureOfUnearnedRevenueExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_DisclosureOfUnearnedRevenueExplanatory_lbl" xml:lang="en-US">Unearned Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfReservesAbstract" xlink:label="MMA_DisclosureOfReservesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfReservesAbstract" xlink:to="MMA_DisclosureOfReservesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfReservesAbstract_lbl" xml:lang="en-US">Reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:label="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US">Reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfIssuedCapitalExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfIssuedCapitalExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIssuedCapitalExplanatory_lbl" xml:lang="en-US">Issued capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:to="ifrs-full_DisclosureOfCashFlowStatementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory_lbl" xml:lang="en-US">Notes to statement of cash flows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US">Related parties transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Disclosure of financial instruments [text block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl" xml:lang="en-US">Financial Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xml:lang="en-US">Share-based payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_2_lbl" xml:lang="en-US">Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:label="ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:to="ifrs-full_DisclosureOfAuditorsRemunerationExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAuditorsRemunerationExplanatory_lbl" xml:lang="en-US">Remuneration of auditors</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_lbl" xml:lang="en-US">Contingent Assets and Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xml:lang="en-US">Commitments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="ifrs-full_EarningsPerShareExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareExplanatory" xlink:to="ifrs-full_EarningsPerShareExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl" xml:lang="en-US">Loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US">Events after the reporting period</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory" xlink:label="MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory" xlink:to="MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_lbl" xml:lang="en-US">Basis of preparation</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory" xlink:label="MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory" xlink:to="MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory_lbl" xml:lang="en-US">New or amended Accounting Standards and Interpretations adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_lbl" xml:lang="en-US">Current and non-current classification</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_lbl" xml:lang="en-US">Trade and other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_lbl" xml:lang="en-US">Trade and other payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_lbl" xml:lang="en-US">Impairment of non-financial assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_lbl" xml:lang="en-US">Borrowings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl" xml:lang="en-US">Employee benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_lbl" xml:lang="en-US">Goods and Services Tax (GST) and other similar taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_lbl" xml:lang="en-US">Issued capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US">Income tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Convertible note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl" xml:lang="en-US">Share-based payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_lbl" xml:lang="en-US">Classification and measurement of financial liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory" xlink:label="MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory" xlink:to="MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xml:lang="en-US">Fair value measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xml:lang="en-US">Earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory" xlink:label="MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory" xlink:to="MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory_lbl" xml:lang="en-US">Parent entity financial information</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfPlantAndEquipmentExplanatory" xlink:label="MMA_DisclosureOfPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfPlantAndEquipmentExplanatory" xlink:to="MMA_DisclosureOfPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Schedule of plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:to="ifrs-full_DisclosureOfProductsAndServicesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory_lbl" xml:lang="en-US">Schedule of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US">Schedule of disaggregation of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory" xlink:label="MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory" xlink:to="MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory_lbl" xml:lang="en-US">Schedule of expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory" xlink:label="MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory" xlink:to="MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory_lbl" xml:lang="en-US">Schedule of Income Tax Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Fair Value Assets and Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDerivativeLiabilityExplanatory" xlink:label="MMA_DisclosureOfDerivativeLiabilityExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDerivativeLiabilityExplanatory" xlink:to="MMA_DisclosureOfDerivativeLiabilityExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfDerivativeLiabilityExplanatory_lbl" xml:lang="en-US">Schedule of Fair Value Measurement of Derivative Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of Unobservable Inputs Level 3 Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfCashEquivalentsExplanatory" xlink:label="MMA_DisclosureOfCashEquivalentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfCashEquivalentsExplanatory" xlink:to="MMA_DisclosureOfCashEquivalentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfCashEquivalentsExplanatory_lbl" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfTradeAndOtherReceivableExplanatory" xlink:label="MMA_DisclosureOfTradeAndOtherReceivableExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfTradeAndOtherReceivableExplanatory" xlink:to="MMA_DisclosureOfTradeAndOtherReceivableExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfTradeAndOtherReceivableExplanatory_lbl" xml:lang="en-US">Schedule of Trade and Other Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory" xlink:label="MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory" xlink:to="MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Reconciliations of the Movement of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables" xlink:label="MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables" xlink:to="MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables_lbl" xml:lang="en-US">Schedule of Trade and Other Payables</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory" xlink:label="MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory" xlink:to="MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory_lbl" xml:lang="en-US">Schedule of Current and Non-current Employee Entitlements</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory" xlink:label="MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory" xlink:to="MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory_lbl" xml:lang="en-US">Schedule of Unearned Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ScheduleOfReservesTableTextBlock" xlink:label="MMA_ScheduleOfReservesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ScheduleOfReservesTableTextBlock" xlink:to="MMA_ScheduleOfReservesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ScheduleOfReservesTableTextBlock_lbl" xml:lang="en-US">Schedule of Reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory" xlink:label="MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory" xlink:to="MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory_lbl" xml:lang="en-US">Schedule of Issued Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory" xlink:label="MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory" xlink:to="MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory_lbl" xml:lang="en-US">Schedule of Statement of Cash Flows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl" xml:lang="en-US">Schedule of Key Management Personnel Remuneration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_lbl" xml:lang="en-US">Schedule of Shares Held by Key Management Personnel</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:label="ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:to="ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable_lbl" xml:lang="en-US">Schedule of Financial Statement of the Parent Entity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_lbl" xml:lang="en-US">Schedule of Country Incorporation Principal Place of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US">Summary of Changes in ROU Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_lbl" xml:lang="en-US">Summary of Future Minimum Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory" xlink:label="MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory" xlink:to="MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of Financial Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl" xml:lang="en-US">Schedule of Convertible Notes held by Investors</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory" xlink:label="MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory" xlink:to="MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory_lbl" xml:lang="en-US">Schedule of Details of Expense from Performance Rights, Options and Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xml:lang="en-US">Schedule of Share Options Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xml:lang="en-US">Schedule of Model Inputs For Options Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:to="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_lbl" xml:lang="en-US">Schedule of Contractual Maturities of Financial Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory" xlink:label="MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory" xlink:to="MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory_lbl" xml:lang="en-US">Schedule of Auditor of Company And Network Firms</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US">Schedule of Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US">Plant and equipment expected useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Estimated useful life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ProfitLoss_3_lbl" xml:lang="en-US">Loss after tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net cash outflows from operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetAssetsLiabilities" xlink:to="ifrs-full_NetAssetsLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetAssetsLiabilities_2_lbl" xml:lang="en-US">Net assets liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetAssetsLiabilities" xlink:to="ifrs-full_NetAssetsLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NetAssetsLiabilities_3_lbl" xml:lang="en-US">Net assets liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsLiabilities" xlink:label="ifrs-full_CurrentAssetsLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_CurrentAssetsLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsLiabilities_lbl" xml:lang="en-US">Net current assets liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RevenueFromContractsWithCustomersAbstract" xlink:to="MMA_RevenueFromContractsWithCustomersAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_RevenueFromContractsWithCustomersAbstract_2_lbl" xml:lang="en-US">Schedule Of Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RevenueFromProgramFees" xlink:to="MMA_RevenueFromProgramFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_RevenueFromProgramFees_2_lbl" xml:lang="en-US">Revenue from program fees</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromContractualPaymentsToGyms" xlink:label="MMA_RevenueFromContractualPaymentsToGyms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RevenueFromContractualPaymentsToGyms" xlink:to="MMA_RevenueFromContractualPaymentsToGyms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_RevenueFromContractualPaymentsToGyms_lbl" xml:lang="en-US">Contractual payments to gyms</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="ifrs-full_RevenueFromRenderingOfServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromRenderingOfServices" xlink:to="ifrs-full_RevenueFromRenderingOfServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_RevenueFromRenderingOfServices_lbl" xml:lang="en-US">Net Revenue from program fees</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReserachAndDevelopmentIncome" xlink:label="MMA_ReserachAndDevelopmentIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReserachAndDevelopmentIncome" xlink:to="MMA_ReserachAndDevelopmentIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ReserachAndDevelopmentIncome_lbl" xml:lang="en-US">Research and Development tax incentive</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FranchiseFeeIncome" xlink:label="ifrs-full_FranchiseFeeIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FranchiseFeeIncome" xlink:to="ifrs-full_FranchiseFeeIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FranchiseFeeIncome_lbl" xml:lang="en-US">Finale, franchise fee and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="ifrs-full_RevenueFromSaleOfGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromSaleOfGoods" xlink:to="ifrs-full_RevenueFromSaleOfGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromSaleOfGoods_lbl" xml:lang="en-US">Merchandise sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="ifrs-full_OtherRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRevenue" xlink:to="ifrs-full_OtherRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherRevenue_lbl" xml:lang="en-US">Total other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfExpensesAbstract" xlink:to="MMA_DisclosureOfExpensesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfExpensesAbstract_2_lbl" xml:lang="en-US">Schedule Of Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesEventCosts" xlink:label="MMA_ProgramExpensesEventCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpensesEventCosts" xlink:to="MMA_ProgramExpensesEventCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ProgramExpensesEventCosts_lbl" xml:lang="en-US">Event Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesProgramCosts" xlink:label="MMA_ProgramExpensesProgramCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpensesProgramCosts" xlink:to="MMA_ProgramExpensesProgramCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ProgramExpensesProgramCosts_lbl" xml:lang="en-US">Program costs</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesMerchantFees" xlink:label="MMA_ProgramExpensesMerchantFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpensesMerchantFees" xlink:to="MMA_ProgramExpensesMerchantFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ProgramExpensesMerchantFees_lbl" xml:lang="en-US">Merchant fees</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesOtherCosts" xlink:label="MMA_ProgramExpensesOtherCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpensesOtherCosts" xlink:to="MMA_ProgramExpensesOtherCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ProgramExpensesOtherCosts_lbl" xml:lang="en-US">Other costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpenses" xlink:to="MMA_ProgramExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="MMA_ProgramExpenses_2_lbl" xml:lang="en-US">Total program expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective" xlink:label="MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective" xlink:to="MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective_lbl" xml:lang="en-US">Convertible notes interest &#8211; contractual and effective</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FinanceCostsBankFees" xlink:label="MMA_FinanceCostsBankFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FinanceCostsBankFees" xlink:to="MMA_FinanceCostsBankFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_FinanceCostsBankFees_lbl" xml:lang="en-US">Bank fees</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FinanceCostsBankInterestAndLeaseInterest" xlink:label="MMA_FinanceCostsBankInterestAndLeaseInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FinanceCostsBankInterestAndLeaseInterest" xlink:to="MMA_FinanceCostsBankInterestAndLeaseInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_FinanceCostsBankInterestAndLeaseInterest_lbl" xml:lang="en-US">Bank interest and lease interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinanceCosts_2_lbl" xml:lang="en-US">Total finance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnrealizedCurrencyGains" xlink:label="MMA_UnrealizedCurrencyGains" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnrealizedCurrencyGains" xlink:to="MMA_UnrealizedCurrencyGains_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="MMA_UnrealizedCurrencyGains_lbl" xml:lang="en-US">Unrealized currency (gains)</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RealizedCurrencyGainslosses" xlink:label="MMA_RealizedCurrencyGainslosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RealizedCurrencyGainslosses" xlink:to="MMA_RealizedCurrencyGainslosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="MMA_RealizedCurrencyGainslosses_lbl" xml:lang="en-US">Realized currency (gains)/losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeGain" xlink:to="ifrs-full_NetForeignExchangeGain_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_NetForeignExchangeGain_2_lbl" xml:lang="en-US">Net foreign exchange (gains)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="ifrs-full_DeferredTaxExpenseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncome_lbl" xml:lang="en-US">Deferred tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="ifrs-full_CurrentTaxExpenseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl" xml:lang="en-US">Current tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_2_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_2_lbl" xml:lang="en-US">Loss before income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_lbl" xml:lang="en-US">Prima facie income tax benefit on loss before income tax calculated at 25% (2022: 25%)</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems" xlink:label="MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems" xlink:to="MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems_lbl" xml:lang="en-US">- other non-allowable items</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" xlink:label="MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" xlink:to="MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes_lbl" xml:lang="en-US">- items not assessable for income tax</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" xlink:label="MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" xlink:to="MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting_lbl" xml:lang="en-US">- items deductible for taxation not accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" xlink:label="MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" xlink:to="MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss_lbl" xml:lang="en-US">Deferred tax not recognised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US">Tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_lbl" xml:lang="en-US">Disclosure of fair value measurement of assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="ifrs-full_FinancialAssetsAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtFairValue" xlink:to="ifrs-full_FinancialAssetsAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsAtFairValue_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtFairValue" xlink:to="ifrs-full_FinancialAssetsAtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinancialAssetsAtFairValue_2_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xml:lang="en-US">Derivative Liabilities &#8211; refer Note 21</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_2_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="ifrs-full_DerivativeFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DerivativeFinancialLiabilities" xlink:to="ifrs-full_DerivativeFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_DerivativeFinancialLiabilities_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" xlink:label="MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" xlink:to="MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_lbl" xml:lang="en-US">Fair value of derivative liability recognised for convertible notes issued during the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability" xlink:label="ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability" xlink:to="ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_lbl" xml:lang="en-US">Fair value of derivative liability recognised for convertible notes issued during the year</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueMovementRecognisedInProfitOrLoss" xlink:label="MMA_FairValueMovementRecognisedInProfitOrLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueMovementRecognisedInProfitOrLoss" xlink:to="MMA_FairValueMovementRecognisedInProfitOrLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_FairValueMovementRecognisedInProfitOrLoss_lbl" xml:lang="en-US">Fair value movement recognised in profit or loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_lbl" xml:lang="en-US">Fair value movement recognised in profit or loss</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:label="MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:to="MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_lbl" xml:lang="en-US">Fair value of derivative liability for convertible notes which converted or matured during the year</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:label="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:to="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_lbl" xml:lang="en-US">Fair value of derivative liability for convertible notes which converted or matured during the year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DerivativeFinancialLiabilities" xlink:to="ifrs-full_DerivativeFinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_DerivativeFinancialLiabilities_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_FinancialLiabilities_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:label="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_lbl" xml:lang="en-US">Disclosure of significant unobservable inputs used in fair value measurement of assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:to="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_lbl" xml:lang="en-US">Implied Valuation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities" xlink:label="ifrs-full_SignificantUnobservableInputLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantUnobservableInputLiabilities" xlink:to="ifrs-full_SignificantUnobservableInputLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantUnobservableInputLiabilities_lbl" xml:lang="en-US">Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashOnHand" xlink:label="ifrs-full_CashOnHand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashOnHand" xlink:to="ifrs-full_CashOnHand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashOnHand_lbl" xml:lang="en-US">Cash on hand</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BalancesWithBanks" xlink:label="ifrs-full_BalancesWithBanks" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BalancesWithBanks" xlink:to="ifrs-full_BalancesWithBanks_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BalancesWithBanks_lbl" xml:lang="en-US">Cash at bank</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashAndCashEquivalents_4_lbl" xml:lang="en-US">Total cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_5_lbl" xml:lang="en-US">Balance as per statement of cash flows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="ifrs-full_TradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivables_lbl" xml:lang="en-US">Trade Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:label="ifrs-full_AccruedIncomeOtherThanContractAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:to="ifrs-full_AccruedIncomeOtherThanContractAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccruedIncomeOtherThanContractAssets_lbl" xml:lang="en-US">Accrued Income</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ResearchAndDevelopmentIncome" xlink:label="MMA_ResearchAndDevelopmentIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ResearchAndDevelopmentIncome" xlink:to="MMA_ResearchAndDevelopmentIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ResearchAndDevelopmentIncome_lbl" xml:lang="en-US">Research and Development Tax incentive receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="ifrs-full_OtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReceivables_lbl" xml:lang="en-US">Other advances</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AllowancesForCreditLoss" xlink:label="MMA_AllowancesForCreditLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AllowancesForCreditLoss" xlink:to="MMA_AllowancesForCreditLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AllowancesForCreditLoss_lbl" xml:lang="en-US">Less; allowance for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="ifrs-full_TradeAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivables" xlink:to="ifrs-full_TradeAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherReceivables_lbl" xml:lang="en-US">Total trade and other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PropertyPlantAndEquipmentCost" xlink:label="MMA_PropertyPlantAndEquipmentCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PropertyPlantAndEquipmentCost" xlink:to="MMA_PropertyPlantAndEquipmentCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_PropertyPlantAndEquipmentCost_lbl" xml:lang="en-US">Furniture &amp; Fittings - at cost</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PropertyPlantAndEquipmentAccumulatedDepreciation" xlink:label="MMA_PropertyPlantAndEquipmentAccumulatedDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PropertyPlantAndEquipmentAccumulatedDepreciation" xlink:to="MMA_PropertyPlantAndEquipmentAccumulatedDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_PropertyPlantAndEquipmentAccumulatedDepreciation_lbl" xml:lang="en-US">Less: Accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Furniture &amp; Fittings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl" xml:lang="en-US">Total property and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:to="ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Disposals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_4_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_lbl" xml:lang="en-US">Caarried forward tax loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_2_lbl" xml:lang="en-US">Total intangible assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_3_lbl" xml:lang="en-US">Balance at beginning of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_4_lbl" xml:lang="en-US">Balance at end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdditionsFromInternalDevelopment" xlink:label="MMA_AdditionsFromInternalDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdditionsFromInternalDevelopment" xlink:to="MMA_AdditionsFromInternalDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AdditionsFromInternalDevelopment_lbl" xml:lang="en-US">Additions from internal development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Additions acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ResearchDevelopmentTaxIncentive" xlink:label="MMA_ResearchDevelopmentTaxIncentive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ResearchDevelopmentTaxIncentive" xlink:to="MMA_ResearchDevelopmentTaxIncentive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ResearchDevelopmentTaxIncentive_lbl" xml:lang="en-US">Research &amp; Development tax incentive</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="ifrs-full_NotionalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotionalAmount" xlink:to="ifrs-full_NotionalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotionalAmount_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="ifrs-full_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Cash" xlink:to="ifrs-full_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xml:lang="en-US">Asset purchased for consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfTradeAndOtherPayablesAbstract" xlink:to="MMA_DisclosureOfTradeAndOtherPayablesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_DisclosureOfTradeAndOtherPayablesAbstract_2_lbl" xml:lang="en-US">Schedule Of Trade And Other Payables</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_TradeAndOtherPayablesPayableToMemberGyms" xlink:label="MMA_TradeAndOtherPayablesPayableToMemberGyms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_TradeAndOtherPayablesPayableToMemberGyms" xlink:to="MMA_TradeAndOtherPayablesPayableToMemberGyms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_TradeAndOtherPayablesPayableToMemberGyms_lbl" xml:lang="en-US">Payable to member gyms</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_TaxesPayable" xlink:label="MMA_TaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_TaxesPayable" xlink:to="MMA_TaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_TaxesPayable_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_TradePayables" xlink:label="MMA_TradePayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_TradePayables" xlink:to="MMA_TradePayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_TradePayables_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProvisionForRefundLiability" xlink:label="MMA_ProvisionForRefundLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProvisionForRefundLiability" xlink:to="MMA_ProvisionForRefundLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ProvisionForRefundLiability_lbl" xml:lang="en-US">Provision for refund liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPayables" xlink:label="ifrs-full_OtherPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPayables" xlink:to="ifrs-full_OtherPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherPayables_lbl" xml:lang="en-US">Other Payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="ifrs-full_TradeAndOtherPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_TradeAndOtherPayables_lbl" xml:lang="en-US">Total trade and other payables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" xlink:to="MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract_2_lbl" xml:lang="en-US">Schedule Of Current And Non-current Employee Entitlements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits_2_lbl" xml:lang="en-US">Current Employee Entitlement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfUnearnedRevenueAbtract" xlink:to="MMA_DisclosureOfUnearnedRevenueAbtract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_DisclosureOfUnearnedRevenueAbtract_2_lbl" xml:lang="en-US">Schedule Of Unearned Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnearnedRevenue" xlink:to="MMA_UnearnedRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_UnearnedRevenue_2_lbl" xml:lang="en-US">Unearned Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfReservesAbstract" xlink:to="MMA_DisclosureOfReservesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_DisclosureOfReservesAbstract_2_lbl" xml:lang="en-US">Schedule Of Reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReserveOfUnbilledShareOption" xlink:label="MMA_ReserveOfUnbilledShareOption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReserveOfUnbilledShareOption" xlink:to="MMA_ReserveOfUnbilledShareOption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ReserveOfUnbilledShareOption_lbl" xml:lang="en-US">Unlisted share option reserve</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPayments" xlink:to="ifrs-full_ReserveOfSharebasedPayments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ReserveOfSharebasedPayments_2_lbl" xml:lang="en-US">Share based payment reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ForeignCurrencyReserves" xlink:label="MMA_ForeignCurrencyReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ForeignCurrencyReserves" xlink:to="MMA_ForeignCurrencyReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_ForeignCurrencyReserves_lbl" xml:lang="en-US">Foreign currency translation reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OwnersShareCapital" xlink:label="MMA_OwnersShareCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OwnersShareCapital" xlink:to="MMA_OwnersShareCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="MMA_OwnersShareCapital_lbl" xml:lang="en-US">Owners share capital, opening (1)</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NumberOfShareIssuedAndFullyPaid" xlink:label="MMA_NumberOfShareIssuedAndFullyPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NumberOfShareIssuedAndFullyPaid" xlink:to="MMA_NumberOfShareIssuedAndFullyPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_NumberOfShareIssuedAndFullyPaid_lbl" xml:lang="en-US">Issued and fully paid</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssueOfSharesFromConversionOfConvertibleNotes" xlink:label="MMA_IssueOfSharesFromConversionOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssueOfSharesFromConversionOfConvertibleNotes" xlink:to="MMA_IssueOfSharesFromConversionOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_IssueOfSharesFromConversionOfConvertibleNotes_lbl" xml:lang="en-US">Issue of shares from the conversion of the convertible notes (2)</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorOptionsExercisedShares" xlink:label="MMA_AdvisorOptionsExercisedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdvisorOptionsExercisedShares" xlink:to="MMA_AdvisorOptionsExercisedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AdvisorOptionsExercisedShares_lbl" xml:lang="en-US">Advisor Options exercised (3)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OwnersShareCapital" xlink:to="MMA_OwnersShareCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="MMA_OwnersShareCapital_2_lbl" xml:lang="en-US">Owners share capital, closing</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_IssuedCapital_2_lbl" xml:lang="en-US">Owners share capital, opening</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssuedAndFullyPaidValue" xlink:label="MMA_IssuedAndFullyPaidValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssuedAndFullyPaidValue" xlink:to="MMA_IssuedAndFullyPaidValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_IssuedAndFullyPaidValue_lbl" xml:lang="en-US">Issued and fully paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="ifrs-full_PaymentsForShareIssueCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForShareIssueCosts" xlink:to="ifrs-full_PaymentsForShareIssueCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsForShareIssueCosts_lbl" xml:lang="en-US">Share issue transaction costs net of tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssueOfEquityFromConversionOfConvertibleNotes" xlink:to="MMA_IssueOfEquityFromConversionOfConvertibleNotes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_IssueOfEquityFromConversionOfConvertibleNotes_2_lbl" xml:lang="en-US">Issue of shares from the conversion of the convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorOptionsExercisedValue" xlink:label="MMA_AdvisorOptionsExercisedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdvisorOptionsExercisedValue" xlink:to="MMA_AdvisorOptionsExercisedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AdvisorOptionsExercisedValue_lbl" xml:lang="en-US">Advisor Options exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_IssuedCapital_3_lbl" xml:lang="en-US">Owners share capital, closing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContractualCapitalisedInterestRate" xlink:label="MMA_ContractualCapitalisedInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ContractualCapitalisedInterestRate" xlink:to="MMA_ContractualCapitalisedInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ContractualCapitalisedInterestRate_lbl" xml:lang="en-US">Contractual capitalised interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdvisorOptionsExercisedShares" xlink:to="MMA_AdvisorOptionsExercisedShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_AdvisorOptionsExercisedShares_2_lbl" xml:lang="en-US">Advisor options exercised, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorOptionsForfeitedShares" xlink:label="MMA_AdvisorOptionsForfeitedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdvisorOptionsForfeitedShares" xlink:to="MMA_AdvisorOptionsForfeitedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AdvisorOptionsForfeitedShares_lbl" xml:lang="en-US">Advisor options forfeited, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLoss_4_lbl" xml:lang="en-US">Loss after income tax</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AccruedInterestOnConvertibleNotes" xlink:label="MMA_AccruedInterestOnConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AccruedInterestOnConvertibleNotes" xlink:to="MMA_AccruedInterestOnConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AccruedInterestOnConvertibleNotes_lbl" xml:lang="en-US">Accrued interest on convertible notes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2_lbl" xml:lang="en-US">Share-based payments</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices" xlink:label="MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices" xlink:to="MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices_lbl" xml:lang="en-US">Convertible notes issued in lieu of payment for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DepreciationExpense_2_lbl" xml:lang="en-US">Depreciation and amortisation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueMovementRecognisedInProfitOrLoss" xlink:to="MMA_FairValueMovementRecognisedInProfitOrLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_FairValueMovementRecognisedInProfitOrLoss_2_lbl" xml:lang="en-US">Fair value movement of derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_lbl" xml:lang="en-US">Decrease in trade and other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xml:lang="en-US">(Increase)/Decrease in other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl" xml:lang="en-US">Increase/(decrease) in trade and other payables</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue" xlink:label="MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue" xlink:to="MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue_lbl" xml:lang="en-US">Decrease in net deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund" xlink:label="MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund" xlink:to="MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund_lbl" xml:lang="en-US">(Decrease)/increase in provision for refund</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl" xml:lang="en-US">Increase in employee entitlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xml:lang="en-US">Short term benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl" xml:lang="en-US">Post employment benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits_lbl" xml:lang="en-US">Long term benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xml:lang="en-US">Share Based payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_lbl" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US">Opening Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssuedSharesHeldByKeyManagementPersonnel" xlink:label="MMA_IssuedSharesHeldByKeyManagementPersonnel" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssuedSharesHeldByKeyManagementPersonnel" xlink:to="MMA_IssuedSharesHeldByKeyManagementPersonnel_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_IssuedSharesHeldByKeyManagementPersonnel_lbl" xml:lang="en-US">Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RepurchasedSharesHeldByKeyManagementPersonnel" xlink:label="MMA_RepurchasedSharesHeldByKeyManagementPersonnel" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RepurchasedSharesHeldByKeyManagementPersonnel" xlink:to="MMA_RepurchasedSharesHeldByKeyManagementPersonnel_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_RepurchasedSharesHeldByKeyManagementPersonnel_lbl" xml:lang="en-US">Repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ResignationOfKeyManagementPersonnelShares" xlink:label="MMA_ResignationOfKeyManagementPersonnelShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ResignationOfKeyManagementPersonnelShares" xlink:to="MMA_ResignationOfKeyManagementPersonnelShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ResignationOfKeyManagementPersonnelShares_lbl" xml:lang="en-US">Resignation of Key Management Personnel</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel" xlink:label="MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel" xlink:to="MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel_lbl" xml:lang="en-US">Reverse Share Split</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_2_lbl" xml:lang="en-US">Closing Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US">Opening Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssuedOptionsHeldByKeyManagementPersonnel" xlink:label="MMA_IssuedOptionsHeldByKeyManagementPersonnel" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssuedOptionsHeldByKeyManagementPersonnel" xlink:to="MMA_IssuedOptionsHeldByKeyManagementPersonnel_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_IssuedOptionsHeldByKeyManagementPersonnel_lbl" xml:lang="en-US">Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpiredOptionsHeldByKeyManagementPersonnel" xlink:label="MMA_ExpiredOptionsHeldByKeyManagementPersonnel" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExpiredOptionsHeldByKeyManagementPersonnel" xlink:to="MMA_ExpiredOptionsHeldByKeyManagementPersonnel_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExpiredOptionsHeldByKeyManagementPersonnel_lbl" xml:lang="en-US">Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisedOptionsHeldByKeyManagementPersonnel" xlink:label="MMA_ExercisedOptionsHeldByKeyManagementPersonnel" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExercisedOptionsHeldByKeyManagementPersonnel" xlink:to="MMA_ExercisedOptionsHeldByKeyManagementPersonnel_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExercisedOptionsHeldByKeyManagementPersonnel_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel" xlink:label="MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel" xlink:to="MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel_lbl" xml:lang="en-US">Reverse share split</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_2_lbl" xml:lang="en-US">Closing Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementTable" xlink:label="MMA_IfrsStatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IfrsStatementTable" xlink:to="MMA_IfrsStatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_IfrsStatementTable_lbl" xml:lang="en-US">IfrsStatementTable [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US">Number of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PercentageOfOrdinarySharesUnderVestAndExercisable" xlink:label="MMA_PercentageOfOrdinarySharesUnderVestAndExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PercentageOfOrdinarySharesUnderVestAndExercisable" xlink:to="MMA_PercentageOfOrdinarySharesUnderVestAndExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_PercentageOfOrdinarySharesUnderVestAndExercisable_lbl" xml:lang="en-US">Percentage vest and exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense_lbl" xml:lang="en-US">Short term incentive</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Share percent rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLoss_5_lbl" xml:lang="en-US">Loss for the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncome_3_lbl" xml:lang="en-US">Other comprehensive loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_2_lbl" xml:lang="en-US">Current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentAssets_2_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="ifrs-full_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesAbstract" xlink:to="ifrs-full_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLiabilities_2_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLiabilities_2_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContributedEquity" xlink:label="MMA_ContributedEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ContributedEquity" xlink:to="MMA_ContributedEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ContributedEquity_lbl" xml:lang="en-US">Contributed equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves" xlink:label="ifrs-full_OtherReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReserves" xlink:to="ifrs-full_OtherReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherReserves_lbl" xml:lang="en-US">Reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US">Accumulated losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:to="ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable_2_lbl" xml:lang="en-US">Disclosure of information about consolidated structured entities [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NameOfParentEntity" xlink:label="ifrs-full_NameOfParentEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NameOfParentEntity" xlink:to="ifrs-full_NameOfParentEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NameOfParentEntity_lbl" xml:lang="en-US">Name of parent entity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PrincipalPlaceOfBusiness" xlink:label="ifrs-full_PrincipalPlaceOfBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PrincipalPlaceOfBusiness" xlink:to="ifrs-full_PrincipalPlaceOfBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PrincipalPlaceOfBusiness_lbl" xml:lang="en-US">Principal place of business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl" xml:lang="en-US">Proportion of ownership interests held by non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_lbl" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RightofuseAsset" xlink:label="MMA_RightofuseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RightofuseAsset" xlink:to="MMA_RightofuseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="MMA_RightofuseAsset_lbl" xml:lang="en-US">Balance at beginning of yea</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AccumulatedAmortization" xlink:label="MMA_AccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AccumulatedAmortization" xlink:to="MMA_AccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AccumulatedAmortization_lbl" xml:lang="en-US">Less: amortization for the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RightofuseAsset" xlink:to="MMA_RightofuseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="MMA_RightofuseAsset_2_lbl" xml:lang="en-US">Balance at end of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Modification" xlink:label="MMA_Modification" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Modification" xlink:to="MMA_Modification_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_Modification_lbl" xml:lang="en-US">Modification</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_2_lbl" xml:lang="en-US">Current lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_2_lbl" xml:lang="en-US">Non-current lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="ifrs-full_LeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US">Total lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_lbl" xml:lang="en-US">Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="ifrs-full_GrossLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossLeaseLiabilities" xlink:to="ifrs-full_GrossLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossLeaseLiabilities_lbl" xml:lang="en-US">Five years and over</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LeaseLiabilities_2_lbl" xml:lang="en-US">Total future lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable_lbl" xml:lang="en-US">Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentFinancialLiabilities_2_lbl" xml:lang="en-US">Convertible note payable - Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_2_lbl" xml:lang="en-US">Convertible note payable &#8211; Non Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinancialLiabilities_3_lbl" xml:lang="en-US">Total Financial Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued" xlink:label="ifrs-full_CurrentDebtInstrumentsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDebtInstrumentsIssued" xlink:to="ifrs-full_CurrentDebtInstrumentsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentDebtInstrumentsIssued_lbl" xml:lang="en-US">Host Liability - Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDebtInstrumentsIssued" xlink:label="ifrs-full_NoncurrentDebtInstrumentsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentDebtInstrumentsIssued" xlink:to="ifrs-full_NoncurrentDebtInstrumentsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentDebtInstrumentsIssued_lbl" xml:lang="en-US">Host Liability &#8211; Non Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities_lbl" xml:lang="en-US">Derivative liability -Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="ifrs-full_NoncurrentDerivativeFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:to="ifrs-full_NoncurrentDerivativeFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentDerivativeFinancialLiabilities_lbl" xml:lang="en-US">Derivative liability - Non Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DebtSecurities" xlink:label="ifrs-full_DebtSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DebtSecurities" xlink:to="ifrs-full_DebtSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_DebtSecurities_lbl" xml:lang="en-US">Total Convertible Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesIssueDate" xlink:label="MMA_ConvertibleNotesIssueDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesIssueDate" xlink:to="MMA_ConvertibleNotesIssueDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ConvertibleNotesIssueDate_lbl" xml:lang="en-US">Issue Date</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesPreModificationMaturityDate" xlink:label="MMA_ConvertibleNotesPreModificationMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesPreModificationMaturityDate" xlink:to="MMA_ConvertibleNotesPreModificationMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ConvertibleNotesPreModificationMaturityDate_lbl" xml:lang="en-US">Pre Modification Maturity Date</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesModificationDate" xlink:label="MMA_ConvertibleNotesModificationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesModificationDate" xlink:to="MMA_ConvertibleNotesModificationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ConvertibleNotesModificationDate_lbl" xml:lang="en-US">Modification Date</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesModifiedMaturityDate" xlink:label="MMA_ConvertibleNotesModifiedMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesModifiedMaturityDate" xlink:to="MMA_ConvertibleNotesModifiedMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ConvertibleNotesModifiedMaturityDate_lbl" xml:lang="en-US">Modified Maturity Date</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesConversionDate" xlink:label="MMA_ConvertibleNotesConversionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesConversionDate" xlink:to="MMA_ConvertibleNotesConversionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ConvertibleNotesConversionDate_lbl" xml:lang="en-US">Conversion Date</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesTerm" xlink:label="MMA_ConvertibleNotesTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesTerm" xlink:to="MMA_ConvertibleNotesTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ConvertibleNotesTerm_lbl" xml:lang="en-US">Term (Years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="ifrs-full_Borrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Borrowings_lbl" xml:lang="en-US">Face Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="ifrs-full_BorrowingsInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsInterestRate_lbl" xml:lang="en-US">Interest Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesConversionDiscount" xlink:label="MMA_ConvertibleNotesConversionDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesConversionDiscount" xlink:to="MMA_ConvertibleNotesConversionDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ConvertibleNotesConversionDiscount_lbl" xml:lang="en-US">Conversion Discount (Qualified Equity Investment)</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachConvertibleNote" xlink:label="MMA_ReachConvertibleNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReachConvertibleNote" xlink:to="MMA_ReachConvertibleNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ReachConvertibleNote_lbl" xml:lang="en-US">Reach convertible note</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RedeemedForCash" xlink:label="MMA_RedeemedForCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RedeemedForCash" xlink:to="MMA_RedeemedForCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_RedeemedForCash_lbl" xml:lang="en-US">Redeemed for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfConversionOfDebtToEquity" xlink:label="ifrs-full_DescriptionOfConversionOfDebtToEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfConversionOfDebtToEquity" xlink:to="ifrs-full_DescriptionOfConversionOfDebtToEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfConversionOfDebtToEquity_lbl" xml:lang="en-US">Conversion of debt to equity</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" xlink:label="MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" xlink:to="MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants_lbl" xml:lang="en-US">ESOP</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromAdvisorOptions" xlink:label="MMA_ExpenseFromAdvisorOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExpenseFromAdvisorOptions" xlink:to="MMA_ExpenseFromAdvisorOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExpenseFromAdvisorOptions_lbl" xml:lang="en-US">Advisor Options ()</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromReach" xlink:label="MMA_ExpenseFromReach" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExpenseFromReach" xlink:to="MMA_ExpenseFromReach_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExpenseFromReach_lbl" xml:lang="en-US">Reach</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromWarrants" xlink:label="MMA_ExpenseFromWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExpenseFromWarrants" xlink:to="MMA_ExpenseFromWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExpenseFromWarrants_lbl" xml:lang="en-US">Warrants ()</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromOverAllotmentOption" xlink:label="MMA_ExpenseFromOverAllotmentOption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExpenseFromOverAllotmentOption" xlink:to="MMA_ExpenseFromOverAllotmentOption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExpenseFromOverAllotmentOption_lbl" xml:lang="en-US">Over allotment Option ()</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromRestrictedShareUnits" xlink:label="MMA_ExpenseFromRestrictedShareUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExpenseFromRestrictedShareUnits" xlink:to="MMA_ExpenseFromRestrictedShareUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExpenseFromRestrictedShareUnits_lbl" xml:lang="en-US">RSU</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US">Total Share based payments*</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Advisor Options vested and were exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Advisor Options forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_2_lbl" xml:lang="en-US">Ordinary Shares on exercise</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PricePerShareEqualPercentage" xlink:label="MMA_PricePerShareEqualPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PricePerShareEqualPercentage" xlink:to="MMA_PricePerShareEqualPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_PricePerShareEqualPercentage_lbl" xml:lang="en-US">Price per share equal percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Total granted during the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Total forfeited/expired during the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Exercised during the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Total exercised during the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_3_lbl" xml:lang="en-US">Forfeited/expired during the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpectedTermShareOptionsGranted" xlink:label="MMA_ExpectedTermShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExpectedTermShareOptionsGranted" xlink:to="MMA_ExpectedTermShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ExpectedTermShareOptionsGranted_lbl" xml:lang="en-US">Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Spot Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US">Share price volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US">Expected Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US">Risk free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NonInterestBearingTradeAndOtherPayables" xlink:label="MMA_NonInterestBearingTradeAndOtherPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NonInterestBearingTradeAndOtherPayables" xlink:to="MMA_NonInterestBearingTradeAndOtherPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="MMA_NonInterestBearingTradeAndOtherPayables_lbl" xml:lang="en-US">Trade and other payables</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_WeightedAverageInterestRateFinancialLiability" xlink:label="MMA_WeightedAverageInterestRateFinancialLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_WeightedAverageInterestRateFinancialLiability" xlink:to="MMA_WeightedAverageInterestRateFinancialLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_WeightedAverageInterestRateFinancialLiability_lbl" xml:lang="en-US">Financial liability host debt, interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_InterestBearingFinancialLiabilities" xlink:label="MMA_InterestBearingFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_InterestBearingFinancialLiabilities" xlink:to="MMA_InterestBearingFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_InterestBearingFinancialLiabilities_lbl" xml:lang="en-US">Financial liability host debt</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_WeightedAverageInterestRateLeaseLiabilities" xlink:label="MMA_WeightedAverageInterestRateLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_WeightedAverageInterestRateLeaseLiabilities" xlink:to="MMA_WeightedAverageInterestRateLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_WeightedAverageInterestRateLeaseLiabilities_lbl" xml:lang="en-US">Lease liability, interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_InterestBearingLeaseLiabilities" xlink:label="MMA_InterestBearingLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_InterestBearingLeaseLiabilities" xlink:to="MMA_InterestBearingLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_InterestBearingLeaseLiabilities_lbl" xml:lang="en-US">Lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_InterestBearingNonderivativesNet" xlink:label="MMA_InterestBearingNonderivativesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_InterestBearingNonderivativesNet" xlink:to="MMA_InterestBearingNonderivativesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_InterestBearingNonderivativesNet_lbl" xml:lang="en-US">Total non derivative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DerivativeFinancialLiabilities" xlink:to="ifrs-full_DerivativeFinancialLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DerivativeFinancialLiabilities_3_lbl" xml:lang="en-US">Derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DerivativeNet" xlink:label="MMA_DerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DerivativeNet" xlink:to="MMA_DerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DerivativeNet_lbl" xml:lang="en-US">Total Derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AuditFees" xlink:label="MMA_AuditFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AuditFees" xlink:to="MMA_AuditFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AuditFees_lbl" xml:lang="en-US">Audit fees</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AuditorsRemunerationForRelatedFees" xlink:label="MMA_AuditorsRemunerationForRelatedFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AuditorsRemunerationForRelatedFees" xlink:to="MMA_AuditorsRemunerationForRelatedFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_AuditorsRemunerationForRelatedFees_lbl" xml:lang="en-US">Audit &#8211; related fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForTaxServices" xlink:label="ifrs-full_AuditorsRemunerationForTaxServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AuditorsRemunerationForTaxServices" xlink:to="ifrs-full_AuditorsRemunerationForTaxServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AuditorsRemunerationForTaxServices_lbl" xml:lang="en-US">Tax fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices" xlink:label="ifrs-full_AuditorsRemunerationForOtherServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AuditorsRemunerationForOtherServices" xlink:to="ifrs-full_AuditorsRemunerationForOtherServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AuditorsRemunerationForOtherServices_lbl" xml:lang="en-US">All other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemuneration" xlink:label="ifrs-full_AuditorsRemuneration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AuditorsRemuneration" xlink:to="ifrs-full_AuditorsRemuneration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_AuditorsRemuneration_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_2_lbl" xml:lang="en-US">Options exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US">Share-based payment expense</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContingentAssetsAndLiabilities" xlink:label="MMA_ContingentAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ContingentAssetsAndLiabilities" xlink:to="MMA_ContingentAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ContingentAssetsAndLiabilities_lbl" xml:lang="en-US">Contingent assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="ifrs-full_WeightedAverageShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="ifrs-full_AdjustedWeightedAverageShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_lbl" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_3_lbl" xml:lang="en-US">Vested and convertible shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:label="ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:to="ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_lbl" xml:lang="en-US">Description of contracts shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfCorporateInformationExplanatory" xlink:to="MMA_DisclosureOfCorporateInformationExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfCorporateInformationExplanatory_doc" xml:lang="en-US">Disclosure of corporate information explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory" xlink:to="MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_doc" xml:lang="en-US">Description of accounting policy for basis of preparation explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory" xlink:to="MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory_doc" xml:lang="en-US">Description of accounting policy for new or amended accounting standards and interpretations adopted explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PlantAndEquipmentMember" xlink:to="MMA_PlantAndEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_PlantAndEquipmentMember_doc" xml:lang="en-US">Plant and equipment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory" xlink:to="MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory_doc" xml:lang="en-US">Disclosure of effective income tax rate reconciliations explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems" xlink:to="MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems_doc" xml:lang="en-US">Deferred tax expense income other non allowable items.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" xlink:to="MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes_doc" xml:lang="en-US">Deferred tax expense income items not assessable for income taxes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" xlink:to="MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting_doc" xml:lang="en-US">Deferred Tax ExpenseIncomeItemsDeductibleForTaxationNotAccounting</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" xlink:to="MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss_doc" xml:lang="en-US">Deferred tax expense income not recognised in profit or loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfCashEquivalentsExplanatory" xlink:to="MMA_DisclosureOfCashEquivalentsExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfCashEquivalentsExplanatory_doc" xml:lang="en-US">Disclosure of cash equivalents explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfTradeAndOtherReceivableExplanatory" xlink:to="MMA_DisclosureOfTradeAndOtherReceivableExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfTradeAndOtherReceivableExplanatory_doc" xml:lang="en-US">Disclosure of trade and other receivable explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AllowancesForCreditLoss" xlink:to="MMA_AllowancesForCreditLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AllowancesForCreditLoss_doc" xml:lang="en-US">Allowances for credit loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory" xlink:to="MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_doc" xml:lang="en-US">Description of accounting policy for right of use assets explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PlatformDevelopmentMember" xlink:to="MMA_PlatformDevelopmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_PlatformDevelopmentMember_doc" xml:lang="en-US">Platform development [member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RevenueFromProgramFees" xlink:to="MMA_RevenueFromProgramFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_RevenueFromProgramFees_doc" xml:lang="en-US">Revenue from program fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ContractualPaymentsToGyms" xlink:to="MMA_ContractualPaymentsToGyms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ContractualPaymentsToGyms_doc" xml:lang="en-US">Contractual payments to gyms.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NetRevenueFromProgramFees" xlink:to="MMA_NetRevenueFromProgramFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_NetRevenueFromProgramFees_doc" xml:lang="en-US">Net revenue from program fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpenses" xlink:to="MMA_ProgramExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ProgramExpenses_doc" xml:lang="en-US">Program expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RentExpenses" xlink:to="MMA_RentExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_RentExpenses_doc" xml:lang="en-US">Rent expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ITCosts" xlink:to="MMA_ITCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ITCosts_doc" xml:lang="en-US">IT costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueMovementInDerivativeLiability" xlink:to="MMA_FairValueMovementInDerivativeLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_FairValueMovementInDerivativeLiability_doc" xml:lang="en-US">Fair value movement in derivative liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnearnedRevenue" xlink:to="MMA_UnearnedRevenue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_UnearnedRevenue_doc" xml:lang="en-US">Unearned revenue.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ResearchAndDevelopmentIncome" xlink:to="MMA_ResearchAndDevelopmentIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ResearchAndDevelopmentIncome_doc" xml:lang="en-US">Research and development income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnlistedOptionsReserve" xlink:to="MMA_UnlistedOptionsReserve_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_UnlistedOptionsReserve_doc" xml:lang="en-US">Unlisted options reserve.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory" xlink:to="MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory_doc" xml:lang="en-US">Disclosure of detailed information about reconciliations of the movement of intangible assets explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssueOfEquityFromConversionOfConvertibleNotes" xlink:to="MMA_IssueOfEquityFromConversionOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_IssueOfEquityFromConversionOfConvertibleNotes_doc" xml:lang="en-US">Issue of equity from conversion of convertible notes.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlatformDevelopmentNet" xlink:label="MMA_PlatformDevelopmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PlatformDevelopmentNet" xlink:to="MMA_PlatformDevelopmentNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_PlatformDevelopmentNet_doc" xml:lang="en-US">Platform development net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes" xlink:to="MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes_doc" xml:lang="en-US">Issue of unlisted shares from conversion of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IncreaseDecreaseThroughOptionsForfeited" xlink:to="MMA_IncreaseDecreaseThroughOptionsForfeited_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_IncreaseDecreaseThroughOptionsForfeited_doc" xml:lang="en-US">Increase decrease through options forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OverAllotmentOptionsLapsed" xlink:to="MMA_OverAllotmentOptionsLapsed_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_OverAllotmentOptionsLapsed_doc" xml:lang="en-US">Over allotment options lapsed.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FurnitrueAndFittingsMember" xlink:to="MMA_FurnitrueAndFittingsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_FurnitrueAndFittingsMember_doc" xml:lang="en-US">Furnitrue and fittings [member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnlistedOptionReserveMember" xlink:to="MMA_UnlistedOptionReserveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_UnlistedOptionReserveMember_doc" xml:lang="en-US">Unlisted option reserve [member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory" xlink:to="MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory_doc" xml:lang="en-US">Description of accounting policy for parent entity financial information explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" xlink:to="MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_doc" xml:lang="en-US">Fair value of derivative liability recognised for convertible notes issued during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueMovementRecognisedInProfitOrLoss" xlink:to="MMA_FairValueMovementRecognisedInProfitOrLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_FairValueMovementRecognisedInProfitOrLoss_doc" xml:lang="en-US">Fair value movement recognised in profit or loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProceedsFromTrainingParticipants" xlink:to="MMA_ProceedsFromTrainingParticipants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ProceedsFromTrainingParticipants_doc" xml:lang="en-US">Receipts from training participants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:to="MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_doc" xml:lang="en-US">Fair value of derivative liability for convertible notes which converted or matured during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdditionsFromInternalDevelopment" xlink:to="MMA_AdditionsFromInternalDevelopment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AdditionsFromInternalDevelopment_doc" xml:lang="en-US">Additions from internal development.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:to="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_doc" xml:lang="en-US">Fair value of liability for convertible notes which converted or matured during year.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdditionsThroughIntangibleAssetsOtherThanGoodwill" xlink:label="MMA_AdditionsThroughIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdditionsThroughIntangibleAssetsOtherThanGoodwill" xlink:to="MMA_AdditionsThroughIntangibleAssetsOtherThanGoodwill_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AdditionsThroughIntangibleAssetsOtherThanGoodwill_doc" xml:lang="en-US">Additions through intangible assets other than goodwill.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDerivativeLiabilityExplanatory" xlink:to="MMA_DisclosureOfDerivativeLiabilityExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfDerivativeLiabilityExplanatory_doc" xml:lang="en-US">Disclosure of derivative liability explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ResearchDevelopmentTaxIncentive" xlink:to="MMA_ResearchDevelopmentTaxIncentive_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ResearchDevelopmentTaxIncentive_doc" xml:lang="en-US">Research &amp; development tax incentive.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SteppenPtyLtdMember" xlink:to="MMA_SteppenPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SteppenPtyLtdMember_doc" xml:lang="en-US">Steppen Pty Ltd [member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" xlink:to="MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure_doc" xml:lang="en-US">Receipts from government grants and tax incentives related to expenditure.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MixedMartialsArtsLLCMember" xlink:to="MMA_MixedMartialsArtsLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_MixedMartialsArtsLLCMember_doc" xml:lang="en-US">Mixed Martials Arts LLC [member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_BankGuaranteeDepositReceivedPaid" xlink:to="MMA_BankGuaranteeDepositReceivedPaid_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_BankGuaranteeDepositReceivedPaid_doc" xml:lang="en-US">Bank guarantee deposit received/(paid).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_HypeKitIncMember" xlink:to="MMA_HypeKitIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_HypeKitIncMember_doc" xml:lang="en-US">Hype Kit, Inc [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RiskFreeRateMember" xlink:label="MMA_RiskFreeRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RiskFreeRateMember" xlink:to="MMA_RiskFreeRateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_RiskFreeRateMember_doc" xml:lang="en-US">Risk free rate [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables" xlink:to="MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables_doc" xml:lang="en-US">Disclosure of detailed information about trade and other payables.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReserachAndDevelopmentIncome" xlink:to="MMA_ReserachAndDevelopmentIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ReserachAndDevelopmentIncome_doc" xml:lang="en-US">Reserach and development income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ImpliedValuationMember" xlink:to="MMA_ImpliedValuationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ImpliedValuationMember_doc" xml:lang="en-US">Implied valuation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAJuly21Member" xlink:to="MMA_SeriesAJuly21Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesAJuly21Member_doc" xml:lang="en-US">Series A July21 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAAugust21Member" xlink:to="MMA_SeriesAAugust21Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesAAugust21Member_doc" xml:lang="en-US">Series A August21 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RevenueFromContractualPaymentsToGyms" xlink:to="MMA_RevenueFromContractualPaymentsToGyms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_RevenueFromContractualPaymentsToGyms_doc" xml:lang="en-US">Contractual payments to gyms.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesB1Member" xlink:to="MMA_SeriesB1Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesB1Member_doc" xml:lang="en-US">Series B1 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesB2Member" xlink:to="MMA_SeriesB2Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesB2Member_doc" xml:lang="en-US">Series B2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_CurrentHostFinancialLiabilities" xlink:label="MMA_CurrentHostFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_CurrentHostFinancialLiabilities" xlink:to="MMA_CurrentHostFinancialLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_CurrentHostFinancialLiabilities_doc" xml:lang="en-US">Current host financial liabilities.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NoncurrentHostFinancialLiabilities" xlink:label="MMA_NoncurrentHostFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NoncurrentHostFinancialLiabilities" xlink:to="MMA_NoncurrentHostFinancialLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_NoncurrentHostFinancialLiabilities_doc" xml:lang="en-US">Non current host financial liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAExtensionMember" xlink:to="MMA_SeriesAExtensionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesAExtensionMember_doc" xml:lang="en-US">Series A extension [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReachMember" xlink:to="MMA_ReachMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ReachMember_doc" xml:lang="en-US">Reach [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MixedMartialArtsLLCMember" xlink:to="MMA_MixedMartialArtsLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_MixedMartialArtsLLCMember_doc" xml:lang="en-US">Mixed martial arts LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SteppenMember" xlink:to="MMA_SteppenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SteppenMember_doc" xml:lang="en-US">Steppen [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PreModificationMaturityDate" xlink:label="MMA_PreModificationMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PreModificationMaturityDate" xlink:to="MMA_PreModificationMaturityDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_PreModificationMaturityDate_doc" xml:lang="en-US">Pre modification maturity date.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ModificationDate" xlink:label="MMA_ModificationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ModificationDate" xlink:to="MMA_ModificationDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ModificationDate_doc" xml:lang="en-US">Modification date.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ModifiedMaturityDate" xlink:label="MMA_ModifiedMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ModifiedMaturityDate" xlink:to="MMA_ModifiedMaturityDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ModifiedMaturityDate_doc" xml:lang="en-US">Modified maturity date.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConversionDate" xlink:label="MMA_ConversionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConversionDate" xlink:to="MMA_ConversionDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ConversionDate_doc" xml:lang="en-US">Conversion date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RealizedCurrencyGainslosses" xlink:to="MMA_RealizedCurrencyGainslosses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_RealizedCurrencyGainslosses_doc" xml:lang="en-US">Realized currency gains losses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_TradePayables" xlink:to="MMA_TradePayables_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_TradePayables_doc" xml:lang="en-US">Trade payables.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_TaxesPayable" xlink:to="MMA_TaxesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_TaxesPayable_doc" xml:lang="en-US">Taxes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProvisionForRefundLiability" xlink:to="MMA_ProvisionForRefundLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ProvisionForRefundLiability_doc" xml:lang="en-US">Provision for refund liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PropertyPlantAndEquipmentAccumulatedDepreciation" xlink:to="MMA_PropertyPlantAndEquipmentAccumulatedDepreciation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_PropertyPlantAndEquipmentAccumulatedDepreciation_doc" xml:lang="en-US">Property plant and equipment accumulated depreciation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory" xlink:to="MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory_doc" xml:lang="en-US">Disclosure of current and non current employee entitlements explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory" xlink:to="MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory_doc" xml:lang="en-US">Disclosure of detailed information about current and non current employee entitlements explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfUnearnedRevenueExplanatory" xlink:to="MMA_DisclosureOfUnearnedRevenueExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfUnearnedRevenueExplanatory_doc" xml:lang="en-US">Disclosure of unearned revenue explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory" xlink:to="MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory_doc" xml:lang="en-US">Disclosure of detailed information about unearned revenue explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OneMajorProductMember" xlink:to="MMA_OneMajorProductMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_OneMajorProductMember_doc" xml:lang="en-US">One major product [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_TradeAndOtherPayablesPayableToMemberGyms" xlink:to="MMA_TradeAndOtherPayablesPayableToMemberGyms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_TradeAndOtherPayablesPayableToMemberGyms_doc" xml:lang="en-US">Trade and other payables payable to member gyms.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpensesEventCosts" xlink:to="MMA_ProgramExpensesEventCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ProgramExpensesEventCosts_doc" xml:lang="en-US">Program expenses, event costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpensesProgramCosts" xlink:to="MMA_ProgramExpensesProgramCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ProgramExpensesProgramCosts_doc" xml:lang="en-US">Program expenses, program costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpensesMerchantFees" xlink:to="MMA_ProgramExpensesMerchantFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ProgramExpensesMerchantFees_doc" xml:lang="en-US">Program expenses, merchant fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ProgramExpensesOtherCosts" xlink:to="MMA_ProgramExpensesOtherCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ProgramExpensesOtherCosts_doc" xml:lang="en-US">Program expenses, other costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective" xlink:to="MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective_doc" xml:lang="en-US">Finance costs convertible notes interest contractual and effective.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FinanceCostsBankFees" xlink:to="MMA_FinanceCostsBankFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_FinanceCostsBankFees_doc" xml:lang="en-US">Finance costs bank fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FinanceCostsBankInterestAndLeaseInterest" xlink:to="MMA_FinanceCostsBankInterestAndLeaseInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_FinanceCostsBankInterestAndLeaseInterest_doc" xml:lang="en-US">Finance costs bank interest and lease interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnrealizedCurrencyGains" xlink:to="MMA_UnrealizedCurrencyGains_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_UnrealizedCurrencyGains_doc" xml:lang="en-US">Unrealized currency gains.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory" xlink:to="MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory_doc" xml:lang="en-US">Disclosure of detailed information about expenses explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfPlantAndEquipmentExplanatory" xlink:to="MMA_DisclosureOfPlantAndEquipmentExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfPlantAndEquipmentExplanatory_doc" xml:lang="en-US">Disclosure of plant and equipment explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ScheduleOfReservesTableTextBlock" xlink:to="MMA_ScheduleOfReservesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ScheduleOfReservesTableTextBlock_doc" xml:lang="en-US">Schedule of reserves table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ForeignCurrencyReserves" xlink:to="MMA_ForeignCurrencyReserves_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ForeignCurrencyReserves_doc" xml:lang="en-US">Foreign currency reserves.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PropertyPlantAndEquipmentCost" xlink:to="MMA_PropertyPlantAndEquipmentCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_PropertyPlantAndEquipmentCost_doc" xml:lang="en-US">Property plant and equipment cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReserveOfUnbilledShareOption" xlink:to="MMA_ReserveOfUnbilledShareOption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ReserveOfUnbilledShareOption_doc" xml:lang="en-US">Reserve of unbilled share option.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OwnersShareCapital" xlink:to="MMA_OwnersShareCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_OwnersShareCapital_doc" xml:lang="en-US">Owners share capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssueOfSharesFromConversionOfConvertibleNotes" xlink:to="MMA_IssueOfSharesFromConversionOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_IssueOfSharesFromConversionOfConvertibleNotes_doc" xml:lang="en-US">Issue of shares from conversion of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorOptionsExercised" xlink:label="MMA_AdvisorOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdvisorOptionsExercised" xlink:to="MMA_AdvisorOptionsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AdvisorOptionsExercised_doc" xml:lang="en-US">Advisor options exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssuedAndFullyPaidValue" xlink:to="MMA_IssuedAndFullyPaidValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_IssuedAndFullyPaidValue_doc" xml:lang="en-US">Issued and fully paid value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ContractualCapitalisedInterestRate" xlink:to="MMA_ContractualCapitalisedInterestRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ContractualCapitalisedInterestRate_doc" xml:lang="en-US">Contractual capitalised interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdvisorOptionsExercisedShares" xlink:to="MMA_AdvisorOptionsExercisedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AdvisorOptionsExercisedShares_doc" xml:lang="en-US">Advisor options exercised shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdvisorOptionsForfeitedShares" xlink:to="MMA_AdvisorOptionsForfeitedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AdvisorOptionsForfeitedShares_doc" xml:lang="en-US">Advisor options forfeited shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory" xlink:to="MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory_doc" xml:lang="en-US">Detailed information of notes to statement of cash flow explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory" xlink:to="MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory_doc" xml:lang="en-US">Disclosure of detailed information issued capital explanatory.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_HostLiabilityCurrent" xlink:label="MMA_HostLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_HostLiabilityCurrent" xlink:to="MMA_HostLiabilityCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_HostLiabilityCurrent_doc" xml:lang="en-US">Host liability current.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_HostLiabilityNonCurrent" xlink:label="MMA_HostLiabilityNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_HostLiabilityNonCurrent" xlink:to="MMA_HostLiabilityNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_HostLiabilityNonCurrent_doc" xml:lang="en-US">Host liability non current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices" xlink:to="MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices_doc" xml:lang="en-US">Convertible notes issued in lieu of payment for services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NumberOfShareIssuedAndFullyPaid" xlink:to="MMA_NumberOfShareIssuedAndFullyPaid_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_NumberOfShareIssuedAndFullyPaid_doc" xml:lang="en-US">Number of share issued and fully paid.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdvisorOptionsExercisedValue" xlink:to="MMA_AdvisorOptionsExercisedValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AdvisorOptionsExercisedValue_doc" xml:lang="en-US">Advisor options exercised value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AccruedInterestOnConvertibleNotes" xlink:to="MMA_AccruedInterestOnConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AccruedInterestOnConvertibleNotes_doc" xml:lang="en-US">Accrued interest on convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue" xlink:to="MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue_doc" xml:lang="en-US">Adjustments for increase decrease in net deferred revenue.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund" xlink:to="MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund_doc" xml:lang="en-US">Adjustments for increase decrease in provision for refund.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_EmploymentAgreementMember" xlink:to="MMA_EmploymentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_EmploymentAgreementMember_doc" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAConvertibleNotesMember" xlink:to="MMA_SeriesAConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesAConvertibleNotesMember_doc" xml:lang="en-US">Series A Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfLeasesLiabilityExplanatory" xlink:label="MMA_DisclosureOfLeasesLiabilityExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfLeasesLiabilityExplanatory" xlink:to="MMA_DisclosureOfLeasesLiabilityExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfLeasesLiabilityExplanatory_doc" xml:lang="en-US">Disclosure of leases liability explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_EmployeementAgreementMember" xlink:to="MMA_EmployeementAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_EmployeementAgreementMember_doc" xml:lang="en-US">Employeement Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_LaterThanTwoYearAndNotLaterThanTwoYearsMember" xlink:label="MMA_LaterThanTwoYearAndNotLaterThanTwoYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_LaterThanTwoYearAndNotLaterThanTwoYearsMember" xlink:to="MMA_LaterThanTwoYearAndNotLaterThanTwoYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_LaterThanTwoYearAndNotLaterThanTwoYearsMember_doc" xml:lang="en-US">Later Than Two Year And Not Later Than Two Years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_EmployeeStockOwnershipPlanMember" xlink:to="MMA_EmployeeStockOwnershipPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_EmployeeStockOwnershipPlanMember_doc" xml:lang="en-US">Employee Stock Ownership Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_TradeAndOtherPayablesMember" xlink:label="MMA_TradeAndOtherPayablesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_TradeAndOtherPayablesMember" xlink:to="MMA_TradeAndOtherPayablesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_TradeAndOtherPayablesMember_doc" xml:lang="en-US">Trade And Other Payables [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Mr.LangtonMember" xlink:to="MMA_Mr.LangtonMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_Mr.LangtonMember_doc" xml:lang="en-US">Mr.Langton [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory" xlink:to="MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory_doc" xml:lang="en-US">Disclosure of information about remuneration of auditors explanatory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AuditFees" xlink:to="MMA_AuditFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AuditFees_doc" xml:lang="en-US">Audit fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesConversionDiscount" xlink:to="MMA_ConvertibleNotesConversionDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ConvertibleNotesConversionDiscount_doc" xml:lang="en-US">Convertible notes conversion discount.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_LessAccumulatedAmortization" xlink:label="MMA_LessAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_LessAccumulatedAmortization" xlink:to="MMA_LessAccumulatedAmortization_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_LessAccumulatedAmortization_doc" xml:lang="en-US">Less accumulated amortization.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AccumulatedDepreciationAmortisationMember" xlink:label="MMA_AccumulatedDepreciationAmortisationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AccumulatedDepreciationAmortisationMember" xlink:to="MMA_AccumulatedDepreciationAmortisationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AccumulatedDepreciationAmortisationMember_doc" xml:lang="en-US">Accumulated Depreciation Amortisation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill" xlink:label="MMA_AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill" xlink:to="MMA_AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_doc" xml:lang="en-US">Accumulated depreciation of intangible assets other than goodwill.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ContingentAssetsAndLiabilities" xlink:to="MMA_ContingentAssetsAndLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ContingentAssetsAndLiabilities_doc" xml:lang="en-US">Contingent assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NonInterestBearingTradePayables" xlink:label="MMA_NonInterestBearingTradePayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NonInterestBearingTradePayables" xlink:to="MMA_NonInterestBearingTradePayables_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_NonInterestBearingTradePayables_doc" xml:lang="en-US">Non interest bearing trade payables.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_BetweenTwoAndFiveYearsMember" xlink:to="MMA_BetweenTwoAndFiveYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_BetweenTwoAndFiveYearsMember_doc" xml:lang="en-US">Between 2 and 5 Years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_BetweenOneAndTwoYearsMember" xlink:to="MMA_BetweenOneAndTwoYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_BetweenOneAndTwoYearsMember_doc" xml:lang="en-US">Between 1 and 2 Years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AuditorsRemunerationForRelatedFees" xlink:to="MMA_AuditorsRemunerationForRelatedFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AuditorsRemunerationForRelatedFees_doc" xml:lang="en-US">Auditors remuneration for related fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExpectedTermShareOptionsGranted" xlink:to="MMA_ExpectedTermShareOptionsGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ExpectedTermShareOptionsGranted_doc" xml:lang="en-US">Expected term share options granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesIssueDate" xlink:to="MMA_ConvertibleNotesIssueDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ConvertibleNotesIssueDate_doc" xml:lang="en-US">Convertible notes issue date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesModificationDate" xlink:to="MMA_ConvertibleNotesModificationDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ConvertibleNotesModificationDate_doc" xml:lang="en-US">Convertible notes modification date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesModifiedMaturityDate" xlink:to="MMA_ConvertibleNotesModifiedMaturityDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ConvertibleNotesModifiedMaturityDate_doc" xml:lang="en-US">Convertible notes modified maturity date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesConversionDate" xlink:to="MMA_ConvertibleNotesConversionDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ConvertibleNotesConversionDate_doc" xml:lang="en-US">Convertible notes conversion date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesPreModificationMaturityDate" xlink:to="MMA_ConvertibleNotesPreModificationMaturityDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ConvertibleNotesPreModificationMaturityDate_doc" xml:lang="en-US">Convertible notes pre modification maturity date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_InterestBearingFinancialLiabilities" xlink:to="MMA_InterestBearingFinancialLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_InterestBearingFinancialLiabilities_doc" xml:lang="en-US">Interest bearing financial liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ConvertibleNotesTerm" xlink:to="MMA_ConvertibleNotesTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ConvertibleNotesTerm_doc" xml:lang="en-US">Convertible notes term.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RightofuseAssetMember" xlink:label="MMA_RightofuseAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RightofuseAssetMember" xlink:to="MMA_RightofuseAssetMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_RightofuseAssetMember_doc" xml:lang="en-US">Right of use Asset [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ContributedEquity" xlink:to="MMA_ContributedEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ContributedEquity_doc" xml:lang="en-US">Contributed equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SharesHeldByKeyManagementPersonnelMember" xlink:to="MMA_SharesHeldByKeyManagementPersonnelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SharesHeldByKeyManagementPersonnelMember_doc" xml:lang="en-US">Shares Held By Key Management Personnel [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAJulyTwentyOneConvertibleNotesMember" xlink:to="MMA_SeriesAJulyTwentyOneConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesAJulyTwentyOneConvertibleNotesMember_doc" xml:lang="en-US">Series A July-21 convertible notes [member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AmortizationMember" xlink:to="MMA_AmortizationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AmortizationMember_doc" xml:lang="en-US">Amortization [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FinancialLiabilityHostDebtMember" xlink:label="MMA_FinancialLiabilityHostDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FinancialLiabilityHostDebtMember" xlink:to="MMA_FinancialLiabilityHostDebtMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_FinancialLiabilityHostDebtMember_doc" xml:lang="en-US">Financial Liability Host Debt [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AdvisorMember" xlink:to="MMA_AdvisorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AdvisorMember_doc" xml:lang="en-US">Advisor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAAugustTwentyOneConvertibleNotesMember" xlink:to="MMA_SeriesAAugustTwentyOneConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesAAugustTwentyOneConvertibleNotesMember_doc" xml:lang="en-US">Series A August 21 convertible notes [member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesB2ConvertibleNotesMember" xlink:to="MMA_SeriesB2ConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesB2ConvertibleNotesMember_doc" xml:lang="en-US">Series B2 Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AccumulatedAmortizationMember" xlink:label="MMA_AccumulatedAmortizationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AccumulatedAmortizationMember" xlink:to="MMA_AccumulatedAmortizationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AccumulatedAmortizationMember_doc" xml:lang="en-US">Accumulated Amortization [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NonInterestBearingTradeAndOtherPayables" xlink:to="MMA_NonInterestBearingTradeAndOtherPayables_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_NonInterestBearingTradeAndOtherPayables_doc" xml:lang="en-US">Non interest bearing trade and other payables.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesBOneConvertibleNotesMember" xlink:to="MMA_SeriesBOneConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesBOneConvertibleNotesMember_doc" xml:lang="en-US">Series B1 convertible notes [member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExercisePricesOneMember" xlink:to="MMA_ExercisePricesOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ExercisePricesOneMember_doc" xml:lang="en-US">Exercise Prices One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_InterestBearingLeaseLiabilities" xlink:to="MMA_InterestBearingLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_InterestBearingLeaseLiabilities_doc" xml:lang="en-US">Interest bearing lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExercisePricesTwoMember" xlink:to="MMA_ExercisePricesTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ExercisePricesTwoMember_doc" xml:lang="en-US">Exercise Prices Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OptionHeldByKeyManagementPersonnelMember" xlink:to="MMA_OptionHeldByKeyManagementPersonnelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_OptionHeldByKeyManagementPersonnelMember_doc" xml:lang="en-US">Option Held By Key Management Personnel [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExercisePricesThreeMember" xlink:to="MMA_ExercisePricesThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ExercisePricesThreeMember_doc" xml:lang="en-US">Exercise Prices Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_InterestBearingNonderivativesNet" xlink:to="MMA_InterestBearingNonderivativesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_InterestBearingNonderivativesNet_doc" xml:lang="en-US">Interest bearing non derivatives net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExercisePricesFourMember" xlink:to="MMA_ExercisePricesFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ExercisePricesFourMember_doc" xml:lang="en-US">Exercise Prices Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NonadjustingEventMember" xlink:to="MMA_NonadjustingEventMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_NonadjustingEventMember_doc" xml:lang="en-US">Nonadjusting Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PerformanceShare" xlink:label="MMA_PerformanceShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PerformanceShare" xlink:to="MMA_PerformanceShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_PerformanceShare_doc" xml:lang="en-US">Performance share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MrMcGregorMember" xlink:to="MMA_MrMcGregorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_MrMcGregorMember_doc" xml:lang="en-US">Mr McGregor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssuedSharesHeldByKeyManagementPersonnel" xlink:to="MMA_IssuedSharesHeldByKeyManagementPersonnel_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_IssuedSharesHeldByKeyManagementPersonnel_doc" xml:lang="en-US">Issued shares held by key management personnel.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RepurchasedSharesHeldByKeyManagementPersonnel" xlink:to="MMA_RepurchasedSharesHeldByKeyManagementPersonnel_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_RepurchasedSharesHeldByKeyManagementPersonnel_doc" xml:lang="en-US">Repurchased shares held by key management personnel.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DerivativeNet" xlink:to="MMA_DerivativeNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_DerivativeNet_doc" xml:lang="en-US">Derivative net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ResignationOfKeyManagementPersonnelShares" xlink:to="MMA_ResignationOfKeyManagementPersonnelShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ResignationOfKeyManagementPersonnelShares_doc" xml:lang="en-US">Resignation of key management personnel shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel" xlink:to="MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel_doc" xml:lang="en-US">Reverse share split shares held by key management personnel.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssuedOptionsHeldByKeyManagementPersonnel" xlink:to="MMA_IssuedOptionsHeldByKeyManagementPersonnel_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_IssuedOptionsHeldByKeyManagementPersonnel_doc" xml:lang="en-US">Issued options held by key management personnel.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExpiredOptionsHeldByKeyManagementPersonnel" xlink:to="MMA_ExpiredOptionsHeldByKeyManagementPersonnel_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ExpiredOptionsHeldByKeyManagementPersonnel_doc" xml:lang="en-US">Expired options held by key management personnel.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ExercisedOptionsHeldByKeyManagementPersonnel" xlink:to="MMA_ExercisedOptionsHeldByKeyManagementPersonnel_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ExercisedOptionsHeldByKeyManagementPersonnel_doc" xml:lang="en-US">Exercised options held by key management personnel.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel" xlink:to="MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel_doc" xml:lang="en-US">Reverse share split options held by key management personnel.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_WeightedAverageInterestRateLeaseLiabilities" xlink:to="MMA_WeightedAverageInterestRateLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_WeightedAverageInterestRateLeaseLiabilities_doc" xml:lang="en-US">Weighted average interest rate lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_WeightedAverageInterestRateFinancialLiability" xlink:to="MMA_WeightedAverageInterestRateFinancialLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_WeightedAverageInterestRateFinancialLiability_doc" xml:lang="en-US">Weighted average interest rate financial liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Wimp2WarriorLLCMember" xlink:to="MMA_Wimp2WarriorLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_Wimp2WarriorLLCMember_doc" xml:lang="en-US">Wimp2 Warrior LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Wimp2WarriorProductionsPtyLtdMember" xlink:to="MMA_Wimp2WarriorProductionsPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_Wimp2WarriorProductionsPtyLtdMember_doc" xml:lang="en-US">Wimp2 Warrior Productions Pty Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Wimp2WarriorDigitalPtyLtdMember" xlink:to="MMA_Wimp2WarriorDigitalPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_Wimp2WarriorDigitalPtyLtdMember_doc" xml:lang="en-US">Wimp2 Warrior Digital Pty Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Wimp2WarriorIrelandLimitedMember" xlink:to="MMA_Wimp2WarriorIrelandLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_Wimp2WarriorIrelandLimitedMember_doc" xml:lang="en-US">Wimp2 Warrior Ireland Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Hype.CoMember" xlink:label="MMA_Hype.CoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Hype.CoMember" xlink:to="MMA_Hype.CoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_Hype.CoMember_doc" xml:lang="en-US">Hype.Co [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AccumulatedAmortization" xlink:to="MMA_AccumulatedAmortization_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AccumulatedAmortization_doc" xml:lang="en-US">Accumulated amortization.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnitedStatesOfAmericaMember" xlink:label="MMA_UnitedStatesOfAmericaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnitedStatesOfAmericaMember" xlink:to="MMA_UnitedStatesOfAmericaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_UnitedStatesOfAmericaMember_doc" xml:lang="en-US">United States Of America [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AustraliaMember" xlink:label="MMA_AustraliaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AustraliaMember" xlink:to="MMA_AustraliaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AustraliaMember_doc" xml:lang="en-US">Australia [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AustraliaOneMember" xlink:label="MMA_AustraliaOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_AustraliaOneMember" xlink:to="MMA_AustraliaOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_AustraliaOneMember_doc" xml:lang="en-US">Australia One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IrelandMember" xlink:label="MMA_IrelandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IrelandMember" xlink:to="MMA_IrelandMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_IrelandMember_doc" xml:lang="en-US">Ireland [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_Modification" xlink:to="MMA_Modification_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_Modification_doc" xml:lang="en-US">Modification.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnitedStatesOfAmericaOneMember" xlink:label="MMA_UnitedStatesOfAmericaOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnitedStatesOfAmericaOneMember" xlink:to="MMA_UnitedStatesOfAmericaOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_UnitedStatesOfAmericaOneMember_doc" xml:lang="en-US">United States Of America One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MrLangtonMember" xlink:to="MMA_MrLangtonMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_MrLangtonMember_doc" xml:lang="en-US">MrLangton [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SnowflowerHoldingsPtyLtdMember" xlink:to="MMA_SnowflowerHoldingsPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SnowflowerHoldingsPtyLtdMember_doc" xml:lang="en-US">Snowflower Holdings Pty Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MrWilliamsMember" xlink:to="MMA_MrWilliamsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_MrWilliamsMember_doc" xml:lang="en-US">MrWilliams [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ChampSevenPtyLtdMember" xlink:to="MMA_ChampSevenPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ChampSevenPtyLtdMember_doc" xml:lang="en-US">Champ Seven Pty Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OverAllotmentOptionsMember" xlink:to="MMA_OverAllotmentOptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_OverAllotmentOptionsMember_doc" xml:lang="en-US">Over Allotment Options [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MrTaylorMember" xlink:to="MMA_MrTaylorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_MrTaylorMember_doc" xml:lang="en-US">MrTaylor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SeriesAExtensionConvertibleNotesMember" xlink:to="MMA_SeriesAExtensionConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SeriesAExtensionConvertibleNotesMember_doc" xml:lang="en-US">Series A Extension Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReachConvertibleNotesMember" xlink:to="MMA_ReachConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ReachConvertibleNotesMember_doc" xml:lang="en-US">Reach Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PrivatePlacementConvertibleNotesMember" xlink:to="MMA_PrivatePlacementConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_PrivatePlacementConvertibleNotesMember_doc" xml:lang="en-US">Private Placement Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MixedMartialArtsLLCConvertibleNotesMember" xlink:to="MMA_MixedMartialArtsLLCConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_MixedMartialArtsLLCConvertibleNotesMember_doc" xml:lang="en-US">Mixed Martial Arts LLC Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_SteppenConvertibleNotesMember" xlink:to="MMA_SteppenConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_SteppenConvertibleNotesMember_doc" xml:lang="en-US">Steppen Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NalarooHoldingsPtyLtdMember" xlink:to="MMA_NalarooHoldingsPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_NalarooHoldingsPtyLtdMember_doc" xml:lang="en-US">Nalaroo Holdings Pty Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_MrHartMember" xlink:to="MMA_MrHartMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_MrHartMember_doc" xml:lang="en-US">Mr Hart [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_JHartFamilyTrustAccountMember" xlink:to="MMA_JHartFamilyTrustAccountMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_JHartFamilyTrustAccountMember_doc" xml:lang="en-US">J Hart Family Trust Account [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_PercentageOfOrdinarySharesUnderVestAndExercisable" xlink:to="MMA_PercentageOfOrdinarySharesUnderVestAndExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_PercentageOfOrdinarySharesUnderVestAndExercisable_doc" xml:lang="en-US">Percentage of ordinary shares under vest and exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ReachConvertibleNote" xlink:to="MMA_ReachConvertibleNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_ReachConvertibleNote_doc" xml:lang="en-US">Reach convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RedeemedForCash" xlink:to="MMA_RedeemedForCash_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_RedeemedForCash_doc" xml:lang="en-US">Redeemed for cash.</link:label>
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_LeaseLiabilitiesPayments" xlink:label="MMA_LeaseLiabilitiesPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_LeaseLiabilitiesPayments" xlink:to="MMA_LeaseLiabilitiesPayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_LeaseLiabilitiesPayments_doc" xml:lang="en-US">Lease liabilities payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RightofuseAsset" xlink:to="MMA_RightofuseAsset_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_RightofuseAsset_doc" xml:lang="en-US">Right of use asset.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_HypeCoMember" xlink:to="MMA_HypeCoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="MMA_HypeCoMember_doc" xml:lang="en-US">Hype Co [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ContractualPaymentsToGyms" xlink:to="MMA_ContractualPaymentsToGyms_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ContractualPaymentsToGyms_3_lbl" xml:lang="en-US">ContractualPaymentsToGyms</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NetRevenueFromProgramFees" xlink:to="MMA_NetRevenueFromProgramFees_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_NetRevenueFromProgramFees_3_lbl" xml:lang="en-US">NetRevenueFromProgramFees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_2_lbl" xml:lang="en-US">Revenue [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeGain" xlink:to="ifrs-full_NetForeignExchangeGain_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetForeignExchangeGain_3_lbl" xml:lang="en-US">Net foreign exchange gain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueMovementInDerivativeLiability" xlink:to="MMA_FairValueMovementInDerivativeLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_FairValueMovementInDerivativeLiability_3_lbl" xml:lang="en-US">FairValueMovementInDerivativeLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseByNature_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseByNature_2_lbl" xml:lang="en-US">Expenses, by nature</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_3_lbl" xml:lang="en-US">Non-current assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_3_lbl" xml:lang="en-US">Current liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_3_lbl" xml:lang="en-US">Non-current liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_4_lbl" xml:lang="en-US">Equity [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:to="ifrs-full_PaymentsToSuppliersForGoodsAndServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsToSuppliersForGoodsAndServices_2_lbl" xml:lang="en-US">Payments to suppliers for goods and services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities_2_lbl" xml:lang="en-US">Interest paid, classified as operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_3_lbl" xml:lang="en-US">Cash flows from (used in) operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2_lbl" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:to="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_2_lbl" xml:lang="en-US">Disclosure of material accounting policy information [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_2_lbl" xml:lang="en-US">Disclosure of revenue from contracts with customers [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfExpensesExplanatory" xlink:to="ifrs-full_DisclosureOfExpensesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory_2_lbl" xml:lang="en-US">Disclosure of expenses [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_2_lbl" xml:lang="en-US">Disclosure of cash and cash equivalents [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2_lbl" xml:lang="en-US">Disclosure of trade and other receivables [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_2_lbl" xml:lang="en-US">Disclosure of intangible assets [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_2_lbl" xml:lang="en-US">Disclosure of trade and other payables [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_DisclosureOfUnearnedRevenueExplanatory" xlink:to="MMA_DisclosureOfUnearnedRevenueExplanatory_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_DisclosureOfUnearnedRevenueExplanatory_3_lbl" xml:lang="en-US">DisclosureOfUnearnedRevenueExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_2_lbl" xml:lang="en-US">Disclosure of reserves within equity [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2_lbl" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for trade and other receivables [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for trade and other payables [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for issued capital [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for fair value measurement [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromRenderingOfServices" xlink:to="ifrs-full_RevenueFromRenderingOfServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromRenderingOfServices_2_lbl" xml:lang="en-US">Revenue from rendering of services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRevenue" xlink:to="ifrs-full_OtherRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherRevenue_2_lbl" xml:lang="en-US">Other revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_UnrealizedCurrencyGains" xlink:to="MMA_UnrealizedCurrencyGains_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_UnrealizedCurrencyGains_3_lbl" xml:lang="en-US">UnrealizedCurrencyGains</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RealizedCurrencyGainslosses" xlink:to="MMA_RealizedCurrencyGainslosses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_RealizedCurrencyGainslosses_3_lbl" xml:lang="en-US">RealizedCurrencyGainslosses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilities_4_lbl" xml:lang="en-US">Financial liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability" xlink:to="ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_2_lbl" xml:lang="en-US">Increase (decrease) in fair value of financial liability, attributable to changes in credit risk of liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_2_lbl" xml:lang="en-US">Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:to="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_3_lbl" xml:lang="en-US">FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_2_lbl" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2_lbl" xml:lang="en-US">Amortisation, intangible assets other than goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherPayables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayables_2_lbl" xml:lang="en-US">Trade and other payables [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_ForeignCurrencyReserves" xlink:to="MMA_ForeignCurrencyReserves_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_ForeignCurrencyReserves_3_lbl" xml:lang="en-US">ForeignCurrencyReserves</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_OwnersShareCapital" xlink:to="MMA_OwnersShareCapital_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_OwnersShareCapital_4_lbl" xml:lang="en-US">OwnersShareCapital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssuedAndFullyPaidValue" xlink:to="MMA_IssuedAndFullyPaidValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_IssuedAndFullyPaidValue_3_lbl" xml:lang="en-US">Issued and fully paid value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForShareIssueCosts" xlink:to="ifrs-full_PaymentsForShareIssueCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsForShareIssueCosts_2_lbl" xml:lang="en-US">Payments for share issue costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_2_lbl" xml:lang="en-US">Key management personnel compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesOutstanding_3_lbl" xml:lang="en-US">Number of shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_3_lbl" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_IssuedOptionsHeldByKeyManagementPersonnel" xlink:to="MMA_IssuedOptionsHeldByKeyManagementPersonnel_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_IssuedOptionsHeldByKeyManagementPersonnel_3_lbl" xml:lang="en-US">IssuedOptionsHeldByKeyManagementPersonnel</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReserves" xlink:to="ifrs-full_OtherReserves_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReserves_2_lbl" xml:lang="en-US">Other reserves</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_2_lbl" xml:lang="en-US">Retained earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_RightofuseAsset" xlink:to="MMA_RightofuseAsset_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_RightofuseAsset_4_lbl" xml:lang="en-US">RightofuseAsset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DebtSecurities" xlink:to="ifrs-full_DebtSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DebtSecurities_2_lbl" xml:lang="en-US">Debt instruments issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MMA_NonInterestBearingTradeAndOtherPayables" xlink:to="MMA_NonInterestBearingTradeAndOtherPayables_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MMA_NonInterestBearingTradeAndOtherPayables_3_lbl" xml:lang="en-US">NonInterestBearingTradeAndOtherPayables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AuditorsRemuneration" xlink:to="ifrs-full_AuditorsRemuneration_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AuditorsRemuneration_2_lbl" xml:lang="en-US">Auditor's remuneration</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>mma-20240630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Cover" xlink:href="mma-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss" xlink:href="mma-20240630.xsd#ProfitOrLossAndOtherComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/StatementOfFinancialPosition" xlink:href="mma-20240630.xsd#StatementOfFinancialPosition" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/StatementOfChangesInEquity" xlink:href="mma-20240630.xsd#StatementOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/StatementOfCashFlows" xlink:href="mma-20240630.xsd#StatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CorporateInformation" xlink:href="mma-20240630.xsd#CorporateInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions" xlink:href="mma-20240630.xsd#CriticalAccountingJudgementsEstimatesAndAssumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/OperatingSegments" xlink:href="mma-20240630.xsd#OperatingSegments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Revenue" xlink:href="mma-20240630.xsd#Revenue" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Expenses" xlink:href="mma-20240630.xsd#Expenses" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IncomeTax" xlink:href="mma-20240630.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FairValueMeasurement" xlink:href="mma-20240630.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CashAndCashEquivalents" xlink:href="mma-20240630.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherReceivables" xlink:href="mma-20240630.xsd#TradeAndOtherReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/PropertyAndEquipment" xlink:href="mma-20240630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IntangibleAssets" xlink:href="mma-20240630.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherPayables" xlink:href="mma-20240630.xsd#TradeAndOtherPayables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements" xlink:href="mma-20240630.xsd#CurrentAndNon-currentEmployeeEntitlements" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/UnearnedRevenue" xlink:href="mma-20240630.xsd#UnearnedRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Reserves" xlink:href="mma-20240630.xsd#Reserves" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IssuedCapital" xlink:href="mma-20240630.xsd#IssuedCapital" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/NotesToStatementOfCashFlows" xlink:href="mma-20240630.xsd#NotesToStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactions" xlink:href="mma-20240630.xsd#RelatedPartiesTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Leases" xlink:href="mma-20240630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialLiabilities" xlink:href="mma-20240630.xsd#FinancialLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Share-basedPayments" xlink:href="mma-20240630.xsd#Share-basedPayments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialInstruments" xlink:href="mma-20240630.xsd#FinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RemunerationOfAuditors" xlink:href="mma-20240630.xsd#RemunerationOfAuditors" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities" xlink:href="mma-20240630.xsd#ContingentAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Commitments" xlink:href="mma-20240630.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/LossPerShare" xlink:href="mma-20240630.xsd#LossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/EventsAfterReportingPeriod" xlink:href="mma-20240630.xsd#EventsAfterReportingPeriod" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RevenueTables" xlink:href="mma-20240630.xsd#RevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ExpensesTables" xlink:href="mma-20240630.xsd#ExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IncomeTaxTables" xlink:href="mma-20240630.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FairValueMeasurementTables" xlink:href="mma-20240630.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CashAndCashEquivalentsTables" xlink:href="mma-20240630.xsd#CashAndCashEquivalentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherReceivablesTables" xlink:href="mma-20240630.xsd#TradeAndOtherReceivablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/PropertyAndEquipmentTables" xlink:href="mma-20240630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IntangibleAssetsTables" xlink:href="mma-20240630.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/TradeAndOtherPayablesTables" xlink:href="mma-20240630.xsd#TradeAndOtherPayablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlementsTables" xlink:href="mma-20240630.xsd#CurrentAndNon-currentEmployeeEntitlementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/UnearnedRevenueTables" xlink:href="mma-20240630.xsd#UnearnedRevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ReservesTables" xlink:href="mma-20240630.xsd#ReservesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IssuedCapitalTables" xlink:href="mma-20240630.xsd#IssuedCapitalTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/NotesToStatementOfCashFlowsTables" xlink:href="mma-20240630.xsd#NotesToStatementOfCashFlowsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables" xlink:href="mma-20240630.xsd#RelatedPartiesTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/LeasesTables" xlink:href="mma-20240630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialLiabilitiesTables" xlink:href="mma-20240630.xsd#FinancialLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Share-basedPaymentsTables" xlink:href="mma-20240630.xsd#Share-basedPaymentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialInstrumentsTables" xlink:href="mma-20240630.xsd#FinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RemunerationOfAuditorsTables" xlink:href="mma-20240630.xsd#RemunerationOfAuditorsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/LossPerShareTables" xlink:href="mma-20240630.xsd#LossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails" xlink:href="mma-20240630.xsd#ScheduleOfPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative" xlink:href="mma-20240630.xsd#MaterialAccountingPolicyInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative" xlink:href="mma-20240630.xsd#CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfRevenueDetails" xlink:href="mma-20240630.xsd#ScheduleOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:href="mma-20240630.xsd#ScheduleOfDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfExpensesDetails" xlink:href="mma-20240630.xsd#ScheduleOfExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails" xlink:href="mma-20240630.xsd#ScheduleOfIncomeTaxExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical" xlink:href="mma-20240630.xsd#ScheduleOfIncomeTaxExpensesDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfFairValueAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails" xlink:href="mma-20240630.xsd#ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfUnobservableInputsLevel3LiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:href="mma-20240630.xsd#ScheduleOfCashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails" xlink:href="mma-20240630.xsd#ScheduleOfTradeAndOtherReceivablesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="mma-20240630.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/IncomeTaxDetailsNarrative" xlink:href="mma-20240630.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="mma-20240630.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails" xlink:href="mma-20240630.xsd#ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails" xlink:href="mma-20240630.xsd#ScheduleOfTradeAndOtherPayablesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails" xlink:href="mma-20240630.xsd#ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfUnearnedRevenueDetails" xlink:href="mma-20240630.xsd#ScheduleOfUnearnedRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfReservesDetails" xlink:href="mma-20240630.xsd#ScheduleOfReservesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails" xlink:href="mma-20240630.xsd#ScheduleOfIssuedCapitalDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical" xlink:href="mma-20240630.xsd#ScheduleOfIssuedCapitalDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails" xlink:href="mma-20240630.xsd#ScheduleOfStatementOfCashFlowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails" xlink:href="mma-20240630.xsd#ScheduleOfKeyManagementPersonnelRemunerationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails" xlink:href="mma-20240630.xsd#ScheduleOfSharesHeldByKeyManagementPersonnelDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:href="mma-20240630.xsd#RelatedPartiesTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails" xlink:href="mma-20240630.xsd#ScheduleOfFinancialStatementOfParentEntityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails" xlink:href="mma-20240630.xsd#ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails" xlink:href="mma-20240630.xsd#SummaryOfChangesInRouAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails" xlink:href="mma-20240630.xsd#SummaryOfFutureMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails" xlink:href="mma-20240630.xsd#ScheduleOfConvertibleNotesHeldByInvestorsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/FinancialLiabilitiesDetailsNarrative" xlink:href="mma-20240630.xsd#FinancialLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails" xlink:href="mma-20240630.xsd#ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical" xlink:href="mma-20240630.xsd#ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails" xlink:href="mma-20240630.xsd#ScheduleOfShareOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails" xlink:href="mma-20240630.xsd#ScheduleOfModelInputsForOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" xlink:href="mma-20240630.xsd#ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails" xlink:href="mma-20240630.xsd#ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative" xlink:href="mma-20240630.xsd#Share-basedPaymentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilitiesDetailsNarrative" xlink:href="mma-20240630.xsd#ContingentAssetsAndLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails" xlink:href="mma-20240630.xsd#ScheduleOfLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative" xlink:href="mma-20240630.xsd#EventsAfterReportingPeriodDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss" xlink:title="00000002 - Statement - Profit or Loss and Other Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-fullIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromProgramFees" xlink:label="loc_MMARevenueFromProgramFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_MMARevenueFromProgramFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContractualPaymentsToGyms" xlink:label="loc_MMAContractualPaymentsToGyms" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_MMAContractualPaymentsToGyms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NetRevenueFromProgramFees" xlink:label="loc_MMANetRevenueFromProgramFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_MMANetRevenueFromProgramFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-fullOtherIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-fullExpenseByNatureAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullExpenseByNatureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpenses" xlink:label="loc_MMAProgramExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_MMAProgramExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-fullWagesAndSalaries" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_ifrs-fullWagesAndSalaries" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdvertisingExpense" xlink:label="loc_ifrs-fullAdvertisingExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_ifrs-fullAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-fullProfessionalFeesExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_ifrs-fullProfessionalFeesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RentExpenses" xlink:label="loc_MMARentExpenses" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_MMARentExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ITCosts" xlink:label="loc_MMAITCosts" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_MMAITCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-fullDepreciationExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_ifrs-fullDepreciationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-fullNetForeignExchangeGain" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_ifrs-fullNetForeignExchangeGain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherExpenseByNature" xlink:label="loc_ifrs-fullOtherExpenseByNature" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_ifrs-fullOtherExpenseByNature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueMovementInDerivativeLiability" xlink:label="loc_MMAFairValueMovementInDerivativeLiability" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_MMAFairValueMovementInDerivativeLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-fullExpenseByNature" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullExpenseByNatureAbstract" xlink:to="loc_ifrs-fullExpenseByNature" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullComprehensiveIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-fullBasicEarningsLossPerShare" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullBasicEarningsLossPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-fullDilutedEarningsLossPerShare" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullDilutedEarningsLossPerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/StatementOfFinancialPosition" xlink:title="00000003 - Statement - Consolidated Statement of Financial Position">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-fullStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-fullCurrentAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullCurrentAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentReceivables" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullTradeAndOtherCurrentReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-fullOtherCurrentAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullOtherCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-fullNoncurrentAssetsAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-fullOtherNoncurrentAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullOtherNoncurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-fullCurrentLiabilitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnearnedRevenue" xlink:label="loc_MMAUnearnedRevenue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_MMAUnearnedRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:label="loc_ifrs-fullCurrentProvisionsForEmployeeBenefits" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentProvisionsForEmployeeBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-fullNoncurrentLiabilitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="loc_ifrs-fullNoncurrentProvisionsForEmployeeBenefits" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentProvisionsForEmployeeBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-fullNetAssetsLiabilities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullNetAssetsLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-fullEquityAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-fullReserveOfSharebasedPayments" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullReserveOfSharebasedPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnlistedOptionsReserve" xlink:label="loc_MMAUnlistedOptionsReserve" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_MMAUnlistedOptionsReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-fullReserveOfExchangeDifferencesOnTranslation" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullReserveOfExchangeDifferencesOnTranslation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:label="loc_ifrs-fullAccumulatedOtherComprehensiveIncome" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullAccumulatedOtherComprehensiveIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/StatementOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated Statement of Changes in Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-fullStatementOfChangesInEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityAbstract" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-fullComponentsOfEquityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullComponentsOfEquityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-fullComponentsOfEquityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullComponentsOfEquityDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-fullIssuedCapitalMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullIssuedCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnlistedOptionReserveMember" xlink:label="loc_MMAUnlistedOptionReserveMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_MMAUnlistedOptionReserveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-fullReserveOfSharebasedPaymentsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullReserveOfSharebasedPaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-fullReserveOfExchangeDifferencesOnTranslationMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullReserveOfExchangeDifferencesOnTranslationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-fullAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullComprehensiveIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-fullIssueOfEquity" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIssueOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssueOfEquityFromConversionOfConvertibleNotes" xlink:label="loc_MMAIssueOfEquityFromConversionOfConvertibleNotes" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIssueOfEquityFromConversionOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes" xlink:label="loc_MMAIssueOfUnlistedSharesFromConversionOfConvertibleNotes" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIssueOfUnlistedSharesFromConversionOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughExerciseOfOptions" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughExerciseOfOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IncreaseDecreaseThroughOptionsForfeited" xlink:label="loc_MMAIncreaseDecreaseThroughOptionsForfeited" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIncreaseDecreaseThroughOptionsForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OverAllotmentOptionsLapsed" xlink:label="loc_MMAOverAllotmentOptionsLapsed" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAOverAllotmentOptionsLapsed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/StatementOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statement of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-fullStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProceedsFromTrainingParticipants" xlink:label="loc_MMAProceedsFromTrainingParticipants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_MMAProceedsFromTrainingParticipants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" xlink:label="loc_MMAReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_MMAReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-fullInterestPaidClassifiedAsOperatingActivities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_ifrs-fullInterestPaidClassifiedAsOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullPurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullProceedsFromGovernmentGrantsClassifiedAsInvestingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_BankGuaranteeDepositReceivedPaid" xlink:label="loc_MMABankGuaranteeDepositReceivedPaid" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_MMABankGuaranteeDepositReceivedPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures" xlink:label="loc_ifrs-fullProceedsFromIssueOfBondsNotesAndDebentures" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullProceedsFromIssueOfBondsNotesAndDebentures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-fullProceedsFromIssuingShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullProceedsFromIssuingShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CorporateInformation" xlink:title="995611 - Disclosure - Corporate information">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureCorporateInformationAbstract" xlink:label="loc_MMADisclosureCorporateInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfCorporateInformationExplanatory" xlink:label="loc_MMADisclosureOfCorporateInformationExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureCorporateInformationAbstract" xlink:to="loc_MMADisclosureOfCorporateInformationExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation" xlink:title="995612 - Disclosure - Material Accounting Policy Information">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfMaterialAccountingPolicyAbstract" xlink:label="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfMaterialAccountingPolicyInformationExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions" xlink:title="995613 - Disclosure - Critical accounting judgements, estimates and assumptions">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract" xlink:label="loc_MMADisclosureOfAccountingJudgementsAndEstimatesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfAccountingJudgementsAndEstimatesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfAccountingJudgementsAndEstimatesAbstract" xlink:to="loc_ifrs-fullDisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/OperatingSegments" xlink:title="995614 - Disclosure - Operating segments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEntitysReportableSegmentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsAbstract" xlink:to="loc_ifrs-fullDisclosureOfEntitysReportableSegmentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Revenue" xlink:title="995615 - Disclosure - Revenue">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromContractsWithCustomersAbstract" xlink:label="loc_MMARevenueFromContractsWithCustomersAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="loc_ifrs-fullDisclosureOfRevenueFromContractsWithCustomersExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_ifrs-fullDisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Expenses" xlink:title="995616 - Disclosure - Expenses">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfExpensesAbstract" xlink:label="loc_MMADisclosureOfExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfExpensesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfExpensesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_ifrs-fullDisclosureOfExpensesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IncomeTax" xlink:title="995617 - Disclosure - Income Tax">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-fullDisclosureOfIncomeTaxExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfIncomeTaxExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FairValueMeasurement" xlink:title="995618 - Disclosure - Fair value measurement">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CashAndCashEquivalents" xlink:title="995619 - Disclosure - Cash and cash equivalents">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfCashAndCashEquivalentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfCashAndCashEquivalentsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherReceivables" xlink:title="995620 - Disclosure - Trade and other receivables">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfTradeAndOtherReceivablesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTradeAndOtherReceivablesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/PropertyAndEquipment" xlink:title="995621 - Disclosure - Property and equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IntangibleAssets" xlink:title="995622 - Disclosure - Intangible assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsAbstract" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherPayables" xlink:title="995623 - Disclosure - Trade and other payables">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfTradeAndOtherPayablesAbstract" xlink:label="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfTradeAndOtherPayablesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" xlink:to="loc_ifrs-fullDisclosureOfTradeAndOtherPayablesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements" xlink:title="995624 - Disclosure - Current and Non-current Employee Entitlements">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" xlink:label="loc_MMADisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory" xlink:label="loc_MMADisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" xlink:to="loc_MMADisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/UnearnedRevenue" xlink:title="995625 - Disclosure - Unearned Revenue">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfUnearnedRevenueAbtract" xlink:label="loc_MMADisclosureOfUnearnedRevenueAbtract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfUnearnedRevenueExplanatory" xlink:label="loc_MMADisclosureOfUnearnedRevenueExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfUnearnedRevenueAbtract" xlink:to="loc_MMADisclosureOfUnearnedRevenueExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Reserves" xlink:title="995626 - Disclosure - Reserves">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfReservesAbstract" xlink:label="loc_MMADisclosureOfReservesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-fullDisclosureOfReservesAndOtherEquityInterestExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfReservesAbstract" xlink:to="loc_ifrs-fullDisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IssuedCapital" xlink:title="995627 - Disclosure - Issued capital">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:label="loc_ifrs-fullDisclosureOfIssuedCapitalExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfIssuedCapitalExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/NotesToStatementOfCashFlows" xlink:title="995628 - Disclosure - Notes to statement of cash flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:label="loc_ifrs-fullDisclosureOfCashFlowStatementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfCashFlowStatementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RelatedPartiesTransactions" xlink:title="995629 - Disclosure - Related parties transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-fullDisclosureOfRelatedPartyExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfRelatedPartyExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Leases" xlink:title="995630 - Disclosure - Leases">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfLeasesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfLeasesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialLiabilities" xlink:title="995631 - Disclosure - Financial Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Share-basedPayments" xlink:title="995632 - Disclosure - Share-based payments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfSharebasedPaymentArrangementsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialInstruments" xlink:title="995633 - Disclosure - Financial Instruments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RemunerationOfAuditors" xlink:title="995634 - Disclosure - Remuneration of auditors">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAuditorsRemunerationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfAuditorsRemunerationExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfAuditorsRemunerationExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities" xlink:title="995635 - Disclosure - Contingent Assets and Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Commitments" xlink:title="995636 - Disclosure - Commitments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfCommitmentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfCommitmentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/LossPerShare" xlink:title="995637 - Disclosure - Loss per share">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-fullIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-fullEarningsPerShareExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullEarningsPerShareExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/EventsAfterReportingPeriod" xlink:title="995638 - Disclosure - Events after the reporting period">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEventsAfterReportingPeriodExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies" xlink:title="995639 - Disclosure - Material Accounting Policy Information (Policies)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfMaterialAccountingPolicyAbstract" xlink:label="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory" xlink:label="loc_MMADescriptionOfAccountingPolicyForBasisOfPreparationExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_MMADescriptionOfAccountingPolicyForBasisOfPreparationExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory" xlink:label="loc_MMADescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_MMADescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForRecognitionOfRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForBorrowingsExplanatory" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForIssuedCapitalExplanatory" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForIncomeTaxExplanatory" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory" xlink:label="loc_MMADescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_MMADescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForLeasesExplanatory" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForEarningsPerShareExplanatory" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory" xlink:label="loc_MMADescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_MMADescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables" xlink:title="995640 - Disclosure - Material Accounting Policy Information (Tables)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfMaterialAccountingPolicyAbstract" xlink:label="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfPlantAndEquipmentExplanatory" xlink:label="loc_MMADisclosureOfPlantAndEquipmentExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_MMADisclosureOfPlantAndEquipmentExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RevenueTables" xlink:title="995641 - Disclosure - Revenue (Tables)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromContractsWithCustomersAbstract" xlink:label="loc_MMARevenueFromContractsWithCustomersAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfProductsAndServicesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_ifrs-fullDisclosureOfProductsAndServicesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ExpensesTables" xlink:title="995642 - Disclosure - Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfExpensesAbstract" xlink:label="loc_MMADisclosureOfExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory" xlink:label="loc_MMADisclosureOfDetailedInformationAboutExpensesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMADisclosureOfDetailedInformationAboutExpensesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IncomeTaxTables" xlink:title="995643 - Disclosure - Income Tax (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory" xlink:label="loc_MMADisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FairValueMeasurementTables" xlink:title="995644 - Disclosure - Fair value measurement (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDerivativeLiabilityExplanatory" xlink:label="loc_MMADisclosureOfDerivativeLiabilityExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADisclosureOfDerivativeLiabilityExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CashAndCashEquivalentsTables" xlink:title="995645 - Disclosure - Cash and cash equivalents (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfCashEquivalentsExplanatory" xlink:label="loc_MMADisclosureOfCashEquivalentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADisclosureOfCashEquivalentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherReceivablesTables" xlink:title="995646 - Disclosure - Trade and other receivables (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfTradeAndOtherReceivableExplanatory" xlink:label="loc_MMADisclosureOfTradeAndOtherReceivableExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADisclosureOfTradeAndOtherReceivableExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/PropertyAndEquipmentTables" xlink:title="995647 - Disclosure - Property and equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IntangibleAssetsTables" xlink:title="995648 - Disclosure - Intangible assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsAbstract" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory" xlink:label="loc_MMADisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsAbstract" xlink:to="loc_MMADisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/TradeAndOtherPayablesTables" xlink:title="995649 - Disclosure - Trade and other payables (Tables)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfTradeAndOtherPayablesAbstract" xlink:label="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables" xlink:label="loc_MMADisclosureOfDetailedInformationAboutTradeAndOtherPayables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" xlink:to="loc_MMADisclosureOfDetailedInformationAboutTradeAndOtherPayables" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlementsTables" xlink:title="995650 - Disclosure - Current and Non-current Employee Entitlements (Tables)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" xlink:label="loc_MMADisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory" xlink:label="loc_MMADisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" xlink:to="loc_MMADisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/UnearnedRevenueTables" xlink:title="995651 - Disclosure - Unearned Revenue (Tables)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfUnearnedRevenueAbtract" xlink:label="loc_MMADisclosureOfUnearnedRevenueAbtract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory" xlink:label="loc_MMADisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfUnearnedRevenueAbtract" xlink:to="loc_MMADisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ReservesTables" xlink:title="995652 - Disclosure - Reserves (Tables)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfReservesAbstract" xlink:label="loc_MMADisclosureOfReservesAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ScheduleOfReservesTableTextBlock" xlink:label="loc_MMAScheduleOfReservesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfReservesAbstract" xlink:to="loc_MMAScheduleOfReservesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IssuedCapitalTables" xlink:title="995653 - Disclosure - Issued capital (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory" xlink:label="loc_MMADisclosureOfDetailedInformationIssuedCapitalExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADisclosureOfDetailedInformationIssuedCapitalExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/NotesToStatementOfCashFlowsTables" xlink:title="995654 - Disclosure - Notes to statement of cash flows (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory" xlink:label="loc_MMADetailedInformationOfNotesToStatementOfCashFlowExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADetailedInformationOfNotesToStatementOfCashFlowExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables" xlink:title="995655 - Disclosure - Related parties transactions (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-fullDisclosureOfInformationAboutKeyManagementPersonnelExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:label="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/LeasesTables" xlink:title="995656 - Disclosure - Leases (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialLiabilitiesTables" xlink:title="995657 - Disclosure - Financial Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory" xlink:label="loc_MMADescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" xlink:to="loc_MMADescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfDebtSecuritiesExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" xlink:to="loc_ifrs-fullDisclosureOfDebtSecuritiesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Share-basedPaymentsTables" xlink:title="995658 - Disclosure - Share-based payments (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory" xlink:label="loc_MMADisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-fullDisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialInstrumentsTables" xlink:title="995659 - Disclosure - Financial Instruments (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullMaturityAnalysisForDerivativeFinancialLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullMaturityAnalysisForDerivativeFinancialLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RemunerationOfAuditorsTables" xlink:title="995660 - Disclosure - Remuneration of auditors (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory" xlink:label="loc_MMADisclosureOfInformationAboutRemunerationOfAuditorsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADisclosureOfInformationAboutRemunerationOfAuditorsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/LossPerShareTables" xlink:title="995661 - Disclosure - Loss per share (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-fullIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEarningsPerShareExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullDisclosureOfEarningsPerShareExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails" xlink:title="995662 - Disclosure - Schedule of plant and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfMaterialAccountingPolicyAbstract" xlink:label="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlantAndEquipmentMember" xlink:label="loc_MMAPlantAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_MMAPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-fullComputerEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-fullOfficeEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullFixturesAndFittingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative" xlink:title="995663 - Disclosure - Material Accounting Policy Information (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfMaterialAccountingPolicyAbstract" xlink:label="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfMaterialAccountingPolicyAbstract" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopmentMember" xlink:label="loc_ifrs-fullIntangibleAssetsUnderDevelopmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullIntangibleAssetsUnderDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative" xlink:title="995664 - Disclosure - Critical accounting judgements, estimates and assumptions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract" xlink:label="loc_MMADisclosureOfAccountingJudgementsAndEstimatesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfAccountingJudgementsAndEstimatesAbstract" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfAccountingJudgementsAndEstimatesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-fullNetAssetsLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfAccountingJudgementsAndEstimatesAbstract" xlink:to="loc_ifrs-fullNetAssetsLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-fullNetAssetsLiabilities_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfAccountingJudgementsAndEstimatesAbstract" xlink:to="loc_ifrs-fullNetAssetsLiabilities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsLiabilities" xlink:label="loc_ifrs-fullCurrentAssetsLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfAccountingJudgementsAndEstimatesAbstract" xlink:to="loc_ifrs-fullCurrentAssetsLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfRevenueDetails" xlink:title="995665 - Disclosure - Schedule of revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromContractsWithCustomersAbstract" xlink:label="loc_MMARevenueFromContractsWithCustomersAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromProgramFees" xlink:label="loc_MMARevenueFromProgramFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_MMARevenueFromProgramFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromContractualPaymentsToGyms" xlink:label="loc_MMARevenueFromContractualPaymentsToGyms" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_MMARevenueFromContractualPaymentsToGyms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-fullRevenueFromRenderingOfServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_ifrs-fullRevenueFromRenderingOfServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReserachAndDevelopmentIncome" xlink:label="loc_MMAReserachAndDevelopmentIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_MMAReserachAndDevelopmentIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FranchiseFeeIncome" xlink:label="loc_ifrs-fullFranchiseFeeIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_ifrs-fullFranchiseFeeIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-fullRevenueFromSaleOfGoods" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_ifrs-fullRevenueFromSaleOfGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-fullOtherRevenue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_ifrs-fullOtherRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:title="995666 - Disclosure - Schedule of disaggregation of revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromContractsWithCustomersAbstract" xlink:label="loc_MMARevenueFromContractsWithCustomersAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMARevenueFromContractsWithCustomersAbstract" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-fullProductsAndServicesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullProductsAndServicesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-fullProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OneMajorProductMember" xlink:label="loc_MMAOneMajorProductMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesDomain" xlink:to="loc_MMAOneMajorProductMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromProgramFees" xlink:label="loc_MMARevenueFromProgramFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARevenueFromProgramFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RevenueFromContractualPaymentsToGyms" xlink:label="loc_MMARevenueFromContractualPaymentsToGyms" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARevenueFromContractualPaymentsToGyms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-fullRevenueFromRenderingOfServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenueFromRenderingOfServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfExpensesDetails" xlink:title="995667 - Disclosure - Schedule of expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfExpensesAbstract" xlink:label="loc_MMADisclosureOfExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesEventCosts" xlink:label="loc_MMAProgramExpensesEventCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMAProgramExpensesEventCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesProgramCosts" xlink:label="loc_MMAProgramExpensesProgramCosts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMAProgramExpensesProgramCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesMerchantFees" xlink:label="loc_MMAProgramExpensesMerchantFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMAProgramExpensesMerchantFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpensesOtherCosts" xlink:label="loc_MMAProgramExpensesOtherCosts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMAProgramExpensesOtherCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProgramExpenses" xlink:label="loc_MMAProgramExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMAProgramExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective" xlink:label="loc_MMAFinanceCostsConvertibleNotesInterestContractualAndEffective" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMAFinanceCostsConvertibleNotesInterestContractualAndEffective" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FinanceCostsBankFees" xlink:label="loc_MMAFinanceCostsBankFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMAFinanceCostsBankFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FinanceCostsBankInterestAndLeaseInterest" xlink:label="loc_MMAFinanceCostsBankInterestAndLeaseInterest" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMAFinanceCostsBankInterestAndLeaseInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnrealizedCurrencyGains" xlink:label="loc_MMAUnrealizedCurrencyGains" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMAUnrealizedCurrencyGains" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RealizedCurrencyGainslosses" xlink:label="loc_MMARealizedCurrencyGainslosses" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_MMARealizedCurrencyGainslosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-fullNetForeignExchangeGain" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfExpensesAbstract" xlink:to="loc_ifrs-fullNetForeignExchangeGain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails" xlink:title="995668 - Disclosure - Schedule of Income Tax Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-fullDeferredTaxExpenseIncome" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDeferredTaxExpenseIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-fullCurrentTaxExpenseIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullCurrentTaxExpenseIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:label="loc_ifrs-fullDeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems" xlink:label="loc_MMADeferredTaxExpenseIncomeOtherNonAllowableItems" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADeferredTaxExpenseIncomeOtherNonAllowableItems" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" xlink:label="loc_MMADeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" xlink:label="loc_MMADeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" xlink:label="loc_MMADeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMADeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical" xlink:title="995669 - Disclosure - Schedule of Income Tax Expenses (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-fullApplicableTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullApplicableTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails" xlink:title="995670 - Disclosure - Schedule of Fair Value Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel1OfFairValueHierarchyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:to="loc_ifrs-fullLevel1OfFairValueHierarchyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel2OfFairValueHierarchyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:to="loc_ifrs-fullLevel2OfFairValueHierarchyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel3OfFairValueHierarchyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:to="loc_ifrs-fullLevel3OfFairValueHierarchyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-fullFinancialAssetsAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-fullFinancialAssetsAtFairValue_2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsAtFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtFairValue_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails" xlink:title="995671 - Disclosure - Schedule of Fair Value Measurement of Derivative Liability (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullDerivativeFinancialLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDerivativeFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" xlink:label="loc_MMAFairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAFairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability" xlink:label="loc_ifrs-fullChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueMovementRecognisedInProfitOrLoss" xlink:label="loc_MMAFairValueMovementRecognisedInProfitOrLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAFairValueMovementRecognisedInProfitOrLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:label="loc_ifrs-fullGainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullGainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:label="loc_MMAFairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAFairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:label="loc_MMAFairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAFairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullDerivativeFinancialLiabilities_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDerivativeFinancialLiabilities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullFinancialLiabilities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails" xlink:title="995672 - Disclosure - Schedule of Unobservable Inputs Level 3 Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="loc_ifrs-fullUnobservableInputsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullUnobservableInputsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnobservableInputsDomain" xlink:label="loc_ifrs-fullUnobservableInputsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullUnobservableInputsAxis" xlink:to="loc_ifrs-fullUnobservableInputsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ImpliedValuationMember" xlink:label="loc_MMAImpliedValuationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullUnobservableInputsDomain" xlink:to="loc_MMAImpliedValuationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember" xlink:label="loc_ifrs-fullHistoricalVolatilityForSharesMeasurementInputMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullUnobservableInputsDomain" xlink:to="loc_ifrs-fullHistoricalVolatilityForSharesMeasurementInputMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateMeasurementInputMember" xlink:label="loc_ifrs-fullInterestRateMeasurementInputMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullUnobservableInputsDomain" xlink:to="loc_ifrs-fullInterestRateMeasurementInputMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProbabilityOfDefaultMeasurementInputMember" xlink:label="loc_ifrs-fullProbabilityOfDefaultMeasurementInputMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullUnobservableInputsDomain" xlink:to="loc_ifrs-fullProbabilityOfDefaultMeasurementInputMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-fullComponentsOfEquityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullComponentsOfEquityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-fullComponentsOfEquityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullComponentsOfEquityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAConvertibleNotesMember" xlink:label="loc_MMASeriesAConvertibleNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesAConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAJuly21Member" xlink:label="loc_MMASeriesAJuly21Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesAJuly21Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAAugust21Member" xlink:label="loc_MMASeriesAAugust21Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesAAugust21Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesB1Member" xlink:label="loc_MMASeriesB1Member" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesB1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesB2Member" xlink:label="loc_MMASeriesB2Member" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesB2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAExtensionMember" xlink:label="loc_MMASeriesAExtensionMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASeriesAExtensionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachMember" xlink:label="loc_MMAReachMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMAReachMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PrivatePlacementsMember" xlink:label="loc_MMAPrivatePlacementsMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMAPrivatePlacementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MixedMartialArtsLLCMember" xlink:label="loc_MMAMixedMartialArtsLLCMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMAMixedMartialArtsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SteppenMember" xlink:label="loc_MMASteppenMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_MMASteppenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities" xlink:label="loc_ifrs-fullSignificantUnobservableInputLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullSignificantUnobservableInputLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:title="995673 - Disclosure - Schedule of Cash and Cash Equivalents (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashOnHand" xlink:label="loc_ifrs-fullCashOnHand" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullCashOnHand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BalancesWithBanks" xlink:label="loc_ifrs-fullBalancesWithBanks" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullBalancesWithBanks" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails" xlink:title="995674 - Disclosure - Schedule of Trade and Other Receivables (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullTradeReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:label="loc_ifrs-fullAccruedIncomeOtherThanContractAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAccruedIncomeOtherThanContractAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ResearchAndDevelopmentIncome" xlink:label="loc_MMAResearchAndDevelopmentIncome" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAResearchAndDevelopmentIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-fullOtherReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AllowancesForCreditLoss" xlink:label="loc_MMAAllowancesForCreditLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAAllowancesForCreditLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-fullTradeAndOtherReceivables" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullTradeAndOtherReceivables" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="995675 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlantAndEquipmentMember" xlink:label="loc_MMAPlantAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_MMAPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-fullComputerEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-fullOfficeEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FurnitrueAndFittingsMember" xlink:label="loc_MMAFurnitrueAndFittingsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_MMAFurnitrueAndFittingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PropertyPlantAndEquipmentCost" xlink:label="loc_MMAPropertyPlantAndEquipmentCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAPropertyPlantAndEquipmentCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PropertyPlantAndEquipmentAccumulatedDepreciation" xlink:label="loc_MMAPropertyPlantAndEquipmentAccumulatedDepreciation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAPropertyPlantAndEquipmentAccumulatedDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDisposalsAndRetirementsPropertyPlantAndEquipment" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisposalsAndRetirementsPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDepreciationPropertyPlantAndEquipment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDepreciationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDepreciationPropertyPlantAndEquipment_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDepreciationPropertyPlantAndEquipment_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment_3" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment_3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/IncomeTaxDetailsNarrative" xlink:title="995676 - Disclosure - Income Tax (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" xlink:label="loc_ifrs-fullDeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="995677 - Disclosure - Schedule of Intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsAbstract" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlatformDevelopmentMember" xlink:label="loc_MMAPlatformDevelopmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_MMAPlatformDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails" xlink:title="995678 - Disclosure - Schedule of Reconciliations of the Movement of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsAbstract" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PlatformDevelopmentMember" xlink:label="loc_MMAPlatformDevelopmentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_MMAPlatformDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-fullCounterpartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullCounterpartiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-fullCounterpartiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCounterpartiesAxis" xlink:to="loc_ifrs-fullCounterpartiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SteppenPtyLtdMember" xlink:label="loc_MMASteppenPtyLtdMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCounterpartiesDomain" xlink:to="loc_MMASteppenPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MixedMartialsArtsLLCMember" xlink:label="loc_MMAMixedMartialsArtsLLCMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCounterpartiesDomain" xlink:to="loc_MMAMixedMartialsArtsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_HypeKitIncMember" xlink:label="loc_MMAHypeKitIncMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCounterpartiesDomain" xlink:to="loc_MMAHypeKitIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdditionsFromInternalDevelopment" xlink:label="loc_MMAAdditionsFromInternalDevelopment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAAdditionsFromInternalDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ResearchDevelopmentTaxIncentive" xlink:label="loc_MMAResearchDevelopmentTaxIncentive" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAResearchDevelopmentTaxIncentive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-fullNotionalAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNotionalAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-fullCash" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails" xlink:title="995679 - Disclosure - Schedule of Trade and Other Payables (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfTradeAndOtherPayablesAbstract" xlink:label="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_TradeAndOtherPayablesPayableToMemberGyms" xlink:label="loc_MMATradeAndOtherPayablesPayableToMemberGyms" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" xlink:to="loc_MMATradeAndOtherPayablesPayableToMemberGyms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_TaxesPayable" xlink:label="loc_MMATaxesPayable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" xlink:to="loc_MMATaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_TradePayables" xlink:label="loc_MMATradePayables" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" xlink:to="loc_MMATradePayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ProvisionForRefundLiability" xlink:label="loc_MMAProvisionForRefundLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" xlink:to="loc_MMAProvisionForRefundLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPayables" xlink:label="loc_ifrs-fullOtherPayables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" xlink:to="loc_ifrs-fullOtherPayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-fullTradeAndOtherPayables" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfTradeAndOtherPayablesAbstract" xlink:to="loc_ifrs-fullTradeAndOtherPayables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails" xlink:title="995680 - Disclosure - Schedule of Current and Non-current Employee Entitlements (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" xlink:label="loc_MMADisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:label="loc_ifrs-fullCurrentProvisionsForEmployeeBenefits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" xlink:to="loc_ifrs-fullCurrentProvisionsForEmployeeBenefits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="loc_ifrs-fullNoncurrentProvisionsForEmployeeBenefits" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract" xlink:to="loc_ifrs-fullNoncurrentProvisionsForEmployeeBenefits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfUnearnedRevenueDetails" xlink:title="995681 - Disclosure - Schedule of Unearned Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfUnearnedRevenueAbtract" xlink:label="loc_MMADisclosureOfUnearnedRevenueAbtract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnearnedRevenue" xlink:label="loc_MMAUnearnedRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfUnearnedRevenueAbtract" xlink:to="loc_MMAUnearnedRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfReservesDetails" xlink:title="995682 - Disclosure - Schedule of Reserves (Details)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfReservesAbstract" xlink:label="loc_MMADisclosureOfReservesAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReserveOfUnbilledShareOption" xlink:label="loc_MMAReserveOfUnbilledShareOption" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfReservesAbstract" xlink:to="loc_MMAReserveOfUnbilledShareOption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-fullReserveOfSharebasedPayments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfReservesAbstract" xlink:to="loc_ifrs-fullReserveOfSharebasedPayments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ForeignCurrencyReserves" xlink:label="loc_MMAForeignCurrencyReserves" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfReservesAbstract" xlink:to="loc_MMAForeignCurrencyReserves" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails" xlink:title="995683 - Disclosure - Schedule of Issued Capital (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OwnersShareCapital" xlink:label="loc_MMAOwnersShareCapital" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAOwnersShareCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NumberOfShareIssuedAndFullyPaid" xlink:label="loc_MMANumberOfShareIssuedAndFullyPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMANumberOfShareIssuedAndFullyPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssueOfSharesFromConversionOfConvertibleNotes" xlink:label="loc_MMAIssueOfSharesFromConversionOfConvertibleNotes" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAIssueOfSharesFromConversionOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorOptionsExercisedShares" xlink:label="loc_MMAAdvisorOptionsExercisedShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAAdvisorOptionsExercisedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OwnersShareCapital" xlink:label="loc_MMAOwnersShareCapital_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAOwnersShareCapital_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssuedAndFullyPaidValue" xlink:label="loc_MMAIssuedAndFullyPaidValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAIssuedAndFullyPaidValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-fullPaymentsForShareIssueCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullPaymentsForShareIssueCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssueOfEquityFromConversionOfConvertibleNotes" xlink:label="loc_MMAIssueOfEquityFromConversionOfConvertibleNotes" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAIssueOfEquityFromConversionOfConvertibleNotes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorOptionsExercisedValue" xlink:label="loc_MMAAdvisorOptionsExercisedValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAAdvisorOptionsExercisedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullIssuedCapital_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical" xlink:title="995684 - Disclosure - Schedule of Issued Capital (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContractualCapitalisedInterestRate" xlink:label="loc_MMAContractualCapitalisedInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAContractualCapitalisedInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorOptionsExercisedShares" xlink:label="loc_MMAAdvisorOptionsExercisedShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAAdvisorOptionsExercisedShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorOptionsForfeitedShares" xlink:label="loc_MMAAdvisorOptionsForfeitedShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAAdvisorOptionsForfeitedShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails" xlink:title="995685 - Disclosure - Schedule of Statement of Cash Flows (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AccruedInterestOnConvertibleNotes" xlink:label="loc_MMAAccruedInterestOnConvertibleNotes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAAccruedInterestOnConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices" xlink:label="loc_MMAConvertibleNotesIssuedInLieuOfPaymentForServices" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAConvertibleNotesIssuedInLieuOfPaymentForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-fullDepreciationExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDepreciationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_FairValueMovementRecognisedInProfitOrLoss" xlink:label="loc_MMAFairValueMovementRecognisedInProfitOrLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAFairValueMovementRecognisedInProfitOrLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue" xlink:label="loc_MMAAdjustmentsForIncreaseDecreaseInNetDeferredRevenue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAAdjustmentsForIncreaseDecreaseInNetDeferredRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund" xlink:label="loc_MMAAdjustmentsForIncreaseDecreaseInProvisionForRefund" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAAdjustmentsForIncreaseDecreaseInProvisionForRefund" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails" xlink:title="995686 - Disclosure - Schedule of Key Management Personnel Remuneration (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationShorttermEmployeeBenefits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationPostemploymentBenefits" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationOtherLongtermBenefits" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationSharebasedPayment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationSharebasedPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails" xlink:title="995687 - Disclosure - Schedule of Shares Held by Key Management Personnel (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SharesHeldByKeyManagementPersonnelMember" xlink:label="loc_MMASharesHeldByKeyManagementPersonnelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_MMASharesHeldByKeyManagementPersonnelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OptionHeldByKeyManagementPersonnelMember" xlink:label="loc_MMAOptionHeldByKeyManagementPersonnelMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_MMAOptionHeldByKeyManagementPersonnelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-fullNumberOfSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssuedSharesHeldByKeyManagementPersonnel" xlink:label="loc_MMAIssuedSharesHeldByKeyManagementPersonnel" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIssuedSharesHeldByKeyManagementPersonnel" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RepurchasedSharesHeldByKeyManagementPersonnel" xlink:label="loc_MMARepurchasedSharesHeldByKeyManagementPersonnel" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARepurchasedSharesHeldByKeyManagementPersonnel" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ResignationOfKeyManagementPersonnelShares" xlink:label="loc_MMAResignationOfKeyManagementPersonnelShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAResignationOfKeyManagementPersonnelShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel" xlink:label="loc_MMAReverseShareSplitSharesHeldByKeyManagementPersonnel" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAReverseShareSplitSharesHeldByKeyManagementPersonnel" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-fullNumberOfSharesOutstanding_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IssuedOptionsHeldByKeyManagementPersonnel" xlink:label="loc_MMAIssuedOptionsHeldByKeyManagementPersonnel" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAIssuedOptionsHeldByKeyManagementPersonnel" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpiredOptionsHeldByKeyManagementPersonnel" xlink:label="loc_MMAExpiredOptionsHeldByKeyManagementPersonnel" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAExpiredOptionsHeldByKeyManagementPersonnel" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisedOptionsHeldByKeyManagementPersonnel" xlink:label="loc_MMAExercisedOptionsHeldByKeyManagementPersonnel" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAExercisedOptionsHeldByKeyManagementPersonnel" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel" xlink:label="loc_MMAReverseShareSplitOptionsHeldByKeyManagementPersonnel" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAReverseShareSplitOptionsHeldByKeyManagementPersonnel" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative" xlink:title="995688 - Disclosure - Related parties transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DisclosureOfRelatedPartiesTransactionsAbstract" xlink:label="loc_MMADisclosureOfRelatedPartiesTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementTable" xlink:label="loc_MMAIfrsStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMADisclosureOfRelatedPartiesTransactionsAbstract" xlink:to="loc_MMAIfrsStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrLangtonMember" xlink:label="loc_MMAMrLangtonMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_MMAMrLangtonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrWilliamsMember" xlink:label="loc_MMAMrWilliamsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_MMAMrWilliamsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrTaylorMember" xlink:label="loc_MMAMrTaylorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_MMAMrTaylorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrHartMember" xlink:label="loc_MMAMrHartMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_MMAMrHartMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SnowflowerHoldingsPtyLtdMember" xlink:label="loc_MMASnowflowerHoldingsPtyLtdMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_MMASnowflowerHoldingsPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ChampSevenPtyLtdMember" xlink:label="loc_MMAChampSevenPtyLtdMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_MMAChampSevenPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NalarooHoldingsPtyLtdMember" xlink:label="loc_MMANalarooHoldingsPtyLtdMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_MMANalarooHoldingsPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_JHartFamilyTrustAccountMember" xlink:label="loc_MMAJHartFamilyTrustAccountMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_MMAJHartFamilyTrustAccountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="loc_ifrs-fullTypesOfContractsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_ifrs-fullTypesOfContractsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfContractsDomain" xlink:label="loc_ifrs-fullTypesOfContractsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfContractsAxis" xlink:to="loc_ifrs-fullTypesOfContractsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_EmploymentAgreementMember" xlink:label="loc_MMAEmploymentAgreementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfContractsDomain" xlink:to="loc_MMAEmploymentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_EmployeementAgreementMember" xlink:label="loc_MMAEmployeementAgreementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfContractsDomain" xlink:to="loc_MMAEmployeementAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Mr.LangtonMember" xlink:label="loc_MMAMr.LangtonMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_MMAMr.LangtonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-fullCounterpartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementTable" xlink:to="loc_ifrs-fullCounterpartiesAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-fullCounterpartiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCounterpartiesAxis" xlink:to="loc_ifrs-fullCounterpartiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Mr.LangtonMember" xlink:label="loc_MMAMr.LangtonMember_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCounterpartiesDomain" xlink:to="loc_MMAMr.LangtonMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PercentageOfOrdinarySharesUnderVestAndExercisable" xlink:label="loc_MMAPercentageOfOrdinarySharesUnderVestAndExercisable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAPercentageOfOrdinarySharesUnderVestAndExercisable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-fullShorttermEmployeeBenefitsExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullShorttermEmployeeBenefitsExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails" xlink:title="995689 - Disclosure - Schedule of Financial Statement of the Parent Entity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParentMember" xlink:label="loc_ifrs-fullParentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_ifrs-fullParentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullComprehensiveIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-fullAssetsAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAssetsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-fullLiabilitiesAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-fullNetAssetsLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNetAssetsLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-fullEquityAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContributedEquity" xlink:label="loc_MMAContributedEquity" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAContributedEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves" xlink:label="loc_ifrs-fullOtherReserves" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherReserves" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullRetainedEarnings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails" xlink:title="995690 - Disclosure - Schedule of Country Incorporation Principal Place of Business (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:label="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-fullConsolidatedStructuredEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:to="loc_ifrs-fullConsolidatedStructuredEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesAxis" xlink:to="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorLLCMember" xlink:label="loc_MMAWimp2WarriorLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:to="loc_MMAWimp2WarriorLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorProductionsPtyLtdMember" xlink:label="loc_MMAWimp2WarriorProductionsPtyLtdMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:to="loc_MMAWimp2WarriorProductionsPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorDigitalPtyLtdMember" xlink:label="loc_MMAWimp2WarriorDigitalPtyLtdMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:to="loc_MMAWimp2WarriorDigitalPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Wimp2WarriorIrelandLimitedMember" xlink:label="loc_MMAWimp2WarriorIrelandLimitedMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:to="loc_MMAWimp2WarriorIrelandLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_HypeCoMember" xlink:label="loc_MMAHypeCoMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullConsolidatedStructuredEntitiesDomain" xlink:to="loc_MMAHypeCoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-fullGeographicalAreasAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInformationAboutConsolidatedStructuredEntitiesTable" xlink:to="loc_ifrs-fullGeographicalAreasAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-fullGeographicalAreasDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullGeographicalAreasAxis" xlink:to="loc_ifrs-fullGeographicalAreasDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnitedStatesOfAmericaCountryMember" xlink:label="loc_MMAUnitedStatesOfAmericaCountryMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullGeographicalAreasDomain" xlink:to="loc_MMAUnitedStatesOfAmericaCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AustraliaCountryMember" xlink:label="loc_MMAAustraliaCountryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullGeographicalAreasDomain" xlink:to="loc_MMAAustraliaCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AustraliaCountryOneMember" xlink:label="loc_MMAAustraliaCountryOneMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullGeographicalAreasDomain" xlink:to="loc_MMAAustraliaCountryOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IrelandCountryMember" xlink:label="loc_MMAIrelandCountryMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullGeographicalAreasDomain" xlink:to="loc_MMAIrelandCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_UnitedStatesOfAmericaCountryOneMember" xlink:label="loc_MMAUnitedStatesOfAmericaCountryOneMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullGeographicalAreasDomain" xlink:to="loc_MMAUnitedStatesOfAmericaCountryOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NameOfParentEntity" xlink:label="loc_ifrs-fullNameOfParentEntity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNameOfParentEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PrincipalPlaceOfBusiness" xlink:label="loc_ifrs-fullPrincipalPlaceOfBusiness" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullPrincipalPlaceOfBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails" xlink:title="995691 - Disclosure - Summary of Changes in ROU Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AmortizationMember" xlink:label="loc_MMAAmortizationMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_MMAAmortizationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RightofuseAsset" xlink:label="loc_MMARightofuseAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARightofuseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AccumulatedAmortization" xlink:label="loc_MMAAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RightofuseAsset" xlink:label="loc_MMARightofuseAsset_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARightofuseAsset_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_Modification" xlink:label="loc_MMAModification" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAModification" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails" xlink:title="995692 - Disclosure - Summary of Future Minimum Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-fullNotLaterThanOneYearMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullNotLaterThanOneYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanTwoYearsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanFiveYearsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-fullGrossLeaseLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullGrossLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails" xlink:title="995693 - Disclosure - Schedule of Financial Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" xlink:to="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConvertibleInstrumentsMember" xlink:label="loc_ifrs-fullConvertibleInstrumentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_ifrs-fullConvertibleInstrumentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued" xlink:label="loc_ifrs-fullCurrentDebtInstrumentsIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentDebtInstrumentsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDebtInstrumentsIssued" xlink:label="loc_ifrs-fullNoncurrentDebtInstrumentsIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentDebtInstrumentsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentDerivativeFinancialLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentDerivativeFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentDerivativeFinancialLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentDerivativeFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DebtSecurities" xlink:label="loc_ifrs-fullDebtSecurities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDebtSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails" xlink:title="995694 - Disclosure - Schedule of Convertible Notes held by Investors (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-fullBorrowingsByNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullBorrowingsByNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-fullBorrowingsByNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameAxis" xlink:to="loc_ifrs-fullBorrowingsByNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAConvertibleNotesMember" xlink:label="loc_MMASeriesAConvertibleNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesAConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAJulyTwentyOneConvertibleNotesMember" xlink:label="loc_MMASeriesAJulyTwentyOneConvertibleNotesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesAJulyTwentyOneConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAAugustTwentyOneConvertibleNotesMember" xlink:label="loc_MMASeriesAAugustTwentyOneConvertibleNotesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesAAugustTwentyOneConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesBOneConvertibleNotesMember" xlink:label="loc_MMASeriesBOneConvertibleNotesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesBOneConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesB2ConvertibleNotesMember" xlink:label="loc_MMASeriesB2ConvertibleNotesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesB2ConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SeriesAExtensionConvertibleNotesMember" xlink:label="loc_MMASeriesAExtensionConvertibleNotesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASeriesAExtensionConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachConvertibleNotesMember" xlink:label="loc_MMAReachConvertibleNotesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMAReachConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PrivatePlacementConvertibleNotesMember" xlink:label="loc_MMAPrivatePlacementConvertibleNotesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMAPrivatePlacementConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MixedMartialArtsLLCConvertibleNotesMember" xlink:label="loc_MMAMixedMartialArtsLLCConvertibleNotesMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMAMixedMartialArtsLLCConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_SteppenConvertibleNotesMember" xlink:label="loc_MMASteppenConvertibleNotesMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameDomain" xlink:to="loc_MMASteppenConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesIssueDate" xlink:label="loc_MMAConvertibleNotesIssueDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesIssueDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesPreModificationMaturityDate" xlink:label="loc_MMAConvertibleNotesPreModificationMaturityDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesPreModificationMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesModificationDate" xlink:label="loc_MMAConvertibleNotesModificationDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesModificationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesModifiedMaturityDate" xlink:label="loc_MMAConvertibleNotesModifiedMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesModifiedMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesConversionDate" xlink:label="loc_MMAConvertibleNotesConversionDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesConversionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesTerm" xlink:label="loc_MMAConvertibleNotesTerm" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-fullBorrowings" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-fullBorrowingsInterestRate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ConvertibleNotesConversionDiscount" xlink:label="loc_MMAConvertibleNotesConversionDiscount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAConvertibleNotesConversionDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachConvertibleNote" xlink:label="loc_MMAReachConvertibleNote" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAReachConvertibleNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_RedeemedForCash" xlink:label="loc_MMARedeemedForCash" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMARedeemedForCash" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/FinancialLiabilitiesDetailsNarrative" xlink:title="995695 - Disclosure - Financial Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfConversionOfDebtToEquity" xlink:label="loc_ifrs-fullDescriptionOfConversionOfDebtToEquity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" xlink:to="loc_ifrs-fullDescriptionOfConversionOfDebtToEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails" xlink:title="995696 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" xlink:label="loc_MMAExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromAdvisorOptions" xlink:label="loc_MMAExpenseFromAdvisorOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAExpenseFromAdvisorOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromReach" xlink:label="loc_MMAExpenseFromReach" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAExpenseFromReach" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromWarrants" xlink:label="loc_MMAExpenseFromWarrants" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAExpenseFromWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromOverAllotmentOption" xlink:label="loc_MMAExpenseFromOverAllotmentOption" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAExpenseFromOverAllotmentOption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpenseFromRestrictedShareUnits" xlink:label="loc_MMAExpenseFromRestrictedShareUnits" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAExpenseFromRestrictedShareUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-fullAdjustmentsForSharebasedPayments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdjustmentsForSharebasedPayments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical" xlink:title="995697 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullNumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullNumberOfSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_PricePerShareEqualPercentage" xlink:label="loc_MMAPricePerShareEqualPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAPricePerShareEqualPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails" xlink:title="995698 - Disclosure - Schedule of Share Options Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOptionsMember" xlink:label="loc_ifrs-fullShareOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_ifrs-fullShareOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorMember" xlink:label="loc_MMAAdvisorMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_MMAAdvisorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachMember" xlink:label="loc_MMAReachMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_MMAReachMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestrictedShareUnitsMember" xlink:label="loc_ifrs-fullRestrictedShareUnitsMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_ifrs-fullRestrictedShareUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_OverAllotmentOptionsMember" xlink:label="loc_MMAOverAllotmentOptionsMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_MMAOverAllotmentOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantsMember" xlink:label="loc_ifrs-fullWarrantsMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsDomain" xlink:to="loc_ifrs-fullWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails" xlink:title="995699 - Disclosure - Schedule of Model Inputs For Options Granted (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_EmployeeStockOwnershipPlanMember" xlink:label="loc_MMAEmployeeStockOwnershipPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_MMAEmployeeStockOwnershipPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AdvisorMember" xlink:label="loc_MMAAdvisorMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_MMAAdvisorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ReachMember" xlink:label="loc_MMAReachMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_MMAReachMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestrictedShareUnitsMember" xlink:label="loc_ifrs-fullRestrictedShareUnitsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_ifrs-fullRestrictedShareUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantsMember" xlink:label="loc_ifrs-fullWarrantsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_ifrs-fullWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:label="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesOneMember" xlink:label="loc_MMAExercisePricesOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="loc_MMAExercisePricesOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesTwoMember" xlink:label="loc_MMAExercisePricesTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="loc_MMAExercisePricesTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesThreeMember" xlink:label="loc_MMAExercisePricesThreeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="loc_MMAExercisePricesThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExercisePricesFourMember" xlink:label="loc_MMAExercisePricesFourMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="loc_MMAExercisePricesFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-fullExercisePriceShareOptionsGranted2019" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullExercisePriceShareOptionsGranted2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ExpectedTermShareOptionsGranted" xlink:label="loc_MMAExpectedTermShareOptionsGranted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAExpectedTermShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" xlink:title="995700 - Disclosure - Schedule of Contractual Maturities of Financial Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-fullNotLaterThanOneYearMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullNotLaterThanOneYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_BetweenOneAndTwoYearsMember" xlink:label="loc_MMABetweenOneAndTwoYearsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_MMABetweenOneAndTwoYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_BetweenTwoAndFiveYearsMember" xlink:label="loc_MMABetweenTwoAndFiveYearsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_MMABetweenTwoAndFiveYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NonInterestBearingTradeAndOtherPayables" xlink:label="loc_MMANonInterestBearingTradeAndOtherPayables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMANonInterestBearingTradeAndOtherPayables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_WeightedAverageInterestRateFinancialLiability" xlink:label="loc_MMAWeightedAverageInterestRateFinancialLiability" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAWeightedAverageInterestRateFinancialLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_InterestBearingFinancialLiabilities" xlink:label="loc_MMAInterestBearingFinancialLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAInterestBearingFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_WeightedAverageInterestRateLeaseLiabilities" xlink:label="loc_MMAWeightedAverageInterestRateLeaseLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAWeightedAverageInterestRateLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_InterestBearingLeaseLiabilities" xlink:label="loc_MMAInterestBearingLeaseLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAInterestBearingLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_InterestBearingNonderivativesNet" xlink:label="loc_MMAInterestBearingNonderivativesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMAInterestBearingNonderivativesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-fullDerivativeFinancialLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDerivativeFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_DerivativeNet" xlink:label="loc_MMADerivativeNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_MMADerivativeNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails" xlink:title="995701 - Disclosure - Schedule of Auditor of Company And Network Firms (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AuditFees" xlink:label="loc_MMAAuditFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAAuditFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_AuditorsRemunerationForRelatedFees" xlink:label="loc_MMAAuditorsRemunerationForRelatedFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAAuditorsRemunerationForRelatedFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForTaxServices" xlink:label="loc_ifrs-fullAuditorsRemunerationForTaxServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAuditorsRemunerationForTaxServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices" xlink:label="loc_ifrs-fullAuditorsRemunerationForOtherServices" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAuditorsRemunerationForOtherServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemuneration" xlink:label="loc_ifrs-fullAuditorsRemuneration" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAuditorsRemuneration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative" xlink:title="995702 - Disclosure - Share-based payments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-fullExercisePriceShareOptionsGranted2019" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullExercisePriceShareOptionsGranted2019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ContingentAssetsAndLiabilitiesDetailsNarrative" xlink:title="995703 - Disclosure - Contingent Assets and Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_ContingentAssetsAndLiabilities" xlink:label="loc_MMAContingentAssetsAndLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_MMAContingentAssetsAndLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails" xlink:title="995704 - Disclosure - Schedule of Loss Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-fullIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-fullWeightedAverageShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullWeightedAverageShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-fullAdjustedWeightedAverageShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullAdjustedWeightedAverageShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-fullBasicEarningsLossPerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullBasicEarningsLossPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-fullDilutedEarningsLossPerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullDilutedEarningsLossPerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative" xlink:title="995705 - Disclosure - Events after the reporting period (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_IfrsStatementLineItems" xlink:label="loc_MMAIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="loc_MMAIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" xlink:to="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_NonadjustingEventMember" xlink:label="loc_MMANonadjustingEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" xlink:to="loc_MMANonadjustingEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-fullCounterpartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="loc_ifrs-fullCounterpartiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-fullCounterpartiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCounterpartiesAxis" xlink:to="loc_ifrs-fullCounterpartiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mma-20240630.xsd#MMA_MrMcGregorMember" xlink:label="loc_MMAMrMcGregorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCounterpartiesDomain" xlink:to="loc_MMAMrMcGregorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:label="loc_ifrs-fullDescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_MMAIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321015984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALTA
GLOBAL GROUP LIMITED<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001981519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">C3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Level
1, Suite 1,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">29-33 The Corso<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Manly<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary
    Shares, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MMA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">10,282,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">2256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">BDO Audit Pty Ltd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Sydney,
Australia<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Level
1, Suite 1,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">29-33 The Corso<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Manly<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1800 151 865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Nick
Langton<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321957008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Profit or Loss and Other Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RevenueFromProgramFees', window );">Revenue from Program Fees</a></td>
<td class="nump">$ 929,319<span></span>
</td>
<td class="nump">$ 937,415<span></span>
</td>
<td class="nump">$ 2,050,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ContractualPaymentsToGyms', window );">Less: Contractual payments to gyms</a></td>
<td class="num">(537,012)<span></span>
</td>
<td class="num">(574,025)<span></span>
</td>
<td class="num">(1,215,191)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_NetRevenueFromProgramFees', window );">Net Revenue from Program Fees</a></td>
<td class="nump">392,307<span></span>
</td>
<td class="nump">363,390<span></span>
</td>
<td class="nump">834,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other Income</a></td>
<td class="nump">170,005<span></span>
</td>
<td class="nump">1,173,421<span></span>
</td>
<td class="nump">105,950<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total Revenue</a></td>
<td class="nump">562,312<span></span>
</td>
<td class="nump">1,536,811<span></span>
</td>
<td class="nump">940,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ProgramExpenses', window );">Program Expenses</a></td>
<td class="nump">160,578<span></span>
</td>
<td class="nump">229,848<span></span>
</td>
<td class="nump">342,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Employee salaries and benefits</a></td>
<td class="nump">5,504,592<span></span>
</td>
<td class="nump">4,219,655<span></span>
</td>
<td class="nump">4,664,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share Based Payments</a></td>
<td class="nump">4,521,598<span></span>
</td>
<td class="nump">2,365,384<span></span>
</td>
<td class="nump">1,546,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdvertisingExpense', window );">Advertising fees</a></td>
<td class="nump">613,348<span></span>
</td>
<td class="nump">721,713<span></span>
</td>
<td class="nump">3,615,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="nump">1,790,344<span></span>
</td>
<td class="nump">864,419<span></span>
</td>
<td class="nump">685,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RentExpenses', window );">Rent</a></td>
<td class="nump">11,169<span></span>
</td>
<td class="nump">11,793<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ITCosts', window );">IT costs</a></td>
<td class="nump">566,709<span></span>
</td>
<td class="nump">633,220<span></span>
</td>
<td class="nump">640,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">520,697<span></span>
</td>
<td class="nump">360,021<span></span>
</td>
<td class="nump">260,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Net foreign exchange gain</a></td>
<td class="num">(146,543)<span></span>
</td>
<td class="num">(47,359)<span></span>
</td>
<td class="num">(26,079)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance costs</a></td>
<td class="nump">3,262,927<span></span>
</td>
<td class="nump">4,472,730<span></span>
</td>
<td class="nump">2,191,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByNature', window );">Other expenses</a></td>
<td class="nump">1,565,924<span></span>
</td>
<td class="nump">1,432,094<span></span>
</td>
<td class="nump">965,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_FairValueMovementInDerivativeLiability', window );">Fair Value movement in derivative liability</a></td>
<td class="num">(3,400,685)<span></span>
</td>
<td class="nump">6,870,729<span></span>
</td>
<td class="num">(2,751,564)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total Expenses</a></td>
<td class="nump">14,970,658<span></span>
</td>
<td class="nump">22,134,247<span></span>
</td>
<td class="nump">12,138,253<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before income tax expense</a></td>
<td class="num">(14,408,346)<span></span>
</td>
<td class="num">(20,597,436)<span></span>
</td>
<td class="num">(11,197,450)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss after income tax expense for the period</a></td>
<td class="num">(14,408,346)<span></span>
</td>
<td class="num">(20,597,436)<span></span>
</td>
<td class="num">(11,197,450)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(20,710)<span></span>
</td>
<td class="num">(36,465)<span></span>
</td>
<td class="num">(31,312)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the period attributable to Alta Global Group Limited</a></td>
<td class="num">$ (14,429,056)<span></span>
</td>
<td class="num">$ (20,633,901)<span></span>
</td>
<td class="num">$ (11,228,762)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per share</a></td>
<td class="num">$ (1.40)<span></span>
</td>
<td class="num">$ (5.26)<span></span>
</td>
<td class="num">$ (2.86)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share</a></td>
<td class="num">$ (1.40)<span></span>
</td>
<td class="num">$ (5.26)<span></span>
</td>
<td class="num">$ (2.86)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ContractualPaymentsToGyms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual payments to gyms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ContractualPaymentsToGyms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_FairValueMovementInDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value movement in derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_FairValueMovementInDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ITCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IT costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ITCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_NetRevenueFromProgramFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net revenue from program fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_NetRevenueFromProgramFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ProgramExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Program expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ProgramExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rent expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RevenueFromProgramFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from program fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RevenueFromProgramFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2024-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 9<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321838832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Financial Position - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,544,837<span></span>
</td>
<td class="nump">$ 3,702,567<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="nump">71,115<span></span>
</td>
<td class="nump">2,365,638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Other assets</a></td>
<td class="nump">7,840<span></span>
</td>
<td class="nump">33,641<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">3,623,792<span></span>
</td>
<td class="nump">6,101,846<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, Plant and Equipment</a></td>
<td class="nump">77,698<span></span>
</td>
<td class="nump">94,928<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use asset</a></td>
<td class="nump">255,463<span></span>
</td>
<td class="nump">157,540<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">1,297,263<span></span>
</td>
<td class="nump">811,361<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other Assets</a></td>
<td class="nump">65,109<span></span>
</td>
<td class="nump">65,110<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">1,695,533<span></span>
</td>
<td class="nump">1,128,939<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">5,319,325<span></span>
</td>
<td class="nump">7,230,785<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="nump">1,991,536<span></span>
</td>
<td class="nump">2,034,436<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_UnearnedRevenue', window );">Unearned revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">174,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisionsForEmployeeBenefits', window );">Current Employee Entitlements</a></td>
<td class="nump">454,342<span></span>
</td>
<td class="nump">357,227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current Financial Liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">25,331,307<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current Lease Liability</a></td>
<td class="nump">128,559<span></span>
</td>
<td class="nump">121,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">2,574,437<span></span>
</td>
<td class="nump">28,018,760<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current Financial Liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,273,278<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisionsForEmployeeBenefits', window );">Non-current Employee Entitlements</a></td>
<td class="nump">55,622<span></span>
</td>
<td class="nump">18,892<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current Lease Liability</a></td>
<td class="nump">130,722<span></span>
</td>
<td class="nump">54,162<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">186,344<span></span>
</td>
<td class="nump">10,346,332<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,760,781<span></span>
</td>
<td class="nump">38,365,092<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Net assets/(liabilities)</a></td>
<td class="nump">2,558,544<span></span>
</td>
<td class="num">(31,134,307)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued Capital</a></td>
<td class="nump">46,779,703<span></span>
</td>
<td class="nump">3,385,281<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfSharebasedPayments', window );">Share-based payment reserve</a></td>
<td class="nump">5,734,601<span></span>
</td>
<td class="nump">3,912,367<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_UnlistedOptionsReserve', window );">Unlisted options reserve</a></td>
<td class="nump">2,741,457<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Foreign currency translation reserve</a></td>
<td class="num">(86,542)<span></span>
</td>
<td class="num">(65,832)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccumulatedOtherComprehensiveIncome', window );">Accumulated losses</a></td>
<td class="num">(52,610,675)<span></span>
</td>
<td class="num">(38,366,123)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity/(deficit)</a></td>
<td class="nump">$ 2,558,544<span></span>
</td>
<td class="num">$ (31,134,307)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
                                            January 24, 2024, there was a reverse share split of our issued and outstanding Ordinary
                                            Shares and Ordinary Share equivalents on the basis of four (4) securities for every five
                                            (5) securities held. All issued and outstanding Ordinary Shares and Ordinary Share equivalents
                                            and per share data have been adjusted throughout the financial statements to reflect the
                                            reverse share split for all periods presented.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_UnearnedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_UnearnedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_UnlistedOptionsReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unlisted options reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_UnlistedOptionsReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccumulatedOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccumulatedOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph IG63<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG63&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2024-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity resulting from share-based payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318367248">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Issued capital [member]</div></th>
<th class="th"><div>Unlisted option reserve [member]</div></th>
<th class="th"><div>Reserve of share-based payments [member]</div></th>
<th class="th"><div>Reserve of exchange differences on translation [member]</div></th>
<th class="th"><div>Accumulated other comprehensive income [member]</div></th>
<th class="th" colspan="2"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Opening balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,385,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,945<span></span>
</td>
<td class="num">$ (6,571,237)<span></span>
</td>
<td class="num">$ (3,184,011)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss after tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(11,197,450)<span></span>
</td>
<td class="num">(11,197,450)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(31,312)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(31,312)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(31,312)<span></span>
</td>
<td class="num">(11,197,450)<span></span>
</td>
<td class="num">(11,228,762)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments (see Note 22)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,546,983<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,546,983<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IssueOfEquityFromConversionOfConvertibleNotes', window );">Issue of Shares from conversion of convertible notes (see Note 17)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Closing balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,385,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,546,983<span></span>
</td>
<td class="num">(29,367)<span></span>
</td>
<td class="num">(17,768,687)<span></span>
</td>
<td class="num">(12,865,790)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss after tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(20,597,436)<span></span>
</td>
<td class="num">(20,597,436)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(36,465)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(36,465)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(36,465)<span></span>
</td>
<td class="num">(20,597,436)<span></span>
</td>
<td class="num">(20,633,901)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments (see Note 22)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,365,384<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,365,384<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IssueOfEquityFromConversionOfConvertibleNotes', window );">Issue of Shares from conversion of convertible notes (see Note 17)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Closing balance at Jun. 30, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,385,281<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,912,367<span></span>
</td>
<td class="num">(65,832)<span></span>
</td>
<td class="num">(38,366,123)<span></span>
</td>
<td class="num">(31,134,307)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss after tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(14,408,346)<span></span>
</td>
<td class="num">(14,408,346)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(20,710)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(20,710)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(20,710)<span></span>
</td>
<td class="num">(14,408,346)<span></span>
</td>
<td class="num">(14,429,056)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments (see Note 22)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,521,598<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,521,598<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issued of Shares fully paid net of Transaction cost (see Note 17)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,789,914<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,789,914<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IssueOfEquityFromConversionOfConvertibleNotes', window );">Issue of Shares from conversion of convertible notes (see Note 17)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32,177,751<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">32,177,751<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes', window );">Issue of Unlisted Shares from conversion of convertible notes (see Note 17)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,741,457<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,741,457<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Advisor options exercised (see Note 17)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,426,757<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,426,757)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IncreaseDecreaseThroughOptionsForfeited', window );">Advisor options forfeited (see Note 22)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(108,813)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(108,813)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_OverAllotmentOptionsLapsed', window );">Over allotment options lapsed (see Note 22)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(163,794)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">163,794<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Closing balance at Jun. 30, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 46,779,703<span></span>
</td>
<td class="nump">$ 2,741,457<span></span>
</td>
<td class="nump">$ 5,734,601<span></span>
</td>
<td class="num">$ (86,542)<span></span>
</td>
<td class="num">$ (52,610,675)<span></span>
</td>
<td class="nump">$ 2,558,544<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The
                                            issue of shares from the conversion of convertible notes reflects and includes the face value
                                            of the note and interest accrued at a fixed rate defined in the agreements, along with the
                                            value of the derivative prior to conversion. This interest figure includes both the accrued
                                            interest rate (contractual and effective) relating to the convertible notes, with the contractual
                                            capitalised interest rate ranging between <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLfugi4sxe0j" title="Contractual capitalised interest rate">8.5</span>% to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_za6aLsj3gMFg" title="Contractual capitalised interest rate">15</span>% per annum, and the derivative reflects the effective interest rate being the cost of the relevant conversion discounts to market value at
the conversion date.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IncreaseDecreaseThroughOptionsForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease through options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IncreaseDecreaseThroughOptionsForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IssueOfEquityFromConversionOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of equity from conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IssueOfEquityFromConversionOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of unlisted shares from conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_OverAllotmentOptionsLapsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Over allotment options lapsed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_OverAllotmentOptionsLapsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550317829520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ProceedsFromTrainingParticipants', window );">Receipts from training participants (inclusive of GST)</a></td>
<td class="nump">$ 1,453,848<span></span>
</td>
<td class="nump">$ 1,493,676<span></span>
</td>
<td class="nump">$ 2,004,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Payments to member gyms, suppliers &amp; employees (inclusive of GST)</a></td>
<td class="num">(10,848,391)<span></span>
</td>
<td class="num">(8,106,683)<span></span>
</td>
<td class="num">(10,136,314)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure', window );">Receipts from Government grants and tax incentives related to expenditure</a></td>
<td class="nump">63,776<span></span>
</td>
<td class="nump">1,109,645<span></span>
</td>
<td class="nump">105,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities', window );">Interest and other finance costs paid</a></td>
<td class="num">(55,429)<span></span>
</td>
<td class="num">(52,506)<span></span>
</td>
<td class="num">(29,157)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(9,386,196)<span></span>
</td>
<td class="num">(5,555,868)<span></span>
</td>
<td class="num">(8,055,185)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Payments for property equipment, net of disposal</a></td>
<td class="num">(18,635)<span></span>
</td>
<td class="num">(14,796)<span></span>
</td>
<td class="num">(59,429)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Payments for intangible assets</a></td>
<td class="num">(205,039)<span></span>
</td>
<td class="num">(352,181)<span></span>
</td>
<td class="num">(1,043,468)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities', window );">Receipt from Government grants and tax incentives related to assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">383,936<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_BankGuaranteeDepositReceivedPaid', window );">Bank guarantee deposit received/(paid)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">52,714<span></span>
</td>
<td class="num">(62,823)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash (used in)/from investing activities</a></td>
<td class="num">(223,674)<span></span>
</td>
<td class="nump">69,673<span></span>
</td>
<td class="num">(1,165,720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures', window );">Proceeds from convertible notes, net of transaction costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,655,252<span></span>
</td>
<td class="nump">5,679,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issue of equity, net of transaction costs</a></td>
<td class="nump">9,472,851<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash from financing activities</a></td>
<td class="nump">9,472,851<span></span>
</td>
<td class="nump">8,655,252<span></span>
</td>
<td class="nump">5,679,651<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net (decrease) /increase in cash and cash equivalents</a></td>
<td class="num">(137,019)<span></span>
</td>
<td class="nump">3,169,057<span></span>
</td>
<td class="num">(3,541,254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at the beginning of the financial period</a></td>
<td class="nump">3,702,567<span></span>
</td>
<td class="nump">569,975<span></span>
</td>
<td class="nump">4,142,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(20,710)<span></span>
</td>
<td class="num">(36,465)<span></span>
</td>
<td class="num">(31,312)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at the end of the financial period</a></td>
<td class="nump">$ 3,544,837<span></span>
</td>
<td class="nump">$ 3,702,567<span></span>
</td>
<td class="nump">$ 569,975<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_BankGuaranteeDepositReceivedPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Bank guarantee deposit received/(paid).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_BankGuaranteeDepositReceivedPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ProceedsFromTrainingParticipants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receipts from training participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ProceedsFromTrainingParticipants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receipts from government grants and tax incentives related to expenditure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to suppliers for goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 14<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_14_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToSuppliersForGoodsAndServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from government grants, classified as investing activities. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of bonds, notes and debentures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319665680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureCorporateInformationAbstract', window );"><strong>Corporate Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfCorporateInformationExplanatory', window );">Corporate information</a></td>
<td class="text"><p id="xdx_802_ecustom--DisclosureOfCorporateInformationExplanatory_zKvUq3Clw8ac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fin_005"></span>Note
1. <span id="xdx_82C_z2zVPpVWW9d4">Corporate information</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alta
Global Group Limited (the &#8220;Company&#8221; or the &#8220;Parent Entity&#8221;) was incorporated and is domiciled in Australia. The
Company changed its registered name from Wimp 2 Warrior Limited to Alta Global Group Limited on 2 February 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, an Australian company, is listed solely on NYSE American and is governed by the rules of the NYSE American and the U.S. Securities
and Exchange Commission. For purposes of U.S. securities law, the Company is a &#8220;foreign private issuer&#8221; (FPI). In addition,
the Company qualifies as an &#8220;emerging growth company&#8221; for U.S. securities law purposes. The Company is a for-profit Australian
unlisted public company limited by shares with a principal place of business at Level 1, Suite 1, 29-33 The Corso, Manly, New South Wales
2095.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureCorporateInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureCorporateInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfCorporateInformationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of corporate information explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfCorporateInformationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321693216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Accounting Policy Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfMaterialAccountingPolicyAbstract', window );"><strong>Material Accounting Policy Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory', window );">Material Accounting Policy Information</a></td>
<td class="text"><p id="xdx_80F_eifrs-full--DisclosureOfMaterialAccountingPolicyInformationExplanatory_zVZKIqpaNDYi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
2. <span id="xdx_82C_zCWmDwl6Zsa2">Material Accounting Policy Information</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting policies that are material to the consolidated entity are set out below. These policies have been consistently applied to
all the periods presented, unless otherwise stated. The consolidated financial statements are presented in AUD, which is also the Company&#8217;s
functional currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zLWoyHT7f1h4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_z5EOTOYkseMa">Basis
of preparation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Statement
of compliance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements have been prepared in accordance with International Financial Reporting Standards and International Accounting Standards
as issued by the International Accounting Standards Board (IASB) and Interpretations (collectively IFRSs).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in compliance with adopted IFRS Accounting Standards requires the use of certain critical accounting
estimates. It also requires Company management to exercise judgment in applying the Company&#8217;s accounting policies. The areas where
significant judgments and estimates have been made in preparing the financial statements and their effect are disclosed in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of measurement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on the basis of historical cost, except for the measurement at fair value of selected financial
assets and financial liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principles
of consolidation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements incorporate all the assets, liabilities and results of the Company and all the subsidiary companies
and other interests it controlled during the period. The Company controls an entity when it is exposed to, or has the rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power over the entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets, liabilities and results of its subsidiaries are fully consolidated into the consolidated financial statements from the date which
control is obtained. The consolidation of a subsidiary is discontinued from the date that control ceases. Intercompany transactions,
balances and unrealised gains or losses on transactions between Company entities are fully eliminated on consolidation. Accounting policies
of subsidiaries have been changed and adjustments made where necessary to ensure uniformity of the accounting policies of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
segments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
segments are presented using the &#8216;management approach&#8217;, where the information presented is on the same basis as the internal
reports provided to the Chief Operating Decision Makers (&#8220;CODM&#8221;). The CODM is responsible for the allocation of resources
to operating segments and assessing their performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
currency translation</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements are presented in Australian dollars, which is the Company&#8217;s functional and presentation currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign
currency transactions</b></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
currency transactions are translated into Australian dollars using the exchange rates prevailing at the dates of the transactions. Foreign
exchange gains and losses resulting from the settlement of such transactions and from the translation at financial year-end exchange
rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_ecustom--DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory_z1Hgye0KsVl2" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_zWuiSy060qmb">New
or amended Accounting Standards and Interpretations adopted</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity has adopted all of the new or amended Accounting Standards and Interpretations issued by the International Accounting
Standards Board (&#8220;IASB&#8221;) that are mandatory for the current reporting period. The adoption of these new or amended Accounting
Standards and Interpretations did not have a material impact on these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
new or amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zWgutcGrSGvf" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zvb94Drawd5g">Revenue
Recognition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
entity recognises revenue as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
is recognised at an amount that reflects the consideration to which the entity is expected to be entitled in exchange for transferring
goods or services to a customer. For each contract with a customer, the entity; identifies the contract with a customer; identifies the
performance obligations in the contract; determines the transaction price which takes into account estimates of variable consideration
and the time value of money; allocates the transaction price to the separate performance obligations on the basis of the relative stand-alone
selling price of each distinct good or service to be delivered; and recognises revenue when or as each performance obligation is satisfied
in a manner that depicts the transfer to the customer of the goods or services promised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variable
consideration within the transaction price, if any, reflects concessions provided to the customer such as discounts, rebates and refunds,
any potential bonuses receivable from the customer and any other contingent events. Such estimates are determined using either the &#8216;expected
value&#8217; or &#8216;most likely amount&#8217; method. The measurement of variable consideration is subject to a constraining principle
whereby revenue will only be recognised to the extent that it is highly probable that a significant reversal in the amount of cumulative
revenue recognised will not occur. The measurement constraint continues until the uncertainty associated with the variable consideration
is subsequently resolved. Amounts received that are subject to the constraining principle are recognised as a refund liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Program
revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Program
revenue consists of license fees which are recognized following the occurrence of both the transfer of the right to use the Company&#8217;s
intellectual property upon signing of the license agreement and once usage of the license occurs at the commencement of the Alta MMA
Training Program. The Company&#8217;s intellectual property consists of a set of mixed martial arts training programs and relevant branding
and support. A license agreement consists of the right to use the intellectual property of the Company and either party may terminate
the license upon written notice to the other party. If the agreement is terminated in this manner, the termination will take effect after
the completion of the relevant series and the series finale, but prior to a new series beginning. The amount of program revenue is dependent
on the number of participants in each series for each gym.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the license agreement, a usage-based royalty arrangement is in place between the Company and the gyms. The Company recognizes program
revenue following the occurrence of both the transfer of the right to use the Company&#8217;s intellectual property upon signing of the
license agreement and once usage of the license which occurs at the commencement of the Alta MMA Training Program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the ultimate responsibility of ensuring the Alta MMA Training Program meets customer specifications and price determination.
The Company is therefore considered the principal in these arrangements. The Company receives training fees directly from the participants
and subsequently distributes a portion of such revenues to our gym partners based on the terms of the license agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contractual
Payments to Gyms</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to settle contractual payments to the gyms as a percentage of the total training fees collected from participants.
Net revenue from program fees is recognised as revenue from program fees less the contractual obligations payable to the gyms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of merchandise</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from the sale of program merchandise is recognised at the point in time when the gyms obtain control of the goods, which is generally
at the time of delivery.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Event
revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from event ticket sales is recognised at the point in time when the event occurs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
income</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income is recognised when it is received or when the right to receive payment is established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
&amp; Development Incentive</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
grant, including the R&amp;D incentives, shall not be recognised until there is reasonable assurance that the Company will comply with
the conditions attaching to them and that the grants will be received.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_zCmauZD2bCv7" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zPdht4323M98">Current
and non-current classification</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities are presented in the statement of financial position based on current and non-current classification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
asset is classified as current when: it is either expected to be realised or intended to be sold or consumed in the consolidated entity&#8217;s
normal operating cycle; it is held primarily for the purpose of trading; it is expected to be realised within 12 months after the reporting
period; or the asset is cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least 12
months after the reporting period. All other assets are classified as non-current.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
liability is classified as current when: it is either expected to be settled in the consolidated entity&#8217;s normal operating cycle;
it is held primarily for the purpose of trading; it is due to be settled within 12 months after the reporting period; or there is no
unconditional right to defer the settlement of the liability for at least 12 months after the reporting period. All other liabilities
are classified as non-current.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are always classified as non-current.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2. Material accounting policies &#8211; continued</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z6JHM18DlQFi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zef1A3MXZ5gf">Cash
and cash equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, deposits held at call with financial institutions, other short- term, highly liquid investments
with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant
risk of changes in value. For the statement of cash flows presentation purposes, cash and cash equivalents also includes bank overdrafts,
which are shown within trade and other payables in current liabilities on the statement of financial position.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_zTN3oWH4mND" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zC3f22kXjIY8">Trade
and other receivables</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
receivables are initially recognised at fair value and subsequently measured at amortised cost using the effective interest method, less
any allowance for expected credit losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
Credit Losses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
entity has applied the simplified approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure
the expected credit losses, trade receivables have been grouped based on days overdue. Trade and other receivables are recognised at
amortised cost, less any allowance for expected credit losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_zOh8kVKiKExi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_z0DuZnRTGZai">Trade
and other payables</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent liabilities for goods and services provided to the entity prior to the end of the financial year and which are
unpaid. Other payables include cash received from the participants on behalf of the gyms. Due to their short-term nature, they are
measured at amortised cost and are not discounted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zyaJcYXLvUoi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_867_ziIbfAwfRSI">Plant
and equipment</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant
and equipment are stated at cost less accumulated depreciation and impairment. Historical cost includes expenditure that is directly
attributable to the acquisition of the items. Depreciation is calculated on a straight- line basis to write off the net cost of each
item of property, plant and equipment over their expected useful lives as follows:</span></p>

<p id="xdx_89B_ecustom--DisclosureOfPlantAndEquipmentExplanatory_zPBliGXyq3T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zv1CcCTCwcm4">Schedule
of plant and equipment</span></span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant</span>
  <span style="font-family: Times New Roman, Times, Serif">and equipment</span></td>
  <td style="text-align: justify; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfsPt9JFpDG7" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvJr7kJy3nya" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment </span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDn0FDktRmE3" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeji3SbvkXEc" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z15C8fLpd4Eg" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0UF2Vhc2Ja3" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fittings</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zopvstrbwii" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zMB2rxsqL89k" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p id="xdx_8AA_zi0EQHikbYs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
item of property, plant and equipment is derecognised upon disposal or when there is no future economic benefit to the entity. Gains
and losses between the carrying amount and the disposal proceeds are taken to profit or loss.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Note 2. Material accounting policies &#8211; continued</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zrpkeb5x5Jyl" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zv3Ku9MmHXh3">Intangible
assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Intangible
assets acquired as part of a business combination, other than goodwill, are initially measured at their fair value at the date of the
acquisition. Intangible assets acquired separately in an asset acquisition are separately recognised at cost. Indefinite life intangible
assets are not amortized and are subsequently measured at cost less any impairment. Finite life intangible assets are subsequently measured
at cost less amortization and any impairment. The gains or losses recognized in profit or loss arising from the derecognition of intangible
assets are measured as the difference between net disposal proceeds and the carrying amount of the intangible asset. The method and useful
lives of finite life intangible assets are reviewed annually. Changes in the expected pattern of consumption or useful life are accounted
for prospectively by changing the amortization method or period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trademarks</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
costs associated with patents or trademarks are deferred and amortised on a straight-line basis over the period of their expected benefit,
being their finite life of <span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230701__20240630__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z8g1pe4TkYFh" title="Finite life">10</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Platform
development cost</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in both internally and from external providers in developing the platform that will contribute to future year financial benefits
through revenue generation and/or cost reduction are capitalised to software. These costs are amortised on a straight-line basis over
the estimated useful life (<span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230701__20240630__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_zsQkVMOUpuC1" title="Estimated useful life">4</span> years) since first used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and development</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
costs are expensed in the period in which they are incurred. Development costs are capitalised when it is probable that the project will
be a success considering its commercial and technical feasibility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_z6jDUkAuXDz4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zTDEIoZr1NUi">Impairment
of non-financial assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired.
Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount
may not be recoverable. An impairment loss is recognised for the amount by which the asset&#8217;s carrying amount exceeds its recoverable
amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverable
amount is the higher of an asset&#8217;s fair value less costs of disposal and value-in-use. The value-in-use is the present value of
the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to
which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForBorrowingsExplanatory_zwuFTkpzwCE" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z0VzBxCjiaEh">Borrowings</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
and borrowings are initially recognised at the fair value of the consideration received, net of transaction costs. They are subsequently
measured at amortised cost using the effective interest method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_zviXwugsp4ci" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zNxA6SudASV6">Employee
benefits</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
employee benefits</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
for wages and salaries, including non-monetary benefits, annual leave and long service leave expected to be settled wholly within 12
months of the reporting date are measured at the amounts expected to be paid when the liabilities are settled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
long-term employee benefits</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
liability for annual leave and long service leave not expected to be settled within 12 months of the reporting date are measured at the
present value of expected future payments to be made in respect of services provided by employees up to the reporting date using the
projected unit credit method. Consideration is given to expected future wage and salary levels, experience of employee departures and
periods of service. Expected future payments are discounted using market yields at the reporting date on corporate bonds with terms to
maturity and currency that match, as closely as possible, the estimated future cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_zagF7g4ZnBnj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zFBEnXYRAhb9">Goods
and Services Tax (GST) and other similar taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues,
expenses, and assets are recognised net of the amount of associated GST, unless the GST incurred is not recoverable from the tax authority.
In this case it is recognised as part of the cost of the acquisition of the asset or as part of the expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
and payables are stated inclusive of the amount of GST receivable or payable. The net amount of GST recoverable from, or payable to,
the tax authority is included in other receivables or other payables in the statement of financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
flows are presented on a gross basis. The GST components of cash flows arising from investing or financing activities which are recoverable
from, or payable to the tax authority, are presented as operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
and contingencies are disclosed net of the amount of GST recoverable from, or payable to, the tax authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_z7UZ10hq7KW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zbxymr0havy1">Issued
capital</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
Shares are classified as equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incremental
costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_z9EXnSHpGG71" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z2Uc5pIoszw3">Income
tax</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax expense for the year is the tax payable on the current year&#8217;s taxable income based on the national income tax rate for
each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences between the tax bases
of assets and liabilities and their carrying amounts in the financial statements, and to unused tax losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are recognised for temporary differences at the tax rates expected to apply when the assets are recovered
or liabilities are settled, based on those tax rates which are enacted or substantively enacted for each jurisdiction. The relevant tax
rates are applied to the cumulative amounts of deductible and taxable temporary differences to measure the deferred tax asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
exception is made for certain temporary differences arising from the initial recognition of an asset or a liability. No deferred tax
asset or liability is recognised in relation to these temporary differences if they arose in a transaction, other than a business combination,
that at the time of the transaction did not affect either accounting profit or taxable profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilise those temporary differences and losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax liabilities and assets are not recognised for temporary differences between the carrying amount and tax bases of investments in controlled
entities where the parent company is able to control the timing of the reversal of the temporary differences and it is probable that
the differences will not reverse in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets and liabilities and when
the deferred tax balances relate to the same taxation authority. Current tax assets and tax liabilities are offset where the Company
has a legally enforceable right to offset and intends either to settle on a net basis, or to realise the asset and settle the liability
simultaneously.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
and deferred tax is recognised as income or an expense and included in profit and loss for the period except where the tax arises from
a transaction which is recognized in other comprehensive oncome or equity, in which case the tax is recognized in other comprehensive
income to equity respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zdTMHsYOXaP6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zVf7QaLVuKyb">Convertible
note</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
issuance of the convertible notes, an assessment is made to determine whether the convertible notes contain an equity instrument or whether
the whole instrument should be classified as a financial liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
it is determined that the whole instrument is a financial liability and no equity instrument, the conversion option is separated from
the host debt and classified as a derivative liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying value of the host contract at initial recognition is determined as a difference between the consideration received and the fair
value of the embedded derivative. The host contract is subsequently measured at amortised cost using the effective interest rate method.
The embedded derivative it subsequently measured at fair value at the end of each reporting period through the profit and loss. Refer
Note 21 Financial Liabilities for disclosure of key terms of the convertible notes. The convertible note and the derivative are presented
as financial liabilities on the Consolidated Statement of Financial Position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
conversion at maturity, the financial liability is reclassified to equity and no gain or loss is recognised. Transaction costs are deducted
from equity, net of associated income tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zbIP0X0RvChc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_z63x5obPaPLh">Share-based
payments</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides benefits to consultants, advisors and employees (including directors) of the consolidated entity in the form of share-based
payment transactions, whereby employees render services in exchange for shares or rights over shares (&#8216;equity-settled transactions&#8217;).
The cost of these equity-settled transactions with employees is measured by reference to the fair value at the date at which they are
granted. The fair value is determined by an external valuation using a Black- Scholes option pricing model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of equity-settled transactions is recognised, together with a corresponding increase in equity, over the period in which the performance
conditions are fulfilled, ending on the date on which the relevant employees become fully entitled to the award (&#8216;vesting date&#8217;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cumulative expense recognised for equity-settled transactions at each reporting date until vesting date reflects (i) the extent to
which the vesting period has expired and (ii) the number of awards that, in the opinion of the directors of the consolidated entity,
will ultimately vest. This opinion is formed based on the best available information at balance date. No adjustment is made for the
likelihood of market performance conditions being met as the effect of these conditions is included in the determination of fair
value at grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
expense is recognised for awards that do not ultimately vest, except for awards where vesting is conditional upon a market condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
an equity-settled award is cancelled, it is treated as if it had vested on the date of cancellation, and any expense not yet recognised
for the award is recognised immediately. However, if a new award is substituted for the cancelled award, and designated as a replacement
award on the date that it is granted, the cancelled and new award are treated as if they were a modification of the original award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_zLWgODhl9lx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zZqvh4CQZkl">Classification
and measurement of financial liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial liabilities include trade and other payables, financial liabilities measured at amortised cost and derivative
financial instruments. Financial liabilities are initially measured at fair value, and, where applicable, adjusted for transaction costs
unless the Company&#8217;s designated a financial liability at fair value through profit or loss. Subsequently, financial liabilities
are measured at amortised cost using the effective interest method except for derivatives and financial liabilities designated at FVTPL,
which are carried subsequently at fair value with gains or losses recognised in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zT3b4FHdxfmd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zB22HaKcvmXh">Right-of-use
assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
right-of-use asset is recognised at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the
initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of
any lease incentives received, any initial direct costs incurred, and, except where included in the cost of inventories, an estimate
of costs expected to be incurred for dismantling and removing the underlying asset, and restoring the site or asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever
is the shorter. Where the consolidated entity expects to obtain ownership of the leased asset at the end of the lease term, the depreciation
is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zl6SNw2t7hH8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zXTYeAfytfQ3">Lease
liabilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
lease liability is recognised at the commencement date of a lease. The lease liability is initially recognised at the present value
of the lease payments to be made over the term of the lease, discounted using the interest rate implicit in the lease or, if that
rate cannot be readily determined, the consolidated entity&#8217;s incremental borrowing rate. Lease payments comprise of fixed
payments less any lease incentives receivable, variable lease payments that depend on an index or a rate, amounts expected to be
paid under residual value guarantees, exercise price of a purchase option when the exercise of the option is reasonably certain to
occur, and any anticipated termination penalties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
variable lease payments that do not depend on an index or a rate are expensed in the period in which they are incurred. Lease liabilities
are measured at amortised cost using the effective interest method. The carrying amounts are remeasured if there is a change in the following:
future lease payments arising from a change in an index or a rate used; residual guarantee; lease term; certainty of a purchase option
and termination penalties. When a lease liability is remeasured, an adjustment is made to the corresponding right-of use asset, or to
profit or loss if the carrying amount of the right-of-use asset is fully written down.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zCfMV6dNjvJj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_z1E0xhyEtYXb">Fair
value measurement</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
an asset or liability, financial or non-financial, is measured at fair value for recognition or disclosure purposes, the fair value is
based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date; and assumes that the transaction will take place either: in the principal market; or in the absence of a principal
market, in the most advantageous market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is measured using the assumptions that market participants would use when pricing the asset or liability, assuming they act in
their economic best interests. For non-financial assets, the fair value measurement is based on its highest and best use. Valuation
techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, are used,
maximising the use of relevant observable inputs and minimising the use of unobservable inputs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities measured at fair value are classified into three levels, using a fair value hierarchy that reflects the significance
of the inputs used in making the measurements. Classifications are reviewed at each reporting date and transfers between levels are determined
based on a reassessment of the lowest level of input that is significant to the fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
recurring and non-recurring fair value measurements, external valuers may be used when internal expertise is either not available or
when the valuation is deemed to be significant. External valuers are selected based on market knowledge and reputation. Where there is
a significant change in fair value of an asset or liability from one period to another, an analysis is undertaken, which includes a verification
of the major inputs applied in the latest valuation and a comparison, where applicable, with external sources of data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zXjiRW99MTq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zOAF0IV5dM12">Earnings
per share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share is calculated by dividing the profit attributable to the owners of the Company, excluding any costs of servicing equity
other than Ordinary Shares, by the weighted average number of Ordinary Shares outstanding during the financial year, adjusted for bonus
elements in Ordinary Shares issued during the financial year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
earnings per share</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
earnings per share adjusts the figures used in the determination of basic earnings per share to take into account the after income tax
effect of interest and other financing costs associated with dilutive potential Ordinary Shares and the weighted average number of shares
assumed to have been issued for no consideration in relation to dilutive potential Ordinary Shares.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory_zOiSGHp5bbcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z9Eg5Ihndbg5">Parent
entity financial information</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial information for the Parent entity, Alta Global Group Limited, disclosed in Note 19 has been prepared on the same basis as the
consolidated financial statement. Investments in subsidiaries are accounted for at cost less provision for impairment in the financial
statements of the Parent entity.</span></p>

<p id="xdx_850_z2I5YxyRBWQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfMaterialAccountingPolicyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfMaterialAccountingPolicyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of material accounting policy information applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322652976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Critical accounting judgements, estimates and assumptions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract', window );"><strong>Critical Accounting Judgements Estimates And Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">Critical accounting judgements, estimates and assumptions</a></td>
<td class="text"><p id="xdx_801_eifrs-full--DisclosureOfAccountingJudgementsAndEstimatesExplanatory_zamoch7k25zl" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
3. <span id="xdx_82A_zM3hqiOvn0Dl">Critical accounting judgements, estimates and assumptions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts
in the financial statements. Management continually evaluates its judgements and estimates in relation to assets, liabilities, contingent
liabilities, revenue and expenses. Management bases its judgements, estimates and assumptions on historical experience and on other various
factors, including expectations of future events, management believes to be reasonable under the circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going
concern</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements for the reporting periods have been prepared on a going concern basis which contemplates continuity
of normal business activities and the realization of assets and settlement of liabilities in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have assessed that there is a substantial doubt related to going concern that may cast significant doubt over our ability to continue
as a going concern as we incurred a loss after tax of A$<span id="xdx_90C_eifrs-full--ProfitLoss_iN_di_c20230701__20240630_zWbS7VEMTIi6" title="Loss after tax">14,408,346</span> for the year ended June 30, 2024 compared to A$<span id="xdx_90B_eifrs-full--ProfitLoss_iN_di_c20220701__20230630_zYmtPEvDJfF8" title="Loss after tax">20,597,436</span> for the
year ended June 30, 2023, had net cash outflows from operating activities of A$<span id="xdx_90F_eifrs-full--CashFlowsFromUsedInOperatingActivities_iN_di_c20230701__20240630_zUp9D04ZiWqd" title="Net cash outflows from operating activities">9,386,196</span> for the year ended June 30, 2024 compared to
$<span id="xdx_908_eifrs-full--CashFlowsFromUsedInOperatingActivities_iN_di_c20220701__20230630_zoW58SEPfcVd" title="Net cash outflows from operating activities">5,555,868</span> for the year ended June 30,2023, had a net asset position of $<span id="xdx_909_eifrs-full--NetAssetsLiabilities_iI_c20240630_zHJjNRQBBxNh" title="Net assets liabilities">2,558,544</span> as at June 30, 2024 compared to net liability $<span id="xdx_900_eifrs-full--NetAssetsLiabilities_iNI_di_c20230630_za0F9jocwZm4" title="Net assets liabilities">31,134,307</span>
as at June 30, 2023, and net current asset position of $<span id="xdx_90B_eifrs-full--CurrentAssetsLiabilities_iI_c20240630_zwyoWwfi5yb5" title="Net current assets liabilities">1,049,355</span> as at June 30, 2024, compared to net current liability position of
$<span id="xdx_900_eifrs-full--CurrentAssetsLiabilities_iI_c20230630_zVBZwfQvHUul" title="Net current assets liabilities">21,916,914</span> as at June, 30 2023. As a result of these conditions, the Company may be unable to realize its assets and discharge its liabilities
in the normal, course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3. Critical accounting judgements, estimates and assumptions - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2024, the Company successfully listed on the NYSE American. In addition, all convertible notes that were on issue prior to
the initial public offering have either been converted into Ordinary Shares or redeemed and therefore there is no convertible note debt,
host or derivative liabilities, on the Consolidated Statement of Financial Position as at June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remaining interest on convertible notes and the final fair value movement in derivative liability is reflected in the Consolidated Statement
of Profit or Loss for the year ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ongoing operation of the Company remains dependent upon raising additional funds. In light of the future expenditures to be incurred
in executing on our strategic plans, we are dependent on obtaining financing through equity financing, debt financing or other means.
The ability to arrange such funding in the future will depend in part upon the prevailing capital market conditions as well as our business
performance. There is no assurance that we will be successful in our efforts to raise additional funding on terms satisfactory to us.
If we do not obtain additional funding, we may be required to delay, reduce the scope of, or eliminate our current operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
we believe that we will be able to raise additional funds as required to meet our obligations as and when they become due and are of
the opinion that the use of the going concern basis remains appropriate. Our ability to continue as a going concern and to pay debts
as and when they become due is dependent on the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we have historically been successful in raising funds,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we have now listed on the New York Stock Exchange in the United States. As a listed vehicle, we have capital raising options such as placements, Share Purchase Plans, Rights issues and entitlement offers, Dividend Reinvestment Plans, Hybrids and Retail notes and PIPEs;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our level of expenditure continues to be managed and will continue to be managed to maximize run-way; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we have reason to believe that in addition to the cash flow currently available, additional revenues will continue to be received through the sale of our products and services throughout the course of the year.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we decide to raise capital, the issuance of additional Ordinary Shares would result in dilution to our existing shareholders. We cannot
assure you that we will be successful in completing any financings or that any such equity or debt financing will be available to us
if and when required or on satisfactory terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
we be unable to raise additional funds on a timely basis, we may be required to realize our assets and discharge our liabilities other
than in the normal course of business and at amounts different to those stated in the financial statements. The financial statements
do not include any adjustments to the recoverability and classification of asset carrying amounts or the amount of liabilities that might
result should we be unable to continue as a going concern and meet our debts as and when they become due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers involving program fees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
recognising revenue in relation to the sale of goods to customers, the key performance obligation of the entity is considered to be the
point in time of the rights to use the license and the relevant training program to the gyms as the customers, as this is deemed to be
the time that the gym obtains control of the promised service and therefore the benefits of unimpeded access.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination
of variable consideration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Judgement
is exercised in estimating variable consideration which is determined having regard to past experience with respect to the cancelled
contracts with the entity where the member gyms maintain a right of terminate pursuant to the licence agreement. Revenue will only be
recognised to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognised under
the contract will not occur when the uncertainty associated with the variable consideration is subsequently resolved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3. Critical accounting judgements, estimates and assumptions - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based
payment transactions</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity measures the cost of equity-settled transactions with employees by reference to the fair value of the equity instruments
at the date at which they are granted. The fair value is determined by using Black-Scholes model taking into account the terms and conditions
upon which the instruments were granted. The accounting estimates and assumptions relating to equity-settled share-based payments would
have no impact on the carrying amounts of assets and liabilities within the next annual reporting period but may impact profit or loss
and equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible
Notes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined the convertible note instrument to be a financial liability. It is separated into two components being the host
debt and derivative liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying value of the host contract at initial recognition is determined as the difference between the consideration received and
the fair value of the embedded derivative. The host contract is subsequently measured at amortised cost using the effective interest
rate method. The derivative liability is recognised as such due to its conversion feature relating to a qualified equity investment
and the likelihood of its occurrence. The embedded derivative is subsequently measured at fair value at the end of each reporting
period through the profit and loss based on the Monte Carlo simulation as valued by an external valuer. The convertible note and the
derivative are presented as financial liabilities on the Consolidated Statement of Financial Position, refer to Note 21 Financial
Liabilities for further details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition
of deferred tax assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilise those temporary differences and losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of unrecognised deferred tax assets are reviewed at each reporting date. Previously unrecognised deferred tax assets
are only recognised to the extent that it is probable that there are future taxable profits available to recover the asset. The Company
has not recognised the benefit of these unused deductible temporary differences and unused tax losses. These losses will only be recognised
where it is probable that future taxable profit will be available against which the benefits of the deferred tax asset will be utilised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
term</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lease term is a significant component in the measurement of both the right-of-use asset and lease liability. Judgement is exercised in
determining whether there is reasonable certainty that an option to extend the lease or purchase the underlying asset will be exercised,
or an option to terminate the lease will not be exercised, when ascertaining the periods to be included in the lease term. In determining
the lease term, all facts and circumstances that create an economical incentive to exercise an extension option, or not to exercise a
termination option, are considered at the lease commencement date. Factors considered may include the importance of the asset to the
consolidated entity&#8217;s operations; comparison of terms and conditions to prevailing market rates; incurrence of significant penalties;
existence of significant leasehold improvements; and the costs and disruption to replace the asset. The consolidated entity reassesses
whether it is reasonably certain to exercise an extension option, or not exercise a termination option, if there is a significant event
or significant change in circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value measurement hierarchy</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity is required to classify all assets and liabilities, measured at fair value, using a three level hierarchy, based
on the lowest level of input that is significant to the entire fair value measurement, being:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly;
and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Unobservable inputs for the asset or liability. Considerable judgement is required to determine what is significant to fair value
and therefore which category the asset or liability is placed in can be subjective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of assets and liabilities classified as level 3 is determined by the use of valuation models. These include discounted cash
flow analysis or the use of observable inputs that require significant adjustments based on unobservable inputs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
3. Critical accounting judgements, estimates and assumptions - continued</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimation
of useful lives of assets</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity determines the estimated useful lives and related depreciation and amortisation charges for its property, plant and
equipment and finite life intangible assets. The useful lives could change significantly as a result of technical innovations or some
other event. The depreciation and amortisation charge will increase where the useful lives are less than previously estimated lives,
or technically obsolete or non-strategic assets that have been abandoned or sold will be written off or written down.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impairment
of non-financial assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity assesses impairment of non-financial assets at each reporting date by evaluating conditions specific to the consolidated
entity and to the particular asset that may lead to impairment. If an impairment trigger exists, the recoverable amount of the asset
is determined. This involves fair value less costs of disposal or value-in-use calculations, which incorporate a number of key estimates
and assumptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
Credit Losses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
allowance for expected credit losses requires a degree of estimation judgment. The Company has applied the simplified approach to measuring
expected credit losses, which uses a lifetime expected loss allowance. To measure the expected credit losses, trade receivables have
been grouped based on days overdue. Trade and other receivables are recognised at amortised cost, less any allowance for expected credit
losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Provision
for Refund Liability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for refund liability is recognised for expected volume payable to customers in relation to sales made until the end of the
reporting period. The Company&#8217;s obligation to provide a refund, cancellation or credit note falls under the Company&#8217;s standard
trading terms, and is recognised as a provision. The estimate of expected returns requires judgement and reflects the amount that the
reporting entity expects to repay or credit customers, using either the expected value method or the most-likely amount method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capitalised
platform development costs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred both internally and from external providers in developing the platform that meet the recognition criteria of development costs
under IAS 38 have been capitalised as intangible assets and are amortised over their useful life.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development Incentive</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Judgement
is required in determining the amount of grant revenue relating to the research and development incentive claim. There are certain transactions
and calculations undertaken during the ordinary course of business for which the ultimate tax determination may be subject to change.
The Company calculates its research and development claim based on the Company&#8217;s understanding of the tax law. Where the final
outcome of these matters is different from the amounts that were initially recorded, such differences will impact the profit or loss
in the year in which such determination is made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319493360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating segments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">Operating segments</a></td>
<td class="text"><p id="xdx_806_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_z8q4UGVZWgn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4. <span id="xdx_82B_zj6fkDj2LyY">Operating segments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identification
of reportable operating segments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Segment
reporting is based on the information that management uses to make decisions about the operation of the Company. Operating segment determination
is based on the internal reports that are reviewed and used by the Board of Directors (who are identified as the Chief Operating Decision
Makers (&#8220;CODM&#8221;)) in assessing performance and in determining the allocation of resources. The Company has identified one
operating segment as the provision and administration of mixed martial arts training programs, gym programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CODM reviews EBITDA (earnings before interest, tax, depreciation, and amortization). The accounting policies adopted for internal reporting
to the CODM are consistent with those adopted in the financial statements. Application of IFRS 8 and quantitative thresholds for determination
of reportable segments sees the consolidated entity disclosing only one reportable operating segment. The consolidated financial statements
for the years ended June 30, 2024, 2023 and 2022 have been presented by this single operating segment and have been presented and disclosed
as one reportable operating segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550387653232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RevenueFromContractsWithCustomersAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory', window );">Revenue</a></td>
<td class="text"><p id="xdx_807_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zOINLqwhVRZg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5. <span id="xdx_827_zJ2bG0nWdlOd">Revenue</span></b></span></p>

<p id="xdx_89D_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zgRfiURJm5Ik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BD_zRj385CWGvBl">Schedule
of revenue</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20230701__20240630_zIQo217YJPrd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20220701__20230630_zQpYeWBDJ2Xd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20210701__20220630_zFnuaU5RM3V" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Program fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--RevenueFromProgramFees_maRFROSz9dU_zNLAODQU0TP1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Revenue from program fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">929,319</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">937,415</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2,050,044</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RevenueFromContractualPaymentsToGyms_msRFROSz9dU_zdeZp0jLQw3e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Contractual payments to gyms</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(537,012</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(574,025</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,215,191</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eifrs-full--RevenueFromRenderingOfServices_iT_mtRFROSz9dU_maRz2tF_zhT4NkeQssek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Revenue from program fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">392,307</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">363,390</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">834,853</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Other Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ReserachAndDevelopmentIncome_maORzfCZ_zv9rjJaX42g5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research and Development tax incentive<span id="xdx_F47_zP06pBrLhtAl">*</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0614">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,149,525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0616">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--FranchiseFeeIncome_maORzfCZ_zaa66nRRvk4c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Finale, franchise fee and other fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">167,021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,378</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--RevenueFromSaleOfGoods_maORzfCZ_zfMcMFP3uw71" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Merchandise sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,984</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,296</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,572</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--OtherRevenue_iT_mtORzfCZ_maRz2tF_zwfzTIvJ2cn3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total other income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">170,005</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,173,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">105,950</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--Revenue_iT_mtRz2tF_zTIGx62L0Xs9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">562,312</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,536,811</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">940,803</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0D_zgTDBqwENKc1" style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F16_zk811PLJDAUd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will continue
                                                                                                                                                              to apply for the Research and Development incentive as long as it continues to be eligible and will conduct eligible research and
                                                                                                                                                              development activities. The applicable legislation that governs the eligibility to participate in the R&amp;D incentive program is
                                                                                                                                                              Division 355 of the Income Tax Assessment Act 1997 (ITAA 1997). The FY 2024 Research and Development incentive will be applied for
                                                                                                                                                              on lodging of the FY 2024 tax return with the Australian Tax Office and recognised once reasonable assurance that the Company will
                                                                                                                                                              comply with the conditions and that the grants will be received.</span></td>
</tr></table>

<p id="xdx_8A3_zEIWAm8Tm0Wd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Disaggregation
of Revenue</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_89E_eifrs-full--DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_zUgRACWRC7W6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disaggregation of revenue from contracts with customers is disclosed below. The Company only has one major product line, being the provision
of Gym Programs. All revenues are generated by the Australian Parent Entity:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BA_zGUPKhuQw4sd">Schedule
of disaggregation of revenue</span></b></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20230701__20240630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_z531tjLvweVk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220701__20230630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_zOPIEMxM5Cc8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20210701__20220630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_z2YKwg6pYU2f" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RevenueFromProgramFees_zmPTuSmNiD3j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Revenue from program fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">929,319</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">937,415</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2,050,044</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--RevenueFromContractualPaymentsToGyms_z0gRDUB3W7a5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Contractual payments to gyms</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(537,012</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(574,025</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,215,191</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eifrs-full--RevenueFromRenderingOfServices_iT_maRz2tF_z3F89R5objXi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net Revenue from program fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">392,307</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">363,390</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">834,853</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AA_zra1ZJXvLff8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Timing
of revenue recognition</i> &#8211; All goods transferred at a point in time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue from contracts with customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g105-109_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g110-129_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319318992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfExpensesAbstract', window );"><strong>Schedule Of Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfExpensesExplanatory', window );">Expenses</a></td>
<td class="text"><p id="xdx_803_eifrs-full--DisclosureOfExpensesExplanatory_zeuAdbXSyMLa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. <span id="xdx_82E_z6MWtveDC26k">Expenses</span></b></span></p>

<p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutExpensesExplanatory_z3e8eACAxv52" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B0_zwL6ZQpkNdwc">Schedule
of expenses</span></b></span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230701__20240630_z7fmhUciUL3f" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20220701__20230630_zLR1IN4xc7og" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20210701__20220630_z8qJsQzhXZCf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--ProgramExpensesEventCosts_maPEzyGE_z1crUWk8SLUk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Event
    Costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,909</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,876</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,513</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--ProgramExpensesProgramCosts_maPEzyGE_zig9SqT0Iqz5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Program
    costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,046</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,447</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253,614</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--ProgramExpensesMerchantFees_maPEzyGE_z5QXY1FBIba2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merchant
    fees</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,550</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,427</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,327</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--ProgramExpensesOtherCosts_maPEzyGE_zAcumNvOKD6h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132,098</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">146</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--ProgramExpenses_iT_mtPEzyGE_zyQPoCeOpQY9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    program expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160,578</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">229,848</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">342,600</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--FinanceCostsConvertibleNotesInterestContractualAndEffective_maFCzg2h_zq1HsTJLnapg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    notes interest &#8211; contractual and effective</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,207,498</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,420,224</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,162,646</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--FinanceCostsBankFees_maFCzg2h_zSZqLiHzNKn2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    fees</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,286</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,071</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,454</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--FinanceCostsBankInterestAndLeaseInterest_maFCzg2h_zKEaGTWQJ1y2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    interest and lease interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,435</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,703</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--FinanceCosts_iT_mtFCzg2h_z7IH9r1XTqL9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    finance costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,262,927</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,472,730</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,191,803</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. Expenses &#8211; continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr id="xdx_40F_ecustom--UnrealizedCurrencyGains_i01N_di_maNFEGzlIR_zxdzxHTpr0qa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left; padding-left: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized
    currency (gains)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(117,094</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(36,181</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(36,660</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_405_ecustom--RealizedCurrencyGainslosses_i01N_di_maNFEGzlIR_zmoIvMjR4wO2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
    currency (gains)/losses</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,449</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,581</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--NetForeignExchangeGain_i01NT_di_mtNFEGzlIR_zWAZunepoqjb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    foreign exchange (gains)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(146,543</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(47,359</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,079</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p id="xdx_8A3_zkhENqCHTiMb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfExpensesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfExpensesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322010784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income Tax</a></td>
<td class="text"><p id="xdx_809_eifrs-full--DisclosureOfIncomeTaxExplanatory_zm3Hho4gqaX3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7. <span id="xdx_823_zHAHMbZhK2l9">Income Tax</span></b></span></p>

<p id="xdx_890_ecustom--DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory_zscoYR2oR6N2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z4CNgLHWqwEl" style="display: none">Schedule
of Income Tax Expenses</span><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230701__20240630_zfxLcEGBTYY8" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220701__20230630_zntEBKkkbrk3" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20210701__20220630_zuLqSjss5J9k" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($</b><b>)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income tax expense consists of the following:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--DeferredTaxExpenseIncome_maITECOzfzo_zESb20Fef0Zc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0705">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0706">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--CurrentTaxExpenseIncome_maITECOzfzo_z4Yfix7ZhNtc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Current tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0710">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0711">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_mtITECOzfzo_zPDylCD3bfil" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Total Income tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0713">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0714">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0715">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Effective tax rate reconciliation:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--ProfitLossBeforeTax_z5MTAICaLnu5" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Loss before income tax expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(14,408,346</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(20,597,436</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(11,197,450</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_maITECOzcFn_zZEoUrsnybQj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prima facie income tax benefit on loss before income tax calculated at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluY29tZSBUYXggRXhwZW5zZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--ApplicableTaxRate_pid_dp_c20230701__20240630_zUiOgGZVODZc" title="Tax rate">25</span>% (2022: <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluY29tZSBUYXggRXhwZW5zZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--ApplicableTaxRate_pid_dp_c20210701__20220630_z2ukeGc6alk5" title="Tax rate">25</span>%)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,602,086</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,149,359</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,799,363</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Add tax effect of</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DeferredTaxExpenseIncomeOtherNonAllowableItems_maITECOzcFn_zYmYfegG7Mag" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left">- other non-allowable items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(831,249</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,297,349</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">143,430</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Less tax effect of</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes_msITECOzcFn_zPEPbeLJLYT4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left">- items not assessable for income tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,590,831</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,435,790</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,377,243</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting_msITECOzcFn_zUb9IH5K4qNf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; text-align: left">- items deductible for taxation not accounting</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">251,784</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">772,848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">114,471</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss_maITECOzcFn_zYSSn8aD2NHa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Deferred tax not recognised</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(431,790</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,189,068</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,680,021</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_mtITECOzcFn_zE1YYBiIuBL3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0745">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0747">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>
<p id="xdx_8AE_zlmeI0SEI5d2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has carried forward tax losses, calculated according to Australian income tax legislation of $<span id="xdx_901_eifrs-full--DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_c20230701__20240630_z5mM5xEQTWlc" title="Caarried forward tax loss">18,042,509</span> at 30 June 2024 (2023
$<span id="xdx_90D_eifrs-full--DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_c20220701__20230630_zQxxAPUSZT2" title="Caarried forward tax loss">16,315,346</span>) which will be deductible from future assessable income provided that income is derived. Deferred tax assets and liabilities
are based on the assumption that no adverse change will occur in the income tax legislation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
benefit of these losses will only be recognized where it is probable that future taxable profit will be available against which the benefits
of the deferred tax asset can be utilised. This is based on the anticipation that the Company will derive sufficient future assessable
income to enable the benefit to be realised and comply with the conditions of deductibility imposed by the law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has assessed future forecast profits and concluded that not enough criteria has been satisfied to recognise any deferred tax
assets at the period ended 30 June 2024. Unused tax losses do not have an expiry date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322580208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementExplanatory', window );">Fair value measurement</a></td>
<td class="text"><p id="xdx_80E_eifrs-full--DisclosureOfFairValueMeasurementExplanatory_zHgM4fnHcQwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. <span id="xdx_829_zobUHEApnBq3">Fair value measurement</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value hierarchy</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables detail the consolidated entity&#8217;s assets and liabilities, measured or disclosed at fair value, using a three level
hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that
                                            the entity can access at the measurement date.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            2: Inputs other than quoted prices included within Level 1 that are observable for the asset
                                            or liability, either directly or indirectly.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            3: Unobservable inputs for the asset or liability. Considerable judgement is required to
                                            determine what is significant to fair value and therefore which category the asset or liability
                                            is placed in can be subjective.</span></td></tr></table>

<p id="xdx_89A_eifrs-full--DisclosureOfFinancialAssetsExplanatory_z8h86UUdFcxh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zTa0x4G2KBib" style="display: none">Schedule
of Fair Value Assets and &#160;Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49D_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zeMVVKkSBJMg" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zoLD7BLiRh5j" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49A_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zTI1Dp2Umppj" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49C_20240630_zZGmXuYbrzB8" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">Consolidated- June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialAssetsAtFairValue_iI_znrdl0xnuuD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; padding-bottom: 1pt; width: 40%">Assets</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0757">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0759">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialAssetsAtFairValue_iTI_zkuPaf0L1W6j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0762">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0763">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0765">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValue_iI_zWJMsn824O9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Derivative Liabilities &#8211; refer Note 21</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0767">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0769">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_zGUV0WEvPhq" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0774">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0775">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49E_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zKFzHVh7ZZX8" style="text-align: center">Level 1</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49C_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zQsvMZmMXTse" style="text-align: center">Level 2</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_490_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z7eUzszco5m3" style="text-align: center">Level 3</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20230630_zZjQJ5h2psV2" style="text-align: center">Total</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">Consolidated &#8211; June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialAssetsAtFairValue_iI_z9lPUJOZCFoe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-style: italic; padding-bottom: 1pt">Assets</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0778">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0779">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0780">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialAssetsAtFairValue_iTI_zFbX6SlvPo3k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0782">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0783">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0785">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValue_iI_zsWxZpZCbt21" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Derivative Liabilities &#8211; refer Note 21</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0787">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,694,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,694,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_zwPEIDdwxdy6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0792">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0793">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,694,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,694,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_z2kXpfF5bD73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no transfers between levels during the financial periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of trade and other receivables and trade and other payables are assumed to approximate their fair values due to their
short-term nature. The fair value of financial liabilities is estimated by discounting the remaining contractual maturities at the current
market interest rate that is available for similar financial liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Valuation
techniques for fair value measurements categorised within level 3</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Financial Liabilities for the host liability and the derivative liability has been determined using a combination of
Monte Carlo Simulation (MCS) and Black-Scholes model (BSM). The Group used valuations specialists to perform these valuations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3 liabilities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Movements
in level 3 liabilities during the current and previous financial years are set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_89C_ecustom--DisclosureOfDerivativeLiabilityExplanatory_zz6cZ8Gpqwmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_z0DzVDLs8pOa" style="display: none">Schedule
of Fair Value Measurement of Derivative Liability</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Derivative liability</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Total</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: normal; text-align: left">Consolidated</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Balance at 1 July 2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DerivativeFinancialLiabilities_iS_c20220701__20230630_z0R7TJj55djc" style="width: 12%; text-align: right" title="Balance">878,653</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eifrs-full--FinancialLiabilities_iS_c20220701__20230630_zuoCRlVBY6zh" style="width: 12%; text-align: right" title="Balance">878,653</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value of derivative liability recognised for convertible notes issued during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_c20220701__20230630_z1AjGBA7dQOd" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year">10,945,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_c20220701__20230630_zYkbUdeWnAie" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year">10,945,347</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Fair value movement recognised in profit or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--FairValueMovementRecognisedInProfitOrLoss_c20220701__20230630_zcgU848FByG6" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value movement recognised in profit or loss">6,870,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_c20220701__20230630_zLriMIYpnDTk" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value movement recognised in profit or loss">6,870,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance at 30 June 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iS_c20230701__20240630_zUyZwqyKuxpa" style="text-align: right" title="Balance">18,694,729</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iS_c20230701__20240630_zwSEuwbL1w7j" style="text-align: right" title="Balance">18,694,729</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value of derivative liability recognised for convertible notes issued during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_c20230701__20240630_zZwxa5bWvOjf" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year">280,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_c20230701__20240630_zRBTYXplDnr3" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year">280,198</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Fair value movement recognised in profit or loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--FairValueMovementRecognisedInProfitOrLoss_c20230701__20240630_zIm3QAun1PMe" style="text-align: right" title="Fair value movement recognised in profit or loss">(3,400,685</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_c20230701__20240630_zxljolWGhcy8" style="text-align: right" title="Fair value movement recognised in profit or loss">(3,400,685</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Fair value of derivative liability for convertible notes which converted or matured during the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_c20230701__20240630_zbI4NgGD8dyg" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of derivative liability for convertible notes which converted or matured during the year">(15,574,242</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_c20230701__20240630_zlodQOI4j9a1" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of derivative liability for convertible notes which converted or matured during the year">(15,574,242</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance at 30 June 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eifrs-full--DerivativeFinancialLiabilities_iE_c20230701__20240630_zMQCn8i4GJHb" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"><span style="-sec-ix-hidden: xdx2ixbrl0827">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eifrs-full--FinancialLiabilities_iE_c20230701__20240630_zM3ylSxHFXo7" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"><span style="-sec-ix-hidden: xdx2ixbrl0829">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zb7fpPVRTIQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Fair value measurement - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eifrs-full--DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_zXNXdVFKxRtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
level 3 liabilities unobservable inputs at issue date of each of the convertible notes series are as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zLarCb241h71" style="display: none">Schedule
of Unobservable Inputs Level 3 Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zp3vfSB85J27" style="width: 18%; text-align: right" title="Implied Valuation">28,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zZuZEBvwtkOh" style="text-align: right" title="Volatility">74</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zz7X8ueMA5a7" style="text-align: right" title="Volatility">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zEPFKyGEfIme" style="text-align: right" title="Volatility">50</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A - July 21</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zVuGci006Ksb" style="width: 18%; text-align: right" title="Implied Valuation">28,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zP3yLd1B7I38" style="text-align: right" title="Volatility">74</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zsuvP1fU9DMc" style="text-align: right" title="Volatility">0.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_ziGwy7zjDOC2" style="text-align: right" title="Volatility">50</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A &#8211; August 21</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_z6TN7GPgOxN" style="width: 18%; text-align: right" title="Implied Valuation">28,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zl5TIWyXdeH2" style="text-align: right" title="Volatility">62</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zEt0xB5LCaR7" style="text-align: right" title="Volatility">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zLjvyPV6RtJ6" style="text-align: right" title="Volatility">50</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series B1</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zQSDF0mM3Zf2" style="width: 18%; text-align: right" title="Implied Valuation">120,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zGrlA1CI2Yqk" style="text-align: right" title="Volatility">74</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zMPstv8V9ubf" style="text-align: right" title="Volatility">0.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zkyr6J9Gc0ki" style="text-align: right" title="Volatility">50</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series B2</i></b></span></p></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_ziaqCXgeU2e6" style="width: 18%; text-align: right" title="Implied Valuation">70,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_z0Wwew0eU187" style="text-align: right" title="Volatility">66</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_ztpjbijgfsRa" style="text-align: right" title="Volatility">3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_zHvD5ZKsQMd4" style="text-align: right" title="Volatility">50</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Fair value measurement - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A Extension</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_z0AOX32bewYc" style="width: 18%; text-align: right" title="Implied Valuation">28,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_zcsirHDeCGW3" style="text-align: right" title="Volatility">65</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_z4qFyH8cKW24" style="text-align: right" title="Volatility">3.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_zcUyIbIbYoa7" style="text-align: right" title="Volatility">0</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Reach</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zCDcShhAlquf" style="width: 18%; text-align: right" title="Implied Valuation">40,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zZrAv0MSz1j9" style="text-align: right" title="Volatility">60</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zcs5oKG0sfj3" style="text-align: right" title="Volatility">3.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zINygeJBMhK7" style="text-align: right" title="Volatility">100</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Private Placement</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zSVK1qaCez68" style="width: 18%; text-align: right" title="Implied Valuation">53,685,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zSb9oj4dlbGf" style="text-align: right" title="Volatility">60</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zOtHhs1KwYWb" style="text-align: right" title="Volatility">3.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_ztoHxmtYGFnb" style="text-align: right" title="Volatility">100</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Mixed Martial Arts LLC</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zFPOfH2Wgr7g" style="width: 18%; text-align: right" title="Implied Valuation">384,750</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zv0Qp6BZ5WO2" style="text-align: right" title="Volatility">49</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zxXFvfO9oiO8" style="text-align: right" title="Volatility">4.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zneXfVnHL4pa" style="text-align: right" title="Volatility">100</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Steppen</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_z7ojOPxh03G9" style="width: 18%; text-align: right" title="Implied Valuation">100,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zrheWO1kl34c" style="text-align: right" title="Volatility">47</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zGVfRKO4ghTd" style="text-align: right" title="Volatility">4.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zSnsYp7Ur1yk" style="text-align: right" title="Volatility">100</td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8AC_zY97X2Z96y8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for fair value measurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS13_g91-99_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318323248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_801_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zQeufRG7NDz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9. <span id="xdx_827_zk8cTcBkazje">Cash and cash equivalents</span></b></span></p>

<p id="xdx_898_ecustom--DisclosureOfCashEquivalentsExplanatory_znCeSEql0yEe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zq6UPO9nt3Nh" style="display: none">Schedule
of Cash and Cash Equivalents</span> &#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240630_zE3HFPXSzMMl" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230630_zzUAlB3ozL8j" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CashOnHand_iI_maCACEz9Hz_z7vm8uu5LhW2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Cash on hand</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--BalancesWithBanks_iI_maCACEz9Hz_zQjt6dNqt0q3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash at bank</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,543,837</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,701,567</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--CashAndCashEquivalents_iTI_mtCACEz9Hz_ztzFeQB6I0X5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total cash and cash equivalents</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,544,837</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,702,567</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--CashAndCashEquivalents_iI_zArdMXCRT3Kj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cash as per above</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,544,837</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,702,567</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--CashAndCashEquivalents_iI_zHAwqU2KunJ1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Balance as per statement of cash flows</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,544,837</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,702,567</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_zxsqNlcv4yVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320881520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Trade and other receivables</a></td>
<td class="text"><p id="xdx_80F_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zlvdalxYgf7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. <span id="xdx_82C_zaBZ9RRnxN02">Trade and other receivables</span></b></span></p>

<p id="xdx_897_ecustom--DisclosureOfTradeAndOtherReceivableExplanatory_z9Kqk8ZxLgz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zGeOOPl2rvgj" style="display: none">Schedule
of Trade and Other Receivables</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240630_z3HBqL7GOEQ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230630_zHNoveeYHHv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--TradeReceivables_iI_zsAQml8LWkt4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Trade Receivables</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">657</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">351,905</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--AccruedIncomeOtherThanContractAssets_iI_zSfGSPbkl2kh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,443</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ResearchAndDevelopmentIncome_iI_zh8sjvLVx2t6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research and Development Tax incentive receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0942">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,776</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--OtherReceivables_iI_zd4qP7ry3Kz2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other advances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,618</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,952,560</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AllowancesForCreditLoss_iI_z2DkDzNVX90f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less; allowance for credit losses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,603</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,603</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eifrs-full--TradeAndOtherReceivables_iI_zLn2rvVIKUk5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total trade and other receivables</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">71,115</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,365,638</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zV6ypdRDyQI8" style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The Company has applied the simplified approach to measuring expected credit losses, which use a lifetime expected loss allowance. The Company also recognizes a refund liability in line with our revenue recognition policy in Note 2.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322222304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property and equipment</a></td>
<td class="text"><p id="xdx_80F_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zRlvJlKEhEn8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. <span id="xdx_82F_zy9uEqfyaXb4">Property and equipment</span></b></span></p>



<p id="xdx_890_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z4Spbpyx1bjc" style="margin: 0"><span id="xdx_8BE_zN9nwSU0bEv3" style="display: none">Schedule
of Property and Equipment</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20240630_z8yuAJ8MDg4g" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230630_z1pR9LZM9mv3" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zWF0lFKBxGBa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Plant and equipment - at cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">72,410</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">69,210</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zhsKji62vnnh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(59,339</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(56,002</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zlbJnq9EQAbc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,071</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,208</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zusnWBfhM3Q5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer equipment - at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,047</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,612</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zg5am1rBKOma" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(82,269</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(54,929</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zNDHpHcK1DJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,778</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,683</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zIM4Jcl8lSX" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office equipment - at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,090</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_znmNN4ZfWcLh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,508</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,313</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zphmh3ylXEb8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">582</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">777</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20240630_zSZhQ5pO2klj" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20230630_z8ignUUSiYHa" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_401_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zbhg8nWwLbE6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Furniture &amp; Fittings - at cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">49,537</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">49,537</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zXX3RNQf27Vi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(14,270</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,277</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zB2QfahSvp6a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture &amp; Fittings</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">35,267</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">40,260</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_iI_zkm2lYfdlUP8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">77,698</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">94,928</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Property Plant and Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zVFYtlUGy7wj" style="text-align: right" title="Balance">13,208</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zk7vtZqiWWD6" style="text-align: right" title="Balance">10,189</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zvjrp2I2G7j9" style="text-align: right" title="Additions">3,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zy1ZnIoxVdTk" style="text-align: right" title="Additions">2,110</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zqDqMIPBKfM5" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1005">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zPdfmzEqGjf2" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1007">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zi58GAOax3G4" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(3,337</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zBGSt9KmaFS8" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">909</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year-</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zfdWwaqGZKm6" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">13,071</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zPWkzJKvfsJ" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">13,208</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Computer Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_dxL_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z0wStTmp5A38" style="text-align: right" title="Balance::XDX::40683"><span style="-sec-ix-hidden: xdx2ixbrl1017">51,971</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4L3npPCvlXd" style="text-align: right" title="Balance">51,971</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zaseSOdCciGk" style="text-align: right" title="Additions">15,435</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhEak30rSyW1" style="text-align: right" title="Additions">12,687</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zCZIanT1yvD3" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1025">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zENb5yXRlG3h" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1027">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zUczSfeONi0d" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(38,628</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zrE1kMCHaAw6" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(23,975</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zuIv6oRJpop1" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">28,778</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zHOwuc7dgvAc" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">40,683</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Office Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zT2gdA7rI0t3" style="text-align: right" title="Balance">777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zN8t4gG398gj" style="text-align: right" title="Balance">1,036</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zLTP0e5mOfIc" style="text-align: right" title="Additions"><span style="-sec-ix-hidden: xdx2ixbrl1041">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zolyYfpC2JQb" style="text-align: right" title="Additions"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zgZmtYyTAoY1" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1045">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zw8BMhz9U5q9" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1047">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zhP0D86yJe92" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(195</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zS1QX8kqxTJe" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(259</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zWmH4FGeTYLd" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">582</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zqDQ2A5bx5f3" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">777</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Furniture &amp; Fittings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zUuFgb9s88Th" style="text-align: right" title="Balance">40,260</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_z0mcpFwLBkek" style="text-align: right" title="Balance">45,224</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zsScsLS2XRJ5" style="text-align: right" title="Additions"><span style="-sec-ix-hidden: xdx2ixbrl1061">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zhsKqTjcgoN8" style="text-align: right" title="Additions"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zuuCmdALG1i3" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1065">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zbCw4R72GJRb" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1067">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zGkHTu3gvSf" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(4,993</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zIbrUGFllXP" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(4,964</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zPHniialTjY3" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">35,267</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zilSXRxgllok" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">40,260</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_zvW3f4OGcHdd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322653632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible assets</a></td>
<td class="text"><p id="xdx_801_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zEYzozc3Twtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. <span id="xdx_82C_zZ3eG6Rctsjf">Intangible assets</span></b></span></p>

<p id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_z4WWHGzNnSo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zy6ZJQJ4JJph" style="display: none">Schedule of Intangible assets</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240630_zbw9mhXi0cv6" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230630_zVFbHzDTLJyg" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWfOL3bUkefb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Trademark - at cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">52,243</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">50,843</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdMrzRmD2v78" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(29,653</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,429</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zGeCtoaUP3yc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark - at cost, net</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,590</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,414</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zg6787Dj2mm2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Platform development - at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,988,033</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,136,149</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbSFxOeozqT4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(713,360</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(351,202</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zldqW3wFluei" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Platform
    development - at cost, net</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,274,673</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">784,947</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_zD3AUrzw6X02" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total intangible assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,297,263</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">811,361</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zb65yvA8fY6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory_zM5JV1YW6tRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliations
of the movement of intangible assets are set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zzUebXIuSik5" style="display: none">Schedule of Reconciliations of the Movement of Intangible Assets</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20230701__20240630_zFOOXYRKZj65" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220701__20230630_zhreG6tQh7Hj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Trademark</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zvsRasfCteeb" style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left">Balance at beginning of the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">26,414</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">26,414</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z5BTHYfs6fwe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1108">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_za34hXYLEzpa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization expense</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,224</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1111">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zAKkxVkEsDnf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Balance at end of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22,590</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26,414</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Platform development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_z6NxPuO4om8h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">784,947</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,034,302</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AdditionsFromInternalDevelopment_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zxLtOsQJ3KCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additions from internal development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">352,182</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zsbD745T533l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additions acquired <span id="xdx_F4D_zkhnk0Ru9lo1">*</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">674,220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ResearchDevelopmentTaxIncentive_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zMTiZn8U98hh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research &amp; Development tax incentive</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1125">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(383,937</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_znukqCAigQqi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization expense</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(361,950</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(217,600</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zQrmniWgl8Fa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Balance at end of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,274,673</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">784,947</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F00_zE8r3Az3I4Oa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F14_zFnGGzVFHNc1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in additions
is acquired intangible assets of:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            September 2023, we completed the acquisition of the assets of Steppen Pty Ltd, a fitness
                                            technology company based in Australia (&#8220;Steppen&#8221;). As consideration for the asset
                                            acquisition, we issued Steppen an unsecured and non-redeemable convertible promissory note
                                            (on the same terms as the recently completed Private Placement), with a principal amount
                                            of US$ <span id="xdx_909_eifrs-full--NotionalAmount_iI_c20230930__ifrs-full--CounterpartiesAxis__custom--SteppenPtyLtdMember_zFJXAam8TyIf" title="Principal amount">64,977</span> (AUD$<span id="xdx_909_eifrs-full--NotionalAmount_iI_uAUD_c20230930__ifrs-full--CounterpartiesAxis__custom--SteppenPtyLtdMember_zRZTSBvMObUa" title="Principal amount">100,000</span>).</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            October 2023, we completed the acquisition of the assets of Mixed Martials Arts LLC, an independent
                                            MMA media company, based in the US. As consideration for the asset acquisition, we issued
                                            Mixed Martials Arts LLC an unsecured and non-redeemable convertible promissory note (on the
                                            same terms as the recently completed Private Placement), with a principal amount of US$<span id="xdx_907_eifrs-full--NotionalAmount_iI_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_zOAvpzW7u2w1" title="Principal amount">250,000</span>
                                            (AUD$<span id="xdx_90C_eifrs-full--NotionalAmount_iI_uAUD_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_z6Z71mZKZNod" title="Principal amount">384,750</span>) and paid US$<span id="xdx_901_eifrs-full--Cash_iI_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_zPWHyb4ReqE4" title="Cash">25,000</span> in cash.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            May 2024, we completed the acquisition of the assets of Hype Kit, Inc, a Delaware corporation
                                            (&#8220;Hype&#8221;), an all in-one digital marketing platform, designed to help small businesses
                                            grow in today&#8217;s age of social media. Hype&#8217;s software platform strengthens the
                                            Company&#8217;s vision to convert 640 million MMA fans to participants by providing invaluable
                                            tools to our gym owner, coach, and athlete partners to not only grow their revenues, but
                                            also operate more efficiently, save costs and enhance the offerings to <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">their
members and community. This acquisition is expected to accelerate Alta&#8217;s technology roadmap, bringing forward new subscription
revenue opportunities for us, whilst creating cost synergies by materially reducing product development overhead and bringing valuable
technology expertise, skills and talent into the business. The acquisition was completed, and the asset purchased for consideration of
USD$<span id="xdx_909_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20240531__ifrs-full--CounterpartiesAxis__custom--HypeKitIncMember_zawEFdzTJqK8" title="Asset purchased for consideration">100,000</span> (AUD$<span id="xdx_90F_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_uAUD_c20240531__ifrs-full--CounterpartiesAxis__custom--HypeKitIncMember_zZK4K0AcQjJ8" title="Asset purchased for consideration">153,000</span>)</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
                                            determined both the acquired intangible assets did not pass the concentration test under
                                            IFRS 3 Business Combinations. Thereby were accounted for as acquisition of intangible assets.</span></td></tr></table>

<p id="xdx_8AF_zbbEO8hZJnC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321652528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other payables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfTradeAndOtherPayablesAbstract', window );"><strong>Trade And Other Payables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory', window );">Trade and other payables</a></td>
<td class="text"><p id="xdx_804_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_zcQYsSvbk3A3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
13. <span id="xdx_822_zGhoTcN7FY48">Trade and other payables</span></b></span></p>

<p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayables_zcigglHseYi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_z1pFUCbStljj" style="display: none">Schedule of Trade and Other Payables</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zzRqt8QejHec" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20230630_zH2rBd2YQCe7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--TradeAndOtherPayablesPayableToMemberGyms_iI_maTAOPzf2r_zCUAJCQhg4Zg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Payable to member gyms</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">69,019</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">61,065</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--TaxesPayable_iI_maTAOPzf2r_zKTaaUbe5Cug" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">603,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">560,204</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--TradePayables_iI_maTAOPzf2r_zgIV4zl7CxY5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">540,102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">723,105</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ProvisionForRefundLiability_iI_maTAOPzf2r_zWEOr8VpVAW6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Provision for refund liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--OtherPayables_iI_maTAOPzf2r_z17Syid3zER2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other Payables</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">778,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">620,062</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--TradeAndOtherPayables_iTI_mtTAOPzf2r_z50oSktPub1h" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total trade and other payables</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,991,536</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,034,436</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zIyO2Ceq2SC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfTradeAndOtherPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfTradeAndOtherPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320875456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Current and Non-current Employee Entitlements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract', window );"><strong>Current And Non-current Employee Entitlements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory', window );">Current and Non-current Employee Entitlements</a></td>
<td class="text"><p id="xdx_802_ecustom--DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory_zbZkKAmb7Nf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 14. <span id="xdx_82D_zkyzW3h2Nzmh">Current and Non-current Employee
   Entitlements</span></b></span></p>

<p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory_zErYGqEv8pT3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>&#160;</span></b></span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zXK32yoCCa14" style="display: none">Schedule of Current and Non-current Employee Entitlements</span></span></p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240630_zqnFK1vvJbF2" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20230630_zcvpot8RqXdk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--CurrentProvisionsForEmployeeBenefits_iI_zCIX6RQcOSr" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Current Employee Entitlement</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">454,342</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">357,227</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NoncurrentProvisionsForEmployeeBenefits_iI_zOZjPFsDm7Za" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Non-current Employee Entitlements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,622</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,892</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A6_zhkCFXDhSoY4" style="margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of current and non current employee entitlements explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319048816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Unearned Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfUnearnedRevenueAbtract', window );"><strong>Unearned Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfUnearnedRevenueExplanatory', window );">Unearned Revenue</a></td>
<td class="text"><p id="xdx_809_ecustom--DisclosureOfUnearnedRevenueExplanatory_z7AejCwtqwGd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Note 15. <span id="xdx_823_zAeQQ3gvKGfb">Unearned Revenue</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;</span></p>

<p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory_z3LdcY8UUL4" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;<span id="xdx_8BD_zxG2tDSKM5E" style="display: none">Schedule
of Unearned Revenue</span> </span></p>



<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20240630_zlEvGQQGNqj7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20230630_z3CsV6nWAyO" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--UnearnedRevenue_iI_zK8QSeSdAgD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 68%">Unearned Revenue</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">174,290</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  </table>

<p id="xdx_8A6_z9WGi1GHZQI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfUnearnedRevenueAbtract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfUnearnedRevenueAbtract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfUnearnedRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of unearned revenue explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfUnearnedRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320887888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reserves<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfReservesAbstract', window );"><strong>Reserves</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory', window );">Reserves</a></td>
<td class="text"><p id="xdx_80C_eifrs-full--DisclosureOfReservesAndOtherEquityInterestExplanatory_z1PhttHcLPxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
16. <span id="xdx_825_zLDmVOVogjB2">Reserves</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>&#160;</span></b></span></p>

<p id="xdx_89E_ecustom--ScheduleOfReservesTableTextBlock_zLJbJUzbgzZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z2pBebaXDblc" style="display: none">Schedule
of Reserves</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zz9bVQNbSrpf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230630_zGg46BUY79G2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220630_ztcrbkNkzbc8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ReserveOfUnbilledShareOption_iI_zMGgFfZ6q9V6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Unlisted share option reserve</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2,741,457</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1193">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ReserveOfSharebasedPayments_iI_zbS34NmH7cqi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share based payment reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,734,601</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,912,367</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,546,983</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ForeignCurrencyReserves_iI_zpouhT90SLgj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign currency translation reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(86,542</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(65,832</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,367</td><td style="text-align: left">)</td></tr>
  </table>
<p id="xdx_8A3_zLb9z1LwcYXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfReservesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfReservesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of reserves within equity. [Refer: Other reserves [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320889712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Issued capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIssuedCapitalExplanatory', window );">Issued capital</a></td>
<td class="text"><p id="xdx_809_eifrs-full--DisclosureOfIssuedCapitalExplanatory_zK2uWri3r9q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
17. <span id="xdx_82F_z8Wgqef40LOc">Issued capital</span></b></span></p>

<p id="xdx_895_ecustom--DisclosureOfDetailedInformationIssuedCapitalExplanatory_zPMktKfppKH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B7_zoD0Hqlev9Rc" style="display: none">Schedule
of Issued Capital</span> </b></span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230701__20240630_zn9pNIbOrWV7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220701__20230630_zgDxKzy7dyEa" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210701__20220630_zG8jp2ktb71k" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--OwnersShareCapital_iS_zKCVHf2eUfy" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Owners share capital, opening (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,918,750</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,918,750</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,918,750</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--NumberOfShareIssuedAndFullyPaid_iI_zUBhQRo77FOj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issued and fully paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,315,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssueOfSharesFromConversionOfConvertibleNotes_iI_zG1RDQWZHy72" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue of shares from the conversion of <br/>the convertible notes (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,706,794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1217">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--AdvisorOptionsExercisedShares_iI_zGuEBkkcJVe4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Advisor Options exercised (3)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">327,142</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1221">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--OwnersShareCapital_iE_ztL346Cfxugi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Owners share capital, closing</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,267,686</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,918,750</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,918,750</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230701__20240630_zbeUkXxhmbZ2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220701__20230630_zXLDYJL3Y0W4" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210701__20220630_zsfkk35OcLkg" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--IssuedCapital_iS_zg69Yz2AiQjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Owners share capital, opening <span id="xdx_F47_zjFCNTsI7pm9">(1)</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,385,281</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,385,281</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,385,281</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--IssuedAndFullyPaidValue_iI_zIhtblNtgsr6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issued and fully paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,964,825</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1233">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--PaymentsForShareIssueCosts_iN_di_zxb1M40zgww4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share issue transaction costs net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,174,911</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1238">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IssueOfEquityFromConversionOfConvertibleNotes_znczo8SFg057" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issue of shares from the conversion of <br/>the convertible notes <span id="xdx_F4A_z5LnXeVHYML3">(2)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,177,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1242">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--AdvisorOptionsExercisedValue_zr5sXAezuH2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Advisor Options exercised <span id="xdx_F45_zRA9StAPqgO3">(3)</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,426,757</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1246">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--IssuedCapital_iE_zRkkrDEpE2b7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Owners share capital, closing</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">46,779,703</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,385,281</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,385,281</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F09_zUXUyW0TuCdi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zk2zoxoSlYo7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 24, 2024, there was a reverse share split of our issued and outstanding Ordinary
                                            Shares and Ordinary Share equivalents on the basis of four (4) securities for every five
                                            (5) securities held. All issued and outstanding Ordinary Shares and Ordinary Share equivalents
                                            and per share data have been adjusted throughout the financial statements to reflect the
                                            reverse share split for all periods presented.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0B_z4wSMrtrgtMl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zV3MPtwn4PV5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            issue of shares from the conversion of convertible notes reflects and includes the face value
                                            of the note and interest accrued at a fixed rate defined in the agreements, along with the
                                            value of the derivative prior to conversion. This interest figure includes both the accrued
                                            interest rate (contractual and effective) relating to the convertible notes, with the contractual
                                            capitalised interest rate ranging between <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLfugi4sxe0j" title="Contractual capitalised interest rate">8.5</span>% to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_za6aLsj3gMFg" title="Contractual capitalised interest rate">15</span>% per annum, and the derivative reflects the effective interest rate being the cost of the relevant conversion discounts to market value at
the conversion date.</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
17. Issued capital - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_zQiZMShGsO8i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z4piaXKlPuyl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                                            that <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--AdvisorOptionsExercisedShares_c20230701__20240630_zL4BG4Y3jk25" title="Advisor options exercised, shares">327,142</span> Advisor Options fully vested and were exercised into Shares between July 2023
                                            and December 2023 and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--AdvisorOptionsForfeitedShares_iI_c20240630_z7hRoX7U4kUl" title="Advisor options forfeited, shares">16,193</span> Advisor Options were forfeited.</span></td></tr></table>

<p id="xdx_8A2_zO7XnYCpxdM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capital
risk management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company&#8217;s objectives when managing capital is to safeguard its ability to continue as a going concern, so that it can provide returns for shareholders and benefits for other stakeholders and to maintain an optimum capital structure.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s capital includes Ordinary Share capital and financial liabilities supported by financial assets. There are no externally
imposed capital requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company effectively manages capital by assessing the Company&#8217;s financial risks and adjusting
its capital structure in response to changes in these risks and the market. These responses include the management of debt and share
issuances.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321704272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes to statement of cash flows<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory', window );">Notes to statement of cash flows</a></td>
<td class="text"><p id="xdx_807_eifrs-full--DisclosureOfCashFlowStatementExplanatory_zsT9oPvTwQPe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
    18. <span><span id="xdx_828_zKzNiEnoiVBe">Notes to statement of cash flows</span></span></b></span></p>

<p id="xdx_893_ecustom--DetailedInformationOfNotesToStatementOfCashFlowExplanatory_z3gzsXiaQOCj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BF_z9B1HJRpJk28" style="display: none">Schedule
of Statement of Cash Flows</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20230701__20240630_zCZgGGC0xLB9" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220701__20230630_zVOfxZpP9ld6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20210701__20220630_zbQ7onH0NoSh" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--ProfitLoss_zjN1Qm2AZwja" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Loss after income tax</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(14,408,346</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(20,597,436</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(11,197,450</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Non-cash flows in operating loss: <br/></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--AccruedInterestOnConvertibleNotes_zypX2Jcdkgn4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued interest on convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,207,497</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,420,225</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,162,646</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_zsUZZzs3Y7Q5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share-based payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,521,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,365,384</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,546,983</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ConvertibleNotesIssuedInLieuOfPaymentForServices_zLCLJwjBx6r9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible notes issued in lieu of payment for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1279">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">624,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1281">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--DepreciationExpense_zU9Y8aFwHzJi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortisation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">520,697</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">360,021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">260,651</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--FairValueMovementRecognisedInProfitOrLoss_zL3EcxUjLw5e" style="vertical-align: bottom; background-color: White">
    <td>Fair value movement of derivatives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,400,685</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,870,729</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,751,564</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in assets and liabilities: <br/></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_zhVXlvxLV4Gc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Decrease in trade and other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">372,390</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">506,737</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130,933</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustmentsForDecreaseIncreaseInOtherAssets_ze3Sk78lgjqb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">(Increase)/Decrease in other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(189,621</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,015,343</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_zdy0c54ElOV4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Increase/(decrease) in trade and other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,719</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(153,292</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">993,662</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--AdjustmentsForIncreaseDecreaseInNetDeferredRevenue_zcQro3SQ9jnd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Decrease in net deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(174,290</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(121,453</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(339,222</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--AdjustmentsForIncreaseDecreaseInProvisionForRefund_zplmHTrvaQX6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">(Decrease)/increase in provision for refund</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(70,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_znZg4nO42Jeh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Increase in employee entitlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">133,845</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">102,833</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CashFlowsFromUsedInOperatingActivities_iT_zC6BozSyb4Hk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,386,196</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,555,868</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(8,055,185</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A5_zgILBGjOaYUa" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section Presentation of a statement of cash flows<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS07_g10-17_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashFlowStatementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322581440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related parties transactions</a></td>
<td class="text"><p id="xdx_807_eifrs-full--DisclosureOfRelatedPartyExplanatory_zl62GiCpgfic" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
19. <span id="xdx_82D_z2h9PnTIZ4Li">Related parties transactions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif">(a)
Directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following persons held office as Directors of the Company during the years reported:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas
                                            Langton</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hugh
                                            Williams</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vaughn
                                            Taylor</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jonathan
                                            Hart</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Remuneration of Key Management Personnels</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key management personnel remuneration:<b></b></b></span></p>

<p id="xdx_89C_eifrs-full--DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_zlyhUauOV7od" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B1_ztW2AXnKZ5hk" style="display: none">Schedule
of Key Management Personnel Remuneration</span></span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230701__20240630_z8Ufl7TIa9M8" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220701__20230630_zGjgdSXwEsl5" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20210701__20220630_z50Pej9t8m4g" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_maKMPCzfQ1_z264cbSzJCg3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Short term benefits</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,031,194</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">657,879</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">671,709</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_maKMPCzfQ1_z7sfxupR6eTc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Post employment benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,730</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,191</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,542</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationOtherLongtermBenefits_maKMPCzfQ1_zywIFKfYPxtj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Long term benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,474</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,892</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1333">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_maKMPCzfQ1_z7Wyf9d7WGxj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Share Based payments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,808,863</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,065,554</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">897,586</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensation_iT_mtKMPCzfQ1_zf2g8IvGk3Hc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,919,261</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,775,516</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,612,837</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p id="xdx_8A8_zjfv98xoiAk3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Related Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
Held by Key Management Personnel:</b></span></p>

<p id="xdx_892_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_gL3DOTBRPE-JAYXU_zCIemTAmLuvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zxAlHNVdoD31" style="display: none">Schedule
of Shares Held by Key Management Personnel</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zRpO73yah3pg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares<br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zbnpnm9YoWB2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zN4pOFKcU7x4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares<br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--NumberOfSharesOutstanding_iS_z6l8k3OwFZy4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Opening Balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,149,362</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,786,093</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">2,955,616</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssuedSharesHeldByKeyManagementPersonnel_zumMm30xbNVh" style="vertical-align: bottom; background-color: White">
    <td>Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">296,535</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1352">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">477,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--RepurchasedSharesHeldByKeyManagementPersonnel_ztRpphVMuAx3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Repurchased</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1355">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1356">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,200,000</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--ResignationOfKeyManagementPersonnelShares_zR9740m7UdG8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Resignation of Key Management Personnel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1359">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(530,609</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1361">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ReverseShareSplitSharesHeldByKeyManagementPersonnel_z68QYMVcqyo4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Reverse Share Split</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1363">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(106,122</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(446,523</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eifrs-full--NumberOfSharesOutstanding_iE_zocCRjlKg23d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Closing Balance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,445,897</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,149,362</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,786,093</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_z91aLLHt8lzl" style="margin: 0">&#160;</p>

<p style="margin: 0"></p>



<p style="margin: 0">&#160;</p>

<p style="margin: 0"><b>Note 19. Related parties transactions - continued</b> <br/>&#160; <br/><b>Options Held by Key Management Personnel:</b></p>

<div id="xdx_C01_gL3DOTBRPE-JAYXU_zMLnDwIEtkV4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zf2re8yb9Pk9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Shares Held by Key Management Personnel (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_z16uc5B0wdi4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_zPEoY8showuh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_zRAtYVHqkyIj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option<br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zNJcdu9WjZP6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Opening Balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">654,364</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">515,850</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1373">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--IssuedOptionsHeldByKeyManagementPersonnel_zItZ45f2rf3d" style="vertical-align: bottom; background-color: White">
    <td>Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">342,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">279,221</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">644,813</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ExpiredOptionsHeldByKeyManagementPersonnel_z58RYCageMSb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Expired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(106,078</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1381">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ExercisedOptionsHeldByKeyManagementPersonnel_zMGYypES4Ac5" style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(205,086</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1385">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ReverseShareSplitOptionsHeldByKeyManagementPersonnel_zJN8YGPKezs2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Reverse share split</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(34,629</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(128,963</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_uShares_zEbdpHm4JAd8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Closing Balance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">791,278</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">654,364</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">515,850</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span id="xdx_C0B_gL3DOTBRPE-JAYXU_zL91IvndAerc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related Party Transaction by Key Management Personnel</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending June 30, 2024, Mr. Langton, through Snowflower Holdings Pty Ltd as trustee for the Snowflower Family Trust Account, was issued <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrLangtonMember__srt--ConsolidatedEntitiesAxis__custom--SnowflowerHoldingsPtyLtdMember_z3efiHHc5Ee8" title="Shares issued">172,000</span> share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_90B_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrLangtonMember__srt--ConsolidatedEntitiesAxis__custom--SnowflowerHoldingsPtyLtdMember_zPIQJVk2PnUb" title="Percentage vest and exercisable">50</span>% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending June 30, 2024, Mr. Williams, through Champ 7 Pty Ltd as trustee for the Williams Family Trust Account, was issued <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrWilliamsMember__srt--ConsolidatedEntitiesAxis__custom--ChampSevenPtyLtdMember_zMcxa8J8xqm5" title="Shares issued">14,400</span> share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_904_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrWilliamsMember__srt--ConsolidatedEntitiesAxis__custom--ChampSevenPtyLtdMember_zy9BhnJG88V1" title="Percentage vest and exercisable">50</span>% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending June 30, 2024, Mr. Taylor, through Nalaroo Holdings Pty Ltd as trustee for the Lavoipierre Taylor Fam Trust Account, was issued <span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrTaylorMember__srt--ConsolidatedEntitiesAxis__custom--NalarooHoldingsPtyLtdMember_z2o4W3FUAdnc" title="Shares issued">73,600</span> share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_906_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrTaylorMember__srt--ConsolidatedEntitiesAxis__custom--NalarooHoldingsPtyLtdMember_z6NwqkrPWWha" title="Percentage vest and exercisable">50</span>% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending June 30, 2024, Mr. Hart, as trustee for the J Hart Family Trust Account, was issued <span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrHartMember__srt--ConsolidatedEntitiesAxis__custom--JHartFamilyTrustAccountMember_zf1QpC1AidL" title="Shares issued">47,600</span> share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_909_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrHartMember__srt--ConsolidatedEntitiesAxis__custom--JHartFamilyTrustAccountMember_z8nNzM1zcBH" title="Percentage vest and exercisable">50</span>% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
19. Related parties transactions - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending June 30, 2024, under Mr. Java&#8217;s employment agreement, Mr. Java was paid a short-term incentive of A$<span id="xdx_90E_eifrs-full--ShorttermEmployeeBenefitsExpense_c20230701__20240630__ifrs-full--TypesOfContractsAxis__custom--EmploymentAgreementMember_zqWMt2fdddG5" title="Short term incentive">98,589</span>. Mr. Java, through 3213 Ventures Pty Ltd as trustee for the Java Holdings Trust, was issued <span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_c20240630__ifrs-full--TypesOfContractsAxis__custom--EmployeementAgreementMember_zEdJosbXeRck" title="Number of shares issued">34,400</span> share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_90A_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfContractsAxis__custom--EmployeementAgreementMember_z1Dyd7BTtm6a" title="Share percent rate">50</span>% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
related parties:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tanya Langton, our Head of Global Events and Logistics and the spouse of Mr. Langton, was issued <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--TitleOfIndividualAxis__custom--Mr.LangtonMember_zAdSyQ260zVk" title="Number of shares issued">6,000</span> share rights
(subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. <span id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_dp_uPure_c20230701__20240630__ifrs-full--CounterpartiesAxis__custom--Mr.LangtonMember_zmGyEy77xI04" title="Share percent rate">50</span>% of the share rights will vest and become
exercisable on October 1, 2025 and the balance of the <span id="xdx_906_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_dp_uPure_c20251001__20251002__ifrs-full--CounterpartiesAxis__custom--Mr.LangtonMember_zXlDlkFMwEvd" title="Share percent rate">50</span>% of the share rights will vest and become exercisable on October 1, 2026. </span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as disclosed, the Company did not enter into any transactions or loans with any:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enterprises
                                            that directly or indirectly, through one or more intermediaries, control, are controlled
                                            by or are under common control with us;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">associates;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">individuals
                                            owning, directly or indirectly, an interest in our voting power that gives them significant
                                            influence over us, and close members of any such individual&#8217;s family;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">key
                                            management personnel and close members of such individuals&#8217; families; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enterprises
                                            in which a substantial shareholder interest in our voting power is owned, directly or indirectly,
                                            by any person described in (iii) or (iv) or over which such person is able to exercise significant
                                            influence.</span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Parent Entity</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
individual financial statements of the Parent Entity show the following aggregate amounts:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of the parent entity</b></span></p>

<p id="xdx_89E_eifrs-full--DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable_zoM2Bmqxj5o2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B0_zjctP2YwIvI3" style="display: none">Schedule
of Financial Statement of the Parent Entity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zSXxUIAl0Cck" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zjM5jYv77izc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zjQKGBBDYFZ6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--ProfitLoss_maCIzNLL_zDn1hZgYZyye" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Loss for the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(14,029,605</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(20,053,426</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(10,667,136</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eifrs-full--OtherComprehensiveIncome_maCIzNLL_zMeO8C25X5x7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other comprehensive loss for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1429">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1430">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1431">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--ComprehensiveIncome_iT_mtCIzNLL_zwEW5ZRdOqhj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total comprehensive loss for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(14,029,605</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(20,053,426</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,667,136</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zWiOzrj7VAKk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zcBJeHqVoGHc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">Financial position of the parent entity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--AssetsAbstract_iB_zO8hUtgYDft8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--CurrentAssets_iI_maAz7FR_zpofYFRmmuw8" style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left">Current assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">5,309,505</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">7,307,155</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--NoncurrentAssets_iI_maAz7FR_zomskbMru34b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Non-current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,687,347</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,120,872</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--Assets_iTI_mtAz7FR_maNALzqK8_z1JShNb2Qfx9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,996,852</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,428,027</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--LiabilitiesAbstract_iB_zi5mrwglFOe3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--CurrentLiabilities_iI_maLzEC6_zBiiu21DG2f7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,577,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,018,760</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--NoncurrentLiabilities_iI_maLzEC6_z9EyNWr0JILf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Non-current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">186,344</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,346,332</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--Liabilities_iTI_mtLzEC6_msNALzqK8_zmxJgWPBkxr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,763,384</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">38,365,092</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NetAssetsLiabilities_iTI_mtNALzqK8_zjlDFZKoVrjb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Assets/Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,233,468</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(29,937,065</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--EquityAbstract_iB_znTnlfsUqlW9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ContributedEquity_iI_msEzyRy_zUQu06RTKUp7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Contributed equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,779,703</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,385,281</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--OtherReserves_iI_maEzyRy_zVvfq1xdVIg1" style="vertical-align: bottom; background-color: White">
    <td>Reserves</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,476,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,912,367</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--RetainedEarnings_iI_maEzyRy_z4RIiPyAcVGc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated losses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(51,022,338</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(37,234,713</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eifrs-full--Equity_iTI_mtEzyRy_zgjPtwCoELr7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,233,468</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(29,937,065</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
</table>

<p id="xdx_8A2_zt2ZAqJHOzEa" style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">There were no material contingent assets and liabilities in the Parent Entity at June 30, 2024 (nil &#8211; June 30, 2023).</p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
19. Related parties transactions - continued</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s subsidiaries at June 30, 2024 are set out below. Unless otherwise stated, they have share capital consisting solely of
Ordinary Shares that are held directly by the company, and the proportion of ownership interests held equals the voting rights held by
the company. The country of incorporation or registration is also their principal place of business.</span></p>

<p id="xdx_893_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesTable_zfQLFJExX3rc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zQpISVlRSD9" style="display: none">Schedule
of Country Incorporation Principal Place of Business</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230701__20240630_zKincIqhWO09" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20220701__20230630_zy4RLrW8z9Zh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span>Name of entity</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span>Place of business</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ownership interest held</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 31%; text-align: left"><span id="xdx_906_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorLLCMember_zjhQuTH3faod">Wimp 2 Warrior LLC</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 31%; text-align: left"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaCountryMember_z1mKcAau5sr7">United States of America</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_dp_uPure_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorLLCMember_z4G0DA1wbnG1" style="width: 14%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorLLCMember_z0THeK77642k" style="width: 14%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_906_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorProductionsPtyLtdMember_fKg_____zFLc9ciUo9y3">Wimp 2 Warrior Productions Pty Ltd</span> *</td><td>&#160;</td>
    <td><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--AustraliaCountryMember_fKg_____zj8Pdp6U7Ttf">Australia</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorProductionsPtyLtdMember_fKg_____zn2k5Omfhzxa" style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorProductionsPtyLtdMember_fKg_____zuvKQUrNqwZ4" style="text-align: right">95</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_90E_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorDigitalPtyLtdMember_fKg_____z8iNRJ5RwCa6">Wimp 2 Warrior Digital Pty Ltd</span> *</td><td>&#160;</td>
    <td><span id="xdx_900_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--AustraliaCountryOneMember_fKg_____zmR4iEqtea1b">Australia</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorDigitalPtyLtdMember_fKg_____ziACokCJrrZg" style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorDigitalPtyLtdMember_fKg_____z13MQWplYtMg" style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_908_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorIrelandLimitedMember_z0VxsEIvAEih">Wimp 2 Warrior (Ireland) Limited</span></td><td>&#160;</td>
    <td><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--IrelandCountryMember_zdUFTcIXkPy4">Ireland</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorIrelandLimitedMember_zztHnkEkO83k" style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorIrelandLimitedMember_z8AcFDgp26y7" style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span id="xdx_905_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--HypeCoMember_zMZL9jajf4Na">Hype.Co</span></td><td>&#160;</td>
    <td style="text-align: left"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaCountryOneMember_zURtWeNeIXP4">United States of America</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--HypeCoMember_zjbbSeN7yLEl" style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--HypeCoMember_zdu1MdFin8h6" style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0E_zm1TLYJpUC48" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F15_zHV6CTquVWrf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entities deregistered
in the period to June 30, 2024.</span></td>
</tr></table>

<p id="xdx_8A9_zoQJgkpoqYFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319504352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Leases</a></td>
<td class="text"><p id="xdx_809_eifrs-full--DisclosureOfLeasesExplanatory_zNkExyc59oRi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
20. <span id="xdx_824_zZoHeZqsNnu2">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the commencement of a lease contract, the Company assesses whether the contract conveys the right to control the use of an identified
asset for a period of time in exchange for consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2024, the Company determined with reasonable certainty that it would exercise its extension option at its current
premises for two additional years. As a result, the Company has reassessed the lease term and related balances, which are reflected in
the table below:</span></p>

<p id="xdx_896_eifrs-full--DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_ziCf63XLziz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zgDoRZq7aEC" style="display: none">Summary
of Changes in ROU Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">(a) Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left">Right of use asset</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_ecustom--RightofuseAsset_iS_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW0f7JEjAIBf" style="width: 12%; text-align: right" title="Right of use asset">613,691</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--RightofuseAsset_iS_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSdyrWfuM371" style="width: 12%; text-align: right" title="Right of use asset">400,829</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--AccumulatedAmortization_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zu5Y3ybHL2k2" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period">(358,228</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--AccumulatedAmortization_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwUwV0tJBMAj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period">(243,290</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Balance at end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--RightofuseAsset_iE_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBKN7ji4A6pg" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year">255,463</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RightofuseAsset_iE_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRbDrCbrBQYh" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year">157,540</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--RightofuseAsset_iS_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zP7koQHKeQ7h" style="text-align: right" title="Balance at beginning of year">157,540</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--RightofuseAsset_iS_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z3DQrTKCygZi" style="text-align: right" title="Balance at beginning of yea">276,907</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Modification</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--Modification_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z15ci9QCcPV4" style="text-align: right" title="Modification">212,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--Modification_iI_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zFcuqlNEuE85" style="text-align: right" title="Modification"><span style="-sec-ix-hidden: xdx2ixbrl1524">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: amortization for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--AccumulatedAmortization_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z9s5QEJz6Znf" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period">(114,759</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--AccumulatedAmortization_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zXSlPeqKqUFj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period">(119,367</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--RightofuseAsset_iE_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zl2WOe0KbKKa" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year">255,463</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RightofuseAsset_iE_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z4q3N2QxJHUa" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year">157,540</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">(b) Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--CurrentLeaseLiabilities_iI_c20240630_zvPMDte7J3Ck" style="text-align: right" title="Current lease liability">128,559</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--CurrentLeaseLiabilities_iI_c20230630_z0Q5x28E5D8f" style="text-align: right" title="Current lease liability">121,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Non-current lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eifrs-full--NoncurrentLeaseLiabilities_iI_c20240630_zH0pDaMPTQg1" style="border-bottom: Black 1pt solid; text-align: right" title="Non-current lease liability">130,722</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--NoncurrentLeaseLiabilities_iI_c20230630_zkpth2DWjvO" style="border-bottom: Black 1pt solid; text-align: right" title="Non-current lease liability">54,162</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--LeaseLiabilities_iI_c20240630_zo6k1lIA5MWb" style="border-bottom: Black 1pt solid; text-align: right" title="Total lease liabilities">259,281</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eifrs-full--LeaseLiabilities_iI_c20230630_zVnNtNHtgcc7" style="border-bottom: Black 1pt solid; text-align: right" title="Total lease liabilities">175,662</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zFubkFPUCDsf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
20. Leases - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total of future lease payments (including those lease payments that are not included in the measurement of the lease liability, e.g.
for short-term leases and leases of low-value items) are disclosed for each of the following periods.</span></p>

<p id="xdx_896_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_z4D0wss8f2u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_z4oesS1LIrvl" style="display: none">Summary
of Future Minimum Lease Payments</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240630_zUciWd6oymo5" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230630_ztQ9kyY1o8H4" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_maLLzHsH_zkrOBgGJZKt2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Less than one year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">135,680</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">127,361</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_maLLzHsH_zFpGlH0qhgBe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">One to two years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_maLLzHsH_zcGWuInT1sGg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Two to five years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_maLLzHsH_zqXC9JRz2M7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Five years and over</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1557">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1558">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--LeaseLiabilities_iI_pp0p0_hifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_mtLLzHsH_zaXrmVWwrCHh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total future lease payments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">217,187</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">183,789</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321413168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory', window );">Financial Liabilities</a></td>
<td class="text"><p id="xdx_803_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_ze4kvS2LGDXd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. <span id="xdx_823_zloOrkesuHc">Financial Liabilities</span></b></span></p>

<p id="xdx_890_ecustom--DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory_zqPXXi9zrlvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Financial Liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ConvertibleInstrumentsMember_zaJvSGUngEdf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ConvertibleInstrumentsMember_zCpBCtaqKjte" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--CurrentFinancialLiabilities_iI_maFLz9PT_zeQSQ1S9pWb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Convertible note payable - Current</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1567">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">25,331,307</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--NoncurrentFinancialLiabilities_iI_maFLz9PT_zppzfpe3V7e6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible note payable &#8211; Non Current</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1570">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,273,278</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--FinancialLiabilities_iTI_mtFLz9PT_zI8Yo4b5cuEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Financial Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1573">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">35,604,585</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CurrentDebtInstrumentsIssued_iI_maDSznTX_zTv2A2z8q3Fi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Host Liability - Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1576">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,567,450</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--NoncurrentDebtInstrumentsIssued_iI_maDSznTX_z4DzOPj9qQP8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Host Liability &#8211; Non Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1579">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">342,406</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_maDSznTX_zmEHtWJZpfW3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Derivative liability -Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1582">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,763,857</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iI_maDSznTX_zsde6Hflx1I2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Derivative liability - Non Current</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1585">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,930,872</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--DebtSecurities_iTI_mtDSznTX_zRBnTMDqk59c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Convertible Notes Payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1588">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">35,604,585</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zrTwn8lBud84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
convertible notes issued by the Company have been split into the debt liability and a derivative component. The fair value of the Financial
Liabilities for the host liability and the derivative liability has been determined using a combination of Monte Carlo Simulation (MCS)
and Black-Scholes model (BSM).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the reporting period <span id="xdx_90F_eifrs-full--DescriptionOfConversionOfDebtToEquity_c20230701__20240630_zIGQYDd4iXLd" title="Conversion of debt to equity">Series A &#8211; July 21 matured and converted to equity on 7 July 2023, while Series A, Series A &#8211; Aug 21,
Series B1, Series B2 and Series A Extension matured and converted to equity on 31 December 2023.</span> During the reporting period the Company
issued two additional Convertible Notes for the acquisition of Mixed Martial Arts LLC and Steppen. Mixed Martial Arts LLC, Steppen, Reach
and Private Placement convertible notes converted to equity or were redeemed for cash on March 28, 2024, on successful listing on the
NYSE by the Company, as per the conversion date in the table below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eifrs-full--DisclosureOfDebtSecuritiesExplanatory_zFeaMSLBtDbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
notes held by investors in the reporting period are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zxHj016l3T8k">Schedule
of Convertible
Notes held by Investors</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="font-style: italic; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series A</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Key Terms of this Series A convertible notes are as follows</i></span></p></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zKTyBiGTOkBg">23-Dec-20</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zckboiGTorYi">23-Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zy6NsfBzcmn1">1-Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zHUeRarlkhh9">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zcIukupuO0J">31 -Dec 23</span> </span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_907_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zgvjtyeejJQb">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zQJ6vqZUYUhj">7,319,818</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zzaC5xHGzy18">8.5</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zyhe1TlxgTyc">20.0</span></td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. - Financial Liabilities - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
A &#8211; July 21</b></span></p></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series A convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zu4HVLcYvDy6">7-Jul-21</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zVw4aqQOT9M6">7-Jul-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zZ9Q6iCydPHg">7-Jul-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_z6nUxvTzCBxg">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_z2VAU81ictC8">525,000</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zNKm7fP3bmN1">8.5</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zr4LC4BBNQCf">20.0</span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Series A &#8211; August 21</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series A convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zGC5Z3bs0jm4">20-Aug-21</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zhjRokEV9uZg">9 -Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zGyLx2NaRVcf">1-Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zqmVPs1uki4e">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zUypov1Yt4I9">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zMyTSVokMg52">1.3</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_z6GWYtXKE1sl">172,000</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zuI6b4KWOevf">8.5</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zTaNP8xp7Vd4">20.0</span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series B1 </b></span></p></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series B1 convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zWfOZme1Qlii" title="Issue Date">15-Dec-21</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zmCvEJVYHqge" title="Pre Modification Maturity Date">15-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zNcDhXuvCkxl" title="Modification Date">1-Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zfod4Eb7KKQi" title="Modified Maturity Date">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zPo4oyaBhY13" title="Conversion Date">31.Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zRR89usCshda" title="Term (Years)">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zh2qeau6QYyd" title="Face Value">4,982,652</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_z2RkfJdY8C14" title="Interest Rate">8.5</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zn8ri5Kc6ZQ2" title="Conversion Discount (Qualified Equity Investment)">20.0</span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. Financial Liabilities - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series B2</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_49B_20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zNADu065PWEg" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series B2 convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zsyxpG9JlFw3" title="Issue Date">1-July-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zaZemu70Nlfa" title="Pre Modification Maturity Date">30-June-24</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zSVSzLOnKTri" title="Modification Date">1-Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zelEyzEEiQI5" title="Modified Maturity Date">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zODcW7e9H2ea" title="Conversion Date">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_908_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_z0Nz8qhfQSqg" title="Term (Years)">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--Borrowings_iI_zYYZTZcwJVXi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">671,284</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--BorrowingsInterestRate_iI_dp_zk827CPePtqk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40D_ecustom--ConvertibleNotesConversionDiscount_iI_dp_z1ZMFc69oupb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20.0</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A Extension</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_490_20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_ze0iFRIDr6x5" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series A Extension convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_z0jHywvp22f3" title="Issue Date">16-Nov-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_z2eM1iM8iNFk" title="Modified Maturity Date">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_zDaBPU3ZfVM9" title="Conversion Date">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90C_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_zE0O8PAIVCB7" title="Term (Years)">1.1</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--Borrowings_iI_zIUvqsnhOYsa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,571,873</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zGDBoyRcRY1l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40C_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zYGxmwqqxsoi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reach</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_49C_20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zTXJDxkEE2R4" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Reach convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zPbnewNmlso2" title="Issue Date">13-Feb-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zuMY3qoLdYEi" title="Modified Maturity Date">13-Feb-25</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date <span>**</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_fKio___zzovJym22qA5" title="Conversion Date">28-Mar-24</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_906_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_z2EoLPwOvzGd" title="Term (Years)">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--Borrowings_iI_z2XJThR4Fri8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value<span id="xdx_F41_zNopM9pTRBHk">*</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,195,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zKBPam9e4uX2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40C_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zyhLh5GJx81b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">%</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%">
<tr style="vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span id="xdx_F0E_zKL2Udiju9o9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_znFHf0D56aPg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_ecustom--ReachConvertibleNote_iI_c20230609_zjH8cFvlAAXd" title="Reach convertible note">3,025,841</span> of Reach convertible
  notes, inclusive of accrued interest, were rolled into the Private Placement on June 9, 2023.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F0E_zxaqEBv0byX2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zLqqctjjK8Xa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_905_ecustom--RedeemedForCash_iI_c20230609_zCA5HXL5Vhw9" title="Redeemed for cash">1,029,617</span> was redeemed for
  cash, the remaining Reach notes were converted to equity.</span></td></tr>
</table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. Financial Liabilities - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private Placement</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_492_20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zxJnD1OVLjCl" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Private Placement convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zwOryoGKMuH6" title="Issue Date">9-June-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zbZSoW7dIIeb" title="Modified Maturity Date">9-June-25</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zah2YYs5M7K9" title="Conversion Date">28-Mar-24</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zhmq8lVWG9h6" title="Term (Years)">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--Borrowings_iI_zwFImW4vuCMc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,215,591</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--BorrowingsInterestRate_iI_dp_zLyRrty2aXwb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40E_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zWkIssbJvNT" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Mixed Martial Arts LLC</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zs9BukUeVvQh" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Mixed Martial Arts LLC convertible note are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zD0tPBtp9qYc" title="Issue Date">26-Oct-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zwXMJjMwZSaa" title="Modified Maturity Date">9-June-25</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zpsVSs6NRFXb" title="Conversion Date">28-Mar-24</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zR8PSRGxxDHl" title="Term (Years)">1.6</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--Borrowings_iI_zlaq9EcrMb04" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">384,750</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zjOm9BPcbhdl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zUwCHLGeSDA8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Steppen</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zV5NkY2FKv9a" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Steppen convertibles note are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zPS1k4VugEkf" title="Issue Date">20-Sept-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_z1Z7w84Wwr8f" title="Modified Maturity Date">9-June-25</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zQZudroVO076" title="Conversion Date">28-Mar-24</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_909_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_z70CTMpfQvjg" title="Term (Years)">1.7</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--Borrowings_iI_zZX5LndO1Qvf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,00</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_z1k97hEW8njb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zhn77hyBMTBl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8A2_zUP2P9rsNNw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322634784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share-based payments</a></td>
<td class="text"><p id="xdx_80A_eifrs-full--DisclosureOfSharebasedPaymentArrangementsExplanatory_z7jXmKXxKkTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
22. <span id="xdx_82F_zXPz7nTRBZd8">Share-based payments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the periods 30 June 2024 and 30 June 2023, the Company granted share options to advisors and consultants (as remuneration for services
provided), as well as select employees and Directors of the Company under the board approved Employee Share Option Plan (ESOP).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share option converts into one Ordinary Share of the Company on exercise. An option may be exercised by either (a) paying to the Company
the Exercise Price of the Option being exercised (Cash Exercise) or (b) if elected by the Option Holder by setting off the total Exercise
Price against the number of Shares which they are entitled to receive upon exercise (Cashless Exercise Facility). The options carry neither
rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting, subject to meeting the vesting
conditions, to the date of their expiry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
are exercisable at a price determined by each option grant and range from $<span id="xdx_903_eifrs-full--ExercisePriceShareOptionsGranted2019_c20230701__20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zm8e2mhUOYG3" title="Options exercise price">0.01</span> (relating to options granted as consideration for foregone
cash payment for services provided), to $<span id="xdx_90C_eifrs-full--ExercisePriceShareOptionsGranted2019_c20230701__20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zMHhzXywCiJj" title="Options exercise price">6.73</span> per share (relating to issuances under the ESOP which qualifies for the ATO ESS start-up
tax concessions available for SME unlisted companies). All options are vested over three years. If the options remain unexercised after
the period agreed from the date of grant the options expire. Options are forfeited if the employee leaves the Company before the options
vest unless otherwise agreed by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
values of the Options are calculated by applying the Black-Scholes model. The Company used valuations specialists to perform these valuations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the reporting periods the Company also issued share rights (RSU&#8217;s) to select employees of the Company under the board approved
Employee Incentive Plan (EIP). These share rights may be converted into Ordinary Shares under the EIP. Fifty percent of the principal
share rights will vest and be exercisable on October 1, 2025 and the remaining fifty percent of the share rights will vest and be exercisable
on and from October 1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
values of the Share Rights are calculated by applying the Black-Scholes model. The Company used valuations specialists to perform these
valuations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_ecustom--DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory_zN7vP3I5GsLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the expense arising from performance rights, options and warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zzlTyOOagvZ9" style="display: none">Schedule
of Details
of Expense from Performance Rights, Options and Warrants</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20230701__20240630_zbTNw46nTdP7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20220701__20230630_zfHF8YVugIP1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210701__20220630_zdrmwvM8F5qb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_401_ecustom--ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants_zsKmtVilZz2l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">ESOP</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,851,329</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,052,245</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">914,682</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ExpenseFromAdvisorOptions_zu5tFb578ita" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Advisor Options (<span id="xdx_F4B_zpQRCuO1gUSj">1</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,086,938</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,164,524</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">632,301</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ExpenseFromReach_zGGVHWYA6tx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Reach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,584</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">148,615</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1750">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ExpenseFromWarrants_zD48Kq8Z27o5" style="vertical-align: bottom; background-color: White">
    <td>Warrants (<span id="xdx_F4A_zfSSfVJn8vod">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">253,391</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1754">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ExpenseFromOverAllotmentOption_zWWZWEjmo0l8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over allotment Option (<span id="xdx_F4D_zxKdHZoVn1U3">3</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">163,794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1757">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ExpenseFromRestrictedShareUnits_zV5Ip81jRSg5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">RSU</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,119,562</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1761">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1762">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--AdjustmentsForSharebasedPayments_zfi1McJs0u3l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Share based payments<span>*</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,521,598</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,365,384</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,546,983</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0F_zfvwNt1Cb1W7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zQbK9VJWeAAb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                                            that <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20231201__20231231_z1ntXt81TKLc" title="Advisor Options vested and were exercised"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20230701__20230731_zsw5zmqiLNi5" title="Advisor Options vested and were exercised">327,142</span></span> Advisor Options vested and were exercised into Shares between July 2023 and
                                            December 2023 and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20230701__20230731_zKizMct8TSnl" title="Advisor Options forfeited"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20231201__20231231_zKUJz83i5Z6a" title="Advisor Options forfeited">16,193</span></span> Advisor Options were forfeited. At June 30, 2024, nil remaining
                                            Advisor Options were on issue.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 22. Share-based payments - continued </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F09_zjH7gYny6ZK4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zbT7EnCd82F1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                                            that this expense is pertaining to the issuance of warrants (equating to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_c20240630_zPVvZcVXmXD9" title="Ordinary Shares on exercise">65,000</span> Ordinary
                                            Shares on exercise) to the Underwriter as part of the underwriting agreement. These Warrants
                                            will be exercisable at any time and from time to time, in whole or in part, during the four
                                            and a half year period commencing 180 days from the commencement of sales of the securities
                                            in the Offering, at a price per share equal to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_ecustom--PricePerShareEqualPercentage_iI_pid_dp_uPure_c20240630_zpx8vpOmpta2" title="Price per share equal percentage">125.0</span>% of the public offering price per share
                                            of common stock at the Offering. The issuance acts as additional compensation for ThinkEquity
                                            services that would be rendered over a 24 month period from the Closing of the initial public
                                            offering. As these services vary and are not for a specific service, the fair value of this
                                            allocation cannot be estimated reliably. Thereby, the fair value of these warrants at grant
                                            date were calculated by applying the Black-Scholes model. The Company used valuations specialists
                                            to perform these valuations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F07_z1ExF2q2dkia" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zuG97JGqyOt6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                                            that this expense is pertaining to the option granted to the underwriter, exercisable within
                                            45 days after the closing of the Offering, to acquire up to an additional 15% of the total
                                            number of Shares to be offered by the company in the offering, solely for the purpose of
                                            covering over-allotments. This over-allotment option essentially granted the underwriter
                                            the right to sell more shares than originally planned if the demand for a security issue
                                            proves higher than expected. The fair value of this service cannot be estimated reliably
                                            as the exercise was subjective on share price performance and/or timing. Thereby, the fair
                                            value of these options at grant date were calculated using the Black-Scholes model. The Company
                                            used valuations specialists to perform these valuations. In addition, please note that these
                                            options have not been exercised and the 45-day limit has expired.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p id="xdx_8A5_zvXasCpC8D23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_gL3DONAWAEPOS-CCDSRYTS_zLdCoagaqoFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the number of share options outstanding during the year, adjusted to account for the 4-for-5 reverse share split, are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zie5q2dMivca" style="display: none">Schedule
of Share Options Outstanding</span> </span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zpIu8TKQSEIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zT0ZdCYCd0Ia" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEL8MFiIDWX8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">ESOP</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zaCuikKPvXwk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">784,098</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">556,074</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1789">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_ziQ24PRGCSJ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1791">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">312,886</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">556,074</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zXiJsBu31pIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1795">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(84,862</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1797">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_ziochB4w4CW" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1799">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1800">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1801">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zy1SwpRnmMj4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">784,098</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">784,098</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">556,074</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zAMLUNedCfVh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zVowqlhaKXa5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zYqWLc91NQT2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Advisor</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NumberOfOutstandingShareOptions_iS_z1L7ZHhxvQ9a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">344,055</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">312,362</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1809">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zyEytC2iajIl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,693</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">312,362</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zm6UOdWMkotd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(16,913</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1816">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1817">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_zXT4V55qKwD7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(327,142</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1821">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zgIWzJvbFhoe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1823">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">344,055</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">312,362</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zl4QMN0nRSI9" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
22. Share-based payments - continued</b></span></p>

<div id="xdx_C05_gL3DONAWAEPOS-CCDSRYTS_zA2sYRtyBcs5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zslACzMhU9tc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_zLNUsYbj6BM4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_zcGgiBCgAs8c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_z1msQrsCpqO3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Reach</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_z0wnwwZW2c55" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">45,794</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1828">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1829">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zIevBLXCvk17" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1831">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1833">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zqLlGVnPiBE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1836">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1837">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zYiK8trvcQJg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1839">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1840">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1841">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_znAfnnCNqR2i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">45,794</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">45,794</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1845">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_134_ztGsmADBP6rg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z3gTDnsoHiC6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zSgZzqTQl59h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zv5DPlOD9FAf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">RSU</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zFUkEMCvCeH6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Beginning of period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1847">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1849">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zdO032jRXR19" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Granted during the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">630,729</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1852">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1853">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zmCPQZbZOM3f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1856">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1857">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zOIdtiSw2wH1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1859">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1860">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zY0EaKJuuY4l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">630,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1864">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1865">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in; text-indent: 415.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zlndA609UQXa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zjy79EmtAnMe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zVSEPxvDiP23" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zm40GPRGot73" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Over
Allotment Option</b></span></p></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zZydOI649Ml7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Beginning of period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1867">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1868">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1869">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zOaT1nzIB0n2" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Granted during the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">195,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1872">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1873">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zeVrQaoAsEEg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(195,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1877">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zKLkeRxCt1e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1879">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1880">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1881">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zROkvJPuz1p5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1883">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1884">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1885">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_134_zkdJ4abczpX5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zVDnI1AIPlq6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zRvjjm2URI49" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z4LVeCGloSO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Warrants</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zEHg2LB82Pkj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Beginning of period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1887">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1888">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1889">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zd12xeSBVpMc" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Granted during the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">65,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1893">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zQT8UOdLmZ69" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1895">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1897">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zWsGAbE1pg4h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercised during the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1899">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1901">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zXzUnf10OM9g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>End of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">65,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1904">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1905">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_307_134_zgsdPe6Mub58" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left; font-weight: bold">-</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230701__20240630_z8wiG2VaH71h" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220701__20230630_zntefkRvtYek" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210701__20220630_zy3dOiDeVKX2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left; font-weight: bold">Total</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zMJsBnROtpL1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Total beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,173,947</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">868,436</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1909">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zc3ZCu4nKXvg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">890,729</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390,373</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">868,436</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zckuoh90y0yl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(211,913</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(84,862</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1917">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_zsaBm20S1mC1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total exercised during the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(327,142</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1920">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1921">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zEMqyJJkkW36" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total end of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,525,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,173,947</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">868,436</td><td style="text-align: left">&#160;</td></tr>
  </table>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C06_gL3DONAWAEPOS-CCDSRYTS_zjNuB6s6Nr3d">&#160;</span></span></p>

<p id="xdx_894_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_zLqMcBhNMhm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
model inputs for options granted during the reporting periods include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zXaxj4jkHgsd" style="display: none">Schedule of Model Inputs For Options Granted</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Spot Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Share price volatility</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expected Dividend yield</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Risk free interest rate</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: left">ESOP</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center">31 Aug 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwiW1HJN1MO4" style="width: 8%; text-align: right" title="Exercise price">0.62</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zDFwX3b0khS7" title="Term">3 years</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwC39eLLumH6" style="width: 8%; text-align: right" title="Spot Price">5.72</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z7vpmOsdVDS2" style="width: 8%; text-align: right" title="Share price volatility">67.3</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zGzIQdSMS2Ue" style="width: 8%; text-align: right" title="Expected Dividend yield">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zbpb4cPW1Oka" style="width: 8%; text-align: right" title="Risk free interest rate">0.2</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">31 Aug 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zN9dtrKZISr6" style="text-align: right" title="Exercise price">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zBlwKFxqdSVc" title="Term">3 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zm7dDir5dXd4" style="text-align: right" title="Exercise price">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z3sq4I7xBfx" style="text-align: right" title="Share price volatility">67.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zGcNvvUIGB8e" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAeOpglSioy3" style="text-align: right" title="Risk free interest rate">0.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">1 March 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zNl5jIFDc18l" style="text-align: right" title="Exercise price">0.62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zn7gmENV0T1b" title="Term">3 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z70HkW9Loazc" style="text-align: right" title="Exercise price">18.51</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zkI6z7rokWq1" style="text-align: right" title="Share price volatility">66.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zKsEONNPaa7b" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z1vY07LGRiV2" style="text-align: right" title="Risk free interest rate">1.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">23 Feb 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zZft4wILXyA8" style="text-align: right" title="Exercise price">0.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zDCyCkERdntl" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl1967">3.0 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zf75uEmCFXZe" style="text-align: right" title="Exercise price">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zhFc5mcLYgE5" style="text-align: right" title="Share price volatility">64.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_ztHGl2tNpBLh" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zhXwOzHtxTB2" style="text-align: right" title="Risk free interest rate">3.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">ADVISOR</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">21 Aug 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zYMipOurz7Ce" style="text-align: right" title="Exercise price">0.62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zYiQrzB11aO4" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl1979">2.86 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zFPHUSJqn0xh" style="text-align: right" title="Spot Price">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zKH0zpSK8td8" style="text-align: right" title="Share price volatility">66.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zCE7KYEMdCHj" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zUdufrAhHwWa" style="text-align: right" title="Risk free interest rate">0.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">21 Aug 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zWn0O9NJtKij" style="text-align: right" title="Exercise price">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zyS8ITAhAVR4" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl1991">2.86 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zyM7LTMrzWo2" style="text-align: right" title="Spot Price">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zhxHmLbKfjw7" style="text-align: right" title="Share price volatility">66.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zdZWkcAX6486" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zNC2K1gdRyR6" style="text-align: right" title="Risk free interest rate">0.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">21 Aug 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zwN0GVWippR6" style="text-align: right" title="Exercise price">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zhBZrWaRMKCc" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2003">4.90 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z8TFcGfj4zdc" style="text-align: right" title="Spot Price">10.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zu4xG2uR458i" style="text-align: right" title="Share price volatility">65.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zuAUfDCcDdlk" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zQVKgHW1k8l9" style="text-align: right" title="Risk free interest rate">3.0</td><td style="text-align: left">%</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>



<p style="margin: 0">&#160;</p>

<p style="margin: 0"><b>Note 22. Share-based payments - continued</b> <br/>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><b>REACH</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center">13 Feb 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zZQEtN6Pzct3" style="width: 8%; text-align: right" title="Exercise price">5.72</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwW1e80gsR66" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2015">3.30 years</span></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_znsVwwLptyL" style="width: 8%; text-align: right" title="Spot Price">5.72</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zfQrBpTA1u8g" style="width: 8%; text-align: right" title="Share price volatility">65.4</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zn5lfo5or8Y2" style="width: 8%; text-align: right" title="Expected Dividend yield">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zR7Va2ECUpH3" style="width: 8%; text-align: right" title="Risk free interest rate">3.5</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">9 June 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zKQSRAJNEPh4" style="text-align: right" title="Exercise price">6.73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_ztyrLtWrhxek" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2027">3.15 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zkfOTVCgvvTj" style="text-align: right" title="Spot Price">6.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAzmPIORftGb" style="text-align: right" title="Share price volatility">60.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zGZ6o6GNw5El" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z2dTS2bmDgc7" style="text-align: right" title="Risk free interest rate">3.8</td><td style="text-align: left">%</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; width: 26%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>RSUs</i></b></span></p></td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">10 Oct 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zibSXiBCyBua" style="text-align: right" title="Exercise price"><span style="-sec-ix-hidden: xdx2ixbrl2037">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z5EkOGDVtM9g" title="Term">3 years</span> </span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zGYXz6SpYCNg" style="text-align: right" title="Spot Price">7.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zZo3vobg82K3" style="text-align: right" title="Expected Dividend yield">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">1 Mar 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAaSYZsNwukf" style="text-align: right" title="Exercise price"><span style="-sec-ix-hidden: xdx2ixbrl2045">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zIxxyPIMTuYd" title="Term">3 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z4Ki0WrJwBef" style="text-align: right" title="Spot Price">7.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zwluHli8TD4a" style="text-align: right" title="Expected Dividend yield">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; width: 26%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">27 March 2024 <br/>Over allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$<span id="xdx_907_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zu5MBbNTMDF2" title="Exercise price">6.25</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zUaywUXzRkNf" title="Term">5 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zjC43O1s1xU" style="text-align: right" title="Spot Price">5.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zLZAbKVM5Ylg" style="text-align: right" title="Share price volatility">62.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zXUTadKNxa54" style="text-align: right" title="Expected Dividend yield">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z0TGklOTh1X9" style="text-align: right" title="Risk free interest rate">3.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">27 March 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zzoC9o8biOs1" style="text-align: right" title="Exercise price">5.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zJbilHvygFM6" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2067">0.12 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z8glpTZU43se" style="text-align: right" title="Spot Price">5.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zC34yg0pE2J1" style="text-align: right" title="Share price volatility">46</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zYwsN2oQZuhb" style="text-align: right" title="Expected Dividend yield">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zzLv8qrWEdm3" style="text-align: right" title="Risk free interest rate">3.7</td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8A1_zQv9I7UmGjic" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
share-based payment expense of $<span id="xdx_900_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_c20230701__20240630_zEMfU1FcYsij" title="Share-based payment expense">4,521,598</span> for the period ended June 30, 2024 ($<span id="xdx_90A_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_c20220701__20230630_zsFF1UkbIxz1" title="Share-based payment expense">2,365,384</span> June 30, 2023 and $<span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_c20210701__20220630_zOvxWlqhnKWf" title="Share-based payment expense">1,546,983</span> June 30, 2022)
has been recognized in the Consolidated Statement of Profit or Loss and Other Comprehensive Loss.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 44<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322703392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Financial Instruments</a></td>
<td class="text"><p id="xdx_80F_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_z19gR1T87w8h" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
23. <span id="xdx_825_zsDDXFtwq5Fb">Financial Instruments</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capital
management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s objectives when managing share capital, reserves, and accumulated losses, which represents the group&#8217;s capital,
are to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27.2pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">safeguard
                                            their ability to continue as a going concern, so that they can continue to provide returns
                                            for shareholders and benefits for other stakeholders; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27.2pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sustain
                                            future product development.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
risk management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities expose it to a variety of financial risks: market risk (primarily currency risk), credit risk, and liquidity
risk. The Company&#8217;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimise
potential adverse effects on the financial performance of the Group. The Group uses different methods to measure different types of risk
to which it is exposed. These methods include sensitivity analysis in the case of foreign exchange risk and aging analysis for credit
risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
risk management is carried out by the Chief Financial Officer (CFO) and overseen by the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
23. Financial Instruments - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
exchange risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
exchange risk arises when future commercial transactions and recognised assets and liabilities are denominated in a currency that is
not the entity&#8217;s functional currency. The risk is measured using sensitivity analysis and cash flow forecasting. The Group operates
internationally and is exposed to foreign exchange risk arising primarily from currency exposures to the NZ Dollar, Euro, and US Dollar.<br/>
<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial results are reported in AU dollar and a substantial portion of our operating revenues and expenses are reported
in AU dollar. Revenue and expenses recorded in local currency other that AU dollar are where practical received in to and paid out of
local currency bank accounts mitigating the Company&#8217;s exposure to foreign currency risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Credit
risk</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span>Credit
risk arises from cash and cash equivalents, derivative financial instruments and deposits with banks and financial institutions, as well
as credit exposures to customers, including outstanding receivables and committed transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no significant concentrations of credit risk. For banks and financial institutions, only independently rated and reputable
parties are accepted. The Company has policies in place to ensure that sales of products and services are made to customers in advance
of the products and service being provided The maximum exposure to credit risk at the reporting date is the carrying amount of the financial
assets recognised in the statement of financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
risk</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
risk arises from the Company&#8217;s management of cash and working capital. It is the risk that the Company will encounter difficulty
in meeting its financial obligations as they fall due. The Company&#8217;s policy is to ensure that it will always have sufficient cash
to allow it to meet its liabilities as and when they fall due. The Company manages its liquidity needs by carefully monitoring scheduled
debt servicing payments for long-term financial liabilities as well as cash-outflows due in day-to-day business.</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining
contractual maturities</b></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables detail the Company&#8217;s remaining contractual maturity for its financial instrument liabilities. The tables have
been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the financial liabilities
are required to be paid. The tables include both interest and principal cash flows disclosed as remaining contractual maturities and
therefore these totals may differ from their carrying amount in the statement of financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p id="xdx_899_eifrs-full--MaturityAnalysisForDerivativeFinancialLiabilities_zmqIs3oMerJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zL7ylA6J4bQ5" style="display: none">Schedule of Contractual Maturities of Financial Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted average interest rate</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">1 year or less</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Between 1 and 2 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Between 2 and 5 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Remaining contractual maturities</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: right">Consolidated 2024</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">%</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: right">Non - Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: right">Non-interest bearing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: right">Trade and other payables</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90D_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zAGFYhjDxtIb" title="Trade and other payables">1,991,536</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90F_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zjEhDrcI2Wv8" title="Trade and other payables">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_905_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zpaaKBwzA6i5" title="Trade and other payables">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_901_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20240630_zldy8Z2iyq19" title="Trade and other payables">1,991,536</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: right">Interest bearing &#8211; fixed rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Financial liability &#8211; host debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--WeightedAverageInterestRateFinancialLiability_iI_dp0_c20240630_zuNNjP2RFd9k" title="Financial liability host debt, interest rate">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zssHN2F98Tul" title="Financial liability host debt">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_z3t7TJ963uBl" title="Financial liability host debt">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z21AJOBZySKi" title="Financial liability host debt">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630_z1yiloxkna74" title="Financial liability host debt">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90B_ecustom--WeightedAverageInterestRateLeaseLiabilities_iI_dp_c20240630_zM1qdZZFqPN" title="Lease liability, interest rate">3.5</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zmGKCmZrR8F8" title="Lease liability">135,680</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zWDbO4mkhAAe" title="Lease liability">46,240</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zI3hjwTvwQv4" title="Lease liability">35,267</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_ecustom--InterestBearingLeaseLiabilities_iI_c20240630_zpg69TbDuLd7" title="Lease liability">217,187</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total non - derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zspTi7iZw5Ia" title="Total non derivative">2,127,216</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zDOvgUrtcnkd" title="Total non derivative">46,240</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zhM2wTrcZvgd" title="Total non derivative">35,267</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--InterestBearingNonderivativesNet_iI_c20240630_zSpfGTsSvth" title="Total non derivative">2,208,723</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Derivative liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zY0puwu87v19" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zFOAZPIeeSlj" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z0PZcVQpVV94" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zzyZZwk2JGs3" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total Derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zJT640jk7xki" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zldH818xG4k5" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zdOlvf57h8pd" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z9FaEzyxcmT3" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted average interest rate</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">1 year or less</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Between 1 and 2 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Between 2 and 5 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Remaining contractual maturities</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: right">Consolidated 2023</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">%</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$&#8217;000</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: right">Non - Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: right">Non-interest bearing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: right">Trade and other payables</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_906_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_z3gL200IRes6" title="Trade and other payables">2,034,436</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90F_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zrKT3uzobfA5" title="Trade and other payables">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_909_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zwqG8zTZpYeb" title="Trade and other payables">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_905_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20230630_zFvFouHP9Rpe" title="Trade and other payables">2,034,436</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: right">Interest bearing &#8211; fixed rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Financial liability &#8211; host debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--WeightedAverageInterestRateFinancialLiability_iI_dp_c20230630_zVjE6ivMpZ37" title="Financial liability host debt, interest rate">9.3</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zHs72L1Ausz" title="Financial liability host debt">16,567,450</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zP3kOTppbBPc" title="Financial liability host debt">342,406</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zAT19ASuhY9c" title="Financial liability host debt">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630_zIEyyFsONtyj" title="Financial liability host debt">16,909,856</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_901_ecustom--WeightedAverageInterestRateLeaseLiabilities_iI_dp_c20230630_zojSqwTSq367" title="Lease liability, interest rate">3.5</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zhDwAz4unqrh" title="Lease liability">127,361</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zjer506cwoua" title="Lease liability">28,214</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zkbLXDcgJUl5" title="Lease liability">28,214</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--InterestBearingLeaseLiabilities_iI_c20230630_zXaOdmWeiSll" title="Lease liability">183,789</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total non- derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zCMf8xnJkdQ5" title="Total non derivative">18,729,247</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_z8DFT3JIkVm9" title="Total non derivative">370,620</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zi0xVLG49y3f" title="Total non derivative">28,214</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--InterestBearingNonderivativesNet_iI_c20230630_z9hiMHw0kdqk" title="Total non derivative">19,128,081</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right">Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Derivative liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zcOMTIzqZbGe" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zM6uQnzhAKn3" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zpAyoNrO7S3i" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_ztZ686PwIUTe" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total Derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zNYDA59I2b86" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zwF3bPnGL0nk" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z7LOudniHYe1" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z4s8KQ3JF9Ef" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_z8FLUolzQ9ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cash flows in the maturity analysis above are not expected to occur significantly earlier than contractually disclosed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
value estimation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of financial assets and financial liabilities must be estimated for recognition and measurement or for disclosure purposes.
The carrying value less impairment provision of trade receivables and payables are assumed to approximate their fair values due to their
short-term nature. The fair value of financial liabilities approximates their carrying values.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320883344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Remuneration of auditors<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory', window );">Remuneration of auditors</a></td>
<td class="text"><p id="xdx_80B_eifrs-full--DisclosureOfAuditorsRemunerationExplanatory_zr4PohzpPwI3" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
24. <span id="xdx_821_zNjg5AvMloTe">Remuneration of auditors</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the financial year the following fees were paid or payable for services provided by BDO Audit Pty Ltd, the auditor of the Company and
its network firms:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_ecustom--DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory_zXikr6Qpbrn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zRyWnlqB32K1" style="display: none">Schedule
of Auditor of Company And Network Firms</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630_zyiCcR45ncQi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20220701__20230630_z0GTml52JB48" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20210701__20220630_zSQQV1q2WU6l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_ecustom--AuditFees_maARzvWE_zoMxcxcCpukl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Audit fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">382,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">200,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">48,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AuditorsRemunerationForRelatedFees_maARzvWE_zy6LK5ZY02q" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit &#8211; related fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">207,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2201">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--AuditorsRemunerationForTaxServices_maARzvWE_z4RJ2TO962s" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2204">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2205">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--AuditorsRemunerationForOtherServices_maARzvWE_zffeOOzGx6jd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">All other fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2207">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2208">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--AuditorsRemuneration_iT_mtARzvWE_zNo5mXFi4NWl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">512,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">407,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zpuBIFsYQq03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAuditorsRemunerationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of compensation to the entity's auditors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAuditorsRemunerationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318323248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Assets and Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory', window );">Contingent Assets and Liabilities</a></td>
<td class="text"><p id="xdx_803_eifrs-full--DisclosureOfContingentLiabilitiesExplanatory_z0QIU8hGybJ" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
25. <span id="xdx_822_zzlVQ9CIeA67">Contingent Assets and Liabilities</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span id="xdx_908_ecustom--ContingentAssetsAndLiabilities_iI_do_c20240630_zFdSoxTw3Dw2" title="Contingent assets and liabilities">no</span> material contingent assets and liabilities at 30 June 2024 (<span id="xdx_90D_ecustom--ContingentAssetsAndLiabilities_iI_dxL_c20230630_zIe52x9SNw9g" title="Contingent assets and liabilities::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2219">nil</span></span> &#8211; 30 June 2023).</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 211.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of contingent liabilities. [Refer: Classes of contingent liabilities [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 86<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_86&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320907776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsExplanatory', window );">Commitments</a></td>
<td class="text"><p id="xdx_80C_eifrs-full--DisclosureOfCommitmentsExplanatory_zOW6WtARr5X6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
26. <span id="xdx_82B_zXjtrYmRRsx5">Commitments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no material Commitments at 30 June 2024 (nil- 30 June 2023).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322578464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Loss per share</a></td>
<td class="text"><p id="xdx_80D_eifrs-full--EarningsPerShareExplanatory_zbq8YVeo4z09" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
27. <span id="xdx_82C_zGz7VkubTiBj">Loss per share</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#160;</span></span></p>

<p id="xdx_894_eifrs-full--DisclosureOfEarningsPerShareExplanatory_z2gfqV42e5sf" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zfG8VLK2iRZ8" style="display: none">Schedule
of Loss Per Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20230701__20240630_z5OKycaLQuzh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20220701__20230630_zyo6SvBhm3Gh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20210701__20220630_zXACTB5yy1vi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--ProfitLoss_z8mOM71kfIce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Reconciliation of loss after tax</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(14,408,346</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(20,597,436</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(11,197,450</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted average number of Ordinary Shares outstanding during the period used in calculating loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_909_eifrs-full--WeightedAverageShares_c20230701__20240630_zqxVKKgyFjbg" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_90E_eifrs-full--AdjustedWeightedAverageShares_c20230701__20240630_zJtY3EvBYG47" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share">10,267,686</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_907_eifrs-full--WeightedAverageShares_c20220701__20230630_zXpNQlPC7uGe" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_901_eifrs-full--AdjustedWeightedAverageShares_c20220701__20230630_zqdX5ODnil6f" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share">3,918,750</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_90A_eifrs-full--WeightedAverageShares_c20210701__20220630_zJUWCLRzmHad" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_900_eifrs-full--AdjustedWeightedAverageShares_c20210701__20220630_zbPAg7HgieJ8" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share">3,918,750</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss per share attributable to the owners of Alta Global Group Limited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_zQrX25DKJi8e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.40</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.26</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.86</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eifrs-full--DilutedEarningsLossPerShare_zzWRcAhXdkp9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diluted loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.40</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.26</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.86</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321832336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events after the reporting period<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Events after the reporting period</a></td>
<td class="text"><p id="xdx_80E_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zJrL28D0u9f9" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
28. <span id="xdx_82A_zy2qSiVgkG6g">Events after the reporting period</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2024, at the discretion of the Board under the Company&#8217;s Employee Incentive Plan (EIP), <span id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20240701__20240731__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zU4wO7MWG1Ji" title="Vested and convertible shares">40,000</span> share rights have fully vested
and converted into Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, various employees and consultants were issued an aggregate of <span id="xdx_904_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20240901__20240930__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zrFFaZd90yf6" title="Vested and convertible shares">139,500</span> share rights (subject to vesting conditions) which
may be converted into Ordinary Shares under the Company&#8217;s Employee Incentive Plan. All share rights granted will vest and become
exercisable in three tranches between May 2025 and August 2027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, we announced a revenue share agreement with UFC Gym, LLC in relation to the intention of rolling out the Warrior Training
Program and Hype across UFC Gym&#8217;s global network of gyms, consisting of both corporate owned locations and franchises (with over
150 locations in 40 countries, including 80 in the United States) (&#8220;UFC Group&#8221;). In the initial phase, these programs will
be introduced in locations across the US, the Middle East, the UK, Germany, Mexico, India and Central Asia. The revenue from the Warrior
Training Program is shared, with the UFC Group receiving 70% and the Company receiving 30%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, Conor McGregor was appointed as a global ambassador (&#8220;Ambassador Agreement&#8221;) and will provide services customarily
associated with such roles for a company in the mixed martial arts and technology sector (&#8220;Services&#8221;). The term of the Ambassador
Agreement shall be effective for three years and either party may terminate the agreement upon 10 days prior written notice if the other
party breaches the agreement and does not cure such breach within such time period. <span id="xdx_903_eifrs-full--DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_c20240901__20240930__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CounterpartiesAxis__custom--MrMcGregorMember_z8ovFbOfBNKd" title="Description of contracts shares">In consideration for providing these Services under
the Ambassador Agreement, and pursuant to the exemption from registration provided for in Regulation S promulgated under the Securities
Act, Mr. McGregor received 700,000 performance share rights that will vest once the 30-day volume-weighted average price (VWAP) achieves
the following trigger: 150,000 shares on execution of the Ambassador Agreement; 100,000 shares when the share price reaches $7.50; 150,000
shares when the share price reaches $10.00; 150,000 shares when the share price reaches $15.00 and 150,000 shares when the share price
reaches $20.00. Aligned with the three (3) year term of the Ambassador Agreement, Mr. McGregor is restricted from selling shares within
three (3) years of issuance unless specific conditions are met, such as the Company&#8217;s written consent, a sale or liquidation of
the Company, or if the Company breaches the agreement.</span></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320164176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Accounting Policy Information (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfMaterialAccountingPolicyAbstract', window );"><strong>Material Accounting Policy Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory', window );">Basis of preparation</a></td>
<td class="text"><p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zLWoyHT7f1h4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_z5EOTOYkseMa">Basis
of preparation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Statement
of compliance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements have been prepared in accordance with International Financial Reporting Standards and International Accounting Standards
as issued by the International Accounting Standards Board (IASB) and Interpretations (collectively IFRSs).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in compliance with adopted IFRS Accounting Standards requires the use of certain critical accounting
estimates. It also requires Company management to exercise judgment in applying the Company&#8217;s accounting policies. The areas where
significant judgments and estimates have been made in preparing the financial statements and their effect are disclosed in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of measurement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on the basis of historical cost, except for the measurement at fair value of selected financial
assets and financial liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principles
of consolidation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements incorporate all the assets, liabilities and results of the Company and all the subsidiary companies
and other interests it controlled during the period. The Company controls an entity when it is exposed to, or has the rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power over the entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets, liabilities and results of its subsidiaries are fully consolidated into the consolidated financial statements from the date which
control is obtained. The consolidation of a subsidiary is discontinued from the date that control ceases. Intercompany transactions,
balances and unrealised gains or losses on transactions between Company entities are fully eliminated on consolidation. Accounting policies
of subsidiaries have been changed and adjustments made where necessary to ensure uniformity of the accounting policies of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
segments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
segments are presented using the &#8216;management approach&#8217;, where the information presented is on the same basis as the internal
reports provided to the Chief Operating Decision Makers (&#8220;CODM&#8221;). The CODM is responsible for the allocation of resources
to operating segments and assessing their performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
currency translation</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements are presented in Australian dollars, which is the Company&#8217;s functional and presentation currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign
currency transactions</b></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
currency transactions are translated into Australian dollars using the exchange rates prevailing at the dates of the transactions. Foreign
exchange gains and losses resulting from the settlement of such transactions and from the translation at financial year-end exchange
rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory', window );">New or amended Accounting Standards and Interpretations adopted</a></td>
<td class="text"><p id="xdx_843_ecustom--DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory_z1Hgye0KsVl2" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_zWuiSy060qmb">New
or amended Accounting Standards and Interpretations adopted</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated entity has adopted all of the new or amended Accounting Standards and Interpretations issued by the International Accounting
Standards Board (&#8220;IASB&#8221;) that are mandatory for the current reporting period. The adoption of these new or amended Accounting
Standards and Interpretations did not have a material impact on these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
new or amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zWgutcGrSGvf" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zvb94Drawd5g">Revenue
Recognition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
entity recognises revenue as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
is recognised at an amount that reflects the consideration to which the entity is expected to be entitled in exchange for transferring
goods or services to a customer. For each contract with a customer, the entity; identifies the contract with a customer; identifies the
performance obligations in the contract; determines the transaction price which takes into account estimates of variable consideration
and the time value of money; allocates the transaction price to the separate performance obligations on the basis of the relative stand-alone
selling price of each distinct good or service to be delivered; and recognises revenue when or as each performance obligation is satisfied
in a manner that depicts the transfer to the customer of the goods or services promised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variable
consideration within the transaction price, if any, reflects concessions provided to the customer such as discounts, rebates and refunds,
any potential bonuses receivable from the customer and any other contingent events. Such estimates are determined using either the &#8216;expected
value&#8217; or &#8216;most likely amount&#8217; method. The measurement of variable consideration is subject to a constraining principle
whereby revenue will only be recognised to the extent that it is highly probable that a significant reversal in the amount of cumulative
revenue recognised will not occur. The measurement constraint continues until the uncertainty associated with the variable consideration
is subsequently resolved. Amounts received that are subject to the constraining principle are recognised as a refund liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Program
revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Program
revenue consists of license fees which are recognized following the occurrence of both the transfer of the right to use the Company&#8217;s
intellectual property upon signing of the license agreement and once usage of the license occurs at the commencement of the Alta MMA
Training Program. The Company&#8217;s intellectual property consists of a set of mixed martial arts training programs and relevant branding
and support. A license agreement consists of the right to use the intellectual property of the Company and either party may terminate
the license upon written notice to the other party. If the agreement is terminated in this manner, the termination will take effect after
the completion of the relevant series and the series finale, but prior to a new series beginning. The amount of program revenue is dependent
on the number of participants in each series for each gym.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the license agreement, a usage-based royalty arrangement is in place between the Company and the gyms. The Company recognizes program
revenue following the occurrence of both the transfer of the right to use the Company&#8217;s intellectual property upon signing of the
license agreement and once usage of the license which occurs at the commencement of the Alta MMA Training Program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the ultimate responsibility of ensuring the Alta MMA Training Program meets customer specifications and price determination.
The Company is therefore considered the principal in these arrangements. The Company receives training fees directly from the participants
and subsequently distributes a portion of such revenues to our gym partners based on the terms of the license agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contractual
Payments to Gyms</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to settle contractual payments to the gyms as a percentage of the total training fees collected from participants.
Net revenue from program fees is recognised as revenue from program fees less the contractual obligations payable to the gyms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of merchandise</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from the sale of program merchandise is recognised at the point in time when the gyms obtain control of the goods, which is generally
at the time of delivery.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Event
revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from event ticket sales is recognised at the point in time when the event occurs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
income</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income is recognised when it is received or when the right to receive payment is established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
&amp; Development Incentive</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
grant, including the R&amp;D incentives, shall not be recognised until there is reasonable assurance that the Company will comply with
the conditions attaching to them and that the grants will be received.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory', window );">Current and non-current classification</a></td>
<td class="text"><p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_zCmauZD2bCv7" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zPdht4323M98">Current
and non-current classification</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities are presented in the statement of financial position based on current and non-current classification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
asset is classified as current when: it is either expected to be realised or intended to be sold or consumed in the consolidated entity&#8217;s
normal operating cycle; it is held primarily for the purpose of trading; it is expected to be realised within 12 months after the reporting
period; or the asset is cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least 12
months after the reporting period. All other assets are classified as non-current.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
liability is classified as current when: it is either expected to be settled in the consolidated entity&#8217;s normal operating cycle;
it is held primarily for the purpose of trading; it is due to be settled within 12 months after the reporting period; or there is no
unconditional right to defer the settlement of the liability for at least 12 months after the reporting period. All other liabilities
are classified as non-current.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are always classified as non-current.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2. Material accounting policies &#8211; continued</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z6JHM18DlQFi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zef1A3MXZ5gf">Cash
and cash equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, deposits held at call with financial institutions, other short- term, highly liquid investments
with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant
risk of changes in value. For the statement of cash flows presentation purposes, cash and cash equivalents also includes bank overdrafts,
which are shown within trade and other payables in current liabilities on the statement of financial position.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory', window );">Trade and other receivables</a></td>
<td class="text"><p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_zTN3oWH4mND" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zC3f22kXjIY8">Trade
and other receivables</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
receivables are initially recognised at fair value and subsequently measured at amortised cost using the effective interest method, less
any allowance for expected credit losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
Credit Losses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
entity has applied the simplified approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure
the expected credit losses, trade receivables have been grouped based on days overdue. Trade and other receivables are recognised at
amortised cost, less any allowance for expected credit losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory', window );">Trade and other payables</a></td>
<td class="text"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_zOh8kVKiKExi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_z0DuZnRTGZai">Trade
and other payables</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
amounts represent liabilities for goods and services provided to the entity prior to the end of the financial year and which are
unpaid. Other payables include cash received from the participants on behalf of the gyms. Due to their short-term nature, they are
measured at amortised cost and are not discounted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Plant and equipment</a></td>
<td class="text"><p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zyaJcYXLvUoi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_867_ziIbfAwfRSI">Plant
and equipment</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant
and equipment are stated at cost less accumulated depreciation and impairment. Historical cost includes expenditure that is directly
attributable to the acquisition of the items. Depreciation is calculated on a straight- line basis to write off the net cost of each
item of property, plant and equipment over their expected useful lives as follows:</span></p>

<p id="xdx_89B_ecustom--DisclosureOfPlantAndEquipmentExplanatory_zPBliGXyq3T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zv1CcCTCwcm4">Schedule
of plant and equipment</span></span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant</span>
  <span style="font-family: Times New Roman, Times, Serif">and equipment</span></td>
  <td style="text-align: justify; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfsPt9JFpDG7" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvJr7kJy3nya" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment </span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDn0FDktRmE3" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeji3SbvkXEc" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z15C8fLpd4Eg" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0UF2Vhc2Ja3" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fittings</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zopvstrbwii" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zMB2rxsqL89k" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p id="xdx_8AA_zi0EQHikbYs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
item of property, plant and equipment is derecognised upon disposal or when there is no future economic benefit to the entity. Gains
and losses between the carrying amount and the disposal proceeds are taken to profit or loss.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Note 2. Material accounting policies &#8211; continued</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zrpkeb5x5Jyl" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zv3Ku9MmHXh3">Intangible
assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Intangible
assets acquired as part of a business combination, other than goodwill, are initially measured at their fair value at the date of the
acquisition. Intangible assets acquired separately in an asset acquisition are separately recognised at cost. Indefinite life intangible
assets are not amortized and are subsequently measured at cost less any impairment. Finite life intangible assets are subsequently measured
at cost less amortization and any impairment. The gains or losses recognized in profit or loss arising from the derecognition of intangible
assets are measured as the difference between net disposal proceeds and the carrying amount of the intangible asset. The method and useful
lives of finite life intangible assets are reviewed annually. Changes in the expected pattern of consumption or useful life are accounted
for prospectively by changing the amortization method or period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trademarks</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
costs associated with patents or trademarks are deferred and amortised on a straight-line basis over the period of their expected benefit,
being their finite life of <span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230701__20240630__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z8g1pe4TkYFh" title="Finite life">10</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Platform
development cost</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in both internally and from external providers in developing the platform that will contribute to future year financial benefits
through revenue generation and/or cost reduction are capitalised to software. These costs are amortised on a straight-line basis over
the estimated useful life (<span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230701__20240630__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_zsQkVMOUpuC1" title="Estimated useful life">4</span> years) since first used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and development</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
costs are expensed in the period in which they are incurred. Development costs are capitalised when it is probable that the project will
be a success considering its commercial and technical feasibility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory', window );">Impairment of non-financial assets</a></td>
<td class="text"><p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_z6jDUkAuXDz4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zTDEIoZr1NUi">Impairment
of non-financial assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired.
Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount
may not be recoverable. An impairment loss is recognised for the amount by which the asset&#8217;s carrying amount exceeds its recoverable
amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverable
amount is the higher of an asset&#8217;s fair value less costs of disposal and value-in-use. The value-in-use is the present value of
the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to
which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory', window );">Borrowings</a></td>
<td class="text"><p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForBorrowingsExplanatory_zwuFTkpzwCE" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z0VzBxCjiaEh">Borrowings</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
and borrowings are initially recognised at the fair value of the consideration received, net of transaction costs. They are subsequently
measured at amortised cost using the effective interest method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Employee benefits</a></td>
<td class="text"><p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_zviXwugsp4ci" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zNxA6SudASV6">Employee
benefits</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
employee benefits</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
for wages and salaries, including non-monetary benefits, annual leave and long service leave expected to be settled wholly within 12
months of the reporting date are measured at the amounts expected to be paid when the liabilities are settled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
long-term employee benefits</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
liability for annual leave and long service leave not expected to be settled within 12 months of the reporting date are measured at the
present value of expected future payments to be made in respect of services provided by employees up to the reporting date using the
projected unit credit method. Consideration is given to expected future wage and salary levels, experience of employee departures and
periods of service. Expected future payments are discounted using market yields at the reporting date on corporate bonds with terms to
maturity and currency that match, as closely as possible, the estimated future cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory', window );">Goods and Services Tax (GST) and other similar taxes</a></td>
<td class="text"><p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_zagF7g4ZnBnj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zFBEnXYRAhb9">Goods
and Services Tax (GST) and other similar taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues,
expenses, and assets are recognised net of the amount of associated GST, unless the GST incurred is not recoverable from the tax authority.
In this case it is recognised as part of the cost of the acquisition of the asset or as part of the expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
and payables are stated inclusive of the amount of GST receivable or payable. The net amount of GST recoverable from, or payable to,
the tax authority is included in other receivables or other payables in the statement of financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
flows are presented on a gross basis. The GST components of cash flows arising from investing or financing activities which are recoverable
from, or payable to the tax authority, are presented as operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
and contingencies are disclosed net of the amount of GST recoverable from, or payable to, the tax authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory', window );">Issued capital</a></td>
<td class="text"><p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_z7UZ10hq7KW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zbxymr0havy1">Issued
capital</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
Shares are classified as equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incremental
costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income tax</a></td>
<td class="text"><p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_z9EXnSHpGG71" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_z2Uc5pIoszw3">Income
tax</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax expense for the year is the tax payable on the current year&#8217;s taxable income based on the national income tax rate for
each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences between the tax bases
of assets and liabilities and their carrying amounts in the financial statements, and to unused tax losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are recognised for temporary differences at the tax rates expected to apply when the assets are recovered
or liabilities are settled, based on those tax rates which are enacted or substantively enacted for each jurisdiction. The relevant tax
rates are applied to the cumulative amounts of deductible and taxable temporary differences to measure the deferred tax asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
exception is made for certain temporary differences arising from the initial recognition of an asset or a liability. No deferred tax
asset or liability is recognised in relation to these temporary differences if they arose in a transaction, other than a business combination,
that at the time of the transaction did not affect either accounting profit or taxable profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilise those temporary differences and losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax liabilities and assets are not recognised for temporary differences between the carrying amount and tax bases of investments in controlled
entities where the parent company is able to control the timing of the reversal of the temporary differences and it is probable that
the differences will not reverse in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets and liabilities and when
the deferred tax balances relate to the same taxation authority. Current tax assets and tax liabilities are offset where the Company
has a legally enforceable right to offset and intends either to settle on a net basis, or to realise the asset and settle the liability
simultaneously.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
and deferred tax is recognised as income or an expense and included in profit and loss for the period except where the tax arises from
a transaction which is recognized in other comprehensive oncome or equity, in which case the tax is recognized in other comprehensive
income to equity respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory', window );">Convertible note</a></td>
<td class="text"><p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zdTMHsYOXaP6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zVf7QaLVuKyb">Convertible
note</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
issuance of the convertible notes, an assessment is made to determine whether the convertible notes contain an equity instrument or whether
the whole instrument should be classified as a financial liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
it is determined that the whole instrument is a financial liability and no equity instrument, the conversion option is separated from
the host debt and classified as a derivative liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying value of the host contract at initial recognition is determined as a difference between the consideration received and the fair
value of the embedded derivative. The host contract is subsequently measured at amortised cost using the effective interest rate method.
The embedded derivative it subsequently measured at fair value at the end of each reporting period through the profit and loss. Refer
Note 21 Financial Liabilities for disclosure of key terms of the convertible notes. The convertible note and the derivative are presented
as financial liabilities on the Consolidated Statement of Financial Position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
conversion at maturity, the financial liability is reclassified to equity and no gain or loss is recognised. Transaction costs are deducted
from equity, net of associated income tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payments</a></td>
<td class="text"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zbIP0X0RvChc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_z63x5obPaPLh">Share-based
payments</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides benefits to consultants, advisors and employees (including directors) of the consolidated entity in the form of share-based
payment transactions, whereby employees render services in exchange for shares or rights over shares (&#8216;equity-settled transactions&#8217;).
The cost of these equity-settled transactions with employees is measured by reference to the fair value at the date at which they are
granted. The fair value is determined by an external valuation using a Black- Scholes option pricing model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of equity-settled transactions is recognised, together with a corresponding increase in equity, over the period in which the performance
conditions are fulfilled, ending on the date on which the relevant employees become fully entitled to the award (&#8216;vesting date&#8217;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cumulative expense recognised for equity-settled transactions at each reporting date until vesting date reflects (i) the extent to
which the vesting period has expired and (ii) the number of awards that, in the opinion of the directors of the consolidated entity,
will ultimately vest. This opinion is formed based on the best available information at balance date. No adjustment is made for the
likelihood of market performance conditions being met as the effect of these conditions is included in the determination of fair
value at grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
expense is recognised for awards that do not ultimately vest, except for awards where vesting is conditional upon a market condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
an equity-settled award is cancelled, it is treated as if it had vested on the date of cancellation, and any expense not yet recognised
for the award is recognised immediately. However, if a new award is substituted for the cancelled award, and designated as a replacement
award on the date that it is granted, the cancelled and new award are treated as if they were a modification of the original award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory', window );">Classification and measurement of financial liabilities</a></td>
<td class="text"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_zLWgODhl9lx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zZqvh4CQZkl">Classification
and measurement of financial liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial liabilities include trade and other payables, financial liabilities measured at amortised cost and derivative
financial instruments. Financial liabilities are initially measured at fair value, and, where applicable, adjusted for transaction costs
unless the Company&#8217;s designated a financial liability at fair value through profit or loss. Subsequently, financial liabilities
are measured at amortised cost using the effective interest method except for derivatives and financial liabilities designated at FVTPL,
which are carried subsequently at fair value with gains or losses recognised in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory', window );">Right-of-use assets</a></td>
<td class="text"><p id="xdx_849_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zT3b4FHdxfmd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zB22HaKcvmXh">Right-of-use
assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
right-of-use asset is recognised at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the
initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of
any lease incentives received, any initial direct costs incurred, and, except where included in the cost of inventories, an estimate
of costs expected to be incurred for dismantling and removing the underlying asset, and restoring the site or asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever
is the shorter. Where the consolidated entity expects to obtain ownership of the leased asset at the end of the lease term, the depreciation
is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Lease liabilities</a></td>
<td class="text"><p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zl6SNw2t7hH8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_861_zXTYeAfytfQ3">Lease
liabilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
lease liability is recognised at the commencement date of a lease. The lease liability is initially recognised at the present value
of the lease payments to be made over the term of the lease, discounted using the interest rate implicit in the lease or, if that
rate cannot be readily determined, the consolidated entity&#8217;s incremental borrowing rate. Lease payments comprise of fixed
payments less any lease incentives receivable, variable lease payments that depend on an index or a rate, amounts expected to be
paid under residual value guarantees, exercise price of a purchase option when the exercise of the option is reasonably certain to
occur, and any anticipated termination penalties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
variable lease payments that do not depend on an index or a rate are expensed in the period in which they are incurred. Lease liabilities
are measured at amortised cost using the effective interest method. The carrying amounts are remeasured if there is a change in the following:
future lease payments arising from a change in an index or a rate used; residual guarantee; lease term; certainty of a purchase option
and termination penalties. When a lease liability is remeasured, an adjustment is made to the corresponding right-of use asset, or to
profit or loss if the carrying amount of the right-of-use asset is fully written down.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory', window );">Fair value measurement</a></td>
<td class="text"><p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zCfMV6dNjvJj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_z1E0xhyEtYXb">Fair
value measurement</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
an asset or liability, financial or non-financial, is measured at fair value for recognition or disclosure purposes, the fair value is
based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date; and assumes that the transaction will take place either: in the principal market; or in the absence of a principal
market, in the most advantageous market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is measured using the assumptions that market participants would use when pricing the asset or liability, assuming they act in
their economic best interests. For non-financial assets, the fair value measurement is based on its highest and best use. Valuation
techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, are used,
maximising the use of relevant observable inputs and minimising the use of unobservable inputs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Material accounting policies - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities measured at fair value are classified into three levels, using a fair value hierarchy that reflects the significance
of the inputs used in making the measurements. Classifications are reviewed at each reporting date and transfers between levels are determined
based on a reassessment of the lowest level of input that is significant to the fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
recurring and non-recurring fair value measurements, external valuers may be used when internal expertise is either not available or
when the valuation is deemed to be significant. External valuers are selected based on market knowledge and reputation. Where there is
a significant change in fair value of an asset or liability from one period to another, an analysis is undertaken, which includes a verification
of the major inputs applied in the latest valuation and a comparison, where applicable, with external sources of data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Earnings per share</a></td>
<td class="text"><p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zXjiRW99MTq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zOAF0IV5dM12">Earnings
per share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share is calculated by dividing the profit attributable to the owners of the Company, excluding any costs of servicing equity
other than Ordinary Shares, by the weighted average number of Ordinary Shares outstanding during the financial year, adjusted for bonus
elements in Ordinary Shares issued during the financial year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
earnings per share</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
earnings per share adjusts the figures used in the determination of basic earnings per share to take into account the after income tax
effect of interest and other financing costs associated with dilutive potential Ordinary Shares and the weighted average number of shares
assumed to have been issued for no consideration in relation to dilutive potential Ordinary Shares.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory', window );">Parent entity financial information</a></td>
<td class="text"><p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory_zOiSGHp5bbcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z9Eg5Ihndbg5">Parent
entity financial information</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial information for the Parent entity, Alta Global Group Limited, disclosed in Note 19 has been prepared on the same basis as the
consolidated financial statement. Investments in subsidiaries are accounted for at cost less provision for impairment in the financial
statements of the Parent entity.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for basis of preparation explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for new or amended accounting standards and interpretations adopted explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for parent entity financial information explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for right of use assets explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfMaterialAccountingPolicyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfMaterialAccountingPolicyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial instruments. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for non-current assets or disposal groups classified as held for sale. [Refer: Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for taxes other than income tax. [Refer: Tax expense other than income tax expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319320400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Accounting Policy Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfMaterialAccountingPolicyAbstract', window );"><strong>Material Accounting Policy Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfPlantAndEquipmentExplanatory', window );">Schedule of plant and equipment</a></td>
<td class="text"><p id="xdx_89B_ecustom--DisclosureOfPlantAndEquipmentExplanatory_zPBliGXyq3T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zv1CcCTCwcm4">Schedule
of plant and equipment</span></span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant</span>
  <span style="font-family: Times New Roman, Times, Serif">and equipment</span></td>
  <td style="text-align: justify; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfsPt9JFpDG7" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvJr7kJy3nya" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment </span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDn0FDktRmE3" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeji3SbvkXEc" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z15C8fLpd4Eg" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0UF2Vhc2Ja3" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fittings</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zopvstrbwii" title="Plant and equipment expected useful lives">3</span> to <span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zMB2rxsqL89k" title="Plant and equipment expected useful lives">5</span> years</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfMaterialAccountingPolicyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfMaterialAccountingPolicyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of plant and equipment explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322230096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RevenueFromContractsWithCustomersAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesExplanatory', window );">Schedule of revenue</a></td>
<td class="text"><p id="xdx_89D_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zgRfiURJm5Ik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BD_zRj385CWGvBl">Schedule
of revenue</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20230701__20240630_zIQo217YJPrd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20220701__20230630_zQpYeWBDJ2Xd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20210701__20220630_zFnuaU5RM3V" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Program fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--RevenueFromProgramFees_maRFROSz9dU_zNLAODQU0TP1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Revenue from program fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">929,319</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">937,415</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2,050,044</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RevenueFromContractualPaymentsToGyms_msRFROSz9dU_zdeZp0jLQw3e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Contractual payments to gyms</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(537,012</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(574,025</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,215,191</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eifrs-full--RevenueFromRenderingOfServices_iT_mtRFROSz9dU_maRz2tF_zhT4NkeQssek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Revenue from program fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">392,307</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">363,390</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">834,853</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Other Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ReserachAndDevelopmentIncome_maORzfCZ_zv9rjJaX42g5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research and Development tax incentive<span id="xdx_F47_zP06pBrLhtAl">*</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0614">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,149,525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0616">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--FranchiseFeeIncome_maORzfCZ_zaa66nRRvk4c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Finale, franchise fee and other fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">167,021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,378</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--RevenueFromSaleOfGoods_maORzfCZ_zfMcMFP3uw71" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Merchandise sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,984</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,296</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,572</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--OtherRevenue_iT_mtORzfCZ_maRz2tF_zwfzTIvJ2cn3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total other income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">170,005</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,173,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">105,950</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--Revenue_iT_mtRz2tF_zTIGx62L0Xs9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">562,312</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,536,811</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">940,803</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0D_zgTDBqwENKc1" style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F16_zk811PLJDAUd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will continue
                                                                                                                                                              to apply for the Research and Development incentive as long as it continues to be eligible and will conduct eligible research and
                                                                                                                                                              development activities. The applicable legislation that governs the eligibility to participate in the R&amp;D incentive program is
                                                                                                                                                              Division 355 of the Income Tax Assessment Act 1997 (ITAA 1997). The FY 2024 Research and Development incentive will be applied for
                                                                                                                                                              on lodging of the FY 2024 tax return with the Australian Tax Office and recognised once reasonable assurance that the Company will
                                                                                                                                                              comply with the conditions and that the grants will be received.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory', window );">Schedule of disaggregation of revenue</a></td>
<td class="text"><p id="xdx_89E_eifrs-full--DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_zUgRACWRC7W6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disaggregation of revenue from contracts with customers is disclosed below. The Company only has one major product line, being the provision
of Gym Programs. All revenues are generated by the Australian Parent Entity:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BA_zGUPKhuQw4sd">Schedule
of disaggregation of revenue</span></b></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20230701__20240630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_z531tjLvweVk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220701__20230630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_zOPIEMxM5Cc8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20210701__20220630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_z2YKwg6pYU2f" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RevenueFromProgramFees_zmPTuSmNiD3j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Revenue from program fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">929,319</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">937,415</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2,050,044</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--RevenueFromContractualPaymentsToGyms_z0gRDUB3W7a5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Contractual payments to gyms</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(537,012</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(574,025</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,215,191</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eifrs-full--RevenueFromRenderingOfServices_iT_maRz2tF_z3F89R5objXi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net Revenue from program fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">392,307</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">363,390</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">834,853</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProductsAndServicesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's products and services. [Refer: Products and services [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProductsAndServicesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320866400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfExpensesAbstract', window );"><strong>Schedule Of Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory', window );">Schedule of expenses</a></td>
<td class="text"><p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutExpensesExplanatory_z3e8eACAxv52" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B0_zwL6ZQpkNdwc">Schedule
of expenses</span></b></span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_499_20230701__20240630_z7fmhUciUL3f" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20220701__20230630_zLR1IN4xc7og" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20210701__20220630_z8qJsQzhXZCf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--ProgramExpensesEventCosts_maPEzyGE_z1crUWk8SLUk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Event
    Costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,909</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,876</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,513</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--ProgramExpensesProgramCosts_maPEzyGE_zig9SqT0Iqz5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Program
    costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,046</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,447</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253,614</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--ProgramExpensesMerchantFees_maPEzyGE_z5QXY1FBIba2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merchant
    fees</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,550</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,427</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,327</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--ProgramExpensesOtherCosts_maPEzyGE_zAcumNvOKD6h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132,098</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">146</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--ProgramExpenses_iT_mtPEzyGE_zyQPoCeOpQY9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    program expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160,578</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">229,848</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">342,600</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--FinanceCostsConvertibleNotesInterestContractualAndEffective_maFCzg2h_zq1HsTJLnapg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    notes interest &#8211; contractual and effective</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,207,498</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,420,224</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,162,646</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--FinanceCostsBankFees_maFCzg2h_zSZqLiHzNKn2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    fees</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,286</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,071</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,454</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--FinanceCostsBankInterestAndLeaseInterest_maFCzg2h_zKEaGTWQJ1y2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    interest and lease interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,435</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,703</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--FinanceCosts_iT_mtFCzg2h_z7IH9r1XTqL9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    finance costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,262,927</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,472,730</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,191,803</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. Expenses &#8211; continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr id="xdx_40F_ecustom--UnrealizedCurrencyGains_i01N_di_maNFEGzlIR_zxdzxHTpr0qa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left; padding-left: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized
    currency (gains)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(117,094</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(36,181</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(36,660</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_405_ecustom--RealizedCurrencyGainslosses_i01N_di_maNFEGzlIR_zmoIvMjR4wO2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
    currency (gains)/losses</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,449</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,581</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--NetForeignExchangeGain_i01NT_di_mtNFEGzlIR_zWAZunepoqjb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    foreign exchange (gains)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(146,543</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(47,359</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,079</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about expenses explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319666560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory', window );">Schedule of Income Tax Expenses</a></td>
<td class="text"><p id="xdx_890_ecustom--DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory_zscoYR2oR6N2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z4CNgLHWqwEl" style="display: none">Schedule
of Income Tax Expenses</span><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230701__20240630_zfxLcEGBTYY8" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220701__20230630_zntEBKkkbrk3" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20210701__20220630_zuLqSjss5J9k" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($</b><b>)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income tax expense consists of the following:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--DeferredTaxExpenseIncome_maITECOzfzo_zESb20Fef0Zc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0705">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0706">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0707">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--CurrentTaxExpenseIncome_maITECOzfzo_z4Yfix7ZhNtc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Current tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0710">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0711">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_mtITECOzfzo_zPDylCD3bfil" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Total Income tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0713">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0714">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0715">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Effective tax rate reconciliation:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--ProfitLossBeforeTax_z5MTAICaLnu5" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Loss before income tax expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(14,408,346</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(20,597,436</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(11,197,450</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_maITECOzcFn_zZEoUrsnybQj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prima facie income tax benefit on loss before income tax calculated at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluY29tZSBUYXggRXhwZW5zZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--ApplicableTaxRate_pid_dp_c20230701__20240630_zUiOgGZVODZc" title="Tax rate">25</span>% (2022: <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluY29tZSBUYXggRXhwZW5zZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--ApplicableTaxRate_pid_dp_c20210701__20220630_z2ukeGc6alk5" title="Tax rate">25</span>%)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,602,086</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,149,359</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,799,363</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Add tax effect of</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DeferredTaxExpenseIncomeOtherNonAllowableItems_maITECOzcFn_zYmYfegG7Mag" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left">- other non-allowable items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(831,249</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,297,349</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">143,430</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Less tax effect of</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes_msITECOzcFn_zPEPbeLJLYT4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left">- items not assessable for income tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,590,831</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,435,790</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,377,243</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting_msITECOzcFn_zUb9IH5K4qNf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; text-align: left">- items deductible for taxation not accounting</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">251,784</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">772,848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">114,471</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss_maITECOzcFn_zYSSn8aD2NHa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Deferred tax not recognised</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(431,790</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,189,068</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,680,021</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_mtITECOzcFn_zE1YYBiIuBL3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0745">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0747">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of effective income tax rate reconciliations explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322197936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsExplanatory', window );">Schedule of Fair Value Assets and Liabilities</a></td>
<td class="text"><p id="xdx_89A_eifrs-full--DisclosureOfFinancialAssetsExplanatory_z8h86UUdFcxh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zTa0x4G2KBib" style="display: none">Schedule
of Fair Value Assets and &#160;Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49D_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zeMVVKkSBJMg" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zoLD7BLiRh5j" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49A_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zTI1Dp2Umppj" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49C_20240630_zZGmXuYbrzB8" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">Consolidated- June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialAssetsAtFairValue_iI_znrdl0xnuuD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; padding-bottom: 1pt; width: 40%">Assets</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0757">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0759">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialAssetsAtFairValue_iTI_zkuPaf0L1W6j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0762">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0763">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0765">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValue_iI_zWJMsn824O9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Derivative Liabilities &#8211; refer Note 21</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0767">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0769">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_zGUV0WEvPhq" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0774">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0775">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49E_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zKFzHVh7ZZX8" style="text-align: center">Level 1</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49C_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zQsvMZmMXTse" style="text-align: center">Level 2</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_490_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z7eUzszco5m3" style="text-align: center">Level 3</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20230630_zZjQJ5h2psV2" style="text-align: center">Total</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">Consolidated &#8211; June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialAssetsAtFairValue_iI_z9lPUJOZCFoe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-style: italic; padding-bottom: 1pt">Assets</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0778">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0779">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0780">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialAssetsAtFairValue_iTI_zFbX6SlvPo3k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0782">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0783">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0785">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValue_iI_zsWxZpZCbt21" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Derivative Liabilities &#8211; refer Note 21</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0787">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,694,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,694,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_zwPEIDdwxdy6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0792">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0793">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,694,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,694,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfDerivativeLiabilityExplanatory', window );">Schedule of Fair Value Measurement of Derivative Liability</a></td>
<td class="text"><p id="xdx_89C_ecustom--DisclosureOfDerivativeLiabilityExplanatory_zz6cZ8Gpqwmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_z0DzVDLs8pOa" style="display: none">Schedule
of Fair Value Measurement of Derivative Liability</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Derivative liability</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Total</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: normal; text-align: left">Consolidated</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">$</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Balance at 1 July 2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DerivativeFinancialLiabilities_iS_c20220701__20230630_z0R7TJj55djc" style="width: 12%; text-align: right" title="Balance">878,653</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eifrs-full--FinancialLiabilities_iS_c20220701__20230630_zuoCRlVBY6zh" style="width: 12%; text-align: right" title="Balance">878,653</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value of derivative liability recognised for convertible notes issued during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_c20220701__20230630_z1AjGBA7dQOd" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year">10,945,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_c20220701__20230630_zYkbUdeWnAie" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year">10,945,347</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Fair value movement recognised in profit or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--FairValueMovementRecognisedInProfitOrLoss_c20220701__20230630_zcgU848FByG6" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value movement recognised in profit or loss">6,870,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_c20220701__20230630_zLriMIYpnDTk" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value movement recognised in profit or loss">6,870,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance at 30 June 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iS_c20230701__20240630_zUyZwqyKuxpa" style="text-align: right" title="Balance">18,694,729</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iS_c20230701__20240630_zwSEuwbL1w7j" style="text-align: right" title="Balance">18,694,729</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value of derivative liability recognised for convertible notes issued during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_c20230701__20240630_zZwxa5bWvOjf" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year">280,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_c20230701__20240630_zRBTYXplDnr3" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year">280,198</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Fair value movement recognised in profit or loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--FairValueMovementRecognisedInProfitOrLoss_c20230701__20240630_zIm3QAun1PMe" style="text-align: right" title="Fair value movement recognised in profit or loss">(3,400,685</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_c20230701__20240630_zxljolWGhcy8" style="text-align: right" title="Fair value movement recognised in profit or loss">(3,400,685</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Fair value of derivative liability for convertible notes which converted or matured during the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_c20230701__20240630_zbI4NgGD8dyg" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of derivative liability for convertible notes which converted or matured during the year">(15,574,242</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_c20230701__20240630_zlodQOI4j9a1" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of derivative liability for convertible notes which converted or matured during the year">(15,574,242</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance at 30 June 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eifrs-full--DerivativeFinancialLiabilities_iE_c20230701__20240630_zMQCn8i4GJHb" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"><span style="-sec-ix-hidden: xdx2ixbrl0827">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eifrs-full--FinancialLiabilities_iE_c20230701__20240630_zM3ylSxHFXo7" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"><span style="-sec-ix-hidden: xdx2ixbrl0829">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory', window );">Schedule of Unobservable Inputs Level 3 Liabilities</a></td>
<td class="text"><p id="xdx_895_eifrs-full--DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_zXNXdVFKxRtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
level 3 liabilities unobservable inputs at issue date of each of the convertible notes series are as follow:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zLarCb241h71" style="display: none">Schedule
of Unobservable Inputs Level 3 Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zp3vfSB85J27" style="width: 18%; text-align: right" title="Implied Valuation">28,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zZuZEBvwtkOh" style="text-align: right" title="Volatility">74</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zz7X8ueMA5a7" style="text-align: right" title="Volatility">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zEPFKyGEfIme" style="text-align: right" title="Volatility">50</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A - July 21</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zVuGci006Ksb" style="width: 18%; text-align: right" title="Implied Valuation">28,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zP3yLd1B7I38" style="text-align: right" title="Volatility">74</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zsuvP1fU9DMc" style="text-align: right" title="Volatility">0.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_ziGwy7zjDOC2" style="text-align: right" title="Volatility">50</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A &#8211; August 21</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_z6TN7GPgOxN" style="width: 18%; text-align: right" title="Implied Valuation">28,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zl5TIWyXdeH2" style="text-align: right" title="Volatility">62</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zEt0xB5LCaR7" style="text-align: right" title="Volatility">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zLjvyPV6RtJ6" style="text-align: right" title="Volatility">50</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series B1</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zQSDF0mM3Zf2" style="width: 18%; text-align: right" title="Implied Valuation">120,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zGrlA1CI2Yqk" style="text-align: right" title="Volatility">74</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zMPstv8V9ubf" style="text-align: right" title="Volatility">0.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zkyr6J9Gc0ki" style="text-align: right" title="Volatility">50</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series B2</i></b></span></p></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_ziaqCXgeU2e6" style="width: 18%; text-align: right" title="Implied Valuation">70,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_z0Wwew0eU187" style="text-align: right" title="Volatility">66</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_ztpjbijgfsRa" style="text-align: right" title="Volatility">3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_zHvD5ZKsQMd4" style="text-align: right" title="Volatility">50</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Fair value measurement - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Series A Extension</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_z0AOX32bewYc" style="width: 18%; text-align: right" title="Implied Valuation">28,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_zcsirHDeCGW3" style="text-align: right" title="Volatility">65</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_z4qFyH8cKW24" style="text-align: right" title="Volatility">3.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_zcUyIbIbYoa7" style="text-align: right" title="Volatility">0</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Reach</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zCDcShhAlquf" style="width: 18%; text-align: right" title="Implied Valuation">40,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zZrAv0MSz1j9" style="text-align: right" title="Volatility">60</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zcs5oKG0sfj3" style="text-align: right" title="Volatility">3.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zINygeJBMhK7" style="text-align: right" title="Volatility">100</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Private Placement</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zSVK1qaCez68" style="width: 18%; text-align: right" title="Implied Valuation">53,685,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zSb9oj4dlbGf" style="text-align: right" title="Volatility">60</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zOtHhs1KwYWb" style="text-align: right" title="Volatility">3.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_ztoHxmtYGFnb" style="text-align: right" title="Volatility">100</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Mixed Martial Arts LLC</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zFPOfH2Wgr7g" style="width: 18%; text-align: right" title="Implied Valuation">384,750</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zv0Qp6BZ5WO2" style="text-align: right" title="Volatility">49</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zxXFvfO9oiO8" style="text-align: right" title="Volatility">4.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zneXfVnHL4pa" style="text-align: right" title="Volatility">100</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: right">Steppen</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: right">Implied valuation</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_z7ojOPxh03G9" style="width: 18%; text-align: right" title="Implied Valuation">100,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zrheWO1kl34c" style="text-align: right" title="Volatility">47</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zGVfRKO4ghTd" style="text-align: right" title="Volatility">4.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Probability of conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zSnsYp7Ur1yk" style="text-align: right" title="Volatility">100</td><td style="text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfDerivativeLiabilityExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of derivative liability explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfDerivativeLiabilityExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of significant inputs for which market data are not available and that are developed using the best information available about the assumptions that market participants would use when measuring the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321200992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfCashEquivalentsExplanatory', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_898_ecustom--DisclosureOfCashEquivalentsExplanatory_znCeSEql0yEe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zq6UPO9nt3Nh" style="display: none">Schedule
of Cash and Cash Equivalents</span> &#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240630_zE3HFPXSzMMl" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230630_zzUAlB3ozL8j" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CashOnHand_iI_maCACEz9Hz_z7vm8uu5LhW2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Cash on hand</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--BalancesWithBanks_iI_maCACEz9Hz_zQjt6dNqt0q3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash at bank</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,543,837</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,701,567</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--CashAndCashEquivalents_iTI_mtCACEz9Hz_ztzFeQB6I0X5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total cash and cash equivalents</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,544,837</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,702,567</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--CashAndCashEquivalents_iI_zArdMXCRT3Kj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cash as per above</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,544,837</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,702,567</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--CashAndCashEquivalents_iI_zHAwqU2KunJ1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Balance as per statement of cash flows</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,544,837</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,702,567</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of cash equivalents explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320905968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfTradeAndOtherReceivableExplanatory', window );">Schedule of Trade and Other Receivables</a></td>
<td class="text"><p id="xdx_897_ecustom--DisclosureOfTradeAndOtherReceivableExplanatory_z9Kqk8ZxLgz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zGeOOPl2rvgj" style="display: none">Schedule
of Trade and Other Receivables</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240630_z3HBqL7GOEQ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230630_zHNoveeYHHv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--TradeReceivables_iI_zsAQml8LWkt4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Trade Receivables</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">657</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">351,905</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--AccruedIncomeOtherThanContractAssets_iI_zSfGSPbkl2kh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,443</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ResearchAndDevelopmentIncome_iI_zh8sjvLVx2t6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research and Development Tax incentive receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0942">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,776</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--OtherReceivables_iI_zd4qP7ry3Kz2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other advances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,618</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,952,560</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AllowancesForCreditLoss_iI_z2DkDzNVX90f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less; allowance for credit losses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,603</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,603</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eifrs-full--TradeAndOtherReceivables_iI_zLn2rvVIKUk5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total trade and other receivables</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">71,115</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,365,638</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfTradeAndOtherReceivableExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of trade and other receivable explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfTradeAndOtherReceivableExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320907248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p id="xdx_890_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z4Spbpyx1bjc" style="margin: 0"><span id="xdx_8BE_zN9nwSU0bEv3" style="display: none">Schedule
of Property and Equipment</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20240630_z8yuAJ8MDg4g" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230630_z1pR9LZM9mv3" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zWF0lFKBxGBa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Plant and equipment - at cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">72,410</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">69,210</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zhsKji62vnnh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(59,339</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(56,002</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zlbJnq9EQAbc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,071</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,208</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zusnWBfhM3Q5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer equipment - at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,047</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,612</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zg5am1rBKOma" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(82,269</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(54,929</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zNDHpHcK1DJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,778</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,683</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zIM4Jcl8lSX" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office equipment - at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,090</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_znmNN4ZfWcLh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,508</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,313</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zphmh3ylXEb8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">582</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">777</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20240630_zSZhQ5pO2klj" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20230630_z8ignUUSiYHa" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_401_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zbhg8nWwLbE6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Furniture &amp; Fittings - at cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">49,537</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">49,537</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zXX3RNQf27Vi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(14,270</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,277</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zB2QfahSvp6a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture &amp; Fittings</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">35,267</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">40,260</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_iI_zkm2lYfdlUP8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">77,698</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">94,928</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Property Plant and Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zVFYtlUGy7wj" style="text-align: right" title="Balance">13,208</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zk7vtZqiWWD6" style="text-align: right" title="Balance">10,189</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zvjrp2I2G7j9" style="text-align: right" title="Additions">3,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zy1ZnIoxVdTk" style="text-align: right" title="Additions">2,110</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zqDqMIPBKfM5" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1005">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zPdfmzEqGjf2" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1007">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zi58GAOax3G4" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(3,337</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zBGSt9KmaFS8" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">909</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year-</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zfdWwaqGZKm6" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">13,071</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zPWkzJKvfsJ" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">13,208</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Computer Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_dxL_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z0wStTmp5A38" style="text-align: right" title="Balance::XDX::40683"><span style="-sec-ix-hidden: xdx2ixbrl1017">51,971</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4L3npPCvlXd" style="text-align: right" title="Balance">51,971</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zaseSOdCciGk" style="text-align: right" title="Additions">15,435</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhEak30rSyW1" style="text-align: right" title="Additions">12,687</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zCZIanT1yvD3" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1025">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zENb5yXRlG3h" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1027">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zUczSfeONi0d" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(38,628</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zrE1kMCHaAw6" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(23,975</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zuIv6oRJpop1" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">28,778</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zHOwuc7dgvAc" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">40,683</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Office Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zT2gdA7rI0t3" style="text-align: right" title="Balance">777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zN8t4gG398gj" style="text-align: right" title="Balance">1,036</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zLTP0e5mOfIc" style="text-align: right" title="Additions"><span style="-sec-ix-hidden: xdx2ixbrl1041">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zolyYfpC2JQb" style="text-align: right" title="Additions"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zgZmtYyTAoY1" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1045">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zw8BMhz9U5q9" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1047">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zhP0D86yJe92" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(195</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zS1QX8kqxTJe" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(259</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zWmH4FGeTYLd" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">582</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zqDQ2A5bx5f3" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">777</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Furniture &amp; Fittings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zUuFgb9s88Th" style="text-align: right" title="Balance">40,260</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_z0mcpFwLBkek" style="text-align: right" title="Balance">45,224</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zsScsLS2XRJ5" style="text-align: right" title="Additions"><span style="-sec-ix-hidden: xdx2ixbrl1061">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zhsKqTjcgoN8" style="text-align: right" title="Additions"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zuuCmdALG1i3" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1065">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zbCw4R72GJRb" style="text-align: right" title="Disposals"><span style="-sec-ix-hidden: xdx2ixbrl1067">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zGkHTu3gvSf" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(4,993</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zIbrUGFllXP" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense">(4,964</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zPHniialTjY3" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">35,267</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zilSXRxgllok" style="border-bottom: Black 1pt solid; text-align: right" title="Balance">40,260</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320477008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of Intangible assets</a></td>
<td class="text"><p id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_z4WWHGzNnSo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zy6ZJQJ4JJph" style="display: none">Schedule of Intangible assets</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240630_zbw9mhXi0cv6" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230630_zVFbHzDTLJyg" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWfOL3bUkefb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Trademark - at cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">52,243</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">50,843</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdMrzRmD2v78" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(29,653</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,429</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zGeCtoaUP3yc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark - at cost, net</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,590</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,414</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zg6787Dj2mm2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Platform development - at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,988,033</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,136,149</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbSFxOeozqT4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(713,360</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(351,202</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zldqW3wFluei" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Platform
    development - at cost, net</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,274,673</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">784,947</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_zD3AUrzw6X02" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total intangible assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,297,263</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">811,361</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory', window );">Schedule of Reconciliations of the Movement of Intangible Assets</a></td>
<td class="text"><p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory_zM5JV1YW6tRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliations
of the movement of intangible assets are set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zzUebXIuSik5" style="display: none">Schedule of Reconciliations of the Movement of Intangible Assets</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20230701__20240630_zFOOXYRKZj65" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220701__20230630_zhreG6tQh7Hj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Trademark</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zvsRasfCteeb" style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left">Balance at beginning of the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">26,414</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">26,414</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z5BTHYfs6fwe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1108">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_za34hXYLEzpa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization expense</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,224</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1111">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zAKkxVkEsDnf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Balance at end of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22,590</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26,414</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Platform development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_z6NxPuO4om8h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">784,947</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,034,302</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AdditionsFromInternalDevelopment_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zxLtOsQJ3KCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additions from internal development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">352,182</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zsbD745T533l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additions acquired <span id="xdx_F4D_zkhnk0Ru9lo1">*</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">674,220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ResearchDevelopmentTaxIncentive_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zMTiZn8U98hh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research &amp; Development tax incentive</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1125">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(383,937</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_znukqCAigQqi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization expense</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(361,950</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(217,600</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zQrmniWgl8Fa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Balance at end of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,274,673</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">784,947</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F00_zE8r3Az3I4Oa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F14_zFnGGzVFHNc1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in additions
is acquired intangible assets of:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            September 2023, we completed the acquisition of the assets of Steppen Pty Ltd, a fitness
                                            technology company based in Australia (&#8220;Steppen&#8221;). As consideration for the asset
                                            acquisition, we issued Steppen an unsecured and non-redeemable convertible promissory note
                                            (on the same terms as the recently completed Private Placement), with a principal amount
                                            of US$ <span id="xdx_909_eifrs-full--NotionalAmount_iI_c20230930__ifrs-full--CounterpartiesAxis__custom--SteppenPtyLtdMember_zFJXAam8TyIf" title="Principal amount">64,977</span> (AUD$<span id="xdx_909_eifrs-full--NotionalAmount_iI_uAUD_c20230930__ifrs-full--CounterpartiesAxis__custom--SteppenPtyLtdMember_zRZTSBvMObUa" title="Principal amount">100,000</span>).</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            October 2023, we completed the acquisition of the assets of Mixed Martials Arts LLC, an independent
                                            MMA media company, based in the US. As consideration for the asset acquisition, we issued
                                            Mixed Martials Arts LLC an unsecured and non-redeemable convertible promissory note (on the
                                            same terms as the recently completed Private Placement), with a principal amount of US$<span id="xdx_907_eifrs-full--NotionalAmount_iI_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_zOAvpzW7u2w1" title="Principal amount">250,000</span>
                                            (AUD$<span id="xdx_90C_eifrs-full--NotionalAmount_iI_uAUD_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_z6Z71mZKZNod" title="Principal amount">384,750</span>) and paid US$<span id="xdx_901_eifrs-full--Cash_iI_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_zPWHyb4ReqE4" title="Cash">25,000</span> in cash.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            May 2024, we completed the acquisition of the assets of Hype Kit, Inc, a Delaware corporation
                                            (&#8220;Hype&#8221;), an all in-one digital marketing platform, designed to help small businesses
                                            grow in today&#8217;s age of social media. Hype&#8217;s software platform strengthens the
                                            Company&#8217;s vision to convert 640 million MMA fans to participants by providing invaluable
                                            tools to our gym owner, coach, and athlete partners to not only grow their revenues, but
                                            also operate more efficiently, save costs and enhance the offerings to <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">their
members and community. This acquisition is expected to accelerate Alta&#8217;s technology roadmap, bringing forward new subscription
revenue opportunities for us, whilst creating cost synergies by materially reducing product development overhead and bringing valuable
technology expertise, skills and talent into the business. The acquisition was completed, and the asset purchased for consideration of
USD$<span id="xdx_909_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20240531__ifrs-full--CounterpartiesAxis__custom--HypeKitIncMember_zawEFdzTJqK8" title="Asset purchased for consideration">100,000</span> (AUD$<span id="xdx_90F_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_uAUD_c20240531__ifrs-full--CounterpartiesAxis__custom--HypeKitIncMember_zZK4K0AcQjJ8" title="Asset purchased for consideration">153,000</span>)</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
                                            determined both the acquired intangible assets did not pass the concentration test under
                                            IFRS 3 Business Combinations. Thereby were accounted for as acquisition of intangible assets.</span></td></tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about reconciliations of the movement of intangible assets explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319662000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other payables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfTradeAndOtherPayablesAbstract', window );"><strong>Trade And Other Payables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables', window );">Schedule of Trade and Other Payables</a></td>
<td class="text"><p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayables_zcigglHseYi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_z1pFUCbStljj" style="display: none">Schedule of Trade and Other Payables</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zzRqt8QejHec" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20230630_zH2rBd2YQCe7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--TradeAndOtherPayablesPayableToMemberGyms_iI_maTAOPzf2r_zCUAJCQhg4Zg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Payable to member gyms</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">69,019</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">61,065</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--TaxesPayable_iI_maTAOPzf2r_zKTaaUbe5Cug" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">603,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">560,204</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--TradePayables_iI_maTAOPzf2r_zgIV4zl7CxY5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">540,102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">723,105</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ProvisionForRefundLiability_iI_maTAOPzf2r_zWEOr8VpVAW6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Provision for refund liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--OtherPayables_iI_maTAOPzf2r_z17Syid3zER2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other Payables</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">778,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">620,062</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--TradeAndOtherPayables_iTI_mtTAOPzf2r_z50oSktPub1h" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total trade and other payables</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,991,536</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,034,436</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about trade and other payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfTradeAndOtherPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfTradeAndOtherPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550387658096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Current and Non-current Employee Entitlements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract', window );"><strong>Current And Non-current Employee Entitlements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory', window );">Schedule of Current and Non-current Employee Entitlements</a></td>
<td class="text"><p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory_zErYGqEv8pT3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>&#160;</span></b></span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zXK32yoCCa14" style="display: none">Schedule of Current and Non-current Employee Entitlements</span></span></p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240630_zqnFK1vvJbF2" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20230630_zcvpot8RqXdk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--CurrentProvisionsForEmployeeBenefits_iI_zCIX6RQcOSr" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Current Employee Entitlement</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">454,342</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">357,227</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NoncurrentProvisionsForEmployeeBenefits_iI_zOZjPFsDm7Za" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Non-current Employee Entitlements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,622</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,892</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about current and non current employee entitlements explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319666560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Unearned Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfUnearnedRevenueAbtract', window );"><strong>Unearned Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory', window );">Schedule of Unearned Revenue</a></td>
<td class="text"><p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory_z3LdcY8UUL4" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;<span id="xdx_8BD_zxG2tDSKM5E" style="display: none">Schedule
of Unearned Revenue</span> </span></p>



<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20240630_zlEvGQQGNqj7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20230630_z3CsV6nWAyO" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--UnearnedRevenue_iI_zK8QSeSdAgD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 68%">Unearned Revenue</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 12%">174,290</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about unearned revenue explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfUnearnedRevenueAbtract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfUnearnedRevenueAbtract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318765936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reserves (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfReservesAbstract', window );"><strong>Reserves</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ScheduleOfReservesTableTextBlock', window );">Schedule of Reserves</a></td>
<td class="text"><p id="xdx_89E_ecustom--ScheduleOfReservesTableTextBlock_zLJbJUzbgzZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z2pBebaXDblc" style="display: none">Schedule
of Reserves</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zz9bVQNbSrpf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230630_zGg46BUY79G2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220630_ztcrbkNkzbc8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ReserveOfUnbilledShareOption_iI_zMGgFfZ6q9V6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Unlisted share option reserve</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2,741,457</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1193">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ReserveOfSharebasedPayments_iI_zbS34NmH7cqi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share based payment reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,734,601</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,912,367</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,546,983</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ForeignCurrencyReserves_iI_zpouhT90SLgj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign currency translation reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(86,542</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(65,832</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,367</td><td style="text-align: left">)</td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfReservesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfReservesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ScheduleOfReservesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of reserves table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ScheduleOfReservesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320898400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Issued capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory', window );">Schedule of Issued Capital</a></td>
<td class="text"><p id="xdx_895_ecustom--DisclosureOfDetailedInformationIssuedCapitalExplanatory_zPMktKfppKH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B7_zoD0Hqlev9Rc" style="display: none">Schedule
of Issued Capital</span> </b></span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230701__20240630_zn9pNIbOrWV7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220701__20230630_zgDxKzy7dyEa" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210701__20220630_zG8jp2ktb71k" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--OwnersShareCapital_iS_zKCVHf2eUfy" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Owners share capital, opening (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,918,750</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,918,750</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,918,750</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--NumberOfShareIssuedAndFullyPaid_iI_zUBhQRo77FOj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issued and fully paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,315,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssueOfSharesFromConversionOfConvertibleNotes_iI_zG1RDQWZHy72" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue of shares from the conversion of <br/>the convertible notes (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,706,794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1217">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--AdvisorOptionsExercisedShares_iI_zGuEBkkcJVe4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Advisor Options exercised (3)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">327,142</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1221">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--OwnersShareCapital_iE_ztL346Cfxugi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Owners share capital, closing</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,267,686</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,918,750</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,918,750</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230701__20240630_zbeUkXxhmbZ2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220701__20230630_zXLDYJL3Y0W4" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210701__20220630_zsfkk35OcLkg" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30 June 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--IssuedCapital_iS_zg69Yz2AiQjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Owners share capital, opening <span id="xdx_F47_zjFCNTsI7pm9">(1)</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,385,281</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,385,281</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">3,385,281</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--IssuedAndFullyPaidValue_iI_zIhtblNtgsr6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issued and fully paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,964,825</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1233">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--PaymentsForShareIssueCosts_iN_di_zxb1M40zgww4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share issue transaction costs net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,174,911</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1238">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IssueOfEquityFromConversionOfConvertibleNotes_znczo8SFg057" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issue of shares from the conversion of <br/>the convertible notes <span id="xdx_F4A_z5LnXeVHYML3">(2)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,177,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1242">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--AdvisorOptionsExercisedValue_zr5sXAezuH2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Advisor Options exercised <span id="xdx_F45_zRA9StAPqgO3">(3)</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,426,757</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1246">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--IssuedCapital_iE_zRkkrDEpE2b7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Owners share capital, closing</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">46,779,703</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,385,281</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,385,281</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F09_zUXUyW0TuCdi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zk2zoxoSlYo7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 24, 2024, there was a reverse share split of our issued and outstanding Ordinary
                                            Shares and Ordinary Share equivalents on the basis of four (4) securities for every five
                                            (5) securities held. All issued and outstanding Ordinary Shares and Ordinary Share equivalents
                                            and per share data have been adjusted throughout the financial statements to reflect the
                                            reverse share split for all periods presented.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0B_z4wSMrtrgtMl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zV3MPtwn4PV5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            issue of shares from the conversion of convertible notes reflects and includes the face value
                                            of the note and interest accrued at a fixed rate defined in the agreements, along with the
                                            value of the derivative prior to conversion. This interest figure includes both the accrued
                                            interest rate (contractual and effective) relating to the convertible notes, with the contractual
                                            capitalised interest rate ranging between <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLfugi4sxe0j" title="Contractual capitalised interest rate">8.5</span>% to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_za6aLsj3gMFg" title="Contractual capitalised interest rate">15</span>% per annum, and the derivative reflects the effective interest rate being the cost of the relevant conversion discounts to market value at
the conversion date.</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
17. Issued capital - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_zQiZMShGsO8i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z4piaXKlPuyl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                                            that <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--AdvisorOptionsExercisedShares_c20230701__20240630_zL4BG4Y3jk25" title="Advisor options exercised, shares">327,142</span> Advisor Options fully vested and were exercised into Shares between July 2023
                                            and December 2023 and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--AdvisorOptionsForfeitedShares_iI_c20240630_z7hRoX7U4kUl" title="Advisor options forfeited, shares">16,193</span> Advisor Options were forfeited.</span></td></tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information issued capital explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322597952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes to statement of cash flows (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory', window );">Schedule of Statement of Cash Flows</a></td>
<td class="text"><p id="xdx_893_ecustom--DetailedInformationOfNotesToStatementOfCashFlowExplanatory_z3gzsXiaQOCj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BF_z9B1HJRpJk28" style="display: none">Schedule
of Statement of Cash Flows</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20230701__20240630_zCZgGGC0xLB9" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220701__20230630_zVOfxZpP9ld6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20210701__20220630_zbQ7onH0NoSh" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--ProfitLoss_zjN1Qm2AZwja" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Loss after income tax</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(14,408,346</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(20,597,436</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(11,197,450</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Non-cash flows in operating loss: <br/></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--AccruedInterestOnConvertibleNotes_zypX2Jcdkgn4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued interest on convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,207,497</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,420,225</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,162,646</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_zsUZZzs3Y7Q5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share-based payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,521,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,365,384</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,546,983</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ConvertibleNotesIssuedInLieuOfPaymentForServices_zLCLJwjBx6r9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible notes issued in lieu of payment for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1279">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">624,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1281">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--DepreciationExpense_zU9Y8aFwHzJi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortisation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">520,697</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">360,021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">260,651</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--FairValueMovementRecognisedInProfitOrLoss_zL3EcxUjLw5e" style="vertical-align: bottom; background-color: White">
    <td>Fair value movement of derivatives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,400,685</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,870,729</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,751,564</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in assets and liabilities: <br/></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_zhVXlvxLV4Gc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Decrease in trade and other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">372,390</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">506,737</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130,933</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustmentsForDecreaseIncreaseInOtherAssets_ze3Sk78lgjqb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">(Increase)/Decrease in other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(189,621</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,015,343</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_zdy0c54ElOV4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Increase/(decrease) in trade and other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,719</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(153,292</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">993,662</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--AdjustmentsForIncreaseDecreaseInNetDeferredRevenue_zcQro3SQ9jnd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Decrease in net deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(174,290</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(121,453</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(339,222</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--AdjustmentsForIncreaseDecreaseInProvisionForRefund_zplmHTrvaQX6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">(Decrease)/increase in provision for refund</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(70,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_znZg4nO42Jeh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Increase in employee entitlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">133,845</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">102,833</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CashFlowsFromUsedInOperatingActivities_iT_zC6BozSyb4Hk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,386,196</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,555,868</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(8,055,185</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detailed information of notes to statement of cash flow explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321184672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory', window );">Schedule of Key Management Personnel Remuneration</a></td>
<td class="text"><p id="xdx_89C_eifrs-full--DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_zlyhUauOV7od" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B1_ztW2AXnKZ5hk" style="display: none">Schedule
of Key Management Personnel Remuneration</span></span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230701__20240630_z8Ufl7TIa9M8" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220701__20230630_zGjgdSXwEsl5" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20210701__20220630_z50Pej9t8m4g" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_maKMPCzfQ1_z264cbSzJCg3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Short term benefits</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,031,194</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">657,879</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">671,709</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_maKMPCzfQ1_z7sfxupR6eTc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Post employment benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,730</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,191</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,542</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationOtherLongtermBenefits_maKMPCzfQ1_zywIFKfYPxtj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Long term benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,474</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,892</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1333">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_maKMPCzfQ1_z7Wyf9d7WGxj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Share Based payments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,808,863</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,065,554</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">897,586</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensation_iT_mtKMPCzfQ1_zf2g8IvGk3Hc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,919,261</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,775,516</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,612,837</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory', window );">Schedule of Shares Held by Key Management Personnel</a></td>
<td class="text"><p id="xdx_892_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_gL3DOTBRPE-JAYXU_zCIemTAmLuvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zxAlHNVdoD31" style="display: none">Schedule
of Shares Held by Key Management Personnel</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zRpO73yah3pg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares<br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zbnpnm9YoWB2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zN4pOFKcU7x4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares<br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--NumberOfSharesOutstanding_iS_z6l8k3OwFZy4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Opening Balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,149,362</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,786,093</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">2,955,616</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssuedSharesHeldByKeyManagementPersonnel_zumMm30xbNVh" style="vertical-align: bottom; background-color: White">
    <td>Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">296,535</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1352">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">477,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--RepurchasedSharesHeldByKeyManagementPersonnel_ztRpphVMuAx3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Repurchased</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1355">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1356">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,200,000</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--ResignationOfKeyManagementPersonnelShares_zR9740m7UdG8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Resignation of Key Management Personnel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1359">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(530,609</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1361">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ReverseShareSplitSharesHeldByKeyManagementPersonnel_z68QYMVcqyo4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Reverse Share Split</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1363">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(106,122</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(446,523</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eifrs-full--NumberOfSharesOutstanding_iE_zocCRjlKg23d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Closing Balance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,445,897</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,149,362</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,786,093</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zf2re8yb9Pk9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Shares Held by Key Management Personnel (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_z16uc5B0wdi4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_zPEoY8showuh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_zRAtYVHqkyIj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option<br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zNJcdu9WjZP6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Opening Balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">654,364</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">515,850</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1373">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--IssuedOptionsHeldByKeyManagementPersonnel_zItZ45f2rf3d" style="vertical-align: bottom; background-color: White">
    <td>Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">342,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">279,221</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">644,813</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ExpiredOptionsHeldByKeyManagementPersonnel_z58RYCageMSb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Expired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(106,078</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1381">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ExercisedOptionsHeldByKeyManagementPersonnel_zMGYypES4Ac5" style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(205,086</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1385">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ReverseShareSplitOptionsHeldByKeyManagementPersonnel_zJN8YGPKezs2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Reverse share split</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(34,629</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(128,963</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_uShares_zEbdpHm4JAd8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Closing Balance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">791,278</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">654,364</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">515,850</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320888688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Summary of Changes in ROU Assets</a></td>
<td class="text"><p id="xdx_896_eifrs-full--DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_ziCf63XLziz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zgDoRZq7aEC" style="display: none">Summary
of Changes in ROU Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">(a) Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left">Right of use asset</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_ecustom--RightofuseAsset_iS_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW0f7JEjAIBf" style="width: 12%; text-align: right" title="Right of use asset">613,691</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--RightofuseAsset_iS_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSdyrWfuM371" style="width: 12%; text-align: right" title="Right of use asset">400,829</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--AccumulatedAmortization_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zu5Y3ybHL2k2" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period">(358,228</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--AccumulatedAmortization_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwUwV0tJBMAj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period">(243,290</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Balance at end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--RightofuseAsset_iE_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBKN7ji4A6pg" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year">255,463</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RightofuseAsset_iE_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRbDrCbrBQYh" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year">157,540</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance at beginning of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--RightofuseAsset_iS_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zP7koQHKeQ7h" style="text-align: right" title="Balance at beginning of year">157,540</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--RightofuseAsset_iS_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z3DQrTKCygZi" style="text-align: right" title="Balance at beginning of yea">276,907</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Modification</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--Modification_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z15ci9QCcPV4" style="text-align: right" title="Modification">212,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--Modification_iI_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zFcuqlNEuE85" style="text-align: right" title="Modification"><span style="-sec-ix-hidden: xdx2ixbrl1524">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: amortization for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--AccumulatedAmortization_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z9s5QEJz6Znf" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period">(114,759</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--AccumulatedAmortization_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zXSlPeqKqUFj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period">(119,367</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance at end of the year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--RightofuseAsset_iE_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zl2WOe0KbKKa" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year">255,463</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RightofuseAsset_iE_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z4q3N2QxJHUa" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year">157,540</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">(b) Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--CurrentLeaseLiabilities_iI_c20240630_zvPMDte7J3Ck" style="text-align: right" title="Current lease liability">128,559</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--CurrentLeaseLiabilities_iI_c20230630_z0Q5x28E5D8f" style="text-align: right" title="Current lease liability">121,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Non-current lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eifrs-full--NoncurrentLeaseLiabilities_iI_c20240630_zH0pDaMPTQg1" style="border-bottom: Black 1pt solid; text-align: right" title="Non-current lease liability">130,722</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eifrs-full--NoncurrentLeaseLiabilities_iI_c20230630_zkpth2DWjvO" style="border-bottom: Black 1pt solid; text-align: right" title="Non-current lease liability">54,162</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--LeaseLiabilities_iI_c20240630_zo6k1lIA5MWb" style="border-bottom: Black 1pt solid; text-align: right" title="Total lease liabilities">259,281</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eifrs-full--LeaseLiabilities_iI_c20230630_zVnNtNHtgcc7" style="border-bottom: Black 1pt solid; text-align: right" title="Total lease liabilities">175,662</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory', window );">Summary of Future Minimum Lease Payments</a></td>
<td class="text"><p id="xdx_896_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_z4D0wss8f2u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_z4oesS1LIrvl" style="display: none">Summary
of Future Minimum Lease Payments</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240630_zUciWd6oymo5" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230630_ztQ9kyY1o8H4" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_maLLzHsH_zkrOBgGJZKt2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Less than one year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">135,680</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">127,361</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_maLLzHsH_zFpGlH0qhgBe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">One to two years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_maLLzHsH_zcGWuInT1sGg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Two to five years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_maLLzHsH_zqXC9JRz2M7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Five years and over</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1557">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1558">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--LeaseLiabilities_iI_pp0p0_hifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_mtLLzHsH_zaXrmVWwrCHh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total future lease payments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">217,187</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">183,789</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 97<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_97&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320866928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory', window );">Schedule of Financial Liabilities</a></td>
<td class="text"><p id="xdx_890_ecustom--DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory_zqPXXi9zrlvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Financial Liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ConvertibleInstrumentsMember_zaJvSGUngEdf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2024</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ConvertibleInstrumentsMember_zCpBCtaqKjte" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2023</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">($)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--CurrentFinancialLiabilities_iI_maFLz9PT_zeQSQ1S9pWb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Convertible note payable - Current</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1567">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">25,331,307</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--NoncurrentFinancialLiabilities_iI_maFLz9PT_zppzfpe3V7e6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible note payable &#8211; Non Current</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1570">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,273,278</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eifrs-full--FinancialLiabilities_iTI_mtFLz9PT_zI8Yo4b5cuEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Financial Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1573">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">35,604,585</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CurrentDebtInstrumentsIssued_iI_maDSznTX_zTv2A2z8q3Fi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Host Liability - Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1576">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,567,450</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--NoncurrentDebtInstrumentsIssued_iI_maDSznTX_z4DzOPj9qQP8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Host Liability &#8211; Non Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1579">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">342,406</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_maDSznTX_zmEHtWJZpfW3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Derivative liability -Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1582">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,763,857</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iI_maDSznTX_zsde6Hflx1I2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Derivative liability - Non Current</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1585">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,930,872</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--DebtSecurities_iTI_mtDSznTX_zRBnTMDqk59c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Convertible Notes Payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1588">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">35,604,585</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDebtSecuritiesExplanatory', window );">Schedule of Convertible Notes held by Investors</a></td>
<td class="text"><p id="xdx_891_eifrs-full--DisclosureOfDebtSecuritiesExplanatory_zFeaMSLBtDbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
notes held by investors in the reporting period are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zxHj016l3T8k">Schedule
of Convertible
Notes held by Investors</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="font-style: italic; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series A</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Key Terms of this Series A convertible notes are as follows</i></span></p></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zKTyBiGTOkBg">23-Dec-20</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zckboiGTorYi">23-Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zy6NsfBzcmn1">1-Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zHUeRarlkhh9">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zcIukupuO0J">31 -Dec 23</span> </span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_907_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zgvjtyeejJQb">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zQJ6vqZUYUhj">7,319,818</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zzaC5xHGzy18">8.5</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zyhe1TlxgTyc">20.0</span></td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. - Financial Liabilities - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
A &#8211; July 21</b></span></p></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series A convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zu4HVLcYvDy6">7-Jul-21</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zVw4aqQOT9M6">7-Jul-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zZ9Q6iCydPHg">7-Jul-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_z6nUxvTzCBxg">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_z2VAU81ictC8">525,000</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zNKm7fP3bmN1">8.5</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zr4LC4BBNQCf">20.0</span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Series A &#8211; August 21</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series A convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zGC5Z3bs0jm4">20-Aug-21</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zhjRokEV9uZg">9 -Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zGyLx2NaRVcf">1-Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zqmVPs1uki4e">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zUypov1Yt4I9">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zMyTSVokMg52">1.3</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_z6GWYtXKE1sl">172,000</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zuI6b4KWOevf">8.5</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zTaNP8xp7Vd4">20.0</span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series B1 </b></span></p></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series B1 convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zWfOZme1Qlii" title="Issue Date">15-Dec-21</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zmCvEJVYHqge" title="Pre Modification Maturity Date">15-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zNcDhXuvCkxl" title="Modification Date">1-Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zfod4Eb7KKQi" title="Modified Maturity Date">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zPo4oyaBhY13" title="Conversion Date">31.Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zRR89usCshda" title="Term (Years)">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zh2qeau6QYyd" title="Face Value">4,982,652</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_z2RkfJdY8C14" title="Interest Rate">8.5</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zn8ri5Kc6ZQ2" title="Conversion Discount (Qualified Equity Investment)">20.0</span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. Financial Liabilities - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series B2</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_49B_20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zNADu065PWEg" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series B2 convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zsyxpG9JlFw3" title="Issue Date">1-July-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pre Modification Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zaZemu70Nlfa" title="Pre Modification Maturity Date">30-June-24</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Modification Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zSVSzLOnKTri" title="Modification Date">1-Dec-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Modified Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zelEyzEEiQI5" title="Modified Maturity Date">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zODcW7e9H2ea" title="Conversion Date">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_908_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_z0Nz8qhfQSqg" title="Term (Years)">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--Borrowings_iI_zYYZTZcwJVXi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">671,284</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--BorrowingsInterestRate_iI_dp_zk827CPePtqk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40D_ecustom--ConvertibleNotesConversionDiscount_iI_dp_z1ZMFc69oupb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20.0</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A Extension</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_490_20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_ze0iFRIDr6x5" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Series A Extension convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_z0jHywvp22f3" title="Issue Date">16-Nov-22</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_z2eM1iM8iNFk" title="Modified Maturity Date">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_zDaBPU3ZfVM9" title="Conversion Date">31-Dec-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90C_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_zE0O8PAIVCB7" title="Term (Years)">1.1</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--Borrowings_iI_zIUvqsnhOYsa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,571,873</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zGDBoyRcRY1l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40C_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zYGxmwqqxsoi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reach</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_49C_20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zTXJDxkEE2R4" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Reach convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zPbnewNmlso2" title="Issue Date">13-Feb-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zuMY3qoLdYEi" title="Modified Maturity Date">13-Feb-25</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date <span>**</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_fKio___zzovJym22qA5" title="Conversion Date">28-Mar-24</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_906_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_z2EoLPwOvzGd" title="Term (Years)">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--Borrowings_iI_z2XJThR4Fri8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value<span id="xdx_F41_zNopM9pTRBHk">*</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,195,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zKBPam9e4uX2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40C_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zyhLh5GJx81b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">%</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%">
<tr style="vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span id="xdx_F0E_zKL2Udiju9o9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_znFHf0D56aPg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_ecustom--ReachConvertibleNote_iI_c20230609_zjH8cFvlAAXd" title="Reach convertible note">3,025,841</span> of Reach convertible
  notes, inclusive of accrued interest, were rolled into the Private Placement on June 9, 2023.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F0E_zxaqEBv0byX2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zLqqctjjK8Xa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_905_ecustom--RedeemedForCash_iI_c20230609_zCA5HXL5Vhw9" title="Redeemed for cash">1,029,617</span> was redeemed for
  cash, the remaining Reach notes were converted to equity.</span></td></tr>
</table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
21. Financial Liabilities - continued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private Placement</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_492_20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zxJnD1OVLjCl" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Private Placement convertible notes are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zwOryoGKMuH6" title="Issue Date">9-June-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zbZSoW7dIIeb" title="Modified Maturity Date">9-June-25</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zah2YYs5M7K9" title="Conversion Date">28-Mar-24</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zhmq8lVWG9h6" title="Term (Years)">2.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--Borrowings_iI_zwFImW4vuCMc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,215,591</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--BorrowingsInterestRate_iI_dp_zLyRrty2aXwb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40E_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zWkIssbJvNT" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Mixed Martial Arts LLC</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zs9BukUeVvQh" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Mixed Martial Arts LLC convertible note are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zD0tPBtp9qYc" title="Issue Date">26-Oct-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zwXMJjMwZSaa" title="Modified Maturity Date">9-June-25</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zpsVSs6NRFXb" title="Conversion Date">28-Mar-24</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zR8PSRGxxDHl" title="Term (Years)">1.6</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--Borrowings_iI_zlaq9EcrMb04" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">384,750</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zjOm9BPcbhdl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zUwCHLGeSDA8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Steppen</b></span></p></td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zV5NkY2FKv9a" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Key Terms of this Steppen convertibles note are as follows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issue Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zPS1k4VugEkf" title="Issue Date">20-Sept-23</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maturity Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_z1Z7w84Wwr8f" title="Modified Maturity Date">9-June-25</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Date</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zQZudroVO076" title="Conversion Date">28-Mar-24</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Term (Years)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_909_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_z70CTMpfQvjg" title="Term (Years)">1.7</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--Borrowings_iI_zZX5LndO1Qvf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Face Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,00</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_z1k97hEW8njb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zhn77hyBMTBl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion Discount (Qualified Equity Investment)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDebtSecuritiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt instruments. [Refer: Debt instruments issued; Debt instruments held]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDebtSecuritiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550388037888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory', window );">Schedule of Details of Expense from Performance Rights, Options and Warrants</a></td>
<td class="text"><p id="xdx_89C_ecustom--DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory_zN7vP3I5GsLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the expense arising from performance rights, options and warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zzlTyOOagvZ9" style="display: none">Schedule
of Details
of Expense from Performance Rights, Options and Warrants</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20230701__20240630_zbTNw46nTdP7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20220701__20230630_zfHF8YVugIP1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210701__20220630_zdrmwvM8F5qb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_401_ecustom--ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants_zsKmtVilZz2l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">ESOP</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,851,329</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,052,245</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">914,682</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ExpenseFromAdvisorOptions_zu5tFb578ita" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Advisor Options (<span id="xdx_F4B_zpQRCuO1gUSj">1</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,086,938</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,164,524</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">632,301</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ExpenseFromReach_zGGVHWYA6tx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Reach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,584</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">148,615</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1750">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ExpenseFromWarrants_zD48Kq8Z27o5" style="vertical-align: bottom; background-color: White">
    <td>Warrants (<span id="xdx_F4A_zfSSfVJn8vod">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">253,391</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1754">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ExpenseFromOverAllotmentOption_zWWZWEjmo0l8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over allotment Option (<span id="xdx_F4D_zxKdHZoVn1U3">3</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">163,794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1757">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ExpenseFromRestrictedShareUnits_zV5Ip81jRSg5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">RSU</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,119,562</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1761">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1762">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--AdjustmentsForSharebasedPayments_zfi1McJs0u3l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Share based payments<span>*</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,521,598</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,365,384</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,546,983</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0F_zfvwNt1Cb1W7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zQbK9VJWeAAb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                                            that <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20231201__20231231_z1ntXt81TKLc" title="Advisor Options vested and were exercised"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20230701__20230731_zsw5zmqiLNi5" title="Advisor Options vested and were exercised">327,142</span></span> Advisor Options vested and were exercised into Shares between July 2023 and
                                            December 2023 and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20230701__20230731_zKizMct8TSnl" title="Advisor Options forfeited"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20231201__20231231_zKUJz83i5Z6a" title="Advisor Options forfeited">16,193</span></span> Advisor Options were forfeited. At June 30, 2024, nil remaining
                                            Advisor Options were on issue.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 22. Share-based payments - continued </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F09_zjH7gYny6ZK4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zbT7EnCd82F1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                                            that this expense is pertaining to the issuance of warrants (equating to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_c20240630_zPVvZcVXmXD9" title="Ordinary Shares on exercise">65,000</span> Ordinary
                                            Shares on exercise) to the Underwriter as part of the underwriting agreement. These Warrants
                                            will be exercisable at any time and from time to time, in whole or in part, during the four
                                            and a half year period commencing 180 days from the commencement of sales of the securities
                                            in the Offering, at a price per share equal to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_ecustom--PricePerShareEqualPercentage_iI_pid_dp_uPure_c20240630_zpx8vpOmpta2" title="Price per share equal percentage">125.0</span>% of the public offering price per share
                                            of common stock at the Offering. The issuance acts as additional compensation for ThinkEquity
                                            services that would be rendered over a 24 month period from the Closing of the initial public
                                            offering. As these services vary and are not for a specific service, the fair value of this
                                            allocation cannot be estimated reliably. Thereby, the fair value of these warrants at grant
                                            date were calculated by applying the Black-Scholes model. The Company used valuations specialists
                                            to perform these valuations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F07_z1ExF2q2dkia" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zuG97JGqyOt6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                                            that this expense is pertaining to the option granted to the underwriter, exercisable within
                                            45 days after the closing of the Offering, to acquire up to an additional 15% of the total
                                            number of Shares to be offered by the company in the offering, solely for the purpose of
                                            covering over-allotments. This over-allotment option essentially granted the underwriter
                                            the right to sell more shares than originally planned if the demand for a security issue
                                            proves higher than expected. The fair value of this service cannot be estimated reliably
                                            as the exercise was subjective on share price performance and/or timing. Thereby, the fair
                                            value of these options at grant date were calculated using the Black-Scholes model. The Company
                                            used valuations specialists to perform these valuations. In addition, please note that these
                                            options have not been exercised and the 45-day limit has expired.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Schedule of Share Options Outstanding</a></td>
<td class="text"><p id="xdx_89B_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_gL3DONAWAEPOS-CCDSRYTS_zLdCoagaqoFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the number of share options outstanding during the year, adjusted to account for the 4-for-5 reverse share split, are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zie5q2dMivca" style="display: none">Schedule
of Share Options Outstanding</span> </span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zpIu8TKQSEIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zT0ZdCYCd0Ia" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEL8MFiIDWX8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">ESOP</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zaCuikKPvXwk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">784,098</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">556,074</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1789">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_ziQ24PRGCSJ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1791">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">312,886</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">556,074</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zXiJsBu31pIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1795">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(84,862</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1797">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_ziochB4w4CW" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1799">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1800">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1801">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zy1SwpRnmMj4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">784,098</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">784,098</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">556,074</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zAMLUNedCfVh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zVowqlhaKXa5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zYqWLc91NQT2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Advisor</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NumberOfOutstandingShareOptions_iS_z1L7ZHhxvQ9a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">344,055</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">312,362</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1809">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zyEytC2iajIl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,693</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">312,362</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zm6UOdWMkotd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(16,913</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1816">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1817">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_zXT4V55qKwD7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(327,142</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1821">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zgIWzJvbFhoe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1823">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">344,055</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">312,362</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zslACzMhU9tc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_zLNUsYbj6BM4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_zcGgiBCgAs8c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_z1msQrsCpqO3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Reach</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_z0wnwwZW2c55" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">45,794</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1828">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1829">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zIevBLXCvk17" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1831">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1833">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zqLlGVnPiBE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1836">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1837">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zYiK8trvcQJg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1839">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1840">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1841">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_znAfnnCNqR2i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">45,794</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">45,794</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1845">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_134_ztGsmADBP6rg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z3gTDnsoHiC6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zSgZzqTQl59h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zv5DPlOD9FAf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">RSU</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zFUkEMCvCeH6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Beginning of period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1847">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1849">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zdO032jRXR19" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Granted during the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">630,729</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1852">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1853">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zmCPQZbZOM3f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1856">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1857">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zOIdtiSw2wH1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1859">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1860">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zY0EaKJuuY4l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">630,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1864">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1865">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in; text-indent: 415.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zlndA609UQXa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zjy79EmtAnMe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zVSEPxvDiP23" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zm40GPRGot73" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Over
Allotment Option</b></span></p></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zZydOI649Ml7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Beginning of period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1867">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1868">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1869">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zOaT1nzIB0n2" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Granted during the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">195,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1872">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1873">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zeVrQaoAsEEg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(195,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1877">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zKLkeRxCt1e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Exercised during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1879">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1880">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1881">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zROkvJPuz1p5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">End of the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1883">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1884">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1885">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_134_zkdJ4abczpX5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zVDnI1AIPlq6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zRvjjm2URI49" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z4LVeCGloSO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Warrants</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zEHg2LB82Pkj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Beginning of period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1887">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1888">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1889">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zd12xeSBVpMc" style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Granted during the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">65,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1893">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zQT8UOdLmZ69" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1895">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1897">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zWsGAbE1pg4h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercised during the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1899">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1901">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zXzUnf10OM9g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>End of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">65,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1904">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1905">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_307_134_zgsdPe6Mub58" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left; font-weight: bold">-</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230701__20240630_z8wiG2VaH71h" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220701__20230630_zntefkRvtYek" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210701__20220630_zy3dOiDeVKX2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left; font-weight: bold">Total</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zMJsBnROtpL1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Total beginning of period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,173,947</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">868,436</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1909">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zc3ZCu4nKXvg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total granted during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">890,729</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390,373</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">868,436</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zckuoh90y0yl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total forfeited/expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(211,913</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(84,862</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1917">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_zsaBm20S1mC1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total exercised during the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(327,142</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1920">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1921">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zEMqyJJkkW36" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total end of the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,525,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,173,947</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">868,436</td><td style="text-align: left">&#160;</td></tr>
  </table>

&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Schedule of Model Inputs For Options Granted</a></td>
<td class="text"><p id="xdx_894_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_zLqMcBhNMhm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
model inputs for options granted during the reporting periods include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zXaxj4jkHgsd" style="display: none">Schedule of Model Inputs For Options Granted</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Spot Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Share price volatility</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expected Dividend yield</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Risk free interest rate</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: left">ESOP</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center">31 Aug 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwiW1HJN1MO4" style="width: 8%; text-align: right" title="Exercise price">0.62</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zDFwX3b0khS7" title="Term">3 years</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwC39eLLumH6" style="width: 8%; text-align: right" title="Spot Price">5.72</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z7vpmOsdVDS2" style="width: 8%; text-align: right" title="Share price volatility">67.3</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zGzIQdSMS2Ue" style="width: 8%; text-align: right" title="Expected Dividend yield">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zbpb4cPW1Oka" style="width: 8%; text-align: right" title="Risk free interest rate">0.2</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">31 Aug 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zN9dtrKZISr6" style="text-align: right" title="Exercise price">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zBlwKFxqdSVc" title="Term">3 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zm7dDir5dXd4" style="text-align: right" title="Exercise price">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z3sq4I7xBfx" style="text-align: right" title="Share price volatility">67.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zGcNvvUIGB8e" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAeOpglSioy3" style="text-align: right" title="Risk free interest rate">0.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">1 March 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zNl5jIFDc18l" style="text-align: right" title="Exercise price">0.62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zn7gmENV0T1b" title="Term">3 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z70HkW9Loazc" style="text-align: right" title="Exercise price">18.51</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zkI6z7rokWq1" style="text-align: right" title="Share price volatility">66.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zKsEONNPaa7b" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z1vY07LGRiV2" style="text-align: right" title="Risk free interest rate">1.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">23 Feb 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zZft4wILXyA8" style="text-align: right" title="Exercise price">0.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zDCyCkERdntl" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl1967">3.0 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zf75uEmCFXZe" style="text-align: right" title="Exercise price">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zhFc5mcLYgE5" style="text-align: right" title="Share price volatility">64.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_ztHGl2tNpBLh" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zhXwOzHtxTB2" style="text-align: right" title="Risk free interest rate">3.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">ADVISOR</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">21 Aug 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zYMipOurz7Ce" style="text-align: right" title="Exercise price">0.62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zYiQrzB11aO4" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl1979">2.86 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zFPHUSJqn0xh" style="text-align: right" title="Spot Price">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zKH0zpSK8td8" style="text-align: right" title="Share price volatility">66.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zCE7KYEMdCHj" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zUdufrAhHwWa" style="text-align: right" title="Risk free interest rate">0.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">21 Aug 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zWn0O9NJtKij" style="text-align: right" title="Exercise price">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zyS8ITAhAVR4" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl1991">2.86 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zyM7LTMrzWo2" style="text-align: right" title="Spot Price">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zhxHmLbKfjw7" style="text-align: right" title="Share price volatility">66.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zdZWkcAX6486" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zNC2K1gdRyR6" style="text-align: right" title="Risk free interest rate">0.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">21 Aug 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zwN0GVWippR6" style="text-align: right" title="Exercise price">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zhBZrWaRMKCc" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2003">4.90 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z8TFcGfj4zdc" style="text-align: right" title="Spot Price">10.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zu4xG2uR458i" style="text-align: right" title="Share price volatility">65.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zuAUfDCcDdlk" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zQVKgHW1k8l9" style="text-align: right" title="Risk free interest rate">3.0</td><td style="text-align: left">%</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>



<p style="margin: 0">&#160;</p>

<p style="margin: 0"><b>Note 22. Share-based payments - continued</b> <br/>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><b>REACH</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center">13 Feb 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zZQEtN6Pzct3" style="width: 8%; text-align: right" title="Exercise price">5.72</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwW1e80gsR66" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2015">3.30 years</span></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_znsVwwLptyL" style="width: 8%; text-align: right" title="Spot Price">5.72</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zfQrBpTA1u8g" style="width: 8%; text-align: right" title="Share price volatility">65.4</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zn5lfo5or8Y2" style="width: 8%; text-align: right" title="Expected Dividend yield">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zR7Va2ECUpH3" style="width: 8%; text-align: right" title="Risk free interest rate">3.5</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">9 June 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zKQSRAJNEPh4" style="text-align: right" title="Exercise price">6.73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_ztyrLtWrhxek" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2027">3.15 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zkfOTVCgvvTj" style="text-align: right" title="Spot Price">6.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAzmPIORftGb" style="text-align: right" title="Share price volatility">60.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zGZ6o6GNw5El" style="text-align: right" title="Expected Dividend yield">0.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z2dTS2bmDgc7" style="text-align: right" title="Risk free interest rate">3.8</td><td style="text-align: left">%</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; width: 26%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>RSUs</i></b></span></p></td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">10 Oct 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zibSXiBCyBua" style="text-align: right" title="Exercise price"><span style="-sec-ix-hidden: xdx2ixbrl2037">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z5EkOGDVtM9g" title="Term">3 years</span> </span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zGYXz6SpYCNg" style="text-align: right" title="Spot Price">7.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zZo3vobg82K3" style="text-align: right" title="Expected Dividend yield">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">1 Mar 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAaSYZsNwukf" style="text-align: right" title="Exercise price"><span style="-sec-ix-hidden: xdx2ixbrl2045">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zIxxyPIMTuYd" title="Term">3 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z4Ki0WrJwBef" style="text-align: right" title="Spot Price">7.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zwluHli8TD4a" style="text-align: right" title="Expected Dividend yield">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; width: 26%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 8%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">27 March 2024 <br/>Over allotment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$<span id="xdx_907_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zu5MBbNTMDF2" title="Exercise price">6.25</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zUaywUXzRkNf" title="Term">5 years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zjC43O1s1xU" style="text-align: right" title="Spot Price">5.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zLZAbKVM5Ylg" style="text-align: right" title="Share price volatility">62.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zXUTadKNxa54" style="text-align: right" title="Expected Dividend yield">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z0TGklOTh1X9" style="text-align: right" title="Risk free interest rate">3.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">27 March 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zzoC9o8biOs1" style="text-align: right" title="Exercise price">5.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zJbilHvygFM6" title="Term"><span style="-sec-ix-hidden: xdx2ixbrl2067">0.12 years</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z8glpTZU43se" style="text-align: right" title="Spot Price">5.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zC34yg0pE2J1" style="text-align: right" title="Share price volatility">46</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zYwsN2oQZuhb" style="text-align: right" title="Expected Dividend yield">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zzLv8qrWEdm3" style="text-align: right" title="Risk free interest rate">3.7</td><td style="text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319491120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities', window );">Schedule of Contractual Maturities of Financial Liabilities</a></td>
<td class="text"><p id="xdx_899_eifrs-full--MaturityAnalysisForDerivativeFinancialLiabilities_zmqIs3oMerJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zL7ylA6J4bQ5" style="display: none">Schedule of Contractual Maturities of Financial Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted average interest rate</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">1 year or less</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Between 1 and 2 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Between 2 and 5 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Remaining contractual maturities</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: right">Consolidated 2024</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">%</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: right">Non - Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: right">Non-interest bearing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: right">Trade and other payables</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90D_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zAGFYhjDxtIb" title="Trade and other payables">1,991,536</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90F_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zjEhDrcI2Wv8" title="Trade and other payables">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_905_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zpaaKBwzA6i5" title="Trade and other payables">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_901_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20240630_zldy8Z2iyq19" title="Trade and other payables">1,991,536</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: right">Interest bearing &#8211; fixed rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Financial liability &#8211; host debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--WeightedAverageInterestRateFinancialLiability_iI_dp0_c20240630_zuNNjP2RFd9k" title="Financial liability host debt, interest rate">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zssHN2F98Tul" title="Financial liability host debt">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_z3t7TJ963uBl" title="Financial liability host debt">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z21AJOBZySKi" title="Financial liability host debt">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630_z1yiloxkna74" title="Financial liability host debt">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90B_ecustom--WeightedAverageInterestRateLeaseLiabilities_iI_dp_c20240630_zM1qdZZFqPN" title="Lease liability, interest rate">3.5</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zmGKCmZrR8F8" title="Lease liability">135,680</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zWDbO4mkhAAe" title="Lease liability">46,240</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zI3hjwTvwQv4" title="Lease liability">35,267</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_ecustom--InterestBearingLeaseLiabilities_iI_c20240630_zpg69TbDuLd7" title="Lease liability">217,187</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total non - derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zspTi7iZw5Ia" title="Total non derivative">2,127,216</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zDOvgUrtcnkd" title="Total non derivative">46,240</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zhM2wTrcZvgd" title="Total non derivative">35,267</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--InterestBearingNonderivativesNet_iI_c20240630_zSpfGTsSvth" title="Total non derivative">2,208,723</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Derivative liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zY0puwu87v19" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zFOAZPIeeSlj" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z0PZcVQpVV94" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zzyZZwk2JGs3" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total Derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zJT640jk7xki" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zldH818xG4k5" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zdOlvf57h8pd" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z9FaEzyxcmT3" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted average interest rate</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">1 year or less</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Between 1 and 2 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Between 2 and 5 years</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Remaining contractual maturities</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: right">Consolidated 2023</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">%</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$&#8217;000</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: right">Non - Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: right">Non-interest bearing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: right">Trade and other payables</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_906_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_z3gL200IRes6" title="Trade and other payables">2,034,436</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90F_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zrKT3uzobfA5" title="Trade and other payables">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_909_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zwqG8zTZpYeb" title="Trade and other payables">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_905_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20230630_zFvFouHP9Rpe" title="Trade and other payables">2,034,436</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: right">Interest bearing &#8211; fixed rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">Financial liability &#8211; host debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--WeightedAverageInterestRateFinancialLiability_iI_dp_c20230630_zVjE6ivMpZ37" title="Financial liability host debt, interest rate">9.3</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zHs72L1Ausz" title="Financial liability host debt">16,567,450</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zP3kOTppbBPc" title="Financial liability host debt">342,406</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zAT19ASuhY9c" title="Financial liability host debt">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630_zIEyyFsONtyj" title="Financial liability host debt">16,909,856</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_901_ecustom--WeightedAverageInterestRateLeaseLiabilities_iI_dp_c20230630_zojSqwTSq367" title="Lease liability, interest rate">3.5</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zhDwAz4unqrh" title="Lease liability">127,361</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zjer506cwoua" title="Lease liability">28,214</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zkbLXDcgJUl5" title="Lease liability">28,214</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--InterestBearingLeaseLiabilities_iI_c20230630_zXaOdmWeiSll" title="Lease liability">183,789</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total non- derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zCMf8xnJkdQ5" title="Total non derivative">18,729,247</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_z8DFT3JIkVm9" title="Total non derivative">370,620</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zi0xVLG49y3f" title="Total non derivative">28,214</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--InterestBearingNonderivativesNet_iI_c20230630_z9hiMHw0kdqk" title="Total non derivative">19,128,081</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right">Derivative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1pt">Derivative liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zcOMTIzqZbGe" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zM6uQnzhAKn3" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zpAyoNrO7S3i" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_ztZ686PwIUTe" title="Derivative liability">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: right; padding-bottom: 1pt">Total Derivative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zNYDA59I2b86" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zwF3bPnGL0nk" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z7LOudniHYe1" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z4s8KQ3JF9Ef" title="Total Derivative">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320474448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Remuneration of auditors (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory', window );">Schedule of Auditor of Company And Network Firms</a></td>
<td class="text"><p id="xdx_894_ecustom--DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory_zXikr6Qpbrn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zRyWnlqB32K1" style="display: none">Schedule
of Auditor of Company And Network Firms</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20240630_zyiCcR45ncQi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20220701__20230630_z0GTml52JB48" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20210701__20220630_zSQQV1q2WU6l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_ecustom--AuditFees_maARzvWE_zoMxcxcCpukl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Audit fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">382,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">200,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">48,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AuditorsRemunerationForRelatedFees_maARzvWE_zy6LK5ZY02q" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit &#8211; related fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">207,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2201">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--AuditorsRemunerationForTaxServices_maARzvWE_z4RJ2TO962s" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2204">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2205">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--AuditorsRemunerationForOtherServices_maARzvWE_zffeOOzGx6jd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">All other fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2207">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2208">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--AuditorsRemuneration_iT_mtARzvWE_zNo5mXFi4NWl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">512,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">407,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of information about remuneration of auditors explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319665680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Schedule of Loss Per Share</a></td>
<td class="text"><p id="xdx_894_eifrs-full--DisclosureOfEarningsPerShareExplanatory_z2gfqV42e5sf" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zfG8VLK2iRZ8" style="display: none">Schedule
of Loss Per Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20230701__20240630_z5OKycaLQuzh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20220701__20230630_zyo6SvBhm3Gh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023<br/> $</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20210701__20220630_zXACTB5yy1vi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">2022</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">$</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--ProfitLoss_z8mOM71kfIce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Reconciliation of loss after tax</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(14,408,346</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(20,597,436</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(11,197,450</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted average number of Ordinary Shares outstanding during the period used in calculating loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_909_eifrs-full--WeightedAverageShares_c20230701__20240630_zqxVKKgyFjbg" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_90E_eifrs-full--AdjustedWeightedAverageShares_c20230701__20240630_zJtY3EvBYG47" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share">10,267,686</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_907_eifrs-full--WeightedAverageShares_c20220701__20230630_zXpNQlPC7uGe" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_901_eifrs-full--AdjustedWeightedAverageShares_c20220701__20230630_zqdX5ODnil6f" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share">3,918,750</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_90A_eifrs-full--WeightedAverageShares_c20210701__20220630_zJUWCLRzmHad" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_900_eifrs-full--AdjustedWeightedAverageShares_c20210701__20220630_zbPAg7HgieJ8" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share">3,918,750</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss per share attributable to the owners of Alta Global Group Limited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_zQrX25DKJi8e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.40</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.26</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.86</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eifrs-full--DilutedEarningsLossPerShare_zzWRcAhXdkp9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diluted loss per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.40</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.26</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.86</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318549856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of plant and equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=MMA_PlantAndEquipmentMember', window );">Plant and equipment [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Plant and equipment expected useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=MMA_PlantAndEquipmentMember', window );">Plant and equipment [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Plant and equipment expected useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Plant and equipment expected useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Plant and equipment expected useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office equipment [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Plant and equipment expected useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office equipment [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Plant and equipment expected useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures and fittings [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Plant and equipment expected useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures and fittings [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Plant and equipment expected useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=MMA_PlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=MMA_PlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319363840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Accounting Policy Information (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_IntangibleAssetsUnderDevelopmentMember', window );">Intangible assets under development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful life</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_IntangibleAssetsUnderDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_IntangibleAssetsUnderDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318270304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Critical accounting judgements, estimates and assumptions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract', window );"><strong>Critical Accounting Judgements Estimates And Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss after tax</a></td>
<td class="nump">$ 14,408,346<span></span>
</td>
<td class="nump">$ 20,597,436<span></span>
</td>
<td class="nump">$ 11,197,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash outflows from operating activities</a></td>
<td class="nump">9,386,196<span></span>
</td>
<td class="nump">5,555,868<span></span>
</td>
<td class="nump">$ 8,055,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Net assets liabilities</a></td>
<td class="nump">2,558,544<span></span>
</td>
<td class="num">(31,134,307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Net assets liabilities</a></td>
<td class="num">(2,558,544)<span></span>
</td>
<td class="nump">31,134,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsLiabilities', window );">Net current assets liabilities</a></td>
<td class="nump">$ 1,049,355<span></span>
</td>
<td class="nump">$ 21,916,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets less the amount of current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph IG63<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG63&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319284928">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of revenue (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RevenueFromContractsWithCustomersAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RevenueFromProgramFees', window );">Revenue from program fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 929,319<span></span>
</td>
<td class="nump">$ 937,415<span></span>
</td>
<td class="nump">$ 2,050,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RevenueFromContractualPaymentsToGyms', window );">Contractual payments to gyms</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(537,012)<span></span>
</td>
<td class="num">(574,025)<span></span>
</td>
<td class="num">(1,215,191)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Net Revenue from program fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">392,307<span></span>
</td>
<td class="nump">363,390<span></span>
</td>
<td class="nump">834,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ReserachAndDevelopmentIncome', window );">Research and Development tax incentive</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,149,525<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FranchiseFeeIncome', window );">Finale, franchise fee and other fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">167,021<span></span>
</td>
<td class="nump">22,600<span></span>
</td>
<td class="nump">100,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Merchandise sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,984<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
<td class="nump">5,572<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Total other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">170,005<span></span>
</td>
<td class="nump">1,173,421<span></span>
</td>
<td class="nump">105,950<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 562,312<span></span>
</td>
<td class="nump">$ 1,536,811<span></span>
</td>
<td class="nump">$ 940,803<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company will continue
                                                                                                                                                              to apply for the Research and Development incentive as long as it continues to be eligible and will conduct eligible research and
                                                                                                                                                              development activities. The applicable legislation that governs the eligibility to participate in the R&amp;D incentive program is
                                                                                                                                                              Division 355 of the Income Tax Assessment Act 1997 (ITAA 1997). The FY 2024 Research and Development incentive will be applied for
                                                                                                                                                              on lodging of the FY 2024 tax return with the Australian Tax Office and recognised once reasonable assurance that the Company will
                                                                                                                                                              comply with the conditions and that the grants will be received.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ReserachAndDevelopmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reserach and development income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ReserachAndDevelopmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RevenueFromContractualPaymentsToGyms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual payments to gyms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RevenueFromContractualPaymentsToGyms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RevenueFromProgramFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from program fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RevenueFromProgramFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FranchiseFeeIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from franchise fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FranchiseFeeIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRenderingOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the rendering of services. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRenderingOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319082560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of disaggregation of revenue (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RevenueFromProgramFees', window );">Revenue from program fees</a></td>
<td class="nump">$ 929,319<span></span>
</td>
<td class="nump">$ 937,415<span></span>
</td>
<td class="nump">$ 2,050,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RevenueFromContractualPaymentsToGyms', window );">Contractual payments to gyms</a></td>
<td class="num">(537,012)<span></span>
</td>
<td class="num">(574,025)<span></span>
</td>
<td class="num">(1,215,191)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Net Revenue from program fees</a></td>
<td class="nump">392,307<span></span>
</td>
<td class="nump">363,390<span></span>
</td>
<td class="nump">834,853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=MMA_OneMajorProductMember', window );">One major product [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RevenueFromProgramFees', window );">Revenue from program fees</a></td>
<td class="nump">929,319<span></span>
</td>
<td class="nump">937,415<span></span>
</td>
<td class="nump">2,050,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RevenueFromContractualPaymentsToGyms', window );">Contractual payments to gyms</a></td>
<td class="num">(537,012)<span></span>
</td>
<td class="num">(574,025)<span></span>
</td>
<td class="num">(1,215,191)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Net Revenue from program fees</a></td>
<td class="nump">$ 392,307<span></span>
</td>
<td class="nump">$ 363,390<span></span>
</td>
<td class="nump">$ 834,853<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RevenueFromContractualPaymentsToGyms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual payments to gyms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RevenueFromContractualPaymentsToGyms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RevenueFromProgramFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from program fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RevenueFromProgramFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRenderingOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the rendering of services. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRenderingOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=MMA_OneMajorProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=MMA_OneMajorProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321890256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of expenses (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfExpensesAbstract', window );"><strong>Schedule Of Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ProgramExpensesEventCosts', window );">Event Costs</a></td>
<td class="nump">$ 36,909<span></span>
</td>
<td class="nump">$ 40,876<span></span>
</td>
<td class="nump">$ 22,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ProgramExpensesProgramCosts', window );">Program costs</a></td>
<td class="nump">7,046<span></span>
</td>
<td class="nump">12,447<span></span>
</td>
<td class="nump">253,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ProgramExpensesMerchantFees', window );">Merchant fees</a></td>
<td class="nump">32,550<span></span>
</td>
<td class="nump">44,427<span></span>
</td>
<td class="nump">66,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ProgramExpensesOtherCosts', window );">Other costs</a></td>
<td class="nump">84,073<span></span>
</td>
<td class="nump">132,098<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ProgramExpenses', window );">Total program expenses</a></td>
<td class="nump">160,578<span></span>
</td>
<td class="nump">229,848<span></span>
</td>
<td class="nump">342,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective', window );">Convertible notes interest &#8211; contractual and effective</a></td>
<td class="nump">3,207,498<span></span>
</td>
<td class="nump">4,420,224<span></span>
</td>
<td class="nump">2,162,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_FinanceCostsBankFees', window );">Bank fees</a></td>
<td class="nump">13,286<span></span>
</td>
<td class="nump">13,071<span></span>
</td>
<td class="nump">6,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_FinanceCostsBankInterestAndLeaseInterest', window );">Bank interest and lease interest</a></td>
<td class="nump">42,143<span></span>
</td>
<td class="nump">39,435<span></span>
</td>
<td class="nump">22,703<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Total finance costs</a></td>
<td class="nump">3,262,927<span></span>
</td>
<td class="nump">4,472,730<span></span>
</td>
<td class="nump">2,191,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_UnrealizedCurrencyGains', window );">Unrealized currency (gains)</a></td>
<td class="num">(117,094)<span></span>
</td>
<td class="num">(36,181)<span></span>
</td>
<td class="num">(36,660)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RealizedCurrencyGainslosses', window );">Realized currency (gains)/losses</a></td>
<td class="num">(29,449)<span></span>
</td>
<td class="num">(11,178)<span></span>
</td>
<td class="nump">10,581<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Net foreign exchange (gains)</a></td>
<td class="num">$ (146,543)<span></span>
</td>
<td class="num">$ (47,359)<span></span>
</td>
<td class="num">$ (26,079)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_FinanceCostsBankFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance costs bank fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_FinanceCostsBankFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_FinanceCostsBankInterestAndLeaseInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance costs bank interest and lease interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_FinanceCostsBankInterestAndLeaseInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance costs convertible notes interest contractual and effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ProgramExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Program expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ProgramExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ProgramExpensesEventCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Program expenses, event costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ProgramExpensesEventCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ProgramExpensesMerchantFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Program expenses, merchant fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ProgramExpensesMerchantFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ProgramExpensesOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Program expenses, other costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ProgramExpensesOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ProgramExpensesProgramCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Program expenses, program costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ProgramExpensesProgramCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RealizedCurrencyGainslosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Realized currency gains losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RealizedCurrencyGainslosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_UnrealizedCurrencyGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized currency gains.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_UnrealizedCurrencyGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2024-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319347872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Income Tax Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred tax expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current tax expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before income tax expense</a></td>
<td class="num">(14,408,346)<span></span>
</td>
<td class="num">(20,597,436)<span></span>
</td>
<td class="num">(11,197,450)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences', window );">Prima facie income tax benefit on loss before income tax calculated at 25% (2022: 25%)</a></td>
<td class="nump">3,602,086<span></span>
</td>
<td class="nump">5,149,359<span></span>
</td>
<td class="nump">2,799,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems', window );">- other non-allowable items</a></td>
<td class="num">(831,249)<span></span>
</td>
<td class="num">(3,297,349)<span></span>
</td>
<td class="nump">143,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes', window );">- items not assessable for income tax</a></td>
<td class="num">(2,590,831)<span></span>
</td>
<td class="num">(1,435,790)<span></span>
</td>
<td class="num">(1,377,243)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting', window );">- items deductible for taxation not accounting</a></td>
<td class="nump">251,784<span></span>
</td>
<td class="nump">772,848<span></span>
</td>
<td class="nump">114,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss', window );">Deferred tax not recognised</a></td>
<td class="num">$ (431,790)<span></span>
</td>
<td class="num">$ (1,189,068)<span></span>
</td>
<td class="num">$ (1,680,021)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax ExpenseIncomeItemsDeductibleForTaxationNotAccounting</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax expense income items not assessable for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax expense income not recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax expense income other non allowable items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax expense or income relating to the creation or reversal of temporary differences. [Refer: Temporary differences [member]; Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 80<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_80_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320993520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Income Tax Expenses (Details) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318699408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Fair Value Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Derivative Liabilities &#8211; refer Note 21</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18,694,729<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18,694,729<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level 1 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Derivative Liabilities &#8211; refer Note 21</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level 2 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Derivative Liabilities &#8211; refer Note 21</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level 3 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Derivative Liabilities &#8211; refer Note 21</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18,694,729<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 18,694,729<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319003296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Fair Value Measurement of Derivative Liability (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Balance</a></td>
<td class="nump">$ 18,694,729<span></span>
</td>
<td class="nump">$ 878,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Balance</a></td>
<td class="nump">18,694,729<span></span>
</td>
<td class="nump">878,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear', window );">Fair value of derivative liability recognised for convertible notes issued during the year</a></td>
<td class="nump">280,198<span></span>
</td>
<td class="nump">10,945,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability', window );">Fair value of derivative liability recognised for convertible notes issued during the year</a></td>
<td class="nump">280,198<span></span>
</td>
<td class="nump">10,945,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_FairValueMovementRecognisedInProfitOrLoss', window );">Fair value movement recognised in profit or loss</a></td>
<td class="num">(3,400,685)<span></span>
</td>
<td class="nump">6,870,729<span></span>
</td>
<td class="num">$ (2,751,564)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value movement recognised in profit or loss</a></td>
<td class="num">(3,400,685)<span></span>
</td>
<td class="nump">6,870,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear', window );">Fair value of derivative liability for convertible notes which converted or matured during the year</a></td>
<td class="num">(15,574,242)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear', window );">Fair value of derivative liability for convertible notes which converted or matured during the year</a></td>
<td class="num">(15,574,242)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18,694,729<span></span>
</td>
<td class="nump">878,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 18,694,729<span></span>
</td>
<td class="nump">$ 878,653<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_FairValueMovementRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value movement recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_FairValueMovementRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of derivative liability for convertible notes which converted or matured during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of derivative liability recognised for convertible notes issued during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of liability for convertible notes which converted or matured during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the fair value of a financial liability that is attributable to changes in the credit risk of that liability. [Refer: Credit risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) including exchange differences recognised in profit or loss on the fair value measurement of liabilities. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321319344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Unobservable Inputs Level 3 Liabilities (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember', window );">Implied valuation [Member] | Series A Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Implied Valuation</a></td>
<td class="nump">$ 28,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember', window );">Implied valuation [Member] | Series A July21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Implied Valuation</a></td>
<td class="nump">28,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember', window );">Implied valuation [Member] | Series A August21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Implied Valuation</a></td>
<td class="nump">28,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember', window );">Implied valuation [Member] | Series B1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Implied Valuation</a></td>
<td class="nump">120,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember', window );">Implied valuation [Member] | Series B2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Implied Valuation</a></td>
<td class="nump">70,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember', window );">Implied valuation [Member] | Series A extension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Implied Valuation</a></td>
<td class="nump">28,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember', window );">Implied valuation [Member] | Reach [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Implied Valuation</a></td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember', window );">Implied valuation [Member] | Private Placements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Implied Valuation</a></td>
<td class="nump">53,685,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember', window );">Implied valuation [Member] | Mixed martial arts LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Implied Valuation</a></td>
<td class="nump">384,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember', window );">Implied valuation [Member] | Steppen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities', window );">Implied Valuation</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Historical volatility for shares, measurement input [member] | Series A Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Historical volatility for shares, measurement input [member] | Series A July21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Historical volatility for shares, measurement input [member] | Series A August21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Historical volatility for shares, measurement input [member] | Series B1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Historical volatility for shares, measurement input [member] | Series B2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Historical volatility for shares, measurement input [member] | Series A extension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Historical volatility for shares, measurement input [member] | Reach [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Historical volatility for shares, measurement input [member] | Private Placements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Historical volatility for shares, measurement input [member] | Mixed martial arts LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember', window );">Historical volatility for shares, measurement input [member] | Steppen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember', window );">Interest rate, measurement input [member] | Series A Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember', window );">Interest rate, measurement input [member] | Series A July21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember', window );">Interest rate, measurement input [member] | Series A August21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember', window );">Interest rate, measurement input [member] | Series B1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember', window );">Interest rate, measurement input [member] | Series B2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember', window );">Interest rate, measurement input [member] | Series A extension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember', window );">Interest rate, measurement input [member] | Reach [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember', window );">Interest rate, measurement input [member] | Private Placements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember', window );">Interest rate, measurement input [member] | Mixed martial arts LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember', window );">Interest rate, measurement input [member] | Steppen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">4.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember', window );">Probability of default, measurement input [member] | Series A Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember', window );">Probability of default, measurement input [member] | Series A July21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember', window );">Probability of default, measurement input [member] | Series A August21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember', window );">Probability of default, measurement input [member] | Series B1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember', window );">Probability of default, measurement input [member] | Series B2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember', window );">Probability of default, measurement input [member] | Series A extension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember', window );">Probability of default, measurement input [member] | Reach [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember', window );">Probability of default, measurement input [member] | Private Placements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember', window );">Probability of default, measurement input [member] | Mixed martial arts LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember', window );">Probability of default, measurement input [member] | Steppen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Volatility</a></td>
<td class="nump">100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of liabilities due to a reasonably possible increase in an unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=MMA_ImpliedValuationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=MMA_SeriesAConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=MMA_SeriesAConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=MMA_SeriesAJuly21Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=MMA_SeriesAJuly21Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=MMA_SeriesAAugust21Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=MMA_SeriesAAugust21Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=MMA_SeriesB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=MMA_SeriesB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=MMA_SeriesB2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=MMA_SeriesB2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=MMA_SeriesAExtensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=MMA_SeriesAExtensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=MMA_ReachMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=MMA_ReachMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=MMA_PrivatePlacementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=MMA_PrivatePlacementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=MMA_MixedMartialArtsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=MMA_MixedMartialArtsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=MMA_SteppenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=MMA_SteppenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_ProbabilityOfDefaultMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319127856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Cash and Cash Equivalents (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOnHand', window );">Cash on hand</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BalancesWithBanks', window );">Cash at bank</a></td>
<td class="nump">3,543,837<span></span>
</td>
<td class="nump">3,701,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Total cash and cash equivalents</a></td>
<td class="nump">3,544,837<span></span>
</td>
<td class="nump">3,702,567<span></span>
</td>
<td class="nump">$ 569,975<span></span>
</td>
<td class="nump">$ 4,142,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Balance as per statement of cash flows</a></td>
<td class="nump">$ 3,544,837<span></span>
</td>
<td class="nump">$ 3,702,567<span></span>
</td>
<td class="nump">$ 569,975<span></span>
</td>
<td class="nump">$ 4,142,541<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BalancesWithBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash balances held at banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BalancesWithBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOnHand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash held by the entity. This does not include demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOnHand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321328880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Trade and Other Receivables (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade Receivables</a></td>
<td class="nump">$ 657<span></span>
</td>
<td class="nump">$ 351,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccruedIncomeOtherThanContractAssets', window );">Accrued Income</a></td>
<td class="nump">29,443<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ResearchAndDevelopmentIncome', window );">Research and Development Tax incentive receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">63,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other advances</a></td>
<td class="nump">43,618<span></span>
</td>
<td class="nump">1,952,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AllowancesForCreditLoss', window );">Less; allowance for credit losses</a></td>
<td class="num">(2,603)<span></span>
</td>
<td class="num">(2,603)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Total trade and other receivables</a></td>
<td class="nump">$ 71,115<span></span>
</td>
<td class="nump">$ 2,365,638<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AllowancesForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowances for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AllowancesForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ResearchAndDevelopmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ResearchAndDevelopmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccruedIncomeOtherThanContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing income that has been earned but is not yet a receivable, other than contract assets. [Refer: Contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccruedIncomeOtherThanContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318594352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Furniture &amp; Fittings</a></td>
<td class="nump">$ 77,698<span></span>
</td>
<td class="nump">$ 94,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Total property and equipment</a></td>
<td class="nump">77,698<span></span>
</td>
<td class="nump">94,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">94,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">77,698<span></span>
</td>
<td class="nump">94,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=MMA_PlantAndEquipmentMember', window );">Plant and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PropertyPlantAndEquipmentCost', window );">Furniture &amp; Fittings - at cost</a></td>
<td class="nump">72,410<span></span>
</td>
<td class="nump">69,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PropertyPlantAndEquipmentAccumulatedDepreciation', window );">Less: Accumulated depreciation</a></td>
<td class="num">(59,339)<span></span>
</td>
<td class="num">(56,002)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Furniture &amp; Fittings</a></td>
<td class="nump">13,071<span></span>
</td>
<td class="nump">13,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">13,208<span></span>
</td>
<td class="nump">10,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(3,337)<span></span>
</td>
<td class="num">(909)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="nump">3,337<span></span>
</td>
<td class="nump">909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">13,071<span></span>
</td>
<td class="nump">13,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PropertyPlantAndEquipmentCost', window );">Furniture &amp; Fittings - at cost</a></td>
<td class="nump">111,047<span></span>
</td>
<td class="nump">95,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PropertyPlantAndEquipmentAccumulatedDepreciation', window );">Less: Accumulated depreciation</a></td>
<td class="num">(82,269)<span></span>
</td>
<td class="num">(54,929)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Furniture &amp; Fittings</a></td>
<td class="nump">28,778<span></span>
</td>
<td class="nump">40,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">40,683<span></span>
</td>
<td class="nump">51,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">15,435<span></span>
</td>
<td class="nump">12,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(38,628)<span></span>
</td>
<td class="num">(23,975)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="nump">38,628<span></span>
</td>
<td class="nump">23,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">28,778<span></span>
</td>
<td class="nump">40,683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PropertyPlantAndEquipmentCost', window );">Furniture &amp; Fittings - at cost</a></td>
<td class="nump">2,090<span></span>
</td>
<td class="nump">2,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PropertyPlantAndEquipmentAccumulatedDepreciation', window );">Less: Accumulated depreciation</a></td>
<td class="num">(1,508)<span></span>
</td>
<td class="num">(1,313)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Furniture &amp; Fittings</a></td>
<td class="nump">582<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">777<span></span>
</td>
<td class="nump">1,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(195)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">582<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=MMA_FurnitrueAndFittingsMember', window );">Furnitrue and fittings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PropertyPlantAndEquipmentCost', window );">Furniture &amp; Fittings - at cost</a></td>
<td class="nump">49,537<span></span>
</td>
<td class="nump">49,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PropertyPlantAndEquipmentAccumulatedDepreciation', window );">Less: Accumulated depreciation</a></td>
<td class="num">(14,270)<span></span>
</td>
<td class="num">(9,277)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Furniture &amp; Fittings</a></td>
<td class="nump">35,267<span></span>
</td>
<td class="nump">40,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">40,260<span></span>
</td>
<td class="nump">45,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(4,993)<span></span>
</td>
<td class="num">(4,964)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="nump">4,993<span></span>
</td>
<td class="nump">4,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance</a></td>
<td class="nump">$ 35,267<span></span>
</td>
<td class="nump">$ 40,260<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_PropertyPlantAndEquipmentAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property plant and equipment accumulated depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_PropertyPlantAndEquipmentAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_PropertyPlantAndEquipmentCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property plant and equipment cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_PropertyPlantAndEquipmentCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals and retirements. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment that would have been recognised had the revalued assets been carried under the cost model. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 77<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_77_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=MMA_PlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=MMA_PlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=MMA_FurnitrueAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=MMA_FurnitrueAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550317803392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes', window );">Caarried forward tax loss</a></td>
<td class="nump">$ 18,042,509<span></span>
</td>
<td class="nump">$ 16,315,346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax expense or income relating to tax rate changes or the imposition of new taxes. [Refer: Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 80<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_80_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321913152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Intangible assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Total intangible assets</a></td>
<td class="nump">$ 1,297,263<span></span>
</td>
<td class="nump">$ 811,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Total intangible assets</a></td>
<td class="nump">22,590<span></span>
</td>
<td class="nump">26,414<span></span>
</td>
<td class="nump">$ 26,414<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Total intangible assets</a></td>
<td class="nump">52,243<span></span>
</td>
<td class="nump">50,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Total intangible assets</a></td>
<td class="num">(29,653)<span></span>
</td>
<td class="num">(24,429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=MMA_PlatformDevelopmentMember', window );">Platform development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Total intangible assets</a></td>
<td class="nump">1,274,673<span></span>
</td>
<td class="nump">784,947<span></span>
</td>
<td class="nump">$ 1,034,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=MMA_PlatformDevelopmentMember', window );">Platform development [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Total intangible assets</a></td>
<td class="nump">1,988,033<span></span>
</td>
<td class="nump">1,136,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=MMA_PlatformDevelopmentMember', window );">Platform development [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Total intangible assets</a></td>
<td class="num">$ (713,360)<span></span>
</td>
<td class="num">$ (351,202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=MMA_PlatformDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=MMA_PlatformDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321027472">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Reconciliations of the Movement of Intangible Assets (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2024 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>AUD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance at beginning of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 811,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance at end of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,297,263<span></span>
</td>
<td class="nump">$ 811,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=MMA_SteppenPtyLtdMember', window );">Steppen Pty Ltd [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,977<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=MMA_MixedMartialsArtsLLCMember', window );">Mixed Martials Arts LLC [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 384,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=MMA_HypeKitIncMember', window );">Hype Kit, Inc [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Asset purchased for consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 153,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance at beginning of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26,414<span></span>
</td>
<td class="nump">26,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,400<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,224)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance at end of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,590<span></span>
</td>
<td class="nump">26,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=MMA_PlatformDevelopmentMember', window );">Platform development [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance at beginning of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">784,947<span></span>
</td>
<td class="nump">1,034,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(361,950)<span></span>
</td>
<td class="num">(217,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Balance at end of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,274,673<span></span>
</td>
<td class="nump">784,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AdditionsFromInternalDevelopment', window );">Additions from internal development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">177,456<span></span>
</td>
<td class="nump">352,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">674,220<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ResearchDevelopmentTaxIncentive', window );">Research &amp; Development tax incentive</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (383,937)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Included in additions
is acquired intangible assets of:</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AdditionsFromInternalDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions from internal development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AdditionsFromInternalDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ResearchDevelopmentTaxIncentive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research &amp; development tax incentive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ResearchDevelopmentTaxIncentive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=MMA_SteppenPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=MMA_SteppenPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=MMA_MixedMartialsArtsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=MMA_MixedMartialsArtsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=MMA_HypeKitIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=MMA_HypeKitIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=MMA_PlatformDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=MMA_PlatformDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319407104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Trade and Other Payables (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfTradeAndOtherPayablesAbstract', window );"><strong>Trade And Other Payables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_TradeAndOtherPayablesPayableToMemberGyms', window );">Payable to member gyms</a></td>
<td class="nump">$ 69,019<span></span>
</td>
<td class="nump">$ 61,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_TaxesPayable', window );">Taxes payable</a></td>
<td class="nump">603,550<span></span>
</td>
<td class="nump">560,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_TradePayables', window );">Trade payables</a></td>
<td class="nump">540,102<span></span>
</td>
<td class="nump">723,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ProvisionForRefundLiability', window );">Provision for refund liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">70,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other Payables</a></td>
<td class="nump">778,865<span></span>
</td>
<td class="nump">620,062<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Total trade and other payables</a></td>
<td class="nump">$ 1,991,536<span></span>
</td>
<td class="nump">$ 2,034,436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfTradeAndOtherPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfTradeAndOtherPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ProvisionForRefundLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision for refund liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ProvisionForRefundLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_TaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Taxes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_TaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_TradeAndOtherPayablesPayableToMemberGyms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trade and other payables payable to member gyms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_TradeAndOtherPayablesPayableToMemberGyms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_TradePayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_TradePayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts payable that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade payables and other payables. [Refer: Trade payables; Other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321901680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Current and Non-current Employee Entitlements (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract', window );"><strong>Current And Non-current Employee Entitlements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisionsForEmployeeBenefits', window );">Current Employee Entitlement</a></td>
<td class="nump">$ 454,342<span></span>
</td>
<td class="nump">$ 357,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisionsForEmployeeBenefits', window );">Non-current Employee Entitlements</a></td>
<td class="nump">$ 55,622<span></span>
</td>
<td class="nump">$ 18,892<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318316960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Unearned Revenue (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfUnearnedRevenueAbtract', window );"><strong>Unearned Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_UnearnedRevenue', window );">Unearned Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 174,290<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfUnearnedRevenueAbtract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfUnearnedRevenueAbtract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_UnearnedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_UnearnedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322753632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Reserves (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DisclosureOfReservesAbstract', window );"><strong>Reserves</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ReserveOfUnbilledShareOption', window );">Unlisted share option reserve</a></td>
<td class="nump">$ 2,741,457<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfSharebasedPayments', window );">Share based payment reserve</a></td>
<td class="nump">5,734,601<span></span>
</td>
<td class="nump">3,912,367<span></span>
</td>
<td class="nump">1,546,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ForeignCurrencyReserves', window );">Foreign currency translation reserve</a></td>
<td class="num">$ (86,542)<span></span>
</td>
<td class="num">$ (65,832)<span></span>
</td>
<td class="num">$ (29,367)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DisclosureOfReservesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DisclosureOfReservesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ForeignCurrencyReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign currency reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ForeignCurrencyReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ReserveOfUnbilledShareOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reserve of unbilled share option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ReserveOfUnbilledShareOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity resulting from share-based payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321806656">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Issued Capital (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2023</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_OwnersShareCapital', window );">Owners share capital, opening (1)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,918,750<span></span>
</td>
<td class="nump">3,918,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,918,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_NumberOfShareIssuedAndFullyPaid', window );">Issued and fully paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,315,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IssueOfSharesFromConversionOfConvertibleNotes', window );">Issue of shares from the conversion of the convertible notes (2)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,706,794<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AdvisorOptionsExercisedShares', window );">Advisor Options exercised (3)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">327,142<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_OwnersShareCapital', window );">Owners share capital, closing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,267,686<span></span>
</td>
<td class="nump">3,918,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,918,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Owners share capital, opening</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 3,385,281<span></span>
</td>
<td class="nump">$ 3,385,281<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,385,281<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IssuedAndFullyPaidValue', window );">Issued and fully paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,964,825<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Share issue transaction costs net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,174,911)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IssueOfEquityFromConversionOfConvertibleNotes', window );">Issue of shares from the conversion of the convertible notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">32,177,751<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AdvisorOptionsExercisedValue', window );">Advisor Options exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">2,426,757<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Owners share capital, closing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 46,779,703<span></span>
</td>
<td class="nump">$ 3,385,281<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 3,385,281<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
                                            January 24, 2024, there was a reverse share split of our issued and outstanding Ordinary
                                            Shares and Ordinary Share equivalents on the basis of four (4) securities for every five
                                            (5) securities held. All issued and outstanding Ordinary Shares and Ordinary Share equivalents
                                            and per share data have been adjusted throughout the financial statements to reflect the
                                            reverse share split for all periods presented.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The
                                            issue of shares from the conversion of convertible notes reflects and includes the face value
                                            of the note and interest accrued at a fixed rate defined in the agreements, along with the
                                            value of the derivative prior to conversion. This interest figure includes both the accrued
                                            interest rate (contractual and effective) relating to the convertible notes, with the contractual
                                            capitalised interest rate ranging between <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLfugi4sxe0j" title="Contractual capitalised interest rate">8.5</span>% to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_za6aLsj3gMFg" title="Contractual capitalised interest rate">15</span>% per annum, and the derivative reflects the effective interest rate being the cost of the relevant conversion discounts to market value at
the conversion date.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Note
                                            that <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--AdvisorOptionsExercisedShares_c20230701__20240630_zL4BG4Y3jk25" title="Advisor options exercised, shares">327,142</span> Advisor Options fully vested and were exercised into Shares between July 2023
                                            and December 2023 and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--AdvisorOptionsForfeitedShares_iI_c20240630_z7hRoX7U4kUl" title="Advisor options forfeited, shares">16,193</span> Advisor Options were forfeited.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AdvisorOptionsExercisedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advisor options exercised shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AdvisorOptionsExercisedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AdvisorOptionsExercisedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advisor options exercised value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AdvisorOptionsExercisedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IssueOfEquityFromConversionOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of equity from conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IssueOfEquityFromConversionOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IssueOfSharesFromConversionOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of shares from conversion of convertible notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IssueOfSharesFromConversionOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IssuedAndFullyPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issued and fully paid value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IssuedAndFullyPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_NumberOfShareIssuedAndFullyPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share issued and fully paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_NumberOfShareIssuedAndFullyPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_OwnersShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Owners share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_OwnersShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550388030560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Issued Capital (Details) (Parenthetical) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AdvisorOptionsExercisedShares', window );">Advisor options exercised, shares</a></td>
<td class="nump">327,142<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AdvisorOptionsForfeitedShares', window );">Advisor options forfeited, shares</a></td>
<td class="nump">16,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ContractualCapitalisedInterestRate', window );">Contractual capitalised interest rate</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ContractualCapitalisedInterestRate', window );">Contractual capitalised interest rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AdvisorOptionsExercisedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advisor options exercised shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AdvisorOptionsExercisedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AdvisorOptionsForfeitedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advisor options forfeited shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AdvisorOptionsForfeitedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ContractualCapitalisedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual capitalised interest rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ContractualCapitalisedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321786912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Statement of Cash Flows (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss after income tax</a></td>
<td class="num">$ (14,408,346)<span></span>
</td>
<td class="num">$ (20,597,436)<span></span>
</td>
<td class="num">$ (11,197,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AccruedInterestOnConvertibleNotes', window );">Accrued interest on convertible notes</a></td>
<td class="nump">3,207,497<span></span>
</td>
<td class="nump">4,420,225<span></span>
</td>
<td class="nump">2,162,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based payments</a></td>
<td class="nump">4,521,598<span></span>
</td>
<td class="nump">2,365,384<span></span>
</td>
<td class="nump">1,546,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices', window );">Convertible notes issued in lieu of payment for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">624,426<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="nump">520,697<span></span>
</td>
<td class="nump">360,021<span></span>
</td>
<td class="nump">260,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_FairValueMovementRecognisedInProfitOrLoss', window );">Fair value movement of derivatives</a></td>
<td class="num">(3,400,685)<span></span>
</td>
<td class="nump">6,870,729<span></span>
</td>
<td class="num">(2,751,564)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">Decrease in trade and other receivables</a></td>
<td class="nump">372,390<span></span>
</td>
<td class="nump">506,737<span></span>
</td>
<td class="nump">130,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">(Increase)/Decrease in other assets</a></td>
<td class="num">(189,621)<span></span>
</td>
<td class="nump">33,091<span></span>
</td>
<td class="nump">1,015,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Increase/(decrease) in trade and other payables</a></td>
<td class="nump">100,719<span></span>
</td>
<td class="num">(153,292)<span></span>
</td>
<td class="nump">993,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue', window );">Decrease in net deferred revenue</a></td>
<td class="num">(174,290)<span></span>
</td>
<td class="num">(121,453)<span></span>
</td>
<td class="num">(339,222)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund', window );">(Decrease)/increase in provision for refund</a></td>
<td class="num">(70,000)<span></span>
</td>
<td class="num">(25,000)<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities', window );">Increase in employee entitlement</a></td>
<td class="nump">133,845<span></span>
</td>
<td class="nump">160,700<span></span>
</td>
<td class="nump">102,833<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">$ (9,386,196)<span></span>
</td>
<td class="num">$ (5,555,868)<span></span>
</td>
<td class="num">$ (8,055,185)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AccruedInterestOnConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued interest on convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AccruedInterestOnConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase decrease in net deferred revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase decrease in provision for refund.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes issued in lieu of payment for services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_FairValueMovementRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value movement recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_FairValueMovementRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319014368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Key Management Personnel Remuneration (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short term benefits</a></td>
<td class="nump">$ 1,031,194<span></span>
</td>
<td class="nump">$ 657,879<span></span>
</td>
<td class="nump">$ 671,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Post employment benefits</a></td>
<td class="nump">62,730<span></span>
</td>
<td class="nump">33,191<span></span>
</td>
<td class="nump">43,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits', window );">Long term benefits</a></td>
<td class="nump">16,474<span></span>
</td>
<td class="nump">18,892<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share Based payments</a></td>
<td class="nump">1,808,863<span></span>
</td>
<td class="nump">1,065,554<span></span>
</td>
<td class="nump">897,586<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">$ 2,919,261<span></span>
</td>
<td class="nump">$ 1,775,516<span></span>
</td>
<td class="nump">$ 1,612,837<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of other long-term employee benefits. [Refer: Other long-term employee benefits; Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321627408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Shares Held by Key Management Personnel (Details)<br></strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance</a></td>
<td class="nump">1,173,947<span></span>
</td>
<td class="nump">1,173,947<span></span>
</td>
<td class="nump">868,436<span></span>
</td>
<td class="nump">868,436<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,525,621<span></span>
</td>
<td class="nump">1,173,947<span></span>
</td>
<td class="nump">1,173,947<span></span>
</td>
<td class="nump">868,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=MMA_SharesHeldByKeyManagementPersonnelMember', window );">Shares Held By Key Management Personnel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Opening Balance</a></td>
<td class="nump">1,149,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,786,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,955,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IssuedSharesHeldByKeyManagementPersonnel', window );">Issued</a></td>
<td class="nump">296,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RepurchasedSharesHeldByKeyManagementPersonnel', window );">Repurchased</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,200,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ResignationOfKeyManagementPersonnelShares', window );">Resignation of Key Management Personnel</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(530,609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel', window );">Reverse Share Split</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(106,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(446,523)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Closing Balance</a></td>
<td class="nump">1,445,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,149,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,786,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=MMA_OptionHeldByKeyManagementPersonnelMember', window );">Option Held By Key Management Personnel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance</a></td>
<td class="nump">654,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IssuedOptionsHeldByKeyManagementPersonnel', window );">Issued</a></td>
<td class="nump">342,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">644,813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpiredOptionsHeldByKeyManagementPersonnel', window );">Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(106,078)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExercisedOptionsHeldByKeyManagementPersonnel', window );">Exercised</a></td>
<td class="num">(205,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel', window );">Reverse share split</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(128,963)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance</a></td>
<td class="nump">791,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">654,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,850<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ExercisedOptionsHeldByKeyManagementPersonnel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercised options held by key management personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ExercisedOptionsHeldByKeyManagementPersonnel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ExpiredOptionsHeldByKeyManagementPersonnel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expired options held by key management personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ExpiredOptionsHeldByKeyManagementPersonnel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IssuedOptionsHeldByKeyManagementPersonnel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issued options held by key management personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IssuedOptionsHeldByKeyManagementPersonnel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IssuedSharesHeldByKeyManagementPersonnel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issued shares held by key management personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IssuedSharesHeldByKeyManagementPersonnel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RepurchasedSharesHeldByKeyManagementPersonnel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchased shares held by key management personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RepurchasedSharesHeldByKeyManagementPersonnel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ResignationOfKeyManagementPersonnelShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Resignation of key management personnel shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ResignationOfKeyManagementPersonnelShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reverse share split options held by key management personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reverse share split shares held by key management personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=MMA_SharesHeldByKeyManagementPersonnelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=MMA_SharesHeldByKeyManagementPersonnelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=MMA_OptionHeldByKeyManagementPersonnelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=MMA_OptionHeldByKeyManagementPersonnelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318167568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties transactions (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 02, 2025</div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Share percent rate | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,142<span></span>
</td>
<td class="nump">327,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=MMA_Mr.LangtonMember', window );">Mr.Langton [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Share percent rate</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=MMA_Mr.LangtonMember', window );">Mr.Langton [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=MMA_EmploymentAgreementMember', window );">Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsExpense', window );">Short term incentive | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=MMA_EmployeementAgreementMember', window );">Employeement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Share percent rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=MMA_MrLangtonMember', window );">MrLangton [Member] | Snowflower Holdings Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PercentageOfOrdinarySharesUnderVestAndExercisable', window );">Percentage vest and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=MMA_MrWilliamsMember', window );">MrWilliams [Member] | Champ Seven Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PercentageOfOrdinarySharesUnderVestAndExercisable', window );">Percentage vest and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=MMA_MrTaylorMember', window );">MrTaylor [Member] | Nalaroo Holdings Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PercentageOfOrdinarySharesUnderVestAndExercisable', window );">Percentage vest and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=MMA_MrHartMember', window );">Mr Hart [Member] | J Hart Family Trust Account [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PercentageOfOrdinarySharesUnderVestAndExercisable', window );">Percentage vest and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_PercentageOfOrdinarySharesUnderVestAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of ordinary shares under vest and exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_PercentageOfOrdinarySharesUnderVestAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=MMA_Mr.LangtonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=MMA_Mr.LangtonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=MMA_Mr.LangtonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=MMA_Mr.LangtonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=MMA_EmploymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=MMA_EmploymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=MMA_EmployeementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=MMA_EmployeementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=MMA_MrLangtonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=MMA_MrLangtonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=MMA_SnowflowerHoldingsPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=MMA_SnowflowerHoldingsPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=MMA_MrWilliamsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=MMA_MrWilliamsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=MMA_ChampSevenPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=MMA_ChampSevenPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=MMA_MrTaylorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=MMA_MrTaylorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=MMA_NalarooHoldingsPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=MMA_NalarooHoldingsPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=MMA_MrHartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=MMA_MrHartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=MMA_JHartFamilyTrustAccountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=MMA_JHartFamilyTrustAccountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321274784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Financial Statement of the Parent Entity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">$ (14,408,346)<span></span>
</td>
<td class="num">$ (20,597,436)<span></span>
</td>
<td class="num">$ (11,197,450)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive loss for the period</a></td>
<td class="num">(20,710)<span></span>
</td>
<td class="num">(36,465)<span></span>
</td>
<td class="num">(31,312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the period attributable to Alta Global Group Limited</a></td>
<td class="num">(14,429,056)<span></span>
</td>
<td class="num">(20,633,901)<span></span>
</td>
<td class="num">(11,228,762)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">3,623,792<span></span>
</td>
<td class="nump">6,101,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">1,695,533<span></span>
</td>
<td class="nump">1,128,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">5,319,325<span></span>
</td>
<td class="nump">7,230,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">2,574,437<span></span>
</td>
<td class="nump">28,018,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">186,344<span></span>
</td>
<td class="nump">10,346,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,760,781<span></span>
</td>
<td class="nump">38,365,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Net assets/(liabilities)</a></td>
<td class="nump">2,558,544<span></span>
</td>
<td class="num">(31,134,307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity/(deficit)</a></td>
<td class="nump">2,558,544<span></span>
</td>
<td class="num">(31,134,307)<span></span>
</td>
<td class="num">(12,865,790)<span></span>
</td>
<td class="num">$ (3,184,011)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember', window );">Parent [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">(14,029,605)<span></span>
</td>
<td class="num">(20,053,426)<span></span>
</td>
<td class="num">(10,667,136)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive loss for the period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the period attributable to Alta Global Group Limited</a></td>
<td class="num">(14,029,605)<span></span>
</td>
<td class="num">(20,053,426)<span></span>
</td>
<td class="num">$ (10,667,136)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">5,309,505<span></span>
</td>
<td class="nump">7,307,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">1,687,347<span></span>
</td>
<td class="nump">1,120,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">6,996,852<span></span>
</td>
<td class="nump">8,428,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">2,577,040<span></span>
</td>
<td class="nump">28,018,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">186,344<span></span>
</td>
<td class="nump">10,346,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,763,384<span></span>
</td>
<td class="nump">38,365,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Net assets/(liabilities)</a></td>
<td class="nump">4,233,468<span></span>
</td>
<td class="num">(29,937,065)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ContributedEquity', window );">Contributed equity</a></td>
<td class="nump">46,779,703<span></span>
</td>
<td class="nump">3,385,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReserves', window );">Reserves</a></td>
<td class="nump">8,476,103<span></span>
</td>
<td class="nump">3,912,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated losses</a></td>
<td class="num">(51,022,338)<span></span>
</td>
<td class="num">(37,234,713)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity/(deficit)</a></td>
<td class="nump">$ 4,233,468<span></span>
</td>
<td class="num">$ (29,937,065)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ContributedEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contributed equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ContributedEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph IG63<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG63&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318210592">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Country Incorporation Principal Place of Business (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=MMA_UnitedStatesOfAmericaCountryMember', window );">United States Of America Country [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United States of America<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=MMA_AustraliaCountryMember', window );">Australia Country [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">Australia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=MMA_AustraliaCountryOneMember', window );">Australia Country One [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">Australia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=MMA_IrelandCountryMember', window );">Ireland Country [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Ireland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=MMA_UnitedStatesOfAmericaCountryOneMember', window );">United States Of America Country One [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United States of America<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorLLCMember', window );">Wimp2 Warrior LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfParentEntity', window );">Name of parent entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Wimp 2 Warrior LLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Proportion of ownership interests held by non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorProductionsPtyLtdMember', window );">Wimp2 Warrior Productions Pty Ltd [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfParentEntity', window );">Name of parent entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">Wimp 2 Warrior Productions Pty Ltd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Proportion of ownership interests held by non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorDigitalPtyLtdMember', window );">Wimp2 Warrior Digital Pty Ltd [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfParentEntity', window );">Name of parent entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">Wimp 2 Warrior Digital Pty Ltd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Proportion of ownership interests held by non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorIrelandLimitedMember', window );">Wimp2 Warrior Ireland Limited [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfParentEntity', window );">Name of parent entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Wimp 2 Warrior (Ireland) Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Proportion of ownership interests held by non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_HypeCoMember', window );">Hype Co [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfParentEntity', window );">Name of parent entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Hype.Co<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Proportion of ownership interests held by non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Entities deregistered
in the period to June 30, 2024.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NameOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The name of the entity's parent. [Refer: Parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 13<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_13&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 138<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_138_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NameOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrincipalPlaceOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The place where an entity principally conducts operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 138<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_138_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrincipalPlaceOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=MMA_UnitedStatesOfAmericaCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=MMA_UnitedStatesOfAmericaCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=MMA_AustraliaCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=MMA_AustraliaCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=MMA_AustraliaCountryOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=MMA_AustraliaCountryOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=MMA_IrelandCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=MMA_IrelandCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=MMA_UnitedStatesOfAmericaCountryOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=MMA_UnitedStatesOfAmericaCountryOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorProductionsPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorProductionsPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorDigitalPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorDigitalPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorIrelandLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_Wimp2WarriorIrelandLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_HypeCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=MMA_HypeCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550323412768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Changes in ROU Assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">13 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current lease liability</a></td>
<td class="nump">$ 128,559<span></span>
</td>
<td class="nump">$ 121,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current lease liability</a></td>
<td class="nump">130,722<span></span>
</td>
<td class="nump">54,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Total lease liabilities</a></td>
<td class="nump">259,281<span></span>
</td>
<td class="nump">175,662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RightofuseAsset', window );">Balance at beginning of yea</a></td>
<td class="nump">613,691<span></span>
</td>
<td class="nump">400,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AccumulatedAmortization', window );">Less: amortization for the period</a></td>
<td class="num">(358,228)<span></span>
</td>
<td class="num">(243,290)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RightofuseAsset', window );">Balance at end of the year</a></td>
<td class="nump">255,463<span></span>
</td>
<td class="nump">157,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=MMA_AmortizationMember', window );">Amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RightofuseAsset', window );">Balance at beginning of yea</a></td>
<td class="nump">157,540<span></span>
</td>
<td class="nump">276,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AccumulatedAmortization', window );">Less: amortization for the period</a></td>
<td class="num">(114,759)<span></span>
</td>
<td class="num">(119,367)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RightofuseAsset', window );">Balance at end of the year</a></td>
<td class="nump">255,463<span></span>
</td>
<td class="nump">157,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_Modification', window );">Modification</a></td>
<td class="nump">$ 212,682<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_Modification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_Modification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RightofuseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right of use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RightofuseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=MMA_AmortizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=MMA_AmortizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318211552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Future Minimum Lease Payments (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Total future lease payments</a></td>
<td class="nump">$ 259,281<span></span>
</td>
<td class="nump">$ 175,662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Total future lease payments</a></td>
<td class="nump">217,187<span></span>
</td>
<td class="nump">183,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Not later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Five years and over</a></td>
<td class="nump">135,680<span></span>
</td>
<td class="nump">127,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Later than one year and not later than two years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Five years and over</a></td>
<td class="nump">46,240<span></span>
</td>
<td class="nump">28,214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">Later than one year and not later than three years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Five years and over</a></td>
<td class="nump">35,267<span></span>
</td>
<td class="nump">28,214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Later than one year and not later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Five years and over</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 58<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_58&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph B11D<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B11D_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319237024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Financial Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Convertible note payable - Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25,331,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Convertible note payable &#8211; Non Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,273,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total Financial Liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18,694,729<span></span>
</td>
<td class="nump">$ 878,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ConvertibleInstrumentsMember', window );">Convertible instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Convertible note payable - Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">25,331,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Convertible note payable &#8211; Non Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,273,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total Financial Liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">35,604,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDebtInstrumentsIssued', window );">Host Liability - Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">16,567,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDebtInstrumentsIssued', window );">Host Liability &#8211; Non Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">342,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative liability -Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,763,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Derivative liability - Non Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,930,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DebtSecurities', window );">Total Convertible Notes Payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 35,604,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDebtInstrumentsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current debt instruments issued. [Refer: Debt instruments issued]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDebtInstrumentsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of instruments issued by the entity that represent indebtedness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDebtInstrumentsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current debt instruments issued. [Refer: Debt instruments issued]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDebtInstrumentsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ConvertibleInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ConvertibleInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550323284016">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Schedule of Convertible Notes held by Investors (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ReachConvertibleNote', window );">Reach convertible note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,025,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_RedeemedForCash', window );">Redeemed for cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,029,617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesAConvertibleNotesMember', window );">Series A Convertible Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssueDate', window );">Issue Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">23-Dec-20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesPreModificationMaturityDate', window );">Pre Modification Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">23-Dec-22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModificationDate', window );">Modification Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1-Dec-22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModifiedMaturityDate', window );">Modified Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31-Dec-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDate', window );">Conversion Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31 -Dec 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesTerm', window );">Term (Years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Face Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7,319,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDiscount', window );">Conversion Discount (Qualified Equity Investment)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesAJulyTwentyOneConvertibleNotesMember', window );">Series A July-21 convertible notes [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssueDate', window );">Issue Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">7-Jul-21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModifiedMaturityDate', window );">Modified Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">7-Jul-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDate', window );">Conversion Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">7-Jul-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesTerm', window );">Term (Years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Face Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDiscount', window );">Conversion Discount (Qualified Equity Investment)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesAAugustTwentyOneConvertibleNotesMember', window );">Series A August 21 convertible notes [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssueDate', window );">Issue Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">20-Aug-21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesPreModificationMaturityDate', window );">Pre Modification Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">9 -Dec-22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModificationDate', window );">Modification Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1-Dec-22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModifiedMaturityDate', window );">Modified Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31-Dec-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDate', window );">Conversion Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31-Dec-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesTerm', window );">Term (Years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Face Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDiscount', window );">Conversion Discount (Qualified Equity Investment)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesBOneConvertibleNotesMember', window );">Series B1 convertible notes [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssueDate', window );">Issue Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">15-Dec-21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesPreModificationMaturityDate', window );">Pre Modification Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">15-Dec-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModificationDate', window );">Modification Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1-Dec-22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModifiedMaturityDate', window );">Modified Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31-Dec-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDate', window );">Conversion Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31.Dec-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesTerm', window );">Term (Years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Face Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,982,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDiscount', window );">Conversion Discount (Qualified Equity Investment)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesB2ConvertibleNotesMember', window );">Series B2 Convertible Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssueDate', window );">Issue Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1-July-22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesPreModificationMaturityDate', window );">Pre Modification Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">30-June-24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModificationDate', window );">Modification Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1-Dec-22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModifiedMaturityDate', window );">Modified Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31-Dec-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDate', window );">Conversion Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31-Dec-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesTerm', window );">Term (Years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Face Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 671,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDiscount', window );">Conversion Discount (Qualified Equity Investment)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesAExtensionConvertibleNotesMember', window );">Series A Extension Convertible Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssueDate', window );">Issue Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">16-Nov-22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModifiedMaturityDate', window );">Modified Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31-Dec-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDate', window );">Conversion Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">31-Dec-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesTerm', window );">Term (Years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Face Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,571,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDiscount', window );">Conversion Discount (Qualified Equity Investment)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=MMA_ReachConvertibleNotesMember', window );">Reach Convertible Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssueDate', window );">Issue Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">13-Feb-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModifiedMaturityDate', window );">Modified Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">13-Feb-25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDate', window );">Conversion Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">28-Mar-24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesTerm', window );">Term (Years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Face Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 3,195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDiscount', window );">Conversion Discount (Qualified Equity Investment)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=MMA_PrivatePlacementConvertibleNotesMember', window );">Private Placement Convertible Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssueDate', window );">Issue Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">9-June-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModifiedMaturityDate', window );">Modified Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">9-June-25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDate', window );">Conversion Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">28-Mar-24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesTerm', window );">Term (Years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Face Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,215,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDiscount', window );">Conversion Discount (Qualified Equity Investment)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=MMA_MixedMartialArtsLLCConvertibleNotesMember', window );">Mixed Martial Arts LLC Convertible Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssueDate', window );">Issue Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">26-Oct-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModifiedMaturityDate', window );">Modified Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">9-June-25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDate', window );">Conversion Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">28-Mar-24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesTerm', window );">Term (Years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Face Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 384,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDiscount', window );">Conversion Discount (Qualified Equity Investment)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=MMA_SteppenConvertibleNotesMember', window );">Steppen Convertible Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesIssueDate', window );">Issue Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">20-Sept-23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesModifiedMaturityDate', window );">Modified Maturity Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">9-June-25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDate', window );">Conversion Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">28-Mar-24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesTerm', window );">Term (Years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Face Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 100.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ConvertibleNotesConversionDiscount', window );">Conversion Discount (Qualified Equity Investment)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">$<span id="xdx_905_ecustom--RedeemedForCash_iI_c20230609_zCA5HXL5Vhw9" title="Redeemed for cash">1,029,617</span> was redeemed for
  cash, the remaining Reach notes were converted to equity.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">$<span id="xdx_90A_ecustom--ReachConvertibleNote_iI_c20230609_zjH8cFvlAAXd" title="Reach convertible note">3,025,841</span> of Reach convertible
  notes, inclusive of accrued interest, were rolled into the Private Placement on June 9, 2023.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ConvertibleNotesConversionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes conversion date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ConvertibleNotesConversionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ConvertibleNotesConversionDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes conversion discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ConvertibleNotesConversionDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ConvertibleNotesIssueDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes issue date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ConvertibleNotesIssueDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ConvertibleNotesModificationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes modification date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ConvertibleNotesModificationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ConvertibleNotesModifiedMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes modified maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ConvertibleNotesModifiedMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ConvertibleNotesPreModificationMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes pre modification maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ConvertibleNotesPreModificationMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ConvertibleNotesTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ConvertibleNotesTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ReachConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reach convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ReachConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_RedeemedForCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redeemed for cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_RedeemedForCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesAConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=MMA_SeriesAConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesAJulyTwentyOneConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=MMA_SeriesAJulyTwentyOneConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesAAugustTwentyOneConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=MMA_SeriesAAugustTwentyOneConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesBOneConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=MMA_SeriesBOneConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesB2ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=MMA_SeriesB2ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=MMA_SeriesAExtensionConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=MMA_SeriesAExtensionConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=MMA_ReachConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=MMA_ReachConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=MMA_PrivatePlacementConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=MMA_PrivatePlacementConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=MMA_MixedMartialArtsLLCConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=MMA_MixedMartialArtsLLCConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=MMA_SteppenConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=MMA_SteppenConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550323299440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Liabilities (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfConversionOfDebtToEquity', window );">Conversion of debt to equity</a></td>
<td class="text">Series A &#8211; July 21 matured and converted to equity on 7 July 2023, while Series A, Series A &#8211; Aug 21,
Series B1, Series B2 and Series A Extension matured and converted to equity on 31 December 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfConversionOfDebtToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the non-cash conversion of debt to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfConversionOfDebtToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322176848">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Details of Expense from Performance Rights, Options and Warrants (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants', window );">ESOP</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,851,329<span></span>
</td>
<td class="nump">$ 1,052,245<span></span>
</td>
<td class="nump">$ 914,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpenseFromAdvisorOptions', window );">Advisor Options ()</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,086,938<span></span>
</td>
<td class="nump">1,164,524<span></span>
</td>
<td class="nump">632,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpenseFromReach', window );">Reach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,584<span></span>
</td>
<td class="nump">148,615<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpenseFromWarrants', window );">Warrants ()</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">253,391<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpenseFromOverAllotmentOption', window );">Over allotment Option ()</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">163,794<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpenseFromRestrictedShareUnits', window );">RSU</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,119,562<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Total Share based payments*</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,521,598<span></span>
</td>
<td class="nump">$ 2,365,384<span></span>
</td>
<td class="nump">$ 1,546,983<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Note
                                            that <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20231201__20231231_z1ntXt81TKLc" title="Advisor Options vested and were exercised"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20230701__20230731_zsw5zmqiLNi5" title="Advisor Options vested and were exercised">327,142</span></span> Advisor Options vested and were exercised into Shares between July 2023 and
                                            December 2023 and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20230701__20230731_zKizMct8TSnl" title="Advisor Options forfeited"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20231201__20231231_zKUJz83i5Z6a" title="Advisor Options forfeited">16,193</span></span> Advisor Options were forfeited. At June 30, 2024, nil remaining
                                            Advisor Options were on issue.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Note
                                            that this expense is pertaining to the issuance of warrants (equating to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_c20240630_zPVvZcVXmXD9" title="Ordinary Shares on exercise">65,000</span> Ordinary
                                            Shares on exercise) to the Underwriter as part of the underwriting agreement. These Warrants
                                            will be exercisable at any time and from time to time, in whole or in part, during the four
                                            and a half year period commencing 180 days from the commencement of sales of the securities
                                            in the Offering, at a price per share equal to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_ecustom--PricePerShareEqualPercentage_iI_pid_dp_uPure_c20240630_zpx8vpOmpta2" title="Price per share equal percentage">125.0</span>% of the public offering price per share
                                            of common stock at the Offering. The issuance acts as additional compensation for ThinkEquity
                                            services that would be rendered over a 24 month period from the Closing of the initial public
                                            offering. As these services vary and are not for a specific service, the fair value of this
                                            allocation cannot be estimated reliably. Thereby, the fair value of these warrants at grant
                                            date were calculated by applying the Black-Scholes model. The Company used valuations specialists
                                            to perform these valuations.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Note
                                            that this expense is pertaining to the option granted to the underwriter, exercisable within
                                            45 days after the closing of the Offering, to acquire up to an additional 15% of the total
                                            number of Shares to be offered by the company in the offering, solely for the purpose of
                                            covering over-allotments. This over-allotment option essentially granted the underwriter
                                            the right to sell more shares than originally planned if the demand for a security issue
                                            proves higher than expected. The fair value of this service cannot be estimated reliably
                                            as the exercise was subjective on share price performance and/or timing. Thereby, the fair
                                            value of these options at grant date were calculated using the Black-Scholes model. The Company
                                            used valuations specialists to perform these valuations. In addition, please note that these
                                            options have not been exercised and the 45-day limit has expired.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ExpenseFromAdvisorOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ExpenseFromAdvisorOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ExpenseFromOverAllotmentOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ExpenseFromOverAllotmentOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ExpenseFromReach">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ExpenseFromReach</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ExpenseFromRestrictedShareUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ExpenseFromRestrictedShareUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ExpenseFromWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ExpenseFromWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550319503824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Details of Expense from Performance Rights, Options and Warrants (Details) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>Integer </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>Integer</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Advisor Options vested and were exercised</a></td>
<td class="nump">327,142<span></span>
</td>
<td class="nump">327,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Advisor Options forfeited</a></td>
<td class="nump">16,193<span></span>
</td>
<td class="nump">16,193<span></span>
</td>
<td class="nump">211,913<span></span>
</td>
<td class="nump">84,862<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary Shares on exercise | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_PricePerShareEqualPercentage', window );">Price per share equal percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_PricePerShareEqualPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_PricePerShareEqualPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550323199216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Share Options Outstanding (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>Integer</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,173,947<span></span>
</td>
<td class="nump">1,173,947<span></span>
</td>
<td class="nump">868,436<span></span>
</td>
<td class="nump">868,436<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">890,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">868,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Total forfeited/expired during the period</a></td>
<td class="num">(16,193)<span></span>
</td>
<td class="num">(16,193)<span></span>
</td>
<td class="num">(211,913)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84,862)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,525,621<span></span>
</td>
<td class="nump">1,173,947<span></span>
</td>
<td class="nump">1,173,947<span></span>
</td>
<td class="nump">868,436<span></span>
</td>
<td class="nump">868,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Total exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(327,142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited/expired during the period</a></td>
<td class="nump">16,193<span></span>
</td>
<td class="nump">16,193<span></span>
</td>
<td class="nump">211,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ShareOptionsMember', window );">Share options [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784,098<span></span>
</td>
<td class="nump">784,098<span></span>
</td>
<td class="nump">556,074<span></span>
</td>
<td class="nump">556,074<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">556,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Total forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84,862)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784,098<span></span>
</td>
<td class="nump">784,098<span></span>
</td>
<td class="nump">784,098<span></span>
</td>
<td class="nump">556,074<span></span>
</td>
<td class="nump">556,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Total exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=MMA_AdvisorMember', window );">Advisor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">344,055<span></span>
</td>
<td class="nump">344,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Total forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,913)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">344,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Total exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(327,142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=MMA_ReachMember', window );">Reach [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,794<span></span>
</td>
<td class="nump">45,794<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Total forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,794<span></span>
</td>
<td class="nump">45,794<span></span>
</td>
<td class="nump">45,794<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Total exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_RestrictedShareUnitsMember', window );">Restricted share units [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">630,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Total forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">630,729<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Total exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=MMA_OverAllotmentOptionsMember', window );">Over Allotment Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Total forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(195,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Total exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_WarrantsMember', window );">Warrants [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Total granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Total forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Total exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited/expired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=MMA_AdvisorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=MMA_AdvisorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=MMA_ReachMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=MMA_ReachMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_RestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_RestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=MMA_OverAllotmentOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=MMA_OverAllotmentOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550321069408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Model Inputs For Options Granted (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_EmployeeStockOwnershipPlanMember', window );">Employee Stock Ownership Plan [Member] | Exercise Prices One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 0.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 5.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">67.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_EmployeeStockOwnershipPlanMember', window );">Employee Stock Ownership Plan [Member] | Exercise Prices Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 5.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 5.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">67.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_EmployeeStockOwnershipPlanMember', window );">Employee Stock Ownership Plan [Member] | Exercise Prices Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 0.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 18.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">66.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_EmployeeStockOwnershipPlanMember', window );">Employee Stock Ownership Plan [Member] | Exercise Prices Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 5.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">64.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_AdvisorMember', window );">Advisor [Member] | Exercise Prices One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 0.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">2 years 313 days 21 hours 36 minutes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 5.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">66.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_AdvisorMember', window );">Advisor [Member] | Exercise Prices Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">2 years 313 days 21 hours 36 minutes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 5.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">66.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_AdvisorMember', window );">Advisor [Member] | Exercise Prices Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">4 years 328 days 12 hours<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 10.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">65.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_ReachMember', window );">Reach [Member] | Exercise Prices One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 5.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">3 years 109 days 12 hours<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 5.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">65.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_ReachMember', window );">Reach [Member] | Exercise Prices Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 6.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">3 years 54 days 18 hours<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 6.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">60.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_RestrictedShareUnitsMember', window );">Restricted share units [member] | Exercise Prices One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 7.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_RestrictedShareUnitsMember', window );">Restricted share units [member] | Exercise Prices Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 7.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_WarrantsMember', window );">Warrants [member] | Exercise Prices One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 6.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">62.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_WarrantsMember', window );">Warrants [member] | Exercise Prices Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ExpectedTermShareOptionsGranted', window );">Term</a></td>
<td class="text">43 days 19 hours 12 minutes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Spot Price</a></td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Share price volatility</a></td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">3.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ExpectedTermShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ExpectedTermShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_EmployeeStockOwnershipPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_EmployeeStockOwnershipPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=MMA_ExercisePricesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=MMA_ExercisePricesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=MMA_ExercisePricesTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=MMA_ExercisePricesTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=MMA_ExercisePricesThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=MMA_ExercisePricesThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=MMA_ExercisePricesFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=MMA_ExercisePricesFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_AdvisorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_AdvisorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_ReachMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=MMA_ReachMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_RestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_RestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550320602016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Contractual Maturities of Financial Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_NonInterestBearingTradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="nump">$ 1,991,536<span></span>
</td>
<td class="nump">$ 2,034,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_WeightedAverageInterestRateFinancialLiability', window );">Financial liability host debt, interest rate</a></td>
<td class="nump">(0.00%)<span></span>
</td>
<td class="nump">9.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingFinancialLiabilities', window );">Financial liability host debt</a></td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">$ 16,909,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_WeightedAverageInterestRateLeaseLiabilities', window );">Lease liability, interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingLeaseLiabilities', window );">Lease liability</a></td>
<td class="nump">$ 217,187<span></span>
</td>
<td class="nump">$ 183,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingNonderivativesNet', window );">Total non derivative</a></td>
<td class="nump">2,208,723<span></span>
</td>
<td class="nump">19,128,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18,694,729<span></span>
</td>
<td class="nump">$ 878,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Not later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_NonInterestBearingTradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="nump">1,991,536<span></span>
</td>
<td class="nump">2,034,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingFinancialLiabilities', window );">Financial liability host debt</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">16,567,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingLeaseLiabilities', window );">Lease liability</a></td>
<td class="nump">135,680<span></span>
</td>
<td class="nump">127,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingNonderivativesNet', window );">Total non derivative</a></td>
<td class="nump">2,127,216<span></span>
</td>
<td class="nump">18,729,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DerivativeNet', window );">Total Derivative</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=MMA_BetweenOneAndTwoYearsMember', window );">Between 1 and 2 Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_NonInterestBearingTradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingFinancialLiabilities', window );">Financial liability host debt</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">342,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingLeaseLiabilities', window );">Lease liability</a></td>
<td class="nump">46,240<span></span>
</td>
<td class="nump">28,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingNonderivativesNet', window );">Total non derivative</a></td>
<td class="nump">46,240<span></span>
</td>
<td class="nump">370,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DerivativeNet', window );">Total Derivative</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=MMA_BetweenTwoAndFiveYearsMember', window );">Between 2 and 5 Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_NonInterestBearingTradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingFinancialLiabilities', window );">Financial liability host debt</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingLeaseLiabilities', window );">Lease liability</a></td>
<td class="nump">35,267<span></span>
</td>
<td class="nump">28,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_InterestBearingNonderivativesNet', window );">Total non derivative</a></td>
<td class="nump">35,267<span></span>
</td>
<td class="nump">28,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_DerivativeNet', window );">Total Derivative</a></td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_DerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_DerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_InterestBearingFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest bearing financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_InterestBearingFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_InterestBearingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest bearing lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_InterestBearingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_InterestBearingNonderivativesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest bearing non derivatives net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_InterestBearingNonderivativesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_NonInterestBearingTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non interest bearing trade and other payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_NonInterestBearingTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_WeightedAverageInterestRateFinancialLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate financial liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_WeightedAverageInterestRateFinancialLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_WeightedAverageInterestRateLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_WeightedAverageInterestRateLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=MMA_BetweenOneAndTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=MMA_BetweenOneAndTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=MMA_BetweenTwoAndFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=MMA_BetweenTwoAndFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550317799376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Auditor of Company And Network Firms (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AuditFees', window );">Audit fees</a></td>
<td class="nump">$ 382,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 48,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_AuditorsRemunerationForRelatedFees', window );">Audit &#8211; related fees</a></td>
<td class="nump">130,000<span></span>
</td>
<td class="nump">207,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForTaxServices', window );">Tax fees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForOtherServices', window );">All other fees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemuneration', window );">Total</a></td>
<td class="nump">$ 512,000<span></span>
</td>
<td class="nump">$ 407,000<span></span>
</td>
<td class="nump">$ 48,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AuditFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AuditFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_AuditorsRemunerationForRelatedFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditors remuneration for related fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_AuditorsRemunerationForRelatedFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemuneration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemuneration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemunerationForOtherServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors for services that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemunerationForOtherServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemunerationForTaxServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors for tax services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemunerationForTaxServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318591664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based payment expense</a></td>
<td class="nump">$ 4,521,598<span></span>
</td>
<td class="nump">$ 2,365,384<span></span>
</td>
<td class="nump">$ 1,546,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="nump">$ 6.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550322551920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingent Assets and Liabilities (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_ContingentAssetsAndLiabilities', window );">Contingent assets and liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_ContingentAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent assets and liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_ContingentAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550472969824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Loss Per Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss after tax</a></td>
<td class="num">$ (14,408,346)<span></span>
</td>
<td class="num">$ (20,597,436)<span></span>
</td>
<td class="num">$ (11,197,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share</a></td>
<td class="nump">10,267,686<span></span>
</td>
<td class="nump">3,918,750<span></span>
</td>
<td class="nump">3,918,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share</a></td>
<td class="nump">10,267,686<span></span>
</td>
<td class="nump">3,918,750<span></span>
</td>
<td class="nump">3,918,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per share</a></td>
<td class="num">$ (1.40)<span></span>
</td>
<td class="num">$ (5.26)<span></span>
</td>
<td class="num">$ (2.86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share</a></td>
<td class="num">$ (1.40)<span></span>
</td>
<td class="num">$ (5.26)<span></span>
</td>
<td class="num">$ (2.86)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45550318127440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events after the reporting period (Details Narrative) - Integer<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Vested and convertible shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,142<span></span>
</td>
<td class="nump">327,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=MMA_NonadjustingEventMember', window );">Nonadjusting Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Vested and convertible shares</a></td>
<td class="nump">139,500<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=MMA_NonadjustingEventMember', window );">Nonadjusting Event [Member] | Mr McGregor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_MMA_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares', window );">Description of contracts shares</a></td>
<td class="text">In consideration for providing these Services under
the Ambassador Agreement, and pursuant to the exemption from registration provided for in Regulation S promulgated under the Securities
Act, Mr. McGregor received 700,000 performance share rights that will vest once the 30-day volume-weighted average price (VWAP) achieves
the following trigger: 150,000 shares on execution of the Ambassador Agreement; 100,000 shares when the share price reaches $7.50; 150,000
shares when the share price reaches $10.00; 150,000 shares when the share price reaches $15.00 and 150,000 shares when the share price
reaches $20.00. Aligned with the three (3) year term of the Ambassador Agreement, Mr. McGregor is restricted from selling shares within
three (3) years of issuance unless specific conditions are met, such as the Company&#8217;s written consent, a sale or liquidation of
the Company, or if the Company breaches the agreement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_MMA_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">MMA_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>MMA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of terms of shares reserved for issue under options and contracts for the sale of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_vii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=MMA_NonadjustingEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=MMA_NonadjustingEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=MMA_MrMcGregorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=MMA_MrMcGregorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>118
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( />!7UD'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #W@5]9U+9NI>\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M:L,P#(=?9?B>R$[V!TSJ2\M.&PQ6V-C-V&IK&CO&UDCZ]DNR-F5L#["CI9\_
M?0(U)DK3)7Q)7<1$#O/-X-N0I8DK=B"*$B"; WJ=RS$1QN:N2U[3^$Q[B-H<
M]1ZAXOP>/)*VFC1,P"(N1*8::Z1)J*E+9[PU"SY^IG:&60/8HL= &40I@*EI
M8CP-;0-7P 0C3#Y_%] NQ+GZ)W;N #LGA^R65-_W95_/N7$' >_/3Z_SNH4+
MF70P./[*3M(IXHI=)K_5Z\WVD:F*5[>%X$4MMA67XD[6#Q^3ZP^_J[#OK-NY
M?VQ\$50-_+H+]0502P,$%     @ ]X%?69E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M%HGYN.0LY#*_ +Y_$D+O#O(?V+]7[_T+4$L#!!0    ( />!7UG42X;BR08
M $ <   8    >&PO=V]R:W-H965T<R]S:&5E=#(N>&ULK5EM;^,V$OXKA.]P
MN .Z,=]$26EB8!/OMEML[X+=OGPXW ?:IFVADNA*M)/TUW<D.99-CM0<D"^)
M+3\<\9D9SCPD;QYM]5N]-<:1IR(OZ]O)UKG=]71:+[>FT/65W9D2?EG;JM .
MOE:;:;VKC%ZU@XI\RBE5TT)GY61VTSY[J&8W=N_RK#0/%:GW1:&KYSN3V\?;
M"9N\//B2;;:N>3"=W>STQGPU[N?=0P7?IB<KJZPP99W9DE1F?3MYSZ[G/&T&
MM(A?,O-8GWTF#96%M;\U7SZM;B>TF9')S=(U)C3\.YA[D^>-)9C'[T>CD],[
MFX'GGU^L?VS) YF%KLV]S7_-5FY[.TDF9&76>I^[+_;Q>W,D%#7VEC:OV[_D
M\8BE$[+<U\X6Q\$P@R(KN__ZZ>B(LP%,#0S@QP'<'R '!HCC /': ?(X0+:>
MZ:BT?IAKIV<WE7TD58,&:\V'UIGM:*"?E4W<O[H*?LU@G)L]5':=.6(K\MG6
M-='EBOS';4U%[FT!B;1M(GPPW8_OR,]?Y^2??__7S=3!JQL#T^7Q-7?=:_C
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M*1 I%=. 08@#8<&YKRPPG*1RJ)^Q7ENP<7$Q-U#TEYGN-LQ0RW1A8;G\T3Y
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M /A];:U[^=*\X'1I./L34$L#!!0    ( />!7UD.9*K$' <  !<?   8
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&ULK5G?;]LV$'[?7T%XPY "32R2HGYD
MB8$T:;$671LTR_8P[(&Q:5NK++HDY=3__4A)MFR1HNTB>8@EZN[X'<F[CT=>
M/7/Q5<X94^#[(B_D]6"NU/)R.)3C.5M0><&7K-!?IEPLJ-*O8C:42\'HI%):
MY$,4!-%P0;-B,+JJVN[%Z(J7*L\*=B^ +!<+*M9O6,Z?KP=PL&GXDLWFRC0,
M1U=+.F,/3#TN[X5^&VZM3+(%*V3&"R#8]'IP R_O<&04*HF_,O8L=YZ!<>6)
M\Z_FY?WD>A 81"QG8V5,4/VS8K<LSXTEC>-;8W2P[=,H[CYOK+^KG-?./%')
M;GG^=S91\^M!,@ 3-J5EKK[PY]]9XQ Q]L8\E]5_\-S(!@,P+J7BBT99(UAD
M1?U+OS<#L:, PQX%U"B@8Q5PHX"["KA'(6P4PFID:E>J<;BCBHZN!'\&PDAK
M:^:A&LQ*6[N?%6;>'Y307S.MIT:WO) \SR94L0EX4/I'3ZH"? K>904MQAG-
MP3V7635)Y^#QX0Z<_?+J:JATW\;"<-ST\Z;N!_7T\Z$L+@ .7@,4H-"A?GN\
M.MY7'VJ/MVZCK=NHLH?[W"Z%,'[>2,F4=+E3ZX=N?1.-EW))Q^QZH,--,K%B
M@]&O/\,H^,WEW L9VW,5;UW%/NNC6RKG@!83,#8/[%N9K6BN?7=Z79N**E,F
M9:Q&F(1A@N.KX6K7(8=<'" 2M7)[6,,MUM"+]4]!)ZP"R]6<"9U8QDS#?<J9
M$VUMC.R@B"&$I(/5ED(X(A%.W%C)%BOQ8OU<(:2]"XC8X)(PZ&"SA3".0NA&
M%FV11?Y1Y$I'[;A9XOT(([OS".$X11V0MEP$ YB$D1MFO(49>V/P$R_.#X.,
M7S(.7\C8GKO)UMW$.ROW0I.U4.O7X#ZGQF6]RM_J:%R:A.OR/+$74!RE26=R
M;*DT3%'/VDZW6%,OUHK^S_GTO)2LGAL7P-0.+$+""'<0VF*0Q&0G%/8@PJ!E
MKL +\GVA:#'+='+P+)_&QE[O*(V1A=(AF$"(HYY8A#L$"X_($_U$TZCOA1>!
M0=K%YQ2#?:/8$B'TDD^3+(JC8K$QM3>844H(M@;3(0A1DN*T!VY+9M#/9C5<
M#T1L]4PP3#'JLH)#,$8XB!/2 ['E,!@>M;?(,_J4Y7KGY"8OZ*7"4S/;2UG;
M][GE0N@GPRYQ+^FZE[6A37HP32'!47>*;$$4X##$/<0#6X*$?H9\+!@5A=[Q
M"K9B1<F<,+TFW",*G%-C\R>,0Y3VA6[+G]#+5]N%]G:QS/F:,?"V4)G*JQV\
M>^1C"TE(0AQV"=\AATF,4,_N#K84"/T<N$'<UA8?#P2)U]XIDV#S)-)Y"^J(
M[W&JY4KH)\N-4Q^9KC^W#JV=[CBX$"6$6,G>)0=)T+-D4,N9R,^9^UO# QD*
MV92(2*SCKUL-N 03O4.,HS[ +7LB>/0F\1!<+P^?7+*]D+5]OW?J4S\M[_I]
M=+3X;9X0+<C!WP&*,8I[-I:H)7#D)_!=QXY.7,C!ZB1"W;SE$(-)LE//[&-N
M&1WYR])=S$=$.;(K3I-G;+BV' EAU >W)6-T@(RM+=VAR'$P<A)IINT"=LAI
M0HXP[L/<,C(ZIF8]A--F4J1S3)S +E!':9OHHC_H70LMZ2(_Z7YBFQWR\&P'
MKO-(#-D\JBNDA-@#:PN>8UU]A+WTA%K.18DW@YH:LV>=_@"Y>A+F"UG;=[-E
M8>1GX?=2EGI#=TN7F5Y)3G=M4@VC.$[CH%N^."0Q3@CJKK.[ YC^@?_Z#O!:
MUL9^UGZ84\'.S?'VQ.RLJQ/:9@R=AW@V'9-8AVG0#1.'($XAPGW'>+BE;>PO
M>A]UBS1'RGQI3HZE%ZY=V:(XA"&Q#AU_@)*!;P):-L9^-G['!<MF1;-Q&J^!
M$K20.57U[4>_:S:/GB<1L3;<+KF()'UI%>^<_?K9]F8\+A=E7IWNYURG+?>I
MK\V;YP1%,(CB;MGL$C6I-8((]X!M:18?./VM.(!5^6IX-F'3;)PI9V)M#$4'
M$ZM#\$!BQ89F]UM:$L-^$M/Q_KGX"9SP]X$6)15K@,+Z9N0U,.4S \]4 EI5
MIT+O-J2)?R"7FFK,S0PO!<CJ=%=5W*622C]DQ0Q\%OI'&SP)1)5>9&5KHU^W
M[=X6 +W2-39SR99)@V)J8)R%KX!D.BPJ$M1M AC,:S#-5NPD$&=DS]*<Y9,+
M<)/GASP]#OU)4(RI)1/-L$^HHF!.5]IUQ@I )_^55693<\'+V5QCJL9ENMVD
MR\TMF@2*F[M1<\=I9$X"X9I[,[Q4#XD&E_&)!%6:*S28"U>6&^[<"BZ8F%6W
MJQ*,>5FH^OIHVUK?X-["R[OJHK/3?H/)Y1TFSB_1YM)WV'917QG_0<4LTYD_
M9U/=77 1ZYPAZEO8^D7Q974O^<25XHOJ<<[HA DCH+]/.5>;%]/!]BY\]#]0
M2P,$%     @ ]X%?6?Z0Z FJ"   PCL  !@   !X;"]W;W)K<VAE971S+W-H
M965T-"YX;6RU6UUSHS@6?<^O4'FGMGJJ.C$2W]DD5=V)@6S-[G1UNF<?IO9!
ML85-#08/R$GZWX_ -!@0,GANOW3XT#WWHG,EZYZ6;E[3[(]\PQA';]LXR6]G
M&\YWU_-YOMRP+<VOTAU+Q)LPS;:4B]ML/<]W&:.KTF@;SXFF6?,MC9+9W4WY
M[%-V=Y/N>1PE[%.&\OUV2[-O'UF<OM[.\.S[@\_1>L.+!_.[FQU=LR?&O^X^
M9>)N7J.LHBU+\BA-4,;"V]D'?/VH:X5!V>*WB+WF1]>H^)3G-/VCN'E<W<ZT
M(B(6LR4O(*CX\\+N61P72"*./RO06>VS,#R^_H[NE1\O/N:9YNP^C?\7K?CF
M=N;,T(J%=!_SS^EKP*H/,@N\91KGY;_HM6JKS=!RG_-T6QF+"+91<OA+WZJ.
M.#+ ^H !J0Q(QX 8 P9Z9:!W#/0A#T9E8'0,##Q@8%8&9L? M 8,K,K ZGIP
M!@SLRL >VTM.9>",-7 K [=,AP-_)?D/E-.[FRQ]15G16J 5%V4&E=:"\R@I
MDOV)9^)M).SXW7V:Y&D<K2AG*_3$Q1^1R1RE(;K?T&3-<A0E:/'G/N+?T"7Z
M^O2 WOWT\\V<"]<%P'Q9N;D_N"$#;A[S?"\<+.DNXC1&OV_9]IEE_Y< /:B!
MOHHG>1%KNN.'\9:S[(6I$!=JQ,\5@OCD?$,S=EF,G17:T6]%3^0J9&\T,GM;
MEMV)5E$8LHPE2]&S(GR>T22/:?DI"D>^VM&'Y7*_W<<EARG?L PMTZV8^S;%
MI"0"B!)QK^RC0.W@2RI8:YO-1:+5V4;J;",ECC& \ZN8HZ-D+::GF(HN0)2C
M?^^3*Z1K[Q'1")8EU@'1*A&+J?OE3M<=DSBB\<MQWB@]%[\9U_F.+MGM;%?E
MS.SNG__ EO8O6<J< 89D"=(/'KN&V8[<[S>ZM$P;$]UN-PPD#77L&!IN^J)%
MBU[3HI>6^M#H#+.\'ON_B)>/XE)D?G&)RFM9SMSK@#W^  FV@ 3S(,%\2+
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M+W=O<FMS:&5E=',O<VAE970V+GAM;(U5;6_;. S^GE]!>,"P 5GL..FN:Y,
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MPJ2_@)FF\*"5JRS<JASSEP Q<1J(I3VQZ_0DXA^-FL L&4.:I/,3>+,AT5G
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MQK5^QZ] *54IN8JB%CN;QW:5EMC1+3M6>93D&22:0U@@0*.!&3&__I[O++V
MX&BBW/MB:TB@^_3ILWQGZ>8W=_WPP>^=&\N/A[;SWS[:C^/QZZ=/_7;O#I5?
M]T?7T3>[?CA4(_TYW#SUQ\%5-;]T:)^^>/;LCT\/5=,]^NX;_NS=\-TW_32V
M3>?>#:6?#H=J.+UR;7_W[:/GC^R#7YJ;_8@/GG[WS;&Z<==N_,?QW4!_/0VC
MU,W!=;[INW)PNV\?O7S^]:NO\#P_\,_&W?GDWR56LNG[#_CC;?WMHV<@R+5N
M.V*$BOYWZUZ[ML5 1,9O.N:C,"5>3/]MHW_/:Z>U;"KO7O?MOYIZW'_[Z,^/
MRMKMJJD=?^GO_N9T/7_ >-N^]?S?\DZ>_?(OC\KMY,?^H"\3!8>FD_]7'Y4/
MR0M_?G;AA1?ZP@NF6R9B*M]48_7=-T-_5PYXFD;#/WBI_#81UW38E.MQH&\;
M>F_\[J=J=$-3M>7+[;:?NK'I;LIW?=ML3^7;3O:<F/?-TY'FPAM/MSKN*QGW
MQ85QG[\H?^J[<>_+OW:UJ_,!GA*1@=(71NFK%_>.^#]3MRZ_?+8J7SQ[\=4]
MXWT95OXEC_?E__G*9=ROEL>%%GWMC]76??N(U,2[X=8]^N[WOWO^QV=7]U#]
M5:#ZJ_M&_R^HOG?<9:K_WH^N>+$N'S9I^7[OBBH^<<03C?/EN*_&LAH<R:V.
M,_;TH2NW?>?IH9H^KDM';XTG?LZ3,2(#4FY@,]88U[LXW+ZZ=?25Z_C]QH_T
M9DLO'H]M0^.,?5&U+8]_I-GZVI>\HHXF6953USKORYZ^'NX:&M:/F)TGR>G9
M-5W5;4$M/T*&:/1,71BM;+KRY3_>K,J[?;/=EPU]W7I9V>O^<*RZT^]_]^<7
MS_]TY8O=U+$5HM&VTS"X;GM:EZ\JHK[H=QCQ6 W"Q&N;#%]L:9BV(3*<,*%8
M)"HR1 82RK 30\WOWC7CGG:*F-]52L7W8:!?W+$?>,-HZJZN!F(8_7_V?++S
MX;&B\K1H/]%\FQ,O^]/OE*]Z^E_Y^.W+ZU=?Q'F(\)%?\^5C,FELLV\=[>K;
M[W^Y]E_P]A0IFX@YB[QHNI1IO/"J[H_8+0RU3-/@?IN:@275E1,)!5COAK'"
M:$,S-EN:)$IVX?S80);]NGP[RJ:'(73G2=8[<FH@"M+N/KIA"W'[=:IO^$/L
M$$GL"90L2$RYH$@BI+2_Q/<[DE]7^.:F:W9$'@UH(\ON!1(3Z3A4M<.\PD>;
M>%G.:0CZLAE*M]O19K#@UXW?MKT7\8)M*+],A/A 9$V#K!B[]5!1I<T$&1N,
M \;O2:/[@5F^[?VX(MYMW7$LR<[P@^D\9%=V%1%Y6[43[YJX^U1[24C)G,B*
M(DDD'YNFI9T%5]\1+[;-D0R#Z)P9 ;-IGS8+]'X_D!K1!Z49'YEWE4[%1)"0
M$&+@I2;[SE_9JW[:^*9N""2Q,%<=O5O@ 39;-!MI#&TPS3N"W'& QM1E/85-
M%<LG F,SZ).@PHPM25&'08CS[N.1MW;L5R5Q>E^)-@Q -9X_O269J3:M*TA7
MIX$T=3?T!WH;R[_MVUO9$E8YO&GVG,BVP801)RA$)6(U[FG2T@8<]T,_W>QY
MS&-_1TOM;]V0C"9VX &<Q0B!B_P]R>]N:MM3;N2)E0NN:'&/>;5X%,^(R2^4
MI>!?OX&Y./<D:JRJ=%/I<>A2#_6&]<R'9G=I(V])VMG.8,^WNI/C4'6^8H?B
M5\6F:F'LA =31^:A;;"3-T2/QUZ2SM(8K&C)BZ2&XQTTT>2#69SSRK4-84[F
M2=_EBUJGIM0L%/0G8WOBJ_=5=T/CL)S7OQ*R%;:R46)K5G:.5N'!(%C,#EI.
MZVD ," UJC!+""/7I77Y,\E_Q:;:.S6*"Q_ESGSRICQL@_]XE5APLM1#7VWW
M:IU72C >;A( E" #;W;-5P<S;JH%C3C)EO0(GA?PI+]M:M8]6<:^<;M(</G&
MD>O ^#]5']Q 'A)DO'AV]?KG-S_Q/Y]??:&J3I]@;J+C"&Q$VAKL)AF7?AOD
MD9[HIX'X7="D?9@J\@;;!+$QKI"5I:=XK21LZ_(,&R[MRY,R"CD%410B=87A
M'Q'&-IK9!P(NDIRA@G\O:S)[U> 3_+7D2!/HA47I8#)MQ&++U)FJW/\M:+3%
MF$TY)S,1,/)HK WEP!Z:2+JMR)#1M]48[$"0ZG2N2&@80]0<2U,]%S.(T8)=
M(7LYMB+*K*'$K7P%76*$TGV!@PW;<G+5\,0!7.C<Q6!T'OJ. !QI;N)M4_-<
MNZXW2T*;N)-%&/_-Z QNVQ.@481!:K$CWZ0&C"3.W17T!^D3(LIE)+<$* W_
MG;ER]5#P3O8,/+"RO7-WY>=,]S!$7)PA8E5J &-3ZC1RHH<)%IV".@OKQG((
M\#WU^;P>5?61PZ>+RRGN7T[=U&77CV+)JQC"-:1EY,#%ROEE&$D^HCL5#V$D
M?3^?.*P=LY\H(HP\8%KP,7L6DDJ$?[*#:XIG;AT9G.(7$:9@7G2W@XQ!4?A)
MV.4=Z6A_Y[\.;[,VL!.F57I!-9*.@06VI]C4!ID%O:0R!RQ/R!_<#GC4!XA!
M9EX#&+(18K82K"0P3  L?;_1+UK1AZ#Q+ )0TIT;@/B*F[X7'B)N;P %@+ "
MO6PTB$TTF:U((Z/PR"HAXZHD*NE?N\8%PA=?FC]8) Z"\%#;W)A*=-DX5V0.
M:*_)'N@$B2TBK6^VSEA#_LZ+/57ODL0U)-F&2'/6%AJ\E/2DBZ$!3!2M3=W@
MQ9G5!WL)-5UY:4WSL(7!LH/9O.6D0E<_J5J:DN!&RZ9=AJ<G>2,(_Y$*$$^Q
M=\G6Z;[7A+P(^KKZ2I'MF= R=(=:>1EPF4Z(E*=_>=JCND#,"37J&%23?-;N
MV)AXFD2%Y(SNLBWN7,C(0!\@^.ORGQ8:Y#(.>=&]/V/TJFP(%7>G5502>AD
MD-D[QT2!&G9>E0)HD@B/ 3:\H<(I\O<UH6(@VF./W!!LTJ;O)N'>UC6W+#/!
MWX6A&?/0:Q)E"7*Y@8T%RV'-KC%WE$".B4V2#4"ZAM].<*2I=,&BJ+@$C#2<
M25$N.<L/2'>(\;!G#H[B([7H:=A[4?1YNZ?-KQQ:L0F@;XGU3:<2*'%NP?!U
M<XK"U,#O=43 )O/"RGSW<71FTB1:W%-82$_3+FV8"C'699J/P-B#AZ<0"5"[
MB A[.DRB*(41D,S)M,"X]UOR<>>+#TL: [@D;$7_D-B9T)YD;D8&(SVYI)%'
MU;#T@LT0QGGWVR391.!C"FF)^2^9;A,=,,4<4\)IL^_GO)X#&X -E=* D$[(
M0?0W0W4(#)G_K:E.-C4$KBDZ(@EVSJNE3";Y-P)*=F<&-YF1P%EL?C:]<B(H
MO%DOA/I8##)@2TE,!"Z<FIMH5VGKR>00DR>*-&3C:3H=RBBL;@:G$12R%Z!@
M\A14S9]C"KVA7PIS#Z#69!V?O6S'JOSIIY?%>^.P<BC+<030OTQJRL1*LLSD
M%YJ/Q+%#-;"AJ!"0);O(<YAI:0FG$TD;8EP-OXM/_70$ ",Y65AU.N$BBY?I
M7$@-J5DAIS0BMTC@DLT.R7:1,I(WXVYH1E)8*%'BT?HXP+I\J[%TH!3!DXU8
MB\HV7GV%@ /[6@P[,E7DG4-Z<$=?%[IY)/4)]HQ\(\=AJ1IQL?PG@&-+[F S
MC=":?A#+!=2H3VS<3=-A/Q3;!D.BVQ/,&/(J[@B8B?2YF)UN.FQ$QK%T"DN)
MI9(G9K=I1!A NCD=/B.V?561:MN,9V*PHN6PV#]!_9 $J3]5+9<Z!N YXS]"
MGK;:NI"8F<L >^'3P>=IO:#VWO@1C,;_BQFX(+,+9J#X3\V V+*'&X-RT1@4
MQAE+.R(:AL>.:1%)0P*+(<MD#+HX+/D?!+41@Y!#9S<7HV=!=X8&)$-6I-LD
MV0DR_!3Z!M_C9%/5601?"99%V3C?;_BAQ$JQ'Z@;^@*>*^":5-[55"4.#@!T
M:$CIH)$EQY"BL@RP5((XD.BG 6+'XW6(?D2*5=JQ8'_1[A/MKQ7UD[04[ZJ3
MI'5HV!](DK/M:D(AAH&'Y"Q"T,#"EKQNRB .E61PBZQ.E*FQ'U%HS'BDE27+
MN*8,6A=_=V,P)/*U;CZ_.HOT_#V/<H$QC7= >AHZT#($-/6)2E]76G\@ 4.<
M5Z-:E$6CDDUL76KYTH?/@E$6@KZ18A,'0QPT!,Y)RCJDFE.<G^34" $32&K;
M4Z%#\DCTL,8HY$W^"GP<K$Y&-$-G>F7[@=@+ZL]8>2^=\KI8A'7Y,S2H0+&%
MGLG^R,=,RAH!M9&!#Z,&$Z??FF!Q $ZQ&^V5WTLNP;N*.%S\OCH<K\HW1$[;
M'_G1MQT$#B__@")%QR5;VA.8>R*JG6HS*[_PRV_PJ;Q!W/7[2E%N#K@#CAUT
M397O.Q86PK+3P-$=X\_4-[ W9K][8IRK?IBD0NW3.))K8W)8X@[J3708)MK+
M*$(-<XPT5U),;#NZOGMB*:=M2\0$^U>^Y)1?,4_YG65N67XM-Y07<(^]ET1-
M,"TVU_US(\$DY2!PR[X3!;4WL.M?6Y%+4-0LR1(J)KW4UKHZ?$5! '\,@ST=
MXCH6\H@!)G<(P]LDJ;X];5MW99&3:]E;$.!LVIC..TX#ZF^LA$,%V;F*A;E%
M8C6X?OX"F0TTVC &4\2E.<%"<H(<;8Y6DV1657[/Z\+_870I-@6SM#T"U45R
M:,%2;AR'MA^MB$-O3CXSTU4,9GA-)%LM">](]!67Z0LYRY>(/WEO+($,+YGM
M9R(%]'P1I_LO=EZ(?\BNEA=VM?C,7:TG-Z/A(?M9YOLI1J+K"PIZ3=V)QF#>
M:K?3$?("@+CJ"]OUZ>G3[4HTOOC$GKT!->3<B['Z>*E.@"&J]JXZS?<T&XE[
M#SZ%SWGGGE\E*/TU"3N;J9G4^WN^$5/N5&&Z$LYVA2@#%DOW'>5:F'/.,42C
MUG2>)&B2*JVRR^^)DT\8-*TLB=(V-!]DD#R#%$4+'JFG?41LA)S[- A_>/,(
M6]DFH3@B<$-S$FC,;*3*35YI;!1G?.CZ.TM-\RB\'JPXY@_2Q%$'ZF,RIQ@:
M_X%?8P/ L0IGLR2U?&;9>?0=,NIYO4WU@=@1YC_C.+?3*-N!-;L/W 50#R20
M?E4D].ZQ)LLQ#J@CQQX)Q5C2$*3V(!6T_D'^:(U0H'9)[T5,('K]+OT$9#6H
M.0 OS5!.TJAR!L8UOR4EA .4#2^A_26M&G*H#<1A#2":(%RQ#'#&$]GM.T8)
M'-&:M=O2V&1WI$!(>,TRDJ_E\Q^E<)A42;@F9@UUX%.#GBI11JV%0TZ$;O$-
M2U,9C.3<*US$SC&^"T_CL4@TL=O&E+3&I5%EMU/.QT:#FZ&?CBC &92H84U8
MA""O[V>",M^^;-.*?#.$T>7#&3V7GB"5[[F;KPJI1=623$0QL"3=65Z2K'N6
M&=<="ZD3^:PV.Y^7;W.5)[]QK)I:@76J,XG1"PAZ,; $@S>.T.PNQ \<SKR9
M++YIS.K!Z)4=;)GCC!+W>A;WB#[GX[4 :.E^X-)W;:6H%'9#X/C29VPDN+V3
M332GV7G_MIJ!1L\46(\<,5>[Z774-9OAP'[F;WDK6K1*V&_XVVE0.-[$ )S"
M) FLTQBOVA)5BG&53PT9'C J)8"16;M5VD!1R2EE\N=/2K3L:KT)Q4/R"  6
M5JS6!6I]J<#H&BAR?F:%W)+BZ<@A:Z]J$A$F7=U-Z)!#CB$MC5YO*2::6L<=
MJ^>#%>\6)OBR_ /']Q.P1/[QS[L=4B;YA]]/0R=LQ3C?-R-\NL=7;)U(2YH:
MX33;43($.;'=;#_%/)I>WS;N#BW L0,)R&\G!HW4AWB^@J!P'C!B'J!!CC,>
MQE+.0:81'?)B)+WD4@ ?8Q1JX*W<3;Q@>@4]$EM2I\ZA\2'3[W7Y _H\BJ3/
M(TT3;JMAX%9238Y:NC!,3$1OG5->('/+%>BS%HO/ U9OR;]W-\ :UFUY_@EK
MP"!@#@9$<O ;N#?H)(6O&\V;&58BQ>K8 "(R7<U\:VHV1(!3_QJ[:"P5F2C@
M.J&NG%-G=5^: M723D.F5'^E0ST\EGMY*"$F(.@-8AW[/#CL.3O4KHG)^[<U
MQ@D,6P8&B0%#MBRQ4]\O3I6&4HN#%OF@0DFTA/-9D(2<]Q0F-:>SCAV:N/%9
M&U)0#+.#RWR)B_8JQ(1\)'%M,@][MR#;*O5S;3"+.V.-U19A)*1YDJU)(=9$
M .$G^&I6A5[O)@CFNGP=(7(&88[D%]S RY9L@C;H#-&([:1:J$I'&P0(0*M#
MOEG[X3<GP> &"K-=TZ7T0^P% @"AH/2#+Z\3.(]=]V?E4:*0$;BTE]A[4N66
MT$WD(GCIW$$E_BFT[0H=N@&IEU$CMRHDM: JG/";7GG^#&Y]1%M#42>I-Y;9
MUU@"TG_3H <>N*)AS97M*3:UH7R-SPPZ#;PY.F+HF-:9Q)]K2JW3%#ELI9II
M1E$15.DZ?&&]RY8%E;2I*=-3SB%Y9)CK:1O,R+8Z-J/F<Y!+Z7?C'7UN1UYT
MFP;W4)X+:-8&A3H3K,?E5S&=*9XR<C1\$6=DB.-C;D1WDOX*;4LGM<FR!>LL
M/1H'2M>8)&;SU@&I@O0<?X+W)!;<,KW=BG.0<@GVJN%&D0,2WXVV=(YNN^\8
MI>W(<C164G\;;!<0"Q((<=LNNRFX1\?0P%2:@7@TA-P>?T 59S<$DTHP0II$
M.*D6+<"V&0AKHAUHRQ_42%S&-9,MYEP-K58F(#86 L87Z<U,3DX6\Q8M%Y]%
MR-QD%B@Q)^EI&A>;!1R4SLEF/L^]AW9C,;V;4]+FQJL(&;6YE<8Y#UCQ1IHM
M;$Z-DI",GW]F+;](I$@!TQQV[/Z-J* 54=)R?/ >D"!^X$G3/2&-$:^0?F+3
M6)!F+64S;5,#D>0^I!\LY-T52TA$7V&X)TB%66C#W<"AMIB_HZG:)V95:("I
M8XQ8S-C+A^8(,Z\U+R];7/>QB9,VWXKD*;&0+8N=Q_[&"0;K2S:*U>+TZ_)5
M/PQ<8?;ER_J6A8N-RR9^?E].A /4[ "/I6%C2Y/%GRMV^I))#:UDO)V\8Z<S
MG'-?:/F K,JZ_.OAV/8GYPHS\N5U"&0+IU\&#U#^F*1"H05WU8T&)21F?!PB
MK0Q!OT/7M(VQ4J.#9.RMTZ9N;LN7YD#Y^$(2^V[?MUH!XCRRY=U#&T8:T<R
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M8L)"A3WAO]5V9TS,[DW4QP56VVXW/A)+RLZ-BI4M/WS#2&] $_-<(D74N;Y
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M QZ@[W<]\5[_P 3AQTB_^U]02P,$%     @ ]X%?6:P\-K<-%    C@  !@
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M!A622LZ+BN=YAYYA_6F^1]KX>-X67N19 ?&</,_R0XXP("V-F/=![%#'0XG
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M% Z:G7$7U36IA94/Y( B9FK/' ^%B4*>[A0P'ZK(=AN.27I]06T[T:,%M[K
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M8] 60.>%HBKN%M9!-^'3OU!+ P04    " #W@5]9R&Y0+CT#   (!P  &0
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M$9Q5E>ZQAL^R4BU"]C::3G-X$UR1,J:KQJ=XCUMRDHY\P<(-NZ5;JVA(+_M
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MASUFFEMR\^!TY6^FR!GNN7Y(FA"&)N#[0J-QMP]D8/^OBLN_ %!+ P04
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MI;%SX9>UO8A N0#KKZ0M>3#< >/5EO\!4$L#!!0    ( />!7UD;*C5B:@(
M %T%   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;)U4T6Z;,!1]SU=<
ML6EJ)1K $))T"5+3==HF=:H:=7MVX":@&IO9IFG_?K8A+)7:/.P%^U[?<WRN
M\?%B+^2C*A$U/->,JZ57:MU<!H'*2ZRI&HL&N5G9"EE3;4*Y"U0CD18.5+.
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M48JB)0D<7[?B4I0E"8(9?P\R#T:5Q+C]>R/]C?4=ODRY$9>J_"IG[?+E07;
M9F+.N[+]K%9OQ>!/3/(*51K[R58];0R-16=:50W,>*YDW7_S[T,<MA@R[QZ&
M8& (K-V](FOE*][RLQ=:K9@F:DBC']95RPWC9$U)N6DU=B7XVK//HN2MF+&&
MZU8*PUK-:\-MQ,R+DQ8:B.ZD&*1=]-*">Z3Y ?N@ZG9IV.MZ)F:[ DY@VFA?
ML+'O(GA0XONN/F:AY[+ "Z('Y(6COZ&5%]XC[Z-JX26O9TRU2Z&9^-Z4O.:M
MTFLFZ[[(J5K^RZ<&L2C:_^V+0J\CVJ^#SM&I:7@A7A[@H!BA;\7!V;,G?N(]
M?\"#:/0@>DCZ/\[8@]+VVTI!<OS\F#VDBTWXH?-*:APOI0W[LA3.7)4XY+)>
ML$9H0S1+42+2\[DL!..&W9&K.4/\V:6J&EZOV:S3Q$9+:\&QKT6C-%2?.L^>
MY$F:/V<?9;%4)3?.%:\7K:K'C;?=8NE\E64I>67&U;\XEFOG"U^72H^K[Q5R
MO>2U\Q8>L<GTT/DLJJX6NL\ZK/J/6+,/J(B% /2T[-HZ4HO2V)WJ;J?9[,#6
M.Q&G[ :X.>M*X3P@C&UK=:BTJ;Y#^@B<IPQ_SLT2_K-6Z(I-12WFLC7,=[W0
M=_T\8DF<NEF:LR3UW=3+G6ME6B:JIE1KJVED20(W#3T6AF#S612Z<10X5XIB
MO2LZ<:,T8G[F9GG CJ">:\$N@'>4?2N4]&<>")*0+$EB-XXCEN6I&V>)\T6U
MO&2!F_NY&R0^*-(4%'Z"7XD?N%F8LDE!\>Y+ZAH)6+,OVP5E=1KG+=7,='UO
M\'9#W#.QQYB<@6[GR_F$WD9U=\$! BA1!#?*W3 )R/PL<;T\))?B&"XDSCMC
M.E@>Y(D;AS$[8E&:NI[GP:>FT\72!NL(?Q/?15.D+48.&[FH'ZTO8HL!=(F7
MLT,DX+.XQ9;H+64W32E;*]E+7#\(0#*)(MB!HCET+DME=MV(HAB)3/<Z1*>;
M/7JZCU@!))<U>?RIZ=<>S8RSH=S]_BG.21S!J(C%/LR,/;@[Q#:, ANV($45
M!3Y+HLC-_-!Y_;T!=,PV$?#2S ;I]7>A"TEAGP1>['I90LM;T3,V>F83O3!R
MDX#B._&#S,V3?<%+<V0/\G^T\=["?2@B#*.#1;6Y- 7.!X$;$_6,%**UB;&U
MN>R#/F8#M+E@T0KXQ6YJM9H#4]&IWJJ2V R[AOJK=D9XVFI," +2!RU;Y&]X
M)4NR$Q3LO"A45[<N6X%)]J'VTS[4<.V?&;F!VCLK+Y>\:ECZD&4;IE^P*W*C
MWS&K1_H[HSXBGUJI7XK;%;]5LI%"HUAZ.63G T:F(0[J;QA);<?=9\%[N_5X
M=*)TH_C7FO3V,?YU4SM,;]H:_)[?\F=/LL!/GYOM!L,76MA:=T<R:V;#)2*,
M<X?N=61;C,2AJFGT)O0[?\KR#/TBQTG?I/D3#6*.WO7B%'FHU_SN1*@.1P"W
M#I+R1ZFF<.#UK>U*-,Q=J84TK2SZ)W+2-*HS5N?.P=H*9;(I_]$&F@PH.3,$
M"*@@9N[ND +7:H4^6\,Q^-4J1LL[\4:(2X5GC/'MDK9/G8D\[%D:#:@RI*6%
M+)J$D&I%DC9/=]6KD ]L50H5*8FY$C/)-2+CVHQJ5:*.L#D\E&+F3*TT6NSS
M5ZBJ CP-%+U%G7D.@V 1-T85$B'O%[!"9MS*6<=+XZ@5X;5[KYF(D[5*H$QE
M;9-SJUH[^5GTL3XND'1#$:P8M4")*9#7K8,QN^P$0:T"2,,BUR;-1IQ5HIJ*
M?CZDV)JN6&X9-E;BW)X3LOSVD'T3:V?O8+97[ \BS2"S%XGX/H>OSN1V-V?P
M<;7$ $JEW>%F #\D*M"V%TREL[X>[H^'A.I5305U3T0I>>1P;SSNE:;0<HHJ
MA;0^/:"WWN+;QJVWQWHS,$$)GY:"H2[%T!CW!_Z836:'#AH9A>LU7*&&AOG]
M+BK B!K=T/K8HDCZ^6\8VG<9<=17/:R,TS]? !T68&.\(@3#:<84A'NR<081
M32]"]"*VY[DWH^*;C>*]>G^8FC$Q7REC1CQ%2*3"6(!NX@4Y,#.FKA]@*(M#
M-PH2.P-@VDI2UP_QY%@$H".#:]"27CH L,H]$H_L?-%/NX]3_[K^.[\;S".;
M:?'G6%FWG_:./W7.C1&(ZF6G+0VWCRQV0R]W8^A,\0L:XMCYJ.JC8I<,@WD&
M@LB.B3 M2X/!L5XL$#+'K)O% <M@<P9/4N=*\BG."6'TJ+:\6\.X'--4'&&&
M P/N$VGB[2C?)O8QDH81KAT>OO SW!APM2,Q34(WS"(69IC(,.;E@?-1M(.5
M)]NTD1O@JA,E&6*=NWF8TCT%T7W]=T<U<TE0**<=-1IAEQC4IA@V4R]DI"1V
M@\RGF9UNPH;\3C%PV\T<MY@P21VTY:[J^FY%.0?9),:%*,!V2'/I!&H#]+?4
MI_FR=VBC;;]]=/H VROZJ!5NF8 2:0N,>O=B*V<$:=L1!#S\?"2!O3L-G4UJ
M63(+=/[SG:WP\/@W!HF).'1N (-R:$D6/(8N.4*TV2;XR2([EB.'JJ/+*G#C
MF/U9EP(GR+Z765GL(@#H>_":+?GM9IPO>"/[XX>#9RS*&E4*PM2Y\TECH.%Z
MO;GIV4Y$7/95Q(B^@%N*6]$;[8YC0Z,5O7@8CA]AMC9+V8SH/KS20#K1.BS'
M@/.:7O\-N].ULR7\F,+#["BGR42:B)2&EN%.J!G 4M+;)OM,*%X:1;*EACV@
ME@W!0LD+.\],.]Q7$*GC'=R\'.2_VQ%^/;)?;]@O!G9G-R$[5>%\Y)4E'D#G
M^D?=[--/D;&N/RCTJ\0M(6!?N08V:G9U=8F<2ZHX"_6VOYQ7J/R" Q$\]J_^
M\T>^:ZUFW5"5FYG^O*/XX6 P8LOCG[E>R84MFOT<>Q5-WM%06L\. 4>5M7-8
MV+'N[;H1QY?J,5>(]-_] :4#@8G!)AU?,V<XQ$//0/O>B>(QV_?6\&3KG2\4
M+>R;;=.76?_Z=UP=7YZ?]^^,[\C[-^\?N%Y(!+,4<[!ZQVE\T)?SYJ%5C7V#
M/%5MJRK[<XE17&@BP/Y< 4*&!U(P_DOA[/]02P,$%     @ ]X%?66,6)B<!
M!0  G0H  !D   !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL?5;;;N,V$'W7
M5PS<HD@ V99HR9<T,9!D&[3%9C=(=MN'H@^T1%O$2J27I.*X7]\94E8NF^3!
MML2YG9DY,^;I3IMOMA+"P4-3*WLVJ)S;GHS'MJA$P^U(;X5"R5J;ACM\-9NQ
MW1K!2V_4U&.6)--QPZ4:+$_]V8U9GNK6U5*)&P.V;1IN]A>BUKNS03HX'-S*
M3>7H8+P\W?*-N!/NZ_;&X-NX]U+*1B@KM0(CUF>#\_3D(B-]K_"7%#O[Y!DH
MDY76W^CEC_)LD! @48O"D0>./_?B4M0U.4(8WSN?@SXD&3Y]/GB_\KEC+BMN
MQ:6N_Y:EJ\X&\P&48LW;VMWJW>^BRR<G?X6NK?^&7=#-,6+16J>;SAC?&ZG"
M+W_HZO#$8)Z\8< Z ^9QAT >Y0?N^/+4Z!T8TD9O].!3]=8(3BIJRITS*)5H
MYY8?!:9D3\<.?=')N.CL+H(=>\,N97"ME:LL_*9*43YW,$80/1)V0'+!WO7X
M9ZM&,$EB8 G+WO$WZ3.;>'^3-_Q]TDY8X*H$[2IA0#QL:ZZXTV8/4@4Z$R_^
MX2OK#++CW]>J$&)DK\>@B3FQ6UZ(LP&.A!7F7@R6O_R43I-?W\D@ZS/(WO/^
M3F_>M7L=%94C8LD(@E<X=Q&6!0K=X(@5 K\<Z#5PJ$F.Y\H7)0;2NM3-EJL]
M<(NF9+VKA"]J<!%4Z>%>[*T_-#0-X'20(JWIL$7'%$.!+#&>7$M11N33 ?8#
M8V^%D;HD'8>3CVW"KA455QOA%="714OC&S>"#ZV1:N/3V N.'28F O)(]#QZ
M#K\43A@<(M3:25?A4N%6*[ZJ,0EA'*XPMT<#[D ZW"9M76)\80J)N*6S^.*Z
M=:2W8:<X?UZTQF ^$5:[D50> NMV&GA92E+DM4=H1W".E,2X%I?&<VP5MQZ/
M+W#I1:$3!-G3V(B:.Q2M./*X$#;&+LBB FX$K4?:<RB5RA?$^:Q6M'1/X"YL
MW CK>NFK::FTMY^_(APLOHVH5%2O273T\S'@)SKBQ^ W]%"OA]0WWZ;('U%_
M^B.8II-XND@A2Y)XSA;11TS@!,Z+HFW: )@WVCCY7QBWHTD^CQF; \9AV21F
MBP2.HXN0$Q54*$\ WU&6YW$VG4":S^(\2YZJK<1&*H7][Y4[)6"S:;Q(9M&U
M+I%A10C+4A9/YPR&';YGF'R[L&@=_8[2-(MG^8(@INDBGDQGKT+LB?<2YM'J
M.(P9U)*O9(T<$#:Z#"SIVGJ0["%E\SC':"E+XSQ)HD]:#8NW=)'8,\8@S^)T
MRJ(OVB&UZI>A$- B9O,4TED>3Z<,7@[_T(^E5"UVYTLE(N?]8$KKUK7FP+PM
MW]-:L' D55&W)17;5=K^(/<C0S14&@?"ZWHF^@HUJ(L^#POFD=A]5C&(T684
M41=LA6T9>LK7 2HQOWM$:Z3S\)[7+<VC:.RQCUI*6]2:IH9<"(XST05:ZQHM
M"'=H+0[@DUFX"LE>2R6;MNDZ=M,E%6:"QH'FPL_$CR?$)<H>%X+JN)!.L.3S
M!+LY0^*DT6<4X!JD;>!7 &33F!%+<0K2+/J"YRA>X]6DDZ,]0\)U\JM'@?\K
MN\>E.T06A\Z_WBZ6SN)T/H-T/HEG\P6\]E<T?G)E:(39^(L1;C+=*A=N#_UI
M?_<Z#U>.1_5P<;OF!D?1(HHUFB:C63X(Z__PXO367T!6VN%UQC]6>'\4AA10
MOM9(S^Z% O0WTN7_4$L#!!0    ( />!7UGB%._9X 4  '$4   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(V+GAM;+U8;5/;.!#^[E^AR;4WE+$36XYCAP-F
M""]3>H7C2*\W]U&Q-T13VTHE&<C]^EO9CLD;H;ST/H M:??9W4>[*T?[=T)^
M4Q, 3>ZS-%<'K8G6T[U.1\43R)AJBRGDN#(6,F,:A_*FHZ826%(J96F'NFZO
MDS&>MP[WR[DK>;@O"IWR'*XD4466,3D;0"KN#EI>:SYQS6\FVDQT#O>G[ :&
MH/^:7DD<=1J4A&>0*RYR(F%\T#KR]@:^D2\%OG*X4POOQ$0R$N*;&9PG!RW7
M. 0IQ-H@,'S<PC&DJ0%"-[[7F*W&I%%<?)^CGY6Q8RPCIN!8I'_S1$\.6E&+
M)#!F1:JOQ=U'J.,)#%XL4E7^)W>5+*4M$A=*BZQ61@\RGE=/=E_SL* 0N8\H
MT%J!EGY7ADHO3YAFA_M2W!%II!'-O)2AEMKH',_-I@RUQ%6.>OKPC.<LCSE+
MR6?.1CSEFH/:[VB$-@*=N(895##T$1B/D@N1ZXDBIWD"R3) !WUJ'*-SQP9T
M*^*G(F\3W[4)=6EW"Y[?!.J7>-W7!KH5QM3(GIJR& Y:6 0*Y"VT#B^%!HMZ
M;;+1"!EB)25%"I88;Y:P3(QDY]T'$ZQO7JQCD=^"U'R4 LD1GDS9C)F!0XX+
M*2'7^$8#V_<]VW?#Q^5__26BGO<;N<02>-#T7)N&/OY%UA>AT9O-GCO$#^R>
MV[6#*+ ^"J6;U=F2(U[/#GJAW0W<5:G-YOTNM;MNSSH!R6^9J4N2/@ _R$5V
MV//M* @?D5R![=M]S)@HI'50BZ28/5+DJF'Q(3#R90)6O,*?(ERI A(RFA$]
M 83*IBR?D0E##T8 .5%3]('P7(M2((&17G"-Y0EA.-EX'2. R-'/MK%'QHQ+
M<LO2 @AFA0%H=L!:W %LN^7JQ-"Z#%]9W4#+A*G*Q00T2&P:&$:A>'Z#'J$;
M(S14=D0T;(H6@V,R%63(LR*M5G8NCH<?+&-DD++XFX,9+%+T)A,)I&1G,+SX
MT"8GA41,R[@A82J0/+0P18=$0H;X0/FC9O\_%>F,4 ];ERXD^F.P:\YQA!S"
M]\+XCL;#6AA+P29W$XX[,H>SUX&/BAO$M:UZ8> U,@-:6FDT3N]U?9C\@!.^
M1TX@AFP$LO2DO9A,5I4A$TC+_."X@(U:8L[D9",=3$)][/%_34Z9LW!OJ2\L
MHE\NH9_/T:TFDM]A1K[@SJHJ=[AZ"'(]CXUM9A(I1:/*.C=I31*&VTY]!V-T
MJ&M=H<R%2/B8QU4"7!B&#!4GBX+46A(JU[SE)8QN6=>O!?RZ1:E&$RDV2XAN
MF6#(SC_ I,(>V':M,^RPY&M9'J'M>WT[\B+K'',5>ZXFUT8]:@?D_1(H5[$H
ML!'L_%FPM/+EM-K0BD/\EM"FQ;9=\IXT/=MYM/<AE[B)V 1JYJVU=+9>OQ,E
M%:&#@ [B+7-73Z]3URQL(R[ X\%UW3>ES=I4?_B5\H9<4-=!3$/&$UG9)S\G
M*^<K2]QZ;7^16R^D/XW;P18J!]ZSN/2"*I@GN9P+^F_,97L3ERMYVK7[$;5[
M ?U)!?ZCY8T'QA;BZ?.(-P4Z,Z0]0;SOHF0.#NW^'UF\PGPO]&P:=5=X]]S7
M)/'".;NM(SP<QL^BM>=<BMN2D=>6L[=4SG: 5$2AOTK%"S/0J%T#BR<;*"CG
MGQ>U[YS!J"S.Y:*MYX.UJ'=W"8V<"R9-7FW+@%WBVUY_TSGQTM!-#NR2=XCK
MXOD3=3UKUPP]'/;MGA<^IRZORH];(%?X$0H&?P.=:S+/HK9?5]\JM?/Y=6I_
MC->^3;W #OK>V]26;]0N^'W9 3 TY.Q(:D4^?S[>0,EFP35>MIW!/>>/6+\!
M+5Z[MTB+'W7M,%A+M1<V').A0PW3*6QL-=7*8MCJR;A=9PC3MPD\7&HPKFNO
ME]C+XR:;;D0Z"]= &<B;\K)+D1*SNA%J9IO[M*/J&NE!O+J,PY!N>*Y("F-4
M==MAT"*RNN"J!EI,RTNED=!:9.7K!!C^'#4"N#X6R'0], ::6\;#_P!02P,$
M%     @ ]X%?64]#ZV4Z"@  MAP  !D   !X;"]W;W)K<VAE971S+W-H965T
M,C<N>&ULO5G;<MLX$GWG5Z \F2E[BZ)XEY1)7.7$SB9;E;'+3F8>MO8!(B&+
M$XI0",J*_GY/ R!%R;*CS%Y>)!)$W[M/-\A7:UE_47,A&O9M45;J]<F\:98O
MAT.5S<6"*T\N184G,UDO>(/;^GZHEK7@N29:E,/0]]/A@A?5R?DKO793G[^2
MJZ8L*G%3,[5:+'B]>2-*N7Y]$IRT"[?%_;RAA>'YJR6_%W>B^;R\J7$W[+CD
MQ4)4JI 5J\7L]<E%\/)-3/OUAM\+L5:]:T:63*7\0C<?\M<G/BDD2I$UQ('C
M[T&\%65)C*#&5\OSI!-)A/WKEOL[;3MLF7(EWLKRCR)OYJ]/QB<L%S.^*IM;
MN7XOK#T)\<MDJ?0O6YN]"21F*]7(A27&_:*HS#__9OW0(QC[3Q"$EB#4>AM!
M6LM+WO#S5[5<LYIV@QM=:%,U-90K*@K*75/C:0&ZYOQNSFLQ(+MRMN0;N+M1
MKX8-.-/S86:YO#%<PB>X!"'[**MFKMA5E8M\E\$0*G5ZA:U>;\)G.?YC57DL
M\ET6^F'\#+^HLS/2_*(G^/TF&Z$8KW(FF[FHF?BV+'G%&UEO6%&9Y*8L^2>?
MJJ9&KOSKD!>,C/BP#*J?EVK),_'Z! 6B1/T@3LY_^2E(_5^?L2#N+(B?XWYT
MI)[E<EA'<HX3AAX[)(-=KNJBNG?@-K84=2%SA< P!$CHX&BG]A8BE]'6MW*Q
MY-6&W=>\:L!.$6LFE^1EQ1K)>/Y0*%F;H&181!UQDG?*%<I] 7:UB0FBPTC3
M(A/*6=;RH4".G;D,^]8H9_HW9<[$8EG*C;"1OBQJ+)((.=O1:84DK?7*5/(Z
M9WQ)7*'DE:4WCF#76EMV@TQAIU=WUS=G'KOBV=SI&T.Z/X@:BA<5S)+PPG6=
M%Q4@SK+9DPX2\4W46:&$QRZJELV";]A4=(]R-MTP4>AD/>5G% Y$@1S7XZ6#
M<F4IV$T-#[72K.Y3051;IJ=ON9IW)&<,KCV=GK%BQK0'C=@>_7M9DJ^PJ$33
M$"\Y,P(:V?"RX^08X?P>?4 U>D.U6DQ!"GVT&Q"L>9'-Z=&&D5N07$530B)L
M0J $T)FMECWO&&5+H=36QG<\*\JBV2 2G^;;?,IX#7=7QE].35"LDRPO*%DJ
MI&P%2Q^DML \]JR)ZK'G><,H4 VZ#YO5<J'-R7FCG?L@%'%QT<>F?U+20<P"
M\*NC@WWVN8.TR LMP&VCUK+ =:$AJ*@WG1J.]HG1@4]+H;5@2^W67#2B!OK;
MK$ *MEFCRTMG.R[NK;HOF._Y 4N]441><AYXN1)J-S.4CD'&RVQ5<AMWU$&Y
M:>UX4_+LR^ NFTM$@"UD+DKC\ZZ*R%7$FAM^:BFR@I>%,JX'5A"L$B_$;;O/
MZP-*+9:RUJYKH:5?*;Q4DA5*K3K\L)$]O;W[_,M/XS 8_:K.2-BC^C^RXIVN
MXC]4&24D<M"6^X<;DV-0?D>VS19;]=!,E_UNR:N>0##RV+MBUFS(1A+2*H?8
M5EFQY*6S(V!= -,HBW18I[M)@9!? ].HL +='!.]R_B2AC#RY>R0M*-E.#0L
M856GTJZPU#N03P;D;@WC_V=2.3M))1I>E,JQ2J&X,#FBB.I":9>0,9::(]36
M$6Z'(&3Q&BA"+>@E@X8B7Y$O9GW.5Y:KYG;3XW9KN5WWN/UAN3FZ2U)GI)^0
MO7"HE<"CXR1PHW""*S\)W3!.V"2(W70<.A>F-W;L3EE N\:I.XG&N K2V$W
M-(U"-_(#YU9#0IRZR3AF03QVTR!A Z?5 /0A"Y/(C28!&^#!-5(7U57*AEI\
MB_6G+&)!&KFC2:QWH<A(5C!QDS34*Y\TYIN [TT)?V.D4N FDS&#4FGB1J2+
MFT"KR3AR H_I,:.9 ]>B<.0&<0AI;C")] /VY/PQH%H#1@ %G+#/I9D7J@LT
M+A'>QE: !5S"#AT?Q&[=.4-\I:PQNZ"G[_LL"!//=Z(?X]Z'8-/&:%57_KHN
M@-CN3NFNT9R*RD&8<[Y!BLP:BQ!9*97IK :?9S-1ZPY#4U+V=84Q!HU1WZ$R
M<]-5$(<@^;FET<W8>=1Q03(EX\%PV]DS6VI%9:SHQ"D49;G1XY:&IU6]E(HV
MH)<]Z#V,_@==XBBJ7;AF=[7U"_HV(2K6MU/@GH-,#Z#:L2!> A-JBU74"V"P
MQ'- *W&AD9UZ8&&,S@%XA%/0EX,X0UL![.E^H<=$<)B#M_8RKW0L:<(Q@#/C
M:,$:R(P/"]7.F,"OJI*-1D6T\H4&LEJ4!:*X<;BR^&('DC5-GV82H.8!NPW0
MFL;=1QSH.B37%FCD]UJ)6DPW9EHF;9R>-M1U.F1J;)?7X\-:["+L2AV+K<Y?
M;M@?MFGG(@@"]8EY"LK80B$L;K6=\P?]$.X357^FLETJ3@9(?U;""PTV*S,&
M453V$'R;S+M'![EJ% X*.9F=ZTE";]\(CGKC^9\X,YMBY%DF5W!;F\_Q %>#
M!*%$NG9=72TQ3KJZ;T&9F406K_<:0/\PH-CU5OX>LFM<WU][(Y"]E2UO,^2P
MT3AV?>!DDJ2N/P+8.G^W]=$SR.X=L"@(W?$X;7<[[V0]PZ K\J%UW4&J4\@8
M [;/P/VJB\*AG03L5W0PGO776QWW=-TWSW:J8ZR.8G!*$FU/1 WE.U:[*5J#
MW7R4T:=H)Y,@(I._8_1IVX#.GK!^\$C;Y\_(.SUJUQ6Z-Q_CGSCI.N]SCFFW
M'9D'WW/%4_&W8CII^U;=?3[&IL%WS$DCWQUA!!K\S^WI2]I3G*8AYV)O&OIO
M6!=,S'1QK'6G+<'W,_@I,P>'#'QB$OUK$?LQD_Z#@&T%#=B>XF8./;@X/6 3
MAMA1Y$[B$1NG8S>.TFZ4O7_2SO'$Y$N$_PCG:$MIZ6;'1#,, HM'?3 V#,3Q
MZ&0)'CD(LW68N&D8'+"/3FEZ L"4MT3#TDVP[: 'C'Y\#L?1M%SE8ML)2?I'
MS?*#8?FN=T"Q^6+RAEW2H-*]LC&3T">!T>)NB<' O"FZZTU)#Q*SC'ZMHT]8
M^C74I7USPS:%*',<L-07'+MP4,=Q&R,03JXUI)B6&P7L8G5/61#H=Q_P=*0'
M H7;Q!N%+!UY$?N97HOHWY#]O$>D=WV?*& ?>8VCECG([8L*QEX2L#3UXHXL
M\!*0(47?B:G)5:+"7X3'N])BVFK)(B\%V<7E[Q_NKF^=\+%]H8>)8)<^)9I.
M6RUVC\X/?I0N;.EB;[+5-_"]L8\"[=D9Z=_C#W*W5Q=OWSO!CE],#+QHWS&[
M<DC!R?9M,W;I]UR1AR-O2Y=Z >A\+^C1C4&'KJ6<P*>W&H9XT(O>R$MC]MOP
M@FE+AA<FV 9E=O<EX<Z^+;R.MND1L\]WI$B8L*1G#Q M#;T)Z:6U&I&[=\CL
M+I],V*&+TSZ5+G'UV,W=D17E^N+Y,SD[]%5BV/N6M!#UO?YBII@>I<UGI6ZU
M^RAW8;Y%;;>;+WHP"EBL6"EF(/6]47)B#GOM32.7^LO45#:-7.C+N> X'=(&
M/)])Y).](0'=I\KS?P-02P,$%     @ ]X%?6>R[=++,"0  Z1@  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&ULS5EK;]LX%OVN7T&XN\4,H#BV[-A.
MFP1HTNEL%VVGZ&,'V,5^H"7:YD82-21EU_]^S[V4)3GCI /L?%@$2/0@[_/<
M<R^5JYVQ]VZCE!??BKQTUX.-]]6+\W.7;E0AW=!4JL2;E;&%]+BUZW-7624S
MWE3DY\EH-#LOI"X'-U?\[*.]N3*USW6I/EKAZJ*0=G^K<K.['HP'AP>?]'KC
MZ<'YS54EU^JS\E^KCQ9WYZV43!>J=-J4PJK5]>#5^,7ME-;S@G]HM7.]:T&>
M+(VYIYNWV?5@1 :I7*6>)$C\V:H[E><D"&;\UL@<M"II8__Z(/T-^PY?EM*I
M.Y/_JC._N1XL!B)3*UGG_I/9_4TU_ER0O-3DCG^+75A[ 8UI[;PIFLVX+W09
M_LIO31QZ&Q:C1S8DS8:$[0Z*V,K7TLN;*VMVPM)J2*,+=I5WPSA=4E(^>XNW
M&OO\S1M=RC+5,A=O2^=MC7A[=W7N(9H6G*>-F-L@)GE$S#@1[TWI-T[\5&8J
M.Q9P#IM:PY*#8;?)DQ+_7I=#,1G%(ADETR?D35I')RQO\HB\#\8K)V29">,W
MR@KUK<IE*;VQ>Z'+@&Z"R;_D$G$ 6/Y]*@I!Q_2T#BJ@%ZZ2J;H>H$*<LELU
MN'G^;#P;O7S"@VGKP?0IZ7\\54^*.6TD12=*)D-Q4HFXDY7V,H\*1&RMZ)GX
MLE'1G2DJ6>Z?/ULDX_E+)\SR/XJKS(G=1I6"E^MR+=Q&6B72("46C5H7<SYD
MFM9%G4NO,I$;Y^CY;J/3#=:QA60!<B;6UM15J^P@+2+1WKR(GC^[G,TO7PHG
M5VI=2YM%V*2MD$N=:[_'&I$"H[JLE9" @E@;L@W/4F7+6#@#+=*3JCVDE]UJ
M[*RLV>I,P21?V])% $SP:F/R3-F K*4JU4K#6GH;8.:\O#^L>4F+.C-1W"#-
M:%5#HB(%69UZ,,H63%E1C'O9B*QV]^([X6>&TUXC_$"W<4IH3[9+L956*X3
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M*0:!YC0C90H11(UXW%DNDE!:50V^SL' TK:E!&]5Y1O:$WT#*Y/KE)8A=)C
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M*K1MY)>U_;= .P=[OE-676^X ,-/F/\&4$L#!!0    ( />!7UG\A4J?.@(
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M8\T/%KI@P/=+RR7HA."@?P*+OU!+ P04    " #W@5]9$,SX&ND"  !6!@
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MBNW*GA1%B6%O<HJTAJJ6!J(A0&D-A*O1[N*G?MRC=PA\,K/K=,%9$L_C.9.
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MP?4[<GK^D7?+1ON#0H/.W]A++.MB]LI K$I9J31!4E: E01<<HX.3 P>9(H
MA0E-);@A1@758\"Y?%H@;:18BY5WL/WHY6H;BFQ0BK,&H4N6A9*;*TS,3@\D
M=("Z1 ^ PMN,V,2+";JTK^"ZVMIZ;"PUU1\#,S,G7GQ5?$/)L1$=V_SC7S<;
MS#?F'[X;^Y;)BG#>N0$=3(]?D8H'%G UYJ+(&($VS9%M)^?)-D:5XZVS=Q8L
M3FR2Q#!DPU8!Q!MHOD)&H21Z=, Q-*&@]WXDI01^F@[!I#)(%S@/&,O$%(Y&
M$L5FI W#*]C&58&XMQ9[LS+]<U;\B*UH)FE%2W/L5=GWU.TNE07-M8>% >G*
M6J$%ECVH?6/:!?;?]_+/+Z+"N%A4&._!'6QOG"2*[+Q_OPQC7EU$P-JN?OP)
MR6?/<0^J7RZOK=&#08U1=;NUI,359P>Q;\E\8-)I-7&?4J7+XI6Z4+$-4:L,
MB7HX*XX($;'3E@Y8 ALA6LDNI-J%E%Y\+'?D4$7@ A"E(K*6W!KTR:;D$*O
M!N/?VEG,X<"\[Y>H5TR$)UKTW>Q2:=9A%JC)@3(F44]/5\'ZPK0I.RDG'[4\
MPL+.9WV<06Q52\_3)6[:BXB!<\LU*95(U,8SDB<R.955M0<3TFC; *HP[CXG
M76=8UW%@\@6ZJLZ#U]L1&?.LN(JA6N:E[L%JV9ZVS8DW:0SLHXK=<". J 0X
M('2@8'=82I*!HO6!8T'U^[-3DZUT?>Q!1/=M5_:??'&=A)5XZOZH\P$PI$B0
M.\?T/6Y@X2P'\T7P<7+SF5C/,/? >,@!I#905/#*<!9.1#BA-[QR_AR=C@$[
MEDR=9-6)9Z]P"YC9'WN9&*-BI7:G-X?8%8R=*?B9.IX]'8Y #",GLA)[&Y(M
M;Z7ZA9I<C CYH-$EE7UXH\,?6N#@BH@*TS-*MWHL'M5C%=1(5>[=(*E/3#MV
MF^$./C]C[[J08^KM?6G.<9'T'M498STNOHZ5"K;CD:+AB[@B.6 ^IA'E).&O
MT)%X$)W,1W"653XBH'2/2<TE[PKB F='>1"D/; %S9Q4%1L'KH3B63GJ =MA
M3<M)3_Q@JVU+/N0&-(?3;IDEFQF'/L\7IS-?O0\*$#D2$W;Q[!>,Z -&/N-*
MYL1*<U85?0U+?I9J((JZHMZF<:@=UI,W?;  X)-QNQJERZ/"JEP/CCLV)E;T
M08TEB7A$8#HH"PN'PPO J1N.O&;QS31DCA:Q C9_/0B1J88WV.R2%,H +O(6
M.I7IFF25\BI@&"]A2[$^) VWM(N0*Y\:%9SK0Z/CN.U+UY20^(R:EO//=,0#
M\X_<2J'^19SVB$Y,PYPOC4'!V"'#TP-/7?L4!)R-6/J)+J,1N3:W3I2#Z+,D
M9<B=J:$"**X/YYA*!/<4D]P:Q]+T1^ARR-^1(LQ358( 8&S)X383\L*)-1T$
M(&=2<>,CKKO8ZPZ'K^TZ*;+(6YK-&;H;RRYC5Y .+V>77U8)<:+Z_ LCU5W?
M4\/,O.@_9)(Z0"Q>U[?$\Z2BU_'SI>0A)4FR.5*M^\2>3\V!K,AUXM)-Z+4E
M+B-&.AQYBTOIC7ND'Y=I'@=?SI<G7_Z^VS?=P=I@;V=)_X!A%@5L%'!Q'5(]
MQDY7+7Y**D.H.N[*&PF+039I9C M[*-2#*-%"F,EFAIK4[=6)I]H=HU[N_GC
M$S6]NVW72 &?RFI:A@Q==&E,/7&FAT31'55@,8L6>Q^FU2M97ILK$%].AAU3
MZ".U=&5EN'ML%Z7]U):G)<1[[]5,-6!<0I1?VBNTMF'"'%O T!.AB>QITA),
MA.[:%^->%=\$G2 :1MP:ZMO @6=. JMT7$T[LV] B%J>N<]Q15:+G'8 PH&W
MY5?T'#">=.R% ZDQ0L47B3VE9NZ3+<5,_Q$U=%J>HQ#9"T8#H#H.SC9U:+R;
M[)ITB4Z2K[NVEJ$8[O\"[2\E-7;.XS@BZGSXJMJNJ-2-4_KHP.,8M:<Q4!D]
MF3->#^C$7%))<3;I?'DXZ<>0V+Y6'OD(YO'QC]<?GR0)>>]V#LZK --Y(BO_
M@/$E6MO\N;6UY<JOC/CV?A7F9(.S%NR*FHFLES:)&&&IE796X$/P=Q&C,4\2
MG;A%R7PF%LI'X'[D@S/S7KJ(X2AM;,=*>N@T6<0VS4>LCA.^P?F8O";[)9],
MZSE$O5 O2!+9I+X]FK*C[>,>D^&0+A0<V E#DAT]G!%@E;R#EQ*8(X)PCR\E
MP2G8.JY# 83C4NN]:JI4;8_>4^QCHI@2G"GO.9;D[> &L&$,#%A:O%8 26Z'
M2^C4TQMB8_09T2-@(Y(/(*A;/$.28Q9939"%LTWZ50)&J$IW.R>%?%(O.IL3
M!G3C#2"SW'V?$YMAX45U$GO@SI>;X-[SN*I$R[.*X@'=;@S5"-3BUQ[\$C >
MYGI;]G:N(0G3[-3[WU8\2E,VDA0(O<-SU1<:MJ4(&3OR&3@RZCZ.F'/; +;4
MTQ+<DEMK.B3ZI>7G55*HD]3>,I%CH\OY<J?+>VX$A35F"?R WA:&2-T_Z/FX
ML( JG1!A4N)(0C/\7IE*.B*T60(?"^$@/$?/"-BLISH,,R=KDMV%!0U56'X'
M4^LA<N9TD]9C-(-H)0LFF;VE_J7I@8.3 2:^/R29V;Q8@L 06>I5/@4UW-$S
MB:R#0IL;96:3A8,'+3?KP4I:4+]O+]8T_)_=CO8Q"U5SAYFN/HKN\L2"TDPF
MCLB?<*-7Z4%B)UU<).I)VY:T&LY20C@VE*UD@/6+,(V2'C-K[C!, X#ED@-*
M(FK/ADY+ZH1=VJ D$DEY[K8.'#A/I-#E826_/V6F(J'"@6I\?!V2.+OD<.-&
M]+JJ$V<Q+21()%Q,R@FA7(,N0+KN+UV&FSG&;>)W4!#0A"'L@=*Q\\BYC>9"
M\2AI>C:)K;-BUHEZE^$NLKQQ?M"I&XG1=?Y?;AZ2UL_4TPW%%SVS:>UQ5CZ.
MY2'A@!/'01?U3,2/)T/=9C:]*^ZZ(B;L9K2;O,3[0U2[C(/#9+&*QDD,9J5^
MJF FU;9[2?X7J[ZJW+B"%;H'BS@F 4)NPGU$\;(=O#&,<N-AED4WK>,5P@')
ME&28D%6>.$F0&<*;O'SFX]PL@[5!U79HT2R[/718#PBK[JM_N\T&Q2\OTX.\
MVAM*;EF\DJAB7$+7K[RC5G)IA983&>9((X6;IDBTXQ1_R=93BC71K[N:7^R(
MS[(M]=D\G*%>N7MMC8Z0&O5#8W?L1"</'3TD\L_)*:7)E%)$16,?[K.B5](\
MSL% *#@V8$1L-_HF[DTJ00F1CN(O<2\HD1.<&D8VABFB:E0N8Z\X5XWD#KQ(
M'B)I3W<5H%(WF<Z,8T5Y>5E'[G?@?FWQSE>,T0)V[%:N8H6*(DI=[#[ @O?6
MJ8\JB2 RO,LN:&Q*/5_N2KU*&H1!$.VL(_J 7M0$KD&XQ:\XK^['4A)#DA+.
MUB9O2N[)TM8:,LG49B]W%N"I#7I;P1$$$O^26R6$:-A_W8\<B/;Z-DDC9B]M
M^CW$!&.#Q>!)%%+.W'4(!_ O%&L9-8A7*H2BT!%X=P*2#. <([Q*-DE7EG7!
M5=&.#ZXITW:VF(VH[9KY?KH#K%?>LGN5; &#A&!4LGP]00NWJ&#'VXR3D^^<
MUSGNCCB=_@\M$E@O,-GZ=K>V=4T->XHX>Y,Y8M,[$!Y:'J!01;*@- ,[LSZ:
MM).+'??[2,_HI+M,5)#6YR6J3+45YH6 A(9[L\Z3RV5_FC2S2@)A)(U??+*'
M?++U2#K";8K9Q[%W+.XTRW'@S;2SEWUJ['>5SO1<IWF?B/N'D/<!39"P-*=:
M1TZMY&'6U!N.'!U5HH@.-@*%1I_,9E#325Y:DAX2="NQJ85Z,D1;2]2?)!9C
M.+NH<2]BB_3%<HLTY3IDJEY3W'-:=QG,O-9-8)N0/O^8S"M+V<#' @E[>YZL
M,<6S]:WS72_WWH;*PN-81N+,"SSR)*WM3:]/BYX<]5#Z8\SRBS<+O=\EKMEC
MF36YNV=ZGU1,[,B]JM3G(Y\^UIMLZ&2?:ODF75/R&D]8X)-DKK?%PFM<0XAH
MHI5214#WTZC^$X?N1"<@MO5DK2L\B:MWGB9OY5IV?6#/1YJ(\!%6JEH9?].4
MU:>GV+W;48)V'RXPHKI)5]M&%+_V#R_L-9.E52QMZ[5:7<\7%!!G.,S2E>S&
MJT1->Z_2CIWT BB3#O_RE:D;UU!ZPC)T439:V8E00GXAGLG:DM3*O:MZ(9DV
M!=R%F_6 0317C' #1S!]8D9"'<U)Q+9$N?G&8IF63A>-ETD]=D^D0,!W%Z7M
M"?J&D!$=>4#*:1?<8R?OQKM#:)O<P;!2<<0&LZ1"$41Y09)7'!?KA11 3T0%
M*81=7@+/D4':I:,L"&Z-IC6&T^GMKN6@ 9 T7/_2)3?99MF8@6JXGVSCMAUW
M[TGQ+[T_+&$?[N';8?SA$WL?A3MY=E+?8#.87AN#Q8OHG #6)*4!9RU>S?3Q
M)/37#I()$;/;N.5Q#DKTM)V/R(*P4V]YJ=L/WY KVN-<S)0CF=6IG@5$8G%B
MCW4 297Z!6=)MF5-R\;3TX9E>5>ZH;475S>N]S#&W9O0Q:2KIZFL'7")(QJ<
M%?_H[C#PYWO5*%D?7J$L(\Y-)EU181/\V$H& '!"4?>"]U31C334N<;0TNTD
M]X&)NEU-0:-'$3#AVVA34I&ZOL-#*E&9QAE]$:$PKTD _KOEX(LXC7.Q/(US
ME=\?@)N:W,8VZ]'-.B(/F-C)ES?W73[U56(3VNR3.E)U:N)S=>*]+XQ'11_8
MY".\')'YL\2EG69=YL<!HB$G?M7;KBG[79743!"*(>&6S-1=-4E9>TJ;E/GG
M0\LL,M&H8YJ*O4ZBFA.$,]..EC_??)5JNTCGA1\3R+8W%._^^?'#3^GH+T:N
M& YD05F^8_)33HP)_/F;D2_B<,O%\G +_530TVY#'9"G.W.7H9RX+#8!K8VW
MKTU_M.#\I379W52JX4NZF4 "['E(T]$/'9>EE!5ES@8J.'*2()]T(."1*7.&
MIQZ;3!K:@[P10AAR!4HZHS7?1C6_%0[?3(00[Z])6@XIV2V(L@<D<:$VC(B@
M9FG"J9>@SC-FW%L<&I3TE38%\8]?^./6MM"5(A$\N"\#WU9.]_7M($ 301HQ
M_.'?-*%C6.GO,N!R\HRGH<!>)TCF>(.C79F2N]>8Q-BJ:YD-3 A-Q1C/]_6G
MK2_"(FCAC52::7 5;_?]5\B]S@6/3#*^R8LO?.KN\!JOK=MGN-2:9\XR+A%5
MOF"!G;HX)FATKQC_SFXC$K*(\CN]'2'IY,8#2'4XWWDVL7BY%+@OS%Q?Q)F
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M P:F;$/%24FD23YH5;B )')[O:33!,2R%2,S#=W(38(^$%T<NG'B=[ZBUC?
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M\=W<\9W#QEVY+939\-)90[=XC^IGLQ3:\P:4O*RPEB6O0>!F[ES[5XO(Q-N
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M@>F;G(N**&V*HRMK 22SH(JZV//F;D5*YB21/=N)).*-HB6#G4"RJ2HB'C=
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MN89ZTT7H(-&-@<Y0O+:M=^!*-[+=%GIR@C .^C[G7)T,$V"8Q<DO4$L#!!0
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MT&AR.<=(]Q/5&U8UH8LWRKJ9",O*74*@O8,[+Y6R>\,G&*^U[ ]02P,$%
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M@H:7D[$'JO=S'QC9.@^MI"%'NFE)3R JFT#[:RG-/K %AD<U^PM02P,$%
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M@NSL_$E9-& 5&,LM$ML6U!(J;M:PI((9&/_.%PV:R32PY,X9!=4>^FZ 9A]
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M$/UP0U\@J)T![:\4O<WW$Q?@\$TS^1=02P,$%     @ ]X%?68^GTCBQ P
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M^NI^.#&@:KC:,KG!<H2$NT^?X<(8;LTAOD<1#_.%,8_W7A[/=<2U)?9FWYX
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M$O(;?,+"?XPDCDT#%_]"Z[/0F,WVI]\$U[<[CF?[H6^]%TK7UOE*(J1C^YW
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MDHM>W!GQ-%42V[,@P947AW8$H7'@VX'K6?>,IBL2QG:4A,0+$SOV(C*V.@O
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M+KE-5<,\'D1OZL0A^65R10R2R543[*8-[M-%_A[=KO]/=^D1DL]S;8@?D6B
M!RTW]IV9MLM8-=7NWF-KJ5P-88\OC(=<QUK09/"I<LW$@_D@*XG9OINOEOUI
M_\WWJOG4N2-O/AC#(#1Z20JV!*OK3/$>(9J/L,V-XI7Y\+G@2O&UN5PQBO=?
M38#G2XY<:&^T@OY+^.5_ %!+ P04    " #W@5]9A_%;3)<#   \"0  &0
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M1PAK7%B'P.GS@)=8UPZ(:/QWP PZE\ZP/WY"?^]CIUCFW."EJC^+RJZG01E
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MO&(O[NZ:A+_O7APWE4)46?+>YIPSL[,ST[54S[H!,&C#F="SJ#&FO8QC73;
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MIJ&R/OVJ+[0HW8G3C1LY;KD FH*T&\SS3 C]>&$3-&>0D[]02P,$%     @
M]X%?6;A^=\R& @  ;0<  !D   !X;"]W;W)K<VAE971S+W-H965T-3@N>&UL
MM55M;],P$/XK5I 02&A)TU=&&VG=0!0Q5&T"/B ^N,DEM>:78%_6[=]S=MI0
MI#4?$/N2W-EWSSUW/I_G.V/OW!8 V8.2VBVB+6)]'L<NWX+B[LS4H&FG-%9Q
M)-56L:LM\"(X*1FG23*)%1<ZRN9A;6VSN6E0"@UKRURC%+>/2Y!FMX@&T6'A
M1E1;] MQ-J]Y!;> 7^NU)2WN4 JA0#MA-+-0+J*+P?ERYNV#P3<!.W<D,Y_)
MQI@[KZR*191X0B A1X_ Z7</ER"E!R(:O_:841?2.Q[+!_0/(7?*9<,=7!KY
M712X742SB!50\D;BC=E]A'T^8X^7&^G"E^U:V_';B.6-0Z/VSL1 "=W^^<.^
M#D<.@\D)AW3OD ;>;:# \HHCS^;6[)CUUH3FA9!J\"9R0OM#N45+NX+\,+OF
M"%9PR2[RW#0:A:[8VDB1/[*5;L_<%^_5%2 7TK$OW%KN"_EZ'B/%]RAQOH^U
M;&.E)V(-4G9M-&X=>Z\+*/X&B(EXQSX]L%^FO8B?&GW&ALD;EB;IJ =OV%5C
M&/!&)_"6ENN"::[ L1\*U ;LSZ?R[$7Q]^C<U3R'1407Q8&]ARA[^6(P2=[U
M<!QU'$<!?7B"XZJT[A;IV.AJX&?:7)%(=+W(@OPDY=$S4!YWE,>]97WO4% C
M0<$:!V4CF10E/$6R'V:0L$?@UO4PFG2,)KU0*XU<5V(C@7'G !UKJ"4MW>=[
MFE.U+VUO _2B_V,UIQWWZ7,TP/09*,\ZRK/_TP#],*/3YQ\?C4 %M@J#WK$P
MT]IIV*UV;\E%.T+_F+</T36WE=".22C)-3F;4E?:=KBW"IHZ#-2-01K/0=S2
M>PC6&]!^:0P>%!^@>V&SWU!+ P04    " #W@5]9T37BYSP#  "<"@  &0
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MCE!D_&6B5/8_NN]L\01E6Z5%U8&A!Q6OVRO]U@FQ!P"B;H#? ?PA(#X""#I
M, 2$1P!A!PB?"H@Z@*7NM=RM<"NJZ7PFQ3V2QAJ\F1NKOD6#7KPV@7*M);SE
M@-/S:XB\?%LR)-8P[G>LWC+T<L4TY:5ZA=Z@S]<K]/*G5S-/P\<,Q,LZQ\O6
ML7_$,?'1!U'K0J'+.F?YH0,/>MEWU=]U=>F?]/C+MCY# 7Z-?.R'C@ZMG@X/
M'/#+I\/]$VR"7OC ^@N.^/O4BNT2M@6&;J#)'.>JH1F[F$!J4$S>L<G\Q8\D
MQF]=HGQ/9Y??R=F!8&$O6'C*^TXPM):B0HT4&TDKM&9,N21L7<76E<F5=_/4
M3P.2SKR[?7$<9D$2DNC0[')LYN,(XS#L[0X813VCZ"2C)<P/"9ER2TO4T =(
MOUHA+=#FH7*2:KU%>]UX$P4))OZ E<LN";$_I.6P(SZ)2$K<O.*>5WR2UZ]0
MW_[3:,6CC@2I'^!DP,MA%@=!B@>TQF;3()Q&@9M4TI-*_B7\%*,R*Q"M<[0"
M=J5HS(@A3;\A7F=P"Q7/P>[=:;]_D;]=DIP$N6<:<DW_9"0&(6$:C6+A_W_O
M0-5IK^KT)/LK7M.2O88PH756<,5,C%B)A2Z8/!HQTS&M.,$^&43,V,SW8SP,
M&(<SC(-DZ@Z8M*>6GJ3V@4&T !-#2@%))X]TW,%T&@Y8C(V(G\8#$F.C*$I\
M-P6"'U<'^"2)&Z$A.;5C 4$N*F?!ZIP<]##!& ^";.6R(TD0#L?MTF6(HS3"
M1_CLK7;($_B<J+T=?C_71[$?C'*LPXY$03PE(RICPS3$4WPD'1&S&CIL>5Q1
MD)/UUZ22FX*AI:@:6C_ 0K(L408UA@/7']"S_H.J1YNF?$"P]4$0;>AHNNU3
M+:(*E:+>F"O7/5%;06\98B7?\-NR328[*?)MIA_?R+UO/'-]\CT%[-Z*:\[4
M&3+C;83C&36,2K;AJJ1V"Z8+JM%&W#%9*RMIRYN77#\8C1HJ-<]X0S4#45O1
M7]"J>6M^JSV==]6;JV<NT@IDL1O8((K,?L90>F^3%KJ!(KU0BBEE)5Q &) T
M3=#+]S>+A;U]U8IY]:?=7CPE_FQ0W7;ZL]R$[C,7"*0I1;[A,&DZ>79TS2)&
M,KV5-=#2A7VW@-VGI"6GM97OM_6:9^UTDBP3FQH*&Y1ID .>J1*UC4"JU-;4
M<M;&GQ[DHV<N$,2*24*]!"9E<#.;E.7=4X+Y8-;JNP@ /1A$1'[F6A%Y>YOS
MBLF-/151X'I;ZW;WT[?V)R_O['G#H'UI3F0<[0OBGZ^("P$% ][8HPCO\=/M
M$= '*B$0((6R-70#GR50;&5[JM(^:-'88X-;H;6H[&W!:,ZD,8#W:R'T[L%\
MH#_;FO\#4$L#!!0    ( />!7UE6%^'=8 ,  &(-   9    >&PO=V]R:W-H
M965T<R]S:&5E=#8Q+GAM;+5776_3,!3]*U9 ""2V?*?-:".Q!<00@VD5\(!X
M\)J;-)#$P7;:[=]C.UGHAY=M4GA9;>><XWMNXKOKV8;0WVP%P-%-651L;JPX
MKT],DRU74&)V3&JHQ).4T!)S,:69R6H*.%&DLC =RPK,$N>5$<W4VB6-9J3A
M15[!)46L*4M,;T^A()NY81MW"U=YMN)RP8QF-<Y@ ?QK?4G%S.Q5DKR$BN6D
M0A32N?'6/HEM15"(;SELV-8822O7A/R6D_-D;E@R(BA@R:4$%C]K.(.BD$HB
MCC^=J-'O*8G;XSOU]\J\,'.-&9R1XGN>\-7<F!HH@10W!;\BFP_0&?*EWI(4
M3/U%FQ;K"_"R89R4'5E$4.95^XMOND1L$>S@'H+3$9Q]@G</P>T([F,)7D?P
M5&9:*RH/,>8XFE&R052BA9H<J&0JMK"?5_*]+S@53W/!X]%"?$A)4P B*4IR
MAK.,0H;5*Q$K%-90-8!>QL!Q7K!7Z A]7<3HY?-7,Y.+[:6(N>RV.FVW<N[9
MRG;0!:GXBJ%W50+)KH IXNZ#=^Z"/W4&%3\VU3%RK=?(L1Q/$]#9X^FNAAX_
MGNX,N''[5^$J/?<>O?.4L@7'',2QXI_$PW,Q9.B''"(U_JE+>BOJZ45EV3AA
M-5["W!!U@0%=@Q&]>&8'UAM=PL84BT<2VTFFUR?3&U*/KKHO-Z6D1#4E&<4E
M2@&8+H6M5*"D9*%<1Z$3NG8X,]?;R=' W(EG^[NP^!#F6+YE>5Z/VW'D]X[\
M04=GXNQ0428;7* :W\J/A"%.4'9;:DVU:OY6&$>^.[%L9\^5#C?Q+&??E@9G
M.[9OA[;>5]#["@9]?1;_W)[TMH*#0-S0<:W)GB\-+'#=T-JS=0B;NM[4=_6F
M)KVIR:"I+^+(EO@7H=)-TBPY^G$!Y350[1$>U'KJ$1Y3+!Y);">'TSZ'T_]1
M#Z=C)G-,L7@DL9UDAGTRP_'J87AP)K3U4 /3U<-#V& ]M*U_K8LU:D7LY!XN
MB5J@KB;J@(-%T=[JR^QQRV*G%SQ4%W4X76'4X+25T=QJ/DN@F6KB&5J2IN)M
M*]>O]A>%MZH]WEL_E1<(U=3^DVEO'Q>89GG%4 &ID+2.)R+AM&WHVPDGM6IQ
MKPD7#;,:KL0E"*@$B.<I(?QN(C?HKU717U!+ P04    " #W@5]9ZOY\\%$$
M  !O#P  &0   'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6RM5]MNXS80_15"
M6RRR0!.1%'7+V@8V=A9M@72#I&F?%9NRA4BD2]%VME_?T26R35':/.R++5'G
M#.<,R>',Y"#52[GA7*/7(A?EU-EHO;UVW7*YX4527LDM%_ EE:I(-+RJM5MN
M%4]6-:G(78IQX!9))IS9I!Z[5[.)W.D\$_Q>H7)7%(GZ?L-S>9@ZQ'D;>,C6
M&UT-N+/)-EGS1ZZ?MO<*WMS.RBHKN"@S*9#BZ=3Y0JX7Q*\(->+OC!_*DV=4
M27F6\J5Z^7TU=7#E$<_Y4E<F$OC;\SG/\\H2^/%O:]3IYJR(I\]OUK_6XD',
M<U+RN<S_R59Z,W4B!ZUXFNQR_2 /O_%64.W@4N9E_8L.#=;W';3<E5H6+1D\
M*#+1_">O;2!.""08(-"60$T"&R!X+<%[+X&U!%9'II%2QV&1Z&0V4?* 5(4&
M:]5#'<R:#?(S4:W[HU;P-0.>GCW"1EKM<HYDBO@K[*:2E^ABP762Y>4G=(F>
M'A?HXI=/$U?#;!7'7;:6;QK+=, RH>A."KTIT:U8\=6Y 1?<['RE;[[>T%&+
M?^S$%?+PKXABRBP.S=]/]RSTQ?OI=$2-UT7>J^UY/XK\MQ3=MI&W1;FQPNQ6
MJK1P76Z3)9\Z<.Y+KO;<F7W\0 +\V1:AGVEL\9.,G46/==%C8]9GMWLN-)K+
M4EN#UI"#FEREOOW,"V(<3]S]:33Z*(:C,#A'+?HH2GWB=:@S__W.?W_4_WLE
MURHIT')(04/W3V8-,3-<F_=!A#(6&@+Z*.I[ 6%V!4&G(!A5<,?5<I/ (J3<
MOG&#WK0>]7UL2.BC&&/4E-!'!8%W@CI3$'8*PE$%W_2&J^$5"'MS1@R'GN%_
M'T4\BN/($&"!G:SFF?M1YWXTZOY?4B<YVK8;B8^DD*@_>8#]T/!QWH=1&D?,
ME-*'>8P&&-O5Q)V:>%3-7(H]5SI[AHPHI(9;*!.:0^+0Z..'B!+R&59*: 6%
MP@YD)V*%>)KRNFRP:8XMNP^'S%R8>1\'VP\R/#-4]W&4!#086D2"CQ<P'A5^
MDXB7P3/4<HWM%9EYP K#(3$T6& !\P?R #DI(<B/%72K5:U,SJ$4ZX:LPD@_
M[I0P\W198%[,/-\4UH=1&N*!'$WH41E]QQ%+,Y&()1_.%*V5\\T6T-A,8W,+
M$-(U#3UL"NH#*8E)-"CI6'60T6MY]B2@/<BS__@*RDNEN%A^1Q=K:!!*>XWG
M]1RY)"3$,3.E68!PR42]/6C%!<% ^B#'@H",5P0/0[+<7)8#B;$U>>8,C1DS
M"P4;CD 8S-1HP1'LG\3@7-NQ6"#CU<*?T !"CP=-C(!$7UV[:SZZ:GZO9KF$
M^\;OGR\+D(6>'YO"+#C(^6%L*'-/.I&"JW7=T95P<G9"-X5^-]IUC5_J7LD8
MOZFZR;K#.9II6M&[1*U!-^28%$SBJQ!<4TUWU[QHN:W[G6>IH7NJ'S?0$7-5
M >![*N%Z:5^J";H>>_8_4$L#!!0    ( />!7UG^I/Y_ P0  -(.   9
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M9-(8P/.%@(JVG9@-NC9V\C]02P,$%     @ ]X%?665B0YQ@ @  KP4  !D
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MFK#*;KA9"V69A!51)H.WDXB9L!Z"@;KQ$[;42//JCQ5M5##.@=Y7FCJC,UR
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M]:GFL0"LXE(;J/4E4]'7#O0&W;\9\W\!4$L#!!0    ( />!7UGF5AKF PD
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M)?7EFH=+GE<&\OM5EHFGFZJ!_7'"^?]02P,$%     @ ]X%?68HO!I=K @
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M1@6$5R!TC1)PVS+"B1;R 2CW V8[]2=9*"U-O_[:5T0?(]L?P\[PF6I)B9/
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MU>1*\$!DY0+%^\LTE;L7Y0KV3PB<_P]02P,$%     @ ]X%?6?/& ES' @
M6P@  !D   !X;"]W;W)K<VAE971S+W-H965T-S0N>&ULK59=;YLP%/TK%INF
M5MJ*^4ZZ!*E--6V3ID5-NST[X2:Q:C"SG:]_/]M01 MA?5@>@FWN.?<<N/9E
M<N#B26X!%#KFK)!39ZM4>>VZ<K6%G,@K7D*A[ZRYR(G24[%Q92F 9!:4,]?'
M.'9S0@LGG=BUN4@G?*<8+6 ND-SE.1&G6V#\,'4\YWGAGFZVRBRXZ:0D&UB
M>BSG0L_<AB6C.122\@()6$^=&^]Z-C+Q-N 7A8-LC9%QLN3\R4R^95,'&T'
M8*4, ]&7/<R ,4.D9?RI.9TFI0&VQ\_L7ZQW[65)),PX^TTSM9TZ(P=EL"8[
MIN[YX2O4?B+#M^),VG]TJ&*CQ$&KG50\K\%:04Z+ZDJ.]7-H ;SP#,"O ?Y;
M 4$-"*S12IFU=4<422>"'Y PT9K-#.RSL6CMAA;F+2Z4T'>IQJETH<LBVS%
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M5[JWV.%6=W\0)D#?7W.NGB>FP33?$^E?4$L#!!0    ( />!7UE8Q J</0(
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M2*7CJ[$[M >A;XWZJUV63NPW.=ZOEIM?Y>8WYE:N535Q9GF:/J(EIK$I'__
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MB!<EU>)%LJ6NZ,&H2;;0CPG!, -4!_@^8\![^:(<5(7M\7]02P,$%     @
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M1I'R\$EYP[)#<5CB*6,L2XK+/0XWF.0%^/MMEK&WFYR@/@(T_Q]02P,$%
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MG=:).X4H+DY(VUL8$D8@810(UE B\*V?\(]17BHJD#B@- )*HU"TICY;?B^
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M=V]R:W-H965T<R]S:&5E=#@U+GAM;+5:76_;-A1]WZ\@/&!H@2VR2#N),\=
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M@N>$ZP?4_053S*J./O.I#P7C_P%02P,$%     @ ]X%?622PP+<R"@  9UX
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MD4^I5W %/HIN"J C]SLLZG';+.K!-T0W* "4BP/4;1R^B!U%;M=BC"Q)1\3
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M!#EN>"7I4==?L:WGTO-E6MKPA;J)O6 19)4E7;9@IZ 4JOGS?7L.)X!A<@;
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M#0E+:]CU\8MW%40GV@VYXF(@6*V=>W0"+D&N[5U%D4QLN:[/&>UH>QVZL[>
MD_&9?WOO=XRG>'VJ;SO_X^N[UR<JUPRK7P$K7,J[&N,;(.O[3-W1HK+G[T>A
M\31OFQN\ H(T$_#Y2N#QINF8!=I+9?(?4$L#!!0    ( />!7UGJC?-RP@L
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MY9UWNRPJX7W>=::JO<_[IFZ*[6*UO??^DHJF6*WKOUX.FW;0KNMP?AS@^FF
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M]A./A*7C_J<O&/O1V9QER#%S!YANM\^0HO@?%Z48:7(RTH0TTLVZK%]9$)
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MM3[1Z;[:+?HIU3K=58=;%6Y45GZ@>/\A3?7QI QPVD!\\S=02P,$%     @
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M4^6=6/E@9.XN?1ZE,3)SPQ0H5B*[ .?G4IKU@S50W4R._@-02P,$%     @
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MO'C(C"Z*L]&X_>"K,+7,CC8_.,A'_F3]EIH_W7, .1LEI[##I32V]M_P^^?
MN!'PY?9=4^L+6=3"?.:U^,/HII)JY78#O^(D^!F^'?;_MHWXWOR?9M3+I<S$
M9YTUI5!UVXY&% Y0V;6L[(@I7HJST4)OA'&_!PYPF;>_K0:HH*7,>PD?F,O<
MX]&A0%\N9<VT85?:6L95SF[KM3!LH4LX*P+("(&,:"$7\%X7,H>CY^S!0;@_
M8'K)+J3B*H"<()"3GP6Y6'.U"B"G".3TIT%RNV8!9(Q QM20IM(&CLVD:G<
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M56\+T-NJWA:@MU6]+4!OJWI;@-Y.]78 O9WJ[0!Z.]7; ?1VLX<E +V=ZNT
M>CO5VP'T=JJW ^CM5&\'T-NIW@Z@MU.]'4!OKWI[@-Y>]?8 O;WJ[0%Z>]7;
M _3VLX?= +V]ZNT!>GO5VP/T]JJW!^CM56\/T-NKWAZ@=U"] T#OH'H'@-Y!
M]0X O8/J'0!Z!]4[ /0.LY>5 +V#ZAT >@?5.P#T#JIW .@=5.\ T#NJWA&@
M=U2](T#OJ'I'@-Y1]8X O:/J'0%Z1]4[ O2.L\TF +VCZAT!>D?5.P+TCJIW
M!.B=5.\$T#NIW@F@=U*]$T#OI'HG@-Y)]4X O9/JG0!Z)]4[ ?1.L\V" +V3
MZIT >B?5.P'TSJIW!NB=5>\,T#NKWAF@=U:],T#OK'IG@-Y9]<X O;/JG0%Z
M9]4[ _3.L\W> +VSZIT!>A?5NP#T+JIW >A=5.\"T+NHW@6@=U&]"T#OHGH7
M@-Y%]2X O8OJ70!Z%]6[ /0NL\,Z +U-,S^N\YU^C]/GH1MO15_K6<!W:CU=
M[NUNOW]=?EV<'1%JKD#7]QGCTU]02P,$%     @ ]X%?686?)TI8 @  PS@
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M;W!S+V%P<"YX;6Q02P$"% ,4    " #W@5]9U+9NI>\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #W@5]9
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( />!7UGB9 :@Q08  &,?   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #W@5]9
MU$N&XLD&  ! '   &               @($)#P  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ ]X%?60YDJL0<!P  %Q\  !@
M     ("!"!8  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M />!7UG^D.@)J@@  ,([   8              " @5H=  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    " #W@5]94DB&V18&   ;&0  &
M            @($Z)@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @ ]X%?67D-;YN- P  Z@<  !@              ("!ABP  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( />!7UD7P\2>\B,  )AT
M   8              " @4DP  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    " #W@5]9K#PVMPT4   ".   &               @(%Q5
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ ]X%?63*6CS0'
M!   ;PD  !@              ("!M&@  'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    ( />!7UE0'%T1M00  +8*   9              "
M@?%L  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ ]X%?
M6<F=XF-Q P  -0<  !D              ("!W7$  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    " #W@5]9J)S'P-\$  "*"@  &0
M        @(&%=0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   ( />!7UGCHHD@8@<  ($5   9              " @9MZ  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ ]X%?61\)=R:) @  [04
M !D              ("!-((  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    " #W@5]9R&Y0+CT#   (!P  &0              @('TA
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( />!7UFKGPYV
MSP,   0*   9              " @6B(  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @ ]X%?66EJ+O,H!P  MA   !D
M ("!;HP  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #W
M@5]94KM=TY@"  #A!0  &0              @('-DP  >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( />!7UG;S?!O. (  *,%   9
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M970R,RYX;6Q02P$"% ,4    " #W@5]9?K/(<>$)  !>&   &0
M    @(%MJ   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (
M />!7UEC%B8G 04  )T*   9              " @86R  !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL4$L! A0#%     @ ]X%?6>(4[]G@!0  <10  !D
M             ("!O;<  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"
M% ,4    " #W@5]93T/K93H*  "V'   &0              @('4O0  >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( />!7UGLNW2RS D
M .D8   9              " @47(  !X;"]W;W)K<VAE971S+W-H965T,C@N
M>&UL4$L! A0#%     @ ]X%?65MOUO#C @  6@8  !D              ("!
M2-(  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " #W@5]9
M(B6ZS2X"   5!0  &0              @(%BU0  >&PO=V]R:W-H965T<R]S
M:&5E=#,P+GAM;%!+ 0(4 Q0    ( />!7UG\A4J?.@(   X%   9
M      " @<?7  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%
M  @ ]X%?61#,^!KI @  5@8  !D              ("!.-H  'AL+W=O<FMS
M:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #W@5]9[*7S0" &  #,#0
M&0              @(%8W0  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+
M 0(4 Q0    ( />!7UD%L[*?CR4  &>!   9              " @:_C  !X
M;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ ]X%?6<)G1VQ$
M @  5P4  !D              ("!=0D! 'AL+W=O<FMS:&5E=',O<VAE970S
M-2YX;6Q02P$"% ,4    " #W@5]9*Q^\V+4$   R"P  &0
M@('P"P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( />!
M7UFW"";+>@,  #D'   9              " @=P0 0!X;"]W;W)K<VAE971S
M+W-H965T,S<N>&UL4$L! A0#%     @ ]X%?6>2(2X>  P  K <  !D
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M=#0R+GAM;%!+ 0(4 Q0    ( />!7UF.]*V6-P<  &41   9
M  " @14G 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @
M]X%?673&I3J9 @  U04  !D              ("!@RX! 'AL+W=O<FMS:&5E
M=',O<VAE970T-"YX;6Q02P$"% ,4    " #W@5]9@94ELSL"  "7!0  &0
M            @(%3,0$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4
M Q0    ( />!7UE7E77%$0(  .($   9              " @<4S 0!X;"]W
M;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ ]X%?68*PK.ML @
M8 4  !D              ("!#38! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX
M;6Q02P$"% ,4    " #W@5]9([T:+*\$   ="P  &0              @(&P
M. $ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( />!7UGO
MV^_[2 0  +D(   9              " @98] 0!X;"]W;W)K<VAE971S+W-H
M965T-#DN>&UL4$L! A0#%     @ ]X%?69[#\I_> P  WP@  !D
M     ("!%4(! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( />!7UE'ZPYCD (  +H%   9              "
M@85; 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ ]X%?
M64??4E'N @  5 8  !D              ("!3%X! 'AL+W=O<FMS:&5E=',O
M<VAE970U-BYX;6Q02P$"% ,4    " #W@5]9J6(5\'X#  "/%   &0
M        @(%Q80$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0
M   ( />!7UFX?G?,A@(  &T'   9              " @29E 0!X;"]W;W)K
M<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ ]X%?6=$UXN<\ P  G H
M !D              ("!XV<! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q0
M2P$"% ,4    " #W@5]9QP+XY!8%  #G$@  &0              @(%6:P$
M>&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( />!7UE6%^'=
M8 ,  &(-   9              " @:-P 0!X;"]W;W)K<VAE971S+W-H965T
M-C$N>&UL4$L! A0#%     @ ]X%?6>K^?/!1!   ;P\  !D
M ("!.G0! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " #W
M@5]9_J3^?P,$  #2#@  &0              @('"> $ >&PO=V]R:W-H965T
M<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( />!7UEE8D.<8 (  *\%   9
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M970V."YX;6Q02P$"% ,4    " #W@5]9-R$@M00#  "X"   &0
M    @($;E $ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    (
M />!7UE!].XZ@08  %HH   9              " @5:7 0!X;"]W;W)K<VAE
M971S+W-H965T-S N>&UL4$L! A0#%     @ ]X%?68HO!I=K @  MP4  !D
M             ("!#IX! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"
M% ,4    " #W@5]9)$L#.4 $  #*&P  &0              @(&PH $ >&PO
M=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( />!7UF:5HK8^P<
M "U0   9              " @2>E 0!X;"]W;W)K<VAE971S+W-H965T-S,N
M>&UL4$L! A0#%     @ ]X%?6?/& ES' @  6P@  !D              ("!
M6:T! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " #W@5]9
M6,0*G#T"  #A!0  &0              @(%7L $ >&PO=V]R:W-H965T<R]S
M:&5E=#<U+GAM;%!+ 0(4 Q0    ( />!7UG\:KSB P(   P%   9
M      " @<NR 0!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%
M  @ ]X%?62'/37:- @  P0<  !D              ("!!;4! 'AL+W=O<FMS
M:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " #W@5]9\:9<RNL%  #D%@
M&0              @(')MP$ >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+
M 0(4 Q0    ( />!7UG+R.*J6P,  (\/   9              " @>N] 0!X
M;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ ]X%?6?4PPUH5
M!0  AQ$  !D              ("!?<$! 'AL+W=O<FMS:&5E=',O<VAE970X
M,"YX;6Q02P$"% ,4    " #W@5]99B.QGCX#  #S"0  &0
M@(')Q@$ >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( />!
M7UGR*&O=9P4   XD   9              " @3[* 0!X;"]W;W)K<VAE971S
M+W-H965T.#(N>&UL4$L! A0#%     @ ]X%?67#HT5\7!@   38  !D
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M=#@W+GAM;%!+ 0(4 Q0    ( />!7UG<O27PR@,  " 4   9
M  " @9KK 0!X;"]W;W)K<VAE971S+W-H965T.#@N>&UL4$L! A0#%     @
M]X%?622PP+<R"@  9UX  !D              ("!F^\! 'AL+W=O<FMS:&5E
M=',O<VAE970X.2YX;6Q02P$"% ,4    " #W@5]9U&X#!D$"  #6!   &0
M            @($$^@$ >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+ 0(4
M Q0    ( />!7UD76["FY ,  -D-   9              " @7S\ 0!X;"]W
M;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%     @ ]X%?60KBH*B/ P
M8 X  !D              ("!EP " 'AL+W=O<FMS:&5E=',O<VAE970Y,BYX
M;6Q02P$"% ,4    " #W@5]9ZHWS<L(+   ^EP  &0              @(%=
M! ( >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0    ( />!7UG/
MX'CW$@@  $P\   9              " @580 @!X;"]W;W)K<VAE971S+W-H
M965T.30N>&UL4$L! A0#%     @ ]X%?66+;( VH!0  (R4  !D
M     ("!GQ@" 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( />!7UD@#Z!;$ 4  *44   :              "
M@>4J @!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4 Q0    ( />!
M7UF60\,C+0,  ,H2   -              "  2TP @!X;"]S='EL97,N>&UL
M4$L! A0#%     @ ]X%?69>*NQS     $P(   L              ( !A3,"
M %]R96QS+RYR96QS4$L! A0#%     @ ]X%?64+C[<QF!P  %$$   \
M         ( !;C0" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( />!7UG#
M*Q\]U@(  ,<Z   :              "  0$\ @!X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( />!7UF%GR=*6 (  ,,X   3
M      "  0\_ @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !L &P K!T
' )A! @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>285</ContextCount>
  <ElementCount>363</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>100</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Profit or Loss and Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss</Role>
      <ShortName>Profit or Loss and Other Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Statement of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/StatementOfFinancialPosition</Role>
      <ShortName>Consolidated Statement of Financial Position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statement of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/StatementOfChangesInEquity</Role>
      <ShortName>Consolidated Statement of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statement of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/StatementOfCashFlows</Role>
      <ShortName>Consolidated Statement of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995611 - Disclosure - Corporate information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/CorporateInformation</Role>
      <ShortName>Corporate information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995612 - Disclosure - Material Accounting Policy Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation</Role>
      <ShortName>Material Accounting Policy Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995613 - Disclosure - Critical accounting judgements, estimates and assumptions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions</Role>
      <ShortName>Critical accounting judgements, estimates and assumptions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995614 - Disclosure - Operating segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/OperatingSegments</Role>
      <ShortName>Operating segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995615 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995616 - Disclosure - Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/Expenses</Role>
      <ShortName>Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995617 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995618 - Disclosure - Fair value measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/FairValueMeasurement</Role>
      <ShortName>Fair value measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995619 - Disclosure - Cash and cash equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/CashAndCashEquivalents</Role>
      <ShortName>Cash and cash equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995620 - Disclosure - Trade and other receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/TradeAndOtherReceivables</Role>
      <ShortName>Trade and other receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995621 - Disclosure - Property and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995622 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/IntangibleAssets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995623 - Disclosure - Trade and other payables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/TradeAndOtherPayables</Role>
      <ShortName>Trade and other payables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995624 - Disclosure - Current and Non-current Employee Entitlements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements</Role>
      <ShortName>Current and Non-current Employee Entitlements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995625 - Disclosure - Unearned Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/UnearnedRevenue</Role>
      <ShortName>Unearned Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995626 - Disclosure - Reserves</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/Reserves</Role>
      <ShortName>Reserves</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995627 - Disclosure - Issued capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/IssuedCapital</Role>
      <ShortName>Issued capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995628 - Disclosure - Notes to statement of cash flows</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://altaglobalgroup.com/role/NotesToStatementOfCashFlows</Role>
      <ShortName>Notes to statement of cash flows</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995629 - Disclosure - Related parties transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/RelatedPartiesTransactions</Role>
      <ShortName>Related parties transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995630 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995631 - Disclosure - Financial Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/FinancialLiabilities</Role>
      <ShortName>Financial Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995632 - Disclosure - Share-based payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/Share-basedPayments</Role>
      <ShortName>Share-based payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995633 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995634 - Disclosure - Remuneration of auditors</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/RemunerationOfAuditors</Role>
      <ShortName>Remuneration of auditors</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995635 - Disclosure - Contingent Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities</Role>
      <ShortName>Contingent Assets and Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995636 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995637 - Disclosure - Loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/LossPerShare</Role>
      <ShortName>Loss per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995638 - Disclosure - Events after the reporting period</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/EventsAfterReportingPeriod</Role>
      <ShortName>Events after the reporting period</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995639 - Disclosure - Material Accounting Policy Information (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies</Role>
      <ShortName>Material Accounting Policy Information (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995640 - Disclosure - Material Accounting Policy Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables</Role>
      <ShortName>Material Accounting Policy Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995641 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/Revenue</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995642 - Disclosure - Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ExpensesTables</Role>
      <ShortName>Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/Expenses</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995643 - Disclosure - Income Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/IncomeTaxTables</Role>
      <ShortName>Income Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/IncomeTax</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995644 - Disclosure - Fair value measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair value measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/FairValueMeasurement</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995645 - Disclosure - Cash and cash equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/CashAndCashEquivalentsTables</Role>
      <ShortName>Cash and cash equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/CashAndCashEquivalents</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995646 - Disclosure - Trade and other receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/TradeAndOtherReceivablesTables</Role>
      <ShortName>Trade and other receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/TradeAndOtherReceivables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995647 - Disclosure - Property and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/PropertyAndEquipment</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995648 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/IntangibleAssets</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995649 - Disclosure - Trade and other payables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/TradeAndOtherPayablesTables</Role>
      <ShortName>Trade and other payables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/TradeAndOtherPayables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995650 - Disclosure - Current and Non-current Employee Entitlements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlementsTables</Role>
      <ShortName>Current and Non-current Employee Entitlements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995651 - Disclosure - Unearned Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/UnearnedRevenueTables</Role>
      <ShortName>Unearned Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/UnearnedRevenue</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995652 - Disclosure - Reserves (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ReservesTables</Role>
      <ShortName>Reserves (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/Reserves</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995653 - Disclosure - Issued capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/IssuedCapitalTables</Role>
      <ShortName>Issued capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/IssuedCapital</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995654 - Disclosure - Notes to statement of cash flows (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://altaglobalgroup.com/role/NotesToStatementOfCashFlowsTables</Role>
      <ShortName>Notes to statement of cash flows (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/NotesToStatementOfCashFlows</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995655 - Disclosure - Related parties transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables</Role>
      <ShortName>Related parties transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/RelatedPartiesTransactions</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995656 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/Leases</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995657 - Disclosure - Financial Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/FinancialLiabilitiesTables</Role>
      <ShortName>Financial Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/FinancialLiabilities</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995658 - Disclosure - Share-based payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/Share-basedPaymentsTables</Role>
      <ShortName>Share-based payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/Share-basedPayments</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995659 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/FinancialInstruments</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995660 - Disclosure - Remuneration of auditors (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/RemunerationOfAuditorsTables</Role>
      <ShortName>Remuneration of auditors (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/RemunerationOfAuditors</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995661 - Disclosure - Loss per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/LossPerShareTables</Role>
      <ShortName>Loss per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/LossPerShare</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995662 - Disclosure - Schedule of plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails</Role>
      <ShortName>Schedule of plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995663 - Disclosure - Material Accounting Policy Information (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative</Role>
      <ShortName>Material Accounting Policy Information (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995664 - Disclosure - Critical accounting judgements, estimates and assumptions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative</Role>
      <ShortName>Critical accounting judgements, estimates and assumptions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995665 - Disclosure - Schedule of revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfRevenueDetails</Role>
      <ShortName>Schedule of revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995666 - Disclosure - Schedule of disaggregation of revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails</Role>
      <ShortName>Schedule of disaggregation of revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>995667 - Disclosure - Schedule of expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfExpensesDetails</Role>
      <ShortName>Schedule of expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>995668 - Disclosure - Schedule of Income Tax Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails</Role>
      <ShortName>Schedule of Income Tax Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>995669 - Disclosure - Schedule of Income Tax Expenses (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical</Role>
      <ShortName>Schedule of Income Tax Expenses (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>995670 - Disclosure - Schedule of Fair Value Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails</Role>
      <ShortName>Schedule of Fair Value Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>995671 - Disclosure - Schedule of Fair Value Measurement of Derivative Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails</Role>
      <ShortName>Schedule of Fair Value Measurement of Derivative Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>995672 - Disclosure - Schedule of Unobservable Inputs Level 3 Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails</Role>
      <ShortName>Schedule of Unobservable Inputs Level 3 Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>995673 - Disclosure - Schedule of Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails</Role>
      <ShortName>Schedule of Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>995674 - Disclosure - Schedule of Trade and Other Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails</Role>
      <ShortName>Schedule of Trade and Other Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>995675 - Disclosure - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>995676 - Disclosure - Income Tax (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/IncomeTaxDetailsNarrative</Role>
      <ShortName>Income Tax (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/IncomeTaxTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>995677 - Disclosure - Schedule of Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Schedule of Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>995678 - Disclosure - Schedule of Reconciliations of the Movement of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails</Role>
      <ShortName>Schedule of Reconciliations of the Movement of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>995679 - Disclosure - Schedule of Trade and Other Payables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails</Role>
      <ShortName>Schedule of Trade and Other Payables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>995680 - Disclosure - Schedule of Current and Non-current Employee Entitlements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails</Role>
      <ShortName>Schedule of Current and Non-current Employee Entitlements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>995681 - Disclosure - Schedule of Unearned Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfUnearnedRevenueDetails</Role>
      <ShortName>Schedule of Unearned Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>995682 - Disclosure - Schedule of Reserves (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfReservesDetails</Role>
      <ShortName>Schedule of Reserves (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>995683 - Disclosure - Schedule of Issued Capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails</Role>
      <ShortName>Schedule of Issued Capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>995684 - Disclosure - Schedule of Issued Capital (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical</Role>
      <ShortName>Schedule of Issued Capital (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>995685 - Disclosure - Schedule of Statement of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails</Role>
      <ShortName>Schedule of Statement of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>995686 - Disclosure - Schedule of Key Management Personnel Remuneration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails</Role>
      <ShortName>Schedule of Key Management Personnel Remuneration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>995687 - Disclosure - Schedule of Shares Held by Key Management Personnel (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails</Role>
      <ShortName>Schedule of Shares Held by Key Management Personnel (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>995688 - Disclosure - Related parties transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative</Role>
      <ShortName>Related parties transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>995689 - Disclosure - Schedule of Financial Statement of the Parent Entity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails</Role>
      <ShortName>Schedule of Financial Statement of the Parent Entity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>995690 - Disclosure - Schedule of Country Incorporation Principal Place of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails</Role>
      <ShortName>Schedule of Country Incorporation Principal Place of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>995691 - Disclosure - Summary of Changes in ROU Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails</Role>
      <ShortName>Summary of Changes in ROU Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>995692 - Disclosure - Summary of Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Summary of Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>995693 - Disclosure - Schedule of Financial Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails</Role>
      <ShortName>Schedule of Financial Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>995694 - Disclosure - Schedule of Convertible Notes held by Investors (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails</Role>
      <ShortName>Schedule of Convertible Notes held by Investors (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>995695 - Disclosure - Financial Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/FinancialLiabilitiesDetailsNarrative</Role>
      <ShortName>Financial Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/FinancialLiabilitiesTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>995696 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails</Role>
      <ShortName>Schedule of Details of Expense from Performance Rights, Options and Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>995697 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical</Role>
      <ShortName>Schedule of Details of Expense from Performance Rights, Options and Warrants (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>995698 - Disclosure - Schedule of Share Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails</Role>
      <ShortName>Schedule of Share Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>995699 - Disclosure - Schedule of Model Inputs For Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails</Role>
      <ShortName>Schedule of Model Inputs For Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>995700 - Disclosure - Schedule of Contractual Maturities of Financial Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails</Role>
      <ShortName>Schedule of Contractual Maturities of Financial Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>995701 - Disclosure - Schedule of Auditor of Company And Network Firms (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails</Role>
      <ShortName>Schedule of Auditor of Company And Network Firms (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>995702 - Disclosure - Share-based payments (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative</Role>
      <ShortName>Share-based payments (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/Share-basedPaymentsTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>995703 - Disclosure - Contingent Assets and Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ContingentAssetsAndLiabilitiesDetailsNarrative</Role>
      <ShortName>Contingent Assets and Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>995704 - Disclosure - Schedule of Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails</Role>
      <ShortName>Schedule of Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>995705 - Disclosure - Events after the reporting period (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative</Role>
      <ShortName>Events after the reporting period (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://altaglobalgroup.com/role/EventsAfterReportingPeriod</ParentRole>
      <Position>100</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" isUsgaap="true" original="form20-f.htm">form20-f.htm</File>
    <File>mma-20240630.xsd</File>
    <File>mma-20240630_cal.xml</File>
    <File>mma-20240630_def.xml</File>
    <File>mma-20240630_lab.xml</File>
    <File>mma-20240630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>logo_001.jpg</File>
    <File>logo_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="43">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="973">https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>125
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form20-f.htm": {
   "nsprefix": "MMA",
   "nsuri": "http://altaglobalgroup.com/20240630",
   "dts": {
    "inline": {
     "local": [
      "form20-f.htm"
     ]
    },
    "schema": {
     "local": [
      "mma-20240630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2024-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd",
      "https://xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "mma-20240630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mma-20240630_def.xml"
     ],
     "remote": [
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/dimensions/dim_full_ifrs_2024-03-27_role-995000.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mma-20240630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mma-20240630_pre.xml"
     ]
    }
   },
   "keyStandard": 241,
   "keyCustom": 122,
   "axisStandard": 24,
   "axisCustom": 0,
   "memberStandard": 30,
   "memberCustom": 63,
   "hidden": {
    "total": 281,
    "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full": 210,
    "http://altaglobalgroup.com/20240630": 68,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 285,
   "entityCount": 1,
   "segmentCount": 100,
   "elementCount": 666,
   "unitCount": 6,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full": 973,
    "http://xbrl.sec.gov/dei/2024": 43
   },
   "report": {
    "R1": {
     "role": "http://altaglobalgroup.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
     "longName": "00000002 - Statement - Profit or Loss and Other Comprehensive Loss",
     "shortName": "Profit or Loss and Other Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:RevenueFromProgramFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:ContractualPaymentsToGyms",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://altaglobalgroup.com/role/StatementOfFinancialPosition",
     "longName": "00000003 - Statement - Consolidated Statement of Financial Position",
     "shortName": "Consolidated Statement of Financial Position",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:TradeAndOtherCurrentReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://altaglobalgroup.com/role/StatementOfChangesInEquity",
     "longName": "00000004 - Statement - Consolidated Statement of Changes in Equity",
     "shortName": "Consolidated Statement of Changes in Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "AsOf2021-06-30_ifrs-full_IssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-06-30_ifrs-full_IssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://altaglobalgroup.com/role/StatementOfCashFlows",
     "longName": "00000005 - Statement - Consolidated Statement of Cash Flows",
     "shortName": "Consolidated Statement of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:ProceedsFromTrainingParticipants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:ProceedsFromTrainingParticipants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://altaglobalgroup.com/role/CorporateInformation",
     "longName": "995611 - Disclosure - Corporate information",
     "shortName": "Corporate information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfCorporateInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfCorporateInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation",
     "longName": "995612 - Disclosure - Material Accounting Policy Information",
     "shortName": "Material Accounting Policy Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions",
     "longName": "995613 - Disclosure - Critical accounting judgements, estimates and assumptions",
     "shortName": "Critical accounting judgements, estimates and assumptions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://altaglobalgroup.com/role/OperatingSegments",
     "longName": "995614 - Disclosure - Operating segments",
     "shortName": "Operating segments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://altaglobalgroup.com/role/Revenue",
     "longName": "995615 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://altaglobalgroup.com/role/Expenses",
     "longName": "995616 - Disclosure - Expenses",
     "shortName": "Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfExpensesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfExpensesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://altaglobalgroup.com/role/IncomeTax",
     "longName": "995617 - Disclosure - Income Tax",
     "shortName": "Income Tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://altaglobalgroup.com/role/FairValueMeasurement",
     "longName": "995618 - Disclosure - Fair value measurement",
     "shortName": "Fair value measurement",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://altaglobalgroup.com/role/CashAndCashEquivalents",
     "longName": "995619 - Disclosure - Cash and cash equivalents",
     "shortName": "Cash and cash equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://altaglobalgroup.com/role/TradeAndOtherReceivables",
     "longName": "995620 - Disclosure - Trade and other receivables",
     "shortName": "Trade and other receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://altaglobalgroup.com/role/PropertyAndEquipment",
     "longName": "995621 - Disclosure - Property and equipment",
     "shortName": "Property and equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://altaglobalgroup.com/role/IntangibleAssets",
     "longName": "995622 - Disclosure - Intangible assets",
     "shortName": "Intangible assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://altaglobalgroup.com/role/TradeAndOtherPayables",
     "longName": "995623 - Disclosure - Trade and other payables",
     "shortName": "Trade and other payables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements",
     "longName": "995624 - Disclosure - Current and Non-current Employee Entitlements",
     "shortName": "Current and Non-current Employee Entitlements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://altaglobalgroup.com/role/UnearnedRevenue",
     "longName": "995625 - Disclosure - Unearned Revenue",
     "shortName": "Unearned Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfUnearnedRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfUnearnedRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://altaglobalgroup.com/role/Reserves",
     "longName": "995626 - Disclosure - Reserves",
     "shortName": "Reserves",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://altaglobalgroup.com/role/IssuedCapital",
     "longName": "995627 - Disclosure - Issued capital",
     "shortName": "Issued capital",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://altaglobalgroup.com/role/NotesToStatementOfCashFlows",
     "longName": "995628 - Disclosure - Notes to statement of cash flows",
     "shortName": "Notes to statement of cash flows",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://altaglobalgroup.com/role/RelatedPartiesTransactions",
     "longName": "995629 - Disclosure - Related parties transactions",
     "shortName": "Related parties transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://altaglobalgroup.com/role/Leases",
     "longName": "995630 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://altaglobalgroup.com/role/FinancialLiabilities",
     "longName": "995631 - Disclosure - Financial Liabilities",
     "shortName": "Financial Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://altaglobalgroup.com/role/Share-basedPayments",
     "longName": "995632 - Disclosure - Share-based payments",
     "shortName": "Share-based payments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://altaglobalgroup.com/role/FinancialInstruments",
     "longName": "995633 - Disclosure - Financial Instruments",
     "shortName": "Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://altaglobalgroup.com/role/RemunerationOfAuditors",
     "longName": "995634 - Disclosure - Remuneration of auditors",
     "shortName": "Remuneration of auditors",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities",
     "longName": "995635 - Disclosure - Contingent Assets and Liabilities",
     "shortName": "Contingent Assets and Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://altaglobalgroup.com/role/Commitments",
     "longName": "995636 - Disclosure - Commitments",
     "shortName": "Commitments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://altaglobalgroup.com/role/LossPerShare",
     "longName": "995637 - Disclosure - Loss per share",
     "shortName": "Loss per share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://altaglobalgroup.com/role/EventsAfterReportingPeriod",
     "longName": "995638 - Disclosure - Events after the reporting period",
     "shortName": "Events after the reporting period",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies",
     "longName": "995639 - Disclosure - Material Accounting Policy Information (Policies)",
     "shortName": "Material Accounting Policy Information (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables",
     "longName": "995640 - Disclosure - Material Accounting Policy Information (Tables)",
     "shortName": "Material Accounting Policy Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://altaglobalgroup.com/role/RevenueTables",
     "longName": "995641 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://altaglobalgroup.com/role/ExpensesTables",
     "longName": "995642 - Disclosure - Expenses (Tables)",
     "shortName": "Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfDetailedInformationAboutExpensesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfDetailedInformationAboutExpensesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://altaglobalgroup.com/role/IncomeTaxTables",
     "longName": "995643 - Disclosure - Income Tax (Tables)",
     "shortName": "Income Tax (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://altaglobalgroup.com/role/FairValueMeasurementTables",
     "longName": "995644 - Disclosure - Fair value measurement (Tables)",
     "shortName": "Fair value measurement (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://altaglobalgroup.com/role/CashAndCashEquivalentsTables",
     "longName": "995645 - Disclosure - Cash and cash equivalents (Tables)",
     "shortName": "Cash and cash equivalents (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://altaglobalgroup.com/role/TradeAndOtherReceivablesTables",
     "longName": "995646 - Disclosure - Trade and other receivables (Tables)",
     "shortName": "Trade and other receivables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfTradeAndOtherReceivableExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfTradeAndOtherReceivableExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://altaglobalgroup.com/role/PropertyAndEquipmentTables",
     "longName": "995647 - Disclosure - Property and equipment (Tables)",
     "shortName": "Property and equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://altaglobalgroup.com/role/IntangibleAssetsTables",
     "longName": "995648 - Disclosure - Intangible assets (Tables)",
     "shortName": "Intangible assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://altaglobalgroup.com/role/TradeAndOtherPayablesTables",
     "longName": "995649 - Disclosure - Trade and other payables (Tables)",
     "shortName": "Trade and other payables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfDetailedInformationAboutTradeAndOtherPayables",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfDetailedInformationAboutTradeAndOtherPayables",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlementsTables",
     "longName": "995650 - Disclosure - Current and Non-current Employee Entitlements (Tables)",
     "shortName": "Current and Non-current Employee Entitlements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "MMA:DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "MMA:DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://altaglobalgroup.com/role/UnearnedRevenueTables",
     "longName": "995651 - Disclosure - Unearned Revenue (Tables)",
     "shortName": "Unearned Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "MMA:DisclosureOfUnearnedRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "MMA:DisclosureOfUnearnedRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://altaglobalgroup.com/role/ReservesTables",
     "longName": "995652 - Disclosure - Reserves (Tables)",
     "shortName": "Reserves (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:ScheduleOfReservesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:ScheduleOfReservesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://altaglobalgroup.com/role/IssuedCapitalTables",
     "longName": "995653 - Disclosure - Issued capital (Tables)",
     "shortName": "Issued capital (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfDetailedInformationIssuedCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfDetailedInformationIssuedCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://altaglobalgroup.com/role/NotesToStatementOfCashFlowsTables",
     "longName": "995654 - Disclosure - Notes to statement of cash flows (Tables)",
     "shortName": "Notes to statement of cash flows (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DetailedInformationOfNotesToStatementOfCashFlowExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DetailedInformationOfNotesToStatementOfCashFlowExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables",
     "longName": "995655 - Disclosure - Related parties transactions (Tables)",
     "shortName": "Related parties transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://altaglobalgroup.com/role/LeasesTables",
     "longName": "995656 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://altaglobalgroup.com/role/FinancialLiabilitiesTables",
     "longName": "995657 - Disclosure - Financial Liabilities (Tables)",
     "shortName": "Financial Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://altaglobalgroup.com/role/Share-basedPaymentsTables",
     "longName": "995658 - Disclosure - Share-based payments (Tables)",
     "shortName": "Share-based payments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://altaglobalgroup.com/role/FinancialInstrumentsTables",
     "longName": "995659 - Disclosure - Financial Instruments (Tables)",
     "shortName": "Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://altaglobalgroup.com/role/RemunerationOfAuditorsTables",
     "longName": "995660 - Disclosure - Remuneration of auditors (Tables)",
     "shortName": "Remuneration of auditors (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://altaglobalgroup.com/role/LossPerShareTables",
     "longName": "995661 - Disclosure - Loss per share (Tables)",
     "shortName": "Loss per share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:EarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:EarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
     "longName": "995662 - Disclosure - Schedule of plant and equipment (Details)",
     "shortName": "Schedule of plant and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_PlantAndEquipmentMember_ifrs-full_BottomOfRangeMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfPlantAndEquipmentExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_PlantAndEquipmentMember_ifrs-full_BottomOfRangeMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfPlantAndEquipmentExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative",
     "longName": "995663 - Disclosure - Material Accounting Policy Information (Details Narrative)",
     "shortName": "Material Accounting Policy Information (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_ifrs-full_BrandNamesMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_ifrs-full_BrandNamesMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative",
     "longName": "995664 - Disclosure - Critical accounting judgements, estimates and assumptions (Details Narrative)",
     "shortName": "Critical accounting judgements, estimates and assumptions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:CurrentAssetsLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails",
     "longName": "995665 - Disclosure - Schedule of revenue (Details)",
     "shortName": "Schedule of revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:RevenueFromProgramFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-012023-06-30",
      "name": "MMA:ReserachAndDevelopmentIncome",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails",
     "longName": "995666 - Disclosure - Schedule of disaggregation of revenue (Details)",
     "shortName": "Schedule of disaggregation of revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:RevenueFromProgramFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_OneMajorProductMember",
      "name": "MMA:RevenueFromProgramFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails",
     "longName": "995667 - Disclosure - Schedule of expenses (Details)",
     "shortName": "Schedule of expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:ProgramExpensesEventCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDetailedInformationAboutExpensesExplanatory",
       "ifrs-full:DisclosureOfExpensesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:ProgramExpensesEventCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDetailedInformationAboutExpensesExplanatory",
       "ifrs-full:DisclosureOfExpensesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails",
     "longName": "995668 - Disclosure - Schedule of Income Tax Expenses (Details)",
     "shortName": "Schedule of Income Tax Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical",
     "longName": "995669 - Disclosure - Schedule of Income Tax Expenses (Details) (Parenthetical)",
     "shortName": "Schedule of Income Tax Expenses (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails",
     "longName": "995670 - Disclosure - Schedule of Fair Value Assets and Liabilities (Details)",
     "shortName": "Schedule of Fair Value Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "ifrs-full:FinancialLiabilitiesAtFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
       "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R66": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails",
     "longName": "995671 - Disclosure - Schedule of Fair Value Measurement of Derivative Liability (Details)",
     "shortName": "Schedule of Fair Value Measurement of Derivative Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "ifrs-full:DerivativeFinancialLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDerivativeLiabilityExplanatory",
       "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDerivativeLiabilityExplanatory",
       "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails",
     "longName": "995672 - Disclosure - Schedule of Unobservable Inputs Level 3 Liabilities (Details)",
     "shortName": "Schedule of Unobservable Inputs Level 3 Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAConvertibleNotesMember",
      "name": "ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory",
       "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAConvertibleNotesMember",
      "name": "ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory",
       "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails",
     "longName": "995673 - Disclosure - Schedule of Cash and Cash Equivalents (Details)",
     "shortName": "Schedule of Cash and Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:CashOnHand",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfCashEquivalentsExplanatory",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:CashOnHand",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfCashEquivalentsExplanatory",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails",
     "longName": "995674 - Disclosure - Schedule of Trade and Other Receivables (Details)",
     "shortName": "Schedule of Trade and Other Receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:TradeReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfTradeAndOtherReceivableExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:TradeReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfTradeAndOtherReceivableExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails",
     "longName": "995675 - Disclosure - Schedule of Property and Equipment (Details)",
     "shortName": "Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://altaglobalgroup.com/role/IncomeTaxDetailsNarrative",
     "longName": "995676 - Disclosure - Income Tax (Details Narrative)",
     "shortName": "Income Tax (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
     "longName": "995677 - Disclosure - Schedule of Intangible assets (Details)",
     "shortName": "Schedule of Intangible assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails",
     "longName": "995678 - Disclosure - Schedule of Reconciliations of the Movement of Intangible Assets (Details)",
     "shortName": "Schedule of Reconciliations of the Movement of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30_custom_SteppenPtyLtdMember",
      "name": "ifrs-full:NotionalAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails",
     "longName": "995679 - Disclosure - Schedule of Trade and Other Payables (Details)",
     "shortName": "Schedule of Trade and Other Payables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "MMA:TradeAndOtherPayablesPayableToMemberGyms",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDetailedInformationAboutTradeAndOtherPayables",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "MMA:TradeAndOtherPayablesPayableToMemberGyms",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDetailedInformationAboutTradeAndOtherPayables",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails",
     "longName": "995680 - Disclosure - Schedule of Current and Non-current Employee Entitlements (Details)",
     "shortName": "Schedule of Current and Non-current Employee Entitlements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:CurrentProvisionsForEmployeeBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R76": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfUnearnedRevenueDetails",
     "longName": "995681 - Disclosure - Schedule of Unearned Revenue (Details)",
     "shortName": "Schedule of Unearned Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "MMA:UnearnedRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R77": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfReservesDetails",
     "longName": "995682 - Disclosure - Schedule of Reserves (Details)",
     "shortName": "Schedule of Reserves (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "MMA:ReserveOfUnbilledShareOption",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:ScheduleOfReservesTableTextBlock",
       "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "MMA:ReserveOfUnbilledShareOption",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:ScheduleOfReservesTableTextBlock",
       "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails",
     "longName": "995683 - Disclosure - Schedule of Issued Capital (Details)",
     "shortName": "Schedule of Issued Capital (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "MMA:OwnersShareCapital",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDetailedInformationIssuedCapitalExplanatory",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-06-30",
      "name": "MMA:OwnersShareCapital",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDetailedInformationIssuedCapitalExplanatory",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical",
     "longName": "995684 - Disclosure - Schedule of Issued Capital (Details) (Parenthetical)",
     "shortName": "Schedule of Issued Capital (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:AdvisorOptionsExercisedShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDetailedInformationIssuedCapitalExplanatory",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "MMA:AdvisorOptionsForfeitedShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfDetailedInformationIssuedCapitalExplanatory",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails",
     "longName": "995685 - Disclosure - Schedule of Statement of Cash Flows (Details)",
     "shortName": "Schedule of Statement of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:AccruedInterestOnConvertibleNotes",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DetailedInformationOfNotesToStatementOfCashFlowExplanatory",
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails",
     "longName": "995686 - Disclosure - Schedule of Key Management Personnel Remuneration (Details)",
     "shortName": "Schedule of Key Management Personnel Remuneration (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails",
     "longName": "995687 - Disclosure - Schedule of Shares Held by Key Management Personnel (Details)",
     "shortName": "Schedule of Shares Held by Key Management Personnel (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-06-30_custom_SharesHeldByKeyManagementPersonnelMember",
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative",
     "longName": "995688 - Disclosure - Related parties transactions (Details Narrative)",
     "shortName": "Related parties transactions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-10-012025-10-02_custom_Mr.LangtonMember",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
     "longName": "995689 - Disclosure - Schedule of Financial Statement of the Parent Entity (Details)",
     "shortName": "Schedule of Financial Statement of the Parent Entity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_ifrs-full_ParentMember",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails",
     "longName": "995690 - Disclosure - Schedule of Country Incorporation Principal Place of Business (Details)",
     "shortName": "Schedule of Country Incorporation Principal Place of Business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_UnitedStatesOfAmericaCountryMember",
      "name": "ifrs-full:PrincipalPlaceOfBusiness",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_UnitedStatesOfAmericaCountryMember",
      "name": "ifrs-full:PrincipalPlaceOfBusiness",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails",
     "longName": "995691 - Disclosure - Summary of Changes in ROU Assets (Details)",
     "shortName": "Summary of Changes in ROU Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:CurrentLeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-05-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember",
      "name": "MMA:RightofuseAsset",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R87": {
     "role": "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails",
     "longName": "995692 - Disclosure - Summary of Future Minimum Lease Payments (Details)",
     "shortName": "Summary of Future Minimum Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "ifrs-full:LeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_ifrs-full_LeaseLiabilitiesMember",
      "name": "ifrs-full:LeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails",
     "longName": "995693 - Disclosure - Schedule of Financial Liabilities (Details)",
     "shortName": "Schedule of Financial Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "ifrs-full:CurrentFinancialLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember",
      "name": "ifrs-full:CurrentFinancialLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory",
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails",
     "longName": "995694 - Disclosure - Schedule of Convertible Notes held by Investors (Details)",
     "shortName": "Schedule of Convertible Notes held by Investors (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-09",
      "name": "MMA:ReachConvertibleNote",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-09",
      "name": "MMA:ReachConvertibleNote",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://altaglobalgroup.com/role/FinancialLiabilitiesDetailsNarrative",
     "longName": "995695 - Disclosure - Financial Liabilities (Details Narrative)",
     "shortName": "Financial Liabilities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DescriptionOfConversionOfDebtToEquity",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:DescriptionOfConversionOfDebtToEquity",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails",
     "longName": "995696 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details)",
     "shortName": "Schedule of Details of Expense from Performance Rights, Options and Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical",
     "longName": "995697 - Disclosure - Schedule of Details of Expense from Performance Rights, Options and Warrants (Details) (Parenthetical)",
     "shortName": "Schedule of Details of Expense from Performance Rights, Options and Warrants (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "From2023-12-012023-12-31",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "MMA:PricePerShareEqualPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R93": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails",
     "longName": "995698 - Disclosure - Schedule of Share Options Outstanding (Details)",
     "shortName": "Schedule of Share Options Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails",
     "longName": "995699 - Disclosure - Schedule of Model Inputs For Options Granted (Details)",
     "shortName": "Schedule of Model Inputs For Options Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember",
      "name": "ifrs-full:ExercisePriceShareOptionsGranted2019",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember",
      "name": "ifrs-full:ExercisePriceShareOptionsGranted2019",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails",
     "longName": "995700 - Disclosure - Schedule of Contractual Maturities of Financial Liabilities (Details)",
     "shortName": "Schedule of Contractual Maturities of Financial Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "MMA:NonInterestBearingTradeAndOtherPayables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "MMA:NonInterestBearingTradeAndOtherPayables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails",
     "longName": "995701 - Disclosure - Schedule of Auditor of Company And Network Firms (Details)",
     "shortName": "Schedule of Auditor of Company And Network Firms (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:AuditFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory",
       "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "MMA:AuditFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory",
       "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative",
     "longName": "995702 - Disclosure - Share-based payments (Details Narrative)",
     "shortName": "Share-based payments (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://altaglobalgroup.com/role/ContingentAssetsAndLiabilitiesDetailsNarrative",
     "longName": "995703 - Disclosure - Contingent Assets and Liabilities (Details Narrative)",
     "shortName": "Contingent Assets and Liabilities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "MMA:ContingentAssetsAndLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "MMA:ContingentAssetsAndLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails",
     "longName": "995704 - Disclosure - Schedule of Loss Per Share (Details)",
     "shortName": "Schedule of Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "ifrs-full:WeightedAverageShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "ifrs-full:EarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative",
     "longName": "995705 - Disclosure - Events after the reporting period (Details Narrative)",
     "shortName": "Events after the reporting period (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "From2023-12-012023-12-31",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-012024-09-30_custom_NonadjustingEventMember",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "ifrs-full_AccruedIncomeOtherThanContractAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccruedIncomeOtherThanContractAssets",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets representing income that has been earned but is not yet a receivable, other than contract assets. [Refer: Contract assets]"
       }
      }
     },
     "auth_ref": [
      "r314",
      "r316"
     ]
    },
    "MMA_AccruedInterestOnConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AccruedInterestOnConvertibleNotes",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest on convertible notes",
        "documentation": "Accrued interest on convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_AccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AccumulatedAmortization",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: amortization for the period",
        "documentation": "Accumulated amortization."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation and amortisation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r318",
      "r324",
      "r325",
      "r326"
     ]
    },
    "ifrs-full_AccumulatedOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccumulatedOtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated losses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset purchased for consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions acquired"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r266"
     ]
    },
    "MMA_AdditionsFromInternalDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AdditionsFromInternalDevelopment",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions from internal development",
        "documentation": "Additions from internal development."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additions",
        "label": "Additions other than through business combinations, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInOtherAssets",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase)/Decrease in other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease in trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in employee entitlement"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "MMA_AdjustmentsForIncreaseDecreaseInNetDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AdjustmentsForIncreaseDecreaseInNetDeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease in net deferred revenue",
        "documentation": "Adjustments for increase decrease in net deferred revenue."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_AdjustmentsForIncreaseDecreaseInProvisionForRefund": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AdjustmentsForIncreaseDecreaseInProvisionForRefund",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Decrease)/increase in provision for refund",
        "documentation": "Adjustments for increase decrease in provision for refund."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase/(decrease) in trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Share based payments*"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "ifrs-full_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising fees"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from advertising."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "MMA_AdvisorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AdvisorMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails",
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisor [Member]",
        "documentation": "Advisor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_AdvisorOptionsExercisedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AdvisorOptionsExercisedShares",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails",
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisor Options exercised (3)",
        "verboseLabel": "Advisor options exercised, shares",
        "documentation": "Advisor options exercised shares"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_AdvisorOptionsExercisedValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AdvisorOptionsExercisedValue",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisor Options exercised",
        "documentation": "Advisor options exercised value."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_AdvisorOptionsForfeitedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AdvisorOptionsForfeitedShares",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisor options forfeited, shares",
        "documentation": "Advisor options forfeited shares."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r237",
      "r248",
      "r258",
      "r284"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r240",
      "r251",
      "r261",
      "r287"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r272"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r279"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r241",
      "r252",
      "r262",
      "r279",
      "r288",
      "r292",
      "r300"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r298"
     ]
    },
    "MMA_AllowancesForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AllowancesForCreditLoss",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less; allowance for credit losses",
        "documentation": "Allowances for credit loss."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization expense",
        "label": "Amortisation, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "MMA_AmortizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AmortizationMember",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization [Member]",
        "documentation": "Amortization [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ApplicableTaxRate",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NetAssetsLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_NetAssetsLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r111",
      "r112",
      "r115",
      "r165",
      "r168"
     ]
    },
    "ifrs-full_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_AuditFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AuditFees",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails": {
       "parentTag": "ifrs-full_AuditorsRemuneration",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit fees",
        "documentation": "Audit fees."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r230",
      "r232",
      "r244"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r230",
      "r232",
      "r244"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r230",
      "r232",
      "r244"
     ]
    },
    "ifrs-full_AuditorsRemuneration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AuditorsRemuneration",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Auditor's remuneration"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "ifrs-full_AuditorsRemunerationForOtherServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AuditorsRemunerationForOtherServices",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails": {
       "parentTag": "ifrs-full_AuditorsRemuneration",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All other fees"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for services that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "MMA_AuditorsRemunerationForRelatedFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AuditorsRemunerationForRelatedFees",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails": {
       "parentTag": "ifrs-full_AuditorsRemuneration",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit \u2013 related fees",
        "documentation": "Auditors remuneration for related fees."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AuditorsRemunerationForTaxServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AuditorsRemunerationForTaxServices",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails": {
       "parentTag": "ifrs-full_AuditorsRemuneration",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfAuditorOfCompanyAndNetworkFirmsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax fees"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for tax services."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "MMA_AustraliaCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AustraliaCountryMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Australia Country [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_AustraliaCountryOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "AustraliaCountryOneMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Australia Country One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r295"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r296"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r291"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r294"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "ifrs-full_BalancesWithBanks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BalancesWithBanks",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash at bank"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash balances held at banks."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "MMA_BankGuaranteeDepositReceivedPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "BankGuaranteeDepositReceivedPaid",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank guarantee deposit received/(paid)",
        "documentation": "Bank guarantee deposit received/(paid)."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66"
     ]
    },
    "MMA_BetweenOneAndTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "BetweenOneAndTwoYearsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Between 1 and 2 Years [Member]",
        "documentation": "Between 1 and 2 Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_BetweenTwoAndFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "BetweenTwoAndFiveYearsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Between 2 and 5 Years [Member]",
        "documentation": "Between 2 and 5 Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Borrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Borrowings",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Face Value"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsByNameAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "ifrs-full_BorrowingsByNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsByNameDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "ifrs-full_BorrowingsInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsInterestRate",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical",
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bottom of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r119",
      "r135",
      "r144",
      "r202",
      "r203",
      "r333"
     ]
    },
    "ifrs-full_BrandNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BrandNamesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand names [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing rights to a group of complementary assets such as a trademark (or service mark) and its related trade name, formulas, recipes and technological expertise. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r232",
      "r244"
     ]
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r43",
      "r74",
      "r77",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r150",
      "r155",
      "r156"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r43",
      "r77",
      "r80",
      "r82",
      "r83",
      "r150",
      "r155",
      "r156"
     ]
    },
    "ifrs-full_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails",
      "http://altaglobalgroup.com/role/StatementOfCashFlows",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodStartLabel": "Cash and cash equivalents at the beginning of the financial period",
        "periodEndLabel": "Cash and cash equivalents at the end of the financial period",
        "totalLabel": "Total cash and cash equivalents",
        "verboseLabel": "Balance as per statement of cash flows"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r91",
      "r107"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash from financing activities",
        "label": "Cash flows from (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r93"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in)/from investing activities",
        "label": "Cash flows from (used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r93"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails",
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "negatedLabel": "Net cash outflows from operating activities",
        "label": "Cash flows from (used in) operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r93"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashOnHand": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashOnHand",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash on hand"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash held by the entity. This does not include demand deposits."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "MMA_ChampSevenPtyLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ChampSevenPtyLtdMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Champ Seven Pty Ltd [Member]",
        "documentation": "Champ Seven Pty Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "ifrs-full_ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value of derivative liability recognised for convertible notes issued during the year",
        "label": "Increase (decrease) in fair value of financial liability, attributable to changes in credit risk of liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the fair value of a financial liability that is attributable to changes in the credit risk of that liability. [Refer: Credit risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails",
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ifrs-full_ComponentsOfEquityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComponentsOfEquityDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails",
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive loss for the period attributable to Alta Global Group Limited",
        "label": "Total comprehensive (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r26",
      "r96",
      "r98",
      "r104",
      "r198"
     ]
    },
    "ifrs-full_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ifrs-full_ConsolidatedStructuredEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ConsolidatedStructuredEntitiesAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated structured entities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ifrs-full_ConsolidatedStructuredEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ConsolidatedStructuredEntitiesDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Consolidated structured entities' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ContingentAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ContingentAssetsAndLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ContingentAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent assets and liabilities",
        "documentation": "Contingent assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ContractualCapitalisedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ContractualCapitalisedInterestRate",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual capitalised interest rate",
        "documentation": "Contractual capitalised interest rate"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ContractualPaymentsToGyms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ContractualPaymentsToGyms",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "MMA_NetRevenueFromProgramFees",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Contractual payments to gyms",
        "documentation": "Contractual payments to gyms.",
        "label": "ContractualPaymentsToGyms"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ContributedEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ContributedEquity",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_Equity",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contributed equity",
        "documentation": "Contributed equity."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ConvertibleInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ConvertibleInstrumentsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible instruments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for convertible instruments."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "MMA_ConvertibleNotesConversionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ConvertibleNotesConversionDate",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion Date",
        "documentation": "Convertible notes conversion date."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ConvertibleNotesConversionDiscount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ConvertibleNotesConversionDiscount",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion Discount (Qualified Equity Investment)",
        "documentation": "Convertible notes conversion discount."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ConvertibleNotesIssueDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ConvertibleNotesIssueDate",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue Date",
        "documentation": "Convertible notes issue date."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ConvertibleNotesIssuedInLieuOfPaymentForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ConvertibleNotesIssuedInLieuOfPaymentForServices",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible notes issued in lieu of payment for services",
        "documentation": "Convertible notes issued in lieu of payment for services."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ConvertibleNotesModificationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ConvertibleNotesModificationDate",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Modification Date",
        "documentation": "Convertible notes modification date."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ConvertibleNotesModifiedMaturityDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ConvertibleNotesModifiedMaturityDate",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Modified Maturity Date",
        "documentation": "Convertible notes modified maturity date."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ConvertibleNotesPreModificationMaturityDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ConvertibleNotesPreModificationMaturityDate",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Modification Maturity Date",
        "documentation": "Convertible notes pre modification maturity date."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ConvertibleNotesTerm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ConvertibleNotesTerm",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term (Years)",
        "documentation": "Convertible notes term."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CounterpartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CounterpartiesAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative",
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ifrs-full_CounterpartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CounterpartiesDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative",
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r100",
      "r198"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAssetsLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net current assets liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current assets less the amount of current liabilities."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_CurrentDebtInstrumentsIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentDebtInstrumentsIssued",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails": {
       "parentTag": "ifrs-full_DebtSecurities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Host Liability - Current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current debt instruments issued. [Refer: Debt instruments issued]"
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_CurrentDerivativeFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentDerivativeFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails": {
       "parentTag": "ifrs-full_DebtSecurities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative liability -Current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_CurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Financial Liabilities",
        "verboseLabel": "Convertible note payable - Current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition",
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Lease Liability",
        "verboseLabel": "Current lease liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "verboseLabel": "Current liabilities",
        "label": "Current liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r102",
      "r198"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentProvisionsForEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentProvisionsForEmployeeBenefits",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Employee Entitlements",
        "verboseLabel": "Current Employee Entitlement"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current tax expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ifrs-full_DebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DebtSecurities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Convertible Notes Payable",
        "label": "Debt instruments issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of instruments issued by the entity that represent indebtedness."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "MMA_DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "- items deductible for taxation not accounting",
        "documentation": "Deferred Tax ExpenseIncomeItemsDeductibleForTaxationNotAccounting"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "- items not assessable for income tax",
        "documentation": "Deferred tax expense income items not assessable for income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax not recognised",
        "documentation": "Deferred tax expense income not recognised in profit or loss."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DeferredTaxExpenseIncomeOtherNonAllowableItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DeferredTaxExpenseIncomeOtherNonAllowableItems",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "- other non-allowable items",
        "documentation": "Deferred tax expense income other non allowable items."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prima facie income tax benefit on loss before income tax calculated at 25% (2022: 25%)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax expense or income relating to the creation or reversal of temporary differences. [Refer: Temporary differences [member]; Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/IncomeTaxDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Caarried forward tax loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax expense or income relating to tax rate changes or the imposition of new taxes. [Refer: Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "ifrs-full_DepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DepreciationExpense",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortisation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DepreciationPropertyPlantAndEquipment",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation expense",
        "label": "Depreciation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r42",
      "r45"
     ]
    },
    "ifrs-full_DerivativeFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DerivativeFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Derivative liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "MMA_DerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DerivativeNet",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Derivative",
        "documentation": "Derivative net."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of preparation",
        "documentation": "Description of accounting policy for basis of preparation explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForBorrowingsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value measurement",
        "label": "Description of accounting policy for fair value measurement [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible note"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classification and measurement of financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of non-financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for income tax."
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets",
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issued capital",
        "label": "Description of accounting policy for issued capital [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "MMA_DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New or amended Accounting Standards and Interpretations adopted",
        "documentation": "Description of accounting policy for new or amended accounting standards and interpretations adopted explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current and non-current classification"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for non-current assets or disposal groups classified as held for sale. [Refer: Non-current assets or disposal groups classified as held for sale]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "MMA_DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent entity financial information",
        "documentation": "Description of accounting policy for parent entity financial information explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "MMA_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "documentation": "Description of accounting policy for right of use assets explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based payments",
        "label": "Description of accounting policy for share-based payment transactions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goods and Services Tax (GST) and other similar taxes"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for taxes other than income tax. [Refer: Tax expense other than income tax expense]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade and other payables",
        "label": "Description of accounting policy for trade and other payables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade and other receivables",
        "label": "Description of accounting policy for trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "ifrs-full_DescriptionOfConversionOfDebtToEquity": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfConversionOfDebtToEquity",
     "presentation": [
      "http://altaglobalgroup.com/role/FinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of debt to equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the non-cash conversion of debt to equity."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "MMA_DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/FinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Financial Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price volatility"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ifrs-full_DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of contracts shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of terms of shares reserved for issue under options and contracts for the sale of shares."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "MMA_DetailedInformationOfNotesToStatementOfCashFlowExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DetailedInformationOfNotesToStatementOfCashFlowExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/NotesToStatementOfCashFlowsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Statement of Cash Flows",
        "documentation": "Detailed information of notes to statement of cash flow explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66"
     ]
    },
    "MMA_DisclosureCorporateInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureCorporateInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Information"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureCurrentAndNoncurrentEmployeeEntitlementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Current And Non-current Employee Entitlements",
        "verboseLabel": "Schedule Of Current And Non-current Employee Entitlements"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DisclosureOfAccountingJudgementsAndEstimatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Critical Accounting Judgements Estimates And Assumptions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Critical accounting judgements, estimates and assumptions"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ifrs-full_DisclosureOfAuditorsRemunerationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAuditorsRemunerationExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/RemunerationOfAuditors"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remuneration of auditors"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of compensation to the entity's auditors."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/CashAndCashEquivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Disclosure of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "MMA_DisclosureOfCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfCashEquivalentsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/CashAndCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cash and Cash Equivalents",
        "documentation": "Disclosure of cash equivalents explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCashFlowStatementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCashFlowStatementExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/NotesToStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes to statement of cash flows"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for a statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ifrs-full_DisclosureOfCommitmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCommitmentsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/Commitments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of commitments."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/ContingentAssetsAndLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Assets and Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of contingent liabilities. [Refer: Classes of contingent liabilities [domain]]"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "MMA_DisclosureOfCorporateInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfCorporateInformationExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/CorporateInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate information",
        "documentation": "Disclosure of corporate information explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current and Non-current Employee Entitlements",
        "documentation": "Disclosure of current and non current employee entitlements explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDebtSecuritiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDebtSecuritiesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/FinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Convertible Notes held by Investors"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of debt instruments. [Refer: Debt instruments issued; Debt instruments held]"
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "MMA_DisclosureOfDerivativeLiabilityExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfDerivativeLiabilityExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value Measurement of Derivative Liability",
        "documentation": "Disclosure of derivative liability explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical",
      "http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "MMA_DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/CurrentAndNon-currentEmployeeEntitlementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Current and Non-current Employee Entitlements",
        "documentation": "Disclosure of detailed information about current and non current employee entitlements explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DisclosureOfDetailedInformationAboutExpensesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfDetailedInformationAboutExpensesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/ExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of expenses",
        "documentation": "Disclosure of detailed information about expenses explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property and Equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "MMA_DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliations of the Movement of Intangible Assets",
        "documentation": "Disclosure of detailed information about reconciliations of the movement of intangible assets explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DisclosureOfDetailedInformationAboutTradeAndOtherPayables": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfDetailedInformationAboutTradeAndOtherPayables",
     "presentation": [
      "http://altaglobalgroup.com/role/TradeAndOtherPayablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Trade and Other Payables",
        "documentation": "Disclosure of detailed information about trade and other payables."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/UnearnedRevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unearned Revenue",
        "documentation": "Disclosure of detailed information about unearned revenue explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DisclosureOfDetailedInformationIssuedCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfDetailedInformationIssuedCapitalExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/IssuedCapitalTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Issued Capital",
        "documentation": "Disclosure of detailed information issued capital explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of disaggregation of revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Loss Per Share"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "MMA_DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income Tax Expenses",
        "documentation": "Disclosure of effective income tax rate reconciliations explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/OperatingSegments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating segments"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriod"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events after the reporting period"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "MMA_DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/Share-basedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Details of Expense from Performance Rights, Options and Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DisclosureOfExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expenses",
        "label": "Schedule Of Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfExpensesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfExpensesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/Expenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expenses",
        "label": "Disclosure of expenses [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of expenses."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/FairValueMeasurement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value measurement"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for fair value measurement."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsTable",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value Assets and Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/FinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments [text block]",
        "verboseLabel": "Financial Instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/FinancialLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/IncomeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/Share-basedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Model Inputs For Options Granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables",
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Financial Statement of the Parent Entity",
        "verboseLabel": "Disclosure of information about consolidated structured entities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to consolidated structured entities."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Key Management Personnel Remuneration"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "MMA_DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/RemunerationOfAuditorsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Auditor of Company And Network Firms",
        "documentation": "Disclosure of information about remuneration of auditors explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing instruments with potential future dilutive effect not included in calculation of diluted earnings per share."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets",
        "label": "Disclosure of intangible assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsTable",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ifrs-full_DisclosureOfIssuedCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIssuedCapitalExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/IssuedCapital"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of issued capital. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfLeasesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r132"
     ]
    },
    "MMA_DisclosureOfMaterialAccountingPolicyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfMaterialAccountingPolicyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Accounting Policy Information"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaterialAccountingPolicyInformationExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Material Accounting Policy Information",
        "label": "Disclosure of material accounting policy information [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure of material accounting policy information applied by the entity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Future Minimum Lease Payments"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/Share-basedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Options Outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DisclosureOfPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfPlantAndEquipmentExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of plant and equipment",
        "documentation": "Disclosure of plant and equipment explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfProductsAndServicesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfProductsAndServicesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's products and services. [Refer: Products and services [domain]]"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Changes in ROU Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in goodwill [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill."
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "MMA_DisclosureOfRelatedPartiesTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfRelatedPartiesTransactionsAbstract",
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related parties transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "MMA_DisclosureOfReservesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfReservesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserves",
        "verboseLabel": "Schedule Of Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/Reserves"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reserves",
        "label": "Disclosure of reserves within equity [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of reserves within equity. [Refer: Other reserves [member]]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "label": "Disclosure of revenue from contracts with customers [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123"
     ]
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/Share-basedPayments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Country Incorporation Principal Place of Business"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to subsidiaries."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r109"
     ]
    },
    "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of significant unobservable inputs used in fair value measurement of assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to significant unobservable inputs used in the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unobservable Inputs Level 3 Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of significant inputs for which market data are not available and that are developed using the best information available about the assumptions that market participants would use when measuring the fair value of liabilities."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "MMA_DisclosureOfTradeAndOtherPayablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfTradeAndOtherPayablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade And Other Payables",
        "verboseLabel": "Schedule Of Trade And Other Payables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/TradeAndOtherPayables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade and other payables",
        "label": "Disclosure of trade and other payables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "MMA_DisclosureOfTradeAndOtherReceivableExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfTradeAndOtherReceivableExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/TradeAndOtherReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Trade and Other Receivables",
        "documentation": "Disclosure of trade and other receivable explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/TradeAndOtherReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade and other receivables",
        "label": "Disclosure of trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Shares Held by Key Management Personnel"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "MMA_DisclosureOfUnearnedRevenueAbtract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfUnearnedRevenueAbtract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned Revenue",
        "verboseLabel": "Schedule Of Unearned Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_DisclosureOfUnearnedRevenueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "DisclosureOfUnearnedRevenueExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/UnearnedRevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned Revenue",
        "documentation": "Disclosure of unearned revenue explanatory.",
        "label": "DisclosureOfUnearnedRevenueExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisposalsAndRetirementsPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposals"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals and retirements. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r232",
      "r244"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r232",
      "r244",
      "r280"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r265"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EarningsPerShareExplanatory",
     "presentation": [
      "http://altaglobalgroup.com/role/LossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88"
     ]
    },
    "MMA_EmployeeStockOwnershipPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "EmployeeStockOwnershipPlanMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Ownership Plan [Member]",
        "documentation": "Employee Stock Ownership Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_EmployeementAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "EmployeementAgreementMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employeement Agreement [Member]",
        "documentation": "Employeement Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_EmploymentAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "EmploymentAgreementMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employment Agreement [Member]",
        "documentation": "Employment Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r307"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r305"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity/(deficit)",
        "periodStartLabel": "Opening balance",
        "periodEndLabel": "Closing balance",
        "label": "Equity [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r20",
      "r95",
      "r97",
      "r111",
      "r112",
      "r115"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r237",
      "r248",
      "r258",
      "r284"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r234",
      "r245",
      "r255",
      "r281"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExercisePriceShareOptionsGranted2019",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails",
      "http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price",
        "verboseLabel": "Options exercise price"
       }
      },
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "MMA_ExercisePricesFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExercisePricesFourMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Prices Four [Member]",
        "documentation": "Exercise Prices Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ExercisePricesOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExercisePricesOneMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Prices One [Member]",
        "documentation": "Exercise Prices One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ExercisePricesThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExercisePricesThreeMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Prices Three [Member]",
        "documentation": "Exercise Prices Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ExercisePricesTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExercisePricesTwoMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Prices Two [Member]",
        "documentation": "Exercise Prices Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ExercisedOptionsHeldByKeyManagementPersonnel": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExercisedOptionsHeldByKeyManagementPersonnel",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised",
        "documentation": "Exercised options held by key management personnel."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected Dividend yield"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "MMA_ExpectedTermShareOptionsGranted": {
     "xbrltype": "durationItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExpectedTermShareOptionsGranted",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term",
        "documentation": "Expected term share options granted."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseByNature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseByNature",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Expenses",
        "label": "Expenses, by nature"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "ifrs-full_ExpenseByNatureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseByNatureAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ExpenseFromAdvisorOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExpenseFromAdvisorOptions",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisor Options ()"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ExpenseFromOverAllotmentOption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExpenseFromOverAllotmentOption",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over allotment Option ()"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ExpenseFromReach": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExpenseFromReach",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reach"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ExpenseFromRestrictedShareUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExpenseFromRestrictedShareUnits",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSU"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payments",
        "verboseLabel": "Share-based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "MMA_ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ESOP"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ExpenseFromWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExpenseFromWarrants",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants ()"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ExpiredOptionsHeldByKeyManagementPersonnel": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ExpiredOptionsHeldByKeyManagementPersonnel",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expired",
        "documentation": "Expired options held by key management personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_FairValueMovementInDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "FairValueMovementInDerivativeLiability",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Fair Value movement in derivative liability",
        "documentation": "Fair value movement in derivative liability.",
        "label": "FairValueMovementInDerivativeLiability"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_FairValueMovementRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "FairValueMovementRecognisedInProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails",
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value movement recognised in profit or loss",
        "verboseLabel": "Fair value movement of derivatives",
        "documentation": "Fair value movement recognised in profit or loss."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of derivative liability for convertible notes which converted or matured during the year",
        "documentation": "Fair value of derivative liability for convertible notes which converted or matured during year."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of derivative liability recognised for convertible notes issued during the year",
        "documentation": "Fair value of derivative liability recognised for convertible notes issued during year."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value of derivative liability for convertible notes which converted or matured during the year",
        "documentation": "Fair value of liability for convertible notes which converted or matured during year.",
        "label": "FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 10.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance costs",
        "totalLabel": "Total finance costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "MMA_FinanceCostsBankFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "FinanceCostsBankFees",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank fees",
        "documentation": "Finance costs bank fees."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_FinanceCostsBankInterestAndLeaseInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "FinanceCostsBankInterestAndLeaseInterest",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank interest and lease interest",
        "documentation": "Finance costs bank interest and lease interest."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_FinanceCostsConvertibleNotesInterestContractualAndEffective": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "FinanceCostsConvertibleNotesInterestContractualAndEffective",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible notes interest \u2013 contractual and effective",
        "documentation": "Finance costs convertible notes interest contractual and effective."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssetsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails",
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "totalLabel": "Total Financial Liabilities",
        "label": "Financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liabilities \u2013 refer Note 21",
        "totalLabel": "Total liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ifrs-full_FixturesAndFittingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FixturesAndFittingsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixtures and fittings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "MMA_ForeignCurrencyReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ForeignCurrencyReserves",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReservesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency translation reserve",
        "documentation": "Foreign currency reserves.",
        "label": "ForeignCurrencyReserves"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r241",
      "r252",
      "r262",
      "r288"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r241",
      "r252",
      "r262",
      "r288"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r241",
      "r252",
      "r262",
      "r288"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r241",
      "r252",
      "r262",
      "r288"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r241",
      "r252",
      "r262",
      "r288"
     ]
    },
    "ifrs-full_FranchiseFeeIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FranchiseFeeIncome",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails": {
       "parentTag": "ifrs-full_OtherRevenue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finale, franchise fee and other fees"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income arising from franchise fees."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "MMA_FurnitrueAndFittingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "FurnitrueAndFittingsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furnitrue and fittings [member]",
        "documentation": "Furnitrue and fittings [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueMeasurementOfDerivativeLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value movement recognised in profit or loss",
        "label": "Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) including exchange differences recognised in profit or loss on the fair value measurement of liabilities. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r186",
      "r205",
      "r209"
     ]
    },
    "ifrs-full_GeographicalAreasDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GeographicalAreasDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r186",
      "r205",
      "r209"
     ]
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r40",
      "r74",
      "r81",
      "r84",
      "r150",
      "r156",
      "r157",
      "r210"
     ]
    },
    "ifrs-full_GrossLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GrossLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": "ifrs-full_LeaseLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Five years and over"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r128",
      "r213"
     ]
    },
    "ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "HistoricalVolatilityForSharesMeasurementInputMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Historical volatility for shares, measurement input [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the historical volatility for shares used as a measurement input."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "MMA_HypeCoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "HypeCoMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hype Co [Member]",
        "documentation": "Hype Co [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_HypeKitIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "HypeKitIncMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hype Kit, Inc [member]",
        "documentation": "Hype Kit, Inc [member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ITCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ITCosts",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IT costs",
        "documentation": "IT costs."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r230",
      "r232",
      "r244"
     ]
    },
    "MMA_IfrsStatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "IfrsStatementLineItems",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative",
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative",
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails",
      "http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails",
      "http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails",
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical",
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails",
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails",
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails",
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails",
      "http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative",
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity",
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails",
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IfrsStatementLineItems [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_IfrsStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "IfrsStatementTable",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IfrsStatementTable [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ImpliedValuationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ImpliedValuationMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Implied valuation [Member]",
        "documentation": "Implied valuation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax expense",
        "totalLabel": "Income tax expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r29",
      "r34",
      "r35",
      "r36",
      "r62",
      "r108",
      "r164"
     ]
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease) /increase in cash and cash equivalents",
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Implied Valuation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of increase (decrease) in the fair value measurement of liabilities due to a reasonably possible increase in an unobservable input."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisor options exercised (see Note 17)"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "MMA_IncreaseDecreaseThroughOptionsForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "IncreaseDecreaseThroughOptionsForfeited",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisor options forfeited (see Note 22)",
        "documentation": "Increase decrease through options forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payments (see Note 22)"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r241",
      "r252",
      "r262",
      "r279",
      "r288",
      "r292",
      "r300"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r298"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r233",
      "r303"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r233",
      "r303"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r233",
      "r303"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets",
        "verboseLabel": "Total intangible assets",
        "periodStartLabel": "Balance at beginning of the period",
        "periodEndLabel": "Balance at end of the period"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r77"
     ]
    },
    "ifrs-full_IntangibleAssetsUnderDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsUnderDevelopmentMember",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets under development [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing such assets under development. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "MMA_InterestBearingFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "InterestBearingFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liability host debt",
        "documentation": "Interest bearing financial liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_InterestBearingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "InterestBearingLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liability",
        "documentation": "Interest bearing lease liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_InterestBearingNonderivativesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "InterestBearingNonderivativesNet",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total non derivative",
        "documentation": "Interest bearing non derivatives net."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestPaidClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestPaidClassifiedAsOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest and other finance costs paid",
        "label": "Interest paid, classified as operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ifrs-full_InterestRateMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestRateMeasurementInputMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate, measurement input [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an interest rate used as a measurement input."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "MMA_IrelandCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "IrelandCountryMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ireland Country [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssueOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssueOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued of Shares fully paid net of Transaction cost (see Note 17)"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "MMA_IssueOfEquityFromConversionOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "IssueOfEquityFromConversionOfConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails",
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue of Shares from conversion of convertible notes (see Note 17)",
        "verboseLabel": "Issue of shares from the conversion of the convertible notes",
        "documentation": "Issue of equity from conversion of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_IssueOfSharesFromConversionOfConvertibleNotes": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "IssueOfSharesFromConversionOfConvertibleNotes",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue of shares from the conversion of the convertible notes (2)",
        "documentation": "Issue of shares from conversion of convertible notes"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_IssueOfUnlistedSharesFromConversionOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "IssueOfUnlistedSharesFromConversionOfConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue of Unlisted Shares from conversion of convertible notes (see Note 17)",
        "documentation": "Issue of unlisted shares from conversion of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_IssuedAndFullyPaidValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "IssuedAndFullyPaidValue",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issued and fully paid",
        "documentation": "Issued and fully paid value",
        "label": "Issued and fully paid value"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued Capital",
        "periodStartLabel": "Owners share capital, opening",
        "periodEndLabel": "Owners share capital, closing"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "MMA_IssuedOptionsHeldByKeyManagementPersonnel": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "IssuedOptionsHeldByKeyManagementPersonnel",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issued",
        "documentation": "Issued options held by key management personnel.",
        "label": "IssuedOptionsHeldByKeyManagementPersonnel"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_IssuedSharesHeldByKeyManagementPersonnel": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "IssuedSharesHeldByKeyManagementPersonnel",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued",
        "documentation": "Issued shares held by key management personnel."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_JHartFamilyTrustAccountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "JHartFamilyTrustAccountMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "J Hart Family Trust Account [Member]",
        "documentation": "J Hart Family Trust Account [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Key management personnel compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationOtherLongtermBenefits",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of other long-term employee benefits. [Refer: Other long-term employee benefits; Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post employment benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfKeyManagementPersonnelRemunerationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short term benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year and not later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r216"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year and not later than three years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than three years."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r214",
      "r216"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year and not later than two years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than two years."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r136",
      "r212",
      "r216",
      "r311"
     ]
    },
    "ifrs-full_LeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails",
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total lease liabilities",
        "verboseLabel": "Total future lease payments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseLiabilitiesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r194",
      "r196"
     ]
    },
    "ifrs-full_Level1OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Level1OfFairValueHierarchyMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 1 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r70",
      "r71",
      "r112"
     ]
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Level2OfFairValueHierarchyMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 2 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r71",
      "r112"
     ]
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Level3OfFairValueHierarchyMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 3 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r71",
      "r112"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r112"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFairValueAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r112"
     ]
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NetAssetsLiabilities",
       "weight": -1.0,
       "order": 2.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_NetAssetsLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r111",
      "r112",
      "r115",
      "r165",
      "r169"
     ]
    },
    "ifrs-full_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityAnalysisForDerivativeFinancialLiabilities",
     "presentation": [
      "http://altaglobalgroup.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Contractual Maturities of Financial Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r121",
      "r129",
      "r130",
      "r133",
      "r134",
      "r135",
      "r136",
      "r153",
      "r159",
      "r187",
      "r212"
     ]
    },
    "ifrs-full_MaturityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r121",
      "r129",
      "r130",
      "r133",
      "r134",
      "r135",
      "r136",
      "r153",
      "r187",
      "r212",
      "r215"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "MMA_MixedMartialArtsLLCConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "MixedMartialArtsLLCConvertibleNotesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mixed Martial Arts LLC Convertible Notes [Member]",
        "documentation": "Mixed Martial Arts LLC Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_MixedMartialArtsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "MixedMartialArtsLLCMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mixed martial arts LLC [Member]",
        "documentation": "Mixed martial arts LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_MixedMartialsArtsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "MixedMartialsArtsLLCMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mixed Martials Arts LLC [member]",
        "documentation": "Mixed Martials Arts LLC [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "MMA_Modification": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "Modification",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Modification",
        "documentation": "Modification."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_Mr.LangtonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "Mr.LangtonMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr.Langton [Member]",
        "documentation": "Mr.Langton [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_MrHartMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "MrHartMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr Hart [Member]",
        "documentation": "Mr Hart [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_MrLangtonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "MrLangtonMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MrLangton [Member]",
        "documentation": "MrLangton [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_MrMcGregorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "MrMcGregorMember",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr McGregor [Member]",
        "documentation": "Mr McGregor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_MrTaylorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "MrTaylorMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MrTaylor [Member]",
        "documentation": "MrTaylor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_MrWilliamsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "MrWilliamsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MrWilliams [Member]",
        "documentation": "MrWilliams [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "MMA_NalarooHoldingsPtyLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "NalarooHoldingsPtyLtdMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nalaroo Holdings Pty Ltd [Member]",
        "documentation": "Nalaroo Holdings Pty Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NameOfParentEntity": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NameOfParentEntity",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of parent entity"
       }
      },
      "en": {
       "role": {
        "documentation": "The name of the entity's parent. [Refer: Parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r51"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_NetAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NetAssetsLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net assets/(liabilities)",
        "label": "Net assets liabilities",
        "negatedLabel": "Net assets liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of liabilities."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r311"
     ]
    },
    "ifrs-full_NetForeignExchangeGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NetForeignExchangeGain",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": -1.0,
       "order": 9.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net foreign exchange gain",
        "negatedTotalLabel": "Net foreign exchange (gains)",
        "label": "Net foreign exchange gain"
       }
      },
      "en": {
       "role": {
        "documentation": "The net gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      }
     },
     "auth_ref": [
      "r313",
      "r322"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_NetRevenueFromProgramFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "NetRevenueFromProgramFees",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Revenue from Program Fees",
        "documentation": "Net revenue from program fees.",
        "label": "NetRevenueFromProgramFees"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "MMA_NonInterestBearingTradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "NonInterestBearingTradeAndOtherPayables",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade and other payables",
        "documentation": "Non interest bearing trade and other payables.",
        "label": "NonInterestBearingTradeAndOtherPayables"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "MMA_NonadjustingEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "NonadjustingEventMember",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonadjusting Event [Member]",
        "documentation": "Nonadjusting Event [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "verboseLabel": "Non-current assets",
        "label": "Non-current assets [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r101",
      "r198"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentDebtInstrumentsIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentDebtInstrumentsIssued",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails": {
       "parentTag": "ifrs-full_DebtSecurities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Host Liability \u2013 Non Current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current debt instruments issued. [Refer: Debt instruments issued]"
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_NoncurrentDerivativeFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentDerivativeFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails": {
       "parentTag": "ifrs-full_DebtSecurities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative liability - Non Current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_NoncurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current Financial Liabilities",
        "verboseLabel": "Convertible note payable \u2013 Non Current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition",
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current Lease Liability",
        "verboseLabel": "Non-current lease liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "verboseLabel": "Non-current liabilities",
        "label": "Non-current liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r103",
      "r198"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentProvisionsForEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentProvisionsForEmployeeBenefits",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCurrentAndNon-currentEmployeeEntitlementsDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current Employee Entitlements"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NotLaterThanOneYearMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/SummaryOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Not later than one year [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r129",
      "r130",
      "r136",
      "r212",
      "r216"
     ]
    },
    "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NotesAndOtherExplanatoryInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes and other explanatory information [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NotionalAmount",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
     "presentation": [
      "http://altaglobalgroup.com/role/EventsAfterReportingPeriodDetailsNarrative",
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share percent rate",
        "verboseLabel": "Advisor Options vested and were exercised",
        "terseLabel": "Vested and convertible shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails",
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Opening Balance",
        "periodEndLabel": "Closing Balance",
        "label": "Number of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r142",
      "r144"
     ]
    },
    "MMA_NumberOfShareIssuedAndFullyPaid": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "NumberOfShareIssuedAndFullyPaid",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued and fully paid",
        "documentation": "Number of share issued and fully paid."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised during the period",
        "negatedLabel": "Total exercised during the period"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical",
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisor Options forfeited",
        "negatedLabel": "Total forfeited/expired during the period",
        "verboseLabel": "Forfeited/expired during the period"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total granted during the period"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative",
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "verboseLabel": "Ordinary Shares on exercise"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfSharesOutstanding",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Opening Balance",
        "periodEndLabel": "Closing Balance",
        "label": "Number of shares outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "ifrs-full_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "MMA_OneMajorProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "OneMajorProductMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One major product [Member]",
        "documentation": "One major product [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_OptionHeldByKeyManagementPersonnelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "OptionHeldByKeyManagementPersonnelMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Held By Key Management Personnel [Member]",
        "documentation": "Option Held By Key Management Personnel [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss, net of tax",
        "verboseLabel": "Other comprehensive (loss)",
        "terseLabel": "Other comprehensive loss for the period"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r25",
      "r30",
      "r106"
     ]
    },
    "ifrs-full_OtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_OtherExpenseByNature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherExpenseByNature",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]"
       }
      }
     },
     "auth_ref": [
      "r31",
      "r175"
     ]
    },
    "ifrs-full_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r175",
      "r176"
     ]
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_OtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherPayables",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "ifrs-full_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other advances"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "ifrs-full_OtherReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherReserves",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reserves",
        "label": "Other reserves"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ifrs-full_OtherRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherRevenue",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income",
        "label": "Other revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r239",
      "r250",
      "r260",
      "r286"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r253",
      "r263",
      "r289"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r253",
      "r263",
      "r289"
     ]
    },
    "MMA_OverAllotmentOptionsLapsed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "OverAllotmentOptionsLapsed",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over allotment options lapsed (see Note 22)",
        "documentation": "Over allotment options lapsed."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_OverAllotmentOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "OverAllotmentOptionsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over Allotment Options [Member]",
        "documentation": "Over Allotment Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_OwnersShareCapital": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "OwnersShareCapital",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Owners share capital, opening (1)",
        "periodEndLabel": "Owners share capital, closing",
        "documentation": "Owners share capital.",
        "label": "OwnersShareCapital"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ParentMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an entity that controls one or more entities."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r267"
     ]
    },
    "ifrs-full_PaymentsForShareIssueCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsForShareIssueCosts",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share issue transaction costs net of tax",
        "label": "Payments for share issue costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for share issue costs."
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "ifrs-full_PaymentsToSuppliersForGoodsAndServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsToSuppliersForGoodsAndServices",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments to member gyms, suppliers &amp; employees (inclusive of GST)",
        "label": "Payments to suppliers for goods and services"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to suppliers for goods and services."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "MMA_PercentageOfOrdinarySharesUnderVestAndExercisable": {
     "xbrltype": "percentItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "PercentageOfOrdinarySharesUnderVestAndExercisable",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage vest and exercisable",
        "documentation": "Percentage of ordinary shares under vest and exercisable."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_PlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "PlantAndEquipmentMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plant and equipment [Member]",
        "documentation": "Plant and equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_PlatformDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "PlatformDevelopmentMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform development [member]",
        "documentation": "Platform development [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r226"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "MMA_PricePerShareEqualPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "PricePerShareEqualPercentage",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDetailsOfExpenseFromPerformanceRightsOptionsAndWarrantsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Price per share equal percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PrincipalPlaceOfBusiness": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PrincipalPlaceOfBusiness",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal place of business"
       }
      },
      "en": {
       "role": {
        "documentation": "The place where an entity principally conducts operations."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "MMA_PrivatePlacementConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "PrivatePlacementConvertibleNotesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Convertible Notes [Member]",
        "documentation": "Private Placement Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_PrivatePlacementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "PrivatePlacementsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProbabilityOfDefaultMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProbabilityOfDefaultMeasurementInputMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Probability of default, measurement input [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the probability of default used as a measurement input."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r203"
     ]
    },
    "ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receipt from Government grants and tax incentives related to assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from government grants, classified as investing activities. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromIssueOfBondsNotesAndDebentures",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from convertible notes, net of transaction costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of bonds, notes and debentures."
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromIssuingShares",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issue of equity, net of transaction costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "MMA_ProceedsFromTrainingParticipants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ProceedsFromTrainingParticipants",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receipts from training participants (inclusive of GST)",
        "documentation": "Receipts from training participants."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProductsAndServicesAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r204"
     ]
    },
    "ifrs-full_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r204"
     ]
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfessionalFeesExpense",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional fees"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/CriticalAccountingJudgementsEstimatesAndAssumptionsDetailsNarrative",
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails",
      "http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails",
      "http://altaglobalgroup.com/role/ScheduleOfStatementOfCashFlowsDetails",
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss after income tax expense for the period",
        "label": "Loss after tax",
        "negatedLabel": "Loss after tax",
        "verboseLabel": "Loss after income tax",
        "terseLabel": "Loss for the period"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r1",
      "r24",
      "r86",
      "r96",
      "r98",
      "r165",
      "r167",
      "r198",
      "r207"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfIncomeTaxExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income tax expense",
        "label": "Loss before income tax expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r151",
      "r175",
      "r176",
      "r217",
      "r218"
     ]
    },
    "MMA_ProgramExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ProgramExpenses",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 1.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Program Expenses",
        "totalLabel": "Total program expenses",
        "documentation": "Program expenses."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ProgramExpensesEventCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ProgramExpensesEventCosts",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": "MMA_ProgramExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event Costs",
        "documentation": "Program expenses, event costs."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ProgramExpensesMerchantFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ProgramExpensesMerchantFees",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": "MMA_ProgramExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merchant fees",
        "documentation": "Program expenses, merchant fees."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ProgramExpensesOtherCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ProgramExpensesOtherCosts",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": "MMA_ProgramExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other costs",
        "documentation": "Program expenses, other costs."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ProgramExpensesProgramCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ProgramExpensesProgramCosts",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": "MMA_ProgramExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Program costs",
        "documentation": "Program expenses, program costs."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment",
        "verboseLabel": "Furniture &amp; Fittings",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r43"
     ]
    },
    "MMA_PropertyPlantAndEquipmentAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "PropertyPlantAndEquipmentAccumulatedDepreciation",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Accumulated depreciation",
        "documentation": "Property plant and equipment accumulated depreciation."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total property and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment that would have been recognised had the revalued assets been carried under the cost model. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "MMA_PropertyPlantAndEquipmentCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "PropertyPlantAndEquipmentCost",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture &amp; Fittings - at cost",
        "documentation": "Property plant and equipment cost."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proportion of ownership interests held by non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "MMA_ProvisionForRefundLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ProvisionForRefundLiability",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for refund liability",
        "documentation": "Provision for refund liability."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments for intangible assets",
        "label": "Purchase of intangible assets, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments for property equipment, net of disposal",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical",
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r119",
      "r135",
      "r144",
      "r202",
      "r203",
      "r333"
     ]
    },
    "ifrs-full_RangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangeDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical",
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r119",
      "r135",
      "r144",
      "r202",
      "r203",
      "r333"
     ]
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Range [domain]]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "MMA_ReachConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ReachConvertibleNote",
     "crdr": "credit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reach convertible note",
        "documentation": "Reach convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ReachConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ReachConvertibleNotesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reach Convertible Notes [Member]",
        "documentation": "Reach Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ReachMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ReachMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails",
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails",
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reach [Member]",
        "documentation": "Reach [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_RealizedCurrencyGainslosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "RealizedCurrencyGainslosses",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": "ifrs-full_NetForeignExchangeGain",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Realized currency (gains)/losses",
        "documentation": "Realized currency gains losses.",
        "label": "RealizedCurrencyGainslosses"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receipts from Government grants and tax incentives related to expenditure",
        "documentation": "Receipts from government grants and tax incentives related to expenditure."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r234",
      "r245",
      "r255",
      "r281"
     ]
    },
    "MMA_RedeemedForCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "RedeemedForCash",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemed for cash",
        "documentation": "Redeemed for cash."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_RentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "RentExpenses",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rent",
        "documentation": "Rent expenses."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "auth_ref": []
    },
    "MMA_RepurchasedSharesHeldByKeyManagementPersonnel": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "RepurchasedSharesHeldByKeyManagementPersonnel",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchased",
        "documentation": "Repurchased shares held by key management personnel."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ResearchAndDevelopmentIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ResearchAndDevelopmentIncome",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Tax incentive receivable",
        "documentation": "Research and development income."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ResearchDevelopmentTaxIncentive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ResearchDevelopmentTaxIncentive",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research &amp; Development tax incentive",
        "documentation": "Research &amp; development tax incentive."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ReserachAndDevelopmentIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ReserachAndDevelopmentIncome",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails": {
       "parentTag": "ifrs-full_OtherRevenue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development tax incentive",
        "documentation": "Reserach and development income."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency translation reserve"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r177"
     ]
    },
    "ifrs-full_ReserveOfSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfSharebasedPayments",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReservesDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment reserve",
        "verboseLabel": "Share based payment reserve"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity resulting from share-based payments."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "ifrs-full_ReserveOfSharebasedPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfSharebasedPaymentsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve of share-based payments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from share-based payments."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "MMA_ReserveOfUnbilledShareOption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ReserveOfUnbilledShareOption",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReservesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unlisted share option reserve",
        "documentation": "Reserve of unbilled share option."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ResignationOfKeyManagementPersonnelShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ResignationOfKeyManagementPersonnelShares",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Resignation of Key Management Personnel",
        "documentation": "Resignation of key management personnel shares."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r235",
      "r246",
      "r256",
      "r282"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r236",
      "r247",
      "r257",
      "r283"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r243",
      "r254",
      "r264",
      "r290"
     ]
    },
    "ifrs-full_RestrictedShareUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RestrictedShareUnitsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails",
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted share units [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for restricted share units."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialStatementOfParentEntityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated losses",
        "label": "Retained earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180"
     ]
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Revenue",
        "label": "Revenue [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r105",
      "r151",
      "r163",
      "r166",
      "r170",
      "r171",
      "r173",
      "r175",
      "r176",
      "r198"
     ]
    },
    "MMA_RevenueFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "RevenueFromContractsWithCustomersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "verboseLabel": "Schedule Of Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_RevenueFromContractualPaymentsToGyms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "RevenueFromContractualPaymentsToGyms",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails": {
       "parentTag": "ifrs-full_RevenueFromRenderingOfServices",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails",
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual payments to gyms",
        "documentation": "Contractual payments to gyms."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_RevenueFromProgramFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "RevenueFromProgramFees",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "MMA_NetRevenueFromProgramFees",
       "weight": 1.0,
       "order": 1.0
      },
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails": {
       "parentTag": "ifrs-full_RevenueFromRenderingOfServices",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss",
      "http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails",
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Program Fees",
        "verboseLabel": "Revenue from program fees",
        "documentation": "Revenue from program fees."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RevenueFromRenderingOfServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevenueFromRenderingOfServices",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfDisaggregationOfRevenueDetails",
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Revenue from program fees",
        "label": "Revenue from rendering of services"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the rendering of services. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "ifrs-full_RevenueFromSaleOfGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevenueFromSaleOfGoods",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails": {
       "parentTag": "ifrs-full_OtherRevenue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merchandise sales"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the sale of goods. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "MMA_ReverseShareSplitOptionsHeldByKeyManagementPersonnel": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ReverseShareSplitOptionsHeldByKeyManagementPersonnel",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse share split",
        "documentation": "Reverse share split options held by key management personnel."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_ReverseShareSplitSharesHeldByKeyManagementPersonnel": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ReverseShareSplitSharesHeldByKeyManagementPersonnel",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Share Split",
        "documentation": "Reverse share split shares held by key management personnel."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_RightofuseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "RightofuseAsset",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/SummaryOfChangesInRouAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of yea",
        "periodEndLabel": "Balance at end of the year",
        "documentation": "Right of use asset.",
        "label": "RightofuseAsset"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use asset"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r126"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "MMA_ScheduleOfReservesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "ScheduleOfReservesTableTextBlock",
     "presentation": [
      "http://altaglobalgroup.com/role/ReservesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reserves",
        "documentation": "Schedule of reserves table text block."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r220"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r224"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "MMA_SeriesAAugust21Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesAAugust21Member",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A August21 [Member]",
        "documentation": "Series A August21 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SeriesAAugustTwentyOneConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesAAugustTwentyOneConvertibleNotesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A August 21 convertible notes [member]",
        "documentation": "Series A August 21 convertible notes [member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SeriesAConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesAConvertibleNotesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails",
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Convertible Notes [Member]",
        "documentation": "Series A Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SeriesAExtensionConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesAExtensionConvertibleNotesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Extension Convertible Notes [Member]",
        "documentation": "Series A Extension Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SeriesAExtensionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesAExtensionMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A extension [Member]",
        "documentation": "Series A extension [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SeriesAJuly21Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesAJuly21Member",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A July21 [Member]",
        "documentation": "Series A July21 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SeriesAJulyTwentyOneConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesAJulyTwentyOneConvertibleNotesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A July-21 convertible notes [member]",
        "documentation": "Series A July-21 convertible notes [member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SeriesB1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesB1Member",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B1 [Member]",
        "documentation": "Series B1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SeriesB2ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesB2ConvertibleNotesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B2 Convertible Notes [Member]",
        "documentation": "Series B2 Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SeriesB2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesB2Member",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B2 [Member]",
        "documentation": "Series B2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SeriesBOneConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SeriesBOneConvertibleNotesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B1 convertible notes [member]",
        "documentation": "Series B1 convertible notes [member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "auth_ref": []
    },
    "ifrs-full_ShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShareOptionsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share options [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share options."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "MMA_SharesHeldByKeyManagementPersonnelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SharesHeldByKeyManagementPersonnelMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfSharesHeldByKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Held By Key Management Personnel [Member]",
        "documentation": "Shares Held By Key Management Personnel [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermEmployeeBenefitsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShorttermEmployeeBenefitsExpense",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short term incentive"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "ifrs-full_SignificantUnobservableInputLiabilities": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SignificantUnobservableInputLiabilities",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility"
       }
      },
      "en": {
       "role": {
        "documentation": "The value of significant unobservable input used in the measurement of the fair value of liabilities."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "MMA_SnowflowerHoldingsPtyLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SnowflowerHoldingsPtyLtdMember",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Snowflower Holdings Pty Ltd [Member]",
        "documentation": "Snowflower Holdings Pty Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityAbstract",
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SteppenConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SteppenConvertibleNotesMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfConvertibleNotesHeldByInvestorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Steppen Convertible Notes [Member]",
        "documentation": "Steppen Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SteppenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SteppenMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Steppen [Member]",
        "documentation": "Steppen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_SteppenPtyLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "SteppenPtyLtdMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfReconciliationsOfMovementOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Steppen Pty Ltd [member]",
        "documentation": "Steppen Pty Ltd [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r238",
      "r249",
      "r259",
      "r285"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "MMA_TaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "TaxesPayable",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes payable",
        "documentation": "Taxes payable."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfIssuedCapitalDetailsParenthetical",
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails",
      "http://altaglobalgroup.com/role/Share-basedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Top of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r119",
      "r135",
      "r144",
      "r202",
      "r203",
      "r333"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r18"
     ]
    },
    "ifrs-full_TradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherPayables",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total trade and other payables",
        "label": "Trade and other payables [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "MMA_TradeAndOtherPayablesPayableToMemberGyms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "TradeAndOtherPayablesPayableToMemberGyms",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payable to member gyms",
        "documentation": "Trade and other payables payable to member gyms."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r18"
     ]
    },
    "MMA_TradePayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "TradePayables",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherPayables",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables",
        "documentation": "Trade payables."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r302"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r302"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfAntidilutiveInstrumentsAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of antidilutive instruments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ifrs-full_TypesOfAntidilutiveInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfAntidilutiveInstrumentsDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ifrs-full_TypesOfContractsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfContractsAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of contracts [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r208"
     ]
    },
    "ifrs-full_TypesOfContractsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfContractsDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/RelatedPartiesTransactionsDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r208"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r297"
     ]
    },
    "MMA_UnearnedRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "UnearnedRevenue",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnearnedRevenueDetails",
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue",
        "verboseLabel": "Unearned Revenue",
        "documentation": "Unearned revenue."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_UnitedStatesOfAmericaCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "UnitedStatesOfAmericaCountryMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States Of America Country [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_UnitedStatesOfAmericaCountryOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "UnitedStatesOfAmericaCountryOneMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States Of America Country One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_UnlistedOptionReserveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "UnlistedOptionReserveMember",
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unlisted option reserve [member]",
        "documentation": "Unlisted option reserve [member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_UnlistedOptionsReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "UnlistedOptionsReserve",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unlisted options reserve",
        "documentation": "Unlisted options reserve."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UnobservableInputsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnobservableInputsAxis",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unobservable inputs [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r331"
     ]
    },
    "ifrs-full_UnobservableInputsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnobservableInputsDomain",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfUnobservableInputsLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all the unobservable inputs. It also represents the standard value for the 'Unobservable inputs' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r331"
     ]
    },
    "MMA_UnrealizedCurrencyGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "UnrealizedCurrencyGains",
     "crdr": "credit",
     "calculation": {
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails": {
       "parentTag": "ifrs-full_NetForeignExchangeGain",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized currency (gains)",
        "documentation": "Unrealized currency gains.",
        "label": "UnrealizedCurrencyGains"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://altaglobalgroup.com/role/MaterialAccountingPolicyInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated useful life"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plant and equipment expected useful lives"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ifrs-full_WagesAndSalaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WagesAndSalaries",
     "crdr": "debit",
     "calculation": {
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://altaglobalgroup.com/role/ProfitOrLossAndOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee salaries and benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]"
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "ifrs-full_WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WarrantsMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails",
      "http://altaglobalgroup.com/role/ScheduleOfShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for warrants."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "MMA_WeightedAverageInterestRateFinancialLiability": {
     "xbrltype": "percentItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "WeightedAverageInterestRateFinancialLiability",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liability host debt, interest rate",
        "documentation": "Weighted average interest rate financial liability."
       }
      }
     },
     "auth_ref": []
    },
    "MMA_WeightedAverageInterestRateLeaseLiabilities": {
     "xbrltype": "percentItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "WeightedAverageInterestRateLeaseLiabilities",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liability, interest rate",
        "documentation": "Weighted average interest rate lease liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfModelInputsForOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Spot Price"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "MMA_Wimp2WarriorDigitalPtyLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "Wimp2WarriorDigitalPtyLtdMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Wimp2 Warrior Digital Pty Ltd [Member]",
        "documentation": "Wimp2 Warrior Digital Pty Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_Wimp2WarriorIrelandLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "Wimp2WarriorIrelandLimitedMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Wimp2 Warrior Ireland Limited [Member]",
        "documentation": "Wimp2 Warrior Ireland Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_Wimp2WarriorLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "Wimp2WarriorLLCMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Wimp2 Warrior LLC [Member]",
        "documentation": "Wimp2 Warrior LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "MMA_Wimp2WarriorProductionsPtyLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://altaglobalgroup.com/20240630",
     "localname": "Wimp2WarriorProductionsPtyLtdMember",
     "presentation": [
      "http://altaglobalgroup.com/role/ScheduleOfCountryIncorporationPrincipalPlaceOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Wimp2 Warrior Productions Pty Ltd [Member]",
        "documentation": "Wimp2 Warrior Productions Pty Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://altaglobalgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "138",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_138_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_vii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2024-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2024-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2024-03-27"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2024-03-27"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "77",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_77_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2024-03-27"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2024-01-01",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "13",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_13&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "18",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "19",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_19_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2024-03-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2024-03-27"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "130",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_130_f_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "iiA",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_e_iiA&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "86",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2024-03-27"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44H_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "Presentation of a statement of cash flows",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI",
   "URIDate": "2024-03-27"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "12",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Section": "Nature of the risks associated with an entity's interests in consolidated structured entities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS12_g14-17_TI",
   "URIDate": "2024-03-27"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_e_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_h_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS13_g91-99_TI",
   "URIDate": "2024-03-27"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2024-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI",
   "URIDate": "2024-03-27"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI",
   "URIDate": "2024-03-27"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "58",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_58&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2024-03-27"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2024-03-27"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "10A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_10A_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B52",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B52&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2024-03-27"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2024-03-27"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "80",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_80_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "80",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_80_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "14",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_14_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI",
   "URIDate": "2024-03-27"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_IG63&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B36_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B36_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "B89",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "96",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_96_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11D",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11D_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "9",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2024-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2024-03-27"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>126
<FILENAME>0001493152-24-043200-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-043200-xbrl.zip
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M *18Z:$M'S!,]#LBCD6,!WHV%CT(4="5DMO&1T%?UUUP6Y[',=CB()>\HZ[
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MA8L-SAR]N.[)A$ UI(,$J"&DV9RF*(,F"9JD69KD;=TUR9Q0&B&+N6*2V?
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M[+T<FL7B;%0*U^UPR8*S)I3?, H\K"(+F5^B>6E$DE1;,B,,MB-Z/.FB?L/
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MEW ]VL9_L7=Z\)W"'U_;WXX__Q]02P,$%     @ ]X%?6<M!MX[9"   ?4H
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M7E]"V?U%CH^E Q$3^(?$TK\LAG^ [/]02P,$%     @ ]X%?64E\4PN[!
MU1\   H   !E>#$S+3$N:'1M[5EM3^I(%/Y.PG\X2W*-)KSJ]687D*1 438L
M$*B;]>/03F'6=J9.AZO<7[]GVH*HZ(UK!737J-#.F=/GO#SGS$SK%]8?O48V
M4[\PC39^@OZI6UVK9S;JI?@31TO)<+TY:%_!V+KJF6<Y5W!5A4HY4& QGX;0
MI[<P$C[A^?A&'L94,C>'$W'J\+7S:N 3.66\"EIT]9=KU#N#OK6NK> 2GWF+
MZL_T1;(A^T'CQ^<:!WP2!K5Z22M$>X>/D"IZIPK$8U/$(-ETIF(5>P*^WFR8
M=S,V82J;J9P4*_52L_&L*7N$^R=.?R/2&JQ'S:9<45F#";&OIU+,N5.PA2=D
M%6YG3-&4P]$R1U:WTVT95G?0SV:&EZ/QI8'JK0%4?H7+XKC8*L+8;.EAJ)R<
MEO/O&;-=>L(89S-&>S"TS#:LN>&SFIO$-)OYK?P-!AVP+DP8&Z.FT3?',/BK
M9UZ!T;+TR'&Y?+P]+_P]#Q5S%UMQPS9IO4V[NCR;L07GU%9,<+AE:@9J1L'@
M?$X\&-% 2 7"!<-3!,X],<&[YX@I@![S$8P#AUK^P'-NYJ+6$GY ^.) 1E='
M@"H[0OJ8&(4./EQ&NET6VJAE08D$RAU4\?N<TVSFI)Q'P>.O#S0^ ++22T+4
MXN',%> QM>>2*8;6$^Z >6?/")]20$0^"T-M'/YJ28<H"C,JJ7#ST,U#G]G7
MT$-A)7@^FVG-&'5Q/NI3[#N%@>LRFTKM ST[L3"/')0Z2A#,93@G7($2ZW4P
M<6A4!S5<XHA >VM=?"FD>96H'Q,Y(9R&A<&=1Q=89NS(^YI8>10@T3Q_ ==<
MW*+]4UI]OYS<&:TLH]DSH67V>N.AT>KVS\]RY5QT/33:[>7UJ\V\98Z::='R
MEQ>,T\O$NC5ZO?KO.B$PL9<T5B+()8O.NM5>ZDM E(NGC-_;;[6?2K[:L$1G
M>M&I%%>1>1O #=4M39Q(G!C<PZKESCUO 382UM-E854J)+V9,TE];**A)M<]
M5P\)EBP)E=-#YVC)R%4E02K&3/:CHE73=6;=/_AO%#E)9W#J^9-*JJ25<!OC
MN:8Z<<7^NB&]W#O^:!QA'/NP3Z*,Q\ZO"./8EAC?T/9=PB0R*) TU%S):RGB
M>=@O</7)4 X' B1/F$_Z.B?<UO=1K\.B)^A>C%)S+Z::"*B,'AW&8!XVU>)&
M.N$7W0\:__>V-_8V'!#2H5+?]$@0(M+EMW=O>[N@9AO3M+J9G:V!=G__+'?\
M:E^GB7!@*S'!M>5))5[Y;L[_SQ651[38Q[ \A;B-8 3$<1B?%B9"*>&CYN!5
M)W))!3C]DJ8GFHMG")0H3PK*$G+3P\JC@4,H/.;\"_A?T\5?"DLQYO5-WHL6
MI12%<JIF["8A=T&]/JZN][MF/Y=)GS4B%E/>GH?DF2.;_T)T/D W/1Q*AMN"
M /<%3T)TM+T5_SOOKW9P0)SJ,?\CX+\4"M!AU'.J,"13W#J,Z<V<<EM/J,$@
MB/9P5:R#H8)"89ET[>Z?2S2Q&:LV^DVWT9=7"PCB?G.TOAEZO%EZN/9XNIEY
MM!MZ:NM]"=A [(>N]J@;S7A\?J=5/SWR6"9NO82>6#IES94E[<O87Q\I.7:3
MV\OGE/1K^?@]O7Z=_P]02P,$%     @ ]X%?67\P^8*S!   \AX   H   !E
M>#$S+3(N:'1M[5EM;^)&$/Z.Q'^8(EV42+SG<KT"03)@$DX4$#A5\W&QU[ ]
M>^VLETOHK^^L7X $FA:=X4C:* G8.SL[\\P\,[MVX];XM=_,9AJWNM;!3U _
M#:-G]/5FHQ1]XF@I'FZTAIU[F!CW??TZ9WM<UJ!2]B48S*4!#.@CC#V7\'QT
M(P\3*IB=PXDX=;3OO#JX1,P8KX$27?W50=(G62 .F^'0'XM ,GN9:S:ZPX&Q
MN43!)BYSEK5_6B24#=B?-+(IUSSCT\"O-TI*(8(P.J3Y@LWFN&2CU=2?YFS*
M)%0NB]5&J77HA5>X)=X>=#63<DE%':;$_#H3WH);!=-S/%&#QSF3-,WH(91M
M?6STNKVV9O2&@VQF=#>>W&FHWAA"Y3/<%2?%=A$F>EL-(]Y7Y7P$^#$"?EPD
MM$DVHW6&(T/OP 8,[]7=.*;9S"_E3S#L@G&KPT0;M[2!/H'A[WW]'K2VH4:J
MY7+U>"C$9#L*#,>L7L?TJ\>S&=/CG)J2>1P>F9R#G%/0.%\0!\;4]X0$SP;-
MD01N'&^*=V_0)A_ZS$5C+#A7\F>.];#PZFW/]0E?GHGPZ@)09=<3+B9&H8N+
MBU"WS0(3M2PI$4"YA2J^+#C-9B[+>12L?GRF\9DA*[TD0"T.SEP9/*'F0C#)
MT'O"+="?S#GA,PIHD<N"0#F'OTK2(I+"G KJV7GHY1$LXE#X0KZ1/+3GC-K9
M3)=QPDV&ZPYMFYE4* 34W-B_/#)0J!B!OQ#!@G )TMNL@C&<8154QA++\Q56
MF^*)D&)5K'Y"Q)1P&A2&3PY=8I$Q0^P5K?(H0,)Y[A*^<N\1O9_1VN$R\H>1
MRM!:?1W:>K\_&6GMWN#F.E?.A=<CK=-)KO=V\Y%9<JY$RQ]><4[MU1K&>'_U
MWU1"8%HG)):>GXMW?@VCD^B+C2@7KQA?^V]TMB7W=BS6F5YT*L559+[/P -O
M+-?E*K(QKEGVPG&68")A'5445H5"T(<%$]3%%AHH<JVY>DZP8 FH7)U;%PDC
M5W4$J1@QV0U+5EU5F4U\\-\X!$EE<.KYDTJJI)5PKVYXUU"<+@SIY5[U#7&$
M<6S +E')'AF*?5\2QK$M,;ZCZ=N$"620+VB@N))74L1QL%_@WE/U1ASPD3Q!
M/N[J2<]$O18+.:4Z,4HMG(AJGD]%N'X0TRNR(VZJQ9UTPB^J'S3_[VW?V=MP
MP!,6%>JF0_P +4V^';SM_0AJ=C!-:[O9V1XJ^ ?7N>K>6*=IX="4WA3WEI>5
M:-^[.__?5U1>T.(4P[)MXBD%HPX^L2S&9X6I)Z7GXAQ?KBK U8<TD6@M_X9
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M1O _8+UK!QD!T:)L>6S+UQ%ZV#.Z*UM:4;Z.^5@-5+/+0@-M/-CJ^?6;KWH
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M$99M+A"9"+V-))S92&]UF#(BN1;9A+89_:#=AIS2\UM-H[TCJDW/1[O2[8:
M8;<NDO>"TF(2'96-CN0=3EPPFTCZ&_.</3;A]W^?_1)EAO/X99/A.(I^@,$
M21&Y_D,8]A.L2FHJ\ *8J:+4:9-HICYF!DVA,[(*LPWME5;I<N!2*,)2*BE'
MHHS;!DN>UAS-^YJ'NMGLSA"G-80\[9Y_PMN=UGW=6F#DORM57DUM/,W%-L8\
M[^Z/IR#.>=T_UXJ'MJU_QE:6.C#?IJ4FGB41#3S91KMD%PG^3D0:[4CA0XL0
MNUEI[CN L$6T(=V*A2'NG'-6:+68,FGFR)2=:#)7+R,^C[TYS)U3*>9MQV?L
M*[5V9DJO39[JO0^'WU-%0LTM_OG\51S6.XP:8B@3WW!J6\QZ@#%O4?>;.4+"
MJ60G@)NC-XQHY_!@8 BZ),8NS;M@=QJ. LAD2F+^S8.NIA5\!BWA(APOX)BU
MTE6O9\_V92WV5HC^:;>S.+^]YP>S)-M:+J+?L'PX]N))4;P7PF!7T= "3UIW
M643#WZG.43Q2C0*B' 83CQ)[A6T2<>7@)]&?W,KGBCD$?3\"L4[C\%\BR;:Q
M5$7=)KCE^-0SCBCA<B:24!7E\-V#,>*(2_QB3XTY>NSW9EJCQ[Z/G_"^[C=P
MXVUOE<H&#U,,1,+)/R%K?O3G!W#>$H/E-D9XF^V2<BIA@@V#S<Q%O;FQ2D\1
MN\FWFP4^M"HR?$B58).[+JG=?E@[>VNF!=Y;?RY8.>/&,:1U.-#)@X\Y#T;5
MF;&43'8:7+:HT7'=0VITQKU9F*R4B3K)(A[TNH_'G-D4+6MZW.(\W\QQWC>_
M4+!%SSGB<U9YE]*:][YRF^8<W]G3G(^QBT%)_W7_^-C%AGPL>1-7E7FA;+I&
M)X&NW6XN3&+?Z7(0)'ZK7IK _5!,>ZM16XA_S,23RE+UNL)A=FB+#Z7F#U-J
M;L1*#>4KU[55G,0^B:&4!L1L93$U8XW'P%;<8,MBQ_RM/V!_2.GIZX2!U]7V
M/+$$XU.P@%1&?9D]2^AE_4&^MDU 0/5H[HE,0_!$<)S8DY1::N$0C,5GEH^V
M26\IZ22L.!*CSL^1A*$.F^>%XY0:JY- )#Q;3S"FE7:W'7PO3=13EM?(PI]G
MZH*:,(>$RMC&*? V/)OZ6/6R8\'_5V@MP;* AIL3NP6N; >U-6GW $*112(1
M?W0M<8L0$U0@Y4Z@VJJ371393],&;\] 1N$Y8KE=*).1L<>;"T1?&$LN"9/=
M&[3\MR-:?D3+CVCY^X26M_U+R3WVK;/_7U.4S3QZRW6EU*'VLT+.MT#R@S\N
M/S%$%W:&'SVZG7ET^5KC6:[/S,F4:< B%GL80T?<!XAKMF-ND(K<E^#!Y7K%
MT%VY6A&O&@4/^/*6N408=.F%R_/ G^SEQ[Q+*=A@N>_3YUJ3/>HZ?'F?9**#
M@+-MM=YI>*8S+I%0OF,P"5V[X3"SP79OE%2^@UJ$(^"_N1'PIO[#[>;#/"H]
MH%E08\F[$^;17QR ,-?+3C+)JLW$GGJ8%HC^)A/GYJ+E^V#67%80>,,,90ZF
MP].M%N#JP/Z-KQ'#OE[E?,ML$;T5E";!^1B><ZWCK4MK@Q$&"3IQB*%[0L;1
ME4UZ,'1OV[IWHPKG!>C,'+576B0-6=,;"NN'X&N,&)']PXB,G_"3Y_I9;4+T
M_'W;.4HO6/;I$7.S>WOF(]/'ZR +$^:,9X0[2$+?G\Y.R@)BS%L%+>/PB+Q0
MY<I%AZ[[QT--@XK1:S;+BX5\ILUESEWS/G86U H3R<[A>=17 W_L70WWQB,Z
M:#<"WL]\%4C )<T3QVC5KIPLMW]L+RA,+&,5!NQY<<2#>HF^QE!"I'#FH/*,
M95AK8#>ZU -:[0IVG@_M;&Y4J/ PJ313"MAD;337>H. 4#O[0!+6.H6-4K#;
MFDZ'U<3JDG.,*-MF<'E1"STA1>JL51EU2TXD6F=I1L-E)OD"!?*/*%4K,!:F
MM=!9A*/)/,(A347U/>/)O0N)6*/GQOXLG:@,U^!V6X]AE=UTJA,J<*+U3PO"
M!R%@A^KOL/N)IL9TDU6H74"F.CT(CWWQU4R/YL"N#HC-VY[WN;']B<:C?6 K
MIZ)YD7*0-=#2#BG?]A:9DVUIK7.&D_;8Y?&XQ+M=8H2%2N ]5+[M+JVG#[\,
M$VR.5:^CG(FBEOJ%N0*'IJQ!1?.AK1Q30PUSPM3=7!_CI=3ET=5>. T1=_1#
MV1; BH#)9CS5[W3B??2-')*1)(:PQ6$6!OVVEI,>!G?60CI4LXR'>XIE]:G5
M%I(U<3Q[4VE$&_+JM7S"L:QE &+R264MZ#Z ;LC3>9"\[\T%;I4(W&XZTBFA
M<M2%*(D=1[0%)@\J^1&[8)(F4Z4(N1$!=6^UW5R(CF:T67=64)$G6+Q'1(>I
MEK^W"Q,\Y7K  UKU1:Q&@V<?5M83W;<I+,?HXY"74V48#T+_8J;R<UG)8@D:
M.P[*>2IB!+(1R3ZBTM8J1U5!W+>%F+MXX3Q2Z04,J[/5&'G<L02\G%I.B,!H
MD.;%GR(/B&4DGP,#4_!L.=P=+[,7"RL*,@\K)90PI?LL([*[4BY"NX$JR_,:
MFS+1N+92#W-979%T$ZD*[WLY!B/+]FPSH$%<G6>,H,L0L$3DSMUKK+4C#X1_
M,:>6^[:CN[4[<@2QC^U25.)(W0A,CJ*ROEI.[-_1ZMQ=O(U+^X.H=JFQOE&S
MPT$&J)6$NX0OCR?1M98O4*38FNDO< KJU26>XUJQ!6/DKW$G_(8PJJS![3@N
M1(.#C5;*CF7C.:A>9:F)V@J\$T;?HB=8@E9.;*.QTZ9ND ;']G@,)="9$U:<
M@L!9U\8@^T- %\RP["6.K2:LBR;\<PQV1Z(:<9H(V8QW]$&;KX[,!%TU[(E6
M%ZZSG7LNSY4"U'VV'%'ML!%7-3"D0:AU(7"Q3H7X:,K<X<3?-"5V=O"AXRT,
M%V%@W:HFP/9N0?/_2MD3 *%*BP6Q9=(.Y5Q5J1=:93X2W4>X4]I?@E5NRKFB
M2KJP:TL(<5I3Z1=!:2V)M.6DZ-V>H0*X;*MVK7V:CK?OI!NHIAZ0G'YU+Q2[
M"@@R-(IS3K$3*K2"'V4]J)O[2F7P>*0R&*D,1BJ#:SQ@;Z@,WNK,LS%CKF8E
MA**L_IB=F>M*1S*#X1H4#F!VW3]K0#0NMZMLH.O"5'(23DVN<HH'3N# )(XL
M8@PBN>'T'A_(BV:2F62[:; %8ZRM:O.,'# ,"JJ=_6[@41/T'O#9UJ!=G^)V
ML^ B:4_.U?-Z)>(W;:AA[7G1%.P(A\@4C.]TVX^!9)P+A^? (*EX,VN+=42U
MF!_4?)%I- 3M-!!CFE-A>CEW((1,Y^?U;,L$- ,72G'('%MGJ>=-KGT[@%*;
M^02,62;_IY@P_"^\.<>:-4RP6&E]/'H7=SCQ%QW;E;B\D!*N1 $VN27=%[7.
M_B/VGXD)=T+!SZ"M!/48]<V&Q&FT/8<\!V+:T%9!;^:B,"GVL4/^#==;9E$@
M9RSNFJ3(IZ J.+=@<&*ZJD^B=\SJ;Z> ',1946%=51E0ZM!3;6N]OHX7Q%!G
MW1'?Y2_<1#PAW$G43;RN&61[461">&=)9:4K*BH>.\T]%(@_22_YT#EF.>::
M7II)@KE5YP2.@%B^V'K36?=1G5<)G]OP[RK.GSA.7EBZOV'MX36$[HV^(A%4
MCT'T745A\2AE9WC%)?FBJ5%1+\ =(P>=:3"][B:]?L0GDU<4GE.Y(?[DX[B_
M06J[J548#+XSMIPQ"GL=V6 +2+5L+D,GO-_W;2YE6,1Y(2RCM,Q%P)-*/Y X
MDE6<.N6@"5@H:5'&K4?90A7'%#'"208F(&WSH=7RR6F%,;&RXQ63)M]NPU+=
M&=E2N&NS%2W5> #OC&.)<DZ;#$OO=5>A_U=)3/KTAU,;]>ZZ@V/">V@K[1?M
M\:9%(^X0[<L\;0R"6;<"'X>J@CG18DN!A<">(4X5NRNU#LY?&PU",-=,"X?%
M]7R:SR:RQ]1=@Y>K3ZH>R OIVIJ021]X_2!O]5+K_#K=,2B;1@C [>9!<$'T
M\,%I;R4()4($;XW90IE(7^J?<1_.7PG2??%V4\$X7@Y/G)E%C'SU1>(K+\47
M*L]5;O[#/W4;*00^7O8FV\V&VSCU#(-_IPHP%<08W0%!'.Y8.XC1%62:@?]2
M5 Y;-F&GUFT7B/0(1_=H*62<$,?@5L1[ 6ZZU#;%*BP2,"[V, O?6/&Z?R32
M:===$LLE19NP=EFWE9^K+*@LGT:?D,=;BVS/%PA3UU=]C01;,DCKR)#G?DMI
M-=/12!N$D395&*14#IJT%@+SR^]^9 ]UU#7L%//VC6T[!5?$U2^S$B4IM0V
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M]A>/&#H#%#-B%0O?3>M2 ;'T<Z.W,RBQ,'.,J\-"$689G1Y;EDJZ(M /5RD
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MQ8>5A\OU-4/Y[$ ! \'#WQKT_65.J$F'=2NFT;.B>,\@F+<Z@6]3?58@^,L
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M,K-7A7&>$BH.9H]''9VDH K2IOO-0I:CDZ7"OY^(^>.S1Y ^"G@:6@Z.U*'
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MJRBMPMF=V]N<84ZQ7MUU&+V'#Z4SJ>!VJ U,ZSB;TWK-CYUE6J>KFU80F=H
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MG!?#=V.0SXNQNU-8S92!NZ/07"!+=Y<@FDE#=J>@ZI\Q&#!\U=1Q+88XCVW
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ML51HC'M,G_^V.[\* -D$P+J/314 ,@: S1VJ*BAD 0IY]' 5@+(*H)PXM@I
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M9<.VWWO\J5P\VB]7SO;+Q\<_1[ $3R MO^R5Y];)J6Y%1.O;Z&[])_E>+)9
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MDE KJF;]:JJY2)&.V]"VGABG(,S1B1TSDD?+<\.W!46XB7[D3^R0'N[/10<
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M95*;7_<U+>LN;/0&:HQW--:IBZW=N6+R\R;%SX.N1F1@83]'U(G.?EP=%'X
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MZ=&1218C?ICL.;Y_]BPN .K38..1/8K&\T5J\@XNK=IQ,<^D=/K!"65*Q$X
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MH^AIS_DIS**06^P!I--G%%["[U,(:[O##M#PXT+X8[4#;!K0$ZA 'H/>!-7
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MY])%\]LU0_9C_ BP'U<_G;\\]]EPOE2]RVP;I*&YM][\\+2= U?C@)$!Q0:
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M(*F;L:AUD?-CSR[L4A8')G@M=<O_@ .:PF0%H>!ALB$>[*.Q64_/WHC;Q$N
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M_4#=?M(<U-OM\_;5S^PK'BU'4E^%"X6;13L&WR_3RJK9&V:Q?0"P.> ]6(%
MG&]TO?7WY:JS@HLVX(*I&R@QG+J]#MMQD HKH +XAF:OX7D(>>"D9.DXX$1&
MER'89S:>BZ[6!UX -5Y+AR1:*U8GLL.S/S..2SHK?;7V+U36VMG=X*V4:#=G
M6&A!R41%L,JG'BQ3?+1AV1NG>_,EWWOW!+HOM.IP9@%+,2#((6@S"6Z%KAK]
MH1\<,A+B?7!Q8UKA]#P@*HQ:%5\(#_>,=FP$<E:+73EM]7;@SS>7[D8XQ_N
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MJC*F[*JXX,K&JI''V*ZSQRV!B;LY$T F54A$146R@[G?O=Q+M9@[34ENQ'
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MI'+PI50./E5*"$;8TG=L%=B!B4L,*R;Z;;M2NH^9^3IY&JW,DT>//UD]P-]
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MRH[5S!%("$AYX$W;G$4?[95/CDFAU(9GKB@;![/6AMQ\&+2\6R _$IB5U#O
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MPJ:2J/6#QP\UNDDV>5D8(HNLU!Y(D -]=?6@>$BGOJ[;:T,S;JLM0_@;#K1
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M(SF\B$N:H96L!872AYI6D993A2]'I?^1ON.NVWD6*L-F* 3*=R=*J(? N^;
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MW6(XOFX7?L%%S#Q<>V/&9]PPVUX8,-76 *3F+S3IOJP"&1CZ/W=N8'R  F0
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M@OY95: :OAO&1B/6UCJ\FJ]\P'.W8Z=T U*"E02]C<TBUAL! 5? ZMA5:#&
M[>+(8UP21K?+N=M4+I[K$5OD[+MR<OZ['3,6'WP\+>H:Y3K6G;!16'@ZBBNB
MC$7_A<,QWQB(+S2R:A:7#/&CY%$XM3O0PPJ[CM;BD"2PV&J9A-^%SD$C@WHZ
MYP>@'"*KTQ0>BW=U-[3[R<W._Z"=MAI4Q#6'2HA%0AV6\,B(=H7E*FI48NY&
M*7,##TS"OU'Y]$FU4\(3#DGAR@Q0U3"$V\XI)13D.700UU?JG<M>=^>X>)SM
MBJNJ',DT2B^(:F-Q/5EAXNE)WN+@(Q:]W/^U<TA ;?%^J^G/)@3FTTB[-8!
MT_4HNEZVXWI@4Z%53B2^_R99O*VPV[7-M4/D/ F5SV8*,K%7+&^P#>D.:UB1
MI#JT,!]A^)S#YK10=9*9(+555K*STG18@N26?6N%&.5HSIDEY.@%^8J=(3E-
MYC(5DJZZY>"B%@N<@2MA6"!]) EMQZU_]DPBVKON:G(Y/EAO_6,L_/OB#UY7
M4O(O?OSF6Q[9I^>)DGL#N,X?;8;PPZKR__JWXO][]!CA9QGCB^^>?__/;Y_^
M^.+[[WBDWW^W^O%OWZR>??_M#T^_^^_I9.Y=M^]_?7R2ZG@$>J1)@DF6].UM
MSF._.4_/L[]5O6?6^@NJYMN]B3J5[?#V_D#+ZEW.VS9L,OAW)6#?%C!F<)O+
MIJW;B\-9"3<RZB;,D;<6%(@29;NHVS4IP1T\;^A@8Q!'N  !-.$4IR%#$QT0
M/1L;LI/0W6C5T,A(L;NA^DW#>]X?)27*+)JE8JTNR-4?N']4TZ-CDS1: O&>
M$&3_? ERY]>,XN*PZS4*B)!-73MN!W1&G[.)U55.FC\Q>(-Q 2W9*V4&&^*B
M:Z^E?^AZK#066@"&@7!]XVK %G8<'J>_;&BV[8[I']E)I\]R11 -Y#W]QC$%
MQRA#UUQH8#_7=^3*QX7<O45;JB83QYQFM-,%>B\Z_>VK])LS[)\M&?8WS; _
M>;1DV)<,^ST5&. SW-?% !T$PC'I9PJO6FG<)C%-* S( #AHD;XR,7K0,J:;
MU(8UL$-,M[FH7<[:L'.7XI-G)?F? YA=VGH,70.V=,#K2B(*QM'6AKZO[DJ_
M?;[ZFI.W?'29:<N9;73==G7I?U'3VB..OZ65!.P-6I43:4 A9EX?,@TN7':_
M2LS,QN%W/#_H&V9J%76X52)6SO^"B*;_,X_@YZ)C*K<?.^VC]T/77G3%+E_]
M]/P9G7G &)Y7@_\X>UH/Q>KIIBC=[A 0I/SI,UMRR>N=?K1R<SN)-O3C!DW6
MA" /V^8Z^-&,XI3-1"\%.,(:ER [8\3TBAKA]DM7[[5A I8(S< Y>X%$"!L6
ML EDSXO-)7*06/1KA&^NV:;PVA[Y!0 W>?$U''\Y]E7!/*WQ^LOSU 3X4-7T
M_9S(M]\^S9 2VK5JOVYI^^A6G<'T8IM.344]61RLX>Z8J 9IZ> DAB?O=#&6
M;#AZ\XT/V ZU(HH"*7T B2YO+U<0P3M/[\QO795%A;/,KU&A4A^TW]J9!!J9
M 8VC2B\E.V=M1+B=#/)6GWZ6/WKTZ%:FL# G,W5:2*_]]/+?'S\Y_WRUEO%'
M'4\8H#(ZH:WO#++^XNL7+W_&G8D;#G'+%WG3_U'L2 >3D& .[1?F"#S5A"'3
M5M+6[[@EJM#&81J/'Y__R=9PM7?MOG:2P13YA6$9OV<R5:3EJGT-QFXAI3RX
MXIWT.UFNX.V]3.L1ZQMBJ7.U'5TM$ MTOJ+S(I 5NK20UQ<CO4>*"42ED@[*
M5S\\_T>^^OZ[;Y"^W^UQXRZKO:B>K\G0!*TW*YRJTW)EY4W/UEU;E!O$V#OF
M48M)"<D;--W%%\8K85.^N?:W%<6PA>ZN$;Z^JDA%<'PC= 15Y1[G]%$>%,N1
MS&P,5MR:)FT;'&.[_W!2!].5D;>ZG.T[-)$?V\PRY&CE(.3HU8Z<':%;9XM&
M[1 ZZ"S_O:KQF']2*<-E[;A:0,V27(_!MF9?#;6(EUQBMFL'>8O \E86-'&2
MD2E;GT./;<+SU7\APD$:H>_I.YT'=/%=JV T^YL&2V^C=VOU%Q0PU4!O["H(
M>OS17R2:]3^*L2M6+XOF5<M#SKX9H6567Y-^X@6\! "%)X4<US-8X/]5;5ZM
MVU_I7)^OGGJV5VA"M87%.#TC(Q6I)EJ+O[>7S>J_BBM@(DG?5I)4:Z0O!68@
M+WB%3W 1,W]QGK7H0O?MYJ^=NV@[6=5+Q^8C+$6'\B:.42)"5(_2 L%^O!<+
M56-(46OK>&GCUN$T0Z@@NKIT9+[^:_8"O4:;=U(&L5S9W^%0EL[M^;20]KGP
M[I=X;&SNC+M1FL22![C16]THZ$N<#]<@+%"JR)>#.I@.4=>T<:YD>Q#6U^1J
M6V"3H9,W&V_DMT%NB+7'QAYT@_1B\;AS]7/)[RW87\%3/OOLD?H[-:F\\F"U
M/^R>_>#/[[53=4="9,-QUY+ADPA= @),PNFZD);7/AP;1S'#^2\KX1[U-RBV
MSE":MOJE&L]^J89^A-G[*X=)Z?[2_QOI#3]>%E6.A&B;<S#X58&L_W)[[M!$
M7N(:9$\>/?Y3/N^Q=R,0>Y^?=/?[R(DWOTB.]F?Y8SK::5R#'M_)5YY\!NB%
MB>3S%:ZQ.BBK75NZFF\E8W:;:$1Y:*DCSV+;L^_-N9&'AG=:LE[?HW# I__^
M./_TR\_G QF9SLP0A 6Z:%X[]RI'E/$,%9ZH5QSI5YNQ'G<>ILF1%]>GH00%
M1K#N4[0D"1"Z(Z0KDSY2T2CSY!&9QQ0>A<:X0%!JB?NB8< $[CI\,1(AHD@;
MN,<DK" (Q-K=D"W>L1@0 Q[_],PD6XQ3PB\\4G72LL0O0Z'SF;Q>$)/!GB4O
MDB'K\1IL+EM ;6+*;R]1@+X09 6*)05FR+\E@=W%@C2W7%*&)J1G#$L-4DM3
M+G(&(-G8"6>]KE$C'RB"M%QDT!V:"(>$XUT2*81H(&G@BPHYB)"]LTUF1"NG
MX+A=?#DJ'81T-2IGXCQQY!0]2E2K^U#R&1<C9UPI /.3S0)V))W6UB2/+-T.
MMW5_66WZHRBTCT*JP(K1Q%NRI&L7@M]1)*HQJ1;'@U<:+^$RWZH\&]HS&#.K
M3Q[U]G3PC2=73KY./O/GC\C>^&M7E*,T<5,_(EC"@T.]\ 9/\!<KI_\\%'6F
MZ^MC9][8P&!AM'SXV<S[.9&?(Q.0RRE(!Y!]6_67T ^K'_2V_1-59,# /;WH
MG,A1:=!&7N%?X?20UU8Z/KO:K*XN1@6P:P!G)HE +W@L&E,.B\GZS"M[?3[?
M,%%LDG=I5UT+J.:H7?9,:Q<;UO$HP'C\V:/_9<8QXS6E;,.\=FY\5QK G@-#
MR\&\0Q.!K$^S29:QRJ4C$?<M# $/SFFQ(49[VG.H@*T4+C*38T"GM&['4J1W
ME!A4E2&5#[[XTMQ\QH2\SD][$36+Y6M@C0&;!B4=J6V;N(,0CL(V@^!,I VV
M+>(L0F-JF%[I-TLGWW$N\&@.6E\RM&V-!2 #U#&RF0V=")'"V%)-9D91QV"<
MV:JJ7,]#DA/7$\4XW#2TW\" /^2IPO-^;N,V$:Y%U-*1[LN5;B*D7G=( >SH
M0%P"XCJN0X$(V_L?Z#6]&0WS^8*&>6,TS.,%#;.@8>ZIP'@!=KN& ]40L.N#
MEFF: 8.2 !+= RKYCL/8/A0RU:ASH<"5#P5&*(PXXR7)6]=<"LV80[T-M,8A
MY"1ZKY#@/[$2/ML)P4")ZER<%JN5[#64*A6KB-=<D)%Y480Z\$HQ,3DJMLGK
M0GB60[;9^A"GYQHN!>][.((:G>2XOI8:HG-UL=M;W2IWJXNTT42'-?@S.C'R
MF,R"_$"5S_V<"$ZSV5U1L$?M.>82<!>(7V]&H*C:)L;XC(WPK*F+X$%46IK,
MQLL$<@!,1SXQYA+[+<\B@!'CO9 *OE J0;.XHIRNW,Q78)"SYN,PWGJ.L=($
M7+'CU'!XBW@Q>OF2 &84F>=A"/R:L=<6"I$G]G(K_8S9XL)B] '.'%4YYP9@
M#L:Q6'C[XA":A',\1H!4H5X[L_NH]:-JY%V[=8X:,GD,PT-JCZZ>I@;Q[A*!
ME=, <LDPQ)9BCT%W>"09J4[60R-'" +U(J7H)SWJ"%E=VQHEWL"OL)@="2CP
M"%1;>O_.K:Z*>ER2$W=I(D_[[-K-X3H8@/$=-]'5OG\"6?KIO_*XN%#H @YM
M(R#,)U]MVG%?6]Z>LVR*&HL/49P TT"%_AR"">@S%4$PS<B5,84'=%@KN $^
M>2J!8HWI[R9.N.)*)4JOJAOW@BD<F!4!6#,[X@&;B%N115XHDI_:ICX 7N R
MAMRV&!4TP*^?/!-DS9.O@U<MA0W-12M>*=IL[)RF3GPA261+= %4&8EGOCZ\
M G#\>O P&(> -M_<AQP#2!HMZ9'(8BLT6>[A^R,,^%IUEB3"Z#_N8=G\Z=JN
M=W>6OEJMR7&G^S\V)1S!MOLS5.G@_O@$[M]'D@"/\]631T\^"8G<D QA64?&
MQK9M!S#0DJH742I7GJ0)[ FZQUU%!D_E":+PYQ?@3&\K&L/3KOJ-]#??Y[\5
MUT55,01=.I;6?9N)K0(-^\M1=(TQY>F3_^F:WUHD)\C/R$,'UQ_;_>I'A[ O
MLG7V:4 9&3[]?<F(=[*O[U6)OY,9DN_+Q]:?6<DMZ&F5"*]"*$U5Y<';]34*
MF@BO0QK8<@'H\<P( 8'[G$1@<BB8U:2'_$O E4LS)&V&H.E8#]49X,@1MHSS
MZYRBTP1*'XP+V/]J!)!_P/:UE$8PWFT#JH$-_ 89>J:QV8%./_WG=H39'$%>
M^T,_N!V[U&+EZHS20LH/^<!\^%="A+G< S./TM-NHMWGI84H13Q0/8RQ 1NG
M!/I#39;IV/L.AJ=+>(#\E%2:OD(OHK\^K#.D,W:,#!%K6R!@81"_5.-J A*[
M!I"Z]F6U$5Q,2COXT>1X\V7B.F/&IS)!G^NYR?<50SC7!QX?_7MPXJ+SM/6^
M1;JFV!8"?"U=U;7YZELXET_)ZKTBW?-=]>I5M?I'W1[*L[]V8&0=+M];1GNY
M3'^4?GGI]H,$.8Z5#)?,\<D*()*A@KN"Z\&WSJ?)(D1PLWK1G"%W[2_-Y/<F
MY$W[]!F#2<>ADIJW38%DP7"P])F99H: :=QPW7:O! \"/LP^&0P#RO!J XK&
MR)GEQ-[K&;[FQ(;$-[TW)50]G0"P6DRCA.(:+#$@HL(=?0S.(42_EZ,1OL>'
M^12HJ/4*]$M<(F\'(5#J0WYL17FJ60ZX>]W&\*'HFR[Y9+5UW,D!X9:QE[3[
M90O..#;#=JZL"O]2CNWNA3RL%W9,QA1NJPT>ZG/X*$I")#.&32=5K57/N$YZ
M)E<.\KC[Z(V9O=%J*S#DZZ)^96MS596N[5</A, 2\,F*%D<_!6"L$2I<(]^(
M!J>I^,-#//<:3(Y%+R5'>(::E1PPOD:D*@E)?\B7XF.]]M.ZZ3T*BL08VU=U
M.RCX:O @J1BY!>7PDH;W]Q:E;L]HHB0.FO=$([:<E+=[4L+AF"&R#9R'S,,Z
MN/W>-:L?2$G\8P!(AS2*5/:&4&_HU,2QHX1O\($F7?5!FG1]>)[9D]FW+0\-
MS7#CGUWL]PF BL3TONKH9%Z,#(H2QD;._7!2IE<1777^$;_0P6^<<@_8RWP\
MG::\>54?,O(JVH:SW'P;#K0;%_X1H=X?=(_8*,\HX?((=1XH_H3ZS]</28:1
M<]815[F^>U5LD54F-R<S>*+H.M0#5>49;=?C=/1/:56 @&2DLUYWC1X@I?[)
MEU()7I+ K]NB1(Z2/)YVAT[T4%"^^E:&R6!'7WWQ^/Q/F95?@]=(BG%[K_OV
M0&-A!"^'%@V3N"2I6'7M&GSRONP(00D\[LD7CW@P*!T?.4,:V12L?X>9F46H
MTZR(.3DE]88W< 21]K%)R@.B!WD%&1*E"FZ3%*SC.$O!7/5\QH$2C7$3,M5=
MNR;5GRG%I<!-X^0&ISC)JZ:+BS6\+@["?2SH.I<8..!GY+ZM4B/,+H*:^X&\
MGNGQ2XDS#956<(57GF<_QPM(\OY :OW"[RJ'G\)-!AB6N:Q"_,?8"J1(B\'E
M ::GG9TY3,!VFG=J]&BO1SK%+<-R+X68$S^#W<%W18 8S'=JC2EDT2QVP#(E
MS2=?.Z,ZM^VC71T;IM74!GQH?@4N$[<3+)72IM!_ QR\HY^#:JY!3>P#/:E]
ML7-*X:!HX3TWT^-3H[2;00+2[/X^-HZ%X^H!OJT"ZP?]T0_V(Q-=#Q5#7UAK
M-N Q=SCD3.#Y\M\__S3_\HLO/C;->3-N\8L%M_C&N,4G"VYQP2U^:)*$+-3O
M27/\J_;IM]6O8 "0Q&%/=X<^_L<_GG%M ":S=SPC!DU8#$!;:'ACU2RB+'F8
M?U9*.@;4@G!VI[65Z&()_YL;4$247O7_S]Z7-K=M96U^QZ_ 9)*W[!J(S45K
MG$Z5HMAN=WLKR^E4SY>I2_*21!L$&"R2F5\_9[L+N,A2+'&1,57O=$R1P%W/
M^ISG*.+_6#\2C)0@H[,Q !#+J"0A.G ],["1*G%HQM@Q*@4;*Q&5*C,P07OB
M3@'560S4S)EIOBEEOLFS&C"CD#.-^QD:O!Y!4/>833GX:S7U##KWC=X1?\.
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MX!VFD_A4?=(>IR0A!PP0BC$^HPRN/#UH$H\GBP7,PCD.2]H(A>T)A5_%>ON
M'95HKSZP#?E3/__;SP&* <2].;<65<VPN*'T5')[?M*Y0!65XS$<QH6.:O'@
MR''/,U">>&KD(83?1/Q+57!20*SFR%;'.T;.J/80;N<J3U_A5XOZVC?4_;X>
MLS?,<8LG[3?<2D\#X0:]CD>:4@K_1K>BT3T[8I[:N%9A5(E?7&,44"1\PKX'
MBV;A )0%DS-@:>]*\>\AENF&)^8<D'O9"CY::DH+=Z=W4+BL8! I-1 VT;)'
ML /[>L6%O?LUQR*17(L022YLU5SK[5YK&^8V64XA;12LBLE 2]B8L[+H<ZZT
M.B,7*#8L+UA8-]!D9'J]6] JI6<Y$)%EG\>>8US;GBA#/VZ "N($U\-5QG"(
M1'H@'#1K4"A;S7 QR#:0!-='<48NS.G8PUN_:6SKO4:ED10JN-:,A.8;0K %
MA)41@[6*J=YVFHEEOFR,(QE4*<XEEE;H@O+K6)YDGB(\'77."M3!>$NIK 1^
M'W#0"%2X06)+PLUXK!X<7Q(>T<++,02U*N9%$#X!Q1@GT[?RAWJ*Y5E[MGG[
M*@.>&UXBH4U+]O'6/QI=3Y79AL5V(JV/#<WI<K4CP4K_Y54]VFK':+'<,3(-
M4[ 0T:=114M/?XX'F32(05+7K"K1DTC3!6)8"]$CJE9'FBOE'KW3D$I5\MBT
M$$52:;K4S%I-<>E">'V$]9Y<A%09[EK+6>W7H9+$,/!>E'LDUQC&7_6Q%(VL
M'!%1=38M2^C["(['G<ELN@UD[:LA:R<-9*V!K.V!$K0LZ"!1B1'![R#ML;A(
M!RK'XDGLGD,$/2QP;]B4IBMA/F?8,=5@EU@,^;D,9_!2H5.QCJ)!2WAE/V#3
M(@QB[I.N^I67<\,FN@+K4(,WU*A)Y4>(=\]JI<N6,< C;+V!=!&]9:IXQ])1
ML+VSY$H/!;U1GX2IMU_^O6DU1BI-F8H3@C8'\=!4L%"*9F5EB[&H?4^:.KIP
M3:2_)*9TQF:2#+6J[6<3YX@18TQ'YI(] 5->P#2'Y.[G.IZBMV^RP!G<9*P$
M6BR*M123^*7UM:RVKQK#YPPLWJQ,B8AN7A#T_@W;)5:ER,%#D\3BP6'QD5]O
M*6"!7>Y*^A<2U(<H'K5K(8&D^.;A]A-XNBW)G1-M)R+$P=BA(N%4Y9@_O]*R
MX[6-5ES:X/7<,'<(JYF8'1^]%PZ)8T51:9+GM.21=&!W$$5)L8^JQ%8+!5@>
MM&<2YU&9W59TN1!ZG0%I5.EE2HJY%#;@04=J+*;(^J56MVEJ*!?R9"0R+)V2
M4&DQD0V)"#T,6"0O8KU65&^28+;EF;52;,&MVA(1,[W(K^\V?R5V#:F>7B#(
M"KSZ:4:0D:1AEA!O;I'MOR=.O2O!\*K"!;[:@$MV<2*_ZP!5&)7EVD(:5FPV
M)E5KZVTTU (%C2G0KYU'Z9-*9\M&&BT%O^4(LZ6[EAK,X1REHAG94=$()GXH
M F'7<U#<YH&]S'IW21O%(A99<)A%,TNHRX;8FE.YO<#4!141D\39PXC4+G L
MW+MS84#+*PH0UK$[6P'OU((7=/8RTEXZ>:'G 3W4E$: %1]\P8I?K'..0E?F
MOJ!-ZTX&A:2I//QW;;L?U^8G%B%,-%AN*(.9\@0-ZFON4;LH"8E5T])\<N-9
MHKGRZ*A\$DZNW);:E7%&-;9LN MS6C8*J ]D*EK9]*8Q/D$CO79H(DNMC S<
M]N:61LRDX"Q(:X*YS=;(W&;ZAZ)'<F#X%>R7#!N \4."8<9U#^3U$VT!\A;"
M$(B)W:-C:%R2#:5AP+7,YEHSI^X_*OA9>*%F%"+X8+";>Z@'[W\_;G=[N_=]
M?8L 7'K+%8!,/82!T+1OX:'\![IU2.;,CER=:)!ZCF$)*<GW*.PL_(A-U!KD
MGW72L?M>$ O%J%S5#,FQ-/IH:F :&X,UF]E6!M3%($>!(9ZFT6'<;$ T.C,$
MVAJ"5OC68R]U@Z3&[EJ2+^R>)JH/J@W4KZ4ANW:ZT[:*2*G/"H8;RQJ[4&CI
M">U+&H%S6P5UWT<<O#ZS<<QTFIHNQ&"[(?DN!GD%^9=41,.-G%%8C$M,.J;B
MQ1"I>74D!"02D*$])=2Q"35@_9"5&0R#6?\PL*@LU1OQB$H@@8#!]'B*?&!L
MDK$+4AULWCW4,U*/L9#S2/":VVHHX0ARG3@$&!DA,AE!$$Q );18?U2P(5S%
M!VN!L9.$2G+\0?D77N:-:A2&/Z!5<@7'B8VC>PS!ENV=[C :RG$I#6_ER5RU
M[$,GE-T%>!;ODR$^DHT2P"8V9I&=E<Y!<YO/-4RT=N$P]@7F_0 )1[ 4D@=!
MG"ANU3@,.^*73= ; '7%3+IP3,':'U;H6E.<B%BB+.6;Q*E@K#/.3S3W?FOW
M_D666^ZA(9Y[U!7:\K;C\0$W'.F0\;ATV\]>82W!<2O\E0X()60N=1I3)_34
MAX9;HZ9%O^SLFUVVK\;D2^3,H71$\$&/*]:WC?&X7=VZU$ !=)+IJ/C?*H^+
MH>%+5.0:6CV)881!N1B*E;@F-^?R$#06\T>Z!#.[D8F#PE."A:?(WUUD'\;Q
MR?)[#U3AK$#39)ZT#VO9^HN=_>A%7'Y\#+NWZAPZL(8/SE@$;]QYMC6 Q5J*
MU" ,/1C'[9^^ O#QG: R',;CSH-]\ 4OA[LYR+/CD[-[&N4#2])9EC"[)8TP
M3HM2S+B(N9 +PH,0& 3N_C &O8WLD@/GK84,I1BI*_ \\>AKD"/9%+X"_SN4
MF@21&^R_TC\YXF0<P9K H*%XA>M9SE %^Y.I,FTS:XM,P**=N &[>>1W<U2;
M-A::@[+A4>V/,"3R:1R<9:E&(N$\S- %NHX+79-S8VM,P_>-,6W),>K8'PQ+
M+,;Q69PQ RJW1$&Y:!N8T$ (6113"AVASD5]-&:8(ENQ.TM-M"Y9EB89H*:(
MQL:QDAC']G.:L^#Y6'K1$:K+_'#U[1$(Y\XC-&]&0O<:)/17(Z%/&R1T@X1^
MS*[/_?@*C?]R[RH;>?J8FZ]@MR$5]4N1=1-N1_<B2?2@K"@.@KY%.><+N4:W
MW?M)VH4SLYO6YJ-R ![?-N^/+!"P*5O.PQ@SX)B^TH41 6/I9(D-?-#.@('X
M]<>-*&A$0;/-CT(4K#$+3(H:Y(&Y_UB/$0]C155!988P%@5.-::\J87?LL\-
M3PZURA%(V4B,1F(TV_PH)(9D.VA\I?I,("2)8S2WO+GES38_BEN>Z((-@B*;
M3:A"@Z+?B1XC$);J41ARBXVMC8E@J4OJ,?MX.E-QO@@8E,@#?4R%Q(JC#AQL
MX$1H)G+&/GA3)\^+/?[UDW,/#UFSSXNAT>;Z/;;KM\(L=_6B<3K*55'FU0!!
M1(TT;I1NL\V/X=8CF%$TI*",0NEH@_SDJ#>1J&NH<D%_(S'^C&@-47E2_AD_
M;PY*(P^:;7X$\L /S1N!,,4" :(6=KB_(4.1AS&*!X0C)RH=5Y@.I\IO*F[!
M*NF82%%2ZF'A*KKCHL!FW*H@EO/2$!8^B9\Z6G,K8&@8_%1DEY#::BRXP5H;
M[+\-;@ #>I;= GA>&4[1O@_[%#6<Q/U82FA_:UVV8-S7X0(F.PD1>3DP/$?P
MHX$>$IN*&<F3&$8ZK==-V,7QO!5IPNQ93O5E,.\;Q2EVBL'6(1GQ&]$O<RW]
MI&K/&U4I0\XC=I9*!3LF$&^W4RZ(ZB.\'4J35B3-:%4(&8";F3GJL61.H54N
M7"Q*TS\>#T>,,^ZK(O;*?QX$>L3_/]9TWP9!?K 9"/E^@N%_UX$YY$(C*MUG
M3-E:4?7_*P4+Q$^*5^,%NM"OJ5;TTAH!Y\R3U3GKG4;(+*:FV.]:"A],:02%
MY/%JD5/M^$V)MNNWE"X@/+*4&_:\PK2_@/:8A B.Z525U'$;7C*-TWA:30^N
M4<#DV,0KU])M*R-5,F6YP^_%XCWA-A>,<RL\KU&3IA7U[Y(JB865L31M]1I:
MXG$&P</M&0PVSU^OD1YJ%'HRVA!'&PFWDT^%*HCK8.V/#.Y:T(92KTL@0UKS
M:XIQV'H.>>Q6F".:*[=N)M388_&N@0*8804M2EQN>&XQI*0!BY+)^:]%RPEX
ME0O[:D78?5U>:YU^B<H%5$V?Z0F848\[UV&QN%8Y"'F5)/S2@@^=[9P)6J^4
M0D*'H)514:B BXTR@NX(N!:4<3F!A\I+<)A#U/,SD HY5C'!+>=>!G*'K=X&
M.V*09 4J2'P0_&# "A+II90TW4,1)$LQQ?8V<%L2:FR /S'Q/%X$*7H<9*#(
M21V.I)@Q0':7;,BD,S+.\(D:E9KKGV<5MDWB"BKE3>1I!!Y1&>IBD&=L,/0S
M4M%.%M$C)UHE,"!:]D@DFFD7:,.,) :)O-U_#>ZOD#.C[H4EL>4>!BQ,X-^9
M'J <6WCJ]423LH87A[B4FG*C\D@\IQGNJ4;3 V1E57*I2.!M%9AI^AJ402-'
M=FHF;U0Z#PPS)=]4)LU<4N9LZ8GVD(/(-&HCC9"ZQ6NL9DA]!-?R-C*D.14[
M-9-S6_V9S-FL<J)8>CKHE#VS"BD@G(!ERH,8]K; ^L^15_4/IT'8 6)NZJ!*
MA8X2G#22'RN,I,@Z;,B"0QJ.-1;92D0(P09.)+I-/*JKF/T=I#Q)R,:[1I99
MQ3W5C3=GW2+;ZQCAQ=@VPR>V?<^M5\,+,%##5_+-@/ND".&8*:YX>W[QCW.P
M;)?'M/9=5-$FU ["?<%LO6ATHOF'_PN2$Y76E1HPKX*)G@4U!4&WCAYG;I[/
ML:$-C\P<TU?(%68*_&W)"U7<I9*_<MN]L+D5JR]_7X/:OGIJU3G3$S#<B0,B
M)!J9G!M,BHF,)Z'?&)D[-Q-A"LCR(O#.C>?JX+G6;)KXYY-NMF?B7<69J 9N
M 6&C,%[(1_BUPT5A0S2R(YVSI G<88SL-8B6A ZSL>!_(YUNBB#/J_K!]"KM
MO9X55%U 0R!^<S^:@A\^;_W6 A$0>"TU%H=+XA"IIDVPRKL]_L#X&J\<62&&
M'8>12 3)VJ)WW#D[/0V?7)23I\$3L4.]/XL=^M2*)#O4U#X%_A=$T8S(3[-4
MZ'CAFEX.)GI8P07NF%(V_[WF9<L/#-P#S>O)NT_8WL9^89K96I&-9N%HF-@3
MLF^[4KA<SZK2A+N&:DJN;FY.HYQ$*3!^(L(Z&"V\:G$&\.<;5^/I@J2&7:O%
MTP:)BJ>%=:Q@\WC#^AXS;8 W 50C@X]E^[RWEAI."I-=FD-GI^7@AFA!3[*<
M^"N)S$C)VD0UD8Y'Q8NL,!?Y9YQ%H/$RX:#=NR,.(RSU5V%_D"."SH2#_Q;*
MRALN=@O97>:RUH5>^212V_XHJ:9<2L>-*J8!S9!AR>K3Q>I(7OW(UJ0OJ#<7
MT(W<!D0NRL']8E#?> '+&KQSHO)I[9&/@'[HYOK'PZ;^\:OK'\^:^L>F_G%/
M^6=?I6LBYHOYKAH7461X."@0P(QPHE7D'Z;7B>MSX!7,PYZF-OE%#A)RT\8)
M)>H"ZN$1VR VDKF#/LZQI4*5.^8A*Z+!&A/&9M W8"-R'P1B()E.XZ*P-"6B
M5\$S@C/-C<.M-6&').Y4P,W(LCXM OP 5+VU<I$&GABDIWI(K,V#1*M<<0ZR
M]EWIR2#!,9U/X]+VE$D9$,A<]?@9OU(>3RH<\PM(&(KS3=!(E)]Y72'8HGXE
MA8\4\2.'ZQI9GN+$&@5SU^K!U_$4'72K5]MFS.9I7+/ \.)3+F,@11%V;8G8
MD9FGX3_B7#I-:'=,ZHE1<FZ%3%_2BC)1TUWVAKD&L7B4_DB9<!$;15HDIM"1
M?NEQN -UFBTV.K!U+C% AD,]2&)J_F.]!>GV06UOE4!&T0!=O",>7-00GAI:
M'4Z#&E?;D6#6\K0<@(G$G$(KJ*B;+PV5]PY-!#.@=3O7Y3E%B%YD>5[! -\;
M0]4E.T]._&1G^,3T4P)WZZ?^SR\NWI\C4Y]QKB)?H(&\/.CG<1\[KJ#4H ^0
M#1]Y>"MLQH3WRN1*'7 AJ\J".E:QGU37 3Z3B"^&<.!7XI7@I<.1A2 \,=H%
M0L9<\R)@+E';RHER0Z054&ARP14)@JGZ1 D;% AQP>S&[/K\2>(@=]SWX/)1
M]3;(ESG'NZRW!'(G'=/MX!X?2&+'BQYXBH=XD6,B'\UL-F8FHHMEO;R3F5Z)
M<-_>359M_F<D(<#[89<^XE #!B2DS-0.V/P@@/L/VP/:QEL]"OV)WBGXP!!\
MA;F8I]@$BXA:M9YA-[-/QK\:9)@NY_#: -X*^Y;,I5U!G%//@5&BA2#&:\53
MF&"_(8RV\4OBDT5'R.\9S&(+AD=$L.2KFY):@I; N_%(23X<L248XJ%=<6?-
M/TZ210AHWB(8O2.,!S5B##Z\AG]ECM6*(P"#]DT+&'B:I0?>1[PYA3!MEW)V
M?W?C(/)LE[!W@^9W,PZ( [.<C^]3YV05PID&HU9C[ 0)$B4L0%><E%(MA.[-
M');SOVH@#<-,,#@H]%@0!R;T+-D1C_>;-IN6K(^I6>939GF#D25%'91A+=TH
M:F0(H'7PB1)/D&9[0OH;880!9A$0I:.<JQH'<V13H-QM;\RC9912[OG2GD<N
ML7R^4J*3%3'[BF*4/E2P!RMP674TE6>Y&6#54JBA'K?'ZQ7YH7_\<&6L ^__
MPI$U+\<FR+*>ZTZ=DRM6+"^,Y!<YW"#OZ>;CF8)[!2<IA2=5:#V66KM%]]+V
M,(YQ#F9&(-WGV,@S(UI>-<JG+ ?8[[2-\(IA)O_MPP0P#"QF.6T!D?/)RAEZ
M/QKF50QZD[(Y/'K2;5:(3&CK44+2&I&T@WL&D@>.)GPJ53/<M44C*94-'XNV
M"DARNF"9.QJ+YY^V>S&2=(WE/XGN)]B-D!<;I1UNFC+@-TS'EXE! <$\4+2S
M0>;=J4"9KU,</))09>$8%$G?P3N8>3^2;EGQV!Y8Y.2'XY#'TUCBU0-0L8D_
M% FQ+5N4B&$"Y:B28+5EZ:*HM7MP"Z-SI<%IS&?BYP8Y\H'0)AP<)U48U&9'
M.\A!7D84<1."^),F[61VP\T"/O93"\);+M@/BX:T_.2(WTJM^LI-0PQ"H]2>
MHT?HDPF+FC.=L,9;DQ>#$$EDI$9/RO#>1NZ<>W<=_9E"ZT\X86PEA&Y;PEDO
M84Y#IO0L#Q(#>Z?/Z;RZ)(AC<9=F@6(K^7I2VJJ9*PB?$%U%KANS?X<F(F:_
M;\0-%[UN2XIJK[28XY1-LSF>N@6.J8RY'-2ZB\KH##@/P\S=XH#/#1Y/RPR(
MU]PW_'P@LXAKX9/&49J_N!Y[RXK<=SQ6&E9!+56QUO^/7!\!TB'V7T_\=!M'
M'11'%0YP#'/?AY@_);DL!O<XRX8D3IFU,,(\C%=?QF_%T M:'(S]JB\.+D)4
M:U'@S\QW[#S)[(;K]A8U&7Z"KQ3D1#I*8@J+F:3,APKDCJ(W_/8)NTLP,S>(
M*\1,K[ (Q'9CEHHI9TR6T7UV##58 *ID;)_A&LRRGJUIU86SN:@R1;VQ:N+F
M:Z*PO(F/%9((HTC,\D6KP]I3Y($(E;CQ+.LQO?");HU;<$9T7^4D=<E5'&8U
MYXMF_*J6Q_K5:[3QBTK%52I@H!C<RCS 1O$T"CB=A>K:I))\==F$;[XI.0Y&
M>> "?,XS0%!F5H%?U<^N!/F&-]2S6+ 4?(""#:T=.AB:$^\V<"''&P0:W&A[
M?K$[8;V7L* P R/#V*@:F@;EFL"TGS25S-E&AB9.;KJY2:?45?W2;8?#A8[N
M)DR]%5K^Q\[*?X_E:_? %/FWG^_A(0];NK:+56L?4453M]/P#O_OR?7U=8MZ
M1RGX:0NT]5,7$N&LV'QJ +$,6J$8'"8L<C2C""?!V',+FJ=>X'<:!MD0W JY
MUD252^\\9"XZ*K9=>%_#3<:1KBC"VNZ9OE<*UCU\__V>]O6EMUO>Y;\DJKY!
MV?2/^4S?72Q-X%<@D9Y2_SFP,/IQHEVH.9Q)Y_6:?3+1R:S6:]WOP2Y&Q)U&
M8H4A-LLS>55!/U/&:)0E%*.35X"G1:6^9/-D0^5:U2D6E%3NFW#,K9%;._;^
M1FXU<LNO.XH_Z^$;MC_.,2T%]M'=Y=@4GR)6C)*GB%!#$$=-EIFL[YLWYZ[?
MO"E^HZ0MQ4?N9EQE]+A42U:)1 ]& C UR'4-\J^P$'2U(SKA%#)EI?188P'T
M//P-,_;L2=QI(#"Y:KHL\VRU_);*Y6_RC+:'>SUJ<*]?BWOMM1O<:X-[_8KQ
M\1:WL7?[PL7B_;BW4?_4EX?%P[]_I_Y?N].#SW@.%ZU:&1^8CI>&2&6I,^I^
MXO_WM.Z,8BTO&:'R$LLDP]?("8#U@XRH ->!<1"$7C$@-OHJ8ZOX5X3<*3CR
MCL\,5SZ3$CW@RIC'^+S@P4V_;,$$=/C\,Z.33EL= ]I['7.M28UA7)[^08]C
M+,E)3:V6(&?1+DB)+I1X>1A!'";\I( ;@KNGW7/V8&>/X?;$Q*$5$[^V@O?2
M."8*WR?*((F?_U'%E&UJA,7F^EB_\OKYV&UI^EAOF8G&P][[>&%7J(@X'VZJ
M0.;<E#L6YCH1W O&@DQ&%4&>(.-*](>FNIQD0@[)P:@BJG4Y+*GZI,!D/N7.
M!KDN&>&98R*LFF4I_RWDOPG"=#:9%U2]0=!7 Q2@3RPUY50KIHR1(@5+Z,SP
M'8L%-*,0P(4;A@\0(,-;6-DR0JGZ9?7C7-ML/4)&:G ]3!Y;H5.KL>!O.U_2
MCB T"Q'\([M&B)D $NV4$)B!F4Q#_6+A>5YIKBDA9E"U26/ZCY<$>5]CK6QI
M,1O3N% SWD4RK );F&N>@I@(Y@Q0=&[< K3"%TQ+@/#%:&&Z.&JJ W6@***H
M&N'*XN+R=ENX^5+CKX#I;,P1PN<93"4A45B3XP@78&\#A;0'7*135)C:K6',
ML).RH-ZPJ3K"S?"I86PJ8Z5V6#+(P13.0OD(ZDMW?]"@,D1+P %J],16H7+#
MC&1.=IT2IA4D0A)J*@%D6HB<3&,"VA.H6M?H_=#V9[HI8BMXC6B?L ,OK, 6
MQ__HGAWT>F3]7V1YD458G([8>QSC95:!I/Q=)6#2=]MG1S>\T.(^X7VGXDQH
M#1.\A-=\"'_-2)S^^CSLG)VU.\TEWMYY2K"R/R15\SF><@5,IWL2%J#*<L1>
M$\$CJAS>W!EV<!*&1'>L9E5>5(KK,2AL7 CP#B0Y%>6 4/]GE>KP&(Y8NWO,
M1\>0T='W@Y&A<:P/YOS[LZC;.X,G@1E04$OI4?CR\B.!A6K?_.WR^^.H<WP6
M(?4I'D=B6ZMR)+?%CO?"FD %)/",[]NMX^.3$T)SCWATW=,(3G;WD*#>LZH/
MGN/$H4N%D@@QVSJ'<?R2J7Q(9E(?;; KYOM*F!#2FFT^,XHFO2?\K%B:I+54
M*] HRS#5>OAX"7P>'D7TP'UL_P+<Y^2>UQ7=MX_/W]#(#L];-6V\(V3:2V&
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M:^ZMI+U-!"K7*>;%%DO31O$8&:%O (*$3P@(\G%>"+\)&E:45WO*7"X,?+$
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MKNK'O<>';X/1V.@(=O#HK(G'[MS6P,7JG$7'1S?F[YNMV9;([D3=T\/HK->
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M[ICI7\Q@JYQOO(.L_C'U?A=PL>5S'TLD3-LU+&2@U@1J(WUK(W5,+@;&5X@
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MMF]=VU[KVB;8]B>[N+?RG*S;F6,,4@SN?,C2ES4JI(ON;)II_V2O#MC^M>/
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MA54AE^VIQ0C-)2?%K1Z0]FZ$WLQK*;^LV#T/4=&L]8#=@;48P5DAA.Z%M^U
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M5XDT2E]:E%DMY[:.#X=DJD0U91@O]U.)+1I0@&B4E[G5]\)">8E95I/EZH1
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MZMDLSS UUXLDO)_-"(N%4A=36"(I$7HE\/NMEPJ!T"R,"I]_D:;5W&'SL=#
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MRJU6>/R>?ZY:FUSA"X1+F2=SGYN^"&[#63].(R)F+/TB'1.M^/JH2A)ZB:C
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MKA&*#GC74?$QYXM/:Q*BCG]0C8@A(WG_*+ LB4.>ZL0K@!H&YEH&]B,FJ'
M],CG,K^83C<J@SC8J9?*/Q^)=X7F0DQ5@LI(^")]D7%@OY6Y-W$L1W3IW X]
M[N'YPR'X=-P^BY%!7<H#N^TC9X?!K0,_<B+HK3P,6* P>""$Z=GWT,]^R"/B
M1@+:K&M6!W0@;5O&"R-?";LFRT-;O7>=#N:]Z)_/W#$,JBE@,>(A5QX1PZ&?
MJE-S@.K,VKT-@44#U=QUJ.;HMPF:2 V>ATQH&P@!S( 9&HF-%#VXE>R. YWD
M/+N#5S*.!_$^K;[C]^BL4?9"FEZ#48>RZ^:@C8O]P'LN6N*J$A?\A-X3@#F
M ;';#G]#/\7 !*HPF0\VDVCV:'O>(QVZ(-,/<.3WT;#2RB[%RNYR[!EQ@<1\
M=0N.(35K//>>Z2^3RB'>NMP4O/AZ4Q,'D%HU7Z390F]@AYX@*9!,"O 1(/ZJ
M /DFGA3SXWA(C'S&HAN6RUGXH\E_S,.Q47]1$#W0\66A==*:^R;E1>)!1<51
M@8^SQ)F!YB(^ATN\L$KCCX.UB#R/(730&8G-4DW3T:<B/PPF0>"]8]:]'LW
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M!)W#R!!FOH,EOE30D.H2LZR:+"W!%88<"D.+TQ^B4@8FJ\$28]Z868P(;/)
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M!U3,Q ;$X:/<Y(N/R>+\':@Q?XQMCYI(4.-"EQ-L_RC,08DEM28L[&!!B1*
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MB%SMR/D3UI8J7TFJ'GE)!;'3VF###@&"UNL\RB!,*FHR-J-$?>B\]=!B9+^
MS=2N0KKU>J,K@J')]CL[I]P,9NH! Y )_<"IJFKYB"WF1KI M?G4V(X08T$:
M^#!P#WDZ6'P.C.&P]E8F?Z$6+$3(A>0?K 55$FX@5D8LW!SF$AU$6=^%/?A
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MF:'8?O1%G/.<O5XA^HZ$4'1P\O6#DW_7ZN*2)#HBN1-:L-JG%Q\$EZ!:',G
M9(#2]M'*4BRZ&# J#I(5Y*/,VQ$Q2&:;Q+,/TS%)TVW!>X&U3@Q!A2)([@S)
M8B?K)F6CXK'/G+WI.)Y:8BE$E'6ON^%J.INK%(7>PH:]A@2+A4P 2O-T;D^
MZSL*.QK$S6'L#\N-OJ0VSQQ1PI<SG*W,W1@*W((9>$(U#@G$'."2@.< ^@X5
M-&L>_9UH$-?.G$'@1XO?MP'8K$NPI$6!E]$RWTA\KY.<!11V,,-.ZDOT=2Y1
MU@?=6*\/NKYBTWV\KWAIB(&XRK =]W2!R)39S^!Y;4(Z"GG4- /XS*YF4\0%
MK8G!;_21/<$,X!W&^\0S\$]XKP\(PA:PAS7Z+^@"!W$B44L!-8)PAH6"X'5P
MFB6LAY!,+0+]:+ +6,F6R429IR;*V.&(-%#!P+U *[#THRS X5&/KNWTU1N6
M$<J/L0Y#<LG#7@30$P;?90S'@Q8#H8,%(G^/K%>/9 !X. 8Q%^N%J%#Q)F3P
MX2VOE$E%'Z4V4#\R3[FAHT;-C) 8P#(5IC*ZU KKEO]6\L\HE4NMZ:6RL0&Q
M:EEP'9*XL)Q7WPX+6AC%/VNT)Z+NLN-3V-$]X<TL-L1Y$/CV"&D(A08L,BHT
M![*9&)B$2@\M8V$/+9%V>6N% %WFXG*4K3I]Z"1 CRO=I^[8&[*^#:' 'IE7
MGHM'DA%%0.0*W-P8U(:E:6(7LQ_V 7(DO0??=0SCH01)4W;&5G&:MS;I .H'
MOR<Z3+"/&/(YVJ9[>?AL2<-GGPV?S6KXK(;/IEL?;-X(Y#>] ;D#>D4!QB*2
M*CL Y<^NTR0KR JYICC&Z6W<G%)J/!0+3"DDH3</JR6IY(_?&NJEF&"+.IZ2
MN)G1"0A-!4[.[V'2C1E9F"1A9A#/V-!O#;$FSN'YN]>]OK;!I[-O MOL81=Y
MZ%S&*X' (O*5^%68&V I6>B!BB26V%_<[D\X+@22'B+N$!*EQXKHL>9>E3<A
M:X;2=<J,L<BCC"4&2>@GVIP/.C'LP<W0A*0"=:#&]DO+YTZ+XD9C(:T_E4[<
MT_3ZO__:TK&.%&N-!O0S XROR/0]$-'_D&<$J1$)%X'21"'TZ2SPKP<CLS.&
MOJU0,^JZ'4&N[=T[>'*G-8E'^BI#D=VF%R*+@U@&50ST>NTY(WP*"Y$ LRTK
MX+1;U$('U=4B0T*]-1@9^\:," K@WQS9TA$48X]Z?0@4 ( 4>6#%H7_]'SJ-
M=^?F>PR1&,IDX7+T"<8+JOW GKIZ)>\[G29=K("\+!NL%OA5!3XP)+4SPO[(
MH^-CB#;:>P305(B_8V(5-J.$&BBU]%= G:+]< 2\B5<8<99G$:GH3XZ,N%S*
M7HC4]?$ 5P#7L(W?B+<F%L.+M)"'7BE4%%G(1KD?PZ (-@ZB7@J?D\.XWIEQ
M:RB7>:S2 =,-MB]JL@0D2 FVA-,65 HP0DYJRD(I-M@95K)A"3C<H2!K;F,C
M#ZP)8- %'LASO3OZZR<>2XO19#,5-AX,X.#+A11Z#-!-@E(?R"P"'E*,J25+
MZ6!JA'I-G^84GV8E^F>$ IF(A6$2'XG_13-SR@&#JT=(C(+3E?Q9\0M-5/$L
MNL@BL7Z?7U!5WQQS*O2(',NT^(4[/%0&I[!9*T4ZLAY);;=*!3FF-N@;,8;.
MPLSL4VW;\S"W &!K:+%*&'9>?C5T%S%O;0_A 3+,"3I#V]ZODX<4[>(-M5V\
MSB^F6VG)<V4PVA5$[81\7H/1F'>9\"=^0 8\RL0N^S ?R:_]#FG36YZINA *
MW:67Z?<0 3U=+  87&0-&_(;=P)9C*[#.%6 KIP_0GDC?H$^:K8^\I-R7')F
M:NJ$IZC")(O1Q<[(R1]E.":L/!=)Q/%P>H 2HAQ;%*JM.V,GB*ETS)2>UAN<
M585-SI@SN2-YQ*;&)])CHF$='4<^\XMDI+&9LN<:VN'%%TP18W4HAN \GHMD
ME9:A]NVQ@AAWC*$7P2MGWWF$=7N&X0OHE"^AKLQ#"N3EA(BKB4),'NU<$JEI
M9TTDL9@@?H'(5"(=PMP]0 LLN@]TL=DZ<T2Y&UN'J62U-*V-T-^CVX\AU;YP
M(.T@0H8G>F/2OV6+OP"\QN-(+/DJ)UJ,0 ^ASW-^N"RQ4@&V&-H,3+%&;70-
M>XY:8ALN]!Q:<@\0T*3?_L44+6G#)F(Q8S N]3&%*&69'=M%$@W.9Z(L1T6W
M^ NZ.(F-7EFRG#NDJB;BQ3.<BQ+J/IZ(YVK;[-5L,V-^8U%3-A8]/(TT,:8B
MIXVX=*N<J+8Q(D:0RA*K&$)J5#&^W8*$#8M3$;XUL^<MA#RGZO2$J0$-R.#B
M=N\XJA2S>K[O4G6#Z"_LCZ/J/<$0Y_MC4#1L8):H8 ;L3<@O"*]F=3/9'/WV
M,.B%'#W(</G 20H-25(HOJCOSUT5YI[HTIAT6X;P]F4%W>DJ+>"5[J:\^E#I
M0&DPDD<KUJ>4MVUO$X:<#TD-K$A#5F40?7KE6\@N@K,RP\I,(*8-/\<:<5I(
M,L(C(AZ59!YB H0<A$]]5E//&ZT[6 ?F?"?,+<$+.WRF['J WT1[%6'"O J=
MI>E]$JN,HCL71%<.X>:BOQ[X%]V <-)IB5>+]F=76^9AP;CD_91HO<@;M)6P
M U9"Y&!^X%:?X*, N/D]@?+?*H-T:!,BW5KW!I@8Y@53X.RBPO+E%GM\BZGY
M+W(5IANJ60'FB21=&!,LEIYZ3'GY1 U(^ :^R+XGT@3QI0TRBQ6#62$*5Y_*
M,L%B[:"^?5$,BD'T$'X<I\&@:A&*IZ9#$BJ &/@-.!\!&R2V5Z671YN]5JZC
M-C92+/;SC U%9*2L^-/2HH@)$AFS;#R5F*CLJAE+Y>Q(Q)LL6L:W4H^9<=W3
M6Y.+5Y 4"V 1VZ[+2#*5/PK'7]Z]]#[W GB*S=<?DL;<;\_GCL#'!QT > B'
M=!G,7%D91?23F#OF:8[PH/'HU=Q/RYA=F'REOW?NX40JWPE/&HY+UD_RU1/+
MI>#$(C@*T50#O9VN:!6 #2$]%BWMD!%A+!!<\<!X!"4UA&WZ= =1[_ AX"A#
M>N_P'8IVT[K@Y5'W98VZ?S;J/J=1]QIUGVY]L 40LVLHB4I(^@VB5[5J9<X+
M^4O'>Y812K4,XWV9CE"$UH4A&1)F&B#6U$.B8P[[/X>1>6J2NR&_D9H:9-^)
MA@XACA\F_T0_*4!XQ6QD?+D2"("?M5O_.F[]&6#JKIE!V)YH3SS=:@?SAW-3
M]*@NPI2\T O1W)ZPNJ&7%<OH4U.::R)ZA.D0Z+T79O"I/XOJ@^H!Y=T&M_65
M>"K&#)%M+<'; !I,".MS[I.X1HGV$Q.ML[#*1\XO(?-MA+Y#<D(T(>R+L4\V
M-6Z0"^<CXFWPFA#&'B,0HP[OC\6@#1V CE.U9B1%1W=4*>RZ1KL!1*QQ-@ZT
M-DNY-KMP%?BR.&XM9%Q .X@>SJ2HA3DGHB$<<LP2,NWGV1U.G^['J*-_C%W&
M"XI*I'KS+SPY0@^*,9$^(.BI1X^0=9QB2*@W85A:Y,/QZ>)A9?XP"--.!\X1
M.;+4^*-\O=!( I3K>0#%!Z24P>F</#*BWP#-5XDF0F%,/!'*GOI6:GJ!'L&;
M 1)*7+\B; W662A/K9]>1S\I@;,S>NOT3*VJTJ^J0BBLK-K / 1A11IPMG O
MZ0ES.%;>%BX5%I@ @6R""Q<V4\0N"S9K="=IOIUACPX([0F&O^P0;"W:,1@6
M4'J/ J/?E/WQ;!Y_Q =(/0$Z5<*ZL%42M>(4J^P.Z$D\AS4OM></F-E>Z,QU
MJ4+RU:85?ML=D4AV6P[UVY@^O^/(#J: L-W1T[SKJN@]5$%B[.!&5$$V-:(K
M[;H("NB9?0/ND-+35!@8+N\/GF @R6JX$/OE#-OC"+HDN396G]'E!__,M["@
M-_WX5*IAPV?C]]:?]2.#/<_I_/'F^VTF5WPC#K^LTT%9N&*T;M4[Q@P8JY;7
M O&J?E1@A,G,+1W4U&[!2YZ6]_'34I*G!4-K6.9"3:S:([7/]#'1QR0]6_"2
MQ^1#_)B4PTO%;8\'(E(#Z,&^/='')$W'!,S+4QY$@A[R/N>/0/8#SA\:99;P
M)0-8+G-8MR0!IB_K].*?*QW^):K-L3.;G] B'KQ)]#!O:J<0M/+'G#,"JXI8
M7UGZ"(7+3$32X LLRB:*,$5!Y<AS[L%?1_.98PSQXP/JQ08,2V4^D);O"")V
M9,P&8+.80ISVU!=Z7RW3Y\]GCX!%9'SIGCL$/('@<N5C/3(OQYY<HI"D-8'#
MXZTQY_5AY;_Z =9(8^R+HJN.^S#LN]C=0Q+_TD%(]US,'ACA'QZ.?-(^NG/O
ML9Q"?%SX$ ;RX^#* V8#=A< \LH3>D$P\G_[]5>[']AW?;=E]^\\=SPZ:KN#
MHP@!=>RKD@Y,(J5BB'KD#%;)<HTPSQQ?-*WIMZ?I&W%-?QP:1&&':F6GM:Y/
MDZ[7)M%+'92/\8-2D0>ERI35M:38O&&=>">"PU.?&7UF-KP%(992Q4[&L94K
MSR6")C5,4P%3+O^0!-CE&XZ-#)&6*X\I<U3>L"# ]=>L?<*19;-'D5,:=-8>
M\8:'&-$Z^8S4.G]_KEXT&\UJL_%/#8=:O3@SZ2_/^>_,L\;-Z?GES>?KVHU9
M/;G\W#0_5:__JC7-Z\;-7_')(IH5-IP#6K6&>D4-]85@&29Y9!PO8?6IY_C?
M!>6R1(JVJ>'MR_)JP:MU9'Y2OB.!")S3 7Y'OX"]@-'' 2R80WU&@#/0ITCZ
M/$.2B758NT_1O(OQ#F)93,BUQX=)O;2V\.X KZ8)G5,](^J]&O1S]AT/?T*1
MT+T NH"X)),ILK]CV2!K119V<P7IE5^BWK+OCK'[= =+HM#%AJ:W4 8]H$]E
M[3U0*@UDR4QL@N,3]1TZG946\:':2G:O@^U!:6!][Z%58 _W'?\!?/3W=I\U
MXQE*C-5AB]@>!J58O1S3'  EA4(MT#]<'EKV\'N4,! #0!YI3<P'.0HNOZ;H
M>HPX#SLD&$:U"CU4J%A)F!<6<X$ :KE*D5PAGQJ_DFP@W\0&!R ! ]</L.-\
M* L6/OL_8C,6A@8$M[C6^7Q3/3*_L+YW:E<$;(<HB)7#/E&\[5('*HX\AJ]@
M<3D6#FT[C-\$(3<@84+B[*&\'@?N/1&$]638.72[AR,Z3U?IP<O*.\-"C+B<
MBNL8(VN<P0^Y(0C0C&H%F"9!Y:HG;*E!KTB @K'"49NUAH[<HI[(HHAJ]^0_
M*ZAWQ0;<[MZ_K.VD/=D->[*YW?!DLV%*L79S>MVX:C8N+W"DEW5(:'R^;C0;
MU'6];'ZH79O-#]4+L_;WYT;SJ_)'[<6F6"V^2)QM__9EJ;KW8UWW_NRZ][RN
M>]_YNO?]..G;>0L[*5N]PW/R#K^J7C>-1F-[79BT&;IC9FA^-\S0O&*&UJN?
MSYLW%H[SK/%/XZQV<696KZ]KU>OJ>\BBT!_/:N>-B[\_URY.M?VYV;*1HVQQ
MLUE[G>C5>FE:+Q5V0R\5I%[Z5&W6KAO5<QSFI\NS1KUQ6@5G^<9L7E+'N&9>
M-]Y_:-XH?O-7\\/E^5GMFJFLSS<U^-O5]>5IK7:FE5::G>;&T/AD>^T>U8>Y
M C9)%)U3698- ]/.T D@4#@:MZAR [9=XO$2^:R5SV2L3"8SS=MM(\^1_# F
M:>$KGV_^IWA$OS B7JRW*M:<VW=W@(L-B'GG0;H8>]"3#I:IC5D;UQ']W:,#
M@>O^!!Y7LHIL$ R?.R2!^EKUZQ8G&.XP@F'Z=Z0V>? <^ ';S(89(;H2 \=G
M;(QA3%X^F3R.R) 1$D,GCJE1%:URJ6P='Y?9J.3WX+'@^2'54[CX'-_<,2"P
MRWA-;.P'"<X>%O +6E*&]G(0:'WG^)!1$N2D_#>L?5>(]64CI%YYAXV%T+%@
M;S&E_5_TNT;X78'!KA]FS8,Z8),OW",SG\\?YLK%4O;XK:19D5-\L'TQL[*%
ML\-VE</OM1]CP*F=GY]"?@6H%?T0*\##UOQA<F. QS7^AG"CY?XBVA@[\(I1
M8((#.V)"&S+6#8?C'$@[D$W4Z,XSJ$&+B \"M8S?]IQ6N+ 0+N]+SNRQ/SUI
M@&UW0J VGIR;<*_@[361BSF5H@7+RY?JF"_5'D6NM#6Q86NBN!O61%@4>GIY
MT;R^/+^1D#$T"\X )?9RAD%J;8"71!178XCB?%B+>,;*:@"D<$J_Z;E]7L,+
MRK5#?ZTAQ:FRVKX0@[&)0'L(*':QPGN'=<AU1K9HR0EWXFD/>)AKC_0ZPDOV
MLMNEUIB'F\S^5I?I8/XWQD$D+07LG2D[6@AQ <1$*"XC*2[F =ZA7>1FHS?H
M]9A> ]F\?9@M'I"W"HNSO!&K[> M;TO\<3PD9CX3&@YX7T)]F2PZ"D=@BA$8
ML1&P=GG L<1N>F2V[("58_ON$.\EV^?->4/H6:2@;!K (>K/0G.+%6$]$%:U
MY7J&/VY!IXSD*4*ATD'V+?T>P-)@WW#$/IH=K#\J$KJP0C5X-C<I^/L"!S@Z
M$=CA,X8Y;/3&_ZJ491EAP1M,B/WK(/<6,$_C@6BVP8W<,529<8,(]E<!YP$"
ML]]W'_#-U*[MT%?ZO->Y*%Z3"Q3NBL^!4H@K14X9>%C(H^?+SHUQ^8(J0MX>
MDG7GB>]S3-+4(D,4?^Q+S1AGZ -Z8SH9@WB>ZX6,5\BZ=P\-RESD%76I*> Y
M@O6+D6(EONP(.U!(/"'0KJNV],+!&FWL:M"?S)=&6(8V/97W?%*.)QYHN@C/
MH&_3>)S4:.,3&PB6P-\"AGVND[%]-]TUSNH+"L92VJ[7Y*?,,WKTK)A>G25
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M18:-.GJ8SI]35!"[,YW7QK%M@?N%[0UBU;"7K0): XSBR'.[! FF@1T=NBL
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MZ&I6Z51J%TV=G=R<^ML"[>078N UBGA3!E7E+J YL_V9B$"HO:M&8P\J41"
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MN6+I]U\C+Q$WV]O(25'-K75/=5PJV %(EN+Z8>[5A/!9RFNC!D=4AD&(3]4
M^XWL(TJ%^HK1_;B>>>[Z+,Y^B1A?0*5XI$>&/B!1\(^ ?A*-[OSD3G?H2<-#
MF"=MS\T?R3Q6]AEIK,6*<QNBIB3A, =7/\SO@_;;F@SFYLE@769\KEP?H9*
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M_( "NTV,B#]GV@,P:-A5WW'\-G56^3.7FR,SZ/@BHSL8CB;LU2(BX=QV&GG
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M=!;]CRWKMJ0X=U3$,2FBM3,YQ42UNK/!^!?+SK_@A/1FI&8S-@BJFZ]]=U*
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MN\0"OF$SZW)$AM2(6LD-:ME]&\!PMF_:@?EQW)^868;X66"Q\?7/_;)5-+E
MM?RR423R7$^&O[*4C(][C?H%#A$/D\ZW"0B6&(#\^,4(^UYOB[3L;9B0I5A9
M2,BB=SO]N[U)3;,0%A75.Z6UN6579G;3DIAZ2=Q 7522*"Z'18L)Y@H,MANA
M"]G.+LXJN-62^9J2N30$,":3SV=^6+UT7LOEGLME3,8V0,^P<B7I2\C8$MT>
MKCRWZP20Z+M]^E[^,GRHG0R*/]8)1VR?CP]&:=K=@'AF8#]JOK&-^#.EXBL3
M3.JM6WOK2GKK=G7K7IO656_=VEMWK+<N95NWT"(,K9RH55CWW &S"LN'F6Q(
M@[,!O^7Y5*[9@E7(4-^E4'IU^DTM<EL2N<"=Q;U4?CYW:XH$*-$3*40\D9FD
MK4]/9?]J>.WUGR[*.\G3BC,SV^K4S ,@;$T+-=S/R$>U['5?SBV\[C5WF985
M)BMY+2M:5I:4E8*6E9]=5A8:D<M1#R_AQ3PK+UA>@09TABF:RUCE;":=+(M:
MYE.I'Q<'-[5^W'-9V8I^G.-RE_=:S\UJQ!AC\IERO[T/)^W+Z]/^UZ+]H@SM
MSY@X5H,MXW'KL-::VGDQ"E('P=.Y=<<9O76[NG59O74IV[J%)LJK>V_'ST?0
MK6;5Z"S4?DG?FAG0X^>CZE*4P-*RMVW9F^V7'1<V(DFYBI4IOKXD+<NRL%XN
M<[M^E38)-ODBO1EZ,_1FZ,W0FZ$W0V^&WHSE*G:H)>T1VR=GA/VWV:,FXEUO
MJO88PP+,QO5OGPI?B@\7HX)]^D\AE;4]"@>M.>+%T^:!3XAYX0;$S.6T.[:A
M&.+_S]Z;-K>-+&O"W_$K,)K;-]P3D)K[8I^C"*VVW-9B25Z_,$"B*,(" 1H
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MY[=WWM^IN-)VP.R7!#.8B(G49MJ2?.#VI>'T0&V!PTH^=1>RQ5Q4V8C:]]
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M'<@&B-#KX>Z(;+ODZN6!:Q0M!E &VU94Y=$&4&U"5^'!!H&=88,F 6FH$"
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M_!1D<60&J&#HL&:YVD%\#^\OZ9#$_<H<L?1: S-%NJ9\QP?XUX@,X$!R LA
M%@ 'RA7Q V.<?<V%&SX:"\IZK_P485_ET"1,78[RT64P9WNXBNPNW(P(N-,Y
MD!"]MB 03J5^:KS'*=_]2$H*J\^WB.P9DXXDSGY,V^PY)D/UPY@\QJX#J<!0
M3@)T$CG<+%6*/1!Z8>N6-5#XD#@2_3$/E6<!G0WQY1E$:M,6SDGYMD<8$D/E
ME!U:C_1:!,X<N0)?Y4'V.#,.,Q[:$, -V%,*@*QU,Q9:SZ[+6Q[C%PDT+LA
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M<0/BZ&W  HJ",'.SDFY'\/Z1'<>VGWS;(<W6?L165X9+[3I/4Z3Y=F!- K;
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MSHWM94,0S4QH!LIPU'B4!)4+]C#HHG1@G9TC)HJ @CS5R?)D%:8I,Q15B,B
M,LN[0L?EI/1ZB!\&K^6Q0BS.(,SM"T8PG60X$0;@',PEIN6*K!PITJ7Q81]
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M-(N<6%0EM3TBU:]Q.'CHAVG+!,8G_C#H"F &><[X"8.)E.$OT6^.,PB<YG0
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M9X*-R7@Y);9.YS:%%^%>8770^;ID3,-[C7G7UPG^D%$6G_PG.$(E_U;]W'>
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M!>PC6H(:I$>M0)-I=LA7+,F0?<# 3KBOQ\>8>8]*9VI1 AXUAN,44-IZ:'_
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M?_0OXK9G($W0A58+?-G?/5VN(]! _1\419/=\6.08=I(,SB%WW4DC)#LGKJ
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MR'#7TC;'Y1RACEC9J1[UP4HXM>;T;\)$+8P$ZMP@T""BKW\-)SOPY&OC:MV
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M;Z#T3!/H]@]WPP*AHK(9M!K%=,%W)RE/MURBF<Z6"A$OF\& ?7/N373<KWJ
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MB[TFY/[<^T_#^R]\8^_?Y:OIM<$_7 G'-\WKP57N_@>[_[,8F[MYL,=?Y0&
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M97&!I%%H*8E5X"FZ:-^OCO02N"]_:-2P##))P5FR'?+5T0?_>',MZ39[U9I
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M6$G$L&DW2*<(=8YA,7]'>USHC-E_.CU_;.-4-X;<K>N6--K+HO8[RYV1'/$
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MS!0P"9:.QM#EOC%FT^;@\KS:SA":,@5,.@(3_N[) F:;J(&FJNMH[*O1((9
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M':QD8KN+#5H97;+B[Q7)+)1![6$I];4LK\CG46O>3']+G/T^[Y"%U<80:O"
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ML=\=/0L]YI-.^]*AJ7T(]/C2"8=I[N[!CZ$7EMX]\0S"(-N@%-DV2(Q:_)M
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MP'U?OO7[-S$^S,2-H+MV\"T<H1]<JCW=7M7NS6XCZ>9CI\F[9OY[0/PU?Z:
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MFT."X4BG,HI$ 25H3GW*%B$3)D"A%S VL:RNICI!8*-GNG%B-V]C]&S+AO]
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M2T7$_EB-QC&;U>#?B!U8[44NRA_EVTEIW$DYJ]%G.&:QFO4W(ABK$4=37<@
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M\Z,.1Z6QN.SH(=7::[DU'9%,KPQI34UHLH(Z *^;(GT!F#@M401OA@6FB*3
M]E#P@0Y@9(?M UL]!/##A5G4!@]0%<"GYT@#0IT)DH98T&@V^-GB%CQQ7(.+
MP6A]Z)BO/MYZJXO=U1=T:XD=$4*S20K8Q@B6[X,5@66TP(M,600OOH7BAA0$
M35:1NF3. (*_^75;J/\^@2\Q9?RLWNZK,EC-0.V(,O(K7[_]?9X! !Z&6XM
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M&%NC;@I4/G]W7^CN+9L8GKV#HE4<)+68UH#GG&/70^''%$U>H<7J) FWCG/
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M0>DX?T!:0(8%=0 6,$5Z@(TA9J$.CQ51A]"^TB&"H= 92[JJZ>;W@<3J(]D
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MGXKQ)&G%F+B;&'O4>Z5BUQF>+GT-1447X6-K%@VA-6<=FGVIY93.1(!!:Y\
M..] GHWE\<W9'3NND17Z0K\1XPJ'QWH=B :P4_43F]E%:Z. SR7=5&90#0V7
M6[95&+JT68&NFN_[[Z/ATM40?S[?G,WDQK1:%7KCMV7>NR/IX"#!6P 3 V\)
MB+78&4$5W44<9+-YPR*5@SMLE8$NC2I JF>;5.NEBX=M@;('ST5J6;&7NL@I
MXT//<@V7C]I'M IO%;+_9]UKGK4:=Q.*41J=&KN>4_7,C&\L8_6FL9+.L!6
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MY>_["<^.UMI_=P_"!2C5]8FVA:NB=G./R!\?4&M,U+GDW?$=0[M^J]0U9EM
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MX=MTV;+\MV_58Z59H8U2Q^^&R^<6PZ;W7M9>#D%U:_"S[[)0=/_9YG((==7
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MP!KEY?T*L<\9_>>SDK-*8N<B(5KE.2L;4UXR%)S!W3N[J/:>U;M2K31/ %>
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M'*NJ0UR\R"0']_B@A)X"!)+;%57N"QI^,!"JDPIN\#8$.@[772-OL^NX$=B
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M;AT=UIE\L"W60Y=.CH&.)X1@& ,0$P#=),E@14I%BJQ."LTPF51M3Z LEN0
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MPU6UC<\A,;NS"RN;%'1,]@O5?H_H55RK2^9O%/VD_2G[[V")_Y?L7[!_NX8
M)2AD97E0-$ !V,*IR=@=X?XL<GJ)[H=*G1F-Z83-%:.P'X4'<STK_ :?.^H0
MY>O#4D%@SLH3!-B;96=#..(F$-!6XBW,J\M2J$8RW7AJT=C57(+W$FVRQTA8
MFEP[JO[N$-7O_ET#:/)1<N9EQQZL?'F(3%E$2_I-U3V>&A?,=ZGKJR=17028
M4;D841PA,!;25](P/Z[,7K?NY%8F/3U!=SBFHC>JK=9YW6Y^0>2)8QTN$L@
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MCU\Q27^DEX3VF*HEM=@'Z8>_JZ* ;_\.4$L#!!0    ( />!7UE0V=P\K0,
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M0\1IXL*-!SF5C8,^B"857>024S%YJ/H1Y#6PSXCS6!-9/H-[#.&O6PP\S(S
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M)LF7)7DNZF+8[RH2P/[_)@!02P,$%     @ ]X%?6?BTWO+5'0  /WT! !
M  !M;6$M,C R-# V,S N>'-D[5U;=]LXDG[?<_8_</TT>V9\B9U+)].9.8HO
M:?=8EM96.K/[T@<B(8D=DM  I&WUKU]<> $) @0EN0/OLA\Z%E H5-6':Z$
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M8 K"J)BENNDL0%-O:N1L67]:,\;-TY"<^0#CSG%DN25O 69#V .TCBA3"EH
MK?@Z;&/+\LJ\LK8!^;V_N]G>$O;!R*)EJ$]&;/LNY]!8=ACM<Y>\9HQOY%K
MJKA9Y)$=%_[_833O"1,U*5@N,5SFRU@S;!W4%C J;AD9QJ#&?@!V%V"+$%(-
MDLUL"^@4IXT,'2PC5@>D>B)5QJEV0*:EL\!.=>-(V$E!KI<#C/N&<0I8-,$*
M\C6(+:;U0A8 *\X?:X"]/]4J&P"W!;R,9&Z[=ZOIPU9ENN%^I_B.9+AY3#2O
M17-]=^C=VX,MA:W3]1#=<C[PC4%AW4T7\+;E+1J!XJ'2- *I2I9355JVB<W0
M(GJWB"\)FK-X%^8%O$[664INZ&(U.NL>!'J4M&@%1I>77)4GZO)X9=[9,"#L
M!'_[Q0@-XF9B"Y 5=Y<,<GFE@O]Q*5^I&&#M":ONYH0&V"YR"V@5?Y4,;15T
M+#Y9>"??NAC [7L"T7+!0G<(82"U -7HK:I=S+@<CB*VO>S9[F;69UO@IKBG
MY N@@S=XA\UQ_<:,UL713F:!G-$[U7++9NALO1WZ/DI\NF#D\I/)8HP>\FV,
M);I;<+  WNC::E3)DM@K,47%C;8Q&MK&'E9-Q5TKFR53D]8";Z.GJ[E>FI:7
MM 9,^VYP;*]>Z?8\?<MW8_^#T>W5\Q[7T"!Z.SQJ][:TSHU6*@MPC>XL]:K7
M@%_O"5Q<S]+.SO5L"\2,KJ?J-MB 5-_5LGS_2[=4;J.QP,SH2<HOC)T7%\8&
MY/: G/D L+. !:9&%Y(.T^'<;TN,VV[\:3JIB=0"5Z,7J>1=NH"OQ 7!H=/V
M!/0?<#,&"1 !@5.("4H2&,G1^!IX[0M:@&V,C*(U>5557EE7_<[  'WOOLQ"
M^<E/, H^;=K1U/5LZX(6T!M]5Z(FCU7ES3?ZEC" O^O-X'9_<@]Z"Z@5;Y7Y
MMO#@<MX^8J.X_29-PF+%P_T VD -RV(66!L]5=7EO-I$SKR3HCKAKA@B,[;P
M7+$H?[QA1S=XC<3<.,4AM?8:1-,(^)3F4T;"!!*M\VH+%MTMXKW9?R7J]&J5
M>F6M'J^6$185#TW#MFED<0SPAL*Z LD2DNOD#F5M1Q7==!8@JWXLP99C+!A[
M8>+=3;X,!PY;XGB5I=2T8RI$G,7\88?B9GL[GMWT%KBJWJX*5U&!E]<@WIKP
MIN7U^ '?;2=OBY!: ZD%JD9_F.99B@'.WC-R\@#I^G8>0?[ D=@W7=-$PBZX
M:R=AJU(6(!L=9%(U^?-+JWRO558U0+[#LS'MVRHK2@MH%1^9N<\..ZDM[@@*
MTY67QJXPBJ<0\TO5B0_OPN4J)1-Q9W:4!%^9A?7GPCMRLV@21D]:T0[HG[D
MWH)*X$DB>$*&OWBY%/Q$N9!C& K^X/9C/#[9)VN+EF5TU.VO90U',[NX<W/;
M3K*4I-2^8;(T^7#UU!;MP1A[QMF72$L5#$-(;V#'*("1N+]RA7!NT\^LV\!
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M'6MJ!S1K.<0T*]>G@ /ZY0=8'=VI@\@!/4;!0TB:3LYFH@-R3J@%1U&$4OX
MI;A4WC@[,5$XH$'AD+I/D?]M\IA 3%;AFH7OM3NN#'0N:/,$L1\22,<DGRZ+
MFVMF?;9SLL\>D4EV.=L]V5<8&BU?)W!._BN489/XM7P'I/\$TT<($]J>1TE
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MF)GY <GHGCU2!M"+5M'=8?VN!AP+ &RW5G$>)KJE(!K;*S4W$$<HCW"+8-@
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M5Y@"&Y!\02Y,3CWG<D49,1^R9Q)<<NHYIRM,D VZ4$69,BD#'SGW*LN7#;E
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MD08KBE6NK6H)DO^1J8Q_\O]02P,$%     @ ]X%?6:U3X]L?.P  GJ,# !0
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M+%P%G&4DK<IV2[]!:"<:>1Y.HX0N0A,<!MY:750-#NU:E=!>[Q6_^]?4GW%
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MKX+8<\-,OBOZ;X ;&6QN"0!BN4UQY&32_1VY1!F";6.K -B7&C1_3Z?BO"S
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M$=,N?&:[5EJ#N,>DX7&$;MU_8)++(DL9%C8=S-51/SYPO>1MSX-"$Q<F<2K
MC+B+*P2]:B%NVWLBJ$[9=HG("J>_5LV[62-3-]Q>L,6_KJ$]M JE+::7*V#1
M>E_0Z9Z=! D]-(^GFR$N34234IH+I(X"X-(_[!L(V^/WIMB4Y+Q=N95?/&^C
M;;&J 7P'V[I5"EI4K^<7M"@4L[HT4:&)RRK"S!%W3HFTJ]S?5];.^=,>\SZU
MW9;S$M6/A*'\7+GL7U26%_GB7(&2DD='D+XC2%1X;3QMD+JCP,AV]XZRK2SV
MY-RP<%-<T/6W !&JR7Q=Y]"IHS3$KZ,.8KDKJ)G&BIT=K$J]1Z">=BB_CB)
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M8*NX5E*UI=:RXH195:'><033#.4+K &B'C<;?7]M0F>VKZ\E>'O,[KI>+,,
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M1/ZO!,=QB4O=MJZS;]JY >P8 BMB%?OB*V2H"-L/MN7K&D)YG]DWER4;P!8
M-WPC9T*GL&Y;)U"ZOG. 1,-M]&0#M R<5'R+)G&HCT=^L9O7PZG#9\"<1!V(
MM54"83<0]]J-M SL6N*GTX_&!WT4E8! ?3=HP&<7,[E'=)GS@C#KG/2(=(M7
M><D_C7"*]'7=TB?8/U%;.9L/E2(NHV/$Y1AQ.49<CA&78\3%>+?Z,>)B]H'[
M&'$QJ_M8=S0_1ESLCKCT?8SJ)^(B.U=]-'&)9MX"1):L%!JJ?1E+U-K.31>H
MMA6NK7WQ56J)B]H/5P(>-+X<)RLW.BU 9?B&Y3 X^RSUGE4FG"3KF\17J+I8
M;$C%'*[VHF005.HN5H6&/0JM[@R*-35CS1*B^^V?3@=[/DK1UG6R@R9O_#J4
MT.2_T?9_"Y+KR),9NMQJT KD2N852PP:U<32"%U'(?JNF=!)%$)6*,' M5SK
M.MU!':#=+]G06[K0V")7:3'N>EC/T6%D1<?05ZCMDYQP[=UVV"NJ'']5,'+#
M@D- O!;741F,B++TD/D_&#CLO'^F09SIU-E<WM(W#.X:'>D*.M+:?; C1I3Y
MO-"-']U7NO6D/Q2NF98?\9 2&0R5JO"0[0V\[7V'F4W=,$M]D@W%_98&HR25
M&(+FLWG0L/KC\CS:>&X###LY(>-_,<_XA<G8IYINWT\83Q]QXM*S>!0'5'8^
M)3\2-XJGB)!=NE;-6J;#T@:(#U(-ZA5?#4FEVRO!/W'7=?7WO^K4W]_P&Z3X
M_GE*4> )ZG<X.O&ROUTNEB%>(W09<:46\K<4OKR3OJ60L>3Z%C[A;+[A%#\R
MB F^1W0YCY!_3]?S*$4214]EBF[8.#F?071A>Q.RDO7-+V?RA,Z,?A#AK^,X
M1?ZYNPP2=BP"-9"^W9$Q<7(NQN@Q<5FOGZ,D\-Q0I)3TR0Y(*>=/>WR/&;7*
M&;69!=FCZ"P1(4O??\9I\@T3@E]8(52M'%ME=K9GW6K:S>(\W'MZQ$9U&1V%
M1H8D<N@"5 :[HK85_E\N=7UVP%ZSH?(WJA868F!CMH8^#&;G9FA!95\**$X2
MO*";1J:#0A9HM?E@B:"B$5+)\13+:]&L]HB7RNB4VW8PL%K$1B@MB$RK21_G
M=!8@KI>D;ICOIX.8+9<)(BA.[NFN2+S+K:?K/2=7QVNM*'[;Z01 [&\5Q)B,
MESR:<?E*MSI,F(<Y/<P 9PPIB=&&KY>\[1E)P>97F$Q1D.C8O$1BD<U%DBO$
MN ?U.&[5S-XVO0KQB\RI(WT4<\MK^[8I9S>(;^1O:'WK1NZ,RS-!),91A,)[
MM$BCW#DLT;)2G[:H)>7L[%@[6]Y.D?D@.F?=[C<4^M_68OTE.DO+V6:<'<;:
M>5[#)CA>N=9V$/$8!5TOV03R#24O"$7WB)=\F&39EUK^(55NMKN']*QFL7?H
MG.HTPR1@%Z'V-:POF":G-,2/I(ED->*K8A\K3F&P*@K746IIAZMRI@20.JXV
M^JNZA-9LSU9'\/=Y&ZEV5R6]HJ1(/6#-,<6!AAOIU,N9,SM_-85(E?KILT48
M:2D%@?39P%7R+F5B;PX[XS2)$S?R@V@F32B$B&PH$U8C?"^>M"PQH'[@ ^<R
M16J#T=#6HI>)[QXM4^+-W;@Y-EHLS :H@2H*[KE64M>#6992#SFF9.Y197+3
MT=%2 ]S<M8O,BGX;\>\^+,,@:3Z*M!F9CE9#A2#<#+Q5M%E8"TLJUS)WYZML
M* !2@['54P%"L^GU$LGF(O]NT]V% KG!J.BK >[9VT3F\G49D .@4:<W&QM=
M/2!PFMX^ <#)0[P'P*/.P72 =#6!(/K:Z?ZB,51-.)D-67.-9$&= 8/JI;!%
M(:ZA\";JETK]ZYR=DQ=A<9("0^$KJ?:'7.NE@8*A94GL"W,"&@P0P)RZ\3,W
M0$P2OK]^B\(D9G_CX'!@Z%^*)=/6K,0E$)"D3<4M^P] RFV,:^3M-)2H:O2=
MCV,T(XAK4986#"E1>@WRG@.&=6;'373H-D9H&F9&1@([P+7'X-\MN7&C62)Y
M?X95F=MOU'<HK]&0P#+I>_%=WY(?01@&[@(N#,VEVV_5>[KYP=85R _:MV4#
M/[KK$!.Y>8MM>G\6Z6#C5J0'9_R63?L;%4YNV%V+)]&<9+192[*#<VVO6Q]6
MV@&' :OZX//+_' 2'%]TH-8F[SOE&G94]/H0 &0;%UG[(7:7-<:5XV#6EK(]
M*,S=-+8 5Y]I8A%^F8;X!9'?<,B"*;%"_6HIS0#[2(6.CS6D;WO6$M^SF[N+
MY0.KA5)O<'';(?:46I:6B UN)5NU\9T;N@1C]9XM(1ABDZEE[3K9P5[=JLG_
MRO9@5^XB"->/)(W94\#29VTIC91DB$VHEMGKI0<G<@.?_GBD7XW'T\UMV-K;
M&N+VAFY5:Z0&<3(?IOIT?(ABJ/L54@CJ\++Q+D5;D!FY\6T3UAXWOUF1/:;2
MUML@6ZC YD]]UY]4'1E847;(W!]:=3]M:AIJ&EQ(,-P#;YHFAZ6'C-[.0VZJ
M1_)'%LQG#YSYP2KP4Q=Z-I>V!9H:NMK# H.]?5"[_PB2.4^>8)D2\V#YB/G>
M<RWSCV@SZ=]_)<= @I6:/8;V: T!HY%;@.Z@[C5N^I-2X'2_5>\W[ X8+EBN
M!61F$Z_4V?BXJ-XY5><=T::O5AC^..6 %0".[XCJ067DLM06G.8O0E\,?W51
M*#!DT2\&KC?[%YJS>R^R,2)JW__;HX=>W"[*#:'5:O>?T%64RNG.Z/9F3/P@
M<LDZ$^5[1+_V.XK9<PSYS0DXKUJ;C<'0-%<'C+.9-[P>YI@D=!Y9;/PFWU!$
MC9_$EZ]+N@I(:XG5T1J,K:8.X*;"/$"W-S79,RZ7_TSI8>0ZBA.2,GOL*GV.
M>>=EM59Y?WYF]^ G;N:J)(35P"VN[-);K6U\R(:NTH'""L&O00M^7M$9+_("
M-RQ4_LP>]\B/N7")2.EK0UN^^V5 J6&=C'WV ,_Z6"/R6"/R6".RI^IRQQJ1
MQQJ1&E7$CC4B_T6A-=RC9%.-R Y[0+9/JG^"H]C.FKJ1H/06S;X3@NDY\@;'
MTD5UU^KID_$GH)*P;3NF.@2#G]G.\6))T)Q-12MT'='SCG0;#-%8 )14=(O&
MD"9B=H*EBY.!3J=1'*,D'CW'/#E+!M%^2PO0$0BLX+4Q!9C-2\I<">G0*3:T
M ):JO! J)M82Q)&G"DRYK078"$6&X#$P@Z(>%&N@4 "@:77&#@&X"=SG(,QN
M<2JL*8+F%D #20WAU+168_>K2T$3A26FT-H"E "A(9":UFSL9;%1Q$E(8 %4
ML-P06DW+-_8S]2E.>18@HXJ'R/$X-"!W*-_%J(X>07L+( +%!K$RT%V0!>55
MM@S[+2W 1R PB$R[%1/8C:O@.66WLKD,XDAYI9FY-@6E!0UJX,&>>_CN48S(
M2CX?[34T%Q2)O" L!I[L[UFZ2D1[E4LB5@]"ADRYK07@"$4&\3'P: ].8:6)
MU@(L5":NPME^T#PRGJQ.ULRY398X>_5X0H+("Y9N. E=C[;YEL94YUCRH/37
M=[*<LOP;SMY'G.U7'/X9UG#SH6-RF7YRV74TQ63!33MZQNE>T9:'A*1>0IMM
MR[=H99HU8FU[VMD!]K0Y!TVJ9?V=PGIJ0W+1#H&W&B94-9HEH5V9.BIWX53H
MA[O&J R6'LY6)JOU +7A26O==H<>KTG^"!;+LQ\N(0$F-S?GLKN2PJ;#I:#I
M#"M<KT3;4VVMM2<$^VF6UEQ?4E&!L/<:?VU"(=,)' B=07,1S(*$'F2T8!$0
M]7[J;!,22!\P[MP9'-<$A6[DWP2+@*JCBH>(ZNFKQ8" "H'AL%81^8VV/\<R
MZQ=;/)WV7>GU4%-7I8<=\@;NOW]%>$;<Y3SPW'!$D%M[[ ((_@5/6E+36)&/
M6=&@?I,-D@QUA)*C4(N9C0>E]F S^SC4"K0]'GJ^1P&?1NAD$H^GHP4B5);<
MWRQ;X.KI>J\FKSQ@L*X6X.K7ZJYBE+((>!BHF%_<=KBRL>HFET@.F;G=HK%E
M <81TK'TMGGO1?I:,/:^\)"]&]?F$\>-LKVZ0J<6M:3CSWPSPX+#\8Q6;2R;
MQVKZMQ+IT^E@'I5V)O.2)B L[;SDU7*:GKM ^[5)I$EZE=9/I^9'_"&I(: ,
MW.%"07\96!"-#9#)9;<H7#<A>(D),^MX.GZ)$&'5;J]9!4(4)_DS["P!FR76
MX9#*--O^4HYM8[9VP'^@>@H^AR$2>U*ZP-+U8GH^9_6LXNOH'J=9^K D>^>T
MDKV3L>').QDC)XB<^_%W)^-U3-#13]"Y1[0S>0'=S6:];HO0KQC[+T$8:N7D
MJ'*S/0U'SVHV9]ZXA*SI-#-:L"W?R//21<K+<5R@)4%>IC_])9VSXNSGR+]>
M+-V \/IUD?\KP7%<XE);-ZJK;QKB>];L/=72--UB8L7^8E_\^K(VXO;#U:3J
M&$)YG]DWEQV^[C8 -]O+;42GL*ZN%62GR"^:JKZ_Z/ 9L"Z69!A7[O)K:M3V
M["]V%/-/_S\Y*,S)6FDW8+*+@M5AD2&SMIO/<A_,Y@F>IC'B9R&Q44N-GD[[
M?IY-Y\Z=4-BV75?B/KH;.$5,@8XJ;FRV;:5"]S(/W&(_F :>Q+#%%F9;LRHI
MN(":MWYN"E8@-T::A3E*) :#I"8Z&"HU#[5"[0H-X& J&["KDQZ"S\!KI3J@
MV0B5'D #WSK=.*>O4I;S=TNY+](%UR!_AD'FI#Z3.*DSAD[.T>$LG0W/H[-:
MWUF=;<#C1_P-,1_:"A'V?,8#2B@>_FB:(/+X@L(5NJ5G[WE\A<EYZ-*](PM<
M9U4967;SME,^SEV6]LENJ$L9?\/)_ [?8H(H/?N#$D;%#_$OWR,>N8EF%]2F
M6DYSV[2RW7EOF[VM#R+<NG0>9-5H:AS_^^T,<=9;VEO* T"$@16._HW@]:G-
MY99#.?>%IH;PL#'MO"DD9KO?&\!FG;/\#B<W+INRZ&PRCM#?D4OJ/>,@T6!N
M<&#P5 ^,$L$MF@++2M EH:C:XPMF_QK7(ZG%Z&FP"W:*\.IK TZR%H).!4 M
MP5YB-=R%AY: %^D#^O;L@_XJ6+6$?(G3<!&V=H 7J=-Z]*VG,N8DB.F^_HJ:
M*G_[,IJ-O"18*54\TF1T/&FU>=)JA*(5MX25-:L_&&BS&NHPUPS-QGW"QN/@
M<-W"[ /E(%W'NB-I.52DL*D14CQ]&6KSTG1PUP7-"GI!@'XQ<!?#LQ!U IQ"
M AL>>)<(#@%FP0#4BT6;CY(>0*?#QJ*W%9"W+]X7))>$H=_+*AUO>3D%9L?X
MLW[\^3J*$Y+R\/V/()E/,,4XH7;- OT709C2J1Y=3J?(2^C!]#KRPI3V@>OH
MW T]EF['KWOP=KN:Z!-$'N8NT8L9]R&)[7'>_M"R.#;[2+_*3M#4,GYND8+=
MZAP-*M2&>!=Z[ WE3JEN8RO"$7)UZ@]Y:O1#'?@UP-+#V<:C?1]0FWV([[@[
M6'=</\?1"I$DH/-=01F%ZW@2NL'BR%H#5E!H6ZJ113-ZGA4O.G,HW ,0D?5>
M++KQ50!0>HN.\+O,>%T(Y906H*B@@$4#41<^2T'3ALK 8%@^?5R@YZ0P_5_'
M<;IS^D@F32&=!=#5B@]N9LR#<#=W:*-80VH!D"H:@$DSYF&Y[9<D6+EL(]=P
M,R-G8 &NZGI Z!IX7Z[869L"K,K# HRU5(%@_F0>S&PF>D >2P6K 7._I060
M"02&@/EL2 BJ<,"]PPG*RP]>TW^,::>01:,^R-_=W+)U.%]G3AD[S^PESISU
M,3:E'YO*+,8<UOL/6WS#A. 7YJS6"C IL[,]2J1I-XM#/3N-OJU9:>"ZX(ZX
MO2'A'%W8REU 9@PK7 5E!>J=\1#%4)$6*01U>-D836D+,K,C)BW VN-3+0]T
M XWB47FO(RM-)B49+)91,T"PNOAM3X(RN_\U#=>/+[1#L<<$&H"@0#_<DSFZ
MD*@J P+4!4*C=);&R2$8*7$8[K:A+DKJZH!K4P<X?6N$#4PUW&NOFGC4J "N
M(EU@<-8  8!FN$N8NO:7*0 ZD+N8J2Z9OX-M8AK,436T3WV7W&H\.ZDH CI^
MVZU(BEQOK@.%A&"XFZG*]J^3'G3#MFKT"7<'(_YZ#-NGZ]A?C7:X>S;*4&@H
M J'2^&*-N-AI\(K\6Y>P?-,12>*;FW,=8)3)AWM^6AD;/5T@>-I]>?HA0<LE
MTELV9"0#/J^GOES4*P [/%NU?ED$'G]FUZS%E@>;]_\BN$Z-X!JQ(5NWZNLH
MRS AJ%BZ>%N$0=GV$@9VH5&K2"\^D<I@+(BD#DJ9RBXDQ-*#)^GNS<]6*]UQ
M(:*T$0:1!N"!NDLHLK_'6N-@G\8N\XMD!\_271K^$9&%FKE92[N,O),8/!";
M'$-2BQL9# DH+7A4-AF.S4.<]^()2J!LD<(NF*J20Y!][FE5"&*/U7C27AER
M.H/-KR$_Z,SHVJVG[L\SV]"PQ* CHEW3^HC*Z+/29FX\AZRZU\AT@PJ$A?T*
M@R8^2BINW+F$\"3;K?"%9,>/Y61'>;D-9\OLSP5UNU%IE\N9?WP\O7Q=HBA&
MK$+1!!&>.Q5YB+^U%8^7[-NLCMX/)J/\X8M/LAS/C:[TQ_R##NM 3N&33O;-
M?W?RKSINY#N;[Q820&VQT<1E^=ASE-##:R@RV.=^#.;\:4^2/@W(2R'DTHW3
M)$ZHA*QD(MR)OLALPMEMM2TP/*8''TO7'$O7'$O7'$O7'$O7F%?/Y%BZYK\-
MU&8G8A]+U^SWB.+VM+Y@3;6UG65JQ'KT$L\<^:L@QO +,^PAXF*3I\\V65@H
M/>@';3^UKC:5;I/+,5@F:4.K5H0'.ZN)CW?<(ZIAX-&=%A]YWZF5%68;F.KI
M;+#["P?-.W4:@7N)=F\QC%>(C,(0)TSFNLF?$L#MG\X&RWQL.)#J= $A,+&L
M^,;353^6]EL^O1\L=_N@\2/2 MQM-<[<[K)F1\H$'T\+CKOB7D2&8 WIT\>^
M\RL;E.A040'"T\#-\T:?HA*_L@[*_ S\'Y_=&/GYZ]8CUG=GJ'A D>&LS=2F
M'M!0.8N\*B)-KS"9HJ#UWJ'(UM;^H:4>N'S;T4,N7Q'Q@KCM'J+(UM8>HJ4>
MN%\PI,+0+?91>!TMZ1I)>_[^'"F)&GZ510TY3R=CZE"NVP!BSO<8/-0/'K),
M21;R/L=T(Y.%=Z>RWJ<5#VS(W/80WT$VM3]J)U-5-7:GP,.0"-YA8 />>643
M6K&)5%%*.6JCQ&7@,)TZ?$WPMSADUUL7L")\UT<WZ;'>TN5B&>(U0@\)]OX8
MOT2(Q/-@.0G=2.:5K:,:.C2G,Q2QEE9F!NJ&#BDULW=5!\BZ[=8GT0K7#1T#
M;6;:L@:MQT%MBM@-5H6A.82J:D&X-B[(8&+$J/='3=L$4*0+N(@TCK5V.1R9
MICP+/_-T36AW1-P_) ZEU!T6F_'[ESPX'F):*_S,N@K6GR::<ASJ<'D0Q(?V
M%QL/G:9T&;,/HP9TJSX/J7N"C2,D/9N*&P]V)#UPT&(5Q=I>$A10>'S!ZBAL
M&P]7_+<C&/8U S=V70)!6VH,B$+SX6K\=@5&23=P6'0(QQ5.I8X;J/5P!7X[
M J.D&KA2&+AMW5-$D"]T]N[TJVS'H4+??QZX?GQ470\(W9:W 4O$/"'L$":0
M!AIO4B*#85 5WJ*@X@_$[LPC?[1"Q)UE7:KI(-/E93#2!^IDD4/@ L4>"9;9
M#=A-[_X=LSNQ89"LU4;USC.CS<V&3M!4*W"%-:\;;+2Z"%:!CR)_Q*X_>]0Z
MFTZOW@<T6=G0 1JI!(;.S$-_KX/?!_$?5W3;7JQA=L@TH,C/AG[07"^H,Q0*
M* []E&5"7"])W3"O:!JP$XBDY%,U[_3SNW<USUIN/N'LOL%^(Z\'=4Q#54Y#
M'2U8K;OX$7]#]\C#=,^"_#%Y0 F%R!]-:3]]?$'A"MU2*.;L0'D>NG',KV#1
M/Q(61RD@\#AWV<L %(1(RO@;3N9W^!831.G9'Y0P*GZ(?_D>+3%)6+4C:E.M
M_%?;M+(]\=8V>X/'+5LR?C<UI.L"M?OM# G 6MI;R@- A($5)_AM ?+:L%NY
MY5 16*&I(3QLC)@VA<3L"&<#V*RK@'.'DQN735ET-AE'Z._(A4,'6RJ0:+ (
M)S!X*M?G9(*W/04*-^3?4/*"$/LXG<8?7S 305I]0D(P7"13;FX%J4%;=V%L
M^GTJQ56P0JK6%E(,%ZM4-3<L-KB8M&KO.QQM? /?J !T&_)(7)]U@7$R1V3B
MKMF.!#A^*A+WGDJK$RS1T:&7>%7)FU_TW%0\'6LQ+EHLC$9'7Y->EH12CQ%Y
MH "'33VAT7BHRM]V<$EWI-P@-T:U:&@P,!H573W:COFHC!$U1&J(C$9!1?:V
MXRTJEJ<K'/T&>TR5[C+B.P2\KU)'99/MQ<(KQ#=,.>-=;*577%L*X1\9I;D@
MZB@  =GT:2GA*-K) 0Z9O2;FFE8H*63#SX8$^T:I'U"@6-1OL72C-=V04]%?
M,/GC*B +68#O5!;@R]EFL3[.V*&<G9RUPWGW^6X)B\6>%*\!*;Q6\_G=647%
M'1]GF3,2/E9S#%,JABDSV[$*3?SI%CZ$GW&:[-Y/TXH/*K.S/3"G:3>+(V(\
M UKIWJ)1L3!=@(3W?JR+0'&I%6]]#1U[JEI8B(&-42=]&,R.-VE!95VDZ1M.
M$KP83[D.]3$F0?-A[\_5A)8 >2V:U1[Q4AF=<MN!+]758".4MO40E.VW@3Z9
M>N345Z/MV$K'>>CYRY*5*@Z/5*W8];B*U]&/>>#-?\78CUE2$%FQ&V[WR$/T
M*.9?!/X=3OXK=<-@NK["A.4/S7+@XBSM2-X_>A+"BD[6IRT4UH<!/"<L(8UN
MWEDA$4'*FHI3X7W9J;!CZ60\^6.EYCR'>X/C[0-X$G_0!YD_B/%@[[/F[Y3V
MY_FY7/'2?WL9@%2. /LJ6%6>*\[8.2[CYR1SY) -4V?)N1Z]08=X@^YPY/K_
M2&-F4!@Y+8^0%DO;O4(-[&>Q9TA-VSK7D0X70WQ+36"N)OSI&L^*HYJ:6O6N
M$3T^0[FP&H#8K!_8Z 0;HBN8[4;KN;OT6(2J(I8LE15H/)@3K=$0Q"KJ6#1Q
MG[,;/H@L7<*./'6+MJCUO]#B#!O#BD(2^^+7S[#B]D,MJA+CRW&R<9%L RJS
M%[T#X>QQ$;LEM]ZO!,WDQ>7+K8:[?"'M_5@N,#A&#)S.ML]3LIL*E_],@V1=
M>)IT^\C8F/R.XE8>\6OE0[V_.W# NY^MZ6M1>&.O@ @O79U7JX[O48S("OE7
MF%S'<8J^LRS;3:U87MZ:%\]@%Z@?7.:AS<CDZ:HM?\R"WM6-SH.&);CQ8N3]
M-,.KM\CS,Q_W9+6D8\7C;R:?4_/0F995;(G"=5ON=?"[([[3Y<.U^^]=1SXK
MNI2Z8;<?&[VXQ&>O"W2O$KL$1\\$Q2<+=A_-^Q'['YOSZ+_\?U!+ P04
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M$M&*:I]1](125(X/Z=LHNLJ-[1QI4F<SK5 Z,6O$7'0BRH!I@TVM#E &DM8
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M:Q("XVY"8T(!\^2F*'8PN8BVB#08J:\C*<>;I$401QNB^R(!<42$B]OHS&1
M+10P51Y@ ?$+O%MQEZ,I#G"H=%S?YZN%/[[C5ZH0$,7T*(57TYTQR>:*>8 K
M*T?:S9.BHH3)W985$:T!"S>JB 7=[>U1 >VV^(BDO#-""XW?\%,)@[R2GHL#
M+B)0<VW))5JM(!D;QK"XR]@5C2FK5*MO+7H+GJ*3J6N26*53]\[3Z9BY2O[U
MI335]$"\!V6G<@)D7L3Q;K-+Z44'UD5EC70=;^HW=V>TXU^O&!!IS=%R]WAV
MFJS^7=!S$]6X13/V\3-<5 T30YMC&* 2SU5!)O+^VP2N4(S*D.<4>B7U+EC
M+FZRRL,EW0LN?0M:/6\E$%5N2*L?BI0"BE!F2)4U#ZONN*#WXE3T!+^Q6L4'
MUSL4WRY*H+>/_XPR>$/^*+QL5"+H[.Y1)=#V*E*AE'>":*%Q\Q)"8? ;_2-@
M?U;2P7=/\-'I&Z\*>Y/7A4NC'N&CY*7?;2&MI0N>HI3>H>?M!5M<1.'V1:MC
MGP"6XAX*3<7_H[[@F:YC</OR7R!^R@NH9K@6J\G-#-_2#%F9"QWUZQQT?4%(
M#<+F.XAN+]!_!]_K%UF,Z0Z42UC]=_F,\]WZF9L,9=,)4:R]@&J",><74DUV
MF+N@RMI20-0^ +[!C'@!OBT@!+=Y"<''CT&W +I^=+?2C-A'4AY6\,80!2MX
MC4A(+!/@DJS@D8$3(U(!J.:>, DES>5"/1*R>Y%[[/KPKP>S2SRLZB._)E_D
M(L](!TYWFI*1(?MS2<LK41#"T9:=OK-!V!2WVK&9C;)W%DY%+.1GGY[$#&%A
M8X>-^#M+(*.FW!&T68>JP$TGJJT=QX2=YN:(N'9&0B+P).12(K=KE]X8[3ZE
MO7J#.$8%>9?U\JYM9B0P$$3J*G7,*%WEM+VS?C)D;L4H>4%%CML%>ECK)2Z"
MLQAZ#?@ZQRM(+Z@3-7A336<!V,Z5-N2:J7FGFSU6'<]6C?R\8R AS^Y(D%ZD
M:5ZR%8L*P.=H6PBII1)VQ28]X(9 <LD@.*.%Q\W3O=#;%AJ-EBTITS&GBN^%
M@1\]+ Q<98G1LL"/DE=_D>:%X;) 0&O$4?%\G>:O^C/[:B5_J\,R!^1+PV,-
M[RW="J9Z49C>(K6B6B=R 5[C)!UL?"4AZB:K;[+/UHNX1"^&-3 MS;B_W<S>
M2?[6,W,; 3%Z$G#A+6D5K=DH,F\L@*@U<93,YQ[G,80) [_$$:+KOO<1&;'&
M:!OQ>^K-5%QE0:;@FUQ()^^=518@N<L3Z#UFV[+F3UDK@FU/$WR+LCC=L24U
M$DH_/2Y#GH!HS@\L\\?==ILBB.D0@M;K+Q99\@CQ"XH51Q5-U1U?%V/EU&BW
M@Y&N&P[_J>)P!M=T)ZDZJ[3"S5TNTRR$E3G8P,T32?[7^TWQ#A2-+?"/T6;[
M9P#K A3'8+DP<C8-CK;33SD9E604Z"=,6QKQ:QF]D?$P^1>"HWB ;,?M,K]Z
MV\(L0>6.NS)\'I.N(N]<SC>1^5![043NF9Q01_;.,%@SRZP<,HFX +7& :ZL
MTT8#._L!!_N;K(3D4Y3W$4HNTJ@HT K!9%$(,BG%/*>%#><W[-BZQ]VU8VH@
MO [ 'KS@&AYFH5?ZN[H1';)U[(*M<@=,;[,QPH%#C#!'?8>,]D([2&&%6E2^
M@<U>[.A$)<J.,L9SR^&;C'0VA\]D*,UXY[2!DUIN*VQXSUP.!*Z;R4"-A=-@
M^3UYI<\171657H/9[\($[T<^#IK!M./1ZFPO8S22/=AN>$G.;#Y)1\"K'(-M
M;9N=B&)&WS6;^Q)4;/,BZ-H=W3L:W\=X>)NRMNBK*4UT7=:"+,V%W'"FN:)L
M+^B$[N_L3_R.IP\FMX]#;#J_2?M0][G385,-!I24'>Z%9#YIVG32/*U(.*%Z
M'F5_?-I%% 6$EY!T9JAD6%_H*0HDVHJC5W$U(6H*OIGPU,E[9Z %R#'!J!I8
M-WH@J10)BRK-]]_2V9J0EY[,!D('CJ/"'-H>,J0]@>D:\RC93M=\6\_7?/?^
M%,>S@G=07S5PZ*R-THQW:ALXJ:6XPH;W\'P@<-VLS:JQ<!HL[R=)]5&/\SQ+
M"G:,@PS!+^$3R65VV#!3UIGPEQB;.2?/@]7Z ;':&C0W#*P-]$_E],[AM-,F
MY>A,Y"G1G+3/ZNB1\6OL:?@E,0==S=E6/&"*CC&J&8F:4V15;:.3Y*-9UW-@
MSQ5F,G%($G$">;(<M31//L6\87QBZ2:C[X)T+_0_=-[^)4J5E:7-#?@]Y*AS
M3'W(4:8=&I$M<8NH_&U2ZWX'WJ/:'%VL9Q2G4V/L#["SY:\ZD,4'E;R&0*N3
M:= *QRZB3P.B$I3/$#S!-<K8;FC:OY)_6+67[568 HY05ZL5C,NN.O%#5,*Z
MH.*=;;":9,MQ<=7I[HZ.V=D;"BBUG(Z>N_J#66)Y9FT+8&*L+:Z95Z'ME*-8
MD$<I-5BM8QC,$B?1JX#Q]^O\Y3V,$Q:WZ!_84@V+2^0OO]^_;$6%=H<_N8@:
M(C"4,/U_]]ZF!6 $"];@I0#W$*]RO&&;6B]1$:=YL<,0_+:<I>:MY4>^>H/Q
MCB[^79!@L<[Q?O&&QAV+0L[5YU?";+@@% J"&"ID7"!O9$$C#'ZCXJZ9<9,E
M9%R7[*)40HFQ@"LNB($U)!C^&L37%T+B=[XW0GX^]R+YZS*G]3LE7WOTNZN/
M+835?.O!CT%\:A$BOO[)7W=%5=2BS $5AEE172/BY<M_(4-?T@%)OOO@5U=?
M70"I^>:]GX+XXCR>\?>N)?Q\W"8E6<*W\IP8_$.1MO1D7*=U'+QQ?M<*!/'1
M9:BL,KYW@-EP3(B+_!&F9*0(DYJ7MQ%W\X]"SA4QE# ;<@B%@B"("ADW)"0]
M0)3M0:,!FH!!=1RS@SXR:3/0N]4*Q?04=Z8*'P8ZKEAC#+]AD%8A"#:9HN3F
MN:D>Z 84C>8[<)WG)5T>=]T;08@_X7RW92O].F(II9WU4'K(;5\E%PV"1GI\
M7/]%- !3 ;6.-^I4LZ))ZX.:.DII9WV8'G+;D\E%@Z".'A_7JU4:H*.0QZB3
ML\LFV+AL,][[*)1P%UV$T+J(,O@Y""J(,7&1X^H.5#=\# :XBTV^RTKWWW\1
ME[LH3?>L,H&*!D)!AVQ0 .V10B 5"C?DT$04::0!%0^ *FS^AGA!D:A[&*FD
MTYDQ.=3!'!DO%@1=U-@4\V;+'%#V]/GBK7>YS3/BPBUA_LM:T\W(19T-D#1@
MVW&11"X(VFC <:.@/#NC;+FE\>8%XF@-@^F:^JXP+WK14\\AH88/*BF@BQ@E
M$ ^.6'*,)OP:,FO0R?GKUUKW#'LWN;S3/DX'>]#3R82#X)<)0O5J49]K XYY
MZORJ0N*_1.F.P5@4Q6[#"K5?HM4*8DB^KIIHM@:<;3B8Y%B[$\%*.PAN3H+,
M[5VHKF]NK8#.#.CL^)M#&L7T7PJ6![##',]YFD#\4*JGE2P-N%LMF>)8MXQB
MHQT$6R=!%BV\2#KIE^+[.D?LF00/L-SAS#MI;V%9W:UJ1U61FC^"RIV0TY+7
M"92,4J"6%*0'%2I#WDG'K6C:D4^E[H^$>J?D9)3K!DI*+6!+<LK6K1U351#X
M?RG:A0H52XTU71'4TI6&FX9J0=#2#JOXSG"^2P:_%+V%)N^QDETQ/RE,2C3]
M14BE*_+@*%0+@H!V6"U#(C/E*PY&3[LTPI]146IW_"EDG<4Z'=PVNLD$@Z"3
M#AT7P2IY0!7\;  41&#Q3+-,T&-O*)A7%DN%P0T5-..NS=.2>=,CF[)%J^%\
MPY89?S3B01#)#*-B\Y9+<JVBXHGYM2O.UE&TK1F6ED7S+QW5ZG_XO1TO?\Z+
M\2$$B8P+.BGA40()!;Q31H5*5 JA$@+?4K%YJS5.V(XNCBYB,6^;T05Q1"3C
MG0D:8,8[T;WT02R9ID<GE,P02KDBA@)BPPN!2!"TD./B+F)F@YK^&99:Y9W'
MM6SY)IOAS^[/*?(4Z/\6Q+<7 #(_I.CIJ],U<_%)I?87A]LT1:>1ZG\.X@L/
ML8AV7GHX7*0^<.;EF)GB<%EH1\KT!\E\G!?+LT\DU:RQ7<(BQH@M]RL/C!DH
M.=S%9NA ;R.;1B,(NAC#%&UG^[18W+?)7T_7>4^?(/K8*/VG'SZ^="=GU3O7
MM#KN<@)#^%VBH%$(@EFF*/F4HM$#1/';E^]Z9Z%=)Q-9D9UGJ[(@:8[F#*),
MTEFRH8;:)A]BL2 (H\;&3UME!5U=.8<97*&R %TJZN_TX17&- =^@#&]1F4O
MJXLE%G.V9U$!LMV9*) )@B0*8-PN0XSS#.:[(MV#Q6N$$S@Z.M08\513ZP$6
M951"RMA+\E])816AE"NJ*" V3!&(!$$4.2[^_J-6DB0Q)<0;E%4$H8I^ZK'T
MT?<A440:9WEQ'VR1@1;19BP;''\D .V(Y#HI7J_+.EA*)L!& L[272&P-K<=
M_!H$$X20N*QUO<;L=D/0=CL!G!MK8)-D>E^@0GG"0BKJ."^1@AWE)IQ<$&31
M@)/F*".RU.J.Z?)8_G&/XSN\+/!54:(- _,%EL]YHJ*.F9HK&MDXT5#*1"<(
M>ED '5/ML22_@7N,8@AR#):/#Z S 2H;KI?N=B7I,;.$WBNAZZX4LLZ6\71P
MV\4\F6 0'-*AXQ;V.GD09C?7<^,V+_\+MAD;5,8M,S4/>9'6"4&V)-4)@G,6
M0*TS*V(0$(N@,^F8?M?D'1!@S73"399(UJYD@JXHI@;:D$HLY91&Y+E/>0$_
M2]BD1!C <M<(W^4.+O.K-\I8>+>ZRE8Y>1UTE"CNZ:RT/5''Q"4)GU2J0<0J
M>[QCRM46N@G&9 ?I_HC:"KVXH6?'TTX)D9N_H#QE0?5N]7.^@1<4%MY_CE[-
MF:HVX9.N)LZI.*O2#Y:X!J!-V=N:HOREQD!M#1!S 9'X$A5_VT4I6J&X]GP9
MO37+1.9$UIOQ2693)U6$UMD(EM2&P$V)/39'^4T,MDN+87";=![$F]K?F\V6
MWMY, #^A%)5[U3!GHAU/[+9S4T)O,R,A\ML*N8[@[T#/'&7UV*"_^1[]8$DE
M[&'&1S-HDDN&-'#2H@Q@\"3 :#0KR E[)(E^7G D&40HTL)3'W/VT4?V5VES
M2&^#?Z"7Y>$VGJHZ1AME'VOH9@Z)5M35FD&0S1JN:K4](19 EI< 5S;:'M#U
M1#3=9E1<I"0$+_,OV1;1K8NR76 J86>3SEK [52S5#((.FGA<=/*3 $P#7JA
M\Q)MV&#@R^W]36_':7&4S6%3#K\RP$OR ,%&,8F,R\.O0GC]PZ\# >^<4:$2
M4@50(4]W[C&,FW5+:]6:EES6:4Q1P1V$%)&@=W:8H).P!&WH.NDHBO@BC';K
MAE32.5G4&S0D8F$1Q6@;QI F/G9=-'CO,4Q*O,F2ZS1:*_P:R;EFAA#FF!<#
MH:!8(4*FY 15\+62W8]Y%UF18!TWQH(^^A@>J*B#Z:2"HH<0FKYKN<BS B40
M>V/(S_EK!]VDAY$IN&:,&OB8.6+IH!BDA*ABTCM 5#W3J4VNR.@KN<[9!J%?
MHE02=932SLZ"ZR&W9\/EHD%02(^/NZ1XF->R47,"5CD>;LFBE=V])+W"&0!M
M>-)I^9^-40<JM4H05#/'.76BQD^91*%?\D4MM;A7GDD6ME2R(2UM&> ,8'&+
MH?R:)3C=KQ]AO,.H1%"R*44AZY0H*K@#EH@$PPD^"G1C8A!12&1IMMV)^V#*
MU1N.V8D-F5,] :><X( -B-#^&L[7'T/B#F*]01PCTL,P(1_?^A..JJ/*UQ'"
M+(&2^2*2=/KUY5 '-.#%PN&#%!NWIX;\7N6S("KH'AJFZ>-$[S" [;_\43*N
M7CQGZ_M8U('H%%QQQ@QX0QVU=! ,,H*H[U3VX$N$_X!E?2BON@K;=9EO'+&#
M8!B?TZU LK5JL9BS$M\*D&V!;X%,$&11 ..*>U>B@,A2*M2U;)[V@.BA%Y3L
MHM13K9+."4F9DK& >VJ(BI,,?PV,#HH59P$1_"P]?REQNH1X4]RMEC@A<%1S
M*2IA9[-S6L#MY)Q4,@B>:.%Q4W,D(\&(1 BFQ?:P\RQR'C8H<OETR.AW=T%#
M *N+&;T?0YKA$ $+8$JCA;5$I21W& HX_\H#8-QG9K\&T>2%D+BN@?[F>I?M
M+H4??GCZYP^TUTKR;0EEZ\)226?[9]50V\VR8K$@:*#&QFV#)=* BI]]&*0+
MM:;[0K_F9%$).RSL:T@9N600K-'"$Q7P#8L\5?QCSY:7NA,)N>U11 "'O4I?
M(@AR2&'QQ7?SK:^*=7WZ+O$F*TTZF;Z@CSZ&!RKJ8CJI(.B@A&;:P2SK^H:^
M^Q@E512RGGH8.6&D@D%P1H?.IGOQ1IUF)*VKIRJ1<]O/2& .NYIE@*535<BX
MX8S?*JD5U*NW+<)Z/HS%W-)!#'+(AJ%,0&00 N/78!LA?U2XW%4(I)YT FX_
M_QC8\,,WOP;TR4>0N$RSUQ\THHZ_^$VUZ;6>)KW/4Q0C6-SC//Z,,GA3PHUH
MI<-(RQ4W+%QH"&.@$@2+S'&.J55KMO/?C2Z(L@10 S"I3G920X!9<KVNTCJ7
M]!U33Y<8Z#BGG0X^1SJ90EB4TZ"<2C@_TRIBKV[SLH:C6M*ST/7+/84[:@X*
M% /FHASM5$[2ZJDS\7*SB1CS?OB7'W]@[/OR9?%[MT/[(L?;G'3T\"9C5X32
M'G_Q5)2T(M'H!=@HNN"=O2.4=.9:WAEG#94O!5.K@)[.D0EUMQ(!;4I>Y7BO
M=-) VSVUC%WB^:55#8QDIGCE3$,.F=;LKEC$,2USU&2D>Z, 9J+N@VNF3HG(
MIM,-CFV&@*7;:CJ]JB_=SQGI!BD=6N&".5A&;WF6;_8LL3O[X<>SC__Z?K5+
MT]^I1/>GLSC'OW<BC+_LWYF$R3LP"I_SF'3!\SF=I]R?PUXH.XEF],5/4]&&
MZN[I_[%+ZEVTBRRI+SN!A6'(-C?C(W3;.BD*X:8V@@OEEL"Y#((>Z(J'/.T,
M@=8,(#;!HBAV&[8F/N\)L.,%>=W;L8WP5O;\A?<);LMCNX4Q[ZUC+@^DS23J
MFLE?6UOO &S;"9U2B$ZNG=QM(5UVR-:/<%V]'G''8*WMKPUH79(S7JH:*+]U
M>,=L[A6MR%<@;[1!4:N#WZ+:P+QK <?C[Q5IDN6^>(!D.%S20T'-F[ -\&:&
M_+':QE$YP4VL!,IU"^C<Y6T<T8^2?S_ %YCMX#7YBA=YQII1\2LJGR]V19EO
M(%8EW1:ZKC)M:W>:]-I8T3O3IJ#E2S S_1.)EUIO;>.FG4%_\7.*X_(X:F,M
M[$F/"9X<J05HYS3JF\-,YRYX<1]S%#+0HKF(L6PHS#'$*=C*QL1.)#0V<*TS
M1Y&>QT11[H8B+^250B&?+> 39.%M3N?KLN2N?(:XYY%^C\!$&V[9.<&](5,M
M#'A/*0]!S1\?:":6<FH#P,Y(?]WW]$;M-UE,<HME]&8;:\6*_H*MRA%YM!5I
M!41<0ZC\9BLJ2B\-/!$6ME6OOL"(_@N=&; EI-:&/VX:NB>GJ<9 H(PU0RVL
M</;"*IQM.KT3(?)%5#R3CH;^Y^IO.T3<F#(#:F#%'YF-793366LB[(S7%#ZW
M@D446 X1TS_ 3O5$R$WW[L(FC7J ,23XGU+[89J1'7\$MW!33G$#(V&3W-P!
M4;4PV,N5<:=\(D2_QW1!KMS?$[]*NDI-FNIV2DYB9L@?U6T<E7/=Q$J@*8H%
M]#'-&U7&=-CHG0C#;[*2^()(FUP4!;3<:R!7]CG\4SND&@**-0-EK :N>I]!
M LL(I3 9S%E$3_FN)/_2V*5[9^ I[D 8OQK[*0V%?CC4MIS@D"J'G7_H@?.S
M'B,&'WT9;) CW4=[EN,8KHEI='TLD!FY(UHM4RIZCZ-3T(IS6KH!EVF!1NU$
M(J/0Y8.&;4(C@8S9% X:#M@$%L*.EH;H=4.U[4RTUAV]W6$,6;Y]2SYT]9>K
MS3;-]Q"RS64I5.V /=28AR.Z$QT6'-NUM!18])T(GYM)JS190*:5O6I+H#$%
M^K:.?^RW[]2%W"F+H\!3+'HY'CS==>&187MS@1'\$!]D+(^"8/G7#$8X@TF]
MQVSQ9)+ERI1\<%7M@(B.8HW@&*>$R=_[4@D#5WL%1^C,@Z!*,0#^&(8TN58H
M&:4U8N^4>H %Q"_&0VU>W =]9*!%I!G+!A=R) #Y_<B5V(D,DUNOFJUB?]NA
M<G^3E9"\1^O%'PMK/C?C6[JLVHEO:"J4P#>/&R?.^9NBV,'D(MJB,DJM9\RE
MRAZGRS4.*>;*)9K>H^\DN-ST.!,'<25_(NRD6V:NT_SUL8S*2;L"U0;\[J+2
M.:;>0"73#I2M!I#%FZ[+'!2-#EW#9)NG5L32J438!YC2VO+W$2[W]CF$1-=G
MQJ!T1Y4?"!4#Y:L:+=_I,VFP)>*TJB5)BK."Y,4G5'_B,XPF'+D2:/FCIM0%
M.2DYE4#I*,,Y)F(E=R*4NT99E,4H2F\R,HS<3:H6H;7A<=N_F7N*;?]J X%2
MU0RU>J/2JK$!4&<$_%;"MQ(\T3+#I[(GJ7T9GU'TA%)$>X?)%)?9"(#B:O<,
M*"XV$#K%E:BYDRTMJ7MJ)\+CQ^<(PR?2MY",:$];8_]2<%M"FQOSQVQ;A^44
M-[44*-<MX8])S]3/F#[=7J)=J_S[Z9T_ACW/:0I?'L5ZBB<2Q1:[!)%G%P]P
ML\L@GE1A6&O#8\U),_<4=2;5!@*-4&:H^2%[)TU3SJBV<B)4IB6"$ G#67E
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MG7%]V33AC*%=C?"9;'HID7:(^\+":%,,>J?[G%Z8#5%F/-[E;#/V4_D(8QH
M)DQW*;1];JS6N*3:/BU1]<[E:7C5XX?N;A6VE@*>Z]FJ:FB28P<E2:J2$;0
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MQ_8&TKZ; ;O.,7?*JBAVS1VL_P4C/')U=NO.CJ_,_TK:$R[SF?:>>!W''ZX
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MQR4JF*,'-"@[*X[;RQ071\W!QD1X\PI3X'-D9C;^.XQQZM'2@2#'K>:P%<D
MI/N_YDP#Q%M0FY!W3;X8P0UQ%J6]K=2B?91:%6>;4@W!M[M3-?+>!WD6(*5]
M%Z#OAXX$F")(.LV0>[7X;SM4#5&+XV20LSW ]?&@>5_,^ C1/-:]-YRCN21O
M9A%]$#[\\E'E<:1>NU]&;S?-D19!V-!JN#Z4I($^/I<D$??.+'.,TM-)U3:[
M_OFDLG\^*>"P?)M3KD=IM8%*VN;&8FY#I!CD,- -9;R32@-LS*1[3,B"MO0N
M/R86,&/H*7:IL]6/[LNLB#E!?PF("3TXHKH8 7_S7I>;D+%MKX(LFY6^(+TE
M2B!F'>\21UE1K5^8=.%V]KRE9E/<EF9B-L8"XN]A'@@OD@5; O$YZMU1TIEP
M/)7![K+OU8P<'.RZC_;L=-;BJ6"'V<<YCK%B.&M2TV"/O^)C_ R370K!W0I4
M52:("5"=K&V,'"5_%L*M_[O,O\#-$\2?]AO145MS55<9M:TS#>U,];P'D0E@
MN12ID@1E#C9,%JR)\'&X19?/Z^>)'!G\[(PC E M#WJ_A?&M>4#<>C85 =M*
MYG@AHB&:C)#=[TX;^QC6H$4W/X;Q*06(Q/6%ML>,]_<X?R')1YY=Y_@!KG99
M(KN;3ROM\)RI#G+O2*E,- @2Z/'Q(]I:@R5VF.ET5T $/-89=$_27'@DY:%
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MG2X-+>:SFS)['L!F)LN2WB3_6S&^K8(:P>;;'",1*E!=&FI9-4M*-D ,69F
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MB342X0+,H:$&#- 214PX=4S/[%#Q.U9E;2IF^;MF=]UD?C0L+&BQ<>OK1FK
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M&4O>RU1^$]0&8IA.@ZTAC!<5]!-5#E\]L(.JLGW. M7 BQU4E\KAH*XZ*1A
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M=)^FWQ%1$$*U0;]UA],W8?FW2\H:KQ"ZI M-GB#(/&_,IU<I/J<H("F*8.N
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M@=Z0R"B@*K,8)S!5F5IXET%3BQHO[YLBV02Y:;C;#JI=BS$"4^V*!/5X)/(
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M(\KJR_\HDM7[=P"X=QNZ3U8P!UDDJDUHQ\6\R'(0N/M-W9^BF,,K%M<BP&<
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M<AS^5<3EM;#,FA?1VS>&5,*C9V"M/M!2L]EI\)7NC.@/M:NZXC=:I$3^E]6
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ME3;GY]MPKR38K"SL%=6U!&<H1;-87:4=1N^%?]Y6^<V8AP%F1WJDNT6PM>6
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MFX&/#D,]^[_9/\<I=9_SF-IRK=^ 6X)*.O>GAB8&+"KHK 7%XYUDE1<NVG\
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MC]D[_9?_'U!+ 0(4 Q0    ( />!7UE6MNUH]S   +'S @ *
M  "  0    !E>#$Q+3$N:'1M4$L! A0#%     @ ]X%?6<M!MX[9"   ?4H
M  H              ( !'S$  &5X,3(M,2YH=&U02P$"% ,4    " #W@5]9
M]%YT/,@(  "'3   "@              @ $@.@  97@Q,BTR+FAT;5!+ 0(4
M Q0    ( />!7UE)?%,+NP0  -4?   *              "  1!#  !E>#$S
M+3$N:'1M4$L! A0#%     @ ]X%?67\P^8*S!   \AX   H
M ( !\T<  &5X,3,M,BYH=&U02P$"% ,4    " #W@5]9F(9^P[=8  #J3 ,
M"0              @ '.3   97@R+3$N:'1M4$L! A0#%     @ ]X%?61WO
MKUT((P  (DD!  H              ( !K*4  &5X.3<M,2YH=&U02P$"% ,4
M    " #W@5]9V4:YHPR@ P!]QR@ #               @ '<R   9F]R;3(P
M+68N:'1M4$L! A0#%     @ ]X%?64(+-.O0!P  C @   P
M ( !$FD$ &QO9V]?,# Q+FIP9U!+ 0(4 Q0    ( />!7UE0V=P\K0,  $X$
M   ,              "  0QQ! !L;V=O7S P,BYJ<&=02P$"% ,4    " #W
M@5]9^+3>\M4=   _?0$ $               @ 'C= 0 ;6UA+3(P,C0P-C,P
M+GAS9%!+ 0(4 Q0    ( />!7UD)AX\0S1L  ,-G 0 4              "
M >:2! !M;6$M,C R-# V,S!?8V%L+GAM;%!+ 0(4 Q0    ( />!7UFM4^/;
M'SL  )ZC P 4              "  >6N! !M;6$M,C R-# V,S!?9&5F+GAM
M;%!+ 0(4 Q0    ( />!7UFBLI]P@94  (MM"  4              "  3;J
M! !M;6$M,C R-# V,S!?;&%B+GAM;%!+ 0(4 Q0    ( />!7UF+/#A\!&(
M &&8!@ 4              "  >E_!0!M;6$M,C R-# V,S!?<')E+GAM;%!+
4!08     #P / 'L#   ?X@4    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>form20-f_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:MMA="http://altaglobalgroup.com/20240630"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mma-20240630.xsd" xlink:type="simple"/>
    <context id="From2023-07-01to2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_UnlistedOptionReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:UnlistedOptionReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:UnlistedOptionReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_UnlistedOptionReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:UnlistedOptionReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_PlantAndEquipmentMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_PlantAndEquipmentMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_FixturesAndFittingsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_FixturesAndFittingsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_IntangibleAssetsUnderDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:IntangibleAssetsUnderDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_OneMajorProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">MMA:OneMajorProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_OneMajorProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">MMA:OneMajorProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_OneMajorProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">MMA:OneMajorProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_Level1OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_Level1OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAJuly21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAJuly21Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAJuly21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAJuly21Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAJuly21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAJuly21Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAJuly21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAJuly21Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAAugust21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAAugust21Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAAugust21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAAugust21Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAAugust21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAAugust21Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAAugust21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAAugust21Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesB1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesB1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesB1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesB1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesB2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesB2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesB2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesB2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesB2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAExtensionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAExtensionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAExtensionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAExtensionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAExtensionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAExtensionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAExtensionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SeriesAExtensionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:ReachMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:ReachMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:ReachMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:ReachMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_PrivatePlacementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:PrivatePlacementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_PrivatePlacementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:PrivatePlacementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_PrivatePlacementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:PrivatePlacementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_PrivatePlacementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:PrivatePlacementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_MixedMartialArtsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:MixedMartialArtsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_MixedMartialArtsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:MixedMartialArtsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_MixedMartialArtsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:MixedMartialArtsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_MixedMartialArtsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:MixedMartialArtsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SteppenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SteppenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">MMA:ImpliedValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SteppenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SteppenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SteppenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SteppenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SteppenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">MMA:SteppenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:ProbabilityOfDefaultMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_PlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_FurnitrueAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:FurnitrueAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_FurnitrueAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:FurnitrueAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_PlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_PlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:PlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_ifrs-full_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_FurnitrueAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:FurnitrueAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_FurnitrueAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:FurnitrueAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_FurnitrueAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">MMA:FurnitrueAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PlatformDevelopmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_PlatformDevelopmentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PlatformDevelopmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_PlatformDevelopmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PlatformDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_PlatformDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PlatformDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_PlatformDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_PlatformDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">MMA:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_SteppenPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:SteppenPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-10-31_custom_MixedMartialsArtsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:MixedMartialsArtsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_HypeKitIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:HypeKitIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_SharesHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:SharesHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_OptionHeldByKeyManagementPersonnelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">MMA:OptionHeldByKeyManagementPersonnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_MrLangtonMember_custom_SnowflowerHoldingsPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">MMA:SnowflowerHoldingsPtyLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">MMA:MrLangtonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_MrWilliamsMember_custom_ChampSevenPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">MMA:ChampSevenPtyLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">MMA:MrWilliamsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_MrTaylorMember_custom_NalarooHoldingsPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">MMA:NalarooHoldingsPtyLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">MMA:MrTaylorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_MrHartMember_custom_JHartFamilyTrustAccountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">MMA:JHartFamilyTrustAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">MMA:MrHartMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">MMA:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_EmployeementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">MMA:EmployeementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_EmployeementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">MMA:EmployeementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_Mr.LangtonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MMA:Mr.LangtonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_Mr.LangtonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:Mr.LangtonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2025-10-012025-10-02_custom_Mr.LangtonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:Mr.LangtonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-10-02</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_ifrs-full_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_Wimp2WarriorLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_UnitedStatesOfAmericaCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">MMA:UnitedStatesOfAmericaCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_Wimp2WarriorLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_Wimp2WarriorProductionsPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorProductionsPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_AustraliaCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">MMA:AustraliaCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_Wimp2WarriorProductionsPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorProductionsPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_Wimp2WarriorDigitalPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorDigitalPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_AustraliaCountryOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">MMA:AustraliaCountryOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_Wimp2WarriorDigitalPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorDigitalPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_Wimp2WarriorIrelandLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorIrelandLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_IrelandCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">MMA:IrelandCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_Wimp2WarriorIrelandLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:Wimp2WarriorIrelandLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_HypeCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:HypeCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_UnitedStatesOfAmericaCountryOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">MMA:UnitedStatesOfAmericaCountryOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_HypeCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">MMA:HypeCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-05-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2022-05-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="From2023-06-012024-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-06-012023-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_custom_AmortizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2022-05-31_custom_AmortizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="From2023-06-012024-06-30_custom_AmortizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-06-012023-06-30_custom_AmortizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_AmortizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_AmortizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">MMA:AmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ConvertibleInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ConvertibleInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesAJulyTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesAAugustTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesBOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesB2ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SeriesAExtensionConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ReachConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:ReachConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
        </entity>
        <period>
            <instant>2023-06-09</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:PrivatePlacementConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:MixedMartialArtsLLCConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_SteppenConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">MMA:SteppenConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-12-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_AdvisorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_AdvisorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_AdvisorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_AdvisorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_AdvisorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_AdvisorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_AdvisorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_OverAllotmentOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_OverAllotmentOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_OverAllotmentOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_OverAllotmentOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_OverAllotmentOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_OverAllotmentOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_OverAllotmentOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">MMA:OverAllotmentOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:EmployeeStockOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:EmployeeStockOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:EmployeeStockOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:EmployeeStockOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:AdvisorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">MMA:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">MMA:ExercisePricesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">MMA:BetweenOneAndTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">MMA:BetweenTwoAndFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">MMA:BetweenOneAndTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">MMA:BetweenTwoAndFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-07-31_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">MMA:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-09-30_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">MMA:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-09-30_custom_NonadjustingEventMember_custom_MrMcGregorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001981519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">MMA:MrMcGregorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">MMA:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>MMA:Integer</measure>
    </unit>
    <unit id="AUD">
        <measure>iso4217:AUD</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-07-01to2024-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-07-01to2024-06-30" id="Fact000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2023-07-01to2024-06-30" id="Fact000005">0001981519</dei:EntityCentralIndexKey>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0135"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0136"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0137"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:UnearnedRevenue
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0201"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0207"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0219"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:UnlistedOptionsReserve
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0247"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30_custom_UnlistedOptionReserveMember"
      id="xdx2ixbrl0259"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember"
      id="xdx2ixbrl0266"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0272"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0279"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember"
      id="xdx2ixbrl0280"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0281"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0286"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember"
      id="xdx2ixbrl0287"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0290"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember"
      id="xdx2ixbrl0294"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0295"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0297"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssueOfEquityFromConversionOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssueOfEquityFromConversionOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0302"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssueOfEquityFromConversionOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0303"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssueOfEquityFromConversionOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0304"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0310"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0311"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember"
      id="xdx2ixbrl0315"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0318"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IncreaseDecreaseThroughOptionsForfeited
      contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IncreaseDecreaseThroughOptionsForfeited
      contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember"
      id="xdx2ixbrl0322"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IncreaseDecreaseThroughOptionsForfeited
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0324"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:OverAllotmentOptionsLapsed
      contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0328"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:OverAllotmentOptionsLapsed
      contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:OverAllotmentOptionsLapsed
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0331"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:OverAllotmentOptionsLapsed
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2022-07-012023-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0348"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0349"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2022-07-012023-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0354"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2022-07-012023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-07-012023-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0360"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0361"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-07-012023-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-07-012023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2021-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2021-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-07-012022-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0390"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2021-07-012022-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2021-07-012022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0399"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-07-012022-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-07-012022-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-07-012022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0464"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:BankGuaranteeDepositReceivedPaid
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0466"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0478"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0483"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0484"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ReserachAndDevelopmentIncome
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0614"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ReserachAndDevelopmentIncome
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0616"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0705"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0706"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0707"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0709"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0710"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0711"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0713"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0714"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0715"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0745"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0746"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0747"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      id="xdx2ixbrl0757"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      id="xdx2ixbrl0758"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      id="xdx2ixbrl0759"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0760"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      id="xdx2ixbrl0762"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      id="xdx2ixbrl0763"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      id="xdx2ixbrl0764"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0765"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      id="xdx2ixbrl0767"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      id="xdx2ixbrl0768"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      id="xdx2ixbrl0769"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0770"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      id="xdx2ixbrl0772"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      id="xdx2ixbrl0773"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2024-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      id="xdx2ixbrl0774"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0775"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      id="xdx2ixbrl0777"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      id="xdx2ixbrl0778"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      id="xdx2ixbrl0779"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0780"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      id="xdx2ixbrl0782"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      id="xdx2ixbrl0783"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      id="xdx2ixbrl0784"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0785"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      id="xdx2ixbrl0787"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      id="xdx2ixbrl0788"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      id="xdx2ixbrl0792"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      id="xdx2ixbrl0793"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0827"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0829"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AccruedIncomeOtherThanContractAssets
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0940"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ResearchAndDevelopmentIncome
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0942"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_custom_PlantAndEquipmentMember"
      id="xdx2ixbrl1005"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_custom_PlantAndEquipmentMember"
      id="xdx2ixbrl1007"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="xdx2ixbrl1017"
      unitRef="USD">40683</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember"
      id="xdx2ixbrl1025"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_ifrs-full_ComputerEquipmentMember"
      id="xdx2ixbrl1027"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember"
      id="xdx2ixbrl1041"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_ifrs-full_OfficeEquipmentMember"
      id="xdx2ixbrl1043"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember"
      id="xdx2ixbrl1045"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_ifrs-full_OfficeEquipmentMember"
      id="xdx2ixbrl1047"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_custom_FurnitrueAndFittingsMember"
      id="xdx2ixbrl1061"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_custom_FurnitrueAndFittingsMember"
      id="xdx2ixbrl1063"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_custom_FurnitrueAndFittingsMember"
      id="xdx2ixbrl1065"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_custom_FurnitrueAndFittingsMember"
      id="xdx2ixbrl1067"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-07-012023-06-30_ifrs-full_BrandNamesMember"
      id="xdx2ixbrl1108"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-07-012023-06-30_ifrs-full_BrandNamesMember"
      id="xdx2ixbrl1111"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-07-012023-06-30_custom_PlatformDevelopmentMember"
      id="xdx2ixbrl1123"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ResearchDevelopmentTaxIncentive
      contextRef="From2023-07-012024-06-30_custom_PlatformDevelopmentMember"
      id="xdx2ixbrl1125"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ProvisionForRefundLiability
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1162"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:UnearnedRevenue
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1185"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ReserveOfUnbilledShareOption
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl1193"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ReserveOfUnbilledShareOption
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1194"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:NumberOfShareIssuedAndFullyPaid
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1213"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:NumberOfShareIssuedAndFullyPaid
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1214"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:IssueOfSharesFromConversionOfConvertibleNotes
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1217"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:IssueOfSharesFromConversionOfConvertibleNotes
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1218"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:AdvisorOptionsExercisedShares
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1221"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:AdvisorOptionsExercisedShares
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1222"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:IssuedAndFullyPaidValue
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1233"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssuedAndFullyPaidValue
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1234"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1237"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1238"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssueOfEquityFromConversionOfConvertibleNotes
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1241"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssueOfEquityFromConversionOfConvertibleNotes
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1242"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:AdvisorOptionsExercisedValue
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1245"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:AdvisorOptionsExercisedValue
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1246"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ConvertibleNotesIssuedInLieuOfPaymentForServices
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl1279"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ConvertibleNotesIssuedInLieuOfPaymentForServices
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1281"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1333"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:IssuedSharesHeldByKeyManagementPersonnel
      contextRef="From2022-07-012023-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1352"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:RepurchasedSharesHeldByKeyManagementPersonnel
      contextRef="From2023-07-012024-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1355"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:RepurchasedSharesHeldByKeyManagementPersonnel
      contextRef="From2022-07-012023-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1356"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:ResignationOfKeyManagementPersonnelShares
      contextRef="From2023-07-012024-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1359"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:ResignationOfKeyManagementPersonnelShares
      contextRef="From2021-07-012022-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1361"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:ReverseShareSplitSharesHeldByKeyManagementPersonnel
      contextRef="From2023-07-012024-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1363"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1373"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:ExpiredOptionsHeldByKeyManagementPersonnel
      contextRef="From2023-07-012024-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1379"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:ExpiredOptionsHeldByKeyManagementPersonnel
      contextRef="From2021-07-012022-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1381"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:ExercisedOptionsHeldByKeyManagementPersonnel
      contextRef="From2022-07-012023-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1384"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:ExercisedOptionsHeldByKeyManagementPersonnel
      contextRef="From2021-07-012022-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1385"
      unitRef="Shares"
      xsi:nil="true"/>
    <MMA:ReverseShareSplitOptionsHeldByKeyManagementPersonnel
      contextRef="From2023-07-012024-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      id="xdx2ixbrl1387"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-07-012024-06-30_ifrs-full_ParentMember"
      id="xdx2ixbrl1429"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2022-07-012023-06-30_ifrs-full_ParentMember"
      id="xdx2ixbrl1430"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2021-07-012022-06-30_ifrs-full_ParentMember"
      id="xdx2ixbrl1431"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:Modification
      contextRef="From2022-06-012023-06-30_custom_AmortizationMember"
      id="xdx2ixbrl1524"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"
      id="xdx2ixbrl1557"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"
      id="xdx2ixbrl1558"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember"
      id="xdx2ixbrl1567"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember"
      id="xdx2ixbrl1570"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember"
      id="xdx2ixbrl1573"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CurrentDebtInstrumentsIssued
      contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember"
      id="xdx2ixbrl1576"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentDebtInstrumentsIssued
      contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember"
      id="xdx2ixbrl1579"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember"
      id="xdx2ixbrl1582"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember"
      id="xdx2ixbrl1585"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:DebtSecurities
      contextRef="AsOf2024-06-30_ifrs-full_ConvertibleInstrumentsMember"
      id="xdx2ixbrl1588"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ExpenseFromReach
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1750"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ExpenseFromWarrants
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1753"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ExpenseFromWarrants
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1754"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ExpenseFromOverAllotmentOption
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1757"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ExpenseFromOverAllotmentOption
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1758"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ExpenseFromRestrictedShareUnits
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1761"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ExpenseFromRestrictedShareUnits
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1762"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-06-30_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl1789"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl1791"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl1795"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl1797"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl1799"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl1800"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl1801"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-06-30_custom_AdvisorMember"
      id="xdx2ixbrl1809"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember"
      id="xdx2ixbrl1811"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_custom_AdvisorMember"
      id="xdx2ixbrl1816"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_custom_AdvisorMember"
      id="xdx2ixbrl1817"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_custom_AdvisorMember"
      id="xdx2ixbrl1820"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_custom_AdvisorMember"
      id="xdx2ixbrl1821"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-06-30_custom_AdvisorMember"
      id="xdx2ixbrl1823"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_custom_ReachMember"
      id="xdx2ixbrl1828"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-06-30_custom_ReachMember"
      id="xdx2ixbrl1829"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_ReachMember"
      id="xdx2ixbrl1831"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_custom_ReachMember"
      id="xdx2ixbrl1833"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_ReachMember"
      id="xdx2ixbrl1835"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_custom_ReachMember"
      id="xdx2ixbrl1836"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_custom_ReachMember"
      id="xdx2ixbrl1837"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_ReachMember"
      id="xdx2ixbrl1839"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_custom_ReachMember"
      id="xdx2ixbrl1840"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_custom_ReachMember"
      id="xdx2ixbrl1841"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_custom_ReachMember"
      id="xdx2ixbrl1845"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1847"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1848"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1849"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1852"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1853"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1855"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1856"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1857"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1859"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1860"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1861"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1864"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1865"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1867"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1868"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1869"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1872"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1873"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1876"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1877"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1879"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1880"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1881"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1883"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1884"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_custom_OverAllotmentOptionsMember"
      id="xdx2ixbrl1885"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1887"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1888"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1889"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1892"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1893"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1895"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1896"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1897"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1899"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1900"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1901"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1904"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1905"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl1909"
      unitRef="Shares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1917"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl1920"
      unitRef="Integer"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1921"
      unitRef="Integer"
      xsi:nil="true"/>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember"
      id="xdx2ixbrl1967">P3Y</MMA:ExpectedTermShareOptionsGranted>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember"
      id="xdx2ixbrl1979">P2Y313DT21H36M</MMA:ExpectedTermShareOptionsGranted>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember"
      id="xdx2ixbrl1991">P2Y313DT21H36M</MMA:ExpectedTermShareOptionsGranted>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember"
      id="xdx2ixbrl2003">P4Y328DT12H</MMA:ExpectedTermShareOptionsGranted>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember"
      id="xdx2ixbrl2015">P3Y109DT12H</MMA:ExpectedTermShareOptionsGranted>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember"
      id="xdx2ixbrl2027">P3Y54DT18H</MMA:ExpectedTermShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesOneMember"
      id="xdx2ixbrl2037"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesTwoMember"
      id="xdx2ixbrl2045"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember"
      id="xdx2ixbrl2067">P43DT19H12M</MMA:ExpectedTermShareOptionsGranted>
    <MMA:AuditorsRemunerationForRelatedFees
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl2201"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AuditorsRemunerationForTaxServices
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl2203"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AuditorsRemunerationForTaxServices
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl2204"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AuditorsRemunerationForTaxServices
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl2205"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AuditorsRemunerationForOtherServices
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl2207"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AuditorsRemunerationForOtherServices
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl2208"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AuditorsRemunerationForOtherServices
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl2209"
      unitRef="USD"
      xsi:nil="true"/>
    <MMA:ContingentAssetsAndLiabilities
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl2219"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-07-01to2024-06-30" id="Fact000014">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="From2023-07-01to2024-06-30" id="Fact000015">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="From2023-07-01to2024-06-30" id="Fact000016">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2023-07-01to2024-06-30" id="Fact000017">2024-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-07-01to2024-06-30" id="Fact000018">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2023-07-01to2024-06-30" id="Fact000019">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2023-07-01to2024-06-30" id="Fact000020">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="From2023-07-01to2024-06-30" id="Fact000021">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="From2023-07-01to2024-06-30" id="Fact000022">001-41978</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2023-07-01to2024-06-30" id="Fact000023">ALTA GLOBAL GROUP LIMITED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-07-01to2024-06-30" id="Fact000024">C3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="From2023-07-01to2024-06-30" id="Fact000025">Level 1, Suite 1,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-07-01to2024-06-30" id="Fact000026">29-33 The Corso</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-07-01to2024-06-30" id="Fact000027">Manly</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="From2023-07-01to2024-06-30" id="Fact000028">2095</dei:EntityAddressPostalZipCode>
    <dei:ContactPersonnelName
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000029">Nick Langton</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000030">Level 1, Suite 1,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000031">29-33 The Corso</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000032">Manly</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000033">2095</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000034">+61</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000035">1800 151 865</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2023-07-01to2024-06-30" id="Fact000036">Ordinary     Shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-07-01to2024-06-30" id="Fact000037">MMA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-07-01to2024-06-30" id="Fact000038">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000039"
      unitRef="Shares">10282686</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2023-07-01to2024-06-30" id="Fact000040">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2023-07-01to2024-06-30" id="Fact000041">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2023-07-01to2024-06-30" id="Fact000042">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2023-07-01to2024-06-30" id="Fact000043">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2023-07-01to2024-06-30" id="Fact000044">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-07-01to2024-06-30" id="Fact000045">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-07-01to2024-06-30" id="Fact000046">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="From2023-07-01to2024-06-30" id="Fact000047">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2023-07-01to2024-06-30" id="Fact000048">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard contextRef="From2023-07-01to2024-06-30" id="Fact000049">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="From2023-07-01to2024-06-30" id="Fact000050">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="From2023-07-01to2024-06-30" id="Fact000051">2256</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2023-07-01to2024-06-30" id="Fact000052">BDO Audit Pty Ltd</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2023-07-01to2024-06-30" id="Fact000053">Sydney, Australia</dei:AuditorLocation>
    <MMA:RevenueFromProgramFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000055"
      unitRef="USD">929319</MMA:RevenueFromProgramFees>
    <MMA:RevenueFromProgramFees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000056"
      unitRef="USD">937415</MMA:RevenueFromProgramFees>
    <MMA:RevenueFromProgramFees
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000057"
      unitRef="USD">2050044</MMA:RevenueFromProgramFees>
    <MMA:ContractualPaymentsToGyms
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000059"
      unitRef="USD">537012</MMA:ContractualPaymentsToGyms>
    <MMA:ContractualPaymentsToGyms
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000060"
      unitRef="USD">574025</MMA:ContractualPaymentsToGyms>
    <MMA:ContractualPaymentsToGyms
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000061"
      unitRef="USD">1215191</MMA:ContractualPaymentsToGyms>
    <MMA:NetRevenueFromProgramFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000063"
      unitRef="USD">392307</MMA:NetRevenueFromProgramFees>
    <MMA:NetRevenueFromProgramFees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000064"
      unitRef="USD">363390</MMA:NetRevenueFromProgramFees>
    <MMA:NetRevenueFromProgramFees
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000065"
      unitRef="USD">834853</MMA:NetRevenueFromProgramFees>
    <ifrs-full:OtherIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000067"
      unitRef="USD">170005</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000068"
      unitRef="USD">1173421</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000069"
      unitRef="USD">105950</ifrs-full:OtherIncome>
    <ifrs-full:Revenue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000071"
      unitRef="USD">562312</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000072"
      unitRef="USD">1536811</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000073"
      unitRef="USD">940803</ifrs-full:Revenue>
    <MMA:ProgramExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000079"
      unitRef="USD">160578</MMA:ProgramExpenses>
    <MMA:ProgramExpenses
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000080"
      unitRef="USD">229848</MMA:ProgramExpenses>
    <MMA:ProgramExpenses
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000081"
      unitRef="USD">342600</MMA:ProgramExpenses>
    <ifrs-full:WagesAndSalaries
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000083"
      unitRef="USD">5504592</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000084"
      unitRef="USD">4219655</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000085"
      unitRef="USD">4664013</ifrs-full:WagesAndSalaries>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000087"
      unitRef="USD">4521598</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000088"
      unitRef="USD">2365384</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000089"
      unitRef="USD">1546983</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:AdvertisingExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000091"
      unitRef="USD">613348</ifrs-full:AdvertisingExpense>
    <ifrs-full:AdvertisingExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000092"
      unitRef="USD">721713</ifrs-full:AdvertisingExpense>
    <ifrs-full:AdvertisingExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000093"
      unitRef="USD">3615399</ifrs-full:AdvertisingExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000095"
      unitRef="USD">1790344</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000096"
      unitRef="USD">864419</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000097"
      unitRef="USD">685870</ifrs-full:ProfessionalFeesExpense>
    <MMA:RentExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000099"
      unitRef="USD">11169</MMA:RentExpenses>
    <MMA:RentExpenses
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000100"
      unitRef="USD">11793</MMA:RentExpenses>
    <MMA:RentExpenses
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000101"
      unitRef="USD">2366</MMA:RentExpenses>
    <MMA:ITCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000103"
      unitRef="USD">566709</MMA:ITCosts>
    <MMA:ITCosts
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000104"
      unitRef="USD">633220</MMA:ITCosts>
    <MMA:ITCosts
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000105"
      unitRef="USD">640403</MMA:ITCosts>
    <ifrs-full:DepreciationExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000107"
      unitRef="USD">520697</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000108"
      unitRef="USD">360021</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000109"
      unitRef="USD">260651</ifrs-full:DepreciationExpense>
    <ifrs-full:NetForeignExchangeGain
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000111"
      unitRef="USD">146543</ifrs-full:NetForeignExchangeGain>
    <ifrs-full:NetForeignExchangeGain
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000112"
      unitRef="USD">47359</ifrs-full:NetForeignExchangeGain>
    <ifrs-full:NetForeignExchangeGain
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000113"
      unitRef="USD">26079</ifrs-full:NetForeignExchangeGain>
    <ifrs-full:FinanceCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000115"
      unitRef="USD">3262927</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000116"
      unitRef="USD">4472730</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000117"
      unitRef="USD">2191803</ifrs-full:FinanceCosts>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000119"
      unitRef="USD">1565924</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000120"
      unitRef="USD">1432094</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000121"
      unitRef="USD">965808</ifrs-full:OtherExpenseByNature>
    <MMA:FairValueMovementInDerivativeLiability
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000123"
      unitRef="USD">3400685</MMA:FairValueMovementInDerivativeLiability>
    <MMA:FairValueMovementInDerivativeLiability
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000124"
      unitRef="USD">-6870729</MMA:FairValueMovementInDerivativeLiability>
    <MMA:FairValueMovementInDerivativeLiability
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000125"
      unitRef="USD">2751564</MMA:FairValueMovementInDerivativeLiability>
    <ifrs-full:ExpenseByNature
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000127"
      unitRef="USD">14970658</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000128"
      unitRef="USD">22134247</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000129"
      unitRef="USD">12138253</ifrs-full:ExpenseByNature>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000131"
      unitRef="USD">-14408346</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000132"
      unitRef="USD">-20597436</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000133"
      unitRef="USD">-11197450</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000139"
      unitRef="USD">-14408346</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000140"
      unitRef="USD">-20597436</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000141"
      unitRef="USD">-11197450</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000143"
      unitRef="USD">-20710</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000144"
      unitRef="USD">-36465</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000145"
      unitRef="USD">-31312</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000147"
      unitRef="USD">-14429056</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000148"
      unitRef="USD">-20633901</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000149"
      unitRef="USD">-11228762</ifrs-full:ComprehensiveIncome>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000151"
      unitRef="USDPShares">-1.40</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000152"
      unitRef="USDPShares">-5.26</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact000153"
      unitRef="USDPShares">-2.86</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000155"
      unitRef="USDPShares">-1.40</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000156"
      unitRef="USDPShares">-5.26</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact000157"
      unitRef="USDPShares">-2.86</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000162"
      unitRef="USD">3544837</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000163"
      unitRef="USD">3702567</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000165"
      unitRef="USD">71115</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000166"
      unitRef="USD">2365638</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000168"
      unitRef="USD">7840</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000169"
      unitRef="USD">33641</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000171"
      unitRef="USD">3623792</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000172"
      unitRef="USD">6101846</ifrs-full:CurrentAssets>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000177"
      unitRef="USD">77698</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000178"
      unitRef="USD">94928</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000180"
      unitRef="USD">255463</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000181"
      unitRef="USD">157540</ifrs-full:RightofuseAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000183"
      unitRef="USD">1297263</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000184"
      unitRef="USD">811361</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000186"
      unitRef="USD">65109</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000187"
      unitRef="USD">65110</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000189"
      unitRef="USD">1695533</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000190"
      unitRef="USD">1128939</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000192"
      unitRef="USD">5319325</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000193"
      unitRef="USD">7230785</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000198"
      unitRef="USD">1991536</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000199"
      unitRef="USD">2034436</ifrs-full:TradeAndOtherCurrentPayables>
    <MMA:UnearnedRevenue
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000202"
      unitRef="USD">174290</MMA:UnearnedRevenue>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000204"
      unitRef="USD">454342</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000205"
      unitRef="USD">357227</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000208"
      unitRef="USD">25331307</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000210"
      unitRef="USD">128559</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000211"
      unitRef="USD">121500</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000213"
      unitRef="USD">2574437</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000214"
      unitRef="USD">28018760</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000220"
      unitRef="USD">10273278</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000222"
      unitRef="USD">55622</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000223"
      unitRef="USD">18892</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000225"
      unitRef="USD">130722</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000226"
      unitRef="USD">54162</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000228"
      unitRef="USD">186344</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000229"
      unitRef="USD">10346332</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000231"
      unitRef="USD">2760781</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000232"
      unitRef="USD">38365092</ifrs-full:Liabilities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000234"
      unitRef="USD">2558544</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000235"
      unitRef="USD">-31134307</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000240"
      unitRef="USD">46779703</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000241"
      unitRef="USD">3385281</ifrs-full:IssuedCapital>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000243"
      unitRef="USD">5734601</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000244"
      unitRef="USD">3912367</ifrs-full:ReserveOfSharebasedPayments>
    <MMA:UnlistedOptionsReserve
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000246"
      unitRef="USD">2741457</MMA:UnlistedOptionsReserve>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000249"
      unitRef="USD">-86542</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000250"
      unitRef="USD">-65832</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:AccumulatedOtherComprehensiveIncome
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000252"
      unitRef="USD">-52610675</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:AccumulatedOtherComprehensiveIncome
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000253"
      unitRef="USD">-38366123</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000255"
      unitRef="USD">2558544</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000256"
      unitRef="USD">-31134307</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000258"
      unitRef="USD">3385281</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000260"
      unitRef="USD">3912367</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000261"
      unitRef="USD">-65832</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000262"
      unitRef="USD">-38366123</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000263"
      unitRef="USD">-31134307</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000269"
      unitRef="USD">-14408346</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000270"
      unitRef="USD">-14408346</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000275"
      unitRef="USD">-20710</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000277"
      unitRef="USD">-20710</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000282"
      unitRef="USD">-20710</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000283"
      unitRef="USD">-14408346</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000284"
      unitRef="USD">-14429056</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000288"
      unitRef="USD">4521598</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000291"
      unitRef="USD">4521598</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000293"
      unitRef="USD">8789914</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000298"
      unitRef="USD">8789914</ifrs-full:IssueOfEquity>
    <MMA:IssueOfEquityFromConversionOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000300"
      unitRef="USD">32177751</MMA:IssueOfEquityFromConversionOfConvertibleNotes>
    <MMA:IssueOfEquityFromConversionOfConvertibleNotes
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000305"
      unitRef="USD">32177751</MMA:IssueOfEquityFromConversionOfConvertibleNotes>
    <MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_custom_UnlistedOptionReserveMember"
      decimals="0"
      id="Fact000308"
      unitRef="USD">2741457</MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes>
    <MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000312"
      unitRef="USD">2741457</MMA:IssueOfUnlistedSharesFromConversionOfConvertibleNotes>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-07-012024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000314"
      unitRef="USD">2426757</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000316"
      unitRef="USD">-2426757</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <MMA:IncreaseDecreaseThroughOptionsForfeited
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000323"
      unitRef="USD">-108813</MMA:IncreaseDecreaseThroughOptionsForfeited>
    <MMA:IncreaseDecreaseThroughOptionsForfeited
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000326"
      unitRef="USD">-108813</MMA:IncreaseDecreaseThroughOptionsForfeited>
    <MMA:OverAllotmentOptionsLapsed
      contextRef="From2023-07-012024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000330"
      unitRef="USD">-163794</MMA:OverAllotmentOptionsLapsed>
    <MMA:OverAllotmentOptionsLapsed
      contextRef="From2023-07-012024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000332"
      unitRef="USD">163794</MMA:OverAllotmentOptionsLapsed>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000335"
      unitRef="USD">46779703</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30_custom_UnlistedOptionReserveMember"
      decimals="0"
      id="Fact000336"
      unitRef="USD">2741457</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000337"
      unitRef="USD">5734601</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000338"
      unitRef="USD">-86542</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000339"
      unitRef="USD">-52610675</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000340"
      unitRef="USD">2558544</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000342"
      unitRef="USD">3385281</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000343"
      unitRef="USD">1546983</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000344"
      unitRef="USD">-29367</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000345"
      unitRef="USD">-17768687</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000346"
      unitRef="USD">-12865790</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2022-07-012023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000351"
      unitRef="USD">-20597436</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000352"
      unitRef="USD">-20597436</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000356"
      unitRef="USD">-36465</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000358"
      unitRef="USD">-36465</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000362"
      unitRef="USD">-36465</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-07-012023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000363"
      unitRef="USD">-20597436</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000364"
      unitRef="USD">-20633901</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-07-012023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000367"
      unitRef="USD">2365384</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000370"
      unitRef="USD">2365384</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000372"
      unitRef="USD">3385281</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000373"
      unitRef="USD">3912367</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000374"
      unitRef="USD">-65832</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000375"
      unitRef="USD">-38366123</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000376"
      unitRef="USD">-31134307</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000378"
      unitRef="USD">3385281</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000380"
      unitRef="USD">1945</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000381"
      unitRef="USD">-6571237</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-06-30"
      decimals="0"
      id="Fact000382"
      unitRef="USD">-3184011</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000384"
      unitRef="USD">3385281</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000386"
      unitRef="USD">1945</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000387"
      unitRef="USD">-6571237</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-06-30"
      decimals="0"
      id="Fact000388"
      unitRef="USD">-3184011</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2021-07-012022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000393"
      unitRef="USD">-11197450</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000394"
      unitRef="USD">-11197450</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000398"
      unitRef="USD">-31312</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000400"
      unitRef="USD">-31312</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000404"
      unitRef="USD">-31312</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-07-012022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000405"
      unitRef="USD">-11197450</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000406"
      unitRef="USD">-11228762</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-07-012022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000409"
      unitRef="USD">1546983</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000412"
      unitRef="USD">1546983</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000414"
      unitRef="USD">3385281</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000415"
      unitRef="USD">1546983</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000416"
      unitRef="USD">-29367</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000417"
      unitRef="USD">-17768687</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000418"
      unitRef="USD">-12865790</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000420"
      unitRef="USD">3385281</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000421"
      unitRef="USD">1546983</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000422"
      unitRef="USD">-29367</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30_ifrs-full_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000423"
      unitRef="USD">-17768687</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000424"
      unitRef="USD">-12865790</ifrs-full:Equity>
    <MMA:ProceedsFromTrainingParticipants
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000430"
      unitRef="USD">1453848</MMA:ProceedsFromTrainingParticipants>
    <MMA:ProceedsFromTrainingParticipants
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000431"
      unitRef="USD">1493676</MMA:ProceedsFromTrainingParticipants>
    <MMA:ProceedsFromTrainingParticipants
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000432"
      unitRef="USD">2004336</MMA:ProceedsFromTrainingParticipants>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000434"
      unitRef="USD">10848391</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000435"
      unitRef="USD">8106683</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000436"
      unitRef="USD">10136314</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <MMA:ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000438"
      unitRef="USD">63776</MMA:ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure>
    <MMA:ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000439"
      unitRef="USD">1109645</MMA:ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure>
    <MMA:ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000440"
      unitRef="USD">105950</MMA:ReceiptsFromGovernmentGrantsAndTaxIncentivesRelatedToExpenditure>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000442"
      unitRef="USD">55429</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000443"
      unitRef="USD">52506</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000444"
      unitRef="USD">29157</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000446"
      unitRef="USD">-9386196</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000447"
      unitRef="USD">-5555868</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000448"
      unitRef="USD">-8055185</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000454"
      unitRef="USD">18635</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000455"
      unitRef="USD">14796</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000456"
      unitRef="USD">59429</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000458"
      unitRef="USD">205039</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000459"
      unitRef="USD">352181</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000460"
      unitRef="USD">1043468</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000463"
      unitRef="USD">383936</ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities>
    <MMA:BankGuaranteeDepositReceivedPaid
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000467"
      unitRef="USD">52714</MMA:BankGuaranteeDepositReceivedPaid>
    <MMA:BankGuaranteeDepositReceivedPaid
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000468"
      unitRef="USD">-62823</MMA:BankGuaranteeDepositReceivedPaid>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000470"
      unitRef="USD">-223674</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000471"
      unitRef="USD">69673</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000472"
      unitRef="USD">-1165720</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000479"
      unitRef="USD">8655252</ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures>
    <ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000480"
      unitRef="USD">5679651</ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000482"
      unitRef="USD">9472851</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000486"
      unitRef="USD">9472851</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000487"
      unitRef="USD">8655252</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000488"
      unitRef="USD">5679651</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000490"
      unitRef="USD">-137019</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000491"
      unitRef="USD">3169057</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000492"
      unitRef="USD">-3541254</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000494"
      unitRef="USD">3702567</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000495"
      unitRef="USD">569975</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2021-06-30"
      decimals="0"
      id="Fact000496"
      unitRef="USD">4142541</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000498"
      unitRef="USD">-20710</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000499"
      unitRef="USD">-36465</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000500"
      unitRef="USD">-31312</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000502"
      unitRef="USD">3544837</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000503"
      unitRef="USD">3702567</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000504"
      unitRef="USD">569975</ifrs-full:CashAndCashEquivalents>
    <MMA:DisclosureOfCorporateInformationExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000506">&lt;p id="xdx_802_ecustom--DisclosureOfCorporateInformationExplanatory_zKvUq3Clw8ac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="fin_005"&gt;&lt;/span&gt;Note
1. &lt;span id="xdx_82C_z2zVPpVWW9d4"&gt;Corporate information&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Alta
Global Group Limited (the &#x201c;Company&#x201d; or the &#x201c;Parent Entity&#x201d;) was incorporated and is domiciled in Australia. The
Company changed its registered name from Wimp 2 Warrior Limited to Alta Global Group Limited on 2 February 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company, an Australian company, is listed solely on NYSE American and is governed by the rules of the NYSE American and the U.S. Securities
and Exchange Commission. For purposes of U.S. securities law, the Company is a &#x201c;foreign private issuer&#x201d; (FPI). In addition,
the Company qualifies as an &#x201c;emerging growth company&#x201d; for U.S. securities law purposes. The Company is a for-profit Australian
unlisted public company limited by shares with a principal place of business at Level 1, Suite 1, 29-33 The Corso, Manly, New South Wales
2095.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</MMA:DisclosureOfCorporateInformationExplanatory>
    <ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000508">&lt;p id="xdx_80F_eifrs-full--DisclosureOfMaterialAccountingPolicyInformationExplanatory_zVZKIqpaNDYi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
2. &lt;span id="xdx_82C_zCWmDwl6Zsa2"&gt;Material Accounting Policy Information&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accounting policies that are material to the consolidated entity are set out below. These policies have been consistently applied to
all the periods presented, unless otherwise stated. The consolidated financial statements are presented in AUD, which is also the Company&#x2019;s
functional currency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zLWoyHT7f1h4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_z5EOTOYkseMa"&gt;Basis
of preparation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Statement
of compliance&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements have been prepared in accordance with International Financial Reporting Standards and International Accounting Standards
as issued by the International Accounting Standards Board (IASB) and Interpretations (collectively IFRSs).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in compliance with adopted IFRS Accounting Standards requires the use of certain critical accounting
estimates. It also requires Company management to exercise judgment in applying the Company&#x2019;s accounting policies. The areas where
significant judgments and estimates have been made in preparing the financial statements and their effect are disclosed in Note 3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of measurement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements have been prepared on the basis of historical cost, except for the measurement at fair value of selected financial
assets and financial liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Principles
of consolidation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements incorporate all the assets, liabilities and results of the Company and all the subsidiary companies
and other interests it controlled during the period. The Company controls an entity when it is exposed to, or has the rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power over the entity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
assets, liabilities and results of its subsidiaries are fully consolidated into the consolidated financial statements from the date which
control is obtained. The consolidation of a subsidiary is discontinued from the date that control ceases. Intercompany transactions,
balances and unrealised gains or losses on transactions between Company entities are fully eliminated on consolidation. Accounting policies
of subsidiaries have been changed and adjustments made where necessary to ensure uniformity of the accounting policies of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Operating
segments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
segments are presented using the &#x2018;management approach&#x2019;, where the information presented is on the same basis as the internal
reports provided to the Chief Operating Decision Makers (&#x201c;CODM&#x201d;). The CODM is responsible for the allocation of resources
to operating segments and assessing their performance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Foreign
currency translation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements are presented in Australian dollars, which is the Company&#x2019;s functional and presentation currency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Foreign
currency transactions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
currency transactions are translated into Australian dollars using the exchange rates prevailing at the dates of the transactions. Foreign
exchange gains and losses resulting from the settlement of such transactions and from the translation at financial year-end exchange
rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_ecustom--DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory_z1Hgye0KsVl2" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86C_zWuiSy060qmb"&gt;New
or amended Accounting Standards and Interpretations adopted&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated entity has adopted all of the new or amended Accounting Standards and Interpretations issued by the International Accounting
Standards Board (&#x201c;IASB&#x201d;) that are mandatory for the current reporting period. The adoption of these new or amended Accounting
Standards and Interpretations did not have a material impact on these financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
new or amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zWgutcGrSGvf" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zvb94Drawd5g"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
entity recognises revenue as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Revenue
from contracts with customers&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
is recognised at an amount that reflects the consideration to which the entity is expected to be entitled in exchange for transferring
goods or services to a customer. For each contract with a customer, the entity; identifies the contract with a customer; identifies the
performance obligations in the contract; determines the transaction price which takes into account estimates of variable consideration
and the time value of money; allocates the transaction price to the separate performance obligations on the basis of the relative stand-alone
selling price of each distinct good or service to be delivered; and recognises revenue when or as each performance obligation is satisfied
in a manner that depicts the transfer to the customer of the goods or services promised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Variable
consideration within the transaction price, if any, reflects concessions provided to the customer such as discounts, rebates and refunds,
any potential bonuses receivable from the customer and any other contingent events. Such estimates are determined using either the &#x2018;expected
value&#x2019; or &#x2018;most likely amount&#x2019; method. The measurement of variable consideration is subject to a constraining principle
whereby revenue will only be recognised to the extent that it is highly probable that a significant reversal in the amount of cumulative
revenue recognised will not occur. The measurement constraint continues until the uncertainty associated with the variable consideration
is subsequently resolved. Amounts received that are subject to the constraining principle are recognised as a refund liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Program
revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Program
revenue consists of license fees which are recognized following the occurrence of both the transfer of the right to use the Company&#x2019;s
intellectual property upon signing of the license agreement and once usage of the license occurs at the commencement of the Alta MMA
Training Program. The Company&#x2019;s intellectual property consists of a set of mixed martial arts training programs and relevant branding
and support. A license agreement consists of the right to use the intellectual property of the Company and either party may terminate
the license upon written notice to the other party. If the agreement is terminated in this manner, the termination will take effect after
the completion of the relevant series and the series finale, but prior to a new series beginning. The amount of program revenue is dependent
on the number of participants in each series for each gym.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on the license agreement, a usage-based royalty arrangement is in place between the Company and the gyms. The Company recognizes program
revenue following the occurrence of both the transfer of the right to use the Company&#x2019;s intellectual property upon signing of the
license agreement and once usage of the license which occurs at the commencement of the Alta MMA Training Program.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has the ultimate responsibility of ensuring the Alta MMA Training Program meets customer specifications and price determination.
The Company is therefore considered the principal in these arrangements. The Company receives training fees directly from the participants
and subsequently distributes a portion of such revenues to our gym partners based on the terms of the license agreements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contractual
Payments to Gyms&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is required to settle contractual payments to the gyms as a percentage of the total training fees collected from participants.
Net revenue from program fees is recognised as revenue from program fees less the contractual obligations payable to the gyms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sales
of merchandise&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from the sale of program merchandise is recognised at the point in time when the gyms obtain control of the goods, which is generally
at the time of delivery.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Event
revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from event ticket sales is recognised at the point in time when the event occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Other
income&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
income is recognised when it is received or when the right to receive payment is established.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Research
&amp;amp; Development Incentive&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government
grant, including the R&amp;amp;D incentives, shall not be recognised until there is reasonable assurance that the Company will comply with
the conditions attaching to them and that the grants will be received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_zCmauZD2bCv7" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86D_zPdht4323M98"&gt;Current
and non-current classification&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
and liabilities are presented in the statement of financial position based on current and non-current classification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
asset is classified as current when: it is either expected to be realised or intended to be sold or consumed in the consolidated entity&#x2019;s
normal operating cycle; it is held primarily for the purpose of trading; it is expected to be realised within 12 months after the reporting
period; or the asset is cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least 12
months after the reporting period. All other assets are classified as non-current.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
liability is classified as current when: it is either expected to be settled in the consolidated entity&#x2019;s normal operating cycle;
it is held primarily for the purpose of trading; it is due to be settled within 12 months after the reporting period; or there is no
unconditional right to defer the settlement of the liability for at least 12 months after the reporting period. All other liabilities
are classified as non-current.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and liabilities are always classified as non-current.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note 2. Material accounting policies &#x2013; continued&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z6JHM18DlQFi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_861_zef1A3MXZ5gf"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents include cash on hand, deposits held at call with financial institutions, other short- term, highly liquid investments
with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant
risk of changes in value. For the statement of cash flows presentation purposes, cash and cash equivalents also includes bank overdrafts,
which are shown within trade and other payables in current liabilities on the statement of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_zTN3oWH4mND" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_862_zC3f22kXjIY8"&gt;Trade
and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
receivables are initially recognised at fair value and subsequently measured at amortised cost using the effective interest method, less
any allowance for expected credit losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Expected
Credit Losses&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
entity has applied the simplified approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure
the expected credit losses, trade receivables have been grouped based on days overdue. Trade and other receivables are recognised at
amortised cost, less any allowance for expected credit losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_zOh8kVKiKExi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_z0DuZnRTGZai"&gt;Trade
and other payables&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
amounts represent liabilities for goods and services provided to the entity prior to the end of the financial year and which are
unpaid. Other payables include cash received from the participants on behalf of the gyms. Due to their short-term nature, they are
measured at amortised cost and are not discounted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zyaJcYXLvUoi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_867_ziIbfAwfRSI"&gt;Plant
and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Plant
and equipment are stated at cost less accumulated depreciation and impairment. Historical cost includes expenditure that is directly
attributable to the acquisition of the items. Depreciation is calculated on a straight- line basis to write off the net cost of each
item of property, plant and equipment over their expected useful lives as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--DisclosureOfPlantAndEquipmentExplanatory_zPBliGXyq3T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zv1CcCTCwcm4"&gt;Schedule
of plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify; width: 70%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Plant&lt;/span&gt;
  &lt;span style="font-family: Times New Roman, Times, Serif"&gt;and equipment&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfsPt9JFpDG7" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvJr7kJy3nya" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer equipment &lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDn0FDktRmE3" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeji3SbvkXEc" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z15C8fLpd4Eg" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0UF2Vhc2Ja3" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture and Fittings&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zopvstrbwii" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zMB2rxsqL89k" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8AA_zi0EQHikbYs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
item of property, plant and equipment is derecognised upon disposal or when there is no future economic benefit to the entity. Gains
and losses between the carrying amount and the disposal proceeds are taken to profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note 2. Material accounting policies &#x2013; continued&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zrpkeb5x5Jyl" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zv3Ku9MmHXh3"&gt;Intangible
assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Intangible
assets acquired as part of a business combination, other than goodwill, are initially measured at their fair value at the date of the
acquisition. Intangible assets acquired separately in an asset acquisition are separately recognised at cost. Indefinite life intangible
assets are not amortized and are subsequently measured at cost less any impairment. Finite life intangible assets are subsequently measured
at cost less amortization and any impairment. The gains or losses recognized in profit or loss arising from the derecognition of intangible
assets are measured as the difference between net disposal proceeds and the carrying amount of the intangible asset. The method and useful
lives of finite life intangible assets are reviewed annually. Changes in the expected pattern of consumption or useful life are accounted
for prospectively by changing the amortization method or period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Trademarks&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant
costs associated with patents or trademarks are deferred and amortised on a straight-line basis over the period of their expected benefit,
being their finite life of &lt;span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230701__20240630__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z8g1pe4TkYFh" title="Finite life"&gt;10&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Platform
development cost&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
incurred in both internally and from external providers in developing the platform that will contribute to future year financial benefits
through revenue generation and/or cost reduction are capitalised to software. These costs are amortised on a straight-line basis over
the estimated useful life (&lt;span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230701__20240630__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_zsQkVMOUpuC1" title="Estimated useful life"&gt;4&lt;/span&gt; years) since first used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Research
and development&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
costs are expensed in the period in which they are incurred. Development costs are capitalised when it is probable that the project will
be a success considering its commercial and technical feasibility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_z6jDUkAuXDz4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zTDEIoZr1NUi"&gt;Impairment
of non-financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired.
Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount
may not be recoverable. An impairment loss is recognised for the amount by which the asset&#x2019;s carrying amount exceeds its recoverable
amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recoverable
amount is the higher of an asset&#x2019;s fair value less costs of disposal and value-in-use. The value-in-use is the present value of
the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to
which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForBorrowingsExplanatory_zwuFTkpzwCE" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_z0VzBxCjiaEh"&gt;Borrowings&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advances
and borrowings are initially recognised at the fair value of the consideration received, net of transaction costs. They are subsequently
measured at amortised cost using the effective interest method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_zviXwugsp4ci" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_866_zNxA6SudASV6"&gt;Employee
benefits&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
employee benefits&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liabilities
for wages and salaries, including non-monetary benefits, annual leave and long service leave expected to be settled wholly within 12
months of the reporting date are measured at the amounts expected to be paid when the liabilities are settled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
long-term employee benefits&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
liability for annual leave and long service leave not expected to be settled within 12 months of the reporting date are measured at the
present value of expected future payments to be made in respect of services provided by employees up to the reporting date using the
projected unit credit method. Consideration is given to expected future wage and salary levels, experience of employee departures and
periods of service. Expected future payments are discounted using market yields at the reporting date on corporate bonds with terms to
maturity and currency that match, as closely as possible, the estimated future cash.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_zagF7g4ZnBnj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_863_zFBEnXYRAhb9"&gt;Goods
and Services Tax (GST) and other similar taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenues,
expenses, and assets are recognised net of the amount of associated GST, unless the GST incurred is not recoverable from the tax authority.
In this case it is recognised as part of the cost of the acquisition of the asset or as part of the expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Receivables
and payables are stated inclusive of the amount of GST receivable or payable. The net amount of GST recoverable from, or payable to,
the tax authority is included in other receivables or other payables in the statement of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
flows are presented on a gross basis. The GST components of cash flows arising from investing or financing activities which are recoverable
from, or payable to the tax authority, are presented as operating cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commitments
and contingencies are disclosed net of the amount of GST recoverable from, or payable to, the tax authority.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_z7UZ10hq7KW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zbxymr0havy1"&gt;Issued
capital&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ordinary
Shares are classified as equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Incremental
costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_z9EXnSHpGG71" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_z2Uc5pIoszw3"&gt;Income
tax&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
income tax expense for the year is the tax payable on the current year&#x2019;s taxable income based on the national income tax rate for
each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences between the tax bases
of assets and liabilities and their carrying amounts in the financial statements, and to unused tax losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and liabilities are recognised for temporary differences at the tax rates expected to apply when the assets are recovered
or liabilities are settled, based on those tax rates which are enacted or substantively enacted for each jurisdiction. The relevant tax
rates are applied to the cumulative amounts of deductible and taxable temporary differences to measure the deferred tax asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
exception is made for certain temporary differences arising from the initial recognition of an asset or a liability. No deferred tax
asset or liability is recognised in relation to these temporary differences if they arose in a transaction, other than a business combination,
that at the time of the transaction did not affect either accounting profit or taxable profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilise those temporary differences and losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax liabilities and assets are not recognised for temporary differences between the carrying amount and tax bases of investments in controlled
entities where the parent company is able to control the timing of the reversal of the temporary differences and it is probable that
the differences will not reverse in the foreseeable future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets and liabilities and when
the deferred tax balances relate to the same taxation authority. Current tax assets and tax liabilities are offset where the Company
has a legally enforceable right to offset and intends either to settle on a net basis, or to realise the asset and settle the liability
simultaneously.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
and deferred tax is recognised as income or an expense and included in profit and loss for the period except where the tax arises from
a transaction which is recognized in other comprehensive oncome or equity, in which case the tax is recognized in other comprehensive
income to equity respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zdTMHsYOXaP6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zVf7QaLVuKyb"&gt;Convertible
note&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
issuance of the convertible notes, an assessment is made to determine whether the convertible notes contain an equity instrument or whether
the whole instrument should be classified as a financial liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
it is determined that the whole instrument is a financial liability and no equity instrument, the conversion option is separated from
the host debt and classified as a derivative liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying value of the host contract at initial recognition is determined as a difference between the consideration received and the fair
value of the embedded derivative. The host contract is subsequently measured at amortised cost using the effective interest rate method.
The embedded derivative it subsequently measured at fair value at the end of each reporting period through the profit and loss. Refer
Note 21 Financial Liabilities for disclosure of key terms of the convertible notes. The convertible note and the derivative are presented
as financial liabilities on the Consolidated Statement of Financial Position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
conversion at maturity, the financial liability is reclassified to equity and no gain or loss is recognised. Transaction costs are deducted
from equity, net of associated income tax.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zbIP0X0RvChc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_862_z63x5obPaPLh"&gt;Share-based
payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company provides benefits to consultants, advisors and employees (including directors) of the consolidated entity in the form of share-based
payment transactions, whereby employees render services in exchange for shares or rights over shares (&#x2018;equity-settled transactions&#x2019;).
The cost of these equity-settled transactions with employees is measured by reference to the fair value at the date at which they are
granted. The fair value is determined by an external valuation using a Black- Scholes option pricing model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cost of equity-settled transactions is recognised, together with a corresponding increase in equity, over the period in which the performance
conditions are fulfilled, ending on the date on which the relevant employees become fully entitled to the award (&#x2018;vesting date&#x2019;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cumulative expense recognised for equity-settled transactions at each reporting date until vesting date reflects (i) the extent to
which the vesting period has expired and (ii) the number of awards that, in the opinion of the directors of the consolidated entity,
will ultimately vest. This opinion is formed based on the best available information at balance date. No adjustment is made for the
likelihood of market performance conditions being met as the effect of these conditions is included in the determination of fair
value at grant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
expense is recognised for awards that do not ultimately vest, except for awards where vesting is conditional upon a market condition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
an equity-settled award is cancelled, it is treated as if it had vested on the date of cancellation, and any expense not yet recognised
for the award is recognised immediately. However, if a new award is substituted for the cancelled award, and designated as a replacement
award on the date that it is granted, the cancelled and new award are treated as if they were a modification of the original award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_zLWgODhl9lx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_zZqvh4CQZkl"&gt;Classification
and measurement of financial liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial liabilities include trade and other payables, financial liabilities measured at amortised cost and derivative
financial instruments. Financial liabilities are initially measured at fair value, and, where applicable, adjusted for transaction costs
unless the Company&#x2019;s designated a financial liability at fair value through profit or loss. Subsequently, financial liabilities
are measured at amortised cost using the effective interest method except for derivatives and financial liabilities designated at FVTPL,
which are carried subsequently at fair value with gains or losses recognised in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zT3b4FHdxfmd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zB22HaKcvmXh"&gt;Right-of-use
assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
right-of-use asset is recognised at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the
initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of
any lease incentives received, any initial direct costs incurred, and, except where included in the cost of inventories, an estimate
of costs expected to be incurred for dismantling and removing the underlying asset, and restoring the site or asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever
is the shorter. Where the consolidated entity expects to obtain ownership of the leased asset at the end of the lease term, the depreciation
is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zl6SNw2t7hH8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_861_zXTYeAfytfQ3"&gt;Lease
liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
lease liability is recognised at the commencement date of a lease. The lease liability is initially recognised at the present value
of the lease payments to be made over the term of the lease, discounted using the interest rate implicit in the lease or, if that
rate cannot be readily determined, the consolidated entity&#x2019;s incremental borrowing rate. Lease payments comprise of fixed
payments less any lease incentives receivable, variable lease payments that depend on an index or a rate, amounts expected to be
paid under residual value guarantees, exercise price of a purchase option when the exercise of the option is reasonably certain to
occur, and any anticipated termination penalties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
variable lease payments that do not depend on an index or a rate are expensed in the period in which they are incurred. Lease liabilities
are measured at amortised cost using the effective interest method. The carrying amounts are remeasured if there is a change in the following:
future lease payments arising from a change in an index or a rate used; residual guarantee; lease term; certainty of a purchase option
and termination penalties. When a lease liability is remeasured, an adjustment is made to the corresponding right-of use asset, or to
profit or loss if the carrying amount of the right-of-use asset is fully written down.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zCfMV6dNjvJj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_z1E0xhyEtYXb"&gt;Fair
value measurement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
an asset or liability, financial or non-financial, is measured at fair value for recognition or disclosure purposes, the fair value is
based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date; and assumes that the transaction will take place either: in the principal market; or in the absence of a principal
market, in the most advantageous market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is measured using the assumptions that market participants would use when pricing the asset or liability, assuming they act in
their economic best interests. For non-financial assets, the fair value measurement is based on its highest and best use. Valuation
techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, are used,
maximising the use of relevant observable inputs and minimising the use of unobservable inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
and liabilities measured at fair value are classified into three levels, using a fair value hierarchy that reflects the significance
of the inputs used in making the measurements. Classifications are reviewed at each reporting date and transfers between levels are determined
based on a reassessment of the lowest level of input that is significant to the fair value measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
recurring and non-recurring fair value measurements, external valuers may be used when internal expertise is either not available or
when the valuation is deemed to be significant. External valuers are selected based on market knowledge and reputation. Where there is
a significant change in fair value of an asset or liability from one period to another, an analysis is undertaken, which includes a verification
of the major inputs applied in the latest valuation and a comparison, where applicable, with external sources of data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zXjiRW99MTq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zOAF0IV5dM12"&gt;Earnings
per share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings per share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings per share is calculated by dividing the profit attributable to the owners of the Company, excluding any costs of servicing equity
other than Ordinary Shares, by the weighted average number of Ordinary Shares outstanding during the financial year, adjusted for bonus
elements in Ordinary Shares issued during the financial year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Diluted
earnings per share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Diluted
earnings per share adjusts the figures used in the determination of basic earnings per share to take into account the after income tax
effect of interest and other financing costs associated with dilutive potential Ordinary Shares and the weighted average number of shares
assumed to have been issued for no consideration in relation to dilutive potential Ordinary Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory_zOiSGHp5bbcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_z9Eg5Ihndbg5"&gt;Parent
entity financial information&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial information for the Parent entity, Alta Global Group Limited, disclosed in Note 19 has been prepared on the same basis as the
consolidated financial statement. Investments in subsidiaries are accounted for at cost less provision for impairment in the financial
statements of the Parent entity.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_850_z2I5YxyRBWQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory>
    <MMA:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000510">&lt;p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zLWoyHT7f1h4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_z5EOTOYkseMa"&gt;Basis
of preparation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Statement
of compliance&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements have been prepared in accordance with International Financial Reporting Standards and International Accounting Standards
as issued by the International Accounting Standards Board (IASB) and Interpretations (collectively IFRSs).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in compliance with adopted IFRS Accounting Standards requires the use of certain critical accounting
estimates. It also requires Company management to exercise judgment in applying the Company&#x2019;s accounting policies. The areas where
significant judgments and estimates have been made in preparing the financial statements and their effect are disclosed in Note 3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of measurement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements have been prepared on the basis of historical cost, except for the measurement at fair value of selected financial
assets and financial liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Principles
of consolidation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements incorporate all the assets, liabilities and results of the Company and all the subsidiary companies
and other interests it controlled during the period. The Company controls an entity when it is exposed to, or has the rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power over the entity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
assets, liabilities and results of its subsidiaries are fully consolidated into the consolidated financial statements from the date which
control is obtained. The consolidation of a subsidiary is discontinued from the date that control ceases. Intercompany transactions,
balances and unrealised gains or losses on transactions between Company entities are fully eliminated on consolidation. Accounting policies
of subsidiaries have been changed and adjustments made where necessary to ensure uniformity of the accounting policies of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Operating
segments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
segments are presented using the &#x2018;management approach&#x2019;, where the information presented is on the same basis as the internal
reports provided to the Chief Operating Decision Makers (&#x201c;CODM&#x201d;). The CODM is responsible for the allocation of resources
to operating segments and assessing their performance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Foreign
currency translation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements are presented in Australian dollars, which is the Company&#x2019;s functional and presentation currency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Foreign
currency transactions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
currency transactions are translated into Australian dollars using the exchange rates prevailing at the dates of the transactions. Foreign
exchange gains and losses resulting from the settlement of such transactions and from the translation at financial year-end exchange
rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</MMA:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory>
    <MMA:DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000512">&lt;p id="xdx_843_ecustom--DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory_z1Hgye0KsVl2" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86C_zWuiSy060qmb"&gt;New
or amended Accounting Standards and Interpretations adopted&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated entity has adopted all of the new or amended Accounting Standards and Interpretations issued by the International Accounting
Standards Board (&#x201c;IASB&#x201d;) that are mandatory for the current reporting period. The adoption of these new or amended Accounting
Standards and Interpretations did not have a material impact on these financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
new or amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</MMA:DescriptionOfAccountingPolicyForNewOrAmendedAccountingStandardsAndInterpretationsAdoptedExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue contextRef="From2023-07-01to2024-06-30" id="Fact000514">&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zWgutcGrSGvf" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zvb94Drawd5g"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
entity recognises revenue as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Revenue
from contracts with customers&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
is recognised at an amount that reflects the consideration to which the entity is expected to be entitled in exchange for transferring
goods or services to a customer. For each contract with a customer, the entity; identifies the contract with a customer; identifies the
performance obligations in the contract; determines the transaction price which takes into account estimates of variable consideration
and the time value of money; allocates the transaction price to the separate performance obligations on the basis of the relative stand-alone
selling price of each distinct good or service to be delivered; and recognises revenue when or as each performance obligation is satisfied
in a manner that depicts the transfer to the customer of the goods or services promised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Variable
consideration within the transaction price, if any, reflects concessions provided to the customer such as discounts, rebates and refunds,
any potential bonuses receivable from the customer and any other contingent events. Such estimates are determined using either the &#x2018;expected
value&#x2019; or &#x2018;most likely amount&#x2019; method. The measurement of variable consideration is subject to a constraining principle
whereby revenue will only be recognised to the extent that it is highly probable that a significant reversal in the amount of cumulative
revenue recognised will not occur. The measurement constraint continues until the uncertainty associated with the variable consideration
is subsequently resolved. Amounts received that are subject to the constraining principle are recognised as a refund liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Program
revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Program
revenue consists of license fees which are recognized following the occurrence of both the transfer of the right to use the Company&#x2019;s
intellectual property upon signing of the license agreement and once usage of the license occurs at the commencement of the Alta MMA
Training Program. The Company&#x2019;s intellectual property consists of a set of mixed martial arts training programs and relevant branding
and support. A license agreement consists of the right to use the intellectual property of the Company and either party may terminate
the license upon written notice to the other party. If the agreement is terminated in this manner, the termination will take effect after
the completion of the relevant series and the series finale, but prior to a new series beginning. The amount of program revenue is dependent
on the number of participants in each series for each gym.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on the license agreement, a usage-based royalty arrangement is in place between the Company and the gyms. The Company recognizes program
revenue following the occurrence of both the transfer of the right to use the Company&#x2019;s intellectual property upon signing of the
license agreement and once usage of the license which occurs at the commencement of the Alta MMA Training Program.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has the ultimate responsibility of ensuring the Alta MMA Training Program meets customer specifications and price determination.
The Company is therefore considered the principal in these arrangements. The Company receives training fees directly from the participants
and subsequently distributes a portion of such revenues to our gym partners based on the terms of the license agreements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contractual
Payments to Gyms&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is required to settle contractual payments to the gyms as a percentage of the total training fees collected from participants.
Net revenue from program fees is recognised as revenue from program fees less the contractual obligations payable to the gyms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sales
of merchandise&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from the sale of program merchandise is recognised at the point in time when the gyms obtain control of the goods, which is generally
at the time of delivery.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Event
revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from event ticket sales is recognised at the point in time when the event occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Other
income&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
income is recognised when it is received or when the right to receive payment is established.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Research
&amp;amp; Development Incentive&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government
grant, including the R&amp;amp;D incentives, shall not be recognised until there is reasonable assurance that the Company will comply with
the conditions attaching to them and that the grants will be received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000516">&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_zCmauZD2bCv7" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86D_zPdht4323M98"&gt;Current
and non-current classification&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
and liabilities are presented in the statement of financial position based on current and non-current classification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
asset is classified as current when: it is either expected to be realised or intended to be sold or consumed in the consolidated entity&#x2019;s
normal operating cycle; it is held primarily for the purpose of trading; it is expected to be realised within 12 months after the reporting
period; or the asset is cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least 12
months after the reporting period. All other assets are classified as non-current.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
liability is classified as current when: it is either expected to be settled in the consolidated entity&#x2019;s normal operating cycle;
it is held primarily for the purpose of trading; it is due to be settled within 12 months after the reporting period; or there is no
unconditional right to defer the settlement of the liability for at least 12 months after the reporting period. All other liabilities
are classified as non-current.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and liabilities are always classified as non-current.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note 2. Material accounting policies &#x2013; continued&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="From2023-07-01to2024-06-30" id="Fact000518">&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z6JHM18DlQFi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_861_zef1A3MXZ5gf"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents include cash on hand, deposits held at call with financial institutions, other short- term, highly liquid investments
with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant
risk of changes in value. For the statement of cash flows presentation purposes, cash and cash equivalents also includes bank overdrafts,
which are shown within trade and other payables in current liabilities on the statement of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000520">&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_zTN3oWH4mND" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_862_zC3f22kXjIY8"&gt;Trade
and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
receivables are initially recognised at fair value and subsequently measured at amortised cost using the effective interest method, less
any allowance for expected credit losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Expected
Credit Losses&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
entity has applied the simplified approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure
the expected credit losses, trade receivables have been grouped based on days overdue. Trade and other receivables are recognised at
amortised cost, less any allowance for expected credit losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000522">&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_zOh8kVKiKExi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_z0DuZnRTGZai"&gt;Trade
and other payables&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
amounts represent liabilities for goods and services provided to the entity prior to the end of the financial year and which are
unpaid. Other payables include cash received from the participants on behalf of the gyms. Due to their short-term nature, they are
measured at amortised cost and are not discounted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000524">&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zyaJcYXLvUoi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_867_ziIbfAwfRSI"&gt;Plant
and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Plant
and equipment are stated at cost less accumulated depreciation and impairment. Historical cost includes expenditure that is directly
attributable to the acquisition of the items. Depreciation is calculated on a straight- line basis to write off the net cost of each
item of property, plant and equipment over their expected useful lives as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--DisclosureOfPlantAndEquipmentExplanatory_zPBliGXyq3T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zv1CcCTCwcm4"&gt;Schedule
of plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify; width: 70%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Plant&lt;/span&gt;
  &lt;span style="font-family: Times New Roman, Times, Serif"&gt;and equipment&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfsPt9JFpDG7" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvJr7kJy3nya" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer equipment &lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDn0FDktRmE3" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeji3SbvkXEc" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z15C8fLpd4Eg" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0UF2Vhc2Ja3" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture and Fittings&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zopvstrbwii" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zMB2rxsqL89k" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8AA_zi0EQHikbYs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
item of property, plant and equipment is derecognised upon disposal or when there is no future economic benefit to the entity. Gains
and losses between the carrying amount and the disposal proceeds are taken to profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note 2. Material accounting policies &#x2013; continued&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <MMA:DisclosureOfPlantAndEquipmentExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000526">&lt;p id="xdx_89B_ecustom--DisclosureOfPlantAndEquipmentExplanatory_zPBliGXyq3T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zv1CcCTCwcm4"&gt;Schedule
of plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify; width: 70%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Plant&lt;/span&gt;
  &lt;span style="font-family: Times New Roman, Times, Serif"&gt;and equipment&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfsPt9JFpDG7" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvJr7kJy3nya" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer equipment &lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDn0FDktRmE3" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeji3SbvkXEc" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z15C8fLpd4Eg" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0UF2Vhc2Ja3" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture and Fittings&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zopvstrbwii" title="Plant and equipment expected useful lives"&gt;3&lt;/span&gt; to &lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zMB2rxsqL89k" title="Plant and equipment expected useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</MMA:DisclosureOfPlantAndEquipmentExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_custom_PlantAndEquipmentMember_ifrs-full_BottomOfRangeMember"
      id="Fact000528">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_custom_PlantAndEquipmentMember_ifrs-full_TopOfRangeMember"
      id="Fact000530">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember_ifrs-full_BottomOfRangeMember"
      id="Fact000532">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember_ifrs-full_TopOfRangeMember"
      id="Fact000534">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember_ifrs-full_BottomOfRangeMember"
      id="Fact000536">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember_ifrs-full_TopOfRangeMember"
      id="Fact000538">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_FixturesAndFittingsMember_ifrs-full_BottomOfRangeMember"
      id="Fact000540">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_FixturesAndFittingsMember_ifrs-full_TopOfRangeMember"
      id="Fact000542">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000544">&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zrpkeb5x5Jyl" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zv3Ku9MmHXh3"&gt;Intangible
assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Intangible
assets acquired as part of a business combination, other than goodwill, are initially measured at their fair value at the date of the
acquisition. Intangible assets acquired separately in an asset acquisition are separately recognised at cost. Indefinite life intangible
assets are not amortized and are subsequently measured at cost less any impairment. Finite life intangible assets are subsequently measured
at cost less amortization and any impairment. The gains or losses recognized in profit or loss arising from the derecognition of intangible
assets are measured as the difference between net disposal proceeds and the carrying amount of the intangible asset. The method and useful
lives of finite life intangible assets are reviewed annually. Changes in the expected pattern of consumption or useful life are accounted
for prospectively by changing the amortization method or period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Trademarks&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant
costs associated with patents or trademarks are deferred and amortised on a straight-line basis over the period of their expected benefit,
being their finite life of &lt;span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230701__20240630__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z8g1pe4TkYFh" title="Finite life"&gt;10&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Platform
development cost&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
incurred in both internally and from external providers in developing the platform that will contribute to future year financial benefits
through revenue generation and/or cost reduction are capitalised to software. These costs are amortised on a straight-line basis over
the estimated useful life (&lt;span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230701__20240630__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--IntangibleAssetsUnderDevelopmentMember_zsQkVMOUpuC1" title="Estimated useful life"&gt;4&lt;/span&gt; years) since first used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Research
and development&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
costs are expensed in the period in which they are incurred. Development costs are capitalised when it is probable that the project will
be a success considering its commercial and technical feasibility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-07-012024-06-30_ifrs-full_BrandNamesMember"
      id="Fact000546">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-07-012024-06-30_ifrs-full_IntangibleAssetsUnderDevelopmentMember"
      id="Fact000548">P4Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000550">&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_z6jDUkAuXDz4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zTDEIoZr1NUi"&gt;Impairment
of non-financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired.
Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount
may not be recoverable. An impairment loss is recognised for the amount by which the asset&#x2019;s carrying amount exceeds its recoverable
amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recoverable
amount is the higher of an asset&#x2019;s fair value less costs of disposal and value-in-use. The value-in-use is the present value of
the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to
which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000552">&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForBorrowingsExplanatory_zwuFTkpzwCE" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_z0VzBxCjiaEh"&gt;Borrowings&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advances
and borrowings are initially recognised at the fair value of the consideration received, net of transaction costs. They are subsequently
measured at amortised cost using the effective interest method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000554">&lt;p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_zviXwugsp4ci" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_866_zNxA6SudASV6"&gt;Employee
benefits&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
employee benefits&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liabilities
for wages and salaries, including non-monetary benefits, annual leave and long service leave expected to be settled wholly within 12
months of the reporting date are measured at the amounts expected to be paid when the liabilities are settled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
long-term employee benefits&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
liability for annual leave and long service leave not expected to be settled within 12 months of the reporting date are measured at the
present value of expected future payments to be made in respect of services provided by employees up to the reporting date using the
projected unit credit method. Consideration is given to expected future wage and salary levels, experience of employee departures and
periods of service. Expected future payments are discounted using market yields at the reporting date on corporate bonds with terms to
maturity and currency that match, as closely as possible, the estimated future cash.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000556">&lt;p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_zagF7g4ZnBnj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_863_zFBEnXYRAhb9"&gt;Goods
and Services Tax (GST) and other similar taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenues,
expenses, and assets are recognised net of the amount of associated GST, unless the GST incurred is not recoverable from the tax authority.
In this case it is recognised as part of the cost of the acquisition of the asset or as part of the expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Receivables
and payables are stated inclusive of the amount of GST receivable or payable. The net amount of GST recoverable from, or payable to,
the tax authority is included in other receivables or other payables in the statement of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
flows are presented on a gross basis. The GST components of cash flows arising from investing or financing activities which are recoverable
from, or payable to the tax authority, are presented as operating cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commitments
and contingencies are disclosed net of the amount of GST recoverable from, or payable to, the tax authority.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000558">&lt;p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_z7UZ10hq7KW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zbxymr0havy1"&gt;Issued
capital&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ordinary
Shares are classified as equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Incremental
costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000560">&lt;p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_z9EXnSHpGG71" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_z2Uc5pIoszw3"&gt;Income
tax&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
income tax expense for the year is the tax payable on the current year&#x2019;s taxable income based on the national income tax rate for
each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences between the tax bases
of assets and liabilities and their carrying amounts in the financial statements, and to unused tax losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and liabilities are recognised for temporary differences at the tax rates expected to apply when the assets are recovered
or liabilities are settled, based on those tax rates which are enacted or substantively enacted for each jurisdiction. The relevant tax
rates are applied to the cumulative amounts of deductible and taxable temporary differences to measure the deferred tax asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
exception is made for certain temporary differences arising from the initial recognition of an asset or a liability. No deferred tax
asset or liability is recognised in relation to these temporary differences if they arose in a transaction, other than a business combination,
that at the time of the transaction did not affect either accounting profit or taxable profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilise those temporary differences and losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax liabilities and assets are not recognised for temporary differences between the carrying amount and tax bases of investments in controlled
entities where the parent company is able to control the timing of the reversal of the temporary differences and it is probable that
the differences will not reverse in the foreseeable future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets and liabilities and when
the deferred tax balances relate to the same taxation authority. Current tax assets and tax liabilities are offset where the Company
has a legally enforceable right to offset and intends either to settle on a net basis, or to realise the asset and settle the liability
simultaneously.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
and deferred tax is recognised as income or an expense and included in profit and loss for the period except where the tax arises from
a transaction which is recognized in other comprehensive oncome or equity, in which case the tax is recognized in other comprehensive
income to equity respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000562">&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zdTMHsYOXaP6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zVf7QaLVuKyb"&gt;Convertible
note&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
issuance of the convertible notes, an assessment is made to determine whether the convertible notes contain an equity instrument or whether
the whole instrument should be classified as a financial liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
it is determined that the whole instrument is a financial liability and no equity instrument, the conversion option is separated from
the host debt and classified as a derivative liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying value of the host contract at initial recognition is determined as a difference between the consideration received and the fair
value of the embedded derivative. The host contract is subsequently measured at amortised cost using the effective interest rate method.
The embedded derivative it subsequently measured at fair value at the end of each reporting period through the profit and loss. Refer
Note 21 Financial Liabilities for disclosure of key terms of the convertible notes. The convertible note and the derivative are presented
as financial liabilities on the Consolidated Statement of Financial Position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
conversion at maturity, the financial liability is reclassified to equity and no gain or loss is recognised. Transaction costs are deducted
from equity, net of associated income tax.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000564">&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zbIP0X0RvChc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_862_z63x5obPaPLh"&gt;Share-based
payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company provides benefits to consultants, advisors and employees (including directors) of the consolidated entity in the form of share-based
payment transactions, whereby employees render services in exchange for shares or rights over shares (&#x2018;equity-settled transactions&#x2019;).
The cost of these equity-settled transactions with employees is measured by reference to the fair value at the date at which they are
granted. The fair value is determined by an external valuation using a Black- Scholes option pricing model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cost of equity-settled transactions is recognised, together with a corresponding increase in equity, over the period in which the performance
conditions are fulfilled, ending on the date on which the relevant employees become fully entitled to the award (&#x2018;vesting date&#x2019;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cumulative expense recognised for equity-settled transactions at each reporting date until vesting date reflects (i) the extent to
which the vesting period has expired and (ii) the number of awards that, in the opinion of the directors of the consolidated entity,
will ultimately vest. This opinion is formed based on the best available information at balance date. No adjustment is made for the
likelihood of market performance conditions being met as the effect of these conditions is included in the determination of fair
value at grant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
expense is recognised for awards that do not ultimately vest, except for awards where vesting is conditional upon a market condition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
an equity-settled award is cancelled, it is treated as if it had vested on the date of cancellation, and any expense not yet recognised
for the award is recognised immediately. However, if a new award is substituted for the cancelled award, and designated as a replacement
award on the date that it is granted, the cancelled and new award are treated as if they were a modification of the original award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000566">&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_zLWgODhl9lx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_zZqvh4CQZkl"&gt;Classification
and measurement of financial liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial liabilities include trade and other payables, financial liabilities measured at amortised cost and derivative
financial instruments. Financial liabilities are initially measured at fair value, and, where applicable, adjusted for transaction costs
unless the Company&#x2019;s designated a financial liability at fair value through profit or loss. Subsequently, financial liabilities
are measured at amortised cost using the effective interest method except for derivatives and financial liabilities designated at FVTPL,
which are carried subsequently at fair value with gains or losses recognised in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory>
    <MMA:DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000568">&lt;p id="xdx_849_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zT3b4FHdxfmd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zB22HaKcvmXh"&gt;Right-of-use
assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
right-of-use asset is recognised at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the
initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of
any lease incentives received, any initial direct costs incurred, and, except where included in the cost of inventories, an estimate
of costs expected to be incurred for dismantling and removing the underlying asset, and restoring the site or asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever
is the shorter. Where the consolidated entity expects to obtain ownership of the leased asset at the end of the lease term, the depreciation
is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</MMA:DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000570">&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zl6SNw2t7hH8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_861_zXTYeAfytfQ3"&gt;Lease
liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
lease liability is recognised at the commencement date of a lease. The lease liability is initially recognised at the present value
of the lease payments to be made over the term of the lease, discounted using the interest rate implicit in the lease or, if that
rate cannot be readily determined, the consolidated entity&#x2019;s incremental borrowing rate. Lease payments comprise of fixed
payments less any lease incentives receivable, variable lease payments that depend on an index or a rate, amounts expected to be
paid under residual value guarantees, exercise price of a purchase option when the exercise of the option is reasonably certain to
occur, and any anticipated termination penalties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
variable lease payments that do not depend on an index or a rate are expensed in the period in which they are incurred. Lease liabilities
are measured at amortised cost using the effective interest method. The carrying amounts are remeasured if there is a change in the following:
future lease payments arising from a change in an index or a rate used; residual guarantee; lease term; certainty of a purchase option
and termination penalties. When a lease liability is remeasured, an adjustment is made to the corresponding right-of use asset, or to
profit or loss if the carrying amount of the right-of-use asset is fully written down.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000572">&lt;p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zCfMV6dNjvJj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_z1E0xhyEtYXb"&gt;Fair
value measurement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
an asset or liability, financial or non-financial, is measured at fair value for recognition or disclosure purposes, the fair value is
based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date; and assumes that the transaction will take place either: in the principal market; or in the absence of a principal
market, in the most advantageous market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is measured using the assumptions that market participants would use when pricing the asset or liability, assuming they act in
their economic best interests. For non-financial assets, the fair value measurement is based on its highest and best use. Valuation
techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, are used,
maximising the use of relevant observable inputs and minimising the use of unobservable inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Material accounting policies - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
and liabilities measured at fair value are classified into three levels, using a fair value hierarchy that reflects the significance
of the inputs used in making the measurements. Classifications are reviewed at each reporting date and transfers between levels are determined
based on a reassessment of the lowest level of input that is significant to the fair value measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
recurring and non-recurring fair value measurements, external valuers may be used when internal expertise is either not available or
when the valuation is deemed to be significant. External valuers are selected based on market knowledge and reputation. Where there is
a significant change in fair value of an asset or liability from one period to another, an analysis is undertaken, which includes a verification
of the major inputs applied in the latest valuation and a comparison, where applicable, with external sources of data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000574">&lt;p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zXjiRW99MTq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zOAF0IV5dM12"&gt;Earnings
per share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings per share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings per share is calculated by dividing the profit attributable to the owners of the Company, excluding any costs of servicing equity
other than Ordinary Shares, by the weighted average number of Ordinary Shares outstanding during the financial year, adjusted for bonus
elements in Ordinary Shares issued during the financial year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Diluted
earnings per share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Diluted
earnings per share adjusts the figures used in the determination of basic earnings per share to take into account the after income tax
effect of interest and other financing costs associated with dilutive potential Ordinary Shares and the weighted average number of shares
assumed to have been issued for no consideration in relation to dilutive potential Ordinary Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <MMA:DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000576">&lt;p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory_zOiSGHp5bbcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_z9Eg5Ihndbg5"&gt;Parent
entity financial information&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial information for the Parent entity, Alta Global Group Limited, disclosed in Note 19 has been prepared on the same basis as the
consolidated financial statement. Investments in subsidiaries are accounted for at cost less provision for impairment in the financial
statements of the Parent entity.&lt;/span&gt;&lt;/p&gt;

</MMA:DescriptionOfAccountingPolicyForParentEntityFinancialInformationExplanatory>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000578">&lt;p id="xdx_801_eifrs-full--DisclosureOfAccountingJudgementsAndEstimatesExplanatory_zamoch7k25zl" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
3. &lt;span id="xdx_82A_zM3hqiOvn0Dl"&gt;Critical accounting judgements, estimates and assumptions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts
in the financial statements. Management continually evaluates its judgements and estimates in relation to assets, liabilities, contingent
liabilities, revenue and expenses. Management bases its judgements, estimates and assumptions on historical experience and on other various
factors, including expectations of future events, management believes to be reasonable under the circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Going
concern&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements for the reporting periods have been prepared on a going concern basis which contemplates continuity
of normal business activities and the realization of assets and settlement of liabilities in the ordinary course of business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have assessed that there is a substantial doubt related to going concern that may cast significant doubt over our ability to continue
as a going concern as we incurred a loss after tax of A$&lt;span id="xdx_90C_eifrs-full--ProfitLoss_iN_di_c20230701__20240630_zWbS7VEMTIi6" title="Loss after tax"&gt;14,408,346&lt;/span&gt; for the year ended June 30, 2024 compared to A$&lt;span id="xdx_90B_eifrs-full--ProfitLoss_iN_di_c20220701__20230630_zYmtPEvDJfF8" title="Loss after tax"&gt;20,597,436&lt;/span&gt; for the
year ended June 30, 2023, had net cash outflows from operating activities of A$&lt;span id="xdx_90F_eifrs-full--CashFlowsFromUsedInOperatingActivities_iN_di_c20230701__20240630_zUp9D04ZiWqd" title="Net cash outflows from operating activities"&gt;9,386,196&lt;/span&gt; for the year ended June 30, 2024 compared to
$&lt;span id="xdx_908_eifrs-full--CashFlowsFromUsedInOperatingActivities_iN_di_c20220701__20230630_zoW58SEPfcVd" title="Net cash outflows from operating activities"&gt;5,555,868&lt;/span&gt; for the year ended June 30,2023, had a net asset position of $&lt;span id="xdx_909_eifrs-full--NetAssetsLiabilities_iI_c20240630_zHJjNRQBBxNh" title="Net assets liabilities"&gt;2,558,544&lt;/span&gt; as at June 30, 2024 compared to net liability $&lt;span id="xdx_900_eifrs-full--NetAssetsLiabilities_iNI_di_c20230630_za0F9jocwZm4" title="Net assets liabilities"&gt;31,134,307&lt;/span&gt;
as at June 30, 2023, and net current asset position of $&lt;span id="xdx_90B_eifrs-full--CurrentAssetsLiabilities_iI_c20240630_zwyoWwfi5yb5" title="Net current assets liabilities"&gt;1,049,355&lt;/span&gt; as at June 30, 2024, compared to net current liability position of
$&lt;span id="xdx_900_eifrs-full--CurrentAssetsLiabilities_iI_c20230630_zVBZwfQvHUul" title="Net current assets liabilities"&gt;21,916,914&lt;/span&gt; as at June, 30 2023. As a result of these conditions, the Company may be unable to realize its assets and discharge its liabilities
in the normal, course of business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
3. Critical accounting judgements, estimates and assumptions - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2024, the Company successfully listed on the NYSE American. In addition, all convertible notes that were on issue prior to
the initial public offering have either been converted into Ordinary Shares or redeemed and therefore there is no convertible note debt,
host or derivative liabilities, on the Consolidated Statement of Financial Position as at June 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
remaining interest on convertible notes and the final fair value movement in derivative liability is reflected in the Consolidated Statement
of Profit or Loss for the year ended June 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
ongoing operation of the Company remains dependent upon raising additional funds. In light of the future expenditures to be incurred
in executing on our strategic plans, we are dependent on obtaining financing through equity financing, debt financing or other means.
The ability to arrange such funding in the future will depend in part upon the prevailing capital market conditions as well as our business
performance. There is no assurance that we will be successful in our efforts to raise additional funding on terms satisfactory to us.
If we do not obtain additional funding, we may be required to delay, reduce the scope of, or eliminate our current operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;However,
we believe that we will be able to raise additional funds as required to meet our obligations as and when they become due and are of
the opinion that the use of the going concern basis remains appropriate. Our ability to continue as a going concern and to pay debts
as and when they become due is dependent on the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we have historically been successful in raising funds,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we have now listed on the New York Stock Exchange in the United States. As a listed vehicle, we have capital raising options such as placements, Share Purchase Plans, Rights issues and entitlement offers, Dividend Reinvestment Plans, Hybrids and Retail notes and PIPEs;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;our level of expenditure continues to be managed and will continue to be managed to maximize run-way; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we have reason to believe that in addition to the cash flow currently available, additional revenues will continue to be received through the sale of our products and services throughout the course of the year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
we decide to raise capital, the issuance of additional Ordinary Shares would result in dilution to our existing shareholders. We cannot
assure you that we will be successful in completing any financings or that any such equity or debt financing will be available to us
if and when required or on satisfactory terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Should
we be unable to raise additional funds on a timely basis, we may be required to realize our assets and discharge our liabilities other
than in the normal course of business and at amounts different to those stated in the financial statements. The financial statements
do not include any adjustments to the recoverability and classification of asset carrying amounts or the amount of liabilities that might
result should we be unable to continue as a going concern and meet our debts as and when they become due.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Revenue
from contracts with customers involving program fees&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
recognising revenue in relation to the sale of goods to customers, the key performance obligation of the entity is considered to be the
point in time of the rights to use the license and the relevant training program to the gyms as the customers, as this is deemed to be
the time that the gym obtains control of the promised service and therefore the benefits of unimpeded access.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Determination
of variable consideration&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Judgement
is exercised in estimating variable consideration which is determined having regard to past experience with respect to the cancelled
contracts with the entity where the member gyms maintain a right of terminate pursuant to the licence agreement. Revenue will only be
recognised to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognised under
the contract will not occur when the uncertainty associated with the variable consideration is subsequently resolved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
3. Critical accounting judgements, estimates and assumptions - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share-based
payment transactions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated entity measures the cost of equity-settled transactions with employees by reference to the fair value of the equity instruments
at the date at which they are granted. The fair value is determined by using Black-Scholes model taking into account the terms and conditions
upon which the instruments were granted. The accounting estimates and assumptions relating to equity-settled share-based payments would
have no impact on the carrying amounts of assets and liabilities within the next annual reporting period but may impact profit or loss
and equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Convertible
Notes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined the convertible note instrument to be a financial liability. It is separated into two components being the host
debt and derivative liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying value of the host contract at initial recognition is determined as the difference between the consideration received and
the fair value of the embedded derivative. The host contract is subsequently measured at amortised cost using the effective interest
rate method. The derivative liability is recognised as such due to its conversion feature relating to a qualified equity investment
and the likelihood of its occurrence. The embedded derivative is subsequently measured at fair value at the end of each reporting
period through the profit and loss based on the Monte Carlo simulation as valued by an external valuer. The convertible note and the
derivative are presented as financial liabilities on the Consolidated Statement of Financial Position, refer to Note 21 Financial
Liabilities for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recognition
of deferred tax assets&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilise those temporary differences and losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of unrecognised deferred tax assets are reviewed at each reporting date. Previously unrecognised deferred tax assets
are only recognised to the extent that it is probable that there are future taxable profits available to recover the asset. The Company
has not recognised the benefit of these unused deductible temporary differences and unused tax losses. These losses will only be recognised
where it is probable that future taxable profit will be available against which the benefits of the deferred tax asset will be utilised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Lease
term&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
lease term is a significant component in the measurement of both the right-of-use asset and lease liability. Judgement is exercised in
determining whether there is reasonable certainty that an option to extend the lease or purchase the underlying asset will be exercised,
or an option to terminate the lease will not be exercised, when ascertaining the periods to be included in the lease term. In determining
the lease term, all facts and circumstances that create an economical incentive to exercise an extension option, or not to exercise a
termination option, are considered at the lease commencement date. Factors considered may include the importance of the asset to the
consolidated entity&#x2019;s operations; comparison of terms and conditions to prevailing market rates; incurrence of significant penalties;
existence of significant leasehold improvements; and the costs and disruption to replace the asset. The consolidated entity reassesses
whether it is reasonably certain to exercise an extension option, or not exercise a termination option, if there is a significant event
or significant change in circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value measurement hierarchy&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated entity is required to classify all assets and liabilities, measured at fair value, using a three level hierarchy, based
on the lowest level of input that is significant to the entire fair value measurement, being:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly;
and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Unobservable inputs for the asset or liability. Considerable judgement is required to determine what is significant to fair value
and therefore which category the asset or liability is placed in can be subjective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of assets and liabilities classified as level 3 is determined by the use of valuation models. These include discounted cash
flow analysis or the use of observable inputs that require significant adjustments based on unobservable inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
3. Critical accounting judgements, estimates and assumptions - continued&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimation
of useful lives of assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated entity determines the estimated useful lives and related depreciation and amortisation charges for its property, plant and
equipment and finite life intangible assets. The useful lives could change significantly as a result of technical innovations or some
other event. The depreciation and amortisation charge will increase where the useful lives are less than previously estimated lives,
or technically obsolete or non-strategic assets that have been abandoned or sold will be written off or written down.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Impairment
of non-financial assets&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated entity assesses impairment of non-financial assets at each reporting date by evaluating conditions specific to the consolidated
entity and to the particular asset that may lead to impairment. If an impairment trigger exists, the recoverable amount of the asset
is determined. This involves fair value less costs of disposal or value-in-use calculations, which incorporate a number of key estimates
and assumptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Expected
Credit Losses&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
allowance for expected credit losses requires a degree of estimation judgment. The Company has applied the simplified approach to measuring
expected credit losses, which uses a lifetime expected loss allowance. To measure the expected credit losses, trade receivables have
been grouped based on days overdue. Trade and other receivables are recognised at amortised cost, less any allowance for expected credit
losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Provision
for Refund Liability&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
provision for refund liability is recognised for expected volume payable to customers in relation to sales made until the end of the
reporting period. The Company&#x2019;s obligation to provide a refund, cancellation or credit note falls under the Company&#x2019;s standard
trading terms, and is recognised as a provision. The estimate of expected returns requires judgement and reflects the amount that the
reporting entity expects to repay or credit customers, using either the expected value method or the most-likely amount method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Capitalised
platform development costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
incurred both internally and from external providers in developing the platform that meet the recognition criteria of development costs
under IAS 38 have been capitalised as intangible assets and are amortised over their useful life.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Research
and Development Incentive&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Judgement
is required in determining the amount of grant revenue relating to the research and development incentive claim. There are certain transactions
and calculations undertaken during the ordinary course of business for which the ultimate tax determination may be subject to change.
The Company calculates its research and development claim based on the Company&#x2019;s understanding of the tax law. Where the final
outcome of these matters is different from the amounts that were initially recorded, such differences will impact the profit or loss
in the year in which such determination is made.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000580"
      unitRef="USD">-14408346</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000582"
      unitRef="USD">-20597436</ifrs-full:ProfitLoss>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000584"
      unitRef="USD">-9386196</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000586"
      unitRef="USD">-5555868</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000588"
      unitRef="USD">2558544</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000590"
      unitRef="USD">-31134307</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:CurrentAssetsLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000592"
      unitRef="USD">1049355</ifrs-full:CurrentAssetsLiabilities>
    <ifrs-full:CurrentAssetsLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000594"
      unitRef="USD">21916914</ifrs-full:CurrentAssetsLiabilities>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000596">&lt;p id="xdx_806_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_z8q4UGVZWgn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
4. &lt;span id="xdx_82B_zj6fkDj2LyY"&gt;Operating segments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Identification
of reportable operating segments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Segment
reporting is based on the information that management uses to make decisions about the operation of the Company. Operating segment determination
is based on the internal reports that are reviewed and used by the Board of Directors (who are identified as the Chief Operating Decision
Makers (&#x201c;CODM&#x201d;)) in assessing performance and in determining the allocation of resources. The Company has identified one
operating segment as the provision and administration of mixed martial arts training programs, gym programs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
CODM reviews EBITDA (earnings before interest, tax, depreciation, and amortization). The accounting policies adopted for internal reporting
to the CODM are consistent with those adopted in the financial statements. Application of IFRS 8 and quantitative thresholds for determination
of reportable segments sees the consolidated entity disclosing only one reportable operating segment. The consolidated financial statements
for the years ended June 30, 2024, 2023 and 2022 have been presented by this single operating segment and have been presented and disclosed
as one reportable operating segment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000598">&lt;p id="xdx_807_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zOINLqwhVRZg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
5. &lt;span id="xdx_827_zJ2bG0nWdlOd"&gt;Revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zgRfiURJm5Ik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8BD_zRj385CWGvBl"&gt;Schedule
of revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20230701__20240630_zIQo217YJPrd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20220701__20230630_zQpYeWBDJ2Xd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20210701__20220630_zFnuaU5RM3V" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Program fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RevenueFromProgramFees_maRFROSz9dU_zNLAODQU0TP1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Revenue from program fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;929,319&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;937,415&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,050,044&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RevenueFromContractualPaymentsToGyms_msRFROSz9dU_zdeZp0jLQw3e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Contractual payments to gyms&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(537,012&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(574,025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,215,191&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--RevenueFromRenderingOfServices_iT_mtRFROSz9dU_maRz2tF_zhT4NkeQssek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Net Revenue from program fees&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;392,307&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;363,390&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;834,853&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Other Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ReserachAndDevelopmentIncome_maORzfCZ_zv9rjJaX42g5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Research and Development tax incentive&lt;span id="xdx_F47_zP06pBrLhtAl"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0614"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,149,525&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0616"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--FranchiseFeeIncome_maORzfCZ_zaa66nRRvk4c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Finale, franchise fee and other fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;167,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,378&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--RevenueFromSaleOfGoods_maORzfCZ_zfMcMFP3uw71" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Merchandise sales&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,984&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,296&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,572&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--OtherRevenue_iT_mtORzfCZ_maRz2tF_zwfzTIvJ2cn3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total other income&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;170,005&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,173,421&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;105,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--Revenue_iT_mtRz2tF_zTIGx62L0Xs9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;562,312&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,536,811&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;940,803&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0D_zgTDBqwENKc1" style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_zk811PLJDAUd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company will continue
                                                                                                                                                              to apply for the Research and Development incentive as long as it continues to be eligible and will conduct eligible research and
                                                                                                                                                              development activities. The applicable legislation that governs the eligibility to participate in the R&amp;amp;D incentive program is
                                                                                                                                                              Division 355 of the Income Tax Assessment Act 1997 (ITAA 1997). The FY 2024 Research and Development incentive will be applied for
                                                                                                                                                              on lodging of the FY 2024 tax return with the Australian Tax Office and recognised once reasonable assurance that the Company will
                                                                                                                                                              comply with the conditions and that the grants will be received.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A3_zEIWAm8Tm0Wd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Disaggregation
of Revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eifrs-full--DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_zUgRACWRC7W6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
disaggregation of revenue from contracts with customers is disclosed below. The Company only has one major product line, being the provision
of Gym Programs. All revenues are generated by the Australian Parent Entity:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8BA_zGUPKhuQw4sd"&gt;Schedule
of disaggregation of revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20230701__20240630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_z531tjLvweVk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220701__20230630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_zOPIEMxM5Cc8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20210701__20220630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_z2YKwg6pYU2f" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--RevenueFromProgramFees_zmPTuSmNiD3j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Revenue from program fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;929,319&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;937,415&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,050,044&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--RevenueFromContractualPaymentsToGyms_z0gRDUB3W7a5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Contractual payments to gyms&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(537,012&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(574,025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,215,191&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--RevenueFromRenderingOfServices_iT_maRz2tF_z3F89R5objXi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net Revenue from program fees&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;392,307&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;363,390&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;834,853&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zra1ZJXvLff8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Timing
of revenue recognition&lt;/i&gt; &#x2013; All goods transferred at a point in time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory>
    <ifrs-full:DisclosureOfProductsAndServicesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000600">&lt;p id="xdx_89D_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zgRfiURJm5Ik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8BD_zRj385CWGvBl"&gt;Schedule
of revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20230701__20240630_zIQo217YJPrd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20220701__20230630_zQpYeWBDJ2Xd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20210701__20220630_zFnuaU5RM3V" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Program fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RevenueFromProgramFees_maRFROSz9dU_zNLAODQU0TP1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Revenue from program fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;929,319&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;937,415&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,050,044&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RevenueFromContractualPaymentsToGyms_msRFROSz9dU_zdeZp0jLQw3e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Contractual payments to gyms&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(537,012&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(574,025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,215,191&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--RevenueFromRenderingOfServices_iT_mtRFROSz9dU_maRz2tF_zhT4NkeQssek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Net Revenue from program fees&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;392,307&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;363,390&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;834,853&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Other Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ReserachAndDevelopmentIncome_maORzfCZ_zv9rjJaX42g5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Research and Development tax incentive&lt;span id="xdx_F47_zP06pBrLhtAl"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0614"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,149,525&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0616"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--FranchiseFeeIncome_maORzfCZ_zaa66nRRvk4c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Finale, franchise fee and other fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;167,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,378&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--RevenueFromSaleOfGoods_maORzfCZ_zfMcMFP3uw71" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Merchandise sales&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,984&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,296&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,572&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--OtherRevenue_iT_mtORzfCZ_maRz2tF_zwfzTIvJ2cn3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total other income&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;170,005&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,173,421&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;105,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--Revenue_iT_mtRz2tF_zTIGx62L0Xs9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;562,312&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,536,811&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;940,803&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0D_zgTDBqwENKc1" style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_zk811PLJDAUd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company will continue
                                                                                                                                                              to apply for the Research and Development incentive as long as it continues to be eligible and will conduct eligible research and
                                                                                                                                                              development activities. The applicable legislation that governs the eligibility to participate in the R&amp;amp;D incentive program is
                                                                                                                                                              Division 355 of the Income Tax Assessment Act 1997 (ITAA 1997). The FY 2024 Research and Development incentive will be applied for
                                                                                                                                                              on lodging of the FY 2024 tax return with the Australian Tax Office and recognised once reasonable assurance that the Company will
                                                                                                                                                              comply with the conditions and that the grants will be received.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ifrs-full:DisclosureOfProductsAndServicesExplanatory>
    <MMA:RevenueFromProgramFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000602"
      unitRef="USD">929319</MMA:RevenueFromProgramFees>
    <MMA:RevenueFromProgramFees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000603"
      unitRef="USD">937415</MMA:RevenueFromProgramFees>
    <MMA:RevenueFromProgramFees
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000604"
      unitRef="USD">2050044</MMA:RevenueFromProgramFees>
    <MMA:RevenueFromContractualPaymentsToGyms
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000606"
      unitRef="USD">-537012</MMA:RevenueFromContractualPaymentsToGyms>
    <MMA:RevenueFromContractualPaymentsToGyms
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000607"
      unitRef="USD">-574025</MMA:RevenueFromContractualPaymentsToGyms>
    <MMA:RevenueFromContractualPaymentsToGyms
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000608"
      unitRef="USD">-1215191</MMA:RevenueFromContractualPaymentsToGyms>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000610"
      unitRef="USD">392307</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000611"
      unitRef="USD">363390</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000612"
      unitRef="USD">834853</ifrs-full:RevenueFromRenderingOfServices>
    <MMA:ReserachAndDevelopmentIncome
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000615"
      unitRef="USD">1149525</MMA:ReserachAndDevelopmentIncome>
    <ifrs-full:FranchiseFeeIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000618"
      unitRef="USD">167021</ifrs-full:FranchiseFeeIncome>
    <ifrs-full:FranchiseFeeIncome
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000619"
      unitRef="USD">22600</ifrs-full:FranchiseFeeIncome>
    <ifrs-full:FranchiseFeeIncome
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000620"
      unitRef="USD">100378</ifrs-full:FranchiseFeeIncome>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000622"
      unitRef="USD">2984</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000623"
      unitRef="USD">1296</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000624"
      unitRef="USD">5572</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:OtherRevenue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000626"
      unitRef="USD">170005</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000627"
      unitRef="USD">1173421</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000628"
      unitRef="USD">105950</ifrs-full:OtherRevenue>
    <ifrs-full:Revenue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000630"
      unitRef="USD">562312</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000631"
      unitRef="USD">1536811</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000632"
      unitRef="USD">940803</ifrs-full:Revenue>
    <ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000635">&lt;p id="xdx_89E_eifrs-full--DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_zUgRACWRC7W6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
disaggregation of revenue from contracts with customers is disclosed below. The Company only has one major product line, being the provision
of Gym Programs. All revenues are generated by the Australian Parent Entity:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8BA_zGUPKhuQw4sd"&gt;Schedule
of disaggregation of revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20230701__20240630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_z531tjLvweVk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220701__20230630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_zOPIEMxM5Cc8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20210701__20220630__ifrs-full--ProductsAndServicesAxis__custom--OneMajorProductMember_z2YKwg6pYU2f" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--RevenueFromProgramFees_zmPTuSmNiD3j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Revenue from program fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;929,319&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;937,415&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,050,044&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--RevenueFromContractualPaymentsToGyms_z0gRDUB3W7a5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Contractual payments to gyms&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(537,012&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(574,025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,215,191&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--RevenueFromRenderingOfServices_iT_maRz2tF_z3F89R5objXi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net Revenue from program fees&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;392,307&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;363,390&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;834,853&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory>
    <MMA:RevenueFromProgramFees
      contextRef="From2023-07-012024-06-30_custom_OneMajorProductMember"
      decimals="0"
      id="Fact000637"
      unitRef="USD">929319</MMA:RevenueFromProgramFees>
    <MMA:RevenueFromProgramFees
      contextRef="From2022-07-012023-06-30_custom_OneMajorProductMember"
      decimals="0"
      id="Fact000638"
      unitRef="USD">937415</MMA:RevenueFromProgramFees>
    <MMA:RevenueFromProgramFees
      contextRef="From2021-07-012022-06-30_custom_OneMajorProductMember"
      decimals="0"
      id="Fact000639"
      unitRef="USD">2050044</MMA:RevenueFromProgramFees>
    <MMA:RevenueFromContractualPaymentsToGyms
      contextRef="From2023-07-012024-06-30_custom_OneMajorProductMember"
      decimals="0"
      id="Fact000641"
      unitRef="USD">-537012</MMA:RevenueFromContractualPaymentsToGyms>
    <MMA:RevenueFromContractualPaymentsToGyms
      contextRef="From2022-07-012023-06-30_custom_OneMajorProductMember"
      decimals="0"
      id="Fact000642"
      unitRef="USD">-574025</MMA:RevenueFromContractualPaymentsToGyms>
    <MMA:RevenueFromContractualPaymentsToGyms
      contextRef="From2021-07-012022-06-30_custom_OneMajorProductMember"
      decimals="0"
      id="Fact000643"
      unitRef="USD">-1215191</MMA:RevenueFromContractualPaymentsToGyms>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="From2023-07-012024-06-30_custom_OneMajorProductMember"
      decimals="0"
      id="Fact000645"
      unitRef="USD">392307</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="From2022-07-012023-06-30_custom_OneMajorProductMember"
      decimals="0"
      id="Fact000646"
      unitRef="USD">363390</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="From2021-07-012022-06-30_custom_OneMajorProductMember"
      decimals="0"
      id="Fact000647"
      unitRef="USD">834853</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:DisclosureOfExpensesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000649">&lt;p id="xdx_803_eifrs-full--DisclosureOfExpensesExplanatory_zeuAdbXSyMLa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
6. &lt;span id="xdx_82E_z6MWtveDC26k"&gt;Expenses&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutExpensesExplanatory_z3e8eACAxv52" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8B0_zwL6ZQpkNdwc"&gt;Schedule
of expenses&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230701__20240630_z7fmhUciUL3f" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220701__20230630_zLR1IN4xc7og" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210701__20220630_z8qJsQzhXZCf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ProgramExpensesEventCosts_maPEzyGE_z1crUWk8SLUk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Event
    Costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,909&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,876&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,513&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ProgramExpensesProgramCosts_maPEzyGE_zig9SqT0Iqz5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Program
    costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,046&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,447&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;253,614&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProgramExpensesMerchantFees_maPEzyGE_z5QXY1FBIba2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Merchant
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,550&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;44,427&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;66,327&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ProgramExpensesOtherCosts_maPEzyGE_zAcumNvOKD6h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;84,073&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;132,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;146&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProgramExpenses_iT_mtPEzyGE_zyQPoCeOpQY9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    program expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160,578&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;229,848&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;342,600&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--FinanceCostsConvertibleNotesInterestContractualAndEffective_maFCzg2h_zq1HsTJLnapg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
    notes interest &#x2013; contractual and effective&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,207,498&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,420,224&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,162,646&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FinanceCostsBankFees_maFCzg2h_zSZqLiHzNKn2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,286&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,071&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,454&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FinanceCostsBankInterestAndLeaseInterest_maFCzg2h_zKEaGTWQJ1y2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank
    interest and lease interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;42,143&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;39,435&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,703&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--FinanceCosts_iT_mtFCzg2h_z7IH9r1XTqL9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    finance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,262,927&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,472,730&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,191,803&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
6. Expenses &#x2013; continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr id="xdx_40F_ecustom--UnrealizedCurrencyGains_i01N_di_maNFEGzlIR_zxdzxHTpr0qa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left; padding-left: 1.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unrealized
    currency (gains)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(117,094&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(36,181&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(36,660&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--RealizedCurrencyGainslosses_i01N_di_maNFEGzlIR_zmoIvMjR4wO2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 1.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Realized
    currency (gains)/losses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(29,449&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,178&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,581&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NetForeignExchangeGain_i01NT_di_mtNFEGzlIR_zWAZunepoqjb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 1.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    foreign exchange (gains)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(146,543&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(47,359&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(26,079&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zkhENqCHTiMb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfExpensesExplanatory>
    <MMA:DisclosureOfDetailedInformationAboutExpensesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000651">&lt;p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutExpensesExplanatory_z3e8eACAxv52" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8B0_zwL6ZQpkNdwc"&gt;Schedule
of expenses&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230701__20240630_z7fmhUciUL3f" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220701__20230630_zLR1IN4xc7og" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210701__20220630_z8qJsQzhXZCf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ProgramExpensesEventCosts_maPEzyGE_z1crUWk8SLUk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Event
    Costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,909&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,876&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,513&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ProgramExpensesProgramCosts_maPEzyGE_zig9SqT0Iqz5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Program
    costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,046&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,447&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;253,614&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProgramExpensesMerchantFees_maPEzyGE_z5QXY1FBIba2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Merchant
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,550&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;44,427&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;66,327&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ProgramExpensesOtherCosts_maPEzyGE_zAcumNvOKD6h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;84,073&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;132,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;146&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProgramExpenses_iT_mtPEzyGE_zyQPoCeOpQY9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    program expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160,578&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;229,848&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;342,600&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--FinanceCostsConvertibleNotesInterestContractualAndEffective_maFCzg2h_zq1HsTJLnapg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
    notes interest &#x2013; contractual and effective&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,207,498&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,420,224&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,162,646&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FinanceCostsBankFees_maFCzg2h_zSZqLiHzNKn2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,286&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,071&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,454&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FinanceCostsBankInterestAndLeaseInterest_maFCzg2h_zKEaGTWQJ1y2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank
    interest and lease interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;42,143&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;39,435&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,703&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--FinanceCosts_iT_mtFCzg2h_z7IH9r1XTqL9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    finance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,262,927&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,472,730&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,191,803&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
6. Expenses &#x2013; continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr id="xdx_40F_ecustom--UnrealizedCurrencyGains_i01N_di_maNFEGzlIR_zxdzxHTpr0qa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left; padding-left: 1.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unrealized
    currency (gains)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(117,094&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(36,181&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(36,660&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--RealizedCurrencyGainslosses_i01N_di_maNFEGzlIR_zmoIvMjR4wO2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 1.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Realized
    currency (gains)/losses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(29,449&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,178&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,581&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NetForeignExchangeGain_i01NT_di_mtNFEGzlIR_zWAZunepoqjb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 1.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    foreign exchange (gains)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(146,543&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(47,359&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(26,079&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</MMA:DisclosureOfDetailedInformationAboutExpensesExplanatory>
    <MMA:ProgramExpensesEventCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000653"
      unitRef="USD">36909</MMA:ProgramExpensesEventCosts>
    <MMA:ProgramExpensesEventCosts
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000654"
      unitRef="USD">40876</MMA:ProgramExpensesEventCosts>
    <MMA:ProgramExpensesEventCosts
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000655"
      unitRef="USD">22513</MMA:ProgramExpensesEventCosts>
    <MMA:ProgramExpensesProgramCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000657"
      unitRef="USD">7046</MMA:ProgramExpensesProgramCosts>
    <MMA:ProgramExpensesProgramCosts
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000658"
      unitRef="USD">12447</MMA:ProgramExpensesProgramCosts>
    <MMA:ProgramExpensesProgramCosts
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000659"
      unitRef="USD">253614</MMA:ProgramExpensesProgramCosts>
    <MMA:ProgramExpensesMerchantFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000661"
      unitRef="USD">32550</MMA:ProgramExpensesMerchantFees>
    <MMA:ProgramExpensesMerchantFees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000662"
      unitRef="USD">44427</MMA:ProgramExpensesMerchantFees>
    <MMA:ProgramExpensesMerchantFees
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000663"
      unitRef="USD">66327</MMA:ProgramExpensesMerchantFees>
    <MMA:ProgramExpensesOtherCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000665"
      unitRef="USD">84073</MMA:ProgramExpensesOtherCosts>
    <MMA:ProgramExpensesOtherCosts
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000666"
      unitRef="USD">132098</MMA:ProgramExpensesOtherCosts>
    <MMA:ProgramExpensesOtherCosts
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000667"
      unitRef="USD">146</MMA:ProgramExpensesOtherCosts>
    <MMA:ProgramExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000669"
      unitRef="USD">160578</MMA:ProgramExpenses>
    <MMA:ProgramExpenses
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000670"
      unitRef="USD">229848</MMA:ProgramExpenses>
    <MMA:ProgramExpenses
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000671"
      unitRef="USD">342600</MMA:ProgramExpenses>
    <MMA:FinanceCostsConvertibleNotesInterestContractualAndEffective
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000673"
      unitRef="USD">3207498</MMA:FinanceCostsConvertibleNotesInterestContractualAndEffective>
    <MMA:FinanceCostsConvertibleNotesInterestContractualAndEffective
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000674"
      unitRef="USD">4420224</MMA:FinanceCostsConvertibleNotesInterestContractualAndEffective>
    <MMA:FinanceCostsConvertibleNotesInterestContractualAndEffective
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000675"
      unitRef="USD">2162646</MMA:FinanceCostsConvertibleNotesInterestContractualAndEffective>
    <MMA:FinanceCostsBankFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000677"
      unitRef="USD">13286</MMA:FinanceCostsBankFees>
    <MMA:FinanceCostsBankFees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000678"
      unitRef="USD">13071</MMA:FinanceCostsBankFees>
    <MMA:FinanceCostsBankFees
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000679"
      unitRef="USD">6454</MMA:FinanceCostsBankFees>
    <MMA:FinanceCostsBankInterestAndLeaseInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000681"
      unitRef="USD">42143</MMA:FinanceCostsBankInterestAndLeaseInterest>
    <MMA:FinanceCostsBankInterestAndLeaseInterest
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000682"
      unitRef="USD">39435</MMA:FinanceCostsBankInterestAndLeaseInterest>
    <MMA:FinanceCostsBankInterestAndLeaseInterest
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000683"
      unitRef="USD">22703</MMA:FinanceCostsBankInterestAndLeaseInterest>
    <ifrs-full:FinanceCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000685"
      unitRef="USD">3262927</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000686"
      unitRef="USD">4472730</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000687"
      unitRef="USD">2191803</ifrs-full:FinanceCosts>
    <MMA:UnrealizedCurrencyGains
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000689"
      unitRef="USD">117094</MMA:UnrealizedCurrencyGains>
    <MMA:UnrealizedCurrencyGains
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000690"
      unitRef="USD">36181</MMA:UnrealizedCurrencyGains>
    <MMA:UnrealizedCurrencyGains
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000691"
      unitRef="USD">36660</MMA:UnrealizedCurrencyGains>
    <MMA:RealizedCurrencyGainslosses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000693"
      unitRef="USD">29449</MMA:RealizedCurrencyGainslosses>
    <MMA:RealizedCurrencyGainslosses
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000694"
      unitRef="USD">11178</MMA:RealizedCurrencyGainslosses>
    <MMA:RealizedCurrencyGainslosses
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000695"
      unitRef="USD">-10581</MMA:RealizedCurrencyGainslosses>
    <ifrs-full:NetForeignExchangeGain
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000697"
      unitRef="USD">146543</ifrs-full:NetForeignExchangeGain>
    <ifrs-full:NetForeignExchangeGain
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000698"
      unitRef="USD">47359</ifrs-full:NetForeignExchangeGain>
    <ifrs-full:NetForeignExchangeGain
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000699"
      unitRef="USD">26079</ifrs-full:NetForeignExchangeGain>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000701">&lt;p id="xdx_809_eifrs-full--DisclosureOfIncomeTaxExplanatory_zm3Hho4gqaX3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
7. &lt;span id="xdx_823_zHAHMbZhK2l9"&gt;Income Tax&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory_zscoYR2oR6N2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z4CNgLHWqwEl" style="display: none"&gt;Schedule
of Income Tax Expenses&lt;/span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230701__20240630_zfxLcEGBTYY8" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220701__20230630_zntEBKkkbrk3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20210701__20220630_zuLqSjss5J9k" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($&lt;/b&gt;&lt;b&gt;)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Income tax expense consists of the following:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DeferredTaxExpenseIncome_maITECOzfzo_zESb20Fef0Zc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0705"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0706"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0707"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--CurrentTaxExpenseIncome_maITECOzfzo_z4Yfix7ZhNtc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Current tax expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0710"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0711"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_mtITECOzfzo_zPDylCD3bfil" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Total Income tax expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0713"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0714"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0715"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Effective tax rate reconciliation:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--ProfitLossBeforeTax_z5MTAICaLnu5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Loss before income tax expense&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(14,408,346&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(20,597,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(11,197,450&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_maITECOzcFn_zZEoUrsnybQj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Prima facie income tax benefit on loss before income tax calculated at &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluY29tZSBUYXggRXhwZW5zZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--ApplicableTaxRate_pid_dp_c20230701__20240630_zUiOgGZVODZc" title="Tax rate"&gt;25&lt;/span&gt;% (2022: &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluY29tZSBUYXggRXhwZW5zZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--ApplicableTaxRate_pid_dp_c20210701__20220630_z2ukeGc6alk5" title="Tax rate"&gt;25&lt;/span&gt;%)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,602,086&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,149,359&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,799,363&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Add tax effect of&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--DeferredTaxExpenseIncomeOtherNonAllowableItems_maITECOzcFn_zYmYfegG7Mag" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt; text-align: left"&gt;- other non-allowable items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(831,249&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,297,349&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;143,430&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Less tax effect of&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes_msITECOzcFn_zPEPbeLJLYT4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt; text-align: left"&gt;- items not assessable for income tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,590,831&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,435,790&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,377,243&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting_msITECOzcFn_zUb9IH5K4qNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt; text-align: left"&gt;- items deductible for taxation not accounting&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;251,784&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;772,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;114,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss_maITECOzcFn_zYSSn8aD2NHa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Deferred tax not recognised&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(431,790&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,189,068&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,680,021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_mtITECOzcFn_zE1YYBiIuBL3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0747"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AE_zlmeI0SEI5d2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has carried forward tax losses, calculated according to Australian income tax legislation of $&lt;span id="xdx_901_eifrs-full--DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_c20230701__20240630_z5mM5xEQTWlc" title="Caarried forward tax loss"&gt;18,042,509&lt;/span&gt; at 30 June 2024 (2023
$&lt;span id="xdx_90D_eifrs-full--DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_c20220701__20230630_zQxxAPUSZT2" title="Caarried forward tax loss"&gt;16,315,346&lt;/span&gt;) which will be deductible from future assessable income provided that income is derived. Deferred tax assets and liabilities
are based on the assumption that no adverse change will occur in the income tax legislation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
benefit of these losses will only be recognized where it is probable that future taxable profit will be available against which the benefits
of the deferred tax asset can be utilised. This is based on the anticipation that the Company will derive sufficient future assessable
income to enable the benefit to be realised and comply with the conditions of deductibility imposed by the law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has assessed future forecast profits and concluded that not enough criteria has been satisfied to recognise any deferred tax
assets at the period ended 30 June 2024. Unused tax losses do not have an expiry date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <MMA:DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000703">&lt;p id="xdx_890_ecustom--DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory_zscoYR2oR6N2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z4CNgLHWqwEl" style="display: none"&gt;Schedule
of Income Tax Expenses&lt;/span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230701__20240630_zfxLcEGBTYY8" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220701__20230630_zntEBKkkbrk3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20210701__20220630_zuLqSjss5J9k" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($&lt;/b&gt;&lt;b&gt;)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Income tax expense consists of the following:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DeferredTaxExpenseIncome_maITECOzfzo_zESb20Fef0Zc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0705"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0706"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0707"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--CurrentTaxExpenseIncome_maITECOzfzo_z4Yfix7ZhNtc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Current tax expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0710"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0711"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_mtITECOzfzo_zPDylCD3bfil" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Total Income tax expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0713"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0714"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0715"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Effective tax rate reconciliation:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--ProfitLossBeforeTax_z5MTAICaLnu5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Loss before income tax expense&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(14,408,346&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(20,597,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(11,197,450&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_maITECOzcFn_zZEoUrsnybQj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Prima facie income tax benefit on loss before income tax calculated at &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluY29tZSBUYXggRXhwZW5zZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--ApplicableTaxRate_pid_dp_c20230701__20240630_zUiOgGZVODZc" title="Tax rate"&gt;25&lt;/span&gt;% (2022: &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEluY29tZSBUYXggRXhwZW5zZXMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--ApplicableTaxRate_pid_dp_c20210701__20220630_z2ukeGc6alk5" title="Tax rate"&gt;25&lt;/span&gt;%)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,602,086&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,149,359&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,799,363&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Add tax effect of&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--DeferredTaxExpenseIncomeOtherNonAllowableItems_maITECOzcFn_zYmYfegG7Mag" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt; text-align: left"&gt;- other non-allowable items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(831,249&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,297,349&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;143,430&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Less tax effect of&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes_msITECOzcFn_zPEPbeLJLYT4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt; text-align: left"&gt;- items not assessable for income tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,590,831&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,435,790&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,377,243&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting_msITECOzcFn_zUb9IH5K4qNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt; text-align: left"&gt;- items deductible for taxation not accounting&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;251,784&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;772,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;114,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss_maITECOzcFn_zYSSn8aD2NHa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Deferred tax not recognised&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(431,790&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,189,068&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,680,021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--IncomeTaxExpenseContinuingOperations_iT_mtITECOzcFn_zE1YYBiIuBL3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0747"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</MMA:DisclosureOfEffectiveIncomeTaxRateReconciliationsExplanatory>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000717"
      unitRef="USD">-14408346</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000718"
      unitRef="USD">-20597436</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000719"
      unitRef="USD">-11197450</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000725"
      unitRef="Pure">0.25</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact000727"
      unitRef="Pure">0.25</ifrs-full:ApplicableTaxRate>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000721"
      unitRef="USD">3602086</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000722"
      unitRef="USD">5149359</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000723"
      unitRef="USD">2799363</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <MMA:DeferredTaxExpenseIncomeOtherNonAllowableItems
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000729"
      unitRef="USD">-831249</MMA:DeferredTaxExpenseIncomeOtherNonAllowableItems>
    <MMA:DeferredTaxExpenseIncomeOtherNonAllowableItems
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000730"
      unitRef="USD">-3297349</MMA:DeferredTaxExpenseIncomeOtherNonAllowableItems>
    <MMA:DeferredTaxExpenseIncomeOtherNonAllowableItems
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000731"
      unitRef="USD">143430</MMA:DeferredTaxExpenseIncomeOtherNonAllowableItems>
    <MMA:DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000733"
      unitRef="USD">-2590831</MMA:DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes>
    <MMA:DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000734"
      unitRef="USD">-1435790</MMA:DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes>
    <MMA:DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000735"
      unitRef="USD">-1377243</MMA:DeferredTaxExpenseIncomeItemsNotAssessableForIncomeTaxes>
    <MMA:DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000737"
      unitRef="USD">251784</MMA:DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting>
    <MMA:DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000738"
      unitRef="USD">772848</MMA:DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting>
    <MMA:DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000739"
      unitRef="USD">114471</MMA:DeferredTaxExpenseIncomeItemsDeductibleForTaxationNotAccounting>
    <MMA:DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000741"
      unitRef="USD">-431790</MMA:DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss>
    <MMA:DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000742"
      unitRef="USD">-1189068</MMA:DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss>
    <MMA:DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact000743"
      unitRef="USD">-1680021</MMA:DeferredTaxExpenseIncomeNotRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000749"
      unitRef="USD">18042509</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000751"
      unitRef="USD">16315346</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:DisclosureOfFairValueMeasurementExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000753">&lt;p id="xdx_80E_eifrs-full--DisclosureOfFairValueMeasurementExplanatory_zHgM4fnHcQwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. &lt;span id="xdx_829_zobUHEApnBq3"&gt;Fair value measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value hierarchy&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables detail the consolidated entity&#x2019;s assets and liabilities, measured or disclosed at fair value, using a three level
hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that
                                            the entity can access at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            2: Inputs other than quoted prices included within Level 1 that are observable for the asset
                                            or liability, either directly or indirectly.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            3: Unobservable inputs for the asset or liability. Considerable judgement is required to
                                            determine what is significant to fair value and therefore which category the asset or liability
                                            is placed in can be subjective.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89A_eifrs-full--DisclosureOfFinancialAssetsExplanatory_z8h86UUdFcxh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zTa0x4G2KBib" style="display: none"&gt;Schedule
of Fair Value Assets and &#160;Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zeMVVKkSBJMg" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zoLD7BLiRh5j" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zTI1Dp2Umppj" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240630_zZGmXuYbrzB8" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;Consolidated- June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--FinancialAssetsAtFairValue_iI_znrdl0xnuuD8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; padding-bottom: 1pt; width: 40%"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0757"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0759"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0760"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--FinancialAssetsAtFairValue_iTI_zkuPaf0L1W6j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0762"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0763"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0764"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0765"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic"&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValue_iI_zWJMsn824O9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Derivative Liabilities &#x2013; refer Note 21&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0767"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0768"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0769"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0770"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_zGUV0WEvPhq" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0772"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0773"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0774"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0775"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zKFzHVh7ZZX8" style="text-align: center"&gt;Level 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zQsvMZmMXTse" style="text-align: center"&gt;Level 2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z7eUzszco5m3" style="text-align: center"&gt;Level 3&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230630_zZjQJ5h2psV2" style="text-align: center"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;Consolidated &#x2013; June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--FinancialAssetsAtFairValue_iI_z9lPUJOZCFoe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-style: italic; padding-bottom: 1pt"&gt;Assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0777"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0778"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0779"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0780"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--FinancialAssetsAtFairValue_iTI_zFbX6SlvPo3k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0783"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0784"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0785"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic"&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValue_iI_zsWxZpZCbt21" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Derivative Liabilities &#x2013; refer Note 21&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18,694,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18,694,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_zwPEIDdwxdy6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0792"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0793"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18,694,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18,694,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_z2kXpfF5bD73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no transfers between levels during the financial periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of trade and other receivables and trade and other payables are assumed to approximate their fair values due to their
short-term nature. The fair value of financial liabilities is estimated by discounting the remaining contractual maturities at the current
market interest rate that is available for similar financial liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Valuation
techniques for fair value measurements categorised within level 3&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Financial Liabilities for the host liability and the derivative liability has been determined using a combination of
Monte Carlo Simulation (MCS) and Black-Scholes model (BSM). The Group used valuations specialists to perform these valuations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
3 liabilities&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Movements
in level 3 liabilities during the current and previous financial years are set out below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--DisclosureOfDerivativeLiabilityExplanatory_zz6cZ8Gpqwmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_z0DzVDLs8pOa" style="display: none"&gt;Schedule
of Fair Value Measurement of Derivative Liability&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Derivative liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;Consolidated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Balance at 1 July 2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DerivativeFinancialLiabilities_iS_c20220701__20230630_z0R7TJj55djc" style="width: 12%; text-align: right" title="Balance"&gt;878,653&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--FinancialLiabilities_iS_c20220701__20230630_zuoCRlVBY6zh" style="width: 12%; text-align: right" title="Balance"&gt;878,653&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value of derivative liability recognised for convertible notes issued during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_c20220701__20230630_z1AjGBA7dQOd" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year"&gt;10,945,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_c20220701__20230630_zYkbUdeWnAie" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year"&gt;10,945,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Fair value movement recognised in profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--FairValueMovementRecognisedInProfitOrLoss_c20220701__20230630_zcgU848FByG6" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value movement recognised in profit or loss"&gt;6,870,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_c20220701__20230630_zLriMIYpnDTk" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value movement recognised in profit or loss"&gt;6,870,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Balance at 30 June 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iS_c20230701__20240630_zUyZwqyKuxpa" style="text-align: right" title="Balance"&gt;18,694,729&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--FinancialLiabilities_iS_c20230701__20240630_zwSEuwbL1w7j" style="text-align: right" title="Balance"&gt;18,694,729&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value of derivative liability recognised for convertible notes issued during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_c20230701__20240630_zZwxa5bWvOjf" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year"&gt;280,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_c20230701__20240630_zRBTYXplDnr3" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year"&gt;280,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fair value movement recognised in profit or loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--FairValueMovementRecognisedInProfitOrLoss_c20230701__20240630_zIm3QAun1PMe" style="text-align: right" title="Fair value movement recognised in profit or loss"&gt;(3,400,685&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_c20230701__20240630_zxljolWGhcy8" style="text-align: right" title="Fair value movement recognised in profit or loss"&gt;(3,400,685&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Fair value of derivative liability for convertible notes which converted or matured during the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_c20230701__20240630_zbI4NgGD8dyg" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of derivative liability for convertible notes which converted or matured during the year"&gt;(15,574,242&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_c20230701__20240630_zlodQOI4j9a1" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of derivative liability for convertible notes which converted or matured during the year"&gt;(15,574,242&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance at 30 June 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--DerivativeFinancialLiabilities_iE_c20230701__20240630_zMQCn8i4GJHb" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0827"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--FinancialLiabilities_iE_c20230701__20240630_zM3ylSxHFXo7" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zb7fpPVRTIQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. Fair value measurement - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eifrs-full--DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_zXNXdVFKxRtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
level 3 liabilities unobservable inputs at issue date of each of the convertible notes series are as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zLarCb241h71" style="display: none"&gt;Schedule
of Unobservable Inputs Level 3 Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Series A&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zp3vfSB85J27" style="width: 18%; text-align: right" title="Implied Valuation"&gt;28,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zZuZEBvwtkOh" style="text-align: right" title="Volatility"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zz7X8ueMA5a7" style="text-align: right" title="Volatility"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zEPFKyGEfIme" style="text-align: right" title="Volatility"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Series A - July 21&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zVuGci006Ksb" style="width: 18%; text-align: right" title="Implied Valuation"&gt;28,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zP3yLd1B7I38" style="text-align: right" title="Volatility"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zsuvP1fU9DMc" style="text-align: right" title="Volatility"&gt;0.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_ziGwy7zjDOC2" style="text-align: right" title="Volatility"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Series A &#x2013; August 21&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_z6TN7GPgOxN" style="width: 18%; text-align: right" title="Implied Valuation"&gt;28,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zl5TIWyXdeH2" style="text-align: right" title="Volatility"&gt;62&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zEt0xB5LCaR7" style="text-align: right" title="Volatility"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zLjvyPV6RtJ6" style="text-align: right" title="Volatility"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Series B1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zQSDF0mM3Zf2" style="width: 18%; text-align: right" title="Implied Valuation"&gt;120,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zGrlA1CI2Yqk" style="text-align: right" title="Volatility"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zMPstv8V9ubf" style="text-align: right" title="Volatility"&gt;0.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zkyr6J9Gc0ki" style="text-align: right" title="Volatility"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series B2&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_ziaqCXgeU2e6" style="width: 18%; text-align: right" title="Implied Valuation"&gt;70,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_z0Wwew0eU187" style="text-align: right" title="Volatility"&gt;66&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_ztpjbijgfsRa" style="text-align: right" title="Volatility"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_zHvD5ZKsQMd4" style="text-align: right" title="Volatility"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. Fair value measurement - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Series A Extension&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_z0AOX32bewYc" style="width: 18%; text-align: right" title="Implied Valuation"&gt;28,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_zcsirHDeCGW3" style="text-align: right" title="Volatility"&gt;65&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_z4qFyH8cKW24" style="text-align: right" title="Volatility"&gt;3.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_zcUyIbIbYoa7" style="text-align: right" title="Volatility"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Reach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zCDcShhAlquf" style="width: 18%; text-align: right" title="Implied Valuation"&gt;40,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zZrAv0MSz1j9" style="text-align: right" title="Volatility"&gt;60&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zcs5oKG0sfj3" style="text-align: right" title="Volatility"&gt;3.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zINygeJBMhK7" style="text-align: right" title="Volatility"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Private Placement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zSVK1qaCez68" style="width: 18%; text-align: right" title="Implied Valuation"&gt;53,685,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zSb9oj4dlbGf" style="text-align: right" title="Volatility"&gt;60&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zOtHhs1KwYWb" style="text-align: right" title="Volatility"&gt;3.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_ztoHxmtYGFnb" style="text-align: right" title="Volatility"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Mixed Martial Arts LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zFPOfH2Wgr7g" style="width: 18%; text-align: right" title="Implied Valuation"&gt;384,750&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zv0Qp6BZ5WO2" style="text-align: right" title="Volatility"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zxXFvfO9oiO8" style="text-align: right" title="Volatility"&gt;4.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zneXfVnHL4pa" style="text-align: right" title="Volatility"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Steppen&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_z7ojOPxh03G9" style="width: 18%; text-align: right" title="Implied Valuation"&gt;100,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zrheWO1kl34c" style="text-align: right" title="Volatility"&gt;47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zGVfRKO4ghTd" style="text-align: right" title="Volatility"&gt;4.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zSnsYp7Ur1yk" style="text-align: right" title="Volatility"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zY97X2Z96y8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfFairValueMeasurementExplanatory>
    <ifrs-full:DisclosureOfFinancialAssetsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000755">&lt;p id="xdx_89A_eifrs-full--DisclosureOfFinancialAssetsExplanatory_z8h86UUdFcxh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zTa0x4G2KBib" style="display: none"&gt;Schedule
of Fair Value Assets and &#160;Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zeMVVKkSBJMg" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zoLD7BLiRh5j" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zTI1Dp2Umppj" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240630_zZGmXuYbrzB8" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;Consolidated- June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--FinancialAssetsAtFairValue_iI_znrdl0xnuuD8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; padding-bottom: 1pt; width: 40%"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0757"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0759"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0760"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--FinancialAssetsAtFairValue_iTI_zkuPaf0L1W6j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0762"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0763"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0764"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0765"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic"&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValue_iI_zWJMsn824O9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Derivative Liabilities &#x2013; refer Note 21&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0767"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0768"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0769"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0770"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_zGUV0WEvPhq" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0772"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0773"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0774"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0775"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zKFzHVh7ZZX8" style="text-align: center"&gt;Level 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zQsvMZmMXTse" style="text-align: center"&gt;Level 2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z7eUzszco5m3" style="text-align: center"&gt;Level 3&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230630_zZjQJ5h2psV2" style="text-align: center"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;Consolidated &#x2013; June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--FinancialAssetsAtFairValue_iI_z9lPUJOZCFoe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-style: italic; padding-bottom: 1pt"&gt;Assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0777"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0778"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0779"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0780"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--FinancialAssetsAtFairValue_iTI_zFbX6SlvPo3k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0783"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0784"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0785"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic"&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--FinancialLiabilitiesAtFairValue_iI_zsWxZpZCbt21" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Derivative Liabilities &#x2013; refer Note 21&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18,694,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18,694,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_zwPEIDdwxdy6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0792"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0793"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18,694,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18,694,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfFinancialAssetsExplanatory>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact000789"
      unitRef="USD">18694729</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000790"
      unitRef="USD">18694729</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact000794"
      unitRef="USD">18694729</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000795"
      unitRef="USD">18694729</ifrs-full:FinancialLiabilitiesAtFairValue>
    <MMA:DisclosureOfDerivativeLiabilityExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000797">&lt;p id="xdx_89C_ecustom--DisclosureOfDerivativeLiabilityExplanatory_zz6cZ8Gpqwmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_z0DzVDLs8pOa" style="display: none"&gt;Schedule
of Fair Value Measurement of Derivative Liability&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Derivative liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;Consolidated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Balance at 1 July 2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DerivativeFinancialLiabilities_iS_c20220701__20230630_z0R7TJj55djc" style="width: 12%; text-align: right" title="Balance"&gt;878,653&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--FinancialLiabilities_iS_c20220701__20230630_zuoCRlVBY6zh" style="width: 12%; text-align: right" title="Balance"&gt;878,653&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value of derivative liability recognised for convertible notes issued during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_c20220701__20230630_z1AjGBA7dQOd" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year"&gt;10,945,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_c20220701__20230630_zYkbUdeWnAie" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year"&gt;10,945,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Fair value movement recognised in profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--FairValueMovementRecognisedInProfitOrLoss_c20220701__20230630_zcgU848FByG6" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value movement recognised in profit or loss"&gt;6,870,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_c20220701__20230630_zLriMIYpnDTk" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value movement recognised in profit or loss"&gt;6,870,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Balance at 30 June 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iS_c20230701__20240630_zUyZwqyKuxpa" style="text-align: right" title="Balance"&gt;18,694,729&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--FinancialLiabilities_iS_c20230701__20240630_zwSEuwbL1w7j" style="text-align: right" title="Balance"&gt;18,694,729&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value of derivative liability recognised for convertible notes issued during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear_c20230701__20240630_zZwxa5bWvOjf" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year"&gt;280,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability_c20230701__20240630_zRBTYXplDnr3" style="text-align: right" title="Fair value of derivative liability recognised for convertible notes issued during the year"&gt;280,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fair value movement recognised in profit or loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--FairValueMovementRecognisedInProfitOrLoss_c20230701__20240630_zIm3QAun1PMe" style="text-align: right" title="Fair value movement recognised in profit or loss"&gt;(3,400,685&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_c20230701__20240630_zxljolWGhcy8" style="text-align: right" title="Fair value movement recognised in profit or loss"&gt;(3,400,685&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Fair value of derivative liability for convertible notes which converted or matured during the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_c20230701__20240630_zbI4NgGD8dyg" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of derivative liability for convertible notes which converted or matured during the year"&gt;(15,574,242&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear_c20230701__20240630_zlodQOI4j9a1" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of derivative liability for convertible notes which converted or matured during the year"&gt;(15,574,242&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance at 30 June 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--DerivativeFinancialLiabilities_iE_c20230701__20240630_zMQCn8i4GJHb" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0827"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--FinancialLiabilities_iE_c20230701__20240630_zM3ylSxHFXo7" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</MMA:DisclosureOfDerivativeLiabilityExplanatory>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000799"
      unitRef="USD">878653</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000801"
      unitRef="USD">878653</ifrs-full:FinancialLiabilities>
    <MMA:FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000803"
      unitRef="USD">10945347</MMA:FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear>
    <ifrs-full:ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000805"
      unitRef="USD">10945347</ifrs-full:ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability>
    <MMA:FairValueMovementRecognisedInProfitOrLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000807"
      unitRef="USD">6870729</MMA:FairValueMovementRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000809"
      unitRef="USD">6870729</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000811"
      unitRef="USD">18694729</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000813"
      unitRef="USD">18694729</ifrs-full:FinancialLiabilities>
    <MMA:FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000815"
      unitRef="USD">280198</MMA:FairValueOfDerivativeLiabilityRecognisedForConvertibleNotesIssuedDuringYear>
    <ifrs-full:ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000817"
      unitRef="USD">280198</ifrs-full:ChangesInFairValueOfFinancialLiabilityAttributableToChangesInCreditRiskOfLiability>
    <MMA:FairValueMovementRecognisedInProfitOrLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000819"
      unitRef="USD">-3400685</MMA:FairValueMovementRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000821"
      unitRef="USD">-3400685</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <MMA:FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000823"
      unitRef="USD">-15574242</MMA:FairValueOfDerivativeLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear>
    <MMA:FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000825"
      unitRef="USD">-15574242</MMA:FairValueOfLiabilityForConvertibleNotesWhichConvertedOrMaturedDuringYear>
    <ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000831">&lt;p id="xdx_895_eifrs-full--DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_zXNXdVFKxRtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
level 3 liabilities unobservable inputs at issue date of each of the convertible notes series are as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zLarCb241h71" style="display: none"&gt;Schedule
of Unobservable Inputs Level 3 Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Series A&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zp3vfSB85J27" style="width: 18%; text-align: right" title="Implied Valuation"&gt;28,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zZuZEBvwtkOh" style="text-align: right" title="Volatility"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zz7X8ueMA5a7" style="text-align: right" title="Volatility"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAConvertibleNotesMember_zEPFKyGEfIme" style="text-align: right" title="Volatility"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Series A - July 21&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zVuGci006Ksb" style="width: 18%; text-align: right" title="Implied Valuation"&gt;28,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zP3yLd1B7I38" style="text-align: right" title="Volatility"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_zsuvP1fU9DMc" style="text-align: right" title="Volatility"&gt;0.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAJuly21Member_ziGwy7zjDOC2" style="text-align: right" title="Volatility"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Series A &#x2013; August 21&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_z6TN7GPgOxN" style="width: 18%; text-align: right" title="Implied Valuation"&gt;28,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zl5TIWyXdeH2" style="text-align: right" title="Volatility"&gt;62&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zEt0xB5LCaR7" style="text-align: right" title="Volatility"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAAugust21Member_zLjvyPV6RtJ6" style="text-align: right" title="Volatility"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Series B1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zQSDF0mM3Zf2" style="width: 18%; text-align: right" title="Implied Valuation"&gt;120,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zGrlA1CI2Yqk" style="text-align: right" title="Volatility"&gt;74&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zMPstv8V9ubf" style="text-align: right" title="Volatility"&gt;0.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB1Member_zkyr6J9Gc0ki" style="text-align: right" title="Volatility"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series B2&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_ziaqCXgeU2e6" style="width: 18%; text-align: right" title="Implied Valuation"&gt;70,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_z0Wwew0eU187" style="text-align: right" title="Volatility"&gt;66&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_ztpjbijgfsRa" style="text-align: right" title="Volatility"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesB2Member_zHvD5ZKsQMd4" style="text-align: right" title="Volatility"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. Fair value measurement - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Series A Extension&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_z0AOX32bewYc" style="width: 18%; text-align: right" title="Implied Valuation"&gt;28,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_zcsirHDeCGW3" style="text-align: right" title="Volatility"&gt;65&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_z4qFyH8cKW24" style="text-align: right" title="Volatility"&gt;3.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SeriesAExtensionMember_zcUyIbIbYoa7" style="text-align: right" title="Volatility"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Reach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zCDcShhAlquf" style="width: 18%; text-align: right" title="Implied Valuation"&gt;40,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zZrAv0MSz1j9" style="text-align: right" title="Volatility"&gt;60&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zcs5oKG0sfj3" style="text-align: right" title="Volatility"&gt;3.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--ReachMember_zINygeJBMhK7" style="text-align: right" title="Volatility"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Private Placement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zSVK1qaCez68" style="width: 18%; text-align: right" title="Implied Valuation"&gt;53,685,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zSb9oj4dlbGf" style="text-align: right" title="Volatility"&gt;60&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_zOtHhs1KwYWb" style="text-align: right" title="Volatility"&gt;3.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivatePlacementsMember_ztoHxmtYGFnb" style="text-align: right" title="Volatility"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Mixed Martial Arts LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zFPOfH2Wgr7g" style="width: 18%; text-align: right" title="Implied Valuation"&gt;384,750&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zv0Qp6BZ5WO2" style="text-align: right" title="Volatility"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zxXFvfO9oiO8" style="text-align: right" title="Volatility"&gt;4.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--MixedMartialArtsLLCMember_zneXfVnHL4pa" style="text-align: right" title="Volatility"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: right"&gt;Steppen&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%; text-align: right"&gt;Implied valuation&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities_c20230701__20240630__ifrs-full--UnobservableInputsAxis__custom--ImpliedValuationMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_z7ojOPxh03G9" style="width: 18%; text-align: right" title="Implied Valuation"&gt;100,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zrheWO1kl34c" style="text-align: right" title="Volatility"&gt;47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--InterestRateMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zGVfRKO4ghTd" style="text-align: right" title="Volatility"&gt;4.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Probability of conversion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--SignificantUnobservableInputLiabilities_iI_pid_uPure_c20240630__ifrs-full--UnobservableInputsAxis__ifrs-full--ProbabilityOfDefaultMeasurementInputMember__ifrs-full--ComponentsOfEquityAxis__custom--SteppenMember_zSnsYp7Ur1yk" style="text-align: right" title="Volatility"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAConvertibleNotesMember"
      decimals="0"
      id="Fact000833"
      unitRef="USD">28000000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAConvertibleNotesMember"
      decimals="INF"
      id="Fact000835"
      unitRef="Pure">74</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAConvertibleNotesMember"
      decimals="INF"
      id="Fact000837"
      unitRef="Pure">0.0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAConvertibleNotesMember"
      decimals="INF"
      id="Fact000839"
      unitRef="Pure">50</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAJuly21Member"
      decimals="0"
      id="Fact000841"
      unitRef="USD">28000000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAJuly21Member"
      decimals="INF"
      id="Fact000843"
      unitRef="Pure">74</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAJuly21Member"
      decimals="INF"
      id="Fact000845"
      unitRef="Pure">0.1</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAJuly21Member"
      decimals="INF"
      id="Fact000847"
      unitRef="Pure">50</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAAugust21Member"
      decimals="0"
      id="Fact000849"
      unitRef="USD">28000000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAAugust21Member"
      decimals="INF"
      id="Fact000851"
      unitRef="Pure">62</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAAugust21Member"
      decimals="INF"
      id="Fact000853"
      unitRef="Pure">0.0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAAugust21Member"
      decimals="INF"
      id="Fact000855"
      unitRef="Pure">50</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesB1Member"
      decimals="0"
      id="Fact000857"
      unitRef="USD">120000000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesB1Member"
      decimals="INF"
      id="Fact000859"
      unitRef="Pure">74</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesB1Member"
      decimals="INF"
      id="Fact000861"
      unitRef="Pure">0.6</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesB1Member"
      decimals="INF"
      id="Fact000863"
      unitRef="Pure">50</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesB2Member"
      decimals="0"
      id="Fact000865"
      unitRef="USD">70000000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesB2Member"
      decimals="INF"
      id="Fact000867"
      unitRef="Pure">66</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesB2Member"
      decimals="INF"
      id="Fact000869"
      unitRef="Pure">3</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesB2Member"
      decimals="INF"
      id="Fact000871"
      unitRef="Pure">50</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SeriesAExtensionMember"
      decimals="0"
      id="Fact000873"
      unitRef="USD">28000000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SeriesAExtensionMember"
      decimals="INF"
      id="Fact000875"
      unitRef="Pure">65</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SeriesAExtensionMember"
      decimals="INF"
      id="Fact000877"
      unitRef="Pure">3.5</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SeriesAExtensionMember"
      decimals="INF"
      id="Fact000879"
      unitRef="Pure">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_ReachMember"
      decimals="0"
      id="Fact000881"
      unitRef="USD">40000000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_ReachMember"
      decimals="INF"
      id="Fact000883"
      unitRef="Pure">60</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_ReachMember"
      decimals="INF"
      id="Fact000885"
      unitRef="Pure">3.6</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_ReachMember"
      decimals="INF"
      id="Fact000887"
      unitRef="Pure">100</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_PrivatePlacementsMember"
      decimals="0"
      id="Fact000889"
      unitRef="USD">53685000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_PrivatePlacementsMember"
      decimals="INF"
      id="Fact000891"
      unitRef="Pure">60</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_PrivatePlacementsMember"
      decimals="INF"
      id="Fact000893"
      unitRef="Pure">3.5</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_PrivatePlacementsMember"
      decimals="INF"
      id="Fact000895"
      unitRef="Pure">100</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_MixedMartialArtsLLCMember"
      decimals="0"
      id="Fact000897"
      unitRef="USD">384750</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_MixedMartialArtsLLCMember"
      decimals="INF"
      id="Fact000899"
      unitRef="Pure">49</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_MixedMartialArtsLLCMember"
      decimals="INF"
      id="Fact000901"
      unitRef="Pure">4.3</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_MixedMartialArtsLLCMember"
      decimals="INF"
      id="Fact000903"
      unitRef="Pure">100</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities
      contextRef="From2023-07-012024-06-30_custom_ImpliedValuationMember_custom_SteppenMember"
      decimals="0"
      id="Fact000905"
      unitRef="USD">100000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember_custom_SteppenMember"
      decimals="INF"
      id="Fact000907"
      unitRef="Pure">47</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_InterestRateMeasurementInputMember_custom_SteppenMember"
      decimals="INF"
      id="Fact000909"
      unitRef="Pure">4.2</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ProbabilityOfDefaultMeasurementInputMember_custom_SteppenMember"
      decimals="INF"
      id="Fact000911"
      unitRef="Pure">100</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000913">&lt;p id="xdx_801_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zQeufRG7NDz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
9. &lt;span id="xdx_827_zk8cTcBkazje"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--DisclosureOfCashEquivalentsExplanatory_znCeSEql0yEe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zq6UPO9nt3Nh" style="display: none"&gt;Schedule
of Cash and Cash Equivalents&lt;/span&gt; &#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240630_zE3HFPXSzMMl" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230630_zzUAlB3ozL8j" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CashOnHand_iI_maCACEz9Hz_z7vm8uu5LhW2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Cash on hand&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--BalancesWithBanks_iI_maCACEz9Hz_zQjt6dNqt0q3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash at bank&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,543,837&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,701,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--CashAndCashEquivalents_iTI_mtCACEz9Hz_ztzFeQB6I0X5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total cash and cash equivalents&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,544,837&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,702,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--CashAndCashEquivalents_iI_zArdMXCRT3Kj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Cash as per above&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,544,837&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,702,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--CashAndCashEquivalents_iI_zHAwqU2KunJ1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Balance as per statement of cash flows&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,544,837&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,702,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zxsqNlcv4yVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <MMA:DisclosureOfCashEquivalentsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000915">&lt;p id="xdx_898_ecustom--DisclosureOfCashEquivalentsExplanatory_znCeSEql0yEe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zq6UPO9nt3Nh" style="display: none"&gt;Schedule
of Cash and Cash Equivalents&lt;/span&gt; &#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240630_zE3HFPXSzMMl" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230630_zzUAlB3ozL8j" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CashOnHand_iI_maCACEz9Hz_z7vm8uu5LhW2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Cash on hand&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--BalancesWithBanks_iI_maCACEz9Hz_zQjt6dNqt0q3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash at bank&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,543,837&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,701,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--CashAndCashEquivalents_iTI_mtCACEz9Hz_ztzFeQB6I0X5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total cash and cash equivalents&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,544,837&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,702,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--CashAndCashEquivalents_iI_zArdMXCRT3Kj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Cash as per above&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,544,837&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,702,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--CashAndCashEquivalents_iI_zHAwqU2KunJ1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Balance as per statement of cash flows&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,544,837&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,702,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</MMA:DisclosureOfCashEquivalentsExplanatory>
    <ifrs-full:CashOnHand
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000917"
      unitRef="USD">1000</ifrs-full:CashOnHand>
    <ifrs-full:CashOnHand
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000918"
      unitRef="USD">1000</ifrs-full:CashOnHand>
    <ifrs-full:BalancesWithBanks
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000920"
      unitRef="USD">3543837</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000921"
      unitRef="USD">3701567</ifrs-full:BalancesWithBanks>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000923"
      unitRef="USD">3544837</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000924"
      unitRef="USD">3702567</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000926"
      unitRef="USD">3544837</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000927"
      unitRef="USD">3702567</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000929"
      unitRef="USD">3544837</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000930"
      unitRef="USD">3702567</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000932">&lt;p id="xdx_80F_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zlvdalxYgf7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
10. &lt;span id="xdx_82C_zaBZ9RRnxN02"&gt;Trade and other receivables&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--DisclosureOfTradeAndOtherReceivableExplanatory_z9Kqk8ZxLgz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zGeOOPl2rvgj" style="display: none"&gt;Schedule
of Trade and Other Receivables&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240630_z3HBqL7GOEQ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230630_zHNoveeYHHv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2023&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--TradeReceivables_iI_zsAQml8LWkt4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Trade Receivables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;657&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;351,905&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--AccruedIncomeOtherThanContractAssets_iI_zSfGSPbkl2kh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,443&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0940"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ResearchAndDevelopmentIncome_iI_zh8sjvLVx2t6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Research and Development Tax incentive receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0942"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,776&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--OtherReceivables_iI_zd4qP7ry3Kz2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Other advances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;43,618&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,952,560&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AllowancesForCreditLoss_iI_z2DkDzNVX90f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less; allowance for credit losses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,603&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,603&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--TradeAndOtherReceivables_iI_zLn2rvVIKUk5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total trade and other receivables&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;71,115&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,365,638&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zV6ypdRDyQI8" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;The Company has applied the simplified approach to measuring expected credit losses, which use a lifetime expected loss allowance. The Company also recognizes a refund liability in line with our revenue recognition policy in Note 2.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <MMA:DisclosureOfTradeAndOtherReceivableExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000934">&lt;p id="xdx_897_ecustom--DisclosureOfTradeAndOtherReceivableExplanatory_z9Kqk8ZxLgz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zGeOOPl2rvgj" style="display: none"&gt;Schedule
of Trade and Other Receivables&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240630_z3HBqL7GOEQ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230630_zHNoveeYHHv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2023&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--TradeReceivables_iI_zsAQml8LWkt4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Trade Receivables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;657&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;351,905&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--AccruedIncomeOtherThanContractAssets_iI_zSfGSPbkl2kh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,443&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0940"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ResearchAndDevelopmentIncome_iI_zh8sjvLVx2t6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Research and Development Tax incentive receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0942"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,776&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--OtherReceivables_iI_zd4qP7ry3Kz2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Other advances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;43,618&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,952,560&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AllowancesForCreditLoss_iI_z2DkDzNVX90f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less; allowance for credit losses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,603&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,603&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--TradeAndOtherReceivables_iI_zLn2rvVIKUk5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total trade and other receivables&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;71,115&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,365,638&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</MMA:DisclosureOfTradeAndOtherReceivableExplanatory>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000936"
      unitRef="USD">657</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000937"
      unitRef="USD">351905</ifrs-full:TradeReceivables>
    <ifrs-full:AccruedIncomeOtherThanContractAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000939"
      unitRef="USD">29443</ifrs-full:AccruedIncomeOtherThanContractAssets>
    <MMA:ResearchAndDevelopmentIncome
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000943"
      unitRef="USD">63776</MMA:ResearchAndDevelopmentIncome>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000945"
      unitRef="USD">43618</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000946"
      unitRef="USD">1952560</ifrs-full:OtherReceivables>
    <MMA:AllowancesForCreditLoss
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000948"
      unitRef="USD">-2603</MMA:AllowancesForCreditLoss>
    <MMA:AllowancesForCreditLoss
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000949"
      unitRef="USD">-2603</MMA:AllowancesForCreditLoss>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000951"
      unitRef="USD">71115</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000952"
      unitRef="USD">2365638</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000954">&lt;p id="xdx_80F_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zRlvJlKEhEn8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
11. &lt;span id="xdx_82F_zy9uEqfyaXb4"&gt;Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p id="xdx_890_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z4Spbpyx1bjc" style="margin: 0"&gt;&lt;span id="xdx_8BE_zN9nwSU0bEv3" style="display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240630_z8yuAJ8MDg4g" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230630_z1pR9LZM9mv3" style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zWF0lFKBxGBa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Plant and equipment - at cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;72,410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;69,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zhsKji62vnnh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(59,339&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(56,002&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zlbJnq9EQAbc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,071&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zusnWBfhM3Q5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computer equipment - at cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111,047&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,612&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zg5am1rBKOma" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(82,269&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(54,929&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zNDHpHcK1DJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,778&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,683&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zIM4Jcl8lSX" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Office equipment - at cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_znmNN4ZfWcLh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,508&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,313&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zphmh3ylXEb8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;582&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240630_zSZhQ5pO2klj" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230630_z8ignUUSiYHa" style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zbhg8nWwLbE6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Furniture &amp;amp; Fittings - at cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;49,537&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;49,537&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zXX3RNQf27Vi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(14,270&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(9,277&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zB2QfahSvp6a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture &amp;amp; Fittings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;35,267&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;40,260&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_iI_zkm2lYfdlUP8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;77,698&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;94,928&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Property Plant and Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zVFYtlUGy7wj" style="text-align: right" title="Balance"&gt;13,208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zk7vtZqiWWD6" style="text-align: right" title="Balance"&gt;10,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zvjrp2I2G7j9" style="text-align: right" title="Additions"&gt;3,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zy1ZnIoxVdTk" style="text-align: right" title="Additions"&gt;2,110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zqDqMIPBKfM5" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1005"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zPdfmzEqGjf2" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1007"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zi58GAOax3G4" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(3,337&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zBGSt9KmaFS8" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;909&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt"&gt;Balance at end of the year-&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zfdWwaqGZKm6" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;13,071&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zPWkzJKvfsJ" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;13,208&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Computer Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_dxL_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z0wStTmp5A38" style="text-align: right" title="Balance::XDX::40683"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1017"&gt;51,971&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4L3npPCvlXd" style="text-align: right" title="Balance"&gt;51,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zaseSOdCciGk" style="text-align: right" title="Additions"&gt;15,435&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhEak30rSyW1" style="text-align: right" title="Additions"&gt;12,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zCZIanT1yvD3" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1025"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zENb5yXRlG3h" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1027"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zUczSfeONi0d" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(38,628&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zrE1kMCHaAw6" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(23,975&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt"&gt;Balance at end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zuIv6oRJpop1" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;28,778&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zHOwuc7dgvAc" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;40,683&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Office Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zT2gdA7rI0t3" style="text-align: right" title="Balance"&gt;777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zN8t4gG398gj" style="text-align: right" title="Balance"&gt;1,036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zLTP0e5mOfIc" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1041"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zolyYfpC2JQb" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1043"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zgZmtYyTAoY1" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1045"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zw8BMhz9U5q9" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1047"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zhP0D86yJe92" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(195&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zS1QX8kqxTJe" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(259&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt"&gt;Balance at end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zWmH4FGeTYLd" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;582&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zqDQ2A5bx5f3" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;777&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Furniture &amp;amp; Fittings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zUuFgb9s88Th" style="text-align: right" title="Balance"&gt;40,260&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_z0mcpFwLBkek" style="text-align: right" title="Balance"&gt;45,224&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zsScsLS2XRJ5" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1061"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zhsKqTjcgoN8" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1063"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zuuCmdALG1i3" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1065"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zbCw4R72GJRb" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1067"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zGkHTu3gvSf" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(4,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zIbrUGFllXP" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(4,964&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt"&gt;Balance at end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zPHniialTjY3" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;35,267&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zilSXRxgllok" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;40,260&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zvW3f4OGcHdd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact000956">&lt;p id="xdx_890_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z4Spbpyx1bjc" style="margin: 0"&gt;&lt;span id="xdx_8BE_zN9nwSU0bEv3" style="display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240630_z8yuAJ8MDg4g" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230630_z1pR9LZM9mv3" style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zWF0lFKBxGBa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Plant and equipment - at cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;72,410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;69,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zhsKji62vnnh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(59,339&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(56,002&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zlbJnq9EQAbc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,071&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zusnWBfhM3Q5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computer equipment - at cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111,047&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,612&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zg5am1rBKOma" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(82,269&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(54,929&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zNDHpHcK1DJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,778&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,683&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zIM4Jcl8lSX" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Office equipment - at cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_znmNN4ZfWcLh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,508&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,313&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zphmh3ylXEb8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;582&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240630_zSZhQ5pO2klj" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230630_z8ignUUSiYHa" style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--PropertyPlantAndEquipmentCost_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zbhg8nWwLbE6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Furniture &amp;amp; Fittings - at cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;49,537&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;49,537&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zXX3RNQf27Vi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(14,270&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(9,277&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--PropertyPlantAndEquipment_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zB2QfahSvp6a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture &amp;amp; Fittings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;35,267&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;40,260&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_iI_zkm2lYfdlUP8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;77,698&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;94,928&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Property Plant and Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zVFYtlUGy7wj" style="text-align: right" title="Balance"&gt;13,208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zk7vtZqiWWD6" style="text-align: right" title="Balance"&gt;10,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zvjrp2I2G7j9" style="text-align: right" title="Additions"&gt;3,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zy1ZnIoxVdTk" style="text-align: right" title="Additions"&gt;2,110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zqDqMIPBKfM5" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1005"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zPdfmzEqGjf2" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1007"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zi58GAOax3G4" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(3,337&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zBGSt9KmaFS8" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;909&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt"&gt;Balance at end of the year-&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zfdWwaqGZKm6" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;13,071&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zPWkzJKvfsJ" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;13,208&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Computer Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_dxL_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z0wStTmp5A38" style="text-align: right" title="Balance::XDX::40683"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1017"&gt;51,971&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4L3npPCvlXd" style="text-align: right" title="Balance"&gt;51,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zaseSOdCciGk" style="text-align: right" title="Additions"&gt;15,435&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhEak30rSyW1" style="text-align: right" title="Additions"&gt;12,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zCZIanT1yvD3" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1025"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zENb5yXRlG3h" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1027"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zUczSfeONi0d" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(38,628&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zrE1kMCHaAw6" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(23,975&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt"&gt;Balance at end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zuIv6oRJpop1" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;28,778&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zHOwuc7dgvAc" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;40,683&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Office Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zT2gdA7rI0t3" style="text-align: right" title="Balance"&gt;777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zN8t4gG398gj" style="text-align: right" title="Balance"&gt;1,036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zLTP0e5mOfIc" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1041"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zolyYfpC2JQb" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1043"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zgZmtYyTAoY1" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1045"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zw8BMhz9U5q9" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1047"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zhP0D86yJe92" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(195&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zS1QX8kqxTJe" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(259&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt"&gt;Balance at end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zWmH4FGeTYLd" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;582&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zqDQ2A5bx5f3" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;777&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Furniture &amp;amp; Fittings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zUuFgb9s88Th" style="text-align: right" title="Balance"&gt;40,260&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_z0mcpFwLBkek" style="text-align: right" title="Balance"&gt;45,224&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zsScsLS2XRJ5" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1061"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zhsKqTjcgoN8" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1063"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zuuCmdALG1i3" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1065"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DisposalsAndRetirementsPropertyPlantAndEquipment_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zbCw4R72GJRb" style="text-align: right" title="Disposals"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1067"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Depreciation expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zGkHTu3gvSf" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(4,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zIbrUGFllXP" style="border-bottom: Black 1pt solid; text-align: right" title="Depreciation expense"&gt;(4,964&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt"&gt;Balance at end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_c20230701__20240630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zPHniialTjY3" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;35,267&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_c20220701__20230630__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitrueAndFittingsMember_zilSXRxgllok" style="border-bottom: Black 1pt solid; text-align: right" title="Balance"&gt;40,260&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <MMA:PropertyPlantAndEquipmentCost
      contextRef="AsOf2024-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact000958"
      unitRef="USD">72410</MMA:PropertyPlantAndEquipmentCost>
    <MMA:PropertyPlantAndEquipmentCost
      contextRef="AsOf2023-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact000959"
      unitRef="USD">69210</MMA:PropertyPlantAndEquipmentCost>
    <MMA:PropertyPlantAndEquipmentAccumulatedDepreciation
      contextRef="AsOf2024-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact000961"
      unitRef="USD">-59339</MMA:PropertyPlantAndEquipmentAccumulatedDepreciation>
    <MMA:PropertyPlantAndEquipmentAccumulatedDepreciation
      contextRef="AsOf2023-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact000962"
      unitRef="USD">-56002</MMA:PropertyPlantAndEquipmentAccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact000964"
      unitRef="USD">13071</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact000965"
      unitRef="USD">13208</ifrs-full:PropertyPlantAndEquipment>
    <MMA:PropertyPlantAndEquipmentCost
      contextRef="AsOf2024-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact000967"
      unitRef="USD">111047</MMA:PropertyPlantAndEquipmentCost>
    <MMA:PropertyPlantAndEquipmentCost
      contextRef="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact000968"
      unitRef="USD">95612</MMA:PropertyPlantAndEquipmentCost>
    <MMA:PropertyPlantAndEquipmentAccumulatedDepreciation
      contextRef="AsOf2024-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact000970"
      unitRef="USD">-82269</MMA:PropertyPlantAndEquipmentAccumulatedDepreciation>
    <MMA:PropertyPlantAndEquipmentAccumulatedDepreciation
      contextRef="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact000971"
      unitRef="USD">-54929</MMA:PropertyPlantAndEquipmentAccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact000973"
      unitRef="USD">28778</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact000974"
      unitRef="USD">40683</ifrs-full:PropertyPlantAndEquipment>
    <MMA:PropertyPlantAndEquipmentCost
      contextRef="AsOf2024-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact000976"
      unitRef="USD">2090</MMA:PropertyPlantAndEquipmentCost>
    <MMA:PropertyPlantAndEquipmentCost
      contextRef="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact000977"
      unitRef="USD">2090</MMA:PropertyPlantAndEquipmentCost>
    <MMA:PropertyPlantAndEquipmentAccumulatedDepreciation
      contextRef="AsOf2024-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact000979"
      unitRef="USD">-1508</MMA:PropertyPlantAndEquipmentAccumulatedDepreciation>
    <MMA:PropertyPlantAndEquipmentAccumulatedDepreciation
      contextRef="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact000980"
      unitRef="USD">-1313</MMA:PropertyPlantAndEquipmentAccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact000982"
      unitRef="USD">582</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact000983"
      unitRef="USD">777</ifrs-full:PropertyPlantAndEquipment>
    <MMA:PropertyPlantAndEquipmentCost
      contextRef="AsOf2024-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact000985"
      unitRef="USD">49537</MMA:PropertyPlantAndEquipmentCost>
    <MMA:PropertyPlantAndEquipmentCost
      contextRef="AsOf2023-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact000986"
      unitRef="USD">49537</MMA:PropertyPlantAndEquipmentCost>
    <MMA:PropertyPlantAndEquipmentAccumulatedDepreciation
      contextRef="AsOf2024-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact000988"
      unitRef="USD">-14270</MMA:PropertyPlantAndEquipmentAccumulatedDepreciation>
    <MMA:PropertyPlantAndEquipmentAccumulatedDepreciation
      contextRef="AsOf2023-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact000989"
      unitRef="USD">-9277</MMA:PropertyPlantAndEquipmentAccumulatedDepreciation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact000991"
      unitRef="USD">35267</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact000992"
      unitRef="USD">40260</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000994"
      unitRef="USD">77698</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000995"
      unitRef="USD">94928</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact000997"
      unitRef="USD">13208</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact000999"
      unitRef="USD">10189</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact001001"
      unitRef="USD">3200</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact001003"
      unitRef="USD">2110</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact001009"
      unitRef="USD">3337</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact001011"
      unitRef="USD">909</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact001013"
      unitRef="USD">13071</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_custom_PlantAndEquipmentMember"
      decimals="0"
      id="Fact001015"
      unitRef="USD">13208</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact001019"
      unitRef="USD">51971</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact001021"
      unitRef="USD">15435</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact001023"
      unitRef="USD">12687</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact001029"
      unitRef="USD">38628</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact001031"
      unitRef="USD">23975</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact001033"
      unitRef="USD">28778</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_ifrs-full_ComputerEquipmentMember"
      decimals="0"
      id="Fact001035"
      unitRef="USD">40683</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact001037"
      unitRef="USD">777</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact001039"
      unitRef="USD">1036</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact001049"
      unitRef="USD">195</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact001051"
      unitRef="USD">259</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact001053"
      unitRef="USD">582</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_ifrs-full_OfficeEquipmentMember"
      decimals="0"
      id="Fact001055"
      unitRef="USD">777</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact001057"
      unitRef="USD">40260</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact001059"
      unitRef="USD">45224</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact001069"
      unitRef="USD">4993</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact001071"
      unitRef="USD">4964</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact001073"
      unitRef="USD">35267</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_custom_FurnitrueAndFittingsMember"
      decimals="0"
      id="Fact001075"
      unitRef="USD">40260</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001077">&lt;p id="xdx_801_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zEYzozc3Twtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
12. &lt;span id="xdx_82C_zZ3eG6Rctsjf"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_z4WWHGzNnSo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zy6ZJQJ4JJph" style="display: none"&gt;Schedule of Intangible assets&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240630_zbw9mhXi0cv6" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230630_zVFbHzDTLJyg" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWfOL3bUkefb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Trademark - at cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;52,243&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;50,843&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdMrzRmD2v78" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(29,653&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,429&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zGeCtoaUP3yc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trademark - at cost, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,590&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zg6787Dj2mm2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Platform development - at cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,988,033&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,136,149&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbSFxOeozqT4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(713,360&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(351,202&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zldqW3wFluei" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Platform
    development - at cost, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,274,673&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;784,947&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_zD3AUrzw6X02" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total intangible assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,297,263&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;811,361&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zb65yvA8fY6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory_zM5JV1YW6tRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reconciliations
of the movement of intangible assets are set out below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zzUebXIuSik5" style="display: none"&gt;Schedule of Reconciliations of the Movement of Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230701__20240630_zFOOXYRKZj65" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220701__20230630_zhreG6tQh7Hj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2023&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Trademark&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zvsRasfCteeb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Balance at beginning of the period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;26,414&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;26,414&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z5BTHYfs6fwe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1108"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_za34hXYLEzpa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortization expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,224&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1111"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zAKkxVkEsDnf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;Balance at end of the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,590&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Platform development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_z6NxPuO4om8h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;784,947&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,034,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AdditionsFromInternalDevelopment_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zxLtOsQJ3KCe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Additions from internal development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;352,182&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zsbD745T533l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additions acquired &lt;span id="xdx_F4D_zkhnk0Ru9lo1"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;674,220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1123"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ResearchDevelopmentTaxIncentive_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zMTiZn8U98hh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Research &amp;amp; Development tax incentive&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1125"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(383,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_znukqCAigQqi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortization expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(361,950&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(217,600&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zQrmniWgl8Fa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;Balance at end of the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,274,673&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;784,947&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F00_zE8r3Az3I4Oa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zFnGGzVFHNc1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Included in additions
is acquired intangible assets of:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            September 2023, we completed the acquisition of the assets of Steppen Pty Ltd, a fitness
                                            technology company based in Australia (&#x201c;Steppen&#x201d;). As consideration for the asset
                                            acquisition, we issued Steppen an unsecured and non-redeemable convertible promissory note
                                            (on the same terms as the recently completed Private Placement), with a principal amount
                                            of US$ &lt;span id="xdx_909_eifrs-full--NotionalAmount_iI_c20230930__ifrs-full--CounterpartiesAxis__custom--SteppenPtyLtdMember_zFJXAam8TyIf" title="Principal amount"&gt;64,977&lt;/span&gt; (AUD$&lt;span id="xdx_909_eifrs-full--NotionalAmount_iI_uAUD_c20230930__ifrs-full--CounterpartiesAxis__custom--SteppenPtyLtdMember_zRZTSBvMObUa" title="Principal amount"&gt;100,000&lt;/span&gt;).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            October 2023, we completed the acquisition of the assets of Mixed Martials Arts LLC, an independent
                                            MMA media company, based in the US. As consideration for the asset acquisition, we issued
                                            Mixed Martials Arts LLC an unsecured and non-redeemable convertible promissory note (on the
                                            same terms as the recently completed Private Placement), with a principal amount of US$&lt;span id="xdx_907_eifrs-full--NotionalAmount_iI_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_zOAvpzW7u2w1" title="Principal amount"&gt;250,000&lt;/span&gt;
                                            (AUD$&lt;span id="xdx_90C_eifrs-full--NotionalAmount_iI_uAUD_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_z6Z71mZKZNod" title="Principal amount"&gt;384,750&lt;/span&gt;) and paid US$&lt;span id="xdx_901_eifrs-full--Cash_iI_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_zPWHyb4ReqE4" title="Cash"&gt;25,000&lt;/span&gt; in cash.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            May 2024, we completed the acquisition of the assets of Hype Kit, Inc, a Delaware corporation
                                            (&#x201c;Hype&#x201d;), an all in-one digital marketing platform, designed to help small businesses
                                            grow in today&#x2019;s age of social media. Hype&#x2019;s software platform strengthens the
                                            Company&#x2019;s vision to convert 640 million MMA fans to participants by providing invaluable
                                            tools to our gym owner, coach, and athlete partners to not only grow their revenues, but
                                            also operate more efficiently, save costs and enhance the offerings to &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;their
members and community. This acquisition is expected to accelerate Alta&#x2019;s technology roadmap, bringing forward new subscription
revenue opportunities for us, whilst creating cost synergies by materially reducing product development overhead and bringing valuable
technology expertise, skills and talent into the business. The acquisition was completed, and the asset purchased for consideration of
USD$&lt;span id="xdx_909_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20240531__ifrs-full--CounterpartiesAxis__custom--HypeKitIncMember_zawEFdzTJqK8" title="Asset purchased for consideration"&gt;100,000&lt;/span&gt; (AUD$&lt;span id="xdx_90F_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_uAUD_c20240531__ifrs-full--CounterpartiesAxis__custom--HypeKitIncMember_zZK4K0AcQjJ8" title="Asset purchased for consideration"&gt;153,000&lt;/span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
                                            determined both the acquired intangible assets did not pass the concentration test under
                                            IFRS 3 Business Combinations. Thereby were accounted for as acquisition of intangible assets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AF_zbbEO8hZJnC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001079">&lt;p id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_z4WWHGzNnSo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zy6ZJQJ4JJph" style="display: none"&gt;Schedule of Intangible assets&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240630_zbw9mhXi0cv6" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230630_zVFbHzDTLJyg" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWfOL3bUkefb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Trademark - at cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;52,243&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;50,843&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdMrzRmD2v78" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(29,653&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,429&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zGeCtoaUP3yc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trademark - at cost, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,590&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zg6787Dj2mm2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Platform development - at cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,988,033&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,136,149&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbSFxOeozqT4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(713,360&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(351,202&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zldqW3wFluei" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Platform
    development - at cost, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,274,673&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;784,947&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_zD3AUrzw6X02" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total intangible assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,297,263&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;811,361&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact001081"
      unitRef="USD">52243</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact001082"
      unitRef="USD">50843</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fact001084"
      unitRef="USD">-29653</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fact001085"
      unitRef="USD">-24429</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30_ifrs-full_BrandNamesMember"
      decimals="0"
      id="Fact001087"
      unitRef="USD">22590</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30_ifrs-full_BrandNamesMember"
      decimals="0"
      id="Fact001088"
      unitRef="USD">26414</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30_custom_PlatformDevelopmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact001090"
      unitRef="USD">1988033</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30_custom_PlatformDevelopmentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact001091"
      unitRef="USD">1136149</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30_custom_PlatformDevelopmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fact001093"
      unitRef="USD">-713360</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30_custom_PlatformDevelopmentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fact001094"
      unitRef="USD">-351202</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001096"
      unitRef="USD">1274673</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001097"
      unitRef="USD">784947</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001099"
      unitRef="USD">1297263</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001100"
      unitRef="USD">811361</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <MMA:DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001102">&lt;p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory_zM5JV1YW6tRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reconciliations
of the movement of intangible assets are set out below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zzUebXIuSik5" style="display: none"&gt;Schedule of Reconciliations of the Movement of Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230701__20240630_zFOOXYRKZj65" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220701__20230630_zhreG6tQh7Hj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2023&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Trademark&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zvsRasfCteeb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Balance at beginning of the period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;26,414&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;26,414&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z5BTHYfs6fwe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1108"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_za34hXYLEzpa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortization expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,224&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1111"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zAKkxVkEsDnf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;Balance at end of the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,590&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Platform development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_z6NxPuO4om8h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;784,947&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,034,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AdditionsFromInternalDevelopment_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zxLtOsQJ3KCe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Additions from internal development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;352,182&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zsbD745T533l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additions acquired &lt;span id="xdx_F4D_zkhnk0Ru9lo1"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;674,220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1123"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ResearchDevelopmentTaxIncentive_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zMTiZn8U98hh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Research &amp;amp; Development tax incentive&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1125"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(383,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_znukqCAigQqi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortization expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(361,950&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(217,600&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_hifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--PlatformDevelopmentMember_zQrmniWgl8Fa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;Balance at end of the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,274,673&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;784,947&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F00_zE8r3Az3I4Oa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zFnGGzVFHNc1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Included in additions
is acquired intangible assets of:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            September 2023, we completed the acquisition of the assets of Steppen Pty Ltd, a fitness
                                            technology company based in Australia (&#x201c;Steppen&#x201d;). As consideration for the asset
                                            acquisition, we issued Steppen an unsecured and non-redeemable convertible promissory note
                                            (on the same terms as the recently completed Private Placement), with a principal amount
                                            of US$ &lt;span id="xdx_909_eifrs-full--NotionalAmount_iI_c20230930__ifrs-full--CounterpartiesAxis__custom--SteppenPtyLtdMember_zFJXAam8TyIf" title="Principal amount"&gt;64,977&lt;/span&gt; (AUD$&lt;span id="xdx_909_eifrs-full--NotionalAmount_iI_uAUD_c20230930__ifrs-full--CounterpartiesAxis__custom--SteppenPtyLtdMember_zRZTSBvMObUa" title="Principal amount"&gt;100,000&lt;/span&gt;).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            October 2023, we completed the acquisition of the assets of Mixed Martials Arts LLC, an independent
                                            MMA media company, based in the US. As consideration for the asset acquisition, we issued
                                            Mixed Martials Arts LLC an unsecured and non-redeemable convertible promissory note (on the
                                            same terms as the recently completed Private Placement), with a principal amount of US$&lt;span id="xdx_907_eifrs-full--NotionalAmount_iI_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_zOAvpzW7u2w1" title="Principal amount"&gt;250,000&lt;/span&gt;
                                            (AUD$&lt;span id="xdx_90C_eifrs-full--NotionalAmount_iI_uAUD_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_z6Z71mZKZNod" title="Principal amount"&gt;384,750&lt;/span&gt;) and paid US$&lt;span id="xdx_901_eifrs-full--Cash_iI_c20231031__ifrs-full--CounterpartiesAxis__custom--MixedMartialsArtsLLCMember_zPWHyb4ReqE4" title="Cash"&gt;25,000&lt;/span&gt; in cash.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            May 2024, we completed the acquisition of the assets of Hype Kit, Inc, a Delaware corporation
                                            (&#x201c;Hype&#x201d;), an all in-one digital marketing platform, designed to help small businesses
                                            grow in today&#x2019;s age of social media. Hype&#x2019;s software platform strengthens the
                                            Company&#x2019;s vision to convert 640 million MMA fans to participants by providing invaluable
                                            tools to our gym owner, coach, and athlete partners to not only grow their revenues, but
                                            also operate more efficiently, save costs and enhance the offerings to &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;their
members and community. This acquisition is expected to accelerate Alta&#x2019;s technology roadmap, bringing forward new subscription
revenue opportunities for us, whilst creating cost synergies by materially reducing product development overhead and bringing valuable
technology expertise, skills and talent into the business. The acquisition was completed, and the asset purchased for consideration of
USD$&lt;span id="xdx_909_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20240531__ifrs-full--CounterpartiesAxis__custom--HypeKitIncMember_zawEFdzTJqK8" title="Asset purchased for consideration"&gt;100,000&lt;/span&gt; (AUD$&lt;span id="xdx_90F_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_uAUD_c20240531__ifrs-full--CounterpartiesAxis__custom--HypeKitIncMember_zZK4K0AcQjJ8" title="Asset purchased for consideration"&gt;153,000&lt;/span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
                                            determined both the acquired intangible assets did not pass the concentration test under
                                            IFRS 3 Business Combinations. Thereby were accounted for as acquisition of intangible assets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</MMA:DisclosureOfDetailedInformationAboutReconciliationsOfMovementOfIntangibleAssetsExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30_ifrs-full_BrandNamesMember"
      decimals="0"
      id="Fact001104"
      unitRef="USD">26414</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2022-06-30_ifrs-full_BrandNamesMember"
      decimals="0"
      id="Fact001105"
      unitRef="USD">26414</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-07-012024-06-30_ifrs-full_BrandNamesMember"
      decimals="0"
      id="Fact001107"
      unitRef="USD">1400</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-07-012024-06-30_ifrs-full_BrandNamesMember"
      decimals="0"
      id="Fact001110"
      unitRef="USD">5224</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30_ifrs-full_BrandNamesMember"
      decimals="0"
      id="Fact001113"
      unitRef="USD">22590</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30_ifrs-full_BrandNamesMember"
      decimals="0"
      id="Fact001114"
      unitRef="USD">26414</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001116"
      unitRef="USD">784947</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2022-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001117"
      unitRef="USD">1034302</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <MMA:AdditionsFromInternalDevelopment
      contextRef="From2023-07-012024-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001119"
      unitRef="USD">177456</MMA:AdditionsFromInternalDevelopment>
    <MMA:AdditionsFromInternalDevelopment
      contextRef="From2022-07-012023-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001120"
      unitRef="USD">352182</MMA:AdditionsFromInternalDevelopment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-07-012024-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001122"
      unitRef="USD">674220</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <MMA:ResearchDevelopmentTaxIncentive
      contextRef="From2022-07-012023-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001126"
      unitRef="USD">-383937</MMA:ResearchDevelopmentTaxIncentive>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-07-012024-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001128"
      unitRef="USD">361950</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-07-012023-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001129"
      unitRef="USD">217600</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001131"
      unitRef="USD">1274673</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-06-30_custom_PlatformDevelopmentMember"
      decimals="0"
      id="Fact001132"
      unitRef="USD">784947</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2023-09-30_custom_SteppenPtyLtdMember"
      decimals="0"
      id="Fact001135"
      unitRef="USD">64977</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2023-09-30_custom_SteppenPtyLtdMember"
      decimals="0"
      id="Fact001137"
      unitRef="AUD">100000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2023-10-31_custom_MixedMartialsArtsLLCMember"
      decimals="0"
      id="Fact001139"
      unitRef="USD">250000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2023-10-31_custom_MixedMartialsArtsLLCMember"
      decimals="0"
      id="Fact001141"
      unitRef="AUD">384750</ifrs-full:NotionalAmount>
    <ifrs-full:Cash
      contextRef="AsOf2023-10-31_custom_MixedMartialsArtsLLCMember"
      decimals="0"
      id="Fact001143"
      unitRef="USD">25000</ifrs-full:Cash>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2024-05-31_custom_HypeKitIncMember"
      decimals="0"
      id="Fact001145"
      unitRef="USD">100000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2024-05-31_custom_HypeKitIncMember"
      decimals="0"
      id="Fact001147"
      unitRef="AUD">153000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001149">&lt;p id="xdx_804_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_zcQYsSvbk3A3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
13. &lt;span id="xdx_822_zGhoTcN7FY48"&gt;Trade and other payables&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayables_zcigglHseYi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_z1pFUCbStljj" style="display: none"&gt;Schedule of Trade and Other Payables&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240630_zzRqt8QejHec" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230630_zH2rBd2YQCe7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2023&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--TradeAndOtherPayablesPayableToMemberGyms_iI_maTAOPzf2r_zCUAJCQhg4Zg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Payable to member gyms&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;69,019&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;61,065&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--TaxesPayable_iI_maTAOPzf2r_zKTaaUbe5Cug" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Taxes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;603,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;560,204&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--TradePayables_iI_maTAOPzf2r_zgIV4zl7CxY5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;540,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;723,105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProvisionForRefundLiability_iI_maTAOPzf2r_zWEOr8VpVAW6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Provision for refund liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--OtherPayables_iI_maTAOPzf2r_z17Syid3zER2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other Payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;778,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;620,062&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--TradeAndOtherPayables_iTI_mtTAOPzf2r_z50oSktPub1h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Total trade and other payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,991,536&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,034,436&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zIyO2Ceq2SC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <MMA:DisclosureOfDetailedInformationAboutTradeAndOtherPayables contextRef="From2023-07-01to2024-06-30" id="Fact001151">&lt;p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayables_zcigglHseYi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_z1pFUCbStljj" style="display: none"&gt;Schedule of Trade and Other Payables&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240630_zzRqt8QejHec" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230630_zH2rBd2YQCe7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2023&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--TradeAndOtherPayablesPayableToMemberGyms_iI_maTAOPzf2r_zCUAJCQhg4Zg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Payable to member gyms&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;69,019&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;61,065&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--TaxesPayable_iI_maTAOPzf2r_zKTaaUbe5Cug" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Taxes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;603,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;560,204&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--TradePayables_iI_maTAOPzf2r_zgIV4zl7CxY5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;540,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;723,105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProvisionForRefundLiability_iI_maTAOPzf2r_zWEOr8VpVAW6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Provision for refund liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--OtherPayables_iI_maTAOPzf2r_z17Syid3zER2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other Payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;778,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;620,062&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--TradeAndOtherPayables_iTI_mtTAOPzf2r_z50oSktPub1h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Total trade and other payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,991,536&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,034,436&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</MMA:DisclosureOfDetailedInformationAboutTradeAndOtherPayables>
    <MMA:TradeAndOtherPayablesPayableToMemberGyms
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001153"
      unitRef="USD">69019</MMA:TradeAndOtherPayablesPayableToMemberGyms>
    <MMA:TradeAndOtherPayablesPayableToMemberGyms
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001154"
      unitRef="USD">61065</MMA:TradeAndOtherPayablesPayableToMemberGyms>
    <MMA:TaxesPayable
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001156"
      unitRef="USD">603550</MMA:TaxesPayable>
    <MMA:TaxesPayable
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001157"
      unitRef="USD">560204</MMA:TaxesPayable>
    <MMA:TradePayables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001159"
      unitRef="USD">540102</MMA:TradePayables>
    <MMA:TradePayables
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001160"
      unitRef="USD">723105</MMA:TradePayables>
    <MMA:ProvisionForRefundLiability
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001163"
      unitRef="USD">70000</MMA:ProvisionForRefundLiability>
    <ifrs-full:OtherPayables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001165"
      unitRef="USD">778865</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001166"
      unitRef="USD">620062</ifrs-full:OtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001168"
      unitRef="USD">1991536</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001169"
      unitRef="USD">2034436</ifrs-full:TradeAndOtherPayables>
    <MMA:DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001171">&lt;p id="xdx_802_ecustom--DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory_zbZkKAmb7Nf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note 14. &lt;span id="xdx_82D_zkyzW3h2Nzmh"&gt;Current and Non-current Employee
   Entitlements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory_zErYGqEv8pT3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zXK32yoCCa14" style="display: none"&gt;Schedule of Current and Non-current Employee Entitlements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20240630_zqnFK1vvJbF2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20230630_zcvpot8RqXdk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--CurrentProvisionsForEmployeeBenefits_iI_zCIX6RQcOSr" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Current Employee Entitlement&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;454,342&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;357,227&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--NoncurrentProvisionsForEmployeeBenefits_iI_zOZjPFsDm7Za" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Non-current Employee Entitlements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,622&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zhkCFXDhSoY4" style="margin: 0"&gt;&#160;&lt;/p&gt;

</MMA:DisclosureOfCurrentAndNonCurrentEmployeeEntitlementsExplanatory>
    <MMA:DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001173">&lt;p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory_zErYGqEv8pT3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zXK32yoCCa14" style="display: none"&gt;Schedule of Current and Non-current Employee Entitlements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20240630_zqnFK1vvJbF2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20230630_zcvpot8RqXdk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--CurrentProvisionsForEmployeeBenefits_iI_zCIX6RQcOSr" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Current Employee Entitlement&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;454,342&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;357,227&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--NoncurrentProvisionsForEmployeeBenefits_iI_zOZjPFsDm7Za" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Non-current Employee Entitlements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,622&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</MMA:DisclosureOfDetailedInformationAboutCurrentAndNonCurrentEmployeeEntitlementsExplanatory>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001175"
      unitRef="USD">454342</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001176"
      unitRef="USD">357227</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001178"
      unitRef="USD">55622</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001179"
      unitRef="USD">18892</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <MMA:DisclosureOfUnearnedRevenueExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001181">&lt;p id="xdx_809_ecustom--DisclosureOfUnearnedRevenueExplanatory_z7AejCwtqwGd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;Note 15. &lt;span id="xdx_823_zAeQQ3gvKGfb"&gt;Unearned Revenue&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory_z3LdcY8UUL4" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span&gt;&#160;&lt;span id="xdx_8BD_zxG2tDSKM5E" style="display: none"&gt;Schedule
of Unearned Revenue&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20240630_zlEvGQQGNqj7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20230630_z3CsV6nWAyO" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--UnearnedRevenue_iI_zK8QSeSdAgD8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 68%"&gt;Unearned Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 12%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1185"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 12%"&gt;174,290&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_z9WGi1GHZQI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</MMA:DisclosureOfUnearnedRevenueExplanatory>
    <MMA:DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001183">&lt;p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory_z3LdcY8UUL4" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span&gt;&#160;&lt;span id="xdx_8BD_zxG2tDSKM5E" style="display: none"&gt;Schedule
of Unearned Revenue&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20240630_zlEvGQQGNqj7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20230630_z3CsV6nWAyO" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--UnearnedRevenue_iI_zK8QSeSdAgD8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 68%"&gt;Unearned Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 12%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1185"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 12%"&gt;174,290&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</MMA:DisclosureOfDetailedInformationAboutUnearnedRevenueExplanatory>
    <MMA:UnearnedRevenue
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001186"
      unitRef="USD">174290</MMA:UnearnedRevenue>
    <ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001188">&lt;p id="xdx_80C_eifrs-full--DisclosureOfReservesAndOtherEquityInterestExplanatory_z1PhttHcLPxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
16. &lt;span id="xdx_825_zLDmVOVogjB2"&gt;Reserves&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfReservesTableTextBlock_zLJbJUzbgzZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z2pBebaXDblc" style="display: none"&gt;Schedule
of Reserves&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240630_zz9bVQNbSrpf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230630_zGg46BUY79G2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220630_ztcrbkNkzbc8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ReserveOfUnbilledShareOption_iI_zMGgFfZ6q9V6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Unlisted share option reserve&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,741,457&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1193"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ReserveOfSharebasedPayments_iI_zbS34NmH7cqi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Share based payment reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,734,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,912,367&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,546,983&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ForeignCurrencyReserves_iI_zpouhT90SLgj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Foreign currency translation reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(86,542&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(65,832&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(29,367&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A3_zLb9z1LwcYXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory>
    <MMA:ScheduleOfReservesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001190">&lt;p id="xdx_89E_ecustom--ScheduleOfReservesTableTextBlock_zLJbJUzbgzZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z2pBebaXDblc" style="display: none"&gt;Schedule
of Reserves&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240630_zz9bVQNbSrpf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230630_zGg46BUY79G2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220630_ztcrbkNkzbc8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ReserveOfUnbilledShareOption_iI_zMGgFfZ6q9V6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Unlisted share option reserve&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,741,457&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1193"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ReserveOfSharebasedPayments_iI_zbS34NmH7cqi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Share based payment reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,734,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,912,367&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,546,983&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ForeignCurrencyReserves_iI_zpouhT90SLgj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Foreign currency translation reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(86,542&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(65,832&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(29,367&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</MMA:ScheduleOfReservesTableTextBlock>
    <MMA:ReserveOfUnbilledShareOption
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001192"
      unitRef="USD">2741457</MMA:ReserveOfUnbilledShareOption>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001196"
      unitRef="USD">5734601</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001197"
      unitRef="USD">3912367</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact001198"
      unitRef="USD">1546983</ifrs-full:ReserveOfSharebasedPayments>
    <MMA:ForeignCurrencyReserves
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001200"
      unitRef="USD">-86542</MMA:ForeignCurrencyReserves>
    <MMA:ForeignCurrencyReserves
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001201"
      unitRef="USD">-65832</MMA:ForeignCurrencyReserves>
    <MMA:ForeignCurrencyReserves
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact001202"
      unitRef="USD">-29367</MMA:ForeignCurrencyReserves>
    <ifrs-full:DisclosureOfIssuedCapitalExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001204">&lt;p id="xdx_809_eifrs-full--DisclosureOfIssuedCapitalExplanatory_zK2uWri3r9q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
17. &lt;span id="xdx_82F_z8Wgqef40LOc"&gt;Issued capital&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--DisclosureOfDetailedInformationIssuedCapitalExplanatory_zPMktKfppKH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8B7_zoD0Hqlev9Rc" style="display: none"&gt;Schedule
of Issued Capital&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230701__20240630_zn9pNIbOrWV7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220701__20230630_zgDxKzy7dyEa" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210701__20220630_zG8jp2ktb71k" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--OwnersShareCapital_iS_zKCVHf2eUfy" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Owners share capital, opening (1)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,918,750&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,918,750&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,918,750&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--NumberOfShareIssuedAndFullyPaid_iI_zUBhQRo77FOj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issued and fully paid&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,315,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1213"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1214"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IssueOfSharesFromConversionOfConvertibleNotes_iI_zG1RDQWZHy72" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue of shares from the conversion of &lt;br/&gt;the convertible notes (2)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,706,794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1217"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AdvisorOptionsExercisedShares_iI_zGuEBkkcJVe4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Advisor Options exercised (3)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;327,142&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1221"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1222"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--OwnersShareCapital_iE_ztL346Cfxugi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Owners share capital, closing&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,267,686&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,918,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,918,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230701__20240630_zbeUkXxhmbZ2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220701__20230630_zXLDYJL3Y0W4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210701__20220630_zsfkk35OcLkg" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--IssuedCapital_iS_zg69Yz2AiQjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Owners share capital, opening &lt;span id="xdx_F47_zjFCNTsI7pm9"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--IssuedAndFullyPaidValue_iI_zIhtblNtgsr6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issued and fully paid&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,964,825&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1233"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1234"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--PaymentsForShareIssueCosts_iN_di_zxb1M40zgww4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Share issue transaction costs net of tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,174,911&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IssueOfEquityFromConversionOfConvertibleNotes_znczo8SFg057" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issue of shares from the conversion of &lt;br/&gt;the convertible notes &lt;span id="xdx_F4A_z5LnXeVHYML3"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,177,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1242"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--AdvisorOptionsExercisedValue_zr5sXAezuH2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Advisor Options exercised &lt;span id="xdx_F45_zRA9StAPqgO3"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,426,757&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1245"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1246"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--IssuedCapital_iE_zRkkrDEpE2b7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Owners share capital, closing&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;46,779,703&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F09_zUXUyW0TuCdi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zk2zoxoSlYo7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 24, 2024, there was a reverse share split of our issued and outstanding Ordinary
                                            Shares and Ordinary Share equivalents on the basis of four (4) securities for every five
                                            (5) securities held. All issued and outstanding Ordinary Shares and Ordinary Share equivalents
                                            and per share data have been adjusted throughout the financial statements to reflect the
                                            reverse share split for all periods presented.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0B_z4wSMrtrgtMl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zV3MPtwn4PV5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            issue of shares from the conversion of convertible notes reflects and includes the face value
                                            of the note and interest accrued at a fixed rate defined in the agreements, along with the
                                            value of the derivative prior to conversion. This interest figure includes both the accrued
                                            interest rate (contractual and effective) relating to the convertible notes, with the contractual
                                            capitalised interest rate ranging between &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLfugi4sxe0j" title="Contractual capitalised interest rate"&gt;8.5&lt;/span&gt;% to &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_za6aLsj3gMFg" title="Contractual capitalised interest rate"&gt;15&lt;/span&gt;% per annum, and the derivative reflects the effective interest rate being the cost of the relevant conversion discounts to market value at
the conversion date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
17. Issued capital - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F05_zQiZMShGsO8i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_z4piaXKlPuyl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
                                            that &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--AdvisorOptionsExercisedShares_c20230701__20240630_zL4BG4Y3jk25" title="Advisor options exercised, shares"&gt;327,142&lt;/span&gt; Advisor Options fully vested and were exercised into Shares between July 2023
                                            and December 2023 and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--AdvisorOptionsForfeitedShares_iI_c20240630_z7hRoX7U4kUl" title="Advisor options forfeited, shares"&gt;16,193&lt;/span&gt; Advisor Options were forfeited.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A2_zO7XnYCpxdM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Capital
risk management&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s objectives when managing capital is to safeguard its ability to continue as a going concern, so that it can provide returns for shareholders and benefits for other stakeholders and to maintain an optimum capital structure.&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s capital includes Ordinary Share capital and financial liabilities supported by financial assets. There are no externally
imposed capital requirements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company effectively manages capital by assessing the Company&#x2019;s financial risks and adjusting
its capital structure in response to changes in these risks and the market. These responses include the management of debt and share
issuances.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfIssuedCapitalExplanatory>
    <MMA:DisclosureOfDetailedInformationIssuedCapitalExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001206">&lt;p id="xdx_895_ecustom--DisclosureOfDetailedInformationIssuedCapitalExplanatory_zPMktKfppKH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8B7_zoD0Hqlev9Rc" style="display: none"&gt;Schedule
of Issued Capital&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230701__20240630_zn9pNIbOrWV7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220701__20230630_zgDxKzy7dyEa" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210701__20220630_zG8jp2ktb71k" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--OwnersShareCapital_iS_zKCVHf2eUfy" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Owners share capital, opening (1)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,918,750&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,918,750&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,918,750&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--NumberOfShareIssuedAndFullyPaid_iI_zUBhQRo77FOj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issued and fully paid&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,315,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1213"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1214"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IssueOfSharesFromConversionOfConvertibleNotes_iI_zG1RDQWZHy72" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue of shares from the conversion of &lt;br/&gt;the convertible notes (2)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,706,794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1217"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AdvisorOptionsExercisedShares_iI_zGuEBkkcJVe4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Advisor Options exercised (3)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;327,142&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1221"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1222"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--OwnersShareCapital_iE_ztL346Cfxugi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Owners share capital, closing&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,267,686&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,918,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,918,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230701__20240630_zbeUkXxhmbZ2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220701__20230630_zXLDYJL3Y0W4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210701__20220630_zsfkk35OcLkg" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30 June 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--IssuedCapital_iS_zg69Yz2AiQjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Owners share capital, opening &lt;span id="xdx_F47_zjFCNTsI7pm9"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--IssuedAndFullyPaidValue_iI_zIhtblNtgsr6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issued and fully paid&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,964,825&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1233"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1234"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--PaymentsForShareIssueCosts_iN_di_zxb1M40zgww4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Share issue transaction costs net of tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,174,911&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IssueOfEquityFromConversionOfConvertibleNotes_znczo8SFg057" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issue of shares from the conversion of &lt;br/&gt;the convertible notes &lt;span id="xdx_F4A_z5LnXeVHYML3"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,177,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1242"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--AdvisorOptionsExercisedValue_zr5sXAezuH2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Advisor Options exercised &lt;span id="xdx_F45_zRA9StAPqgO3"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,426,757&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1245"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1246"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--IssuedCapital_iE_zRkkrDEpE2b7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Owners share capital, closing&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;46,779,703&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F09_zUXUyW0TuCdi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zk2zoxoSlYo7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 24, 2024, there was a reverse share split of our issued and outstanding Ordinary
                                            Shares and Ordinary Share equivalents on the basis of four (4) securities for every five
                                            (5) securities held. All issued and outstanding Ordinary Shares and Ordinary Share equivalents
                                            and per share data have been adjusted throughout the financial statements to reflect the
                                            reverse share split for all periods presented.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0B_z4wSMrtrgtMl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zV3MPtwn4PV5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            issue of shares from the conversion of convertible notes reflects and includes the face value
                                            of the note and interest accrued at a fixed rate defined in the agreements, along with the
                                            value of the derivative prior to conversion. This interest figure includes both the accrued
                                            interest rate (contractual and effective) relating to the convertible notes, with the contractual
                                            capitalised interest rate ranging between &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLfugi4sxe0j" title="Contractual capitalised interest rate"&gt;8.5&lt;/span&gt;% to &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_za6aLsj3gMFg" title="Contractual capitalised interest rate"&gt;15&lt;/span&gt;% per annum, and the derivative reflects the effective interest rate being the cost of the relevant conversion discounts to market value at
the conversion date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
17. Issued capital - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F05_zQiZMShGsO8i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_z4piaXKlPuyl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
                                            that &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--AdvisorOptionsExercisedShares_c20230701__20240630_zL4BG4Y3jk25" title="Advisor options exercised, shares"&gt;327,142&lt;/span&gt; Advisor Options fully vested and were exercised into Shares between July 2023
                                            and December 2023 and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--AdvisorOptionsForfeitedShares_iI_c20240630_z7hRoX7U4kUl" title="Advisor options forfeited, shares"&gt;16,193&lt;/span&gt; Advisor Options were forfeited.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</MMA:DisclosureOfDetailedInformationIssuedCapitalExplanatory>
    <MMA:OwnersShareCapital
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001208"
      unitRef="Shares">3918750</MMA:OwnersShareCapital>
    <MMA:OwnersShareCapital
      contextRef="AsOf2022-06-30"
      decimals="INF"
      id="Fact001209"
      unitRef="Shares">3918750</MMA:OwnersShareCapital>
    <MMA:OwnersShareCapital
      contextRef="AsOf2021-06-30"
      decimals="INF"
      id="Fact001210"
      unitRef="Shares">3918750</MMA:OwnersShareCapital>
    <MMA:NumberOfShareIssuedAndFullyPaid
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001212"
      unitRef="Shares">1315000</MMA:NumberOfShareIssuedAndFullyPaid>
    <MMA:IssueOfSharesFromConversionOfConvertibleNotes
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001216"
      unitRef="Shares">4706794</MMA:IssueOfSharesFromConversionOfConvertibleNotes>
    <MMA:AdvisorOptionsExercisedShares
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001220"
      unitRef="Shares">327142</MMA:AdvisorOptionsExercisedShares>
    <MMA:OwnersShareCapital
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001224"
      unitRef="Shares">10267686</MMA:OwnersShareCapital>
    <MMA:OwnersShareCapital
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001225"
      unitRef="Shares">3918750</MMA:OwnersShareCapital>
    <MMA:OwnersShareCapital
      contextRef="AsOf2022-06-30"
      decimals="INF"
      id="Fact001226"
      unitRef="Shares">3918750</MMA:OwnersShareCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001228"
      unitRef="USD">3385281</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact001229"
      unitRef="USD">3385281</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2021-06-30"
      decimals="0"
      id="Fact001230"
      unitRef="USD">3385281</ifrs-full:IssuedCapital>
    <MMA:IssuedAndFullyPaidValue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001232"
      unitRef="USD">9964825</MMA:IssuedAndFullyPaidValue>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001236"
      unitRef="USD">1174911</ifrs-full:PaymentsForShareIssueCosts>
    <MMA:IssueOfEquityFromConversionOfConvertibleNotes
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001240"
      unitRef="USD">32177751</MMA:IssueOfEquityFromConversionOfConvertibleNotes>
    <MMA:AdvisorOptionsExercisedValue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001244"
      unitRef="USD">2426757</MMA:AdvisorOptionsExercisedValue>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001248"
      unitRef="USD">46779703</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001249"
      unitRef="USD">3385281</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact001250"
      unitRef="USD">3385281</ifrs-full:IssuedCapital>
    <MMA:ContractualCapitalisedInterestRate
      contextRef="AsOf2024-06-30_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact001254"
      unitRef="Pure">0.085</MMA:ContractualCapitalisedInterestRate>
    <MMA:ContractualCapitalisedInterestRate
      contextRef="AsOf2024-06-30_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact001256"
      unitRef="Pure">0.15</MMA:ContractualCapitalisedInterestRate>
    <MMA:AdvisorOptionsExercisedShares
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001259"
      unitRef="Shares">327142</MMA:AdvisorOptionsExercisedShares>
    <MMA:AdvisorOptionsForfeitedShares
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001261"
      unitRef="Shares">16193</MMA:AdvisorOptionsForfeitedShares>
    <ifrs-full:DisclosureOfCashFlowStatementExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001263">&lt;p id="xdx_807_eifrs-full--DisclosureOfCashFlowStatementExplanatory_zsT9oPvTwQPe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
    18. &lt;span&gt;&lt;span id="xdx_828_zKzNiEnoiVBe"&gt;Notes to statement of cash flows&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_ecustom--DetailedInformationOfNotesToStatementOfCashFlowExplanatory_z3gzsXiaQOCj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8BF_z9B1HJRpJk28" style="display: none"&gt;Schedule
of Statement of Cash Flows&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230701__20240630_zCZgGGC0xLB9" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220701__20230630_zVOfxZpP9ld6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20210701__20220630_zbQ7onH0NoSh" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ProfitLoss_zjN1Qm2AZwja" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Loss after income tax&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(14,408,346&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(20,597,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(11,197,450&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Non-cash flows in operating loss: &lt;br/&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AccruedInterestOnConvertibleNotes_zypX2Jcdkgn4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest on convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,207,497&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,420,225&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,162,646&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_zsUZZzs3Y7Q5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Share-based payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,521,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,365,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,546,983&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ConvertibleNotesIssuedInLieuOfPaymentForServices_zLCLJwjBx6r9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible notes issued in lieu of payment for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1279"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;624,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1281"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DepreciationExpense_zU9Y8aFwHzJi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortisation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;520,697&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;360,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;260,651&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--FairValueMovementRecognisedInProfitOrLoss_zL3EcxUjLw5e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fair value movement of derivatives&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,400,685&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,870,729&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,751,564&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Changes in assets and liabilities: &lt;br/&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_zhVXlvxLV4Gc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Decrease in trade and other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;372,390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;506,737&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;130,933&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--AdjustmentsForDecreaseIncreaseInOtherAssets_ze3Sk78lgjqb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;(Increase)/Decrease in other assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(189,621&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,015,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_zdy0c54ElOV4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Increase/(decrease) in trade and other payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,719&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(153,292&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;993,662&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AdjustmentsForIncreaseDecreaseInNetDeferredRevenue_zcQro3SQ9jnd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Decrease in net deferred revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(174,290&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(121,453&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(339,222&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AdjustmentsForIncreaseDecreaseInProvisionForRefund_zplmHTrvaQX6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;(Decrease)/increase in provision for refund&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(70,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_znZg4nO42Jeh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Increase in employee entitlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;133,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;102,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CashFlowsFromUsedInOperatingActivities_iT_zC6BozSyb4Hk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Net cash used in operating activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(9,386,196&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,555,868&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,055,185&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zgILBGjOaYUa" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfCashFlowStatementExplanatory>
    <MMA:DetailedInformationOfNotesToStatementOfCashFlowExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001265">&lt;p id="xdx_893_ecustom--DetailedInformationOfNotesToStatementOfCashFlowExplanatory_z3gzsXiaQOCj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;span id="xdx_8BF_z9B1HJRpJk28" style="display: none"&gt;Schedule
of Statement of Cash Flows&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230701__20240630_zCZgGGC0xLB9" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220701__20230630_zVOfxZpP9ld6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20210701__20220630_zbQ7onH0NoSh" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ProfitLoss_zjN1Qm2AZwja" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Loss after income tax&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(14,408,346&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(20,597,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(11,197,450&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Non-cash flows in operating loss: &lt;br/&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AccruedInterestOnConvertibleNotes_zypX2Jcdkgn4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest on convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,207,497&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,420,225&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,162,646&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_zsUZZzs3Y7Q5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Share-based payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,521,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,365,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,546,983&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ConvertibleNotesIssuedInLieuOfPaymentForServices_zLCLJwjBx6r9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible notes issued in lieu of payment for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1279"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;624,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1281"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DepreciationExpense_zU9Y8aFwHzJi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortisation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;520,697&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;360,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;260,651&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--FairValueMovementRecognisedInProfitOrLoss_zL3EcxUjLw5e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fair value movement of derivatives&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,400,685&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,870,729&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,751,564&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Changes in assets and liabilities: &lt;br/&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_zhVXlvxLV4Gc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Decrease in trade and other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;372,390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;506,737&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;130,933&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--AdjustmentsForDecreaseIncreaseInOtherAssets_ze3Sk78lgjqb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;(Increase)/Decrease in other assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(189,621&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,015,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_zdy0c54ElOV4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Increase/(decrease) in trade and other payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,719&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(153,292&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;993,662&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AdjustmentsForIncreaseDecreaseInNetDeferredRevenue_zcQro3SQ9jnd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Decrease in net deferred revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(174,290&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(121,453&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(339,222&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AdjustmentsForIncreaseDecreaseInProvisionForRefund_zplmHTrvaQX6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;(Decrease)/increase in provision for refund&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(70,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_znZg4nO42Jeh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Increase in employee entitlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;133,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;102,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CashFlowsFromUsedInOperatingActivities_iT_zC6BozSyb4Hk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Net cash used in operating activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(9,386,196&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,555,868&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,055,185&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</MMA:DetailedInformationOfNotesToStatementOfCashFlowExplanatory>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001267"
      unitRef="USD">-14408346</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001268"
      unitRef="USD">-20597436</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001269"
      unitRef="USD">-11197450</ifrs-full:ProfitLoss>
    <MMA:AccruedInterestOnConvertibleNotes
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001271"
      unitRef="USD">3207497</MMA:AccruedInterestOnConvertibleNotes>
    <MMA:AccruedInterestOnConvertibleNotes
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001272"
      unitRef="USD">4420225</MMA:AccruedInterestOnConvertibleNotes>
    <MMA:AccruedInterestOnConvertibleNotes
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001273"
      unitRef="USD">2162646</MMA:AccruedInterestOnConvertibleNotes>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001275"
      unitRef="USD">4521598</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001276"
      unitRef="USD">2365384</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001277"
      unitRef="USD">1546983</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <MMA:ConvertibleNotesIssuedInLieuOfPaymentForServices
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001280"
      unitRef="USD">624426</MMA:ConvertibleNotesIssuedInLieuOfPaymentForServices>
    <ifrs-full:DepreciationExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001283"
      unitRef="USD">520697</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001284"
      unitRef="USD">360021</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001285"
      unitRef="USD">260651</ifrs-full:DepreciationExpense>
    <MMA:FairValueMovementRecognisedInProfitOrLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001287"
      unitRef="USD">-3400685</MMA:FairValueMovementRecognisedInProfitOrLoss>
    <MMA:FairValueMovementRecognisedInProfitOrLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001288"
      unitRef="USD">6870729</MMA:FairValueMovementRecognisedInProfitOrLoss>
    <MMA:FairValueMovementRecognisedInProfitOrLoss
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001289"
      unitRef="USD">-2751564</MMA:FairValueMovementRecognisedInProfitOrLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001291"
      unitRef="USD">372390</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001292"
      unitRef="USD">506737</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001293"
      unitRef="USD">130933</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001295"
      unitRef="USD">-189621</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001296"
      unitRef="USD">33091</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001297"
      unitRef="USD">1015343</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001299"
      unitRef="USD">100719</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001300"
      unitRef="USD">-153292</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001301"
      unitRef="USD">993662</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <MMA:AdjustmentsForIncreaseDecreaseInNetDeferredRevenue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001303"
      unitRef="USD">-174290</MMA:AdjustmentsForIncreaseDecreaseInNetDeferredRevenue>
    <MMA:AdjustmentsForIncreaseDecreaseInNetDeferredRevenue
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001304"
      unitRef="USD">-121453</MMA:AdjustmentsForIncreaseDecreaseInNetDeferredRevenue>
    <MMA:AdjustmentsForIncreaseDecreaseInNetDeferredRevenue
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001305"
      unitRef="USD">-339222</MMA:AdjustmentsForIncreaseDecreaseInNetDeferredRevenue>
    <MMA:AdjustmentsForIncreaseDecreaseInProvisionForRefund
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001307"
      unitRef="USD">-70000</MMA:AdjustmentsForIncreaseDecreaseInProvisionForRefund>
    <MMA:AdjustmentsForIncreaseDecreaseInProvisionForRefund
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001308"
      unitRef="USD">-25000</MMA:AdjustmentsForIncreaseDecreaseInProvisionForRefund>
    <MMA:AdjustmentsForIncreaseDecreaseInProvisionForRefund
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001309"
      unitRef="USD">20000</MMA:AdjustmentsForIncreaseDecreaseInProvisionForRefund>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001311"
      unitRef="USD">133845</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001312"
      unitRef="USD">160700</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001313"
      unitRef="USD">102833</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001315"
      unitRef="USD">-9386196</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001316"
      unitRef="USD">-5555868</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001317"
      unitRef="USD">-8055185</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001319">&lt;p id="xdx_807_eifrs-full--DisclosureOfRelatedPartyExplanatory_zl62GiCpgfic" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
19. &lt;span id="xdx_82D_z2h9PnTIZ4Li"&gt;Related parties transactions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;(a)
Directors&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following persons held office as Directors of the Company during the years reported:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nicholas
                                            Langton&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Hugh
                                            Williams&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vaughn
                                            Taylor&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jonathan
                                            Hart&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(b)
Remuneration of Key Management Personnels&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Key management personnel remuneration:&lt;b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eifrs-full--DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_zlyhUauOV7od" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B1_ztW2AXnKZ5hk" style="display: none"&gt;Schedule
of Key Management Personnel Remuneration&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230701__20240630_z8Ufl7TIa9M8" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220701__20230630_zGjgdSXwEsl5" style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210701__20220630_z50Pej9t8m4g" style="font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_maKMPCzfQ1_z264cbSzJCg3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Short term benefits&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,031,194&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;657,879&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;671,709&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_maKMPCzfQ1_z7sfxupR6eTc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Post employment benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,730&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,191&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;43,542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationOtherLongtermBenefits_maKMPCzfQ1_zywIFKfYPxtj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Long term benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,474&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1333"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_maKMPCzfQ1_z7Wyf9d7WGxj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Share Based payments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,808,863&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,065,554&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;897,586&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensation_iT_mtKMPCzfQ1_zf2g8IvGk3Hc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,919,261&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,775,516&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,612,837&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p id="xdx_8A8_zjfv98xoiAk3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(c)
Related Party Transactions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares
Held by Key Management Personnel:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_gL3DOTBRPE-JAYXU_zCIemTAmLuvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zxAlHNVdoD31" style="display: none"&gt;Schedule
of Shares Held by Key Management Personnel&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zRpO73yah3pg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zbnpnm9YoWB2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zN4pOFKcU7x4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NumberOfSharesOutstanding_iS_z6l8k3OwFZy4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Opening Balance&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,149,362&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,786,093&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,955,616&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IssuedSharesHeldByKeyManagementPersonnel_zumMm30xbNVh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;296,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1352"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;477,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RepurchasedSharesHeldByKeyManagementPersonnel_ztRpphVMuAx3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Repurchased&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1355"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1356"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ResignationOfKeyManagementPersonnelShares_zR9740m7UdG8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Resignation of Key Management Personnel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1359"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(530,609&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1361"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ReverseShareSplitSharesHeldByKeyManagementPersonnel_z68QYMVcqyo4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Reverse Share Split&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1363"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(106,122&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(446,523&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--NumberOfSharesOutstanding_iE_zocCRjlKg23d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Closing Balance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,445,897&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,149,362&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,786,093&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_z91aLLHt8lzl" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;b&gt;Note 19. Related parties transactions - continued&lt;/b&gt; &lt;br/&gt;&#160; &lt;br/&gt;&lt;b&gt;Options Held by Key Management Personnel:&lt;/b&gt;&lt;/p&gt;

&lt;div id="xdx_C01_gL3DOTBRPE-JAYXU_zMLnDwIEtkV4"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_zf2re8yb9Pk9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Shares Held by Key Management Personnel (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_z16uc5B0wdi4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_zPEoY8showuh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_zRAtYVHqkyIj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Option&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zNJcdu9WjZP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Opening Balance&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;654,364&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;515,850&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1373"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--IssuedOptionsHeldByKeyManagementPersonnel_zItZ45f2rf3d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;342,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;279,221&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;644,813&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ExpiredOptionsHeldByKeyManagementPersonnel_z58RYCageMSb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(106,078&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1381"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ExercisedOptionsHeldByKeyManagementPersonnel_zMGYypES4Ac5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,086&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1384"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1385"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ReverseShareSplitOptionsHeldByKeyManagementPersonnel_zJN8YGPKezs2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Reverse share split&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1387"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(34,629&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(128,963&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_uShares_zEbdpHm4JAd8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Closing Balance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;791,278&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;654,364&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;515,850&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;/div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span id="xdx_C0B_gL3DOTBRPE-JAYXU_zL91IvndAerc"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Related Party Transaction by Key Management Personnel&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the fiscal year ending June 30, 2024, Mr. Langton, through Snowflower Holdings Pty Ltd as trustee for the Snowflower Family Trust Account, was issued &lt;span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrLangtonMember__srt--ConsolidatedEntitiesAxis__custom--SnowflowerHoldingsPtyLtdMember_z3efiHHc5Ee8" title="Shares issued"&gt;172,000&lt;/span&gt; share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. &lt;span id="xdx_90B_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrLangtonMember__srt--ConsolidatedEntitiesAxis__custom--SnowflowerHoldingsPtyLtdMember_zPIQJVk2PnUb" title="Percentage vest and exercisable"&gt;50&lt;/span&gt;% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the fiscal year ending June 30, 2024, Mr. Williams, through Champ 7 Pty Ltd as trustee for the Williams Family Trust Account, was issued &lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrWilliamsMember__srt--ConsolidatedEntitiesAxis__custom--ChampSevenPtyLtdMember_zMcxa8J8xqm5" title="Shares issued"&gt;14,400&lt;/span&gt; share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. &lt;span id="xdx_904_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrWilliamsMember__srt--ConsolidatedEntitiesAxis__custom--ChampSevenPtyLtdMember_zy9BhnJG88V1" title="Percentage vest and exercisable"&gt;50&lt;/span&gt;% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the fiscal year ending June 30, 2024, Mr. Taylor, through Nalaroo Holdings Pty Ltd as trustee for the Lavoipierre Taylor Fam Trust Account, was issued &lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrTaylorMember__srt--ConsolidatedEntitiesAxis__custom--NalarooHoldingsPtyLtdMember_z2o4W3FUAdnc" title="Shares issued"&gt;73,600&lt;/span&gt; share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. &lt;span id="xdx_906_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrTaylorMember__srt--ConsolidatedEntitiesAxis__custom--NalarooHoldingsPtyLtdMember_z6NwqkrPWWha" title="Percentage vest and exercisable"&gt;50&lt;/span&gt;% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the fiscal year ending June 30, 2024, Mr. Hart, as trustee for the J Hart Family Trust Account, was issued &lt;span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--CounterpartyNameAxis__custom--MrHartMember__srt--ConsolidatedEntitiesAxis__custom--JHartFamilyTrustAccountMember_zf1QpC1AidL" title="Shares issued"&gt;47,600&lt;/span&gt; share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. &lt;span id="xdx_909_ecustom--PercentageOfOrdinarySharesUnderVestAndExercisable_iI_pid_dp_uPure_c20240630__srt--CounterpartyNameAxis__custom--MrHartMember__srt--ConsolidatedEntitiesAxis__custom--JHartFamilyTrustAccountMember_z8nNzM1zcBH" title="Percentage vest and exercisable"&gt;50&lt;/span&gt;% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
19. Related parties transactions - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the fiscal year ending June 30, 2024, under Mr. Java&#x2019;s employment agreement, Mr. Java was paid a short-term incentive of A$&lt;span id="xdx_90E_eifrs-full--ShorttermEmployeeBenefitsExpense_c20230701__20240630__ifrs-full--TypesOfContractsAxis__custom--EmploymentAgreementMember_zqWMt2fdddG5" title="Short term incentive"&gt;98,589&lt;/span&gt;. Mr. Java, through 3213 Ventures Pty Ltd as trustee for the Java Holdings Trust, was issued &lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_c20240630__ifrs-full--TypesOfContractsAxis__custom--EmployeementAgreementMember_zEdJosbXeRck" title="Number of shares issued"&gt;34,400&lt;/span&gt; share rights (subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. &lt;span id="xdx_90A_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfContractsAxis__custom--EmployeementAgreementMember_z1Dyd7BTtm6a" title="Share percent rate"&gt;50&lt;/span&gt;% of the share rights will vest and become exercisable on October 1, 2025 and the balance of the share rights will vest and become exercisable on October 1, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Other
related parties:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tanya Langton, our Head of Global Events and Logistics and the spouse of Mr. Langton, was issued &lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_c20240630__srt--TitleOfIndividualAxis__custom--Mr.LangtonMember_zAdSyQ260zVk" title="Number of shares issued"&gt;6,000&lt;/span&gt; share rights
(subject to vesting conditions) which may be converted into Ordinary Shares under the EIP. &lt;span id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_dp_uPure_c20230701__20240630__ifrs-full--CounterpartiesAxis__custom--Mr.LangtonMember_zmGyEy77xI04" title="Share percent rate"&gt;50&lt;/span&gt;% of the share rights will vest and become
exercisable on October 1, 2025 and the balance of the &lt;span id="xdx_906_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_dp_uPure_c20251001__20251002__ifrs-full--CounterpartiesAxis__custom--Mr.LangtonMember_zXlDlkFMwEvd" title="Share percent rate"&gt;50&lt;/span&gt;% of the share rights will vest and become exercisable on October 1, 2026. &lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
than as disclosed, the Company did not enter into any transactions or loans with any:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;enterprises
                                            that directly or indirectly, through one or more intermediaries, control, are controlled
                                            by or are under common control with us;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;associates;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;individuals
                                            owning, directly or indirectly, an interest in our voting power that gives them significant
                                            influence over us, and close members of any such individual&#x2019;s family;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iv)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;key
                                            management personnel and close members of such individuals&#x2019; families; or&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(v)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;enterprises
                                            in which a substantial shareholder interest in our voting power is owned, directly or indirectly,
                                            by any person described in (iii) or (iv) or over which such person is able to exercise significant
                                            influence.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)
Parent Entity&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
individual financial statements of the Parent Entity show the following aggregate amounts:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Results
of the parent entity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eifrs-full--DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable_zoM2Bmqxj5o2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B0_zjctP2YwIvI3" style="display: none"&gt;Schedule
of Financial Statement of the Parent Entity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zSXxUIAl0Cck" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zjM5jYv77izc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zjQKGBBDYFZ6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--ProfitLoss_maCIzNLL_zDn1hZgYZyye" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Loss for the period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(14,029,605&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(20,053,426&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(10,667,136&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--OtherComprehensiveIncome_maCIzNLL_zMeO8C25X5x7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other comprehensive loss for the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1429"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1430"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1431"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--ComprehensiveIncome_iT_mtCIzNLL_zwEW5ZRdOqhj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total comprehensive loss for the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(14,029,605&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(20,053,426&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(10,667,136&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zWiOzrj7VAKk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--ParentMember_zcBJeHqVoGHc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Financial position of the parent entity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2023&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--AssetsAbstract_iB_zO8hUtgYDft8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--CurrentAssets_iI_maAz7FR_zpofYFRmmuw8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;5,309,505&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;7,307,155&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--NoncurrentAssets_iI_maAz7FR_zomskbMru34b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Non-current assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,687,347&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,120,872&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--Assets_iTI_mtAz7FR_maNALzqK8_z1JShNb2Qfx9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total Assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,996,852&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,428,027&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--LiabilitiesAbstract_iB_zi5mrwglFOe3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--CurrentLiabilities_iI_maLzEC6_zBiiu21DG2f7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,577,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,018,760&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--NoncurrentLiabilities_iI_maLzEC6_z9EyNWr0JILf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Non-current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;186,344&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,346,332&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--Liabilities_iTI_mtLzEC6_msNALzqK8_zmxJgWPBkxr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,763,384&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;38,365,092&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NetAssetsLiabilities_iTI_mtNALzqK8_zjlDFZKoVrjb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Net Assets/Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,233,468&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(29,937,065&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--EquityAbstract_iB_znTnlfsUqlW9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Equity&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ContributedEquity_iI_msEzyRy_zUQu06RTKUp7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contributed equity&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,779,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,385,281&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--OtherReserves_iI_maEzyRy_zVvfq1xdVIg1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Reserves&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,476,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,912,367&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--RetainedEarnings_iI_maEzyRy_z4RIiPyAcVGc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accumulated losses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(51,022,338&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(37,234,713&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--Equity_iTI_mtEzyRy_zgjPtwCoELr7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,233,468&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(29,937,065&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_zt2ZAqJHOzEa" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;There were no material contingent assets and liabilities in the Parent Entity at June 30, 2024 (nil &#x2013; June 30, 2023).&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
19. Related parties transactions - continued&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(e)
Subsidiaries&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s subsidiaries at June 30, 2024 are set out below. Unless otherwise stated, they have share capital consisting solely of
Ordinary Shares that are held directly by the company, and the proportion of ownership interests held equals the voting rights held by
the company. The country of incorporation or registration is also their principal place of business.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesTable_zfQLFJExX3rc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zQpISVlRSD9" style="display: none"&gt;Schedule
of Country Incorporation Principal Place of Business&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230701__20240630_zKincIqhWO09" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220701__20230630_zy4RLrW8z9Zh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span&gt;Name of entity&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span&gt;Place of business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ownership interest held&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 31%; text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorLLCMember_zjhQuTH3faod"&gt;Wimp 2 Warrior LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 31%; text-align: left"&gt;&lt;span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaCountryMember_z1mKcAau5sr7"&gt;United States of America&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_dp_uPure_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorLLCMember_z4G0DA1wbnG1" style="width: 14%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorLLCMember_z0THeK77642k" style="width: 14%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_906_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorProductionsPtyLtdMember_fKg_____zFLc9ciUo9y3"&gt;Wimp 2 Warrior Productions Pty Ltd&lt;/span&gt; *&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--AustraliaCountryMember_fKg_____zj8Pdp6U7Ttf"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorProductionsPtyLtdMember_fKg_____zn2k5Omfhzxa" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorProductionsPtyLtdMember_fKg_____zuvKQUrNqwZ4" style="text-align: right"&gt;95&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorDigitalPtyLtdMember_fKg_____z8iNRJ5RwCa6"&gt;Wimp 2 Warrior Digital Pty Ltd&lt;/span&gt; *&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_900_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--AustraliaCountryOneMember_fKg_____zmR4iEqtea1b"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorDigitalPtyLtdMember_fKg_____ziACokCJrrZg" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorDigitalPtyLtdMember_fKg_____z13MQWplYtMg" style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_908_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorIrelandLimitedMember_z0VxsEIvAEih"&gt;Wimp 2 Warrior (Ireland) Limited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--IrelandCountryMember_zdUFTcIXkPy4"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorIrelandLimitedMember_zztHnkEkO83k" style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--Wimp2WarriorIrelandLimitedMember_z8AcFDgp26y7" style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span id="xdx_905_eifrs-full--NameOfParentEntity_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--HypeCoMember_zMZL9jajf4Na"&gt;Hype.Co&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusiness_c20230701__20240630__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesOfAmericaCountryOneMember_zURtWeNeIXP4"&gt;United States of America&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20230701__20240630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--HypeCoMember_zjbbSeN7yLEl" style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20220701__20230630__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--HypeCoMember_zdu1MdFin8h6" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0E_zm1TLYJpUC48" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zHV6CTquVWrf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Entities deregistered
in the period to June 30, 2024.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A9_zoQJgkpoqYFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001321">&lt;p id="xdx_89C_eifrs-full--DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_zlyhUauOV7od" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B1_ztW2AXnKZ5hk" style="display: none"&gt;Schedule
of Key Management Personnel Remuneration&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230701__20240630_z8Ufl7TIa9M8" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220701__20230630_zGjgdSXwEsl5" style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210701__20220630_z50Pej9t8m4g" style="font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_maKMPCzfQ1_z264cbSzJCg3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Short term benefits&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,031,194&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;657,879&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;671,709&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_maKMPCzfQ1_z7sfxupR6eTc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Post employment benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,730&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,191&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;43,542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationOtherLongtermBenefits_maKMPCzfQ1_zywIFKfYPxtj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Long term benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,474&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1333"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_maKMPCzfQ1_z7Wyf9d7WGxj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Share Based payments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,808,863&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,065,554&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;897,586&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--KeyManagementPersonnelCompensation_iT_mtKMPCzfQ1_zf2g8IvGk3Hc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,919,261&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,775,516&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,612,837&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



</ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001323"
      unitRef="USD">1031194</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001324"
      unitRef="USD">657879</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001325"
      unitRef="USD">671709</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001327"
      unitRef="USD">62730</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001328"
      unitRef="USD">33191</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001329"
      unitRef="USD">43542</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001331"
      unitRef="USD">16474</ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001332"
      unitRef="USD">18892</ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001335"
      unitRef="USD">1808863</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001336"
      unitRef="USD">1065554</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001337"
      unitRef="USD">897586</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001339"
      unitRef="USD">2919261</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001340"
      unitRef="USD">1775516</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001341"
      unitRef="USD">1612837</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001345">&lt;p id="xdx_892_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_gL3DOTBRPE-JAYXU_zCIemTAmLuvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zxAlHNVdoD31" style="display: none"&gt;Schedule
of Shares Held by Key Management Personnel&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zRpO73yah3pg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zbnpnm9YoWB2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SharesHeldByKeyManagementPersonnelMember_zN4pOFKcU7x4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NumberOfSharesOutstanding_iS_z6l8k3OwFZy4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Opening Balance&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,149,362&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,786,093&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,955,616&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IssuedSharesHeldByKeyManagementPersonnel_zumMm30xbNVh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;296,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1352"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;477,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RepurchasedSharesHeldByKeyManagementPersonnel_ztRpphVMuAx3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Repurchased&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1355"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1356"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ResignationOfKeyManagementPersonnelShares_zR9740m7UdG8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Resignation of Key Management Personnel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1359"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(530,609&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1361"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ReverseShareSplitSharesHeldByKeyManagementPersonnel_z68QYMVcqyo4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Reverse Share Split&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1363"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(106,122&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(446,523&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--NumberOfSharesOutstanding_iE_zocCRjlKg23d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Closing Balance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,445,897&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,149,362&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,786,093&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_zf2re8yb9Pk9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Shares Held by Key Management Personnel (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_z16uc5B0wdi4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220701__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_zPEoY8showuh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210701__20220630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OptionHeldByKeyManagementPersonnelMember_zRAtYVHqkyIj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Option&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zNJcdu9WjZP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Opening Balance&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;654,364&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;515,850&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1373"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--IssuedOptionsHeldByKeyManagementPersonnel_zItZ45f2rf3d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;342,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;279,221&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;644,813&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ExpiredOptionsHeldByKeyManagementPersonnel_z58RYCageMSb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(106,078&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1381"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ExercisedOptionsHeldByKeyManagementPersonnel_zMGYypES4Ac5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,086&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1384"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1385"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ReverseShareSplitOptionsHeldByKeyManagementPersonnel_zJN8YGPKezs2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Reverse share split&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1387"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(34,629&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(128,963&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_uShares_zEbdpHm4JAd8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Closing Balance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;791,278&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;654,364&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;515,850&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;</ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2023-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001347"
      unitRef="Shares">1149362</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2022-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001348"
      unitRef="Shares">1786093</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2021-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001349"
      unitRef="Shares">2955616</ifrs-full:NumberOfSharesOutstanding>
    <MMA:IssuedSharesHeldByKeyManagementPersonnel
      contextRef="From2023-07-012024-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001351"
      unitRef="Shares">296535</MMA:IssuedSharesHeldByKeyManagementPersonnel>
    <MMA:IssuedSharesHeldByKeyManagementPersonnel
      contextRef="From2021-07-012022-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001353"
      unitRef="Shares">477000</MMA:IssuedSharesHeldByKeyManagementPersonnel>
    <MMA:RepurchasedSharesHeldByKeyManagementPersonnel
      contextRef="From2021-07-012022-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001357"
      unitRef="Shares">-1200000</MMA:RepurchasedSharesHeldByKeyManagementPersonnel>
    <MMA:ResignationOfKeyManagementPersonnelShares
      contextRef="From2022-07-012023-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001360"
      unitRef="Shares">-530609</MMA:ResignationOfKeyManagementPersonnelShares>
    <MMA:ReverseShareSplitSharesHeldByKeyManagementPersonnel
      contextRef="From2022-07-012023-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001364"
      unitRef="Shares">-106122</MMA:ReverseShareSplitSharesHeldByKeyManagementPersonnel>
    <MMA:ReverseShareSplitSharesHeldByKeyManagementPersonnel
      contextRef="From2021-07-012022-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001365"
      unitRef="Shares">-446523</MMA:ReverseShareSplitSharesHeldByKeyManagementPersonnel>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001367"
      unitRef="Shares">1445897</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2023-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001368"
      unitRef="Shares">1149362</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2022-06-30_custom_SharesHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001369"
      unitRef="Shares">1786093</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001371"
      unitRef="Shares">654364</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001372"
      unitRef="Shares">515850</ifrs-full:NumberOfOutstandingShareOptions>
    <MMA:IssuedOptionsHeldByKeyManagementPersonnel
      contextRef="From2023-07-012024-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001375"
      unitRef="Shares">342000</MMA:IssuedOptionsHeldByKeyManagementPersonnel>
    <MMA:IssuedOptionsHeldByKeyManagementPersonnel
      contextRef="From2022-07-012023-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001376"
      unitRef="Shares">279221</MMA:IssuedOptionsHeldByKeyManagementPersonnel>
    <MMA:IssuedOptionsHeldByKeyManagementPersonnel
      contextRef="From2021-07-012022-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001377"
      unitRef="Shares">644813</MMA:IssuedOptionsHeldByKeyManagementPersonnel>
    <MMA:ExpiredOptionsHeldByKeyManagementPersonnel
      contextRef="From2022-07-012023-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001380"
      unitRef="Shares">-106078</MMA:ExpiredOptionsHeldByKeyManagementPersonnel>
    <MMA:ExercisedOptionsHeldByKeyManagementPersonnel
      contextRef="From2023-07-012024-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001383"
      unitRef="Shares">-205086</MMA:ExercisedOptionsHeldByKeyManagementPersonnel>
    <MMA:ReverseShareSplitOptionsHeldByKeyManagementPersonnel
      contextRef="From2022-07-012023-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001388"
      unitRef="Shares">-34629</MMA:ReverseShareSplitOptionsHeldByKeyManagementPersonnel>
    <MMA:ReverseShareSplitOptionsHeldByKeyManagementPersonnel
      contextRef="From2021-07-012022-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001389"
      unitRef="Shares">-128963</MMA:ReverseShareSplitOptionsHeldByKeyManagementPersonnel>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001391"
      unitRef="Shares">791278</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001392"
      unitRef="Shares">654364</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_custom_OptionHeldByKeyManagementPersonnelMember"
      decimals="INF"
      id="Fact001393"
      unitRef="Shares">515850</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-30_custom_MrLangtonMember_custom_SnowflowerHoldingsPtyLtdMember"
      decimals="INF"
      id="Fact001395"
      unitRef="Shares">172000</ifrs-full:NumberOfSharesIssued>
    <MMA:PercentageOfOrdinarySharesUnderVestAndExercisable
      contextRef="AsOf2024-06-30_custom_MrLangtonMember_custom_SnowflowerHoldingsPtyLtdMember"
      decimals="INF"
      id="Fact001397"
      unitRef="Pure">0.50</MMA:PercentageOfOrdinarySharesUnderVestAndExercisable>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-30_custom_MrWilliamsMember_custom_ChampSevenPtyLtdMember"
      decimals="INF"
      id="Fact001399"
      unitRef="Shares">14400</ifrs-full:NumberOfSharesIssued>
    <MMA:PercentageOfOrdinarySharesUnderVestAndExercisable
      contextRef="AsOf2024-06-30_custom_MrWilliamsMember_custom_ChampSevenPtyLtdMember"
      decimals="INF"
      id="Fact001401"
      unitRef="Pure">0.50</MMA:PercentageOfOrdinarySharesUnderVestAndExercisable>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-30_custom_MrTaylorMember_custom_NalarooHoldingsPtyLtdMember"
      decimals="INF"
      id="Fact001403"
      unitRef="Shares">73600</ifrs-full:NumberOfSharesIssued>
    <MMA:PercentageOfOrdinarySharesUnderVestAndExercisable
      contextRef="AsOf2024-06-30_custom_MrTaylorMember_custom_NalarooHoldingsPtyLtdMember"
      decimals="INF"
      id="Fact001405"
      unitRef="Pure">0.50</MMA:PercentageOfOrdinarySharesUnderVestAndExercisable>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-30_custom_MrHartMember_custom_JHartFamilyTrustAccountMember"
      decimals="INF"
      id="Fact001407"
      unitRef="Shares">47600</ifrs-full:NumberOfSharesIssued>
    <MMA:PercentageOfOrdinarySharesUnderVestAndExercisable
      contextRef="AsOf2024-06-30_custom_MrHartMember_custom_JHartFamilyTrustAccountMember"
      decimals="INF"
      id="Fact001409"
      unitRef="Pure">0.50</MMA:PercentageOfOrdinarySharesUnderVestAndExercisable>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="From2023-07-012024-06-30_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact001411"
      unitRef="USD">98589</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-30_custom_EmployeementAgreementMember"
      decimals="INF"
      id="Fact001413"
      unitRef="Shares">34400</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_EmployeementAgreementMember"
      decimals="INF"
      id="Fact001415"
      unitRef="Pure">0.50</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-30_custom_Mr.LangtonMember"
      decimals="INF"
      id="Fact001417"
      unitRef="Shares">6000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_Mr.LangtonMember"
      decimals="INF"
      id="Fact001419"
      unitRef="Pure">0.50</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="From2025-10-012025-10-02_custom_Mr.LangtonMember"
      decimals="INF"
      id="Fact001421"
      unitRef="Pure">0.50</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-012024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001425"
      unitRef="USD">-14029605</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-07-012023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001426"
      unitRef="USD">-20053426</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-07-012022-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001427"
      unitRef="USD">-10667136</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-07-012024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001433"
      unitRef="USD">-14029605</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-07-012023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001434"
      unitRef="USD">-20053426</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-07-012022-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001435"
      unitRef="USD">-10667136</ifrs-full:ComprehensiveIncome>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001440"
      unitRef="USD">5309505</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001441"
      unitRef="USD">7307155</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001443"
      unitRef="USD">1687347</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001444"
      unitRef="USD">1120872</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001446"
      unitRef="USD">6996852</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001447"
      unitRef="USD">8428027</ifrs-full:Assets>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001452"
      unitRef="USD">2577040</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001453"
      unitRef="USD">28018760</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001455"
      unitRef="USD">186344</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001456"
      unitRef="USD">10346332</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001458"
      unitRef="USD">2763384</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001459"
      unitRef="USD">38365092</ifrs-full:Liabilities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001461"
      unitRef="USD">4233468</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001462"
      unitRef="USD">-29937065</ifrs-full:NetAssetsLiabilities>
    <MMA:ContributedEquity
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001467"
      unitRef="USD">46779703</MMA:ContributedEquity>
    <MMA:ContributedEquity
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001468"
      unitRef="USD">3385281</MMA:ContributedEquity>
    <ifrs-full:OtherReserves
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001470"
      unitRef="USD">8476103</ifrs-full:OtherReserves>
    <ifrs-full:OtherReserves
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001471"
      unitRef="USD">3912367</ifrs-full:OtherReserves>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001473"
      unitRef="USD">-51022338</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001474"
      unitRef="USD">-37234713</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001476"
      unitRef="USD">4233468</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-30_ifrs-full_ParentMember"
      decimals="0"
      id="Fact001477"
      unitRef="USD">-29937065</ifrs-full:Equity>
    <ifrs-full:NameOfParentEntity
      contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorLLCMember"
      id="Fact001480">Wimp 2 Warrior LLC</ifrs-full:NameOfParentEntity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="From2023-07-012024-06-30_custom_UnitedStatesOfAmericaCountryMember"
      id="Fact001481">United States of America</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorLLCMember"
      decimals="INF"
      id="Fact001482"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-07-012023-06-30_custom_Wimp2WarriorLLCMember"
      decimals="INF"
      id="Fact001483"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfParentEntity
      contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorProductionsPtyLtdMember"
      id="Fact001484">Wimp 2 Warrior Productions Pty Ltd</ifrs-full:NameOfParentEntity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="From2023-07-012024-06-30_custom_AustraliaCountryMember"
      id="Fact001485">Australia</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorProductionsPtyLtdMember"
      decimals="INF"
      id="Fact001486"
      unitRef="Pure">0</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-07-012023-06-30_custom_Wimp2WarriorProductionsPtyLtdMember"
      decimals="INF"
      id="Fact001487"
      unitRef="Pure">0.95</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfParentEntity
      contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorDigitalPtyLtdMember"
      id="Fact001488">Wimp 2 Warrior Digital Pty Ltd</ifrs-full:NameOfParentEntity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="From2023-07-012024-06-30_custom_AustraliaCountryOneMember"
      id="Fact001489">Australia</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorDigitalPtyLtdMember"
      decimals="INF"
      id="Fact001490"
      unitRef="Pure">0</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-07-012023-06-30_custom_Wimp2WarriorDigitalPtyLtdMember"
      decimals="INF"
      id="Fact001491"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfParentEntity
      contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorIrelandLimitedMember"
      id="Fact001492">Wimp 2 Warrior (Ireland) Limited</ifrs-full:NameOfParentEntity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="From2023-07-012024-06-30_custom_IrelandCountryMember"
      id="Fact001493">Ireland</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-07-012024-06-30_custom_Wimp2WarriorIrelandLimitedMember"
      decimals="INF"
      id="Fact001494"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-07-012023-06-30_custom_Wimp2WarriorIrelandLimitedMember"
      decimals="INF"
      id="Fact001495"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfParentEntity
      contextRef="From2023-07-012024-06-30_custom_HypeCoMember"
      id="Fact001496">Hype.Co</ifrs-full:NameOfParentEntity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="From2023-07-012024-06-30_custom_UnitedStatesOfAmericaCountryOneMember"
      id="Fact001497">United States of America</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-07-012024-06-30_custom_HypeCoMember"
      decimals="INF"
      id="Fact001498"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-07-012023-06-30_custom_HypeCoMember"
      decimals="INF"
      id="Fact001499"
      unitRef="Pure">0</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:DisclosureOfLeasesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001502">&lt;p id="xdx_809_eifrs-full--DisclosureOfLeasesExplanatory_zNkExyc59oRi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
20. &lt;span id="xdx_824_zZoHeZqsNnu2"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the commencement of a lease contract, the Company assesses whether the contract conveys the right to control the use of an identified
asset for a period of time in exchange for consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended June 30, 2024, the Company determined with reasonable certainty that it would exercise its extension option at its current
premises for two additional years. As a result, the Company has reassessed the lease term and related balances, which are reflected in
the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eifrs-full--DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_ziCf63XLziz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zgDoRZq7aEC" style="display: none"&gt;Summary
of Changes in ROU Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;(a) Right-of-use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Right of use asset&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--RightofuseAsset_iS_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW0f7JEjAIBf" style="width: 12%; text-align: right" title="Right of use asset"&gt;613,691&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--RightofuseAsset_iS_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSdyrWfuM371" style="width: 12%; text-align: right" title="Right of use asset"&gt;400,829&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccumulatedAmortization_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zu5Y3ybHL2k2" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period"&gt;(358,228&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccumulatedAmortization_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwUwV0tJBMAj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period"&gt;(243,290&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance at end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--RightofuseAsset_iE_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBKN7ji4A6pg" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year"&gt;255,463&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RightofuseAsset_iE_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRbDrCbrBQYh" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year"&gt;157,540&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--RightofuseAsset_iS_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zP7koQHKeQ7h" style="text-align: right" title="Balance at beginning of year"&gt;157,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--RightofuseAsset_iS_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z3DQrTKCygZi" style="text-align: right" title="Balance at beginning of yea"&gt;276,907&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Modification&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--Modification_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z15ci9QCcPV4" style="text-align: right" title="Modification"&gt;212,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--Modification_iI_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zFcuqlNEuE85" style="text-align: right" title="Modification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1524"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: amortization for the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AccumulatedAmortization_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z9s5QEJz6Znf" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period"&gt;(114,759&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccumulatedAmortization_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zXSlPeqKqUFj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period"&gt;(119,367&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance at end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--RightofuseAsset_iE_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zl2WOe0KbKKa" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year"&gt;255,463&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RightofuseAsset_iE_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z4q3N2QxJHUa" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year"&gt;157,540&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;(b) Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Current lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--CurrentLeaseLiabilities_iI_c20240630_zvPMDte7J3Ck" style="text-align: right" title="Current lease liability"&gt;128,559&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--CurrentLeaseLiabilities_iI_c20230630_z0Q5x28E5D8f" style="text-align: right" title="Current lease liability"&gt;121,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Non-current lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NoncurrentLeaseLiabilities_iI_c20240630_zH0pDaMPTQg1" style="border-bottom: Black 1pt solid; text-align: right" title="Non-current lease liability"&gt;130,722&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NoncurrentLeaseLiabilities_iI_c20230630_zkpth2DWjvO" style="border-bottom: Black 1pt solid; text-align: right" title="Non-current lease liability"&gt;54,162&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--LeaseLiabilities_iI_c20240630_zo6k1lIA5MWb" style="border-bottom: Black 1pt solid; text-align: right" title="Total lease liabilities"&gt;259,281&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--LeaseLiabilities_iI_c20230630_zVnNtNHtgcc7" style="border-bottom: Black 1pt solid; text-align: right" title="Total lease liabilities"&gt;175,662&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zFubkFPUCDsf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
20. Leases - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total of future lease payments (including those lease payments that are not included in the measurement of the lease liability, e.g.
for short-term leases and leases of low-value items) are disclosed for each of the following periods.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_z4D0wss8f2u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_z4oesS1LIrvl" style="display: none"&gt;Summary
of Future Minimum Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240630_zUciWd6oymo5" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230630_ztQ9kyY1o8H4" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_maLLzHsH_zkrOBgGJZKt2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Less than one year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;135,680&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;127,361&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_maLLzHsH_zFpGlH0qhgBe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;One to two years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_maLLzHsH_zcGWuInT1sGg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Two to five years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_maLLzHsH_zqXC9JRz2M7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Five years and over&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1557"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1558"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--LeaseLiabilities_iI_pp0p0_hifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_mtLLzHsH_zaXrmVWwrCHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total future lease payments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;217,187&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;183,789&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfLeasesExplanatory>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001504">&lt;p id="xdx_896_eifrs-full--DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_ziCf63XLziz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zgDoRZq7aEC" style="display: none"&gt;Summary
of Changes in ROU Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;(a) Right-of-use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Right of use asset&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--RightofuseAsset_iS_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW0f7JEjAIBf" style="width: 12%; text-align: right" title="Right of use asset"&gt;613,691&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--RightofuseAsset_iS_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSdyrWfuM371" style="width: 12%; text-align: right" title="Right of use asset"&gt;400,829&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccumulatedAmortization_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zu5Y3ybHL2k2" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period"&gt;(358,228&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccumulatedAmortization_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwUwV0tJBMAj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period"&gt;(243,290&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance at end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--RightofuseAsset_iE_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBKN7ji4A6pg" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year"&gt;255,463&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RightofuseAsset_iE_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRbDrCbrBQYh" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year"&gt;157,540&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--RightofuseAsset_iS_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zP7koQHKeQ7h" style="text-align: right" title="Balance at beginning of year"&gt;157,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--RightofuseAsset_iS_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z3DQrTKCygZi" style="text-align: right" title="Balance at beginning of yea"&gt;276,907&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Modification&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--Modification_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z15ci9QCcPV4" style="text-align: right" title="Modification"&gt;212,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--Modification_iI_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zFcuqlNEuE85" style="text-align: right" title="Modification"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1524"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: amortization for the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AccumulatedAmortization_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z9s5QEJz6Znf" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period"&gt;(114,759&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccumulatedAmortization_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zXSlPeqKqUFj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: amortization for the period"&gt;(119,367&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance at end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--RightofuseAsset_iE_c20230601__20240630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_zl2WOe0KbKKa" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year"&gt;255,463&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RightofuseAsset_iE_c20220601__20230630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AmortizationMember_z4q3N2QxJHUa" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at end of the year"&gt;157,540&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;(b) Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Current lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--CurrentLeaseLiabilities_iI_c20240630_zvPMDte7J3Ck" style="text-align: right" title="Current lease liability"&gt;128,559&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--CurrentLeaseLiabilities_iI_c20230630_z0Q5x28E5D8f" style="text-align: right" title="Current lease liability"&gt;121,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Non-current lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NoncurrentLeaseLiabilities_iI_c20240630_zH0pDaMPTQg1" style="border-bottom: Black 1pt solid; text-align: right" title="Non-current lease liability"&gt;130,722&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NoncurrentLeaseLiabilities_iI_c20230630_zkpth2DWjvO" style="border-bottom: Black 1pt solid; text-align: right" title="Non-current lease liability"&gt;54,162&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--LeaseLiabilities_iI_c20240630_zo6k1lIA5MWb" style="border-bottom: Black 1pt solid; text-align: right" title="Total lease liabilities"&gt;259,281&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--LeaseLiabilities_iI_c20230630_zVnNtNHtgcc7" style="border-bottom: Black 1pt solid; text-align: right" title="Total lease liabilities"&gt;175,662&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <MMA:RightofuseAsset
      contextRef="AsOf2023-05-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fact001506"
      unitRef="USD">613691</MMA:RightofuseAsset>
    <MMA:RightofuseAsset
      contextRef="AsOf2022-05-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fact001508"
      unitRef="USD">400829</MMA:RightofuseAsset>
    <MMA:AccumulatedAmortization
      contextRef="From2023-06-012024-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fact001510"
      unitRef="USD">-358228</MMA:AccumulatedAmortization>
    <MMA:AccumulatedAmortization
      contextRef="From2022-06-012023-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fact001512"
      unitRef="USD">-243290</MMA:AccumulatedAmortization>
    <MMA:RightofuseAsset
      contextRef="AsOf2024-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fact001514"
      unitRef="USD">255463</MMA:RightofuseAsset>
    <MMA:RightofuseAsset
      contextRef="AsOf2023-06-30_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fact001516"
      unitRef="USD">157540</MMA:RightofuseAsset>
    <MMA:RightofuseAsset
      contextRef="AsOf2023-05-31_custom_AmortizationMember"
      decimals="0"
      id="Fact001518"
      unitRef="USD">157540</MMA:RightofuseAsset>
    <MMA:RightofuseAsset
      contextRef="AsOf2022-05-31_custom_AmortizationMember"
      decimals="0"
      id="Fact001520"
      unitRef="USD">276907</MMA:RightofuseAsset>
    <MMA:Modification
      contextRef="From2023-06-012024-06-30_custom_AmortizationMember"
      decimals="0"
      id="Fact001522"
      unitRef="USD">212682</MMA:Modification>
    <MMA:AccumulatedAmortization
      contextRef="From2023-06-012024-06-30_custom_AmortizationMember"
      decimals="0"
      id="Fact001526"
      unitRef="USD">-114759</MMA:AccumulatedAmortization>
    <MMA:AccumulatedAmortization
      contextRef="From2022-06-012023-06-30_custom_AmortizationMember"
      decimals="0"
      id="Fact001528"
      unitRef="USD">-119367</MMA:AccumulatedAmortization>
    <MMA:RightofuseAsset
      contextRef="AsOf2024-06-30_custom_AmortizationMember"
      decimals="0"
      id="Fact001530"
      unitRef="USD">255463</MMA:RightofuseAsset>
    <MMA:RightofuseAsset
      contextRef="AsOf2023-06-30_custom_AmortizationMember"
      decimals="0"
      id="Fact001532"
      unitRef="USD">157540</MMA:RightofuseAsset>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001534"
      unitRef="USD">128559</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001536"
      unitRef="USD">121500</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001538"
      unitRef="USD">130722</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001540"
      unitRef="USD">54162</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001542"
      unitRef="USD">259281</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001544"
      unitRef="USD">175662</ifrs-full:LeaseLiabilities>
    <ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001546">&lt;p id="xdx_896_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_z4D0wss8f2u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_z4oesS1LIrvl" style="display: none"&gt;Summary
of Future Minimum Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240630_zUciWd6oymo5" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230630_ztQ9kyY1o8H4" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_maLLzHsH_zkrOBgGJZKt2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Less than one year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;135,680&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;127,361&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_maLLzHsH_zFpGlH0qhgBe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;One to two years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_maLLzHsH_zcGWuInT1sGg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Two to five years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--GrossLeaseLiabilities_iI_pp0p0_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_maLLzHsH_zqXC9JRz2M7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Five years and over&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1557"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1558"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--LeaseLiabilities_iI_pp0p0_hifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_mtLLzHsH_zaXrmVWwrCHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total future lease payments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;217,187&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;183,789&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact001548"
      unitRef="USD">135680</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact001549"
      unitRef="USD">127361</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="0"
      id="Fact001551"
      unitRef="USD">46240</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="0"
      id="Fact001552"
      unitRef="USD">28214</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="0"
      id="Fact001554"
      unitRef="USD">35267</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="0"
      id="Fact001555"
      unitRef="USD">28214</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_LeaseLiabilitiesMember"
      decimals="0"
      id="Fact001560"
      unitRef="USD">217187</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_LeaseLiabilitiesMember"
      decimals="0"
      id="Fact001561"
      unitRef="USD">183789</ifrs-full:LeaseLiabilities>
    <ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001563">&lt;p id="xdx_803_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_ze4kvS2LGDXd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
21. &lt;span id="xdx_823_zloOrkesuHc"&gt;Financial Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory_zqPXXi9zrlvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Schedule
of Financial Liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ConvertibleInstrumentsMember_zaJvSGUngEdf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ConvertibleInstrumentsMember_zCpBCtaqKjte" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2023&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--CurrentFinancialLiabilities_iI_maFLz9PT_zeQSQ1S9pWb1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Convertible note payable - Current&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;25,331,307&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--NoncurrentFinancialLiabilities_iI_maFLz9PT_zppzfpe3V7e6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Convertible note payable &#x2013; Non Current&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1570"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,273,278&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--FinancialLiabilities_iTI_mtFLz9PT_zI8Yo4b5cuEf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total Financial Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1573"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;35,604,585&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CurrentDebtInstrumentsIssued_iI_maDSznTX_zTv2A2z8q3Fi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Host Liability - Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1576"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,567,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--NoncurrentDebtInstrumentsIssued_iI_maDSznTX_z4DzOPj9qQP8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Host Liability &#x2013; Non Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1579"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;342,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_maDSznTX_zmEHtWJZpfW3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Derivative liability -Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1582"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,763,857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iI_maDSznTX_zsde6Hflx1I2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Derivative liability - Non Current&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1585"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9,930,872&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--DebtSecurities_iTI_mtDSznTX_zRBnTMDqk59c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total Convertible Notes Payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1588"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;35,604,585&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zrTwn8lBud84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
convertible notes issued by the Company have been split into the debt liability and a derivative component. The fair value of the Financial
Liabilities for the host liability and the derivative liability has been determined using a combination of Monte Carlo Simulation (MCS)
and Black-Scholes model (BSM).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the reporting period &lt;span id="xdx_90F_eifrs-full--DescriptionOfConversionOfDebtToEquity_c20230701__20240630_zIGQYDd4iXLd" title="Conversion of debt to equity"&gt;Series A &#x2013; July 21 matured and converted to equity on 7 July 2023, while Series A, Series A &#x2013; Aug 21,
Series B1, Series B2 and Series A Extension matured and converted to equity on 31 December 2023.&lt;/span&gt; During the reporting period the Company
issued two additional Convertible Notes for the acquisition of Mixed Martial Arts LLC and Steppen. Mixed Martial Arts LLC, Steppen, Reach
and Private Placement convertible notes converted to equity or were redeemed for cash on March 28, 2024, on successful listing on the
NYSE by the Company, as per the conversion date in the table below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eifrs-full--DisclosureOfDebtSecuritiesExplanatory_zFeaMSLBtDbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
notes held by investors in the reporting period are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zxHj016l3T8k"&gt;Schedule
of Convertible
Notes held by Investors&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series A&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Key Terms of this Series A convertible notes are as follows&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zKTyBiGTOkBg"&gt;23-Dec-20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Pre Modification Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zckboiGTorYi"&gt;23-Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Modification Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zy6NsfBzcmn1"&gt;1-Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Modified Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zHUeRarlkhh9"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zcIukupuO0J"&gt;31 -Dec 23&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zgvjtyeejJQb"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zQJ6vqZUYUhj"&gt;7,319,818&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zzaC5xHGzy18"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zyhe1TlxgTyc"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
21. - Financial Liabilities - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series
A &#x2013; July 21&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Series A convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zu4HVLcYvDy6"&gt;7-Jul-21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zVw4aqQOT9M6"&gt;7-Jul-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zZ9Q6iCydPHg"&gt;7-Jul-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_z6nUxvTzCBxg"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_z2VAU81ictC8"&gt;525,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zNKm7fP3bmN1"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zr4LC4BBNQCf"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Series A &#x2013; August 21&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Series A convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zGC5Z3bs0jm4"&gt;20-Aug-21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Pre Modification Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zhjRokEV9uZg"&gt;9 -Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Modification Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zGyLx2NaRVcf"&gt;1-Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Modified Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zqmVPs1uki4e"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zUypov1Yt4I9"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zMyTSVokMg52"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_z6GWYtXKE1sl"&gt;172,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zuI6b4KWOevf"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zTaNP8xp7Vd4"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series B1 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Series B1 convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zWfOZme1Qlii" title="Issue Date"&gt;15-Dec-21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Pre Modification Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zmCvEJVYHqge" title="Pre Modification Maturity Date"&gt;15-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Modification Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zNcDhXuvCkxl" title="Modification Date"&gt;1-Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Modified Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zfod4Eb7KKQi" title="Modified Maturity Date"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zPo4oyaBhY13" title="Conversion Date"&gt;31.Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zRR89usCshda" title="Term (Years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zh2qeau6QYyd" title="Face Value"&gt;4,982,652&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_z2RkfJdY8C14" title="Interest Rate"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zn8ri5Kc6ZQ2" title="Conversion Discount (Qualified Equity Investment)"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
21. Financial Liabilities - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series B2&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zNADu065PWEg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Series B2 convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zsyxpG9JlFw3" title="Issue Date"&gt;1-July-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Pre Modification Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zaZemu70Nlfa" title="Pre Modification Maturity Date"&gt;30-June-24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Modification Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zSVSzLOnKTri" title="Modification Date"&gt;1-Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Modified Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zelEyzEEiQI5" title="Modified Maturity Date"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zODcW7e9H2ea" title="Conversion Date"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_z0Nz8qhfQSqg" title="Term (Years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--Borrowings_iI_zYYZTZcwJVXi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;671,284&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--BorrowingsInterestRate_iI_dp_zk827CPePtqk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ConvertibleNotesConversionDiscount_iI_dp_z1ZMFc69oupb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A Extension&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_ze0iFRIDr6x5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Series A Extension convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_z0jHywvp22f3" title="Issue Date"&gt;16-Nov-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_z2eM1iM8iNFk" title="Modified Maturity Date"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_zDaBPU3ZfVM9" title="Conversion Date"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_zE0O8PAIVCB7" title="Term (Years)"&gt;1.1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--Borrowings_iI_zIUvqsnhOYsa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,571,873&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zGDBoyRcRY1l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zYGxmwqqxsoi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reach&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zTXJDxkEE2R4" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Reach convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zPbnewNmlso2" title="Issue Date"&gt;13-Feb-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zuMY3qoLdYEi" title="Modified Maturity Date"&gt;13-Feb-25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date &lt;span&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_fKio___zzovJym22qA5" title="Conversion Date"&gt;28-Mar-24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_z2EoLPwOvzGd" title="Term (Years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--Borrowings_iI_z2XJThR4Fri8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;span id="xdx_F41_zNopM9pTRBHk"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,195,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zKBPam9e4uX2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zyhLh5GJx81b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span id="xdx_F0E_zKL2Udiju9o9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_znFHf0D56aPg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90A_ecustom--ReachConvertibleNote_iI_c20230609_zjH8cFvlAAXd" title="Reach convertible note"&gt;3,025,841&lt;/span&gt; of Reach convertible
  notes, inclusive of accrued interest, were rolled into the Private Placement on June 9, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F0E_zxaqEBv0byX2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zLqqctjjK8Xa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_905_ecustom--RedeemedForCash_iI_c20230609_zCA5HXL5Vhw9" title="Redeemed for cash"&gt;1,029,617&lt;/span&gt; was redeemed for
  cash, the remaining Reach notes were converted to equity.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
21. Financial Liabilities - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Private Placement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zxJnD1OVLjCl" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Private Placement convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zwOryoGKMuH6" title="Issue Date"&gt;9-June-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zbZSoW7dIIeb" title="Modified Maturity Date"&gt;9-June-25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zah2YYs5M7K9" title="Conversion Date"&gt;28-Mar-24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zhmq8lVWG9h6" title="Term (Years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--Borrowings_iI_zwFImW4vuCMc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,215,591&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--BorrowingsInterestRate_iI_dp_zLyRrty2aXwb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zWkIssbJvNT" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Mixed Martial Arts LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zs9BukUeVvQh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Mixed Martial Arts LLC convertible note are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zD0tPBtp9qYc" title="Issue Date"&gt;26-Oct-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zwXMJjMwZSaa" title="Modified Maturity Date"&gt;9-June-25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zpsVSs6NRFXb" title="Conversion Date"&gt;28-Mar-24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zR8PSRGxxDHl" title="Term (Years)"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--Borrowings_iI_zlaq9EcrMb04" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;384,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zjOm9BPcbhdl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zUwCHLGeSDA8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Steppen&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zV5NkY2FKv9a" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Steppen convertibles note are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zPS1k4VugEkf" title="Issue Date"&gt;20-Sept-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_z1Z7w84Wwr8f" title="Modified Maturity Date"&gt;9-June-25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zQZudroVO076" title="Conversion Date"&gt;28-Mar-24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_z70CTMpfQvjg" title="Term (Years)"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--Borrowings_iI_zZX5LndO1Qvf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_z1k97hEW8njb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zhn77hyBMTBl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zUP2P9rsNNw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory>
    <MMA:DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001565">&lt;p id="xdx_890_ecustom--DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory_zqPXXi9zrlvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Schedule
of Financial Liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ConvertibleInstrumentsMember_zaJvSGUngEdf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ConvertibleInstrumentsMember_zCpBCtaqKjte" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2023&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;($)&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--CurrentFinancialLiabilities_iI_maFLz9PT_zeQSQ1S9pWb1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 68%; text-align: left"&gt;Convertible note payable - Current&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;25,331,307&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--NoncurrentFinancialLiabilities_iI_maFLz9PT_zppzfpe3V7e6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Convertible note payable &#x2013; Non Current&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1570"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,273,278&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--FinancialLiabilities_iTI_mtFLz9PT_zI8Yo4b5cuEf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total Financial Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1573"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;35,604,585&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CurrentDebtInstrumentsIssued_iI_maDSznTX_zTv2A2z8q3Fi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Host Liability - Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1576"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,567,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--NoncurrentDebtInstrumentsIssued_iI_maDSznTX_z4DzOPj9qQP8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Host Liability &#x2013; Non Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1579"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;342,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_maDSznTX_zmEHtWJZpfW3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Derivative liability -Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1582"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,763,857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iI_maDSznTX_zsde6Hflx1I2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Derivative liability - Non Current&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1585"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9,930,872&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--DebtSecurities_iTI_mtDSznTX_zRBnTMDqk59c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total Convertible Notes Payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1588"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;35,604,585&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</MMA:DescriptionOfDetailedInformationOfFinancialLiabilitiesExplanatory>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember"
      decimals="0"
      id="Fact001568"
      unitRef="USD">25331307</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember"
      decimals="0"
      id="Fact001571"
      unitRef="USD">10273278</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember"
      decimals="0"
      id="Fact001574"
      unitRef="USD">35604585</ifrs-full:FinancialLiabilities>
    <ifrs-full:CurrentDebtInstrumentsIssued
      contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember"
      decimals="0"
      id="Fact001577"
      unitRef="USD">16567450</ifrs-full:CurrentDebtInstrumentsIssued>
    <ifrs-full:NoncurrentDebtInstrumentsIssued
      contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember"
      decimals="0"
      id="Fact001580"
      unitRef="USD">342406</ifrs-full:NoncurrentDebtInstrumentsIssued>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember"
      decimals="0"
      id="Fact001583"
      unitRef="USD">8763857</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember"
      decimals="0"
      id="Fact001586"
      unitRef="USD">9930872</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:DebtSecurities
      contextRef="AsOf2023-06-30_ifrs-full_ConvertibleInstrumentsMember"
      decimals="0"
      id="Fact001589"
      unitRef="USD">35604585</ifrs-full:DebtSecurities>
    <ifrs-full:DescriptionOfConversionOfDebtToEquity contextRef="From2023-07-01to2024-06-30" id="Fact001591">Series A &#x2013; July 21 matured and converted to equity on 7 July 2023, while Series A, Series A &#x2013; Aug 21,
Series B1, Series B2 and Series A Extension matured and converted to equity on 31 December 2023.</ifrs-full:DescriptionOfConversionOfDebtToEquity>
    <ifrs-full:DisclosureOfDebtSecuritiesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001593">&lt;p id="xdx_891_eifrs-full--DisclosureOfDebtSecuritiesExplanatory_zFeaMSLBtDbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
notes held by investors in the reporting period are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zxHj016l3T8k"&gt;Schedule
of Convertible
Notes held by Investors&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series A&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Key Terms of this Series A convertible notes are as follows&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zKTyBiGTOkBg"&gt;23-Dec-20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Pre Modification Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zckboiGTorYi"&gt;23-Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Modification Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zy6NsfBzcmn1"&gt;1-Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Modified Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zHUeRarlkhh9"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zcIukupuO0J"&gt;31 -Dec 23&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zgvjtyeejJQb"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zQJ6vqZUYUhj"&gt;7,319,818&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zzaC5xHGzy18"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAConvertibleNotesMember_zyhe1TlxgTyc"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
21. - Financial Liabilities - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series
A &#x2013; July 21&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Series A convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zu4HVLcYvDy6"&gt;7-Jul-21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zVw4aqQOT9M6"&gt;7-Jul-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zZ9Q6iCydPHg"&gt;7-Jul-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_z6nUxvTzCBxg"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_z2VAU81ictC8"&gt;525,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zNKm7fP3bmN1"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAJulyTwentyOneConvertibleNotesMember_zr4LC4BBNQCf"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Series A &#x2013; August 21&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Series A convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zGC5Z3bs0jm4"&gt;20-Aug-21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Pre Modification Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zhjRokEV9uZg"&gt;9 -Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Modification Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zGyLx2NaRVcf"&gt;1-Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Modified Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zqmVPs1uki4e"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zUypov1Yt4I9"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zMyTSVokMg52"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_z6GWYtXKE1sl"&gt;172,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zuI6b4KWOevf"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAAugustTwentyOneConvertibleNotesMember_zTaNP8xp7Vd4"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series B1 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Series B1 convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zWfOZme1Qlii" title="Issue Date"&gt;15-Dec-21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Pre Modification Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zmCvEJVYHqge" title="Pre Modification Maturity Date"&gt;15-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Modification Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zNcDhXuvCkxl" title="Modification Date"&gt;1-Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Modified Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zfod4Eb7KKQi" title="Modified Maturity Date"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zPo4oyaBhY13" title="Conversion Date"&gt;31.Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zRR89usCshda" title="Term (Years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--Borrowings_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zh2qeau6QYyd" title="Face Value"&gt;4,982,652&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_z2RkfJdY8C14" title="Interest Rate"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleNotesConversionDiscount_iI_pid_dp_uPure_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesBOneConvertibleNotesMember_zn8ri5Kc6ZQ2" title="Conversion Discount (Qualified Equity Investment)"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
21. Financial Liabilities - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series B2&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zNADu065PWEg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Series B2 convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zsyxpG9JlFw3" title="Issue Date"&gt;1-July-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Pre Modification Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ConvertibleNotesPreModificationMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zaZemu70Nlfa" title="Pre Modification Maturity Date"&gt;30-June-24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Modification Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleNotesModificationDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zSVSzLOnKTri" title="Modification Date"&gt;1-Dec-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Modified Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zelEyzEEiQI5" title="Modified Maturity Date"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_zODcW7e9H2ea" title="Conversion Date"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesB2ConvertibleNotesMember_z0Nz8qhfQSqg" title="Term (Years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--Borrowings_iI_zYYZTZcwJVXi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;671,284&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--BorrowingsInterestRate_iI_dp_zk827CPePtqk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ConvertibleNotesConversionDiscount_iI_dp_z1ZMFc69oupb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A Extension&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_ze0iFRIDr6x5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Series A Extension convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_z0jHywvp22f3" title="Issue Date"&gt;16-Nov-22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_z2eM1iM8iNFk" title="Modified Maturity Date"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_zDaBPU3ZfVM9" title="Conversion Date"&gt;31-Dec-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SeriesAExtensionConvertibleNotesMember_zE0O8PAIVCB7" title="Term (Years)"&gt;1.1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--Borrowings_iI_zIUvqsnhOYsa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,571,873&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zGDBoyRcRY1l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zYGxmwqqxsoi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reach&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zTXJDxkEE2R4" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Reach convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zPbnewNmlso2" title="Issue Date"&gt;13-Feb-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_zuMY3qoLdYEi" title="Modified Maturity Date"&gt;13-Feb-25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date &lt;span&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_fKio___zzovJym22qA5" title="Conversion Date"&gt;28-Mar-24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--ReachConvertibleNotesMember_z2EoLPwOvzGd" title="Term (Years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--Borrowings_iI_z2XJThR4Fri8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;span id="xdx_F41_zNopM9pTRBHk"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,195,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zKBPam9e4uX2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zyhLh5GJx81b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span id="xdx_F0E_zKL2Udiju9o9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_znFHf0D56aPg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90A_ecustom--ReachConvertibleNote_iI_c20230609_zjH8cFvlAAXd" title="Reach convertible note"&gt;3,025,841&lt;/span&gt; of Reach convertible
  notes, inclusive of accrued interest, were rolled into the Private Placement on June 9, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F0E_zxaqEBv0byX2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt;
  &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zLqqctjjK8Xa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_905_ecustom--RedeemedForCash_iI_c20230609_zCA5HXL5Vhw9" title="Redeemed for cash"&gt;1,029,617&lt;/span&gt; was redeemed for
  cash, the remaining Reach notes were converted to equity.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
21. Financial Liabilities - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Private Placement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zxJnD1OVLjCl" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Private Placement convertible notes are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zwOryoGKMuH6" title="Issue Date"&gt;9-June-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zbZSoW7dIIeb" title="Modified Maturity Date"&gt;9-June-25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zah2YYs5M7K9" title="Conversion Date"&gt;28-Mar-24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--PrivatePlacementConvertibleNotesMember_zhmq8lVWG9h6" title="Term (Years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--Borrowings_iI_zwFImW4vuCMc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,215,591&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--BorrowingsInterestRate_iI_dp_zLyRrty2aXwb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zWkIssbJvNT" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Mixed Martial Arts LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zs9BukUeVvQh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Mixed Martial Arts LLC convertible note are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zD0tPBtp9qYc" title="Issue Date"&gt;26-Oct-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zwXMJjMwZSaa" title="Modified Maturity Date"&gt;9-June-25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zpsVSs6NRFXb" title="Conversion Date"&gt;28-Mar-24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--MixedMartialArtsLLCConvertibleNotesMember_zR8PSRGxxDHl" title="Term (Years)"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--Borrowings_iI_zlaq9EcrMb04" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;384,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_zjOm9BPcbhdl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zUwCHLGeSDA8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Steppen&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zV5NkY2FKv9a" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Key Terms of this Steppen convertibles note are as follows&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issue Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--ConvertibleNotesIssueDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zPS1k4VugEkf" title="Issue Date"&gt;20-Sept-23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Maturity Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ConvertibleNotesModifiedMaturityDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_z1Z7w84Wwr8f" title="Modified Maturity Date"&gt;9-June-25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--ConvertibleNotesConversionDate_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_zQZudroVO076" title="Conversion Date"&gt;28-Mar-24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Term (Years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConvertibleNotesTerm_iI_c20240630__ifrs-full--BorrowingsByNameAxis__custom--SteppenConvertibleNotesMember_z70CTMpfQvjg" title="Term (Years)"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--Borrowings_iI_zZX5LndO1Qvf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Face Value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--BorrowingsInterestRate_iI_dp_z1k97hEW8njb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Interest Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ConvertibleNotesConversionDiscount_iI_dp_zhn77hyBMTBl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion Discount (Qualified Equity Investment)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfDebtSecuritiesExplanatory>
    <MMA:ConvertibleNotesIssueDate
      contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember"
      id="Fact001594">23-Dec-20</MMA:ConvertibleNotesIssueDate>
    <MMA:ConvertibleNotesPreModificationMaturityDate
      contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember"
      id="Fact001595">23-Dec-22</MMA:ConvertibleNotesPreModificationMaturityDate>
    <MMA:ConvertibleNotesModificationDate
      contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember"
      id="Fact001596">1-Dec-22</MMA:ConvertibleNotesModificationDate>
    <MMA:ConvertibleNotesModifiedMaturityDate
      contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember"
      id="Fact001597">31-Dec-23</MMA:ConvertibleNotesModifiedMaturityDate>
    <MMA:ConvertibleNotesConversionDate
      contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember"
      id="Fact001598">31 -Dec 23</MMA:ConvertibleNotesConversionDate>
    <MMA:ConvertibleNotesTerm
      contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember"
      id="Fact001599">2.0</MMA:ConvertibleNotesTerm>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember"
      decimals="0"
      id="Fact001600"
      unitRef="USD">7319818</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember"
      decimals="INF"
      id="Fact001601"
      unitRef="Pure">0.085</ifrs-full:BorrowingsInterestRate>
    <MMA:ConvertibleNotesConversionDiscount
      contextRef="AsOf2024-06-30_custom_SeriesAConvertibleNotesMember"
      decimals="INF"
      id="Fact001602"
      unitRef="Pure">0.200</MMA:ConvertibleNotesConversionDiscount>
    <MMA:ConvertibleNotesIssueDate
      contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember"
      id="Fact001603">7-Jul-21</MMA:ConvertibleNotesIssueDate>
    <MMA:ConvertibleNotesModifiedMaturityDate
      contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember"
      id="Fact001604">7-Jul-23</MMA:ConvertibleNotesModifiedMaturityDate>
    <MMA:ConvertibleNotesConversionDate
      contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember"
      id="Fact001605">7-Jul-23</MMA:ConvertibleNotesConversionDate>
    <MMA:ConvertibleNotesTerm
      contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember"
      id="Fact001606">2.0</MMA:ConvertibleNotesTerm>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember"
      decimals="0"
      id="Fact001607"
      unitRef="USD">525000</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember"
      decimals="INF"
      id="Fact001608"
      unitRef="Pure">0.085</ifrs-full:BorrowingsInterestRate>
    <MMA:ConvertibleNotesConversionDiscount
      contextRef="AsOf2024-06-30_custom_SeriesAJulyTwentyOneConvertibleNotesMember"
      decimals="INF"
      id="Fact001609"
      unitRef="Pure">0.200</MMA:ConvertibleNotesConversionDiscount>
    <MMA:ConvertibleNotesIssueDate
      contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember"
      id="Fact001610">20-Aug-21</MMA:ConvertibleNotesIssueDate>
    <MMA:ConvertibleNotesPreModificationMaturityDate
      contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember"
      id="Fact001611">9 -Dec-22</MMA:ConvertibleNotesPreModificationMaturityDate>
    <MMA:ConvertibleNotesModificationDate
      contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember"
      id="Fact001612">1-Dec-22</MMA:ConvertibleNotesModificationDate>
    <MMA:ConvertibleNotesModifiedMaturityDate
      contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember"
      id="Fact001613">31-Dec-23</MMA:ConvertibleNotesModifiedMaturityDate>
    <MMA:ConvertibleNotesConversionDate
      contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember"
      id="Fact001614">31-Dec-23</MMA:ConvertibleNotesConversionDate>
    <MMA:ConvertibleNotesTerm
      contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember"
      id="Fact001615">1.3</MMA:ConvertibleNotesTerm>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember"
      decimals="0"
      id="Fact001616"
      unitRef="USD">172000</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember"
      decimals="INF"
      id="Fact001617"
      unitRef="Pure">0.085</ifrs-full:BorrowingsInterestRate>
    <MMA:ConvertibleNotesConversionDiscount
      contextRef="AsOf2024-06-30_custom_SeriesAAugustTwentyOneConvertibleNotesMember"
      decimals="INF"
      id="Fact001618"
      unitRef="Pure">0.200</MMA:ConvertibleNotesConversionDiscount>
    <MMA:ConvertibleNotesIssueDate
      contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember"
      id="Fact001620">15-Dec-21</MMA:ConvertibleNotesIssueDate>
    <MMA:ConvertibleNotesPreModificationMaturityDate
      contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember"
      id="Fact001622">15-Dec-23</MMA:ConvertibleNotesPreModificationMaturityDate>
    <MMA:ConvertibleNotesModificationDate
      contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember"
      id="Fact001624">1-Dec-22</MMA:ConvertibleNotesModificationDate>
    <MMA:ConvertibleNotesModifiedMaturityDate
      contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember"
      id="Fact001626">31-Dec-23</MMA:ConvertibleNotesModifiedMaturityDate>
    <MMA:ConvertibleNotesConversionDate
      contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember"
      id="Fact001628">31.Dec-23</MMA:ConvertibleNotesConversionDate>
    <MMA:ConvertibleNotesTerm
      contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember"
      id="Fact001630">2.0</MMA:ConvertibleNotesTerm>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember"
      decimals="0"
      id="Fact001632"
      unitRef="USD">4982652</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember"
      decimals="INF"
      id="Fact001634"
      unitRef="Pure">0.085</ifrs-full:BorrowingsInterestRate>
    <MMA:ConvertibleNotesConversionDiscount
      contextRef="AsOf2024-06-30_custom_SeriesBOneConvertibleNotesMember"
      decimals="INF"
      id="Fact001636"
      unitRef="Pure">0.200</MMA:ConvertibleNotesConversionDiscount>
    <MMA:ConvertibleNotesIssueDate
      contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember"
      id="Fact001638">1-July-22</MMA:ConvertibleNotesIssueDate>
    <MMA:ConvertibleNotesPreModificationMaturityDate
      contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember"
      id="Fact001640">30-June-24</MMA:ConvertibleNotesPreModificationMaturityDate>
    <MMA:ConvertibleNotesModificationDate
      contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember"
      id="Fact001642">1-Dec-22</MMA:ConvertibleNotesModificationDate>
    <MMA:ConvertibleNotesModifiedMaturityDate
      contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember"
      id="Fact001644">31-Dec-23</MMA:ConvertibleNotesModifiedMaturityDate>
    <MMA:ConvertibleNotesConversionDate
      contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember"
      id="Fact001646">31-Dec-23</MMA:ConvertibleNotesConversionDate>
    <MMA:ConvertibleNotesTerm
      contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember"
      id="Fact001648">2.0</MMA:ConvertibleNotesTerm>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember"
      decimals="0"
      id="Fact001650"
      unitRef="USD">671284</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember"
      decimals="INF"
      id="Fact001652"
      unitRef="Pure">0.10</ifrs-full:BorrowingsInterestRate>
    <MMA:ConvertibleNotesConversionDiscount
      contextRef="AsOf2024-06-30_custom_SeriesB2ConvertibleNotesMember"
      decimals="INF"
      id="Fact001654"
      unitRef="Pure">0.200</MMA:ConvertibleNotesConversionDiscount>
    <MMA:ConvertibleNotesIssueDate
      contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember"
      id="Fact001656">16-Nov-22</MMA:ConvertibleNotesIssueDate>
    <MMA:ConvertibleNotesModifiedMaturityDate
      contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember"
      id="Fact001658">31-Dec-23</MMA:ConvertibleNotesModifiedMaturityDate>
    <MMA:ConvertibleNotesConversionDate
      contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember"
      id="Fact001660">31-Dec-23</MMA:ConvertibleNotesConversionDate>
    <MMA:ConvertibleNotesTerm
      contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember"
      id="Fact001662">1.1</MMA:ConvertibleNotesTerm>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember"
      decimals="0"
      id="Fact001664"
      unitRef="USD">1571873</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember"
      decimals="INF"
      id="Fact001666"
      unitRef="Pure">0.15</ifrs-full:BorrowingsInterestRate>
    <MMA:ConvertibleNotesConversionDiscount
      contextRef="AsOf2024-06-30_custom_SeriesAExtensionConvertibleNotesMember"
      decimals="INF"
      id="Fact001668"
      unitRef="Pure">0.25</MMA:ConvertibleNotesConversionDiscount>
    <MMA:ConvertibleNotesIssueDate
      contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember"
      id="Fact001670">13-Feb-23</MMA:ConvertibleNotesIssueDate>
    <MMA:ConvertibleNotesModifiedMaturityDate
      contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember"
      id="Fact001672">13-Feb-25</MMA:ConvertibleNotesModifiedMaturityDate>
    <MMA:ConvertibleNotesConversionDate
      contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember"
      id="Fact001674">28-Mar-24</MMA:ConvertibleNotesConversionDate>
    <MMA:ConvertibleNotesTerm
      contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember"
      id="Fact001676">2.0</MMA:ConvertibleNotesTerm>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember"
      decimals="0"
      id="Fact001678"
      unitRef="USD">3195000</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember"
      decimals="INF"
      id="Fact001680"
      unitRef="Pure">0.15</ifrs-full:BorrowingsInterestRate>
    <MMA:ConvertibleNotesConversionDiscount
      contextRef="AsOf2024-06-30_custom_ReachConvertibleNotesMember"
      decimals="INF"
      id="Fact001682"
      unitRef="Pure">0.20</MMA:ConvertibleNotesConversionDiscount>
    <MMA:ReachConvertibleNote
      contextRef="AsOf2023-06-09"
      decimals="0"
      id="Fact001685"
      unitRef="USD">3025841</MMA:ReachConvertibleNote>
    <MMA:RedeemedForCash
      contextRef="AsOf2023-06-09"
      decimals="0"
      id="Fact001688"
      unitRef="USD">1029617</MMA:RedeemedForCash>
    <MMA:ConvertibleNotesIssueDate
      contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember"
      id="Fact001690">9-June-23</MMA:ConvertibleNotesIssueDate>
    <MMA:ConvertibleNotesModifiedMaturityDate
      contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember"
      id="Fact001692">9-June-25</MMA:ConvertibleNotesModifiedMaturityDate>
    <MMA:ConvertibleNotesConversionDate
      contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember"
      id="Fact001694">28-Mar-24</MMA:ConvertibleNotesConversionDate>
    <MMA:ConvertibleNotesTerm
      contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember"
      id="Fact001696">2.0</MMA:ConvertibleNotesTerm>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember"
      decimals="0"
      id="Fact001698"
      unitRef="USD">9215591</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember"
      decimals="INF"
      id="Fact001700"
      unitRef="Pure">0.10</ifrs-full:BorrowingsInterestRate>
    <MMA:ConvertibleNotesConversionDiscount
      contextRef="AsOf2024-06-30_custom_PrivatePlacementConvertibleNotesMember"
      decimals="INF"
      id="Fact001702"
      unitRef="Pure">0.30</MMA:ConvertibleNotesConversionDiscount>
    <MMA:ConvertibleNotesIssueDate
      contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember"
      id="Fact001704">26-Oct-23</MMA:ConvertibleNotesIssueDate>
    <MMA:ConvertibleNotesModifiedMaturityDate
      contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember"
      id="Fact001706">9-June-25</MMA:ConvertibleNotesModifiedMaturityDate>
    <MMA:ConvertibleNotesConversionDate
      contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember"
      id="Fact001708">28-Mar-24</MMA:ConvertibleNotesConversionDate>
    <MMA:ConvertibleNotesTerm
      contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember"
      id="Fact001710">1.6</MMA:ConvertibleNotesTerm>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember"
      decimals="0"
      id="Fact001712"
      unitRef="USD">384750</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember"
      decimals="INF"
      id="Fact001714"
      unitRef="Pure">0.10</ifrs-full:BorrowingsInterestRate>
    <MMA:ConvertibleNotesConversionDiscount
      contextRef="AsOf2024-06-30_custom_MixedMartialArtsLLCConvertibleNotesMember"
      decimals="INF"
      id="Fact001716"
      unitRef="Pure">0.25</MMA:ConvertibleNotesConversionDiscount>
    <MMA:ConvertibleNotesIssueDate
      contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember"
      id="Fact001718">20-Sept-23</MMA:ConvertibleNotesIssueDate>
    <MMA:ConvertibleNotesModifiedMaturityDate
      contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember"
      id="Fact001720">9-June-25</MMA:ConvertibleNotesModifiedMaturityDate>
    <MMA:ConvertibleNotesConversionDate
      contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember"
      id="Fact001722">28-Mar-24</MMA:ConvertibleNotesConversionDate>
    <MMA:ConvertibleNotesTerm
      contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember"
      id="Fact001724">1.7</MMA:ConvertibleNotesTerm>
    <ifrs-full:Borrowings
      contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember"
      decimals="0"
      id="Fact001726"
      unitRef="USD">100.00</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember"
      decimals="INF"
      id="Fact001728"
      unitRef="Pure">0.10</ifrs-full:BorrowingsInterestRate>
    <MMA:ConvertibleNotesConversionDiscount
      contextRef="AsOf2024-06-30_custom_SteppenConvertibleNotesMember"
      decimals="INF"
      id="Fact001730"
      unitRef="Pure">0.25</MMA:ConvertibleNotesConversionDiscount>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001732">&lt;p id="xdx_80A_eifrs-full--DisclosureOfSharebasedPaymentArrangementsExplanatory_z7jXmKXxKkTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
22. &lt;span id="xdx_82F_zXPz7nTRBZd8"&gt;Share-based payments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the periods 30 June 2024 and 30 June 2023, the Company granted share options to advisors and consultants (as remuneration for services
provided), as well as select employees and Directors of the Company under the board approved Employee Share Option Plan (ESOP).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
share option converts into one Ordinary Share of the Company on exercise. An option may be exercised by either (a) paying to the Company
the Exercise Price of the Option being exercised (Cash Exercise) or (b) if elected by the Option Holder by setting off the total Exercise
Price against the number of Shares which they are entitled to receive upon exercise (Cashless Exercise Facility). The options carry neither
rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting, subject to meeting the vesting
conditions, to the date of their expiry.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options
are exercisable at a price determined by each option grant and range from $&lt;span id="xdx_903_eifrs-full--ExercisePriceShareOptionsGranted2019_c20230701__20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zm8e2mhUOYG3" title="Options exercise price"&gt;0.01&lt;/span&gt; (relating to options granted as consideration for foregone
cash payment for services provided), to $&lt;span id="xdx_90C_eifrs-full--ExercisePriceShareOptionsGranted2019_c20230701__20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zMHhzXywCiJj" title="Options exercise price"&gt;6.73&lt;/span&gt; per share (relating to issuances under the ESOP which qualifies for the ATO ESS start-up
tax concessions available for SME unlisted companies). All options are vested over three years. If the options remain unexercised after
the period agreed from the date of grant the options expire. Options are forfeited if the employee leaves the Company before the options
vest unless otherwise agreed by the Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
values of the Options are calculated by applying the Black-Scholes model. The Company used valuations specialists to perform these valuations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the reporting periods the Company also issued share rights (RSU&#x2019;s) to select employees of the Company under the board approved
Employee Incentive Plan (EIP). These share rights may be converted into Ordinary Shares under the EIP. Fifty percent of the principal
share rights will vest and be exercisable on October 1, 2025 and the remaining fifty percent of the share rights will vest and be exercisable
on and from October 1, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
values of the Share Rights are calculated by applying the Black-Scholes model. The Company used valuations specialists to perform these
valuations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory_zN7vP3I5GsLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the expense arising from performance rights, options and warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zzlTyOOagvZ9" style="display: none"&gt;Schedule
of Details
of Expense from Performance Rights, Options and Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230701__20240630_zbTNw46nTdP7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220701__20230630_zfHF8YVugIP1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210701__20220630_zdrmwvM8F5qb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants_zsKmtVilZz2l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;ESOP&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,851,329&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,052,245&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;914,682&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ExpenseFromAdvisorOptions_zu5tFb578ita" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Advisor Options (&lt;span id="xdx_F4B_zpQRCuO1gUSj"&gt;1&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,086,938&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,164,524&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;632,301&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ExpenseFromReach_zGGVHWYA6tx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Reach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,584&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;148,615&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1750"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ExpenseFromWarrants_zD48Kq8Z27o5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Warrants (&lt;span id="xdx_F4A_zfSSfVJn8vod"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;253,391&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ExpenseFromOverAllotmentOption_zWWZWEjmo0l8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Over allotment Option (&lt;span id="xdx_F4D_zxKdHZoVn1U3"&gt;3&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;163,794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1757"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ExpenseFromRestrictedShareUnits_zV5Ip81jRSg5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;RSU&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,119,562&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1761"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1762"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--AdjustmentsForSharebasedPayments_zfi1McJs0u3l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total Share based payments&lt;span&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,521,598&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,365,384&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,546,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0F_zfvwNt1Cb1W7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zQbK9VJWeAAb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
                                            that &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20231201__20231231_z1ntXt81TKLc" title="Advisor Options vested and were exercised"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20230701__20230731_zsw5zmqiLNi5" title="Advisor Options vested and were exercised"&gt;327,142&lt;/span&gt;&lt;/span&gt; Advisor Options vested and were exercised into Shares between July 2023 and
                                            December 2023 and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20230701__20230731_zKizMct8TSnl" title="Advisor Options forfeited"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20231201__20231231_zKUJz83i5Z6a" title="Advisor Options forfeited"&gt;16,193&lt;/span&gt;&lt;/span&gt; Advisor Options were forfeited. At June 30, 2024, nil remaining
                                            Advisor Options were on issue.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note 22. Share-based payments - continued &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F09_zjH7gYny6ZK4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zbT7EnCd82F1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
                                            that this expense is pertaining to the issuance of warrants (equating to &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_c20240630_zPVvZcVXmXD9" title="Ordinary Shares on exercise"&gt;65,000&lt;/span&gt; Ordinary
                                            Shares on exercise) to the Underwriter as part of the underwriting agreement. These Warrants
                                            will be exercisable at any time and from time to time, in whole or in part, during the four
                                            and a half year period commencing 180 days from the commencement of sales of the securities
                                            in the Offering, at a price per share equal to &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_ecustom--PricePerShareEqualPercentage_iI_pid_dp_uPure_c20240630_zpx8vpOmpta2" title="Price per share equal percentage"&gt;125.0&lt;/span&gt;% of the public offering price per share
                                            of common stock at the Offering. The issuance acts as additional compensation for ThinkEquity
                                            services that would be rendered over a 24 month period from the Closing of the initial public
                                            offering. As these services vary and are not for a specific service, the fair value of this
                                            allocation cannot be estimated reliably. Thereby, the fair value of these warrants at grant
                                            date were calculated by applying the Black-Scholes model. The Company used valuations specialists
                                            to perform these valuations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F07_z1ExF2q2dkia" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zuG97JGqyOt6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
                                            that this expense is pertaining to the option granted to the underwriter, exercisable within
                                            45 days after the closing of the Offering, to acquire up to an additional 15% of the total
                                            number of Shares to be offered by the company in the offering, solely for the purpose of
                                            covering over-allotments. This over-allotment option essentially granted the underwriter
                                            the right to sell more shares than originally planned if the demand for a security issue
                                            proves higher than expected. The fair value of this service cannot be estimated reliably
                                            as the exercise was subjective on share price performance and/or timing. Thereby, the fair
                                            value of these options at grant date were calculated using the Black-Scholes model. The Company
                                            used valuations specialists to perform these valuations. In addition, please note that these
                                            options have not been exercised and the 45-day limit has expired.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_8A5_zvXasCpC8D23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_gL3DONAWAEPOS-CCDSRYTS_zLdCoagaqoFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the number of share options outstanding during the year, adjusted to account for the 4-for-5 reverse share split, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zie5q2dMivca" style="display: none"&gt;Schedule
of Share Options Outstanding&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zpIu8TKQSEIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zT0ZdCYCd0Ia" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEL8MFiIDWX8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;ESOP&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zaCuikKPvXwk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Beginning of period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;784,098&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;556,074&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1789"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_ziQ24PRGCSJ2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1791"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;312,886&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;556,074&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zXiJsBu31pIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1795"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(84,862&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1797"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_ziochB4w4CW" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised during the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1799"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1800"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1801"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zy1SwpRnmMj4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;End of the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;784,098&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;784,098&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;556,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zAMLUNedCfVh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zVowqlhaKXa5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zYqWLc91NQT2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Advisor&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--NumberOfOutstandingShareOptions_iS_z1L7ZHhxvQ9a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Beginning of period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;344,055&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;312,362&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1809"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zyEytC2iajIl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1811"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,693&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;312,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zm6UOdWMkotd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,913&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1816"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1817"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_zXT4V55qKwD7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised during the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(327,142&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1820"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1821"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zgIWzJvbFhoe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;End of the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1823"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;344,055&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;312,362&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zl4QMN0nRSI9" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
22. Share-based payments - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div id="xdx_C05_gL3DONAWAEPOS-CCDSRYTS_zA2sYRtyBcs5"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zslACzMhU9tc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_zLNUsYbj6BM4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_zcGgiBCgAs8c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_z1msQrsCpqO3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Reach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_z0wnwwZW2c55" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Beginning of period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;45,794&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1828"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zIevBLXCvk17" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1831"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45,794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1833"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zqLlGVnPiBE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1835"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1836"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1837"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zYiK8trvcQJg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised during the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1839"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1840"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1841"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_znAfnnCNqR2i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;End of the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;45,794&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;45,794&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1845"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30F_134_ztGsmADBP6rg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z3gTDnsoHiC6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zSgZzqTQl59h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zv5DPlOD9FAf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;RSU&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zFUkEMCvCeH6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Beginning of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1847"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1848"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1849"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zdO032jRXR19" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;630,729&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1852"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1853"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zmCPQZbZOM3f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1856"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1857"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zOIdtiSw2wH1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised during the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1859"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1860"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1861"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zY0EaKJuuY4l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;End of the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;630,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1864"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1865"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in; text-indent: 415.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zlndA609UQXa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zjy79EmtAnMe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zVSEPxvDiP23" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zm40GPRGot73" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Over
Allotment Option&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zZydOI649Ml7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Beginning of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1867"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1868"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1869"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zOaT1nzIB0n2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;195,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1872"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1873"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zeVrQaoAsEEg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(195,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1876"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1877"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zKLkeRxCt1e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised during the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1879"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1880"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1881"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zROkvJPuz1p5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;End of the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1883"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1884"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1885"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_302_134_zkdJ4abczpX5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zVDnI1AIPlq6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zRvjjm2URI49" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z4LVeCGloSO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zEHg2LB82Pkj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Beginning of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1887"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1888"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1889"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zd12xeSBVpMc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;65,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1892"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1893"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zQT8UOdLmZ69" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1895"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1896"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1897"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zWsGAbE1pg4h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercised during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1899"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1900"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1901"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zXzUnf10OM9g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;End of the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;65,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1904"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1905"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_307_134_zgsdPe6Mub58" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; font-weight: bold"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230701__20240630_z8wiG2VaH71h" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220701__20230630_zntefkRvtYek" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210701__20220630_zy3dOiDeVKX2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zMJsBnROtpL1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Total beginning of period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,173,947&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;868,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zc3ZCu4nKXvg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total granted during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;890,729&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;390,373&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;868,436&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zckuoh90y0yl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(211,913&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(84,862&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1917"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_zsaBm20S1mC1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total exercised during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(327,142&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1920"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1921"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zEMqyJJkkW36" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Total end of the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,525,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,173,947&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;868,436&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_C06_gL3DONAWAEPOS-CCDSRYTS_zjNuB6s6Nr3d"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_zLqMcBhNMhm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
model inputs for options granted during the reporting periods include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zXaxj4jkHgsd" style="display: none"&gt;Schedule of Model Inputs For Options Granted&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Grant Date&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Term&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Spot Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Share price volatility&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Expected Dividend yield&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;ESOP&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: center"&gt;31 Aug 2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwiW1HJN1MO4" style="width: 8%; text-align: right" title="Exercise price"&gt;0.62&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zDFwX3b0khS7" title="Term"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwC39eLLumH6" style="width: 8%; text-align: right" title="Spot Price"&gt;5.72&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z7vpmOsdVDS2" style="width: 8%; text-align: right" title="Share price volatility"&gt;67.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zGzIQdSMS2Ue" style="width: 8%; text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zbpb4cPW1Oka" style="width: 8%; text-align: right" title="Risk free interest rate"&gt;0.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;31 Aug 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zN9dtrKZISr6" style="text-align: right" title="Exercise price"&gt;5.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zBlwKFxqdSVc" title="Term"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zm7dDir5dXd4" style="text-align: right" title="Exercise price"&gt;5.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z3sq4I7xBfx" style="text-align: right" title="Share price volatility"&gt;67.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zGcNvvUIGB8e" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAeOpglSioy3" style="text-align: right" title="Risk free interest rate"&gt;0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;1 March 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zNl5jIFDc18l" style="text-align: right" title="Exercise price"&gt;0.62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zn7gmENV0T1b" title="Term"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z70HkW9Loazc" style="text-align: right" title="Exercise price"&gt;18.51&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zkI6z7rokWq1" style="text-align: right" title="Share price volatility"&gt;66.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zKsEONNPaa7b" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z1vY07LGRiV2" style="text-align: right" title="Risk free interest rate"&gt;1.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;23 Feb 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zZft4wILXyA8" style="text-align: right" title="Exercise price"&gt;0.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zDCyCkERdntl" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1967"&gt;3.0 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zf75uEmCFXZe" style="text-align: right" title="Exercise price"&gt;5.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zhFc5mcLYgE5" style="text-align: right" title="Share price volatility"&gt;64.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_ztHGl2tNpBLh" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zhXwOzHtxTB2" style="text-align: right" title="Risk free interest rate"&gt;3.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;ADVISOR&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;21 Aug 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zYMipOurz7Ce" style="text-align: right" title="Exercise price"&gt;0.62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zYiQrzB11aO4" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1979"&gt;2.86 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zFPHUSJqn0xh" style="text-align: right" title="Spot Price"&gt;5.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zKH0zpSK8td8" style="text-align: right" title="Share price volatility"&gt;66.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zCE7KYEMdCHj" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zUdufrAhHwWa" style="text-align: right" title="Risk free interest rate"&gt;0.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;21 Aug 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zWn0O9NJtKij" style="text-align: right" title="Exercise price"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zyS8ITAhAVR4" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1991"&gt;2.86 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zyM7LTMrzWo2" style="text-align: right" title="Spot Price"&gt;5.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zhxHmLbKfjw7" style="text-align: right" title="Share price volatility"&gt;66.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zdZWkcAX6486" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zNC2K1gdRyR6" style="text-align: right" title="Risk free interest rate"&gt;0.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;21 Aug 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zwN0GVWippR6" style="text-align: right" title="Exercise price"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zhBZrWaRMKCc" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2003"&gt;4.90 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z8TFcGfj4zdc" style="text-align: right" title="Spot Price"&gt;10.80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zu4xG2uR458i" style="text-align: right" title="Share price volatility"&gt;65.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zuAUfDCcDdlk" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zQVKgHW1k8l9" style="text-align: right" title="Risk free interest rate"&gt;3.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;b&gt;Note 22. Share-based payments - continued&lt;/b&gt; &lt;br/&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;REACH&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: center"&gt;13 Feb 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zZQEtN6Pzct3" style="width: 8%; text-align: right" title="Exercise price"&gt;5.72&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwW1e80gsR66" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2015"&gt;3.30 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_znsVwwLptyL" style="width: 8%; text-align: right" title="Spot Price"&gt;5.72&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zfQrBpTA1u8g" style="width: 8%; text-align: right" title="Share price volatility"&gt;65.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zn5lfo5or8Y2" style="width: 8%; text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zR7Va2ECUpH3" style="width: 8%; text-align: right" title="Risk free interest rate"&gt;3.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;9 June 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zKQSRAJNEPh4" style="text-align: right" title="Exercise price"&gt;6.73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_ztyrLtWrhxek" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2027"&gt;3.15 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zkfOTVCgvvTj" style="text-align: right" title="Spot Price"&gt;6.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAzmPIORftGb" style="text-align: right" title="Share price volatility"&gt;60.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zGZ6o6GNw5El" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z2dTS2bmDgc7" style="text-align: right" title="Risk free interest rate"&gt;3.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; width: 26%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;RSUs&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;10 Oct 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zibSXiBCyBua" style="text-align: right" title="Exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2037"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z5EkOGDVtM9g" title="Term"&gt;3 years&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zGYXz6SpYCNg" style="text-align: right" title="Spot Price"&gt;7.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zZo3vobg82K3" style="text-align: right" title="Expected Dividend yield"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;1 Mar 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAaSYZsNwukf" style="text-align: right" title="Exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2045"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zIxxyPIMTuYd" title="Term"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z4Ki0WrJwBef" style="text-align: right" title="Spot Price"&gt;7.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zwluHli8TD4a" style="text-align: right" title="Expected Dividend yield"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; width: 26%"&gt;Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;27 March 2024 &lt;br/&gt;Over allotment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;span id="xdx_907_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zu5MBbNTMDF2" title="Exercise price"&gt;6.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zUaywUXzRkNf" title="Term"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zjC43O1s1xU" style="text-align: right" title="Spot Price"&gt;5.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zLZAbKVM5Ylg" style="text-align: right" title="Share price volatility"&gt;62.9&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zXUTadKNxa54" style="text-align: right" title="Expected Dividend yield"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z0TGklOTh1X9" style="text-align: right" title="Risk free interest rate"&gt;3.7&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;27 March 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zzoC9o8biOs1" style="text-align: right" title="Exercise price"&gt;5.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zJbilHvygFM6" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2067"&gt;0.12 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z8glpTZU43se" style="text-align: right" title="Spot Price"&gt;5.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zC34yg0pE2J1" style="text-align: right" title="Share price volatility"&gt;46&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zYwsN2oQZuhb" style="text-align: right" title="Expected Dividend yield"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zzLv8qrWEdm3" style="text-align: right" title="Risk free interest rate"&gt;3.7&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zQv9I7UmGjic" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
share-based payment expense of $&lt;span id="xdx_900_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_c20230701__20240630_zEMfU1FcYsij" title="Share-based payment expense"&gt;4,521,598&lt;/span&gt; for the period ended June 30, 2024 ($&lt;span id="xdx_90A_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_c20220701__20230630_zsFF1UkbIxz1" title="Share-based payment expense"&gt;2,365,384&lt;/span&gt; June 30, 2023 and $&lt;span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_c20210701__20220630_zOvxWlqhnKWf" title="Share-based payment expense"&gt;1,546,983&lt;/span&gt; June 30, 2022)
has been recognized in the Consolidated Statement of Profit or Loss and Other Comprehensive Loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact001734"
      unitRef="USDPShares">0.01</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact001736"
      unitRef="USDPShares">6.73</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001738">&lt;p id="xdx_89C_ecustom--DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory_zN7vP3I5GsLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the expense arising from performance rights, options and warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zzlTyOOagvZ9" style="display: none"&gt;Schedule
of Details
of Expense from Performance Rights, Options and Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230701__20240630_zbTNw46nTdP7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220701__20230630_zfHF8YVugIP1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210701__20220630_zdrmwvM8F5qb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants_zsKmtVilZz2l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;ESOP&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,851,329&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,052,245&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;914,682&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ExpenseFromAdvisorOptions_zu5tFb578ita" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Advisor Options (&lt;span id="xdx_F4B_zpQRCuO1gUSj"&gt;1&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,086,938&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,164,524&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;632,301&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ExpenseFromReach_zGGVHWYA6tx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Reach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,584&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;148,615&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1750"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ExpenseFromWarrants_zD48Kq8Z27o5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Warrants (&lt;span id="xdx_F4A_zfSSfVJn8vod"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;253,391&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ExpenseFromOverAllotmentOption_zWWZWEjmo0l8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Over allotment Option (&lt;span id="xdx_F4D_zxKdHZoVn1U3"&gt;3&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;163,794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1757"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ExpenseFromRestrictedShareUnits_zV5Ip81jRSg5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;RSU&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,119,562&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1761"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1762"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--AdjustmentsForSharebasedPayments_zfi1McJs0u3l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total Share based payments&lt;span&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,521,598&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,365,384&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,546,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0F_zfvwNt1Cb1W7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zQbK9VJWeAAb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
                                            that &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20231201__20231231_z1ntXt81TKLc" title="Advisor Options vested and were exercised"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20230701__20230731_zsw5zmqiLNi5" title="Advisor Options vested and were exercised"&gt;327,142&lt;/span&gt;&lt;/span&gt; Advisor Options vested and were exercised into Shares between July 2023 and
                                            December 2023 and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20230701__20230731_zKizMct8TSnl" title="Advisor Options forfeited"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20231201__20231231_zKUJz83i5Z6a" title="Advisor Options forfeited"&gt;16,193&lt;/span&gt;&lt;/span&gt; Advisor Options were forfeited. At June 30, 2024, nil remaining
                                            Advisor Options were on issue.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note 22. Share-based payments - continued &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F09_zjH7gYny6ZK4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zbT7EnCd82F1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
                                            that this expense is pertaining to the issuance of warrants (equating to &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_c20240630_zPVvZcVXmXD9" title="Ordinary Shares on exercise"&gt;65,000&lt;/span&gt; Ordinary
                                            Shares on exercise) to the Underwriter as part of the underwriting agreement. These Warrants
                                            will be exercisable at any time and from time to time, in whole or in part, during the four
                                            and a half year period commencing 180 days from the commencement of sales of the securities
                                            in the Offering, at a price per share equal to &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_ecustom--PricePerShareEqualPercentage_iI_pid_dp_uPure_c20240630_zpx8vpOmpta2" title="Price per share equal percentage"&gt;125.0&lt;/span&gt;% of the public offering price per share
                                            of common stock at the Offering. The issuance acts as additional compensation for ThinkEquity
                                            services that would be rendered over a 24 month period from the Closing of the initial public
                                            offering. As these services vary and are not for a specific service, the fair value of this
                                            allocation cannot be estimated reliably. Thereby, the fair value of these warrants at grant
                                            date were calculated by applying the Black-Scholes model. The Company used valuations specialists
                                            to perform these valuations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F07_z1ExF2q2dkia" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zuG97JGqyOt6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
                                            that this expense is pertaining to the option granted to the underwriter, exercisable within
                                            45 days after the closing of the Offering, to acquire up to an additional 15% of the total
                                            number of Shares to be offered by the company in the offering, solely for the purpose of
                                            covering over-allotments. This over-allotment option essentially granted the underwriter
                                            the right to sell more shares than originally planned if the demand for a security issue
                                            proves higher than expected. The fair value of this service cannot be estimated reliably
                                            as the exercise was subjective on share price performance and/or timing. Thereby, the fair
                                            value of these options at grant date were calculated using the Black-Scholes model. The Company
                                            used valuations specialists to perform these valuations. In addition, please note that these
                                            options have not been exercised and the 45-day limit has expired.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</MMA:DisclosureOfExpenseFromPerformanceRightsOptionsAndwarrantsExplanatory>
    <MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001740"
      unitRef="USD">1851329</MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants>
    <MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001741"
      unitRef="USD">1052245</MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants>
    <MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001742"
      unitRef="USD">914682</MMA:ExpenseFromSharebasedPaymentTransactionsWithEmployeesOptionsAndWarrants>
    <MMA:ExpenseFromAdvisorOptions
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001744"
      unitRef="USD">1086938</MMA:ExpenseFromAdvisorOptions>
    <MMA:ExpenseFromAdvisorOptions
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001745"
      unitRef="USD">1164524</MMA:ExpenseFromAdvisorOptions>
    <MMA:ExpenseFromAdvisorOptions
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001746"
      unitRef="USD">632301</MMA:ExpenseFromAdvisorOptions>
    <MMA:ExpenseFromReach
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001748"
      unitRef="USD">46584</MMA:ExpenseFromReach>
    <MMA:ExpenseFromReach
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001749"
      unitRef="USD">148615</MMA:ExpenseFromReach>
    <MMA:ExpenseFromWarrants
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001752"
      unitRef="USD">253391</MMA:ExpenseFromWarrants>
    <MMA:ExpenseFromOverAllotmentOption
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001756"
      unitRef="USD">163794</MMA:ExpenseFromOverAllotmentOption>
    <MMA:ExpenseFromRestrictedShareUnits
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001760"
      unitRef="USD">1119562</MMA:ExpenseFromRestrictedShareUnits>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001764"
      unitRef="USD">4521598</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001765"
      unitRef="USD">2365384</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001766"
      unitRef="USD">1546983</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="From2023-12-012023-12-31"
      decimals="INF"
      id="Fact001769"
      unitRef="Integer">327142</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="From2023-07-012023-07-31"
      decimals="INF"
      id="Fact001771"
      unitRef="Integer">327142</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-07-012023-07-31"
      decimals="INF"
      id="Fact001773"
      unitRef="Integer">16193</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-12-012023-12-31"
      decimals="INF"
      id="Fact001775"
      unitRef="Integer">16193</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001778"
      unitRef="Shares">65000</ifrs-full:NumberOfSharesIssued>
    <MMA:PricePerShareEqualPercentage
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001780"
      unitRef="Pure">1.250</MMA:PricePerShareEqualPercentage>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001785">&lt;p id="xdx_89B_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_gL3DONAWAEPOS-CCDSRYTS_zLdCoagaqoFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the number of share options outstanding during the year, adjusted to account for the 4-for-5 reverse share split, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zie5q2dMivca" style="display: none"&gt;Schedule
of Share Options Outstanding&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zpIu8TKQSEIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zT0ZdCYCd0Ia" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEL8MFiIDWX8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;ESOP&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zaCuikKPvXwk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Beginning of period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;784,098&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;556,074&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1789"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_ziQ24PRGCSJ2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1791"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;312,886&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;556,074&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zXiJsBu31pIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1795"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(84,862&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1797"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_ziochB4w4CW" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised during the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1799"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1800"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1801"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zy1SwpRnmMj4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;End of the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;784,098&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;784,098&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;556,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zAMLUNedCfVh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zVowqlhaKXa5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--AdvisorMember_zYqWLc91NQT2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Advisor&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--NumberOfOutstandingShareOptions_iS_z1L7ZHhxvQ9a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Beginning of period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;344,055&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;312,362&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1809"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zyEytC2iajIl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1811"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,693&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;312,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zm6UOdWMkotd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,913&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1816"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1817"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_zXT4V55qKwD7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised during the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(327,142&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1820"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1821"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zgIWzJvbFhoe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;End of the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1823"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;344,055&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;312,362&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zslACzMhU9tc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_zLNUsYbj6BM4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_zcGgiBCgAs8c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--ReachMember_z1msQrsCpqO3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Reach&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_z0wnwwZW2c55" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Beginning of period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;45,794&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1828"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zIevBLXCvk17" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1831"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45,794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1833"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zqLlGVnPiBE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1835"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1836"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1837"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zYiK8trvcQJg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised during the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1839"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1840"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1841"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_znAfnnCNqR2i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;End of the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;45,794&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;45,794&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1845"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30F_134_ztGsmADBP6rg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z3gTDnsoHiC6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zSgZzqTQl59h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zv5DPlOD9FAf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;RSU&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zFUkEMCvCeH6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Beginning of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1847"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1848"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1849"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zdO032jRXR19" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;630,729&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1852"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1853"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zmCPQZbZOM3f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1856"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1857"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zOIdtiSw2wH1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised during the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1859"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1860"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1861"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zY0EaKJuuY4l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;End of the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;630,729&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1864"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1865"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in; text-indent: 415.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zlndA609UQXa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zjy79EmtAnMe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zVSEPxvDiP23" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--OverAllotmentOptionsMember_zm40GPRGot73" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Over
Allotment Option&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zZydOI649Ml7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Beginning of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1867"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1868"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1869"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zOaT1nzIB0n2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;195,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1872"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1873"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zeVrQaoAsEEg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(195,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1876"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1877"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zKLkeRxCt1e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Exercised during the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1879"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1880"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1881"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zROkvJPuz1p5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;End of the period&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1883"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1884"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1885"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_302_134_zkdJ4abczpX5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230701__20240630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zVDnI1AIPlq6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220701__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zRvjjm2URI49" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210701__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z4LVeCGloSO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zEHg2LB82Pkj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Beginning of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1887"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1888"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1889"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zd12xeSBVpMc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;65,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1892"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1893"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_zQT8UOdLmZ69" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1895"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1896"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1897"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_zWsGAbE1pg4h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercised during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1899"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1900"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1901"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zXzUnf10OM9g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;End of the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;65,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1904"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1905"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_307_134_zgsdPe6Mub58" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Schedule of Share Options Outstanding (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; font-weight: bold"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230701__20240630_z8wiG2VaH71h" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220701__20230630_zntefkRvtYek" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210701__20220630_zy3dOiDeVKX2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_zMJsBnROtpL1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Total beginning of period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,173,947&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;868,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_zc3ZCu4nKXvg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total granted during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;890,729&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;390,373&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;868,436&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_zckuoh90y0yl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total forfeited/expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(211,913&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(84,862&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1917"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_zsaBm20S1mC1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total exercised during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(327,142&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1920"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1921"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NumberOfOutstandingShareOptions_iE_zEMqyJJkkW36" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Total end of the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,525,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,173,947&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;868,436&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&#160;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact001787"
      unitRef="Shares">784098</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact001788"
      unitRef="Shares">556074</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact001792"
      unitRef="Integer">312886</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact001793"
      unitRef="Integer">556074</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact001796"
      unitRef="Integer">84862</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-06-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact001803"
      unitRef="Integer">784098</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact001804"
      unitRef="Integer">784098</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact001805"
      unitRef="Integer">556074</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_custom_AdvisorMember"
      decimals="INF"
      id="Fact001807"
      unitRef="Integer">344055</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_custom_AdvisorMember"
      decimals="INF"
      id="Fact001808"
      unitRef="Integer">312362</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_custom_AdvisorMember"
      decimals="INF"
      id="Fact001812"
      unitRef="Integer">31693</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30_custom_AdvisorMember"
      decimals="INF"
      id="Fact001813"
      unitRef="Integer">312362</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember"
      decimals="INF"
      id="Fact001815"
      unitRef="Integer">16913</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember"
      decimals="INF"
      id="Fact001819"
      unitRef="Integer">327142</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_custom_AdvisorMember"
      decimals="INF"
      id="Fact001824"
      unitRef="Integer">344055</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30_custom_AdvisorMember"
      decimals="INF"
      id="Fact001825"
      unitRef="Integer">312362</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_custom_ReachMember"
      decimals="INF"
      id="Fact001827"
      unitRef="Shares">45794</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30_custom_ReachMember"
      decimals="INF"
      id="Fact001832"
      unitRef="Integer">45794</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-06-30_custom_ReachMember"
      decimals="INF"
      id="Fact001843"
      unitRef="Integer">45794</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30_custom_ReachMember"
      decimals="INF"
      id="Fact001844"
      unitRef="Integer">45794</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact001851"
      unitRef="Integer">630729</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-06-30_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact001863"
      unitRef="Integer">630729</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_OverAllotmentOptionsMember"
      decimals="INF"
      id="Fact001871"
      unitRef="Integer">195000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_custom_OverAllotmentOptionsMember"
      decimals="INF"
      id="Fact001875"
      unitRef="Integer">195000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001891"
      unitRef="Integer">65000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001903"
      unitRef="Integer">65000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001907"
      unitRef="Shares">1173947</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30"
      decimals="INF"
      id="Fact001908"
      unitRef="Shares">868436</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001911"
      unitRef="Integer">890729</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001912"
      unitRef="Integer">390373</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact001913"
      unitRef="Integer">868436</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001915"
      unitRef="Integer">211913</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001916"
      unitRef="Integer">84862</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001919"
      unitRef="Integer">327142</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001923"
      unitRef="Integer">1525621</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001924"
      unitRef="Integer">1173947</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-06-30"
      decimals="INF"
      id="Fact001925"
      unitRef="Integer">868436</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact001927">&lt;p id="xdx_894_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_zLqMcBhNMhm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
model inputs for options granted during the reporting periods include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zXaxj4jkHgsd" style="display: none"&gt;Schedule of Model Inputs For Options Granted&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Grant Date&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Term&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Spot Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Share price volatility&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Expected Dividend yield&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;ESOP&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: center"&gt;31 Aug 2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwiW1HJN1MO4" style="width: 8%; text-align: right" title="Exercise price"&gt;0.62&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zDFwX3b0khS7" title="Term"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwC39eLLumH6" style="width: 8%; text-align: right" title="Spot Price"&gt;5.72&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z7vpmOsdVDS2" style="width: 8%; text-align: right" title="Share price volatility"&gt;67.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zGzIQdSMS2Ue" style="width: 8%; text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zbpb4cPW1Oka" style="width: 8%; text-align: right" title="Risk free interest rate"&gt;0.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;31 Aug 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zN9dtrKZISr6" style="text-align: right" title="Exercise price"&gt;5.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zBlwKFxqdSVc" title="Term"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zm7dDir5dXd4" style="text-align: right" title="Exercise price"&gt;5.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z3sq4I7xBfx" style="text-align: right" title="Share price volatility"&gt;67.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zGcNvvUIGB8e" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAeOpglSioy3" style="text-align: right" title="Risk free interest rate"&gt;0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;1 March 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zNl5jIFDc18l" style="text-align: right" title="Exercise price"&gt;0.62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zn7gmENV0T1b" title="Term"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z70HkW9Loazc" style="text-align: right" title="Exercise price"&gt;18.51&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zkI6z7rokWq1" style="text-align: right" title="Share price volatility"&gt;66.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zKsEONNPaa7b" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z1vY07LGRiV2" style="text-align: right" title="Risk free interest rate"&gt;1.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;23 Feb 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zZft4wILXyA8" style="text-align: right" title="Exercise price"&gt;0.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zDCyCkERdntl" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1967"&gt;3.0 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zf75uEmCFXZe" style="text-align: right" title="Exercise price"&gt;5.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zhFc5mcLYgE5" style="text-align: right" title="Share price volatility"&gt;64.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_ztHGl2tNpBLh" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--EmployeeStockOwnershipPlanMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesFourMember_zhXwOzHtxTB2" style="text-align: right" title="Risk free interest rate"&gt;3.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;ADVISOR&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;21 Aug 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zYMipOurz7Ce" style="text-align: right" title="Exercise price"&gt;0.62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zYiQrzB11aO4" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1979"&gt;2.86 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zFPHUSJqn0xh" style="text-align: right" title="Spot Price"&gt;5.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zKH0zpSK8td8" style="text-align: right" title="Share price volatility"&gt;66.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zCE7KYEMdCHj" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zUdufrAhHwWa" style="text-align: right" title="Risk free interest rate"&gt;0.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;21 Aug 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zWn0O9NJtKij" style="text-align: right" title="Exercise price"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zyS8ITAhAVR4" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1991"&gt;2.86 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zyM7LTMrzWo2" style="text-align: right" title="Spot Price"&gt;5.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zhxHmLbKfjw7" style="text-align: right" title="Share price volatility"&gt;66.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zdZWkcAX6486" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zNC2K1gdRyR6" style="text-align: right" title="Risk free interest rate"&gt;0.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;21 Aug 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zwN0GVWippR6" style="text-align: right" title="Exercise price"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zhBZrWaRMKCc" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2003"&gt;4.90 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_z8TFcGfj4zdc" style="text-align: right" title="Spot Price"&gt;10.80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zu4xG2uR458i" style="text-align: right" title="Share price volatility"&gt;65.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zuAUfDCcDdlk" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--AdvisorMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesThreeMember_zQVKgHW1k8l9" style="text-align: right" title="Risk free interest rate"&gt;3.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;b&gt;Note 22. Share-based payments - continued&lt;/b&gt; &lt;br/&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;REACH&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: center"&gt;13 Feb 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zZQEtN6Pzct3" style="width: 8%; text-align: right" title="Exercise price"&gt;5.72&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zwW1e80gsR66" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2015"&gt;3.30 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_znsVwwLptyL" style="width: 8%; text-align: right" title="Spot Price"&gt;5.72&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zfQrBpTA1u8g" style="width: 8%; text-align: right" title="Share price volatility"&gt;65.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zn5lfo5or8Y2" style="width: 8%; text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zR7Va2ECUpH3" style="width: 8%; text-align: right" title="Risk free interest rate"&gt;3.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;9 June 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zKQSRAJNEPh4" style="text-align: right" title="Exercise price"&gt;6.73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_ztyrLtWrhxek" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2027"&gt;3.15 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zkfOTVCgvvTj" style="text-align: right" title="Spot Price"&gt;6.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAzmPIORftGb" style="text-align: right" title="Share price volatility"&gt;60.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zGZ6o6GNw5El" style="text-align: right" title="Expected Dividend yield"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ReachMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z2dTS2bmDgc7" style="text-align: right" title="Risk free interest rate"&gt;3.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; width: 26%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;RSUs&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;10 Oct 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zibSXiBCyBua" style="text-align: right" title="Exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2037"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z5EkOGDVtM9g" title="Term"&gt;3 years&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zGYXz6SpYCNg" style="text-align: right" title="Spot Price"&gt;7.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zZo3vobg82K3" style="text-align: right" title="Expected Dividend yield"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;1 Mar 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zAaSYZsNwukf" style="text-align: right" title="Exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2045"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zIxxyPIMTuYd" title="Term"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z4Ki0WrJwBef" style="text-align: right" title="Spot Price"&gt;7.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zwluHli8TD4a" style="text-align: right" title="Expected Dividend yield"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; width: 26%"&gt;Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; width: 10%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 8%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;27 March 2024 &lt;br/&gt;Over allotment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;span id="xdx_907_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zu5MBbNTMDF2" title="Exercise price"&gt;6.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zUaywUXzRkNf" title="Term"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zjC43O1s1xU" style="text-align: right" title="Spot Price"&gt;5.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zLZAbKVM5Ylg" style="text-align: right" title="Share price volatility"&gt;62.9&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_zXUTadKNxa54" style="text-align: right" title="Expected Dividend yield"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesOneMember_z0TGklOTh1X9" style="text-align: right" title="Risk free interest rate"&gt;3.7&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;27 March 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zzoC9o8biOs1" style="text-align: right" title="Exercise price"&gt;5.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--ExpectedTermShareOptionsGranted_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zJbilHvygFM6" title="Term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2067"&gt;0.12 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_z8glpTZU43se" style="text-align: right" title="Spot Price"&gt;5.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zC34yg0pE2J1" style="text-align: right" title="Share price volatility"&gt;46&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zYwsN2oQZuhb" style="text-align: right" title="Expected Dividend yield"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230701__20240630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePricesTwoMember_zzLv8qrWEdm3" style="text-align: right" title="Risk free interest rate"&gt;3.7&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact001929"
      unitRef="USDPShares">0.62</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember"
      id="Fact001931">P3Y</MMA:ExpectedTermShareOptionsGranted>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact001933"
      unitRef="USDPShares">5.72</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact001935"
      unitRef="Pure">0.673</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact001937"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact001939"
      unitRef="Pure">0.002</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact001941"
      unitRef="USDPShares">5.72</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember"
      id="Fact001943">P3Y</MMA:ExpectedTermShareOptionsGranted>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact001945"
      unitRef="USDPShares">5.72</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact001947"
      unitRef="Pure">0.673</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact001949"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact001951"
      unitRef="Pure">0.002</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember"
      decimals="INF"
      id="Fact001953"
      unitRef="USDPShares">0.62</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember"
      id="Fact001955">P3Y</MMA:ExpectedTermShareOptionsGranted>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember"
      decimals="INF"
      id="Fact001957"
      unitRef="USDPShares">18.51</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember"
      decimals="INF"
      id="Fact001959"
      unitRef="Pure">0.664</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember"
      decimals="INF"
      id="Fact001961"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesThreeMember"
      decimals="INF"
      id="Fact001963"
      unitRef="Pure">0.015</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember"
      decimals="INF"
      id="Fact001965"
      unitRef="USDPShares">0.23</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember"
      decimals="INF"
      id="Fact001969"
      unitRef="USDPShares">5.72</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember"
      decimals="INF"
      id="Fact001971"
      unitRef="Pure">0.645</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember"
      decimals="INF"
      id="Fact001973"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_EmployeeStockOwnershipPlanMember_custom_ExercisePricesFourMember"
      decimals="INF"
      id="Fact001975"
      unitRef="Pure">0.036</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact001977"
      unitRef="USDPShares">0.62</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact001981"
      unitRef="USDPShares">5.72</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact001983"
      unitRef="Pure">0.666</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact001985"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact001987"
      unitRef="Pure">0.005</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact001989"
      unitRef="USDPShares">0.01</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact001993"
      unitRef="USDPShares">5.72</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact001995"
      unitRef="Pure">0.666</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact001997"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact001999"
      unitRef="Pure">0.005</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember"
      decimals="INF"
      id="Fact002001"
      unitRef="USDPShares">0.01</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember"
      decimals="INF"
      id="Fact002005"
      unitRef="USDPShares">10.80</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember"
      decimals="INF"
      id="Fact002007"
      unitRef="Pure">0.654</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember"
      decimals="INF"
      id="Fact002009"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_AdvisorMember_custom_ExercisePricesThreeMember"
      decimals="INF"
      id="Fact002011"
      unitRef="Pure">0.030</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002013"
      unitRef="USDPShares">5.72</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002017"
      unitRef="USDPShares">5.72</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002019"
      unitRef="Pure">0.654</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002021"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002023"
      unitRef="Pure">0.035</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002025"
      unitRef="USDPShares">6.73</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002029"
      unitRef="USDPShares">6.12</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002031"
      unitRef="Pure">0.601</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002033"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_custom_ReachMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002035"
      unitRef="Pure">0.038</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesOneMember"
      id="Fact002039">P3Y</MMA:ExpectedTermShareOptionsGranted>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002041"
      unitRef="USDPShares">7.64</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002043"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesTwoMember"
      id="Fact002047">P3Y</MMA:ExpectedTermShareOptionsGranted>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002049"
      unitRef="USDPShares">7.52</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_RestrictedShareUnitsMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002051"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002053"
      unitRef="USDPShares">6.25</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <MMA:ExpectedTermShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember"
      id="Fact002055">P5Y</MMA:ExpectedTermShareOptionsGranted>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002057"
      unitRef="USDPShares">5.00</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002059"
      unitRef="Pure">0.629</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002061"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesOneMember"
      decimals="INF"
      id="Fact002063"
      unitRef="Pure">0.037</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002065"
      unitRef="USDPShares">5.00</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002069"
      unitRef="USDPShares">5.00</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002071"
      unitRef="Pure">0.46</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002073"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-012024-06-30_ifrs-full_WarrantsMember_custom_ExercisePricesTwoMember"
      decimals="INF"
      id="Fact002075"
      unitRef="Pure">0.037</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact002077"
      unitRef="USD">4521598</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact002079"
      unitRef="USD">2365384</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact002081"
      unitRef="USD">1546983</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact002083">&lt;p id="xdx_80F_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_z19gR1T87w8h" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
23. &lt;span id="xdx_825_zsDDXFtwq5Fb"&gt;Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Capital
management&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s objectives when managing share capital, reserves, and accumulated losses, which represents the group&#x2019;s capital,
are to:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 27.2pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;safeguard
                                            their ability to continue as a going concern, so that they can continue to provide returns
                                            for shareholders and benefits for other stakeholders; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 27.2pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;sustain
                                            future product development.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Financial
risk management&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s activities expose it to a variety of financial risks: market risk (primarily currency risk), credit risk, and liquidity
risk. The Company&#x2019;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimise
potential adverse effects on the financial performance of the Group. The Group uses different methods to measure different types of risk
to which it is exposed. These methods include sensitivity analysis in the case of foreign exchange risk and aging analysis for credit
risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
risk management is carried out by the Chief Financial Officer (CFO) and overseen by the Board of Directors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
23. Financial Instruments - continued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Market
Risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Foreign
exchange risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
exchange risk arises when future commercial transactions and recognised assets and liabilities are denominated in a currency that is
not the entity&#x2019;s functional currency. The risk is measured using sensitivity analysis and cash flow forecasting. The Group operates
internationally and is exposed to foreign exchange risk arising primarily from currency exposures to the NZ Dollar, Euro, and US Dollar.&lt;br/&gt;
&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial results are reported in AU dollar and a substantial portion of our operating revenues and expenses are reported
in AU dollar. Revenue and expenses recorded in local currency other that AU dollar are where practical received in to and paid out of
local currency bank accounts mitigating the Company&#x2019;s exposure to foreign currency risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Credit
risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;Credit
risk arises from cash and cash equivalents, derivative financial instruments and deposits with banks and financial institutions, as well
as credit exposures to customers, including outstanding receivables and committed transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has no significant concentrations of credit risk. For banks and financial institutions, only independently rated and reputable
parties are accepted. The Company has policies in place to ensure that sales of products and services are made to customers in advance
of the products and service being provided The maximum exposure to credit risk at the reporting date is the carrying amount of the financial
assets recognised in the statement of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidity
risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liquidity
risk arises from the Company&#x2019;s management of cash and working capital. It is the risk that the Company will encounter difficulty
in meeting its financial obligations as they fall due. The Company&#x2019;s policy is to ensure that it will always have sufficient cash
to allow it to meet its liabilities as and when they fall due. The Company manages its liquidity needs by carefully monitoring scheduled
debt servicing payments for long-term financial liabilities as well as cash-outflows due in day-to-day business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining
contractual maturities&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables detail the Company&#x2019;s remaining contractual maturity for its financial instrument liabilities. The tables have
been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the financial liabilities
are required to be paid. The tables include both interest and principal cash flows disclosed as remaining contractual maturities and
therefore these totals may differ from their carrying amount in the statement of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p id="xdx_899_eifrs-full--MaturityAnalysisForDerivativeFinancialLiabilities_zmqIs3oMerJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zL7ylA6J4bQ5" style="display: none"&gt;Schedule of Contractual Maturities of Financial Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted average interest rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;1 year or less&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Between 1 and 2 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Between 2 and 5 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Remaining contractual maturities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: right"&gt;Consolidated 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: right"&gt;Non - Derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: right"&gt;Non-interest bearing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 35%; text-align: right"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zAGFYhjDxtIb" title="Trade and other payables"&gt;1,991,536&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zjEhDrcI2Wv8" title="Trade and other payables"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zpaaKBwzA6i5" title="Trade and other payables"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20240630_zldy8Z2iyq19" title="Trade and other payables"&gt;1,991,536&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: right"&gt;Interest bearing &#x2013; fixed rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Financial liability &#x2013; host debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageInterestRateFinancialLiability_iI_dp0_c20240630_zuNNjP2RFd9k" title="Financial liability host debt, interest rate"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zssHN2F98Tul" title="Financial liability host debt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_z3t7TJ963uBl" title="Financial liability host debt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z21AJOBZySKi" title="Financial liability host debt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630_z1yiloxkna74" title="Financial liability host debt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;Lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageInterestRateLeaseLiabilities_iI_dp_c20240630_zM1qdZZFqPN" title="Lease liability, interest rate"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zmGKCmZrR8F8" title="Lease liability"&gt;135,680&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zWDbO4mkhAAe" title="Lease liability"&gt;46,240&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zI3hjwTvwQv4" title="Lease liability"&gt;35,267&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestBearingLeaseLiabilities_iI_c20240630_zpg69TbDuLd7" title="Lease liability"&gt;217,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: right; padding-bottom: 1pt"&gt;Total non - derivative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zspTi7iZw5Ia" title="Total non derivative"&gt;2,127,216&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zDOvgUrtcnkd" title="Total non derivative"&gt;46,240&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zhM2wTrcZvgd" title="Total non derivative"&gt;35,267&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestBearingNonderivativesNet_iI_c20240630_zSpfGTsSvth" title="Total non derivative"&gt;2,208,723&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;Derivative liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zY0puwu87v19" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zFOAZPIeeSlj" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z0PZcVQpVV94" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zzyZZwk2JGs3" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: right; padding-bottom: 1pt"&gt;Total Derivative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zJT640jk7xki" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zldH818xG4k5" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zdOlvf57h8pd" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z9FaEzyxcmT3" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted average interest rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;1 year or less&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Between 1 and 2 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Between 2 and 5 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Remaining contractual maturities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: right"&gt;Consolidated 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&#x2019;000&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: right"&gt;Non - Derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: right"&gt;Non-interest bearing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 35%; text-align: right"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_z3gL200IRes6" title="Trade and other payables"&gt;2,034,436&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zrKT3uzobfA5" title="Trade and other payables"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zwqG8zTZpYeb" title="Trade and other payables"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20230630_zFvFouHP9Rpe" title="Trade and other payables"&gt;2,034,436&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: right"&gt;Interest bearing &#x2013; fixed rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Financial liability &#x2013; host debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageInterestRateFinancialLiability_iI_dp_c20230630_zVjE6ivMpZ37" title="Financial liability host debt, interest rate"&gt;9.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zHs72L1Ausz" title="Financial liability host debt"&gt;16,567,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zP3kOTppbBPc" title="Financial liability host debt"&gt;342,406&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zAT19ASuhY9c" title="Financial liability host debt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630_zIEyyFsONtyj" title="Financial liability host debt"&gt;16,909,856&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;Lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_901_ecustom--WeightedAverageInterestRateLeaseLiabilities_iI_dp_c20230630_zojSqwTSq367" title="Lease liability, interest rate"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zhDwAz4unqrh" title="Lease liability"&gt;127,361&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zjer506cwoua" title="Lease liability"&gt;28,214&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zkbLXDcgJUl5" title="Lease liability"&gt;28,214&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--InterestBearingLeaseLiabilities_iI_c20230630_zXaOdmWeiSll" title="Lease liability"&gt;183,789&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: right; padding-bottom: 1pt"&gt;Total non- derivative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zCMf8xnJkdQ5" title="Total non derivative"&gt;18,729,247&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_z8DFT3JIkVm9" title="Total non derivative"&gt;370,620&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zi0xVLG49y3f" title="Total non derivative"&gt;28,214&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestBearingNonderivativesNet_iI_c20230630_z9hiMHw0kdqk" title="Total non derivative"&gt;19,128,081&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: right"&gt;Derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;Derivative liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zcOMTIzqZbGe" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zM6uQnzhAKn3" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zpAyoNrO7S3i" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_ztZ686PwIUTe" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: right; padding-bottom: 1pt"&gt;Total Derivative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zNYDA59I2b86" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zwF3bPnGL0nk" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z7LOudniHYe1" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z4s8KQ3JF9Ef" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_z8FLUolzQ9ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cash flows in the maturity analysis above are not expected to occur significantly earlier than contractually disclosed above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
value estimation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of financial assets and financial liabilities must be estimated for recognition and measurement or for disclosure purposes.
The carrying value less impairment provision of trade receivables and payables are assumed to approximate their fair values due to their
short-term nature. The fair value of financial liabilities approximates their carrying values.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 9.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities contextRef="From2023-07-01to2024-06-30" id="Fact002085">&lt;p id="xdx_899_eifrs-full--MaturityAnalysisForDerivativeFinancialLiabilities_zmqIs3oMerJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zL7ylA6J4bQ5" style="display: none"&gt;Schedule of Contractual Maturities of Financial Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted average interest rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;1 year or less&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Between 1 and 2 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Between 2 and 5 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Remaining contractual maturities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: right"&gt;Consolidated 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: right"&gt;Non - Derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: right"&gt;Non-interest bearing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 35%; text-align: right"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zAGFYhjDxtIb" title="Trade and other payables"&gt;1,991,536&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zjEhDrcI2Wv8" title="Trade and other payables"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zpaaKBwzA6i5" title="Trade and other payables"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20240630_zldy8Z2iyq19" title="Trade and other payables"&gt;1,991,536&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: right"&gt;Interest bearing &#x2013; fixed rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Financial liability &#x2013; host debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageInterestRateFinancialLiability_iI_dp0_c20240630_zuNNjP2RFd9k" title="Financial liability host debt, interest rate"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zssHN2F98Tul" title="Financial liability host debt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_z3t7TJ963uBl" title="Financial liability host debt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z21AJOBZySKi" title="Financial liability host debt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20240630_z1yiloxkna74" title="Financial liability host debt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;Lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageInterestRateLeaseLiabilities_iI_dp_c20240630_zM1qdZZFqPN" title="Lease liability, interest rate"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zmGKCmZrR8F8" title="Lease liability"&gt;135,680&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zWDbO4mkhAAe" title="Lease liability"&gt;46,240&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--InterestBearingLeaseLiabilities_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zI3hjwTvwQv4" title="Lease liability"&gt;35,267&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--InterestBearingLeaseLiabilities_iI_c20240630_zpg69TbDuLd7" title="Lease liability"&gt;217,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: right; padding-bottom: 1pt"&gt;Total non - derivative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zspTi7iZw5Ia" title="Total non derivative"&gt;2,127,216&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zDOvgUrtcnkd" title="Total non derivative"&gt;46,240&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--InterestBearingNonderivativesNet_iI_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zhM2wTrcZvgd" title="Total non derivative"&gt;35,267&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestBearingNonderivativesNet_iI_c20240630_zSpfGTsSvth" title="Total non derivative"&gt;2,208,723&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;Derivative liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zY0puwu87v19" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zFOAZPIeeSlj" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z0PZcVQpVV94" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zzyZZwk2JGs3" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: right; padding-bottom: 1pt"&gt;Total Derivative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zJT640jk7xki" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zldH818xG4k5" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zdOlvf57h8pd" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_905_ecustom--DerivativeNet_iI_d0_c20240630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z9FaEzyxcmT3" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted average interest rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;1 year or less&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Between 1 and 2 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Between 2 and 5 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Remaining contractual maturities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: right"&gt;Consolidated 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;$&#x2019;000&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: right"&gt;Non - Derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: right"&gt;Non-interest bearing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 35%; text-align: right"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_z3gL200IRes6" title="Trade and other payables"&gt;2,034,436&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zrKT3uzobfA5" title="Trade and other payables"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--NonInterestBearingTradeAndOtherPayables_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zwqG8zTZpYeb" title="Trade and other payables"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--NonInterestBearingTradeAndOtherPayables_iI_c20230630_zFvFouHP9Rpe" title="Trade and other payables"&gt;2,034,436&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: right"&gt;Interest bearing &#x2013; fixed rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;Financial liability &#x2013; host debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageInterestRateFinancialLiability_iI_dp_c20230630_zVjE6ivMpZ37" title="Financial liability host debt, interest rate"&gt;9.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zHs72L1Ausz" title="Financial liability host debt"&gt;16,567,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zP3kOTppbBPc" title="Financial liability host debt"&gt;342,406&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zAT19ASuhY9c" title="Financial liability host debt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestBearingFinancialLiabilities_iI_d0_c20230630_zIEyyFsONtyj" title="Financial liability host debt"&gt;16,909,856&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;Lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_901_ecustom--WeightedAverageInterestRateLeaseLiabilities_iI_dp_c20230630_zojSqwTSq367" title="Lease liability, interest rate"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zhDwAz4unqrh" title="Lease liability"&gt;127,361&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zjer506cwoua" title="Lease liability"&gt;28,214&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--InterestBearingLeaseLiabilities_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zkbLXDcgJUl5" title="Lease liability"&gt;28,214&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--InterestBearingLeaseLiabilities_iI_c20230630_zXaOdmWeiSll" title="Lease liability"&gt;183,789&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: right; padding-bottom: 1pt"&gt;Total non- derivative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zCMf8xnJkdQ5" title="Total non derivative"&gt;18,729,247&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_z8DFT3JIkVm9" title="Total non derivative"&gt;370,620&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestBearingNonderivativesNet_iI_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zi0xVLG49y3f" title="Total non derivative"&gt;28,214&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--InterestBearingNonderivativesNet_iI_c20230630_z9hiMHw0kdqk" title="Total non derivative"&gt;19,128,081&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: right"&gt;Derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;Derivative liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zcOMTIzqZbGe" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenOneAndTwoYearsMember_zM6uQnzhAKn3" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_zpAyoNrO7S3i" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--DerivativeFinancialLiabilities_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_ztZ686PwIUTe" title="Derivative liability"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: right; padding-bottom: 1pt"&gt;Total Derivative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zNYDA59I2b86" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zwF3bPnGL0nk" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z7LOudniHYe1" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--DerivativeNet_iI_d0_c20230630__ifrs-full--MaturityAxis__custom--BetweenTwoAndFiveYearsMember_z4s8KQ3JF9Ef" title="Total Derivative"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities>
    <MMA:NonInterestBearingTradeAndOtherPayables
      contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002087"
      unitRef="USD">1991536</MMA:NonInterestBearingTradeAndOtherPayables>
    <MMA:NonInterestBearingTradeAndOtherPayables
      contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002089"
      unitRef="USD">-0</MMA:NonInterestBearingTradeAndOtherPayables>
    <MMA:NonInterestBearingTradeAndOtherPayables
      contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002091"
      unitRef="USD">-0</MMA:NonInterestBearingTradeAndOtherPayables>
    <MMA:NonInterestBearingTradeAndOtherPayables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002093"
      unitRef="USD">1991536</MMA:NonInterestBearingTradeAndOtherPayables>
    <MMA:WeightedAverageInterestRateFinancialLiability
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002095"
      unitRef="Pure">-0</MMA:WeightedAverageInterestRateFinancialLiability>
    <MMA:InterestBearingFinancialLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002097"
      unitRef="USD">-0</MMA:InterestBearingFinancialLiabilities>
    <MMA:InterestBearingFinancialLiabilities
      contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002099"
      unitRef="USD">-0</MMA:InterestBearingFinancialLiabilities>
    <MMA:InterestBearingFinancialLiabilities
      contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002101"
      unitRef="USD">-0</MMA:InterestBearingFinancialLiabilities>
    <MMA:InterestBearingFinancialLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002103"
      unitRef="USD">-0</MMA:InterestBearingFinancialLiabilities>
    <MMA:WeightedAverageInterestRateLeaseLiabilities
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002105"
      unitRef="Pure">0.035</MMA:WeightedAverageInterestRateLeaseLiabilities>
    <MMA:InterestBearingLeaseLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002107"
      unitRef="USD">135680</MMA:InterestBearingLeaseLiabilities>
    <MMA:InterestBearingLeaseLiabilities
      contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002109"
      unitRef="USD">46240</MMA:InterestBearingLeaseLiabilities>
    <MMA:InterestBearingLeaseLiabilities
      contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002111"
      unitRef="USD">35267</MMA:InterestBearingLeaseLiabilities>
    <MMA:InterestBearingLeaseLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002113"
      unitRef="USD">217187</MMA:InterestBearingLeaseLiabilities>
    <MMA:InterestBearingNonderivativesNet
      contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002115"
      unitRef="USD">2127216</MMA:InterestBearingNonderivativesNet>
    <MMA:InterestBearingNonderivativesNet
      contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002117"
      unitRef="USD">46240</MMA:InterestBearingNonderivativesNet>
    <MMA:InterestBearingNonderivativesNet
      contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002119"
      unitRef="USD">35267</MMA:InterestBearingNonderivativesNet>
    <MMA:InterestBearingNonderivativesNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002121"
      unitRef="USD">2208723</MMA:InterestBearingNonderivativesNet>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002123"
      unitRef="USD">-0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002125"
      unitRef="USD">-0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002127"
      unitRef="USD">-0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002129"
      unitRef="USD">-0</ifrs-full:DerivativeFinancialLiabilities>
    <MMA:DerivativeNet
      contextRef="AsOf2024-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002131"
      unitRef="USD">-0</MMA:DerivativeNet>
    <MMA:DerivativeNet
      contextRef="AsOf2024-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002133"
      unitRef="USD">-0</MMA:DerivativeNet>
    <MMA:DerivativeNet
      contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002135"
      unitRef="USD">-0</MMA:DerivativeNet>
    <MMA:DerivativeNet
      contextRef="AsOf2024-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002137"
      unitRef="USD">-0</MMA:DerivativeNet>
    <MMA:NonInterestBearingTradeAndOtherPayables
      contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002139"
      unitRef="USD">2034436</MMA:NonInterestBearingTradeAndOtherPayables>
    <MMA:NonInterestBearingTradeAndOtherPayables
      contextRef="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002141"
      unitRef="USD">-0</MMA:NonInterestBearingTradeAndOtherPayables>
    <MMA:NonInterestBearingTradeAndOtherPayables
      contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002143"
      unitRef="USD">-0</MMA:NonInterestBearingTradeAndOtherPayables>
    <MMA:NonInterestBearingTradeAndOtherPayables
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact002145"
      unitRef="USD">2034436</MMA:NonInterestBearingTradeAndOtherPayables>
    <MMA:WeightedAverageInterestRateFinancialLiability
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact002147"
      unitRef="Pure">0.093</MMA:WeightedAverageInterestRateFinancialLiability>
    <MMA:InterestBearingFinancialLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002149"
      unitRef="USD">16567450</MMA:InterestBearingFinancialLiabilities>
    <MMA:InterestBearingFinancialLiabilities
      contextRef="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002151"
      unitRef="USD">342406</MMA:InterestBearingFinancialLiabilities>
    <MMA:InterestBearingFinancialLiabilities
      contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002153"
      unitRef="USD">-0</MMA:InterestBearingFinancialLiabilities>
    <MMA:InterestBearingFinancialLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact002155"
      unitRef="USD">16909856</MMA:InterestBearingFinancialLiabilities>
    <MMA:WeightedAverageInterestRateLeaseLiabilities
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact002157"
      unitRef="Pure">0.035</MMA:WeightedAverageInterestRateLeaseLiabilities>
    <MMA:InterestBearingLeaseLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002159"
      unitRef="USD">127361</MMA:InterestBearingLeaseLiabilities>
    <MMA:InterestBearingLeaseLiabilities
      contextRef="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002161"
      unitRef="USD">28214</MMA:InterestBearingLeaseLiabilities>
    <MMA:InterestBearingLeaseLiabilities
      contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002163"
      unitRef="USD">28214</MMA:InterestBearingLeaseLiabilities>
    <MMA:InterestBearingLeaseLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact002165"
      unitRef="USD">183789</MMA:InterestBearingLeaseLiabilities>
    <MMA:InterestBearingNonderivativesNet
      contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002167"
      unitRef="USD">18729247</MMA:InterestBearingNonderivativesNet>
    <MMA:InterestBearingNonderivativesNet
      contextRef="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002169"
      unitRef="USD">370620</MMA:InterestBearingNonderivativesNet>
    <MMA:InterestBearingNonderivativesNet
      contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002171"
      unitRef="USD">28214</MMA:InterestBearingNonderivativesNet>
    <MMA:InterestBearingNonderivativesNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact002173"
      unitRef="USD">19128081</MMA:InterestBearingNonderivativesNet>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002175"
      unitRef="USD">-0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-06-30_custom_BetweenOneAndTwoYearsMember"
      decimals="0"
      id="Fact002177"
      unitRef="USD">-0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002179"
      unitRef="USD">-0</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002181"
      unitRef="USD">-0</ifrs-full:DerivativeFinancialLiabilities>
    <MMA:DerivativeNet
      contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002183"
      unitRef="USD">-0</MMA:DerivativeNet>
    <MMA:DerivativeNet
      contextRef="AsOf2023-06-30_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact002185"
      unitRef="USD">-0</MMA:DerivativeNet>
    <MMA:DerivativeNet
      contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002187"
      unitRef="USD">-0</MMA:DerivativeNet>
    <MMA:DerivativeNet
      contextRef="AsOf2023-06-30_custom_BetweenTwoAndFiveYearsMember"
      decimals="0"
      id="Fact002189"
      unitRef="USD">-0</MMA:DerivativeNet>
    <ifrs-full:DisclosureOfAuditorsRemunerationExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact002191">&lt;p id="xdx_80B_eifrs-full--DisclosureOfAuditorsRemunerationExplanatory_zr4PohzpPwI3" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
24. &lt;span id="xdx_821_zNjg5AvMloTe"&gt;Remuneration of auditors&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the financial year the following fees were paid or payable for services provided by BDO Audit Pty Ltd, the auditor of the Company and
its network firms:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory_zXikr6Qpbrn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zRyWnlqB32K1" style="display: none"&gt;Schedule
of Auditor of Company And Network Firms&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230701__20240630_zyiCcR45ncQi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220701__20230630_z0GTml52JB48" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20210701__20220630_zSQQV1q2WU6l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AuditFees_maARzvWE_zoMxcxcCpukl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Audit fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;382,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;200,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;48,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AuditorsRemunerationForRelatedFees_maARzvWE_zy6LK5ZY02q" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Audit &#x2013; related fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;130,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;207,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2201"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AuditorsRemunerationForTaxServices_maARzvWE_z4RJ2TO962s" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2203"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2204"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2205"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--AuditorsRemunerationForOtherServices_maARzvWE_zffeOOzGx6jd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;All other fees&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2207"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2208"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2209"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AuditorsRemuneration_iT_mtARzvWE_zNo5mXFi4NWl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;512,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;407,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zpuBIFsYQq03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfAuditorsRemunerationExplanatory>
    <MMA:DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact002193">&lt;p id="xdx_894_ecustom--DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory_zXikr6Qpbrn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zRyWnlqB32K1" style="display: none"&gt;Schedule
of Auditor of Company And Network Firms&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230701__20240630_zyiCcR45ncQi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220701__20230630_z0GTml52JB48" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20210701__20220630_zSQQV1q2WU6l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AuditFees_maARzvWE_zoMxcxcCpukl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Audit fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;382,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;200,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;48,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AuditorsRemunerationForRelatedFees_maARzvWE_zy6LK5ZY02q" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Audit &#x2013; related fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;130,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;207,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2201"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AuditorsRemunerationForTaxServices_maARzvWE_z4RJ2TO962s" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2203"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2204"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2205"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--AuditorsRemunerationForOtherServices_maARzvWE_zffeOOzGx6jd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;All other fees&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2207"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2208"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2209"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--AuditorsRemuneration_iT_mtARzvWE_zNo5mXFi4NWl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;512,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;407,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</MMA:DisclosureOfInformationAboutRemunerationOfAuditorsExplanatory>
    <MMA:AuditFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact002195"
      unitRef="USD">382000</MMA:AuditFees>
    <MMA:AuditFees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact002196"
      unitRef="USD">200000</MMA:AuditFees>
    <MMA:AuditFees
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact002197"
      unitRef="USD">48000</MMA:AuditFees>
    <MMA:AuditorsRemunerationForRelatedFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact002199"
      unitRef="USD">130000</MMA:AuditorsRemunerationForRelatedFees>
    <MMA:AuditorsRemunerationForRelatedFees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact002200"
      unitRef="USD">207000</MMA:AuditorsRemunerationForRelatedFees>
    <ifrs-full:AuditorsRemuneration
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact002211"
      unitRef="USD">512000</ifrs-full:AuditorsRemuneration>
    <ifrs-full:AuditorsRemuneration
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact002212"
      unitRef="USD">407000</ifrs-full:AuditorsRemuneration>
    <ifrs-full:AuditorsRemuneration
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact002213"
      unitRef="USD">48000</ifrs-full:AuditorsRemuneration>
    <ifrs-full:DisclosureOfContingentLiabilitiesExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact002215">&lt;p id="xdx_803_eifrs-full--DisclosureOfContingentLiabilitiesExplanatory_z0QIU8hGybJ" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
25. &lt;span id="xdx_822_zzlVQ9CIeA67"&gt;Contingent Assets and Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were &lt;span id="xdx_908_ecustom--ContingentAssetsAndLiabilities_iI_do_c20240630_zFdSoxTw3Dw2" title="Contingent assets and liabilities"&gt;no&lt;/span&gt; material contingent assets and liabilities at 30 June 2024 (&lt;span id="xdx_90D_ecustom--ContingentAssetsAndLiabilities_iI_dxL_c20230630_zIe52x9SNw9g" title="Contingent assets and liabilities::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2219"&gt;nil&lt;/span&gt;&lt;/span&gt; &#x2013; 30 June 2023).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 211.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfContingentLiabilitiesExplanatory>
    <MMA:ContingentAssetsAndLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002217"
      unitRef="USD">0</MMA:ContingentAssetsAndLiabilities>
    <ifrs-full:DisclosureOfCommitmentsExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact002221">&lt;p id="xdx_80C_eifrs-full--DisclosureOfCommitmentsExplanatory_zOW6WtARr5X6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
26. &lt;span id="xdx_82B_zXjtrYmRRsx5"&gt;Commitments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has no material Commitments at 30 June 2024 (nil- 30 June 2023).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfCommitmentsExplanatory>
    <ifrs-full:EarningsPerShareExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact002223">&lt;p id="xdx_80D_eifrs-full--EarningsPerShareExplanatory_zbq8YVeo4z09" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
27. &lt;span id="xdx_82C_zGz7VkubTiBj"&gt;Loss per share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eifrs-full--DisclosureOfEarningsPerShareExplanatory_z2gfqV42e5sf" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zfG8VLK2iRZ8" style="display: none"&gt;Schedule
of Loss Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230701__20240630_z5OKycaLQuzh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220701__20230630_zyo6SvBhm3Gh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20210701__20220630_zXACTB5yy1vi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--ProfitLoss_z8mOM71kfIce" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Reconciliation of loss after tax&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(14,408,346&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(20,597,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(11,197,450&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted average number of Ordinary Shares outstanding during the period used in calculating loss per share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_909_eifrs-full--WeightedAverageShares_c20230701__20240630_zqxVKKgyFjbg" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_90E_eifrs-full--AdjustedWeightedAverageShares_c20230701__20240630_zJtY3EvBYG47" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share"&gt;10,267,686&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_907_eifrs-full--WeightedAverageShares_c20220701__20230630_zXpNQlPC7uGe" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_901_eifrs-full--AdjustedWeightedAverageShares_c20220701__20230630_zqdX5ODnil6f" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share"&gt;3,918,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_90A_eifrs-full--WeightedAverageShares_c20210701__20220630_zJUWCLRzmHad" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_900_eifrs-full--AdjustedWeightedAverageShares_c20210701__20220630_zbPAg7HgieJ8" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share"&gt;3,918,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss per share attributable to the owners of Alta Global Group Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_zQrX25DKJi8e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Basic loss per share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.40&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.26&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.86&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--DilutedEarningsLossPerShare_zzWRcAhXdkp9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Diluted loss per share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.40&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.26&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.86&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:EarningsPerShareExplanatory>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact002225">&lt;p id="xdx_894_eifrs-full--DisclosureOfEarningsPerShareExplanatory_z2gfqV42e5sf" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zfG8VLK2iRZ8" style="display: none"&gt;Schedule
of Loss Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230701__20240630_z5OKycaLQuzh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220701__20230630_zyo6SvBhm3Gh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;br/&gt; $&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20210701__20220630_zXACTB5yy1vi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;
                                                                  &lt;p style="margin-top: 0; margin-bottom: 0"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--ProfitLoss_z8mOM71kfIce" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Reconciliation of loss after tax&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(14,408,346&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(20,597,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(11,197,450&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted average number of Ordinary Shares outstanding during the period used in calculating loss per share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_909_eifrs-full--WeightedAverageShares_c20230701__20240630_zqxVKKgyFjbg" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_90E_eifrs-full--AdjustedWeightedAverageShares_c20230701__20240630_zJtY3EvBYG47" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share"&gt;10,267,686&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_907_eifrs-full--WeightedAverageShares_c20220701__20230630_zXpNQlPC7uGe" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_901_eifrs-full--AdjustedWeightedAverageShares_c20220701__20230630_zqdX5ODnil6f" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share"&gt;3,918,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_90A_eifrs-full--WeightedAverageShares_c20210701__20220630_zJUWCLRzmHad" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating basic loss per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvc3MgUGVyIFNoYXJlIChEZXRhaWxzKQA_" id="xdx_900_eifrs-full--AdjustedWeightedAverageShares_c20210701__20220630_zbPAg7HgieJ8" title="Weighted average number of Ordinary Shares outstanding during the period used in calculating diluted loss per share"&gt;3,918,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss per share attributable to the owners of Alta Global Group Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_zQrX25DKJi8e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Basic loss per share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.40&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.26&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.86&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--DilutedEarningsLossPerShare_zzWRcAhXdkp9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Diluted loss per share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.40&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.26&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.86&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:ProfitLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact002227"
      unitRef="USD">-14408346</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact002228"
      unitRef="USD">-20597436</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact002229"
      unitRef="USD">-11197450</ifrs-full:ProfitLoss>
    <ifrs-full:WeightedAverageShares
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact002231"
      unitRef="Shares">10267686</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact002233"
      unitRef="Shares">10267686</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact002235"
      unitRef="Shares">3918750</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact002237"
      unitRef="Shares">3918750</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact002239"
      unitRef="Shares">3918750</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact002241"
      unitRef="Shares">3918750</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact002243"
      unitRef="USDPShares">-1.40</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact002244"
      unitRef="USDPShares">-5.26</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact002245"
      unitRef="USDPShares">-2.86</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact002247"
      unitRef="USDPShares">-1.40</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact002248"
      unitRef="USDPShares">-5.26</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact002249"
      unitRef="USDPShares">-2.86</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="From2023-07-01to2024-06-30" id="Fact002251">&lt;p id="xdx_80E_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zJrL28D0u9f9" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
28. &lt;span id="xdx_82A_zy2qSiVgkG6g"&gt;Events after the reporting period&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2024, at the discretion of the Board under the Company&#x2019;s Employee Incentive Plan (EIP), &lt;span id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20240701__20240731__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zU4wO7MWG1Ji" title="Vested and convertible shares"&gt;40,000&lt;/span&gt; share rights have fully vested
and converted into Ordinary Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2024, various employees and consultants were issued an aggregate of &lt;span id="xdx_904_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20240901__20240930__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zrFFaZd90yf6" title="Vested and convertible shares"&gt;139,500&lt;/span&gt; share rights (subject to vesting conditions) which
may be converted into Ordinary Shares under the Company&#x2019;s Employee Incentive Plan. All share rights granted will vest and become
exercisable in three tranches between May 2025 and August 2027.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2024, we announced a revenue share agreement with UFC Gym, LLC in relation to the intention of rolling out the Warrior Training
Program and Hype across UFC Gym&#x2019;s global network of gyms, consisting of both corporate owned locations and franchises (with over
150 locations in 40 countries, including 80 in the United States) (&#x201c;UFC Group&#x201d;). In the initial phase, these programs will
be introduced in locations across the US, the Middle East, the UK, Germany, Mexico, India and Central Asia. The revenue from the Warrior
Training Program is shared, with the UFC Group receiving 70% and the Company receiving 30%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2024, Conor McGregor was appointed as a global ambassador (&#x201c;Ambassador Agreement&#x201d;) and will provide services customarily
associated with such roles for a company in the mixed martial arts and technology sector (&#x201c;Services&#x201d;). The term of the Ambassador
Agreement shall be effective for three years and either party may terminate the agreement upon 10 days prior written notice if the other
party breaches the agreement and does not cure such breach within such time period. &lt;span id="xdx_903_eifrs-full--DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_c20240901__20240930__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CounterpartiesAxis__custom--MrMcGregorMember_z8ovFbOfBNKd" title="Description of contracts shares"&gt;In consideration for providing these Services under
the Ambassador Agreement, and pursuant to the exemption from registration provided for in Regulation S promulgated under the Securities
Act, Mr. McGregor received 700,000 performance share rights that will vest once the 30-day volume-weighted average price (VWAP) achieves
the following trigger: 150,000 shares on execution of the Ambassador Agreement; 100,000 shares when the share price reaches $7.50; 150,000
shares when the share price reaches $10.00; 150,000 shares when the share price reaches $15.00 and 150,000 shares when the share price
reaches $20.00. Aligned with the three (3) year term of the Ambassador Agreement, Mr. McGregor is restricted from selling shares within
three (3) years of issuance unless specific conditions are met, such as the Company&#x2019;s written consent, a sale or liquidation of
the Company, or if the Company breaches the agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="From2024-07-012024-07-31_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact002253"
      unitRef="Integer">40000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="From2024-09-012024-09-30_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact002255"
      unitRef="Integer">139500</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares
      contextRef="From2024-09-012024-09-30_custom_NonadjustingEventMember_custom_MrMcGregorMember"
      id="Fact002257">In consideration for providing these Services under
the Ambassador Agreement, and pursuant to the exemption from registration provided for in Regulation S promulgated under the Securities
Act, Mr. McGregor received 700,000 performance share rights that will vest once the 30-day volume-weighted average price (VWAP) achieves
the following trigger: 150,000 shares on execution of the Ambassador Agreement; 100,000 shares when the share price reaches $7.50; 150,000
shares when the share price reaches $10.00; 150,000 shares when the share price reaches $15.00 and 150,000 shares when the share price
reaches $20.00. Aligned with the three (3) year term of the Ambassador Agreement, Mr. McGregor is restricted from selling shares within
three (3) years of issuance unless specific conditions are met, such as the Company&#x2019;s written consent, a sale or liquidation of
the Company, or if the Company breaches the agreement.</ifrs-full:DescriptionOfTermsOfSharesReservedForIssueUnderOptionsAndContractsForSaleOfShares>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#xdx2ixbrl0614"
          xlink:label="xdx2ixbrl0614"
          xlink:type="locator"/>
        <link:footnote id="Footnote000633" xlink:label="Footnote000633" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company will continue
                                                                                                                                                              to apply for the Research and Development incentive as long as it continues to be eligible and will conduct eligible research and
                                                                                                                                                              development activities. The applicable legislation that governs the eligibility to participate in the R&amp;D incentive program is
                                                                                                                                                              Division 355 of the Income Tax Assessment Act 1997 (ITAA 1997). The FY 2024 Research and Development incentive will be applied for
                                                                                                                                                              on lodging of the FY 2024 tax return with the Australian Tax Office and recognised once reasonable assurance that the Company will
                                                                                                                                                              comply with the conditions and that the grants will be received.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0614"
          xlink:to="Footnote000633"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000615"
          xlink:label="Fact000615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000615"
          xlink:to="Footnote000633"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0616"
          xlink:label="xdx2ixbrl0616"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0616"
          xlink:to="Footnote000633"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001122"
          xlink:label="Fact001122"
          xlink:type="locator"/>
        <link:footnote id="Footnote001133" xlink:label="Footnote001133" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Included in additions
is acquired intangible assets of:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001122"
          xlink:to="Footnote001133"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1123"
          xlink:label="xdx2ixbrl1123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1123"
          xlink:to="Footnote001133"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001228"
          xlink:label="Fact001228"
          xlink:type="locator"/>
        <link:footnote id="Footnote001251" xlink:label="Footnote001251" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
                                            January 24, 2024, there was a reverse share split of our issued and outstanding Ordinary
                                            Shares and Ordinary Share equivalents on the basis of four (4) securities for every five
                                            (5) securities held. All issued and outstanding Ordinary Shares and Ordinary Share equivalents
                                            and per share data have been adjusted throughout the financial statements to reflect the
                                            reverse share split for all periods presented.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001228"
          xlink:to="Footnote001251"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001229"
          xlink:label="Fact001229"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001229"
          xlink:to="Footnote001251"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001230"
          xlink:label="Fact001230"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001230"
          xlink:to="Footnote001251"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001240"
          xlink:label="Fact001240"
          xlink:type="locator"/>
        <link:footnote id="Footnote001252" xlink:label="Footnote001252" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
                                            issue of shares from the conversion of convertible notes reflects and includes the face value
                                            of the note and interest accrued at a fixed rate defined in the agreements, along with the
                                            value of the derivative prior to conversion. This interest figure includes both the accrued
                                            interest rate (contractual and effective) relating to the convertible notes, with the contractual
                                            capitalised interest rate ranging between <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_902_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLfugi4sxe0j"
  title="Contractual capitalised interest rate">8.5</xhtml:span>% to <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_90B_ecustom--ContractualCapitalisedInterestRate_iI_pid_dp_uPure_c20240630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_za6aLsj3gMFg"
  title="Contractual capitalised interest rate">15</xhtml:span>% per annum, and the derivative reflects the effective interest rate being the cost of the relevant conversion discounts to market value at
the conversion date.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001240"
          xlink:to="Footnote001252"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1241"
          xlink:label="xdx2ixbrl1241"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1241"
          xlink:to="Footnote001252"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1242"
          xlink:label="xdx2ixbrl1242"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1242"
          xlink:to="Footnote001252"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001244"
          xlink:label="Fact001244"
          xlink:type="locator"/>
        <link:footnote id="Footnote001257" xlink:label="Footnote001257" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Note
                                            that <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_905_ecustom--AdvisorOptionsExercisedShares_c20230701__20240630_zL4BG4Y3jk25"
  title="Advisor options exercised, shares">327,142</xhtml:span> Advisor Options fully vested and were exercised into Shares between July 2023
                                            and December 2023 and <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIElzc3VlZCBDYXBpdGFsIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_901_ecustom--AdvisorOptionsForfeitedShares_iI_c20240630_z7hRoX7U4kUl"
  title="Advisor options forfeited, shares">16,193</xhtml:span> Advisor Options were forfeited.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001244"
          xlink:to="Footnote001257"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1245"
          xlink:label="xdx2ixbrl1245"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1245"
          xlink:to="Footnote001257"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1246"
          xlink:label="xdx2ixbrl1246"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1246"
          xlink:to="Footnote001257"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001484"
          xlink:label="Fact001484"
          xlink:type="locator"/>
        <link:footnote id="Footnote001500" xlink:label="Footnote001500" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Entities deregistered
in the period to June 30, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001484"
          xlink:to="Footnote001500"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001485"
          xlink:label="Fact001485"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001485"
          xlink:to="Footnote001500"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001486"
          xlink:label="Fact001486"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001486"
          xlink:to="Footnote001500"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001487"
          xlink:label="Fact001487"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001487"
          xlink:to="Footnote001500"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001488"
          xlink:label="Fact001488"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001488"
          xlink:to="Footnote001500"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001489"
          xlink:label="Fact001489"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001489"
          xlink:to="Footnote001500"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001490"
          xlink:label="Fact001490"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001490"
          xlink:to="Footnote001500"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001491"
          xlink:label="Fact001491"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001491"
          xlink:to="Footnote001500"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001678"
          xlink:label="Fact001678"
          xlink:type="locator"/>
        <link:footnote id="Footnote001683" xlink:label="Footnote001683" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">$<xhtml:span
  id="xdx_90A_ecustom--ReachConvertibleNote_iI_c20230609_zjH8cFvlAAXd"
  title="Reach convertible note">3,025,841</xhtml:span> of Reach convertible
  notes, inclusive of accrued interest, were rolled into the Private Placement on June 9, 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001678"
          xlink:to="Footnote001683"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001674"
          xlink:label="Fact001674"
          xlink:type="locator"/>
        <link:footnote id="Footnote001686" xlink:label="Footnote001686" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">$<xhtml:span
  id="xdx_905_ecustom--RedeemedForCash_iI_c20230609_zCA5HXL5Vhw9"
  title="Redeemed for cash">1,029,617</xhtml:span> was redeemed for
  cash, the remaining Reach notes were converted to equity.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001674"
          xlink:to="Footnote001686"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001744"
          xlink:label="Fact001744"
          xlink:type="locator"/>
        <link:footnote id="Footnote001767" xlink:label="Footnote001767" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Note
                                            that <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_90F_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20231201__20231231_z1ntXt81TKLc"
  title="Advisor Options vested and were exercised"><xhtml:span
      class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
      id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_c20230701__20230731_zsw5zmqiLNi5"
      title="Advisor Options vested and were exercised">327,142</xhtml:span></xhtml:span> Advisor Options vested and were exercised into Shares between July 2023 and
                                            December 2023 and <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_90D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20230701__20230731_zKizMct8TSnl"
  title="Advisor Options forfeited"><xhtml:span
      class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
      id="xdx_903_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20231201__20231231_zKUJz83i5Z6a"
      title="Advisor Options forfeited">16,193</xhtml:span></xhtml:span> Advisor Options were forfeited. At June 30, 2024, nil remaining
                                            Advisor Options were on issue.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001744"
          xlink:to="Footnote001767"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001745"
          xlink:label="Fact001745"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001745"
          xlink:to="Footnote001767"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001746"
          xlink:label="Fact001746"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001746"
          xlink:to="Footnote001767"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001752"
          xlink:label="Fact001752"
          xlink:type="locator"/>
        <link:footnote id="Footnote001776" xlink:label="Footnote001776" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Note
                                            that this expense is pertaining to the issuance of warrants (equating to <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_c20240630_zPVvZcVXmXD9"
  title="Ordinary Shares on exercise">65,000</xhtml:span> Ordinary
                                            Shares on exercise) to the Underwriter as part of the underwriting agreement. These Warrants
                                            will be exercisable at any time and from time to time, in whole or in part, during the four
                                            and a half year period commencing 180 days from the commencement of sales of the securities
                                            in the Offering, at a price per share equal to <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIERldGFpbHMgb2YgRXhwZW5zZSBmcm9tIFBlcmZvcm1hbmNlIFJpZ2h0cywgT3B0aW9ucyBhbmQgV2FycmFudHMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"
  id="xdx_905_ecustom--PricePerShareEqualPercentage_iI_pid_dp_uPure_c20240630_zpx8vpOmpta2"
  title="Price per share equal percentage">125.0</xhtml:span>% of the public offering price per share
                                            of common stock at the Offering. The issuance acts as additional compensation for ThinkEquity
                                            services that would be rendered over a 24 month period from the Closing of the initial public
                                            offering. As these services vary and are not for a specific service, the fair value of this
                                            allocation cannot be estimated reliably. Thereby, the fair value of these warrants at grant
                                            date were calculated by applying the Black-Scholes model. The Company used valuations specialists
                                            to perform these valuations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001752"
          xlink:to="Footnote001776"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1753"
          xlink:label="xdx2ixbrl1753"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1753"
          xlink:to="Footnote001776"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1754"
          xlink:label="xdx2ixbrl1754"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1754"
          xlink:to="Footnote001776"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001756"
          xlink:label="Fact001756"
          xlink:type="locator"/>
        <link:footnote id="Footnote001781" xlink:label="Footnote001781" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Note
                                            that this expense is pertaining to the option granted to the underwriter, exercisable within
                                            45 days after the closing of the Offering, to acquire up to an additional 15% of the total
                                            number of Shares to be offered by the company in the offering, solely for the purpose of
                                            covering over-allotments. This over-allotment option essentially granted the underwriter
                                            the right to sell more shares than originally planned if the demand for a security issue
                                            proves higher than expected. The fair value of this service cannot be estimated reliably
                                            as the exercise was subjective on share price performance and/or timing. Thereby, the fair
                                            value of these options at grant date were calculated using the Black-Scholes model. The Company
                                            used valuations specialists to perform these valuations. In addition, please note that these
                                            options have not been exercised and the 45-day limit has expired.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001756"
          xlink:to="Footnote001781"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1757"
          xlink:label="xdx2ixbrl1757"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1757"
          xlink:to="Footnote001781"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1758"
          xlink:label="xdx2ixbrl1758"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1758"
          xlink:to="Footnote001781"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
